PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Darnill, S; Gamage, B				Darnill, Stephanie; Gamage, Bernadette			The patient's journey: palliative care - a parent's view	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Paediat Palliat Care, Lifeforce Team, London NW1 0PE, England		Gamage, B (corresponding author), Paediat Palliat Care, Lifeforce Team, London NW1 0PE, England.	bernigamage@hotmail.com							0	7	8	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2006	332	7556					1494	1495		10.1136/bmj.332.7556.1494	http://dx.doi.org/10.1136/bmj.332.7556.1494			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	060RV	16793812	Green Published			2022-12-24	WOS:000238820200020
J	Sheth, U; Parker, R				Sheth, Ujwal; Parker, Roy			Targeting of aberrant mRNAs to cytoplasmic processing bodies	CELL			English	Article							NONSENSE-MEDIATED DECAY; ENDONUCLEOLYTIC CLEAVAGE; YEAST; TRANSLATION; DEGRADATION; UPF1P; SURVEILLANCE; TERMINATION; IDENTIFICATION; DEADENYLATION	In eukaryotes, a specialized pathway of mRNA degradation termed nonsense-mediated decay (NMD) functions in mRNA quality control by recognizing and degrading mRNAs with aberrant termination codons. We demonstrate that NMD in yeast targets premature termination codon (PTC)-containing mRNA to P-bodies. Upf1p is sufficient for targeting mRNAs to P-bodies, whereas Upf2p and Upf3p act, at least in part, downstream of P-body targeting to trigger decapping. The ATPase activity of Upf1p is required for NMD after the targeting of mRNAs to P-bodies. Moreover, Upf1p can target normal mRNAs to P-bodies but not promote their degradation. These observations lead us to propose a new model for NMD wherein two successive steps are used to distinguish normal and aberrant mRNAs.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, Howard Hughes Med Inst, Tucson, AZ 85721 USA	University of Arizona; Howard Hughes Medical Institute; University of Arizona	Sheth, U (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	rrparker@email.arizona.edu			NIGMS NIH HHS [R01 GM045443, R37 GM045443, GM45443] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045443, R01GM045443] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; ATKIN AL, 1995, MOL BIOL CELL, V6, P611; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Beelman CA, 1996, NATURE, V382, P642, DOI 10.1038/382642a0; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Boeck R, 1998, MOL CELL BIOL, V18, P5062, DOI 10.1128/MCB.18.9.5062; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brodsky AS, 2000, RNA, V6, P1737, DOI 10.1017/S1355838200001059; Buhler M, 2006, NAT STRUCT MOL BIOL, V13, P462, DOI 10.1038/nsmb1081; Cao D, 2003, CELL, V113, P533, DOI 10.1016/S0092-8674(03)00353-2; Chen CYA, 2003, MOL CELL BIOL, V23, P4805, DOI 10.1128/MCB.23.14.4805-4813.2003; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Culbertson MR, 2003, CURR OPIN GENET DEV, V13, P207, DOI 10.1016/S0959-437X(03)00014-5; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039; Fukuhara N, 2005, MOL CELL, V17, P537, DOI 10.1016/j.molcel.2005.01.010; Gatfield D, 2004, NATURE, V429, P575, DOI 10.1038/nature02559; Gonzalez CI, 2000, MOL CELL, V5, P489, DOI 10.1016/S1097-2765(00)80443-8; He F, 2001, MOL CELL BIOL, V21, P1515, DOI 10.1128/MCB.21.5.1515-1530.2001; HE F, 1993, P NATL ACAD SCI USA, V90, P7034, DOI 10.1073/pnas.90.15.7034; Hilleren P, 1999, ANNU REV GENET, V33, P229, DOI 10.1146/annurev.genet.33.1.229; Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kshirsagar M, 2004, GENETICS, V166, P729, DOI 10.1534/genetics.166.2.729; Lejeune F, 2003, MOL CELL, V12, P675, DOI 10.1016/S1097-2765(03)00349-6; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Maderazo AB, 2000, MOL CELL BIOL, V20, P4591, DOI 10.1128/MCB.20.13.4591-4603.2000; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Mitchell P, 2003, MOL CELL, V11, P1405, DOI 10.1016/S1097-2765(03)00190-4; MUHLRAD D, 1994, NATURE, V370, P578, DOI 10.1038/370578a0; Muhlrad D, 1999, MOL BIOL CELL, V10, P3971, DOI 10.1091/mbc.10.11.3971; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Page MF, 1999, MOL CELL BIOL, V19, P5943; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Shirley RL, 1998, J CELL SCI, V111, P3129; Stevens A, 2002, P NATL ACAD SCI USA, V99, P12741, DOI 10.1073/pnas.192442399; Takahashi S, 2003, EMBO J, V22, P3951, DOI 10.1093/emboj/cdg374; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Unterholzner L, 2004, MOL CELL, V16, P587, DOI 10.1016/j.molcel.2004.10.013; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; Weng YM, 1996, MOL CELL BIOL, V16, P5477; Zhang J, 1998, RNA, V4, P801, DOI 10.1017/S1355838298971849	47	226	232	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2006	125	6					1095	1109		10.1016/j.cell.2006.04.037	http://dx.doi.org/10.1016/j.cell.2006.04.037			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777600	Bronze, Green Accepted			2022-12-24	WOS:000238602700015
J	Allen, SA				Allen, SA			Dining with Wilkey	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material													Allen, Scott/D-2403-2015	Allen, Scott/0000-0001-8815-4714					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2006	295	22					2583	2584		10.1001/jama.295.22.2583	http://dx.doi.org/10.1001/jama.295.22.2583			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HI	16772612				2022-12-24	WOS:000238224000001
J	Ong, MEH; Ornato, JP; Edwards, DP; Dhindsa, HS; Best, AM; Ines, CS; Hickey, S; Clark, B; Williams, DC; Powell, RG; Overton, JL; Peberdy, MA				Ong, Marcus Eng Hock; Ornato, Joseph P.; Edwards, David P.; Dhindsa, Harinder S.; Best, Al M.; Ines, Caesar S.; Hickey, Scott; Clark, Bryan; Williams, Dean C.; Powell, Robert G.; Overton, Jerry L.; Peberdy, Mary Ann			Use of an automated, load-distributing band chest compression device for out-of-hospital cardiac arrest resuscitation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMERICAN-HEART-ASSOCIATION; PROLONGED CARDIOPULMONARY-RESUSCITATION; INTERNATIONAL LIAISON COMMITTEE; CORONARY PERFUSION-PRESSURE; HEALTH-CARE PROFESSIONALS; VENTRICULAR-FIBRILLATION; STROKE-FOUNDATION; TASK-FORCE; RECOMMENDED GUIDELINES; MYOCARDIAL PERFUSION	Context Only 1% to 8% of adults with out-of-hospital cardiac arrest survive to hospital discharge. Objective To compare resuscitation outcomes before and after an urban emergency medical services ( EMS) system switched from manual cardiopulmonary resuscitation ( CPR) to load-distributing band ( LDB) CPR. Design, Setting, and Patients A phased, observational cohort evaluation with intention-to-treat analysis of 783 adults with out-of-hospital, nontraumatic cardiac arrest. A total of 499 patients were included in the manual CPR phase ( January 1, 2001, to March 31, 2003) and 284 patients in the LDB-CPR phase ( December 20, 2003, to March 31, 2005); of these patients, the LDB device was applied in 210 patients. Intervention Urban EMS system change from manual CPR to LDB-CPR. Main Outcome Measures Return of spontaneous circulation ( ROSC), with secondary outcome measures of survival to hospital admission and hospital discharge, and neurological outcome at discharge. Results Patients in the manual CPR and LDB-CPR phases were comparable except for a faster response time interval ( mean difference, 26 seconds) and more EMS-witnessed arrests ( 18.7% vs 12.6%) with LDB. Rates for ROSC and survival were increased with LDB-CPR compared with manual CPR ( for ROSC, 34.5%; 95% confidence interval [ CI], 29.2%-40.3% vs 20.2%; 95% CI, 16.9%-24.0%; adjusted odds ratio [ OR], 1.94; 95% CI, 1.38-2.72; for survival to hospital admission, 20.9%; 95% CI, 16.6%-26.1% vs 11.1%; 95% CI, 8.6%-14.2%; adjusted OR, 1.88; 95% CI, 1.23-2.86; and for survival to hospital discharge, 9.7%; 95% CI, 6.7%-13.8% vs 2.9%; 95% CI, 1.7%-4.8%; adjusted OR, 2.27; 95% CI, 1.11-4.77). In secondary analysis of the 210 patients in whom the LDB device was applied, 38 patients ( 18.1%) survived to hospital admission ( 95% CI, 13.4%-23.9%) and 12 patients ( 5.7%) survived to hospital discharge ( 95% CI, 3.0%9.3%). Among patients in the manual CPR and LDB-CPR groups who survived to hospital discharge, there was no significant difference between groups in Cerebral Performance Category ( P=. 36) or Overall Performance Category ( P=. 40). The number needed to treat for the adjusted outcome survival to discharge was 15 ( 95% CI, 9-33). Conclusion Compared with resuscitation using manual CPR, a resuscitation strategy using LDB-CPR on EMS ambulances is associated with improved survival to hospital discharge in adults with out-of-hospital nontraumatic cardiac arrest.	Virginia Commonwealth Univ, Dept Epidemiol & Community Hlth, Richmond, VA 23284 USA; Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23284 USA; Virginia Commonwealth Univ Hlth Syst, Dept Emergency Med, Richmond, VA USA; Virginia Commonwealth Univ Hlth Syst, Dept Internal Med, Div Cardiol, Richmond, VA USA; Virginia Commonwealth Univ Hlth Syst, Dept Emergency Med, Richmond, VA USA; Virginia Commonwealth Univ Hlth Syst, Virginia Commonwealth Univ Reanimat Engn & Shock, Richmond, VA USA; Richmond Ambulance Author, Richmond, VA USA; Chippenham & Johnston Willis Hosp, Dept Emergency Med, Richmond, VA USA; Richmond Community Hosp, Dept Emergency Med, Richmond, VA USA; St Marys Hosp, Dept Emergency Med, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Ornato, JP (corresponding author), Virginia Commonwealth Univ, Med Ctr, Dept Emergency Med, 1250E Marshall St,2nd Floor, Richmond, VA 23298 USA.	ornato@aol.com	Best, Al/F-6425-2012	Best, Al/0000-0002-6300-3925				Abella BS, 2005, JAMA-J AM MED ASSOC, V293, P305, DOI 10.1001/jama.293.3.305; Abella BS, 2005, CIRCULATION, V111, P428, DOI 10.1161/01.CIR.0000153811.84257.59; BECKER LB, 1991, ANN EMERG MED, V20, P355, DOI 10.1016/S0196-0644(05)81654-3; BECKER LB, 1993, ANN EMERG MED, V22, P86, DOI 10.1016/S0196-0644(05)80257-4; Caffrey SL, 2002, NEW ENGL J MED, V347, P1242, DOI 10.1056/NEJMoa020932; Casner Michael, 2005, Prehosp Emerg Care, V9, P61, DOI 10.1080/10903120590891714; Cobb LA, 1999, JAMA-J AM MED ASSOC, V281, P1182, DOI 10.1001/jama.281.13.1182; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; CUMMINS RO, 1991, ANN EMERG MED, V20, P861; Eftestol T, 2004, CIRCULATION, V110, P10, DOI 10.1161/01.CIR.0000133323.15565.75; EISENBERG MS, 1990, ANN EMERG MED, V19, P179, DOI 10.1016/S0196-0644(05)81805-0; Hallstrom AP, 2004, NEW ENGL J MED, V351, P637; HALPERIN HR, 1993, NEW ENGL J MED, V329, P762, DOI 10.1056/NEJM199309093291104; Halperin HR, 2002, CIRCULATION, V106, P538; HALPERIN HR, 1986, CIRCULATION, V74, P1407, DOI 10.1161/01.CIR.74.6.1407; Jacobs I, 2004, RESUSCITATION, V63, P233, DOI 10.1016/j.resuscitation.2004.09.008; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; KELSEY SF, 1991, CONTROL CLIN TRIALS, V12, P525; KERN KB, 1988, RESUSCITATION, V16, P241, DOI 10.1016/0300-9572(88)90111-6; Kern KB, 2000, BAILLIERE CLIN ANAES, V14, P591; LOMBARDI G, 1994, JAMA-J AM MED ASSOC, V271, P678; MCDONALD JL, 1983, ANN EMERG MED, V12, P144; MICHAEL JR, 1984, CIRCULATION, V69, P822, DOI 10.1161/01.CIR.69.4.822; OMATO JP, 2003, RESUSCITATION, V56, P135; PARADIS NA, 1990, JAMA-J AM MED ASSOC, V263, P1106, DOI 10.1001/jama.263.8.1106; RALSTON SH, 1984, ANN EMERG MED, V13, P79, DOI 10.1016/S0196-0644(84)80566-1; SANDERS AB, 1985, AM J EMERG MED, V3, P11, DOI 10.1016/0735-6757(85)90003-8; SANDERS AB, 1984, CRIT CARE MED, V12, P871, DOI 10.1097/00003246-198410000-00007; Timerman S, 2004, RESUSCITATION, V61, P273, DOI 10.1016/j.resuscitation.2004.01.025; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; Weisfeldt ML, 2002, JAMA-J AM MED ASSOC, V288, P3035, DOI 10.1001/jama.288.23.3035; White RD, 1998, RESUSCITATION, V39, P145, DOI 10.1016/S0300-9572(98)00135-X; Wik L, 2005, JAMA-J AM MED ASSOC, V293, P299, DOI 10.1001/jama.293.3.299; Wik L, 2003, JAMA-J AM MED ASSOC, V289, P1389, DOI 10.1001/jama.289.11.1389; WOLFE JA, 1988, J THORAC CARDIOV SUR, V95, P523; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	36	164	180	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2006	295	22					2629	2637		10.1001/jama.295.22.2629	http://dx.doi.org/10.1001/jama.295.22.2629			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HI	16772626	Bronze			2022-12-24	WOS:000238224000025
J	Birkhead, J; Weston, C; Lowe, D				Birkhead, John; Weston, Clive; Lowe, Derek		MINAP Steering Grp	Impact of specialty of admitting physician and type of hospital on care and outcome for myocardial infarction in England and Wales during 2004-5: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE CORONARY SYNDROMES; ELDERLY-PATIENTS; MANAGEMENT	Objective To examine process of care and outcome for patients admitted with acute myocardial infarction to hospitals in England and Wales in relation to type of consultant care and type of hospital. Design Observational study of 88 782 patients admitted with myocardial infarction during 2004-5, using records from the national audit of myocardial infarction project (MINAP) database. Outcome measures Use of reperfusion treatment and secondary prevention drugs, use of angiography, and 90 day mortality of patients admitted under the care of cardiologists and non-cardiologists in hospitals with and without facilities for coronary intervention. Findings 36% of patients were admitted under the care of a cardiologist and 20% to a hospital with coronary interventional facilities. Patients admitted under cardiologists had fewer comorbidities than other patients and were more likely to have reperfusion treatment (12 266/14 433 (85%) v 13 682/17 064 (80%)) and appropriate secondary prevention drugs. Overall, 27 431/79 374 (35%) of patients had angiography. Relatively more patients admitted to interventional hospitals (8167/14 661; 56%) than to other hospitals had angiography (19 264/64 713; 30%). The adjusted risk of death by 90 days for patients treated in interventional compared with non-interventional hospitals was 0.93 (95% confidence interval 0.82 to 1.06). The adjusted risk of death at 90 days for patients admitted under cardiologists compared with non-cardiologists was 0.86 (0.81 to 0.91). Conclusions Patients cared for by cardiologists had less comorbidity than other patients. They were more likely to receive proved treatments and angiography, and they had a lower adjusted 90 day mortality. Large differences existed in the use of angiography between interventional and non-interventional hospitals. These findings show wide variations in the management and outcome of patients with myocardial infarction in England and Wales.	Royal Coll Physicians, Clin Effectiveness & Evaluat Unit, London NW1 4LE, England; Northampton Gen Hosp, Northampton NN1 5BD, England; Singleton Hosp, Swansea SA2 8QA, W Glam, Wales	Royal College of Physicians; Singleton Hospital	Birkhead, J (corresponding author), Royal Coll Physicians, Clin Effectiveness & Evaluat Unit, London NW1 4LE, England.	john.birkhead@btinternet.com		Weston, Clive/0000-0002-8995-8199				Ayanian JZ, 1997, ARCH INTERN MED, V157, P2570, DOI 10.1001/archinte.157.22.2570; Bach RG, 2004, ANN INTERN MED, V141, P186, DOI 10.7326/0003-4819-141-3-200408030-00007; Bertrand ME, 2002, EUR HEART J, V23, P1809, DOI 10.1053/euhj.2002.3385; Birkhead JS, 2004, HEART, V90, P1004, DOI 10.1136/hrt.2004.034470; BIRKHEAD JS, 2001, BASELINE SURVEY FACI; Birkhead JS, 2002, J CLIN EXCELLENCE, V4, P379; Block P, 2003, EUR HEART J, V24, P299, DOI 10.1016/S0195-668X(02)00474-8; BRAUNWALD E, ACC AHA 2002 GUIDELI; British Cardiac Soc Guidelines Med, 2001, HEART, V85, P133; Chen J, 2000, AM J MED, V108, P460, DOI 10.1016/S0002-9343(00)00331-4; Department of Health, 1997, NEW NHS MOD DEP; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Frances CD, 1999, ARCH INTERN MED, V159, P1429, DOI 10.1001/archinte.159.13.1429; Go AS, 2000, AM J MED, V108, P216, DOI 10.1016/S0002-9343(99)00430-1; Jollis JG, 1996, NEW ENGL J MED, V335, P1880, DOI 10.1056/NEJM199612193352505; Kaul P, 2004, CIRCULATION, V110, P1754, DOI 10.1161/01.CIR.0000142671.06167.91; LEON DA, 1993, LANCET, V342, P479, DOI 10.1016/0140-6736(93)91599-H; Rickards A, 1999, HEART, V82, P18; *ROYAL COLL PHYS, MINAP DAT SET; Van de Werf F, 2005, BRIT MED J, V330, P441, DOI 10.1136/bmj.38335.390718.82; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8	21	60	60	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 3	2006	332	7553					1306	1308B		10.1136/bmj.38849.440914.AE	http://dx.doi.org/10.1136/bmj.38849.440914.AE			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051YG	16705004	Green Published, Bronze			2022-12-24	WOS:000238197000021
J	Dalton, WS; Friend, SH				Dalton, William S.; Friend, Stephen H.			Cancer biomarkers - An invitation to the table	SCIENCE			English	Editorial Material							DISCOVERY; CHEMOTHERAPY; PACLITAXEL; SIGNATURE; OPINION		Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33613 USA; Merck Res Labs, West Point, PA 19486 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Merck & Company	Friend, SH (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33613 USA.	stephen_friend@merck.com						*AM CANC SOC, CANC STAT 2005; Ayers M, 2004, J CLIN ONCOL, V22, P2284, DOI 10.1200/JCO.2004.05.166; Baker SC, 2005, NAT METHODS, V2, P731, DOI 10.1038/nmeth1005-731; Baker SG, 2006, CLIN TRIALS, V3, P43, DOI 10.1191/1740774506cn130oa; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Foekens JA, 2006, J CLIN ONCOL, V24, P1665, DOI 10.1200/JCO.2005.03.9115; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hernandez, 2005, IMPLICATIONS GENOMIC; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Naughton John, 2001, BRIEF HIST FUTURE RA; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; Ransohoff DF, 2005, NAT REV CANCER, V5, P142, DOI 10.1038/nrc1550; RUSSO E, 2006, FDA NCI CMS ANNOUNCE; SIMON R, 2006, PHARMACOGENOMIC 0117, DOI DOI 10.1038/SJ.TPJ.6500349; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wagner P, 2005, CELL CYCLE, V4, P1149, DOI 10.4161/cc.4.9.2038; Whetzel PL, 2006, BIOINFORMATICS, V22, P866, DOI 10.1093/bioinformatics/btl005	23	158	171	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1165	1168		10.1126/science.1125948	http://dx.doi.org/10.1126/science.1125948			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728629				2022-12-24	WOS:000237957400039
J	Vierimaa, O; Georgitsi, M; Lehtonen, R; Vahteristo, P; Kokko, A; Raitila, A; Tuppurainen, K; Ebeling, TML; Salmela, PI; Paschke, R; Gundogdu, S; De Menis, E; Makinen, MJ; Launonen, V; Karhu, A; Aaltonen, LA				Vierimaa, Outi; Georgitsi, Marianthi; Lehtonen, Rainer; Vahteristo, Pia; Kokko, Antti; Raitila, Anniina; Tuppurainen, Karoliina; Ebeling, Tapani M. L.; Salmela, Pasi I.; Paschke, Ralf; Gundogdu, Sadi; De Menis, Ernesto; Makinen, Markus J.; Launonen, Virpi; Karhu, Auli; Aaltonen, Lauri A.			Pituitary adenoma predisposition caused by germline mutations in the AIP gene	SCIENCE			English	Article							ARYL-HYDROCARBON RECEPTOR; ISOLATED FAMILIAL SOMATOTROPINOMA; ENDOCRINE NEOPLASIA TYPE-1; CHROMOSOME 11Q13; CORE COMPLEX; PROTEIN; XAP2; TUMORS; AHR	Pituitary adenomas are common in the general population, and understanding their molecular basis is of great interest. Combining chip-based technologies with genealogy data, we identified germline mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene in individuals with pituitary adenoma predisposition (PAP). AIP acts in cytoplasmic retention of the latent form of the aryl hydrocarbon receptor and also has other functions. In a population-based series from Northern Finland, two AIP mutations account for 16% of all patients diagnosed with pituitary adenomas secreting growth hormone and for 40% of the subset of patients who were diagnosed when they were younger than 35 years of age. Typically, PAP patients do not display a strong family history of pituitary adenoma; thus, AIP is an example of a low-penetrance tumor susceptibility gene.	Univ Helsinki, Dept Med Genet, Mol & Canc Biol Res Program, Helsinki 00014, Finland; Oulu Univ Hosp, Dept Clin Genet, Oulu 90029, Finland; Oulu Univ Hosp, Dept Internal Med, Oulu 90029, Finland; Univ Oulu, Dept Pathol, Oulu 90014, Finland; Univ Leipzig, Dept Med 3, D-04103 Leipzig, Germany; Istanbul Univ, Cerrahpasa Med Fac, Div Endocrinol Metab & Diabet, TR-34303 Cerrahpasa, Turkey; Gen Hosp, Dept Internal Med, I-31100 Treviso, Italy	University of Helsinki; University of Oulu; University of Oulu; University of Oulu; Leipzig University; Istanbul University; Istanbul University - Cerrahpasa	Aaltonen, LA (corresponding author), Univ Helsinki, Dept Med Genet, Mol & Canc Biol Res Program, Helsinki 00014, Finland.	lauri.aaltonen@helsinki.fi	Aaltonen, Lauri/A-5375-2010	Aaltonen, Lauri/0000-0001-6839-4286; Stefanius, Karoliina/0000-0002-9456-1954; Ebeling, Tapani/0000-0003-0323-8893; Karhu, Auli/0000-0002-7927-0796; Kuismin, Outi/0000-0002-0157-8985; Lehtonen, Rainer Juhani/0000-0002-8343-0318; Georgitsi, Marianthi/0000-0002-0354-0913				Ackermann F, 1999, EXP CLIN ENDOCR DIAB, V107, P93, DOI 10.1055/s-0029-1212081; Bell DR, 2000, J BIOL CHEM, V275, P36407, DOI 10.1074/jbc.M004236200; BENLIAN P, 1995, EUR J ENDOCRINOL, V133, P451, DOI 10.1530/eje.0.1330451; Bolger GB, 2003, J BIOL CHEM, V278, P33351, DOI 10.1074/jbc.M303269200; Carver LA, 1997, J BIOL CHEM, V272, P11452; Daly AF, 2005, HORM METAB RES, V37, P347, DOI 10.1055/s-2005-870135; De Menis Ernesto, 2002, Pituitary, V5, P11; Frohman LA, 2004, GROWTH HORM IGF RES, V14, pS90, DOI 10.1016/j.ghir.2004.03.021; Gadelha MR, 1999, J CLIN ENDOCR METAB, V84, P249, DOI 10.1210/jc.84.1.249; Gadelha MR, 2000, J CLIN ENDOCR METAB, V85, P707, DOI 10.1210/jc.85.2.707; Heaney AP, 2004, NAT REV CANCER, V4, P285, DOI 10.1038/nrc1320; Kauppinen-Makelin R, 2005, J CLIN ENDOCR METAB, V90, P4081, DOI 10.1210/jc.2004-1381; Kuzhandaivelu N, 1996, NUCLEIC ACIDS RES, V24, P4741, DOI 10.1093/nar/24.23.4741; Luccio-Camelo DC, 2004, EUR J ENDOCRINOL, V150, P643, DOI 10.1530/eje.0.1500643; Marlowe JL, 2005, J CELL BIOCHEM, V96, P1174, DOI 10.1002/jcb.20656; Meyer BK, 1999, BIOCHEMISTRY-US, V38, P8907, DOI 10.1021/bi982223w; Petrulis JR, 2002, CHEM-BIOL INTERACT, V141, P25, DOI 10.1016/S0009-2797(02)00064-9; Pollenz RS, 2005, J BIOL CHEM, V280, P33346, DOI 10.1074/jbc.M506619200; Riss D, 2003, CANCER RES, V63, P2251; Soares Beatriz Santana, 2004, Pituitary, V7, P95, DOI 10.1007/s11102-005-0-04-0; Soares BS, 2005, J CLIN ENDOCR METAB, V90, P6580, DOI 10.1210/jc.2005-1478; Sumanasekera WK, 2003, J BIOL CHEM, V278, P4467, DOI 10.1074/jbc.M211261200; Tanaka C, 1998, J CLIN ENDOCR METAB, V83, P960, DOI 10.1210/jc.83.3.960; THAKKER RV, 1993, J CLIN INVEST, V91, P2815, DOI 10.1172/JCI116524; Verloes A, 1999, Pituitary, V1, P273, DOI 10.1023/A:1009958510378; Yamada S, 1997, J CLIN ENDOCR METAB, V82, P239, DOI 10.1210/jc.82.1.239	26	407	424	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1228	1230		10.1126/science.1126100	http://dx.doi.org/10.1126/science.1126100			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728643				2022-12-24	WOS:000237957400058
J	Rassoulzadegan, M; Grandjean, V; Gounon, P; Vincent, S; Gillot, I; Cuzin, F				Rassoulzadegan, Minoo; Grandjean, Valerie; Gounon, Pierre; Vincent, Stephane; Gillot, Isabelle; Cuzin, Francois			RNA-mediated non-mendelian inheritance of an epigenetic change in the mouse	NATURE			English	Article							C-KIT; EXPRESSION; LOCUS; METHYLATION; MUTATIONS; PATTERNS	Paramutation is a heritable epigenetic modification induced in plants by cross-talk between allelic loci. Here we report a similar modification of the mouse Kit gene in the progeny of heterozygotes with the null mutant Kit(tm1Alf) (a lacZ insertion). In spite of a homozygous wild-type genotype, their offspring maintain, to a variable extent, the white spots characteristic of Kit mutant animals. Efficiently inherited from either male or female parents, the modified phenotype results from a decrease in Kit messenger RNA levels with the accumulation of non-polyadenylated RNA molecules of abnormal sizes. Sustained transcriptional activity at the postmeiotic stages-at which time the gene is normally silent leads to the accumulation of RNA in spermatozoa. Microinjection into fertilized eggs either of total RNA from Kit(tm1Alf/+) heterozygotes or of Kit-specific microRNAs induced a heritable white tail phenotype. Our results identify an unexpected mode of epigenetic inheritance associated with the zygotic transfer of RNA molecules.	INSERM, U636, F-06108 Nice, France; Univ Nice, Lab Genet Dev Normal & Pathol, F-06108 Nice, France; Univ Nice, Ctr Commun Microscopie Appl, F-06108 Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Rassoulzadegan, M (corresponding author), INSERM, U636, F-06108 Nice, France.	minoo@unice.fr	Vincent, Stéphane D/M-2046-2013; Rassoulzadegan, Minoo/O-7939-2016; Grandjean, Valerie/O-3935-2016	Vincent, Stéphane D/0000-0003-1638-9615; Valerie, GRANDJEAN/0000-0003-1661-7411				Albanesi C, 1996, DEVELOPMENT, V122, P1291; Bernex F, 1996, DEVELOPMENT, V122, P3023; BERNHARD W, 1969, J ULTRA MOL STRUCT R, V27, P250, DOI 10.1016/S0022-5320(69)80016-X; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Biggiogera M, 1998, J HISTOCHEM CYTOCHEM, V46, P389, DOI 10.1177/002215549804600313; BRINK RA, 1956, GENETICS, V41, P872; Chandler VL, 2004, NAT REV GENET, V5, P532, DOI 10.1038/nrg1378; Darzynkiewicz Z, 1990, Methods Cell Biol, V33, P285; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Herman H, 2003, NAT GENET, V34, P199, DOI 10.1038/ng1162; Hogan B, 1994, MANIPULATING MOUSE E; Kluppel M, 1997, DEVELOPMENT, V124, P65; Krawetz SA, 2005, NAT REV GENET, V6, P633, DOI 10.1038/nrg1654; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lolle SJ, 2005, NATURE, V434, P505, DOI 10.1038/nature03380; MANOVA K, 1990, DEVELOPMENT, V110, P1057; MOTRO B, 1991, DEVELOPMENT, V113, P1207; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; Olek A, 1996, NUCLEIC ACIDS RES, V24, P5064, DOI 10.1093/nar/24.24.5064; Rassoulzadegan M, 2002, EMBO J, V21, P440, DOI 10.1093/emboj/21.3.440; Sage J, 1999, MECH DEVELOP, V80, P29, DOI 10.1016/S0925-4773(98)00191-9; Sambrook J., 2001, MOL CLONING LAB MANU; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; SORRENTINO V, 1991, ONCOGENE, V6, P149; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Vincent S, 1998, DEVELOPMENT, V125, P4585; YASUDA H, 1993, BIOCHEM BIOPH RES CO, V191, P893, DOI 10.1006/bbrc.1993.1301	28	636	691	2	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					469	474		10.1038/nature04674	http://dx.doi.org/10.1038/nature04674			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724059	Green Submitted			2022-12-24	WOS:000237778900041
J	Bettelli, E; Carrier, YJ; Gao, WD; Korn, T; Strom, TB; Oukka, M; Weiner, HL; Kuchroo, VK				Bettelli, E; Carrier, YJ; Gao, WD; Korn, T; Strom, TB; Oukka, M; Weiner, HL; Kuchroo, VK			Reciprocal developmental pathways for the generation of pathogenic effector T(H)17 and regulatory T cells	NATURE			English	Article							MYELIN OLIGODENDROCYTE GLYCOPROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TRANSCRIPTION FACTOR FOXP3; IL-6-DEFICIENT MICE; TGF-BETA; DISTINCT; DIFFERENTIATION; INTERLEUKIN-17; INFLAMMATION; ACTIVATION	On activation, T cells undergo distinct developmental pathways, attaining specialized properties and effector functions. T-helper (T-H) cells are traditionally thought to differentiate into T(H)1 and T(H)2 cell subsets. T(H)1 cells are necessary to clear intracellular pathogens and T(H)2 cells are important for clearing extracellular organisms(1,2). Recently, a subset of interleukin ( IL)-17-producing T (T(H)17) cells distinct from T(H)1 or T(H)2 cells has been described and shown to have a crucial role in the induction of autoimmune tissue injury(3-5). In contrast, CD4(+) CD25(+) Foxp3(+) regulatory T (T-reg) cells inhibit autoimmunity and protect against tissue injury(6). Transforming growth factor-beta (TGF-beta) is a critical differentiation factor for the generation of T-reg cells(7). Here we show, using mice with a reporter introduced into the endogenous Foxp3 locus, that IL-6, an acute phase protein induced during inflammation(8,9), completely inhibits the generation of Foxp3(+) T-reg cells induced by TGF-beta. We also demonstrate that IL-23 is not the differentiation factor for the generation of T(H)17 cells. Instead, IL-6 and TGF-beta together induce the differentiation of pathogenic T(H)17 cells from naive T cells. Our data demonstrate a dichotomy in the generation of pathogenic (T(H)17) T cells that induce autoimmunity and regulatory (Foxp3(+)) T cells that inhibit autoimmune tissue injury.	Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Beth Israel Hosp, Transplant Res Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Kuchroo, VK (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	moukka@rics.bwh.harvard.edu; vkuchroo@rics.bwh.harvard.edu	Strom, Terry B./E-9268-2010; Korn, Thomas/AAE-6960-2019	Strom, Terry B./0000-0002-7570-0736; Korn, Thomas/0000-0002-3633-0955				Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; BOTTOMLY K, 1988, IMMUNOL TODAY, V9, P268, DOI 10.1016/0167-5699(88)91308-4; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Eugster HP, 2001, EUR J IMMUNOL, V31, P2302, DOI 10.1002/1521-4141(200108)31:8<2302::AID-IMMU2302>3.0.CO;2-#; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirano T, 1998, Int Rev Immunol, V16, P249; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nardelli DT, 2004, CLIN DIAGN LAB IMMUN, V11, P1075, DOI 10.1128/CDLI.11.6.1075-1084.2004; Okuda Y, 1999, J NEUROIMMUNOL, V101, P188, DOI 10.1016/S0165-5728(99)00139-3; Okuda Y, 2000, J NEUROIMMUNOL, V105, P120, DOI 10.1016/S0165-5728(00)00192-2; Ozato K, 2002, BIOTECHNIQUES, V33, pS66; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Samoilova EB, 1998, J IMMUNOL, V161, P6480; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001	23	4946	5358	17	438	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2006	441	7090					235	238		10.1038/nature04753	http://dx.doi.org/10.1038/nature04753			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16648838				2022-12-24	WOS:000237418800050
J	Mangan, PR; Harrington, LE; O'Quinn, DB; Helms, WS; Bullard, DC; Elson, CO; Hatton, RD; Wahl, SM; Schoeb, TR; Weaver, CT				Mangan, PR; Harrington, LE; O'Quinn, DB; Helms, WS; Bullard, DC; Elson, CO; Hatton, RD; Wahl, SM; Schoeb, TR; Weaver, CT			Transforming growth factor-beta induces development of the T(H)17 lineage	NATURE			English	Article							CD4(+) T-CELLS; CITROBACTER-RODENTIUM; AUTOIMMUNE INFLAMMATION; EFFACING PATHOGEN; HELPER TYPE-1; TGF-BETA; CYTOKINE; IL-23; DISTINCT; INFECTION	A new lineage of effector CD4(+) T cells characterized by production of interleukin (IL)-17,the T-helper-17 (T(H)17) lineage, was recently described based on developmental and functional features distinct from those of classical T(H)1 and T(H)2 lineages(1,2). Like T(H)1 and T(H)2, T(H)17 cells almost certainly evolved to provide adaptive immunity tailored to specific classes of pathogens(3), such as extracellular bacteria(4). Aberrant T(H)17 responses have been implicated in a growing list of autoimmune disorders(5-7). T(H)17 development has been linked to IL-23, an IL-12 cytokine family member that shares with IL-12 a common subunit, IL-12p40 (ref. 8). The IL-23 and IL-12 receptors also share a subunit, IL-12R beta 1, that pairs with unique, inducible components, IL-23R and IL-12R beta 2, to confer receptor responsiveness(9). Here we identify transforming growth factor-beta (TGF-beta) as a cytokine critical for commitment to T(H)17 development. TGF-beta acts to upregulate IL-23R expression, thereby conferring responsiveness to IL-23. Although dispensable for the development of IL-17-producing T cells in vitro and in vivo, IL-23 is required for host protection against a bacterial pathogen, Citrobacter rodentium. The action of TGF-beta on naive T cells is antagonized by interferon-gamma and IL-4, thus providing a mechanism for divergence of the T(H)1, T(H)2 and T(H)17 lineages.	Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; Univ Alabama, Dept Genom, Birmingham, AL 35294 USA; Univ Alabama, Dept Med, Birmingham, AL 35294 USA; Natl Inst Dent & Craniofacial Dis, Cellular Immunol Sect, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Weaver, CT (corresponding author), Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA.	cweaver@uab.edu	O'Quinn, Darrell/B-3318-2008; Eckhardt, Erik/G-1567-2010	Hatton, Robin/0000-0002-4797-9899; Weaver, Casey/0000-0002-2180-1793	NIAID NIH HHS [T32 AI007051] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000046] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Berenson LS, 2004, IMMUNOL REV, V202, P157, DOI 10.1111/j.0105-2896.2004.00208.x; Bry L, 2004, J IMMUNOL, V172, P433, DOI 10.4049/jimmunol.172.1.433; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Higgins LM, 1999, INFECT IMMUN, V67, P3031, DOI 10.1128/IAI.67.6.3031-3039.1999; Iqbal N, 2002, J EXP MED, V195, P71, DOI 10.1084/jem.2001889; Kubo T, 2004, J IMMUNOL, V173, P7249, DOI 10.4049/jimmunol.173.12.7249; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laouar Y, 2005, NAT IMMUNOL, V6, P600, DOI 10.1038/ni1197; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lin JT, 2005, J IMMUNOL, V174, P5950, DOI 10.4049/jimmunol.174.10.5950; Maaser C, 2004, INFECT IMMUN, V72, P3315, DOI 10.1128/IAI.72.6.3315-3324.2004; MacDonald TT, 2003, INT J MED MICROBIOL, V293, P87, DOI 10.1078/1438-4221-00247; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Simmons CP, 2003, INFECT IMMUN, V71, P5077, DOI 10.1128/IAI.71.9.5077-5086.2003; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102	26	2447	2627	1	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2006	441	7090					231	234		10.1038/nature04754	http://dx.doi.org/10.1038/nature04754			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16648837				2022-12-24	WOS:000237418800049
J	Matthews, PGD; Seymour, RS				Matthews, PGD; Seymour, RS			Diving insects boost their buoyancy bubbles	NATURE			English	Article							ANISOPS; NOTONECTIDAE; HAEMOGLOBIN; HEMIPTERA		Univ Adelaide, Adelaide, SA, Australia	University of Adelaide	Matthews, PGD (corresponding author), Univ Adelaide, Adelaide, SA, Australia.	philip.matthews@adelaide.edu.au	Seymour, Roger/C-3469-2009	Seymour, Roger/0000-0002-3395-0059				BARE CO, 1929, U KANSAS SCI B, V18, P265; EGE R, 1915, Z ALLG PHYSL, V17, P81; MILLER PL, 1964, NATURE, V201, P1052, DOI 10.1038/2011052a0; MILLER PL, 1966, J EXP BIOL, V44, P529; THORPE WH, 1947, J EXP BIOL, V24, P227; WELLS RMG, 1981, J COMP PHYSIOL, V142, P515, DOI 10.1007/BF00688984	6	35	35	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 11	2006	441	7090					171	171		10.1038/441171a	http://dx.doi.org/10.1038/441171a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16688167	Bronze			2022-12-24	WOS:000237418800034
J	Namy, O; Moran, SJ; Stuart, DI; Gilbert, RJC; Brierley, I				Namy, O; Moran, SJ; Stuart, DI; Gilbert, RJC; Brierley, I			A mechanical explanation of RNA pseudoknot function in programmed ribosomal frameshifting	NATURE			English	Article							ELECTRON-DENSITY MAPS; MESSENGER-RNA; GENE-EXPRESSION; 80S RIBOSOME; SIGNAL; TRANSLOCATION; MICROSCOPY	The triplet-based genetic code requires that translating ribosomes maintain the reading frame of a messenger RNA faithfully to ensure correct protein synthesis(1). However, in programmed -1 ribosomal frameshifting(2), a specific subversion of frame maintenance takes place, wherein the ribosome is forced to shift one nucleotide backwards into an overlapping reading frame and to translate an entirely new sequence of amino acids. This process is indispensable in the replication of numerous viral pathogens, including HIV and the coronavirus associated with severe acute respiratory syndrome(3), and is also exploited in the expression of several cellular genes(4). Frameshifting is promoted by an mRNA signal composed of two essential elements: a heptanucleotide 'slippery' sequence(5) and an adjacent mRNA secondary structure, most often an mRNA pseudoknot(6). How these components operate together to manipulate the ribosome is unknown. Here we describe the observation of a ribosome - mRNA pseudoknot complex that is stalled in the process of -1 frameshifting. Cryoelectron microscopic imaging of purified mammalian 80S ribosomes from rabbit reticulocytes paused at a coronavirus pseudoknot reveals an intermediate of the frameshifting process. From this it can be seen how the pseudoknot interacts with the ribosome to block the mRNA entrance channel, compromising the translocation process and leading to a spring-like deformation of the P-site transfer RNA. In addition, we identify movements of the likely eukaryotic ribosomal helicase and confirm a direct interaction between the translocase eEF2 and the P-site tRNA. Together, the structural changes provide a mechanical explanation of how the pseudoknot manipulates the ribosome into a different reading frame.	Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England; Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England; Univ Oxford, Cent Chem Lab, Oxford Ctr Mol Sci, Oxford OX1 3QH, England	University of Cambridge; University of Oxford; University of Oxford	Brierley, I (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Tennis Court Rd, Cambridge CB2 1QP, England.	gilbert@strubi.ox.ac.uk; ib103@mole.bio.cam.ac.uk	Namy, olivier/B-8906-2008	Stuart, David/0000-0002-3426-4210; Namy, Olivier/0000-0002-1143-5961	BBSRC [BB/D009499/1, BB/D013305/1] Funding Source: UKRI; MRC [G0500365] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D009499/1, BB/D013305/1] Funding Source: Medline; Medical Research Council [G0500365] Funding Source: Medline; Wellcome Trust Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Atkins JF, 2001, COLD SPRING HARB SYM, V66, P217, DOI 10.1101/sqb.2001.66.217; BRIERLEY I, 1989, CELL, V57, P537, DOI 10.1016/0092-8674(89)90124-4; BRIERLEY I, 1992, J MOL BIOL, V227, P463, DOI 10.1016/0022-2836(92)90901-U; BRIERLEY I, 2005, VIRUS RES       1128; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Farabaugh PJ, 1996, MICROBIOL REV, V60, P103, DOI 10.1128/MMBR.60.1.103-134.1996; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; JACKS T, 1985, SCIENCE, V230, P1237, DOI 10.1126/science.2416054; JACKS T, 1988, CELL, V55, P447, DOI 10.1016/0092-8674(88)90031-1; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jorgensen R, 2003, NAT STRUCT BIOL, V10, P379, DOI 10.1038/nsb923; Kontos H, 2001, MOL CELL BIOL, V21, P8657, DOI 10.1128/MCB.21.24.8657-8670.2001; Lopinski JD, 2000, MOL CELL BIOL, V20, P1095, DOI 10.1128/MCB.20.4.1095-1103.2000; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Namy O, 2004, MOL CELL, V13, P157, DOI 10.1016/S1097-2765(04)00031-0; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Plant EP, 2003, RNA, V9, P168, DOI 10.1261/rna.2132503; SOMOGYI P, 1993, MOL CELL BIOL, V13, P6931, DOI 10.1128/MCB.13.11.6931; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Takyar S, 2005, CELL, V120, P49, DOI 10.1016/j.cell.2004.11.042; TU CL, 1992, P NATL ACAD SCI USA, V89, P8636, DOI 10.1073/pnas.89.18.8636; Valle M, 2003, NAT STRUCT BIOL, V10, P899, DOI 10.1038/nsb1003; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; WEISS R B, 1989, New Biologist, V1, P159; YELVERTON E, 1994, MOL MICROBIOL, V11, P303, DOI 10.1111/j.1365-2958.1994.tb00310.x; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	29	211	217	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2006	441	7090					244	247		10.1038/nature04735	http://dx.doi.org/10.1038/nature04735			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16688178	Bronze, Green Published			2022-12-24	WOS:000237418800052
J	Wells, CD; Fawcett, JP; Traweger, A; Yamanaka, Y; Goudreault, M; Elder, K; Kulkarni, S; Gish, G; Virag, C; Lim, C; Colwill, K; Starostine, A; Metalnikov, P; Pawson, T				Wells, Clark D.; Fawcett, James P.; Traweger, Andreas; Yamanaka, Yojiro; Goudreault, Marilyn; Elder, Kelly; Kulkarni, Sarang; Gish, Gerald; Virag, Cristina; Lim, Caesar; Colwill, Karen; Starostine, Andrei; Metalnikov, Pavel; Pawson, Tony			A Rich1/Amot complex regulates the Cdc42 GTPase and apical-polarity proteins in epithelial cells	CELL			English	Article							TIGHT JUNCTION FORMATION; SACCHAROMYCES-CEREVISIAE; DOWN-REGULATION; MEMBRANE; BINDING; DOMAIN; ANGIOMOTIN; RAC1; INTERACTS; FAMILY	Using functional and proteomic screens of proteins that regulate the Cdc42 GTPase, we have identified a network of protein interactions that center around the Cdc42 RhoGAP Rich1 and organize apical polarity in MDCK epithelial cells. Rich1 binds the scaffolding protein angiomotin (Amot) and is thereby targeted to a protein complex at tight junctions (TJs) containing the PDZ-domain proteins Pals1, Patj, and Par-3. Regulation of Cdc42 by Rich1 is necessary for maintenance of TJs, and Rich1 is therefore an important mediator of this polarity complex. Furthermore, the coiled-coil domain of Amot, with which it binds Rich1, is necessary for localization to apical membranes and is required for Amot to relocalize Pals1 and Par-3 to internal puncta. We propose that Rich1 and Amot maintain TJ integrity by the coordinate regulation of Cdc42 and by linking specific components of the TJ to intracellular protein trafficking.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Pawson, T (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada.	pawson@mshri.on.ca	Traweger, Andreas/M-1460-2015; Gish, Gerald D/C-7228-2017; Pawson, Tony J/E-4578-2013; Colwill, Karen/K-5101-2012	Colwill, Karen/0000-0002-8979-1659; Fawcett, Jim/0000-0003-0043-2164; Yamanaka, Yojiro/0000-0003-1483-8691; Metalnikov, Pavel/0000-0003-3261-4421; Traweger, Andreas/0000-0002-0220-4766				Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200; Bruewer M, 2004, AM J PHYSIOL-CELL PH, V287, pC327, DOI 10.1152/ajpcell.00087.2004; Czuchra A, 2005, MOL BIOL CELL, V16, P4473, DOI 10.1091/mbc.E05-01-0061; Dobrosotskaya IY, 2000, BIOCHEM BIOPH RES CO, V270, P903, DOI 10.1006/bbrc.2000.2471; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Fogg VC, 2005, J CELL SCI, V118, P2859, DOI 10.1242/jcs.02412; Garrard SM, 2003, EMBO J, V22, P1125, DOI 10.1093/emboj/cdg110; Hutchings NJ, 2003, J BIOL CHEM, V278, P22396, DOI 10.1074/jbc.M302540200; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Irazoqui JE, 2003, NAT CELL BIOL, V5, P1062, DOI 10.1038/ncb1068; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Ivanov AI, 2005, BIOESSAYS, V27, P356, DOI 10.1002/bies.20203; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Levchenko T, 2004, ONCOGENE, V23, P1469, DOI 10.1038/sj.onc.1207264; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Macara AG, 2004, CURR BIOL, V14, pR160, DOI 10.1016/j.cub.2004.01.048; Minoshima Y, 2003, DEV CELL, V4, P549, DOI 10.1016/S1534-5807(03)00089-3; Moreau J, 2005, GENE, V350, P137, DOI 10.1016/j.gene.2005.02.001; Nakaya Y, 2004, DEV CELL, V7, P425, DOI 10.1016/j.devcel.2004.08.003; Navarro P, 1997, BBA-PROTEIN STRUCT M, V1343, P187, DOI 10.1016/S0167-4838(97)00108-8; Nishimura M, 2002, J BIOL CHEM, V277, P5583, DOI 10.1074/jbc.M110154200; NOBES C, 1994, CURR OPIN GENET DEV, V4, P77, DOI 10.1016/0959-437X(94)90094-9; Parsons M, 2005, MOL CELL BIOL, V25, P1680, DOI 10.1128/MCB.25.5.1680-1695.2005; Patrie KM, 2005, BBA-MOL CELL RES, V1745, P131, DOI 10.1016/j.bbamcr.2005.05.011; Peck J, 2002, FEBS LETT, V528, P27, DOI 10.1016/S0014-5793(02)03331-8; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Richnau N, 2004, BIOCHEM BIOPH RES CO, V320, P1034, DOI 10.1016/j.bbrc.2004.05.221; Richnau N, 2001, J BIOL CHEM, V276, P35060, DOI 10.1074/jbc.M103540200; Roh MH, 2003, AM J PHYSIOL-RENAL, V285, pF377, DOI 10.1152/ajprenal.00086.2003; Roh MH, 2003, J CELL SCI, V116, P2895, DOI 10.1242/jcs.00500; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; Rojas R, 2001, MOL BIOL CELL, V12, P2257, DOI 10.1091/mbc.12.8.2257; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Shimono A, 2003, CURR BIOL, V13, P613, DOI 10.1016/S0960-9822(03)00204-5; Shin K, 2005, J CELL BIOL, V168, P705, DOI 10.1083/jcb.200408064; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Straight SW, 2004, MOL BIOL CELL, V15, P1981, DOI 10.1091/mbc.E03-08-0620; Takekuni K, 2003, J BIOL CHEM, V278, P5497, DOI 10.1074/jbc.C200707200; TEPASS U, 1993, DEV BIOL, V159, P311, DOI 10.1006/dbio.1993.1243; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Wang Q, 2004, J BIOL CHEM, V279, P30715, DOI 10.1074/jbc.M401930200; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049	50	263	280	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					535	548		10.1016/j.cell.2006.02.045	http://dx.doi.org/10.1016/j.cell.2006.02.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678097	Bronze			2022-12-24	WOS:000237506100019
J	Taylor, JRA; Kier, WM				Taylor, JRA; Kier, WM			A pneumo-hydrostatic skeleton in land crabs - A sophisticated dual support system enables a crab to stay mobile immediately after moulting.	NATURE			English	Editorial Material							IMAGINAL ECDYSIS		Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Taylor, JRA (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	jataylor@email.unc.edu						BLISS DE, 1968, AM ZOOL, V8, P355; BLISS DE, 1979, AM ZOOL, V19, P385; CHAPMAN G, 1975, J EXP ZOOL, V194, P249, DOI 10.1002/jez.1401940118; CHAPMAN G, 1958, BIOL REV, V33, P338, DOI 10.1111/j.1469-185X.1958.tb01260.x; Clark R. B., 1964, DYNAMICS METAZOAN EV; COTTRELL CB, 1962, J EXP BIOL, V39, P431; Drach P., 1939, Ann Inst oceanogr Paris, V19, P103; HUGHES TD, 1980, PHYSIOL ENTOMOL, V5, P153, DOI 10.1111/j.1365-3032.1980.tb00222.x; Miles CI, 1998, J EXP BIOL, V201, P1785; Passano L., 1960, PHYSIOL CRUSTACEA, P473, DOI DOI 10.1016/B978-0-12-395628-6.50021-X; Reynolds S.E., 1980, Advances in Insect Physiology, V15, P475, DOI 10.1016/S0065-2806(08)60144-7; SKINNER D M, 1985, P43; Taylor JRA, 2003, SCIENCE, V301, P209, DOI 10.1126/science.1085987	13	10	11	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 20	2006	440	7087					1005	1005		10.1038/4401005a	http://dx.doi.org/10.1038/4401005a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	034DL	16625186				2022-12-24	WOS:000236906000025
J	Karakozova, M; Kozak, M; Wong, CCL; Bailey, AO; Yates, JR; Mogilner, A; Zebroski, H; Kashina, A				Karakozova, Marina; Kozak, Marina; Wong, Catherine C. L.; Bailey, Aaron O.; Yates, John R., III; Mogilner, Alexander; Zebroski, Henry; Kashina, Anna			Arginylation of beta-actin regulates actin cytoskeleton and cell motility	SCIENCE			English	Article							AMINO; POLYMERIZATION; MUTATION; REMOVAL; PROTEIN; INVIVO	Posttranslational arginylation is critical for mouse embryogenesis, cardiovascular development, and angiogenesis, but its molecular effects and the identity of proteins arginylated in vivo are unknown. We found that beta-actin was arginylated in vivo to regulate actin filament properties, beta-actin localization, and lamella formation in motile cells. Arginylation of beta-actin apparently represents a critical step in the actin N-terminal processing needed for actin functioning in vivo. Thus, posttranslational arginylation of a single protein target can regulate its intracellular function, inducing global changes on the cellular level, and may contribute to cardiovascular development and angiogenesis.	Univ Penn, Dept Anim Biol, Philadelphia, PA 19104 USA; Scripps Res Inst, La Jolla, CA 92037 USA; Univ Calif Davis, Davis, CA 95616 USA; Rockefeller Univ, New York, NY 10021 USA	University of Pennsylvania; Scripps Research Institute; University of California System; University of California Davis; Rockefeller University	Kashina, A (corresponding author), Univ Penn, Dept Anim Biol, Philadelphia, PA 19104 USA.	akashina@vet.upenn.edu	Bailey, Aaron/ABB-8522-2021; Karakozova, Marina/Q-9008-2019; Mogilner, Alex/A-3135-2008	Bailey, Aaron/0000-0001-8063-3032; Wong, Catherine CL/0000-0001-7270-980X	NCRR NIH HHS [P41 RR11823-09] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BALZI E, 1990, J BIOL CHEM, V265, P7464; Condeelis J, 2005, BIOL CELL, V97, P97; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; COOPER JA, 1982, METHOD ENZYMOL, V85, P182; HENNESSEY ES, 1991, EUR J BIOCHEM, V197, P345, DOI 10.1111/j.1432-1033.1991.tb15917.x; Hofer D, 1997, J CELL SCI, V110, P765; HOLMES KC, 1993, ADV EXP MED BIOL, V332, P15; KAJI H, 1968, BIOCHEMISTRY-US, V7, P3844, DOI 10.1021/bi00851a009; KAJI H, 1963, Biochim Biophys Acta, V76, P474; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; MARTIN DJ, 1987, J BIOL CHEM, V262, P6350; OTEY CA, 1986, J CELL BIOL, V102, P1726, DOI 10.1083/jcb.102.5.1726; RUBENSTEIN PA, 1983, J BIOL CHEM, V258, P3961; RUBENSTEIN PA, 1983, J BIOL CHEM, V258, P1354; RUBENSTEIN PA, 1977, P NATL ACAD SCI USA, V74, P120, DOI 10.1073/pnas.74.1.120; Schmitz S, 2000, J MOL BIOL, V295, P1201, DOI 10.1006/jmbi.1999.3407; SHEFF DR, 1989, J BIOL CHEM, V264, P11491	19	194	196	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2006	313	5784					192	196		10.1126/science.1129344	http://dx.doi.org/10.1126/science.1129344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16794040				2022-12-24	WOS:000239008000035
J	Aravin, A; Gaidatzis, D; Pfeffer, S; Lagos-Quintana, M; Landgraf, P; Iovino, N; Morris, P; Brownstein, MJ; Kuramochi-Miyagawa, S; Nakano, T; Chien, MC; Russo, JJ; Ju, JY; Sheridan, R; Sander, C; Zavolan, M; Tuschl, T				Aravin, Alexei; Gaidatzis, Dimos; Pfeffer, Sebastien; Lagos-Quintana, Mariana; Landgraf, Pablo; Iovino, Nicola; Morris, Patricia; Brownstein, Michael J.; Kuramochi-Miyagawa, Satomi; Nakano, Toru; Chien, Minchen; Russo, James J.; Ju, Jingyue; Sheridan, Robert; Sander, Chris; Zavolan, Mihaela; Tuschl, Thomas			A novel class of small RNAs bind to MILI protein in mouse testes	NATURE			English	Article							MICRORNA GENES; IDENTIFICATION; PIWI; GENOMES; FAMILY; CELLS; SPERMATOGENESIS; VERTEBRATE; PROFILE; WORLD	Small RNAs bound to Argonaute proteins recognize partially or fully complementary nucleic acid targets in diverse gene-silencing processes(1-4). A subgroup of the Argonaute proteins - known as the 'Piwi family'(5) - is required for germ- and stem-cell development in invertebrates(6,7), and two Piwi members - MILI and MIWI - are essential for spermatogenesis in mouse(8,9). Here we describe a new class of small RNAs that bind to MILI in mouse male germ cells, where they accumulate at the onset of meiosis. The sequences of the over 1,000 identified unique molecules share a strong preference for a 50 uridine, but otherwise cannot be readily classified into sequence families. Genomic mapping of these small RNAs reveals a limited number of clusters, suggesting that these RNAs are processed from long primary transcripts. The small RNAs are 26 - 31 nucleotides (nt) in length - clearly distinct from the 21 - 23 nt of microRNAs ( miRNAs) or short interfering RNAs (siRNAs) - and we refer to them as 'Piwi-interacting RNAs' or piRNAs. Orthologous human chromosomal regions also give rise to small RNAs with the characteristics of piRNAs, but the cloned sequences are distinct. The identification of this new class of small RNAs provides an important starting point to determine the molecular function of Piwi proteins in mammalian spermatogenesis.	Univ Basel, Bioctr, CH-4056 Basel, Switzerland; Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10021 USA; Rockefeller Univ, Populat Council, New York, NY 10021 USA; J Craig Venter Inst, Rockville, MD 20850 USA; Osaka Univ, Grad Sch Frontier Biosci, Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan; Columbia Genome Ctr, New York, NY 10032 USA; Columbia Univ, Dept Chem Engn, New York, NY 10027 USA; Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA	University of Basel; Howard Hughes Medical Institute; Rockefeller University; Population Council; Rockefeller University; J. Craig Venter Institute; Osaka University; Columbia University; Columbia University; Memorial Sloan Kettering Cancer Center	Tuschl, T (corresponding author), Univ Basel, Bioctr, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.	ttuschl@rockefeller.edu	Sander, Chris/H-1452-2011; Quintana, Mariana Lagos/A-7919-2010; Pfeffer, Sébastien/H-3212-2019; Zavolan, Mihaela/S-3888-2016; Pfeffer, Sebastien/A-6512-2010	Sander, Chris/0000-0001-6059-6270; Pfeffer, Sébastien/0000-0002-8458-348X; Pfeffer, Sebastien/0000-0002-8458-348X; Zavolan, Mihaela/0000-0002-8832-2041	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039024] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD039024] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Grewal SIS, 2004, CURR OPIN CELL BIOL, V16, P230, DOI 10.1016/j.ceb.2004.04.002; Jenab S, 1998, ENDOCRINOLOGY, V139, P1883, DOI 10.1210/en.139.4.1883; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Legendre M, 2005, BIOINFORMATICS, V21, P841, DOI 10.1093/bioinformatics/bti073; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Mochizuki K, 2004, CURR OPIN GENET DEV, V14, P181, DOI 10.1016/j.gde.2004.01.004; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; PFEFFER S, 2003, CURRENT PROTOCOLS MO; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	25	1052	1140	9	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2006	442	7099					203	207		10.1038/nature04916	http://dx.doi.org/10.1038/nature04916			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062XJ	16751777				2022-12-24	WOS:000238979700048
J	Montagna, P; McCulloch, M; Taviani, M; Mazzoli, C; Vendrell, B				Montagna, Paolo; McCulloch, Malcolm; Taviani, Marco; Mazzoli, Claudio; Vendrell, Begona			Phosphorus in cold-water corals as a proxy for seawater nutrient chemistry	SCIENCE			English	Article							MARINE-SEDIMENTS; SEA; ACCUMULATION; SKELETONS; CARBONATE; PRIMNOA; BARIUM	Phosphorus is a key macronutrient being strongly enriched in the deep ocean as a result of continuous export and remineralization of biomass from primary production. We show that phosphorus incorporated within the skeletons of the cosmopolitan cold-water coral Desmophyllum dianthus is directly proportional to the ambient seawater phosphorus concentration and thus may serve as a paleo-oceanographic proxy for variations in ocean productivity as well as changes in the residence times and sources of deep-water masses. The application of this tool to fossil specimens from the Mediterranean reveals phosphorus-enriched bottom waters at the end of the Younger Dryas period.	ICRAM, I-00166 Rome, Italy; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; CNR, Ist Sci Marine, I-40129 Bologna, Italy; Univ Padua, Dipartimento Mineral & Petrol, I-35137 Padua, Italy; CNR, Ist Geosci & Georisorse, I-35137 Padua, Italy; CSIC, Inst Ciencias Mar, E-08003 Barcelona, Spain	Australian National University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); University of Padua; Consiglio Nazionale delle Ricerche (CNR); Istituto di Geoscienze e Georisorse (IGG-CNR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Montagna, P (corresponding author), ICRAM, Via Casalotti 300, I-00166 Rome, Italy.	p.montagna@icram.org	Montagna, Paolo/H-9632-2015; McCulloch, Malcolm T/C-3651-2009; Taviani, Marco/AAF-2168-2020; Mazzoli, Claudio/H-9651-2015; Montagna, Paolo/F-3457-2010; CNR, Ismar/P-1247-2014	Montagna, Paolo/0000-0001-5598-2214; McCulloch, Malcolm T/0000-0003-1538-1558; Taviani, Marco/0000-0003-0414-4274; Mazzoli, Claudio/0000-0002-0374-8415; CNR, Ismar/0000-0001-5351-1486				Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Adkins JF, 1998, SCIENCE, V280, P725, DOI 10.1126/science.280.5364.725; Alibert C, 2003, GEOCHIM COSMOCHIM AC, V67, P231, DOI 10.1016/S0016-7037(02)01055-4; Barcena MA, 2001, PALAEOGEOGR PALAEOCL, V167, P337, DOI 10.1016/S0031-0182(00)00246-7; Benitez-Nelson CR, 2000, EARTH-SCI REV, V51, P109, DOI 10.1016/S0012-8252(00)00018-0; BERTRAND P, 1993, NATURE, V364, P786, DOI 10.1038/364786a0; Bethoux JP, 1998, MAR CHEM, V63, P155, DOI 10.1016/S0304-4203(98)00059-0; CAIRNS SD, 1981, 4TH P INT COR REEF S, V1, P611; Cheng H, 2000, GEOCHIM COSMOCHIM AC, V64, P2401, DOI 10.1016/S0016-7037(99)00422-6; Delaney ML, 1998, GLOBAL BIOGEOCHEM CY, V12, P563, DOI 10.1029/98GB02263; DODGE RE, 1984, MAR POLLUT BULL, V15, P178, DOI 10.1016/0025-326X(84)90317-5; Dymond J, 1992, PALEOCEANOGRAPHY, V7, P163, DOI 10.1029/92PA00181; Forsterra G., 2003, ZOOL VERH, V345, P117; Heikoop JM, 2002, HYDROBIOLOGIA, V471, P117, DOI 10.1023/A:1016505421115; Marchitto TM, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000753; McCulloch M., 2005, 3 INT S DEEP SEA COR, P191; McManus J, 1998, GEOCHIM COSMOCHIM AC, V62, P3453, DOI 10.1016/S0016-7037(98)00248-8; Montagna P, 2005, ERLANGEN EARTH C SER, P1109, DOI 10.1007/3-540-27673-4_56; MONTAGNA P, 2005, 3 INT S DEEP SEA COR, P193; NORAMBUENA F, 2002, THESIS U AUSTRAL CHI; RASMUSSEN CE, 1990, P 4 PAC C MAR SCI TE, V1, P13; Rickaby REM, 1999, PALEOCEANOGRAPHY, V14, P293, DOI 10.1029/1999PA900007; Sherwood OA, 2005, MAR ECOL PROG SER, V301, P135, DOI 10.3354/meps301135; SHOTYK W, 1995, J CHROMATOGR A, V706, P209, DOI 10.1016/0021-9673(94)01153-6; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Spero HJ, 1997, NATURE, V390, P497, DOI 10.1038/37333; Stolarski J, 2003, ACTA PALAEONTOL POL, V48, P497; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; WAKEHAM SG, 1993, ORG GEOCHEM, P145, DOI DOI 10.1007/978-1-4615-2890-6_6	29	74	76	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1788	1791		10.1126/science.1125781	http://dx.doi.org/10.1126/science.1125781			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16794077				2022-12-24	WOS:000238452800056
J	Hall, WD				Hall, WD			How have the SSRI antidepressants affected suicide risk?	LANCET			English	Editorial Material							SEROTONIN REUPTAKE INHIBITORS; RANDOMIZED CONTROLLED-TRIALS; TIME-SERIES ANALYSIS; ADOLESCENTS; DEPRESSION; METAANALYSIS; ASSOCIATION; MEDICATION; EFFICACY; PLACEBO		Univ Queensland, Sch Populat Hlth, Herston, Qld 4066, Australia	University of Queensland	Hall, WD (corresponding author), Univ Queensland, Sch Populat Hlth, Herston, Qld 4066, Australia.	w.hall@sph.uq.edu.au	Hall, Wayne D/A-3283-2008	Hall, Wayne D/0000-0003-1984-0096				Barbui C, 1999, SOC PSYCH PSYCH EPID, V34, P152, DOI 10.1007/s001270050127; Carlsten A, 2001, PHARMACOEPIDEM DR S, V10, P525, DOI 10.1002/pds.618; Ernst CL, 2004, HARVARD REV PSYCHIAT, V12, P14, DOI 10.1080/10673220490425924; Fergusson D, 2005, BMJ-BRIT MED J, V330, P396, DOI 10.1136/bmj.330.7488.396; Grunebaum MF, 2004, J CLIN PSYCHIAT, V65, P1456, DOI 10.4088/JCP.v65n1103; Gunnell D, 2003, SOC SCI MED, V57, P595, DOI 10.1016/S0277-9536(02)00408-2; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; Hall WD, 2003, BRIT MED J, V326, P1008, DOI 10.1136/bmj.326.7397.1008; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Healy D, 2003, PSYCHOTHER PSYCHOSOM, V72, P71, DOI 10.1159/000068691; Helgason T, 2004, BRIT J PSYCHIAT, V184, P157, DOI 10.1192/bjp.184.2.157; Isacsson G, 2005, ACTA PSYCHIAT SCAND, V111, P286, DOI 10.1111/j.1600-0447.2004.00504.x; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; Jureidini JN, 2004, BMJ-BRIT MED J, V328, P879, DOI 10.1136/bmj.328.7444.879; Juurlink DN, 2006, AM J PSYCHIAT, V163, P813, DOI 10.1176/appi.ajp.163.5.813; Kelly CB, 2003, EUR PSYCHIAT, V18, P325, DOI 10.1016/j.eurpsy.2003.03.005; Ludwig J, 2005, J POLICY ANAL MANAG, V24, P249, DOI 10.1002/pam.20089; MacGillivray S, 2003, BMJ-BRIT MED J, V326, P1014, DOI 10.1136/bmj.326.7397.1014; Mann JJ, 2006, NEUROPSYCHOPHARMACOL, V31, P473, DOI 10.1038/sj.npp.1300958; March J, 2004, JAMA-J AM MED ASSOC, V292, P807; Martinez C, 2005, BRIT MED J, V330, P389, DOI 10.1136/bmj.330.7488.389; Ohberg A, 1998, J AFFECT DISORDERS, V50, P225, DOI 10.1016/S0165-0327(98)00114-1; Olfson M, 2003, ARCH GEN PSYCHIAT, V60, P978, DOI 10.1001/archpsyc.60.9.978; Rihmer Z, 2003, PSYCHOTHER PSYCHOSOM, V72, P357, DOI 10.1159/000073033; Sondergard L, 2006, EUR CHILD ADOLES PSY, V15, P232, DOI 10.1007/s00787-006-0527-6; Valuck RJ, 2004, CNS DRUGS, V18, P1119, DOI 10.2165/00023210-200418150-00006; van Praag H M, 2002, Crisis, V23, P77	27	34	35	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2006	367	9527					1959	1962		10.1016/S0140-6736(06)68860-0	http://dx.doi.org/10.1016/S0140-6736(06)68860-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055ZC	16782468				2022-12-24	WOS:000238488900007
J	Daw, ND; O'Doherty, JP; Dayan, P; Seymour, B; Dolan, RJ				Daw, Nathaniel D.; O'Doherty, John P.; Dayan, Peter; Seymour, Ben; Dolan, Raymond J.			Cortical substrates for exploratory decisions in humans	NATURE			English	Article							PREFRONTAL CORTEX; PARIETAL CORTEX; ORBITOFRONTAL CORTEX; HUMAN BRAIN; REWARD; PREDICTION; DOPAMINE; STRIATUM; SYSTEMS; REPRESENTATIONS	Decision making in an uncertain environment poses a conflict between the opposing demands of gathering and exploiting information. In a classic illustration of this 'exploration-exploitation' dilemma(1), a gambler choosing between multiple slot machines balances the desire to select what seems, on the basis of accumulated experience, the richest option, against the desire to choose a less familiar option that might turn out more advantageous ( and thereby provide information for improving future decisions). Far from representing idle curiosity, such exploration is often critical for organisms to discover how best to harvest resources such as food and water. In appetitive choice, substantial experimental evidence, underpinned by computational reinforcement learning(2) (RL) theory, indicates that a dopaminergic(3,4), striatal(5-9) and medial prefrontal network mediates learning to exploit. In contrast, although exploration has been well studied from both theoretical(1) and ethological(10) perspectives, its neural substrates are much less clear. Here we show, in a gambling task, that human subjects' choices can be characterized by a computationally well-regarded strategy for addressing the explore/exploit dilemma. Furthermore, using this characterization to classify decisions as exploratory or exploitative, we employ functional magnetic resonance imaging to show that the frontopolar cortex and intraparietal sulcus are preferentially active during exploratory decisions. In contrast, regions of striatum and ventromedial prefrontal cortex exhibit activity characteristic of an involvement in value-based exploitative decision making. The results suggest a model of action selection under uncertainty that involves switching between exploratory and exploitative behavioural modes, and provide a computationally precise characterization of the contribution of key decision-related brain systems to each of these functions.	UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England; UCL, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England	University of London; University College London; University of London; University College London	O'Doherty, JP (corresponding author), UCL, Gatsby Computat Neurosci Unit, Alexandra House,17 Queen Sq, London WC1N 3AR, England.	jdoherty@hss.caltech.edu	O'Doherty, John P/F-1204-2013	Dolan, Ray/0000-0001-9356-761X; Dayan, Peter/0000-0003-3476-1839; Seymour, Ben/0000-0003-1724-5832	Wellcome Trust [078865] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Gittins J., 1974, PROGR STAT, P241; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Kaelbling L.P., 1993, LEARNING EMBEDDED SY; Kakade S, 2002, NEURAL NETWORKS, V15, P549, DOI 10.1016/S0893-6080(02)00048-5; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Owen AM, 1997, PROG NEUROBIOL, V53, P431, DOI 10.1016/S0301-0082(97)00042-7; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sutton Richard S., 1998, REINFORCEMENT LEARNI; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Usher M, 1999, SCIENCE, V283, P549, DOI 10.1126/science.283.5401.549	30	1278	1286	11	259	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					876	879		10.1038/nature04766	http://dx.doi.org/10.1038/nature04766			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16778890	Green Published, Green Accepted			2022-12-24	WOS:000238254100043
J	Crowder, R				Crowder, Richard			Applied physics - Toward robots that can sense texture by touch	SCIENCE			English	Editorial Material									Univ Southampton, Sch Elect & Comp Sci, Southampton SO17 1BJ, Hants, England	University of Southampton	Crowder, R (corresponding author), Univ Southampton, Sch Elect & Comp Sci, Southampton SO17 1BJ, Hants, England.	rmc@ecs.soton.ac.uk						BICCHI A, 2000, P IEEE INT C ROB AUT, P328; Brown M., 1994, NEUROFUZZY ADAPTIVE; CROWDER RM, 2000, HDB INT AUTOMATION, P377; Dominguez-Lopez JA, 2004, IEEE SYS MAN CYBERN, P3193, DOI 10.1109/ICSMC.2004.1400831; FUENTAS O, 1996, IEEE SICE RSJ INT C, P342; HUANG G, 2006, NEW SCI         0204, V46; Lee MH, 2000, INT J ROBOT RES, V19, P636, DOI 10.1177/027836490001900702; Maheshwari V, 2006, SCIENCE, V312, P1501, DOI 10.1126/science.1126216	8	20	20	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1478	1479		10.1126/science.1129110	http://dx.doi.org/10.1126/science.1129110			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763135	Green Accepted			2022-12-24	WOS:000238124100031
J	Avorn, J; Shrank, W				Avorn, J; Shrank, W			Highlights and a hidden hazard - The FDA's new labeling regulations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Avorn, J (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							*FOOD DRUG ADM, 2006, NEW REQ PRESCR INF; *GOV ACC OFF, 2006, IMPR NEED FDAS POSTM; HARRIS G, 2006, NY TIMES        0119, pA20; Lasser KE, 2006, ARCH INTERN MED, V166, P338, DOI 10.1001/archinte.166.3.338; 2006, FED REG, V71, P3922	5	15	15	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2006	354	23					2409	2411		10.1056/NEJMp068119	http://dx.doi.org/10.1056/NEJMp068119			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	050PQ	16760439				2022-12-24	WOS:000238100800001
J	Marek, PE; Bond, JE				Marek, Paul E.; Bond, Jason E.			Rediscovery of the world's leggiest animal	NATURE			English	Article							MILLIPEDES DIPLOPODA		E Carolina Univ, Dept Biol, Greenville, NC 27858 USA	University of North Carolina; East Carolina University	Marek, PE (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	pm0623@ecu.edu	Bond, Jason E./P-1501-2017	Bond, Jason E./0000-0001-6373-3875				COOK O. F., 1928, PROC U S NAT MUS, V72, P1; Edgecombe GD, 1998, NATURE, V394, P172, DOI 10.1038/28156; ENGHOFF H, 1993, ZOOL J LINN SOC-LOND, V109, P103, DOI 10.1111/j.1096-3642.1993.tb00305.x; Hoffman R.L., 2002, P505; Hoffman RL, 1979, CLASSIFICATION DIPLO; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 1988, Environmentalist, V8, P187, DOI 10.1007/BF02240252; Regier JC, 2005, MOL PHYLOGENET EVOL, V34, P147, DOI 10.1016/j.ympev.2004.09.005; Shear William A., 2003, Zootaxa, V243, P1; Shelley Rowland M., 1996, Myriapodologica, V4, P21; Sierwald P, 2003, J ZOOL SYST EVOL RES, V41, P87, DOI 10.1046/j.1439-0469.2003.00202.x; Wilson HM, 2004, J PALEONTOL, V78, P169, DOI 10.1666/0022-3360(2004)078<0169:MATOPM>2.0.CO;2	12	14	16	0	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					707	707		10.1038/441707a	http://dx.doi.org/10.1038/441707a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760967	Bronze			2022-12-24	WOS:000238095100041
J	Kagan, JC; Medzhitov, R				Kagan, Jonathan C.; Medzhitov, Ruslan			Phosphoinositide-mediated adaptor recruitment controls toll-like receptor signaling	CELL			English	Article							GENE-EXPRESSION; INTERFERON-BETA; PATHWAY; MOLECULE; PROTEIN; SALMONELLA; TIRAP; CELLS; PTDINS(4,5)P-2; IDENTIFICATION	Toll-like receptors (TLRs) play a critical role in the immune system as sensors of microbial infection. Signaling downstream from TLRs is initiated by the recruitment of adaptor proteins, including MyD88 and TRAP. These adaptors play essential roles in TLR signaling, but the mechanism of their function is currently unknown. Here we demonstrate that TRAP and MyD88 have distinct functions and describe a mechanism of recruitment of TRAP and MyD88 to TLR4. We find that TRAP contains a phosphatidylinositol 4,5-bisphosphate (PIP2) binding domain, which mediates TRAP recruitment to the plasma membrane. TRAP then functions to facilitate MyD88 delivery to activated TLR4 to initiate signal transduction. These results establish that phosphoinositide-mediated adaptor recruitment initiates a specific signal-transduction pathway.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA.	ruslan.medzhitov@yale.edu			NIAID NIH HHS [AI-46688, AI07019, K99 AI072955] Funding Source: Medline; PHS HHS [U01A161360-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007019, R01AI046688, K99AI072955, R37AI046688] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Bhat N, 1999, J IMMUNOL, V162, P7335; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; De Matteis MA, 2004, NAT CELL BIOL, V6, P487, DOI 10.1038/ncb0604-487; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Flo TH, 2000, INFECT IMMUN, V68, P6770, DOI 10.1128/IAI.68.12.6770-6776.2000; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Pizarro-Cerda J, 2004, NAT CELL BIOL, V6, P1026, DOI 10.1038/ncb1104-1026; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Terebiznik MR, 2002, NAT CELL BIOL, V4, P766, DOI 10.1038/ncb854; van't Hof W, 1999, J CELL BIOL, V145, P377, DOI 10.1083/jcb.145.2.377; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986	35	650	680	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					943	955		10.1016/j.cell.2006.03.047	http://dx.doi.org/10.1016/j.cell.2006.03.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751103	Bronze			2022-12-24	WOS:000238116400020
J	Jansen, TL; Spoorenberg, A				Jansen, TL; Spoorenberg, A			A medical mystery - Arthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Med Ctr Leeuwarden, NL-8934 AD Leeuwarden, Netherlands	Medical Center Leeuwarden	Jansen, TL (corresponding author), Med Ctr Leeuwarden, NL-8934 AD Leeuwarden, Netherlands.			Jansen, Tim L/0000-0003-3026-3154					0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 1	2006	354	22					2375	2375		10.1056/NEJMicm041004	http://dx.doi.org/10.1056/NEJMicm041004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047ZZ	16738274				2022-12-24	WOS:000237918500010
J	Johnson, BA				Johnson, BA			Pills for speedballing or cocaine dependence	LANCET			English	Editorial Material							PLACEBO-CONTROLLED TRIAL; CONTINGENCY MANAGEMENT; DRUG-ABUSE; METHADONE; ADDICTION; BUPROPION; TOPIRAMATE; OUTCOMES		Univ Virginia, Dept Psychiat Med, Charlottesville, VA 22908 USA	University of Virginia	Johnson, BA (corresponding author), Univ Virginia, Dept Psychiat Med, Charlottesville, VA 22908 USA.	bankolejohnson@virginia.edu			NIDA NIH HHS [1 R01 DA017296-01A1, 2 R01 DA12191-05] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012191, R01DA017296] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ahmed SH, 2005, P NATL ACAD SCI USA, V102, P11533, DOI 10.1073/pnas.0504438102; Carroll KM, 2004, ARCH GEN PSYCHIAT, V61, P264, DOI 10.1001/archpsyc.61.3.264; Grabowski J, 2004, NEUROPSYCHOPHARMACOL, V29, P969, DOI 10.1038/sj.npp.1300392; Hubbard RL, 1997, PSYCHOL ADDICT BEHAV, V11, P261, DOI 10.1037/0893-164X.11.4.261; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Johnson BA, 2005, ALCOHOL CLIN EXP RES, V29, P1528, DOI 10.1097/01.alc.0000174690.63787.fc; Johnson BA, 2005, CNS DRUGS, V19, P873, DOI 10.2165/00023210-200519100-00005; JOHNSON BA, 2006, DRUG ALCOHOL DE 0502; Kampman KM, 2004, DRUG ALCOHOL DEPEN, V75, P233, DOI 10.1016/j.drugalcdep.2004.03.008; Kosten T, 2005, PHARMACOL THERAPEUT, V108, P76, DOI 10.1016/j.pharmthera.2005.06.009; Lindsey KP, 2004, J PHARMACOL EXP THER, V309, P959, DOI 10.1124/jpet.103.060293; Margolin A, 1995, DRUG ALCOHOL DEPEN, V40, P125, DOI 10.1016/0376-8716(95)01198-6; Oliveto A, 2001, DRUG ALCOHOL DEPEN, V63, P155, DOI 10.1016/S0376-8716(00)00198-8; Poling J, 2006, ARCH GEN PSYCHIAT, V63, P219, DOI 10.1001/archpsyc.63.2.219; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Robinson TE, 2004, SCIENCE, V305, P951, DOI 10.1126/science.1102496; Schottenfeld RS, 2005, AM J PSYCHIAT, V162, P340, DOI 10.1176/appi.ajp.162.2.340; Shoptaw S, 2003, J CLIN PSYCHIAT, V64, P1440, DOI 10.4088/JCP.v64n1207; Sofuoglu M, 2005, ADDICT BEHAV, V30, P1125, DOI 10.1016/j.addbeh.2004.10.010; Vocci FJ, 2005, AM J PSYCHIAT, V162, P1432, DOI 10.1176/appi.ajp.162.8.1432	20	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY-JUN	2006	367	9524					1714	1716		10.1016/S0140-6736(06)68749-7	http://dx.doi.org/10.1016/S0140-6736(06)68749-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	047BE	16731254				2022-12-24	WOS:000237854000009
J	Tolstrup, J; Jensen, MK; Tjonneland, A; Overvad, K; Mukamal, KJ; Gronbaek, M				Tolstrup, Janne; Jensen, Majken K.; Tjonneland, Anne; Overvad, Kim; Mukamal, Kenneth J.; Gronbaek, Morten			Prospective study of alcohol drinking coronary heart disease in women and patterns and men	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOOD FREQUENCY QUESTIONNAIRE; CONTROLLED-TRIAL; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; REGULAR DRINKERS; DANISH MEN; MORTALITY; RISK; CONSUMPTION	Objective To determine the association between alcohol drinking patterns and risk of coronary heart disease in women and men. Design Population based cohort study. Setting Denmark, 1993-2002.. Participants 28 448 women and 25 052 men aged 50-65 years, who were free of cardiovascular disease at entry to the study. Main outcome measures Incidence of coronary heart disease occurring during a median follow-up period of 5.7 years. Results 749 and 1283 coronary heart disease events occurred among women and men. Women who drank alcohol on at least one day a week had a lower risk of coronary heart disease than women who drank alcohol on less than one day a week. Little difference was found, however, between drinking frequency: one day a week (hazard ratio 0.64, 95% confidence interval 0.51 to 0.81), 2-4 days a week (0.63, 0.52 to 0.77), five or six days a week (0.79, 0.61 to 1.03), and seven days a week (0.65, 0.51 to 0.84). For men an inverse association was found between drinking frequency and risk of coronary heart disease across the entire range of drinking frequencies. The lowest risk was observed among men who drank daily (0.59, 0.48 to 0.71) compared with men who drank alcohol on less than one day a week. Conclusions Among women alcohol intake may be the primary determinant of the inverse association between drinking alcohol and risk of coronary heart disease whereas among men, drinking frequency, not alcohol intake, seems more important.	Natl Inst Publ Hlth, Alcohol Res Ctr, DK-1399 Copenhagen, Denmark; Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; Aarhus Univ Hosp, Cardiovasc Res Ctr, Dept Clin Epidemiol, Aalborg, Denmark; Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA	Danish Cancer Society; Aarhus University; Harvard University; Beth Israel Deaconess Medical Center	Tolstrup, J (corresponding author), Natl Inst Publ Hlth, Alcohol Res Ctr, Oster Farimagsgade 5, DK-1399 Copenhagen, Denmark.	jst@niph.dk	Mukamal, Kenneth/GVR-7978-2022	Tolstrup, Janne/0000-0002-9796-3967; Tjonneland, Anne/0000-0003-4385-2097; Jensen, Majken Karoline/0000-0003-4729-7545; Overvad, Kim/0000-0001-6429-7921; Gronbaek, Morten Klocker/0000-0002-8473-6474				Agarwal DP, 2002, ALCOHOL ALCOHOLISM, V37, P409, DOI 10.1093/alcalc/37.5.409; BIEN TH, 1990, INT J ADDICT, V25, P1429, DOI 10.3109/10826089009056229; COLDITZ GA, 1987, NEW ENGL J MED, V316, P1105, DOI 10.1056/NEJM198704303161801; Dimmitt SB, 1998, BLOOD COAGUL FIBRIN, V9, P39, DOI 10.1097/00001721-199801000-00005; Flesch M, 2001, BASIC RES CARDIOL, V96, P128, DOI 10.1007/s003950170062; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; GOLDITZ GA, 1987, NEW ENGL J MED, V316, P1105; Gronbaek M, 2000, ANN INTERN MED, V133, P411, DOI 10.7326/0003-4819-133-6-200009190-00008; Gronbaek M, 2000, EUR J CLIN NUTR, V54, P174, DOI 10.1038/sj.ejcn.1600919; GRUCHOW HW, 1982, ATHEROSCLEROSIS, V43, P393, DOI 10.1016/0021-9150(82)90038-7; HOJNACKI JL, 1991, ATHEROSCLEROSIS, V88, P49, DOI 10.1016/0021-9150(91)90256-3; Juel K, 1999, DAN MED BULL, V46, P354; JURGENSEN HJ, 1986, METHOD INFORM MED, V25, P158; Malyutina S, 2002, LANCET, V360, P1448, DOI 10.1016/S0140-6736(02)11470-X; MARMOT MG, 1994, BRIT MED J, V308, P1263, DOI 10.1136/bmj.308.6939.1263; McElduff P, 1997, BRIT MED J, V314, P1159, DOI 10.1136/bmj.314.7088.1159; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; Mumenthaler MS, 1999, ALCOHOL RES HEALTH, V23, P55; Murray RP, 2002, AM J EPIDEMIOL, V155, P242, DOI 10.1093/aje/155.3.242; OVERVAD K, 1991, INT J EPIDEMIOL, V20, P900, DOI 10.1093/ije/20.4.900; Puddey IB, 1999, ADDICTION, V94, P649, DOI 10.1046/j.1360-0443.1999.9456493.x; Rakic V, 1998, ATHEROSCLEROSIS, V137, P243, DOI 10.1016/S0021-9150(97)00269-4; Rakic V, 1998, J HYPERTENS, V16, P165, DOI 10.1097/00004872-199816020-00006; Register TC, 2002, ALCOHOL RES HEALTH, V26, P299; SHAPER AG, 1995, BRIT MED J, V310, P325, DOI 10.1136/bmj.310.6975.325; TJONNELAND A, 1991, INT J EPIDEMIOL, V20, P906, DOI 10.1093/ije/20.4.906; Tjonneland A, 1999, AM J CLIN NUTR, V69, P49; Trevisan M, 2004, ADDICTION, V99, P313, DOI 10.1111/j.1360-0443.2003.00630.x; WANNAMETHEE G, 1991, J HUM HYPERTENS, V5, P59	29	125	130	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 27	2006	332	7552					1244	1247		10.1136/bmj.38831.503113.7C	http://dx.doi.org/10.1136/bmj.38831.503113.7C			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048ZC	16672312	Green Published, Bronze			2022-12-24	WOS:000237984100017
J	De Gobbi, M; Viprakisit, V; Hughes, JR; Fisher, C; Buckle, VJ; Ayyub, H; Gibbons, RJ; Vernimmen, D; Yoshinaga, Y; de Jong, P; Cheng, JF; Rubin, EM; Wood, WG; Bowden, D; Higgs, DR				De Gobbi, Marco; Viprakisit, Vip; Hughes, Jim R.; Fisher, Chris; Buckle, Veronica J.; Ayyub, Helena; Gibbons, Richard J.; Vernimmen, Douglas; Yoshinaga, Yuko; de Jong, Pieter; Cheng, Jan-Fang; Rubin, Edward M.; Wood, William G.; Bowden, Don; Higgs, Douglas R.			A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter	SCIENCE			English	Article							GLOBIN GENES; HUMAN GENOME; CLUSTER; REGION; POLYMORPHISMS; ACTIVATION; SEQUENCES; COMPLEX; GATA-1; ZETA	We describe a pathogenetic mechanism underlying a variant form of the inherited blood disorder a thalassemia. Association studies of affected individuals from Melanesia localized the disease trait to the telomeric region of human chromosome 16, which includes the alpha-globin gene cluster, but no molecular defects were detected by conventional approaches. After resequencing and using a. combination of chromatin immunoprecipitation and expression analysis on a tiled oligonucleotide array, we identified a gain-of-function regulatory single-nucleotide polymorphism (rSNP) in a nongenic region between the alpha-globin genes and their upstream regulatory elements. The rSNP creates a new promoterlike element that interferes with normal activation of at[ downstream alpha-like globin genes. Thus, our work illustrates a strategy for distinguishing between neutral and functionally important rSNPs, and it also identifies a pathogenetic mechanism that could potentially underlie other genetic diseases.	John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England; Mahidol Univ, Siriraj Hosp, Dept Pediat, Bangkok 10700, Thailand; Childrens Hosp, Oakland Res Inst, BACPAC Resources, Oakland, CA 94609 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; Monash Univ, Dept Anat & Cell Biol, Melbourne, Vic 3004, Australia	University of Oxford; Mahidol University; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Monash University	Higgs, DR (corresponding author), John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford OX3 9DS, England.	doug.higgs@imm.ox.ac.uk	De Gobbi, Marco/E-8136-2013	De Gobbi, Marco/0000-0003-4261-7642; Cheng, Jan-Fang/0000-0001-7315-7613	Medical Research Council [MC_U137961147, MC_U137961145, MC_U137961143] Funding Source: Medline; MRC [MC_U137961143, MC_U137961145, MC_U137961147] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anguita E, 2004, EMBO J, V23, P2841, DOI 10.1038/sj.emboj.7600274; Anguita E, 2002, BLOOD, V100, P3450, DOI 10.1182/blood-2002-05-1409; Esperet C, 2000, J BIOL CHEM, V275, P25831, DOI 10.1074/jbc.M001757200; Flint J, 1997, NAT GENET, V15, P252, DOI 10.1038/ng0397-252; Hardison R., 2001, DISORDERS HEMOGLOBIN, P95, DOI 10.1017/CBO9780511596582; HIGGS DR, 1989, BLOOD, V73, P1081; HIGGS DR, 1990, GENE DEV, V4, P1588, DOI 10.1101/gad.4.9.1588; Hughes JR, 2005, P NATL ACAD SCI USA, V102, P9830, DOI 10.1073/pnas.0503401102; JARMAN AP, 1986, EMBO J, V5, P1857, DOI 10.1002/j.1460-2075.1986.tb04437.x; Knight JC, 2005, J MOL MED, V83, P97, DOI 10.1007/s00109-004-0603-7; Leder A, 1997, BLOOD, V90, P1275, DOI 10.1182/blood.V90.3.1275.1275_1275_1282; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; VYAS P, 1992, CELL, V69, P781, DOI 10.1016/0092-8674(92)90290-S; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; WINICHAGOON P, 1982, NUCLEIC ACIDS RES, V10, P5853, DOI 10.1093/nar/10.19.5853	16	202	223	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1215	1217		10.1126/science.1126431	http://dx.doi.org/10.1126/science.1126431			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728641				2022-12-24	WOS:000237957400054
J	Miech, RA; Kumanyika, SK; Stettler, N; Link, BG; Phelan, JC; Chang, VW				Miech, Richard A.; Kumanyika, Shiriki K.; Stettler, Nicolas; Link, Bruce G.; Phelan, Jo C.; Chang, Virginia W.			Trends in the association of poverty with overweight among US adolescents, 1971-2004	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS-INDEX; QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; UNITED-STATES; SOCIOECONOMIC-STATUS; NUTRIENT INTAKE; CHILDREN; OBESITY; HEALTH; PREVALENCE	Context Prevalence of adolescent overweight in the United States has increased substantially during the past 3 decades. Whether socioeconomic disparities in adolescent overweight increased, decreased, or remained constant during this period is not known. Objective To examine trends in adolescent overweight from 1971 to 2004 by family poverty status, as well as trends in potentially relevant eating and physical activity behaviors. Design, Setting, and Participants Four cross-sectional, nationally representative surveys (US National Health and Nutrition Examination Surveys [NHANES] of 1971-1974, 1976-1980, 1988-1994, and 1999-2004) were examined for trends in the prevalence of overweight among adolescents aged 12 to 17 years by family poverty status. Main Outcome Measures Prevalence of adolescent overweight, defined as body mass index at or above the 95th percentile for age and sex in the 2000 Centers for Disease Control and Prevention growth charts. Intermediate outcomes were physical inactivity in the past 30 days, proportion of caloric intake from sweetened beverages (24-hour recall), and whether respondent skipped breakfast (24-hour recall). Results Trends in the association of adolescent overweight with family poverty differed by age stratum (P=.01). In 12- to 14-year-old adolescents, prevalence did not significantly differ by family poverty status in any of the surveys; however, among non-Hispanic black adolescents, overweight prevalence increased faster in nonpoor vs poor families. In contrast, a widening disparity that disfavored adolescents from poor families was present in the 15- to 17-year-old adolescents. This trend was similar among male, female, non-Hispanic white, and non-Hispanic black adolescents, resulting in an overall prevalence of overweight in 1999-2004 more than 50% higher among adolescents in poor vs nonpoor families (23.3% vs 14.4%, respectively; P <.001). Additional analyses suggest that physical inactivity, sweetened beverage consumption, and skipping breakfast may contribute to these disparities. Conclusions Trends of increasing overweight showed a greater impact in families living below the poverty line vs not living below the poverty line among older (15-17 years) but not younger (12-14 years) adolescents. Furthermore, physical inactivity, high consumption of sweetened beverages, and breakfast skipping may be candidate targets for prevention programs aimed at reducing this recently emerged disparity.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21205 USA; Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY USA; New York State Psychiat Inst & Hosp, New York, NY 10032 USA; Univ Penn, Sch Med, Dept Med, Vet Affairs Ctr Hlth Equity Res & Promot, Philadelphia, PA 19104 USA; Univ Penn, Dept Sociol, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Columbia University; Columbia University; New York State Psychiatry Institute; University of Pennsylvania; University of Pennsylvania	Miech, RA (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mental Hlth, 624 N Broadway,Hampton House 853, Baltimore, MD 21205 USA.	rmiech@jhsph.edu	Link, Bruce/AAO-9094-2021; Link, Bruce G/N-9087-2013; Miech, Richard/B-3170-2016	Miech, Richard/0000-0002-2722-3277; Link, Bruce/0000-0001-9980-7450	NCRR NIH HHS [5K23RR016073, K23 RR016073] Funding Source: Medline; NICHD NIH HHS [K12HD043459] Funding Source: Medline; NIDA NIH HHS [K01 DA015089, 1K01DA015089] Funding Source: Medline; NIMHD NIH HHS [P60 MD000209] Funding Source: Medline; NIMH NIH HHS [K02MH65330] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD043459] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016073] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P60MD000209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH065330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA015089] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aiken L.S., 1991, MULTIPLE REGRESSION; [Anonymous], CENS BUR MEAS POV; [Anonymous], 2004, GLOB STRAT DIET PHYS; Berkey CS, 2003, INT J OBESITY, V27, P1258, DOI 10.1038/sj.ijo.0802402; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Briefel RR, 2004, ANNU REV NUTR, V24, P401, DOI 10.1146/annurev.nutr.23.011702.073349; Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437; Chang VW, 2005, ARCH INTERN MED, V165, P2122, DOI 10.1001/archinte.165.18.2122; Cohen J., 1983, APPL MULTIPLE REGRES; Daniels SR, 2005, CIRCULATION, V111, P1999, DOI 10.1161/01.CIR.0000161369.71722.10; DELVA J, 2005, OBESITY LIFESTYLE HA; Demory-Luce D, 2004, J AM DIET ASSOC, V104, P1684, DOI 10.1016/j.jada.2004.07.026; Dowda M, 2001, ARCH PEDIAT ADOL MED, V155, P711, DOI 10.1001/archpedi.155.6.711; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Drewnowski A, 2003, J NUTR, V133, p838S, DOI 10.1093/jn/133.3.838S; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Fisher GM, DEV ORSHANSKY POVERT; French SA, 2001, INT J OBESITY, V25, P1823, DOI 10.1038/sj.ijo.0801820; Goran MI, 1998, AM J CLIN NUTR, V67, P309, DOI 10.1093/ajcn/67.2.309; Gordon-Larsen P, 2003, OBES RES, V11, P121, DOI 10.1038/oby.2003.20; Gordon-Larsen P, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e83; Guenther PM, 2005, J AM DIET ASSOC, V105, P1266, DOI 10.1016/j.jada.2005.05.014; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Jahns L, 2003, EUR J CLIN NUTR, V57, P1295, DOI 10.1038/sj.ejcn.1601691; Janz KF, 2000, MED SCI SPORT EXER, V32, P1250, DOI 10.1097/00005768-200007000-00011; Kuczmarski RJ., 2000, VITAL HLTH STAT, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Lee RE, 2002, AM J PUBLIC HEALTH, V92, P428, DOI 10.2105/AJPH.92.3.428; Levin S, 2003, ARCH PEDIAT ADOL MED, V157, P816, DOI 10.1001/archpedi.157.8.816; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; MCDOWELL M, 1989, 14 NAT NUTR DAT C JU; Molnar BE, 2004, AM J HEALTH PROMOT, V18, P378, DOI 10.4278/0890-1171-18.5.378; Morland K, 2002, AM J PREV MED, V22, P23, DOI 10.1016/S0749-3797(01)00403-2; *NAT CTR HLTH STAT, 2000, NHANES 1999 2001 DIE; *NAT CTR HLTH STAT, 2000, PERS DIET INT PROC M; Nawaz H, 2001, AM J PREV MED, V20, P294, DOI 10.1016/S0749-3797(01)00293-8; Nelson MC, 2005, AM J PREV MED, V28, P259, DOI 10.1016/j.amepre.2004.12.006; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Phelan JC, 2004, J HEALTH SOC BEHAV, V45, P265, DOI 10.1177/002214650404500303; Post GB, 2001, BRIT J NUTR, V85, P375, DOI 10.1079/BJN2000249; Schwimmer JB, 2003, JAMA-J AM MED ASSOC, V289, P1813, DOI 10.1001/jama.289.14.1813; StataCorp, 2004, STAT STAT SOFTW REL; STEWART AW, 1987, AM J EPIDEMIOL, V125, P122, DOI 10.1093/oxfordjournals.aje.a114494; *THOMS W BUS HLTH, STAT ACT PROM NUTR I; Troiano RP, 1998, PEDIATRICS, V101, P497; TROIANO RP, 1995, ARCH PEDIAT ADOL MED, V149, P1085, DOI 10.1001/archpedi.1995.02170230039005; US Bureau of the Census, CURR POP SURV 2005; *US DEP HHS, 2004, PHYS ACT HLTH REP SU; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2; *USDA, 2004, US DEP AGR SURV NUTR; *WEST INC, 1992, NHANES 3 REF MAN REP; Williams J, 2005, JAMA-J AM MED ASSOC, V293, P70, DOI 10.1001/jama.293.1.70; Zhang Q, 2004, OBES RES, V12, P1622, DOI 10.1038/oby.2004.202	53	196	200	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2006	295	20					2385	2393		10.1001/jama.295.20.2385	http://dx.doi.org/10.1001/jama.295.20.2385			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	045HY	16720824	Bronze			2022-12-24	WOS:000237734400024
J	Panatier, A; Theodosis, DT; Mothet, JP; Touquet, B; Pollegioni, L; Poulain, DA; Oliet, SHR				Panatier, Aude; Theodosis, Dionysia T.; Mothet, Jean-Pierre; Touquet, Bastien; Pollegioni, Loredano; Poulain, Dominique A.; Oliet, Stephane H. R.			Glia-derived D-serine controls NMDA receptor activity and synaptic memory	CELL			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; AMINO-ACID OXIDASE; BACILLUS-SUBTILIS; OXYTOCIN NEURONS; GLYCINE OXIDASE; RAT-BRAIN; RELEASE; ASTROCYTES; PLASTICITY	The NMDA receptor is a key player in excitatory transmission and synaptic plasticity in the central nervous system. Its activation requires the binding of both glutamate and a coagonist like D-serine to its glycine site. AS D-serine is released exclusively by astrocytes, we studied the physiological impact of the glial environment on NMDA receptor-dependent activity and plasticity. To this end, we took advantage of the changing astrocytic ensheathing of neurons occurring in the supraoptic nucleus during lactation. We provide direct evidence that in this hypothalamic structure the endogenous coagonist of NMDA receptors is D-serine and not glycine. Consequently, the degree of astrocytic coverage of neurons governs the level of glycine site occupancy on the NMDA receptor, thereby affecting their availability for activation and thus the activity dependence of long-term synaptic changes. Such a contribution of astrocytes to synaptic metaplasticity fuels the emerging concept that astrocytes are dynamic partners of brain signaling.	INSERM, U378, F-33077 Bordeaux, France; Univ Bordeaux 2, F-33077 Bordeaux, France; CNRS, UPR9040, F-91198 Gif Sur Yvette, France; Ecole Prat Hautes Etud, F-33077 Bordeaux, France; Univ Insubria, Dept Biotechnol & Mol Sci, I-21100 Varese, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Insubria	Oliet, SHR (corresponding author), INSERM, U378, F-33077 Bordeaux, France.	stephane.oliet@bordeaux.inserm.fr	Touquet, Bastien/AAO-9681-2020; Touquet, Bastien/F-4757-2019; Jansen, Heiko T./A-5770-2008; Mothet, Jean-Pierre/ABE-3066-2020	Touquet, Bastien/0000-0002-2619-9818; Touquet, Bastien/0000-0002-2619-9818; Jansen, Heiko T./0000-0003-0178-396X; Panatier, Aude/0000-0002-6107-4463; POLLEGIONI, LOREDANO/0000-0003-1733-7243; MOTHET, Jean-Pierre/0000-0003-4991-0614; Oliet, Stephane/0000-0003-0595-9029				Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Brussaard AB, 1997, NEURON, V19, P1103, DOI 10.1016/S0896-6273(00)80401-8; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; DANIELLO A, 1993, COMP BIOCHEM PHYS B, V105, P731, DOI 10.1016/0305-0491(93)90113-J; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Gordon GRJ, 2005, NAT NEUROSCI, V8, P1078, DOI 10.1038/nn1498; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hashimoto A, 1997, PROG NEUROBIOL, V52, P325, DOI 10.1016/S0301-0082(97)00019-1; Hatton GI, 1997, ANNU REV NEUROSCI, V20, P375, DOI 10.1146/annurev.neuro.20.1.375; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hirrlinger J, 2004, EUR J NEUROSCI, V20, P2235, DOI 10.1111/j.1460-9568.2004.03689.x; Hussy N, 1997, J PHYSIOL-LONDON, V502, P609, DOI 10.1111/j.1469-7793.1997.609bj.x; Job V, 2002, J BIOL CHEM, V277, P6985, DOI 10.1074/jbc.M111095200; Job V, 2002, EUR J BIOCHEM, V269, P1456, DOI 10.1046/j.1432-1033.2002.02790.x; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Jourdain P, 1998, J NEUROSCI, V18, P6641; Kim PM, 2005, P NATL ACAD SCI USA, V102, P2105, DOI 10.1073/pnas.0409723102; KUBO T, 1987, NEUROSCI LETT, V74, P331, DOI 10.1016/0304-3940(87)90319-3; Laming PR, 2000, NEUROSCI BIOBEHAV R, V24, P295, DOI 10.1016/S0149-7634(99)00080-9; LAURIE DJ, 1994, EUR J PHARM-MOLEC PH, V268, P335, DOI 10.1016/0922-4106(94)90058-2; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Miyazaki M, 1999, EXP BRAIN RES, V129, P191; Molla G, 1998, PROTEIN EXPRES PURIF, V14, P289, DOI 10.1006/prep.1998.0956; Mortl M, 2004, J BIOL CHEM, V279, P29718, DOI 10.1074/jbc.M401224200; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Newman EA, 2003, J NEUROSCI, V23, P1659, DOI 10.1523/jneurosci.23-05-01659.2003; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; Oliet SHR, 1999, J PHYSIOL-LONDON, V520, P815, DOI 10.1111/j.1469-7793.1999.00815.x; Piet R, 2004, P NATL ACAD SCI USA, V101, P2151, DOI 10.1073/pnas.0308408100; Rampon C, 1996, NEUROSCIENCE, V75, P737, DOI 10.1016/0306-4522(96)00278-3; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Schell MJ, 1997, J NEUROSCI, V17, P1604; Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005; Stern JE, 2000, J PHYSIOL-LONDON, V526, P109, DOI 10.1111/j.1469-7793.2000.t01-1-00109.x; Stern JE, 1999, J NEUROSCI, V19, P3367; Stevens ER, 2003, P NATL ACAD SCI USA, V100, P6789, DOI 10.1073/pnas.1237052100; THEODOSIS DT, 1993, NEUROSCIENCE, V57, P501, DOI 10.1016/0306-4522(93)90002-W; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7	51	643	670	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2006	125	4					775	784		10.1016/j.cell.2006.02.051	http://dx.doi.org/10.1016/j.cell.2006.02.051			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713567	Bronze			2022-12-24	WOS:000237886000021
J	Scaffidi, P; Misteli, T				Scaffidi, P; Misteli, T			Lamin A-dependent nuclear defects in human aging	SCIENCE			English	Article							HUTCHINSON-GILFORD-PROGERIA; ARCHITECTURE; ZMPSTE24	Mutations in the nuclear structural protein lamin A cause the premature aging syndrome Hutchinson-Gilford progeria (HGPS). Whether lamin A plays any role in normal aging is unknown. We show that the same molecular mechanism responsible for HGPS is active in healthy cells. Cell nuclei from old individuals acquire defects similar to those of HGPS patient cells, including changes in histone modifications and increased DNA damage. Age-related nuclear defects are caused by sporadic use, in healthy individuals, of the same cryptic splice site in lamin A whose constitutive activation causes HGPS. Inhibition of this splice site reverses the nuclear defects associated with aging. These observations implicate lamin A in physiological aging.	NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov	Scaffidi, Paola/GRS-9019-2022	Scaffidi, Paola/0000-0002-3642-4193	NATIONAL CANCER INSTITUTE [Z01BC010309] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [Z01 BC010309-07] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDREW W, 1964, Adv Gerontol Res, V18, P87; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Haithcock E, 2005, P NATL ACAD SCI USA, V102, P16690, DOI [10.1073/pnas.0506955102, 10.1073/pnas.0506755102]; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Machiels BM, 1996, J BIOL CHEM, V271, P9249, DOI 10.1074/jbc.271.16.9249; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Young SG, 2005, J LIPID RES, V46, P2531, DOI 10.1194/jlr.R500011-JLR200	14	822	865	2	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1059	1063		10.1126/science.1127168	http://dx.doi.org/10.1126/science.1127168			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16645051	Green Accepted			2022-12-24	WOS:000237628800047
J	Tomlin, D; Kayali, MA; King-Casas, B; Anen, C; Camerer, CF; Quartz, SR; Montague, PR				Tomlin, D; Kayali, MA; King-Casas, B; Anen, C; Camerer, CF; Quartz, SR; Montague, PR			Agent-specific responses in the cingulate cortex during economic exchanges	SCIENCE			English	Article							ANTERIOR CINGULATE; NEURAL BASIS; SELF; FMRI; MIND; EVOLUTION; ATTRIBUTION; COOPERATION; INTUITION; ATTENTION	Interactions with other responsive agents lie at the core of all social exchange. During a social exchange with a partner, one fundamental variable that must be computed correctly is who gets credit for a shared outcome; this assignment is crucial for deciding on an optimal level of cooperation that avoids simple exploitation. We carried out an iterated, two-person economic exchange and made simultaneous hemodynamic measurements from each player's brain. These joint measurements revealed agent-specific responses in the social domain ("me'' and "not me'') arranged in a systematic spatial pattern along the cingulate cortex. This systematic response pattern did not depend on metrical aspects of the exchange, and it disappeared completely in the absence of a responding partner.	Baylor Coll Med, Dept Neurol, Human Neuroimaging Lab, Houston, TX 77030 USA; Baylor Coll Med, Ctr Theoret Neurosci, Dept Psychiat, Houston, TX 77030 USA; CALTECH, Social Cognit Neurosci Lab, Div Humanities & Social Sci 228 77, Pasadena, CA 91125 USA	Baylor College of Medicine; Baylor College of Medicine; California Institute of Technology	Tomlin, D (corresponding author), Baylor Coll Med, Dept Neurol, Human Neuroimaging Lab, 1 Baylor Plaza, Houston, TX 77030 USA.				NIDA NIH HHS [DA11723, DA14883] Funding Source: Medline; NIMH NIH HHS [MH52797] Funding Source: Medline; NINDS NIH HHS [NS045790] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011723, R21DA014883] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Allman JM, 2005, TRENDS COGN SCI, V9, P367, DOI 10.1016/j.tics.2005.06.008; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Baron-Cohen S, 2005, ANNU REV NEUROSCI, V28, P109, DOI 10.1146/annurev.neuro.27.070203.144137; Bhatt M, 2005, GAME ECON BEHAV, V52, P424, DOI 10.1016/j.geb.2005.03.007; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Brune M, 2005, SCHIZOPHRENIA BULL, V31, P21, DOI 10.1093/schbul/sbi002; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; CICHOCKI A, 2003, ADAPTIVE BLIND SIGNA; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Decety J, 2004, NEUROIMAGE, V23, P744, DOI 10.1016/j.neuroimage.2004.05.025; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Dougherty DD, 1999, BIOL PSYCHIAT, V46, P466, DOI 10.1016/S0006-3223(99)00063-3; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Frith U, 2001, CURR DIR PSYCHOL SCI, V10, P151, DOI 10.1111/1467-8721.00137; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Georgieff N, 1998, CONSCIOUS COGN, V7, P465, DOI 10.1006/ccog.1998.0367; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Holroyd CB, 2003, NEUROREPORT, V14, P2481, DOI 10.1097/00001756-200312190-00037; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI [10.1037//0033-295X.109.4.679, 10.1037/0033-295X.109.4.679]; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Johns LC, 2001, PSYCHOL MED, V31, P705, DOI 10.1017/S0033291701003774; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Lieberman MD, 2005, COGNITIVE NEUROSCIENCE OF SOCIAL BEHAVIOUR, P195, DOI 10.4324/9780203311875_chapter_7; Lieberman MD, 2004, J PERS SOC PSYCHOL, V87, P421, DOI 10.1037/0022-3514.87.4.421; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Milham MP, 2003, NEUROIMAGE, V18, P483, DOI 10.1016/S1053-8119(02)00050-2; Montague PR, 2002, NEUROIMAGE, V16, P1159, DOI 10.1006/nimg.2002.1150; Nielsen FA, 2005, NEUROIMAGE, V27, P520, DOI 10.1016/j.neuroimage.2005.04.034; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; Ochsner KN, 2001, NEUROPSYCHOLOGIA, V39, P219, DOI 10.1016/S0028-3932(00)00114-7; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Phan KL, 2003, NEUROPSYCHOPHARMACOL, V28, P1344, DOI 10.1038/sj.npp.1300186; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Seger CA, 2004, NEUROPSYCHOLOGIA, V42, P1168, DOI 10.1016/j.neuropsychologia.2004.02.003; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; Weissman DH, 2003, NEUROIMAGE, V19, P1361, DOI 10.1016/S1053-8119(03)00167-8; Wicker B, 2003, NEUROPSYCHOLOGIA, V41, P139, DOI 10.1016/S0028-3932(02)00144-6	53	151	155	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1047	1050		10.1126/science.1125596	http://dx.doi.org/10.1126/science.1125596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	043UX	16709783				2022-12-24	WOS:000237628800044
J	Heymann, DL; Aylward, RB				Heymann, DL; Aylward, RB			Poliomyelitis eradication and pandemic influenza	LANCET			English	Editorial Material							POLIO		World Hlth Org, Polio Eradicat Initiat, Geneva 27, Switzerland	World Health Organization	Heymann, DL (corresponding author), World Hlth Org, Polio Eradicat Initiat, Geneva 27, Switzerland.	heymannd@who.int						[Anonymous], 2004, Wkly Epidemiol Rec, V79, P425; Heymann DL, 2004, EPIDEMIOL INFECT, V132, P779, DOI 10.1017/s0950268804002638; Heymann DL, 2004, NEW ENGL J MED, V351, P1275, DOI 10.1056/NEJMp048204; 2005, WKLY EPIDEMIOL REC, V80, P141	4	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 6	2006	367	9521					1462	1464		10.1016/S0140-6736(06)68624-8	http://dx.doi.org/10.1016/S0140-6736(06)68624-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	039RJ	16679142	Bronze, Green Published			2022-12-24	WOS:000237324200005
J	Forouhar, AS; Liebling, M; Hickerson, A; Nasiraei-Moghaddam, A; Tsai, HJ; Hove, JR; Fraser, SE; Dickinson, ME; Gharib, M				Forouhar, AS; Liebling, M; Hickerson, A; Nasiraei-Moghaddam, A; Tsai, HJ; Hove, JR; Fraser, SE; Dickinson, ME; Gharib, M			The embryonic vertebrate heart tube is a dynamic suction pump	SCIENCE			English	Article							ZEBRAFISH	The embryonic vertebrate heart begins pumping blood long before the development of discernable chambers and valves. At these early stages, the heart tube has been described as a peristaltic pump. Recent advances in confocal laser scanning microscopy and four-dimensional visualization have warranted another look at early cardiac structure and function. We examined the movement of cells in the embryonic zebrafish heart tube and the flow of blood through the heart and obtained results that contradict peristalsis as a pumping mechanism in the embryonic heart. We propose a more likely explanation of early cardiac dynamics in which the pumping action results from suction due to elastic wave propagation in the heart tube.	CALTECH, Grad Aeronaut Labs, Pasadena, CA 91125 USA; CALTECH, Biol Imaging Ctr, Beckman Inst, Pasadena, CA 91125 USA; Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei, Taiwan; Univ Cincinnati, Genome Res Inst, Cincinnati, OH 45221 USA; Baylor Coll Med, Dept Physiol & Mol Biophys, Houston, TX 77030 USA	California Institute of Technology; California Institute of Technology; National Taiwan University; University System of Ohio; University of Cincinnati; Baylor College of Medicine	Gharib, M (corresponding author), CALTECH, Grad Aeronaut Labs, Pasadena, CA 91125 USA.	mgharib@caltech.edu	Liebling, Michael/A-1498-2009; Fraser, Scott/Y-3406-2019	Fraser, Scott/0000-0002-5377-0223; Gharib, Mohammed/0000-0001-9611-1693; Liebling, Michael/0000-0001-7608-2733	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078694] Funding Source: NIH RePORTER; NHLBI NIH HHS [5R01HL078694] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Buckberg G D, 2001, Semin Thorac Cardiovasc Surg, V13, P342; Fishman MC, 1997, DEVELOPMENT, V124, P2099; Fishman MC, 2001, SCIENCE, V294, P1290, DOI 10.1126/science.1066652; Gilbert S.F., 2000, DEV BIOL, V6th ed.; Hickerson AI, 2005, EXP FLUIDS, V38, P534, DOI 10.1007/s00348-005-0946-z; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Liebling M, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2061567; NICHOLS WW, 1988, MCDONALDS BLOOD FLOW, P98; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; VOGEL S, 1994, LIFE MOVING FLUIDS, P323; Yelon D, 2001, DEV DYNAM, V222, P552, DOI 10.1002/dvdy.1243	11	200	206	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					751	753		10.1126/science.1123775	http://dx.doi.org/10.1126/science.1123775			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675702	Green Published			2022-12-24	WOS:000237312100052
J	Song, K; Backs, J; McAnally, J; Qi, X; Gerard, RD; Richardson, JA; Hill, JA; Bassel-Duby, R; Olson, EN				Song, Kunhua; Backs, Johannes; McAnally, John; Qi, Xiaoxia; Gerard, Robert D.; Richardson, James A.; Hill, Joseph A.; Bassel-Duby, Rhonda; Olson, Eric N.			The transcriptional coactivator CAMTA2 stimulates cardiac growth by opposing class II histone deacetylases	CELL			English	Article							CONGENITAL HEART-DISEASE; SERUM RESPONSE FACTOR; HOMEOBOX GENE NKX2-5; DNA-BINDING PROTEIN; HOLT-ORAM-SYNDROME; PRESSURE-OVERLOAD; NUCLEAR EXPORT; HYPERTROPHY; EXPRESSION; DIFFERENTIATION	Postnatal cardiac myocytes respond to diverse signals by hypertrophic growth and activation of a fetal gene program. In an effort to discover regulators of cardiac hypertrophy, we performed a eukaryotic expression screen for activators of the atrial natriuretic factor (ANF) gene, a cardiac-specific marker of hypertrophic signaling. We discovered that a family of transcriptional coactivators, called CAMTAs, promotes cardiomyocyte hypertrophy and activates the ANF gene, at least in part, by associating with the cardiac homeodomain protein Nkx2-5. The transcriptional activity of CAMTAs is governed by association with class II histone deacetylases (HDACs), which negatively regulate cardiac growth. Mice homozygous for a mutation in a CAMTA gene are defective in cardiac growth in response to pressure overload and neurohumoral signaling, whereas mice lacking HDAC5, a class II HDAC, are sensitized to the prohypertrophic actions of CAMTA. These findings reveal a transcriptional regulatory mechanism that modulates cardiac growth and gene expression by linking hypertrophic signals to the cardiac genome.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Song, K (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu						Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Biben C, 2000, CIRC RES, V87, P888, DOI 10.1161/01.RES.87.10.888; Bouche N, 2002, J BIOL CHEM, V277, P21851, DOI 10.1074/jbc.M200268200; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chen CY, 1996, MOL CELL BIOL, V16, P6372; Chen JN, 1996, DEVELOPMENT, V122, P3809; Cleaver OB, 1996, DEVELOPMENT, V122, P3549; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Durocher D, 1996, MOL CELL BIOL, V16, P4648, DOI 10.1128/mcb.16.9.4648; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Fu YC, 1998, DEVELOPMENT, V125, P4439; HARRISON BC, 2006, IN PRESS MOL CELL BI; Hill JA, 2000, CIRCULATION, V101, P2863, DOI 10.1161/01.CIR.101.24.2863; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Kasahara H, 2003, J MOL CELL CARDIOL, V35, P243, DOI 10.1016/S0022-2828(03)00002-6; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2006, MOL BIOL CELL, V17, P438, DOI 10.1091/mbc.E05-07-0612; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Rosenthal N, 1999, J CLIN INVEST, V104, P1483, DOI 10.1172/JCI8825; Saadane N, 1999, BRIT J PHARMACOL, V127, P1165, DOI 10.1038/sj.bjp.0702676; Schonberger J, 2005, NAT GENET, V37, P418, DOI 10.1038/ng1527; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; SILVA ODE, 1994, PLANT MOL BIOL, V25, P921, DOI 10.1007/BF00028887; Small EA, 2003, DEV BIOL, V261, P116, DOI 10.1016/S0012-1606(03)00306-3; SPRENKLE AB, 1995, CIRC RES, V77, P1060, DOI 10.1161/01.RES.77.6.1060; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Temsah R, 2005, REGUL PEPTIDES, V128, P177, DOI 10.1016/j.regpep.2004.12.026; Thompson JT, 1998, AM J PHYSIOL-HEART C, V274, pH1569, DOI 10.1152/ajpheart.1998.274.5.H1569; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Yang TB, 2002, J BIOL CHEM, V277, P45049, DOI 10.1074/jbc.M207941200; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	42	128	134	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					453	466		10.1016/j.cell.2006.02.048	http://dx.doi.org/10.1016/j.cell.2006.02.048			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678093	Bronze			2022-12-24	WOS:000237506100013
J	Davis, S				Davis, S			The patient's journey: living with diabetes	BMJ-BRITISH MEDICAL JOURNAL			English	Article											Davis, S (corresponding author), Buckingham Grove, Hillingdon UB10 0QZ, Middx, England.	sali@salisplat.co.uk							0	1	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2006	332	7548					1018	1020		10.1136/bmj.332.7548.1018	http://dx.doi.org/10.1136/bmj.332.7548.1018			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040TK	16644829	Green Published			2022-12-24	WOS:000237403100022
J	O'Regan, RM				O'Regan, RM			Chemoprevention of breast cancer	LANCET			English	Editorial Material							SURGICAL ADJUVANT BREAST; SERUM-CHOLESTEROL; RANDOMIZED-TRIAL; TAMOXIFEN; PREVENTION; RALOXIFENE; OUTCOMES; WOMEN		Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University	O'Regan, RM (corresponding author), Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA.	Ruth_ORegan@emoryhealthcare.org						BLACK LJ, 1994, J CLIN INVEST, V93, P63, DOI 10.1172/JCI116985; Clarke M, 1998, LANCET, V351, P1451; Cuzick J, 2002, LANCET, V360, P817; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; Delmas PD, 1997, NEW ENGL J MED, V337, P1641, DOI 10.1056/NEJM199712043372301; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; JORDAN VC, 1976, EUR J CANCER, V12, P419, DOI 10.1016/0014-2964(76)90030-X; Kudchadkar R, 2005, CA-CANCER J CLIN, V55, P145, DOI 10.3322/canjclin.55.3.145; Martino S, 2004, J NATL CANCER I, V96, P1751, DOI 10.1093/jnci/djh319; Powles T, 1998, LANCET, V352, P98; Veronesi U, 2003, J NATL CANCER I, V95, P160, DOI 10.1093/jnci/95.2.160	12	7	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2006	367	9520					1382	1383		10.1016/S0140-6736(06)68594-2	http://dx.doi.org/10.1016/S0140-6736(06)68594-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650636				2022-12-24	WOS:000237195600010
J	Bibring, JP; Langevin, Y; Mustard, JF; Poulet, F; Arvidson, R; Gendrin, A; Gondet, B; Mangold, N; Pinet, P; Forget, F				Bibring, JP; Langevin, Y; Mustard, JF; Poulet, F; Arvidson, R; Gendrin, A; Gondet, B; Mangold, N; Pinet, P; Forget, F		OMEGA team	Global mineralogical and aqueous mars history derived from OMEGA/Mars express data	SCIENCE			English	Article							SURFACE; SPIRIT; IDENTIFICATION; MERIDIANI; DIVERSITY; EVOLUTION; ROVER; CRUST	Global mineralogical mapping of Mars by the Observatoire pour la Mineralogie, l'Eau, les Glaces et l'Activite (OMEGA) instrument on the European Space Agency's Mars Express spacecraft provides new information on Mars' geological and climatic history. Phyllosilicates formed by aqueous alteration very early in the planet's history (the "phyllocian" era) are found in the oldest terrains; sulfates were formed in a second era (the "theiikian" era) in an acidic environment. Beginning about 3.5 billion years ago, the last era (the "siderikian") is dominated by the formation of anhydrous ferric oxides in a slow superficial weathering, without liquid water playing a major role across the planet.	Inst Astrophys Spatiale, F-91405 Orsay, France; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Interact & Dynam Environm Surface, F-91405 Orsay, France; Observ Midi Pyrenees, F-31400 Toulouse, France; Univ Paris 06, Meteorol Dynam Lab, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Brown University; Washington University (WUSTL); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; Sorbonne Universite	Bibring, JP (corresponding author), Inst Astrophys Spatiale, Batiment 121,Orsay Campus, F-91405 Orsay, France.		Douté, Sylvain/C-2082-2013; Korablev, Oleg/L-5083-2013; pinet, patrick/ABF-6172-2021; Gomez, Cécile/B-8473-2012; Loizeau, Damien/P-4435-2017; Schmitt, Bernard/A-1064-2009; Fouchet, Thierry/C-6374-2017; Bellucci, Giancarlo/ABA-9201-2020; Gomez, cecile/Q-2526-2019; Korablev, Oleg I/K-6770-2017; Hauber, Ernst/U-2521-2018	Korablev, Oleg/0000-0003-1115-0656; pinet, patrick/0000-0002-1933-5631; Gomez, Cécile/0000-0002-2986-430X; Loizeau, Damien/0000-0001-6001-3880; Schmitt, Bernard/0000-0002-1230-6627; Fouchet, Thierry/0000-0001-9040-8285; Bellucci, Giancarlo/0000-0003-0867-8679; Gomez, cecile/0000-0002-2986-430X; Korablev, Oleg I/0000-0003-1115-0656; Hauber, Ernst/0000-0002-1375-304X; Capaccioni, Fabrizio/0000-0003-1631-4314; Altieri, Francesca/0000-0002-6338-8300; Ignatiev, Nikolay/0000-0002-6358-7094; Cerroni, Priscilla/0000-0003-0239-2741				Arvidson RE, 2005, SCIENCE, V307, P1591, DOI 10.1126/science.1109509; Bandfield JL, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001469; Bandfield JL, 2003, SCIENCE, V301, P1084, DOI 10.1126/science.1088054; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Bell JF, 2000, J GEOPHYS RES-PLANET, V105, P1721, DOI 10.1029/1999JE001060; Bernal J.D., 1951, PHYS BASIS LIFE; Bertelsen P, 2004, SCIENCE, V305, P827, DOI 10.1126/science.1100112; Bibring J.-P., 2004, EUR SPACE AGENCY SPE, V1240, P37; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Bibring JP, 2004, NATURE, V428, P627, DOI 10.1038/nature02461; Bridges JC, 2001, SPACE SCI REV, V96, P365, DOI 10.1023/A:1011965826553; Carr M.H, 1996, WATER MARS; Chassefiere E, 2004, PLANET SPACE SCI, V52, P1039, DOI 10.1016/j.pss.2004.07.002; CHICARRO A, 2004, ESA SPEC PUBL, V1240, P00003; Christensen P.R., 2001, J GEOPHYS RES, V106, P23; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23873, DOI 10.1029/2000JE001415; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23823, DOI 10.1029/2000JE001370; CHRISTENSEN PR, 2001, J GEOPHYS RES, V106, P885; Encrenaz T, 2004, ICARUS, V170, P424, DOI 10.1016/j.icarus.2004.05.008; Gendrin A, 2005, SCIENCE, V307, P1587, DOI 10.1126/science.1109087; Griffith LL, 1997, J GEOPHYS RES-PLANET, V102, P9135, DOI 10.1029/96JE02939; Jakosky BM, 2001, NATURE, V412, P237, DOI 10.1038/35084184; KAHN R, 1985, ICARUS, V62, P175, DOI 10.1016/0019-1035(85)90116-2; Langevin Y, 2005, SCIENCE, V307, P1584, DOI 10.1126/science.1109091; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Mustard JF, 2005, SCIENCE, V307, P1594, DOI 10.1126/science.1109098; NEWSOM HE, 1980, ICARUS, V44, P207, DOI 10.1016/0019-1035(80)90066-4; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; Pieters C., 1993, REMOTE GEOCHEMICAL A, P309; PINET P, 1990, J GEOPHYS RES-SOLID, V95, P14435, DOI 10.1029/JB095iB09p14435; Poulet F, 2005, NATURE, V438, P623, DOI 10.1038/nature04274; Solomon SC, 2005, SCIENCE, V307, P1214, DOI 10.1126/science.1101812; Squyres SW, 2004, SCIENCE, V306, P1709, DOI 10.1126/science.1104559	33	1149	1164	6	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					400	404		10.1126/science.1122659	http://dx.doi.org/10.1126/science.1122659			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16627738				2022-12-24	WOS:000236941800040
J	D'Angelo, MA; Anderson, DJ; Richard, E; Hetzer, MW				D'Angelo, MA; Anderson, DJ; Richard, E; Hetzer, MW			Nuclear pores form de novo from both sides of the nuclear envelope	SCIENCE			English	Article							COMPLEX; RAN; ORGANIZATION; STEPS; CYCLE	Nuclear pore complexes are multiprotein channels that span the double lipid bilayer of the nuclear envelope. How new pores are inserted into the intact nuclear envelope of proliferating and differentiating eukaryotic cells is unknown. We found that the Nup107-160 complex was incorporated into assembly sites in the nuclear envelope from both the nucleoplasmic and the cytoplasmic sides. Nuclear pore insertion required the generation of Ran guanosine triphosphate in the nuclear and cytoplasmic compartments. Newly formed nuclear pore complexes did not contain structural components of preexisting pores, suggesting that they can form de novo.	Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Hetzer, MW (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hetzer@salk.edu		Anderson, Daniel/0000-0002-3249-2439				BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Bodoor K, 1999, BIOCHEM CELL BIOL, V77, P321, DOI 10.1139/bcb-77-4-321; Burke B, 2002, NAT REV MOL CELL BIO, V3, P487, DOI 10.1038/nrm860; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; Dasso M, 2002, CURR BIOL, V12, pR502, DOI 10.1016/S0960-9822(02)00970-3; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; FINLAY DR, 1991, J CELL BIOL, V114, P169, DOI 10.1083/jcb.114.1.169; Gorlich D, 1997, CURR OPIN CELL BIOL, V9, P412, DOI 10.1016/S0955-0674(97)80015-4; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Harel A, 2003, MOL BIOL CELL, V14, P4387, DOI 10.1091/mbc.E03-05-0275; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; HETZER M, 2005, ANN REV CELL DEV BIO; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; Macaulay C, 1996, J CELL BIOL, V132, P5, DOI 10.1083/jcb.132.1.5; MAUL GG, 1972, J CELL BIOL, V55, P433, DOI 10.1083/jcb.55.2.433; MAUL GG, 1980, CYTOGENET CELL GENET, V26, P175, DOI 10.1159/000131439; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rabut G, 2004, CURR OPIN CELL BIOL, V16, P314, DOI 10.1016/j.ceb.2004.04.001; Ryan KJ, 2003, J CELL BIOL, V160, P1041, DOI 10.1083/jcb.200209116; Walther TC, 2003, NATURE, V424, P689, DOI 10.1038/nature01898; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Wente SR, 2000, SCIENCE, V288, P1374, DOI 10.1126/science.288.5470.1374; Winey M, 1997, MOL BIOL CELL, V8, P2119, DOI 10.1091/mbc.8.11.2119	27	170	171	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					440	443		10.1126/science.1124196	http://dx.doi.org/10.1126/science.1124196			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16627745				2022-12-24	WOS:000236941800051
J	Dey, S; Joshi, A				Dey, S; Joshi, A			Stability via asynchrony in Drosophila metapopulations with low migration rates	SCIENCE			English	Article							SPATIAL POPULATION-DYNAMICS; DISPERSAL; MODELS; HETEROGENEITY; CHAOS	Very few experimental studies have examined how migration rate affects metapopulation dynamics and stability. We studied the dynamics of replicate laboratory metapopulations of Drosophila under different migration rates. Low migration stabilized metapopulation dynamics, while promoting unstable subpopulation dynamics, by inducing asynchrony among neighboring subpopulations. High migration synchronized subpopulation dynamics, thereby destabilizing the meta populations. Contrary to some theoretical predictions, increased migration did not affect average population size. Simulations based on a simple non-species-specific population growth model captured most features of the data, which suggests that our results are generalizable.	Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary & Organismal Biol Unit, Evolutionary Biol Lab, Bangalore 560064, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Joshi, A (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary & Organismal Biol Unit, Evolutionary Biol Lab, Jakkur PO, Bangalore 560064, Karnataka, India.	ajoshi@incasr.ac.in						ALLEN JC, 1993, NATURE, V364, P229, DOI 10.1038/364229a0; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Brannstrom A, 2005, P ROY SOC B-BIOL SCI, V272, P2065, DOI 10.1098/rspb.2005.3185; CHEKE RA, 1993, ECOL ENTOMOL, V18, P109, DOI 10.1111/j.1365-2311.1993.tb01191.x; Dey S, 2006, J THEOR BIOL, V238, P78, DOI 10.1016/j.jtbi.2005.05.013; Earn DJD, 2000, SCIENCE, V290, P1360, DOI 10.1126/science.290.5495.1360; Grimm V, 1997, OECOLOGIA, V109, P323, DOI 10.1007/s004420050090; GYLLENBERG M, 1993, MATH BIOSCI, V118, P25, DOI 10.1016/0025-5564(93)90032-6; HANSKI I, 1993, J THEOR BIOL, V163, P491, DOI 10.1006/jtbi.1993.1134; Hanski I., 1999, METAPOPULATION ECOLO; HASTINGS A, 1993, ECOLOGY, V74, P1362, DOI 10.2307/1940066; Ims RA, 2005, P ROY SOC B-BIOL SCI, V272, P913, DOI 10.1098/rspb.2004.3025; Ives AR, 2004, AM NAT, V163, P375, DOI 10.1086/381942; Kendall BE, 1998, THEOR POPUL BIOL, V54, P11, DOI 10.1006/tpbi.1998.1365; Lecomte J, 2004, J ANIM ECOL, V73, P179, DOI 10.1111/j.1365-2656.2004.00796.x; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; MAY RM, 1976, AM NAT, V110, P573, DOI 10.1086/283092; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Mueller L.D., 2000, STABILITY MODEL POPU; Nachman G, 2000, OIKOS, V91, P51, DOI 10.1034/j.1600-0706.2000.910105.x; NACHMAN G, 1987, J ANIM ECOL, V56, P267, DOI 10.2307/4814; NACHMAN G, 1991, BIOL J LINN SOC, V42, P285, DOI 10.1111/j.1095-8312.1991.tb00564.x; Ranta E, 1998, OIKOS, V83, P376, DOI 10.2307/3546852; Ripa J, 2000, OIKOS, V89, P175, DOI 10.1034/j.1600-0706.2000.890119.x; RUXTON GD, 1994, P ROY SOC B-BIOL SCI, V256, P189, DOI 10.1098/rspb.1994.0069; Ruxton GD, 1996, J ANIM ECOL, V65, P161, DOI 10.2307/5719; Sheeba V, 1998, CURR SCI INDIA, V75, P1406	27	99	100	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					434	436		10.1126/science.1125317	http://dx.doi.org/10.1126/science.1125317			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16627743				2022-12-24	WOS:000236941800049
J	Hajitou, A; Trepel, M; Lilley, CE; Soghomonyan, S; Alauddin, MM; Marini, FC; Restel, BH; Ozawa, MG; Moya, CA; Rangel, R; Sun, Y; Zaoui, K; Schmidt, M; von Kalle, C; Weitzman, MD; Gelovani, JG; Pasqualini, R; Arap, W				Hajitou, A; Trepel, M; Lilley, CE; Soghomonyan, S; Alauddin, MM; Marini, FC; Restel, BH; Ozawa, MG; Moya, CA; Rangel, R; Sun, Y; Zaoui, K; Schmidt, M; von Kalle, C; Weitzman, MD; Gelovani, JG; Pasqualini, R; Arap, W			A hybrid vector for ligand-directed tumor targeting and molecular imaging	CELL			English	Article							PROTEIN-PROTEIN INTERACTIONS; KINASE GENE-TRANSFER; ADENOASSOCIATED VIRUS; IN-VIVO; THYMIDINE KINASE; MAMMALIAN-CELLS; LIVING SUBJECTS; EXPRESSION; DELIVERY; THERAPY	Merging tumor targeting and molecular-genetic imaging into an integrated platform is limited by lack of strategies to enable systemic yet ligand-directed delivery and imaging of specific transgenes. Many eukaryotic viruses serve for transgene delivery but require elimination of native tropism for mammalian cells; in contrast, prokaryotic viruses can be adapted to bind to mammalian receptors but are otherwise poor vehicles. Here we introduce a system containing cis-elements from adeno-associated virus (AAV) and single-stranded bacteriophage. Our AAV/phage (AAVP) prototype targets an integrin. We show that AAVP provides superior tumor transduction over phage and that incorporation of inverted terminal repeats is associated with improved fate of the delivered transgene. Moreover, we show that the temporal dynamics and spatial heterogeneity of gene expression mediated by targeted AAVP can be monitored by positron emission tomography. This new class of targeted hybrid viral particles will enable a wide range of applications in biology and medicine.	Univ Texas, MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Bone Marrow Transplantat, Houston, TX 77030 USA; Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; Univ Freiburg, Ctr Med, Dept Hematol & Oncol, D-79106 Freiburg, Germany; Univ Freiburg, Ctr Med, Inst Mol Med & Cell Res, D-79106 Freiburg, Germany; Salk Inst Biol Studies, La Jolla, CA 92037 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Freiburg; University of Freiburg; Salk Institute	Pasqualini, R (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	rpasqual@mdanderson.org; warap@mdanderson.org	Marini, Frank C/L-8018-2016; Rangel, Roberto/AHE-6583-2022	Rangel, Roberto/0000-0002-9088-7957; Soghomonyan, Suren/0000-0001-5930-9051; Hajitou, Amin/0000-0003-1119-5686	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alauddin MM, 2003, J LABELLED COMPD RAD, V46, P285, DOI 10.1002/jlcr.637; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Arap W, 2002, NAT MED, V8, P121, DOI 10.1038/nm0202-121; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; Barrow PA, 1997, TRENDS MICROBIOL, V5, P268, DOI 10.1016/S0966-842X(97)01054-8; Blasberg RG, 2003, J CLIN INVEST, V111, P1620, DOI 10.1172/JCI200318855; Chen LM, 2004, CHEM BIOL, V11, P1081, DOI 10.1016/j.chembiol.2004.05.019; De A, 2005, FASEB J, V19, P2017, DOI 10.1096/fj.05-4628fje; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; GEIER MR, 1973, NATURE, V246, P221, DOI 10.1038/246221a0; Giordano RJ, 2001, NAT MED, V7, P1249, DOI 10.1038/nm1101-1249; Gross S, 2005, METHOD ENZYMOL, V399, P512, DOI 10.1016/S0076-6879(05)99035-6; Gross S, 2005, CANCER CELL, V7, P5, DOI 10.1016/j.ccr.2004.12.011; Hajitou A, 2006, TRENDS CARDIOVAS MED, V16, P80, DOI 10.1016/j.tcm.2006.01.003; Hajitou A, 2001, CANCER RES, V61, P3450; Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200; Hsiao CD, 2001, DEV DYNAM, V220, P323, DOI 10.1002/dvdy.1113; Ivanenkov VV, 1999, BBA-MOL CELL RES, V1448, P463, DOI 10.1016/S0167-4889(98)00163-3; Kang KW, 2005, MOL IMAGING BIOL, V7, P296, DOI 10.1007/s11307-005-0010-7; Kootstra NA, 2003, ANNU REV PHARMACOL, V43, P413, DOI 10.1146/annurev.pharmtox.43.100901.140257; Larocca D, 1999, FASEB J, V13, P727, DOI 10.1096/fasebj.13.6.727; Lieber A, 1999, J VIROL, V73, P9314, DOI 10.1128/JVI.73.11.9314-9324.1999; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Marchio S, 2004, CANCER CELL, V5, P151, DOI 10.1016/S1535-6108(04)00025-X; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; McCarty DM, 2004, ANNU REV GENET, V38, P819, DOI 10.1146/annurev.genet.37.110801.143717; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Mizuguchi H, 2004, HUM GENE THER, V15, P1034, DOI 10.1089/hum.2004.15.1034; Muller OJ, 2003, NAT BIOTECHNOL, V21, P1040, DOI 10.1038/nbt856; Pasqualini R, 1997, NAT BIOTECHNOL, V15, P542, DOI 10.1038/nbt0697-542; Pentz RD, 2005, NAT MED, V11, P1145, DOI 10.1038/nm1105-1145; Piersanti S, 2004, J MOL MED, V82, P467, DOI 10.1007/s00109-004-0543-2; Poul MA, 1999, J MOL BIOL, V288, P203, DOI 10.1006/jmbi.1999.2678; Ray P, 2001, SEMIN NUCL MED, V31, P312, DOI 10.1053/snuc.2001.26209; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; Souza GR, 2006, P NATL ACAD SCI USA, V103, P1215, DOI 10.1073/pnas.0509739103; Tai YC, 2005, ANNU REV BIOMED ENG, V7, P255, DOI 10.1146/annurev.bioeng.6.040803.140021; Tjuvajev JG, 1998, CANCER RES, V58, P4333; Tjuvajev JG, 1999, CANCER RES, V59, P5186; Tjuvajev JG, 2003, CANCER CELL, V3, P327, DOI 10.1016/S1535-6108(03)00082-5; Trepel M, 2001, CANCER RES, V61, P8110; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Yang CC, 1997, J VIROL, V71, P9231, DOI 10.1128/JVI.71.12.9231-9247.1997; ZACHER AN, 1980, GENE, V9, P127, DOI 10.1016/0378-1119(80)90171-7	45	206	223	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					385	398		10.1016/j.cell.2006.02.042	http://dx.doi.org/10.1016/j.cell.2006.02.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630824	Bronze			2022-12-24	WOS:000237241500026
J	Lee, TI; Jenner, RG; Boyer, LA; Guenther, MG; Levine, SS; Kumar, RM; Chevalier, B; Johnstone, SE; Cole, MF; Isono, K; Koseki, H; Fuchikami, T; Abe, K; Murray, HL; Zucker, JP; Yuan, BB; Bell, GW; Herbolsheimer, E; Hannett, NM; Sun, KM; Odom, DT; Otte, AP; Volkert, TL; Bartel, DP; Melton, DA; Gifford, DK; Jaenisch, R; Young, RA				Lee, TI; Jenner, RG; Boyer, LA; Guenther, MG; Levine, SS; Kumar, RM; Chevalier, B; Johnstone, SE; Cole, MF; Isono, K; Koseki, H; Fuchikami, T; Abe, K; Murray, HL; Zucker, JP; Yuan, BB; Bell, GW; Herbolsheimer, E; Hannett, NM; Sun, KM; Odom, DT; Otte, AP; Volkert, TL; Bartel, DP; Melton, DA; Gifford, DK; Jaenisch, R; Young, RA			Control of developmental regulator's by polycomb in human embryonic stem cells	CELL			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; GROUP GENE; MONOCLONAL-ANTIBODIES; MOUSE DEVELOPMENT; RESPONSE ELEMENT; GROUP-COMPLEXES; DROSOPHILA; TRANSCRIPTION; MAINTENANCE; PROTEIN	Polycomb group proteins are essential for early development in metazoans, but their contributions to human development are not well understood. We have mapped the Polycomb Repressive Complex 2 (PRC2) subunit SUZ12 across the entire nonrepeat portion of the genome in human embryonic stem (ES) cells. We found that SUZ12 is distributed across large portions of over two hundred genes encoding key developmental regulators. These genes are occupied by nucleosomes trimethylated at histone H3K27, are transcriptionally repressed, and contain some of the most highly conserved noncoding elements in the genome. We found that PRC2 target genes are preferentially activated during ES cell differentiation and that the ES cell regulators OCT4, SOX2, and NANOG cooccupy a significant subset of these genes. These results indicate that PRC2 occupies a special set of developmental genes in ES cells that must be repressed to maintain pluripotency and that are poised for activation during ES cell differentiation.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; RIKEN, Ctr Allergy & Immunol, Dev Genet Grp, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; RIKEN, Tsukuba Inst, BioResource Ctr, Technol & Dev Team Mammalian Cellular Dynam, Tsukuba, Ibaraki 2300045, Japan; Univ Amsterdam, Swammerdam Inst Life Sci, NL-1098 SM Amsterdam, Netherlands; Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; MIT, CSAIL, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); RIKEN; RIKEN; University of Amsterdam; Harvard University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012; Koseki, Haruhiko/I-3825-2014; Jenner, Richard/J-8683-2012	Young, Richard A/0000-0001-8855-8647; Koseki, Haruhiko/0000-0001-8424-5854; Jenner, Richard/0000-0002-2946-6811; Odom, Duncan/0000-0001-6201-5599; Isono, Kyoichi/0000-0002-4609-8985; Levine, Stuart/0000-0001-7363-562X	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K25DK070813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069400] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG002668, R01 HG002668-03, R01 HG002668] Funding Source: Medline; NIDDK NIH HHS [K25 DK070813, DK070813] Funding Source: Medline; NIGMS NIH HHS [GM069400, R01 GM069400] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abeyta MJ, 2004, HUM MOL GENET, V13, P601, DOI 10.1093/hmg/ddh068; Akasaka T, 2001, DEVELOPMENT, V128, P1587; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; BENDER M, 1987, DEV BIOL, V119, P418, DOI 10.1016/0012-1606(87)90046-7; Birve A, 2001, DEVELOPMENT, V128, P3371; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; BOYER LA, 2006, IN PRESS NATURE; Brand-Saberi B, 2005, ANN ANAT, V187, P199, DOI 10.1016/j.aanat.2004.12.018; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; DENELL RE, 1983, DEV BIOL, V97, P34, DOI 10.1016/0012-1606(83)90061-1; DUNCAN I, 1986, CELL, V47, P297, DOI 10.1016/0092-8674(86)90452-6; Faust C, 1998, DEVELOPMENT, V125, P4495; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; FRANKE A, 1992, EMBO J, V11, P2941, DOI 10.1002/j.1460-2075.1992.tb05364.x; Hamer KM, 2002, HYBRIDOMA HYBRIDOM, V21, P245, DOI 10.1089/153685902760213859; Hodgson JW, 2001, MOL CELL BIOL, V21, P4528, DOI 10.1128/MCB.21.14.4528-4543.2001; Horard B, 2000, MOL CELL BIOL, V20, P3187, DOI 10.1128/MCB.20.9.3187-3197.2000; Kennison JA, 2004, METHOD ENZYMOL, V377, P61; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Loebel DAF, 2003, DEV BIOL, V264, P1, DOI 10.1016/S0012-1606(03)00390-7; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Mayhall EA, 2004, CURR OPIN CELL BIOL, V16, P713, DOI 10.1016/j.ceb.2004.09.007; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Mulholland NM, 2003, GENE DEV, V17, P2741, DOI 10.1101/gad.1143303; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; ORLANDO V, 1995, CURR OPIN GENET DEV, V5, P174, DOI 10.1016/0959-437X(95)80005-0; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pera MF, 2004, DEVELOPMENT, V131, P5515, DOI 10.1242/dev.01451; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SIMON J, 1992, DEVELOPMENT, V114, P493; Strutt H, 1997, EMBO J, V16, P3621, DOI 10.1093/emboj/16.12.3621; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; THOMPSON NE, 1989, J BIOL CHEM, V264, P11511; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tie F, 2001, DEVELOPMENT, V128, P275; vanderLugt NMT, 1996, MECH DEVELOP, V58, P153, DOI 10.1016/S0925-4773(96)00570-9; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang JB, 2002, MAMM GENOME, V13, P493, DOI 10.1007/s00335-002-2182-7; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007	66	1792	1871	0	123	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					301	313		10.1016/j.cell.2006.02.043	http://dx.doi.org/10.1016/j.cell.2006.02.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630818	Green Accepted, Bronze			2022-12-24	WOS:000237241500020
J	Nabi, H; Gueguen, A; Chiron, M; Lafont, S; Zins, M; Lagarde, E				Nabi, Hermann; Gueguen, Alice; Chiron, Mireille; Lafont, Sylviane; Zins, Marie; Lagarde, Emmanuel			Awareness of driving while sleepy and road traffic accidents: prospective study in GAZEL cohort	BRITISH MEDICAL JOURNAL			English	Article							DRIVER SLEEPINESS; FATIGUE; CRASHES; POPULATION; BEHAVIORS	Objectives To examine the association between self assessed driving while sleep), and the risk of serious road traffic accidents (RTAs). Design Prospective cohort study. Setting France. Participants 13 299 of the 19 894 living members of die GAZEL cohort, workers and recent retirees of a French national utility company followed up since 1989. Main outcome measures Frequency of driving while sleepy in the previous 12 months, reported in 2001; rate ratios for serious RTAs in 2001-3, estimated by using generalised linear Poisson regression models with time dependent covariates. Results The risk of serious RTAs increased proportionally with the frequency of self reported driving while sleepy After adjustment for graphic characteristics driving behaviour variables, work conditions, retirement, medical conditions mid treatments, depressive symptoms, and sleep disorders, the adjusted rate ratios of serious RTAs for participants who reported driving while sleep), in the previous 12 months "a few times" or "once a month or more often" were 1.5 (95% confidence interval 1.2 to 2.0) and 2.9 (1.3 to 6.3) respectively compared with those who reported not driving while sleepy over the same period. These associations were not explained by any reported sleep disorders. Conclusions Self assessed driving while sleepy was a powerful predictor of serious RTAs, suggesting that drivers' awareness of their sleepiness while driving is not sufficient to prevent them from having RTAs. Messages on prevention should therefore focus on convincing sleepy drivers to Stop driving and sleep before resuming their journey.	INSERM, U687, IFR69, F-94415 St Maurice, France; UMRESTTE, Inst Natl Rech Transports & Leur Secur, F-69675 Bron, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Gustave-Eiffel; Institut National de Recherche sur les Transports et leur Securite (INRETS)	Lagarde, E (corresponding author), Univ Bordeaux 2, INSERM, U593, Equipe Avenir Sante & Insecur Routiere, Case 11,146 Rue Leo Saignat, F-33076 Bordeaux, France.	emmanuel.lagarde@isped.u-bordeaux2.fr	Zins, Marie/AAX-6551-2021; Lafont, Sylviane/AAD-4464-2019; Lagarde, Emmanuel/F-7132-2013	Lafont, Sylviane/0000-0003-0483-6238; Nabi, Hermann/0000-0002-7832-0413; Lagarde, Emmanuel/0000-0001-8031-7400				Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; Connor J, 2001, ACCIDENT ANAL PREV, V33, P31, DOI 10.1016/S0001-4575(00)00013-0; Dalziel JR, 1997, ACCIDENT ANAL PREV, V29, P489, DOI 10.1016/S0001-4575(97)00028-6; Drake C, 2005, SLEEP AM POLL SUMMAR; Drobnich D, 2005, IND HEALTH, V43, P197, DOI 10.2486/indhealth.43.197; Fergusson D, 2003, AUST NZ J PUBL HEAL, V27, P337, DOI 10.1111/j.1467-842X.2003.tb00404.x; Horne J., 2001, TRANSP RES F, V4, P63, DOI [10.1016/s1369-8478(01)00014-6, DOI 10.1016/S1369-8478(01)00014-6]; Knipling RR., 1994, CRASHES FATALITIES R; Lagarde E, 2005, J CLIN EPIDEMIOL, V58, P524, DOI 10.1016/j.jclinepi.2004.09.008; Lagarde E, 2004, J EPIDEMIOL COMMUN H, V58, P562, DOI 10.1136/jech.2003.011833; Lyznicki JM, 1998, JAMA-J AM MED ASSOC, V279, P1908, DOI 10.1001/jama.279.23.1908; MacLean AW, 2003, SLEEP MED REV, V7, P507, DOI 10.1016/S1087-0792(03)90004-9; MCCULLAGH P., 1991, GEN LINEAR MODELS; Nabi H, 2005, AM J EPIDEMIOL, V161, P864, DOI 10.1093/aje/kwi110; Philip P, 2005, ACCIDENT ANAL PREV, V37, P473, DOI 10.1016/j.aap.2004.07.007; Philip P, 2001, BRIT MED J, V322, P829, DOI 10.1136/bmj.322.7290.829; Pierce RJ, 1999, AUST NZ J MED, V29, P658, DOI 10.1111/j.1445-5994.1999.tb01613.x; Reyner LA, 1998, INT J LEGAL MED, V111, P120, DOI 10.1007/s004140050131; Rosen Ilene M, 2005, J Clin Sleep Med, V1, P337; Rothman K., 1998, MODERN EPIDEMIOLOGY; Smith S, 2005, ACCIDENT ANAL PREV, V37, P1066, DOI 10.1016/j.aap.2005.06.008; *TNS SOFR, 2004, FRANC SOMN RES ET	22	72	76	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 8	2006	333	7558					75	77		10.1136/bmj.38863.638194.AE	http://dx.doi.org/10.1136/bmj.38863.638194.AE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	065BA	16798754	Bronze, Green Submitted, Green Published			2022-12-24	WOS:000239133200017
J	Culley, AI; Lang, AS; Suttle, CA				Culley, Alexander I.; Lang, Andrew S.; Suttle, Curtis A.			Metagenomic analysis of coastal RNA virus communities	SCIENCE			English	Article							HETEROSIGMA-AKASHIWO; NUCLEOTIDE-SEQUENCE; VIRAL COMMUNITIES; GENOME SEQUENCES; DIVERSITY; HARNAV; SEA	RNA viruses infect marine organisms from bacteria to whales, but RNA virus communities in the sea remain essentially unknown. Reverse-transcribed whole-genome shotgun sequencing was used to characterize the diversity of uncultivated marine RNA virus assemblages. A diverse assemblage of RNA viruses, including a broad group of marine picorna-like viruses, and distant relatives of viruses infecting arthropods and higher plants were found. Communities were dominated by distinct genotypes with small genome sizes, and we completely assembled the genomes of several hitherto undiscovered viruses. Our results show that the oceans are a reservoir of previously unknown RNA viruses.	Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; Univ Alaska, Inst Marine Sci, Fairbanks, AK 99775 USA	University of British Columbia; University of British Columbia; University of British Columbia; University of Alaska System; University of Alaska Fairbanks	Suttle, CA (corresponding author), Univ British Columbia, Dept Earth & Ocean Sci, 1461-6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	csuttle@eos.ubc.ca	suttle, c/N-1144-2019; Suttle, Curtis A/C-3150-2008	suttle, c/0000-0002-0372-0033; Suttle, Curtis A/0000-0002-0372-0033; Lang, Andrew/0000-0002-4510-7683				Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angly F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-41; BORSHEIM KY, 1993, FEMS MICROBIOL ECOL, V102, P141, DOI 10.1016/0378-1097(93)90197-A; Breitbart M, 2004, P ROY SOC B-BIOL SCI, V271, P565, DOI 10.1098/rspb.2003.2628; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Brussaard CPD, 2004, VIROLOGY, V319, P280, DOI 10.1016/j.virol.2003.10.033; CHRISTIAN P, 2005, MICR CHANG WORLD M I; Culley AI, 2003, NATURE, V424, P1054, DOI 10.1038/nature01886; DeLong EF, 2005, NATURE, V437, P336, DOI 10.1038/nature04157; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Kim DH, 2005, VIRUS RES, V107, P1, DOI 10.1016/j.virusres.2004.06.004; KOONIN EV, 1993, CRIT REV BIOCHEM MOL, V28, P375, DOI 10.3109/10409239309078440; Lang AS, 2004, VIROLOGY, V320, P206, DOI 10.1016/j.virol.2003.10.015; LOMMEL SA, 2004, VIRUS TAXONOMY 8 REP, P907; Mari J, 2002, J GEN VIROL, V83, P915, DOI 10.1099/0022-1317-83-4-915; Nagasaki K, 2005, APPL ENVIRON MICROB, V71, P8888, DOI 10.1128/AEM.71.12.8888-8894.2005; Nagasaki K, 2004, APPL ENVIRON MICROB, V70, P704, DOI 10.1128/AEM.70.2.704-711.2004; Rima BK, 2005, VIRUS GENES, V30, P113, DOI 10.1007/s11262-004-4588-7; Swofford D., 2002, PAUP 4 0B10; Tai V, 2003, J PHYCOL, V39, P343, DOI 10.1046/j.1529-8817.2003.01162.x; TALIANSKY ME, 2004, VIRUS TAXONOMY 8 REP, P901; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vetten HJ, 2004, VIRUS TAXONOMY, P343; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Wommack KE, 1999, APPL ENVIRON MICROB, V65, P241; Yokoi T, 2003, VIROLOGY, V311, P394, DOI 10.1016/S0042-6822(03)00183-1	29	261	276	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1795	1798		10.1126/science.1127404	http://dx.doi.org/10.1126/science.1127404			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16794078				2022-12-24	WOS:000238452800058
J	Bahar, R; Hartmann, CH; Rodriguez, KA; Denny, AD; Busuttil, RA; Dolle, MET; Calder, RB; Chisholm, GB; Pollock, BH; Klein, CA; Vijg, J				Bahar, Rumana; Hartmann, Claudia H.; Rodriguez, Karl A.; Denny, Ashley D.; Busuttil, Rita A.; Dolle, Martijn E. T.; Calder, R. Brent; Chisholm, Gary B.; Pollock, Brad H.; Klein, Christoph A.; Vijg, Jan			Increased cell-to-cell variation in gene expression in ageing mouse heart	NATURE			English	Article							IN-VIVO MUTATIONS; MODEL; AGE	The accumulation of somatic DNA damage has been implicated as a cause of ageing in metazoa(1,2). One possible mechanism by which increased DNA damage could lead to cellular degeneration and death is by stochastic deregulation of gene expression. Here we directly test for increased transcriptional noise in aged tissue by dissociating single cardiomyocytes from fresh heart samples of both young and old mice, followed by global mRNA amplification and quantification of mRNA levels in a panel of housekeeping and heart-specific genes. Although gene expression levels already varied among cardiomyocytes from young heart, this heterogeneity was significantly elevated at old age. We had demonstrated previously an increased load of genome rearrangements and other mutations in the heart of aged mice(3,4). To confirm that increased stochasticity of gene expression could be a result of increased genome damage, we treated mouse embryonic fibroblasts in culture with hydrogen peroxide. Such treatment resulted in a significant increase in cell-to-cell variation in gene expression, which was found to parallel the induction and persistence of genome rearrangement mutations at a lacZ reporter locus. These results underscore the stochastic nature of the ageing process, and could provide a mechanism for age-related cellular degeneration and death in tissues of multicellular organisms.	Buck Inst Age Res, Novato, CA 94945 USA; Univ Munich, Inst Immunol, D-80336 Munich, Germany; Univ Texas, Hlth Sci Ctr, San Antonio, TX 78245 USA; Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Buck Institute for Research on Aging; University of Munich; University of Texas System; University of Texas Health San Antonio; Netherlands National Institute for Public Health & the Environment	Vijg, J (corresponding author), Buck Inst Age Res, Novato, CA 94945 USA.	jvijg@buckinstitute.org	Rodriguez, Karl A/F-2689-2012	Klein, Christoph A./0000-0001-7128-1725	NIA NIH HHS [R36 AG033401] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R36AG033401] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; BOERRIGTER METI, 1995, NATURE, V377, P657, DOI 10.1038/377657a0; Busuttil RA, 2003, AGING CELL, V2, P287, DOI 10.1046/j.1474-9728.2003.00066.x; Dolle MET, 1996, MUTAGENESIS, V11, P111, DOI 10.1093/mutage/11.1.111; Dolle MET, 2000, P NATL ACAD SCI USA, V97, P8403, DOI 10.1073/pnas.97.15.8403; Dolle MET, 2002, GENOME RES, V12, P1732, DOI 10.1101/gr.125502; Finch C, 2000, CHANCE DEV AGING; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Golden TR, 2004, AGING CELL, V3, P111, DOI 10.1111/j.1474-9728.2004.00095.x; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kang PM, 2000, CIRC RES, V87, P118, DOI 10.1161/01.RES.87.2.118; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Klein CA, 2002, NAT BIOTECHNOL, V20, P387, DOI 10.1038/nbt0402-387; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Levsky JM, 2003, TRENDS CELL BIOL, V13, P4, DOI 10.1016/S0962-8924(02)00002-8; ORGEL LE, 1963, P NATL ACAD SCI USA, V49, P517, DOI 10.1073/pnas.49.4.517; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Vijg J, 2002, MECH AGEING DEV, V123, P907, DOI 10.1016/S0047-6374(02)00028-3	19	390	401	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 22	2006	441	7096					1011	1014		10.1038/nature04844	http://dx.doi.org/10.1038/nature04844			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791200	Green Submitted			2022-12-24	WOS:000238422300049
J	Donley-Hayes, K				Donley-Hayes, Karen			At face value	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											No Org, W Farmington, OH 44491 USA.	kdonley@bright.net							0	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2006	295	23					2701	2702		10.1001/jama.295.23.2701	http://dx.doi.org/10.1001/jama.295.23.2701			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	054OZ	16788117				2022-12-24	WOS:000238389700001
J	Wilson, JF				Wilson, Jennifer Fisher			The rocky road to useful cancer biomarkers	ANNALS OF INTERNAL MEDICINE			English	News Item							OVARIAN-CANCER; SERUM					jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Baggerly KA, 2005, JNCI-J NATL CANCER I, V97, P307, DOI 10.1093/jnci/dji008; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967	4	13	13	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2006	144	12					945	948		10.7326/0003-4819-144-12-200606200-00022	http://dx.doi.org/10.7326/0003-4819-144-12-200606200-00022			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056WJ	16785487				2022-12-24	WOS:000238555500017
J	Brar, GA; Kiburz, BM; Zhang, Y; Kim, JE; White, F; Amon, A				Brar, Gloria A.; Kiburz, Brendan M.; Zhang, Yi; Kim, Ji-Eun; White, Forest; Amon, Angelika			Rec8 phosphorylation and recombination promote the step-wise loss of cohesins in meiosis	NATURE			English	Article							SISTER-CHROMATID COHESION; POLO-LIKE KINASE; PROTEIN PHOSPHATASE 2A; HOMOLOGOUS CHROMOSOMES; CENTROMERIC COHESION; SPINDLE CHECKPOINT; YEAST MEIOSIS; I DEPENDS; SEGREGATION; MEI-S332	During meiosis, cohesins-protein complexes that hold sister chromatids together-are lost from chromosomes in a step-wise manner(1). Loss of cohesins from chromosome arms is necessary for homologous chromosomes to segregate during meiosis I. Retention of cohesins around centromeres until meiosis II is required for the accurate segregation of sister chromatids. Here we show that phosphorylation of the cohesin subunit Rec8 contributes to step-wise cohesin removal. Our data further implicate two other key regulators of meiotic chromosome segregation, the cohesin protector Sgo1 and meiotic recombination in bringing about the step-wise loss of cohesins and thus the establishment of the meiotic chromosome segregation pattern. Understanding the interplay between these processes should provide insight into the events underlying meiotic chromosome mis-segregation, the leading cause of miscarriages and mental retardation in humans.	MIT, Howard Hughes Med Inst, Ctr Canc Res, Cambridge, MA 02139 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, Howard Hughes Med Inst, Ctr Canc Res, E17-233 40 Ames St, Cambridge, MA 02139 USA.	angelika@mit.edu		Amon, Angelika/0000-0001-9837-0314; White, Forest/0000-0002-1545-1651	NIGMS NIH HHS [R01 GM062207] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Buonomo SBC, 2003, DEV CELL, V4, P727, DOI 10.1016/S1534-5807(03)00129-1; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Hornig NCD, 2004, EMBO J, V23, P3144, DOI 10.1038/sj.emboj.7600303; Katis VL, 2004, CURR BIOL, V14, P560, DOI 10.1016/j.cub.2004.03.001; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; KERREBROCK AW, 1995, CELL, V83, P247, DOI 10.1016/0092-8674(95)90166-3; Kiburz BM, 2005, GENE DEV, V19, P3017, DOI 10.1101/gad.1373005; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300; Shonn MA, 2003, CURR BIOL, V13, P1979, DOI 10.1016/j.cub.2003.10.057; Tang TTL, 1998, GENE DEV, V12, P3843, DOI 10.1101/gad.12.24.3843; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Yu HG, 2005, CELL, V123, P397, DOI 10.1016/j.cell.2005.09.014	28	103	105	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					532	536		10.1038/nature04794	http://dx.doi.org/10.1038/nature04794			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16672979				2022-12-24	WOS:000237778900055
J	Armstrong, GL; Wasley, A; Simard, EP; McQuillan, GM; Kuhnert, WL; Alter, MJ				Armstrong, Gregory L.; Wasley, Annemarie; Simard, Edgar P.; McQuillan, Geraldine M.; Kuhnert, Wendi L.; Alter, Miriam J.			The prevalence of hepatitis C virus infection in the United States, 1999 through 2002	ANNALS OF INTERNAL MEDICINE			English	Article							INJECTION-DRUG USERS; RISK-FACTORS; HEPATOCELLULAR-CARCINOMA; LIVER-DISEASE; INCREASE	Background: Defining the primary characteristics of persons infected with hepatitis C virus (HCV) enables physicians to more easily identify persons who are most likely to benefit from testing for the disease. Objective: To describe the HCV-infected population in the United States. Design: Nationally representative household survey. Setting: U.S. civilian, noninstitutionalized population. Participants: 15 079 participants in the National Health and Nutrition Examination Survey between 1999 and 2002. Measurements: All participants provided medical histories, and those who were 20 to 59 years of age provided histories of drug use and sexual practices. Participants were tested for antibodies to HCV (anti-HCV) and HCV RNA, and their serum alanine aminotransferase (ALT) levels were measured. Results: The prevalence of anti-HCV in the United States was 1.6% (95% CI, 1.3% to 1.9%), equating to an estimated 4.1 million (C), 3.4 million to 4.9 million) anti-HCV-positive persons nationwide; 1.3% or 3.2 million (CI, 2.7 million to 3.9 million) persons had chronic HCV infection. Peak prevalence of anti-HCV (4.3%) was observed among persons 40 to 49 years of age. A total of 48.4% of anti-HCV-positive persons between 20 and 59 years of age reported a history of injection drug use, the strongest risk factor for HCV infection. Of all persons reporting such a history, 83.3% had not used injection drugs for at least 1 year before the survey. Other significant risk factors included 20 or more lifetime sex partners and blood transfusion before 1992. Abnormal serum ALT levels were found in 58.7% of HCV RNA-positive persons. Three characteristics (abnormal serum ALT level, any history of injection drug use, and history of blood transfusion before 1992) identified 85.1% of HCV RNA-positive participants between 20 and 59 years of age. Limitations: Incarcerated and homeless persons were not included in the survey. Conclusions: Many Americans are infected with HCV. Most were born between 1945 and 1964 and can be identified with current screening criteria. History of injection drug use is the strongest risk factor for infection.	Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Armstrong, GL (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr Infect Dis, Mailstop G-37,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	GArmstrong@cdc.gov	Simard, Edgar/G-4552-2010	Simard, Edgar/0000-0001-8093-2067				Alter HJ, 2000, NAT MED, V6, P1082, DOI 10.1038/80394; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Alter MJ, 2004, ANN INTERN MED, V141, P715, DOI 10.7326/0003-4819-141-9-200411020-00013; ALTER MJ, 1990, JAMA-J AM MED ASSOC, V264, P2231, DOI 10.1001/jama.264.17.2231; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332; ARMSTRONG GL, 2004, P 42 ANN M INF DIS S, P191; *CDCP, GEN INF NHANES INT D; *CDCP, NHANES 2001 2002 PUB; *CDCP, 58 DCP; *CDCP, NHANES AN GUID; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Cheung RC, 2002, J CLIN GASTROENTEROL, V34, P476, DOI 10.1097/00004836-200204000-00021; ConryCantilena C, 1996, NEW ENGL J MED, V334, P1691, DOI 10.1056/NEJM199606273342602; Davis GL, 2003, LIVER TRANSPLANT, V9, P331, DOI 10.1053/jlts.2003.50073; Des Jarlais DC, 2003, AM J EPIDEMIOL, V157, P467, DOI 10.1093/aje/kwf222; DONAHUE JG, 1992, NEW ENGL J MED, V327, P369, DOI 10.1056/NEJM199208063270601; El-Serag H, 2003, ANN INTERN MED, V139, P817, DOI 10.7326/0003-4819-139-10-200311180-00009; Fuller CM, 2004, J URBAN HEALTH, V81, P20, DOI 10.1093/jurban/jth084; Hagan H, 2004, EPIDEMIOLOGY, V15, P543, DOI 10.1097/01.ede.0000135170.54913.9d; Hahn JA, 2002, J INFECT DIS, V186, P1558, DOI 10.1086/345554; Johnston L D, 1997, NIDA Res Monogr, V167, P59; Murphy EL, 2000, HEPATOLOGY, V31, P756, DOI 10.1002/hep.510310329; Orton SL, 2004, TRANSFUSION, V44, P275, DOI 10.1111/j.1537-2995.2004.00623.x; Salomon JA, 2002, AM J EPIDEMIOL, V156, P761, DOI 10.1093/aje/kwf100; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P15584, DOI 10.1073/pnas.242608099; Thomas DL, 2000, HEPATOLOGY, V31, P790, DOI 10.1002/hep.510310336; Thorpe LE, 2002, AM J EPIDEMIOL, V155, P645, DOI 10.1093/aje/155.7.645; Wong JB, 2000, AM J PUBLIC HEALTH, V90, P1562, DOI 10.2105/AJPH.90.10.1562	30	1556	1601	0	48	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2006	144	10					705	714		10.7326/0003-4819-144-10-200605160-00004	http://dx.doi.org/10.7326/0003-4819-144-10-200605160-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043XO	16702586				2022-12-24	WOS:000237636400001
J	Yoon, A; Peng, G; Brandenburg, Y; Zollo, O; Xu, W; Rego, E; Ruggero, D				Yoon, A; Peng, G; Brandenburg, Y; Zollo, O; Xu, W; Rego, E; Ruggero, D			Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita	SCIENCE			English	Article							P27(KIP1) MESSENGER-RNA; RIBOSOME-ENTRY-SITE; MICE LACKING; CELL-DEATH; ACCUMULATION; ASSOCIATION; HYPERPLASIA; EXPRESSION; INITIATION; DEFICIENT	The DKC1 gene encodes a pseudouridine synthase that modifies ribosomal RNA ( rRNA). DKC1 is mutated in people with X-linked dyskeratosis congenita (X-DC), a disease characterized by bone marrow failure, skin abnormalities, and increased susceptibility to cancer. How alterations in ribosome modification might lead to cancer and other features of the disease remains unknown. Using an unbiased proteomics strategy, we discovered a specific defect in IRES ( internal ribosome entry site) - dependent translation in Dkc1(m) mice and in cells from X-DC patients. This defect results in impaired translation of messenger RNAs containing IRES elements, including those encoding the tumor suppressor p27(Kip1) and the antiapoptotic factors Bcl-xL and XIAP (X-linked Inhibitor of Apoptosis Protein). Moreover, Dkc1(m) ribosomes were unable to direct translation from IRES elements present in viral messenger RNAs. These findings reveal a potential mechanism by which defective ribosome activity leads to disease and cancer.	Fox Chase Canc Ctr, Human Genet Program, Philadelphia, PA 19111 USA; Univ Sao Paulo, Ctr Cell Based Therapy, Fdn Hemoctr Ribeirao Preto, BR-05508 Sao Paulo, Brazil	Fox Chase Cancer Center; Universidade de Sao Paulo	Ruggero, D (corresponding author), Fox Chase Canc Ctr, Human Genet Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	davide.ruggero@fccc.edu	Rego, Eduardo M./Y-5572-2019; Rego, Eduardo M/A-1058-2012; Rego, Eduardo/AFS-7973-2022	Rego, Eduardo M./0000-0003-1567-4086; Rego, Eduardo M/0000-0003-1567-4086; Rego, Eduardo/0000-0003-1567-4086				Cho SC, 2005, MOL CELL BIOL, V25, P1283, DOI 10.1128/MCB.25.4.1283-1297.2005; Dokal I, 1996, Curr Opin Hematol, V3, P453; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fero ML, 1998, NATURE, V396, P177, DOI 10.1038/24179; Gasper NA, 2002, INFECT IMMUN, V70, P4075, DOI 10.1128/IAI.70.8.4075-4082.2002; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Holcik M, 1999, NAT CELL BIOL, V1, P190, DOI 10.1038/11109; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Meier UT, 2005, CHROMOSOMA, V114, P1, DOI 10.1007/s00412-005-0333-9; Millard SS, 1997, J BIOL CHEM, V272, P7093, DOI 10.1074/jbc.272.11.7093; Miskimins WK, 2001, MOL CELL BIOL, V21, P4960, DOI 10.1128/MCB.21.15.4960-4967.2001; Mochizuki Y, 2004, P NATL ACAD SCI USA, V101, P10756, DOI 10.1073/pnas.0402560101; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; PELLETIER J, 1989, J VIROL, V63, P441, DOI 10.1128/JVI.63.1.441-444.1989; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Philipp-Staheli J, 2001, EXP CELL RES, V264, P148, DOI 10.1006/excr.2000.5143; Ruggero D, 2003, SCIENCE, V299, P259, DOI 10.1126/science.1079447; Sharma V, 2006, J IMMUNOL, V176, P97, DOI 10.4049/jimmunol.176.1.97; Socolovsky M, 1999, CELL, V98, P181, DOI 10.1016/S0092-8674(00)81013-2; Stauber AJ, 2005, MOL PHARMACOL, V67, P681, DOI 10.1124/mol.104.007278; Stoneley M, 1998, ONCOGENE, V16, P423, DOI 10.1038/sj.onc.1201763; Wang C, 2002, MOL CELL BIOL, V22, P8457, DOI 10.1128/MCB.22.24.8457-8466.2002; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6	29	306	316	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					902	906		10.1126/science.1123835	http://dx.doi.org/10.1126/science.1123835			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690864				2022-12-24	WOS:000237452900045
J	Yin, Y; He, X; Szewczyk, P; Nguyen, T; Chang, G				Yin, Y; He, X; Szewczyk, P; Nguyen, T; Chang, G			Structure of the multidrug transporter EmrD from Escherichia coli	SCIENCE			English	Article							MAJOR FACILITATOR SUPERFAMILY; EFFLUX PUMP; CRYSTAL-STRUCTURE; MECHANISM; RESISTANCE; MEMBRANE; BINDING; PROTEIN; MDFA; MSBA	EmrD is a multidrug transporter from the Major Facilitator Superfamily that expels amphipathic compounds across the inner membrane of Escherichia coli. Here, we report the x-ray structure of EmrD determined to a resolution of 3.5 angstroms. The structure reveals an interior that is composed mostly of hydrophobic residues, which is consistent with its role transporting amphipathic molecules. Two long loops extend into the inner leaflet side of the cell membrane. This region can serve to recognize and bind substrate directly from the lipid bilayer. We propose that multisubstrate specificity, binding, and transport are facilitated by these loop regions and the internal cavity.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Chang, G (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,CB-105, La Jolla, CA 92037 USA.	gchang@scripps.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM065798, R01GM070480] Funding Source: NIH RePORTER; NIGMS NIH HHS [R21 GM065798-01, R01 GM070480, R21 GM065798-02, GM70480, GM65798] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Adler J, 2005, J BIOL CHEM, V280, P2721, DOI 10.1074/jbc.M412332200; Adler J, 2004, J BIOL CHEM, V279, P8957, DOI 10.1074/jbc.M313422200; Bolhuis H, 1996, J BIOL CHEM, V271, P24123, DOI 10.1074/jbc.271.39.24123; Bolhuis H, 1996, EMBO J, V15, P4239, DOI 10.1002/j.1460-2075.1996.tb00798.x; Braibant M, 2005, ANTIMICROB AGENTS CH, V49, P2965, DOI 10.1128/AAC.49.7.2965-2971.2005; Chang AB, 2004, MOL MEMBR BIOL, V21, P171, DOI 10.1080/09687680410001720830; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; DELANO WL, PYMOL MOL VISUALIZAT; Edgar R, 1999, EMBO J, V18, P822, DOI 10.1093/emboj/18.4.822; Fralick JA, 1996, J BACTERIOL, V178, P5803, DOI 10.1128/jb.178.19.5803-5805.1996; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; KASIANOWICZ J, 1984, J MEMBRANE BIOL, V82, P179, DOI 10.1007/BF01868942; Klyachko KA, 1997, J BACTERIOL, V179, P2189, DOI 10.1128/jb.179.7.2189-2193.1997; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; KRULWICH TA, 1990, MICROBIOL REV, V54, P52, DOI 10.1128/MMBR.54.1.52-65.1990; Mazurkiewicz P, 2002, J BIOL CHEM, V277, P26081, DOI 10.1074/jbc.M203141200; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murray DS, 2004, J BIOL CHEM, V279, P14365, DOI 10.1074/jbc.M313870200; NARODITSKAYA V, 1993, BIOCHEM BIOPH RES CO, V196, P803, DOI 10.1006/bbrc.1993.2320; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Nishino K, 2006, MOL MICROBIOL, V59, P126, DOI 10.1111/j.1365-2958.2005.04940.x; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; PAULSEN IT, 2002, MICROBIAL MULTIDRUG; Pornillos O, 2005, SCIENCE, V310, P1950, DOI 10.1126/science.1119776; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Reyes CL, 2005, SCIENCE, V308, P1028, DOI 10.1126/science.1107733; Saier MH, 2003, MOL MICROBIOL, V48, P1145, DOI 10.1046/j.1365-2958.2003.03499.x; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Schumacher MA, 2004, EMBO J, V23, P2923, DOI 10.1038/sj.emboj.7600288; Woebking B, 2005, J BACTERIOL, V187, P6363, DOI 10.1128/JB.187.18.6363-6369.2005	33	303	309	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					741	744		10.1126/science.1125629	http://dx.doi.org/10.1126/science.1125629			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675700	Green Accepted			2022-12-24	WOS:000237312100049
J	Both, C; Bouwhuis, S; Lessells, CM; Visser, ME				Both, C; Bouwhuis, S; Lessells, CM; Visser, ME			Climate change and population declines in a long-distance migratory bird	NATURE			English	Article							TIT PARUS-MAJOR; LIFE-HISTORY TRAITS; FICEDULA-HYPOLEUCA; AVIAN REPRODUCTION; WINTER MOTH; PHENOLOGY; TEMPERATURE; SONGBIRDS; RESPONSES; MIGRANT	Phenological responses to climate change differ across trophic levels(1-3), which may lead to birds failing to breed at the time of maximal food abundance. Here we investigate the population consequences of such mistiming in the migratory pied flycatcher, Ficedula hypoleuca(4). In a comparison of nine Dutch populations, we find that populations have declined by about 90% over the past two decades in areas where the food for provisioning nestlings peaks early in the season and the birds are currently mistimed. In areas with a late food peak, early-breeding birds still breed at the right time, and there is, at most, a weak population decline. If food phenology advances further, we also predict population declines in areas with a late food peak, as in these areas adjustment to an advanced food peak is insufficient(4). Mistiming as a result of climate change is probably a widespread phenomenon(1), and here we provide evidence that it can lead to population declines.	NIOO KNAW, Netherlands Inst Ecol, NL-6666 ZG Heteren, Netherlands; Univ Groningen, Anim Ecol Grp, Ctr Ecol & Evolut Studies, NL-9750 AA Haren, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of Groningen	Both, C (corresponding author), NIOO KNAW, Netherlands Inst Ecol, POB 40, NL-6666 ZG Heteren, Netherlands.	C.Both@rug.nl	Lessells, C.M./B-3891-2011; Bouwhuis, Sandra/H-5270-2011; Visser, Marcel E/A-9151-2009; Both, Christiaan/E-6459-2011	Bouwhuis, Sandra/0000-0003-4023-1578; Visser, Marcel E/0000-0002-1456-1939; Both, Christiaan/0000-0001-7099-9831; van der Heijden, Marianne/0000-0002-0795-3619				Berthold P, 1998, NATURWISSENSCHAFTEN, V85, P350, DOI 10.1007/s001140050514; Boele Arjan, 2001, Limosa, V74, P103; Both C, 2005, J AVIAN BIOL, V36, P368, DOI 10.1111/j.0908-8857.2005.03484.x; Both C, 2005, GLOBAL CHANGE BIOL, V11, P1606, DOI 10.1111/j.1365-2486.2005.01038.x; Both C, 2004, P ROY SOC B-BIOL SCI, V271, P1657, DOI 10.1098/rspb.2004.2770; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Brommer JE, 2005, EVOLUTION, V59, P1362; Buse A, 1999, FUNCT ECOL, V13, P74, DOI 10.1046/j.1365-2435.1999.00010.x; Gwinner E, 1996, IBIS, V138, P47, DOI 10.1111/j.1474-919X.1996.tb04312.x; McLaughlin JF, 2002, P NATL ACAD SCI USA, V99, P6070, DOI 10.1073/pnas.052131199; Merila J, 2001, NATURE, V412, P76, DOI 10.1038/35083580; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sanz JJ, 1998, ARDEA, V86, P81; Sauer JR, 1996, CONSERV BIOL, V10, P465, DOI 10.1046/j.1523-1739.1996.10020465.x; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; TINBERGEN JM, 1994, FUNCT ECOL, V8, P563, DOI 10.2307/2389916; VANBALEN JH, 1973, ARDEA, V61, P1; Verboven N, 2001, ARDEA, V89, P387; Visser ME, 2003, P ROY SOC B-BIOL SCI, V270, P367, DOI 10.1098/rspb.2002.2244; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Visser ME, 2004, ADV ECOL RES, V35, P89, DOI 10.1016/S0065-2504(04)35005-1; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P289, DOI 10.1098/rspb.2000.1363; von HAARTMAN LARS, 1954, ACTA ZOOL FENNICA, V83, P1; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Winkler DW, 2002, P NATL ACAD SCI USA, V99, P13595, DOI 10.1073/pnas.212251999	28	972	1025	6	774	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 4	2006	441	7089					81	83		10.1038/nature04539	http://dx.doi.org/10.1038/nature04539			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16672969	Green Submitted, Green Published			2022-12-24	WOS:000237248600036
J	Berry, JF; Bill, E; Bothe, E; George, SD; Mienert, B; Neese, F; Wieghardt, K				Berry, John F.; Bill, Eckhard; Bothe, Eberhard; George, Serena DeBeer; Mienert, Bernd; Neese, Frank; Wieghardt, Karl			An octahedral coordination complex of iron(VI)	SCIENCE			English	Article							WASTE-WATER TREATMENT; SPECTROSCOPIC CHARACTERIZATION; METHANE MONOOXYGENASE; ELECTRONIC-STRUCTURE; CYTOCHROME P450CAM; CRYSTAL-STRUCTURE; DFT CALCULATIONS; NONHEME; HYDROXYLATION; HYDROGENASE	The hexavalent state, considered to be the highest oxidation level accessible for iron, has previously been found only in the tetrahedral ferrate dianion, FeO42-. We report the photochemical synthesis of another Fe(VI) compound, an octahedrally coordinated dication bearing a terminal nitrido ligand. Mossbauer and x-ray absorption spectra, supported by density functional theory, are consistent with the octahedral structure having an Fe=N triple bond of 1.57 angstroms and a singlet d(xy)(2) ground electronic configuration. The compound is stable at 77 kelvin and yields a high-spin spin Fe(III) species upon warming.	Max Planck Inst Bioanorgan Chem, D-45470 Mulheim, Germany; Stanford Univ, Stanford Synchrotron Radiat Lab, Stanford, CA 94309 USA	Max Planck Society; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Wieghardt, K (corresponding author), Max Planck Inst Bioanorgan Chem, Stiftstr 34-36, D-45470 Mulheim, Germany.	wieghardt@mpi-muelheim.mpg.de	DeBeer, Serena/T-6420-2018; Neese, Frank/J-4959-2014; Wieghardt, Karl/B-4179-2014; DeBeer, Serena/G-6718-2012	DeBeer, Serena/0000-0002-5196-3400; Neese, Frank/0000-0003-4691-0547; Wieghardt, Karl/0000-0003-0600-7855; Berry, John/0000-0002-6805-0640				Aliaga-Alcalde N, 2005, ANGEW CHEM INT EDIT, V44, P2908, DOI 10.1002/anie.200462368; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Berry JF, 2006, INORG CHEM, V45, P2027, DOI 10.1021/ic051823y; Berry JF, 2005, J AM CHEM SOC, V127, P11550, DOI 10.1021/ja052673t; Betley TA, 2004, J AM CHEM SOC, V126, P6252, DOI 10.1021/ja048713v; Bowen L.H., 1993, MOSSBAUER SPECTROSCO, V1, P115; Bukowski MR, 2005, SCIENCE, V310, P1000, DOI 10.1126/science.1119092; Chanda A, 2006, J INORG BIOCHEM, V100, P606, DOI 10.1016/j.jinorgbio.2005.12.016; Costas M, 2001, J AM CHEM SOC, V123, P12931, DOI 10.1021/ja017204f; Cummins CC, 2006, ANGEW CHEM INT EDIT, V45, P862, DOI 10.1002/anie.200503327; CUMMINS CC, 1994, INORG CHEM, V33, P395, DOI 10.1021/ic00080a033; Davydov R, 2001, J AM CHEM SOC, V123, P1403, DOI 10.1021/ja003583l; Delaude L, 1996, J ORG CHEM, V61, P6360, DOI 10.1021/jo960633p; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Grapperhaus CA, 2000, INORG CHEM, V39, P5306, DOI 10.1021/ic0005238; Grapperhaus CA, 2001, INORG CHEM, V40, P4191, DOI 10.1021/ic001370r; Greenwood N. N., 1971, MOSSBAUER SPECTROSCO; Haskin LA, 2005, NATURE, V436, P66, DOI 10.1038/nature03640; Jensen MP, 2005, J AM CHEM SOC, V127, P10512, DOI 10.1021/ja0438765; Jiang JQ, 2002, WATER RES, V36, P1397, DOI 10.1016/S0043-1354(01)00358-X; Kaizer J, 2004, J AM CHEM SOC, V126, P472, DOI 10.1021/ja037288n; KAZAMA F, 1994, FEMS MICROBIOL LETT, V118, P345, DOI 10.1016/0378-1097(94)90527-4; Klingelhofer G, 2004, SCIENCE, V306, P1740, DOI 10.1126/science.1104653; Klinker EJ, 2005, ANGEW CHEM INT EDIT, V44, P3690, DOI 10.1002/anie.200500485; Kumar D, 2005, J AM CHEM SOC, V127, P8026, DOI 10.1021/ja0512428; Licht S, 1999, SCIENCE, V285, P1039, DOI 10.1126/science.285.5430.1039; Lowdin P.-O., 1970, ADV QUANTUM CHEM, V5, P185, DOI [DOI 10.1016/S0065-3276(08)60339-1, 10.1016/S0065-3276(08)60339-1]; Merkx M, 2001, ANGEW CHEM INT EDIT, V40, P2782, DOI 10.1002/1521-3773(20010803)40:15<2782::AID-ANIE2782>3.0.CO;2-P; Meyer K, 1999, J AM CHEM SOC, V121, P4859, DOI 10.1021/ja983454t; MISKOWSKI VM, 1996, ADV TRANSIT MET COOR, V1, P159; Murad E., 1987, MOSSBAUER SPECTROSCO, V2, P507; Nakamoto K, 2002, COORDIN CHEM REV, V226, P153, DOI 10.1016/S0010-8545(01)00425-8; Newcomb M, 2006, J AM CHEM SOC, V128, P4580, DOI 10.1021/ja060048y; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Rohde JU, 2004, J AM CHEM SOC, V126, P16750, DOI 10.1021/ja047667w; Rohde JU, 2003, SCIENCE, V299, P1037, DOI 10.1126/science.299.5609.1037; Russo U., 1989, MOSSBAUER SPECTROSCO, V3, P289; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Sharma VK, 2004, WATER SCI TECHNOL, V49, P69, DOI 10.2166/wst.2004.0223; Shima S, 2005, J AM CHEM SOC, V127, P10430, DOI 10.1021/ja051895o; Slep LD, 2003, J AM CHEM SOC, V125, P15554, DOI 10.1021/ja030377f; Thomas CM, 2006, J AM CHEM SOC, V128, P4956, DOI 10.1021/ja0604358; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0	44	232	235	7	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 30	2006	312	5782					1937	1941		10.1126/science.1128506	http://dx.doi.org/10.1126/science.1128506			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061CF	16741074				2022-12-24	WOS:000238848100055
J	Okada, K; Inoue, A; Okada, M; Murata, Y; Kakuta, S; Jigami, T; Kubo, S; Shiraishi, H; Eguchi, K; Motomura, M; Akiyama, T; Iwakura, Y; Higuchi, O; Yamanashi, Y				Okada, Kumiko; Inoue, Akane; Okada, Momoko; Murata, Yoji; Kakuta, Shigeru; Jigami, Takafumi; Kubo, Sachiko; Shiraishi, Hirokazu; Eguchi, Katsumi; Motomura, Masakatsu; Akiyama, Tetsu; Iwakura, Yoichiro; Higuchi, Osamu; Yamanashi, Yuji			The muscle protein Dok-7 is essential for neuromuscular synaptogenesis	SCIENCE			English	Article							TYROSINE KINASE MUSK; ACETYLCHOLINE-RECEPTOR; SYNAPSE FORMATION; MUTANT MICE; IN-VIVO; JUNCTION; NEUROTRANSMITTER; DIFFERENTIATION	The formation of the neuromuscular synapse requires muscle-specific receptor kinase (MuSK) to orchestrate postsynaptic differentiation, including the clustering of receptors for the neurotransmitter acetylcholine. Upon innervation, neural agrin activates MuSK to establish the postsynaptic apparatus, although agrin-independent formation of neuromuscular synapses can also occur experimentally in the absence of neurotransmission. Dok-7, a MuSK-interacting cytoplasmic protein, is essential for MuSK activation in cultured myotubes; in particular, the Dok-7 phosphotyrosine-binding domain and its target in MuSK are indispensable. Mice lacking Dok-7 formed neither acetylcholine receptor clusters nor neuromuscular synapses. Thus, Dok-7 is essential for neuromuscular synaptogenesis through its interaction with MuSK.	Tokyo Med & Dent Univ, Inst Med Res, Dept Cell Regulat, Tokyo 1138510, Japan; Tokyo Med & Dent Univ, Sch Biomed Sci, Tokyo 1138510, Japan; Univ Tokyo, Inst Med Sci, Ctr Med Expt, Tokyo 1088639, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Tokyo 1130032, Japan; Nagasaki Univ, Grad Sch Biomed Sci, Dept Internal Med 1, Nagasaki 8528501, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Tokyo; University of Tokyo; Nagasaki University	Higuchi, O (corresponding author), Tokyo Med & Dent Univ, Inst Med Res, Dept Cell Regulat, Tokyo 1138510, Japan.	higuchi.creg@mri.tmd.ac.jp; yamanashi.creg@mri.tmd.ac.jp	Iwakura, Yoichiro/E-5457-2011; Kakuta, Shigeru/L-2241-2018	Iwakura, Yoichiro/0000-0002-9934-5775; Kakuta, Shigeru/0000-0002-5900-1425; Murata, Yoji/0000-0002-9576-7030				Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; Carpino N, 1997, CELL, V88, P197, DOI 10.1016/S0092-8674(00)81840-1; Chevessier F, 2004, HUM MOL GENET, V13, P3229, DOI 10.1093/hmg/ddh333; Crowder RJ, 2004, J BIOL CHEM, V279, P42072, DOI 10.1074/jbc.M403726200; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Engel AG, 2003, NAT REV NEUROSCI, V4, P339, DOI 10.1038/nrn1101; Fuhrer C, 1997, EMBO J, V16, P4951, DOI 10.1093/emboj/16.16.4951; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0; Gillespie SKH, 1996, NEURON, V16, P953, DOI 10.1016/S0896-6273(00)80118-X; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Herbst R, 2002, DEVELOPMENT, V129, P5449, DOI 10.1242/dev.00112; Herbst R, 2000, EMBO J, V19, P67, DOI 10.1038/sj.emboj.7592228b; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sugiyama JE, 1997, J CELL BIOL, V139, P181, DOI 10.1083/jcb.139.1.181; Vincent A, 2003, ANN NY ACAD SCI, V998, P324, DOI 10.1196/annals.1254.036; Watty A, 2000, P NATL ACAD SCI USA, V97, P4585, DOI 10.1073/pnas.080061997; Yamanashi Y, 1997, CELL, V88, P205, DOI 10.1016/S0092-8674(00)81841-3; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Zhou H, 1999, J CELL BIOL, V146, P1133, DOI 10.1083/jcb.146.5.1133	25	290	308	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1802	1805		10.1126/science.1127142	http://dx.doi.org/10.1126/science.1127142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16794080				2022-12-24	WOS:000238452800060
J	Ghabrial, AS; Krasnow, MA				Ghabrial, Amin S.; Krasnow, Mark A.			Social interactions among epithelial cells during tracheal branching morphogenesis	NATURE			English	Article							MIDLINE GLIAL-CELLS; DROSOPHILA TRACHEA; FGF; GENE; ACTIVATION; ENCODES; NOTCH; FATE; TUBULOGENESIS; BREATHLESS	Many organs are composed of tubular networks that arise by branching morphogenesis in which cells bud from an epithelium and organize into a tube(1-3). Fibroblast growth factors ( FGFs) and other signalling molecules have been shown to guide branch budding and outgrowth(4-7), but it is not known how epithelial cells coordinate their movements and morphogenesis. Here we use genetic mosaic analysis in Drosophila melanogaster to show that there are two functionally distinct classes of cells in budding tracheal branches: cells at the tip that respond directly to Branchless FGF and lead branch outgrowth, and trailing cells that receive a secondary signal to follow the lead cells and form a tube. These roles are not pre-specified; rather, there is competition between cells such that those with the highest FGF receptor activity take the lead positions, whereas those with less FGF receptor activity assume subsidiary positions and form the branch stalk. Competition appears to involve Notch-mediated lateral inhibition that prevents extra cells from assuming the lead. There may also be cooperation between budding cells, because in a mosaic epithelium, cells that cannot respond to the chemoattractant, or respond only poorly, allow other cells in the epithelium to move ahead of them.	Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Biochem, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Krasnow, MA (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Biochem, Stanford, CA 94305 USA.	krasnow@cmgm.stanford.edu	Ghabrial, Amin S/J-4586-2013; Ghabrial, Amin/ABB-1364-2020	Ghabrial, Amin S/0000-0002-6160-3003; 	NIGMS NIH HHS [F32 GM020723-03, F32 GM020723] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM020723] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cabernard C, 2005, DEV CELL, V9, P831, DOI 10.1016/j.devcel.2005.10.008; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Chihara T, 2000, DEVELOPMENT, V127, P4433; Gabay L, 1997, DEVELOPMENT, V124, P3535; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; Ikeya T, 1999, DEVELOPMENT, V126, P4455; Imam F, 1999, GENETICS, V152, P307; Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9; KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668; KLAMBT C, 1993, DEVELOPMENT, V117, P163; Llimargas M, 2000, DEVELOPMENT, V127, P4407; Llimargas M, 1999, DEVELOPMENT, V126, P2355; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Ohshiro T, 2002, MECH DEVELOP, V114, P3, DOI 10.1016/S0925-4773(02)00042-4; Park WY, 1998, DEV BIOL, V201, P125, DOI 10.1006/dbio.1998.8994; Pepicelli CV, 1997, DEV BIOL, V192, P193, DOI 10.1006/dbio.1997.8745; Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Shakya R, 2005, DEV CELL, V8, P65, DOI 10.1016/j.devcel.2004.11.008; Steneberg P, 1999, MECH DEVELOP, V87, P153, DOI 10.1016/S0925-4773(99)00157-4; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3; Weaver M, 2000, DEVELOPMENT, V127, P2695	30	171	176	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					746	749		10.1038/nature04829	http://dx.doi.org/10.1038/nature04829			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760977	Green Published			2022-12-24	WOS:000238095100053
J	Nordt, C; Stohler, R				Nordt, C; Stohler, R			Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis	LANCET			English	Article							HARM REDUCTION; DRUG-TREATMENT; PREVALENCE; TRENDS; PROJECTION; NUMBER; SCENE	Background Switzerland has been criticised for its liberal drug policy, which could attract new users and lengthen periods of heroin addiction. We sought to estimate incidence trends and prevalence of problem heroin use in Switzerland. Methods We obtained information about first year of regular heroin use from the case register of substitution treatments in the canton of Zurich for 7256 patients (76% of those treated between 1991 and March, 2005). We estimated the proportion of heroin users not yet in substitution treatment programmes using the conditional lag-time distribution. Cessation rate was the proportion of individuals leaving substitution treatment programmes and not re-entering within the subsequent 10 years. Overall prevalence of problematic heroin use was modelled as a function of incidence and cessation rate. Findings Every second person began their first substitution treatment within 2 years of starting to use heroin regularly. Incidence of heroin use rose steeply, starting with about 80 people in 1975, culminating in 1990 with 850 new users, and declining substantially to about 150 users in 2002. Two-thirds of those who had left substitution treatment programmes re-entered within the next 10 years. The population of problematic heroin users declined by 4% a year. The cessation rate in Switzerland was low, and therefore, the prevalence rate declined slowly. Our prevalence model accords with data generated by different approaches. Interpretation The harm reduction policy of Switzerland and its emphasis on the medicalisation of the heroin problem seems to have contributed to the image of heroin as unattractive for young people. Our model could enable the study of incidence trends across different countries and thus urgently needed assessments of the effect of different drug policies.	Psychiat Univ Hosp, Zurich, Switzerland		Nordt, C (corresponding author), Psychiat Univ Hosp, Militar Str, Zurich, Switzerland.	cnordt@bli.unizh.ch	Nordt, Carlos/H-1033-2017	Nordt, Carlos/0000-0002-1156-152X				[Anonymous], 1973, AM DIS ORIGINS NARCO; De Angelis D, 2004, AM J EPIDEMIOL, V160, P994, DOI 10.1093/aje/kwh306; De Preux E, 2004, SWISS MED WKLY, V134, P313; Ditton J, 2001, SUBST USE MISUSE, V36, P151, DOI 10.1081/JA-100000233; Estermann J, 1998, SOZ PRAVENTIV MED, V43, P173, DOI 10.1007/BF01359726; Falcato L, 2001, ADDICTION, V96, P623, DOI 10.1046/j.1360-0443.2001.96462310.x; *FED OFF POL, 2004, BETAUBUNGSMITTELSTAT; Hickman M, 2001, AM J EPIDEMIOL, V153, P632, DOI 10.1093/aje/153.7.632; Hser YI, 2001, ARCH GEN PSYCHIAT, V58, P503, DOI 10.1001/archpsyc.58.5.503; Hunt G., 1998, DRUG TREATMENT SYSTE, P94; International Narcotics Control Board, 2003, REP INT NARC CONTR B; Klingemann H, 1999, EUR ADDICT RES, V5, P109, DOI 10.1159/000018978; Klingemann HKH, 1996, ADDICTION, V91, P723, DOI 10.1046/j.1360-0443.1996.9157238.x; Law MG, 2001, ADDICTION, V96, P433, DOI 10.1046/j.1360-0443.2001.9634337.x; Maag V, 2003, EUR ADDICT RES, V9, P176, DOI 10.1159/000070984; Millar T, 2001, J EPIDEMIOL COMMUN H, V55, P930, DOI 10.1136/jech.55.12.930; MUSTO DF, 1999, AM DIS ORIGINS NAROC; Negrete JC, 2001, ADDICTION, V96, P543, DOI 10.1046/j.1360-0443.2001.9645432.x; RAVA L, 2001, UN B NARCOTICS, V53, P135; ROHRIG S, 1990, SCHWEIZ MED WSCHR, V120, P621; Stohler R, 2004, SOZ PRAVENTIV MED, V49, P276, DOI 10.1007/s00038-004-3046-6; *SWISS FED OFF PUB, 2005, NAT SUBST STAT METH	22	90	93	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2006	367	9525					1830	1834		10.1016/S0140-6736(06)68804-1	http://dx.doi.org/10.1016/S0140-6736(06)68804-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051XE	16753485				2022-12-24	WOS:000238194200028
J	He, W; Dorn, DC; Erdjument-Bromage, H; Tempst, P; Moore, MAS; Massague, J				He, Wei; Dorn, David C.; Erdjument-Bromage, Hediye; Tempst, Paul; Moore, Malcolm A. S.; Massague, Joan			Hematopoiesis controlled by distinct TIF1 gamma and Smad4 branches of the TGF beta pathway	CELL			English	Article							NUCLEAR RECEPTORS; PROGENITOR CELLS; STRUCTURAL BASIS; SWI/SNF COMPLEX; GROWTH; TRANSCRIPTION; FAMILY; DOMAIN; PROTEIN; KINASE	Tissue homeostasis in mammals relies on powerful cytostatic and differentiation signals delivered by the cytolkine TGF beta and relayed within the cell via the activation of Smad transcription factors. Formation of transcription regulatory complexes by the association of Smad4 with receptor-phosphorylated Smads 2 and 3 is a central event in the canonical TGF beta pathway. Here we provide evidence for a branching of this pathway. The ubiquitious nuclear protein Transcriptional Intermediary Factor 1 gamma(TIF1 gamma) selectively binds receptor-phosphorylated Smad2/3 in competition with Smad4. Rapid and robust binding of TIF1 gamma to Smad2/3 occurs in hematopoietic, mesenchymal, and epithelial cell types in response to TGF beta. In human hematopoietic stem/progenitor cells, where TGF beta inhibits proliferation and stimulates erythroid differentiation, TIF1 gamma mediates the differentiation response while Smad4 mediates the anti proliferative response with Smad2/3 participating in both responses. Thus, Smad2/3-TIF1 gamma and Smad2/3-Smad4 function as complementary effector arms in the control of hematopoietic cell fate by the TGF beta/Smad pathway.	Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA.	j-massague@ski.mskcc.org		Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Massague, Joan/0000-0001-9324-8408	NCI NIH HHS [P01 CA59350, R01 CA34610, P30 CA08748] Funding Source: Medline; NHLBI NIH HHS [R01 HL61401] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA034610, P01CA059350, P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061401] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beckstead R, 2001, MOL CELL, V7, P753, DOI 10.1016/S1097-2765(01)00220-9; Chacko BM, 2004, MOL CELL, V15, P813, DOI 10.1016/j.molcel.2004.07.016; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Cohen Y, 2004, BLOOD REV, V18, P167, DOI 10.1016/S0268-960X(03)00064-X; Davidson AJ, 2000, CURR TOP DEV BIOL, V50, P45, DOI 10.1016/S0070-2153(00)50003-9; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; Epperly MW, 2005, EXP HEMATOL, V33, P353, DOI 10.1016/j.exphem.2004.11.010; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Hata A, 1997, NATURE, V388, P82, DOI 10.1038/40424; JOHANSSON M, 1994, INT J CANCER, V57, P463, DOI 10.1002/ijc.2910570404; Khetchoumian K, 2004, J BIOL CHEM, V279, P48329, DOI 10.1074/jbc.M404779200; Klugbauer S, 1999, ONCOGENE, V18, P4388, DOI 10.1038/sj.onc.1202824; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Larsson J, 2005, ONCOGENE, V24, P5676, DOI 10.1038/sj.onc.1208920; LeDouarin B, 1996, EMBO J, V15, P6701, DOI 10.1002/j.1460-2075.1996.tb01060.x; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ng KC, 1999, J PEDIAT HEMATOL ONC, V21, P428, DOI 10.1097/00043426-199909000-00017; OHTA M, 1987, NATURE, V329, P539, DOI 10.1038/329539a0; Peng HZ, 2002, J MOL BIOL, V320, P629, DOI 10.1016/S0022-2836(02)00477-1; Qin BY, 2001, MOL CELL, V8, P1303, DOI 10.1016/S1097-2765(01)00417-8; Ransom DG, 2004, PLOS BIOL, V2, P1188, DOI 10.1371/journal.pbio.0020237; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Ruscetti FW, 2005, ONCOGENE, V24, P5751, DOI 10.1038/sj.onc.1208921; Sawyer JR, 2002, CANCER GENET CYTOGEN, V138, P102, DOI 10.1016/S0165-4608(02)00598-8; Schmerer M, 2003, BLOOD, V102, P3196, DOI 10.1182/blood-2003-04-1094; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Shen MM, 2000, TRENDS GENET, V16, P303, DOI 10.1016/S0168-9525(00)02006-0; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shizuru JA, 2005, ANNU REV MED, V56, P509, DOI 10.1146/annurev.med.54.101601.152334; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; SPORN MB, 1990, CELL REGUL, V1, P875, DOI 10.1091/mbc.1.12.875; Subramanian G, 2004, CANCER RES, V64, P5200, DOI 10.1158/0008-5472.CAN-04-0018; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; Venturini L, 1999, ONCOGENE, V18, P1209, DOI 10.1038/sj.onc.1202655; Wisotzkey RG, 1998, DEVELOPMENT, V125, P1433; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X	44	285	304	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 2	2006	125	5					929	941		10.1016/j.cell.2006.03.045	http://dx.doi.org/10.1016/j.cell.2006.03.045			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751102	Bronze			2022-12-24	WOS:000238116400019
J	Mukherjee, S; Keitany, G; Li, Y; Wang, Y; Ball, HL; Goldsmith, EJ; Orth, K				Mukherjee, Sohini; Keitany, Gladys; Li, Yan; Wang, Yong; Ball, Haydn L.; Goldsmith, Elizabeth J.; Orth, Kim			Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation	SCIENCE			English	Article							ARYLAMINE N-ACETYLTRANSFERASES; EFFECTOR YOPJ; RESPONSES; PROTEINS	Yersinia species use a variety of type III effector proteins to target eukaryotic signaling systems. The effector Yop) inhibits mitogen-activated protein kinase (MAPK) and the nu clear factor kappa B (NF kappa B) signaling pathways used in innate immune response by preventing activation of the family of MAPK kinases (MAPKK). We show that Yop) acted as an acetyltransferase, using acetylcoenzyme A (CoA) to modify the critical serine and threonine residues in the activation loop of MAPKK6 and thereby blocking phosphorylation. The acetylation on MAPKK6 directly competed with phosphorylation, preventing activation of the modified protein. This covalent modification may be used as a general regulatory mechanism in biological signaling.	Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Prot Chem Technol Ctr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Orth, K (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA.	Kim.Orth@utsouthwestern.edu	Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK072134] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI056404] Funding Source: Medline; NIDDK NIH HHS [R21-DK072134] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BODE AM, 2005, SCI STKE, pRE4; Brooke EW, 2003, BIOORGAN MED CHEM, V11, P1227, DOI 10.1016/S0968-0896(02)00642-9; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Ding JZ, 1996, EMBO J, V15, P1778, DOI 10.1002/j.1460-2075.1996.tb00526.x; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hardie G., 1995, PROTEIN KINASE FACTS, P418; Hinnebusch BJ, 2005, CURR ISSUES MOL BIOL, V7, P197, DOI 10.21775/cimb.007.197; Navarro L, 2005, CURR OPIN MICROBIOL, V8, P21, DOI 10.1016/j.mib.2004.12.014; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Orth K, 2002, CURR OPIN MICROBIOL, V5, P38, DOI 10.1016/S1369-5274(02)00283-7; Palmer LE, 1999, INFECT IMMUN, V67, P708, DOI 10.1128/IAI.67.2.708-716.1999; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Sim E, 2000, HUM MOL GENET, V9, P2435, DOI 10.1093/hmg/9.16.2435; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Yoon S, 2003, J BIOL CHEM, V278, P2131, DOI 10.1074/jbc.M209905200	16	453	475	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1211	1214		10.1126/science.1126867	http://dx.doi.org/10.1126/science.1126867			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728640				2022-12-24	WOS:000237957400053
J	Grantham, JJ; Torres, VE; Chapman, AB; Guay-Woodford, LM; Bae, KT; King, BF; Wetzel, LH; Baumgarten, DA; Kenney, PJ; Harris, PC; Klahr, S; Bennett, WM; Hirschman, GN; Meyers, CM; Zhang, XL; Zhu, F; Miller, JP				Grantham, JJ; Torres, VE; Chapman, AB; Guay-Woodford, LM; Bae, KT; King, BF; Wetzel, LH; Baumgarten, DA; Kenney, PJ; Harris, PC; Klahr, S; Bennett, WM; Hirschman, GN; Meyers, CM; Zhang, XL; Zhu, F; Miller, JP		CRISP Investigators	Volume progression in polycystic kidney disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOSOMAL-DOMINANT; RENAL-FUNCTION; MANAGEMENT; CONSORTIUM; SEVERITY; CRISP; ADPKD; CYST	Background: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive enlargement of cyst-filled kidneys. Methods: In a three-year study, we measured the rates of change in total kidney volume, total cyst volume, and iothalamate clearance in patients with ADPKD. Of a total of 241 patients, in 232 patients without azotemia who were 15 to 46 years old at baseline we used magnetic-resonance imaging to correlate the total kidney volume and total cyst volume with iothalamate clearance. Statistical methods included analysis of variance, Pearson correlation, and multivariate regression analysis. Results: Total kidney volume and total cyst volume increased exponentially, a result consistent with an expansion process dependent on growth. The mean (+/-SD) total kidney volume was 1060+/-642 ml at baseline and increased by a mean of 204+/-246 ml (5.27+/-3.92 percent per year, P < 0.001) over a three-year period among 214 patients. Total cyst volume increased by 218+/-263 ml (P < 0.001) during the same period among 210 patients. The baseline total kidney volume predicted the subsequent rate of increase in volume, independently of age. A baseline total kidney volume above 1500 ml in 51 patients was associated with a declining glomerular filtration rate (by 4.33+/-8.07 ml per minute per year, P < 0.001). Total kidney volume increased more in 135 patients with PKD1 mutations (by 245+/-268 ml) than in 28 patients with PKD2 mutations (by 136+/-100 ml, P=0.03). Conclusions: Kidney enlargement resulting from the expansion of cysts in patients with ADPKD is continuous and quantifiable and is associated with the decline of renal function. Higher rates of kidney enlargement are associated with a more rapid decrease in renal function.	Univ Kansas, Med Ctr, Dept Internal Med, Kidney Inst, Kansas City, KS 66160 USA; Mayo Clin Coll Med, Dept Radiol, Rochester, MN USA; Mayo Clin Coll Med, Div Nephrol & Hypertens, Rochester, MN USA; Emory Univ, Sch Med, Div Nephrol, Atlanta, GA USA; Univ Alabama Birmingham, Sch Med, Dept Med, Div Renal, Birmingham, AL USA; Univ Alabama Birmingham, Sch Med, Dept Radiol, Birmingham, AL USA; Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Biostat, St Louis, MO 63110 USA; Legacy Good Samaritan Hosp, Portland, OR USA; NIDDKD, NIH, Bethesda, MD 20892 USA	University of Kansas; University of Kansas Medical Center; Mayo Clinic; Mayo Clinic; Emory University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Grantham, JJ (corresponding author), Univ Kansas, Med Ctr, Dept Internal Med, Kidney Inst, Maildrop 3018,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	jgrantha@kumc.edu		Miller, J Philip/0000-0003-4568-6846	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039, M01RR000052, M01RR000585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK056943, U01DK056961, U01DK056956, U01DK056957] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00039, M01-RR00585, M01-RR00052] Funding Source: Medline; NIDDK NIH HHS [DK56961, DK56957, DK56956, DK56943] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bae KT, 2000, J COMPUT ASSIST TOMO, V24, P614, DOI 10.1097/00004728-200007000-00019; Bajwa ZH, 2004, KIDNEY INT, V66, P1561, DOI 10.1111/j.1523-1755.2004.00921.x; Bajwa ZH, 2001, KIDNEY INT, V60, P1631, DOI 10.1046/j.1523-1755.2001.00985.x; Chapman AB, 2003, KIDNEY INT, V64, P1035, DOI 10.1046/j.1523-1755.2003.00185.x; Chapman AB, 2003, ADV RENAL REPLACE TH, V10, P24, DOI 10.1053/jarr.2003.50005; Choukroun G, 1995, J AM SOC NEPHROL, V6, P1634; Fick-Brosnahan G, 1999, AM J KIDNEY DIS, V34, P639, DOI 10.1016/S0272-6386(99)70387-2; Fick-Brosnahan GM, 2002, AM J KIDNEY DIS, V39, P1127, DOI 10.1053/ajkd.2002.33379; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; GABOW PA, 1992, KIDNEY INT, V41, P1311, DOI 10.1038/ki.1992.195; Grantham J, 2000, KIDNEY PHYSL PATHOPH, V2, P2513; Grantham JJ, 2006, CLIN J AM SOC NEPHRO, V1, P148, DOI 10.2215/CJN.00330705; Grantham JJ, 1997, KIDNEY INT, pS93; Hateboer N, 1999, LANCET, V353, P103, DOI 10.1016/S0140-6736(98)03495-3; Johnson AM, 1997, J AM SOC NEPHROL, V8, P1560; King BF, 2000, J AM SOC NEPHROL, V11, P1505, DOI 10.1681/ASN.V1181505; King BF, 2003, KIDNEY INT, V64, P2214, DOI 10.1046/j.1523-1755.2003.00326.x; Magistroni R, 2003, J AM SOC NEPHROL, V14, P1164, DOI 10.1097/01.ASN.0000061774.90975.25; O'Neill WC, 2005, AM J KIDNEY DIS, V46, P1058, DOI 10.1053/j.ajkd.2005.08.026; RAVINE D, 1993, AM J KIDNEY DIS, V22, P803, DOI 10.1016/S0272-6386(12)70338-4; Rossetti S, 2002, KIDNEY INT, V61, P1588, DOI 10.1046/j.1523-1755.2002.00326.x; Ruggenenti P, 2005, KIDNEY INT, V68, P206, DOI 10.1111/j.1523-1755.2005.00395.x; Sise C, 2000, KIDNEY INT, V58, P2492, DOI 10.1046/j.1523-1755.2000.00433.x; Tao YX, 2005, J AM SOC NEPHROL, V16, P46, DOI 10.1681/ASN.2004080660; THOMPSON PA, 2002, P 27 ANN SAS US GROU; THOMSEN HS, 1981, UROL RADIOL, V3, P85, DOI 10.1007/BF02927815; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; van den Dool SW, 2005, RADIOLOGY, V236, P189, DOI 10.1148/radiol.2361021463; Wilson DM, 1997, AM J KIDNEY DIS, V30, P646, DOI 10.1016/S0272-6386(97)90488-1	29	539	560	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2006	354	20					2122	2130		10.1056/NEJMoa054341	http://dx.doi.org/10.1056/NEJMoa054341			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043BX	16707749	Bronze			2022-12-24	WOS:000237575400006
J	Pace, NR				Pace, NR			Time for a change	NATURE			English	Editorial Material									Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Pace, NR (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.							Sapp J, 2005, MICROBIOL MOL BIOL R, V69, P292, DOI 10.1128/MMBR.69.2.292-305.2005; Woese CR, 2004, MICROBIOL MOL BIOL R, V68, P173, DOI 10.1128/MMBR.68.2.173-186.2004	2	113	123	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 18	2006	441	7091					289	289		10.1038/441289a	http://dx.doi.org/10.1038/441289a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710401				2022-12-24	WOS:000237593200025
J	Wood, AJJ; Darbyshire, J				Wood, AJJ; Darbyshire, J			Injury to research volunteers - The clinical-research nightmare	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Drazen JM, 2005, NEW ENGL J MED, V353, P2809, DOI 10.1056/NEJMe058279; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Stein CM, 2003, CLIN PHARMACOL THER, V74, P511, DOI 10.1016/j.clpt.2003.08.007	3	36	38	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2006	354	18					1869	1871		10.1056/NEJMp068082	http://dx.doi.org/10.1056/NEJMp068082			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038RE	16672696				2022-12-24	WOS:000237239900001
J	Barrett, MP				Barrett, MP			The rise and fall of sleeping sickness	LANCET			English	Editorial Material							DRUGS		Univ Glasgow, Inst Biomed & Life Sci, Div Imfect & Immun, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Barrett, MP (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, Div Imfect & Immun, Glasgow G12 8QQ, Lanark, Scotland.	m.barrett@bio.gla.ac.uk		Barrett, Mike/0000-0001-9447-3519				[Anonymous], 2006, Wkly Epidemiol Rec, V81, P71; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Barrett MP, 1999, LANCET, V353, P1113, DOI 10.1016/S0140-6736(98)00416-4; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Fevre EM, 2005, LANCET, V366, P745, DOI 10.1016/S0140-6736(05)67179-6; Pecoul B, 1999, JAMA-J AM MED ASSOC, V281, P361, DOI 10.1001/jama.281.4.361; Pharmaceutical R&D Policy Project, 2005, NEW LANDSC NEGL DIS; Sharp D, 2004, LANCET, V364, P1472, DOI 10.1016/S0140-6736(04)17291-7	8	70	70	1	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 29	2006	367	9520					1377	1378		10.1016/S0140-6736(06)68591-7	http://dx.doi.org/10.1016/S0140-6736(06)68591-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650633				2022-12-24	WOS:000237195600007
J	Sedrakyan, A; Atkins, D; Treasure, T				Sedrakyan, A; Atkins, D; Treasure, T			The risk of aprotinin: a conflict of evidence	LANCET			English	Editorial Material							CARDIAC-SURGERY; CLINICAL-TRIALS; METAANALYSIS		Agcy Healthcare Res & Qual, Rockville, MD 20850 USA; Guys Hosp, Thorac Unit, London SE1 9RT, England	Agency for Healthcare Research & Quality; Guy's & St Thomas' NHS Foundation Trust	Treasure, T (corresponding author), Agcy Healthcare Res & Qual, Rockville, MD 20850 USA.	tom.treasure@ukgateway.net						BIDSTRUP BP, 1993, ANN THORAC SURG, V55, P971, DOI 10.1016/0003-4975(93)90128-5; Deeks J J, 2003, Health Technol Assess, V7, piii; Fergusson D, 2005, CLIN TRIALS, V2, P218, DOI 10.1191/1740774505cn085oa; Henry DA, 2001, COCHRANE DB SYST REV, V1; *ISRCTN, 2006, BLOOD CONS US ANT RA; Levi M, 1999, LANCET, V354, P1940, DOI 10.1016/S0140-6736(99)01264-7; Mangano DT, 2006, NEW ENGL J MED, V354, P353, DOI 10.1056/NEJMoa051379; Mangano DT, 2002, NEW ENGL J MED, V347, P1309, DOI 10.1056/NEJMoa020798; OTT E, 2003, ANESTHESIOLOGY, V99, pA254; ROYSTON D, 1987, LANCET, V2, P1289; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Sedrakyan A, 2004, J THORAC CARDIOV SUR, V128, P442, DOI 10.1016/j.jtcvs.2004.03.041; Young C, 2005, LANCET, V366, P107, DOI 10.1016/S0140-6736(05)66846-8	13	20	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2006	367	9520					1376	1377		10.1016/S0140-6736(06)68590-5	http://dx.doi.org/10.1016/S0140-6736(06)68590-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650632				2022-12-24	WOS:000237195600006
J	Chen, FS; Hasegawa, H; Schmitt-Ulms, G; Kawarai, T; Bohm, C; Katayama, T; Gu, YJ; Sanjo, N; Glista, M; Rogaeva, E; Wakutani, Y; Pardossi-Piquard, R; Ruan, XY; Tandon, A; Checler, F; Marambaud, P; Hansen, K; Westaway, D; St George-Hyslop, P; Fraser, P				Chen, FS; Hasegawa, H; Schmitt-Ulms, G; Kawarai, T; Bohm, C; Katayama, T; Gu, YJ; Sanjo, N; Glista, M; Rogaeva, E; Wakutani, Y; Pardossi-Piquard, R; Ruan, XY; Tandon, A; Checler, F; Marambaud, P; Hansen, K; Westaway, D; St George-Hyslop, P; Fraser, P			TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity	NATURE			English	Article							AMYLOID PRECURSOR PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; CAENORHABDITIS-ELEGANS; MISSENSE MUTATIONS; P24 PROTEINS; BETA-APP; MEMBRANE; CLEAVAGE; NOTCH; NICASTRIN	The presenilin proteins (PS1 and PS2)(1,2) and their interacting partners nicastrin(3), aph-1 (refs 4, 5) and pen-2 (ref. 5) forma series of high-molecular-mass, membrane-bound protein complexes(6-8) that are necessary for gamma-secretase and epsilon-secretase cleavage of selected type 1 transmembrane proteins, including the amyloid precursor protein(9), Notch(10) and cadherins(11). Modest cleavage activity can be generated by reconstituting these four proteins in yeast and Spodoptera frugiperda (sf9) cells(12-14). However, a critical but unanswered question about the biology of the presenilin complexes is how their activity is modulated in terms of substrate specificity and/or relative activities at the gamma and epsilon sites. A corollary to this question is whether additional proteins in the presenilin complexes might subsume these putative regulatory functions. The hypothesis that additional proteins might exist in the presenilin complexes is supported by the fact that enzymatically active complexes have a mass that is much greater than predicted for a 1:1:1:1 stoichiometric complex (at least 650 kDa observed, compared with about 220 kDa predicted)(6-8). To address these questions we undertook a search for presenilin-interacting proteins that differentially affected gamma- and epsilon-site cleavage events. Here we report that TMP21, a member of the p24 cargo protein family, is a component of presenilin complexes and differentially regulates gamma-secretase cleavage without affecting epsilon-secretase activity.	Univ Toronto, Dept Med, Toronto, ON M5S 3H2, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 3H2, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5S 3H2, Canada; Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; UNSA, Equipe Labellisee FRM, Inst Pharmacol Mol & Cellulaire, CNRS,UMR6097, F-06560 Valbonne, France; Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; N Shore LIJ Inst Med Res, Litwin Zucker Res Ctr, Manhasset, NY 11030 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; Univ Hlth Sci Ctr, Proteom Core, Aurora, CO 80045 USA; Univ Hlth Network, Toronto Western Hosp, Res Inst, Dept Med,Div Neurol, Toronto, ON M5G 1Z5, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Yeshiva University; Albert Einstein College of Medicine; Northwell Health; University of California System; University of California San Francisco; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Toronto; University Toronto Affiliates; University Health Network Toronto	St George-Hyslop, P (corresponding author), Univ Toronto, Dept Med, Toronto, ON M5S 3H2, Canada.	p.hyslop@utoronto.ca	Checler, Frederic/C-1241-2009; Glista, Michael/F-2907-2011; Kawarai, Toshitaka/C-2822-2013; Pardossi-Piquard, Raphaëlle/ABA-4472-2021; Pardossi-Piquard, Raphaëlle/D-6263-2012	Checler, Frederic/0000-0003-2098-1750; Kawarai, Toshitaka/0000-0003-4547-8131; Pardossi-Piquard, Raphaëlle/0000-0001-5292-4414; Sanjo, Nobuo/0000-0002-1226-2425; Marambaud, Philippe/0000-0002-8983-1497				Blum R, 1996, J BIOL CHEM, V271, P17183, DOI 10.1074/jbc.271.29.17183; Chen FS, 2002, J BIOL CHEM, V277, P36521, DOI 10.1074/jbc.M205093200; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; DE SB, 1999, NATURE, V398, P518; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Evin G, 2005, BIOCHEMISTRY-US, V44, P4332, DOI 10.1021/bi0481702; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Gu YJ, 2004, J BIOL CHEM, V279, P31329, DOI 10.1074/jbc.M401548200; Hasegawa H, 2004, J BIOL CHEM, V279, P46455, DOI 10.1074/jbc.M406289200; HERRANZ H, IN PRESS EMBO REP; Jenne N, 2002, J BIOL CHEM, V277, P46504, DOI 10.1074/jbc.M206989200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Li KC, 2004, P NATL ACAD SCI USA, V101, P15561, DOI 10.1073/pnas.0402962101; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Petit A, 2001, NAT CELL BIOL, V3, P507, DOI 10.1038/35074581; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Schmitt-Ulms G, 2004, NAT BIOTECHNOL, V22, P724, DOI 10.1038/nbt969; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Trower MK, 1996, P NATL ACAD SCI USA, V93, P1366, DOI 10.1073/pnas.93.4.1366; Wen CH, 1999, J CELL BIOL, V145, P1165, DOI 10.1083/jcb.145.6.1165; Yu CJ, 2001, J BIOL CHEM, V276, P43756, DOI 10.1074/jbc.C100410200; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	30	250	260	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1208	1212		10.1038/nature04667	http://dx.doi.org/10.1038/nature04667			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641999				2022-12-24	WOS:000237080000049
J	Gentner, TQ; Fenn, KM; Margoliash, D; Nusbaum, HC				Gentner, TQ; Fenn, KM; Margoliash, D; Nusbaum, HC			Recursive syntactic pattern learning by songbirds	NATURE			English	Article							EUROPEAN STARLINGS; LANGUAGE; FACULTY	Humans regularly produce new utterances that are understood by other members of the same language community(1). Linguistic theories account for this ability through the use of syntactic rules (or generative grammars) that describe the acceptable structure of utterances(2). The recursive, hierarchical embedding of language units (for example, words or phrases within shorter sentences) that is part of the ability to construct new utterances minimally requires a 'context-free' grammar(2,3) that is more complex than the 'finite-state' grammars thought sufficient to specify the structure of all non-human communication signals. Recent hypotheses make the central claim that the capacity for syntactic recursion forms the computational core of a uniquely human language faculty(4,5). Here we show that European starlings (Sturnus vulgaris) accurately recognize acoustic patterns defined by a recursive, self-embedding, context-free grammar. They are also able to classify new patterns defined by the grammar and reliably exclude agrammatical patterns. Thus, the capacity to classify sequences from recursive, centre-embedded grammars is not uniquely human. This finding opens a new range of complex syntactic processing mechanisms to physiological investigation.	Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; Univ Chicago, Dept Psychol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Gentner, TQ (corresponding author), Univ Calif San Diego, Dept Psychol, La Jolla, CA 92093 USA.	tgentner@ucsd.edu	Galantucci, Bruno/E-5770-2010		NIDCD NIH HHS [F32 DC000389-03, F32 DC000389] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC000389] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Chomsky N., 2002, JANUA LINGUARUM; Eens M, 1997, ADV STUD BEHAV, V26, P355, DOI 10.1016/S0065-3454(08)60384-8; Fitch WT, 2005, COGNITION, V97, P179, DOI 10.1016/j.cognition.2005.02.005; Fitch WT, 2004, SCIENCE, V303, P377, DOI 10.1126/science.1089401; Gentner TQ, 1998, ANIM BEHAV, V56, P579, DOI 10.1006/anbe.1998.0810; Gentner TQ, 2003, NATURE, V424, P669, DOI 10.1038/nature01731; Gentner TQ, 2000, J ACOUST SOC AM, V107, P3369, DOI 10.1121/1.429408; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hauser MD, 2002, COGNITION, V86, pB15, DOI 10.1016/S0010-0277(02)00139-7; Hauser MD, 2001, COGNITION, V78, pB53, DOI 10.1016/S0010-0277(00)00132-3; HOCKETT CF, 1960, SCI AM, V203, P88, DOI 10.1038/scientificamerican0960-88; Hopcroft J. E., 1979, INTRO AUTOMATA THEOR; Pinker S, 2005, COGNITION, V95, P201, DOI 10.1016/j.cognition.2004.08.004	13	372	385	2	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1204	1207		10.1038/nature04675	http://dx.doi.org/10.1038/nature04675			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641998	Green Accepted			2022-12-24	WOS:000237080000048
J	Guermah, M; Palhan, VB; Tackett, AJ; Chait, BT; Roeder, RG				Guermah, M; Palhan, VB; Tackett, AJ; Chait, BT; Roeder, RG			Synergistic functions of SII and p300 in productive activator-dependent transcription of chromatin templates	CELL			English	Article							RNA-POLYMERASE-II; ELONGATION-FACTOR-SII; NF-KAPPA-B; IN-VITRO; SACCHAROMYCES-CEREVISIAE; GENETIC INTERACTIONS; HISTONE CHAPERONE; H2A-H2B DIMERS; FACTOR TFIIS; INITIATION	We have reconstituted a highly purified RNA polymerase II transcription system containing chromatin templates assembled with purified histones and assembly factors, the histone acetyltransferase p300, and components of the general transcription machinery that, by themselves, suffice for activated transcription (initiation and elongation) on DNA templates. We show that this system mediates activator-dependent initiation, but not productive elongation, on chromatin templates. We further report the purification of a chromatin transcription-enabling activity (CTEA) that, in a manner dependent upon p300 and acetyl-CoA, strongly potentiates transcription elongation through several contiguous nucleosomes as must occur in vivo. The transcription elongation factor SII is a major component of CTEA and strongly synergizes with p300 (histone acetylation) at a step subsequent to preinitiation complex formation. The purification of CTEA also identified HMGB2 as a coactivator that, while inactive on its own, enhances SII and p300 functions.	Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA; Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Guermah, M (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.	guermam@mail.rockefeller.edu; roeder@mail.rockefeller.edu			NATIONAL CANCER INSTITUTE [R01CA113872] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM066496] Funding Source: NIH RePORTER; NCI NIH HHS [CA113872] Funding Source: Medline; NCRR NIH HHS [RR00862] Funding Source: Medline; NIDDK NIH HHS [DK071900] Funding Source: Medline; NIGMS NIH HHS [GM066496] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; An WJ, 2002, MOL CELL, V9, P811, DOI 10.1016/S1097-2765(02)00497-5; Arndt KM, 2003, TRENDS GENET, V19, P543, DOI 10.1016/j.tig.2003.08.008; Awrey DE, 1997, J BIOL CHEM, V272, P14747, DOI 10.1074/jbc.272.23.14747; BECKER PB, 1992, MOL CELL BIOL, V12, P2241, DOI 10.1128/MCB.12.5.2241; Belotserkovskaya R, 2004, BBA-GENE STRUCT EXPR, V1677, P87, DOI 10.1016/j.bbaexp.2003.09.017; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P152, DOI 10.1016/S0968-0004(00)01777-1; Chang CH, 1997, J BIOL CHEM, V272, P23427, DOI 10.1074/jbc.272.37.23427; Davie JK, 2000, MOL CELL BIOL, V20, P5960, DOI 10.1128/MCB.20.16.5960-5973.2000; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Fukuda A, 2002, P NATL ACAD SCI USA, V99, P1206, DOI 10.1073/pnas.251674198; Gamble MJ, 2005, MOL CELL BIOL, V25, P797, DOI 10.1128/MCB.25.2.797-807.2005; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Guermah M, 1998, MOL CELL BIOL, V18, P3234, DOI 10.1128/MCB.18.6.3234; Guermah M, 2001, MOL CELL BIOL, V21, P6882, DOI 10.1128/MCB.21.20.6882-6894.2001; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Ito T, 2000, GENE DEV, V14, P1899; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; Jiang W, 2000, J BIOL CHEM, V275, P39819, DOI 10.1074/jbc.C000713200; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; KNEZETIC JA, 1986, CELL, V45, P95, DOI 10.1016/0092-8674(86)90541-6; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Krutchinsky AN, 2001, ANAL CHEM, V73, P5066, DOI 10.1021/ac010682o; Kundu TK, 2000, MOL CELL, V6, P551, DOI 10.1016/S1097-2765(00)00054-X; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Lennon JC, 1998, MOL CELL BIOL, V18, P5771, DOI 10.1128/MCB.18.10.5771; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; Levchenko V, 2005, BIOCHEMISTRY-US, V44, P5357, DOI 10.1021/bi047786o; Levchenko V, 2004, BIOCHEMISTRY-US, V43, P2359, DOI 10.1021/bi035737q; Levenstein ME, 2002, J BIOL CHEM, V277, P8749, DOI 10.1074/jbc.M111212200; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Malagon F, 2004, GENETICS, V166, P1215, DOI 10.1534/genetics.166.3.1215; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; McBryant SJ, 2003, J BIOL CHEM, V278, P44574, DOI 10.1074/jbc.M305636200; Mizuguchi G, 2001, J BIOL CHEM, V276, P14773, DOI 10.1074/jbc.M100125200; Neely KE, 1999, MOL CELL, V4, P649, DOI 10.1016/S1097-2765(00)80216-6; Neely KE, 2002, BBA-REV CANCER, V1603, P19, DOI 10.1016/S0304-419X(02)00067-7; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Pazin MJ, 1996, GENE DEV, V10, P37, DOI 10.1101/gad.10.1.37; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; REINES D, 1989, J BIOL CHEM, V264, P10799; REMPEL RE, 1990, J VIROL, V64, P574, DOI 10.1128/JVI.64.2.574-583.1990; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; SHYKIND BM, 1995, GENE DEV, V9, P1354, DOI 10.1101/gad.9.11.1354; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; SZENTIRMAY MN, 1993, EMBO J, V12, P4677, DOI 10.1002/j.1460-2075.1993.tb06156.x; Tackett AJ, 2005, J CELL BIOL, V169, P35, DOI 10.1083/jcb.200502104; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Ubukata T, 2003, J BIOL CHEM, V278, P8580, DOI 10.1074/jbc.M211384200; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; VAQUERO A, 2003, SCI AGING KNOWLEDGE, pRE4, DOI DOI 10.1126/SAGEKE.2003.14.RE4; Wery M, 2004, EMBO J, V23, P4232, DOI 10.1038/sj.emboj.7600326; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; WORKMAN JL, 1987, CELL, V51, P613, DOI 10.1016/0092-8674(87)90130-9; ZHOU QA, 1995, EMBO J, V14, P321, DOI 10.1002/j.1460-2075.1995.tb07006.x	64	71	73	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					275	286		10.1016/j.cell.2006.01.055	http://dx.doi.org/10.1016/j.cell.2006.01.055			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630816	Bronze, Green Submitted			2022-12-24	WOS:000237241500018
J	Hilgenberg, LGW; Su, HL; Gu, HY; O'Dowd, DK; Smith, MA				Hilgenberg, LGW; Su, HL; Gu, HY; O'Dowd, DK; Smith, MA			a3Na(+)/K+-ATPase is a neuronal receptor for Agrin	CELL			English	Article							ACETYLCHOLINE-RECEPTORS; NEUROMUSCULAR-JUNCTION; SYNAPSE FORMATION; CORTICAL-NEURONS; MESSENGER-RNA; EXPRESSION; DEFICIENT; NA+; MUSCLE; ATPASE	Agrin, through its interaction with the receptor tyrosine kinase MuSK, mediates accumulation of acetylcholine receptors (AChR) at the developing neuromuscular junction. Agrin has also been implicated in several functions in brain. However, the mechanism by which agrin exerts its effects in neural tissue is unknown. Here we present biochemical evidence that agrin binds to the alpha 3 subunit of the Na+/K+-ATPase (NKA) in CNS neurons. Colocalization with agrin binding sites at synapses supports the hypothesis that the alpha 3NKA is a neuronal agrin receptor. Agrin inhibition of alpha 3NKA activity results in membrane depolarization and increased action potential frequency in cortical neurons in culture and acute slice. An agrin fragment that acts as a competitive antagonist depresses action potential frequency, showing that endogenous agrin regulates native alpha 3NKA function. These data demonstrate that, through its interaction with the alpha 3NKA, agrin regulates activity-dependent processes in neurons, providing a molecular framework for agrin action in the CNS.	Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Smith, MA (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.	masmith@uci.edu			NIDA NIH HHS [DA14960] Funding Source: Medline; NINDS NIH HHS [NS33213, NS45540, NS27501] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS027501, R29NS027501, R01NS027501, T32NS045540, R01NS033213] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Annunziato L, 2004, PHARMACOL REV, V56, P633, DOI 10.1124/pr.56.4.5; Blaustein MP, 2002, ANN NY ACAD SCI, V976, P356; Bose CM, 2000, J NEUROSCI, V20, P9086; Bouron A, 1996, NEURON, V17, P969, DOI 10.1016/S0896-6273(00)80227-5; BRINES ML, 1995, NEUROSCI LETT, V191, P145, DOI 10.1016/0304-3940(95)11577-J; BRINES ML, 1993, BRAIN RES, V631, P1, DOI 10.1016/0006-8993(93)91179-V; Campagna JA, 1997, EUR J NEUROSCI, V9, P2269, DOI 10.1111/j.1460-9568.1997.tb01645.x; Cohen I, 1997, MOL CELL NEUROSCI, V9, P237, DOI 10.1006/mcne.1997.0623; Cohen NA, 1997, NEUROSCIENCE, V76, P581, DOI 10.1016/S0306-4522(96)00345-4; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; DAVIDSON DLW, 1978, CAN J NEUROL SCI, V5, P405, DOI 10.1017/S0317167100024185; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671; FALLON JR, 1985, NATURE, V315, P571, DOI 10.1038/315571a0; Ferreira A, 1999, J CELL SCI, V112, P4729; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GIBBS ME, 1978, PHARMACOL BIOCHEM BE, V8, P271, DOI 10.1016/0091-3057(78)90315-5; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Glitsch HG, 2001, PHYSIOL REV, V81, P1791, DOI 10.1152/physrev.2001.81.4.1791; GODFREY EW, 1988, J CELL BIOL, V106, P1263, DOI 10.1083/jcb.106.4.1263; Herbst R, 2000, EMBO J, V19, P67, DOI 10.1038/sj.emboj.7592228b; Hilgenberg LGW, 1999, J NEUROSCI, V19, P7384, DOI 10.1523/JNEUROSCI.19-17-07384.1999; Hilgenberg LGW, 2004, J NEUROBIOL, V61, P289, DOI 10.1002/neu.20049; Hilgenberg LGW, 2002, MOL CELL NEUROSCI, V19, P97, DOI 10.1006/mcne.2001.1056; HOCH W, 1993, NEURON, V11, P479, DOI 10.1016/0896-6273(93)90152-H; Hoover CL, 2003, J CELL BIOL, V161, P923, DOI 10.1083/jcb.200301013; Jeon D, 2003, NEURON, V38, P965, DOI 10.1016/S0896-6273(03)00334-9; Juhaszova M, 1997, P NATL ACAD SCI USA, V94, P1800, DOI 10.1073/pnas.94.5.1800; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Li Z, 1999, J NEUROBIOL, V39, P547, DOI 10.1002/(SICI)1097-4695(19990615)39:4<547::AID-NEU8>3.0.CO;2-C; Li Z, 1997, NEUROSCIENCE, V79, P191, DOI 10.1016/S0306-4522(96)00654-9; Liu IH, 2005, GLYCOBIOLOGY, V15, P1320, DOI 10.1093/glycob/cwj014; Mann S, 1996, MOL CELL NEUROSCI, V8, P1, DOI 10.1006/mcne.1996.0039; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; OCONNOR LT, 1995, MOL BRAIN RES, V33, P277, DOI 10.1016/0169-328X(95)00147-K; OCONNOR LT, 1994, J NEUROSCI, V14, P1141, DOI 10.1523/JNEUROSCI.14-03-01141.1994; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; REIST NE, 1987, J CELL BIOL, V105, P2457, DOI 10.1083/jcb.105.6.2457; Ross ST, 2001, P NATL ACAD SCI USA, V98, P8874, DOI 10.1073/pnas.141042398; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sato T, 2004, PHARMACOL RES, V49, P151, DOI 10.1016/j.phrs.2003.09.006; Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112; Vaillend C, 2002, J NEUROPHYSIOL, V88, P2963, DOI 10.1152/jn.00244.2002; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; Verbeek MM, 1999, AM J PATHOL, V155, P2115, DOI 10.1016/S0002-9440(10)65529-0; Xia SZ, 1997, PHARMACOL BIOCHEM BE, V58, P727, DOI 10.1016/S0091-3057(97)00045-2; Xiao AY, 2002, J NEUROSCI, V22, P1350, DOI 10.1523/JNEUROSCI.22-04-01350.2002; Zahler R, 1996, CIRC RES, V78, P870, DOI 10.1161/01.RES.78.5.870; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501	50	93	96	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					359	369		10.1016/j.cell.2006.01.052	http://dx.doi.org/10.1016/j.cell.2006.01.052			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630822	Bronze			2022-12-24	WOS:000237241500024
J	Smith, DJ				Smith, DJ			Predictability and preparedness in influenza control	SCIENCE			English	Editorial Material							TRANSMISSION DYNAMICS; PANDEMIC INFLUENZA; MOUTH EPIDEMIC; PUBLIC-HEALTH; VIRUS; EVOLUTION; IMPACT; FOOT	The threat of pandemic human influenza looms as we survey the ongoing avian influenza pandemic and wonder if and when it will jump species. What are the risks and how can we plan? The nub of the problem ties in the inherent variability of the virus, which makes prediction difficult. However, it is not impossible; mathematical models can help determine and quantify critical parameters and thresholds in the relationships of those parameters, even if the relationships are nonlinear and obscure to simple reasoning. Mathematical models can derive estimates for the levels of drug stockpiles needed to buy time, how and when to modify vaccines, whom to target with vaccines and drugs, and when to enforce quarantine measures. Regardless, the models used for pandemic planning must be tested, and for this we must continue to gather data, not just for exceptional scenarios but also for seasonal influenza.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Erasmus MC, Dept Virol, NL-3015 GE Rotterdam, Netherlands; Erasmus MC, Natl Influenza Ctr, NL-3015 GE Rotterdam, Netherlands	University of Cambridge; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Smith, DJ (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	dsmith@zoo.cam.ac.uk	Smith, Derek/Z-3075-2019	Smith, Derek/0000-0002-2393-1890	NIH HHS [DP1-OD000490-01] Funding Source: Medline; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000490] Funding Source: NIH RePORTER	NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Efron Bradley., 1994, INTRO BOOTSTRAP; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Halloran ME, 2006, SCIENCE, V311, P615, DOI 10.1126/science.1122143; Hampson AW, 2002, PERSP MED V, V7, P49; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mills CE, 2006, PLOS MED, V3, P769, DOI 10.1371/journal.pmed.0030135; MONTO AS, 1969, B WORLD HEALTH ORGAN, V41, P537; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; TABER LH, 1981, J HYG-CAMBRIDGE, V86, P303, DOI 10.1017/S0022172400069059; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; *WHO, WHO PAND INFL DRAFT	18	56	62	4	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					392	394		10.1126/science.1122665	http://dx.doi.org/10.1126/science.1122665			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	034OZ	16627736				2022-12-24	WOS:000236941800037
J	Tryggvason, K; Pikkarainen, T; Patrakka, J				Tryggvason, K; Pikkarainen, T; Patrakka, J			Nck links nephrin to actin in kidney podocytes	CELL			English	Editorial Material							PHOSPHORYLATION; PROTEIN; PODOCIN		Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, S-17177 Stockholm, Sweden	Karolinska Institutet	Tryggvason, K (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, S-17177 Stockholm, Sweden.	karl.tryggvason@ki.se	Patrakka, Jaakko/AAG-8796-2019					Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; JONES N, 2006, NATURE; Lahdenpera J, 2003, KIDNEY INT, V64, P404, DOI 10.1046/j.1523-1755.2003.00097.x; Li H, 2004, J AM SOC NEPHROL, V15, P3006, DOI 10.1097/01.ASN.0000146689.88078.80; Rivera GM, 2004, CURR BIOL, V14, P11, DOI 10.1016/j.cub.2003.12.033; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Simons M, 2001, AM J PATHOL, V159, P1069, DOI 10.1016/S0002-9440(10)61782-8; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; VERMA R, 2006, J CLIN INVEST	10	69	74	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 21	2006	125	2					221	224		10.1016/j.cell.2006.04.002	http://dx.doi.org/10.1016/j.cell.2006.04.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630808	Bronze			2022-12-24	WOS:000237241500010
J	Bredemeyer, AL; Sharma, GG; Huang, CY; Helmink, BA; Walker, LM; Khor, KC; Nuskey, B; Sullivan, KE; Pandita, TK; Bassing, CH; Sleckman, BP				Bredemeyer, Andrea L.; Sharma, Girdhar G.; Huang, Ching-Yu; Helmink, Beth A.; Walker, Laura M.; Khor, Katrina C.; Nuskey, Beth; Sullivan, Kathleen E.; Pandita, Tej K.; Bassing, Craig H.; Sleckman, Barry P.			ATM stabilizes DNA double-strand-break complexes during V(D)J recombination	NATURE			English	Article							T-CELL DEVELOPMENT; ATAXIA-TELANGIECTASIA; RAG PROTEINS; B-CELL; ENDS; TUMORIGENESIS; REARRANGEMENT; INHIBITOR; DEFICIENT; LYMPHOMA	The ATM (ataxia-telangiectasia mutated) protein kinase mediates early cellular responses to DNA double-strand breaks (DSBs) generated during metabolic processes or by DNA-damaging agents(1-4). ATM deficiency leads to ataxia-telangiectasia, a disease marked by lymphopenia, genomic instability and an increased predisposition to lymphoid malignancies with chromosomal translocations involving lymphocyte antigen receptor loci(5,6). ATM activates cell-cycle checkpoints and can induce apoptosis in response to DNA DSBs(1-4). However, defects in these pathways of the DNA damage response cannot fully account for the phenotypes of ATM deficiency. Here, we show that ATM also functions directly in the repair of chromosomal DNA DSBs by maintaining DNA ends in repair complexes generated during lymphocyte antigen receptor gene assembly. When coupled with the cell-cycle checkpoint and pro-apoptotic activities of ATM, these findings provide a molecular explanation for the increase in lymphoid tumours with translocations involving antigen receptor loci associated with ataxia-telangiectasia.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Radiat Oncol, St Louis, MO 63110 USA; Univ Penn, Childrens Hosp Philadelphia, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Allergy & Immunol, Philadelphia, PA 19104 USA; Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	Washington University (WUSTL); Washington University (WUSTL); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Sleckman, BP (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	Sleckman@immunology.wustl.edu	Huang, Ching-Yu/E-3981-2010; Pandita, Tej K/AAM-9188-2020	Helmink, Beth/0000-0002-8206-0351; Sullivan, Kathleen/0000-0003-4018-1646; Bredemeyer, Andrea/0000-0003-2970-5998; Huang, Ching-yu/0000-0002-5758-281X				Agrawal A, 1997, CELL, V89, P43, DOI 10.1016/S0092-8674(00)80181-6; Bassing CH, 2004, DNA REPAIR, V3, P781, DOI 10.1016/j.dnarep.2004.06.001; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hiom K, 1998, MOL CELL, V1, P1011, DOI 10.1016/S1097-2765(00)80101-X; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; LEWIS SM, 1988, CELL, V55, P1099, DOI 10.1016/0092-8674(88)90254-1; Liang HE, 2002, IMMUNITY, V17, P639, DOI 10.1016/S1074-7613(02)00448-X; Liao MJ, 1999, GENE DEV, V13, P1246, DOI 10.1101/gad.13.10.1246; Matei IR, 2006, IMMUNOL REV, V209, P142, DOI 10.1111/j.0105-2896.2006.00361.x; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; MORZYCKAWROBLEWSKA E, 1988, SCIENCE, V242, P261, DOI 10.1126/science.3140378; Muljo SA, 2003, NAT IMMUNOL, V4, P31, DOI 10.1038/ni870; Oettinger MA, 1999, CURR OPIN CELL BIOL, V11, P325, DOI 10.1016/S0955-0674(99)80044-1; Pandita Tej K, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006318; Perkins EJ, 2002, GENE DEV, V16, P159, DOI 10.1101/gad.956902; Petiniot LK, 2000, P NATL ACAD SCI USA, V97, P6664, DOI 10.1073/pnas.97.12.6664; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; Sekiguchi J, 2001, MOL CELL, V8, P1383, DOI 10.1016/S1097-2765(01)00423-3; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Taylor AMR, 1996, BLOOD, V87, P423, DOI 10.1182/blood.V87.2.423.bloodjournal872423; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0	29	302	316	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2006	442	7101					466	470		10.1038/nature04866	http://dx.doi.org/10.1038/nature04866			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16799570				2022-12-24	WOS:000239278900046
J	Bartlett, JG				Bartlett, John G.			Planning for avian influenza	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE-RESPIRATORY-SYNDROME; PANDEMIC INFLUENZA; RESISTANCE; VIRUS; WORK; TIME; SARS; CARE	Avian influenza, or influenza A (H5N1), has 3 of the 4 properties necessary to cause a serious pandemic: It can infect people, nearly all people are immunologically naive, and it is highly lethal. The Achilles heel of the virus is the lack of sustained human-human transmission. Fortunately, among the 124 cases reported through 30 May 2006, nearly all were acquired by direct contact with poultry. Unfortunately, the capability for efficient human-human transmission requires only a single mutation by a virus that is notoriously genetically unstable, hence the need for a new vaccine each year for seasonal influenza. Influenza A (H5N1) is being compared to another avian strain, the agent of the "Spanish flu" of 1918-1919, which traversed the world in 3 months and caused an estimated 50 million deaths. The question is, are we ready for this type of pandemic? The answer is probably no. The main problems are the lack of an effective vaccine, very poor surge capacity, a health care system that could not accommodate even a modest pandemic, and erratic regional planning. It's time to get ready, and in the process be ready for bioterrorism, natural disasters, and epidemics of other infectious diseases.	Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University	Bartlett, JG (corresponding author), Johns Hopkins Univ, Sch Med, 1830 E Monument St,Room 439, Baltimore, MD 21205 USA.	jb@jhmi.edu						*AM COLL PHYS, 2006, ANN INTERN MED, V145, P135; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Belshe RB, 2005, NEW ENGL J MED, V353, P2209, DOI 10.1056/NEJMp058281; Blank S, 2003, EMERG INFECT DIS, V9, P615; Bournes DA, 2005, NURS SCI QUART, V18, P324, DOI 10.1177/0894318405280353; Clark CC, 2005, J MED PHILOS, V30, P65, DOI 10.1080/03605310590907066; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Hayden F, 2005, ANTIVIR THER, V10, P873; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Homeland Security Council, 2006, NAT STRAT PAND INFL; INGLESBY T, 2006, SENATE SUBCOMMITTEE; Koh D, 2005, MED CARE, V43, P676, DOI 10.1097/01.mlr.0000167181.36730.cc; MARGHELLA PD, 2005, HOMELAND DEFENSE J, P2; Masur H, 2003, JAMA-J AM MED ASSOC, V289, P2861, DOI 10.1001/jama.289.21.JED30036; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Mounier-Jack S, 2006, LANCET, V367, P1405, DOI 10.1016/S0140-6736(06)68511-5; Poland GA, 2006, NEW ENGL J MED, V354, P1411, DOI 10.1056/NEJMe068047; Starr I, 2006, ANN INTERN MED, V145, P138, DOI 10.7326/0003-4819-145-2-200607180-00132; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; TONER E, 2006, BIOSECUR BIOTERROR, V4, P1; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024	24	42	55	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2006	145	2					141	144		10.7326/0003-4819-145-2-200607180-00133	http://dx.doi.org/10.7326/0003-4819-145-2-200607180-00133			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	063WU	16801627				2022-12-24	WOS:000239051400009
J	Liu, J; Taylor, DW; Krementsova, EB; Trybus, KM; Taylor, KA				Liu, Jun; Taylor, Dianne W.; Krementsova, Elena B.; Trybus, Kathleen M.; Taylor, Kenneth A.			Three-dimensional structure of the myosin V inhibited state by cryoelectron tomography	NATURE			English	Article							UNCONVENTIONAL MYOSIN; TAIL DOMAIN; ELECTRON TOMOGRAPHY; ATPASE ACTIVITY; MOTOR-ACTIVITY; TILT SERIES; ACTIN; RECONSTRUCTION; LOCALIZATION; CALMODULIN	Unconventional myosin V (myoV) is an actin-based molecular motor that has a key function in organelle and mRNA transport, as well as in membrane trafficking(1). MyoV was the first member of the myosin superfamily shown to be processive, meaning that a single motor protein can 'walk' hand-over-hand along an actin filament for many steps before detaching(2-4). Full-length myoV has a low actin-activated MgATPase activity at low [Ca2+], whereas expressed constructs lacking the cargo-binding domain have a high activity regardless of [Ca2+] (refs 5 - 7). Hydrodynamic data and electron micrographs indicate that the active state is extended, whereas the inactive state is compact(8-10). Here we show the first three-dimensional structure of the myoV inactive state. Each myoV molecule consists of two heads that contain an amino-terminal motor domain followed by a lever arm that binds six calmodulins. The heads are followed by a coiled-coil dimerization domain (S2) and a carboxy-terminal globular cargo-binding domain. In the inactive structure, bending of myoV at the head S2 junction places the cargo-binding domain near the motor domain's ATP-binding pocket, indicating that ATPase inhibition might occur through decreased rates of nucleotide exchange. The actin-binding interfaces are unobstructed, and the lever arm is oriented in a position typical of strong actin-binding states. This structure indicates that motor recycling after cargo delivery might occur through transport on actively treadmilling actin filaments rather than by diffusion.	Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA	State University System of Florida; Florida State University; University of Vermont	Trybus, KM (corresponding author), Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA.	trybus@physiology.med.uvm.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047421] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR047421] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Coy DL, 1999, NAT CELL BIOL, V1, P288, DOI 10.1038/13001; ESPREAFICO EM, 1992, J CELL BIOL, V119, P1541, DOI 10.1083/jcb.119.6.1541; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Frank J., 1996, 3 DIMENSIONAL ELECT, Ved, ppp 54; Hackney DD, 2000, NAT CELL BIOL, V2, P257, DOI 10.1038/35010525; HACKNEY DD, 1992, J BIOL CHEM, V267, P8696; Homma K, 2000, J BIOL CHEM, V275, P34766, DOI 10.1074/jbc.M003132200; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Reck-Peterson SL, 2000, BBA-MOL CELL RES, V1496, P36, DOI 10.1016/S0167-4889(00)00007-0; Sellers JR, 1991, CURR OPIN CELL BIOL, V3, P98, DOI 10.1016/0955-0674(91)90171-T; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Stock MF, 1999, J BIOL CHEM, V274, P14617, DOI 10.1074/jbc.274.21.14617; Sweeney HL, 1998, J BIOL CHEM, V273, P6262, DOI 10.1074/jbc.273.11.6262; Tama F, 2004, J STRUCT BIOL, V147, P315, DOI 10.1016/j.jsb.2004.03.002; Terrak M, 2003, EMBO J, V22, P362, DOI 10.1093/emboj/cdg058; Trybus KM, 1999, J BIOL CHEM, V274, P27448, DOI 10.1074/jbc.274.39.27448; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Wang FS, 1996, SCIENCE, V273, P660, DOI 10.1126/science.273.5275.660; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; Winkler H, 2006, ULTRAMICROSCOPY, V106, P240, DOI 10.1016/j.ultramic.2005.07.007; Winkler H, 2003, J STRUCT BIOL, V143, P24, DOI 10.1016/S1047-8477(03)00120-5; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	30	158	162	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2006	442	7099					208	211		10.1038/nature04719	http://dx.doi.org/10.1038/nature04719			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062XJ	16625208				2022-12-24	WOS:000238979700049
J	Chang, MM; Zhang, JY; Miao, DD				Chang, Mee-mann; Zhang, Jiangyong; Miao, Desui			A lamprey from the Cretaceous Jehol biota of China	NATURE			English	Article							PETROMYZON-MARINUS; SEA LAMPREY; BEAR-GULCH; MONTANA; LARVAE; USA	Widespread nowadays in freshwater and coastal seas of the cold and temporal zones, lampreys are a jawless vertebrate group that has been in existence for more than 300 million years but left a meagre fossil record. Only two fossil lamprey species, namely Mayomyzon pieckoensis(1,2) and Hardistiella montanensis(3-5), have been recognized with certainty from North American Carboniferous marine deposits(6). Here we report a freshwater lamprey from the Early Cretaceous epoch ( about 125 million years ago) of Inner Mongolia, China. The new taxon, Mesomyzon mengae, has a long snout, a well-developed sucking oral disk, a relatively long branchial apparatus showing branchial basket, seven gill pouches, gill arches and impressions of gill filaments, about 80 myomeres and several other characters that are previously unknown or ambiguous. Our finding not only indicates Mesomyzon's closer relationship to extant lampreys but also reveals the group's invasion into a freshwater environment no later than the Early Cretaceous. The new material furthers our understanding of ancient lampreys, bridges the gap between the Carboniferous ones and their recent relatives, and adds to our knowledge of the evolutionary history of lampreys.	Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; Univ Kansas, Museum Nat Hist, Lawrence, KS 66045 USA; Univ Kansas, Biodivers Res Ctr, Lawrence, KS 66045 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of Kansas; University of Kansas	Chang, MM (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, POB 643, Beijing 100044, Peoples R China.	zhangmiman@ivpp.ac.cn						BARDACK D, 1977, Fieldiana Geology, V33, P489; BARDACK D, 1968, SCIENCE, V162, P1265, DOI 10.1126/science.162.3859.1265; Bardack D., 1971, BIOL LAMPREYS, V1, P67; Barker LA, 1998, COPEIA, P1070; BRIGGS DEG, 1994, LETHAIA, V26, P275, DOI DOI 10.1111/J.1502-3931.1993.TB01532.X); Chang M., 2003, JEHOL BIOTA; Grogan Eileen D., 2002, Geodiversitas, V24, P295; HARDISTY MW, 1974, BIOL LAMPREYS; Janvier P, 1996, PALAEONTOLOGY, V39, P259; Janvier P, 2004, J VERTEBR PALEONTOL, V24, P742, DOI 10.1671/0272-4634(2004)024[0742:FCOTEK]2.0.CO;2; JANVIER P, 1983, Journal of Vertebrate Paleontology, V2, P407; Janvier P., 1996, EARLY VERTEBRATES; LUND R, 1986, GEOBIOS-LYON, V19, P647, DOI 10.1016/S0016-6995(86)80061-4; POTTER IC, 1987, J ZOOL, V212, P713, DOI 10.1111/j.1469-7998.1987.tb05966.x; Wang H., 1985, ATLAS PALAEOGEOGRAPH; Wicks BJ, 1998, J GREAT LAKES RES, V24, P962, DOI 10.1016/S0380-1330(98)70876-7; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420; Zhu Y. D., 2001, FAUNA SINICA CYCLOST	18	46	49	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					972	974		10.1038/nature04730	http://dx.doi.org/10.1038/nature04730			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791193				2022-12-24	WOS:000238422300040
J	Lindenauer, PK; Pekow, P; Gao, S; Crawford, AS; Gutierrez, B; Benjamin, EM				Lindenauer, Peter K.; Pekow, Penelope; Gao, Shan; Crawford, Allison S.; Gutierrez, Benjamin; Benjamin, Evan M.			Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease	ANNALS OF INTERNAL MEDICINE			English	Article							ELDERLY-PATIENTS; MANAGEMENT; OUTCOMES; DISPARITIES; APPRAISAL; PNEUMONIA	Background: Acute exacerbation of chronic obstructive pulmonary disease (COPD) is 1 of the 10 leading causes of hospitalization among adults in the United States. Objective: To evaluate the quality of care provided to patients hospitalized for acute exacerbations of COPD and to determine whether hospital or patient characteristics influence treatment. Design: Retrospective cohort study. Setting: 360 hospitals throughout the United States. Patients: 69 820 patients hospitalized for acute exacerbations of COPD. Measurements: Adherence to diagnosis and treatment recommendations contained in guidelines produced by the American College of Physicians and the American College of Chest Physicians; analyses of associations between hospital and patient characteristics and composite measures of performance. Results: Of the 69 820 patients, 66 276 (95%) underwent chest radiography, 63 715 (91%) received supplemental oxygen, 67 515 (97%) received bronchodilators, 59 240 (85%) received systemic steroids, and 59 053 (85%) were given antibiotics. In total, 45 800 (66%) received this entire set of recommended care processes. Numerous participants received tests or treatments that were not beneficial: 16 607 (24%) were treated with methylxanthine bronchodilators, 10 051 (14%) had sputum testing, 8354 (12%) underwent acute spirometry, 4299 (6%) had chest physiotherapy, and 1409 (2%) were treated with mucolytic medications. Overall, 31 519 patients (45%) received at least 1 of these non-recommended care elements, and 22 929 (33%) received ideal care, defined as all of the recommended care processes and none of the non-recommended ones. Individual hospital performance varied widely; whereas older patients and women were more likely to receive ideal care than their counterparts, a higher annual volume of admissions for COPD was not associated with improved hospital performance. Limitations: The study used administrative data, not chart review, and was limited to the inpatient management of COPD. Conclusions: The quality of care for patients hospitalized for acute exacerbations of COPD may be improved by increasing the use of systemic corticosteroid and antibiotic therapy, decreasing the use of unnecessary and potentially harmful treatments, and reducing variation in practice across hospitals.	Baystate Med Ctr, Div Healthcare Qual, Springfield, MA 01199 USA; Tufts Univ, Sch Med, Baystate Med Ctr, Springfield, MA 01199 USA; Univ Massachusetts, Amherst, MA 01003 USA; Premier Healthcare Informat, Charlotte, NC USA	Baystate Medical Center; Baystate Medical Center; Tufts University; University of Massachusetts System; University of Massachusetts Amherst	Lindenauer, PK (corresponding author), Baystate Med Ctr, Div Healthcare Qual, 759 Chestnut St,P-5928, Springfield, MA 01199 USA.	Peter.Lindenauer@bhs.org						Agency for Healthcare Research and Quality, HCUPNET HEALTHC COST; *AM THOR SOC EUR R, 2005, STAND DIAGN MAN PAT; [Anonymous], 1987, AM REV RESPIR DIS, V136, P225; [Anonymous], AHRQ PUBL; Bach PB, 2001, ANN INTERN MED, V134, P600, DOI 10.7326/0003-4819-134-7-200104030-00016; Barnato AE, 2005, MED CARE, V43, P308, DOI 10.1097/01.mlr.0000156848.62086.06; Bratzler Dale W, 2004, J Okla State Med Assoc, V97, P227; *CTR MED SERV, MED PAY PERF DEM SHO; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fine JM, 2002, ARCH INTERN MED, V162, P827, DOI 10.1001/archinte.162.7.827; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; Gibson P G, 1998, J Qual Clin Pract, V18, P125; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Houck PM, 2004, ARCH INTERN MED, V164, P637, DOI 10.1001/archinte.164.6.637; Hoyert DL, 2005, NATL VITAL STAT REPO, V53; *I HEALTHC IMP R, BUNDL SAF; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; *JOINT COMM ACCR H, 2005, SPEC MAN NAT HOSP QU; McCrory DC, 2001, CHEST, V119, P1190, DOI 10.1378/chest.119.4.1190; Meehan TP, 2000, CHEST, V117, P1378, DOI 10.1378/chest.117.5.1378; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Meehan TP, 2001, AM J MED, V111, P203, DOI 10.1016/S0002-9343(01)00803-8; Moody A, 2004, THORAX, V59, P1; O'Donnell Denis E, 2003, Can Respir J, V10 Suppl A, p11A; Snow V, 2001, ANN INTERN MED, V134, P595, DOI 10.7326/0003-4819-134-7-200104030-00015; *US DEP HHS, HOSP COMP QUAL TOOOL	27	152	160	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2006	144	12					894	903		10.7326/0003-4819-144-12-200606200-00006	http://dx.doi.org/10.7326/0003-4819-144-12-200606200-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056WJ	16785478				2022-12-24	WOS:000238555500004
J	Haugen, SP; Berkmen, MB; Ross, W; Gaal, T; Ward, C; Gourse, RL				Haugen, Shanil P.; Berkmen, Melanie B.; Ross, Wilma; Gaal, Tamas; Ward, Christopher; Gourse, Richard L.			rRNA promoter regulation by nonoptimal binding of a region 1.2: An additional recognition element for RNA polymerase	CELL			English	Article							RATE-DEPENDENT CONTROL; TRANSCRIPTION INITIATION; STRINGENT CONTROL; DNA-BINDING; STRUCTURAL ORGANIZATION; COMPLEX-FORMATION; PPGPP; SEQUENCE; HOLOENZYME; SIGMA(70)	Regulation of transcription initiation is generally attributable to activator/repressor proteins that bind to specific DNA sequences. However, regulators can also achieve specificity by binding directly to RNA polymerase (RNAP) and exploiting the kinetic variation intrinsic to different RNAP-promoter complexes. We report here a previously unknown interaction with Escherichia coli RNAP that defines an additional recognition element in bacterial promoters. The strength of this sequence-specific interaction varies at different promoters and affects the lifetime of the complex with RNAP. Selection of rRNA promoter mutants forming long-lived complexes, kinetic analyses of duplex and bubble templates, dimethylsulfate footprinting, and zero-Angstrom crosslinking demonstrated that sigma subunit region 1.2 directly contacts the nontemplate strand base two positions downstream of the -10 element (within the "discriminator" region). By making a nonoptimal sigma 1.2-discriminator interaction, rRNA promoters create the short-lived complex required for specific responses to the RNAP binding factors ppGpp and DksA, ultimately accounting for regulation of ribosome synthesis.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Haugen, SP (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	rgourse@bact.wisc.edu	Ward, Christopher S/H-6889-2019	Ward, Christopher S/0000-0002-3445-6327; Berkmen, Melanie/0000-0003-0365-6040; Haugen, Shanil/0000-0001-7386-094X	NIGMS NIH HHS [R37 GM037048, GM37048] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037048, R01GM037048] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Baldwin NE, 2001, MOL MICROBIOL, V42, P427, DOI 10.1046/j.1365-2958.2001.02642.x; Barker MM, 2001, J BACTERIOL, V183, P6315, DOI 10.1128/JB.183.21.6315-6323.2001; Barker MM, 2001, J MOL BIOL, V305, P673, DOI 10.1006/jmbi.2000.4327; Barker MM, 2001, J MOL BIOL, V305, P689, DOI 10.1006/jmbi.2000.4328; BARTLETT MS, 1994, J BACTERIOL, V176, P5560, DOI 10.1128/JB.176.17.5560-5564.1994; Becker G, 2001, MOL MICROBIOL, V39, P1153, DOI 10.1046/j.1365-2958.2001.02313.x; Brodolin K, 2005, J MOL BIOL, V350, P930, DOI 10.1016/j.jmb.2005.05.048; DUVALVALENTIN G, 1986, NUCLEIC ACIDS RES, V14, P1967, DOI 10.1093/nar/14.5.1967; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; Geszvain Kati, 2005, P283; GOURSE RL, 1988, NUCLEIC ACIDS RES, V16, P9789, DOI 10.1093/nar/16.20.9789; Gralla JD, 2005, MOL MICROBIOL, V55, P973, DOI 10.1111/j.1365-2958.2004.04455.x; Helmann JD, 1999, BIOCHEMISTRY-US, V38, P5959, DOI 10.1021/bi990206g; JOSAITIS CA, 1995, P NATL ACAD SCI USA, V92, P1117, DOI 10.1073/pnas.92.4.1117; Jung YH, 1997, BIOCHEM BIOPH RES CO, V230, P582, DOI 10.1006/bbrc.1996.6005; KEENER J, 1996, REGULATION RIBOSOME, P1417; LAMOND AI, 1985, CELL, V41, P6, DOI 10.1016/0092-8674(85)90050-9; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; Mekler V, 2002, CELL, V108, P599, DOI 10.1016/S0092-8674(02)00667-0; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Murray HD, 2003, MOL CELL, V12, P125, DOI 10.1016/S1097-2765(03)00266-1; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; NEWLANDS JT, 1991, J MOL BIOL, V220, P569, DOI 10.1016/0022-2836(91)90101-B; NIKIFOROV TT, 1992, NUCLEIC ACIDS RES, V20, P1209, DOI 10.1093/nar/20.6.1209; Paul BJ, 2005, P NATL ACAD SCI USA, V102, P7823, DOI 10.1073/pnas.0501170102; Paul BJ, 2004, ANNU REV GENET, V38, P749, DOI 10.1146/annurev.genet.38.072902.091347; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Pemberton IK, 2000, J MOL BIOL, V299, P859, DOI 10.1006/jmbi.2000.3780; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; Roberts CW, 1996, CELL, V86, P495; Ross W, 2005, P NATL ACAD SCI USA, V102, P291, DOI 10.1073/pnas.0405814102; Saecker RM, 2002, J MOL BIOL, V319, P649, DOI 10.1016/S0022-2836(02)00293-0; SIEBENLIST U, 1980, CELL, V20, P269, DOI 10.1016/0092-8674(80)90613-3; TRAVERS AA, 1980, J BACTERIOL, V141, P973, DOI 10.1128/JB.141.2.973-976.1980; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Villemain J, 1998, J MOL BIOL, V281, P793, DOI 10.1006/jmbi.1998.1989; Walker KA, 2004, J BIOL CHEM, V279, P50818, DOI 10.1074/jbc.M406285200; WILSON BA, 1997, J REHABILITATION OUT, V1, P60	41	162	165	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2006	125	6					1069	1082		10.1016/j.cell.2006.04.034	http://dx.doi.org/10.1016/j.cell.2006.04.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777598	Bronze			2022-12-24	WOS:000238602700013
J	Qi, H; Egen, JG; Huang, AYC; Germain, RN				Qi, Hai; Egen, Jackson G.; Huang, Alex Y. C.; Germain, Ronald N.			Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells	SCIENCE			English	Article							ANTIBODY-RESPONSES; IN-VIVO; LYMPHOCYTES; FOLLICLES; TRANSPORT; MEMBRANE; INTERACT; MOTILITY; PROTEIN; CORTEX	In contrast to naive T cells that recognize short antigen-derived peptides displayed by specialized antigen-presenting cells, immunoglobulin receptors of B lymphocytes primarily recognize intact proteins. How and where within a lymph node such unprocessed antigens become available for naive B cell recognition is not clear. We used two-photon intravital imaging to show that, after exiting high-endothelial venules and before entry into lymph node follicles, B cells survey locally concentrated dendritic cells. Engagement of the B cell receptor by the dendritic cell (DC)-associated antigen leads to lymphocyte calcium signaling, migration arrest, antigen acquisition, and extrafollicular accumulation. These findings suggest a possible role for antigen-specific B-DC interactions in promoting T cell - dependent antibody responses in vivo.	NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA.	rgermain@nih.gov	Huang, Alex Y./ABG-8182-2021; Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020; Qi, Hai/A-3955-2009	Huang, Alex Y./0000-0002-5701-4521; Qi, Hai/0000-0001-5475-3989; Egen, Jackson/0000-0003-2053-0837	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000545, ZIAAI000545] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ANDERSON AO, 1975, AM J PATHOL, V80, P387; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Berney C, 1999, J EXP MED, V190, P851, DOI 10.1084/jem.190.6.851; Bhakta NR, 2005, NAT IMMUNOL, V6, P143, DOI 10.1038/ni1161; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Colino J, 2002, J EXP MED, V195, P1, DOI 10.1084/jem.20011432; Cyster JG, 1995, IMMUNITY, V3, P691, DOI 10.1016/1074-7613(95)90059-4; DRINEKR C, 1935, ANAT REC, V56, P261; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113; Ludewig B, 2000, EUR J IMMUNOL, V30, P185, DOI 10.1002/1521-4141(200001)30:1<185::AID-IMMU185>3.3.CO;2-C; Lutz MB, 1997, J IMMUNOL, V159, P3707; MacLennan ICM, 1997, IMMUNOL REV, V156, P53, DOI 10.1111/j.1600-065X.1997.tb00958.x; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Wang H, 2000, P NATL ACAD SCI USA, V97, P847, DOI 10.1073/pnas.97.2.847; Wykes M, 1998, J IMMUNOL, V161, P1313	29	390	418	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 16	2006	312	5780					1672	1676		10.1126/science.1125703	http://dx.doi.org/10.1126/science.1125703			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778060				2022-12-24	WOS:000238288600052
J	Graham, TE; Yang, Q; Bluher, M; Hammarstedt, A; Ciaraldi, TP; Henry, RR; Wason, CJ; Oberbach, A; Jansson, P; Smith, U; Kahn, BB				Graham, Timothy E.; Yang, Qin; Blueher, Matthias; Hammarstedt, Ann; Ciaraldi, Theodore P.; Henry, Robert R.; Wason, Christopher J.; Oberbach, Andreas; Jansson, Per-Anders; Smith, Ulf; Kahn, Barbara B.			Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RETINOL-BINDING-PROTEIN; CORONARY-HEART-DISEASE; PLASMA-CONCENTRATIONS; METABOLIC DEFECTS; FAT DISTRIBUTION; GLUCOSE; HYPERINSULINEMIA; DYSLIPIDEMIA; ADIPOSITY; NIDDM	BACKGROUND: Insulin resistance has a causal role in type 2 diabetes. Serum levels of retinol-binding protein 4 (RBP4), a protein secreted by adipocytes, are increased in insulin-resistant states. Experiments in mice suggest that elevated RBP4 levels cause insulin resistance. We sought to determine whether serum RBP4 levels correlate with insulin resistance and change after an intervention that improves insulin sensitivity. We also determined whether elevated serum RBP4 levels are associated with reduced expression of glucose transporter 4 (GLUT4) in adipocytes, an early pathological feature of insulin resistance. METHODS: We measured serum RBP4, insulin resistance, and components of the metabolic syndrome in three groups of subjects. Measurements were repeated after exercise training in one group. GLUT4 protein was measured in isolated adipocytes. RESULTS: Serum RBP4 levels correlated with the magnitude of insulin resistance in subjects with obesity, impaired glucose tolerance, or type 2 diabetes and in nonobese, nondiabetic subjects with a strong family history of type 2 diabetes. Elevated serum RBP4 was associated with components of the metabolic syndrome, including increased body-mass index, waist-to-hip ratio, serum triglyceride levels, and systolic blood pressure and decreased high-density lipoprotein cholesterol levels. Exercise training was associated with a reduction in serum RBP4 levels only in subjects in whom insulin resistance improved. Adipocyte GLUT4 protein and serum RBP4 levels were inversely correlated. CONCLUSIONS: RBP4 is an adipocyte-secreted molecule that is elevated in the serum before the development of frank diabetes and appears to identify insulin resistance and associated cardiovascular risk factors in subjects with varied clinical presentations. These findings provide a rationale for antidiabetic therapies aimed at lowering serum RBP4 levels.	Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Leipzig, Med Ctr, Dept Med, D-7010 Leipzig, Germany; Sahlgrens Univ Hosp, Dept Internal Med, Lundberg Lab Diabet Res, Gothenburg, Sweden; Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Leipzig University; Sahlgrenska University Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego	Kahn, BB (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Dept Med, 99 Brookline Ave, Boston, MA 02215 USA.	bkahn@bidmc.harvard.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058291, K08DK069624, R01DK043051] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR-00827] Funding Source: Medline; NIDDK NIH HHS [R01 DK-58291, K08 DK-69624, R01 DK-43051, R01 DK043051] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abahusain MA, 1999, EUR J CLIN NUTR, V53, P630, DOI 10.1038/sj.ejcn.1600825; Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Basu TK, 1997, NUTRITION, V13, P804, DOI 10.1016/S0899-9007(97)00192-5; Basualdo CG, 1997, J AM COLL NUTR, V16, P39, DOI 10.1080/07315724.1997.10718647; BLANER WS, 1989, ENDOCR REV, V10, P308, DOI 10.1210/edrv-10-3-308; Bluher M, 2005, EXP CLIN ENDOCR DIAB, V113, P534, DOI 10.1055/s-2005-872851; Bluher M, 2002, DIABETOLOGIA, V45, P210, DOI 10.1007/s00125-001-0723-3; Carvalho Eugenia, 2001, FASEB Journal, V15, P1101; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DIMITROV NV, 1990, AM J CLIN NUTR, V51, P1082, DOI 10.1093/ajcn/51.6.1082; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; ERIKSSON J, 1989, NEW ENGL J MED, V321, P337, DOI 10.1056/NEJM198908103210601; Gavin JR, 2000, DIABETES CARE, V23, pS4; Jansson PA, 2003, FASEB J, V17, P1434, DOI 10.1096/fj.02-1132com; Johanson EH, 2003, J CLIN ENDOCR METAB, V88, P4232, DOI 10.1210/jc.2002-021961; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kahn CR, 1996, ANNU REV MED, V47, P509; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Meigs JB, 2002, DIABETES, V51, P833, DOI 10.2337/diabetes.51.3.833; Miyazaki Y, 2002, AM J PHYSIOL-ENDOC M, V283, pE1135, DOI 10.1152/ajpendo.0327.2001; Newcomer ME, 2000, BBA-PROTEIN STRUCT M, V1482, P57, DOI 10.1016/S0167-4838(00)00150-3; Organization WH, 1998, WELLB MEAS PRIM HLTH; Perseghin G, 1997, DIABETES, V46, P1001, DOI 10.2337/diabetes.46.6.1001; Reaven GM, 2005, ANNU REV NUTR, V25, P391, DOI 10.1146/annurev.nutr.24.012003.132155; REAVEN GM, 1991, DIABETES METAB, V17, P78; Rexrode KM, 1998, JAMA-J AM MED ASSOC, V280, P1843, DOI 10.1001/jama.280.21.1843; Rexrode KM, 2001, INT J OBESITY, V25, P1047, DOI 10.1038/sj.ijo.0801615; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Smith U, 2002, INT J OBESITY, V26, P897, DOI 10.1038/sj.ijo.0802028; Tamori Y, 2006, NAT MED, V12, P30, DOI 10.1038/nm0106-30; THORBURN AW, 1990, J CLIN INVEST, V85, P522, DOI 10.1172/JCI114468; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711	34	1003	1084	2	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2006	354	24					2552	2563		10.1056/NEJMoa054862	http://dx.doi.org/10.1056/NEJMoa054862			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052KU	16775236				2022-12-24	WOS:000238233400005
J	Loureiro, J; Lilley, BN; Spooner, E; Noriega, V; Tortorella, D; Ploegh, HL				Loureiro, Joana; Lilley, Brendan N.; Spooner, Eric; Noriega, Vanessa; Tortorella, Domenico; Ploegh, Hidde L.			Signal peptide peptidase is required for dislocation from the endoplasmic reticulum	NATURE			English	Article							I MEMBRANE-PROTEIN; COMPLEX CLASS-I; INTRAMEMBRANE PROTEOLYSIS; MISFOLDED PROTEINS; ASPARTIC PROTEASES; CYTOSOL; ER; DIFFERENTIATION; GLYCOPROTEIN; DESTRUCTION	Human cytomegalovirus ( HCMV) prevents the display of class I major histocompatibility complex (MHC) peptide complexes at the surface of infected cells as a means of escaping immune detection(1). Two HCMV-encoded immunoevasins, US2 and US11, induce the dislocation of class I MHC heavy chains from the endoplasmic reticulum membrane and target them for proteasomal degradation in the cytosol(2,3). Although the outcome of the dislocation reactions catalysed is similar, US2 and US11 operate differently: Derlin-1 is a key component of the US11 but not the US2 pathway(4). So far, proteins essential for US2-dependent dislocation have not been identified. Here we compare interacting partners of wild-type US2 with those of a dislocation-incompetent US2 mutant, and identify signal peptide peptidase (SPP) as a partner for the active form of US2. We show that a decrease in SPP levels by RNA-mediated interference inhibits heavy-chain dislocation by US2 but not by US11. Our data implicate SPP in the US2 pathway and indicate the possibility of a previously unknown function for this intramembrane-cleaving aspartic protease in dislocation from the endoplasmic reticulum.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Pathol Funct Proteom Ctr, Boston, MA 02115 USA; Mt Sinai Sch Med, Dept Microbiol, New York, NY 10021 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai	Ploegh, HL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu		Tortorella, Domenico/0000-0003-0961-3535; Loureiro, Joana/0000-0003-2793-5810				Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Crawshaw SG, 2004, BIOCHEM J, V384, P9, DOI 10.1042/BJ20041216; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; Furman MH, 2002, J BIOL CHEM, V277, P3258, DOI 10.1074/jbc.M109765200; Gewurz BE, 2002, J BIOL CHEM, V277, P11306, DOI 10.1074/jbc.M107904200; Gewurz BE, 2001, J VIROL, V75, P5197, DOI 10.1128/JVI.75.11.5197-5204.2001; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Lemberg MK, 2004, FEBS LETT, V564, P213, DOI 10.1016/S0014-5793(04)00192-9; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Martoglio B, 2003, BIOCHEM SOC T, V31, P1243; Martoglio B, 2003, HUM MOL GENET, V12, pR201, DOI 10.1093/hmg/ddg303; Martoglio B, 1997, EMBO J, V16, P6636, DOI 10.1093/emboj/16.22.6636; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Misaghi S, 2004, CHEM BIOL, V11, P1677, DOI 10.1016/j.chembiol.2004.11.010; Nyborg AC, 2004, J BIOL CHEM, V279, P15153, DOI 10.1074/jbc.M309305200; ROQUES BP, 1983, P NATL ACAD SCI-BIOL, V80, P3178, DOI 10.1073/pnas.80.11.3178; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Tarasova NI, 2005, J MED CHEM, V48, P3768, DOI 10.1021/jm049065t; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	30	111	112	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					894	897		10.1038/nature04830	http://dx.doi.org/10.1038/nature04830			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16738546				2022-12-24	WOS:000238254100047
J	Zwi, AB; Grove, NJ; Kelly, P; Gayer, M; Ramos-Jimenez, P; Sommerfeld, J				Zwi, Anthony B.; Grove, Natalie J.; Kelly, Paul; Gayer, Michelle; Ramos-Jimenez, Pilar; Sommerfeld, Johannes			Child health in armed conflict: time to rethink	LANCET			English	Editorial Material							COMPLEX EMERGENCIES		Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia; Australian Natl Univ, Natl Ctr Epidemiol & Publ Hlth, Canberra, ACT, Australia; WHO, Dis Control Humanitarian Emergencies, Communicable Dis Cluster CDS NTD, CH-1211 Geneva, Switzerland; De La Salle Univ, Social Dev Res Ctr, Manila, Philippines; De La Salle Univ, Dept Behav Sci, Manila, Philippines; WHO, Special Programme Res & Training Trop Dis, CH-1211 Geneva, Switzerland	University of New South Wales Sydney; Australian National University; World Health Organization; De La Salle University; De La Salle University; World Health Organization	Zwi, AB (corresponding author), Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia.	a.zwi@unsw.edu.au	Zwi, Anthony/AAP-7026-2021; Zwi, Anthony/AAP-8731-2020; Sommerfeld, Johannes/AAI-5816-2020	Zwi, Anthony/0000-0001-6902-6602; 				Amnesty International, 2005, NEP CHILDR CAUGHT CO; [Anonymous], 1992, MMWR MORB MORTAL WKL, V41, P1; Boyden J., 2004, CHILDREN YOUTH FRONT; Christensen P., 2000, RES CHILDREN PERSPEC; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; Gbesso S, 2006, LANCET, V367, P1221, DOI 10.1016/S0140-6736(06)68518-8; Horton R, 2006, LANCET, V367, P3, DOI 10.1016/S0140-6736(06)67899-9; Lansdown G, 2006, LANCET, V367, P690, DOI 10.1016/S0140-6736(06)68268-8; Moss WJ, 2006, B WORLD HEALTH ORGAN, V84, P58, DOI 10.2471/BLT.04.019570; Moss WJ, 2006, CHILD HLTH COMPLEX E; Rutta E, 2005, DISASTERS, V29, P291, DOI 10.1111/j.0361-3666.2005.00293.x; *SCH PUBL HLTH COM, 2006, INT S MAN JAN 9 13; Singh S, 2005, PLOS MED, V2, P705, DOI 10.1371/journal.pmed.0020216; Toole MJ, 1997, ANNU REV PUBL HEALTH, V18, P283, DOI 10.1146/annurev.publhealth.18.1.283; Women's Commission for Refugee Women and Children, 2004, NO SAF PLAC CALL HOM	15	10	11	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 10	2006	367	9526					1886	1888		10.1016/S0140-6736(06)68823-5	http://dx.doi.org/10.1016/S0140-6736(06)68823-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051XG	16765745				2022-12-24	WOS:000238194400009
J	Shu, YS; Hasenstaub, A; Duque, A; Yu, YG; McCormick, DA				Shu, Yousheng; Hasenstaub, Andrea; Duque, Alvaro; Yu, Yuguo; McCormick, David A.			Modulation of intracortical synaptic potentials by presynaptic somatic membrane potential	NATURE			English	Article							CAT VISUAL-CORTEX; UNDERLYING CONTRAST ADAPTATION; NEOCORTICAL PYRAMIDAL NEURONS; TRANSMITTER RELEASE; HIPPOCAMPAL-NEURONS; NERVE-TERMINALS; RAT NEOCORTEX; IN-VIVO; CELLS; CONNECTIONS	Traditionally, neuronal operations in the cerebral cortex have been viewed as occurring through the interaction of synaptic potentials in the dendrite and soma, followed by the initiation of an action potential, typically in the axon(1,2). Propagation of this action potential to the synaptic terminals is widely believed to be the only form of rapid communication of information between the soma and axonal synapses, and hence to postsynaptic neurons. Here we show that the voltage fluctuations associated with dendrosomatic synaptic activity propagate significant distances along the axon, and that modest changes in the somatic membrane potential of the presynaptic neuron modulate the amplitude and duration of axonal action potentials and, through a Ca2+-dependent mechanism, the average amplitude of the postsynaptic potential evoked by these spikes. These results indicate that synaptic activity in the dendrite and soma controls not only the pattern of action potentials generated, but also the amplitude of the synaptic potentials that these action potentials initiate in local cortical circuits, resulting in synaptic transmission that is a mixture of triggered and graded ( analogue) signals.	Yale Univ, Sch Med, Dept Neurobiol, Kavli Inst Neurosci, New Haven, CT 06510 USA	Yale University	McCormick, DA (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, Kavli Inst Neurosci, 333 Cedar St, New Haven, CT 06510 USA.	david.mccormick@yale.edu	Shu, Yousheng/AAC-3881-2020; Kobelt, Liza/F-5926-2011	Shu, Yousheng/0000-0002-2834-2876; Yu, Yuguo/0000-0003-0603-2890				Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Binzegger T, 2005, CEREB CORTEX, V15, P152, DOI 10.1093/cercor/bhh118; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Cox CL, 2000, P NATL ACAD SCI USA, V97, P9724, DOI 10.1073/pnas.170278697; Debanne D, 1997, NATURE, V389, P286, DOI 10.1038/38502; Dorval AD, 2001, ANN BIOMED ENG, V29, P897, DOI 10.1114/1.1408929; Fricker D, 1999, J PHYSIOL-LONDON, V517, P791, DOI 10.1111/j.1469-7793.1999.0791s.x; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Ivanov AI, 2003, J NEUROSCI, V23, P1206, DOI 10.1523/JNEUROSCI.23-04-01206.2003; JACKSON MB, 1991, P NATL ACAD SCI USA, V88, P380, DOI 10.1073/pnas.88.2.380; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; NICHOLLS J, 1978, J PHYSIOL-LONDON, V281, P171, DOI 10.1113/jphysiol.1978.sp012415; Peters A, 1984, CEREBRAL CORTEX, V1; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; SHAPIRO E, 1980, P NATL ACAD SCI-BIOL, V77, P629, DOI 10.1073/pnas.77.1.629; SHIMAHARA T, 1975, J PHYSIOL-LONDON, V247, P299, DOI 10.1113/jphysiol.1975.sp010933; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Shu YS, 2003, J NEUROSCI, V23, P10388; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; STORM JF, 1988, NATURE, V336, P379, DOI 10.1038/336379a0; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Welch KMA, 2003, NEUROLOGY, V61, pS2, DOI 10.1212/WNL.61.8_suppl_4.S2	31	295	304	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					761	765		10.1038/nature04720	http://dx.doi.org/10.1038/nature04720			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16625207				2022-12-24	WOS:000238095100057
J	Carey, LA; Perou, CM; Livasy, CA; Dressler, LG; Cowan, D; Conway, K; Karaca, G; Troester, MA; Tse, CK; Edmiston, S; Deming, SL; Geradts, J; Cheang, MCU; Nielsen, TO; Moorman, PG; Earp, HS; Millikan, RC				Carey, Lisa A.; Perou, Charles M.; Livasy, Chad A.; Dressler, Lynn G.; Cowan, David; Conway, Kathleen; Karaca, Gamze; Troester, Melissa A.; Tse, Chiu Kit; Edmiston, Sharon; Deming, Sandra L.; Geradts, Joseph; Cheang, Maggie C. U.; Nielsen, Torsten O.; Moorman, Patricia G.; Earp, H. Shelton; Millikan, Robert C.			Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	40th Annual Meeting of the American-Society-of-Clinical-Oncology	JUN 05-08, 2004	New Orleans, LA	Amer Soc Clin Oncol			GENE-EXPRESSION PROFILES; RACIAL-DIFFERENCES; AFRICAN-AMERICAN; BRCA1 MUTATIONS; HER-2/NEU GENE; CELL-CYCLE; TUMORS; CARCINOMAS; PHENOTYPE; WOMEN	Context Gene expression analysis has identified several breast cancer subtypes, including basal-like, human epidermal growth factor receptor-2 positive/estrogen receptor negative (HER2+/ER-), luminal A, and luminal B. Objectives To determine population-based distributions and clinical associations for breast cancer subtypes. Design, Setting, and Participants Immunohistochemical surrogates for each subtype were applied to 496 incident cases of invasive breast cancer from the Carolina Breast Cancer Study ( ascertained between May 1993 and December 1996), a population-based, case-control study that oversampled premenopausal and African American women. Subtype definitions were as follows: luminal A ( ER + and/or progesterone receptor positive [PR+], HER2-), luminal B ( ER + and/or PR +, HER2+), basal-like (ER-, PR-, HER2-, cytokeratin 5/6 positive, and/or HER1+), HER2+/ ER- ( ER-, PR-, and HER2+), and unclassified ( negative for all 5 markers). Main Outcome Measures We examined the prevalence of breast cancer subtypes within racial and menopausal subsets and determined their associations with tumor size, axillary nodal status, mitotic index, nuclear pleomorphism, combined grade, p53 mutation status, and breast cancer - specific survival. Results The basal-like breast cancer subtype was more prevalent among premenopausal African American women (39%) compared with postmenopausal African American women (14%) and non - African American women (16%) of any age ( P <. 001), whereas the luminal A subtype was less prevalent (36% vs 59% and 54%, respectively). The HER2+/ER-subtype did not vary with race or menopausal status (6%-9%). Compared with luminal A, basal-like tumors had more TP53 mutations (44% vs 15%, P <. 001), higher mitotic index ( odds ratio [ OR], 11.0; 95% confidence interval [CI], 5.6-21.7), more marked nuclear pleomorphism ( OR, 9.7; 95% CI, 5.3-18.0), and higher combined grade ( OR, 8.3; 95% CI, 4.4-15.6). Breast cancer - specific survival differed by subtype ( P <. 001), with shortest survival among HER2+/ER- and basal-like subtypes. Conclusions Basal-like breast tumors occurred at a higher prevalence among premenopausal African American patients compared with postmenopausal African American and non - African American patients in this population-based study. A higher prevalence of basal-like breast tumors and a lower prevalence of luminal A tumors could contribute to the poor prognosis of young African American women with breast cancer.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Div Hematol Oncol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pathol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA; Duke Univ, Med Ctr, Dept Community & Family Med, Durham, NC 27710 USA; Univ British Columbia, Genet Pathol Evaluat Ctr, Vancouver, BC V5Z 1M9, Canada; Roswell Pk Canc Inst, Buffalo, NY 14263 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; University of British Columbia; Roswell Park Cancer Institute	Carey, LA (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Div Hematol Oncol, CB 7305,3009 Old Clin Bldg, Chapel Hill, NC 27599 USA.	Lisa_Carey@med.unc.edu	Perou, Charles M/H-9934-2014; , Pathology Services Core/CEZ-2246-2022	Perou, Charles M/0000-0001-9827-2247; Cheang, Maggie Chon U/0000-0001-5718-2501	NATIONAL CANCER INSTITUTE [P50CA058223, R01CA101227] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000046] Funding Source: NIH RePORTER; NCI NIH HHS [P50-CA58223, R01-CA-101227-01] Funding Source: Medline; NCRR NIH HHS [M01RR00046] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ademuyiwa FO, 2003, CANCER METAST REV, V22, P47, DOI 10.1023/A:1022259901319; Bland JM, 1998, BRIT MED J, V317, P1572, DOI 10.1136/bmj.317.7172.1572; Bland JM, 2004, BRIT MED J, V328, P1073, DOI 10.1136/bmj.328.7447.1073; Clegg LX, 2002, ARCH INTERN MED, V162, P1985, DOI 10.1001/archinte.162.17.1985; Conway K, 2002, CANCER RES, V62, P1987; Cox D. R., 1984, ANAL SURVIVAL DATA; Crook T, 1998, ONCOGENE, V17, P1681, DOI 10.1038/sj.onc.1202106; del Carmen MG, 2003, CANCER-AM CANCER SOC, V98, P590, DOI 10.1002/cncr.11517; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; ELEY JW, 1994, JAMA-J AM MED ASSOC, V272, P947, DOI 10.1001/jama.272.12.947; Finlin BS, 2001, J BIOL CHEM, V276, P42259, DOI 10.1074/jbc.M105888200; Foulkes WD, 2004, CANCER RES, V64, P830, DOI 10.1158/0008-5472.CAN-03-2970; Foulkes WD, 2003, J NATL CANCER I, V95, P1482, DOI 10.1093/jnci/djg050; Foulkes WD, 1997, CLIN CANCER RES, V3, P2465; Furberg H, 2001, BREAST CANCER RES TR, V68, P33, DOI 10.1023/A:1017994726207; Genestie C, 1998, ANTICANCER RES, V18, P571; Grushko TA, 2002, CANCER RES, V62, P1481; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; Huang WY, 2000, AM J EPIDEMIOL, V151, P703, DOI 10.1093/oxfordjournals.aje.a010265; Joslyn SA, 2002, CANCER, V95, P1759, DOI 10.1002/cncr.10827; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Millikan R, 2003, BREAST CANCER RES TR, V79, P355, DOI 10.1023/A:1024068525763; Millikan RC, 1998, CANCER EPIDEM BIOMAR, V7, P371; Moorman PG, 1999, ANN EPIDEMIOL, V9, P188, DOI 10.1016/S1047-2797(98)00057-X; Mountain JL, 2004, NAT GENET, V36, pS48, DOI 10.1038/ng1456; *NAT CANC I DC CPS, 2004, SURV EP END RES PROG; Newman B, 1998, JAMA-J AM MED ASSOC, V279, P915, DOI 10.1001/jama.279.12.915; NEWMAN B, 1995, BREAST CANCER RES TR, V35, P51, DOI 10.1007/BF00694745; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Olopade OI, 2001, NEW ENGL J MED, V344, P2028; OLOPADE OI, 2004, AM SOC CLIN ONC ANN; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Porter PL, 2004, CANCER-AM CANCER SOC, V100, P2533, DOI 10.1002/cncr.20279; Press MF, 1997, J CLIN ONCOL, V15, P2894, DOI 10.1200/JCO.1997.15.8.2894; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Schwartz RS, 2001, NEW ENGL J MED, V344, P1392, DOI 10.1056/NEJM200105033441810; Shavers VL, 2002, JNCI-J NATL CANCER I, V94, P334; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Stoppa-Lyonnet D, 2000, J CLIN ONCOL, V18, P4053, DOI 10.1200/JCO.2000.18.24.4053; Tate SK, 2004, NAT GENET, V36, pS34, DOI 10.1038/ng1437; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; van de Rijn M, 2002, AM J PATHOL, V161, P1991, DOI 10.1016/S0002-9440(10)64476-8; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Yu K, 2004, CLIN CANCER RES, V10, P5508, DOI 10.1158/1078-0432.CCR-04-0085	48	2716	2874	9	184	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 7	2006	295	21					2492	2502		10.1001/jama.295.21.2492	http://dx.doi.org/10.1001/jama.295.21.2492			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	049ZQ	16757721	Bronze, Green Submitted			2022-12-24	WOS:000238057300024
J	Roux, AVD; Ranjit, N; Powell, L; Jackson, S; Lewis, TT; Shea, S; Wu, C				Roux, Ana V. Diez; Ranjit, Nalini; Powell, Lynda; Jackson, Sharon; Lewis, Tene T.; Shea, Steven; Wu, Colin			Psychosocial factors and coronary calcium in adults without clinical cardiovascular disease	ANNALS OF INTERNAL MEDICINE			English	Article							BEAM COMPUTED-TOMOGRAPHY; HEART-RATE-VARIABILITY; ARTERY-DISEASE; MYOCARDIAL-INFARCTION; MAJOR DEPRESSION; YOUNG-ADULTS; CAROTID ATHEROSCLEROSIS; PSYCHOLOGICAL-FACTORS; PLATELET REACTIVITY; TRAIT ANXIETY	Background: Psychosocial factors have been linked to coronary events, but the mechanisms underlying these associations have not been established. Evidence is mixed regarding associations of psychosocial factors with subclinical coronary atherosclerosis. Objective: To examine associations of 4 psychosocial factors (depressive symptoms, anger, anxiety, and chronic stress) with the presence of subclinical coronary atherosclerosis. Design: Cross-sectional study. Setting: The Multiethnic Study of Atherosclerosis, a population-based study of subclinical atherosclerosis. Patients: A multiethnic sample of 6789 adults, 45 to 84 years of age, with no history of clinical cardiovascular disease. Measurements: Coronary calcium was assessed by using chest computed tomography, and psychosocial factors were assessed by using questionnaires with validated scales. Results: There was no evidence that higher levels of the psychosocial measures were associated with greater prevalence of calcification or with greater amounts of calcium among persons with calcium. Age- and risk factor-adjusted relative prevalences of coronary calcification in men for the top fourth category versus the bottom fourth category of anger, anxiety, and depressive symptoms were 0.94 (95% Cl, 0.88 to 1.01), 0.97 (Cl, 0.90 to 1.04), and 0.97 (Cl, 0.90 to 1.05), respectively; these values for women were 1.01 (Cl, 0.90 to 1.15), 0.93 (Cl, 0.83 to 1.05), and 0.92 (Cl, 0.82 to 1.04), respectively. Relative prevalences for the top versus the bottom category of chronic stress burden were 1.02 (Cl, 0.94 to 1.11) for men and 0.88 (Cl, 0.79 to 0.99) for women. Limitations: Current measures of psychosocial factors may be a poor proxy for cumulative exposure during development of atherosclerosis. Conclusion: Depressive symptoms, anger, anxiety, and chronic stress burden were not associated with coronary calcification in a multiethnic sample of asymptomatic adults.	Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48103 USA; Rush Univ, Med Ctr, Chicago, IL 60612 USA; Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; Columbia Univ, New York, NY USA; NIH, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; Rush University; Wake Forest University; Columbia University; National Institutes of Health (NIH) - USA	Roux, AVD (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, 1214 S Univ,2nd Floor, Ann Arbor, MI 48103 USA.	adiezrou@umich.edu			DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095161, N01HC095163, N01HC095164, N01HC095160, N01HC095165, N01HC095162, N01HC095159, N01HC095169] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-95163, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95165, N01-HC-95164, N01-HC-95169, N01-HC-95159, R01 HL0768] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agatisa PIK, 2005, ARCH INTERN MED, V165, P1229, DOI 10.1001/archinte.165.11.1229; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; ANGELL M, 1985, NEW ENGL J MED, V312, P1570, DOI 10.1056/NEJM198506133122411; [Anonymous], 1980, PRELIMINARY MANUAL S; Arad Y, 2000, J AM COLL CARDIOL, V36, P1253, DOI 10.1016/S0735-1097(00)00872-X; BAREFOOT JC, 1994, AM J CARDIOL, V74, P439, DOI 10.1016/0002-9149(94)90899-0; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bild DE, 2005, CIRCULATION, V111, P1313, DOI 10.1161/01.CIR.0000157730.94423.4B; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Black HR, 1997, ARCH INTERN MED, V157, P2413; BREEN JF, 1992, RADIOLOGY, V185, P435, DOI 10.1148/radiology.185.2.1410350; Bromberger JT, 1996, PSYCHOL AGING, V11, P207, DOI 10.1037/0882-7974.11.2.207; Canalis E, 2001, J CLIN ENDOCR METAB, V86, P5681, DOI 10.1210/jc.86.12.5681; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Carr JJ, 2000, AM J ROENTGENOL, V174, P915, DOI 10.2214/ajr.174.4.1740915; COSTA PT, 1993, DIAGNOSIS TREATMENT, P155; deLeon CFM, 1996, AM J CARDIOL, V77, P252, DOI 10.1016/S0002-9149(97)89388-5; Dennison E, 1999, J CLIN ENDOCR METAB, V84, P3058, DOI 10.1210/jc.84.9.3058; Denollet J, 1998, CIRCULATION, V97, P167, DOI 10.1161/01.CIR.97.2.167; Detrano RC, 2000, CURR PROB CARDIOLOGY, V25, P374, DOI 10.1067/mcd.2000.104848; Di Somma C, 2002, CLIN ENDOCRINOL, V56, P153, DOI 10.1046/j.0300-0664.2001.01454.doc.x; Doherty TM, 2003, P NATL ACAD SCI USA, V100, P11201, DOI 10.1073/pnas.1932554100; Everson SA, 1996, PSYCHOSOM MED, V58, P113, DOI 10.1097/00006842-199603000-00003; Ferketich AK, 2000, ARCH INTERN MED, V160, P1261, DOI 10.1001/archinte.160.9.1261; Finney ML, 2002, PSYCHOPHYSIOLOGY, V39, P340, DOI 10.1017/S0048577201393101; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Frimerman A, 1997, AM J CARDIOL, V79, P72, DOI 10.1016/S0002-9149(96)00680-7; Gavin JR, 1997, DIABETES CARE, V20, P1183; Ghiadoni L, 2000, CIRCULATION, V102, P2473, DOI 10.1161/01.CIR.102.20.2473; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Guyll M, 1998, HEALTH PSYCHOL, V17, P30, DOI 10.1037/0278-6133.17.1.30; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; Iribarren C, 2000, JAMA-J AM MED ASSOC, V283, P2546, DOI 10.1001/jama.283.19.2546; JULKUNEN J, 1994, PSYCHOSOM MED, V56, P519, DOI 10.1097/00006842-199411000-00007; Kawachi I, 1996, CIRCULATION, V94, P2090, DOI 10.1161/01.CIR.94.9.2090; KAWACHI I, 1994, CIRCULATION, V90, P2225, DOI 10.1161/01.CIR.90.5.2225; KAWACHI I, 1995, AM J CARDIOL, V75, P882, DOI 10.1016/S0002-9149(99)80680-8; Kop WJ, 2002, AM J CARDIOL, V89, P419, DOI 10.1016/S0002-9149(01)02264-0; Krantz DS, 2002, ANNU REV PSYCHOL, V53, P341, DOI 10.1146/annurev.psych.53.100901.135208; Low KG, 1998, ANN BEHAV MED, V20, P221, DOI 10.1007/BF02884964; Lumley T, 2002, ANNU REV PUBL HEALTH, V23, P151, DOI 10.1146/annurev.publhealth.23.100901.140546; Markovitz JH, 1998, PSYCHOSOM MED, V60, P586, DOI 10.1097/00006842-199809000-00013; Matthews KA, 1998, PSYCHOSOM MED, V60, P633, DOI 10.1097/00006842-199809000-00021; MITTLEMAN MA, 1995, CIRCULATION, V92, P1720, DOI 10.1161/01.CIR.92.7.1720; Musselman DL, 1996, AM J PSYCHIAT, V153, P1313; NEMEROFF CB, 1984, SCIENCE, V226, P1342, DOI 10.1126/science.6334362; O'Malley PG, 2000, NEW ENGL J MED, V343, P1298, DOI 10.1056/NEJM200011023431803; O'Malley PG, 2000, AM J CARDIOL, V85, P945, DOI 10.1016/S0002-9149(99)00906-6; Papanicolaou DA, 1998, ANN INTERN MED, V128, P127, DOI 10.7326/0003-4819-128-2-199801150-00009; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rajagopalan S, 2001, AM J CARDIOL, V88, P196, DOI 10.1016/S0002-9149(01)01623-X; Reilly MP, 2004, ATHEROSCLEROSIS, V173, P69, DOI 10.1016/j.atherosclerosis.2003.10.010; REINSCH CH, 1967, NUMER MATH, V10, P177, DOI 10.1007/BF02162161; Robbins AS, 2002, ANN EPIDEMIOL, V12, P452, DOI 10.1016/S1047-2797(01)00278-2; ROYALL RM, 1986, INT STAT REV, V54, P221, DOI 10.2307/1403146; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Rugulies R, 2002, AM J PREV MED, V23, P51, DOI 10.1016/S0749-3797(02)00439-7; Sas Institute inc, 2004, SAS STAT VERS 9 1 US; Scheidt S, 2000, J PSYCHOSOM RES, V48, P317, DOI 10.1016/S0022-3999(00)00091-X; Shimbo D, 2002, AM J CARDIOL, V89, P331, DOI 10.1016/S0002-9149(01)02236-6; Skantze HB, 1998, ATHEROSCLEROSIS, V136, P153, DOI 10.1016/S0021-9150(97)00202-5; Stein PK, 2000, J PSYCHOSOM RES, V48, P493, DOI 10.1016/S0022-3999(99)00085-9; Strike PC, 2004, PROG CARDIOVASC DIS, V46, P337, DOI 10.1016/j.pcad.2003.09.001; Suarez EC, 2002, BRAIN BEHAV IMMUN, V16, P675, DOI 10.1016/S0889-1591(02)00019-3; Tiemeier H, 2004, ARCH GEN PSYCHIAT, V61, P369, DOI 10.1001/archpsyc.61.4.369; USALA PD, 1991, J PERS SOC PSYCHOL, V60, P471, DOI 10.1037/0022-3514.60.3.471; Williams JE, 2002, STROKE, V33, P13, DOI 10.1161/hs0102.101625; WILLIAMS RB, 1988, PSYCHOSOM MED, V50, P139, DOI 10.1097/00006842-198803000-00004; WILLIAMS RB, 1980, PSYCHOSOM MED, V42, P539, DOI 10.1097/00006842-198011000-00002; Wulsin LR, 2003, PSYCHOSOM MED, V65, P201, DOI 10.1097/01.PSY.0000058371.50240.E3; Yaghoubi S, 1995, Am J Card Imaging, V9, P231; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	73	64	64	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 6	2006	144	11					822	831		10.7326/0003-4819-144-11-200606060-00008	http://dx.doi.org/10.7326/0003-4819-144-11-200606060-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	049ZN	16754924	Green Published			2022-12-24	WOS:000238057000005
J	Davenport, TRB; Stanley, WT; Sargis, EJ; De Luca, DW; Mpunga, NE; Machaga, SJ; Olson, LE				Davenport, TRB; Stanley, WT; Sargis, EJ; De Luca, DW; Mpunga, NE; Machaga, SJ; Olson, LE			A new genus of African monkey, Rungwecebus: Morphology, ecology, and molecular phylogenetics	SCIENCE			English	Article							OLD-WORLD MONKEYS; MANGABEYS; PAPIONINI; SEQUENCES; ORIGIN; CLADE	A new species of African monkey, Lophocebus kipunji, was described in 2005 based on observations from two sites in Tanzania. We have since obtained a specimen killed by a farmer on Mount Rungwe, the type locality. Detailed molecular phylogenetic analyses of this specimen demonstrate that the genus Lophocebus is diphyletic. We provide a description of a new genus of African monkey and of the only preserved specimen of this primate. We also present information on the animal's ecology and conservation.	Wildlife Conservat Soc, So Highlands Conservat Programme, Mbeya, Tanzania; Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA; Yale Univ, Dept Anthropol, New Haven, CT 06520 USA; Univ Alaska Museum, Fairbanks, AK 99775 USA	Field Museum of Natural History (Chicago); Yale University; University of Alaska System; University of Alaska Fairbanks	Davenport, TRB (corresponding author), Wildlife Conservat Soc, So Highlands Conservat Programme, POB 1475, Mbeya, Tanzania.	tdavenport@wcs.org		Olson, Link/0000-0002-2481-5701	NCRR NIH HHS [RR-16466-01] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016466] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BYRNE RW, 1981, BEHAVIOUR, V78, P283, DOI 10.1163/156853981X00365; CRONIN JE, 1976, NATURE, V260, P700, DOI 10.1038/260700a0; Davenport T.R.B., 2005, AFR GEOGR, V13, P56; Dinesen Lars, 1994, Ibis, V136, P2; DISOTELL TR, 1994, AM J PHYS ANTHROPOL, V94, P47, DOI 10.1002/ajpa.1330940105; Fleagle JG, 2002, J HUM EVOL, V42, P267, DOI 10.1006/jhev.2001.0526; GROVES C P, 1978, Primates, V19, P1, DOI 10.1007/BF02373224; Groves CP, 2001, PRIMATE TAXONOMY; Grubb P, 2003, INT J PRIMATOL, V24, P1301, DOI 10.1023/B:IJOP.0000005994.86792.b9; Harris EE, 2000, J HUM EVOL, V38, P235, DOI 10.1006/jhev.1999.0318; Jones, 2005, ARC J, V18, P1; Jones T, 2005, SCIENCE, V308, P1161, DOI 10.1126/science.1109191; Kingdon J., 1997, KINGDOM FIELD GUIDE; Page SL, 2001, MOL PHYLOGENET EVOL, V18, P14, DOI 10.1006/mpev.2000.0895; Page SL, 1999, MOL PHYLOGENET EVOL, V13, P348, DOI 10.1006/mpev.1999.0653; Range F, 2004, ETHOLOGY, V110, P301, DOI 10.1111/j.1439-0310.2004.00973.x; SCHWARTZ E, 1928, ANN MAG NAT HIST, V10, P664; Stanley WT, 2005, J ZOOL, V265, P269, DOI 10.1017/S0952836904006314; Waser P.M., 1982, P117	19	95	101	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2006	312	5778					1378	1381		10.1126/science.1125631	http://dx.doi.org/10.1126/science.1125631			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048QM	16690815				2022-12-24	WOS:000237961600055
J	Roth, AF; Wan, JM; Bailey, AO; Sun, BM; Kuchar, JA; Green, WN; Phinney, BS; Yates, JR; Davis, NG				Roth, Amy F.; Wan, Junmei; Bailey, Aaron O.; Sun, Beimeng; Kuchar, Jason A.; Green, William N.; Phinney, Brett S.; Yates, John R., III; Davis, Nicholas G.			Global analysis of protein palmitoylation in yeast	CELL			English	Article							SNARE YKT6; CRYSTAL-STRUCTURE; EARLY-STAGE; MEMBRANE; LOCALIZATION; IDENTIFICATION; ACYLATION; KINASE; RAS; ACYLTRANSFERASE	Protein palmitoylation is a reversible lipid modification that regulates membrane tethering for key proteins in cell signaling, cancer, neuronal transmission, and membrane trafficking. Palmitoylation has proven to be a difficult study: Specifying consensuses for predicting palmitoylation remain unavailable, and first-example palmitoylation enzymes-i.e., protein acyltransferases (PATs)-were identified only recently. Here, we use a new proteomic methodology that purifies and identifies palmitoylated proteins to characterize the palmitoyl proteome of the yeast Saccharomyces cerevisiae. Thirty-five new palmitoyl proteins are identified, including many SNARE proteins and amino acid permeases as well as many other participants in cellular signaling and membrane trafficking. Analysis of mutant yeast strains defective for members of the DHHC protein family, a putative PAT family, allows a matching of substrate palmitoyl proteins to modifying PATs and reveals the DHHC family to be a family of diverse PAT specificities responsible for most of the palmitoylation within the cell.	Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	Wayne State University; Scripps Research Institute; Michigan State University; University of Chicago	Davis, NG (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA.	ndavis@med.wayne.edu	Phinney, Brett/S-6404-2016; Bailey, Aaron/ABB-8522-2021	Phinney, Brett/0000-0003-3870-3302; Bailey, Aaron/0000-0001-8063-3032	NCRR NIH HHS [P41 RR011823, RR11823] Funding Source: Medline; NIGMS NIH HHS [GM65525, R01 GM065525] Funding Source: Medline; NINDS NIH HHS [R01 NS043782, R01 NS043782-01A2, R01 NS043782-05, R01 NS043782-02, R01 NS043782-04, R01 NS043782-03] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043782] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AEL DE, 2002, CELL, V108, P849; Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; COUVE A, 1995, P NATL ACAD SCI USA, V92, P5987, DOI 10.1073/pnas.92.13.5987; Dietrich LEP, 2005, EMBO REP, V6, P245, DOI 10.1038/sj.embor.7400350; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Dietrich LEP, 2004, EMBO J, V23, P45, DOI 10.1038/sj.emboj.7600015; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Ducker CE, 2004, ONCOGENE, V23, P9230, DOI 10.1038/sj.onc.1208171; Duncan JA, 1996, J BIOL CHEM, V271, P23594, DOI 10.1074/jbc.271.38.23594; Dunphy JT, 1998, BBA-MOL CELL BIOL L, V1436, P245, DOI 10.1016/S0005-2760(98)00130-1; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fukasawa M, 2004, P NATL ACAD SCI USA, V101, P4815, DOI 10.1073/pnas.0401183101; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Harashima T, 2005, MOL BIOL CELL, V16, P4557, DOI 10.1091/mbc.E05-05-0403; Hou HT, 2005, P NATL ACAD SCI USA, V102, P17366, DOI 10.1073/pnas.0508885102; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Jones TLZ, 1997, BIOCHEMISTRY-US, V36, P7185, DOI 10.1021/bi9628376; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Kihara A, 2005, MOL CELL BIOL, V25, P9189, DOI 10.1128/MCB.25.21.9189-9197.2005; Kim YG, 2005, NAT STRUCT MOL BIOL, V12, P38, DOI 10.1038/nsmb871; Leventis R, 1997, BIOCHEMISTRY-US, V36, P5546, DOI 10.1021/bi963029h; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Moffett S, 2001, J NEUROCHEM, V76, P269, DOI 10.1046/j.1471-4159.2001.00005.x; Panek HR, 1997, EMBO J, V16, P4194, DOI 10.1093/emboj/16.14.4194; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Smotrys JE, 2005, J CELL BIOL, V170, P1091, DOI 10.1083/jcb.200507048; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Tu YP, 1997, SCIENCE, V278, P1132, DOI 10.1126/science.278.5340.1132; Turnbull AP, 2005, EMBO J, V24, P875, DOI 10.1038/sj.emboj.7600565; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; Veit M, 2000, BIOCHEM J, V345, P145, DOI 10.1042/0264-6021:3450145; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	48	410	428	2	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					1003	1013		10.1016/j.cell.2006.03.042	http://dx.doi.org/10.1016/j.cell.2006.03.042			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751107	Green Accepted, Bronze			2022-12-24	WOS:000238116400024
J	Tang, YC; Chang, HC; Roeben, A; Wischnewski, D; Wischnewski, N; Kerner, MJ; Hartl, FU; Hayer-Hartl, M				Tang, Yun-Chi; Chang, Hung-Chun; Roeben, Annette; Wischnewski, Dirk; Wischnewski, Nadine; Kerner, Michael J.; Hartl, F. Ulrich; Hayer-Hartl, Manajit			Structural features of the GroEL-GroES nano-cage required for rapid folding of encapsulated protein	CELL			English	Article							MALTOSE-BINDING PROTEIN; CHAPERONIN GROEL; IN-VIVO; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; CENTRAL CAVITY; POLYPEPTIDE; EVOLUTION; INTERMEDIATE; CONFINEMENT	GroEL and GroES form a chaperonin nano-cage for proteins up to similar to 60 kDa to fold in isolation. Here we explored the structural features of the chaperonin cage critical for rapid folding of encapsulated substrates. Modulating the volume of the GroEL central cavity affected folding speed in accordance with confinement theory. Small proteins (similar to 30 kDa) folded more rapidly as the size of the cage was gradually reduced to a point where restriction in space slowed folding dramatically. For larger proteins (similar to 40-50 kDa), either expanding or reducing cage volume decelerated folding. Additionally, interactions with the C-terminal, mildly hydrophobic Gly-Gly-Met repeat sequences of GroEL protruding into the cavity, and repulsion effects from the negatively charged cavity wall were required for rapid folding of some proteins. We suggest that by combining these features, the chaperonin cage provides a physical environment optimized to catalyze the structural annealing of proteins with kinetically complex folding pathways.	Tech Univ Denmark, BioCent, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany	Technical University of Denmark; Max Planck Society	Hartl, FU (corresponding author), Tech Univ Denmark, BioCent, Ctr Biol Sequence Anal, Kemitorvet 208, DK-2800 Lyngby, Denmark.	uhartl@biochem.mpg.de; mhartl@biochem.mpg.de	Hartl, F. Ulrich/Y-8206-2019; Tang, Yun-Chi/GRE-8205-2022; Hayer-Hartl, Manajit/V-8078-2017	Hayer-Hartl, Manajit/0000-0001-8213-6742; tang, yun qi/0000-0001-9385-2787; zhang, hong jun/0000-0003-0030-8323				Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Bakkes PJ, 2005, P NATL ACAD SCI USA, V102, P8144, DOI 10.1073/pnas.0500048102; Baumketner A, 2003, J MOL BIOL, V332, P701, DOI 10.1016/S0022-2836(03)00929-X; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Brocchieri L, 2000, PROTEIN SCI, V9, P476; Chang HC, 2005, J MOL BIOL, V353, P397, DOI 10.1016/j.jmb.2005.08.052; CHUN SY, 1993, J BIOL CHEM, V268, P20855; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Fenton WA, 2003, Q REV BIOPHYS, V36, P229, DOI 10.1017/S0033583503003883; Ganesh C, 2001, PROTEIN SCI, V10, P1635, DOI 10.1110/ps.8101; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; Horst R, 2005, P NATL ACAD SCI USA, V102, P12748, DOI 10.1073/pnas.0505642102; HORWICH AL, 1993, CELL, V74, P909, DOI 10.1016/0092-8674(93)90470-B; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Hunt JF, 1997, CELL, V90, P361, DOI 10.1016/S0092-8674(00)80343-8; Jewett AI, 2004, P NATL ACAD SCI USA, V101, P13192, DOI 10.1073/pnas.0400720101; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; LANDRY SJ, 1993, NATURE, V364, P255, DOI 10.1038/364255a0; Lin Z, 2004, MOL CELL, V16, P23, DOI 10.1016/j.molcel.2004.09.003; Maisnier-Patin S, 2005, NAT GENET, V37, P1376, DOI 10.1038/ng1676; Marvin JS, 1997, P NATL ACAD SCI USA, V94, P4366, DOI 10.1073/pnas.94.9.4366; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; MCLENNAN NF, 1993, MOL MICROBIOL, V7, P49, DOI 10.1111/j.1365-2958.1993.tb01096.x; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Saibil HR, 2002, TRENDS BIOCHEM SCI, V27, P627, DOI 10.1016/S0968-0004(02)02211-9; Sparrer H, 1997, P NATL ACAD SCI USA, V94, P1096, DOI 10.1073/pnas.94.4.1096; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Stan G, 2003, BIOPHYS CHEM, V100, P453, DOI 10.1016/S0301-4622(02)00298-3; Takagi F, 2003, P NATL ACAD SCI USA, V100, P11367, DOI 10.1073/pnas.1831920100; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; Vendruscolo M, 2003, P NATL ACAD SCI USA, V100, P14817, DOI 10.1073/pnas.2036516100; Wang JD, 1998, P NATL ACAD SCI USA, V95, P12163, DOI 10.1073/pnas.95.21.12163; Wang JD, 2002, CELL, V111, P1027, DOI 10.1016/S0092-8674(02)01198-4; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zhou HX, 2004, J MOL RECOGNIT, V17, P368, DOI 10.1002/jmr.711	43	227	231	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					903	914		10.1016/j.cell.2006.04.027	http://dx.doi.org/10.1016/j.cell.2006.04.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751100	hybrid, Green Submitted			2022-12-24	WOS:000238116400017
J	England, R				England, Roger			Coordinating HIV control efforts: what to do with the national AIDS commissions	LANCET			English	Editorial Material							SEX WORKERS; PREVALENCE; AFRICA; HEALTH				England, R (corresponding author), POB 1350, Grande Anse, Grenada.	rengland@caribsurf.com						*AIDSP, GLOB FUND OBS NEWSL; Ainsworth M, 2000, LANCET, V356, P55, DOI 10.1016/S0140-6736(00)02440-5; Basu I, 2004, JAIDS-J ACQ IMM DEF, V36, P845, DOI 10.1097/00126334-200407010-00012; *CENTR BUR STAT MI, 2003, ORC MACR KEN DEM HLT; Cote AM, 2004, AIDS, V18, P917, DOI [10.1097/01.aids.0000111475.61782.98, 10.1097/00002030-200404090-00009]; De Cock KM, 2002, LANCET, V360, P67, DOI 10.1016/S0140-6736(02)09337-6; *DEP INT DEV HLTH, 2004, ENGL R EXP CONTR PRI; *GLOB FUND FIGHT A, TUB MAL CURR GRANT C; Halperin DT, 2004, LANCET, V364, P4, DOI 10.1016/S0140-6736(04)16606-3; *JOINT UN PROGR HI, 3 ON ACT WE AR WE GO; *JOINT UN PROGR HI, GLOB TASK TEAM IMPR; *JOINT UN PROGR HI, SUPP MAINSTR AIDS DE; Loevinsohn B, 2005, LANCET, V366, P676, DOI 10.1016/S0140-6736(05)67140-1; Lowndes CM, 2002, SEX TRANSM INFECT, V78, pI69, DOI 10.1136/sti.78.suppl_1.i69; LOWNDES CM, 2003, 15 BIENN C INT SOC S; *MON AIDS PAND NET, 2001, STAT TRENDS HIV AIDS; Ramjee G, 2002, SEX TRANSM DIS, V29, P44, DOI 10.1097/00007435-200201000-00008; Rojanapithayakorn W, 1996, AIDS, V10, P1, DOI 10.1097/00002030-199601000-00001; Sandiford P, 2002, PUBLIC POLICY PRIVAT; *TANZ COMM AIDS NB, TANZ HIV AIDS IND SU; *UN DEV PROGR WORL, MAINSTR HIV AIDS SEC; Wong ML, 2004, AIDS, V18, P1195, DOI 10.1097/00002030-200405210-00013; *WORLD BANK, INT REV MULT HIV AID; *WORLD BANK OP EV, COMM RES IMPR EFF HI; 2004, MONITORING AIDS PAND	25	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 27	2006	367	9524					1786	1789		10.1016/S0140-6736(06)68774-6	http://dx.doi.org/10.1016/S0140-6736(06)68774-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	047BE	16731274				2022-12-24	WOS:000237854000034
J	Baselga, J				Baselga, Jose			Targeting tyrosine kinases in cancer: The second wave	SCIENCE			English	Editorial Material							MONOCLONAL-ANTIBODY CETUXIMAB; SQUAMOUS-CELL CARCINOMA; LUNG ADENOCARCINOMAS; ADJUVANT CHEMOTHERAPY; SINGLE-AGENT; GROWTH; MUTATIONS; INHIBITOR; GEFITINIB; RESISTANCE		Vall Hebron Univ Hosp, Oncol Program, Barcelona 08035, Spain; Univ Autonoma Barcelona, Vall Hebron Res Inst, Barcelona 08035, Spain	Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Baselga, J (corresponding author), Vall Hebron Univ Hosp, Oncol Program, Barcelona 08035, Spain.	jbaselga@vhebron.net						Baselga J, 2005, J CLIN ONCOL, V23, P2445, DOI 10.1200/JCO.2005.11.890; Baselga J, 2004, NAT MED, V10, P786, DOI 10.1038/nm0804-786; Baselga J, 2005, J CLIN ONCOL, V23, P5568, DOI 10.1200/JCO.2005.07.119; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Burris HA, 2005, J CLIN ONCOL, V23, P5305, DOI 10.1200/JCO.2005.16.584; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Chakravarti A, 2002, CANCER RES, V62, P200; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Daub H, 2004, NAT REV DRUG DISCOV, V3, P1001, DOI 10.1038/nrd1579; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DEMETRI GD, 2004, ASCO M ABSTR, V22, P3001; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Fujimoto N, 2005, CANCER RES, V65, P11478, DOI 10.1158/0008-5472.CAN-05-1977; GOMEZ HL, 2005, ASCO ANN M ABSTR 13, V23, P3046; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Kobayashi S, 2005, CANCER RES, V65, P7096, DOI 10.1158/0008-5472.CAN-05-1346; LORUSSO P, 2005, ASCO M ABSTR, V23, P3011; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matar P, 2004, CLIN CANCER RES, V10, P6487, DOI 10.1158/1078-0432.CCR-04-0870; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Moore M.J., 2005, J CLIN ONCOL, V23, P1; Nakao M, 1996, LEUKEMIA, V10, P1911; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; STORNIOLO AM, 2005, ASCO M ABSTR, V23, P559; Talpaz M, 2005, BLOOD, V106, p16A; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949; Xia WL, 2002, ONCOGENE, V21, P6255, DOI 10.1038/sj.onc.1205794; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	52	380	423	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1175	1178		10.1126/science.1125951	http://dx.doi.org/10.1126/science.1125951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728632				2022-12-24	WOS:000237957400042
J	Parashar, UD; Glass, RI				Parashar, UD; Glass, RI			Public health - Progress toward rotavirus vaccines	SCIENCE			English	Editorial Material							ORAL VACCINES; INTUSSUSCEPTION; EFFICACY; INFANTS; SAFETY		Ctr Dis Control & Prevent, Viral Gastroenteritis Sect, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Parashar, UD (corresponding author), Ctr Dis Control & Prevent, Viral Gastroenteritis Sect, Atlanta, GA 30333 USA.	uap2@cdc.gov						Glass RI, 2005, J INFECT DIS, V192, pS160, DOI 10.1086/431504; JOHN TJ, 1976, BRIT MED J, V1, P812, DOI 10.1136/bmj.1.6013.812; Levine MM, 1997, LANCET, V349, P220, DOI 10.1016/S0140-6736(97)22004-0; Murphy TV, 2001, NEW ENGL J MED, V344, P564, DOI 10.1056/NEJM200102223440804; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; PARASHAR UD, 2005, 43 ANN M INF DIS SOC; Peter G, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.6.e67; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Weijer C, 2000, BRIT MED J, V321, P525, DOI 10.1136/bmj.321.7260.525	10	39	40	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					851	852		10.1126/science.1128827	http://dx.doi.org/10.1126/science.1128827			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	041JQ	16690845				2022-12-24	WOS:000237452900024
J	van den Heuvel, MGL; De Graaff, MP; Dekker, C				van den Heuvel, MGL; De Graaff, MP; Dekker, C			Molecular sorting by electrical steering of microtubules in kinesin-coated channels	SCIENCE			English	Article							FLEXURAL RIGIDITY; DRIVEN; TRANSPORT; MOTOR; ELECTROPHORESIS; NANOSTRUCTURES; MOVEMENTS; MOTILITY; SHUTTLES; DNA	Integration of biomolecular motors in nanoengineered structures raises the intriguing possibility of manipulating materials on nanometer scales. We have managed to integrate kinesin motor proteins in closed submicron channels and to realize active electrical control of the direction of individual kinesin-propelled microtubule filaments at Y junctions. Using this technique, we demonstrate molecular sorting of differently labeled microtubules. We attribute the steering of microtubules to electric field - induced bending of the leading tip. From measurements of the orientation-dependent electrophoretic motion of individual, freely suspended microtubules, we estimate the net applied force on the tip to be in the picoNewton range and we infer an effective charge of 12 e - per tubulin dimer under physiological conditions.	Delft Univ Technol, Kavli Inst nanosci, Sect Mol Biophys, NL-2628 CJ Delft, Netherlands	Delft University of Technology	Dekker, C (corresponding author), Delft Univ Technol, Kavli Inst nanosci, Sect Mol Biophys, Lorentzweg 1, NL-2628 CJ Delft, Netherlands.	dekker@mb.tn.tudelft.nl		Dekker, Cees/0000-0001-6273-071X				Bohm KJ, 2005, IEEE T ADV PACKAGING, V28, P571, DOI 10.1109/TADVP.2005.858314; Clemmens J, 2003, LANGMUIR, V19, P10967, DOI 10.1021/la035519y; Dittrich PS, 2003, ANAL CHEM, V75, P5767, DOI 10.1021/ac034568c; DUKE T, 1995, PHYS REV LETT, V74, P330, DOI 10.1103/PhysRevLett.74.330; Felgner H, 1996, J CELL SCI, V109, P509; Fu AY, 1999, NAT BIOTECHNOL, V17, P1109, DOI 10.1038/15095; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Hess H, 2004, CHEM-EUR J, V10, P2110, DOI 10.1002/chem.200305712; Hess H, 2001, J Biotechnol, V82, P67, DOI 10.1016/S1389-0352(01)00029-0; Hiratsuka Y, 2001, BIOPHYS J, V81, P1555, DOI 10.1016/S0006-3495(01)75809-2; HUNT AJ, 1994, BIOPHYS J, V67, P766, DOI 10.1016/S0006-3495(94)80537-5; Jia LL, 2004, BIOMED MICRODEVICES, V6, P67, DOI 10.1023/B:BMMD.0000013368.89455.8d; Kis A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.248101; Moorjani SG, 2003, NANO LETT, V3, P633, DOI 10.1021/nl034001b; Nitta T, 2005, NANO LETT, V5, P1337, DOI 10.1021/nl050586t; Nogales E, 1998, NATURE, V393, P191, DOI 10.1038/30288; Patolsky F, 2004, NAT MATER, V3, P692, DOI 10.1038/nmat1205; Ramachandran S, 2006, SMALL, V2, P330, DOI 10.1002/smll.200500265; ROBINSON KR, 1975, SCIENCE, V187, P70, DOI 10.1126/science.1167318; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Song B, 2002, P NATL ACAD SCI USA, V99, P13577, DOI 10.1073/pnas.202235299; Soong RK, 2000, SCIENCE, V290, P1555, DOI 10.1126/science.290.5496.1555; STIGTER D, 1991, BIOPOLYMERS, V31, P169, DOI 10.1002/bip.360310205; Stigter D, 1998, BIOPHYS J, V75, P1197, DOI 10.1016/S0006-3495(98)74039-1; STIGTER D, 1978, J PHYS CHEM-US, V82, P1417, DOI 10.1021/j100501a019; Stone HA, 2004, ANNU REV FLUID MECH, V36, P381, DOI 10.1146/annurev.fluid.36.050802.122124; Stracke R, 2002, BIOCHEM BIOPH RES CO, V293, P602, DOI 10.1016/S0006-291X(02)00251-6; van den Heuvel MGL, 2005, NANO LETT, V5, P1117, DOI 10.1021/nl0506554; van den Heuvel MGL, 2005, NANO LETT, V5, P235, DOI 10.1021/nl048291n; Xi JZ, 2005, NAT MATER, V4, P180, DOI 10.1038/nmat1308; Yokokawa R, 2004, NANO LETT, V4, P2265, DOI 10.1021/nl048851i	31	197	200	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					910	914		10.1126/science.1124258	http://dx.doi.org/10.1126/science.1124258			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690866				2022-12-24	WOS:000237452900047
J	Xue, S; Calvin, K; Li, H				Xue, S; Calvin, K; Li, H			RNA recognition and cleavage by a splicing endonuclease	SCIENCE			English	Article							SUBSTRATE RECOGNITION; INTRON ENDONUCLEASE; RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; HALOBACTERIUM-VOLCANII; CRYSTAL-STRUCTURE; ARCHAEAL INTRONS; IDENTIFICATION; PROTEIN; EVOLUTION	The RNA splicing endonuclease cleaves two phosphodiester bonds within folded precursor RNAs during intron removal, producing the functional RNAs required for protein synthesis. Here we describe at a resolution of 2.85 angstroms the structure of a splicing endonuclease from Archaeglobus fulgidus bound with a bulge-helix-bulge RNA containing a noncleaved and a cleaved splice site. The endonuclease dimer cooperatively recognized a flipped-out bulge base and stabilizes sharply bent bulge backbones that are poised for an in-line RNA cleavage reaction. Cooperativity arises because an arginine pair from one catalytic domain sandwiches a nucleobase within the bulge cleaved by the other catalytic domain.	Florida State Univ, Inst Mol Biophys, Dept Chem & Biochem, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Li, H (corresponding author), Florida State Univ, Inst Mol Biophys, Dept Chem & Biochem, Tallahassee, FL 32306 USA.	hongli@sb.fsu.edu		Li, Hong/0000-0003-2046-9861	NIGMS NIH HHS [R01 GM099604] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; BALDI MI, 1992, SCIENCE, V255, P1404, DOI 10.1126/science.1542788; Battle DJ, 2002, P NATL ACAD SCI USA, V99, P11676, DOI 10.1073/pnas.182221799; Biot C, 2002, J BIOL CHEM, V277, P40816, DOI 10.1074/jbc.M205719200; BUFARDECI E, 1993, EMBO J, V12, P4697, DOI 10.1002/j.1460-2075.1993.tb06158.x; Calvin K, 2005, J MOL BIOL, V353, P952, DOI 10.1016/j.jmb.2005.09.035; CULVER GM, 1993, SCIENCE, V261, P206, DOI 10.1126/science.8392224; Diener JL, 1998, MOL CELL, V1, P883, DOI 10.1016/S1097-2765(00)80087-8; GREER CL, 1987, MOL CELL BIOL, V7, P76, DOI 10.1128/MCB.7.1.76; GREER CL, 1983, CELL, V32, P537, DOI 10.1016/0092-8674(83)90473-7; Hershkovitz E, 2003, NUCLEIC ACIDS RES, V31, P6249, DOI 10.1093/nar/gkg835; KJEMS J, 1989, CAN J MICROBIOL, V35, P210, DOI 10.1139/m89-033; KlemanLeyer K, 1997, CELL, V89, P839, DOI 10.1016/S0092-8674(00)80269-X; KNAPP G, 1979, CELL, V18, P37, DOI 10.1016/0092-8674(79)90351-9; Li H, 2000, J MOL BIOL, V302, P639, DOI 10.1006/jmbi.2000.3941; Li H, 1998, SCIENCE, V280, P279, DOI 10.1126/science.280.5361.279; LykkeAndersen J, 1997, EMBO J, V16, P6290, DOI 10.1093/emboj/16.20.6290; LykkeAndersen J, 1997, TRENDS BIOCHEM SCI, V22, P326, DOI 10.1016/S0968-0004(97)01113-4; Marck C, 2003, RNA, V9, P1516, DOI 10.1261/rna.5132503; MIAO F, 1993, J BIOL CHEM, V268, P672; Negri ED, 1997, CELL, V89, P859, DOI 10.1016/S0092-8674(00)80271-8; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; PEEBLES CL, 1983, CELL, V32, P525, DOI 10.1016/0092-8674(83)90472-5; PHIZICKY EM, 1986, J BIOL CHEM, V261, P2978; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; RAUHUT R, 1990, J BIOL CHEM, V265, P18180; REYES VM, 1988, CELL, V55, P719, DOI 10.1016/0092-8674(88)90230-9; Tang TH, 2002, NUCLEIC ACIDS RES, V30, P921, DOI 10.1093/nar/30.4.921; THOMPSON LD, 1988, J BIOL CHEM, V263, P17951; THOMPSON LD, 1990, J BIOL CHEM, V265, P18104; Tocchini-Valentini GD, 2005, P NATL ACAD SCI USA, V102, P8933, DOI 10.1073/pnas.0502350102; Trotta CR, 1997, CELL, V89, P849, DOI 10.1016/S0092-8674(00)80270-6; TROTTA CR, IN PRESS NATURE; Watanabe Y, 2002, FEBS LETT, V510, P27, DOI 10.1016/S0014-5793(01)03219-7; Zhang YM, 2004, ACTA CRYSTALLOGR D, V60, P447, DOI 10.1107/S0907444903029482	36	78	84	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					906	910		10.1126/science.1126629	http://dx.doi.org/10.1126/science.1126629			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690865				2022-12-24	WOS:000237452900046
J	Basch, ML; Bronner-Fraser, M; Garcia-Castro, MI				Basch, ML; Bronner-Fraser, M; Garcia-Castro, MI			Specification of the neural crest occurs during gastrulation and requires Pax7	NATURE			English	Article							PLATE; SIGNALS; DIFFERENTIATION; INDUCTION; EPIDERMIS; XENOPUS; BORDER; CHICK; CELLS; FATE	The neural crest is a stem population critical for development of the vertebrate craniofacial skeleton and peripheral ganglia. Neural crest cells originate along the border between the neural plate and epidermis(1), migrate extensively and generate numerous derivatives, including neurons and glia of the peripheral nervous system, melanocytes, bone and cartilage of the head skeleton(2). Impaired neural crest development is associated with human defects, including cleft palate(3). Classically, the neural crest has been thought to form by interactions at the border between neural and non-neural ectoderm or mesoderm(4-7), and defined factors such as bone morphogenetic proteins (BMPs) and Wnt proteins have been postulated as neural crest-inducers(8-13). Although competence to induce crest cells declines after stage 10 ( ref. 14), little is known about when neural crest induction begins in vivo. Here we report that neural crest induction is underway during gastrulation and well before proper neural plate appearance. We show that a restricted region of chick epiblast ( stage 3 - 4) is specified to generate neural crest cells when explanted under non-inducing conditions. This region expresses the transcription factor Pax7 by stage 41 and later contributes to neural folds and migrating neural crest. In chicken embryos, Pax7 is required for neural crest formation in vivo, because blocking its translation inhibits expression of the neural crest markers Slug, Sox9, Sox10 and HNK-1. Our results indicate that neural crest specification initiates earlier than previously assumed, independently of mesodermal and neural tissues, and that Pax7 has a crucial function during neural crest development.	CALTECH, Div Biol 139 74, Pasadena, CA 91125 USA; Yale Univ, MCDB, New Haven, CT 06520 USA	California Institute of Technology; Yale University	Garcia-Castro, MI (corresponding author), CALTECH, Div Biol 139 74, Pasadena, CA 91125 USA.	martin.garcia-castro@yale.edu	Basch, Martin/I-6632-2012	Bronner, Marianne/0000-0003-4274-1862; Garcia-Castro, Martin I./0000-0001-5128-0004				Bang AG, 1997, DEVELOPMENT, V124, P2075; Basch Martin L, 2004, Birth Defects Res C Embryo Today, V72, P109, DOI 10.1002/bdrc.20015; Basch ML, 2000, DEV NEUROSCI-BASEL, V22, P217, DOI 10.1159/000017444; BASLER K, 1993, CELL, V73, P687, DOI 10.1016/0092-8674(93)90249-P; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; DICKINSON ME, 1995, DEVELOPMENT, V121, P2099; Fernandez-Garre P, 2002, DEVELOPMENT, V129, P2807; Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824; GARCIAMARTINEZ V, 1993, J EXP ZOOL, V267, P431, DOI 10.1002/jez.1402670409; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; His W., 1868, UNTERSUCHUNGEN ERSTE; LaBonne C, 1998, DEVELOPMENT, V125, P2403; Le Douarin NM, 1999, NEURAL CREST, V2; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Mansouri A, 1996, DEVELOPMENT, V122, P831; Mansouri A, 1998, CRIT REV ONCOGENESIS, V9, P141, DOI 10.1615/CritRevOncog.v9.i2.40; Mansouri A, 1998, MECH DEVELOP, V78, P171, DOI 10.1016/S0925-4773(98)00168-3; Mayor R, 1997, DEV BIOL, V189, P1, DOI 10.1006/dbio.1997.8634; McLarren KW, 2003, DEV BIOL, V259, P34, DOI 10.1016/S0012-1606(03)00177-5; Monsoro-Burq AH, 2005, DEV CELL, V8, P167, DOI 10.1016/j.devcel.2004.12.017; MOURY JD, 1989, DEV BIOL, V133, P44, DOI 10.1016/0012-1606(89)90295-9; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Pera E, 1999, DEVELOPMENT, V126, P63; SaintJeannet JP, 1997, P NATL ACAD SCI USA, V94, P13713, DOI 10.1073/pnas.94.25.13713; SELLECK MAJ, 1995, DEVELOPMENT, V121, P525; Sheng GJ, 2003, CELL, V115, P603, DOI 10.1016/S0092-8674(03)00927-9; Streit A, 1998, DEVELOPMENT, V125, P507; Streit A, 1999, MECH DEVELOP, V82, P51, DOI 10.1016/S0925-4773(99)00013-1; Wilkie AOM, 2001, NAT REV GENET, V2, P458, DOI 10.1038/35076601	30	267	272	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2006	441	7090					218	222		10.1038/nature04684	http://dx.doi.org/10.1038/nature04684			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16688176				2022-12-24	WOS:000237418800046
J	Vitale, S; Cotch, MF; Sperduto, RD				Vitale, S; Cotch, MF; Sperduto, RD			Prevalence of visual impairment in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BLUE MOUNTAINS EYE; MEXICAN-AMERICAN POPULATION; HIP FRACTURE; VISION IMPAIRMENT; OLDER POPULATION; PROYECTO VER; BLINDNESS; RISK	Context The prevalence of visual impairment in the US public has not been surveyed nationally in several decades. Objective To estimate the number of US individuals aged 12 years or older who have impaired distance vision due to uncorrected refractive error. Design, Setting, and Participants The National Health and Nutrition Examination Survey ( NHANES), using a multistage probability sampling design, included a vision evaluation in a mobile examination center. Visual acuity data were obtained from 13 265 of 14 203 participants (93.4%) who visited the mobile examination center in 1999-2002. Visual impairment was defined as presenting distance visual acuity of 20/50 or worse in the better-seeing eye. Visual impairment due to uncorrected refractive error was defined as ( presenting) visual impairment that improved, aided by automated refraction results, to 20/40 or better in the better-seeing eye. Main Outcome Measures Presenting distance visual acuity ( measured with usual corrective lenses, if any) and distance visual acuity after automated refraction. Results Overall, 1190 study participants had visual impairment ( weighted prevalence, 6.4%; 95% confidence interval [CI], 6.0%-6.8%), and of these, 83.3% could achieve good visual acuity with correction ( 95% CI, 80.9%-85.8%). Extrapolating these findings to the general US population, approximately 14 million individuals aged 12 years or older have visual impairment ( defined as distance visual acuity of 20/50 or worse), and of these, more than 11 million individuals could have their vision improved to 20/40 or better with refractive correction. Conclusions Visual impairment due to uncorrected refractive error is a common condition in the United States. Providing appropriate refractive correction to those individuals whose vision can be improved is an important public health endeavor with implications for safety and quality of life.	NEI, Div Epidemiol & Clin Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Vitale, S (corresponding author), NEI, Div Epidemiol & Clin Res, NIH, 5635 Fishers Ln 1100,MSC 9301, Bethesda, MD 20892 USA.	sev@nei.nih.gov		Cotch, Mary Frances/0000-0002-2046-4350; vitale, susan/0000-0002-5972-6848	NATIONAL EYE INSTITUTE [Z01EY000402] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA EY000402-12, ZIA EY000402-09, Z01 EY000402-07, ZIA EY000402-15, Z01 EY000402-06, ZIA EY000402-13, ZIA EY000402-10, ZIA EY000402-08, ZIA EY000402-14, ZIA EY000402-11, Z99 EY999999] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Allen PM, 2003, OPTOMETRY VISION SCI, V80, P245, DOI 10.1097/00006324-200303000-00014; Broman AT, 2002, INVEST OPHTH VIS SCI, V43, P3393; DargentMolina P, 1996, LANCET, V348, P145, DOI 10.1016/S0140-6736(96)01440-7; Dimitrov PN, 2003, INVEST OPHTH VIS SCI, V44, P5075, DOI 10.1167/iovs.02-0457; Engel A, 1978, Vital Health Stat 1, P1; Evans BJW, 2004, OPHTHAL PHYSL OPT, V24, P161, DOI 10.1111/j.1475-1313.2004.00197.x; FELSON DT, 1989, J AM GERIATR SOC, V37, P495, DOI 10.1111/j.1532-5415.1989.tb05678.x; Foran S, 2002, AM J OPHTHALMOL, V134, P712, DOI 10.1016/S0002-9394(02)01673-2; HERON G, 1995, OPHTHAL PHYSL OPT, V15, P23, DOI 10.1016/0275-5408(95)92788-G; Ivers RQ, 2000, AM J EPIDEMIOL, V152, P633, DOI 10.1093/aje/152.7.633; Ivers RQ, 1998, J AM GERIATR SOC, V46, P58; Keeffe JE, 2002, BRIT J OPHTHALMOL, V86, P1118, DOI 10.1136/bjo.86.10.1118; Klein RJ, 2001, HLTH PEOPLE 2010 STA; Munoz B, 2000, ARCH OPHTHALMOL-CHIC, V118, P819, DOI 10.1001/archopht.118.6.819; Munoz B, 2002, INVEST OPHTH VIS SCI, V43, P608; *NAT CTR HLTH STAT, 2004, DHHS PUBL; *NAT CTR HLTH STAT, 2002, NHANES 1999 2000 ADD; *NAT CTR HLTH STAT, 2004, NHANES AN GUID JUN 2; *NAT HLTH NUTR EX, PUBL US DAT FIL; *NAT HLTH NUTR EX, VIS PROC MAN; National Center for Health Statistics, 1996, AN REP GUID 3 NAT HL; Owsley C, 1999, SURV OPHTHALMOL, V43, P535, DOI 10.1016/S0039-6257(99)00035-1; Pesudovs K, 2004, J CATARACT REFR SURG, V30, P1921, DOI 10.1016/j.jcrs.2004.01.033; Roberts I, 1995, Inj Prev, V1, P12, DOI 10.1136/ip.1.1.12; Rose K, 2001, CLIN EXP OPHTHALMOL, V29, P116, DOI 10.1046/j.1442-9071.2001.00389.x; Swanson MW, 2004, OPHTHAL EPIDEMIOL, V11, P227, DOI 10.1080/09286580490514540; Thiagalingam S, 2002, BRIT J OPHTHALMOL, V86, P1041, DOI 10.1136/bjo.86.9.1041; Tsai SY, 2003, J FORMOS MED ASSOC, V102, P86; Zwerling C, 1998, J OCCUP ENVIRON MED, V40, P720, DOI 10.1097/00043764-199808000-00010; 1985, VITAL HLTH STAT, V1, P1	30	238	244	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2006	295	18					2158	2163		10.1001/jama.295.18.2158	http://dx.doi.org/10.1001/jama.295.18.2158			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040OW	16684986				2022-12-24	WOS:000237391300025
J	Barrett, G; Cassell, JA; Peacock, JL; Coleman, MP				Barrett, G; Cassell, JA; Peacock, JL; Coleman, MP			National survey of British public's views on use of identifiable medical data by the National Cancer Registry	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFORMED-CONSENT; INFORMATION	Objectives To describe the views of the British public on the use of personal medical data by the National Cancer Registry without individual consent, and to assess the relative importance attached by the public to personal privacy in relation to public health uses of identifiable health data. Design Cross sectional, face to face interview survey. Setting England, Wales, and Scotland. Participants 2872 respondents, 97% of those who took part in the Office for National Statistics' omnibus survey, a national multistage probability sample in March and April 2005 (response rates 62% and 69%, respectively). Results 72% (95% confidence interval 70% to 74%) of all respondents did not consider any of the following to be an invasion of their privacy by the National Cancer Registry: inclusion of postcode, inclusion of name and address, and the receipt of a letter inviting them to a research study on the basis of inclusion in the registry. Only 2% (2% to 3%) of the sample considered all of these to amount to an invasion of privacy. Logistic regression analysis showed that the proportions not concerned about invasion of privacy varied significantly by country, ethnicity, socioeconomic status, and housing tenure, although in all subgroups examined most respondents had no concerns. 81% (79% to 83%) of all respondents said that they would support a law making cancer registration statutory. Conclusions Most of the British public considers the confidential use of personal, identifiable patient information by the National Cancer Registry for the purposes of public health research and surveillance not to be an invasion of privacy.	Brunel Univ, Sch Hlth Sci & Social Care, Uxbridge TW7 5DU, Middx, England; UCL, Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat, London WC1E 6BT, England; London Sch Hyg & Trop Med, Non Communicable Dis Epidemiol Unit, London, England	Brunel University; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Barrett, G (corresponding author), Brunel Univ, Sch Hlth Sci & Social Care, Uxbridge TW7 5DU, Middx, England.	geraldine.barrett@brunel.ac.uk	Coleman, Michel/AAA-9543-2020	Coleman, Michel/0000-0001-8940-3807; Peacock, Janet/0000-0002-0310-2518; Barrett, Geraldine/0000-0002-9738-1051; Cassell, Jackie/0000-0003-0777-0385				BOYD P, 2003, J HLTH SERV RES P S1, V8, pS1; *BRIT MED ASS, 2005, CONF PART BIGG PICT; de Vet HCW, 2003, INT J EPIDEMIOL, V32, P1114, DOI 10.1093/ije/dyg314; Department of Health, 2003, CONF NHS COD PRACT; *EUR COMM RES GROU, 2003, DAT PROT; *GEN MED COUNC, 2000, CONF PROT PROV INF; HIGGINS J, 2003, J HLTH SERV RES P S1, V8, pS1; Ingelfinger JR, 2004, NEW ENGL J MED, V350, P1452, DOI 10.1056/NEJMe048027; McKinney PA, 2005, BRIT MED J, V330, P877, DOI 10.1136/bmj.38404.650208.ae; O'Neill O, 2003, J MED ETHICS, V29, P4, DOI 10.1136/jme.29.1.4; *OFF NAT STAT, KS18 TEN CENS 2001 K; Peto J, 2004, BRIT MED J, V328, P1029, DOI 10.1136/bmj.328.7447.1029; Tu JV, 2004, NEW ENGL J MED, V350, P1414, DOI 10.1056/NEJMsa031697; Walley T, 2006, BRIT MED J, V332, P130, DOI 10.1136/bmj.332.7534.130; *WELLC TRUST PUBL, 2004, PUBL HLTH SCI CHALL	15	83	84	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2006	332	7549					1068	1070A		10.1136/bmj.38805.473738.7C	http://dx.doi.org/10.1136/bmj.38805.473738.7C			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	042HI	16648132	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000237518400018
J	Perucca, E; Tomson, T				Perucca, E; Tomson, T			Prenatal exposure to antiepileptic drugs	LANCET			English	Editorial Material							FETAL ANTICONVULSANT SYNDROMES; IN-UTERO; CHILDREN; TERATOGENICITY; EPILEPSY; RISKS; BIRTH		Univ Pavia, Dept Internal Med & Therapeut, Clin Pharmacol Unit, I-27100 Pavia, Italy; Mondino Fdn, IRCCS C, Inst Neurol, Diagnost Lab, I-27100 Pavia, Italy; Mondino Fdn, IRCCS C, Inst Neurol, Lab Appl Biol Res, I-27100 Pavia, Italy; Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	University of Pavia; IRCCS Fondazione Casimiro Mondino; IRCCS Fondazione Casimiro Mondino; Karolinska Institutet	Perucca, E (corresponding author), Univ Pavia, Dept Internal Med & Therapeut, Clin Pharmacol Unit, I-27100 Pavia, Italy.	perucca@unipv.it	Perucca, Emilio/Q-7308-2019	Perucca, Emilio/0000-0001-8703-223X				Adab N, 2001, J NEUROL NEUROSUR PS, V70, P15, DOI 10.1136/jnnp.70.1.15; ADAMS J, 1990, NEUROTOXICOL TERATOL, V12, P203, DOI 10.1016/0892-0362(90)90092-Q; ARDINGER HH, 1988, AM J MED GENET, V29, P171, DOI 10.1002/ajmg.1320290123; Dean JCS, 2002, J MED GENET, V39, P251, DOI 10.1136/jmg.39.4.251; Eriksson K, 2005, EPILEPSY RES, V65, P189, DOI 10.1016/j.eplepsyres.2005.06.001; Gaily E, 2004, NEUROLOGY, V62, P28, DOI 10.1212/WNL.62.1.28; Holmes LB, 2001, NEW ENGL J MED, V344, P1132, DOI 10.1056/NEJM200104123441504; Holmes LB, 2002, J MED GENET, V39, P245, DOI 10.1136/jmg.39.4.245; JONES KL, 1989, NEW ENGL J MED, V320, P1480; Kini U, 2006, ARCH DIS CHILD-FETAL, V91, pF90, DOI 10.1136/adc.2004.067421; LOMBROSO C, 1897, UOMO DELINQUENTE; Moore SJ, 2000, J MED GENET, V37, P489, DOI 10.1136/jmg.37.7.489; Morrow J, 2006, J NEUROL NEUROSUR PS, V77, P193, DOI 10.1136/jnnp.2005.074203; Perucca E, 2005, LANCET NEUROL, V4, P781, DOI 10.1016/S1474-4422(05)70224-6; Vinten J, 2005, NEUROLOGY, V64, P949, DOI 10.1212/01.WNL.0000154514.82948.69	15	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 6	2006	367	9521					1467	1469		10.1016/S0140-6736(06)68627-3	http://dx.doi.org/10.1016/S0140-6736(06)68627-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	039RJ	16679145				2022-12-24	WOS:000237324200008
J	Bartscherer, K; Pelte, N; Ingelfinger, D; Boutros, M				Bartscherer, Kerstin; Pelte, Nadege; Ingelfinger, Dierk; Boutros, Michael			Secretion of Wnt Ligands requires Evi, a conserved transmembrane protein	CELL			English	Article							DORSAL-VENTRAL AXIS; LONG-RANGE ACTION; TRANSCRIPTION FACTOR; PLASMA-MEMBRANE; GENE-PRODUCT; WINGLESS; DROSOPHILA; POLARITY; TRANSPORT; HEDGEHOG	Wnt signaling pathways are important for multiple biological processes during development and disease. Wnt proteins are secreted factors that activate target-gene expression in both a short- and long-range manner. Currently, little is known about how Writs are released from cells and which factors facilitate their secretion. Here, we identify a conserved multipass transmembrane protein, Evenness interrupted (Evi/Wls), through an RNAi survey for transmembrane proteins involved in Drosophila Wingless (Wg) signaling. During development, evi mutants have patterning defects that phenocopy wg loss-of-function alleles and fail to express Wg target genes. evi's function is evolutionarily conserved as depletion of its human homolog disrupts Wnt signaling in human cells. Epistasis experiments and clonal analysis place evi in the Wg-producing cell. Our results show that Wg is retained by evi mutant cells and suggest that evi is the founding member of a gene family specifically required for Wg/Wnt secretion.	German Canc Res Ctr, Boveri Grp Signalling & Funct Genom, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Boutros, M (corresponding author), German Canc Res Ctr, Boveri Grp Signalling & Funct Genom, Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	m.boutros@dkfz.de	Boutros, Michael/C-3566-2008	Boutros, Michael/0000-0002-9458-817X				Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; BAKER NE, 1988, DEVELOPMENT, V102, P489; Baonza A, 2002, DEVELOPMENT, V129, P5313, DOI 10.1242/dev.00096; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BEJSOVEC A, 1991, DEVELOPMENT, V113, P471; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Cadigan KM, 2002, SEMIN CELL DEV BIOL, V13, P83, DOI 10.1016/S1084-9521(02)00014-9; Campbell G, 1998, DEVELOPMENT, V125, P4483; Chou TB, 1996, GENETICS, V144, P1673; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; DIAZBENJUMEA FJ, 1994, DEVELOPMENT, V120, P1661; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; Hild M, 2004, GENOME BIOL, V5; Ikonen E, 1998, SEMIN CELL DEV BIOL, V9, P503, DOI 10.1006/scdb.1998.0258; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lawrence PA, 1996, DEVELOPMENT, V122, P4095; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Marois E, 2006, DEVELOPMENT, V133, P307, DOI 10.1242/dev.02197; Moline MM, 1999, DEVELOPMENT, V126, P4375; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Pfeiffer S, 2002, CURR BIOL, V12, P957, DOI 10.1016/S0960-9822(02)00867-9; Piddini E, 2005, DEVELOPMENT, V132, P5479, DOI 10.1242/dev.02145; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; Seto ES, 2004, TRENDS CELL BIOL, V14, P45, DOI 10.1016/j.tcb.2003.11.004; STAPLETON M, 2002, GENOME BIOL, V0003; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Tanaka K, 2002, J BIOL CHEM, V277, P12816, DOI 10.1074/jbc.M200187200; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vervoort M, 1999, CURR BIOL, V9, P632, DOI 10.1016/S0960-9822(99)80285-1; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200	52	420	435	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					523	533		10.1016/j.cell.2006.04.009	http://dx.doi.org/10.1016/j.cell.2006.04.009			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678096	Bronze			2022-12-24	WOS:000237506100018
J	Helenius, J; Brouhard, G; Kalaidzidis, Y; Diez, S; Howard, J				Helenius, J; Brouhard, G; Kalaidzidis, Y; Diez, S; Howard, J			The depolymerizing kinesin MCAK uses lattice diffusion to rapidly target microtubule ends	NATURE			English	Article							CENTROMERE-ASSOCIATED KINESIN; REPRESSOR-OPERATOR INTERACTION; C-TERMINUS; CYTOPLASMIC DYNEIN; DYNAMICS; PROTEIN; TUBULIN; XKCM1; ASSOCIATION; COOPERATE	The microtubule cytoskeleton is a dynamic structure in which the lengths of the microtubules are tightly regulated. One regulatory mechanism is the depolymerization of microtubules by motor proteins in the kinesin-13 family(1). These proteins are crucial for the control of microtubule length in cell division(2-4), neuronal development(5) and interphase microtubule dynamics(6,7). The mechanism by which kinesin-13 proteins depolymerize microtubules is poorly understood. A central question is how these proteins target to microtubule ends at rates exceeding those of standard enzyme-substrate kinetics(8). To address this question we developed a single-molecule microscopy assay for MCAK, the founding member of the kinesin-13 family(9). Here we show that MCAK moves along the microtubule lattice in a one-dimensional (1D) random walk. MCAK-microtubule interactions were transient: the average MCAK molecule diffused for 0.83 s with a diffusion coefficient of 0.38 mu m(2) s(-1). Although the catalytic depolymerization by MCAK requires the hydrolysis of ATP, we found that the diffusion did not. The transient transition from three-dimensional diffusion to 1D diffusion corresponds to a "reduction in dimensionality"(10) that has been proposed as the search strategy by which DNA enzymes find specific binding sites(11). We show that MCAK uses this strategy to target to both microtubule ends more rapidly than direct binding from solution.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119899, Russia	Max Planck Society; Lomonosov Moscow State University	Howard, J (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	howard@mpi-cbg.de	Brouhard, Gary/AAZ-7789-2021; Howard, Jonathon/J-7492-2016; Diez, Stefan/E-8172-2010; Kalaidzidis, Yannis/H-3094-2016; Howard, Jonathon/D-4229-2011	Howard, Jonathon/0000-0003-0086-1196; Diez, Stefan/0000-0002-0750-8515; Kalaidzidis, Yannis/0000-0002-6137-1193; Howard, Jonathon/0000-0003-0086-1196				Adam G., 1968, STRUCTURAL CHEM MOL, P198; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Howard J., 2001, MECH MOTOR PROTEINS; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; Kalaidzidis YL, 1997, PROGRAM COMPUT SOFT+, V23, P206; Klein GA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108102; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Maney T, 2001, J BIOL CHEM, V276, P34753, DOI 10.1074/jbc.M106626200; Mennella V, 2005, NAT CELL BIOL, V7, P235, DOI 10.1038/ncb1222; Moores CA, 2002, MOL CELL, V9, P903, DOI 10.1016/S1097-2765(02)00503-8; Niederstrasser H, 2002, J MOL BIOL, V316, P817, DOI 10.1006/jmbi.2001.5360; Nitta R, 2004, SCIENCE, V305, P678, DOI 10.1126/science.1096621; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; Ovechkina Y, 2002, J CELL BIOL, V159, P557, DOI 10.1083/jcb.200205089; PASCHAL BM, 1989, NATURE, V342, P569, DOI 10.1038/342569a0; RICHTER PH, 1974, BIOPHYS CHEM, V2, P255, DOI 10.1016/0301-4622(74)80050-5; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Wang ZH, 2000, BIOPHYS J, V78, P1955, DOI 10.1016/S0006-3495(00)76743-9; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6961, DOI 10.1021/bi00527a030; WORDEMAN L, 1995, J CELL BIOL, V128, P95, DOI 10.1083/jcb.128.1.95	30	338	347	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2006	441	7089					115	119		10.1038/nature04736	http://dx.doi.org/10.1038/nature04736			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16672973				2022-12-24	WOS:000237248600044
J	Bascompte, J; Jordano, P; Olesen, JM				Bascompte, J; Jordano, P; Olesen, JM			Asymmetric coevolutionary networks facilitate biodiversity maintenance	SCIENCE			English	Article							INTERACTION STRENGTH; FOOD WEBS; STABILITY; PATTERNS	The mutualistic interactions between plants and their pollinators or seed dispersers have played a major role in the maintenance of Earth's biodiversity. To investigate how coevolutionary interactions are shaped within species-rich communities, we characterized the architecture of an array of quantitative, mutualistic networks spanning a broad geographic range. These coevolutionary networks are highly asymmetric, so that if a plant species depends strongly on an animal species, the animal depends weakly on the plant. By using a simple dynamical model, we showed that asymmetries inherent in coevolutionary networks may enhance long-term coexistence and facilitate biodiversity maintenance.	CSIC, Estac Biol Donana, Integrat Ecol Grp, E-41080 Seville, Spain; Aarhus Univ, Dept Ecol & Genet, DK-8000 Aarhus, Denmark	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Aarhus University	Bascompte, J (corresponding author), CSIC, Estac Biol Donana, Integrat Ecol Grp, Apartado 1056, E-41080 Seville, Spain.	bascompte@ebd.csic.es	Olesen, Jens M/A-3011-2009; Bascompte, Jordi/B-7596-2008; Jordano, Pedro/A-5162-2008	Olesen, Jens M/0000-0003-1998-1083; Bascompte, Jordi/0000-0002-0108-6411; Jordano, Pedro/0000-0003-2142-9116; Olesen, Jes/0000-0002-6712-2702				Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bersier LF, 2002, ECOLOGY, V83, P2394, DOI 10.1890/0012-9658(2002)083[2394:QDOFWM]2.0.CO;2; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; FAGAN WF, 1994, ECOLOGY, V75, P2022, DOI 10.2307/1941607; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Kokkoris GD, 1999, ECOL LETT, V2, P70, DOI 10.1046/j.1461-0248.1999.22058.x; May R. M., 1973, STABILITY COMPLEXITY; May R. M., 1981, THEOR ECOL-NETH, P78; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; PAINE RT, 1980, J ANIM ECOL, V49, P667; PAINE RT, 1992, NATURE, V355, P73, DOI 10.1038/355073a0; RAFFAELLI DG, 1995, FOOD WEBS INTEGRATIO, P185; Ringel MS, 1996, THEOR POPUL BIOL, V50, P281, DOI 10.1006/tpbi.1996.0032; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; Thompson J.N, 2005, INTERSPEC INTERACT; Thompson J. N., 1994, COEVOLUTIONARY PROCE, DOI 10.7208/chicago/9780226797670.001.0001; ULANOWICZ RE, 1991, MATH BIOSCI, V103, P45, DOI 10.1016/0025-5564(91)90090-6; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; Vazquez DP, 2004, ECOLOGY, V85, P1251, DOI 10.1890/03-3112; Wootton JT, 1997, ECOL MONOGR, V67, P45, DOI 10.1890/0012-9615(1997)067[0045:EATOPC]2.0.CO;2	25	800	833	13	275	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					431	433		10.1126/science.1123412	http://dx.doi.org/10.1126/science.1123412			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16627742	Green Submitted			2022-12-24	WOS:000236941800048
J	Naundorf, B; Wolf, F; Volgushev, M				Naundorf, B; Wolf, F; Volgushev, M			Unique features of action potential initiation in cortical neurons	NATURE			English	Article							IN-VIVO; COINCIDENCE DETECTION; PYRAMIDAL NEURONS; VISUAL-CORTEX; THRESHOLD; MECHANISM; KINETICS	Neurons process and encode information by generating sequences of action potentials(1,2). For all spiking neurons, the encoding of single-neuron computations into sequences of spikes is biophysically determined by the cell's action-potential-generating mechanism. It has recently been discovered that apparently minor modifications of this mechanism can qualitatively change the nature of neuronal encoding(3,4). Here we quantitatively analyse the dynamics of action potential initiation in cortical neurons in vivo, in vitro and in computational models. Unexpectedly, key features of the initiation dynamics of cortical neuron action potentials-their rapid initiation and variable onset potential are outside the range of behaviours described by the classical Hodgkin-Huxley theory. We propose a new model based on the cooperative activation of sodium channels that reproduces the observed dynamics of action potential initiation. This new model predicts that Hodgkin-Huxley-type dynamics of action potential initiation can be induced by artificially decreasing the effective density of sodium channels. In vitro experiments confirm this prediction, supporting the hypothesis that cooperative sodium channel activation underlies the dynamics of action potential initiation in cortical neurons.	Univ Gottingen, Max Planck Inst Dynam & Self Org, D-37073 Gottingen, Germany; Univ Gottingen, Dept Phys, D-37073 Gottingen, Germany; Univ Gottingen, Bernstein Ctr Computat Neurosci, D-37073 Gottingen, Germany; Ruhr Univ Bochum, Dept Neurophysiol, D-44780 Bochum, Germany; Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Moscow 117485, Russia	Max Planck Society; University of Gottingen; University of Gottingen; University of Gottingen; Ruhr University Bochum; Institute of Higher Nervous Activity & Neurophysiology of RAS; Russian Academy of Sciences	Wolf, F (corresponding author), Univ Gottingen, Max Planck Inst Dynam & Self Org, Bunsenstr 10, D-37073 Gottingen, Germany.	fred@chaos.gwdg.de	Wolf, Fred/D-5771-2011; Volgushev, Maxim/AAO-6793-2020	Wolf, Fred/0000-0002-7068-3762; Volgushev, Maxim/0000-0002-8080-1136				ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; BERNSTEIN J, 1868, ARCH GES PHYSL, V1, P173, DOI DOI 10.1007/BF01; Colbert CM, 2002, NAT NEUROSCI, V5, P533, DOI 10.1038/nn857; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; Goldman L, 1995, BIOPHYS J, V69, P2364, DOI 10.1016/S0006-3495(95)80105-0; Henze DA, 2001, NEUROSCIENCE, V105, P121, DOI 10.1016/S0306-4522(01)00167-1; HUGUENARD JR, 1988, J NEUROPHYSIOL, V59, P778, DOI 10.1152/jn.1988.59.3.778; HUXLEY AF, 1972, NOBEL LECT PHYSL MED; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Naundorf B, 2005, J COMPUT NEUROSCI, V18, P297, DOI 10.1007/s10827-005-0329-8; PATLAK J, 1991, PHYSIOL REV, V71, P1047, DOI 10.1152/physrev.1991.71.4.1047; Schneidman E, 1998, NEURAL COMPUT, V10, P1679, DOI 10.1162/089976698300017089; Volgushev M, 2002, J PHYSIOL-LONDON, V540, P307, DOI 10.1113/jphysiol.2001.012974; Wang XJ, 2003, J NEUROPHYSIOL, V89, P3279, DOI 10.1152/jn.00242.2003	18	240	245	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2006	440	7087					1060	1063		10.1038/nature04610	http://dx.doi.org/10.1038/nature04610			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16625198				2022-12-24	WOS:000236906000038
J	Hampton, T				Hampton, T			Interplay of genes and environment found in adolescents' alcohol abuse	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item								This study aims to understand the underlying developmental mechanisms that lead to adolescent substance use and abuse. A mutation in the gene encoding aldehyde dehydrogenase 2 that affects alcohol metabolism can cause high levels of toxic aldehyde to build up causing it to affect human behavior.										Higuchi S, 1994, Alcohol Alcohol Suppl, V2, P29; Wu G, 2000, ALCOHOL ALCOHOLISM, V35, P55, DOI 10.1093/alcalc/35.1.55	2	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2006	295	15					1760	+		10.1001/jama.295.15.1760	http://dx.doi.org/10.1001/jama.295.15.1760			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	033XG	16622132				2022-12-24	WOS:000236886900003
J	Kumar, R; Jha, P; Arora, P; Mony, P; Bhatia, P; Millson, P; Dhingra, N; Bhattacharya, M; Remis, RS; Nagelkerke, N				Kumar, R; Jha, P; Arora, P; Mony, P; Bhatia, P; Millson, P; Dhingra, N; Bhattacharya, M; Remis, RS; Nagelkerke, N		ISHA Investigators	Trends in HIV-1 in young adults in south India from 2000 to 2004: a prevalence study	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUALLY-TRANSMITTED-DISEASES; COMMUNITY PREVALENCE; PREGNANT-WOMEN; INFECTION; HIV/AIDS; CLINICS; IMPACT; MEN; SEX	Background Major increases in HIV-1 prevalence in India have been predicted. Incident infections need to be tracked to understand the epidemic's course, especially in some southern states of India where the epidemic is more advanced. To estimate incidence, we investigated the prevalence of HIV-1 in young people attending antenatal and sexually transmitted infection (STI) clinics in India. Methods We analysed unlinked, anonymous HIV-1 prevalence data from 294050 women attending 216 antenatal clinics and 58 790 men attending 132 STI clinics in 2000-04. Southern and northern states were analysed separately. Findings The age-standardised HIV-1 prevalence in women aged 15-24 years in southern states fell from 1.7% to 1.1% in 2000-04 (relative reduction 35%; p(trend)<0.0001, yearly reduction 11%), but did not fall significantly in women aged 25-34 years. Reductions in women aged 15-24 years were seen in key demographic groups and were similar in sites tested continuously or in all sites. Prevalence in the north was about a fifth of that in the south, with no significant decreases (or increases) in 2000-04. Prevalence fell in men aged 20-29 years attending STI clinics in the south (p(trend)<0.0001), including those with ulcerative STIs (P-trend=0.0008), but reductions were more modest in their northern counterparts. Interpretation A reduction of more than a third in HIV-1 prevalence in 2000-04 in young women in south India seems realistic, and is not easily attributable to bias or to mortality. This fall is probably due to rising condom use by men and female sex workers in south India, and thus reduced transmission to wives. Expansion of peer-based condom and education programmes for sex workers remains a top priority to control HIV-1 in India.	Univ Toronto, Toronto, ON M5C 1N8, Canada; Postgrad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh 160012, India; St Johns Natl Acad Hlth Sci, Inst Populat Hlth & Clin Res, Bangalore, Karnataka, India; Osmania Med Coll & Hosp, Hyderabad, Andhra Pradesh, India; Natl Inst Hlth & Family Welfare, New Delhi, India; United Arab Emirates Univ, Al Ain, U Arab Emirates	University of Toronto; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; St. John's National Academy of Health Sciences; United Arab Emirates University	Jha, P (corresponding author), Univ Toronto, Toronto, ON M5C 1N8, Canada.	prabhat.jha@utoronto.ca	Mony, Prem K./GRF-4752-2022	Mony, Prem K./0000-0002-1399-0520				*AIDS PREV CONTR P, 2005, VOL HLTH SERV EX SUM; [Anonymous], 2019, NATL FAMILY HLTH SUR; *AV SOC, 2004, BEH SURV SURV MAH WA, V2; Bhore AV, 2003, INT J STD AIDS, V14, P37, DOI 10.1258/095646203321043246; Boerma JT, 2003, LANCET, V362, P1929, DOI 10.1016/S0140-6736(03)14967-7; Go VF, 2004, JAIDS-J ACQ IMM DEF, V35, P314, DOI 10.1097/00126334-200403010-00014; Hira SK, 2003, NATL MED J INDIA, V16, P126; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; Hunter SC, 2003, J BIOSOC SCI, V35, P189, DOI 10.1017/S0021932003001895; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Jha P, 2001, SCIENCE, V292, P224, DOI 10.1126/science.1058187; Kang G, 2005, NATL MED J INDIA, V18, P15; KUMAR R, 2005, COMMISSION MACROECON, P58; *NACO, 2001, NAT BAS GEN POP BEH; *NACO, 2000, HIV TEST MAN LAB DIA; *NACO, 2004, ANN REP 2002 2003 20, P1; Nagelkerke NJD, 2002, B WORLD HEALTH ORGAN, V80, P89; National Intelligence Council, 2002, NEXT WAV HIV AIDS NI; Nicoll A, 1998, AIDS, V12, P1861, DOI 10.1097/00002030-199814000-00018; Pettifor A, 2000, SEX TRANSM DIS, V27, P371, DOI 10.1097/00007435-200008000-00002; Rao JVRP, 2004, LANCET, V364, P1296, DOI 10.1016/S0140-6736(04)17205-X; Risbud A, 2005, INDIAN J MED RES, V121, P369; RODRIGUES JJ, 1995, BRIT MED J, V311, P283, DOI 10.1136/bmj.311.7000.283; SHEFALEE V, 2004, INDIA TODAY     0926, P26; Thomas K, 2002, NATL MED J INDIA, V15, P135; Venkataramana CBS, 2001, TROP MED INT HEALTH, V6, P1040, DOI 10.1046/j.1365-3156.2001.00814.x; Verma RK, 2004, AIDS, V18, P1845, DOI 10.1097/00002030-200409030-00014; WAWAR M, 2005, 12 C RETR OPP INF BO; Williams BG, 2005, P NATL ACAD SCI USA, V102, P9619, DOI 10.1073/pnas.0501615102; Zaba B, 2000, AIDS, V14, P1633, DOI 10.1097/00002030-200007280-00020	30	87	89	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2006	367	9517					1164	1172		10.1016/S0140-6736(06)68435-3	http://dx.doi.org/10.1016/S0140-6736(06)68435-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZH	16616559				2022-12-24	WOS:000236673400025
J	Cromie, MJ; Shi, YX; Latifi, T; Groisman, EA				Cromie, MJ; Shi, YX; Latifi, T; Groisman, EA			An RNA sensor for intracellular Mg2+	CELL			English	Article							CONTROLS GENE-EXPRESSION; ESCHERICHIA-COLI; SALMONELLA-ENTERICA; TRANSCRIPTION ATTENUATION; MAGNESIUM TRANSPORT; BACILLUS-SUBTILIS; PHOP; RIBOSWITCHES; TYPHIMURIUM; BACTERIA	Most RNA molecules require Mg2+ for their structure and enzymatic properties. Here we report the first example of an RNA serving as sensor for cytoplasmic Mg2+. We establish that expression of the Mg2+ transporter MgtA of Salmoneila enterica serovar Typhimurium is controlled by its 51 untranslated region (5'UTR). We show that the 5'UTR of the mgtA gene can adopt different stem-loop structures depending on the Mg2+ levels, which determine whether transcription reads through into the mgtA coding region or stops within the 5'UTR. We could recapitulate the Mg2+-regulated transcription using a defined in vitro transcription system with RNA polymerase as the only protein component. The initiation of mgtA transcription responds to extracytoplasmic Mg2+ and its elongation into the coding region to cytoplasmic Mg2+, providing a singular example in which the same ligand is sensed in different cellular compartments to regulate disparate steps in gene transcription.	Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Microbiol, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL)	Groisman, EA (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Microbiol, 660 S Euclild Ave,Campus Box 8230, St Louis, MO 63110 USA.	groisman@borcim.wustl.edu			NIAID NIH HHS [AI49561] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049561] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barrick JE, 2004, P NATL ACAD SCI USA, V101, P6421, DOI 10.1073/pnas.0308014101; BENNETT GN, 1978, J MOL BIOL, V121, P179, DOI 10.1016/S0022-2836(78)80004-7; Brantl S, 2004, TRENDS MICROBIOL, V12, P473, DOI 10.1016/j.tim.2004.09.008; Castelli ME, 2000, J BIOL CHEM, V275, P22948, DOI 10.1074/jbc.M909335199; CASTILHO BA, 1984, J BACTERIOL, V158, P488, DOI 10.1128/JB.158.2.488-495.1984; Chamnongpol S, 2002, MOL MICROBIOL, V44, P561, DOI 10.1046/j.1365-2958.2002.02917.x; Chamnongpol S, 2000, J MOL BIOL, V300, P291, DOI 10.1006/jmbi.2000.3848; Chamnongpol S, 2003, J MOL BIOL, V325, P795, DOI 10.1016/S0022-2836(02)01268-8; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DAVIS RW, 1980, ADV BACT GENETICS; Draper DE, 2005, ANNU REV BIOPH BIOM, V34, P221, DOI 10.1146/annurev.biophys.34.040204.144511; England T E, 1980, Methods Enzymol, V65, P65; Epshtein V, 2003, P NATL ACAD SCI USA, V100, P5052, DOI 10.1073/pnas.0531307100; Froschauer EM, 2004, FEMS MICROBIOL LETT, V237, P49, DOI 10.1016/j.femsle.2004.06.013; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Henkin TM, 2002, BIOESSAYS, V24, P700, DOI 10.1002/bies.10125; Hilbert F, 1999, J BACTERIOL, V181, P2158, DOI 10.1128/JB.181.7.2158-2165.1999; Jacquier A, 1996, BIOCHIMIE, V78, P474, DOI 10.1016/0300-9084(96)84754-7; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; KAJITANI M, 1983, NUCLEIC ACIDS RES, V11, P671, DOI 10.1093/nar/11.3.671; Kato A, 2003, P NATL ACAD SCI USA, V100, P4706, DOI 10.1073/pnas.0836837100; Kawano M, 2005, NUCLEIC ACIDS RES, V33, P1040, DOI 10.1093/nar/gki256; KNAPP G, 1989, METHOD ENZYMOL, V180, P192; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LANDICK R, 1996, ESCHERICHIA COLI SAL; Liu MF, 2004, P NATL ACAD SCI USA, V101, P6911, DOI 10.1073/pnas.0401929101; LOWMAN HB, 1986, J BIOL CHEM, V261, P5396; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Merino E, 2005, TRENDS GENET, V21, P260, DOI 10.1016/j.tig.2005.03.002; Montagne M, 2001, J BACTERIOL, V183, P1787, DOI 10.1128/JB.183.5.1787-1791.2001; Nahvi A, 2004, NUCLEIC ACIDS RES, V32, P143, DOI 10.1093/nar/gkh167; NIYOGI SK, 1981, NUCLEIC ACIDS RES, V9, P2615, DOI 10.1093/nar/9.11.2615; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; REINHART RA, 1988, ARCH INTERN MED, V148, P2415, DOI 10.1001/archinte.148.11.2415; Romani AMP, 2000, FRONT BIOSCI, V5, pD720, DOI 10.2741/Romani; Shi YX, 2004, J BIOL CHEM, V279, P38618, DOI 10.1074/jbc.M406149200; Smith RL, 1998, MOL MICROBIOL, V28, P217, DOI 10.1046/j.1365-2958.1998.00810.x; SNAVELY MD, 1991, J BIOL CHEM, V266, P815; SNAVELY MD, 1989, J BACTERIOL, V171, P4761, DOI 10.1128/jb.171.9.4761-4766.1989; Soncini FC, 1996, J BACTERIOL, V178, P5092, DOI 10.1128/jb.178.17.5092-5099.1996; Sudarsan N, 2003, GENE DEV, V17, P2688, DOI 10.1101/gad.1140003; Tao T, 1998, MICROBIOL-SGM, V144, P655, DOI 10.1099/00221287-144-3-655; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Winkler WC, 2003, CHEMBIOCHEM, V4, P1024, DOI 10.1002/cbic.200300685; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899; Yamamoto K, 2002, MOL MICROBIOL, V45, P423, DOI 10.1046/j.1365-2958.2002.03017.x; Yanofsky C, 2004, TRENDS GENET, V20, P367, DOI 10.1016/j.tig.2004.06.007; Zwir I, 2005, P NATL ACAD SCI USA, V102, P2862, DOI 10.1073/pnas.0408238102	49	245	259	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2006	125	1					71	84		10.1016/j.cell.2006.01.043	http://dx.doi.org/10.1016/j.cell.2006.01.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615891	Bronze			2022-12-24	WOS:000237314200015
J	Cloos, PAC; Christensen, J; Agger, K; Maiolica, A; Rappsilber, J; Antal, T; Hansen, KH; Helin, K				Cloos, Paul A. C.; Christensen, Jesper; Agger, Karl; Maiolica, Alessio; Rappsilber, Juri; Antal, Torben; Hansen, Klaus H.; Helin, Kristian			The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3	NATURE			English	Article							HYPOXIA-INDUCIBLE FACTOR; PROSTATE-CANCER; METHYLATION; SENESCENCE; HETEROCHROMATIN; GENE; IDENTIFICATION; PROTEINS; AMPLICON; REVEALS	Methylation of lysine and arginine residues on histone tails affects chromatin structure and gene transcription(1-3). Tri- and dimethylation of lysine 9 on histone H3 (H3K9me3/me2) is required for the binding of the repressive protein HP1 and is associated with heterochromatin formation and transcriptional repression in a variety of species(4-6). H3K9me3 has long been regarded as a 'permanent' epigenetic mark(7,8). In a search for proteins and complexes interacting with H3K9me3, we identified the protein GASC1 ( gene amplified in squamous cell carcinoma 1)(9), which belongs to the JMJD2 ( jumonji domain containing 2) subfamily of the jumonji family, and is also known as JMJD2C(10). Here we show that three members of this subfamily of proteins demethylate H3K9me3/me2 in vitro through a hydroxylation reaction requiring iron and alpha-ketoglutarate as cofactors. Furthermore, we demonstrate that ectopic expression of GASC1 or other JMJD2 members markedly decreases H3K9me3/me2 levels, increases H3K9me1 levels, delocalizes HP1 and reduces heterochromatin in vivo. Previously, GASC1 was found to be amplified in several cell lines derived from oesophageal squamous carcinomas(9,11,12), and in agreement with a contribution of GASC1 to tumour development, inhibition of GASC1 expression decreases cell proliferation. Thus, in addition to identifying GASC1 as a histone trimethyl demethylase, we suggest a model for how this enzyme might be involved in cancer development, and propose it as a target for anti-cancer therapy.	Biotech Res & Innovat Ctr, DK-2100 Copenhagen, Denmark; FIRC Inst Mol Oncol, I-20139 Milan, Italy; Univ Copenhagen, Fac Hlth Sci, DK-2200 Copenhagen, Denmark	IFOM - FIRC Institute of Molecular Oncology; University of Copenhagen	Helin, K (corresponding author), Biotech Res & Innovat Ctr, Fruebjergvej 3, DK-2100 Copenhagen, Denmark.	kristian.helin@bric.dk	Helin, Kristian/K-2526-2019; Hu, Ruogu/B-2203-2008; Rappsilber, Juri/ABF-3328-2020; Rappsilber, Juri/B-7265-2015; Helin, Kristian/HDM-8306-2022	Rappsilber, Juri/0000-0001-5999-1310; Helin, Kristian/0000-0003-1975-6097; Hansen, Klaus/0000-0001-9657-8816; Cloos, Paul/0000-0001-5863-0054				Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Hegg EL, 1997, EUR J BIOCHEM, V250, P625, DOI 10.1111/j.1432-1033.1997.t01-1-00625.x; Hu N, 2005, CANCER RES, V65, P2542, DOI 10.1158/0008-5472.CAN-04-3247; Katoh M, 2004, INT J ONCOL, V24, P1623; Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9; Knowles HJ, 2003, CANCER RES, V63, P1764; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lee C, 2003, J BIOL CHEM, V278, P7558, DOI 10.1074/jbc.M210385200; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Pidoux AL, 2005, PHILOS T R SOC B, V360, P569, DOI 10.1098/rstb.2004.1611; Ragvin A, 2004, J MOL BIOL, V337, P773, DOI 10.1016/j.jmb.2004.01.051; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Yang ZQ, 2001, JPN J CANCER RES, V92, P423, DOI 10.1111/j.1349-7006.2001.tb01112.x; Yang ZQ, 2000, CANCER RES, V60, P4735; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	30	562	594	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2006	442	7100					307	311		10.1038/nature04837	http://dx.doi.org/10.1038/nature04837			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16732293				2022-12-24	WOS:000239122100040
J	Ebrahim, S; Sung, JH; Song, YM; Ferrer, R; Lawlor, DA; Smith, GD				Ebrahim, Shah; Sung, Joohon; Song, Yun-Mi; Ferrer, Robert; Lawlor, Debbie A.; Smith, George Davey			Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; RISK-FACTORS; ALCOHOL-CONSUMPTION; MORTALITY; MEN; TRENDS; METAANALYSIS; POPULATION; PREVENTION; LEVEL	Objective To investigate risk factors, such as heavy alcohol consumption, that might explain any increased risk of haemorrhagic stroke associated with low blood cholesterol. Design Prospective cohort study. Setting Korea. Participants 787 442 civil servants (661700 men, 125 742 women) aged 30-64. Main outcome measures Cardiovascular risk factors were assessed at biennial health check. Data on morbidity and mortality were ascertained from 1990 to 2001 using hospital admissions and mortality surveillance systems. Results 6328 cases of ischaemic stroke (6021 men, 307 women), 3947 cases of haemorrhagic stroke (3748 men, 199 women), 3170 cases of undefined stroke (2902 men, 268 women), and 4417 cases of myocardial infarction (4305 men, 112 women) occurred. Ischaemic stroke and myocardial infarction were strongly and positively associated With blood cholesterol (hazard ratio per 1 mmol/l cholesterol 1.20 (95% confidence interval 1.16 to 1.24) and 1.48 (1.43 to 1.53), respectively). Haemorrhagic stroke showed an inverse association in fully adjusted models (0.91, 0.87 to 0.95). This inverse association was confined to participants with hypertension. When stratified by concentration of gamma glutamyl transferase (GGT), an indicator of alcohol consumption, the association was not seen in participants with low concentrations of GGT, and it was independent of hypertension in those With high concentrations of GGT (> 80 U/l). Conclusions High alcohol consumption may underlie the association between low blood cholesterol and increased risk of haemorrhagic stroke.	Kangwon Natl Univ, Coll Med, Dept Prevent Med, Chunchon, Kangwon Do, South Korea; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Family Med, Seoul, South Korea; Univ Texas, Hlth Sci Ctr, Dept Family & Community Med, San Antonio, TX 78229 USA	Kangwon National University; University of Bristol; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Texas System; University of Texas Health San Antonio	Sung, JH (corresponding author), Kangwon Natl Univ, Coll Med, Dept Prevent Med, Hyoja 2 Dong, Chunchon, Kangwon Do, South Korea.	sungjohn@kangwon.ac.kr	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Lawlor, Debbie A/0000-0002-6793-2262; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063749] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ariesen MJ, 2003, STROKE, V34, P2060, DOI 10.1161/01.STR.0000080678.09344.8D; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bots ML, 2002, J EPIDEMIOL COMMUN H, V56, pI19, DOI 10.1136/jech.56.suppl_1.i19; CHEN ZM, 1993, BMJ-BRIT MED J, V306, P890, DOI 10.1136/bmj.306.6882.890; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; CHUNG WS, 1991, J CLIN PATHOL QUAL C, V13, P1; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Corvol JC, 2003, ARCH INTERN MED, V163, P669, DOI 10.1001/archinte.163.6.669; Hart CL, 2000, J EPIDEMIOL COMMUN H, V54, P874, DOI 10.1136/jech.54.11.874; Hart CL, 1999, STROKE, V30, P1999, DOI 10.1161/01.STR.30.10.1999; Hart CL, 1999, BMJ-BRIT MED J, V318, P1725, DOI 10.1136/bmj.318.7200.1725; IRIBARREN C, 1995, JAMA-J AM MED ASSOC, V273, P1926, DOI 10.1001/jama.273.24.1926; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; *KOR NAT STAT OFF, 2002, ANN REP CAUS DEATH S; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; Lawlor DA, 2004, LANCET, V363, P1724, DOI 10.1016/S0140-6736(04)16260-0; Lawlor DA, 2002, LANCET, V360, P1818, DOI 10.1016/S0140-6736(02)11769-7; NEATON JD, 1992, ARCH INTERN MED, V152, P1490, DOI 10.1001/archinte.152.7.1490; Park JK, 2000, KOREAN J PREV MED, V33, P76, DOI DOI 10.1161/01.STR.0000078562.82918.F6; Qizilbash N, 1995, LANCET, V346, P1647; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; SHIMAMOTO T, 1989, CIRCULATION, V79, P503, DOI 10.1161/01.CIR.79.3.503; Song YM, 2000, AM J EPIDEMIOL, V151, P739, DOI 10.1093/oxfordjournals.aje.a010272; Suh I, 2001, LANCET, V357, P922, DOI 10.1016/S0140-6736(00)04213-6; SUH SI, 1997, KOREAN J HOSP MANAGE, V3, P121; TUOMILEHTO J, 1991, STROKE, V22, P7, DOI 10.1161/01.STR.22.1.7; VARTIAINEN E, 1995, BMJ-BRIT MED J, V310, P901, DOI 10.1136/bmj.310.6984.901; Wannamethee SG, 2000, STROKE, V31, P1882, DOI 10.1161/01.STR.31.8.1882; YANO K, 1989, STROKE, V20, P1460, DOI 10.1161/01.STR.20.11.1460; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Zhang X, 2003, INT J EPIDEMIOL, V32, P563, DOI 10.1093/ije/dyg106	31	127	135	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2006	333	7557					22	25		10.1136/bmj.38855.610324.80	http://dx.doi.org/10.1136/bmj.38855.610324.80			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062CT	16757495	Green Submitted, Green Accepted, Green Published, Bronze			2022-12-24	WOS:000238922900022
J	Schindler, M; Munch, J; Kutsch, O; Li, H; Santiago, ML; Bibollet-Ruche, F; Muller-Trutwin, MC; Novembre, FJ; Peeters, M; Courgnaud, V; Bailes, E; Roques, P; Sodora, DL; Silvestri, G; Sharp, PM; Hahn, BH; Kirchhoff, F				Schindler, Michael; Muench, Jan; Kutsch, Olaf; Li, Hui; Santiago, Mario L.; Bibollet-Ruche, Frederic; Muller-Trutwin, Michaela C.; Novembre, Francis J.; Peeters, Martine; Courgnaud, Valerie; Bailes, Elizabeth; Roques, Pierre; Sodora, Donald L.; Silvestri, Guido; Sharp, Paul M.; Hahn, Beatrice H.; Kirchhoff, Frank			Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1	CELL			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; SURFACE EXPRESSION; IN-VIVO; GASTROINTESTINAL-TRACT; LYMPHOCYTE-ACTIVATION; IMMUNE ACTIVATION; DOWN-MODULATION; SOOTY MANGABEYS; RHESUS MACAQUES; HUMAN RECEPTORS	High-level immune activation and T cell apoptosis represent a hallmark of HIV-1 infection that is absent from nonpathogenic SIV infections in natural primate hosts. The mechanisms causing these varying levels of immune activation are not understood. Here, we report that nef alleles from the great majority of primate lentiviruses, including HIV-2, downmodulate TCR-CD3 from infected T cells, thereby blocking their responsiveness to activation. In contrast, nef alleles from HIV-1 and a subset of closely related SIVs fail to downregulate TCR-CD3 and to inhibit cell death. Thus, Nef-mediated suppression of T cell activation is a fundamental property of primate lentiviruses; that likely evolved to maintain viral persistence in the context of an intact host immune system. This function was lost during viral evolution in a lineage that gave rise to HIV-1 and may have predisposed the simian precursor of HIV-1 for greater pathogenicity in humans.	Univ Ulm, Dept Virol, D-89081 Ulm, Germany; Univ Alabama, Dept Med & Microbiol, Birmingham, AL 35294 USA; Inst Pasteur, Unite Biol Retrovirus, F-75015 Paris, France; Emory Univ, Yerkes Reg Primate Res Ctr, Atlanta, GA 30329 USA; Univ Montpellier, Retrovirus Lab, UMR145, Inst Rech Dev, F-34032 Montpellier, France; Univ Montpellier, Dept Int Hlth, F-34032 Montpellier, France; Univ Nottingham, Queens Med Ctr, Genet Inst, Nottingham NG7 2UH, England; CIRMF, Dept Virol, Franceville, Gabon; Univ Texas, SW Med Ctr, Dept Internal Med, Div Infect Dis, Dallas, TX 75390 USA; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Ulm University; University of Alabama System; University of Alabama Birmingham; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Emory University; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; University of Nottingham; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania	Schindler, M (corresponding author), Univ Ulm, Dept Virol, D-89081 Ulm, Germany.	frank.kirchhoff@medizin.uni-ulm.de	Kirchhoff, Frank/O-8367-2018; Sharp, Paul M/GPX-1497-2022; Sharp, Paul M/F-5783-2010; Schindler, Michael/C-1647-2015; Sharp, Paul/Y-3787-2019; Roques, Pierre/M-2212-2013	Kirchhoff, Frank/0000-0002-7052-2360; Sharp, Paul M/0000-0001-9771-543X; Sharp, Paul M/0000-0001-9771-543X; Schindler, Michael/0000-0001-8989-5813; Roques, Pierre/0000-0003-1825-1054; Jan, Munch/0000-0001-7316-7141; Santiago, Mario L./0000-0001-7792-2706; Hahn, Beatrice/0000-0002-9400-9887; Muller-Trutwin, Michaela/0000-0002-3854-2396	NCI NIH HHS [P30 CA 13148] Funding Source: Medline; NCRR NIH HHS [P51 RR-00165] Funding Source: Medline; NIAID NIH HHS [R01 AI-052775, R01 AI 50529, R01 AI 058718, U01 AI-067854, P30 AI 27767, N01 AI 85338, R01 AI-06998, R21 AI 55380] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI085338, P30AI027767, R01AI050529, U01AI067854, R21AI055380] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aghokeng AF, 2006, VIROLOGY, V345, P174, DOI 10.1016/j.virol.2005.09.046; Alexander L, 1999, J VIROL, V73, P5814, DOI 10.1128/JVI.73.7.5814-5825.1999; Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Bell I, 1998, J GEN VIROL, V79, P2717, DOI 10.1099/0022-1317-79-11-2717; Bibollet-Ruche F, 2004, J VIROL, V78, P7748, DOI 10.1128/JVI.78.14.7748-7762.2004; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; DANIEL MD, 1985, SCIENCE, V228, P1201, DOI 10.1126/science.3159089; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; DU ZJ, 1995, CELL, V82, P665, DOI 10.1016/0092-8674(95)90038-1; Fenard D, 2005, J IMMUNOL, V175, P6050, DOI 10.4049/jimmunol.175.9.6050; Fortin JF, 2004, J BIOL CHEM, V279, P39520, DOI 10.1074/jbc.M407477200; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Hirsch VM, 2004, AIDS REV, V6, P40; Howe AYM, 1998, J VIROL, V72, P9827, DOI 10.1128/JVI.72.12.9827-9834.1998; Hrecka K, 2005, J VIROL, V79, P10650, DOI 10.1128/JVI.79.16.10650-10659.2005; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johnson WE, 2002, ANNU REV MED, V53, P499, DOI 10.1146/annurev.med.53.082901.104053; Kaur A, 1998, J VIROL, V72, P9597, DOI 10.1128/JVI.72.12.9597-9611.1998; KEELE BF, 2006, SCIENCE; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Kirchhoff F, 2004, J VIROL, V78, P6864, DOI 10.1128/JVI.78.13.6864-6874.2004; Kirchhoff F, 1999, J VIROL, V73, P8371, DOI 10.1128/JVI.73.10.8371-8383.1999; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; LEITNER T, 2005, HIV SEQUENCE COMPEND; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; MARLINK RG, 1988, AIDS RES HUM RETROV, V4, P137, DOI 10.1089/aid.1988.4.137; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Michel P, 2000, J INFECT DIS, V181, P64, DOI 10.1086/315170; Munch J, 2005, J VIROL, V79, P10547, DOI 10.1128/JVI.79.16.10547-10560.2005; Munch J, 2002, J VIROL, V76, P12360, DOI 10.1128/JVI.76.23.12360-12364.2002; PEPIN J, 1991, AIDS, V5, P1165, DOI 10.1097/00002030-199110000-00002; RAMBAUT A, 2003, TRACER V1 2; Renkema GH, 2000, FRONT BIOSCI-LANDMRK, V5, pD268, DOI 10.2741/Renkema; Riley JL, 2005, BLOOD, V105, P13, DOI 10.1182/blood-2004-04-1596; Schindler M, 2005, J VIROL, V79, P5489, DOI 10.1128/JVI.79.9.5489-5498.2005; Schindler M, 2003, J VIROL, V77, P10548, DOI 10.1128/JVI.77.19.10548-10556.2003; Sharp PM, 2005, J VIROL, V79, P3891, DOI 10.1128/JVI.79.7.3891-3902.2005; Silvestri G, 2005, J MED PRIMATOL, V34, P243, DOI 10.1111/j.1600-0684.2005.00122.x; Skowronski J, 1999, COLD SPRING HARB SYM, V64, P453, DOI 10.1101/sqb.1999.64.453; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trickett A, 2003, J IMMUNOL METHODS, V275, P251, DOI 10.1016/S0022-1759(03)00010-3; Wang JK, 2000, P NATL ACAD SCI USA, V97, P394, DOI 10.1073/pnas.97.1.394; Wei BL, 2003, CURR HIV RES, V1, P41, DOI 10.2174/1570162033352057	50	312	321	0	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 16	2006	125	6					1055	1067		10.1016/j.cell.2006.04.033	http://dx.doi.org/10.1016/j.cell.2006.04.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777597	Bronze			2022-12-24	WOS:000238602700012
J	Mougous, JD; Cuff, ME; Raunser, S; Shen, A; Zhou, M; Gifford, CA; Goodman, AL; Joachimiak, G; Ordonez, CL; Lory, S; Walz, T; Joachimiak, A; Mekalanos, JJ				Mougous, Joseph D.; Cuff, Marianne E.; Raunser, Stefan; Shen, Aimee; Zhou, Min; Gifford, Casey A.; Goodman, Andrew L.; Joachimiak, Grazyna; Ordonez, Claudia L.; Lory, Stephen; Walz, Thomas; Joachimiak, Andrzej; Mekalanos, John J.			A virulence locus of Pseudomonas aeruginosa encodes a protein secretion apparatus	SCIENCE			English	Article							ACUTE INFECTION; GENES; TRANSLOCATION; SYSTEM; CLPB; ICMF	Bacterial pathogens frequently use protein secretion to mediate interactions with their hosts. Here we found that a virulence locus (HSI-I) of Pseudomonas aeruginosa encodes a protein secretion apparatus. The apparatus assembled in discrete subcellular locations and exported Hcp1, a hexameric protein that forms rings with a 40 angstrom internal diameter. Regulatory patterns of HSI-I suggested that the apparatus functions during chronic infections. We detected Hcp1 in pulmonary secretions of cystic fibrosis (CF) patients and Hcp1-specific antibodies in their sera. Thus, HSI-I likely contributes to the pathogenesis of P. aeruginosa in CF patients. HSI-I-related loci are widely distributed among bacterial pathogens and may play a general role in mediating host interactions.	Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Argonne Natl Lab, Midw Ctr Struct Genom & Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA; Harvard Univ, Sch Med, Childrens Hosp Boston, Div Resp Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp Boston, Cyst Fibrosis Ctr, Boston, MA 02115 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; United States Department of Energy (DOE); Argonne National Laboratory; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Chicago	Joachimiak, A (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.	andrzejj@anl.gov; John_Mekalanos@hms.harvard.edu	Raunser, Stefan/AHE-1573-2022	Walz, Thomas/0000-0003-2606-2835; Raunser, Stefan/0000-0001-9373-3016; Shen, Aimee/0000-0002-9786-5742; Gifford, Casey/0000-0002-7757-573X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021451, R37AI021451, R01AI026289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM062414, U54GM074942] Funding Source: NIH RePORTER; NIAID NIH HHS [AI26289, R01 AI021451, R01 AI026289, R37 AI021451, AI21451] Funding Source: Medline; NIGMS NIH HHS [GM62414, P50 GM062414-02, P50 GM062414, U54 GM074942, U54 GM074942-04S2, GM074942] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Bladergroen MR, 2003, MOL PLANT MICROBE IN, V16, P53, DOI 10.1094/MPMI.2003.16.1.53; Das Soumita, 2003, In Silico Biology, V3, P287; Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Mogk A, 2003, J BIOL CHEM, V278, P17615, DOI 10.1074/jbc.M209686200; Parsons DA, 2005, INFECT IMMUN, V73, P4338, DOI 10.1128/IAI.73.7.4338-4345.2005; Potvin E, 2003, ENVIRON MICROBIOL, V5, P1294, DOI 10.1046/j.1462-2920.2003.00542.x; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Schlieker C, 2005, BIOL CHEM, V386, P1115, DOI 10.1515/BC.2005.128; VanRheenen SM, 2004, INFECT IMMUN, V72, P5972, DOI 10.1128/IAI.72.10.5972-5982.2004; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Williams SG, 1996, INFECT IMMUN, V64, P283, DOI 10.1128/IAI.64.1.283-289.1996; Yahr TL, 2004, MOL CELL, V16, P497, DOI 10.1016/j.molcel.2004.11.009; Yeo HJ, 2004, J BACTERIOL, V186, P1919, DOI 10.1128/JB.186.7.1919-1926.2004	17	761	815	9	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1526	1530		10.1126/science.1128393	http://dx.doi.org/10.1126/science.1128393			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763151	Green Accepted			2022-12-24	WOS:000238124100049
J	Wadman, M				Wadman, M			Biochemist strikes gold	NATURE			English	News Item							MACULAR DEGENERATION; VISUAL CYCLE; RPE65; BINDING											Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gollapalli DR, 2004, P NATL ACAD SCI USA, V101, P10030, DOI 10.1073/pnas.0401936101; Maiti P, 2006, BIOCHEMISTRY-US, V45, P852, DOI 10.1021/bi0518545; Maiti P, 2005, BIOCHEMISTRY-US, V44, P14463, DOI 10.1021/bi0510779; Xue LL, 2004, CELL, V117, P761, DOI 10.1016/j.cell.2004.05.016	5	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2006	441	7094					689	689		10.1038/441689a	http://dx.doi.org/10.1038/441689a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760950				2022-12-24	WOS:000238095100024
J	Buhl, J; Sumpter, DJT; Couzin, ID; Hale, JJ; Despland, E; Miller, ER; Simpson, SJ				Buhl, J; Sumpter, DJT; Couzin, ID; Hale, JJ; Despland, E; Miller, ER; Simpson, SJ			From disorder to order in marching locusts	SCIENCE			English	Article							SELF-PROPELLED PARTICLES; DESERT LOCUST; VEGETATION PATTERNS; PHASE-TRANSITION; DECISION-MAKING; ANIMAL GROUPS; GREGARIZATION; ENVIRONMENT; BEHAVIOR; MOTION	Recent models from theoretical physics have predicted that mass-migrating animal groups may share group-level properties, irrespective of the type of animals in the group. One key prediction is that as the density of animals in the group increases, a rapid transition occurs from disordered movement of individuals within the group to highly aligned collective motion. Understanding such a transition is crucial to the control of mobile swarming insect pests such as the desert locust. We confirmed the prediction of a rapid transition from disordered to ordered movement and identified a critical density for the onset of coordinated marching in locust nymphs. We also demonstrated a dynamic instability in motion at densities typical of locusts in the field, in which groups can switch direction without external perturbation, potentially facilitating the rapid transfer of directional information.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	University of Oxford; University of Sydney; Princeton University	Buhl, J (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	jbuhl@usyd.edu.au	Despland, Emma/ABI-5924-2020; Buhl, Jerome/AAE-1687-2020; BUHL, Jerome/B-6755-2008; Couzin, Iain D./Q-6862-2018	Buhl, Jerome/0000-0002-7506-6835; Couzin, Iain D./0000-0001-8556-4558; Simpson, Stephen J./0000-0003-0256-7687				Collett M, 1998, P NATL ACAD SCI USA, V95, P13052, DOI 10.1073/pnas.95.22.13052; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Couzin ID, 2003, ADV STUD BEHAV, V32, P1, DOI 10.1016/S0065-3454(03)01001-5; Czirok A, 1997, J PHYS A-MATH GEN, V30, P1375, DOI 10.1088/0305-4470/30/5/009; Czirok A, 1999, PHYS REV LETT, V82, P209, DOI 10.1103/PhysRevLett.82.209; DENEUBOURG JL, 1989, ETHOL ECOL EVOL, V1, P295, DOI 10.1080/08927014.1989.9525500; Despland E, 2000, OIKOS, V88, P652, DOI 10.1034/j.1600-0706.2000.880322.x; Despland E, 2004, ECOGRAPHY, V27, P381, DOI 10.1111/j.0906-7590.2004.03779.x; Despland E, 2000, PHYSIOL ENTOMOL, V25, P74, DOI 10.1046/j.1365-3032.2000.00166.x; Ellis P.E., 1951, ANTILOCUST B, V7, P1; ELLIS PE, 1961, BEHAVIOUR, V20, P282; Enserink M, 2004, SCIENCE, V306, P1880, DOI 10.1126/science.306.5703.1880; Gregoire G, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.025702; Gregoire G, 2003, PHYSICA D, V181, P157, DOI 10.1016/S0167-2789(03)00102-7; Grunbaum D, 1998, EVOL ECOL, V12, P503, DOI 10.1023/A:1006574607845; Gueron S, 1996, J THEOR BIOL, V182, P85, DOI 10.1006/jtbi.1996.0144; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Huepe C, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.168701; Kennedy J. S., 1945, TRANS ROY ENT SOC LONDON, V95, P247; Lorch PD, 2005, ECOL ENTOMOL, V30, P548, DOI 10.1111/j.0307-6946.2005.00725.x; Okubo A., 1986, Advances in Biophysics, V22, P1, DOI 10.1016/0065-227X(86)90003-1; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Reynolds C., 1987, ACM SIGGRAPH COMPUTE, V21, P25, DOI DOI 10.1145/37402.37406; Rogers SM, 2003, J EXP BIOL, V206, P3991, DOI 10.1242/jeb.00648; Simpson SJ, 1999, BIOL REV, V74, P461, DOI 10.1017/S000632319900540X; Simpson SJ, 2001, P NATL ACAD SCI USA, V98, P3895, DOI 10.1073/pnas.071527998; SIMPSON SJ, IN PRESS J ORTHOPTER; Symmons P.M., 2001, DESERT LOCUST GUIDEL; Toner J, 1998, PHYS REV E, V58, P4828, DOI 10.1103/PhysRevE.58.4828; UVAROV BP, 1977, GRASSHOPPER LOCUST H, V2; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226	32	711	724	8	225	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2006	312	5778					1402	1406		10.1126/science.1125142	http://dx.doi.org/10.1126/science.1125142			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741126				2022-12-24	WOS:000237961600062
J	Klussmann, M; Iwamura, H; Mathew, SP; Wells, DH; Pandya, U; Armstrong, A; Blackmond, DG				Klussmann, Martin; Iwamura, Hiroshi; Mathew, Suju P.; Wells, David H., Jr.; Pandya, Urvish; Armstrong, Alan; Blackmond, Donna G.			Thermodynamic control of asymmetric amplification in amino acid catalysis	NATURE			English	Article							ENANTIOMERIC EXCESS; SYMMETRY-BREAKING; AUTOCATALYSIS; ORIGIN; MECHANISM	Ever since Pasteur noticed that tartrate crystals exist in two non-superimposable forms that are mirror images of one another - as are left and right hands - the phenomenon of chirality has intrigued scientists. On the molecular level, chirality often has a profound impact on recognition and interaction events and is thus important to biochemistry and pharmacology. In chemical synthesis, much effort has been directed towards developing asymmetric synthesis strategies that yield product molecules with a significant excess of either the left-handed or right-handed enantiomer. This is usually achieved by making use of chiral auxiliaries or catalysts that influence the course of a reaction, with the enantiomeric excess (ee) of the product linearly related to the ee of the auxiliary or catalyst used. In recent years, however, an increasing number of asymmetric reactions have been documented where this relationship is nonlinear(1), an effect that can lead to asymmetric amplification. Theoretical models(2,3) have long suggested that autocatalytic processes can result in kinetically controlled asymmetric amplification, a prediction that has now been verified experimentally(4-6) and rationalized mechanistically(7-14) for an autocatalytic alkylation reaction. Here we show an alternative mechanism that gives rise to asymmetric amplification based on the equilibrium solid-liquid phase behaviour of amino acids in solution. This amplification mechanismis robust and can operate in aqueous systems, making it an appealing proposition for explaining one of the most tantalizing examples of asymmetric amplification - the development of high enantiomeric excess in biomolecules from a presumably racemic prebiotic world.	Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England; Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn & Chem Technol, London SW7 2AZ, England	Imperial College London; Imperial College London	Blackmond, DG (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England.	d.blackmond@imperial.ac.uk		Klussmann, Martin/0000-0002-9026-205X; Armstrong, Alan/0000-0002-3692-3099				Agami C., 1988, B SOC CHIM FR    MAY, V3, P499; Blackmond DG, 2000, ACCOUNTS CHEM RES, V33, P402, DOI 10.1021/ar990083s; Blackmond DG, 2001, J AM CHEM SOC, V123, P10103, DOI 10.1021/ja0165133; Blackmond DG, 2004, P NATL ACAD SCI USA, V101, P5732, DOI 10.1073/pnas.0308363101; Blackmond DG, 2002, ADV SYNTH CATAL, V344, P156, DOI 10.1002/1615-4169(200202)344:2<156::AID-ADSC156>3.0.CO;2-1; Borsenberger V, 2004, CHEM BIODIVERS, V1, P203, DOI 10.1002/cbdv.200490020; Buono FG, 2003, J AM CHEM SOC, V125, P8978, DOI 10.1021/ja034705n; Buono FG, 2004, ANGEW CHEM INT EDIT, V43, P2099, DOI 10.1002/anie.200353086; Calvin M., 1969, MOL EVOLUTION; Cordova A, 2005, CHEM COMMUN, P3586, DOI 10.1039/b507968n; FRANK FC, 1953, BIOCHIM BIOPHYS ACTA, V11, P459, DOI 10.1016/0006-3002(53)90082-1; Girard C, 1998, ANGEW CHEM INT EDIT, V37, P2923, DOI 10.1002/(SICI)1521-3773(19981116)37:21<2922::AID-ANIE2922>3.0.CO;2-1; Gridnev ID, 2003, ORG BIOMOL CHEM, V1, P3811, DOI 10.1039/b307382n; Gridnev ID, 2004, ANGEW CHEM INT EDIT, V43, P4884, DOI 10.1002/anie.200353572; Gridnev ID, 2004, P NATL ACAD SCI USA, V101, P5727, DOI 10.1073/pnas.0308178101; Hoang L, 2003, J AM CHEM SOC, V125, P16, DOI 10.1021/ja028634o; Iwamura H, 2004, J AM CHEM SOC, V126, P11770, DOI 10.1021/ja046258x; JACQUES J, 1981, ENANTIOMERS RACEMATE, pCH3; Kondepudi DK, 2001, ACCOUNTS CHEM RES, V34, P946, DOI 10.1021/ar010089t; KONDEPUDI DK, 1990, SCIENCE, V250, P975, DOI 10.1126/science.250.4983.975; Mathew SP, 2004, ANGEW CHEM INT EDIT, V43, P3317, DOI 10.1002/anie.200453997; MOROWITZ HJ, 1969, J THEOR BIOL, V25, P491, DOI 10.1016/S0022-5193(69)80035-4; Podlech J, 2001, CELL MOL LIFE SCI, V58, P44, DOI 10.1007/PL00000777; Rodrigo AA, 2004, CHIRALITY, V16, P499, DOI 10.1002/chir.20067; Roozeboom H.W.B., 1899, Z. Physik. Ch., V28, P494; Shibata T, 1996, CHEM COMMUN, P1235, DOI 10.1039/cc9960001235; Shibata T, 1996, J AM CHEM SOC, V118, P471, DOI 10.1021/ja953066g; SOAI K, 1995, NATURE, V378, P767, DOI 10.1038/378767a0; Takats Z, 2003, ANGEW CHEM INT EDIT, V42, P3521, DOI 10.1002/anie.200351210; Welch CJ, 2001, CHIRALITY, V13, P425, DOI 10.1002/chir.1055	30	320	326	3	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					621	623		10.1038/nature04780	http://dx.doi.org/10.1038/nature04780			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16738656				2022-12-24	WOS:000237920800044
J	Thore, S; Leibundgut, M; Ban, NN				Thore, Stephane; Leibundgut, Marc; Ban, Nenad			Structure of the eukaryotic thiamine pyrophosphate riboswitch with its regulatory ligand	SCIENCE			English	Article							BACTERIAL GENE-EXPRESSION; MESSENGER-RNA STRUCTURE; CRYSTAL-STRUCTURE; HAMMERHEAD RIBOZYME; TRANSCRIPTION; METABOLISM; MECHANISM; CATALYSIS; ELEMENTS; DOMAIN	Riboswitches are untranslated regions of messenger RNA, which adopt alternate structures, depending on the binding of specific metabolites. Such conformational switching regulates the expression of proteins involved in the biosynthesis of riboswitch substrates. Here, we present the 2.9 angstrom-resolution crystal structure of the eukaryotic Arobidopsis thaliana thiamine pyrophosphate (TPP)-specific riboswitch in complex with its natural ligand. The riboswitch specifically recognizes the TIPP via conserved residues located within two highly distorted parallel "sensor" helices. The structure provides the basis for understanding the reorganization of the riboswitch fold upon TPP binding and explains the mechanism of resistance to the antibiotic pyrithiamine.	ETH, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Ban, NN (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland.	ban@mot.biol.ethz.ch	Thore, Stephane/AAW-6482-2020; Thore, stéphane/M-7759-2014	Thore, Stephane/0000-0001-7058-3887; Thore, stéphane/0000-0001-7058-3887				Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; CARLISLE CH, 1969, ACTA CRYSTALL B-STRU, VB 25, P1359, DOI 10.1107/S0567740869004043; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; De la Pena M, 2003, EMBO J, V22, P5561, DOI 10.1093/emboj/cdg530; Doudna JA, 2005, NAT STRUCT MOL BIOL, V12, P395, DOI 10.1038/nsmb932; Epshtein V, 2003, P NATL ACAD SCI USA, V100, P5052, DOI 10.1073/pnas.0531307100; Khvorova A, 2003, NAT STRUCT BIOL, V10, P708, DOI 10.1038/nsb959; Kubodera T, 2003, FEBS LETT, V555, P516, DOI 10.1016/S0014-5793(03)01335-8; Lescoute A, 2006, RNA, V12, P83, DOI 10.1261/rna.2208106; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; MORAS D, 1985, J BIOMOL STRUCT DYN, V3, P479, DOI 10.1080/07391102.1985.10508436; MULLER YA, 1993, SCIENCE, V259, P965, DOI 10.1126/science.8438155; Nahvi A, 2004, NUCLEIC ACIDS RES, V32, P143, DOI 10.1093/nar/gkh167; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; PLEY HW, 1994, NATURE, V372, P68, DOI 10.1038/372068a0; Rodionov DA, 2003, NUCLEIC ACIDS RES, V31, P6748, DOI 10.1093/nar/gkg900; Rupert PB, 2001, NATURE, V410, P780, DOI 10.1038/35071009; Soukup JK, 2004, CURR OPIN STRUC BIOL, V14, P344, DOI 10.1016/j.sbi.2004.04.007; Sudarsan N, 2003, RNA, V9, P644, DOI 10.1261/rna.5090103; Sudarsan N, 2005, CHEM BIOL, V12, P1325, DOI 10.1016/j.chembiol.2005.10.007; Vitreschak AG, 2004, TRENDS GENET, V20, P44, DOI 10.1016/j.tig.2003.11.008; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Winkler WC, 2002, P NATL ACAD SCI USA, V99, P15908, DOI 10.1073/pnas.212628899; Winkler WC, 2003, NAT STRUCT BIOL, V10, P701, DOI 10.1038/nsb967; Yamauchi T, 2005, FEBS LETT, V579, P2583, DOI 10.1016/j.febslet.2005.03.074	28	259	278	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1208	1211		10.1126/science.1128451	http://dx.doi.org/10.1126/science.1128451			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16675665				2022-12-24	WOS:000237957400052
J	Roux, A; Uyhazi, K; Frost, A; De Camilli, P				Roux, Aurelien; Uyhazi, Katherine; Frost, Adam; De Camilli, Pietro			GTP-dependent twisting of dynamin implicates constriction and tension in membrane fission	NATURE			English	Article							MECHANOCHEMICAL ENZYME; INVAGINATION; TUBULATION; CURVATURE; CORTACTIN; RINGS	Dynamin, a crucial factor in endocytosis(1-3), is a member of a family of GTPases that participates in membrane fission(4-6). It was initially proposed to act as a machine that constricts and cuts the neck of nascent vesicles in a GTP-hydrolysis-dependent reaction(4,5), but subsequent studies suggested alternative models(2,7,8). Here we monitored the effect of nucleotides on dynamin-coated lipid tubules in real time. Addition of GTP, but not of GDP or GTP-gamma S, resulted in twisting of the tubules and supercoiling, suggesting a rotatory movement of the helix turns relative to each other during GTP hydrolysis. Rotation was confirmed by the movement of beads attached to the tubules. Twisting activity produced a longitudinal tension that was released by tubule breakage when both ends of the tubule were anchored. Fission also occurred when dynamin and GTP were added to lipid tubules that had been generated from liposomes by the motor activity of kinesin on microtubules. No fission events were observed in the absence of longitudinal tension. These findings demonstrate a mechanoenzyme activity of dynamin in endocytosis, but also imply that constriction is not sufficient for fission. At the short necks of endocytic vesicles, other factors(6,9,10) leading to tension may cooperate with the constricting activity of dynamin to induce fission(11-13).	Yale Univ, Sch Med, Kavli Inst Neurosci, Howard Hughes Med Inst,Dept Cell Biol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Biochem & Mol Biophys, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University	De Camilli, P (corresponding author), Yale Univ, Sch Med, Kavli Inst Neurosci, Howard Hughes Med Inst,Dept Cell Biol, 333 Cedar St, New Haven, CT 06510 USA.	pietro.decamilli@yale.edu	Roux, Aurelien/AAU-1262-2021; Roux, Aurelien R/G-9541-2013	Roux, Aurelien R/0000-0002-6088-0711; Uyhazi, Katherine/0000-0002-4280-1397; Frost, Adam/0000-0003-2231-2577				Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; Charvin G, 2003, P NATL ACAD SCI USA, V100, P9820, DOI 10.1073/pnas.1631550100; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Leduc C, 2004, P NATL ACAD SCI USA, V101, P17096, DOI 10.1073/pnas.0406598101; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Moscho A, 1996, P NATL ACAD SCI USA, V93, P11443, DOI 10.1073/pnas.93.21.11443; OBAR RA, 1990, NATURE, V347, P256, DOI 10.1038/347256a0; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Qualmann B, 2000, J CELL BIOL, V150, pF111, DOI 10.1083/jcb.150.5.F111; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Roux A, 2002, P NATL ACAD SCI USA, V99, P5394, DOI 10.1073/pnas.082107299; Schafer DA, 2004, TRAFFIC, V5, P463, DOI 10.1111/j.1600-0854.2004.00199.x; Sever S, 2000, TRAFFIC, V1, P385, DOI 10.1034/j.1600-0854.2000.010503.x; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Thompson HM, 2001, CURR BIOL, V11, pR850, DOI 10.1016/S0960-9822(01)00513-9; Tsafrir I, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.138102; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	30	357	371	3	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					528	531		10.1038/nature04718	http://dx.doi.org/10.1038/nature04718			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16648839				2022-12-24	WOS:000237778900054
J	Smyth, MJ				Smyth, MJ			Imatinib mesylate - Uncovering a fast track to adaptive immunity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DENDRITIC CELLS		Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic, Australia	Peter Maccallum Cancer Center	Smyth, MJ (corresponding author), Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic, Australia.		Smyth, Mark J/H-8709-2014	Smyth, Mark J/0000-0001-7098-7240				Borg C, 2004, J CLIN INVEST, V114, P379, DOI 10.1172/jci20041102; Chan CW, 2006, NAT MED, V12, P207, DOI 10.1038/nm1352; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Josien R, 1997, J EXP MED, V186, P467, DOI 10.1084/jem.186.3.467; Taieb J, 2006, NAT MED, V12, P214, DOI 10.1038/nm1356	5	17	22	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 25	2006	354	21					2282	2284		10.1056/NEJMcibr061878	http://dx.doi.org/10.1056/NEJMcibr061878			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	045RF	16723621				2022-12-24	WOS:000237758900014
J	Lin, OS; Kozarek, RA; Schembre, DB; Ayub, K; Gluck, M; Drennan, F; Soon, MS; Rabeneck, L				Lin, OS; Kozarek, RA; Schembre, DB; Ayub, K; Gluck, M; Drennan, F; Soon, MS; Rabeneck, L			Screening colonoscopy in very elderly patients - Prevalence of neoplasia and estimated impact on life expectancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FECAL-OCCULT-BLOOD; QUALITY-OF-LIFE; COLORECTAL-CANCER; COLONIC POLYPS; CONVENIENT APPROXIMATION; UNRESECTED POLYPS; NATURAL-HISTORY; RISK; SIGMOIDOSCOPY; OCTOGENARIANS	Context Current guidelines do not include an upper age cutoff for colorectal cancer screening with colonoscopy. Although the prevalence of colonic neoplasia increases with age, life expectancy decreases. Thus, the benefit of screening colonoscopy in very elderly patients may be limited. Objective To compare estimated life-years saved with screening colonoscopy in very elderly vs younger persons. Design, Setting, and Participants Cross-sectional study conducted among 1244 asymptomatic individuals in 3 age groups (50-54 years [n = 1034], 75-79 years [n = 147], and >= 80 years [n = 63]) who underwent screening colonoscopy at a US teaching hospital and clinic. Main Outcome Measures Prevalence of various types of colon neoplasia; estimated gain in life expectancy, calculated as life expectancy - (life expectancy during polyp lag time + life expectancy after colorectal cancer diagnosis); and comparison of mean gain in life expectancy across the 3 groups. Life expectancy and mortality data were derived from life tables, previous studies, and national databases. Results The prevalence of neoplasia was 13.8% in the 50- to 54-year-old group, 26.5% in the 75- to 79-year-old group, and 28.6% in the group aged 80 years or older. Despite higher prevalence of neoplasia in elderly patients, mean extension in life expectancy was much lower in the group aged 80 years or older than in the 50- to 54-year-old group (0.13 vs 0.85 years). In sensitivity analysis, with longer polyp lag times the mean extension in life expectancy decreased more in the elderly than in the younger patients; alternatively, if it was assumed that a smaller proportion of adenomas progress to colorectal cancer, the mean extension in life expectancy decreased less in the elderly than in the younger patients. Conclusions Even though prevalence of neoplasia increases with age, screening colonoscopy in very elderly persons (aged >= 80 years) results in only 15% of the expected gain in life expectancy in younger patients. Screening colonoscopy in very elderly patients should be performed only after careful consideration of potential benefits, risks, and patient preferences.	Virginia Mason Med Ctr, Gastroenterol Sect, Seattle, WA 98101 USA; Changhua Christian Med Ctr, Div Gastroenterol, Changhua, Taiwan; Univ Toronto, Dept Med, Div Gastroenterol, Toronto, ON, Canada	Virginia Mason Medical Center; University of Toronto	Lin, OS (corresponding author), Virginia Mason Med Ctr, Gastroenterol Sect, 1100 9th Ave,C3-Gas, Seattle, WA 98101 USA.	Otto.Lin@vmmc.org	Kozarek, Richard/AAF-2695-2020					Arora A, 2004, GASTROINTEST ENDOSC, V60, P408, DOI 10.1016/S0016-5107(04)01715-8; ATKIN WS, 1992, NEW ENGL J MED, V326, P658, DOI 10.1056/NEJM199203053261002; BAT L, 1992, POSTGRAD MED J, V68, P355, DOI 10.1136/pgmj.68.799.355; BECK JR, 1982, AM J MED, V73, P883, DOI 10.1016/0002-9343(82)90786-0; BECK JR, 1982, AM J MED, V73, P889, DOI 10.1016/0002-9343(82)90787-2; Bersentes K, 1997, AM J GASTROENTEROL, V92, P1117; CARROLL RLA, 1980, PREV MED, V9, P741, DOI 10.1016/0091-7435(80)90018-3; Chatrenet P, 1993, Eur J Med, V2, P411; Chen CD, 2003, BRIT J CANCER, V88, P1866, DOI 10.1038/sj.bjc.6601007; FIGIEL LS, 1965, ACTA RADIOL DIAGN, V3, P417, DOI 10.1177/028418516500300504; Gatto NM, 2003, J NATL CANCER I, V95, P230, DOI 10.1093/jnci/95.3.230; Hardcastle JD, 1996, LANCET, V348, P1472, DOI 10.1016/S0140-6736(96)03386-7; Harewood GC, 2004, CLIN GASTROENTEROL H, V2, P72, DOI 10.1016/S1542-3565(03)00294-5; HOFSTAD B, 1994, SCAND J GASTROENTERO, V29, P640, DOI 10.3109/00365529409092485; Hofstad B, 1996, GUT, V39, P449, DOI 10.1136/gut.39.3.449; Hofstad B, 1997, Gastrointest Endosc Clin N Am, V7, P345; Inadomi JM, 2000, GASTROINTEST ENDOSC, V51, P517, DOI 10.1016/S0016-5107(00)70282-3; KNOERNSCHILD H E, 1963, Surg Forum, V14, P137; Ko CW, 2005, GASTROENTEROLOGY, V129, P1163, DOI 10.1053/j.gastro.2005.07.027; KOZUKA S, 1975, DIS COLON RECTUM, V18, P494, DOI 10.1007/BF02587218; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Lagares-Garcia JA, 2001, SURG ENDOSC, V15, P262, DOI 10.1007/s004640000339; Loeve F, 2005, EUR J CANCER, V41, P416, DOI 10.1016/j.ejca.2004.11.007; Loeve F, 1999, COMPUT BIOMED RES, V32, P13, DOI 10.1006/cbmr.1998.1498; Loeve F, 2000, J NATL CANCER I, V92, P557, DOI 10.1093/jnci/92.7.557; Lukens FJ, 2002, AM J GASTROENTEROL, V97, P1722; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; MULLER AD, 1995, ARCH INTERN MED, V155, P1741, DOI 10.1001/archinte.155.16.1741; Nelson DB, 2002, GASTROINTEST ENDOSC, V55, P307, DOI 10.1067/mge.2002.121883; NEWCOMB PA, 1992, JNCI-J NATL CANCER I, V84, P1572, DOI 10.1093/jnci/84.20.1572; Ramsey SD, 2002, AM J GASTROENTEROL, V97, P1228, DOI 10.1111/j.1572-0241.2002.05694.x; Ramsey SD, 2000, CANCER-AM CANCER SOC, V88, P1294, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1294::AID-CNCR4>3.3.CO;2-D; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Sardinha TC, 1999, INT J COLORECTAL DIS, V14, P172, DOI 10.1007/s003840050205; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; SHINYA H, 1979, ANN SURG, V190, P679, DOI 10.1097/00000658-197912000-00001; Stevens T, 2003, AM J GASTROENTEROL, V98, P1881, DOI 10.1016/S0002-9270(03)00425-8; STRYKER SJ, 1987, GASTROENTEROLOGY, V93, P1009, DOI 10.1016/0016-5085(87)90563-4; URE T, 1995, SURG ENDOSC-ULTRAS, V9, P505; Villavicencio R T, 2000, Semin Gastrointest Dis, V11, P185; Welch HG, 1996, ANN INTERN MED, V124, P577, DOI 10.7326/0003-4819-124-6-199603150-00007; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Yoong KKY, 2005, POSTGRAD MED J, V81, P196, DOI 10.1136/pgmj.2004.023374	45	121	122	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2006	295	20					2357	2365		10.1001/jama.295.20.2357	http://dx.doi.org/10.1001/jama.295.20.2357			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045HY	16720821	Bronze			2022-12-24	WOS:000237734400021
J	Fleire, SJ; Goldman, JP; Carrasco, YR; Weber, M; Bray, D; Batista, FD				Fleire, SJ; Goldman, JP; Carrasco, YR; Weber, M; Bray, D; Batista, FD			B cell ligand discrimination through a spreading and contraction response	SCIENCE			English	Article							FOLLICULAR DENDRITIC CELLS; REACTIVE LYMPHOCYTES-B; IMMUNOLOGICAL SYNAPSE; ACTIN POLYMERIZATION; ANTIGEN RECEPTOR; TRANSGENIC MICE; T-CELLS; ACTIVATION; SEGREGATION; SENSITIVITY	B cells recognize foreign antigens by virtue of cell surface immunoglobulin receptors and are most effectively activated by membrane-bound ligands. Here, we show that in the early stages of this process, B cells exhibit a two-phase response in which they first spread over the antigen-bearing membrane and then contract, thereby collecting bound antigen into a central aggregate. The extent of this response, which is both signaling- and actin-dependent, determines the quantity of antigen accumulated and hence the degree of B cell activation. Brownian dynamic simulations reproduce essential features of the antigen collection process and suggest a possible basis for affinity discrimination. We propose that dynamic spreading is an important step of the immune response.	Canc Res UK, London Res Inst, Lymphocyte Interact Lab, London WC2A 3PX, England; Univ Kent, Comp Lab, Canterbury CT2 7NF, Kent, England; Univ Cambridge, Cambridge CB2 3DY, England	Cancer Research UK; University of Kent; University of Cambridge	Batista, FD (corresponding author), Canc Res UK, London Res Inst, Lymphocyte Interact Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	facundo.batista@cancer.org.uk	Carrasco, Yolanda/X-2629-2019	Carrasco, Yolanda R./0000-0003-2148-1926; Goldman, Jacki/0000-0002-2981-5022; Weber, Michele/0000-0003-2056-3751	PHS HHS [G64713] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Andrews SS, 2004, PHYS BIOL, V1, P137, DOI 10.1088/1478-3967/1/3/001; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Burroughs NJ, 2002, BIOPHYS J, V83, P1784, DOI 10.1016/S0006-3495(02)73944-1; Carrasco YR, 2004, IMMUNITY, V20, P589, DOI 10.1016/S1074-7613(04)00105-0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Haberman AM, 2003, NAT REV IMMUNOL, V3, P757, DOI 10.1038/nri1178; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Kosco-Vilbois MH, 2003, NAT REV IMMUNOL, V3, P764, DOI 10.1038/nri1179; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee SJE, 2002, TRENDS IMMUNOL, V23, P500, DOI 10.1016/S1471-4906(02)02325-6; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; PARSEY MV, 1993, J IMMUNOL, V151, P1881; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; Teh YM, 1997, J EXP MED, V185, P1753, DOI 10.1084/jem.185.10.1753; TEW JG, 1990, IMMUNOL REV, V117, P185, DOI 10.1111/j.1600-065X.1990.tb00573.x; WILLIAMS GT, 1994, P NATL ACAD SCI USA, V91, P474, DOI 10.1073/pnas.91.2.474; Wykes M, 1998, J IMMUNOL, V161, P1313	25	316	321	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					738	741		10.1126/science.1123940	http://dx.doi.org/10.1126/science.1123940			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675699				2022-12-24	WOS:000237312100048
J	Bonacci, TM; Mathews, JL; Yuan, CJ; Lehmann, DM; Malik, S; Wu, DQ; Font, JL; Bidlack, JM; Smrcka, AV				Bonacci, TM; Mathews, JL; Yuan, CJ; Lehmann, DM; Malik, S; Wu, DQ; Font, JL; Bidlack, JM; Smrcka, AV			Differential targeting of G beta gamma-subunit signaling with small molecules	SCIENCE			English	Article							PROTEIN; RECEPTORS; BINDING	G protein beta gamma subunits have potential as a target for therapeutic treatment of a number of diseases. We performed virtual docking of a small-molecule library to a site on G beta gamma subunits that mediates protein interactions. We hypothesized that differential targeting of this surface could allow for selective modulation of G beta gamma subunit functions. Several compounds bound to G beta gamma subunits with affinities from 0.1 to 60 mu M and selectively modulated functional G beta gamma-protein-protein interactions in vitro, chemotactic peptide signaling pathways in HL-60 leukocytes, and opioid receptor-dependent analgesia in vivo. These data demonstrate an approach for modulation of G protein-coupled receptor signaling that may represent an important therapeutic strategy.	Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA	University of Rochester; University of Rochester; University of Connecticut	Smrcka, AV (corresponding author), Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA.	Alan_Smrcka@URMC.rochester.edu		Lehmann, David/0000-0003-0174-344X	NCI NIH HHS [R01 CA132317] Funding Source: Medline; NHLBI NIH HHS [HL080706, R01 HL080706-11, HL-T3207949, R01 HL080706, R01 HL080706-10] Funding Source: Medline; NIDA NIH HHS [T32DA07232, K05-DA00360] Funding Source: Medline; NIGMS NIH HHS [R01 GM054597, GM60286, R01 GM054597-09] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA132317] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080706, T32HL007949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054597, R01GM060286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000360, T32DA007232] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Clark RD, 2002, J MOL GRAPH MODEL, V20, P281, DOI 10.1016/S1093-3263(01)00125-5; Cochran AG, 2001, CURR OPIN CHEM BIOL, V5, P654, DOI 10.1016/S1367-5931(01)00262-9; Connor M, 1999, CLIN EXP PHARMACOL P, V26, P493, DOI 10.1046/j.1440-1681.1999.03049.x; DAAKA Y, 2004, SCI STKE, pRE2; Davis TL, 2005, BIOCHEMISTRY-US, V44, P10593, DOI 10.1021/bi050655i; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Ghosh M, 2003, J BIOL CHEM, V278, P34747, DOI 10.1074/jbc.C300271200; Iaccarino G, 1999, P NATL ACAD SCI USA, V96, P3945, DOI 10.1073/pnas.96.7.3945; Iaccarino G, 2003, ASSAY DRUG DEV TECHN, V1, P347, DOI 10.1089/154065803321204484; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Li Y, 1998, J BIOL CHEM, V273, P16265, DOI 10.1074/jbc.273.26.16265; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Rane MJ, 1997, J IMMUNOL, V159, P5070; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Sarvazyan NA, 1998, J BIOL CHEM, V273, P7934, DOI 10.1074/jbc.273.14.7934; Scott JK, 2001, EMBO J, V20, P767, DOI 10.1093/emboj/20.4.767; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Xie W, 1999, P NATL ACAD SCI USA, V96, P10385, DOI 10.1073/pnas.96.18.10385	24	181	190	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					443	446		10.1126/science.1120378	http://dx.doi.org/10.1126/science.1120378			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16627746				2022-12-24	WOS:000236941800052
J	Teo, HL; Gill, DJ; Sun, J; Perisic, O; Veprintsev, DB; Vallis, Y; Emr, SD; Williams, RL				Teo, HL; Gill, DJ; Sun, J; Perisic, O; Veprintsev, DB; Vallis, Y; Emr, SD; Williams, RL			ESCRT-I core and ESCRT-II GLUE domain structures reveal role for GLUE in linking to ESCRT-I and membranes	CELL			English	Article							MULTIVESICULAR BODY PATHWAY; ENDOSOME-ASSOCIATED COMPLEX; SORTING COMPLEX; PROTEIN-TRANSPORT; UBIQUITIN; TSG101; BINDING; YEAST; RECOGNITION; HRS	ESCRT complexes form the main machinery driving protein sorting from endosomes to lysosomes. Currently, the picture regarding assembly of ESCRTs on endosomes is incomplete. The structure of the conserved heterotrimeric ESCRT-I core presented here shows a fan-like arrangement of three helical hairpins, each corresponding to a different subunit. Vps23/Tsg101 is the central hairpin sandwiched between the other subunits, explaining the critical role of its "steadiness box" in the stability of ESCRT-I. We show that yeast ESCRT-I links directly to ESCRT-II, through a tight interaction of Vps28 (ESCRT-I) with the yeast-specific zinc-finger insertion within the GLUE domain of Vps36 (ESCRT-II). The crystal structure of the GLUE domain missing this insertion reveals it is a split PH domain, with a noncanonical lipid binding pocket that binds Ptdlns3P. The simultaneous and reinforcing interactions of ESCRT-II GLUE domain with membranes, ESCRT-II, and ubiquitin are critical for ubiquitinated cargo progression from early to late endosomes.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; MRC, Ctr Prot Engn, Cambridge CB2 2QH, England; Univ Calif San Diego, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	MRC Laboratory Molecular Biology; University of Cambridge; Howard Hughes Medical Institute; University of California System; University of California San Diego	Teo, HL (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	hlt@mrc-lmb.cam.ac.uk; rlw@mrc-lmb.cam.ac.uk	Veprintsev, Dmitry B/H-2228-2012; Gill, David/H-7691-2013	Veprintsev, Dmitry B/0000-0002-3583-5409; Gill, David/0000-0002-0937-9737; Perisic, Olga/0000-0002-3842-2896; Teo, Hsiang Ling/0000-0002-3849-809X; Williams, Roger/0000-0001-7754-4207	MRC [MC_U105184308, MC_U105178795] Funding Source: UKRI; Medical Research Council [MC_U105178795, MC_U105184308] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Amit I, 2004, GENE DEV, V18, P1737, DOI 10.1101/gad.294904; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Bache KG, 2004, MOL BIOL CELL, V15, P4337, DOI 10.1091/mbc.E04-03-0250; Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Bilodeau PS, 2003, J CELL BIOL, V163, P237, DOI 10.1083/jcb.200305007; Bishop N, 2001, J BIOL CHEM, V276, P11735, DOI 10.1074/jbc.M009863200; Bowers K, 2004, TRAFFIC, V5, P194, DOI 10.1111/j.1600-0854.2004.00169.x; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Di Lello P, 2005, BIOCHEMISTRY-US, V44, P7678, DOI 10.1021/bi050099s; Doyotte A, 2005, J CELL SCI, V118, P3003, DOI 10.1242/jcs.02421; Eastman SW, 2005, J BIOL CHEM, V280, P628, DOI 10.1074/jbc.M410384200; Feng GH, 2000, CANCER RES, V60, P1736; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Fernandez-Borja M, 1999, CURR BIOL, V9, P55, DOI 10.1016/S0960-9822(99)80048-7; Futter CE, 2001, J CELL BIOL, V155, P1251, DOI 10.1083/jcb.200108152; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Goila-Gaur R, 2003, J VIROL, V77, P6507, DOI 10.1128/JVI.77.11.6507-6519.2003; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; HYVONEN M, 1995, EMBO J, V14, P4676, DOI 10.1002/j.1460-2075.1995.tb00149.x; Johnson MC, 2005, J VIROL, V79, P3775, DOI 10.1128/JVI.79.6.3775-3786.2005; Katoh K, 2003, J BIOL CHEM, V278, P39104, DOI 10.1074/jbc.M301604200; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kim JW, 2005, DEV CELL, V8, P937, DOI 10.1016/j.devcel.2005.04.001; Lemmon MA, 2005, CELL, V120, P574, DOI 10.1016/j.cell.2005.02.023; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; Luhtala N, 2004, J CELL BIOL, V166, P717, DOI 10.1083/jcb.200403139; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Peck JW, 2004, BIOCHEM J, V377, P693, DOI 10.1042/bj20031347; Pornillos O, 2003, J CELL BIOL, V162, P425, DOI 10.1083/jcb.200302138; Puertollano R, 2005, J BIOL CHEM, V280, P9258, DOI 10.1074/jbc.M412481200; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Schug S A, 1993, Pharmacoeconomics, V3, P260, DOI 10.2165/00019053-199303040-00002; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shirk AJ, 2005, J NEUROSCI RES, V82, P43, DOI 10.1002/jnr.20628; Slagsvold T, 2005, J BIOL CHEM, V280, P19600, DOI 10.1074/jbc.M501510200; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Stuchell MD, 2004, J BIOL CHEM, V279, P36059, DOI 10.1074/jbc.M405226200; Sundquist WI, 2004, MOL CELL, V13, P783, DOI 10.1016/S1097-2765(04)00129-7; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Teo H, 2004, J BIOL CHEM, V279, P28689, DOI 10.1074/jbc.M400023200; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Whitley P, 2003, J BIOL CHEM, V278, P38786, DOI 10.1074/jbc.M306864200; Yorikawa C, 2005, BIOCHEM J, V387, P17, DOI 10.1042/BJ20041227; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Zhou HY, 2005, PROTEINS, V58, P321, DOI 10.1002/prot.20308	65	157	161	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2006	125	1					99	111		10.1016/j.cell.2006.01.047	http://dx.doi.org/10.1016/j.cell.2006.01.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615893	Bronze			2022-12-24	WOS:000237314200017
J	du Toit, J; Hamilton, W; Barraclough, K				du Toit, Jennifer; Hamilton, William; Barraclough, Kevin			Risk in primary care of colorectal cancer from new onset rectal bleeding: 10 year prospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE	Objective To measure the risk of colorectal cancer and adenoma with new onset rectal bleeding reported to primary care. Design Cohort study. Setting A rural general practice in the United Kingdom. Participants Patients aged 45 or more with new onset rectal bleeding, irrespective of other symptoms. Main outcome measures Percentage of participants in whom colorectal cancer or colonic adenoma was identified after investigation of the bowel. Results During a 10 year period, 265 patients reported new rectal bleeding. Of these, 15 (5.7%,95% confidence interval 3.2% to 9.2%) had colorectal cancer, and 13 (4.9%,2.6% to 8.4%) had colonic adenoma. Only two of the patients with cancer had had diarrhoea. Conclusions One in 10 patients aged 45 or more with new onset rectal bleeding had colonic neoplasia, so investigation of the bowel should be offered to all such patients, whether or not they have other symptoms.	Univ Bristol, Dept Community Based Med, Acad Unit Primary Hlth Care, Bristol BS8 1AU, Avon, England	University of Bristol	du Toit, J (corresponding author), Hoyland House, Painswick GL6 6RD, Glos, England.	kbarraclough@ehotspot.co.uk	Hamilton, Willie/G-8612-2014	Hamilton, William/0000-0003-1611-1373				*DEP HLTH, 2000, REF GUID SUSP CANC; Ellis BG, 2005, BRIT J GEN PRACT, V55, P949; FIJTEN GH, 1995, FAM PRACT, V12, P279, DOI 10.1093/fampra/12.3.279; Hamilton W, 2005, BRIT J CANCER, V93, P399, DOI 10.1038/sj.bjc.6602714; *NICE, 2005, REF GUID SUSP CANC; Wauters H, 2000, BRIT MED J, V321, P998, DOI 10.1136/bmj.321.7267.998; 2003, UPDATE CANC TRENDS E	7	33	33	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 8	2006	333	7558					69	70		10.1136/bmj.38846.684850.2F	http://dx.doi.org/10.1136/bmj.38846.684850.2F			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065BA	16790459	Bronze, Green Submitted, Green Published			2022-12-24	WOS:000239133200014
J	Collinge, J; Whitfield, J; McKintosh, E; Beck, J; Mead, S; Thomas, DJ; Alpers, MP				Collinge, John; Whitfield, Jerome; McKintosh, Edward; Beck, John; Mead, Simon; Thomas, Dafydd J.; Alpers, Michael P.			Kuru in the 21st century - an acquired human prion disease with very long incubation periods	LANCET			English	Article							CREUTZFELDT-JAKOB-DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; PROTEIN GENE PRND; VARIANT; LOCI; MICE; SUSCEPTIBILITY; POLYMORPHISMS; IDENTIFICATION; TRANSMISSION	Background Kuru provides the principal experience of epidemic human prion disease. Its incidence has steadily fallen after the abrupt cessation of its route of transmission (endocannibalism) in Papua New Guinea in the 1950s. The onset of variant Creutzfeldt-Jakob disease (vCJD), and the unknown prevalence of infection after the extensive dietary exposure to bovine spongiform encephalopathy (BSE) prions in the UK, has led to renewed interest in kuru. We investigated possible incubation periods, pathogenesis, and genetic susceptibility factors in kuru patients in Papua New Guinea. Methods We strengthened active kuru surveillance in 1996 with an expanded field team to investigate all suspected patients. Detailed histories of residence and exposure to mortuary feasts were obtained together with serial neurological examination, if possible. Findings We identified 11 patients with kuru from July, 1996, to June, 2004, all living in the South Fore. All patients were born before the cessation of cannibalism in the late 1950s. The minimum estimated incubation periods ranged from 34 to 41 years. However, likely incubation periods in men ranged from 39 to 56 years and could have been up to 7 years longer. PRNP analysis showed that most patients with kuru were heterozygous at polymorphic codon 129, a genotype associated with extended incubation periods and resistance to prion disease. Interpretation Incubation periods of infection with human prions can exceed 50 years. In human infection with BSE prions, species-barrier effects, which are characteristic of cross-species transmission, would be expected to further increase the mean and range of incubation periods, compared with recycling of prions within species. These data should inform attempts to model variant CJD epidemiology.	UCL, Inst Neurol, MRC, Prion Unit, London WC1N 3BG, England; UCL, Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; Papua New Guinea Inst Med Res, Goroka, EHP, Papua N Guinea; Curtin Univ Technol, Ctr Int Hlth, Perth, WA 6001, Australia	University of London; University College London; University of London; University College London; PNG Institute Of Medical Research; Curtin University	Collinge, J (corresponding author), UCL, Inst Neurol, MRC, Prion Unit, London WC1N 3BG, England.	j.collinge@prion.ucl.ac.uk	Mead, Simon/E-9414-2011	Mead, Simon/0000-0002-4326-1468	Medical Research Council [MC_U123160657, MC_U123160651, MC_U123192748] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [MC_U123160657, MC_U123160651] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALPERS M, 1987, P451; ALPERS MP, 1968, CENTRAL NERVOUS SYST, P234; Alpers MP., 1965, NINDB MONOGRAPH, V2, P65; AMOUYEL P, 1994, LANCET, V344, P1315, DOI 10.1016/S0140-6736(94)90691-2; BARLOW RM, 1990, VET REC, V126, P111; BROWN P, 1991, LANCET, V337, P269, DOI 10.1016/0140-6736(91)90873-N; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; Chapman J, 1998, NEUROLOGY, V51, P548, DOI 10.1212/WNL.51.2.548; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Collinge J, 2005, J NEUROL NEUROSUR PS, V76, P906, DOI 10.1136/jnnp.2004.048660; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; d'Aignaux JNH, 2001, SCIENCE, V294, P1729, DOI 10.1126/science.1064748; Donnelly CA, 2002, P ROY SOC B-BIOL SCI, V269, P2179, DOI 10.1098/rspb.2002.2156; GAJDUSEK DC, 1966, NATURE, V209, P794, DOI 10.1038/209794a0; GAJDUSEK DC, 1977, SCIENCE, V197, P943, DOI 10.1126/science.142303; Ghani AC, 2000, NATURE, V406, P583, DOI 10.1038/35020688; Ghani AC, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-4; GLASSE R, 1967, T NEW YORK ACAD SCI, V29, P748, DOI 10.1111/j.2164-0947.1967.tb02298.x; HADLOW WJ, 1959, LANCET, V2, P289; Jackson GS, 2001, NATURE, V414, P269, DOI 10.1038/35104694; KLITZMAN R L, 1984, Neuroepidemiology, V3, P3, DOI 10.1159/000110837; Lee HS, 2001, J INFECT DIS, V183, P192, DOI 10.1086/317935; Lindenbaum S., 1979, KURU SORCERY DIS DAN; Lloyd SE, 2002, NEUROGENETICS, V4, P77, DOI 10.1007/s10048-002-0133-9; Lloyd SE, 2001, P NATL ACAD SCI USA, V98, P6279, DOI 10.1073/pnas.101130398; Mead S, 2000, NEUROSCI LETT, V290, P117, DOI 10.1016/S0304-3940(00)01319-7; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Mead S, 2001, AM J HUM GENET, V69, P1225, DOI 10.1086/324710; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; Peoc'h K, 2000, NEUROSCI LETT, V286, P144, DOI 10.1016/S0304-3940(00)01100-9; Pepys MB, 2003, LANCET, V361, P487, DOI 10.1016/S0140-6736(03)12455-5; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Schroder B, 2001, HUM GENET, V109, P319, DOI 10.1007/s004390100591; Stephenson DA, 2000, GENOMICS, V69, P47, DOI 10.1006/geno.2000.6320; Wells GAH, 1998, VET REC, V142, P103, DOI 10.1136/vr.142.5.103	36	254	262	0	95	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 24	2006	367	9528					2068	2074		10.1016/S0140-6736(06)68930-7	http://dx.doi.org/10.1016/S0140-6736(06)68930-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058HZ	16798390				2022-12-24	WOS:000238657400032
J	Mitchell, AJ				Mitchell, AJ			Depressed patients and treatment adherence	LANCET			English	Editorial Material							ANTIDEPRESSANT ADHERENCE; PHYSICIAN COMMUNICATION; PRIMARY-CARE; MEDICATION; ATTITUDES; PREDICTORS; DISORDERS; SYMPTOMS; BELIEFS		Leicester Gen Hosp, Dept Liaison Psychiat, Brandon Unit, Leicester LE5 4PW, Leics, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital	Mitchell, AJ (corresponding author), Leicester Gen Hosp, Dept Liaison Psychiat, Brandon Unit, Gwendolen Rd, Leicester LE5 4PW, Leics, England.	alex.mitchell@leicspart.nhs.uk	Mitchell, Alex J/A-3090-2009; Mitchell, Alex J/P-5671-2015; Mitchell, Alex/Z-1920-2019	Mitchell, Alex J/0000-0001-6014-598X; Mitchell, Alex J/0000-0001-6014-598X; Mitchell, Alex/0000-0001-6014-598X				Aikens JE, 2005, GEN HOSP PSYCHIAT, V27, P229, DOI 10.1016/j.genhosppsych.2005.04.001; Aikens JE, 2005, ANN FAM MED, V3, P23, DOI 10.1370/afm.238; Althaus D, 2002, NERVENARZT, V73, P659, DOI 10.1007/s00115-002-1321-4; Ashton AK, 2005, CURR THER RES CLIN E, V66, P96, DOI 10.1016/j.curtheres.2005.04.006; Bambauer KZ, 2006, ARCH INTERN MED, V166, P498, DOI 10.1001/archinte.166.5.498; Beck CA, 2004, COMPR PSYCHIAT, V45, P268, DOI 10.1016/j.comppsych.2004.03.003; Brambilla P, 2005, PHARMACOPSYCHIATRY, V38, P69, DOI 10.1055/s-2005-837806; Bull SA, 2002, ANN PHARMACOTHER, V36, P578, DOI 10.1345/aph.1A254; Bull SA, 2002, JAMA-J AM MED ASSOC, V288, P1403, DOI 10.1001/jama.288.11.1403; Bultman DC, 2000, PATIENT EDUC COUNS, V40, P173, DOI 10.1016/S0738-3991(99)00083-X; COL N, 1990, ARCH INTERN MED, V150, P841, DOI 10.1001/archinte.150.4.841; Judd LL, 1998, ARCH GEN PSYCHIAT, V55, P694, DOI 10.1001/archpsyc.55.8.694; MADDOX JC, 1994, J PSYCHOPHARMACOL, V8, P48, DOI 10.1177/026988119400800108; National Institute for Clinical Excellence, 2004, DEPR MAN DEPR PRIM S; Olfson M, 2006, AM J PSYCHIAT, V163, P101, DOI 10.1176/appi.ajp.163.1.101; Paykel ES, 1998, BRIT J PSYCHIAT, V173, P519, DOI 10.1192/bjp.173.6.519; Pyne JM, 2005, PSYCHOL MED, V35, P839, DOI 10.1017/S0033291704003332; Sirey JA, 2001, PSYCHIAT SERV, V52, P1615, DOI 10.1176/appi.ps.52.12.1615; Sleath B, 2003, COMPR PSYCHIAT, V44, P198, DOI 10.1016/S0010-440X(03)00007-5; Vos T, 2004, ARCH GEN PSYCHIAT, V61, P1097, DOI 10.1001/archpsyc.61.11.1097	20	27	28	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 24	2006	367	9528					2041	2043		10.1016/S0140-6736(06)68902-2	http://dx.doi.org/10.1016/S0140-6736(06)68902-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	058HZ	16798371				2022-12-24	WOS:000238657400008
J	Uno, K; Katagiri, H; Yamada, T; Ishigaki, Y; Ogihara, T; Imai, J; Hasegawa, Y; Gao, JH; Kaneko, K; Iwasaki, H; Ishihara, H; Sasano, H; Inukai, K; Mizuguchi, H; Asano, T; Shiota, M; Nakazato, M; Oka, Y				Uno, Kenji; Katagiri, Hideki; Yamada, Tetsuya; Ishigaki, Yasushi; Ogihara, Takehide; Imai, Junta; Hasegawa, Yutaka; Gao, Junhong; Kaneko, Keizo; Iwasaki, Hiroko; Ishihara, Hisamitsu; Sasano, Hironobu; Inukai, Kouichi; Mizuguchi, Hiroyuki; Asano, Tomoichiro; Shiota, Masakazu; Nakazato, Masamitsu; Oka, Yoshitomo			Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity	SCIENCE			English	Article							PPAR-GAMMA; GLUCOSE-HOMEOSTASIS; ADIPOSE-TISSUE; EXPRESSION; LEPTIN; MUSCLE; FAT; RESISTANCE; AGONIST; OBESITY	Coordinated control of energy metabolism and glucose homeostasis requires communication between organs and tissues. We identified a neuronal pathway that participates in the cross talk between the liver and adipose tissue. By studying a mouse model, we showed that adenovirus-mediated expression of peroxisome proliferator - activated receptor ( PPAR) - gamma 2 in the liver induces acute hepatic steatosis while markedly decreasing peripheral adiposity. These changes were accompanied by increased energy expenditure and improved systemic insulin sensitivity. Hepatic vagotomy and selective afferent blockage of the hepatic vagus revealed that the effects on peripheral tissues involve the afferent vagal nerve. Furthermore, an antidiabetic thiazolidinedione, a PPAR gamma agonist, enhanced this pathway. This neuronal pathway from the liver may function to protect against metabolic perturbation induced by excessive energy storage.	Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Anim Res, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Grad Sch Med, Div Mol Metab & Diabet, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 9808575, Japan; Saitama Med Sch, Dept Internal Med 4, Moroyama, Saitama 3500495, Japan; Natl Inst Biomed Innovat, Lab Gene Transfer & Regulat, Osaka 5670085, Japan; Univ Tokyo, Dept Physiol Chem & Metab, Tokyo 1138655, Japan; Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; Miyazaki Univ, Miyazaki Med Coll, Dept Internal Med 3, Miyazaki 8891692, Japan	Tohoku University; Tohoku University; Tohoku University; Saitama Medical University; National Institute of Health Sciences - Japan; University of Tokyo; Vanderbilt University; University of Miyazaki	Katagiri, H (corresponding author), Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Anim Res, Sendai, Miyagi 9808575, Japan.	katagiri@mail.tains.tohoku.ac.jp		Mizuguchi, Hiroyuki/0000-0003-0594-8178				An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Bocher V, 2002, ANN NY ACAD SCI, V967, P7; Burant CF, 1997, J CLIN INVEST, V100, P2900, DOI 10.1172/JCI119839; Chao L, 2000, J CLIN INVEST, V106, P1221, DOI 10.1172/JCI11245; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Gomez-Ambrosi J, 2001, MOL CELL ENDOCRINOL, V176, P85, DOI 10.1016/S0303-7207(01)00451-8; Hatakeyama Y, 2004, AM J PHYSIOL-REG I, V287, pR336, DOI 10.1152/ajpregu.00131.2004; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Hosono T, 2005, GENE, V348, P157, DOI 10.1016/j.gene.2005.01.005; Ishigaki Y, 2005, DIABETES, V54, P322, DOI 10.2337/diabetes.54.2.322; Kitamura T, 2003, ANNU REV PHYSIOL, V65, P313, DOI 10.1146/annurev.physiol.65.092101.142540; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Matsusue K, 2003, J CLIN INVEST, V111, P737, DOI 10.1172/JCI200317223; Minokoshi Y, 2003, J BIOL CHEM, V278, P33609, DOI 10.1074/jbc.R300019200; Nagase I, 1996, J CLIN INVEST, V97, P2898, DOI 10.1172/JCI118748; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; Rahimian R, 2001, MOL CELL BIOCHEM, V224, P29, DOI 10.1023/A:1011927113563; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; WELLSTEIN A, 1986, J CARDIOVASC PHARM, V8, pS36; Yamada T, 2006, CELL METAB, V3, P223, DOI 10.1016/j.cmet.2006.02.001	25	185	200	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1656	1659		10.1126/science.1126010	http://dx.doi.org/10.1126/science.1126010			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778057				2022-12-24	WOS:000238288600047
J	Nestle, M				Nestle, M			Food marketing and childhood obesity - A matter of policy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NYU, New York, NY 10012 USA	New York University	Nestle, M (corresponding author), NYU, 550 1st Ave, New York, NY 10012 USA.							California Pan-Ethnic Health Network and Consumers Union, 2005, OUT BAL MARK SOD CAN; *CTR SCI PUBL INT, 2003, PEST PAR FOOD CO MAR; Koplan J., 2005, PREVENTING CHILDHOOD; McGinnis J.M., 2006, FOOD MARKETING CHILD	4	116	121	2	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2006	354	24					2527	2529		10.1056/NEJMp068014	http://dx.doi.org/10.1056/NEJMp068014			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	052KU	16775233				2022-12-24	WOS:000238233400002
J	Bondevik, S; Mangerud, J; Birks, HH; Gulliksen, S; Reimer, P				Bondevik, S; Mangerud, J; Birks, HH; Gulliksen, S; Reimer, P			Changes in North Atlantic radiocarbon reservoir ages during the Allerod and Younger Dryas	SCIENCE			English	Article							CAL KYR BP; LAST DEGLACIATION; MARINE SAMPLES; NORWEGIAN SEA; ICE CORES; C-14 AGES; VEDDE ASH; CALIBRATION; NORWAY; COAST	Estimates of the radiocarbon age of seawater are required in correlations between marine and terrestrial records of the late Quaternary climate. We radiocarbon-dated marine shells and terrestrial plant remains deposited in two bays on Norway's west coast between 11,000 and 14,000 years ago, a time of large and abrupt climatic changes that included the Younger Dryas (YD) cold episode. The radiocarbon age difference between the shells and the plants showed that sea surface reservoir ages increased from 400 to 600 years in the early YD, stabilized for 900 years, and dropped by 300 years within a century across the YD-Holocene transition.	Univ Tromso, Dept Geol, N-9037 Tromso, Norway; Univ Bergen, Dept Earth Sci, N-5007 Bergen, Norway; Univ Bergen, Bjerknes Ctr Climate Res, N-5007 Bergen, Norway; Univ Bergen, Dept Biol, N-5007 Bergen, Norway; Radiol Dating Lab, N-7034 Trondheim, Norway; Queens Univ Belfast, Sch Archaeol & Palaeoecol, Belfast BT7 1NN, Antrim, North Ireland	UiT The Arctic University of Tromso; University of Bergen; Bjerknes Centre for Climate Research; University of Bergen; University of Bergen; Queens University Belfast	Bondevik, S (corresponding author), Univ Tromso, Dept Geol, N-9037 Tromso, Norway.	stein.bondevik@ig.uit.no	Reimer, Paula/I-5915-2015; Birks, Hilary H/C-1859-2008					Aure J., 1993, FISKEN HAV, V6, P1; AUSTIN WEN, 1995, RADIOCARBON, V37, P53, DOI 10.1017/S0033822200014788; BARD E, 1994, EARTH PLANET SC LETT, V126, P275, DOI 10.1016/0012-821X(94)90112-0; Bjorck S, 2003, QUATERNARY SCI REV, V22, P429, DOI 10.1016/S0277-3791(03)00002-7; Bondevik S, 1999, QUATERNARY RES, V52, P104, DOI 10.1006/qres.1999.2048; Bondevik S, 2001, J QUATERNARY SCI, V16, P3, DOI 10.1002/1099-1417(200101)16:1<3::AID-JQS592>3.0.CO;2-G; Cleveland WS, 1994, ELEMENTS GRAPHING DA; Deo JN, 2004, AM ANTIQUITY, V69, P771, DOI 10.2307/4128449; Forman SL, 1997, GEOPHYS RES LETT, V24, P885, DOI 10.1029/97GL00761; Friedrich M, 2004, RADIOCARBON, V46, P1111, DOI 10.1017/S003382220003304X; Gulliksen S, 1998, HOLOCENE, V8, P249, DOI 10.1191/095968398672301347; HAFLIDASON H, 1995, GEOLOGY, V23, P1059, DOI 10.1130/0091-7613(1995)023<1059:CROTLG>2.3.CO;2; Hughen KA, 2004, RADIOCARBON, V46, P1059, DOI 10.1017/S0033822200033002; Hughen KA, 2000, SCIENCE, V290, P1951, DOI 10.1126/science.290.5498.1951; Klitgaard-Kristensen D, 2001, PALEOCEANOGRAPHY, V16, P455, DOI 10.1029/1999PA000495; Kromer B, 2004, RADIOCARBON, V46, P1203, DOI 10.1017/S0033822200033099; LEHMAN SJ, 1992, NATURE, V356, P757, DOI 10.1038/356757a0; MANGERUD J, 1972, Boreas (Oslo), V1, P143; MANGERUD J, IN PRESS QUAT SCI RE; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Rochon A, 1998, QUATERNARY RES, V49, P197, DOI 10.1006/qres.1997.1956; Siani G, 2001, SCIENCE, V294, P1917, DOI 10.1126/science.1063649; Southon J, 2004, RADIOCARBON, V46, P1239, DOI 10.1017/S0033822200033129; Stocker TF, 1996, PALEOCEANOGRAPHY, V11, P773, DOI 10.1029/96PA02640; STUIVER M, 1993, RADIOCARBON, V35, P137; STUIVER M, 1986, RADIOCARBON, V28, P980, DOI 10.1017/S0033822200060264; Waelbroeck C, 2001, NATURE, V412, P724, DOI 10.1038/35089060	27	143	146	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 9	2006	312	5779					1514	1517		10.1126/science.1123300	http://dx.doi.org/10.1126/science.1123300			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763147				2022-12-24	WOS:000238124100045
J	Crinion, J; Turner, R; Grogan, A; Hanakawa, T; Noppeney, U; Devlin, JT; Aso, T; Urayama, S; Fukuyama, H; Stockton, K; Usui, K; Green, DW; Price, CJ				Crinion, J.; Turner, R.; Grogan, A.; Hanakawa, T.; Noppeney, U.; Devlin, J. T.; Aso, T.; Urayama, S.; Fukuyama, H.; Stockton, K.; Usui, K.; Green, D. W.; Price, C. J.			Language control in the bilingual brain	SCIENCE			English	Article							PARKINSONS-DISEASE; CORTICAL-LESIONS; BASAL GANGLIA; SIGNAL CHANGE; FMRI; SENTENCES; WORDS; INDIVIDUALS; PROFICIENCY; APHASIA	How does the bilingual brain distinguish and control which language is in use? Previous functional imaging experiments have not been able to answer this question because proficient bilinguals activate the same brain regions irrespective of the language being tested. Here, we reveal that neuronal responses within the left caudate are sensitive to changes in the language or the meaning of words. By demonstrating this effect in populations of German-English and Japanese-English bilinguals, we suggest that the left caudate plays a universal role in monitoring and controlling the language in use.	UCL, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; Natl Ctr Neurol & Psychiat, Dept Cort Funct Disorders, Tokyo 1878502, Japan; Kyoto Univ, Human Brain Res Ctr, Kyoto 6068507, Japan; Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; Univ Oxford, Ctr Funct Magnet Resonance Imaging Brain, Oxford OX3 9DU, England; UCL, Dept Psychol, London WC1E 6BT, England	University of London; University College London; National Center for Neurology & Psychiatry - Japan; Kyoto University; Max Planck Society; University of Oxford; University of London; University College London	Price, CJ (corresponding author), UCL, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England.	c.price@fil.ion.ucl.ac.uk	Crinion, Jennifer/A-1992-2019; Devlin, Joseph T/C-1525-2008; Hanakawa, Takashi/A-6536-2011	Crinion, Jennifer/0000-0001-8080-6562; Devlin, Joseph/0000-0001-9737-3070; Price, Catherine/0000-0001-7448-4835; Green, David/0000-0001-7152-1485; Noppeney, Uta/0000-0002-7697-2290	Wellcome Trust [051067] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abutalebi J, 2000, NEUROCASE, V6, P51, DOI 10.1080/13554790008402757; BROWN RG, 1988, NEUROSCIENCE, V25, P363, DOI 10.1016/0306-4522(88)90246-1; Chee MWL, 2003, NEUROIMAGE, V18, P468, DOI 10.1016/S1053-8119(02)00019-8; Chee MWL, 2003, J COGNITIVE NEUROSCI, V15, P85, DOI 10.1162/089892903321107846; Chee MWL, 1999, NEURON, V23, P127, DOI 10.1016/S0896-6273(00)80759-X; Chee MWL, 2001, NEUROIMAGE, V13, P1155, DOI 10.1006/nimg.2001.0781; Chee MWL, 2000, NEUROIMAGE, V12, P392, DOI 10.1006/nimg.2000.0631; Copland D, 2003, J INT NEUROPSYCH SOC, V9, P1041, DOI 10.1017/S1355617703970081; Copland DA, 2000, CORTEX, V36, P601, DOI 10.1016/S0010-9452(08)70541-0; Devlin JT, 2000, NEUROIMAGE, V11, P589, DOI 10.1006/nimg.2000.0595; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hasegawa M, 2002, NEUROIMAGE, V15, P647, DOI 10.1006/nimg.2001.1001; Hernandez AE, 2001, NEUROIMAGE, V14, P510, DOI 10.1006/nimg.2001.0810; Jueptner M, 1998, BRAIN, V121, P1437, DOI 10.1093/brain/121.8.1437; Kim KHS, 1997, NATURE, V388, P171, DOI 10.1038/40623; Lucas TH, 2004, J NEUROSURG, V101, P449, DOI 10.3171/jns.2004.101.3.0449; Meschyan G, 2006, NEUROIMAGE, V29, P1135, DOI 10.1016/j.neuroimage.2005.08.055; Moretti R, 2001, PERCEPT MOTOR SKILL, V92, P803, DOI 10.2466/PMS.92.3.803-814; Mummery CJ, 1998, J COGNITIVE NEUROSCI, V10, P766, DOI 10.1162/089892998563059; Mummery CJ, 1999, NEUROIMAGE, V9, P516, DOI 10.1006/nimg.1999.0434; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Nadeau SE, 1997, BRAIN LANG, V58, P355, DOI 10.1006/brln.1997.1707; Nakamura K, 2005, J COGNITIVE NEUROSCI, V17, P954, DOI 10.1162/0898929054021166; Neely J. H., 1991, BASIC PROCESSES READ, P264; Perani D, 2005, CURR OPIN NEUROBIOL, V15, P202, DOI 10.1016/j.conb.2005.03.007; Price CJ, 1999, BRAIN, V122, P2221, DOI 10.1093/brain/122.12.2221; Price CJ, 1997, J COGNITIVE NEUROSCI, V9, P727, DOI 10.1162/jocn.1997.9.6.727; Robles SG, 2005, J NEUROL NEUROSUR PS, V76, P940, DOI 10.1136/jnnp.2004.045948; Rodriguez-Fornells A, 2005, J COGNITIVE NEUROSCI, V17, P422, DOI 10.1162/0898929053279559; Rodriguez-Fornells A, 2002, NATURE, V415, P1026, DOI 10.1038/4151026a; Rossell SL, 2003, NEUROPSYCHOLOGIA, V41, P550, DOI 10.1016/S0028-3932(02)00181-1; Roux FE, 2004, BRAIN, V127, P1796, DOI 10.1093/brain/awh204; Vingerhoets G, 2003, NEUROIMAGE, V20, P2181, DOI 10.1016/j.neuroimage.2003.07.029; Wallesch, 1992, NEUROPSYCHOLOGICAL D, P7; Wallesch C-W., 1988, APHASIA, P256; Yeterian EH, 1998, J COMP NEUROL, V399, P384; Yokoyama S, 2006, NEUROIMAGE, V30, P570, DOI 10.1016/j.neuroimage.2005.09.066	37	366	371	2	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1537	1540		10.1126/science.1127761	http://dx.doi.org/10.1126/science.1127761			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	050XT	16763154				2022-12-24	WOS:000238124100052
J	van de Lavoir, MC; Diamond, JH; Leighton, PA; Mather-Love, C; Heyer, BS; Bradshaw, R; Kerchner, A; Hooi, LT; Gessaro, TM; Swanberg, SE; Delany, ME; Etches, RJ				van de lavoir, Marie-Cecile; Diamond, Jennifer H.; Leighton, Philip A.; Mather-Love, Christine; Heyer, Babette S.; Bradshaw, Renee; Kerchner, Allyn; Hooi, Lisa T.; Gessaro, Terri M.; Swanberg, Susan E.; Delany, Mary E.; Etches, Robert J.			Germline transmission of genetically modified primordial germ cells	NATURE			English	Article							CHIMERIC CHICKENS; DOMESTIC-FOWL; EMBRYO; BLOOD	Primordial germ cells ( PGCs) are the precursors of sperm and eggs(1). In most animals, segregation of the germ line from the somatic lineages is one of the earliest events in development(2); in avian embryos, PGCs are first identified in an extra-embryonic region, the germinal crescent, after approximately 18 h of incubation. After 50-55 h of development, PGCs migrate to the gonad and subsequently produce functional sperm and oocytes(3,4). So far, cultures of PGCs that remain restricted to the germ line have not been reported in any species(5,6). Here we show that chicken PGCs can be isolated, cultured and genetically modified while maintaining their commitment to the germline. Furthermore, we show that chicken PGCs can be induced in vitro to differentiate into embryonic germ cells that contribute to somatic tissues. Retention of the commitment of PGCs to the germ line after extended periods in culture and after genetic modification combined with their capacity to acquire somatic competence in vitro provides a new model for developmental biology. The utility of the model is enhanced by the accessibility of the avian embryo, which facilitates access to the earliest stages of development and supplies a facile route for the reintroduction of PGCs into the embryonic vasculature. In addition, these attributes create new opportunities to manipulate the genome of chickens for agricultural and pharmaceutical applications.	Origen Therapeut, Burlingame, CA 94010 USA; Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Etches, RJ (corresponding author), Origen Therapeut, 1450 Rollins Rd, Burlingame, CA 94010 USA.	retches@origentherapeutics.com		Swanberg, Susan/0000-0001-7487-7065				BABA TW, 1985, VIROLOGY, V144, P139, DOI 10.1016/0042-6822(85)90312-5; Burgess-Beusse B, 2002, P NATL ACAD SCI USA, V99, P16433, DOI 10.1073/pnas.162342499; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; FUJIMOTO T, 1976, DEV BIOL, V49, P278, DOI 10.1016/0012-1606(76)90273-6; Halfter W, 1996, DEVELOPMENT, V122, P915; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; KODAMA H, 1987, CHROMOSOMA, V96, P18, DOI 10.1007/BF00285878; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; MCLAREN A, 1992, NATURE, V359, P482, DOI 10.1038/359482a0; Naito M, 1999, J REPROD FERTIL, V117, P291, DOI 10.1530/jrf.0.1170291; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Petitte J.N., 2004, HDB STEM CELLS, P471; ROWLETT K, 1987, BRIT POULTRY SCI, V28, P91, DOI 10.1080/00071668708416940; Stern CD, 2005, DEV CELL, V8, P9, DOI 10.1016/j.devcel.2004.11.018; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Sutasurya L. A., 1979, PRIMORDIAL GERM CELL; Swift CH, 1914, AM J ANAT, V15, P483, DOI DOI 10.1002/AJA.1000150404; Tsunekawa N, 2000, DEVELOPMENT, V127, P2741; van de Lavoir MC, 2006, MECH DEVELOP, V123, P31, DOI 10.1016/j.mod.2005.10.002; Wylie C, 1999, CELL, V96, P165, DOI 10.1016/S0092-8674(00)80557-7; Zhu L, 2005, NAT BIOTECHNOL, V23, P1159, DOI 10.1038/nbt1132	22	302	339	3	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					766	769		10.1038/nature04831	http://dx.doi.org/10.1038/nature04831			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760981				2022-12-24	WOS:000238095100058
J	Kerbel, RS				Kerbel, Robert S.			Antiangiogenic therapy: A universal chemosensitization strategy for cancer?	SCIENCE			English	Editorial Material							ENDOTHELIAL GROWTH-FACTOR; METASTATIC BREAST-CANCER; METRONOMIC CHEMOTHERAPY; TUMOR ANGIOGENESIS; RANDOMIZED-TRIAL; CELLS; CYCLOPHOSPHAMIDE; CHEMORESISTANCE; NORMALIZATION; BEVACIZUMAB		Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med Biophys, Toronto, ON M4N 3M5, Canada; Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Lab Med & Pathobiol, Toronto, ON M4N 3M5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Kerbel, RS (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Med Biophys, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	robert.kerbel@sri.utoronto.ca						ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bertolini F, 2003, CANCER RES, V63, P4342; Browder T, 2000, CANCER RES, V60, P1878; CANADY C, 2005, ONCOL NEWS INT, V14, P8; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Citron ML, 2004, CANCER INVEST, V22, P555, DOI 10.1081/CNV-200027134; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cohn DE, 2006, GYNECOL ONCOL, V102, P134, DOI 10.1016/j.ygyno.2006.01.030; Colleoni M, 2002, ANN ONCOL, V13, P73, DOI 10.1093/annonc/mdf013; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Emmenegger U, 2004, CANCER RES, V64, P3994, DOI 10.1158/0008-5472.CAN-04-0580; ESCUDIER B, 2005, 2005 ASCO ANN M P, V23, pS380; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Franco M, 2006, CANCER RES, V66, P3639, DOI 10.1158/0008-5472.CAN-05-3295; Furstenberger G, 2006, BRIT J CANCER, V94, P524, DOI 10.1038/sj.bjc.6602952; Giannoni DS, 2002, APPL LINGUIST, V23, P1, DOI 10.1093/applin/23.1.1; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Hudis Clifford A, 2005, Oncology (Williston Park), V19, P26; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Kieran MW, 2005, J PEDIAT HEMATOL ONC, V27, P573, DOI 10.1097/01.mph.0000183863.10792.d4; Kim JE, 2005, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2005/01/005; Kindler HL, 2005, J CLIN ONCOL, V23, P8033, DOI 10.1200/JCO.2005.01.9661; Klement G, 2000, J CLIN INVEST, V105, pR15, DOI 10.1172/JCI8829; Ma L, 2005, CANCER RES, V65, P5365, DOI 10.1158/0008-5472.CAN-04-3156; Marx J, 2005, SCIENCE, V308, P1248, DOI 10.1126/science.308.5726.1248; Miller KD, 2001, J CLIN ONCOL, V19, P1195, DOI 10.1200/JCO.2001.19.4.1195; MILLER KD, 2005, 41 ANN M AM SOC CLIN; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Munoz R, 2006, CANCER RES, V66, P3386, DOI 10.1158/0008-5472.CAN-05-4411; Natori T, 2002, BIOCHEM BIOPH RES CO, V297, P1058, DOI 10.1016/S0006-291X(02)02335-5; Okazaki T, 2006, INT IMMUNOL, V18, P1, DOI 10.1093/intimm/dxh334; Pietras K, 2005, J CLIN ONCOL, V23, P939, DOI 10.1200/JCO.2005.07.093; SANDLER AB, 2005, 2005 ASCO ANN M P, V23, pS2; Schrag D, 2004, NEW ENGL J MED, V351, P317, DOI 10.1056/NEJMp048143; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Shaked Y, 2005, CANCER CELL, V7, P101, DOI 10.1016/j.ccr.2004.11.023; Shaked Y, 2005, BLOOD, V106, P3058, DOI 10.1182/blood-2005-04-1422; Sweeney CJ, 2001, CANCER RES, V61, P3369; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Tran J, 2002, P NATL ACAD SCI USA, V99, P4349, DOI 10.1073/pnas.072586399; Udagawa T, 2006, FASEB J, V20, P95, DOI 10.1096/fj.04-3669com; Vogelzang NJ, 2006, J CLIN ONCOL, V24, P1, DOI 10.1200/JCO.2005.03.7234; Wang JY, 2003, ANTI-CANCER DRUG, V14, P13, DOI 10.1097/00001813-200301000-00003; Wey JS, 2005, BRIT J CANCER, V93, P233, DOI 10.1038/sj.bjc.6602663; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Yu JL, 2002, SCIENCE, V295, P1526, DOI 10.1126/science.1068327	53	397	419	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1171	1175		10.1126/science.1125950	http://dx.doi.org/10.1126/science.1125950			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728631				2022-12-24	WOS:000237957400041
J	Singh, H; Turner, D; Xue, L; Targownik, LE; Bernstein, CN				Singh, Harminder; Turner, Donna; Xue, Lin; Targownik, Laura E.; Bernstein, Charles N.			Risk of developing colorectal cancer following a negative colonoscopy examination - Evidence for a 10-year interval between colonoscopies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SURVEILLANCE COLONOSCOPY; ASYMPTOMATIC ADULTS; PREVENTION; SIGMOIDOSCOPY; PREVALENCE; CARCINOMAS; MANITOBA; SCREEN; COLON; RATES	Context Limited evidence exists to guide the optimal frequency of repeat endoscopic examination for colorectal cancer screening after a negative colonoscopy. Objective To determine the duration and magnitude of the risk of developing colorectal cancer following performance of a negative colonoscopy. Design, Setting, and Patients Population-based retrospective analysis of individuals whose colonoscopy evaluations did not result in a diagnosis of colorectal neoplasia. Patients who had been evaluated between April 1, 1989, and December 31, 2003, were identified using Manitoba Health's physician billing claims database (N = 35 975). Standardized incidence ratios (SIRs) were calculated to compare colorectal cancer incidence in our cohort with colorectal cancer incidence in the provincial population. Stratified analysis was performed to determine the duration of the reduced risk. Patients with a history of colorectal cancer prior to the index colonoscopy, inflammatory bowel disease, resective colorectal surgery, and lower gastrointestinal endoscopy within the 5 years before the index colonoscopy were excluded. Cohort members were followed up from the time of the index colonoscopy until diagnosis of colorectal cancer, death, out-migration from Manitoba, or end of the study period on December 31, 2003. Main Outcome Measure Incidence of colorectal cancer. Results A negative colonoscopy was associated with SIRs of 0.69 (95% confidence interval [CI], 0.59-0.81) at 6 months, 0.66 (95% CI, 0.56-0.78) at 1 year, 0.59 (95% CI, 0.48-0.72) at 2 years, 0.55 (95% CI, 0.41-0.73) at 5 years, and 0.28 (95% CI, 0.09-0.65) at 10 years. The proportion of colorectal cancer located in the right side of the colon was significantly higher in the colonoscopy cohort than the rate in the Manitoba population (47% vs 28%; P <. 001). Conclusions The risk of developing colorectal cancer remains decreased for more than 10 years following the performance of a negative colonoscopy. There is a need to improve the early detection rate of right-sided colorectal neoplasia in usual clinical practice.	Canc Care Manitoba, Dept Internal Med, Winnipeg, MB, Canada; Canc Care Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada; Univ Manitoba, Inflammatory Bowel Dis Clin & Res Ctr, Winnipeg, MB, Canada	University of Manitoba	Singh, H (corresponding author), Gastroenterol Sect, 804-715 McDermot Ave, Winnipeg, MB R3E 3P4, Canada.	singh@cc.umanitoba.ca	Targownik, Laura/ABD-2427-2021	Targownik, Laura/0000-0002-4366-9076				Alberts DS, 2000, NEW ENGL J MED, V342, P1156, DOI 10.1056/NEJM200004203421602; BAILAR JC, 1964, BIOMETRICS, V20, P639; Barclay RI, 2005, GASTROINTEST ENDOSC, V61, pAB107, DOI 10.1016/S0016-5107(05)00682-6; Bernstein CN, 1999, AM J EPIDEMIOL, V149, P916, DOI 10.1093/oxfordjournals.aje.a009735; Birkenkamp-Demtroder K, 2005, GUT, V54, P374, DOI 10.1136/gut.2003.036848; Blanchard JF, 1996, DIABETES CARE, V19, P807, DOI 10.2337/diacare.19.8.807; Blanchard JF, 1997, DIABETES CARE, V20, P512, DOI 10.2337/diacare.20.4.512; *CAN CANC SOC NCI, 2005, CAN CANC STAT 2005; Chirieac LR, 2005, AM J SURG PATHOL, V29, P429, DOI 10.1097/01.pas.0000155144.53047.7d; Cotterchio M, 2005, CANCER CAUSE CONTROL, V16, P865, DOI 10.1007/s10552-005-2370-3; Gorski TF, 1999, DIS COLON RECTUM, V42, P877, DOI 10.1007/BF02237093; HENNEKENS CH, 1997, EPIDEMIOLOGY MED, P82; Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Konishi K, 1999, GUT, V45, P818, DOI 10.1136/gut.45.6.818; Lewis JD, 2003, ARCH INTERN MED, V163, P413, DOI 10.1001/archinte.163.4.413; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; Newcomb PA, 2003, J NATL CANCER I, V95, P622, DOI 10.1093/jnci/95.8.622; Okamoto M, 2005, DIS COLON RECTUM, V48, P101, DOI 10.1007/s10350-004-0754-1; Pabby A, 2005, GASTROINTEST ENDOSC, V61, P385, DOI 10.1016/S0016-5107(04)02765-8; Pickhardt PJ, 2004, ANN INTERN MED, V141, P352, DOI 10.7326/0003-4819-141-5-200409070-00009; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Rex DK, 2000, GASTROINTEST ENDOSC, V51, P33, DOI 10.1016/S0016-5107(00)70383-X; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; ROOS LL, 1982, MED CARE, V20, P266, DOI 10.1097/00005650-198203000-00003; ROOS LL, 1993, MED CARE, V31, P201, DOI 10.1097/00005650-199303000-00002; Schoen RE, 2003, AM J GASTROENTEROL, V98, P1237, DOI 10.1016/S0002-9270(03)00271-5; Soetikno R, 2006, GASTROENTEROLOGY, V130, P566, DOI 10.1053/j.gastro.2005.12.006; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	36	333	368	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2006	295	20					2366	2373		10.1001/jama.295.20.2366	http://dx.doi.org/10.1001/jama.295.20.2366			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045HY	16720822	Bronze			2022-12-24	WOS:000237734400022
J	Telford, RJ; Vandvik, V; Birks, HJB				Telford, RJ; Vandvik, V; Birks, HJB			Dispersal limitations matter for microbial morphospecies	SCIENCE			English	Article									Bjerknes Ctr Climate Res, N-5007 Bergen, Norway; Univ Bergen, Dept Biol, Ecol & Environm Change Res Grp, N-5007 Bergen, Norway; UCL, Environm Change Res Ctr, London WC1H 0AP, England	Bjerknes Centre for Climate Research; University of Bergen; University of London; University College London	Telford, RJ (corresponding author), Bjerknes Ctr Climate Res, Allegaten 55, N-5007 Bergen, Norway.	richard.telford@bjerknes.uib.no	Telford, Richard/AAD-2249-2019; Birks, John B/C-3103-2008; Vandvik, Vigdis/C-1924-2008; Telford, Richard/C-1668-2008	Telford, Richard/0000-0001-9826-3076; Birks, John B/0000-0002-5891-9859; Vandvik, Vigdis/0000-0003-4651-4798; Telford, Richard/0000-0001-9826-3076				de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; Fenchel T, 2003, SCIENCE, V301, P925, DOI 10.1126/science.1089242; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Theriot EC, 2006, PALEOBIOLOGY, V32, P38, DOI 10.1666/0094-8373(2006)032[0038:LQRMEO]2.0.CO;2; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909	6	170	174	7	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 19	2006	312	5776					1015	1015		10.1126/science.1125669	http://dx.doi.org/10.1126/science.1125669			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16709777	Green Accepted			2022-12-24	WOS:000237628800034
J	Zipfel, C; Kunze, G; Chinchilla, D; Caniard, A; Jones, JDG; Boller, T; Felix, G				Zipfel, Cyril; Kunze, Gernot; Chinchilla, Delphine; Caniard, Anne; Jones, Jonathan D. G.; Boller, Thomas; Felix, Georg			Perception of the bacterial PAMP EF-Tu by the receptor EFR restricts Agrobacterium-mediated transformation	CELL			English	Article							ELONGATION-FACTOR TU; INNATE IMMUNITY; ARABIDOPSIS-THALIANA; ELICITOR FLAGELLIN; KINASE; DEFENSE; PLANTS; PROTEINS; ANIMALS; CELLS	Higher eukaryotes sense microbes through the perception of pathogen-associated molecular patterns (PAMPs). Arabidopsis plants detect a variety of PAMPs including conserved domains of bacterial flagellin and of bacterial EF-Tu. Here, we show that flagellin and EF-Tu activate a common set of signaling events and defense responses but without clear synergistic effects. Treatment with either PAMP results in increased binding sites for both PAMPs. We used this finding in a targeted reverse-genetic approach to identify a receptor kinase essential for EF-Tu perception, which we called EFR. Nicotiana benthamiana, a plant unable to perceive EFTu, acquires EF-Tu binding sites and responsiveness upon transient expression of EFR. Arabidopsis efr mutants show enhanced susceptibility to the bacterium Agrobacterium tumefaciens, as revealed by a higher efficiency of T-DNA transformation. These results demonstrate that EFR is the EF-Tu receptor and that plant defense responses induced by PAMPs such as EF-Tu reduce transformation by Agrobacterium.	Univ Basel, Inst Bot, Zurich Basel Plant Sci Ctr, CH-4056 Basel, Switzerland; John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	University of Basel; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Zipfel, C (corresponding author), Univ Tubingen, ZMBP, Morgenstelle 5, D-72076 Tubingen, Germany.	cyril.zipfel@sainsbury-laboratory.ac.uk; georg.felix@unibas.ch	Boller, Thomas/G-3500-2012; ZIPFEL, CYRIL B/D-7103-2011; Jones, Jonathan DG/J-5129-2012; ZIPFEL, CYRIL/ABD-5076-2021	Boller, Thomas/0000-0001-6768-7503; ZIPFEL, CYRIL B/0000-0003-4935-8583; Jones, Jonathan DG/0000-0002-4953-261X; ZIPFEL, CYRIL/0000-0003-4935-8583; Kunze, Gernot/0000-0002-2039-2836				Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Bauer Z, 2001, J BIOL CHEM, V276, P45669, DOI 10.1074/jbc.M102390200; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Dievart A, 2003, CURR OPIN PLANT BIOL, V6, P507, DOI 10.1016/S1369-5266(03)00089-X; Ditt RF, 2005, FEMS MICROBIOL LETT, V247, P207, DOI 10.1016/j.femsle.2005.05.010; Escobar MA, 2003, TRENDS PLANT SCI, V8, P380, DOI 10.1016/S1360-1385(03)00162-6; Espinosa A, 2004, CELL MICROBIOL, V6, P1027, DOI 10.1111/j.1462-5822.2004.00452.x; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Fliegmann J, 2004, J BIOL CHEM, V279, P1132, DOI 10.1074/jbc.M308552200; Gelvin SB, 2005, NATURE, V433, P583, DOI 10.1038/433583a; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jeppesen MG, 2005, J BIOL CHEM, V280, P5071, DOI 10.1074/jbc.M411782200; Jones DA, 2004, CURR OPIN IMMUNOL, V16, P48, DOI 10.1016/j.coi.2003.11.016; Kazemi-Pour N, 2004, PROTEOMICS, V4, P3177, DOI 10.1002/pmic.200300814; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Matsubayashi Y, 2000, J BIOL CHEM, V275, P15520, DOI 10.1074/jbc.275.20.15520; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Meindl T, 1998, PLANT CELL, V10, P1561, DOI 10.1105/tpc.10.9.1561; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Nomura K, 2005, CURR OPIN PLANT BIOL, V8, P361, DOI 10.1016/j.pbi.2005.05.005; Nuhse TS, 2000, J BIOL CHEM, V275, P7521, DOI 10.1074/jbc.275.11.7521; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Pfund C, 2004, MOL PLANT MICROBE IN, V17, P696, DOI 10.1094/MPMI.2004.17.6.696; Post DMB, 2005, J BIOL CHEM, V280, P38383, DOI 10.1074/jbc.M508063200; Ramos HC, 2004, TRENDS MICROBIOL, V12, P509, DOI 10.1016/j.tim.2004.09.002; Ron M, 2004, PLANT CELL, V16, P1604, DOI 10.1105/tpc.022475; Scheer JM, 2002, P NATL ACAD SCI USA, V99, P9585, DOI 10.1073/pnas.132266499; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Singh P, 2004, ENVIRON MICROBIOL, V6, P1149, DOI 10.1111/j.1462-2920.2004.00622.x; SUZUKI K, 1995, PLANT CELL, V7, P639, DOI 10.1105/tpc.7.5.639; Umemoto N, 1997, P NATL ACAD SCI USA, V94, P1029, DOI 10.1073/pnas.94.3.1029; Veena, 2003, PLANT J, V35, P219, DOI 10.1046/j.1365-313X.2003.01796.x; Watt SA, 2005, PROTEOMICS, V5, P153, DOI 10.1002/pmic.200400905; Wroblewski T, 2005, PLANT BIOTECHNOL J, V3, P259, DOI 10.1111/j.1467-7652.2005.00123.x; Zhu YM, 2003, PLANT PHYSIOL, V132, P494, DOI 10.1104/pp.103.020420; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zipfel C, 2005, CURR OPIN PLANT BIOL, V8, P353, DOI 10.1016/j.pbi.2005.05.004; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	50	1219	1303	10	282	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2006	125	4					749	760		10.1016/j.cell.2006.03.037	http://dx.doi.org/10.1016/j.cell.2006.03.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713565	Bronze			2022-12-24	WOS:000237886000019
J	Boyer, LA; Plath, K; Zeitlinger, J; Brambrink, T; Medeiros, LA; Lee, TI; Levine, SS; Wernig, M; Tajonar, A; Ray, MK; Bell, GW; Otte, AP; Vidal, M; Gifford, DK; Young, RA; Jaenisch, R				Boyer, LA; Plath, K; Zeitlinger, J; Brambrink, T; Medeiros, LA; Lee, TI; Levine, SS; Wernig, M; Tajonar, A; Ray, MK; Bell, GW; Otte, AP; Vidal, M; Gifford, DK; Young, RA; Jaenisch, R			Polycomb complexes repress developmental regulators in murine embryonic stem cells	NATURE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; H3 LYSINE-27 METHYLATION; DNA METHYLATION; EARLY EMBRYOGENESIS; MOUSE DEVELOPMENT; GENE-EXPRESSION; PROTEIN; EZH2; ENHANCER; OCT-3/4	The mechanisms by which embryonic stem (ES) cells self-renew while maintaining the ability to differentiate into virtually all adult cell types are not well understood. Polycomb group (PcG) proteins are transcriptional repressors that help to maintain cellular identity during metazoan development by epigenetic modification of chromatin structure(1). PcG proteins have essential roles in early embryonic development(2-6) and have been implicated in ES cell pluripotency(2), but few of their target genes are known in mammals. Here we show that PcG proteins directly repress a large cohort of developmental regulators in murine ES cells, the expression of which would otherwise promote differentiation. Using genome-wide location analysis in murine ES cells, we found that the Polycomb repressive complexes PRC1 and PRC2 co-occupied 512 genes, many of which encode transcription factors with important roles in development. All of the co-occupied genes contained modified nucleosomes (trimethylated Lys 27 on histone H3). Consistent with a causal role in gene silencing in ES cells, PcG target genes were de-repressed in cells deficient for the PRC2 component Eed, and were preferentially activated on induction of differentiation. Our results indicate that dynamic repression of developmental pathways by Polycomb complexes may be required for maintaining ES cell pluripotency and plasticity during embryonic development.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Univ Amsterdam, Swammerdam Inst Life Sci, NL-1098 SM Amsterdam, Netherlands; CSIC, Dev & Cell Biol Ctr Invest Biol, E-28040 Madrid, Spain; MIT, Comp Sci Lab, Cambridge, MA 02139 USA; MIT, Artificial Intelligence Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Amsterdam; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Young, Richard A/F-6495-2012; Vidal, Miguel/M-8861-2016	Young, Richard A/0000-0001-8855-8647; Vidal, Miguel/0000-0003-4374-6761; Plath, Kathrin/0000-0001-7796-3372; Levine, Stuart/0000-0001-7363-562X	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG002668-03, R01 HG002668] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burch JBE, 2005, SEMIN CELL DEV BIOL, V16, P71, DOI 10.1016/j.semcdb.2004.10.002; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Gidekel S, 2002, J BIOL CHEM, V277, P34521, DOI 10.1074/jbc.M203338200; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hombria JCG, 2003, DIFFERENTIATION, V71, P461, DOI 10.1046/j.1432-0436.2003.7108004.x; Isono K, 2005, MOL CELL BIOL, V25, P6694, DOI 10.1128/MCB.25.15.6694-6706.2005; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lehmann OJ, 2003, TRENDS GENET, V19, P339, DOI 10.1016/S0168-9525(03)00111-2; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Meissner A, 2005, NUCLEIC ACIDS RES, V33, P5868, DOI 10.1093/nar/gki901; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Schumacher A, 1996, NATURE, V383, P250, DOI 10.1038/383250a0; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100	26	1927	2013	4	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					349	353		10.1038/nature04733	http://dx.doi.org/10.1038/nature04733			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16625203				2022-12-24	WOS:000237593200048
J	Verma, S; Lindsay, TF				Verma, S; Lindsay, TF			Regression of aortic aneurysms through pharmacologic therapy?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RUPTURE		Univ Toronto, Toronto, ON, Canada	University of Toronto	Verma, S (corresponding author), Univ Toronto, Toronto, ON, Canada.							Fillinger MF, 2002, J VASC SURG, V36, P589, DOI 10.1067/mva.2002.125478; Sakalihasan N, 2005, LANCET, V365, P1577, DOI 10.1016/S0140-6736(05)66459-8; Wilson WRW, 2006, CIRCULATION, V113, P438, DOI 10.1161/CIRCULATIONAHA.105.551572; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335	4	12	14	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2006	354	19					2067	2068		10.1056/NEJMcibr060899	http://dx.doi.org/10.1056/NEJMcibr060899			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040XA	16687722	Green Published			2022-12-24	WOS:000237413100016
J	King, AW; Gunderson, CA; Post, WM; Weston, DJ; Wullschleger, SD				King, AW; Gunderson, CA; Post, WM; Weston, DJ; Wullschleger, SD			Atmosphere - Plant respiration in a warmer world	SCIENCE			English	Editorial Material							CARBON-CYCLE; TEMPERATURE; CLIMATE; ACCLIMATION; Q(10); MODEL		Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory	King, AW (corresponding author), Oak Ridge Natl Lab, Div Environm Sci, POB 2008, Oak Ridge, TN 37831 USA.	kingaw@ornl.gov	Weston, David/A-9116-2011; Post, Wilfred M/B-8959-2012; Wullschleger, Stan D/B-8297-2012	Weston, David/0000-0002-4794-9913; Wullschleger, Stan D/0000-0002-9869-0446; Post, Wilfred/0000-0002-1410-8499				Amthor Jeffrey S., 1994, P501; Amthor JS, 2000, ANN BOT-LONDON, V86, P1, DOI 10.1006/anbo.2000.1175; Atkin OK, 2005, FUNCT PLANT BIOL, V32, P87, DOI 10.1071/FP03176; Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; DEVRIES FWT, 1975, ANN BOTANY, V39, P77; Forward D. F, 1960, ENCY PLANT PHYSL, P234; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Fung IY, 2005, P NATL ACAD SCI USA, V102, P11201, DOI 10.1073/pnas.0504949102; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Tjoelker MG, 2001, GLOBAL CHANGE BIOL, V7, P223, DOI 10.1046/j.1365-2486.2001.00397.x; Wythers KR, 2005, GLOBAL CHANGE BIOL, V11, P435, DOI 10.1111/j.1365-2486.2005.00922.x	12	105	115	3	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 28	2006	312	5773					536	537		10.1126/science.1114166	http://dx.doi.org/10.1126/science.1114166			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16645083				2022-12-24	WOS:000237296700030
J	Dloniak, SM; French, JA; Holekamp, KE				Dloniak, SM; French, JA; Holekamp, KE			Rank-related maternal effects of androgens on behaviour in wild spotted hyaenas	NATURE			English	Article							HYENA CROCUTA-CROCUTA; SOCIAL-STATUS; FETAL LIFE; TESTOSTERONE; MASCULINIZATION; YOLK; REPRODUCTION; AGGRESSION; DOMINANCE; FEMALES	Within any hierarchical society, an individual's social rank can have profound effects on its health and reproductive success(1,2), and rank-related variation in these traits is often mediated by variation in endocrine function(2). Maternal effects mediated by prenatal hormone exposure are potentially important for non-genetic inheritance of phenotypic traits related to social rank(3), and thus for shaping individual variation in behaviour and social structure. Here we show that androgen concentrations in wild female spotted hyaenas (Crocuta crocuta) are higher during late gestation in dominant females than in subordinate females. Furthermore, both male and female cubs born to mothers with high concentrations of androgens in late pregnancy exhibit higher rates of aggression and mounting behaviour than cubs born to mothers with lower androgen concentrations. Both behaviours are strongly affected in other mammals by organizational effects of androgens(4), and both have important effects on fitness in hyaenas. Therefore, our results suggest that rank-related maternal effects of prenatal androgen exposure can adaptively influence offspring phenotype in mammals, as has previously been shown to occur in birds. They also suggest an organizational mechanism for the development of female dominance and aggressiveness in spotted hyaenas, traits that may offset the costs of extreme virilization.	Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; Univ Nebraska, Dept Psychol, Omaha, NE 68182 USA; Univ Nebraska, Dept Biol, Omaha, NE 68182 USA	Michigan State University; University of Nebraska System; University of Nebraska System	Dloniak, SM (corresponding author), Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA.	dloniak@kenyaweb.co	French, Jeffrey/F-1779-2011; Holekamp, Kay E/G-6054-2010	French, Jeffrey/0000-0001-5304-1592				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Becker JB., 2002, BEHAV ENDOCRINOLOGY, P1; Clutton-Brock T. H., 1988, REPROD SUCCESS; Dloniak SM, 2004, GEN COMP ENDOCR, V135, P51, DOI 10.1016/j.ygcen.2003.08.011; Drea CM, 2002, P ROY SOC B-BIOL SCI, V269, P1981, DOI 10.1098/rspb.2002.2109; East ML, 2003, P ROY SOC B-BIOL SCI, V270, P1247, DOI 10.1098/rspb.2003.2363; Eising CM, 2001, P ROY SOC B-BIOL SCI, V268, P839, DOI 10.1098/rspb.2001.1594; Frank Laurence G., 1996, P78; FRANK LG, 1986, ANIM BEHAV, V34, P1510, DOI 10.1016/S0003-3472(86)80221-4; FRANK LG, 1995, NATURE, V377, P584, DOI 10.1038/377584b0; GOY RW, 1988, HORM BEHAV, V22, P552, DOI 10.1016/0018-506X(88)90058-X; Goymann W, 1999, GEN COMP ENDOCR, V114, P340, DOI 10.1006/gcen.1999.7268; Holekamp KE, 1996, J REPROD FERTIL, V108, P229; KRUUK H, 1972, SPOTTED HYENA; Licht P, 1998, J REPROD FERTIL, V113, P105; Lipar JL, 2000, P ROY SOC B-BIOL SCI, V267, P2005, DOI 10.1098/rspb.2000.1242; Marchlewska-Koj A, 2003, PHYSIOL BEHAV, V79, P671, DOI 10.1016/S0031-9384(03)00168-9; Mousseau T. A., 1998, MATERNAL EFFECTS ADA; Muller W, 2002, P ROY SOC B-BIOL SCI, V269, P2249, DOI 10.1098/rspb.2002.2159; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Schwabl H, 1996, COMP BIOCHEM PHYS A, V114, P271, DOI 10.1016/0300-9629(96)00009-6; SMALE L, 1993, ANIM BEHAV, V46, P467, DOI 10.1006/anbe.1993.1215; Szykman M, 2003, AGGRESSIVE BEHAV, V29, P457, DOI 10.1002/ab.10065; Whittingham LA, 2002, ANIM BEHAV, V63, P63, DOI 10.1006/anbe.2001.1889; YALCINKAYA TM, 1993, SCIENCE, V260, P1929, DOI 10.1126/science.8391165	27	134	138	3	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 27	2006	440	7088					1190	1193		10.1038/nature04540	http://dx.doi.org/10.1038/nature04540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641996				2022-12-24	WOS:000237080000045
J	Navarro, L; Dunoyer, P; Jay, F; Arnold, B; Dharmasiri, N; Estelle, M; Voinnet, O; Jones, JDG				Navarro, L; Dunoyer, P; Jay, F; Arnold, B; Dharmasiri, N; Estelle, M; Voinnet, O; Jones, JDG			A plant miRNA contributes to antibacterial resistance by repressing auxin signaling	SCIENCE			English	Article							BOX PROTEIN TIR1; PSEUDOMONAS-SYRINGAE; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; MICRORNAS; IDENTIFICATION; RECEPTOR; DICER-LIKE-4; SUPPRESSORS; BIOGENESIS	Plants and animals activate defenses after perceiving pathogen-associated molecular patterns (PAMPs) such as bacterial flagellin. In Arabidopsis, perception of flagellin increases resistance to the bacterium Pseudomonas syringae, although the molecular mechanisms involved remain elusive. Here, we show that a flagellin-derived peptide induces a plant microRNA (miRNA) that negatively regulates messenger RNAs for the F-box auxin receptors TIR1, AFB2, and AFB3. Repression of auxin signaling restricts P. syringae growth, implicating auxin in disease susceptibility and miRNA-mediated suppression of auxin signaling in resistance.	CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France; John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Indiana University System; Indiana University Bloomington	Voinnet, O (corresponding author), CNRS, Inst Biol Mol Plantes, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	olivier.voinnet@ibmp-ulp.u-strasbg.fr; jonathan.jones@sainsbury-laboratory.ac.uk	Estelle, Mark/ABD-6742-2021; Jones, Jonathan DG/J-5129-2012	Jones, Jonathan DG/0000-0002-4953-261X; Voinnet, Olivier/0000-0001-6982-9544; JAY, Florence/0000-0001-7353-8299				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Glickmann E, 1998, MOL PLANT MICROBE IN, V11, P156, DOI 10.1094/MPMI.1998.11.2.156; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Gustafson AM, 2005, NUCLEIC ACIDS RES, V33, pD637, DOI 10.1093/nar/gki127; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; O'Donnell PJ, 2003, PLANT J, V33, P245, DOI 10.1046/j.1365-313X.2003.01619.x; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; YAMADA T, 1991, MOLECULAR STRATEGIES OF PATHOGENS AND HOST PLANTS, P83	26	1281	1408	9	274	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 21	2006	312	5772					436	439		10.1126/science.1126088	http://dx.doi.org/10.1126/science.1126088			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16627744				2022-12-24	WOS:000236941800050
J	Williams, D; Baverstock, K				Williams, D; Baverstock, K			Too soon for a final diagnosis	NATURE			English	Editorial Material							BOMB SURVIVORS; CANCER-RISKS; RADIATION; CHERNOBYL		Strangeways Res Lab, Thyroid Carcinogenesis Res Grp, Cambridge CB1 8RN, England; Univ Kuopio, Dept Environm Sci, FIN-70211 Kuopio, Finland	University of Eastern Finland	Williams, D (corresponding author), Strangeways Res Lab, Thyroid Carcinogenesis Res Grp, Worts Causeway, Cambridge CB1 8RN, England.							BAVERSTOCK K, 1992, NATURE, V359, P21, DOI 10.1038/359021b0; Brenner DJ, 2006, RADIAT ENVIRON BIOPH, V44, P253, DOI 10.1007/s00411-006-0029-4; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; *INT AT EN AG, 1991, INT CHERN PROJ TECH; KAZAKOV VS, 1992, NATURE, V359, P21, DOI 10.1038/359021a0; PUKKALA E, 2006, INT J CANC; SHIMIZU Y, 1992, RADIAT RES, V130, P249, DOI 10.2307/3578283; THOMPSON DE, 1994, RADIAT RES, V137, pS17, DOI 10.2307/3578892; Williams D, 2002, NAT REV CANCER, V2, P543, DOI 10.1038/nrc845	9	19	20	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 20	2006	440	7087					993	994		10.1038/440993a	http://dx.doi.org/10.1038/440993a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	034DL	16625177				2022-12-24	WOS:000236906000017
J	Laxminarayan, R; Mills, AJ; Breman, JG; Measham, AR; Alleyne, G; Claeson, M; Jha, P; Musgrove, P; Chow, J; Shahid-Salles, S; Jamison, DT				Laxminarayan, R; Mills, AJ; Breman, JG; Measham, AR; Alleyne, G; Claeson, M; Jha, P; Musgrove, P; Chow, J; Shahid-Salles, S; Jamison, DT			Advancement of global health: key messages from the Disease Control Priorities Project	LANCET			English	Article							ANTIMICROBIAL RESISTANCE; DEVELOPING-COUNTRIES	The Disease Control Priorities Project (DCPP), a joint project of the Fogarty International Center of the US National Institutes of Health, the WHO, and The World Bank, was launched in 2001 to identify policy changes and intervention strategies for the health problems of low-income and middle-income countries. Nearly 500 experts worldwide compiled and reviewed the scientific research on a broad range of diseases and conditions, the results of which are published this week. A major product of DCPP, Disease Control Priorities in Developing Countries, 2nd edition (DCP2), focuses on the assessment of the cost-effectiveness of health-improving strategies (or interventions) for the conditions responsible for the greatest burden of disease. DCP2 also examines crosscutting issues crucial to the delivery of quality health services, including the organisation, financial support, and capacity of health systems. Here, we summarise the key messages of the project.	Resources Future Inc, Washington, DC 20036 USA; London Sch Hyg & Trop Med, London WC1, England; NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; Pan Amer Hlth Org, Washington, DC USA; World Bank, Washington, DC 20433 USA; Univ Toronto, Toronto, ON, Canada; St Michaels Hosp, McLaughlin Ctr Mol Med, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada; Global Hlth, Hlth Affairs, Bethesda, MD USA; Populat Reference Bur, Washington, DC USA	Resources for the Future; University of London; London School of Hygiene & Tropical Medicine; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Pan American Health Organization; The World Bank; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Laxminarayan, R (corresponding author), Resources Future Inc, 1616 P St NW Suite 600, Washington, DC 20036 USA.	ramanan@rff.org	Laxminarayan, Ramanan/ABD-5050-2021	Mills, Anne/0000-0001-9863-9950				Becker G. S., 2003, AM ECON REV, V95, P277; Bourguignon F, 2002, AM ECON REV, V92, P727, DOI 10.1257/00028280260344443; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Creese A, 2002, LANCET, V359, P1635, DOI 10.1016/S0140-6736(02)08595-1; Deaton A, 2004, 10669 NAT BUR EC RES; Easterlin R. A, 1996, GROWTH TRIUMPHANT 21; JAMISON D, 2004, WHY INFANT MORTALITY, P21; Jamison D.T., 1993, DIS CONTROL PRIORITI; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jamison DT, 2006, PRIORITIES HLTH; Levine R, 2004, WHAT WORKS WORKING G; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; MASON JB, 2003, 1 DCPP; Mulligan J, 2003, 9 DCPP; Okeke IN, 2005, LANCET INFECT DIS, V5, P568, DOI 10.1016/S1473-3099(05)70217-6; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; World Bank, 1993, WORLD DEV REP INV HL	17	208	211	0	29	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2006	367	9517					1193	1208		10.1016/S0140-6736(06)68440-7	http://dx.doi.org/10.1016/S0140-6736(06)68440-7			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZH	16616562				2022-12-24	WOS:000236673400028
J	Ding, QJ; Hesketh, T				Ding, Qu Jian; Hesketh, Therese			Family size, fertility preferences, and sex ratio in China in the era of the one child family policy: results from national family planning and reproductive health survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BIRTHS	Objectives To examine the impact of the one child family policy in China on fertility, preferred family size, and sex ratio. Design Secondary analysis of data from the Chinese cross sectional national family planning and reproductive health survey, 2001. Interviews of representative sample of women aged 15-49. Results Data were obtained from 39 585 women, with a total of 73202 pregnancies and 56 830 live births. The average fertility rate in women over 35 (n = 17 078) was 1.94 (2.1 in rural areas and 1.4 in urban areas) and for women under 35 (n = 11543) 1.73 (1.25 and 1.79). Smaller families were associated with younger age, higher level of education, and living in an urban area. The male to female ratio was 1.15 and rose from 1.11 in 1980-9 to 1.23 for 1996-2001. Most women wanted small families: 35% preferred one child and 57% preferred two. Conclusion Since the one child family policy began, the total birth rate and preferred family size have decreased, and a gross imbalance in the sex ratio has emerged.	Inst Child Hlth, Ctr Int Child Hlth, London WC1N 1EH, England; Zhejiang Univ, Inst Populat Studies, Hangzhou 310012, Peoples R China	University of London; University College London; Zhejiang University	Hesketh, T (corresponding author), Inst Child Hlth, Ctr Int Child Hlth, 30 Guilford St, London WC1N 1EH, England.	t.hesketh@ich.ucl.ac.uk		Hesketh, Therese/0000-0002-7564-9221				Bogg L, 1998, AM J PUBLIC HEALTH, V88, P649, DOI 10.2105/AJPH.88.4.649; COALE AJ, 1994, DEMOGRAPHY, V31, P459, DOI 10.2307/2061752; Davis DL, 1998, JAMA-J AM MED ASSOC, V279, P1018, DOI 10.1001/jama.279.13.1018; Goodkind DM, 2004, POP STUD-J DEMOG, V58, P281, DOI 10.1080/0032472042000272348; GREENHALGH S, 1987, SCIENCE, V235, P1167, DOI 10.1126/science.3823877; Gu B, 1995, Asia Pac Popul J, V10, P17; Hesketh T, 2005, NEW ENGL J MED, V353, P1171, DOI 10.1056/NEJMhpr051833; Li JH, 2004, SOC SCI MED, V59, P695, DOI 10.1016/j.socscimed.2003.11.041; Merli MG, 2000, DEMOGRAPHY, V37, P109, DOI 10.2307/2648100; PEABODY JW, 1992, AM J PERINAT, V9, P401, DOI 10.1055/s-2007-999275; Retherford RD, 2005, POPUL DEV REV, V31, P57, DOI 10.1111/j.1728-4457.2005.00052.x; Sen A, 2003, BMJ-BRIT MED J, V327, P1297, DOI 10.1136/bmj.327.7427.1297; *UNDP, 2003, HUM DEV IND WORLD DE; Winckler EA, 2002, POPUL DEV REV, V28, P379, DOI 10.1111/j.1728-4457.2002.00379.x; *WORLD BANK HLTH N, DEV DAT 2004; YAO XW, 1994, BASIC DATA CHINAS PO; Zhu WX, 2003, ARCH DIS CHILD, V88, P463, DOI 10.1136/adc.88.6.463	17	107	109	5	91	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2006	333	7564					371	373		10.1136/bmj.38775.672662.80	http://dx.doi.org/10.1136/bmj.38775.672662.80			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	078OD	16690642	Green Published			2022-12-24	WOS:000240112200015
J	Baroni, SS; Santillo, M; Bevilacqua, F; Luchetti, M; Spadoni, T; Mancini, M; Fraticelli, P; Sambo, P; Funaro, A; Kazlauskas, A; Avvedimento, EV; Gabrielli, A				Baroni, Silvia Svegliati; Santillo, Mariarosaria; Bevilacqua, Federica; Luchetti, Michele; Spadoni, Tatiana; Mancini, Matteo; Fraticelli, Paolo; Sambo, Paola; Funaro, Ada; Kazlauskas, Andrius; Avvedimento, Enrico V.; Gabrielli, Armando			Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GROWTH-FACTOR; FIBROBLAST PHENOTYPE; REVISED CRITERIA; SCLERODERMA; CLASSIFICATION; GENERATION; OXIDATION	Background: Systemic sclerosis (scleroderma) is characterized by immunologic abnormalities, injury of endothelial cells, and tissue fibrosis. Abnormal oxidative stress has been documented in scleroderma and linked to fibroblast activation. Since platelet-derived growth factor (PDGF) stimulates the production of reactive oxygen species (ROS) and since IgG from patients with scleroderma reacts with human fibroblasts, we tested the hypothesis that patients with scleroderma have serum autoantibodies that stimulate the PDGF receptor (PDGFR), activating collagen-gene expression. Methods: We analyzed serum from 46 patients with scleroderma and 75 controls, including patients with other autoimmune diseases, for stimulatory autoantibodies to PDGFR by measuring the production of ROS produced by the incubation of purified IgG with mouse-embryo fibroblasts carrying inactive copies of PDGFR (alpha) or (beta) chains or the same cells expressing PDGFR (alpha) or (beta). Generation of ROS was assayed with and without specific PDGFR inhibitors. Antibodies were characterized by immunoprecipitation, immunoblotting, and absorption experiments. Results: Stimulatory antibodies to the PDGFR were found in all the patients with scleroderma. The antibodies recognized native PDGFR, inducing tyrosine phosphorylation and ROS accumulation. Autoantibody activity was abolished by preincubation with cells expressing the PDGFR (alpha) chain or with recombinant PDGFR or by PDGFR tyrosine kinase inhibitors. Stimulatory PDGFR antibodies selectively induced the Ha-Ras-ERK1/2 and ROS cascades and stimulated type I collagen-gene expression and myofibroblast phenotype conversion in normal human primary fibroblasts. Conclusions: Stimulatory autoantibodies against PDGFR appear to be a specific hallmark of scleroderma. Their biologic activity on fibroblasts strongly suggests that they have a causal role in the pathogenesis of the disease.	Univ Politecn Marche, Dipartimento Sci Med & Chirurg, Sez Clin Med, I-60020 Ancona, Italy; Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA USA; Univ Turin, Dipartimento Genet Biol & Biochim, Turin, Italy; Univ Turin, Res Ctr Expt Med, Turin, Italy; Univ Naples Federico II, Dipartimento Biol & Patol Mol & Cellulare, CNR, Ctr Endocrinol & Oncol Sperimentale, Naples, Italy; Univ Naples Federico II, Sez Fisiol, Naples, Italy	Marche Polytechnic University; Harvard University; Harvard Medical School; Schepens Eye Research Institute; University of Turin; University of Turin; Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; University of Naples Federico II	Gabrielli, A (corresponding author), Univ Politecn Marche, Dipartimento Sci Med & Chirurg, Sez Clin Med, Polo Didattico,Via Tronto 10, I-60020 Ancona, Italy.	avvedim@unina.it; a.gabrielli@univpm.it	Svegliati, Silvia/L-2614-2016; Gabrielli, Armando/AAC-3173-2019; Funaro, Ada/AAC-3203-2019; Luchetti, Michele Maria/J-6955-2019; fraticelli, paolo/AAN-1803-2020	Svegliati, Silvia/0000-0001-6863-2600; Luchetti, Michele Maria/0000-0001-9132-7401; Fraticelli, Paolo/0000-0001-8220-9593; Funaro, Ada/0000-0001-6341-1817	NATIONAL EYE INSTITUTE [R01EY012509] Funding Source: NIH RePORTER; NEI NIH HHS [EY012509] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		*AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; Andrews A, 1999, INVEST OPHTH VIS SCI, V40, P2683; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Black CM, 1993, OXFORD TXB RHEUMATOL, P771; BRUCKDORFER KR, 1995, ARTHRITIS RHEUM-US, V38, P1060, DOI 10.1002/art.1780380807; CasciolaRosen L, 1997, J EXP MED, V185, P71, DOI 10.1084/jem.185.1.71; Chizzolini C, 2002, ARTHRITIS RHEUM-US, V46, P1602, DOI 10.1002/art.10361; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Jimenez SA, 2004, ANN INTERN MED, V140, P37, DOI 10.7326/0003-4819-140-1-200401060-00010; LEROY EC, 1988, J RHEUMATOL, V15, P202; LEROY EC, 1992, CLIN EXP RHEUMATOL, V10, P485; POLLARD TD, 2004, CELL BIOL, P394; Sambo P, 2001, ARTHRITIS RHEUM-US, V44, P2653, DOI 10.1002/1529-0131(200111)44:11<2653::AID-ART445>3.0.CO;2-1; Sambo P, 1999, J INVEST DERMATOL, V112, P78, DOI 10.1046/j.1523-1747.1999.00476.x; Steen VD, 1996, SYSTEMIC SCLEROSIS, P51; Stein CM, 1996, ARTHRITIS RHEUM-US, V39, P1146, DOI 10.1002/art.1780390711; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Svegliati S, 2005, J BIOL CHEM, V280, P36474, DOI 10.1074/jbc.M502851200	19	439	457	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2006	354	25					2667	2676						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	054ZJ	16790699				2022-12-24	WOS:000238416900005
J	Deplancke, B; Mukhopadhyay, A; Ao, WY; Elewa, AM; Grove, CA; Martinez, NJ; Sequerra, R; Doucette-Stamm, L; Reece-Hoyes, JS; Hope, IA; Tissenbaum, HA; Mango, SE; Walhout, AJM				Deplancke, Bart; Mukhopadhyay, Arnab; Ao, Wanyuan; Elewa, Ahmed M.; Grove, Christian A.; Martinez, Natalia J.; Sequerra, Reynaldo; Doucette-Stamm, Lynn; Reece-Hoyes, John S.; Hope, Ian A.; Tissenbaum, Heidi A.; Mango, Susan E.; Walhout, Albertha J. M.			A gene-centered C. elegans protein-DNA interaction network	CELL			English	Article							CAENORHABDITIS-ELEGANS; TRANSCRIPTIONAL REGULATION; BINDING SPECIFICITIES; REGULATORY NETWORKS; GENOMIC ANALYSIS; LIFE-SPAN; EXPRESSION; RESOURCE; COMPLEX; TARGETS	Transcription regulatory networks consist of physical and functional interactions between transcription factors (TFs) and their target genes. The systematic mapping of TF-target gene interactions has been pioneered in unicellular systems, using "TF-centered" methods (e.g., chromatin immunoprecipitation). However, metazoan systems are less amenable to such methods. Here, we used "gene-centered" high-throughput yeast one-hybrid (Y1 H) assays to identify 283 interactions between 72 C. elegans digestive tract gene promoters and 117 proteins. The resulting protein-DNA interaction (PDI) network is highly connected and enriched for TFs that are expressed in the digestive tract. We provide functional annotations for similar to 10% of all worm TFs, many of which were previously uncharacterized, and find ten novel putative TFs, illustrating the power of a gene-centered approach. We provide additional in vivo evidence for multiple PDIs and illustrate how the PDI network provides insights into metazoan differential gene expression at a systems level.	Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; Agencourt Biosci Corp, Beverly, MA 01915 USA; Univ Leeds, Sch Biol, Fac Biol Sci, Inst Integrat & Comparat Biol, Leeds LS2 9JT, W Yorkshire, England	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Leeds	Deplancke, B (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	marian.walhout@umassmed.edu	Deplancke, Bart/B-3250-2008; Hope, Ian/M-4186-2018; Reece-Hoyes, John/B-2321-2008; Mukhopadhyay, Arnab/N-6005-2016; Rosa, Bruce/F-6393-2010	Hope, Ian/0000-0002-8990-3163; Mukhopadhyay, Arnab/0000-0002-5266-7849; Elewa, Ahmed/0000-0002-1988-7970; Mango, Susan/0000-0002-2146-3237; Reece-Hoyes, John/0000-0001-5251-5813; Deplancke, Bart/0000-0001-9935-843X; Grove, Christian/0000-0001-9076-6015; Walhout, Marian/0000-0001-5587-3608	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025891] Funding Source: NIH RePORTER; NIA NIH HHS [AG025891] Funding Source: Medline; NIDDK NIH HHS [DK068429] Funding Source: Medline; NIGMS NIH HHS [R01 GM056264-08, R01 GM056264-10, R01 GM056264, R01 GM056264-09, GM056246, R01 GM056264-08S1] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ao W, 2004, SCIENCE, V305, P1743, DOI 10.1126/science.1102216; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chen NS, 2005, NUCLEIC ACIDS RES, V33, pD383, DOI 10.1093/nar/gki066; Davidson E, 2005, P NATL ACAD SCI USA, V102, P4935, DOI 10.1073/pnas.0502024102; Deplancke B, 2004, GENOME RES, V14, P2093, DOI 10.1101/gr.2445504; Dupuy D, 2004, GENOME RES, V14, P2169, DOI 10.1101/gr.2497604; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Gaudet J, 2004, PLOS BIOL, V2, P1828, DOI 10.1371/journal.pbio.0020352; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; Hall DA, 2004, SCIENCE, V306, P482, DOI 10.1126/science.1096773; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; Labouesse M, 1999, TRENDS GENET, V15, P307, DOI 10.1016/S0168-9525(99)01750-3; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; LI JJ, 1993, SCIENCE, V262, P1870, DOI 10.1126/science.8266075; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Maduro MF, 2002, DEV BIOL, V246, P68, DOI 10.1006/dbio.2002.0655; MANGO SE, 1994, DEVELOPMENT, V120, P3019; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Mukhopadhyay A, 2005, CELL METAB, V2, P35, DOI 10.1016/j.cmet.2005.06.004; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Patterson GI, 1997, GENE DEV, V11, P2679, DOI 10.1101/gad.11.20.2679; Patterson GI, 2003, CURR BIOL, V13, pR279, DOI 10.1016/S0960-9822(03)00201-X; Pauli F, 2006, DEVELOPMENT, V133, P287, DOI 10.1242/dev.02185; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Schwenger GTF, 2001, J BIOL CHEM, V276, P48502, DOI 10.1074/jbc.M107836200; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Thatcher JD, 1999, DEVELOPMENT, V126, P97; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Wang J, 2003, DEVELOPMENT, V130, P1621, DOI 10.1242/dev.00363; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008	48	168	194	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2006	125	6					1193	1205		10.1016/j.cell.2006.04.038	http://dx.doi.org/10.1016/j.cell.2006.04.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777607	Bronze			2022-12-24	WOS:000238602700022
J	Graham, RK; Deng, Y; Slow, EJ; Haigh, B; Bissada, N; Lu, G; Pearson, J; Shehadeh, J; Bertram, L; Murphy, Z; Warby, SC; Doty, CN; Roy, S; Wellinpton, CL; Leavitt, BR; Raymond, LA; Nicholson, DW; Hayden, MR				Graham, Rona K.; Deng, Yu; Slow, Elizabeth J.; Haigh, Brendan; Bissada, Nagat; Lu, Ge; Pearson, Jacqueline; Shehadeh, Jacqueline; Bertram, Lisa; Murphy, Zoe; Warby, Simon C.; Doty, Crystal N.; Roy, Sophie; Wellinpton, Cheryl L.; Leavitt, Blair R.; Raymond, Lynn A.; Nicholson, Donald W.; Hayden, Michael R.			Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin	CELL			English	Article							YAC128 MOUSE MODEL; WILD-TYPE HUNTINGTIN; INTRANUCLEAR INCLUSIONS; NUCLEAR-LOCALIZATION; 3-NITROPROPIONIC ACID; REDUCES TOXICITY; IN-VIVO; DISEASE; MICE; NEURODEGENERATION	Cleavage of huntingtin (htt) has been characterized in vitro, and accumulation of caspase cleavage fragments represents an early pathological change in brains of Huntington's disease (HD) patients. However, the relationship between htt proteolysis and the pathogenesis of HD is unknown. To determine whether caspase cleavage of htt is a key event in the neuronal dysfunction and selective neurodegeneration in HID, we generated YAC mice expressing caspase-3- and caspase-6- resistant mutant htt. Mice expressing mutant htt, resistant to cleavage by caspase-6 but not caspase-3, maintain normal neuronal function and do not develop striatal neurodegeneration. Furthermore, caspase-6-resistant mutant htt mice are protected against neurotoxicity induced by multiple stressors including NMDA, quinolinic acid (QA), and staurosporine. These results are consistent with proteolysis of htt at the caspase-6 cleavage site being an important event in mediating neuronal dysfunction and neurodegeneration and highlight the significant role of htt proteolysis; and excitotoxicity in HID.	Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada; Univ British Columbia, Dept Psychiat, Vancouver, BC V5Z 4H4, Canada; Univ British Columbia, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; Merck Res Labs, Whitehouse Stn, NJ 08889 USA	University of British Columbia; University of British Columbia; Child & Family Research Institute; University of British Columbia; Merck & Company	Graham, RK (corresponding author), Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada.	mrh@cmmt.ubc.ca	Graham, Rona K/R-7358-2018; Leavitt, Blair R/G-1934-2012; Raymond, Lynn A/A-6664-2010; Hayden, Michael R/D-8581-2011; Raymond, Lynn A./R-6707-2016	Graham, Rona K/0000-0003-3722-6241; Raymond, Lynn A/0000-0002-8610-1042; Hayden, Michael R/0000-0001-5159-1419; Raymond, Lynn A./0000-0002-8610-1042; leavitt, Blair/0000-0002-4532-766X				ALBIN RL, 1990, NEW ENGL J MED, V322, P1293, DOI 10.1056/NEJM199005033221807; ALBIN RL, 1992, ANN NEUROL, V31, P425, DOI 10.1002/ana.410310412; Auerbach W, 2001, HUM MOL GENET, V10, P2515, DOI 10.1093/hmg/10.22.2515; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; Bizat N, 2005, NEUROPHARMACOLOGY, V49, P695, DOI 10.1016/j.neuropharm.2005.04.030; Bizat N, 2003, J BIOL CHEM, V278, P43245, DOI 10.1074/jbc.M305057200; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Graham RK, 2006, NEUROBIOL DIS, V21, P444, DOI 10.1016/j.nbd.2005.08.007; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hackam AS, 1998, J CELL BIOL, V141, P1097, DOI 10.1083/jcb.141.5.1097; Hansson O, 1999, P NATL ACAD SCI USA, V96, P8727, DOI 10.1073/pnas.96.15.8727; Hermel E, 2004, CELL DEATH DIFFER, V11, P424, DOI 10.1038/sj.cdd.4401358; Hodgson JG, 1996, HUM MOL GENET, V5, P1875, DOI 10.1093/hmg/5.12.1875; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Jarabek BR, 2004, BRAIN, V127, P505, DOI 10.1093/brain/awh058; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Leavitt BR, 2006, J NEUROCHEM, V96, P1121, DOI 10.1111/j.1471-4159.2005.03605.x; Levine MS, 1999, J NEUROSCI RES, V58, P515, DOI 10.1002/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Ordway JM, 1997, CELL, V91, P753, DOI 10.1016/S0092-8674(00)80464-X; Rigamonti D, 2001, J BIOL CHEM, V276, P14545, DOI 10.1074/jbc.C100044200; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Shehadeh J, 2006, NEUROBIOL DIS, V21, P392, DOI 10.1016/j.nbd.2005.08.001; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P1379, DOI 10.1093/hmg/ddi147; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P3823, DOI 10.1093/hmg/ddi407; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wellington CL, 2000, J BIOL CHEM, V275, P19831, DOI 10.1074/jbc.M001475200; Wellington CL, 1998, J BIOL CHEM, V273, P9158, DOI 10.1074/jbc.273.15.9158; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Yu ZX, 2003, J NEUROSCI, V23, P2193; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3; Zeron MM, 2001, MOL CELL NEUROSCI, V17, P41, DOI 10.1006/mcne.2000.0909; Zhang YU, 2003, J NEUROCHEM, V87, P101, DOI 10.1046/j.1471-4159.2003.01980.x	39	488	508	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2006	125	6					1179	1191		10.1016/j.cell.2006.04.026	http://dx.doi.org/10.1016/j.cell.2006.04.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777606	Bronze			2022-12-24	WOS:000238602700021
J	Steinbrook, R				Steinbrook, Robert			New technology, old dilemma - Monitoring EEG activity during executions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						[Anonymous], 2006, ANESTHESIOLOGY, V104, P847; Gawande A, 2006, NEW ENGL J MED, V354, P1221, DOI 10.1056/NEJMp068042; Koniaris LG, 2005, LANCET, V365, P1412, DOI 10.1016/S0140-6736(05)66377-5; Mendoza Moises, 2006, LOS ANGELES TIM 0428, pB1; Zimmerman Rachel, 2005, Wall St J (East Ed), pB5	5	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 15	2006	354	24					2525	2527		10.1056/NEJMp068117	http://dx.doi.org/10.1056/NEJMp068117			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052KU	16775232				2022-12-24	WOS:000238233400001
J	Lake, RA; van der Most, RG				Lake, RA; van der Most, RG			A better way for a cancer cell to die	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHEMOTHERAPY		Univ Western Australia, Perth, WA 6009, Australia	University of Western Australia	Lake, RA (corresponding author), Univ Western Australia, Perth, WA 6009, Australia.							Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Lake RA, 2005, NAT REV CANCER, V5, P397, DOI 10.1038/nrc1613; Scheffer SR, 2003, INT J CANCER, V103, P205, DOI 10.1002/ijc.10777; van Ruth S, 2003, ANN SURG ONCOL, V10, P176, DOI 10.1245/ASO.2003.03.022	4	49	55	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2006	354	23					2503	2504		10.1056/NEJMcibr061443	http://dx.doi.org/10.1056/NEJMcibr061443			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	050PQ	16760453				2022-12-24	WOS:000238100800016
J	Martin, DR; Semelka, R				Martin, DR; Semelka, R			Health effects of ionising radiation from diagnostic CT	LANCET			English	Editorial Material									Emory Univ, Sch Med, Dept Radiol, Atlanta, GA 30322 USA; Univ N Carolina, Dept Radiol, Chapel Hill, NC USA	Emory University; University of North Carolina; University of North Carolina Chapel Hill	Martin, DR (corresponding author), Emory Univ, Sch Med, Dept Radiol, Atlanta, GA 30322 USA.	dmartin@emory.edu						*COMM ASS HLTH RIS, 2005, BEIR 7 HLTH RISKS EX; Katz SI, 2006, AM J ROENTGENOL, V186, P1120, DOI 10.2214/AJR.04.1838; Lee CI, 2004, RADIOLOGY, V231, P393, DOI 10.1148/radiol.2312030767; Linton OW, 2003, AM J ROENTGENOL, V181, P321, DOI 10.2214/ajr.181.2.1810321; Lobrich M, 2005, P NATL ACAD SCI USA, V102, P8984, DOI 10.1073/pnas.0501895102; Lynch DA, 2005, RADIOLOGY, V236, P10, DOI 10.1148/radiol.2361031674; MARTIN DR, 2005, ABDOMINAL PELVIC MRI; MARTIN DR, 2005, MAGN RESON IMAGING C, V13, P211; Morcos SK, 2005, J VASC INTERV RADIOL, V16, P13, DOI 10.1097/01.RVI.0000145224.02920.C2; Parker MS, 2005, AM J ROENTGENOL, V185, P1228, DOI 10.2214/AJR.04.0770; ULRICH H, 1946, NEW ENGL J MED, V234, P742	11	68	69	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY-JUN	2006	367	9524					1712	1714		10.1016/S0140-6736(06)68748-5	http://dx.doi.org/10.1016/S0140-6736(06)68748-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047BE	16731253				2022-12-24	WOS:000237854000008
J	Uehara, T; Nakamura, T; Yao, DD; Shi, ZQ; Gu, ZZ; Ma, YL; Masliah, E; Nomura, Y; Lipton, SA				Uehara, Takashi; Nakamura, Tomohiro; Yao, Dongdong; Shi, Zhong-Qing; Gu, Zezong; Ma, Yuliang; Masliah, Eliezer; Nomura, Yasuyuki; Lipton, Stuart A.			S-Nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration	NATURE			English	Article							ENDOPLASMIC-RETICULUM STRESS; APOPTOTIC CELL-DEATH; PARKINSONS-DISEASE; NITRIC-OXIDE; PATHWAY; THIOREDOXIN; POLYPEPTIDE; ISCHEMIA; CULTURES	Stress proteins located in the cytosol or endoplasmic reticulum (ER) maintain cell homeostasis and afford tolerance to severe insults(1-3). In neurodegenerative diseases, several chaperones ameliorate the accumulation of misfolded proteins triggered by oxidative or nitrosative stress, or of mutated gene products(4,5). Although severe ER stress can induce apoptosis(2,6), the ER withstands relatively mild insults through the expression of stress proteins or chaperones such as glucose-regulated protein (GRP) and protein-disulphide isomerase (PDI), which assist in the maturation and transport of unfolded secretory proteins. PDI catalyses thiol-disulphide exchange, thus facilitating disulphide bond formation and rearrangement reactions(7-10). PDI has two domains that function as independent active sites with homology to the small, redox-active protein thioredoxin(7,8). During neurodegenerative disorders and cerebral ischaemia, the accumulation of immature and denatured proteins results in ER dysfunction(11), but the upregulation of PDI represents an adaptive response to protect neuronal cells(12-14). Here we show, in brains manifesting sporadic Parkinson's or Alzheimer's disease, that PDI is S-nitrosylated, a reaction transferring a nitric oxide (NO) group to a critical cysteine thiol to affect protein function(15-18). NO-induced S-nitrosylation of PDI inhibits its enzymatic activity, leads to the accumulation of polyubiquitinated proteins, and activates the unfolded protein response. S-Nitrosylation also abrogates PDI-mediated attenuation of neuronal cell death triggered by ER stress, misfolded proteins or proteasome inhibition. Thus, PDI prevents neurotoxicity associated with ER stress and protein misfolding, but NO blocks this protective effect in neurodegenerative disorders through the S-nitrosylation of PDI.	Burnham Inst Med Res, Ctr Neurosci & Aging, La Jolla, CA 92037 USA; Burnham Inst Med Res, Proteom Facil, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sapporo, Hokkaido 0600812, Japan	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; Hokkaido University	Lipton, SA (corresponding author), Burnham Inst Med Res, Ctr Neurosci & Aging, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	slipton@burnham.org		Uehara, Takashi/0000-0002-8545-4006; Lipton, Stuart/0000-0002-3490-1259				Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Conn KJ, 2004, BRAIN RES, V1022, P164, DOI 10.1016/j.brainres.2004.07.026; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Gilbert HF, 1998, METHOD ENZYMOL, V290, P26, DOI 10.1016/S0076-6879(98)90005-2; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Haendeler J, 2002, NAT CELL BIOL, V4, P743, DOI 10.1038/ncb851; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Hu BR, 2000, J NEUROSCI, V20, P3191, DOI 10.1523/JNEUROSCI.20-09-03191.2000; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Ko HS, 2002, J BIOL CHEM, V277, P35386, DOI 10.1074/jbc.M203412200; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Murakami T, 2004, ANN NEUROL, V55, P439, DOI 10.1002/ana.20064; Nishikawa A, 2004, BIOCHEM BIOPH RES CO, V318, P435, DOI 10.1016/j.bbrc.2004.04.048; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Sliskovic I, 2005, J BIOL CHEM, V280, P8733, DOI 10.1074/jbc.M408080200; SONG JL, 1995, EUR J BIOCHEM, V231, P312, DOI 10.1111/j.1432-1033.1995.tb20702.x; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Tanaka S, 2000, J BIOL CHEM, V275, P10388, DOI 10.1074/jbc.275.14.10388; VUORI K, 1992, J BIOL CHEM, V267, P7211; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101	30	722	745	1	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					513	517		10.1038/nature04782	http://dx.doi.org/10.1038/nature04782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724068				2022-12-24	WOS:000237778900051
J	Friedman, WE				Friedman, WE			Embryological evidence for developmental lability during early angiosperm evolution	NATURE			English	Article							BASAL ANGIOSPERMS; PHYLOGENETIC ANALYSES; FEMALE GAMETOPHYTE; FLORAL STRUCTURES; FLOWERING PLANTS; LINEAGES; GENES; AUSTROBAILEYALES; MITOCHONDRIAL; ORIGIN	Recent advances in angiosperm phylogeny reconstruction(1-3), palaeobotany(4,5) and comparative organismic biology(6-8) have provided the impetus for a major re-evaluation of the earliest phases of the diversification of flowering plants. We now know that within the first fifteen million years of angiosperm history, three major lineages of flowering plants - monocotyledons, eumagnoliids and eudicotyledons - were established(5), and that within this window of time, tremendous variation in vegetative and floral characteristics evolved. Here I report on a novel type of embryo sac ( angiosperm female gametophyte or haploid egg-producing structure) in Amborella trichopoda, the sole member of the most ancient extant angiosperm lineage. This is the first new pattern of embryo sac structure to be discovered among angiosperms in well over half a century. This discovery also supports the emerging view(9-12) that the earliest phases of angiosperm evolution were characterized by an extensive degree of developmental experimentation and structural lability, and may provide evidence of a critical link to the gymnospermous ancestors of flowering plants.	Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Friedman, WE (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	ned@colorado.edu		Friedman, William Edward/0000-0003-0374-3427				Carlquist S, 2002, AM J BOT, V89, P185, DOI 10.3732/ajb.89.2.185; Crane PR, 2004, AM J BOT, V91, P1683, DOI 10.3732/ajb.91.10.1683; Cronquist A., 1988, EVOLUTION CLASSIFICA; Davis, 1966, SYSTEMATIC EMBRYOLOG; De Craene LPR, 2003, INT J PLANT SCI, V164, pS329, DOI 10.1086/377063; DONOGHUE MJ, 1992, ECOLOGY AND EVOLUTION OF PLANT REPRODUCTION, P356; Doyle JA, 2000, INT J PLANT SCI, V161, pS121, DOI 10.1086/317578; Endress PK, 2001, J EXP ZOOL, V291, P105, DOI 10.1002/jez.1063; Feild TS, 2003, INT J PLANT SCI, V164, pS129, DOI 10.1086/374193; Friedman WE, 2004, PLANT CELL, V16, pS119, DOI 10.1105/tpc.017277; Friedman WE, 2003, INT J PLANT SCI, V164, pS293, DOI 10.1086/376877; Friis EM, 2000, GRANA, V39, P226, DOI 10.1080/00173130052017262; Gifford EM, 1989, MORPHOLOGY EVOLUTION; Guo FL, 2004, PROTOPLASMA, V223, P111, DOI 10.1007/s00709-004-0045-7; HUANG BQ, 1992, INT REV CYTOL, V140, P233, DOI 10.1016/S0074-7696(08)61099-2; Johri, 1963, RECENT ADV EMBRYOLOG; Leebens-Mack J, 2005, MOL BIOL EVOL, V22, P1948, DOI 10.1093/molbev/msi191; Mathews S, 1999, SCIENCE, V286, P947, DOI 10.1126/science.286.5441.947; Parkinson CL, 1999, CURR BIOL, V9, P1485, DOI 10.1016/S0960-9822(00)80119-0; Porsch O., 1907, VERSUCH PHYLOGENETIS; Qiu YL, 2005, INT J PLANT SCI, V166, P815, DOI 10.1086/431800; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Schnarf K, 1931, VERGLEICHENDE EMBRYO; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Soltis PS, 2004, AM J BOT, V91, P1614, DOI 10.3732/ajb.91.10.1614; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Tobe H, 2000, J PLANT RES, V113, P271, DOI 10.1007/PL00013935; Williams JH, 2004, AM J BOT, V91, P332, DOI 10.3732/ajb.91.3.332; Williams JH, 2002, NATURE, V415, P522, DOI 10.1038/415522a; Zanis MJ, 2003, ANN MO BOT GARD, V90, P129, DOI 10.2307/3298579	30	78	82	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					337	340		10.1038/nature04690	http://dx.doi.org/10.1038/nature04690			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710419				2022-12-24	WOS:000237593200045
J	Kwok, TCY; Ricker, N; Fraser, R; Chan, AW; Burns, A; Stanley, EF; McCourt, P; Cutler, SR; Roy, PJ				Kwok, TCY; Ricker, N; Fraser, R; Chan, AW; Burns, A; Stanley, EF; McCourt, P; Cutler, SR; Roy, PJ			A small-molecule screen in C-elegans yields a new calcium channel antagonist	NATURE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; EGG-LAYING BEHAVIOR; SEROTONIN; MORPHOGENESIS; IMIPRAMINE; DOPAMINE; EGL-19; STATES; CCA-1	Small-molecule inhibitors of protein function are powerful tools for biological analysis(1) and can lead to the development of new drugs. However, a major bottleneck in generating useful small-molecule tools is target identification. Here we show that Caenorhabditis elegans can provide a platform for both the discovery of new bioactive compounds and target identification. We screened 14,100 small molecules for bioactivity in wild-type worms and identified 308 compounds that induce a variety of phenotypes. One compound that we named nemadipine-A induces marked defects in morphology and egg-laying. Nemadipine-A resembles a class of widely prescribed anti-hypertension drugs called the 1,4-dihydropyridines (DHPs) that antagonize the alpha(1)-subunit of L-type calcium channels(2,3). Through a genetic suppressor screen, we identified egl-19 as the sole candidate target of nemadipine-A, a conclusion that is supported by several additional lines of evidence. egl-19 encodes the only L-type calcium channel alpha(1)-subunit in the C. elegans genome(4,5). We show that nemadipine-A can also antagonize vertebrate L-type calcium channels, demonstrating that worms and vertebrates share the orthologous protein target. Conversely, FDA-approved DHPs fail to elicit robust phenotypes, making nemadipine-A a unique tool to screen for genetic interactions with this important class of drugs. Finally, we demonstrate the utility of nemadipine- A by using it to reveal redundancy among three calcium channels in the egg-laying circuit. Our study demonstrates that C. elegans enables rapid identification of new small-molecule tools and their targets.	Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 3E1, Canada; Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; Univ Toronto, Dept Bot, Toronto, ON M5S 3B2, Canada; Univ Toronto, Collaborat Program Dev Biol, Toronto, ON M5S 3G5, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5T 2S8, Canada; Univ Toronto, Toronto Western Res Inst, Toronto, ON M5T 2S8, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Roy, PJ (corresponding author), Univ Toronto, Dept Med Genet & Microbiol, 160 Coll St, Toronto, ON M5S 3E1, Canada.	peter.roy@utoronto.ca	Cutler, Sean R/D-6617-2011; Chan, Allen/AAF-4718-2020; Roy, Peter/G-5357-2014	Roy, Peter/0000-0003-2959-2276; Ricker, Nicole/0000-0001-5706-5399				BRENNER S, 1974, GENETICS, V77, P71; Dempsey CM, 2005, GENETICS, V169, P1425, DOI 10.1534/genetics.104.032540; Franks CJ, 2002, J NEUROPHYSIOL, V87, P954, DOI 10.1152/jn.00233.2001; Furukawa T, 1999, J PHARMACOL EXP THER, V291, P464; HARROLD M, 2002, FOYES PRINCIPLES MED, P533; Hockerman GH, 1997, ANNU REV PHARMACOL, V37, P361, DOI 10.1146/annurev.pharmtox.37.1.361; Jospin M, 2002, J CELL BIOL, V159, P337, DOI 10.1083/jcb.200203055; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; LEWIS JA, 1995, CAENORHABDITIS ELEGA; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; LOEV B, 1972, J PHARM PHARMACOL, V24, P917, DOI 10.1111/j.2042-7158.1972.tb08919.x; Mathews EA, 2003, J NEUROSCI, V23, P6537; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; PRIESS JR, 1986, DEV BIOL, V117, P156, DOI 10.1016/0012-1606(86)90358-1; Roy PJ, 2000, DEVELOPMENT, V127, P755; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Schafer WR, 1996, GENETICS, V143, P1219; Shtonda B, 2005, J EXP BIOL, V208, P2177, DOI 10.1242/jeb.01615; Shyn SI, 2003, CURR BIOL, V13, P1910, DOI 10.1016/j.cub.2003.10.025; STANLEY EF, 1990, P NATL ACAD SCI USA, V87, P9683, DOI 10.1073/pnas.87.24.9683; Steger KA, 2005, J EXP BIOL, V208, P2191, DOI 10.1242/jeb.01616; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; TRENT C, 1983, GENETICS, V104, P619; Waggoner LE, 1998, NEURON, V21, P203, DOI 10.1016/S0896-6273(00)80527-9; Weinshenker D, 1999, J NEUROSCI, V19, P9831; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086	28	217	236	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2006	441	7089					91	95		10.1038/nature04657	http://dx.doi.org/10.1038/nature04657			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16672971				2022-12-24	WOS:000237248600039
J	Trollope-Kumar, K; Guyatt, G				Trollope-Kumar, K; Guyatt, G			Syndromic approach for treatment of STIs: time for a change	LANCET			English	Editorial Material							SEXUALLY-TRANSMITTED INFECTIONS; VAGINAL DISCHARGE; LOW-PREVALENCE; WOMEN; MANAGEMENT		McMaster Univ, Dept Family Med, Hamilton, ON L8S 4L8, Canada; W End Clin, Hamilton, ON, Canada; McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	McMaster University; McMaster University	Trollope-Kumar, K (corresponding author), McMaster Univ, Dept Family Med, Hamilton, ON L8S 4L8, Canada.	kumarak@mcmaster.ca						Bogaerts J, 1999, SEX TRANSM INFECT, V75, P437, DOI 10.1136/sti.75.6.437; Chalamilla G, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-22; Desai VK, 2003, SEX TRANSM INFECT, V79, P111, DOI 10.1136/sti.79.2.111; Hawkes S, 1999, LANCET, V354, P1776, DOI 10.1016/S0140-6736(99)02463-0; Hawkes S, 2002, SEX TRANSM INFECT, V78, pI31, DOI 10.1136/sti.78.suppl_1.i31; Koenig M., 1998, Reproductive Health Matters, V6, P84, DOI 10.1016/S0968-8080(98)90085-4; Patel V, 2005, INT J EPIDEMIOL, V34, P853, DOI 10.1093/ije/dyi072; Pepin J, 2004, SEX TRANSM INFECT, V80, P230, DOI 10.1136/sti.2003.007534; Trollope-Kumar K, 2001, TROP MED INT HEALTH, V6, P260, DOI 10.1046/j.1365-3156.2001.00699.x	9	12	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2006	367	9520					1380	1381		10.1016/S0140-6736(06)68593-0	http://dx.doi.org/10.1016/S0140-6736(06)68593-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650635				2022-12-24	WOS:000237195600009
J	Gross, R; Webb, P				Gross, R; Webb, P			Wasting time for wasted children: severe child undernutrition must be resolved in non-emergency settings	LANCET			English	Editorial Material							COMPLEX EMERGENCIES		UNICEF, Nutr Sect, Program Div, New York, NY 10017 USA; Tufts Univ, Friedman Sch Nutr, Boston, MA 02111 USA	UNICEF; Tufts University	Webb, P (corresponding author), UNICEF, Nutr Sect, Program Div, New York, NY 10017 USA.	patrick.webb@tufts.edu	Webb, Patrick/P-3420-2017	Webb, Patrick/0000-0002-9857-3354				[Anonymous], 2004, 2004 REP GLOB AIDS E; *EM FOOD SEC NUTR, 2005, PROV REP; GILLESPIE S, 2005, P INT C HIV AIDS FOO; Salama P, 2004, LANCET, V364, P1801, DOI 10.1016/S0140-6736(04)17405-9; *UN, 2005, NIG 2005 MAY SEPT FL; *UNICEF, 2004, STAT WORLDS CHILDR; *UNICEF, 2003, DROUGHT HIV AIDS C 1; *WHO UNICEF UNHCR, 1999, FOOD NUTR NEEDS EM; *WORLD BANK, 2003, COMB MALN TIM ACT; Young H, 2004, LANCET, V364, P1899, DOI 10.1016/S0140-6736(04)17447-3	10	35	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2006	367	9517					1209	1211		10.1016/S0140-6736(06)68509-7	http://dx.doi.org/10.1016/S0140-6736(06)68509-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZH	16616563				2022-12-24	WOS:000236673400029
J	Sheppard, SS; Trujillo, CA				Sheppard, Scott S.; Trujillo, Chadwick A.			A thick cloud of Neptune Trojans and their colors	SCIENCE			English	Article							KUIPER-BELT OBJECTS; ESO LARGE PROGRAM; PHOTOMETRIC SURVEY; SIZE DISTRIBUTION; GIANT PLANETS; CENTAURS; CAPTURE; ORIGIN; MIGRATION; ACCRETION	The dynamical and physical properties of asteroids offer one of the few constraints on the formation, evolution, and migration of the giant planets. Trojan asteroids share a planet's semimajor axis but lead or follow it by about 60 degrees near the two triangular Lagrangian points of gravitational equilibrium. Here we report the discovery of a high-inclination Neptune Trojan, 2005 TN53. This discovery demonstrates that the Neptune Trojan population occupies a thick disk, which is indicative of "freeze-in'' capture instead of in situ or collisional formation. The Neptune Trojans appear to have a population that is several times larger than the Jupiter Trojans. Our color measurements show that Neptune Trojans have statistically indistinguishable slightly red colors, which suggests that they had a common formation and evolutionary history and are distinct from the classical Kuiper Belt objects.	Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; Gemini Observ, Hilo, HI 96720 USA	Carnegie Institution for Science	Sheppard, SS (corresponding author), Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	sheppard@dtm.ciw.edu		Trujillo, Chadwick/0000-0001-9859-0894				Barucci MA, 2005, ASTRON J, V130, P1291, DOI 10.1086/431957; Bernstein GM, 2004, ASTRON J, V128, P1364, DOI 10.1086/422919; Chambers JE, 1999, MON NOT R ASTRON SOC, V304, P793, DOI 10.1046/j.1365-8711.1999.02379.x; Chiang EI, 2005, ASTROPHYS J, V628, P520, DOI 10.1086/430825; Chiang EI, 2003, ASTRON J, V126, P430, DOI 10.1086/375207; Cruikshank DP, 2003, EARTH MOON PLANETS, V92, P315, DOI 10.1023/B:MOON.0000031948.39136.7d; Doressoundiram A, 2003, ASTRON J, V125, P2721, DOI 10.1086/374632; Fleming HJ, 2000, ICARUS, V148, P479, DOI 10.1006/icar.2000.6523; Fornasier S, 2004, ICARUS, V172, P221, DOI 10.1016/j.icarus.2004.06.015; Gomes RS, 2003, ICARUS, V161, P404, DOI 10.1016/S0019-1035(02)00056-8; Gomes RS, 1998, ASTRON J, V116, P2590, DOI 10.1086/300582; Grav T, 2003, ICARUS, V166, P33, DOI 10.1016/j.icarus.2003.07.005; Hahn JM, 2005, ASTRON J, V130, P2392, DOI 10.1086/452638; Horner J, 2006, MON NOT R ASTRON SOC, V367, pL20, DOI 10.1111/j.1745-3933.2006.00131.x; Jewitt DC, 2000, ASTRON J, V120, P1140, DOI 10.1086/301453; Jewitt DC, 2002, ASTRON J, V123, P1039, DOI 10.1086/338692; Kortenkamp SJ, 2004, ICARUS, V167, P347, DOI 10.1016/j.icarus.2003.09.021; Levison HF, 2003, NATURE, V426, P419, DOI 10.1038/nature02120; Marzari F, 1998, ICARUS, V131, P41, DOI 10.1006/icar.1997.5841; Marzari F, 2000, ICARUS, V146, P232, DOI 10.1006/icar.2000.6376; Morbidelli A, 2005, NATURE, V435, P462, DOI 10.1038/nature03540; Nesvorny D, 2002, ICARUS, V160, P271, DOI 10.1006/icar.2002.6961; PEALE SJ, 1993, ICARUS, V106, P308, DOI 10.1006/icar.1993.1173; Peixinho N, 2004, ICARUS, V170, P153, DOI 10.1016/j.icarus.2004.03.004; Pollack JB, 1996, ICARUS, V124, P62, DOI 10.1006/icar.1996.0190; SHOEMAKER EM, 1989, ASTEROIDS, V2, P487; Smith JA, 2002, ASTRON J, V123, P2121, DOI 10.1086/339311; Tegler SC, 2000, NATURE, V407, P979, DOI 10.1038/35039572; Trujillo CA, 2002, ASTROPHYS J, V566, pL125, DOI 10.1086/339437; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539	30	83	88	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2006	313	5786					511	514		10.1126/science.1127173	http://dx.doi.org/10.1126/science.1127173			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16778021				2022-12-24	WOS:000239308600059
J	Holmberg, J; Genander, M; Halford, MM; Anneren, C; Sondell, M; Chumley, MJ; Silvany, RE; Henkemeyer, M; Frisen, J				Holmberg, Johan; Genander, Maria; Halford, Michael M.; Anneren, Cecilia; Sondell, Mariann; Chumley, Michael J.; Silvany, Robert E.; Henkemeyer, Mark; Frisen, Jonas			EphB receptors coordinate migrationand proliferation in the intestinal stem cell niche	CELL			English	Article							COLORECTAL-CANCER; PROGENITOR CELLS; COMMISSURAL AXONS; BETA-CATENIN; PANETH CELLS; MOUSE; EPHRINS; EXPRESSION; HEDGEHOG; DIFFERENTIATION	More than 10(10) cells are generated every day in the human intestine. Wnt proteins are key regulators of proliferation and are known endogenous mitogens for intestinal progenitor cells. The positioning of cells within the stem cell niche in the intestinal epithelium is controlled by B subclass ephrins through their interaction with EphB receptors. We report that EphB receptors, in addition to directing cell migration, regulate proliferation in the intestine. EphB signaling promotes cell-cycle reentry of progenitor cells and accounts for approximately 50% of the mitogenic activity in the adult mouse small intestine and colon. These data establish EphB receptors as key coordinators of migration and proliferation in the intestinal stem cell niche.	Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA	Karolinska Institutet; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Holmberg, J (corresponding author), Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@ki.se		Anneren, Cecilia/0000-0003-3600-6650; Genander, Maria/0000-0002-2428-8040; Henkemeyer, Mark/0000-0002-7525-1061	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006225] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC006225] Funding Source: Medline; NIDDK NIH HHS [R01 DK059164] Funding Source: Medline; NIMH NIH HHS [R01 MH66332, R01 MH066332] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ayabe T, 2004, TRENDS MICROBIOL, V12, P394, DOI 10.1016/j.tim.2004.06.007; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Clevers H, 2006, CANCER RES, V66, P2, DOI 10.1158/0008-5472.CAN-05-3849; Cowan CA, 2002, TRENDS CELL BIOL, V12, P339, DOI 10.1016/S0962-8924(02)02317-6; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Guo DL, 2006, CARCINOGENESIS, V27, P454, DOI 10.1093/carcin/bgi259; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hearn CJ, 1999, DEV DYNAM, V214, P239, DOI 10.1002/(SICI)1097-0177(199903)214:3<239::AID-AJA7>3.0.CO;2-O; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Holmberg J, 2005, GENE DEV, V19, P462, DOI 10.1101/gad.326905; Holmberg J, 2002, TRENDS NEUROSCI, V25, P239, DOI 10.1016/S0166-2236(02)02149-5; Jubb AM, 2005, CLIN CANCER RES, V11, P5181, DOI 10.1158/1078-0432.CCR-05-0143; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Kayahara T, 2003, FEBS LETT, V535, P131, DOI 10.1016/S0014-5793(02)03896-6; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lugli A, 2005, CLIN CANCER RES, V11, P6450, DOI 10.1158/1078-0432.CCR-04-2458; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Mikkers H, 2005, EMBO J, V24, P2715, DOI 10.1038/sj.emboj.7600749; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Potten CS, 2002, J CELL SCI, V115, P2381; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; SCHMAHL W, 1983, ANAT EMBRYOL, V167, P355, DOI 10.1007/BF00315673; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Stanger BZ, 2005, P NATL ACAD SCI USA, V102, P12443, DOI 10.1073/pnas.0505690102; Stappenbeck TS, 2003, P NATL ACAD SCI USA, V100, P1004, DOI 10.1073/pnas.242735899; Stappenbeck TS, 1998, CURR OPIN CELL BIOL, V10, P702, DOI 10.1016/S0955-0674(98)80110-5; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van den Brink GR, 2004, NAT GENET, V36, P277, DOI 10.1038/ng1304; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Vearing CJ, 2005, GROWTH FACTORS, V23, P67, DOI 10.1080/08977190500055869; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2	50	225	238	2	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2006	125	6					1151	1163		10.1016/j.cell.2006.04.030	http://dx.doi.org/10.1016/j.cell.2006.04.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777604	Bronze			2022-12-24	WOS:000238602700019
J	Levine, OS; O'Brien, KL; Knoll, M; Adegbola, RA; Black, S; Cherian, T; Dagan, R; Goldblatt, D; Grange, A; Greenwood, B; Hennessy, T; Klugman, KP; Madhi, SA; Mulholland, K; Nohynek, H; Santosham, M; Saha, SK; Scott, JA; Sow, S; Whitney, CG; Cutts, F				Levine, Orin S.; O'Brien, Katherine L.; Knoll, Maria; Adegbola, Richard A.; Black, Steven; Cherian, Thomas; Dagan, Ron; Goldblatt, David; Grange, Adenike; Greenwood, Brian; Hennessy, Tom; Klugman, Keith P.; Madhi, Shabir A.; Mulholland, Kim; Nohynek, Hanna; Santosham, Mathuram; Saha, Samir K.; Scott, J. Anthony; Sow, Samba; Whitney, Cynthia G.; Cutts, Felicity			Pneumococcal vaccination in developing countries	LANCET			English	Editorial Material							CONJUGATE VACCINE; CHILDREN; DISEASE; PNEUMONIA; FORMULATION; INFECTIONS; SEROGROUPS; IMPACT; TRIAL		Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; MRC Labs, Fajara, Gambia; Kaiser Permanente Vaccine Study Ctr, Oakland, CA USA; WHO, CH-1211 Geneva, Switzerland; Soroka Univ, Med Ctr, Paediat Infect Dis Unit, Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; UCL, Inst Child Hlth, London, England; Great Ormond St Hosp Sick Children, London WC1N 3JH, England; Int Paediat Assoc, Lagos, Nigeria; London Sch Hyg & Trop Med, London WC1, England; Ctr Dis Control & Prevent, Arctic Invest Program, Natl Ctr Infect Dis, Anchorage, AK USA; Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; Univ Witwatersrand, MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; Natl Publ Hlth Inst, Helsinki, Finland; Dhaka Shishu Hosp, Bangladesh Inst Child Hlth, Dept Microbiol, Dhaka, Bangladesh; Wellcome Trust Kenya Med Res Inst, Ctr Geog Med Res Coast, Kilifi, Kenya; Ctr Dev Vaccins Mali, Bamako, Mali	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; MRC Laboratory Molecular Biology; Kaiser Permanente; World Health Organization; Ben Gurion University; Soroka Medical Center; Ben Gurion University; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health; University of Witwatersrand; Finland National Institute for Health & Welfare; Kenya Medical Research Institute	Levine, OS (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	olevine@jhsph.edu	Goldblatt, David/C-5972-2008	Goldblatt, David/0000-0002-0769-5242; Deloria Knoll, Maria/0000-0001-9041-2671; O'Brien, Katherine/0000-0002-0164-4030	Wellcome Trust [081835, 061089] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Campbell JD, 2004, PEDIATR INFECT DIS J, V23, P642, DOI 10.1097/01.inf.0000130951.85974.79; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P893; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P122, DOI 10.1086/313609; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Madhi SA, 2005, CLIN INFECT DIS, V40, P1511, DOI 10.1086/429828; Madhi SA, 2000, PEDIATR INFECT DIS J, V19, P1141, DOI 10.1097/00006454-200012000-00004; OBRIEN KL, 2006, 5 INT S PNEUM PNEUM, P189; SHANN F, 1986, PEDIATR INFECT DIS J, V5, P247, DOI 10.1097/00006454-198603000-00017; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; *WHO, 2003, WKLY EPIDEMIOL REC, V14, P110; *WHO, 1999, MEN PNEUM DIS VACC; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; *WYETH, 2006, WYETH ANN M STOCKH D	16	119	134	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 10	2006	367	9526					1880	1882		10.1016/S0140-6736(06)68703-5	http://dx.doi.org/10.1016/S0140-6736(06)68703-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051XG	16765742				2022-12-24	WOS:000238194400006
J	Maheshwari, V; Saraf, RF				Maheshwari, Vivek; Saraf, Ravi F.			High-resolution thin-film device to sense texture by touch	SCIENCE			English	Article							TACTILE SENSOR; CONTACT FORCE; PERCEPTION; SHAPE	Touch ( or tactile) sensors are gaining renewed interest as the level of sophistication in the application of minimum invasive surgery and humanoid robots increases. The spatial resolution of current large-area ( greater than 1 cm(2)) tactile sensor lags by more than an order of magnitude compared with the human finger. By using metal and semiconducting nanoparticles, a similar to 100-nm- thick, large-area thin-film device is self-assembled such that the change in current density through the film and the electroluminescent light intensity are linearly proportional to the local stress. A stress image is obtained by pressing a copper grid and a United States 1-cent coin on the device and focusing the resulting electroluminescent light directly on the charge-coupled device. Both the lateral and height resolution of texture are comparable to the human finger at similar stress levels of similar to 10 kilopascals.	Univ Nebraska, Dept Chem Engn, Lincoln, NE 68588 USA; Edward Via Virginia Coll Osteopath Med, Blacksburg, VA 24060 USA	University of Nebraska System; University of Nebraska Lincoln	Saraf, RF (corresponding author), Univ Nebraska, Dept Chem Engn, Lincoln, NE 68588 USA.	rsaraf@unlnotes.unl.edu						Brett PN, 1997, P I MECH ENG H, V211, P309, DOI 10.1243/0954411971534430; Cassagneau T, 1998, J AM CHEM SOC, V120, P7848, DOI 10.1021/ja9806027; Dario P, 2001, J ROBOTIC SYST, V18, P673, DOI 10.1002/rob.8106; De Rossi D, 2005, ADV COLLOID INTERFAC, V116, P165, DOI 10.1016/j.cis.2005.05.002; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; DeLongchamp DM, 2003, CHEM MATER, V15, P1165, DOI 10.1021/cm020945a; DOMENICI C, 1992, SENSOR ACTUAT A-PHYS, V31, P97, DOI 10.1016/0924-4247(92)80086-I; Durstock MF, 2001, LANGMUIR, V17, P7865, DOI 10.1021/la010954i; Engel J, 2003, J MICROMECH MICROENG, V13, P359, DOI 10.1088/0960-1317/13/3/302; Ferrier NJ, 2000, INT J ROBOT RES, V19, P795, DOI 10.1177/02783640022067184; Fowler RH, 1928, P R SOC LOND A-CONTA, V119, P173, DOI 10.1098/rspa.1928.0091; Gray BL, 1996, IEEE INT CONF ROBOT, P1, DOI 10.1109/ROBOT.1996.503564; HOWE RD, 1993, IEEE T ROBOTIC AUTOM, V9, P140, DOI 10.1109/70.238278; Jia YB, 2005, IEEE T ROBOT, V21, P726, DOI 10.1109/TRO.2005.844675; Jiang CY, 2004, NAT MATER, V3, P721, DOI 10.1038/nmat1212; JOHANSSON RS, 1983, SOMATOSENS RES, V1, P21, DOI 10.3109/07367228309144538; Johnson K. L., 1985, CONTACT MECH, DOI 10.1201/b17110-2; KANEKO M, 1994, IEEE T ROBOTIC AUTOM, V10, P355, DOI 10.1109/70.294210; KASAP SO, 2000, PRINCIPLES ELECT ENG, P284; Kelley TW, 2004, CHEM MATER, V16, P4413, DOI 10.1021/cm049614j; Lacour SP, 2004, IEEE ELECTR DEVICE L, V25, P792, DOI 10.1109/LED.2004.839227; Mascaro SA, 2001, IEEE T ROBOTIC AUTOM, V17, P698, DOI 10.1109/70.964669; Matsumoto S, 1997, SURG ENDOSC-ULTRAS, V11, P939, DOI 10.1007/s004649900492; MORLEY JW, 1983, EXP BRAIN RES, V49, P291; Okamura AM, 2001, INT J ROBOT RES, V20, P925, DOI 10.1177/02783640122068191; Okumura Y, 2004, ADV ROBOTICS, V18, P699, DOI 10.1163/1568553041719447; Ouyang JY, 2004, NAT MATER, V3, P918, DOI 10.1038/nmat1269; Plinkert PK, 1997, LARYNGO RHINO OTOL, V76, P543, DOI 10.1055/s-2007-997476; Robles-De-La-Torre G, 2001, NATURE, V412, P445, DOI 10.1038/35086588; Sakai N, 2000, GASTROINTEST ENDOSC, V51, P69, DOI 10.1016/S0016-5107(00)70390-7; Seeger A, 2001, J VAC SCI TECHNOL B, V19, P2717, DOI 10.1116/1.1412890; Shikida M, 2003, SENSOR ACTUAT A-PHYS, V103, P213, DOI 10.1016/S0924-4247(02)00336-9; Someya T, 2004, P NATL ACAD SCI USA, V101, P9966, DOI 10.1073/pnas.0401918101; Tajima R, 2002, ADV ROBOTICS, V16, P381, DOI 10.1163/15685530260174548; Tohyama O, 1999, IEEE J SEL TOP QUANT, V5, P115, DOI 10.1109/2944.748114	35	219	235	12	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1501	1504		10.1126/science.1126216	http://dx.doi.org/10.1126/science.1126216			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763143	Green Submitted			2022-12-24	WOS:000238124100041
J	Harries, AD; Schouten, EJ; Libamba, E				Harries, AD; Schouten, EJ; Libamba, E			Scaling up antiretroviral treatment in resource-poor settings	LANCET			English	Editorial Material							SUB-SAHARAN AFRICA; THERAPY; MALAWI; TUBERCULOSIS; HIV		Malawi Country Off, Lilongwe 3, Malawi; Minist Hlth, Lilongwe, Malawi; London Sch Hyg & Trop Med, London WC1, England; Management Sci Hlth, Lilongwe, Malawi	University of London; London School of Hygiene & Tropical Medicine	Harries, AD (corresponding author), Malawi Country Off, POB 30455, Lilongwe 3, Malawi.	adharries@malawi.net						Bates I, 2006, CLIN INFECT DIS, V42, P383, DOI 10.1086/499368; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Gebrekristos HT, 2005, BMJ-BRIT MED J, V331, P772, DOI 10.1136/bmj.331.7519.772; Harries AD, 2004, BMJ-BRIT MED J, V329, P1163, DOI 10.1136/bmj.329.7475.1163; Harries AD, 2001, LANCET, V358, P410, DOI 10.1016/S0140-6736(01)05551-9; Libamba E, 2005, INT J TUBERC LUNG D, V9, P1062; *MIN HLTH REP MAL, 2004, HUM RES HLTH SECT SO; *NAT AIDS COMM, 2003, NAT EST HIV AIDS MAL; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; van Oosterhout JJG, 2005, JAIDS-J ACQ IMM DEF, V39, P626; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; World Health Organization, 2003, SCAL ANT THER RES LT	13	103	105	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2006	367	9525					1870	1872		10.1016/S0140-6736(06)68809-0	http://dx.doi.org/10.1016/S0140-6736(06)68809-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051XE	16753490				2022-12-24	WOS:000238194200033
J	Bieber, FR; Brenner, CH; Lazer, D				Bieber, FR; Brenner, CH; Lazer, D			Human genetics - Finding criminals through DNA of their relatives	SCIENCE			English	Editorial Material							IDENTIFICATION; INFORMATION; VICTIMS; ISSUES		Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; DNA VIEW, Oakland, CA 94611 USA; Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of California System; University of California Berkeley; Harvard University	Bieber, FR (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	fbieber@partners.org	Bieber, Frederick/W-7764-2019	Bieber, Frederick/0000-0002-2120-9829	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002836] Funding Source: NIH RePORTER; NHGRI NIH HHS [1R01 HG2836-01] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Altshuter D, 2005, SCIENCE, V307, P1052, DOI 10.1126/science.1109682; BIEBER FR, 2004, DNA CRIMINAL JUSTICE, P23; Bieber FR, 2006, J LAW MED ETHICS, V34, P222, DOI 10.1111/j.1748-720X.2006.00029.x; Biesecker LG, 2005, SCIENCE, V310, P1122, DOI 10.1126/science.1116608; Brenner CH, 2006, FORENSIC SCI INT, V157, P172, DOI 10.1016/j.forsciint.2005.11.003; Brenner CH, 2003, THEOR POPUL BIOL, V63, P173, DOI 10.1016/S0040-5809(03)00008-X; Budowle B, 1999, J FORENSIC SCI, V44, P1277; Budowle Bruce, 2005, Legal Medicine, V7, P230, DOI 10.1016/j.legalmed.2005.01.001; Butler J.M., 2005, FORENSIC DNA TYPING, V2nd ed.; CARDWELL D, 2006, NY TIMES        0504; Etzioni A, 2004, DNA CRIMINAL JUSTICE, P197; GRIFFITHS A, 2004, INTRO GENETIC ANAL; Kaye DH, 2004, DNA CRIMINAL JUSTICE, P247; Lazer D, 2004, DNA CRIMINAL JUSTICE, P357; Lazer D, 2006, J LAW MED ETHICS, V34, P366, DOI 10.1111/j.1748-720X.2006.00041.x; LI CC, 1954, BIOMETRICS, V10, P347, DOI 10.2307/3001590; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Smith CA, 2004, J CHILD PSYCHOL PSYC, V45, P230, DOI 10.1111/j.1469-7610.2004.00216.x; *US BUR JUST STAT, 1999, 170013 NJC US DEP JU, P62; Williams R, 2005, J LAW MED ETHICS, V33, P545, DOI 10.1111/j.1748-720X.2005.tb00517.x; WILLING R, 2005, US TODAY        0607, P1	21	108	113	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2006	312	5778					1315	1316		10.1126/science.1122655	http://dx.doi.org/10.1126/science.1122655			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048QM	16690817				2022-12-24	WOS:000237961600031
J	Gill, SR; Pop, M; DeBoy, RT; Eckburg, PB; Turnbaugh, PJ; Samuel, BS; Gordon, JI; Relman, DA; Fraser-Liggett, CM; Nelson, KE				Gill, Steven R.; Pop, Mihai; DeBoy, Robert T.; Eckburg, Paul B.; Turnbaugh, Peter J.; Samuel, Buck S.; Gordon, Jeffrey I.; Relman, David A.; Fraser-Liggett, Claire M.; Nelson, Karen E.			Metagenomic analysis of the human distal gut microbiome	SCIENCE			English	Article							ISOPRENOID BIOSYNTHESIS; ANTIOXIDANT ACTIVITY; BACTERIA; MICROORGANISMS; MICROFLORA; FLAVONOIDS; INDUCTION; DIVERSITY; EVOLUTION; INTESTINE	The human intestinal microbiota is composed of 10(13) to 10(14) microorganisms whose collective genome ("microbiome'') contains at least 100 times as many genes as our own genome. We analyzed similar to 78 million base pairs of unique DNA sequence and 2062 polymerase chain reaction amplified 16S ribosomal DNA sequences obtained from the fecal DNAs of two healthy adults. Using metabolic function analyses of identified genes, we compared our human genome with the average content of previously sequenced microbial genomes. Our microbiome has significantly enriched metabolism of glycans, amino acids, and xenobiotics; methanogenesis; and 2-methyl-D-erythritol 4-phosphate pathway - mediated biosynthesis of vitamins and isoprenoids. Thus, humans are superorganisms whose metabolism represents an amalgamation of microbial and human attributes.	Inst Genom Res, Rockville, MD 20850 USA; Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; Washington Univ, Sch Med, Ctr Genome Sci, St Louis, MO 63108 USA; George Washington Univ, Sch Med, Dept Physiol & Pharmacol, Washington, DC 20037 USA; George Washington Univ, Sch Med, Dept Microbiol & Trop Dis, Washington, DC 20037 USA	J. Craig Venter Institute; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Washington University (WUSTL); George Washington University; George Washington University	Gill, SR (corresponding author), SUNY Buffalo, Dept Oral Biol, Buffalo, NY 14214 USA.	srgill@buffalo.edu	ravegnini, gloria/K-1330-2016; Pop, Mihai/A-7987-2013; WU, TAKLON/A-2827-2010; Samuel, Buck/I-3837-2019	ravegnini, gloria/0000-0002-7774-402X; Pop, Mihai/0000-0001-9617-5304; Samuel, Buck/0000-0002-4347-3997; Fraser, Claire/0000-0003-1462-2428; Relman, David A./0000-0001-8331-1354; Turnbaugh, Peter/0000-0002-0888-2875	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070977] Funding Source: NIH RePORTER; NIAID NIH HHS [AI51259, R01 AI051259, R01 AI051259-04] Funding Source: Medline; NIDDK NIH HHS [DK70977] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Begley M, 2004, FEBS LETT, V561, P99, DOI 10.1016/S0014-5793(04)00131-0; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; MALLETT AK, 1983, APPL ENVIRON MICROB, V46, P591, DOI 10.1128/AEM.46.3.591-595.1983; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; McOrist AL, 2002, J MICROBIOL METH, V50, P131, DOI 10.1016/S0167-7012(02)00018-0; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Pereto J, 2004, TRENDS BIOCHEM SCI, V29, P469, DOI 10.1016/j.tibs.2004.07.002; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reiners JJ, 1999, CARCINOGENESIS, V20, P1561, DOI 10.1093/carcin/20.8.1561; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; Rychlik JL, 2000, CURR MICROBIOL, V40, P176, DOI 10.1007/s002849910035; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Schneider H, 1999, ARCH MICROBIOL, V171, P81, DOI 10.1007/s002030050682; STAMS AJM, 1994, ANTON LEEUW INT J G, V66, P271, DOI 10.1007/BF00871644; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Umeno D, 2005, MICROBIOL MOL BIOL R, V69, P51, DOI 10.1128/MMBR.69.1.51-78.2005; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang KC, 2000, BBA-MOL CELL BIOL L, V1529, P33, DOI 10.1016/S1388-1981(00)00136-0; Williamson G, 1996, CARCINOGENESIS, V17, P2385, DOI 10.1093/carcin/17.11.2385	29	2987	3244	25	1026	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 2	2006	312	5778					1355	1359		10.1126/science.1124234	http://dx.doi.org/10.1126/science.1124234			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741115	Green Accepted			2022-12-24	WOS:000237961600048
J	Behringer, DC; Butler, MJ; Shields, JD				Behringer, Donald C.; Butler, Mark J.; Shields, Jeffrey D.			Avoidance of disease by social lobsters	NATURE			English	Article							PATHOGEN TRANSMISSION; PANULIRUS-ARGUS; PARASITES		Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; Virginia Inst Marine Sci, Gloucester Point, VA 23062 USA	Old Dominion University; William & Mary; Virginia Institute of Marine Science	Behringer, DC (corresponding author), Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA.	mbutler@odu.edu						ANDERSON RM, 1982, POPULATION BIOL INFE; Bushmann PJ, 2000, J CHEM ECOL, V26, P883, DOI 10.1023/A:1005404107918; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Derby CD, 2000, PHYSIOL BEHAV, V69, P203, DOI 10.1016/S0031-9384(00)00202-X; Hudson P, 1998, TRENDS ECOL EVOL, V13, P387, DOI 10.1016/S0169-5347(98)01475-X; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; MINCHELLA DJ, 1985, PARASITOLOGY, V90, P205, DOI 10.1017/S0031182000049143; Nevitt G, 2000, MAR ECOL PROG SER, V203, P225, DOI 10.3354/meps203225; Penn D, 1998, TRENDS ECOL EVOL, V13, P391, DOI 10.1016/S0169-5347(98)01473-6; ROSENQVIST G, 1995, ANIM BEHAV, V49, P1039, DOI 10.1006/anbe.1995.0133; Shields JD, 2004, DIS AQUAT ORGAN, V59, P109, DOI 10.3354/dao059109; WASHBURN JO, 1991, SCIENCE, V253, P185, DOI 10.1126/science.1906637	13	200	202	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					421	421		10.1038/441421a	http://dx.doi.org/10.1038/441421a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724051	Bronze			2022-12-24	WOS:000237778900030
J	Zhang, JW; Grindley, JC; Yin, T; Jayasinghe, S; He, XC; Ross, JT; Haug, JS; Rupp, D; Porter-Westpfahl, KS; Wiedemann, LM; Wu, H; Li, LH				Zhang, Jiwang; Grindley, Justin C.; Yin, Tong; Jayasinghe, Sachintha; He, Xi C.; Ross, Jason T.; Haug, Jeffrey S.; Rupp, Dawn; Porter-Westpfahl, Kimberly S.; Wiedemann, Leanne M.; Wu, Hong; Li, Linheng			PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention	NATURE			English	Article							BONE-MARROW NICHE; SELF-RENEWAL; PROGENITOR CELLS; IDENTIFICATION; GENE; PHOSPHORYLATION; DIFFERENTIATION; RECRUITMENT; QUIESCENCE; COMMITMENT	Haematopoietic stem cells (HSCs) must achieve a balance between quiescence and activation that fulfils immediate demands for haematopoiesis without compromising long-term stem cell maintenance, yet little is known about the molecular events governing this balance(1-3). Phosphatase and tensin homologue ( PTEN) functions as a negative regulator of the phosphatidylinositol-3-OH kinase (PI(3)K)-Akt pathway, which has crucial roles in cell proliferation, survival, differentiation and migration(4,5). Here we show that inactivation of PTEN in bone marrow HSCs causes their short-term expansion, but long-term decline, primarily owing to an enhanced level of HSC activation. PTEN-deficient HSCs engraft normally in recipient mice, but have an impaired ability to sustain haematopoietic reconstitution, reflecting the dysregulation of their cell cycle and decreased retention in the bone marrow niche. Mice with PTEN-mutant bone marrow also have an increased representation of myeloid and T-lymphoid lineages and develop myeloproliferative disorder (MPD)(6). Notably, the cell populations that expand in PTEN mutants match those that become dominant in the acute myeloid/lymphoid leukaemia that develops in the later stages of MPD. Thus, PTEN has essential roles in restricting the activation of HSCs, in lineage fate determination, and in the prevention of leukaemogenesis.	Stowers Inst Med Res, Kansas City, MO 64110 USA; Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Kansas; University of Kansas Medical Center	Li, LH (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	lil@stowers-institute.org	Zhang, Jiwang/AAG-2706-2021; Wiedemann, Leanne/E-3316-2010	Li, Linheng/0000-0001-9963-430X; Jayasinghe, Sachintha/0000-0002-3254-4892; Wiedemann, Leanne/0000-0002-0964-4676				Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Akashi K, 2005, CELL, V121, P160, DOI 10.1016/j.cell.2005.04.005; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Suzuki A, 2003, J EXP MED, V197, P657, DOI 10.1084/jem.20021101; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; van der Loo JCM, 1998, J CLIN INVEST, V102, P1051, DOI 10.1172/JCI3687; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	30	639	685	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					518	522		10.1038/nature04747	http://dx.doi.org/10.1038/nature04747			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16633340				2022-12-24	WOS:000237778900052
J	Massoumi, R; Chmielarska, K; Hennecke, K; Pfeifer, A; Fassler, R				Massoumi, Ramin; Chmielarska, Katarzyna; Hennecke, Katharina; Pfeifer, Alexander; Faessler, Reinhard			Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappa B signaling	CELL			English	Article							BCL-3 EXPRESSION; ACTIVATION; ENCODES; GROWTH; P50; IDENTIFICATION; KERATINOCYTES; TRANSLOCATION; TRANSCRIPTION; ASSOCIATION	Mutations in the CYLD gene cause tumors of hair-follicle keratinocytes. The CYLD gene encodes a deubiquitinase that removes lysine 63-linked ubiquitin chains from TRAF2 and inhibits p65/p50 NF-kappa B activation. Here we show that mice lacking Cyld are highly susceptible to chemically induced skin tumors. Cyld(-/-) tumors and keratinocytes treated with 12-O-tetradecanoylphorbol-13 acetate (TPA) or UV light are hyperproliferative and have elevated cyclin D1 levels. The cyclin 131 elevation is caused not by increased p65/p5O action but rather by increased nuclear activity of Bcl-3-associated NF-kappa B p50 and p52. In Cyld(+/+) keratinocytes, TPA or UV light triggers the translocation of Cyld from the cytoplasm to the perinuclear region, where Cyld binds and deubiquitinates Bcl-3, thereby preventing nuclear accumulation of Bcl-3 and p50/Bcl-3- or p52/Bcl-3-dependent proliferation. These data indicate that, depending on the external signals, Cyld can negatively regulate different NF-kappa B pathways; inactivation of TRAF2 controls survival and inflammation, while inhibition of Bcl-3 controls proliferation and tumor growth.	Max Planck Inst Biochem, Dept Mol Biol, D-82152 Martinsried, Germany; Univ Munich, Dept Pharm, D-81377 Munich, Germany	Max Planck Society; University of Munich	Fassler, R (corresponding author), Max Planck Inst Biochem, Dept Mol Biol, D-82152 Martinsried, Germany.	faessler@biochem.mpg.de	Massoumi, Ramin/AAG-4786-2019	Masoumi, Katarzyna/0000-0002-9277-6505				Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; Brasier AR, 2001, J BIOL CHEM, V276, P32080, DOI 10.1074/jbc.M102949200; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Budunova IV, 1999, ONCOGENE, V18, P7423, DOI 10.1038/sj.onc.1203104; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hashimoto K, 2004, MODERN PATHOL, V17, P617, DOI 10.1038/modpathol.3800107; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Hirai Y, 2004, INT J ONCOL, V24, P977; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Joyce D, 2001, CYTOKINE GROWTH F R, V12, P73, DOI 10.1016/S1359-6101(00)00018-6; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kollisch G, 2005, IMMUNOLOGY, V114, P531, DOI 10.1111/j.1365-2567.2005.02122.x; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; MCKEITHAN TW, 1990, GENE CHROMOSOME CANC, V1, P247, DOI 10.1002/gcc.2870010310; Mempel M, 2003, J INVEST DERMATOL, V121, P1389, DOI 10.1111/j.1523-1747.2003.12630.x; Nishikori M, 2003, BLOOD, V101, P2789, DOI 10.1182/blood-2002-08-2464; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557; Pfeifer A, 2000, P NATL ACAD SCI USA, V97, P12227, DOI 10.1073/pnas.220399597; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Plafker SM, 2004, J CELL BIOL, V167, P649, DOI 10.1083/jcb.200406001; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Regamey A, 2003, J EXP MED, V198, P1959, DOI 10.1084/jem.20031187; Rocha S, 2003, MOL CELL BIOL, V23, P4713, DOI 10.1128/MCB.23.13.4713-4727.2003; Romero MR, 1999, EXP DERMATOL, V8, P53, DOI 10.1111/j.1600-0625.1999.tb00348.x; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; Strobel P, 2002, AM J SURG PATHOL, V26, P119, DOI 10.1097/00000478-200201000-00016; Thornburg NJ, 2003, CANCER RES, V63, P8293; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; VANBALKOM IDC, 1994, J MED GENET, V31, P321, DOI 10.1136/jmg.31.4.321; Watanabe N, 1997, EMBO J, V16, P3609, DOI 10.1093/emboj/16.12.3609; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; WEST R, 2001, CHEM ORGANIC SILICON, V3, P1; Wilkinson MG, 2000, FASEB J, V14, P2147, DOI 10.1096/fj.00-0102rev; Zhang MY, 1998, BLOOD, V92, P1225, DOI 10.1182/blood.V92.4.1225.416k20_1225_1234; ZHANG Q, 1994, MOL CELL BIOL, V14, P3915, DOI 10.1128/MCB.14.6.3915	40	389	409	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2006	125	4					665	677		10.1016/j.cell.2006.03.041	http://dx.doi.org/10.1016/j.cell.2006.03.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713561	Bronze			2022-12-24	WOS:000237886000013
J	Wang, Q; Pan, J; Snell, WJ				Wang, Qian; Pan, Junmin; Snell, William J.			Intraflagellar transport particles participate directly in cilium-generated signaling in Chlamydomonas	CELL			English	Article							DEPENDENT PROTEIN-KINASE; LEFT-RIGHT ASYMMETRY; MATING-TYPE PLUS; KINESIN-II; MOLECULAR CHARACTERIZATION; FLAGELLAR ADHESION; GREEN-ALGA; C-ELEGANS; WILD-TYPE; PHOSPHORYLATION	Primary cilia are widely used for signal transduction during development and in homeostasis and are assembled and maintained by intraflagellar transport (IFT). Here, we have dissected the role of IFT in signaling within the flagella (structural and functional counterparts of cilia) of the biflagellated green alga Chlamydomonas. Using a conditional IFT mutant enables us to deplete the IFT machinery from intact, existing flagella. We identify a cGMP-dependent protein kinase (CrPKG) within flagella as the substrate of a protein tyrosine kinase activated by flagellar adhesion during fertilization. We demonstrate that flagellar adhesion stimulates association of CrPKG with a new flagellar compartment. Moreover, formation of the compartment requires IFT, and IFT particles themselves are part of the compartment. Our results lead to a model in which the IFT machinery is required not only for assembling cilia and flagella but also for organizing a signaling pathway within the organelles during cilium-generated signaling.	Univ Texas, SW Med Sch, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Snell, WJ (corresponding author), Univ Texas, SW Med Sch, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	william.snell@utsouthwestern.edu	Pan, Junmin/H-2673-2014		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025661] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-025661, R01 GM025661] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAIR WS, 1983, CELL, V33, P183, DOI 10.1016/0092-8674(83)90347-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANN KS, 1995, CELL MOTIL CYTOSKEL, V30, P252, DOI 10.1002/cm.970300403; Asamizu E, 1999, DNA Res, V6, P369, DOI 10.1093/dnares/6.6.369; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Baker DA, 2005, FRONT BIOSCI, V10, P1229, DOI 10.2741/1615; Bastin P, 1999, MOL CELL BIOL, V19, P8191; Bloodgood RA, 2000, CELL BIOL INT, V24, P857, DOI 10.1006/cbir.2000.0598; Boletta A, 2003, TRENDS CELL BIOL, V13, P484, DOI 10.1016/S0962-8924(03)00169-7; Christensen ST, 2005, CELL BIOL INT, V29, P347, DOI 10.1016/j.cellbi.2005.02.003; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Deng WS, 2003, BIOCHEM J, V374, P559, DOI 10.1042/BJ20030474; Donald RGK, 2002, MOL BIOCHEM PARASIT, V120, P165, DOI 10.1016/S0166-6851(01)00451-0; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gertsberg I, 2004, J GEN PHYSIOL, V124, P527, DOI 10.1085/jgp.200409153; GOODENOUGH UW, 1975, J CELL BIOL, V67, P623, DOI 10.1083/jcb.67.3.623; Gurnett AM, 2002, J BIOL CHEM, V277, P15913, DOI 10.1074/jbc.M108393200; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Harris PC, 2004, MOL GENET METAB, V81, P75, DOI 10.1016/j.ymgme.2003.10.010; Huang KY, 2004, MOL BIOL CELL, V15, P3605, DOI 10.1091/mbc.E04-01-0010; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; KINDLE KL, 1989, J CELL BIOL, V109, P2589, DOI 10.1083/jcb.109.6.2589; Koutoulis A, 1997, J CELL BIOL, V137, P1069, DOI 10.1083/jcb.137.5.1069; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Lohmann SM, 1997, TRENDS BIOCHEM SCI, V22, P307, DOI 10.1016/S0968-0004(97)01086-4; LUX FG, 1991, GENETICS, V128, P549; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Mendez A, 2003, J NEUROSCI, V23, P3124; MESLAND DAM, 1980, J CELL BIOL, V84, P599, DOI 10.1083/jcb.84.3.599; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Nauli SM, 2004, BIOESSAYS, V26, P844, DOI 10.1002/bies.20069; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Pan JM, 2000, CURR OPIN MICROBIOL, V3, P596, DOI 10.1016/S1369-5274(00)00146-6; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; Pan JM, 2004, DEV CELL, V6, P445, DOI 10.1016/S1534-5807(04)00064-4; Pan JM, 2003, J CELL SCI, V116, P2179, DOI 10.1242/jcs.00438; Pan JM, 2002, MOL BIOL CELL, V13, P1417, DOI 10.1091/mbc.01-11-0531; PASQUALE SM, 1987, J CELL BIOL, V105, P2279, DOI 10.1083/jcb.105.5.2279; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Pedersen LB, 2003, CURR BIOL, V13, P1969, DOI 10.1016/j.cub.2003.10.058; Piperno G, 1996, J CELL BIOL, V133, P371, DOI 10.1083/jcb.133.2.371; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; POOLE CA, 1985, CELL MOTIL CYTOSKEL, V5, P175, DOI 10.1002/cm.970050302; Praetorius HA, 2004, AM J PHYSIOL-RENAL, V287, pF969, DOI 10.1152/ajprenal.00096.2004; Qin HM, 2005, CURR BIOL, V15, P1695, DOI 10.1016/j.cub.2005.08.047; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; Quarmby LM, 2005, J CELL SCI, V118, P5161, DOI 10.1242/jcs.02681; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; SHABB JB, 1991, J BIOL CHEM, V266, P24320; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; Snell WJ, 2004, CELL, V117, P693, DOI 10.1016/j.cell.2004.05.019; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; Teilmann SC, 2005, CELL BIOL INT, V29, P340, DOI 10.1016/j.cellbi.2005.03.006; Vaandrager AB, 1998, P NATL ACAD SCI USA, V95, P1466, DOI 10.1073/pnas.95.4.1466; Vondriska TM, 2004, J MOL CELL CARDIOL, V37, P391, DOI 10.1016/j.yjmcc.2004.04.021; Wang Q, 2003, J BIOL CHEM, V278, P32936, DOI 10.1074/jbc.M303261200; Werlen G, 2002, CURR OPIN IMMUNOL, V14, P299, DOI 10.1016/S0952-7915(02)00339-4; White MA, 2005, ANNU REV PHARMACOL, V45, P587, DOI 10.1146/annurev.pharmtox.45.120403.095807; Wiersma HI, 2004, INT J PARASITOL, V34, P369, DOI 10.1016/j.ijpara.2003.11.019; WITMAN GB, 1972, J CELL BIOL, V54, P507, DOI 10.1083/jcb.54.3.507; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; ZHANG YH, 1994, J CELL BIOL, V125, P617, DOI 10.1083/jcb.125.3.617; Zhao YX, 2003, ANAL CHEM, V75, P3751, DOI 10.1021/ac034184m	76	114	119	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					549	562		10.1016/j.cell.2006.02.044	http://dx.doi.org/10.1016/j.cell.2006.02.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678098	Bronze			2022-12-24	WOS:000237506100020
J	Daddario-DiCaprio, KM; Geisbert, TW; Stroher, U; Geisbert, JB; Grolla, A; Fritz, EA; Fernando, L; Kagan, E; Jahrling, PB; Hensley, LE; Jones, SM; Feldmann, H				Daddario-DiCaprio, KM; Geisbert, TW; Stroher, U; Geisbert, JB; Grolla, A; Fritz, EA; Fernando, L; Kagan, E; Jahrling, PB; Hensley, LE; Jones, SM; Feldmann, H			Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment	LANCET			English	Article							REPLICATION-COMPETENT; GUINEA-PIGS; INFECTION; VACCINATION; EBOLA; GLYCOPROTEINS; PROPHYLAXIS; ANTIBODIES; RESPONSES; SMALLPOX	Background Effective countermeasures are urgently needed to prevent and treat infections caused by highly pathogenic and biological threat agents such as Marburg virus (MARV). We aimed to test the efficacy of a replication-competent vaccine based on attenuated recombinant vesicular stomatitis virus (rVSV), as a postexposure treatment for MARV haemorrhagic fever. Methods We used a rhesus macaque model of MARV haemorrhagic fever that produced 100% lethality. We administered rVSV vectors expressing the MARV Musoke strain glycoprotein to five macaques 20-30 min after a high-dose lethal injection of homologous MARV. Three animals were MARV-positive controls and received nonspecific rVSV vectors. We tested for viraemia, undertook analyses for haematology and serum biochemistry, and measured humoral and cellular immune responses. Findings All five rhesus monkeys that were treated with the rVSV MARV vectors as a postexposure treatment survived a high-dose lethal challenge of MARV for at least 80 days. None of these five animals developed clinical symptoms consistent with MARV haemorrhagic fever. All the control animals developed fulminant disease and succumbed to the MARV challenge by day 12. MARV disease in the controls was indicated by: high titres of MARV (10(3)-10(5) plaque-forming units per mL); development of leucocytosis with concurrent neutrophilia at end-stage disease; and possible damage to the liver, kidney, and pancreas. Interpretation Postexposure protection against MARV in non-human primates provides a paradigm for the treatment of MARV haemorrhagic fever. indeed, these data suggest that rVSV-based filoviral vaccines might not only have potential as preventive vaccines, but also could be equally useful for postexposure treatment of filoviral infections.	USA, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; Publ Hlth Agcy Canada, Special Pathogens Program, Natl Microbiol Lab, Winnipeg, MB, Canada; Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; NIAID, Integrated Res Facil, NIH, Bethesda, MD 20892 USA	Uniformed Services University of the Health Sciences - USA; Public Health Agency of Canada; University of Manitoba; University of Manitoba; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Geisbert, TW (corresponding author), USA, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA.	tom.geisbert@amedd.army.mil		Hensley, Lisa/0000-0003-1188-4342				Agafonova OA, 1997, VOP VIRUSOL+, V42, P109; Bachmann MF, 1995, EUR J IMMUNOL, V25, P3445, DOI 10.1002/eji.1830251236; Bachmann MF, 1996, IMMUNOL TODAY, V17, P553, DOI 10.1016/S0167-5699(96)10066-9; Borio L, 2002, JAMA-J AM MED ASSOC, V287, P2391, DOI 10.1001/jama.287.18.2391; Fehr T, 1996, CELL IMMUNOL, V168, P184, DOI 10.1006/cimm.1996.0065; Garbutt M, 2004, J VIROL, V78, P5458, DOI 10.1128/JVI.78.10.5458-5465.2004; GONCHAR NI, 1991, VOP VIRUSOL+, V36, P435; Graham MB, 1997, J EXP MED, V186, P2063, DOI 10.1084/jem.186.12.2063; Hevey M, 1998, VIROLOGY, V251, P28, DOI 10.1006/viro.1998.9367; IGNATYEV GM, 1994, VOP VIRUSOL+, V39, P169; Ignatyev GM, 1996, J BIOTECHNOL, V44, P111, DOI 10.1016/0168-1656(95)00104-2; Ignatyev GM, 1996, VOP VIRUSOL+, V41, P206; *INT SOC INF DIS, 2004, EB VIR LAB ACC US MA; International Society for Infectious Diseases, 2004, EB LAB ACC DEATH RUS; Jahrling PB, 1999, J INFECT DIS, V179, pS224, DOI 10.1086/514310; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Kahn JS, 2001, J VIROL, V75, P11079, DOI 10.1128/JVI.75.22.11079-11087.2001; Kolokol'tsov AA, 2001, B EXP BIOL MED+, V132, P686, DOI 10.1023/A:1012540614713; Lee BO, 2005, J IMMUNOL, V175, P5827, DOI 10.4049/jimmunol.175.9.5827; LEFRANCOIS L, 1984, J VIROL, V51, P208, DOI 10.1128/JVI.51.1.208-214.1984; MARTINI GA, 1968, DEUT MED WOCHENSCHR, V93, P559, DOI 10.1055/s-0028-1105098; Massoudi MS, 2003, J INFECT DIS, V188, P973, DOI 10.1086/378357; Mortimer PP, 2003, CLIN INFECT DIS, V36, P622, DOI 10.1086/374054; Noble S, 2004, VACCINE, V22, P3018, DOI 10.1016/j.vaccine.2004.02.013; Rupprecht CE, 2004, NEW ENGL J MED, V351, P2626, DOI 10.1056/NEJMcp042140; Rupprecht CE, 2002, LANCET INFECT DIS, V2, P327, DOI 10.1016/S1473-3099(02)00287-6; Schnell MJ, 1996, P NATL ACAD SCI USA, V93, P11359, DOI 10.1073/pnas.93.21.11359; Sergeev A N, 1995, Antibiot Khimioter, V40, P24; Sha Z, 2000, J VIROL, V74, P4999, DOI 10.1128/JVI.74.11.4999-5005.2000; SMITH DH, 1982, LANCET, V1, P816; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876; SzomolanyiTsuda E, 1996, J EXP MED, V183, P403, DOI 10.1084/jem.183.2.403; World Health Organization, 2005, Wkly Epidemiol Rec, V80, P158; Yu Andy S, 2004, Clin Liver Dis, V8, P283, DOI 10.1016/j.cld.2004.02.010	35	136	145	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2006	367	9520					1399	1404		10.1016/S0140-6736(06)68546-2	http://dx.doi.org/10.1016/S0140-6736(06)68546-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650649				2022-12-24	WOS:000237195600027
J	Bernstein, BE; Mikkelsen, TS; Xie, XH; Kamal, M; Huebert, DJ; Cuff, J; Fry, B; Meissner, A; Wernig, M; Plath, K; Jaenisch, R; Wagschal, A; Feil, R; Schreiber, SL; Lander, ES				Bernstein, BE; Mikkelsen, TS; Xie, XH; Kamal, M; Huebert, DJ; Cuff, J; Fry, B; Meissner, A; Wernig, M; Plath, K; Jaenisch, R; Wagschal, A; Feil, R; Schreiber, SL; Lander, ES			A bivalent chromatin structure marks key developmental genes in embryonic stem cells	CELL			English	Article							TRANSPOSABLE ELEMENTS; EPIGENETIC REGULATION; POLYCOMB; METHYLATION; BINDING; HUMAN-CHROMOSOME-21; TRANSCRIPTION; RECRUITMENT; TRITHORAX; ISLANDS	The most highly conserved noncoding elements (HCNEs) in mammalian genomes cluster within regions enriched for genes encoding developmentally important transcription factors (TFs). This suggests that HCNE-rich regions may contain key regulatory controls involved in development. We explored this by examining histone methylation in mouse embryonic stem (ES) cells across 56 large HCNE-rich loci. We identified a specific modification pattern, termed "bivalent domains," consisting of large regions of H3 lysine 27 methylation harboring smaller regions of H3 lysine 4 methylation. Bivalent domains tend to coincide with TF genes expressed at low levels. We propose that bivalent domains silence developmental genes in ES cells while keeping them poised for activation. We also found striking correspondences between genome sequence and histone methylation in ES cells, which become notably weaker in differentiated cells. These results highlight the importance of DNA sequence in defining the initial epigenetic landscape and suggest a novel chromatin-based mechanism for maintaining pluripotency.	Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Canc Res Ctr, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Cambridge, MA 02139 USA; MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; MIT, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; CNRS, Inst Genet Mol, UMR 5535, Montpellier, France; Univ Montpellier 2, Montpellier, France; Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Harvard University; Howard Hughes Medical Institute	Bernstein, BE (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA.	bbernstein@partners.org	Feil, Robert P/D-2087-2013; Mikkelsen, Tarjei S/A-1306-2007	Feil, Robert P/0000-0002-5671-5860; Mikkelsen, Tarjei S/0000-0002-8133-3135; Plath, Kathrin/0000-0001-7796-3372; Xie, Xiaohui/0000-0002-5479-6345; Cuff, James/0000-0003-0570-4106	NCI NIH HHS [CA84198] Funding Source: Medline; NICHD NIH HHS [HD045022] Funding Source: Medline; NIGMS NIH HHS [GM38627] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA084198, R37CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038627, R01GM038627] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnaud P, 2000, MOL CELL BIOL, V20, P3434, DOI 10.1128/MCB.20.10.3434-3441.2000; Ayton PM, 2004, MOL CELL BIOL, V24, P10470, DOI 10.1128/MCB.24.23.10470-10478.2004; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Delaval K, 2004, CURR OPIN GENET DEV, V14, P188, DOI 10.1016/j.gde.2004.01.005; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Greally JM, 2002, P NATL ACAD SCI USA, V99, P327, DOI 10.1073/pnas.012539199; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kimura H, 2004, MOL CELL BIOL, V24, P5710, DOI 10.1128/MCB.24.13.5710-5720.2004; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Koli K, 2004, J CELL BIOL, V167, P123, DOI 10.1083/jcb.200403067; Kosak ST, 2004, SCIENCE, V306, P644, DOI 10.1126/science.1103864; Koyanagi M, 2005, J BIOL CHEM, V280, P31470, DOI 10.1074/jbc.M504766200; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Liu CL, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-19; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Mogass M, 2004, BIOCHEM BIOPH RES CO, V325, P124, DOI 10.1016/j.bbrc.2004.10.004; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; O'Neill LP, 2003, METHODS, V31, P76, DOI 10.1016/S1046-2023(03)00090-2; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Orlando V, 1998, EMBO J, V17, P5141, DOI 10.1093/emboj/17.17.5141; Perez-Iratxeta C, 2005, FEBS LETT, V579, P1795, DOI 10.1016/j.febslet.2005.02.020; Perry P, 2004, CELL CYCLE, V3, P1645; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Rideout WM, 2000, NAT GENET, V24, P109, DOI 10.1038/72753; Ringrose L, 2004, MOL CELL, V16, P641, DOI 10.1016/j.molcel.2004.10.015; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Sado T, 2005, HUM MOL GENET, V14, pR59, DOI 10.1093/hmg/ddi117; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Schraets D, 2003, ONCOGENE, V22, P3655, DOI 10.1038/sj.onc.1206438; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Szutorisz H, 2005, BIOESSAYS, V27, P1286, DOI 10.1002/bies.20330; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van Steensel B, 2005, NAT GENET, V37, pS18, DOI 10.1038/ng1559; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036	59	3830	3952	8	410	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					315	326		10.1016/j.cell.2006.02.041	http://dx.doi.org/10.1016/j.cell.2006.02.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630819	Bronze			2022-12-24	WOS:000237241500021
J	Sengoku, T; Nureki, O; Nakamura, A; Satoru, KI; Yokoyama, S				Sengoku, T; Nureki, O; Nakamura, A; Satoru, KI; Yokoyama, S			Structural basis for RNA unwinding by the DEAD-box protein Drosophila vasa	CELL			English	Article							INITIATION-FACTOR 4A; CRYSTAL-STRUCTURE; HELICASE ACTIVITY; SACCHAROMYCES-CEREVISIAE; TERMINAL DOMAIN; OSKAR PROTEIN; Q-MOTIF; ATP; TRANSLATION; BINDING	DEAD-box RNA helicases, which regulate various processes involving RNA, have two RecA-like domains as a catalytic core to alter higher-order RNA structures. We determined the 2.2 angstrom resolution structure of the core of the Drosophila DEAD-box protein Vasa in complex with a single-stranded RNA and an ATP analog. The ATP analog intensively interacts with both of the domains, thereby bringing them into the closed form, with many interdomain interactions of conserved residues. The bound RNA is sharply bent, avoiding a clash with a conserved alpha helix in the N-terminal domain. This "wedge" helix should disrupt base pairs by bending one of the strands when a duplex is bound. Mutational analyses indicated that the interdomain interactions couple ATP hydrolysis to RNA unwinding, probably through fine positioning of the duplex relative to the wedge helix. This mechanism, which differs from those for canonical translocating helicases, may enable the targeted modulation of intricate RNA structures.	Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; Okazaki Natl Res Inst, Ctr Integrat Biosci, Okazaki, Aichi 4448585, Japan; RIKEN, SPring 8 Ctr, Harima Inst, Sayo, Hyogo 6795148, Japan	University of Tokyo; RIKEN; RIKEN; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Japan Synchrotron Radiation Research Institute; RIKEN	Yokoyama, S (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yokoyama@biochem.s.u-tokyo.ac.jp	Yokoyama, Shigeyuki/N-6911-2015; Sengoku, Toru/E-4304-2013; Nakamura, Akira/V-6869-2019	Yokoyama, Shigeyuki/0000-0003-3133-7338; Sengoku, Toru/0000-0001-9461-8714; Nakamura, Akira/0000-0001-6506-9146				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benz J, 1999, STRUCTURE, V7, P671, DOI 10.1016/S0969-2126(99)80088-4; BESSMAN MJ, 1963, METHOD ENZYMOL, V6, P166, DOI 10.1016/0076-6879(63)06160-7; Bizebard T, 2004, BIOCHEMISTRY-US, V43, P7857, DOI 10.1021/bi049852s; Breitwieser W, 1996, GENE DEV, V10, P2179, DOI 10.1101/gad.10.17.2179; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carmel AB, 2004, RNA, V10, P66, DOI 10.1261/rna.5134304; Carrera P, 2000, MOL CELL, V5, P181, DOI 10.1016/S1097-2765(00)80414-1; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Cheng ZH, 2005, RNA, V11, P1258, DOI 10.1261/rna.2920905; Cordin O, 2004, EMBO J, V23, P2478, DOI 10.1038/sj.emboj.7600272; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Diges CM, 2005, BIOCHEMISTRY-US, V44, P7903, DOI 10.1021/bi050033x; Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; FULLERPACE FV, 1993, EMBO J, V12, P3619, DOI 10.1002/j.1460-2075.1993.tb06035.x; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Johnson ER, 1999, RNA, V5, P1526, DOI 10.1017/S1355838299991410; Johnstone O, 2004, DEVELOPMENT, V131, P4167, DOI 10.1242/dev.01286; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kurimoto K, 2005, J STRUCT BIOL, V150, P58, DOI 10.1016/j.jsb.2005.01.006; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; LIANG L, 1994, DEVELOPMENT, V120, P1201; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g; Luking A, 1998, CRIT REV BIOCHEM MOL, V33, P259, DOI 10.1080/10409239891204233; Markussen FH, 1997, COLD SPRING HARB SYM, V62, P13; Mohr S, 2002, CELL, V109, P769, DOI 10.1016/S0092-8674(02)00771-7; NICOL SM, 1995, P NATL ACAD SCI USA, V92, P11681, DOI 10.1073/pnas.92.25.11681; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; PAUSE A, 1993, MOL CELL BIOL, V13, P6789, DOI 10.1128/MCB.13.11.6789; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Polach KJ, 2002, BIOCHEMISTRY-US, V41, P3693, DOI 10.1021/bi012062n; Raz E, 2000, GENOME BIOL, V1, DOI [10.1186/gb-2000-1-3-reviews1017, DOI 10.1186/GB-2000-1-3-REVIEWS1017]; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236; Rogers GW, 2001, J BIOL CHEM, V276, P12598, DOI 10.1074/jbc.M007560200; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Sengoku T, 2004, ACTA CRYSTALLOGR D, V60, P320, DOI 10.1107/S0907444903025897; Shi H, 2004, P NATL ACAD SCI USA, V101, P17628, DOI 10.1073/pnas.0408172101; Silverman E, 2003, GENE, V312, P1, DOI 10.1016/S0378-1119(03)00626-7; Singleton MR, 2002, J BACTERIOL, V184, P1819, DOI 10.1128/JB.184.7.1819-1826.2002; Story RM, 2001, P NATL ACAD SCI USA, V98, P1465, DOI 10.1073/pnas.98.4.1465; Styhler S, 1998, DEVELOPMENT, V125, P1569; Svitkin YV, 2001, RNA, V7, P1743; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tinker R, 1998, DEV BIOL, V199, P1, DOI 10.1006/dbio.1998.8941; Tomancak P, 1998, DEVELOPMENT, V125, P1723; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Zhao CY, 2004, J ARID ENVIRON, V56, P1, DOI 10.1016/S0140-1963(03)00005-3	61	432	440	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					287	300		10.1016/j.cell.2006.01.054	http://dx.doi.org/10.1016/j.cell.2006.01.054			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630817	Bronze			2022-12-24	WOS:000237241500019
J	Kislinger, T; Cox, B; Kannan, A; Chung, C; Hu, PZ; Ignatchenko, A; Scott, MS; Gramolini, AO; Morris, Q; Hallett, MT; Rossant, J; Hughes, TR; Frey, B; Emili, A				Kislinger, T; Cox, B; Kannan, A; Chung, C; Hu, PZ; Ignatchenko, A; Scott, MS; Gramolini, AO; Morris, Q; Hallett, MT; Rossant, J; Hughes, TR; Frey, B; Emili, A			Global survey of organ and organelle protein expression in mouse: Combined proteomic and transcriptomic profiling	CELL			English	Article							PREDICTING SUBCELLULAR-LOCALIZATION; SPECTROMETRY-BASED PROTEOMICS; YEAST PROTEOME; MEMBRANE PROTEINS; GENE-EXPRESSION; SCALE; IDENTIFICATION; ABUNDANCE; GENOME; LOCATIONS	Organs and organelles represent core biological systems in mammals, but the diversity in protein composition remains unclear. Here, we combine subcellular fractionation with exhaustive tandem mass spectrometry-based shotgun sequencing to examine the protein content of four major organellar compartments (cytosol, membranes [microsomes], mitochondria, and nuclei) in six organs (brain, heart, kidney, liver, lung, and placenta) of the laboratory mouse, Mus musculus. Using rigorous statistical filtering and machine-learning methods, the subcellular localization of 3274 of the 4768 proteins identified was determined with high confidence, including 1503 previously uncharacterized factors, while tissue selectivity was evaluated by comparison to previously reported mRNA expression patterns. This molecular compendium, fully accessible via a searchable web-browser interface, serves as a reliable reference of the expressed tissue and organelle proteomes of a leading model mammal.	Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Hosp Sick Children, Dept Dev Biol, Toronto, ON M5G 1L7, Canada; Univ Toronto, Dept Comp Sci, Toronto, ON M5S 2E4, Canada; McGill Univ, Ctr Bioinformat, Montreal, PQ H3A 2B4, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; McGill University	Emili, A (corresponding author), Univ Toronto, Donnelly Ctr Cellular & Biomol Res, 160 Coll St,Room 914, Toronto, ON M5S 3E1, Canada.	andrew.emili@utoronto.ca	Morris, Quaid/ABE-8343-2020; Scott, Michelle/C-7445-2013; Kislinger, Thomas/A-5934-2008	Scott, Michelle/0000-0001-6231-7714; Morris, Quaid/0000-0002-2760-6999; Hallett, Michael/0000-0001-6738-6786; Hu, Pingzhao/0000-0002-9546-2245; Kislinger, Thomas/0000-0003-3525-5540; Ignatchenko, Alexandr/0000-0002-6083-941X				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Brunet S, 2003, TRENDS CELL BIOL, V13, P629, DOI 10.1016/j.tcb.2003.10.006; Cai YD, 2004, BIOINFORMATICS, V20, P1151, DOI 10.1093/bioinformatics/bth054; Chou KC, 2005, BIOINFORMATICS, V21, P944, DOI 10.1093/bioinformatics/bti104; Cox B, 2005, METHODS, V35, P303, DOI 10.1016/j.ymeth.2004.08.021; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; HECHENBICHLER K, 2004, 399 SFB; Huang Y, 2004, BIOINFORMATICS, V20, P21, DOI 10.1093/bioinformatics/btg366; IMAOKA S, 1995, ARCH BIOCHEM BIOPHYS, V321, P255, DOI 10.1006/abbi.1995.1393; Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500; Kislinger T, 2003, MOL CELL PROTEOMICS, V2, P96, DOI 10.1074/mcp.M200074-MCP200; Krapfenbauer K, 2003, ELECTROPHORESIS, V24, P1847, DOI 10.1002/elps.200305401; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Kuo WP, 2002, BIOINFORMATICS, V18, P405, DOI 10.1093/bioinformatics/18.3.405; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Lian Z, 2001, BLOOD, V98, P513, DOI 10.1182/blood.V98.3.513; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lu Z, 2004, BIOINFORMATICS, V20, P547, DOI 10.1093/bioinformatics/btg447; Margulies EH, 2005, P NATL ACAD SCI USA, V102, P4795, DOI 10.1073/pnas.0409882102; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Mott R, 2002, GENOME RES, V12, P1168, DOI 10.1101/gr.96802; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; Nielsen PA, 2005, MOL CELL PROTEOMICS, V4, P402, DOI 10.1074/mcp.T500002-MCP200; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Park KJ, 2003, BIOINFORMATICS, V19, P1656, DOI 10.1093/bioinformatics/btg222; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Phizicky E, 2003, NATURE, V422, P208, DOI 10.1038/nature01512; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Scott MS, 2004, GENOME RES, V14, P1957, DOI 10.1101/gr.2650004; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wu CC, 2004, MOL BIOL CELL, V15, P2907, DOI 10.1091/mbc.E04-02-0101; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16; Zybailov B, 2005, ANAL CHEM, V77, P6218, DOI 10.1021/ac050846r	50	384	402	0	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 7	2006	125	1					173	186		10.1016/j.cell.2006.01.044	http://dx.doi.org/10.1016/j.cell.2006.01.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615898	Bronze			2022-12-24	WOS:000237314200022
J	Bruno, RM; Sakmann, B				Bruno, Randy M.; Sakmann, Bert			Cortex is driven by weak but synchronously active thalamocortical synapses	SCIENCE			English	Article							RAT BARREL CORTEX; CAT VISUAL-CORTEX; INFORMATION-PROCESSING STATES; SHORT-TERM DEPRESSION; SPINY STELLATE CELLS; SOMATOSENSORY CORTEX; IN-VIVO; MONOSYNAPTIC CONNECTIONS; SYNAPTIC CONNECTIONS; THALAMIC BARRELOIDS	Sensory stimuli reach the brain via the thalamocortical projection, a group of axons thought to be among the most powerful in the neocortex. Surprisingly, these axons account for only similar to 15% of synapses onto cortical neurons. The thalamocortical pathway might thus achieve its effectiveness via high-efficacy thalamocortical synapses or via amplification within cortical layer 4. In rat somatosensory cortex, we measured in vivo the excitatory postsynaptic potential evoked by a single synaptic connection and found that thalamocortical synapses have low efficacy. Convergent inputs, however, are both numerous and synchronous, and intracortical amplification is not required. Our results suggest a mechanism of cortical activation by which thalamic input alone can drive cortex.	Max Planck Inst Med Res, Dept Cell Physiol, D-69120 Heidelberg, Germany	Max Planck Society	Bruno, RM (corresponding author), Max Planck Inst Med Res, Dept Cell Physiol, Jahnstr 29, D-69120 Heidelberg, Germany.	bruno@mpimf-heidelberg.mpg.de	Bruno, Randy M./ABC-2117-2021	Bruno, Randy M./0000-0002-5122-4632				Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Arnold PB, 2001, EXP BRAIN RES, V136, P152, DOI 10.1007/s002210000570; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; BENSHALOM G, 1986, J COMP NEUROL, V253, P303, DOI 10.1002/cne.902530303; Boudreau CE, 2005, J NEUROSCI, V25, P7179, DOI 10.1523/JNEUROSCI.1445-05.2005; Brecht M, 2002, J PHYSIOL-LONDON, V538, P495, DOI 10.1113/jphysiol.2001.012334; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Bruno RM, 2002, J NEUROSCI, V22, P10966; Castro-Alamancos MA, 2004, PROG NEUROBIOL, V74, P213, DOI 10.1016/j.pneurobio.2004.09.002; Castro-Alamancos MA, 2004, NEURON, V41, P455, DOI 10.1016/S0896-6273(03)00853-5; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Feldmeyer D, 2005, J NEUROSCI, V25, P3423, DOI 10.1523/JNEUROSCI.5227-04.2005; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; LAND PW, 1995, J COMP NEUROL, V355, P573, DOI 10.1002/cne.903550407; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Lubke J, 2000, J NEUROSCI, V20, P5300, DOI 10.1523/JNEUROSCI.20-14-05300.2000; Matsumura M, 1996, J NEUROSCI, V16, P7757; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Pinto DJ, 2003, CEREB CORTEX, V13, P33, DOI 10.1093/cercor/13.1.33; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; SIMONS DJ, 1984, J COMP NEUROL, V230, P119, DOI 10.1002/cne.902300111; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; SUAREZ H, 1995, J NEUROSCI, V15, P6700; Swadlow HA, 2002, J NEUROSCI, V22, P7766; Swadlow HA, 2002, NAT NEUROSCI, V5, P403, DOI 10.1038/nn847; Temereanca S, 2003, J NEUROPHYSIOL, V89, P2137, DOI 10.1152/jn.00582.2002; Varga C, 2002, J NEUROSCI, V22, P6186; Waters J, 2004, J NEUROSCI, V24, P11127, DOI 10.1523/JNEUROSCI.2933-04.2004; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wilent WB, 2005, J NEUROSCI, V25, P2983, DOI 10.1523/JNEUROSCI.4906-04.2005	40	502	505	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1622	1627		10.1126/science.1124593	http://dx.doi.org/10.1126/science.1124593			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778049				2022-12-24	WOS:000238288600037
J	Wang, J; Soisson, SM; Young, K; Shoop, W; Kodali, S; Galgoci, A; Painter, R; Parthasarathy, G; Tang, YS; Cummings, R; Ha, S; Dorso, K; Motyl, M; Jayasuriya, H; Ondeyka, J; Herath, K; Zhang, CW; Hernandez, L; Allocco, J; Basilio, A; Tormo, JR; Genilloud, O; Vicente, F; Pelaez, F; Colwell, L; Lee, SH; Michael, B; Felcetto, T; Gill, C; Silver, LL; Hermes, JD; Bartizal, K; Barrett, J; Schmatz, D; Becker, JW; Cully, D; Singh, SB				Wang, J; Soisson, SM; Young, K; Shoop, W; Kodali, S; Galgoci, A; Painter, R; Parthasarathy, G; Tang, YS; Cummings, R; Ha, S; Dorso, K; Motyl, M; Jayasuriya, H; Ondeyka, J; Herath, K; Zhang, CW; Hernandez, L; Allocco, J; Basilio, A; Tormo, JR; Genilloud, O; Vicente, F; Pelaez, F; Colwell, L; Lee, SH; Michael, B; Felcetto, T; Gill, C; Silver, LL; Hermes, JD; Bartizal, K; Barrett, J; Schmatz, D; Becker, JW; Cully, D; Singh, SB			Platensimycin is a selective FabF inhibitor with potent antibiotic properties	NATURE			English	Article							FATTY-ACID BIOSYNTHESIS; SYNTHASE-III FABH; ESCHERICHIA-COLI; CARRIER; THIOLACTOMYCIN; DISCOVERY; CERULENIN; CONDENSATION	Bacterial infection remains a serious threat to human lives because of emerging resistance to existing antibiotics. Although the scientific community has avidly pursued the discovery of new antibiotics that interact with new targets, these efforts have met with limited success since the early 1960s(1,2). Here we report the discovery of platensimycin, a previously unknown class of antibiotics produced by Streptomyces platensis. Platensimycin demonstrates strong, broad-spectrum Gram-positive antibacterial activity by selectively inhibiting cellular lipid biosynthesis. We show that this anti-bacterial effect is exerted through the selective targeting of beta-ketoacyl-(acyl-carrier-protein(ACP)) synthase I/II (FabF/B) in the synthetic pathway of fatty acids. Direct binding assays show that platensimycin interacts specifically with the acyl-enzyme intermediate of the target protein, and X-ray crystallographic studies reveal that a specific conformational change that occurs on acylation must take place before the inhibitor can bind. Treatment with platensimycin eradicates Staphylococcus aureus infection in mice. Because of its unique mode of action, platensimycin shows no cross-resistance to other key antibiotic-resistant strains tested, including methicillin-resistant S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant enterococci. Platensimycin is the most potent inhibitor reported for the FabF/ B condensing enzymes, and is the only inhibitor of these targets that shows broad-spectrum activity, in vivo efficacy and no observed toxicity.	Merck Res Labs, Rahway, NJ 07065 USA	Merck & Company	Wang, J (corresponding author), Merck Res Labs, Rahway, NJ 07065 USA.	jun_wang2@merck.com; stephen_soisson@merck.com; sheo_singh@merck.com	Genilloud, Olga/I-2779-2015; vicente, francisca/N-5126-2014; Silver, Lynn L/A-7789-2009; Pelaez, Fernando/K-1790-2014; Tormo, Jose R/M-1044-2014	Genilloud, Olga/0000-0002-4202-1219; vicente, francisca/0000-0003-3198-9205; Silver, Lynn L/0000-0002-8416-0487; Tormo, Jose R/0000-0001-6984-2941; Pelaez, Fernando/0000-0002-4861-586X				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Butler MS, 2006, BIOCHEM PHARMACOL, V71, P919, DOI 10.1016/j.bcp.2005.10.012; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; Heath Richard J, 2004, Curr Opin Investig Drugs, V5, P146; Heath RJ, 2002, NAT PROD REP, V19, P581, DOI 10.1039/b110221b; Huang WJ, 1998, EMBO J, V17, P1183, DOI 10.1093/emboj/17.5.1183; HUNTER CA, 1991, J MOL BIOL, V218, P837, DOI 10.1016/0022-2836(91)90271-7; Kodali S, 2005, J BIOL CHEM, V280, P1669, DOI 10.1074/jbc.M406848200; Lai CY, 2003, J BIOL CHEM, V278, P51494, DOI 10.1074/jbc.M308638200; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; MATSUMAE A, 1964, J ANTIBIOT, V17, P1; McGuire KA, 2001, BIOCHEMISTRY-US, V40, P9836, DOI 10.1021/bi0105577; NOTO T, 1982, J ANTIBIOT, V35, P401, DOI 10.7164/antibiotics.35.401; Olsen JG, 2001, STRUCTURE, V9, P233, DOI 10.1016/S0969-2126(01)00583-4; Price AC, 2001, J BIOL CHEM, V276, P6551, DOI 10.1074/jbc.M007101200; Revill WP, 2001, J BACTERIOL, V183, P3526, DOI 10.1128/JB.183.11.3526-3530.2001; Schujman GE, 2001, J BACTERIOL, V183, P3032, DOI 10.1128/JB.183.10.3032-3040.2001; Singh SB, 2006, BIOCHEM PHARMACOL, V71, P1006, DOI 10.1016/j.bcp.2005.12.016; Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X; TSAY JT, 1992, J BACTERIOL, V174, P508, DOI 10.1128/jb.174.2.508-513.1992; Wang J, 2003, J BIOL CHEM, V278, P44424, DOI 10.1074/jbc.M307625200; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Witkowski A, 1999, BIOCHEMISTRY-US, V38, P11643, DOI 10.1021/bi990993h; Young K, 2006, ANTIMICROB AGENTS CH, V50, P519, DOI 10.1128/AAC.50.2.519-526.2006; Zhang YM, 2003, J LIPID RES, V44, P1, DOI 10.1194/jlr.R200016-JLR200	25	671	711	4	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					358	361		10.1038/nature04784	http://dx.doi.org/10.1038/nature04784			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	043IB	16710421				2022-12-24	WOS:000237593200050
J	Brown, KM; Kondeatis, E; Vaughan, RW; Kon, SP; Farmer, CKT; Taylor, JD; He, X; Johnston, A; Horsfield, C; Janssen, BJC; Gros, P; Zhou, WD; Sacks, SH; Sheerin, NS				Brown, KM; Kondeatis, E; Vaughan, RW; Kon, SP; Farmer, CKT; Taylor, JD; He, X; Johnston, A; Horsfield, C; Janssen, BJC; Gros, P; Zhou, WD; Sacks, SH; Sheerin, NS			Influence of donor C3 allotype on late renal-transplantation outcome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-COMPLEMENT COMPONENT-C3; CHRONIC ALLOGRAFT NEPHROPATHY; MOLECULAR ANALYSIS; REJECTION; CELLS; SYSTEM; POLYMORPHISMS; ACTIVATION; CAPACITY; IMMUNITY	BACKGROUND: The complement system has a critical role in both the innate and the adaptive immune responses. In humans, C3 exists as two main allotypes, F (fast) and S (slow), which are known to affect the incidence of inflammatory disease. We conducted a study to address the influence of these alleles on late renal-graft outcome. METHODS: We determined the C3 allotypes of 662 pairs of adult kidney donors and recipients from 1993 through 2002 and then related C3F/S polymorphism status to demographic and clinical outcome data. The median length of follow-up was 3.3 years. RESULTS: Analysis of 513 pairs of white donors and recipients identified 113 C3S/S recipients of a C3S/F or a C3F/F kidney and 179 C3S/S recipients of a C3S/S kidney. Graft survival was significantly better with a C3F/F or C3F/S donor allotype than a C3S/S allotype (P=0.05). The hazard ratio for graft loss of C3S/S kidneys, as compared with C3F/F or C3F/S kidneys, was 2.21 (95 percent confidence interval, 1.04 to 4.72; P=0.04). The graft function of C3F/F or C3F/S donor kidneys was significantly better than that of C3S/S donor kidneys (P<0.001). The effect of the C3F allele was specific to recipients who did not themselves possess this allele. Multivariate analysis excluded effects of other factors known to influence graft outcome. CONCLUSIONS: Expression of C3 alleles by donor renal cells appears to have a differential effect on late graft outcome. Among white C3S/S recipients, receipt of a C3F/F or C3F/S donor kidney, rather than a C3S/S donor kidney, is associated with a significantly better long-term outcome. These findings suggest that the two alleles have functional differences.	Guys Hosp, Univ London Kings Coll, Dept Nephrol & Transplantat, London SE1 9RT, England; Guys Hosp, Clin Transplantat Lab, London SE1 9RT, England; Kings Coll Hosp London, London, England; Kent & Canterbury Hosp, Canterbury, Kent, England; Barts & London Queen Marys Sch Med & Dent, Barts & London, Dept Clin Pharmacol, London, England; Guys & St Thomas Natl Hlth Serv Fdn Trust, Dept Histopathol, London, England; Univ Utrecht, Fac Sci, Bijvoet Ctr Biomol Res, Dept Crystal & Struct Chem, Utrecht, Netherlands	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Kent; University of London; Queen Mary University London; Guy's & St Thomas' NHS Foundation Trust; Utrecht University	Sheerin, NS (corresponding author), Guys Hosp, Univ London Kings Coll, Dept Nephrol & Transplantat, 5th Fl,Thomas Guy House, London SE1 9RT, England.	neil.sheerin@kcl.ac.uk	Gros, Piet/I-5569-2016; Janssen, Bert/I-3338-2016; Gros, Piet/AAD-6452-2019	Gros, Piet/0000-0002-7782-2585; Janssen, Bert/0000-0002-8101-8370; Gros, Piet/0000-0002-7782-2585; Farmer, Christopher/0000-0003-1736-8242; Sacks, Steven/0000-0001-6361-9095; Johnston, Atholl/0000-0001-5787-2270	MRC [G0000771] Funding Source: UKRI; Medical Research Council [G0000771] Funding Source: Medline; Wellcome Trust [066800-Z-02-2] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aftali B, 2005, TRANSPLANTATION, V79, P304, DOI 10.1097/01.TP.0000151145.12706.2A; ALPER CA, 1968, J CLIN INVEST, V47, P2181, DOI 10.1172/JCI105904; Andrews PA, 1995, TRANSPLANTATION, V60, P1342; [Anonymous], 2004, 2004 ANN REP US ORG; ARVILOMMI H, 1974, NATURE, V251, P740, DOI 10.1038/251740a0; Barton MK, 2001, GENOME BIOL, V2; Bostom AG, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022011.35035.F3; BOTTO M, 1990, J EXP MED, V172, P1011, DOI 10.1084/jem.172.4.1011; ERDEI A, 1991, IMMUNOL TODAY, V12, P332, DOI 10.1016/0167-5699(91)90011-H; Exner M, 2004, TRANSPLANTATION, V77, P538, DOI 10.1097/01.TP.0000113467.36269.F8; FEUCHT HE, 1993, KIDNEY INT, V43, P1333, DOI 10.1038/ki.1993.187; FINN JE, 1993, CLIN EXP IMMUNOL, V91, P410; FINN JE, 1994, NEPHROL DIAL TRANSPL, V9, P1564; Heeger PS, 2005, J EXP MED, V201, P1523, DOI 10.1084/jem.20041967; Hoffmann S, 2004, KIDNEY INT, V66, P1686, DOI 10.1111/j.1523-1755.2004.00936.x; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Kemper C, 2003, NATURE, V421, P388, DOI 10.1038/nature01315; KOCH C, 1986, IMMUNOGENETICS, V23, P322, DOI 10.1007/BF00398796; Li K, 2004, J AM SOC NEPHROL, V15, P2414, DOI 10.1097/01.ASN.0000135974.06478.7B; MCLEAN RH, 1984, J PEDIATR-US, V105, P179, DOI 10.1016/S0022-3476(84)80110-9; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Naughton MA, 1996, J IMMUNOL, V156, P3051; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Paul LC, 1999, KIDNEY INT, V56, P783, DOI 10.1046/j.1523-1755.1999.00611.x; POZNANSKY MC, 1989, J IMMUNOL, V143, P1254; Pratt JR, 2002, NAT MED, V8, P582, DOI 10.1038/nm0602-582; Pratt JR, 2000, AM J PATHOL, V157, P825, DOI 10.1016/S0002-9440(10)64596-8; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; RAMBAUSEK M, 1987, Nephrology Dialysis Transplantation, V2, P208; Sacks SH, 2003, CURR OPIN IMMUNOL, V15, P487, DOI 10.1016/S0952-7915(03)00100-6; Sacks SH, 2002, CURR OPIN NEPHROL HY, V11, P627, DOI 10.1097/00041552-200211000-00009; Tang S, 1999, J IMMUNOL, V162, P4336; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Zhou WD, 2006, BLOOD, V107, P2461, DOI 10.1182/blood-2005-08-3144; Zhou WD, 2000, J CLIN INVEST, V105, P1363, DOI 10.1172/JCI8621	35	137	139	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2006	354	19					2014	2023		10.1056/NEJMoa052825	http://dx.doi.org/10.1056/NEJMoa052825			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040XA	16687714	Green Published			2022-12-24	WOS:000237413100006
J	Padoa-Schioppa, C; Assad, JA				Padoa-Schioppa, C; Assad, JA			Neurons in the orbitofrontal cortex encode economic value	NATURE			English	Article							ORBITAL PREFRONTAL CORTEX; REWARD PREFERENCE; EXPECTED REWARD; MONKEYS; SIGNALS; CINGULATE; RESPONSES; BEHAVIOR; LESIONS	Economic choice is the behaviour observed when individuals select one among many available options. There is no intrinsically 'correct' answer: economic choice depends on subjective preferences. This behaviour is traditionally the object of economic analysis(1) and is also of primary interest in psychology(2). However, the underlying mental processes and neuronal mechanisms are not well understood. Theories of human and animal choice(1-3) have a cornerstone in the concept of 'value'. Consider, for example, a monkey offered one raisin versus one piece of apple: behavioural evidence suggests that the animal chooses by assigning values to the two options(4). But where and how values are represented in the brain is unclear. Here we show that, during economic choice, neurons in the orbitofrontal cortex(5-18) (OFC) encode the value of offered and chosen goods. Notably, OFC neurons encode value independently of visuospatial factors and motor responses. If a monkey chooses between A and B, neurons in the OFC encode the value of the two goods independently of whether A is presented on the right and B on the left, or vice versa. This trait distinguishes the OFC from other brain areas in which value modulates activity related to sensory or motor processes(19-25). Our results have broad implications for possible psychological models, suggesting that economic choice is essentially choice between goods rather than choice between actions. In this framework, neurons in the OFC seem to be a good candidate network for value assignment underlying economic choice.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Padoa-Schioppa, C (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	camillo@alum.mit.edu		Padoa-Schioppa, Camillo/0000-0002-7519-8790	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041000] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS041000, R01 NS041000-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; BUTTER CM, 1969, SCIENCE, V164, P1306, DOI 10.1126/science.164.3885.1306; Deaner RO, 2005, CURR BIOL, V15, P543, DOI 10.1016/j.cub.2005.01.044; Glimcher PW, 2005, GAME ECON BEHAV, V52, P213, DOI 10.1016/j.geb.2004.06.011; HODGES JR, 2001, NEUROLOGY S4, V56, P6; Ikeda T, 2003, NEURON, V39, P693, DOI 10.1016/S0896-6273(03)00464-1; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Kagel John H., 1995, EC CHOICE THEORY EXP; Kahneman D, 2000, CHOICES VALUES FRAME; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; McCoy AN, 2003, NEURON, V40, P1031, DOI 10.1016/S0896-6273(03)00719-0; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Padoa-Schioppa C, 2006, COGNITION, V99, pB1, DOI 10.1016/j.cognition.2005.04.008; Pasquier F, 1997, EUR NEUROL, V38, P1, DOI 10.1159/000112894; Pinker S., 1997, MIND WORKS; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rahman S, 1999, BRAIN, V122, P1469, DOI 10.1093/brain/122.8.1469; RALEIGH MJ, 1981, EXP NEUROL, V73, P378, DOI 10.1016/0014-4886(81)90273-9; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; ROLLS ET, 1989, EUR J NEUROSCI, V1, P53, DOI 10.1111/j.1460-9568.1989.tb00774.x; SAMUELSON P. A., 1947, FDN EC ANAL; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Simon HA, 1982, P AM PHILOS SOC, V106, P467; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; ZIGMOND MJ, 1999, FUNDAMENTAL NEUROSCI, pCH53	30	1002	1017	7	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2006	441	7090					223	226		10.1038/nature04676	http://dx.doi.org/10.1038/nature04676			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16633341	Green Accepted			2022-12-24	WOS:000237418800047
J	Banziger, C; Soldini, D; Schutt, C; Zipperlen, P; Hausmann, G; Basler, K				Banziger, Carla; Soldini, Davide; Schuett, Corina; Zipperlen, Peder; Hausmann, George; Basler, Konrad			Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells	CELL			English	Article							LONG-RANGE ACTION; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; WINGLESS SIGNAL; POLARITY; ENCODES; PATHWAY; MECHANISMS; GLYPICANS; TRANSDUCE	Cell-cell communication via Wnt signals represents a fundamental means by which animal development and homeostasis are controlled. The identification of components of the Wnt pathway is reaching saturation for the transduction process in receiving cells but is incomplete concerning the events occurring in Wnt-secreting cells. Here, we describe the discovery of a novel Wnt pathway component, Wntless (Wls/Evi), and show that it is required for Wingless-dependent patterning processes in Drosophila, for MOM-2-governed polarization of blastomeres; in C. elegans, and for Wnt3a-mediated communication between cultured human cells. In each of these cases, Wls is acting in the Wnt-sending cells to promote the secretion of Wnt proteins. Since loss of Wls function has no effect on other signaling pathways yet appears to impede all the Wnt signals we analyzed, we propose that Wls represents an ancient partner for Writs dedicated to promoting their secretion into the extracellular milieu.	Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland; PhD Program Mol Life Sci, Zurich, Switzerland; Genet Co Inc, CH-8952 Schlieren, Switzerland	University of Zurich	Basler, K (corresponding author), Univ Zurich, Inst Mol Biol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	basler@molbio.unizh.ch		Basler, Konrad/0000-0003-3534-1529				Baeg GH, 2001, DEVELOPMENT, V128, P87; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Blair SS, 2005, CURR BIOL, V15, pR92, DOI 10.1016/j.cub.2005.01.026; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cohen ED, 2002, DEV CELL, V2, P437, DOI 10.1016/S1534-5807(02)00142-9; COUSO JP, 1994, DEVELOPMENT, V120, P621; Culi J, 2003, CELL, V112, P343, DOI 10.1016/S0092-8674(02)01279-5; DINARDO S, 1988, NATURE, V332, P604, DOI 10.1038/332604a0; Eisenmann DM, 2000, GENETICS, V156, P1097; Franch-Marro X, 2005, DEVELOPMENT, V132, P659, DOI 10.1242/dev.01639; Gerlitz O, 2002, INT J DEV BIOL, V46, P173; HERMAN MA, 1995, CELL, V83, P101, DOI 10.1016/0092-8674(95)90238-4; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Jiang LI, 1999, DEV BIOL, V211, P88, DOI 10.1006/dbio.1999.9293; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Kozopas KM, 1998, GENE DEV, V12, P1155, DOI 10.1101/gad.12.8.1155; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Millar JBA, 2002, GENOME BIOL, V3; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; PEIFER M, 1991, DEVELOPMENT, V111, P1029; Pfeiffer S, 2002, CURR BIOL, V12, P957, DOI 10.1016/S0960-9822(02)00867-9; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Tanaka K, 2002, J BIOL CHEM, V277, P12816, DOI 10.1074/jbc.M200187200; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Thorpe CJ, 2000, TRENDS CELL BIOL, V10, P10, DOI 10.1016/S0962-8924(99)01672-4; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	43	528	547	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					509	522		10.1016/j.cell.2006.02.049	http://dx.doi.org/10.1016/j.cell.2006.02.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678095	Bronze			2022-12-24	WOS:000237506100017
J	Bazin, E; Glemin, S; Galtier, N				Bazin, E; Glemin, S; Galtier, N			Population size does not influence mitochondrial genetic diversity in animals	SCIENCE			English	Article							SELECTION; DRIFT; DNA; POLYMORPHISM; EVOLUTION	Within-species genetic diversity is thought to reflect population size, history, ecology, and ability to adapt. Using a comprehensive collection of polymorphism data sets covering 3000 animal species, we show that the widely used mitochondria) DNA (mtDNA) marker does not reflect species abundance or ecology: mtDNA diversity is not higher in invertebrates than in vertebrates, in marine than in terrestrial species, or in small than in large organisms. Nuclear loci, in contrast, fit these intuitive expectations. The unexpected mitochondria( diversity distribution is explained by recurrent adaptive evolution, challenging the neutral theory of molecular evolution and questioning the relevance of mtDNA in biodiversity and conservation studies.	Univ Montpellier 2, CNRS, UMR Genome Populat Interact Adaptat 5171, F-34095 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Galtier, N (corresponding author), Univ Montpellier 2, CNRS, UMR Genome Populat Interact Adaptat 5171, F-34095 Montpellier 5, France.	galtier@univ-montp2.fr	Bazin, Eric/A-4033-2010					Amos W, 1998, PHILOS T ROY SOC B, V353, P177, DOI 10.1098/rstb.1998.0200; Amos W, 2001, HEREDITY, V87, P257, DOI 10.1046/j.1365-2540.2001.00940.x; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Barton NH, 2000, PHILOS T R SOC B, V355, P1553, DOI 10.1098/rstb.2000.0716; Bazin E, 2005, NUCLEIC ACIDS RES, V33, pD481, DOI 10.1093/nar/gki076; CABALLERO A, 1992, GENETICS, V131, P493; CHARLESWORTH B, 1993, GENETICS, V134, P1289; CHARLESWORTH D, 1995, GENETICS, V141, P1619; Cherry JL, 2003, GENETICS, V163, P421; Foltz DW, 2003, J MOL EVOL, V57, P607, DOI 10.1007/s00239-003-2495-5; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Gillespie J. H., 1991, CAUSES MOL EVOLUTION; Gillespie JH, 2001, EVOLUTION, V55, P2161; Gillespie JH, 2000, GENETICS, V155, P909; Grossman LI, 2004, TRENDS GENET, V20, P578, DOI 10.1016/j.tig.2004.09.002; Hedrick P, 2005, EVOLUTION, V59, P1596; Hudson RR, 2003, EVOLUTION, V57, P182; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Iizuka M, 2002, GENETICS, V161, P381; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672300014634, 10.1017/S0016672308009579]; Nevo E., 1984, Lecture Notes in Biomathematics, V53, P13; OBRIEN SJ, 1994, P NATL ACAD SCI USA, V91, P5748, DOI 10.1073/pnas.91.13.5748; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Roze D, 2005, GENETICS, V170, P1385, DOI 10.1534/genetics.104.039495; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Willett CS, 2004, MOL BIOL EVOL, V21, P443, DOI 10.1093/molbev/msh031	29	665	677	2	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					570	572		10.1126/science.1122033	http://dx.doi.org/10.1126/science.1122033			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16645093				2022-12-24	WOS:000237296700043
J	Regoes, RR; Bonhoeffer, S				Regoes, RR; Bonhoeffer, S			Emergence of drug-resistant influenza virus: Population dynamical considerations	SCIENCE			English	Editorial Material							NEURAMINIDASE INHIBITORS; ADAMANTANE RESISTANCE; A VIRUSES; IN-VITRO; OSELTAMIVIR; ZANAMIVIR; ANTIVIRALS; CHILDREN; MUTATION; SPREAD	Given the considerable challenges to the rapid development of an effective vaccine against influenza, antiviral agents wilt play an important role as a first-tine defense if a new pandemic occurs. The large-scale use of drugs for chemoprophylaxis and treatment wilt impose strong selection for the evolution of drug-resistant strains. The ensuing transmission of those strains could substantially limit the effectiveness of the drugs as a first-tine defense. Summarizing recent data on the rate at which the treatment of influenza infection generates resistance de novo and on the transmission fitness of resistant virus, we discuss possible implications for the epidemiological spread of drug resistance in the context of an established population dynamic model.	ETH, ETH Zentrum CHN, Inst Intergrat Biol, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Bonhoeffer, S (corresponding author), ETH, ETH Zentrum CHN, Inst Intergrat Biol, K12-1,Univ Str 16, CH-8092 Zurich, Switzerland.	sebastian.bonhoeffer@env.ethz.ch	Regoes, Roland R/A-6538-2008; Bonhoeffer, Sebastian/A-2735-2008	Regoes, Roland R/0000-0001-8319-5293; Bonhoeffer, Sebastian/0000-0001-8052-3925				ANDERSON R M, 1991; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; BEAN WJ, 1989, J INFECT DIS, V159, P1050, DOI 10.1093/infdis/159.6.1050; BELSHE RB, 1988, J VIROL, V62, P1508, DOI 10.1128/JVI.62.5.1508-1512.1988; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Carr J, 2002, ANTIVIR RES, V54, P79, DOI 10.1016/S0166-3542(01)00215-7; Ferguson NM, 2003, J ANTIMICROB CHEMOTH, V51, P977, DOI 10.1093/jac/dkg136; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Gubareva LV, 1998, J INFECT DIS, V178, P1257, DOI 10.1086/314440; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Harper Scott A., 2005, Morbidity and Mortality Weekly Report, V54, P1; HAY AJ, 1996, ANTIVIRAL DRUG RESIS, P43; Hayden FG, 2001, PHILOS T R SOC B, V356, P1877, DOI 10.1098/rstb.2001.1007; Hayden FG, 1997, NEW ENGL J MED, V337, P874, DOI 10.1056/NEJM199709253371302; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Herlocher ML, 2002, ANTIVIR RES, V54, P99, DOI 10.1016/S0166-3542(01)00214-5; Heymann DL, 2006, CELL, V124, P671, DOI 10.1016/j.cell.2006.02.009; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Jackson HC, 2000, CLIN DRUG INVEST, V20, P447, DOI 10.2165/00044011-200020060-00007; Jefferson T., 2004, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD001169.pub2, DOI 10.1002/14651858.CD001169.PUB2]; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; McKimm-Breschkin J, 2003, ANTIMICROB AGENTS CH, V47, P2264, DOI 10.1128/AAC.47.7.2264-2272.2003; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Monto AS, 2003, VACCINE, V21, P1796, DOI 10.1016/S0264-410X(03)00075-6; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Roberts NA, 2001, PHILOS T ROY SOC B, V356, P1895, DOI 10.1098/rstb.2001.1002; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; Shiraishi K, 2003, J INFECT DIS, V188, P57, DOI 10.1086/375799; Stilianakis NI, 1998, J INFECT DIS, V177, P863, DOI 10.1086/515246; WHO, 2021, REP IND ALL VACC GRO; Yen HL, 2005, ANTIMICROB AGENTS CH, V49, P4075, DOI 10.1128/AAC.49.10.4075-4084.2005	35	144	151	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					389	391		10.1126/science.1122947	http://dx.doi.org/10.1126/science.1122947			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	034OZ	16627735				2022-12-24	WOS:000236941800036
J	Foster, LJ; de Hoog, CL; Zhang, YL; Zhang, Y; Xie, XH; Mootha, VK; Mann, M				Foster, LJ; de Hoog, CL; Zhang, YL; Zhang, Y; Xie, XH; Mootha, VK; Mann, M			A mammalian organelle map by protein correlation profiling	CELL			English	Article							LARGE-SCALE ANALYSIS; SUBCELLULAR-LOCALIZATION; PROTEOMIC ANALYSIS; GENE-EXPRESSION; GLOBAL ANALYSIS; GENOMICS; YEAST; PROTEASOME; ARGININE; COMPLEX	Protein localization to membrane-enclosed organelles is a central feature of cellular organization. Using protein correlation profiling, we have mapped 1,404 proteins to ten subcellular locations in mouse liver, and these correspond with enzymatic assays, marker protein profiles, and confocal microscopy. These localizations allowed assessment of the specificity in published organellar proteomic inventories and demonstrate multiple locations for 39% of all organellar proteins. Integration of proteomic and genomic data enabled us to identify networks of coexpressed genes, cis-regulatory motifs, and putative transcriptional regulators involved in organelle biogenesis., Our analysis ties biochemistry, cell biology, and genomics into a common framework for organelle analysis.	Univ So Denmark, Dept Biochem & Mol Biol, CEBI, DK-5230 Odense, Denmark; Univ British Columbia, Dept Biochem & Mol Biol, Ctr Proteom, Vancouver, BC V6T 1Z4, Canada; Max Planck Inst Biochem, Dept Proteom & Signal Transduct, D-82152 Martinsried, Germany; Chinese Acad Sci, Beijing Inst Genom, Beijing 101300, Peoples R China; Harvard Univ, Broad Inst, Cambridge, MA 02139 USA; MIT, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Syst Biol, Boston, MA 02115 USA	University of Southern Denmark; University of British Columbia; Max Planck Society; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital	Mann, M (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, CEBI, Campusvej 55, DK-5230 Odense, Denmark.	mmann@biochem.mpg.de	Mann, Matthias/A-3454-2013	Mann, Matthias/0000-0003-1292-4799; Xie, Xiaohui/0000-0002-5479-6345				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Agaton C, 2003, MOL CELL PROTEOMICS, V2, P405, DOI 10.1074/mcp.M300022-MCP200; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Andreoli C, 2004, NUCLEIC ACIDS RES, V32, pD459, DOI 10.1093/nar/gkh137; Azarani A, 1998, BIOCHEM J, V333, P439, DOI 10.1042/bj3330439; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Breuza L, 2004, J BIOL CHEM, V279, P47242, DOI 10.1074/jbc.M406644200; Cotter D, 2004, NUCLEIC ACIDS RES, V32, pD463, DOI 10.1093/nar/gkh048; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; de Hoog CL, 2004, ANNU REV GENOM HUM G, V5, P267, DOI 10.1146/annurev.genom.4.070802.110305; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dunkley TPJ, 2004, MOL CELL PROTEOMICS, V3, P1128, DOI 10.1074/mcp.T400009-MCP200; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Gaucher SP, 2004, J PROTEOME RES, V3, P495, DOI 10.1021/pr034102a; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Glaser P, 2004, CURR OPIN MICROBIOL, V7, P489, DOI 10.1016/j.mib.2004.08.016; Hashiramoto M, 2000, MOL CELL BIOL, V20, P416, DOI 10.1128/MCB.20.1.416-427.2000; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jover R, 2001, HEPATOLOGY, V33, P668, DOI 10.1053/jhep.2001.22176; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; PETERS JM, 1994, J BIOL CHEM, V269, P7709; RAPPSILBER J, 2003, 51 C MASS SPECTR ALL; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; Scarpulla RC, 1997, J BIOENERG BIOMEMBR, V29, P109, DOI 10.1023/A:1022681828846; Schulze WX, 2004, J BIOL CHEM, V279, P10756, DOI 10.1074/jbc.M309909200; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Syka JEP, 2004, J PROTEOME RES, V3, P621, DOI 10.1021/pr0499794; Tulp A, 1998, ELECTROPHORESIS, V19, P1288, DOI 10.1002/elps.1150190812; Wiemann S, 2004, GENOME RES, V14, P2136, DOI 10.1101/gr.2576704; Wu CC, 2004, MOL BIOL CELL, V15, P2907, DOI 10.1091/mbc.E04-02-0101; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yates JR, 2005, NAT REV MOL CELL BIO, V6, P702, DOI 10.1038/nrm1711; Zhao YX, 2004, ANAL CHEM, V76, P1817, DOI 10.1021/ac0354037	43	439	452	0	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2006	125	1					187	199		10.1016/j.cell.2006.03.022	http://dx.doi.org/10.1016/j.cell.2006.03.022			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615899	Bronze			2022-12-24	WOS:000237314200023
J	Sadqi, M; Fushman, D; Munoz, V				Sadqi, Mourad; Fushman, David; Munoz, Victor			Atom-by-atom analysis of global downhill protein folding	NATURE			English	Article							CHEMICAL-SHIFTS; SPEED LIMIT; 2-STATE; MODEL; STABILITY; DOMAIN	Protein folding is an inherently complex process involving coordination of the intricate networks of weak interactions that stabilize native three-dimensional structures. In the conventional paradigm, simple protein structures are assumed to fold in an all-or-none process(1) that is inaccessible to experiment. Existing experimental methods therefore probe folding mechanisms indirectly. A widely used approach interprets changes in protein stability(2) and/or folding kinetics(3,4), induced by engineered mutations, in terms of the structure of the native protein. In addition to limitations in connecting energetics with structure(5), mutational methods have significant experimental uncertainties(6) and are unable to map complex networks of interactions. In contrast, analytical theory predicts small barriers to folding and the possibility of downhill folding(7,8). These theoretical predictions have been confirmed experimentally in recent years(9-11), including the observation of global downhill folding(12). However, a key remaining question is whether downhill folding can indeed lead to the high-resolution analysis of protein folding processes(13). Here we show, with the use of nuclear magnetic resonance (NMR), that the downhill protein BBL from Escherichia coli unfolds atom by atom starting from a defined three-dimensional structure. Thermal unfolding data on 158 backbone and side-chain protons out of a total of 204 provide a detailed view of the structural events during folding. This view confirms the statistical nature of folding, and exposes the interplay between hydrogen bonding, hydrophobic forces, backbone conformation and side-chain entropy. From the data we also obtain a map of the interaction network in this protein, which reveals the source of folding cooperativity. Our approach can be extended to other proteins with marginal barriers ( less than 3RT), providing a new tool for the study of protein folding.	Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; Univ Maryland, Ctr Biomol Struct & Org, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Munoz, V (corresponding author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.	vmunoz@umd.edu	Sadqi, Mourad/J-3180-2018	Sadqi, Mourad/0000-0003-3553-3408				Akmal A, 2004, PROTEINS, V57, P142, DOI 10.1002/prot.20172; Arai M, 1996, FOLD DES, V1, P275, DOI 10.1016/S1359-0278(96)00041-7; BRYNGELSON JD, 1995, PROTEINS STRUCT DESI, V1, P167; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Garcia-Mira MM, 2002, SCIENCE, V298, P2191, DOI 10.1126/science.1077809; Goldenberg David P., 1992, P353; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; Holtzer ME, 1997, BIOPHYS J, V73, P1031, DOI 10.1016/S0006-3495(97)78136-0; HONIG B, 1995, ADV PROTEIN CHEM, V46, P27, DOI 10.1016/S0065-3233(08)60331-9; Klimov DK, 2002, J COMPUT CHEM, V23, P161, DOI 10.1002/jcc.10005; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Maity H, 2005, P NATL ACAD SCI USA, V102, P4741, DOI 10.1073/pnas.0501043102; MATTHEWS BW, 1993, CURR OPIN STRUC BIOL, V3, P589, DOI 10.1016/0959-440X(93)90088-3; Munoz V, 2004, P NATL ACAD SCI USA, V101, P17646, DOI 10.1073/pnas.0405829101; Munoz V, 2002, INT J QUANTUM CHEM, V90, P1522, DOI 10.1002/qua.10384; Naganathan AN, 2005, BIOCHEMISTRY-US, V44, P7435, DOI 10.1021/bi050118y; Naganathan AN, 2005, J AM CHEM SOC, V127, P480, DOI 10.1021/ja044449u; Oliva FY, 2004, J AM CHEM SOC, V126, P8596, DOI 10.1021/ja048309w; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Plotkin SS, 1997, J CHEM PHYS, V106, P2932, DOI 10.1063/1.473355; ROBIEN MA, 1992, BIOCHEMISTRY-US, V31, P3463, DOI 10.1021/bi00128a021; Sanchez IE, 2003, J MOL BIOL, V334, P1077, DOI 10.1016/j.jmb.2003.10.016; Shimizu S, 2002, PROTEINS, V48, P15, DOI 10.1002/prot.10108; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; WAGNER G, 1983, J AM CHEM SOC, V105, P5948, DOI 10.1021/ja00356a056; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; Yang WY, 2003, NATURE, V423, P193, DOI 10.1038/nature01609	29	212	212	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2006	442	7100					317	321		10.1038/nature04859	http://dx.doi.org/10.1038/nature04859			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16799571				2022-12-24	WOS:000239122100042
J	Condit, R; Ashton, P; Bunyavejchewin, S; Dattaraja, HS; Davies, S; Esufali, S; Ewango, C; Foster, R; Gunatilleke, IAUN; Gunatilleke, CVS; Hall, P; Harms, KE; Hart, T; Hernandez, C; Hubbell, S; Itoh, A; Kiratiprayoon, S; LaFrankie, J; de Lao, SL; Makana, JR; Noor, MNS; Kassim, AR; Russo, S; Sukumar, R; Samper, C; Suresh, HS; Tan, S; Thomas, S; Valencia, R; Vallejo, M; Villa, G; Zillio, T				Condit, Richard; Ashton, Peter; Bunyavejchewin, Sarayudh; Dattaraja, H. S.; Davies, Stuart; Esufali, Shameema; Ewango, Corneille; Foster, Robin; Gunatilleke, I. A. U. N.; Gunatilleke, C. V. S.; Hall, Pamela; Harms, Kyle E.; Hart, Terese; Hernandez, Consuelo; Hubbell, Stephen; Itoh, Akira; Kiratiprayoon, Somboon; LaFrankie, James; de Lao, Suzanne Loo; Makana, Jean-Remy; Noor, Md. Nur Supardi; Kassim, Abdul Rahman; Russo, Sabrina; Sukumar, Raman; Samper, Cristian; Suresh, Hebbalalu S.; Tan, Sylvester; Thomas, Sean; Valencia, Renato; Vallejo, Martha; Villa, Gorky; Zillio, Tommaso			The importance of demographic niches to tree diversity	SCIENCE			English	Article							PLANT COMMUNITIES; SPECIES-RICHNESS; TROPICAL FOREST; LONG-TERM; DYNAMICS; RATES; DISTRIBUTIONS; COEXISTENCE; COMPETITION	Most ecological hypotheses about species coexistence hinge on species differences, but quantifying trait differences across species in diverse communities is often unfeasible. We examined the variation of demographic traits using a global tropical forest data set covering 4500 species in 10 large-scale tree inventories. With a hierarchical Bayesian approach, we quantified the distribution of mortality and growth rates of all tree species at each site. This allowed us to test the prediction that demographic differences facilitate species richness, as suggested by the theory that a tradeoff between high growth and high survival allows species to coexist. Contrary to the prediction, the most diverse forests had the least demographic variation. Although demographic differences may foster coexistence, they do not explain any of the 16-fold variation in tree species richness observed across the tropics.	Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; Smithsonian Trop Res Inst, Ctr Trop Forest Sci, Unit 0948, APO, AA 34002 USA; Harvard Univ Herbaria, Ctr Trop Forest Sci, Asia Program, Arnold Arboretum Asia Program, Cambridge, MA 02138 USA; Thai Natl Pk Wildlife & Plant Conservat Dept, Res Off, Bangkok 10900, Thailand; Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; Univ Peradeniya, Fac Sci, Dept Bot, Peradeniya 20400, Sri Lanka; Univ Missouri, St Louis, MO 63121 USA; Field Museum, Dept Bot, Chicago, IL 60605 USA; Florida State Univ, Dept Biol, Tallahassee, FL 32309 USA; Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; Wildlife Conservat Soc, Kinshasa 1, DEM REP CONGO; Pontificia Univ Catolica Ecuador, Quito, Ecuador; Univ Georgia, Dept Plant Sci, Athens, GA 30602 USA; Osaka City Univ, Fac Sci, Plant Ecol Lab, Sumiyoshi Ku, Osaka 558, Japan; Thammasat Univ Rangsit, Fac Sci & Technol, Pathum Thani 12121, Thailand; Nanyang Technol Univ, Ctr Trop Forest Sci, Asia Program, Natl Inst Educ, Singapore 637616, Singapore; Forest Res Inst, Forest Environm Div, Kuala Lumpur 52109, Malaysia; Natl Museum Nat Hist, Smithsonian Inst, Washington, DC 20560 USA; Sarawak forest Dept, Forest Res Ctr, Kuching 93250, Sarawak, Malaysia; Univ Toronto, Toronto, ON M5S 3B3, Canada; Inst Alexander von Humboldt, Bogota, Colombia	National Center for Ecological Analysis & Synthesis; Smithsonian Institution; Smithsonian Tropical Research Institute; Harvard University; Indian Institute of Science (IISC) - Bangalore; University of Peradeniya; University of Missouri System; University of Missouri Saint Louis; Field Museum of Natural History (Chicago); State University System of Florida; Florida State University; Louisiana State University System; Louisiana State University; Pontificia Universidad Catolica del Ecuador; University System of Georgia; University of Georgia; Osaka Metropolitan University; Thammasat University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Institute of Education (NIE) Singapore; Institute Penyelidikan Perhutanan Malaysia; Smithsonian Institution; Smithsonian National Museum of Natural History; Jabatan Hutan Sarawak; Pusat Penyelidikan Hutan; University of Toronto	Condit, R (corresponding author), Natl Ctr Ecol Anal & Synth, 735 State St, Santa Barbara, CA 93101 USA.	condit@ctfs.si.edu	Bunyavejchewin, Sarayudh/P-1529-2017; Raman, Sukumar/C-9809-2013; THOMAS, Sean C./B-6089-2008	Bunyavejchewin, Sarayudh/0000-0002-1976-5041; THOMAS, Sean C./0000-0002-0686-2483; Makana, Jean-Remy/0000-0002-6006-2938; Esufali, Shameema/0000-0002-6522-0050; Valencia, Renato/0000-0001-9770-6568				Bolker BM, 2003, AM NAT, V162, P135, DOI 10.1086/376575; Bonsall MB, 2004, SCIENCE, V306, P111, DOI 10.1126/science.1100680; Clark JS, 2004, ECOL MONOGR, V74, P415, DOI 10.1890/02-4093; Clark JS, 2003, ECOLOGY, V84, P17, DOI 10.1890/0012-9658(2003)084[0017:CHTITT]2.0.CO;2; Condit R, 1999, PHILOS T R SOC B, V354, P1739, DOI 10.1098/rstb.1999.0517; CONDIT R, 1995, TRENDS ECOL EVOL, V10, P18, DOI 10.1016/S0169-5347(00)88955-7; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Gelman A, 2013, BAYESIAN DATA ANAL, P16; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; HUBBELL SP, IN PRESS ECOLOGY; Liermann M, 1997, CAN J FISH AQUAT SCI, V54, P1976, DOI 10.1139/cjfas-54-9-1976; Pacala SW, 1998, AM NAT, V152, P729, DOI 10.1086/286203; PHILLIPS OL, 1994, P NATL ACAD SCI USA, V91, P2805, DOI 10.1073/pnas.91.7.2805; Pitman NCA, 1999, ECOLOGY, V80, P2651, DOI 10.1890/0012-9658(1999)080[2651:TSDIAU]2.0.CO;2; Rees M, 2001, SCIENCE, V293, P650, DOI 10.1126/science.1062586; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Stephenson NL, 2005, ECOL LETT, V8, P524, DOI 10.1111/j.1461-0248.2005.00746.x; Sukumar R, 1998, MAN BIOSPH, V20, P495; SWAINE MD, 1987, J TROP ECOL, V3, P359, DOI 10.1017/S0266467400002339; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; TILMAN D, 1988; Vanclay J. K., 1991, Journal of Tropical Forest Science, V4, P15; Wright SJ, 2003, ECOLOGY, V84, P3174, DOI 10.1890/02-0038; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	24	189	233	4	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2006	313	5783					98	101		10.1126/science.1124712	http://dx.doi.org/10.1126/science.1124712			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16763113	Green Published			2022-12-24	WOS:000238850200040
J	Garb, JE; DiMauro, T; Vo, V; Hayashi, CY				Garb, Jessica E.; DiMauro, Teresa; Vo, Victoria; Hayashi, Cheryl Y.			Silk genes support the single origin of orb webs	SCIENCE			English	Article							SPIDER SILK		Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Garb, JE (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	jessica.garb@ucr.edu	Garb, Jessica E/J-4566-2015					Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; Griswold CE, 1998, ZOOL J LINN SOC-LOND, V123, P1; Platnick N. I., 1991, AM MUS NOVIT, V3016, P1; SELDEN PA, 1989, NATURE, V340, P711, DOI 10.1038/340711a0; Shear W, 1986, SPIDERS WEBS BEHAV E; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000	6	74	77	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2006	312	5781					1762	1762		10.1126/science.1127946	http://dx.doi.org/10.1126/science.1127946			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16794073	Green Submitted			2022-12-24	WOS:000238452800047
J	Long, JA; Ohno, C; Smith, ZR; Meyerowitz, EM				Long, JA; Ohno, C; Smith, ZR; Meyerowitz, EM			TOPLESS regulates apical embryonic fate in Arabidopsis	SCIENCE			English	Article							HISTONE ACETYLTRANSFERASE; THALIANA; MERISTEM; GENE; EMBRYOGENESIS; SHOOT; COREPRESSOR; EXPRESSION; DYNAMICS; ENCODES	The embryos of seed plants develop with an apical shoot pole and a basal root pole. In Arabidopsis, the topless-1 (tpl-1) mutation transforms the shoot pole into a second root pole. Here, we show that TPL resembles known transcriptional corepressors and that tpl-1 acts as a dominant negative mutation for multiple TPL-related proteins. Mutations in the putative coactivator HISTONE ACETYLTRANSFERASE GNAT SUPERFAMILY1 suppress the tpl-1 phenotype. Mutations in HISTONE DEACETYLASE19, a putative corepressor, increase the penetrance of tpl-1 and display similar apical defects. These data point to a transcriptional repression mechanism that prevents root formation in the shoot pole during Arabidopsis embryogenesis.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	Salk Institute; California Institute of Technology	Long, JA (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	long@salk.edu	Meyerowitz, Elliot M/A-7118-2009		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072764] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM072764, GM072764, GM45697] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aida M, 1999, DEVELOPMENT, V126, P1563; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BARTON MK, 1993, DEVELOPMENT, V119, P823; Bertrand C, 2003, J BIOL CHEM, V278, P28246, DOI 10.1074/jbc.M302787200; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Conner J, 2000, P NATL ACAD SCI USA, V97, P12902, DOI 10.1073/pnas.230352397; Emes RD, 2001, HUM MOL GENET, V10, P2813, DOI 10.1093/hmg/10.24.2813; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; GOODNER B, 1993, PLANT CELL, V5, P1471; Haecker A, 2004, DEVELOPMENT, V131, P657, DOI 10.1242/dev.00963; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Kieffer M, 2006, PLANT CELL, V18, P560, DOI 10.1105/tpc.105.039107; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Laux T, 1996, DEVELOPMENT, V122, P87; Long JA, 2002, DEVELOPMENT, V129, P2797; Long JA, 1998, DEVELOPMENT, V125, P3027; MANSFIELD SG, 1991, CAN J BOT, V69, P461, DOI 10.1139/b91-063; OHNO C, COMMUNICATION; Pandey R, 2002, NUCLEIC ACIDS RES, V30, P5036, DOI 10.1093/nar/gkf660; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Tian L, 2001, P NATL ACAD SCI USA, V98, P200, DOI 10.1073/pnas.011347998; Vlachonasios KE, 2003, PLANT CELL, V15, P626, DOI 10.1105/tpc.007922; Wu KQ, 2000, PLANT J, V22, P19, DOI 10.1046/j.1365-313x.2000.00711.x; Zhou CH, 2005, PLANT CELL, V17, P1196, DOI 10.1105/tpc.104.028514	27	359	391	1	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 9	2006	312	5779					1520	1523		10.1126/science.1123841	http://dx.doi.org/10.1126/science.1123841			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763149				2022-12-24	WOS:000238124100047
J	Cabal, GG; Genovesio, A; Rodriguez-Navarro, S; Zimmer, C; Gadal, O; Lesne, A; Buc, H; Feuerbach-Fournier, F; Olivo-Marin, JC; Hurt, EC; Nehrbass, U				Cabal, Ghislain G.; Genovesio, Auguste; Rodriguez-Navarro, Susana; Zimmer, Christophe; Gadal, Olivier; Lesne, Annick; Buc, Henri; Feuerbach-Fournier, Frank; Olivo-Marin, Jean-Christophe; Hurt, Eduard C.; Nehrbass, Ulf			SAGA interacting factors confine sub-diffusion of transcribed genes to the nuclear envelope	NATURE			English	Article							RNA EXPORT MACHINERY; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; DISORDERED MEDIA; IN-VIVO; ORGANIZATION; COMPLEX; LOCALIZATION; RECRUITMENT; PROTEINS	Changes in the transcriptional state of genes have been correlated with their repositioning within the nuclear space(1). Tethering reporter genes to the nuclear envelope alone can impose repression(2) and recent reports have shown that, after activation, certain genes can also be found closer to the nuclear periphery(3-6). The molecular mechanisms underlying these phenomena have remained elusive. Here, with the use of dynamic three-dimensional tracking of a single locus in live yeast ( Saccharomyces cerevisiae) cells, we show that the activation of GAL genes ( GAL7, GAL10 and GAL1) leads to a confinement in dynamic motility. We demonstrate that the GAL locus is subject to sub-diffusive movement, which after activation can become constrained to a two-dimensional sliding motion along the nuclear envelope. RNA-fluorescence in situ hybridization analysis after activation reveals a higher transcriptional activity for the peripherally constrained GAL genes than for loci remaining intranuclear. This confinement was mediated by Sus1 and Ada2, members of the SAGA histone acetyltransferase complex, and Sac3, a messenger RNA export factor, physically linking the activated GAL genes to the nuclear-pore-complex component Nup1. Deleting ADA2 or NUP1 abrogates perinuclear GAL confinement without affecting GAL1 transcription. Accordingly, transcriptional activation is necessary but not sufficient for the confinement of GAL genes at the nuclear periphery. The observed real-time dynamic mooring of active GAL genes to the inner side of the nuclear pore complex is in accordance with the 'gene gating' hypothesis(7).	Inst Pasteur Korea, Seoul 136791, South Korea; Inst Pasteur, Unite Biol Cellulaire Noyau, F-75724 Paris 15, France; Inst Pasteur, Unite Anal Images Quantitat, F-75724 Paris 15, France; Inst Pasteur, Dept Biol Cellulaire & Infect, F-75724 Paris 15, France; Univ Heidelberg BZH, Zentrum Biochem, D-69120 Heidelberg, Germany; Lab Phys Theor Mat Condensee, F-75252 Paris 05, France	Institut Pasteur Korea; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Ruprecht Karls University Heidelberg	Nehrbass, U (corresponding author), Inst Pasteur Korea, 39-1 Hawolgok Dong, Seoul 136791, South Korea.	jcolivo@pasteur.fr; cg5@ix.urz.uni-heidelberg.de; nehrbass@pasteur.fr	GENOVESIO, Auguste/I-1656-2017; Ed Hurt, Dr./AAE-8874-2019; Rodríguez-Navarro, Susana/B-5182-2014; Gadal, Olivier/A-4731-2008; Olivo-Marin, Jean-Christophe/K-4428-2015; Lesne, Annick/W-9444-2018	Ed Hurt, Dr./0000-0002-4535-8255; Rodríguez-Navarro, Susana/0000-0001-7472-3111; Gadal, Olivier/0000-0001-9421-0831; Olivo-Marin, Jean-Christophe/0000-0001-6796-0696; feuerbach, frank/0000-0002-8631-5120; Lesne, Annick/0000-0002-6647-612X; Nehrbass, Ulf/0000-0002-7028-8076; Genovesio, Auguste/0000-0003-1877-5595; Cabal, Ghislain/0000-0002-9728-506X				Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; BOUCHAUD JP, 1990, PHYS REP, V195, P127, DOI 10.1016/0370-1573(90)90099-N; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Casolari JM, 2005, GENE DEV, V19, P1188, DOI 10.1101/gad.1307205; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Fischer T, 2004, NAT CELL BIOL, V6, P840, DOI 10.1038/ncb1163; Fischer T, 2002, EMBO J, V21, P5843, DOI 10.1093/emboj/cdf590; Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Havlin S, 2002, ADV PHYS, V51, P187, DOI 10.1080/00018730110116353; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Kimura H, 2002, J CELL BIOL, V159, P777, DOI 10.1083/jcb.200206019; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Menon BB, 2005, P NATL ACAD SCI USA, V102, P5749, DOI 10.1073/pnas.0501768102; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6	20	354	365	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					770	773		10.1038/nature04752	http://dx.doi.org/10.1038/nature04752			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760982				2022-12-24	WOS:000238095100059
J	Joiner, WJ; Crocker, A; White, BH; Sehgal, A				Joiner, William J.; Crocker, Amanda; White, Benjamin H.; Sehgal, Amita			Sleep in Drosophila is regulated by adult mushroom bodies	NATURE			English	Article							SHORT-TERM-MEMORY; LOCOMOTOR-ACTIVITY; REST; EXPRESSION; ABLATION	Sleep is one of the few major whole-organ phenomena for which no function and no underlying mechanism have been conclusively demonstrated. Sleep could result from global changes in the brain during wakefulness or it could be regulated by specific loci that recruit the rest of the brain into the electrical and metabolic states characteristic of sleep. Here we address this issue by exploiting the genetic tractability of the fruitfly, Drosophila melanogaster, which exhibits the hallmarks of vertebrate sleep(1-4). We show that large changes in sleep are achieved by spatial and temporal enhancement of cyclic-AMP-dependent protein kinase ( PKA) activity specifically in the adult mushroom bodies of Drosophila. Other manipulations of the mushroom bodies, such as electrical silencing, increasing excitation or ablation, also alter sleep. These results link sleep regulation to an anatomical locus known to be involved in learning and memory.	Univ Penn, Sch Med, Ctr Sleep & Resp Neurobiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; NIMH, Mol Biol Lab, Bethesda, MD 20892 USA	University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Sehgal, A (corresponding author), Univ Penn, Sch Med, Ctr Sleep & Resp Neurobiol, Philadelphia, PA 19104 USA.	amita@mail.med.upenn.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072431] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NINDS NIH HHS [R01 NS072431] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Armstrong JD, 1998, LEARN MEMORY, V5, P102; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Crittenden JR, 1998, LEARN MEMORY, V5, P38; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Helfrich-Forster C, 2002, J NEUROGENET, V16, P73, DOI 10.1080/01677060290024592; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2001, NAT NEUROSCI, V4, P1108, DOI 10.1038/nn743; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Joiner MLA, 1999, LEARN MEMORY, V6, P177; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; Luan HJ, 2006, J NEUROSCI, V26, P573, DOI 10.1523/JNEUROSCI.3916-05.2006; Mao ZM, 2004, P NATL ACAD SCI USA, V101, P198, DOI 10.1073/pnas.0306128101; Martin JR, 1998, LEARN MEMORY, V5, P179; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; van Swinderen B, 2003, NAT NEUROSCI, V6, P579, DOI 10.1038/nn1054; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; White BH, 2001, NEURON, V31, P699, DOI 10.1016/S0896-6273(01)00415-9; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zhu SJ, 2003, DEVELOPMENT, V130, P2603, DOI 10.1242/dev.00466	30	318	322	0	41	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					757	760		10.1038/nature04811	http://dx.doi.org/10.1038/nature04811			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760980				2022-12-24	WOS:000238095100056
J	Truman, JW; Hiruma, K; Allee, JP; MacWhinnie, SGB; Champlin, DT; Riddiford, LM				Truman, JW; Hiruma, K; Allee, JP; MacWhinnie, SGB; Champlin, DT; Riddiford, LM			Juvenile hormone is required to couple imaginal disc formation with nutrition in insects	SCIENCE			English	Article							MANDUCA-SEXTA L; TOBACCO HORNWORM; BROAD-COMPLEX; METAMORPHOSIS; DROSOPHILA; GROWTH; SIZE; EPIDERMIS; EXPRESSION; WEIGHT	In starved larvae of the tobacco hornworm moth Manduca sexta, larval and imaginal tissues stop growing, the former because they lack nutrient-dependent signals but the latter because of suppression by juvenile hormone. Without juvenile hormone, imaginal discs form and grow despite severe starvation. This hormone inhibits the intrinsic signaling needed for disc morphogenesis and does so independently of ecdysteroid action. Starvation and juvenile hormone treatments allowed the separation of intrinsic and nutrient-dependent aspects of disc growth and showed that both aspects must occur during the early phases of disc morphogenesis to ensure normal growth leading to typical-sized adults.	Univ Washington, Dept Biol, Seattle, WA 98195 USA; Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori 0368561, Japan; Univ So Maine, Dept Biol Sci, Portland, ME 04103 USA	University of Washington; University of Washington Seattle; Hirosaki University; University of Maine System; University of Southern Maine	Truman, JW (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	jwt@u.washington.edu		Riddiford, Lynn/0000-0002-3026-7430				ALLEE JP, IN PRESS J INSECT PH; Biggers WJ, 1996, ARCH INSECT BIOCHEM, V32, P475, DOI 10.1002/(SICI)1520-6327(1996)32:3/4<475::AID-ARCH19>3.0.CO;2-9; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Champlin DT, 1998, DEVELOPMENT, V125, P2009; Cohen Stephen M., 1993, P747; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; CYMBOROWSKI B, 1982, J INSECT PHYSIOL, V28, P129, DOI 10.1016/0022-1910(82)90120-2; Day SJ, 2000, DEVELOPMENT, V127, P2977; Erezyilmaz DF, 2004, DEV GENES EVOL, V214, P313, DOI 10.1007/s00427-004-0408-2; Fristrom Dianne, 1993, P843; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; HATAKOSHI M, 1988, J INSECT PHYSIOL, V34, P373, DOI 10.1016/0022-1910(88)90106-0; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; MacWhinnie SGB, 2005, DEV BIOL, V285, P285, DOI 10.1016/j.ydbio.2005.06.021; MILES CI, 1993, DEV BIOL, V155, P147, DOI 10.1006/dbio.1993.1014; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; NARDI JB, 1985, TISSUE CELL, V17, P473, DOI 10.1016/0040-8166(85)90026-6; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; NIJHOUT HF, 1975, BIOL BULL, V149, P214, DOI 10.2307/1540491; Nijhout HF, 2002, P NATL ACAD SCI USA, V99, P15446, DOI 10.1073/pnas.242548399; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; RIDDIFORD LM, 1994, ADV INSECT PHYSL, V24, P211; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sawaya AL, 2004, NUTR REV, V62, pS127, DOI 10.1111/j.1753-4887.2004.tb00082.x; SVACHA P, 1992, DEV BIOL, V154, P101, DOI 10.1016/0012-1606(92)90052-I; Tanaka K, 2005, DEV GENES EVOL, V215, P78, DOI 10.1007/s00427-004-0458-5; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; WILLIAMS CM, 1961, BIOL BULL-US, V121, P572, DOI 10.2307/1539456; Zhou BH, 1998, DEV BIOL, V203, P233, DOI 10.1006/dbio.1998.9059; Zhou BH, 2001, DEV BIOL, V231, P125, DOI 10.1006/dbio.2000.0143	31	115	123	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 2	2006	312	5778					1385	1388		10.1126/science.1123652	http://dx.doi.org/10.1126/science.1123652			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741122				2022-12-24	WOS:000237961600057
J	Tilman, D; Reich, PB; Knops, JMH				Tilman, David; Reich, Peter B.; Knops, Johannes M. H.			Biodiversity and ecosystem stability in a decade-long grassland experiment	NATURE			English	Article							PLANT-COMMUNITIES; PRODUCTIVITY; DIVERSITY; DROUGHT	Human-driven ecosystem simplification has highlighted questions about how the number of species in an ecosystem influences its functioning. Although biodiversity is now known to affect ecosystem productivity(1-6), its effects on stability are debated(6-13). Here we present a long-term experimental field test of the diversity - stability hypothesis. During a decade of data collection in an experiment that directly controlled the number of perennial prairie species(4), growing-season climate varied considerably, causing year-to-year variation in abundances of plant species and in ecosystem productivity. We found that greater numbers of plant species led to greater temporal stability of ecosystem annual aboveground plant production. In particular, the decadal temporal stability of the ecosystem, whether measured with intervals of two, five or ten years, was significantly greater at higher plant diversity and tended to increase as plots matured. Ecosystem stability was also positively dependent on root mass, which is a measure of perenniating biomass. Temporal stability of the ecosystem increased with diversity, despite a lower temporal stability of individual species, because of both portfolio ( statistical averaging) and overyielding effects. However, we found no evidence of a covariance effect. Our results indicate that the reliable, efficient and sustainable supply of some foods ( for example, livestock fodder), biofuels and ecosystem services can be enhanced by the use of biodiversity.	Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Nebraska System; University of Nebraska Lincoln	Tilman, D (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, 1987 Upper Buford Circle, St Paul, MN 55108 USA.	tilman@umn.edu	Knops, Johannes/AAA-8546-2020; Tilman, David/ABD-5309-2021	Reich, Peter/0000-0003-4424-662X				[Anonymous], 2013, THE FUTURE OF NATURE, DOI DOI 10.12987/9780300188479-039; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Elton C. S., 1958, ECOLOGY INVASIONS; Fargione JE, 2005, ECOL LETT, V8, P604, DOI 10.1111/j.1461-0248.2005.00753.x; FRANK DA, 1991, OIKOS, V62, P360, DOI 10.2307/3545501; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; May R. M., 1973, STABILITY COMPLEXITY; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; MCNAUGHTON SJ, 1978, NATURE, V274, P251, DOI 10.1038/274251a0; MCNAUGHTON SJ, 1993, ECOL STU AN, V99, P361; Naeem S, 2002, NATURE, V416, P23, DOI 10.1038/416023a; Naeem S, 1996, OIKOS, V76, P259, DOI 10.2307/3546198; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; Pfisterer AB, 2004, BASIC APPL ECOL, V5, P5, DOI 10.1078/1439-1791-00215; Pfisterer AB, 2002, NATURE, V416, P84, DOI 10.1038/416084a; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Tilman D, 1998, AM NAT, V151, P277, DOI 10.1086/286118; TILMAN D, 1992, OECOLOGIA, V89, P257, DOI 10.1007/BF00317226; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 1996, ECOLOGY, V77, P350, DOI 10.2307/2265614; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0	29	1235	1417	65	1528	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 1	2006	441	7093					629	632		10.1038/nature04742	http://dx.doi.org/10.1038/nature04742			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16738658	Green Published			2022-12-24	WOS:000237920800046
J	Halic, M; Gartmann, M; Schlenker, O; Mielke, T; Pool, MR; Sinning, I; Beckmann, R				Halic, M; Gartmann, M; Schlenker, O; Mielke, T; Pool, MR; Sinning, I; Beckmann, R			Signal recognition particle receptor exposes the ribosomal translocon binding site	SCIENCE			English	Article							SRP RECEPTOR; ESCHERICHIA-COLI; BETA-SUBUNIT; ENDOPLASMIC-RETICULUM; GTPASE; DOMAIN; COMPLEXES; CHANNEL; FTSY; RNA	Signal sequences of secretory and membrane proteins are recognized by the signal recognition particle (SRP) as they emerge from the ribosome. This results in their targeting to the membrane by docking with the SRP receptor, which facilitates transfer of the ribosome to the translocon. Here, we present the 8 angstrom cryo - electron microscopy structure of a "docking complex'' consisting of a SRP-bound 80S ribosome and the SRP receptor. Interaction of the SRP receptor with both SRP and the ribosome rearranged the S domain of SRP such that a ribosomal binding site for the translocon, the L23e/L35 site, became exposed, whereas Alu domain - mediated elongation arrest persisted.	Univ Med Sch Berlin, Charite, Inst Biochem, D-10117 Berlin, Germany; Univ Heidelberg, Biochem Ctr BZH, D-69120 Heidelberg, Germany; Max Planck Inst Mol Genet, Ultrastruct Network, USN, D-14195 Berlin, Germany; Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; Max Planck Society; University of Manchester	Beckmann, R (corresponding author), Univ Med Sch Berlin, Charite, Inst Biochem, Monbijoustr 2, D-10117 Berlin, Germany.	beckmann@lmb.uni-muenchen.de	Pool, Martin R./AAB-9181-2021; Sinning, Irmgard/A-2982-2010; Halic, Mario/X-2163-2018	Pool, Martin R./0000-0003-3071-1535; 				Angelini S, 2005, EMBO REP, V6, P476, DOI 10.1038/sj.embor.7400385; Bacher G, 1999, J CELL BIOL, V146, P723, DOI 10.1083/jcb.146.4.723; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Buskiewicz I, 2005, RNA, V11, P947, DOI 10.1261/rna.7242305; Buskiewicz I, 2004, P NATL ACAD SCI USA, V101, P7902, DOI 10.1073/pnas.0402231101; Chu FX, 2004, P NATL ACAD SCI USA, V101, P16454, DOI 10.1073/pnas.0407456101; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Fulga TA, 2001, EMBO J, V20, P2338, DOI 10.1093/emboj/20.9.2338; Gu SQ, 2003, RNA, V9, P566, DOI 10.1261/rna.2196403; Halic M, 2005, CURR OPIN STRUC BIOL, V15, P116, DOI 10.1016/j.sbi.2005.01.013; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Herskovits AA, 2002, J CELL BIOL, V159, P403, DOI 10.1083/jcb.200204144; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Legate KR, 2000, J BIOL CHEM, V275, P27439; Mandon EC, 2003, J CELL BIOL, V162, P575, DOI 10.1083/jcb.200303143; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Moller I, 1998, P NATL ACAD SCI USA, V95, P13425, DOI 10.1073/pnas.95.23.13425; Pool MR, 2002, SCIENCE, V297, P1345, DOI 10.1126/science.1072366; POWERS T, 1995, SCIENCE, V269, P1422, DOI 10.1126/science.7660124; Rapiejko PJ, 1997, CELL, V89, P703, DOI 10.1016/S0092-8674(00)80253-6; Schlenker O, 2006, J BIOL CHEM, V281, P8898, DOI 10.1074/jbc.M512415200; Schwartz T, 2003, CELL, V112, P793, DOI 10.1016/S0092-8674(03)00161-2; SIEGEL V, 1988, CELL, V52, P39, DOI 10.1016/0092-8674(88)90529-6; SIEGEL V, 1986, NATURE, V320, P81, DOI 10.1038/320081a0; Song WQ, 2000, CELL, V100, P333, DOI 10.1016/S0092-8674(00)80669-8; Spanggord RJ, 2005, NAT STRUCT MOL BIOL, V12, P1116, DOI 10.1038/nsmb1025; Wild K, 2004, NAT STRUCT MOL BIOL, V11, P1049, DOI 10.1038/nsmb853	28	109	116	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					745	747		10.1126/science.1124864	http://dx.doi.org/10.1126/science.1124864			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675701				2022-12-24	WOS:000237312100050
J	Iwahara, J; Clore, GM				Iwahara, J; Clore, GM			Detecting transient intermediates in macromolecular binding by paramagnetic NMR	NATURE			English	Article							HOMEODOMAIN-DNA COMPLEX; RELAXATION ENHANCEMENT; ANTENNAPEDIA HOMEODOMAIN; ASSOCIATION; PROTEINS; REFINEMENT; RATES	Macromolecular complex formation is governed by two opposing constraints of specificity and speed(1,2). Kinetic(3-6) and theoretical considerations suggest that significant rate enhancement can be achieved either by reducing the dimensionality of the search process(1,7) or by the creation of a short-range attractive potential around the target site(2). This implies the existence of transient intermediates involving non-specific binding modes. Here we show that intermolecular paramagnetic relaxation enhancement (PRE) provides a means of directly detecting the presence of, and investigating the nature of, low population transient intermediates under equilibrium conditions. Applying this approach, we characterize the search process whereby a sequence-specific transcription factor (the homeodomain of HOXD9) binds to non-cognate DNA sites as a means of enhancing the rate of specific association. The PRE data in the fast exchange regime reveal the presence of transient intermediates formed in a stochastic manner at non-cognate sites whose structure is similar to that of the specific complex. Two distinct search processes involving intra- as well as intermolecular translocations can be delineated. The intermolecular PRE method is general and can be readily applied to investigations of transient intermediates in many other macromolecular binding processes.	NIDDKD, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Clore, GM (corresponding author), NIDDKD, Chem Phys Lab, NIH, Bldg 2, Bethesda, MD 20892 USA.	mariusc@intra.niddk.nih.gov	Clore, G Marius/L-2546-2018; Clore, G. Marius/A-3511-2008	Clore, G Marius/0000-0003-3809-1027; Clore, G. Marius/0000-0003-3809-1027; Iwahara, Junji/0000-0003-4732-2173	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK029023, ZIADK029023, Z01DK029039] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adam G., 1968, STRUCTURAL CHEM MOL, P198; AFFOLTER M, 1990, P NATL ACAD SCI USA, V87, P4093, DOI 10.1073/pnas.87.11.4093; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; BILLETER M, 1993, J MOL BIOL, V234, P1084, DOI 10.1006/jmbi.1993.1661; BLOEMBERGEN N, 1961, J CHEM PHYS, V34, P842, DOI 10.1063/1.1731684; CATRON KM, 1993, MOL CELL BIOL, V13, P2354, DOI 10.1128/MCB.13.4.2354; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Donaldson LW, 2001, J AM CHEM SOC, V123, P9843, DOI 10.1021/ja011241p; Dvoretsky A, 2002, FEBS LETT, V528, P189, DOI 10.1016/S0014-5793(02)03297-0; Fraenkel E, 1998, NAT STRUCT BIOL, V5, P692, DOI 10.1038/1382; Gabdoulline RR, 2002, CURR OPIN STRUC BIOL, V12, P204, DOI 10.1016/S0959-440X(02)00311-1; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; Gillespie JR, 1997, J MOL BIOL, V268, P158, DOI 10.1006/jmbi.1997.0954; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Iwahara J, 2006, J AM CHEM SOC, V128, P404, DOI 10.1021/ja056786o; Iwahara J, 2004, J AM CHEM SOC, V126, P12800, DOI 10.1021/ja046246b; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Iwahara J, 2003, J AM CHEM SOC, V125, P6634, DOI 10.1021/ja034488q; Lewin B., 2000, GENES; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SOLOMON I, 1955, PHYS REV, V99, P559, DOI 10.1103/PhysRev.99.559; Vijayakumar M, 1998, J MOL BIOL, V278, P1015, DOI 10.1006/jmbi.1998.1747; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Zhou HX, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.178101	27	309	310	1	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1227	1230		10.1038/nature04673	http://dx.doi.org/10.1038/nature04673			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16642002				2022-12-24	WOS:000237080000053
J	Gostin, LO				Gostin, LO			Physician-assisted suicide - A legitimate medical practice?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Georgetown Univ, Ctr Law & Publ Hlth, Washington, DC USA; Johns Hopkins Univ, Baltimore, MD USA	Georgetown University; Johns Hopkins University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, 600 New Jersey Law Ctr NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						*AM MED ASS, 1993, COD MED ETH PHYS ASS; [Anonymous], 2001, FED REG, V66, P56; Bloche MG, 2006, NEW ENGL J MED, V354, P993, DOI 10.1056/NEJMp068019; Gostin LO, 1997, JAMA-J AM MED ASSOC, V278, P1523, DOI 10.1001/jama.278.18.1523; Gostin LO, 2005, JAMA-J AM MED ASSOC, V294, P842, DOI 10.1001/jama.294.7.842; Greenhouse Linda, 2006, NY TIMES, pA1; LANE C, 2006, WASH POST       0221, pA1; *OR DEP HUM SERV, 2006, 8 OR DEP HUM SERV; Pew Research Center, 2006, STRONG PUBL SUPP RIG; VOGEL N, 2005, LOS ANGELES TIM 0524, pA1	10	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2006	295	16					1941	1943		10.1001/jama.295.16.1941	http://dx.doi.org/10.1001/jama.295.16.1941			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036GI	16639054				2022-12-24	WOS:000237059200030
J	Coppens, I; Dunn, JD; Romano, JD; Pypaert, M; Zhang, H; Boothroyd, JC; Joiner, KA				Coppens, I; Dunn, JD; Romano, JD; Pypaert, M; Zhang, H; Boothroyd, JC; Joiner, KA			Toxoplasma gondii sequesters lysosomes from mammalian hosts in the vacuolar space	CELL			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; PARASITOPHOROUS VACUOLE; MEMBRANE; CHOLESTEROL; PROTEINS; PLASMODIUM; MECHANISMS; SECRETION; FISSION; NETWORK	The intracellular compartment harboring Toxoplasma gondii satisfies the parasite's nutritional needs for rapid growth in mammalian cells. We demonstrate that the parasitophorous vacuole (PV) of T. gondii accumulates material coming from the host mammalian cell via the exploitation of the host endo-lysosomal system. The parasite actively recruits host microtubules, resulting in selective attraction of endo-lysosomes to the PV. Microtubule-based invaginations of the PV membrane serve as conduits for the delivery of host endo-lysosomes within the PV. These tubular conduits are decorated by a parasite coat, including the tubulogenic protein GRA7, which acts like a garrote that sequesters host endocytic organelles in the vacuolar space. These data define an unanticipated process allowing the parasite intimate and concentrated access to a diverse range of low molecular weight components produced by the endo-lysosomal system. More generally, they identify a unique mechanism for unidirectional transport and sequestration of host organelles.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; Univ Arizona, Coll Med, Arizona Hlth Sci Ctr, Tucson, AZ 85724 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Stanford University; Yale University; University of Arizona; University of Arizona Health Sciences	Coppens, I (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, 615 N Wolfe St, Baltimore, MD 21205 USA.	icoppens@jhsph.edu	Joiner, Keith/AAH-1059-2021	Joiner, Keith/0000-0003-3062-823X; Romano, Julia/0000-0001-8956-7377; Boothroyd, John C./0000-0001-9719-745X; Dunn, Joe Dan/0000-0002-5091-4527	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045057, R01AI060767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007276] Funding Source: NIH RePORTER; NIAID NIH HHS [AI060767, AI45057, AI488443] Funding Source: Medline; NIGMS NIH HHS [T32 GM07276] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		COPPENS I, 1987, J PROTOZOOL, V34, P465, DOI 10.1111/j.1550-7408.1987.tb03216.x; Coppens I, 2003, MOL BIOL CELL, V14, P3804, DOI 10.1091/mbc.E02-12-0830; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; DINITTO JP, 2003, SCI STKE, pRE16, DOI DOI 10.1126/STKE.2132003RE16; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; Haldar K, 2001, INT J PARASITOL, V31, P1393, DOI 10.1016/S0020-7519(01)00251-X; Hall S, 2001, TOXOPLASMOSIS COMPRE, P58; HALONEN SK, 1994, J EUKARYOT MICROBIOL, V41, P65, DOI 10.1111/j.1550-7408.1994.tb05936.x; Holopainen JM, 2000, EUR J BIOCHEM, V267, P6231, DOI 10.1046/j.1432-1327.2000.01708.x; Infante AS, 2000, J CELL SCI, V113, P3907; Jacobs D, 1998, MOL BIOCHEM PARASIT, V91, P237, DOI 10.1016/S0166-6851(97)00204-1; Joiner KA, 2002, J CELL BIOL, V157, P557, DOI 10.1083/jcb.200112144; Kaneko T, 1998, J MOL BIOL, V284, P1671, DOI 10.1006/jmbi.1998.2251; Karsten V, 2004, J BIOL CHEM, V279, P26052, DOI 10.1074/jbc.M400480200; Kim J, 2000, ANNU REV BIOCHEM, V69, P303, DOI 10.1146/annurev.biochem.69.1.303; Kozlov MM, 2001, TRAFFIC, V2, P51, DOI 10.1034/j.1600-0854.2001.020107.x; Labruyere E, 1999, MOL BIOCHEM PARASIT, V102, P311, DOI 10.1016/S0166-6851(99)00092-4; Lange Y, 2002, J LIPID RES, V43, P198; Lingelbach K, 1998, J CELL SCI, V111, P1467; Mercier C, 2005, INT J PARASITOL, V35, P829, DOI 10.1016/j.ijpara.2005.03.011; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; RUSSELL DG, 1995, TRENDS CELL BIOL, V5, P125, DOI 10.1016/S0962-8924(00)88963-1; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; SCHWAB JC, 1994, P NATL ACAD SCI USA, V91, P509, DOI 10.1073/pnas.91.2.509; SIBLEY LD, 1995, J CELL SCI, V108, P1669; Sinai AP, 1997, J CELL SCI, V110, P2117	29	229	235	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 21	2006	125	2					261	274		10.1016/j.cell.2006.01.056	http://dx.doi.org/10.1016/j.cell.2006.01.056			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630815	Bronze			2022-12-24	WOS:000237241500017
J	Mosimann, C; Hausmann, G; Basler, K				Mosimann, C; Hausmann, G; Basler, K			Parafibromin/hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/armadillo	CELL			English	Article							RNA-POLYMERASE-II; TUMOR-SUPPRESSOR GENE; CATENIN-TCF COMPLEX; LONG-RANGE ACTION; HISTONE METHYLATION; SIGNALING PATHWAY; PAF1 COMPLEX; CHROMATIN-STRUCTURE; WINGLESS SIGNAL; DROSOPHILA	The Wnt pathway controls cell fates, tissue homeostasis, and cancer. Its activation entails the association of beta-catenin with nuclear TCF/LEF proteins and results in transcriptional activation of target genes. The mechanism by which nuclear beta-catenin controls transcription is largely unknown. Here we genetically identify a novel Wnt/Wg pathway component that mediates the transcriptional outputs of beta-catenin/Armadillo. We show that Drosophila Hyrax and its human ortholog, Parafibromin, components of the Polymerase-Associated Factor 1 (PAF1) complex, are required for nuclear transduction of the Wnt/Wg signal and bind directly to the C-terminal region of beta-catenin/Armadillo. Moreover, we find that the transactivation potential of Parafibromin/Hyrax depends on the recruitment of Pygopus to beta-catenin/Armadillo. Our results assign to the tumor suppressor Parafibromin an unexpected role in Wnt signaling and provide a molecular mechanism for Wnt target gene control, in which the nuclear Wnt signaling complex directly engages the PAF1 complex, thereby controlling transcriptional initiation and elongation by RNA Polymerase II.	Univ Zurich, Inst Mol Biol, Natl Res Ctr Frontiers Genet, CH-8057 Zurich, Switzerland	University of Zurich	Basler, K (corresponding author), Univ Zurich, Inst Mol Biol, Natl Res Ctr Frontiers Genet, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	basler@molbio.uniz.ch		Mosimann, Christian/0000-0002-0749-2576; Basler, Konrad/0000-0003-3534-1529				Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Belenkaya TY, 2002, DEVELOPMENT, V129, P4089; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Carpten JD, 2002, NAT GENET, V32, P676, DOI 10.1038/ng1048; Cox RT, 1999, GENETICS, V153, P319; Daniels DL, 2001, TRENDS BIOCHEM SCI, V26, P672, DOI 10.1016/S0968-0004(01)01952-1; Geuking P, 2005, GENETICS, V171, P1683, DOI 10.1534/genetics.105.045534; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hahn MA, 2005, ONCOGENE, V24, P6241, DOI 10.1038/sj.onc.1208778; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hendy G N, 2000, Rev Endocr Metab Disord, V1, P297, DOI 10.1023/A:1026518502081; Hoeck H. N., 1990, GRZIMEKS ENCY MAMMAL, P535; Hoffmans R, 2004, DEVELOPMENT, V131, P4393, DOI 10.1242/dev.01296; Hoffmans R, 2005, CURR BIOL, V15, P1207, DOI 10.1016/j.cub.2005.05.054; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Neumann CJ, 1997, DEVELOPMENT, V124, P871; Orsulic S, 1996, J CELL BIOL, V134, P1283, DOI 10.1083/jcb.134.5.1283; Parisi M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r40; Parker DS, 2002, DEVELOPMENT, V129, P2565; PEIFER M, 1994, DEVELOPMENT, V120, P369; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PHILLIPS RG, 1993, DEVELOPMENT, V118, P427; Porter SE, 2002, EUKARYOT CELL, V1, P830, DOI 10.1128/EC.1.5.830-842.2002; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Rozenblatt-Rosen O, 2005, MOL CELL BIOL, V25, P612, DOI 10.1128/MCB.25.2.612-620.2005; Schweizer L, 2003, BMC CELL BIOL, V4, DOI 10.1186/1471-2121-4-4; Shi XM, 1997, MOL CELL BIOL, V17, P1160, DOI 10.1128/MCB.17.3.1160; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Sivasankaran R, 2000, MECH DEVELOP, V91, P427, DOI 10.1016/S0925-4773(99)00313-5; Stadeli R, 2005, MECH DEVELOP, V122, P1171, DOI 10.1016/j.mod.2005.07.004; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Thompson B, 2002, NAT CELL BIOL, V4, P367, DOI 10.1038/ncb786; Tolwinski NS, 2004, PLOS BIOL, V2, P486, DOI 10.1371/journal.pbio.0020095; Tutter AV, 2001, GENE DEV, V15, P3342, DOI 10.1101/gad.946501; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; Wang PF, 2005, HORM METAB RES, V37, P380, DOI 10.1055/s-2005-870150; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Worby C A, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.95.pl1; Yart A, 2005, MOL CELL BIOL, V25, P5052, DOI 10.1128/MCB.25.12.5052-5060.2005; Yeh E, 2001, CURR BIOL, V11, P1675, DOI 10.1016/S0960-9822(01)00527-9; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zeng WL, 2000, NATURE, V403, P789, DOI 10.1038/35001615	51	249	255	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					327	341		10.1016/j.cell.2006.01.053	http://dx.doi.org/10.1016/j.cell.2006.01.053			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630820	Bronze			2022-12-24	WOS:000237241500022
J	Bhattacharyya, SN; Habermacher, R; Martine, U; Closs, EI; Filipowicz, W				Bhattacharyya, Suvendra N.; Habermacher, Regula; Martine, Ursula; Closs, Ellen I.; Filipowicz, Witold			Relief of microRNA-mediated translational repression in human cells subjected to stress	CELL			English	Article							PROTEIN-SYNTHESIS; MESSENGER-RNAS; HUR; INITIATION; ARGONAUTE2; TRANSPORT	In metazoans, most microRNAs imperfectly base-pair with the 3' untranslated region (3'UTR) of target mRNAs and prevent protein accumulation by either repressing translation or inducing mRNA degradation. Examples of specific mRNAs undergoing microRNA-mediated repression are numerous, but whether the repression is a reversible process remains largely unknown. Here we show that cationic amino acid transporter 1 (CAT-1) mRNA and reporters bearing its 3'UTR can be relieved from the microRNA miR-122-induced inhibition in human hepatocarcinoma cells subjected to different stress conditions. The derepression of CAT-1 mRNA is accompanied by its release from cytoplasmic processing bodies and its recruitment to polysomes. The derepression requires binding of HuR, an AU-rich-element binding protein, to the TUTR of CAT-1 mRNA. We propose that proteins interacting with the 3'UTR will generally act as modifiers altering the potential of miRNAs to repress gene expression.	Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland; Johannes Gutenberg Univ Mainz, Dept Pharmacol, D-55101 Mainz, Germany	Friedrich Miescher Institute for Biomedical Research; Johannes Gutenberg University of Mainz	Bhattacharyya, SN (corresponding author), Friedrich Miescher Inst Biomed Res, POB 2543, CH-4002 Basel, Switzerland.	Filipowi@fmi.ch	Closs, Ellen/ABD-5217-2020	Closs, Ellen/0000-0002-9505-2289				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anderson P, 2002, J CELL SCI, V115, P3227; Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Graf P, 2001, BRIT J PHARMACOL, V132, P1193, DOI 10.1038/sj.bjp.0703921; Hatzoglou M, 2004, ANNU REV NUTR, V24, P377, DOI 10.1146/annurev.nutr.23.011702.073120; Heinonen M, 2005, CANCER RES, V65, P2157, DOI 10.1158/0008-5472.CAN-04-3765; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lal A, 2005, EMBO J, V24, P1852, DOI 10.1038/sj.emboj.7600661; Li HW, 2002, J BIOL CHEM, V277, P44623, DOI 10.1074/jbc.M206187200; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; WU JY, 1994, J VIROL, V68, P1615, DOI 10.1128/JVI.68.3.1615-1623.1994; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3; Yaman I, 2002, J BIOL CHEM, V277, P41539, DOI 10.1074/jbc.M204850200	32	1010	1055	0	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2006	125	6					1111	1124		10.1016/j.cell.2006.04.031	http://dx.doi.org/10.1016/j.cell.2006.04.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777601	Bronze			2022-12-24	WOS:000238602700016
J	Wu, ZY; Sun, XH; Sullivan, SG; Detels, R				Wu, Zunyou; Sun, Xinhua; Sullivan, Sheena G.; Detels, Roger			Public health - HIV testing in China	SCIENCE			English	Editorial Material							SEXUAL-BEHAVIOR		Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90095 USA; Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing 100050, Peoples R China; Minist Hlth, Dept Dis Prevent & Control, Div AIDS, Beijing 100044, Peoples R China; Edith Cowan Univ, Ctr Human Genet, Perth, WA 6207, Australia	University of California System; University of California Los Angeles; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Edith Cowan University	Detels, R (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90095 USA.	detels@ucla.edu		Sullivan, Sheena G./0000-0002-0856-0294				Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; Amaro H, 2005, J HEALTH PSYCHOL, V10, P287, DOI 10.1177/1359105305048780; Bayer R, 1996, NEW ENGL J MED, V334, P1540, DOI 10.1056/NEJM199606063342312; Bentley ME, 1998, AIDS, V12, P1869, DOI 10.1097/00002030-199814000-00019; *CHIN MIN HLTH, 2005, 3 C HIV AIDS INT COO; Coates TJ, 2000, LANCET, V356, P103, DOI 10.1016/S0140-6736(00)02446-6; ERIKSON A, 2006, CORRESPONDENT, V15, P24; FOX R, 1987, AIDS, V1, P241; Frieden TR, 2005, NEW ENGL J MED, V353, P2397, DOI 10.1056/NEJMsb053133; Inciardi JA, 2005, AIDS CARE, V17, pS88, DOI 10.1080/09540120500121011; Leveton Lauren B., 1995, HIV BLOOD SUPPLY ANA, P49; *MIN HLTH CHIN, 2006, UPD HIV AIDS EP RESP; *MIN HLTH EXP CONS, 2005, REP HIV SCREEN KEY P; Robles R R, 1996, Drugs Soc (New York), V9, P173, DOI 10.1300/J023v09n01_10; Rotheram-Borus MJ, 2000, J ACQ IMMUN DEF SYND, V25, pS105, DOI 10.1097/00126334-200012152-00004; *STAT COUNC AIDS W, 2004, JOINT ASS HIV AIDS P; Watts J, 2003, LANCET, V362, P1983, DOI 10.1016/S0140-6736(03)15085-4	17	119	135	3	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1475	1476		10.1126/science.1120682	http://dx.doi.org/10.1126/science.1120682			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	050XT	16763133				2022-12-24	WOS:000238124100029
J	Cooper, WO; Hernandez-Diaz, S; Arbogast, PG; Dudley, JA; Dyer, S; Gideon, PS; Hall, K; Ray, WA				Cooper, William O.; Hernandez-Diaz, Sonia; Arbogast, Patrick G.; Dudley, Judith A.; Dyer, Shannon; Gideon, Patricia S.; Hall, Kathi; Ray, Wayne A.			Major congenital malformations after first-trimester exposure to ACE inhibitors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONVERTING-ENZYME-INHIBITORS; OVINE FETAL; ANGIOTENSIN; PREGNANCY; PRESCRIPTION; OUTCOMES	Background: Use of angiotensin-converting-enzyme (ACE) inhibitors during the second and third trimesters of pregnancy is contraindicated because of their association with an increased risk of fetopathy. In contrast, first-trimester use of ACE inhibitors has not been linked to adverse fetal outcomes. We conducted a study to assess the association between exposure to ACE inhibitors during the first trimester of pregnancy only and the risk of congenital malformations. Methods: We studied a cohort of 29,507 infants enrolled in Tennessee Medicaid and born between 1985 and 2000 for whom there was no evidence of maternal diabetes. We identified 209 infants with exposure to ACE inhibitors in the first trimester alone, 202 infants with exposure to other antihypertensive medications in the first trimester alone, and 29,096 infants with no exposure to antihypertensive drugs at any time during gestation. Major congenital malformations were identified from linked vital records and hospitalization claims during the first year of life and confirmed by review of medical records. Results: Infants with only first-trimester exposure to ACE inhibitors had an increased risk of major congenital malformations (risk ratio, 2.71; 95 percent confidence interval, 1.72 to 4.27) as compared with infants who had no exposure to antihypertensive medications. In contrast, fetal exposure to other antihypertensive medications during only the first trimester did not confer an increased risk (risk ratio, 0.66; 95 percent confidence interval, 0.25 to 1.75). Infants exposed to ACE inhibitors were at increased risk for malformations of the cardiovascular system (risk ratio, 3.72; 95 percent confidence interval, 1.89 to 7.30) and the central nervous system (risk ratio, 4.39; 95 percent confidence interval, 1.37 to 14.02). Conclusions: Exposure to ACE inhibitors during the first trimester cannot be considered safe and should be avoided.	Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Prevent Med, Nashville, TN 37232 USA; Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Boston University	Cooper, WO (corresponding author), Vanderbilt Univ, Sch Med, Dept Pediat, AA-0216 MCN, Nashville, TN 37232 USA.	william.cooper@vanderbilt.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS010384] Funding Source: NIH RePORTER	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		BHATTMEHTA V, 1993, PHARMACOTHERAPY, V13, P515; Briggs GG, 2002, CLIN OBSTET GYNECOL, V45, P6, DOI 10.1097/00003081-200203000-00004; Burrell JH, 2001, EXP PHYSIOL, V86, P71, DOI 10.1113/eph8602075; Centers for Disease Control and Prevention, METR ATL CONG DEF PR; Chisholm CA, 1997, AM J PERINAT, V14, P511, DOI 10.1055/s-2007-994324; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cooper WO, 2002, OBSTET GYNECOL, V100, P101, DOI 10.1016/S0029-7844(02)02001-X; Correa-Villasenor A, 2003, BIRTH DEFECTS RES A, V67, P617, DOI 10.1002/bdra.10111; Eriksson UJ, 2003, REV ENDOCR METAB DIS, V4, P79, DOI 10.1023/A:1021879504372; Feldkamp M, 1997, JAMA-J AM MED ASSOC, V277, P1193; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Hu F, 2004, DEV BRAIN RES, V150, P51, DOI 10.1016/j.devbrainres.2004.02.007; JOHNSON RE, 1991, J AM GERIATR SOC, V39, P1079, DOI 10.1111/j.1532-5415.1991.tb02872.x; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1414, DOI 10.2105/AJPH.84.9.1414; LANE PW, 1982, BIOMETRICS, V38, P613, DOI 10.2307/2530043; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Lip GYH, 1997, LANCET, V350, P1446, DOI 10.1016/S0140-6736(05)64207-9; LONN EM, 1994, CIRCULATION, V90, P2056, DOI 10.1161/01.CIR.90.4.2056; MARTIN RA, 1992, TERATOLOGY, V46, P317, DOI 10.1002/tera.1420460402; Moore KL, 1993, DEV HUMAN CLIN ORIEN DEV HUMAN CLIN ORIEN, V7th; *NAT CTR HLTH STAT, NAT HLTH CAR SURV; PIPER JM, 1990, AM J EPIDEMIOL, V132, P561, DOI 10.1093/oxfordjournals.aje.a115692; PIPER JM, 1993, AM J EPIDEMIOL, V137, P758, DOI 10.1093/oxfordjournals.aje.a116736; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; REY E, 1994, AM J OBSTET GYNECOL, V171, P410, DOI 10.1016/0002-9378(94)90276-3; Saji H, 2001, LANCET, V357, P363, DOI 10.1016/S0140-6736(00)03648-5; Sheffield JS, 2002, OBSTET GYNECOL, V100, P925, DOI 10.1016/S0029-7844(02)02242-1; Steffensen FH, 1998, LANCET, V351, P596, DOI 10.1016/S0140-6736(05)78584-6; Tabacova S, 2003, PHARMACOEPIDEM DR S, V12, P633, DOI 10.1002/pds.796; Tsuchida S, 1998, J CLIN INVEST, V101, P755, DOI 10.1172/JCI1899; *US BUR CENS, 2004, US CENS BUR POP EST; WEST SL, 1995, AM J EPIDEMIOL, V142, P1103, DOI 10.1093/oxfordjournals.aje.a117563; Yip SK, 1998, ACTA OBSTET GYN SCAN, V77, P570, DOI 10.1034/j.1600-0412.1998.770517.x; ZEGER SL, 1989, BIOMETRICS, V45, P347; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	36	680	712	1	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2006	354	23					2443	2451		10.1056/NEJMoa055202	http://dx.doi.org/10.1056/NEJMoa055202			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	050PQ	16760444				2022-12-24	WOS:000238100800006
J	Dobreva, G; Chahrour, M; Dautzenberg, M; Chirivella, L; Kanzler, B; Farinas, I; Karsenty, G; Grosschedl, R				Dobreva, Gergana; Chahrour, Maria; Dautzenberg, Marcel; Chirivella, Laura; Kanzler, Benoit; Farinas, Isabel; Karsenty, Gerard; Grosschedl, Rudolf			SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation	CELL			English	Article							CRANIAL NEURAL CREST; MAR-BINDING PROTEIN; GENE-EXPRESSION; CLEFT-PALATE; HOMEOTIC TRANSFORMATION; TRANSCRIPTION; ELEMENTS; REGIONS; HOXA-2; MICE	Vertebrate skeletogenesis involves two processes, skeletal patterning and osteoblast differentiation. Here, we show that Satb2, encoding a nuclear matrix protein, is expressed in branchial arches and in cells of the osteoblast lineage. Satb2(-/-) mice exhibit both craniofacial abnormalities that resemble those observed in humans carrying a translocation in SATB2 and defects in osteoblast differentiation and function. Multiple osteoblast-specific genes were identified as targets positively regulated by SATB2. In addition, SATB2 was found to repress the expression of several Hox genes including Hoxa2, an inhibitor of bone formation and regulator of branchial arch patterning. Molecular analysis revealed that SATB2 directly interacts with and enhances the activity of both Runx2 and ATF4, transcription factors that regulate osteoblast differentiation. This synergy was genetically confirmed by bone formation defects in Satb2/Runx2 and Satb2/Atf4 double heterozygous mice. Thus, SATB2 acts as a molecular node in a transcriptional network regulating skeletal development and osteoblast differentiation.	Max Planck Inst Immunobiol, Dept Cellular & Mol Immunol, D-79108 Freiburg, Germany; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Valencia, Dept Biol Celular, Unidad Mixta CIPF, UVEG, E-46100 Burjassot, Spain	Max Planck Society; Baylor College of Medicine; Prince Felipe Research Center; University of Valencia	Grosschedl, R (corresponding author), Max Planck Inst Immunobiol, Dept Cellular & Mol Immunol, D-79108 Freiburg, Germany.	grosschedl@immunbio.mpg.de	Chirivella, Laura/L-5932-2017; Farinas, Isabel/L-7118-2014	Chirivella, Laura/0000-0002-3637-5168; Dobreva, Gergana/0000-0002-4814-9416; Farinas, Isabel/0000-0003-2903-4960; Chahrour, Maria/0000-0002-3174-1480				Alvarez JD, 2000, GENE DEV, V14, P521; Benson MD, 2000, J BIOL CHEM, V275, P13907, DOI 10.1074/jbc.275.18.13907; BIDWELL JP, 1993, P NATL ACAD SCI USA, V90, P3162, DOI 10.1073/pnas.90.8.3162; Bode J, 2000, CRIT REV EUKAR GENE, V10, P73; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; Bronner-Fraser Marianne, 1993, Trends in Cell Biology, V3, P392, DOI 10.1016/0962-8924(93)90089-J; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; CHISAKA O, 1992, NATURE, V355, P516, DOI 10.1038/355516a0; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; COCKERILL PN, 1986, CELL, V44, P273, DOI 10.1016/0092-8674(86)90761-0; Creuzet S, 2002, DEVELOPMENT, V129, P4301; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Depew MJ, 2002, SCIENCE, V298, P381, DOI 10.1126/science.1075703; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; DUCY P, 1995, MOL CELL BIOL, V15, P1858; FitzPatrick DR, 2003, HUM MOL GENET, V12, P2491, DOI 10.1093/hmg/ddg248; FRASCH M, 1995, DEVELOPMENT, V121, P957; GASSER SM, 1986, CELL, V46, P521, DOI 10.1016/0092-8674(86)90877-9; GENDRONMAGUIRE M, 1993, CELL, V75, P1317, DOI 10.1016/0092-8674(93)90619-2; Graham A, 2001, BIOESSAYS, V23, P54, DOI 10.1002/1521-1878(200101)23:1<54::AID-BIES1007>3.0.CO;2-5; HUNT P, 1991, CELL, V66, P1075, DOI 10.1016/0092-8674(91)90029-X; Jenuwein T, 1997, NATURE, V385, P269, DOI 10.1038/385269a0; Kanzler B, 1998, DEVELOPMENT, V125, P2587; KohwiShigematsu T, 1997, BIOCHEMISTRY-US, V36, P12005, DOI 10.1021/bi971444j; Kontges G, 1996, DEVELOPMENT, V122, P3229; Lampe X, 2004, BIOCHEM BIOPH RES CO, V316, P898, DOI 10.1016/j.bbrc.2004.02.138; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Namciu SJ, 2004, MAMM GENOME, V15, P162, DOI 10.1007/s00335-003-2311-y; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; RIJLI FM, 1993, CELL, V75, P1333, DOI 10.1016/0092-8674(93)90620-6; Santagati F, 2003, NAT REV NEUROSCI, V4, P806, DOI 10.1038/nrn1221; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Trainor PA, 2001, CURR OPIN CELL BIOL, V13, P698, DOI 10.1016/S0955-0674(00)00273-8; Tumpel S, 2002, DEV BIOL, V246, P45, DOI 10.1006/dbio.2002.0665; VALENTIN D, 2003, J BONE MINER RES J B, V18, P1622; Veitch E, 1999, CURR BIOL, V9, P1481, DOI 10.1016/S0960-9822(00)80118-9; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zaidi SK, 2005, EMBO REP, V6, P128, DOI 10.1038/sj.embor.7400337; Zhao YG, 1999, P NATL ACAD SCI USA, V96, P15002, DOI 10.1073/pnas.96.26.15002	43	387	415	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					971	986		10.1016/j.cell.2006.05.012	http://dx.doi.org/10.1016/j.cell.2006.05.012			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751105	Bronze			2022-12-24	WOS:000238116400022
J	Jacobson, BC; Somers, SC; Fuchs, CS; Kelly, CP; Camargo, CA				Jacobson, Brian C.; Somers, Samuel C.; Fuchs, Charles S.; Kelly, Ciaran P.; Camargo, Carlos A., Jr.			Body-mass index and symptoms of gastroesophageal reflux in women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RISK-FACTORS; EROSIVE ESOPHAGITIS; UNITED-STATES; DISEASE; POPULATION; OBESITY; PREVALENCE; ADENOCARCINOMA; QUESTIONNAIRE; HEARTBURN	Background: Overweight and obese persons are at increased risk for gastroesophageal reflux disease. An association between body-mass index (BMI) -- the weight in kilograms divided by the square of the height in meters -- and symptoms of gastroesophageal reflux disease in persons of normal weight has not been demonstrated. Methods: In 2000, we used a supplemental questionnaire to determine the frequency, severity, and duration of symptoms of gastroesophageal reflux disease among randomly selected participants in the Nurses' Health Study. After categorizing women according to BMI as measured in 1998, we used logistic-regression models to study the association between BMI and symptoms of gastroesophageal reflux disease. Results: Of 10,545 women who completed the questionnaire (response rate, 86 percent), 2310 (22 percent) reported having symptoms at least once a week, and 3419 (55 percent of those who had any symptoms) described their symptoms as moderate in severity. We observed a dose-dependent relationship between increasing BMI and frequent reflux symptoms (multivariate P for trend <0.001). As compared with women who had a BMI of 20.0 to 22.4, the multivariate odds ratios for frequent symptoms were 0.67 (95 percent confidence interval, 0.48 to 0.93) for a BMI of less than 20.0, 1.38 (95 percent confidence interval, 1.13 to 1.67) for a BMI of 22.5 to 24.9, 2.20 (95 percent confidence interval, 1.81 to 2.66) for a BMI of 25.0 to 27.4, 2.43 (95 percent confidence interval, 1.96 to 3.01) for a BMI of 27.5 to 29.9, 2.92 (95 percent confidence interval, 2.35 to 3.62) for a BMI of 30.0 to 34.9, and 2.93 (95 percent confidence interval, 2.24 to 3.85) for a BMI of 35.0 or more. Even in women with a normal baseline BMI, an increase in BMI of more than 3.5, as compared with no weight changes, was associated with an increased risk of frequent symptoms of reflux (odds ratio, 2.80; 95 percent confidence interval, 1.63 to 4.82). Conclusions: BMI is associated with symptoms of gastroesophageal reflux disease in both normal-weight and overweight women. Even moderate weight gain among persons of normal weight may cause or exacerbate symptoms of reflux.	Boston Univ, Med Ctr, Sch Med, Boston, MA 02118 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Boston Med Ctr, Boston, MA USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital; Boston Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Jacobson, BC (corresponding author), Boston Univ, Med Ctr, Sch Med, 85 E Concord St,Rm 7721, Boston, MA 02118 USA.	brian.jacobson@bmc.org	Camargo, Carlos A./C-2145-2008	Camargo, Carlos A./0000-0002-5071-7654; Jacobson, Brian/0000-0001-7064-2357	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI052338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK070706] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI052338, R21 AI-52338] Funding Source: Medline; NIDDK NIH HHS [K08 DK070706, K08 DK070706-02] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSEN LI, 1991, J INTERN MED, V230, P5, DOI 10.1111/j.1365-2796.1991.tb00399.x; Diaz-Rubio M, 2004, ALIMENT PHARM THER, V19, P95, DOI 10.1046/j.1365-2036.2003.01769.x; El-Serag HB, 2005, AM J GASTROENTEROL, V100, P1243, DOI 10.1111/j.1572-0241.2005.41703.x; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P1692, DOI 10.1053/j.gastro.2004.03.077; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Hampel H, 2005, ANN INTERN MED, V143, P199, DOI 10.7326/0003-4819-143-3-200508020-00006; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Henke CJ, 2000, AM J GASTROENTEROL, V95, P788; Johnson DA, 2004, GASTROENTEROLOGY, V126, P660, DOI 10.1053/j.gastro.2003.12.001; KLAUSER AG, 1990, LANCET, V335, P205, DOI 10.1016/0140-6736(90)90287-F; Kulig M, 2004, J CLIN EPIDEMIOL, V57, P580, DOI 10.1016/j.jclinepi.2003.10.010; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lagergren J, 2000, GUT, V47, P26, DOI 10.1136/gut.47.1.26; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; LOCKE GR, 1994, MAYO CLIN PROC, V69, P539, DOI 10.1016/S0025-6196(12)62245-9; Locke GR, 1999, AM J MED, V106, P642, DOI 10.1016/S0002-9343(99)00121-7; Murray L, 2003, INT J EPIDEMIOL, V32, P645, DOI 10.1093/ije/dyg108; Nilsson M, 2003, JAMA-J AM MED ASSOC, V290, P66, DOI 10.1001/jama.290.1.66; Oliveria SA, 1999, ARCH INTERN MED, V159, P1592, DOI 10.1001/archinte.159.14.1592; Revicki DA, 1998, AM J MED, V104, P252, DOI 10.1016/S0002-9343(97)00354-9; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; STRANGHELLINI V, 1999, SCAND J GASTROENTE S, V231, P20; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Wu AH, 2003, CANCER, V98, P940, DOI 10.1002/cncr.11568	25	373	396	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 1	2006	354	22					2340	U18		10.1056/NEJMoa054391	http://dx.doi.org/10.1056/NEJMoa054391			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	047ZZ	16738270	Green Accepted			2022-12-24	WOS:000237918500006
J	Embley, RW; Chadwick, WW; Baker, ET; Butterfield, DA; Resing, JA; De Ronde, CEJ; Tunnicliffe, V; Lupton, JE; Juniper, SK; Rubin, KH; Stern, RJ; Lebon, GT; Nakamura, K; Merle, SG; Hein, JR; Wiens, DA; Tamura, Y				Embley, Robert W.; Chadwick, William W., Jr.; Baker, Edward T.; Butterfield, David A.; Resing, Joseph A.; De Ronde, Cornel E. J.; Tunnicliffe, Verena; Lupton, John E.; Juniper, S. Kim; Rubin, Kenneth H.; Stern, Robert J.; Lebon, Geoffrey T.; Nakamura, Ko-ichi; Merle, Susan G.; Hein, James R.; Wiens, Douglas A.; Tamura, Yoshihiko			Long-term eruptive activity at a submarine arc volcano	NATURE			English	Article							EVENT; EVOLUTION; MAGMA; RIDGE	Three-quarters of the Earth's volcanic activity is submarine, located mostly along the mid-ocean ridges, with the remainder along intraoceanic arcs and hotspots at depths varying from greater than 4,000 m to near the sea surface. Most observations and sampling of submarine eruptions have been indirect, made from surface vessels or made after the fact(1-6). We describe here direct observations and sampling of an eruption at a submarine arc volcano named NW Rota-1, located 60 km northwest of the island of Rota (Commonwealth of the Northern Mariana Islands). We observed a pulsating plume permeated with droplets of molten sulphur disgorging volcanic ash and lapilli from a 15-m diameter pit in March 2004 and again in October 2005 near the summit of the volcano at a water depth of 555 m (depth in 2004). A turbid layer found on the flanks of the volcano (in 2004) at depths from 700 m to more than 1,400 m was probably formed by mass-wasting events related to the eruption. Long-term eruptive activity has produced an unusual chemical environment and a very unstable benthic habitat exploited by only a few mobile decapod species. Such conditions are perhaps distinctive of active arc and hotspot volcanoes.	NOAA, PMEL, Newport, OR 97365 USA; Oregon State Univ, CIMRS, Newport, OR 97365 USA; NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; Univ Washington, JISAO, Seattle, WA 98115 USA; Inst Geol & Nucl Sci, Lower Hutt, New Zealand; Univ Victoria, Sch Earth & Ocean Sci, Dept Biol, Victoria, BC V8W 3N5, Canada; Univ Quebec, GEOTOP Res Ctr, Montreal, PQ H3C 3P8, Canada; Univ Hawaii, Dept Geol & Geophys, Honolulu, HI 96822 USA; Univ Texas, Dept Geosci, Richardson, TX 75083 USA; Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058567, Japan; US Geol Survey, Menlo Pk, CA 94025 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Japan Agcy Marine Earth Sci & Technol, IFREE, Yokosuka, Kanagawa, Japan	National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle; GNS Science - New Zealand; University of Victoria; University of Quebec; University of Quebec Montreal; University of Hawaii System; University of Texas System; University of Texas Dallas; National Institute of Advanced Industrial Science & Technology (AIST); United States Department of the Interior; United States Geological Survey; Washington University (WUSTL); Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Embley, RW (corresponding author), NOAA, PMEL, 2115 SE OSU Dr, Newport, OR 97365 USA.	robert.w.embley@noaa.gov	Tunnicliffe, Verena/D-1056-2014; Stern, Robert/N-8344-2019; Wiens, Douglas A/J-9259-2016; Hein, James/R-7123-2019; Rubin, Kenneth H/B-3685-2008; Baker, Edward/C-7688-2015; Resing, Joseph A/J-6110-2017; Chadwick, William W./R-7623-2019; Butterfield, David/H-3815-2016; Juniper, Kim/N-6769-2015	Stern, Robert/0000-0002-8083-4632; Wiens, Douglas A/0000-0002-5169-4386; Rubin, Kenneth H/0000-0002-8554-1337; Baker, Edward/0000-0002-8794-4180; Resing, Joseph A/0000-0002-7334-4176; Chadwick, William W./0000-0002-5129-4569; Butterfield, David/0000-0002-1595-9279; Juniper, Kim/0000-0002-7608-260X; Tamura, Yoshihiko/0000-0002-3705-7815				Baker ET, 2002, GEOLOGY, V30, P975, DOI 10.1130/0091-7613(2002)030<0975:OASOAO>2.0.CO;2; BAKER ET, 1987, NATURE, V329, P149, DOI 10.1038/329149a0; Butterfield DA, 1997, PHILOS T R SOC A, V355, P369, DOI 10.1098/rsta.1997.0013; Chadwick WW, 1998, DEEP-SEA RES PT II, V45, P2547, DOI 10.1016/S0967-0645(98)00083-6; CHEMINEE JL, 1991, EARTH PLANET SC LETT, V107, P318, DOI 10.1016/0012-821X(91)90079-W; Cowen JP, 2004, GEOPH MONOG SERIES, V144, P227, DOI 10.1029/144GM15; Delaney JR, 1998, SCIENCE, V281, P222, DOI 10.1126/science.281.5374.222; Embley RW, 2004, GEOPHYS MONOGR SER, V144, P75, DOI 10.1029/144GM06; EMBLEY RW, 1995, GEOPHYS RES LETT, V22, P143, DOI 10.1029/94GL02281; Embley RW, 2004, EOS T AM GEOPHYS UN, V85, P37, DOI DOI 10.1029/2004EO040001; Fiske RS, 1998, B VOLCANOL, V59, P262, DOI 10.1007/s004450050190; Fox CG, 2001, NATURE, V412, P727, DOI 10.1038/35089066; GREGG TKP, 1995, GEOLOGY, V23, P73, DOI 10.1130/0091-7613(1995)023<0073:QOSLFM>2.3.CO;2; HAYMON RM, 1993, EARTH PLANET SC LETT, V119, P85, DOI 10.1016/0012-821X(93)90008-W; HUBER R, 1990, NATURE, V345, P179, DOI 10.1038/345179a0; KARL DM, 1988, NATURE, V335, P532, DOI 10.1038/335532a0; KOKELAAR BP, 1983, J VOLCANOL GEOTH RES, V19, P239, DOI 10.1016/0377-0273(83)90112-9; Koyaguchi T, 1996, J GEOPHYS RES-SOL EA, V101, P5561, DOI 10.1029/95JB01687; LEBON GT, 2004, T AGU, V85; MIYABE S, 2004, EOS S, V85; RUBIN KH, 1989, NATURE, V341, P50, DOI 10.1038/341050a0; RUBIN KH, 1994, NATURE, V368, P841, DOI 10.1038/368841a0; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; Stern RJ, 2002, REV GEOPHYS, V40, DOI 10.1029/2001RG000108; STERN RJ, 2004, EOS S, V85; Tunnicliffe V, 1997, DEEP-SEA RES PT I, V44, P1627, DOI 10.1016/S0967-0637(97)00041-1; VONDAMM KL, 1995, NATURE, V375, P47, DOI 10.1038/375047a0; White JD., 2003, EXPLOSIVE SUBAQUEOUS, V140, P1, DOI DOI 10.1029/140GM01	28	109	112	3	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					494	497		10.1038/nature04762	http://dx.doi.org/10.1038/nature04762			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724063				2022-12-24	WOS:000237778900046
J	MacLean, RC; Gudelj, I				MacLean, RC; Gudelj, I			Resource competition and social conflict in experimental populations of yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PRISONERS-DILEMMA; EVOLUTION; COOPERATION	Understanding the conditions that promote the maintenance of cooperation is a classic problem in evolutionary biology(1-5). The essence of this dilemma is captured by the 'tragedy of the commons' 6: how can a group of individuals that exploit resources in a cooperative manner resist invasion by 'cheaters' who selfishly use common resources to maximize their individual reproduction at the expense of the group(7,8)? Here, we investigate this conflict through experimental competitions between isogenic cheater and cooperator strains of yeast with alternative pathways of glucose metabolism(9), and by using mathematical models of microbial biochemistry(10). We show that both coexistence and competitive exclusion are possible outcomes of this conflict, depending on the spatial and temporal structure of the environment. Both of these outcomes are driven by trade-offs between the rate and efficiency of conversion of resources into offspring that are mediated by metabolic intermediates.	Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; Univ Bath, Dept Math Sci, Bath BA2 7AY, Avon, England	Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Bath	MacLean, RC (corresponding author), Univ London Imperial Coll Sci Technol & Med, NERC, Ctr Populat Biol, Silwood Pk Campus, Ascot SL5 7PY, Berks, England.	c.maclean@imperial.ac.uk		MacLean, Craig/0000-0002-7941-813X	Natural Environment Research Council [NE/B501998/2, NE/B501998/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		AXELROD R, 1988, SCIENCE, V242, P1385, DOI 10.1126/science.242.4884.1385; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; BAUCHOP T, 1960, J GEN MICROBIOL, V23, P469; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Elbing K, 2004, APPL ENVIRON MICROB, V70, P5323, DOI 10.1128/AEM.70.9.5323-5330.2004; Frick T, 2003, NATURWISSENSCHAFTEN, V90, P327, DOI 10.1007/s00114-003-0434-3; Greig D, 2004, P ROY SOC B-BIOL SCI, V271, pS25, DOI 10.1098/rsbl.2003.0083; HARDIN G, 1968, SCIENCE, V162, P1248; Kreft JU, 2004, MICROBIOL-SGM, V150, P2751, DOI 10.1099/mic.0.26829-0; Ludovico P, 2001, MICROBIOL-SGM, V147, P2409, DOI 10.1099/00221287-147-9-2409; NOWAK M, 1993, P NATL ACAD SCI USA, V90, P5091, DOI 10.1073/pnas.90.11.5091; NOWAK MA, 1994, P NATL ACAD SCI USA, V91, P4877, DOI 10.1073/pnas.91.11.4877; Otterstedt K, 2004, EMBO REP, V5, P532, DOI 10.1038/sj.embor.7400132; Pfeiffer T, 2004, AM NAT, V163, pE126, DOI 10.1086/383593; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Pfeiffer T, 2005, TRENDS BIOCHEM SCI, V30, P20, DOI 10.1016/j.tibs.2004.11.006; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Travisano M, 2004, TRENDS MICROBIOL, V12, P72, DOI 10.1016/j.tim.2003.12.009; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; Velicer GJ, 2003, TRENDS MICROBIOL, V11, P330, DOI 10.1016/S0966-842X(03)00152-5	20	209	213	2	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2006	441	7092					498	501		10.1038/nature04624	http://dx.doi.org/10.1038/nature04624			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724064				2022-12-24	WOS:000237778900047
J	Trotman, LC; Alimonti, A; Scaglioni, PP; Koutcher, JA; Cordon-Cardo, C; Pandolfi, PP				Trotman, Lloyd C.; Alimonti, Andrea; Scaglioni, Pier Paolo; Koutcher, Jason A.; Cordon-Cardo, Carlos; Pandolfi, Pier Paolo			Identification of a tumour suppressor network opposing nuclear Akt function	NATURE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; PROSTATE-CANCER; CELL-SURVIVAL; PTEN; MICE; PML; PHOSPHATASES; APOPTOSIS; MUTATION; FOXO3A	The proto-oncogene AKT (also known as PKB) is activated in many human cancers, mostly owing to loss of the PTEN tumour suppressor(1). In such tumours, AKT becomes enriched at cell membranes where it is activated by phosphorylation. Yet many targets inhibited by phosphorylated AKT (for example, the FOXO transcription factors) are nuclear; it has remained unclear how relevant nuclear phosphorylated AKT (pAKT) function is for tumorigenesis. Here we show that the PML tumour suppressor prevents cancer by inactivating pAKT inside the nucleus. We find in a mouse model that Pml loss markedly accelerates tumour onset, incidence and progression in Pten-heterozygous mutants, and leads to female sterility with features that recapitulate the phenotype of Foxo3a knockout mice(2). We show that Pml deficiency on its own leads to tumorigenesis in the prostate, a tissue that is exquisitely sensitive to pAkt levels, and demonstrate that Pml specifically recruits the Akt phosphatase PP2a as well as pAkt into Pml nuclear bodies. Notably, we find that Pml-null cells are impaired in PP2a phosphatase activity towards Akt, and thus accumulate nuclear pAkt. As a consequence, the progressive reduction in Pml dose leads to inactivation of Foxo3a-mediated transcription of proapoptotic Bim and the cell cycle inhibitor p27(kip1). Our results demonstrate that Pml orchestrates a nuclear tumour suppressor network for inactivation of nuclear pAkt, and thus highlight the importance of AKT compartmentalization in human cancer pathogenesis and treatment.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Med, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Radiol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Med Phys, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	p-pandolfi@ski.mskcc.org	Alimonti, Andrea/J-4150-2012	Scaglioni, Pier Paolo/0000-0002-6036-5138; Alimonti, Andrea/0000-0002-9362-2313	NCI NIH HHS [R01 CA137050, P50 CA092629-05, P50 CA092629] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA137050, P50CA092629] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Brenkman AB, 2003, TRENDS MOL MED, V9, P464, DOI 10.1016/j.molmed.2003.09.003; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Goel A, 2004, CANCER RES, V64, P3014, DOI 10.1158/0008-5472.CAN-2401-2; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Li LK, 2003, MOL CELL BIOL, V23, P9389, DOI 10.1128/MCB.23.24.9389-9404.2003; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Porkka KP, 2004, EUR UROL, V45, P683, DOI 10.1016/j.eururo.2004.01.012; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073	30	326	336	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 25	2006	441	7092					523	527		10.1038/nature04809	http://dx.doi.org/10.1038/nature04809			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16680151	Green Accepted			2022-12-24	WOS:000237778900053
J	Das, SK; Sarwate, D; Mordani, JK; Ng, KJ; Nel, M				Das, Saroj Kumar; Sarwate, Devdatta; Mordani, J. K.; Ng, K. J.; Nel, Mark			Interactive case report - 70 year old man with scrotal swelling, abdominal aortic aneurysm, and renal lesions: case outcome	BRITISH MEDICAL JOURNAL			English	Editorial Material									Hillingdon Hosp, Uxbridge UB8 3NN, Middx, England		Das, SK (corresponding author), Hillingdon Hosp, Uxbridge UB8 3NN, Middx, England.	saroj.das@imperial.ac.uk		Das, Saroj/0000-0003-3228-1225					0	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	MAY 20	2006	332	7551					1198	1198		10.1136/bmj.332.7551.1198	http://dx.doi.org/10.1136/bmj.332.7551.1198			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	048GJ	16709994	Green Published			2022-12-24	WOS:000237935300021
J	Fiegna, F; Yu, YTN; Kadam, SV; Velicer, GJ				Fiegna, F; Yu, YTN; Kadam, SV; Velicer, GJ			Evolution of an obligate social cheater to a superior cooperator	NATURE			English	Article							BACTERIUM MYXOCOCCUS-XANTHUS; PARASITE WASP; MOTILITY; ORIGIN; RESISTANCE; MUTUALISM; CONFLICT; BIOLOGY; BROOD; PILI	Obligate relationships have evolved many times and can be parasitic or mutualistic. Obligate organisms rely on others to survive and thus coevolve with their host or partner. An important but little explored question is whether obligate status is an evolutionarily terminal condition or whether obligate lineages can evolve back to an autonomous lifestyle. The bacterium Myxococcus xanthus survives starvation by the social development of spore-bearing fruiting bodies. Some M. xanthus genotypes defective at fruiting body development in isolation can nonetheless exploit proficient genotypes in chimaeric groups. Here we report an evolutionary transition from obligate dependence on an altruistic host to an autonomous mode of social cooperation. This restoration of social independence was caused by a single mutation of large effect that confers fitness superiority over both ancestral genotypes, including immunity from exploitation by the ancestral cheater. Thus, a temporary state of obligate cheating served as an evolutionary stepping-stone to a novel state of autonomous social dominance.	Max Planck Inst Dev Biol, D-72076 Tubingen, Germany	Max Planck Society	Velicer, GJ (corresponding author), Max Planck Inst Dev Biol, Spemannstr 35, D-72076 Tubingen, Germany.	gregory.velicer@tuebingen.mpg.de						Alexander J, 1999, J CELL SCI, V112, P2993; BRETSCHER AP, 1978, J BACTERIOL, V133, P763, DOI 10.1128/JB.133.2.763-768.1978; Cervo R, 2004, AM NAT, V164, P814, DOI 10.1086/425987; Dale C, 2003, MOL BIOL EVOL, V20, P1188, DOI 10.1093/molbev/msg138; Dawid W, 2000, FEMS MICROBIOL REV, V24, P403, DOI 10.1111/j.1574-6976.2000.tb00548.x; Dugatkin LA, 2005, P ROY SOC B-BIOL SCI, V272, P79, DOI 10.1098/rspb.2004.2916; Fiegna F, 2005, PLOS BIOL, V3, P1980, DOI 10.1371/journal.pbio.0030370; Fiegna F, 2003, P ROY SOC B-BIOL SCI, V270, P1527, DOI 10.1098/rspb.2003.2387; Foitzik S, 2003, BEHAV ECOL, V14, P80, DOI 10.1093/beheco/14.1.80; Foster KR, 2004, NATURE, V431, P693, DOI 10.1038/nature02894; Frank SA, 2003, EVOLUTION, V57, P693; Greig D, 2004, P ROY SOC B-BIOL SCI, V271, pS25, DOI 10.1098/rsbl.2003.0083; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; Keller L, 1999, LEVELS SELECTION EVO; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; Lopez-Vaamonde C, 2001, MOL PHYLOGENET EVOL, V21, P55, DOI 10.1006/mpev.2001.0993; Lorenzi MC, 2004, PARASITOLOGY, V129, P643, DOI 10.1017/S0031182004005992; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Moran NA, 2003, CURR OPIN MICROBIOL, V6, P512, DOI 10.1016/j.mib.2003.08.001; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; PELLMYR O, 1992, P NATL ACAD SCI USA, V89, P2927, DOI 10.1073/pnas.89.7.2927; Pellmyr O, 2002, P NATL ACAD SCI USA, V99, P5498, DOI 10.1073/pnas.072588699; Pierce NE, 2002, ANNU REV ENTOMOL, V47, P733, DOI 10.1146/annurev.ento.47.091201.145257; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Rodriguez AM, 1999, J BACTERIOL, V181, P4381, DOI 10.1128/JB.181.14.4381-4390.1999; Rosenberg E, 1984, MYXOBACTERIA DEV CEL, P109; Rothstein SI, 1998, PARASITIC BIRDS THEI; Sachs JL, 2005, P NATL ACAD SCI USA, V102, P390, DOI 10.1073/pnas.0405738102; SEIDLER RJ, 1969, J BACTERIOL, V100, P769, DOI 10.1128/JB.100.2.769-785.1969; Shimkets LJ, 1999, ANNU REV MICROBIOL, V53, P525, DOI 10.1146/annurev.micro.53.1.525; Smith J. M., 1995, MAJOR TRANSITIONS EV; Sorenson MD, 2001, EVOLUTION, V55, P2550; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; Sumner S, 2004, INSECT SOC, V51, P37, DOI 10.1007/s00040-003-0723-z; Travisano M, 2004, TRENDS MICROBIOL, V12, P72, DOI 10.1016/j.tim.2003.12.009; Velicer GJ, 1998, P NATL ACAD SCI USA, V95, P12376, DOI 10.1073/pnas.95.21.12376; Velicer GJ, 2000, NATURE, V404, P598, DOI 10.1038/35007066; Velicer GJ, 2003, TRENDS MICROBIOL, V11, P330, DOI 10.1016/S0966-842X(03)00152-5; Velicer GJ, 2003, NATURE, V425, P75, DOI 10.1038/nature01908; Velicer GJ, 2002, J BACTERIOL, V184, P2719, DOI 10.1128/JB.184.10.2719-2727.2002; VELICER GJ, IN PRESS P NATL ACAD; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wall D, 1999, J BACTERIOL, V181, P24, DOI 10.1128/JB.181.1.24-33.1999; Williamson VM, 2003, CURR OPIN PLANT BIOL, V6, P327, DOI 10.1016/S1369-5266(03)00059-1; WIREMAN JW, 1977, J BACTERIOL, V129, P796, DOI 10.1128/JB.129.2.798-802.1977; WU SS, 1995, MOL MICROBIOL, V18, P547, DOI 10.1111/j.1365-2958.1995.mmi_18030547.x	48	121	123	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 18	2006	441	7091					310	314		10.1038/nature04677	http://dx.doi.org/10.1038/nature04677			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710413				2022-12-24	WOS:000237593200039
J	Kim, S; Wong, P; Coulombe, PA				Kim, S; Wong, P; Coulombe, PA			A keratin cytoskeletal protein regulates protein synthesis and epithelial cell growth	NATURE			English	Article							INTERMEDIATE-FILAMENTS; SIGNALING PATHWAY; IN-VIVO; MTOR; SKIN; DOWNSTREAM; COMPLEX; BINDING; PHOSPHORYLATION; PROGRESSION	Cell growth, an increase in mass and size, is a highly regulated cellular event. The Akt/mTOR ( mammalian target of rapamycin) signalling pathway has a central role in the control of protein synthesis and thus the growth of cells, tissues and organisms(1). A striking example of a physiological context requiring rapid cell growth is tissue repair in response to injury(2). Here we show that keratin 17, an intermediate filament protein rapidly induced in wounded stratified epithelia(3), regulates cell growth through binding to the adaptor protein 14-3-3 sigma. Mouse skin keratinocytes lacking keratin 17 (ref. 4) show depressed protein translation and are of smaller size, correlating with decreased Akt/mTOR signalling activity. Other signalling kinases have normal activity, pointing to the specificity of this defect. Two amino acid residues located in the amino-terminal head domain of keratin 17 are required for the serum-dependent relocalization of 14-3-3 sigma from the nucleus to the cytoplasm, and for the concomitant stimulation of mTOR activity and cell growth. These findings reveal a new and unexpected role for the intermediate filament cytoskeleton in influencing cell growth and size by regulating protein synthesis.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Coulombe, PA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	coulombe@jhmi.edu	Kim, Seyun/B-3387-2012					Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bereiter-Hahn J., 1986, BIOL INTEGUMENT, P443; Bernot KM, 2004, METHOD CELL BIOL, V78, P453; Bertram PG, 1998, CURR BIOL, V8, P1259, DOI 10.1016/S0960-9822(07)00535-0; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; Coulombe PA, 2004, EUR J CELL BIOL, V83, P735, DOI 10.1078/0171-9335-00443; DePianto D, 2004, EXP CELL RES, V301, P68, DOI 10.1016/j.yexcr.2004.08.007; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; Ku NO, 2002, P NATL ACAD SCI USA, V99, P4373, DOI 10.1073/pnas.072624299; Li Y, 2002, J BIOL CHEM, V277, P44593, DOI 10.1074/jbc.C200510200; Liao J, 1996, J CELL BIOL, V133, P345, DOI 10.1083/jcb.133.2.345; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mazzalupo S, 2003, DEV DYNAM, V226, P356, DOI 10.1002/dvdy.10245; McGowan KM, 2002, GENE DEV, V16, P1412, DOI 10.1101/gad.979502; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Paladini RD, 1996, J CELL BIOL, V132, P381, DOI 10.1083/jcb.132.3.381; PRASAD GL, 1992, CELL GROWTH DIFFER, V3, P507; Redpath NT, 1996, EMBO J, V15, P2291, DOI 10.1002/j.1460-2075.1996.tb00582.x; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; STADDON JM, 1995, J CELL BIOL, V130, P369, DOI 10.1083/jcb.130.2.369; Tzivion G, 2000, J BIOL CHEM, V275, P29772, DOI 10.1074/jbc.M001207200; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0	30	339	356	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					362	365		10.1038/nature04659	http://dx.doi.org/10.1038/nature04659			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710422				2022-12-24	WOS:000237593200051
J	Busemann, H; Young, AF; Alexander, CMO; Hoppe, P; Mukhopadhyay, S; Nittler, LR				Busemann, H; Young, AF; Alexander, CMO; Hoppe, P; Mukhopadhyay, S; Nittler, LR			Interstellar chemistry recorded in organic matter from primitive meteorites	SCIENCE			English	Article							NITROGEN; PRESOLAR; CARBON; DEUTERIUM; FRACTIONATION; ORIGIN	Organic matter in extraterrestrial materials has isotopic anomalies in hydrogen and nitrogen that suggest an origin in the presolar molecular cloud or perhaps in the protoplanetary disk. Interplanetary dust particles are generally regarded as the most primitive solar system matter available, in part because until recently they exhibited the most extreme isotope anomalies. However, we show that hydrogen and nitrogen isotopic compositions in carbonaceous chondrite organic matter reach and even exceed those found in interplanetary dust particles. Hence, both meteorites ( originating from the asteroid belt) and interplanetary dust particles ( possibly from comets) preserve primitive organics that were a component of the original building blocks of the solar system.	Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; Max Planck Inst Chem, Otto Hahn Inst, D-55128 Mainz, Germany	Carnegie Institution for Science; Max Planck Society	Busemann, H (corresponding author), Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	busemann@dtm.ciw.edu	Alexander, Conel M. O'D./N-7533-2013; Young, Andrea F/H-9697-2012; Hoppe, Peter/B-3032-2015	Alexander, Conel M. O'D./0000-0002-8558-1427; Young, Andrea F/0000-0001-5954-8028; Hoppe, Peter/0000-0003-3681-050X; Busemann, Henner/0000-0002-0867-6908				Aikawa Y, 2002, ASTRON ASTROPHYS, V386, P622, DOI 10.1051/0004-6361:20020037; Aikawa Y, 1999, ASTROPHYS J, V526, P314, DOI 10.1086/307973; Aleon J, 2005, NATURE, V437, P385, DOI 10.1038/nature03947; Aleon J, 2004, ICARUS, V167, P424, DOI 10.1016/j.icarus.2003.10.012; Alexander CMO, 1998, METEORIT PLANET SCI, V33, P603, DOI 10.1111/j.1945-5100.1998.tb01667.x; Alexander CMOD, 2005, METEORIT PLANET SCI, V40, pA15; Bradley J, 2005, SCIENCE, V307, P244, DOI 10.1126/science.1106717; Charnley SB, 2002, ASTROPHYS J, V569, pL133, DOI 10.1086/340484; CLAYTON RN, 2002, LUNAR PLANET SCI, V33, P1326; Cody GD, 2005, GEOCHIM COSMOCHIM AC, V69, P1085, DOI 10.1016/j.gca.2004.08.031; Floss C, 2004, SCIENCE, V303, P1355, DOI 10.1126/science.1093283; Gail HP, 2001, ASTRON ASTROPHYS, V378, P192, DOI 10.1051/0004-6361:20011130; Geiss J, 2003, SPACE SCI REV, V106, P3, DOI 10.1023/A:1024651232758; Gilmour I, 2005, TREATISE GEOCHEM, V1, P269; GUAN Y, 1998, LUNAR PLANET SCI, V29, P1760; Hashizume K, 2000, SCIENCE, V290, P1142, DOI 10.1126/science.290.5494.1142; Huss GR, 2003, GEOCHIM COSMOCHIM AC, V67, P4823, DOI 10.1016/j.gca.2003.07.019; Meier R, 1998, SCIENCE, V279, P1707, DOI 10.1126/science.279.5357.1707; Messenger S, 2000, NATURE, V404, P968, DOI 10.1038/35010053; Messenger S, 2003, SPACE SCI REV, V106, P155, DOI 10.1023/A:1024637704533; Nakamura K., 2002, INT J ASTROBIOL, V1, P179, DOI DOI 10.1017/; Nittler LR, 2003, EARTH PLANET SC LETT, V209, P259, DOI 10.1016/S0012-821X(02)01153-6; PENDLETON YJ, 1994, ASTROPHYS J, V437, P683, DOI 10.1086/175031; Robert F, 2003, SPACE SCI REV, V106, P87, DOI 10.1023/A:1024629402715; Sandford SA, 2001, METEORIT PLANET SCI, V36, P1117, DOI 10.1111/j.1945-5100.2001.tb01948.x; Sugiura N, 2001, METEORIT PLANET SCI, V36, P515, DOI 10.1111/j.1945-5100.2001.tb01893.x; Terzieva R, 2000, MON NOT R ASTRON SOC, V317, P563, DOI 10.1046/j.1365-8711.2000.03618.x; Wooden DH, 2005, ASP C SER, V341, P774	28	297	299	0	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					727	730		10.1126/science.1123878	http://dx.doi.org/10.1126/science.1123878			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675696				2022-12-24	WOS:000237312100045
J	Iso, H; Date, C; Wakai, K; Fukui, M; Tamakoshi, A				Iso, H; Date, C; Wakai, K; Fukui, M; Tamakoshi, A		JACC Study Grp	The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults	ANNALS OF INTERNAL MEDICINE			English	Article							COFFEE CONSUMPTION; EPIGALLOCATECHIN GALLATE; MELLITUS; PREVALENCE; TOLERANCE	Background: in western populations, coffee consumption is associated with a reduced risk for type 2 diabetes; however, the effect of green, black, and oolong teas is unclear. Objective: To examine the relationship between consumption of these beverages and risk for diabetes. Design: Retrospective cohort study. Setting: 25 communities across Japan. Participants: A total of 17 413 persons (6727 men and 10 686 women; 49% of the original study population) who were 40 to 65 years of age; had no history of type 2 diabetes, cardiovascular disease, or cancer at the baseline lifestyle survey; and completed the 5-year follow-up questionnaire. There was no difference in body mass index levels at baseline between respondents and non-respondents. Measurements: Questionnaire on consumption of coffee; black, green, and oolong teas; and physician-diagnosed diabetes. Results: During the 5-year follow-up, there were 444 self-reported new cases of diabetes in 231 men and 213 women (5-year event rates, 3.4% and 2.0%, respectively). Consumption of green tea and coffee was inversely associated with risk for diabetes after adjustment for age, sex, body mass index, and other risk factors. Multivariable odds ratios for diabetes among participants who frequently drank green tea and coffee ( :6 cups of green tea per day and 3 cups of coffee per day) were 0.67 (95% Cl, 0.47 to 0.94) and 0.58 (Cl, 0.37 to 0.90), respectively, compared with those who drank less than I cup per week. No association was found between consumption of black or oolong teas and the risk for diabetes. Total caffeine intake from these beverages was associated with a 33% reduced risk for diabetes. These inverse associations were more pronounced in women and in overweight men. Limitations: Diabetes was self-reported, no data were available on consumption of soda, and the follow-up rate was low. Conclusions: Consumption of green tea, coffee, and total caffeine was associated with a reduced risk for type 2 diabetes.	Osaka Univ, Grad Sch Med, Dept Social & Environm Hlth, Suita, Osaka 5650871, Japan; Osaka City Univ, Osaka 558, Japan; Nara Womens Univ, Nara 630, Japan; Aichi Canc Ctr, Nagoya, Aichi 464, Japan; Nagoya Univ, Nagoya, Aichi, Japan	Osaka University; Osaka Metropolitan University; Nara Womens University; Aichi Cancer Center; Nagoya University	Iso, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Social & Environm Hlth, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	iso@pbhei.med.osaka-u-ac.jp	Tamakoshi, Akiko/D-5105-2012; Wakai, Kenji/I-7248-2014	Wakai, Kenji/0000-0001-7388-7157; Iso, Hiroyasu/0000-0002-9241-7289; TOKUDOME, SHINKAN/0000-0001-7311-2458				ASTRUP A, 1990, AM J CLIN NUTR, V51, P759, DOI 10.1093/ajcn/51.5.759; Carlsson S, 2004, INT J EPIDEMIOL, V33, P616, DOI 10.1093/ije/dyh185; Date C, 2005, J EPIDEMIOL, V15, pS9, DOI 10.2188/jea.15.S9; Devasagayam TPA, 1996, BBA-BIOMEMBRANES, V1282, P63, DOI 10.1016/0005-2736(96)00040-5; Gavin JR, 1997, DIABETES CARE, V20, P1183; Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360; Kao WHL, 1999, ARCH INTERN MED, V159, P2151, DOI 10.1001/archinte.159.18.2151; Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; OHMURA T, 1993, DIABETOLOGIA, V36, P1198, DOI 10.1007/BF00401066; Ohno Y, 2001, J Epidemiol, V11, P144; Resource Council Science and Technology Agency the Government of Japan, 2000, STAND TABL FOOD COMP; ROBERTSON D, 1981, J CLIN INVEST, V67, P1111, DOI 10.1172/JCI110124; Rosengren A, 2004, J INTERN MED, V255, P89, DOI 10.1046/j.1365-2796.2003.01260.x; Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Sasazuki S, 2004, CANCER CAUSE CONTROL, V15, P483, DOI 10.1023/B:CACO.0000036449.68454.42; Song EK, 2003, ARCH PHARM RES, V26, P559, DOI 10.1007/BF02976881; SPRIET LL, 1992, AM J PHYSIOL, V262, pE891, DOI 10.1152/ajpendo.1992.262.6.E891; Tuomilehto J, 2004, JAMA-J AM MED ASSOC, V291, P1213, DOI 10.1001/jama.291.10.1213; van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X; Waltner-Law ME, 2002, J BIOL CHEM, V277, P34933, DOI 10.1074/jbc.M204672200	22	330	353	1	49	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2006	144	8					554	562		10.7326/0003-4819-144-8-200604180-00005	http://dx.doi.org/10.7326/0003-4819-144-8-200604180-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035QZ	16618952				2022-12-24	WOS:000237017900002
J	Breban, R; Blower, S				Breban, R; Blower, S			Role of parametric resonance in virological failure during HIV treatment interruption therapy	LANCET			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; STRUCTURED TREATMENT INTERRUPTIONS; HUMAN-IMMUNODEFICIENCY-VIRUS; DYNAMICS IN-VIVO; T-CELL DYNAMICS; VIRAL DYNAMICS; INTERMITTENT; INFECTION; TOXICITY	We present a novel hypothesis that could explain virological failure to structured treatment interruptions (STI). We analysed a classic mathematical model of HIV within-host viral dynamics and found that non-linear parametric resonance occurs when STI are added to the model; resonance is observed as virological failure. We simulated clinical trial data and calculated patient-specific resonant spectra. We gained two important insights. First, within an STI trial, patients who begin with similar viral loads can be expected to show very different virological responses as a result of resonance. Second, and more importantly, virological failure is not simply due to STI or patients' characteristics; instead it is the result of complex interaction between STI and the patient's viral dynamics. Hence, our analyses show that no universal regimen with periodic interruptions will be effective for all patients.	Semel Inst Neurosci & Human Behav, Dept Biomath, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, AIDS Inst, David Geffen Sch Med, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Blower, S (corresponding author), Semel Inst Neurosci & Human Behav, Dept Biomath, Los Angeles, CA 90024 USA.	sblower@mednet.ucla.edu		Breban, Romulus/0000-0002-5821-8139	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041935] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI041935] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agur Z., 1995, Journal of Biological Systems, V3, P241, DOI 10.1142/S021833909500023X; AGUR Z, 1989, LANCET, V2, P1400; AGUR Z, 1987, ANN NY ACAD SCI, V504, P274, DOI 10.1111/j.1749-6632.1987.tb48738.x; AGUR Z, 1991, EXP HEMATOL, V19, P364; AGUR Z, 1985, J THEOR BIOL, V112, P677, DOI 10.1016/S0022-5193(85)80053-9; Agur Z., 1998, COMPUT MATH METHOD M, V1, P237; Altfeld M, 2001, NAT MED, V7, P881, DOI 10.1038/90901; Ananworanich J, 2003, AIDS, V17, pF33, DOI 10.1097/00002030-200310170-00001; Austin DJ, 1998, J THEOR BIOL, V194, P313, DOI 10.1006/jtbi.1997.0438; BERGE P, 1986, ORDER WITHIN CHAOS; BREBAN R, ROLE PARAMETRIC RESO; Butikov EI, 1999, COMPUT SCI ENG, V1, P76, DOI 10.1109/5992.764219; CHARLENE L, 2004, MEDSCAPE TODAY  0713; Clark DR, 1999, ADV IMMUNOL, V73, P301, DOI 10.1016/S0065-2776(08)60789-0; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Dybul M, 2004, J INFECT DIS, V189, P1974, DOI 10.1086/386344; Dybul M, 2003, J INFECT DIS, V188, P388, DOI 10.1086/376535; Dybul M, 2001, P NATL ACAD SCI USA, V98, P15161, DOI 10.1073/pnas.261568398; Fagard C, 2003, ARCH INTERN MED, V163, P1220, DOI 10.1001/archinte.163.10.1220; Garcia F, 2001, AIDS, V15, pF29, DOI 10.1097/00002030-200106150-00002; GUCKENHEIMER J, 1997, NONLINEAR OSCILLATIO; Howe L, 2002, J VIROL, V76, P10588, DOI 10.1128/JVI.76.21.10588-10597.2002; Lori F, 2000, LANCET, V355, P287, DOI 10.1016/S0140-6736(99)03515-1; MCLEAN AR, 1995, P NATL ACAD SCI USA, V92, P3707, DOI 10.1073/pnas.92.9.3707; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Nowak M.A., 2000, VIRUS DYNAMICS MATH; Nowak MA, 1996, SCIENCE, V272, P74, DOI 10.1126/science.272.5258.74; Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398; Ortiz GM, 2001, P NATL ACAD SCI USA, V98, P13288, DOI 10.1073/pnas.221452198; Papasavvas E, 2004, PLOS MED, V1, P218, DOI 10.1371/journal.pmed.0010064; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Swierniak A, 1996, CELL PROLIFERAT, V29, P117, DOI 10.1046/j.1365-2184.1996.00995.x	35	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 15	2006	367	9518					1285	1289		10.1016/S0140-6736(06)68543-7	http://dx.doi.org/10.1016/S0140-6736(06)68543-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	034FC	16631884				2022-12-24	WOS:000236913400033
J	Hallem, EA; Carlson, JR				Hallem, EA; Carlson, JR			Coding of odors by a receptor repertoire	CELL			English	Article							OLFACTORY RECEPTOR; ANTENNAL LOBE; FUNCTIONAL EXPRESSION; MOLECULAR-BASIS; ORGANIZATION; REPRESENTATIONS; NEURONS; MAP; DISCRIMINATION; IDENTIFICATION	We provide a systematic analysis of how odor quality, quantity, and duration are encoded by the odorant receptor repertoire of the Drosophila antenna. We test the receptors with a panel of over 100 odors and find that strong responses are sparse, with response density dependent on chemical class. Individual receptors range along a continuum from narrowly tuned to broadly tuned. Broadly tuned receptors are most sensitive to structurally similar odorants. Strikingly, inhibitory responses are widespread among receptors. The temporal dynamics of the receptor repertoire provide a rich representation of odor quality, quantity, and duration. Receptors with similar odor sensitivity often map to widely dispersed glomeruli in the antennal lobe. We construct a multidimensional "odor space" based on the responses of each individual receptor and find that the positions of odors depend on their chemical class, concentration, and molecular complexity. The space provides a basis for predicting behavioral responses to odors.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	john.carlson@yale.edu		Hallem, Elissa/0000-0003-0260-3174	NIDCD NIH HHS [DC02174, DC04729] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002174, R01DC004729] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Bichao H, 2003, J COMP PHYSIOL A, V189, P203, DOI 10.1007/s00369-003-0391-5; BOECKH J, 1965, COLD SPRING HARB SYM, V30, P263, DOI 10.1101/SQB.1965.030.01.028; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; CAIN WS, 1977, SCIENCE, V195, P796, DOI 10.1126/science.836592; Christensen TA, 2002, CURR OPIN NEUROBIOL, V12, P393, DOI 10.1016/S0959-4388(02)00336-7; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; DOTY RL, 1992, HUMAN SENSE SMELL, P95; Duchamp-Viret P, 1999, SCIENCE, V284, P2171, DOI 10.1126/science.284.5423.2171; Elmore T, 2003, J NEUROSCI, V23, P9906; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Fried HU, 2002, P NATL ACAD SCI USA, V99, P3222, DOI 10.1073/pnas.052658399; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; GROSSISSEROFF R, 1988, CHEM SENSES, V13, P191, DOI 10.1093/chemse/13.2.191; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hallem EA, 2004, NATURE, V427, P212, DOI 10.1038/427212a; Heinbockel T, 1996, J INSECT PHYSIOL, V42, P565, DOI 10.1016/0022-1910(95)00133-6; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Laissue PP, 1999, J COMP NEUROL, V405, P543; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Lei H, 2004, J NEUROSCI, V24, P11108, DOI 10.1523/JNEUROSCI.3677-04.2004; Ma MH, 2000, P NATL ACAD SCI USA, V97, P12869, DOI 10.1073/pnas.220301797; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Meister M, 2001, J NEUROSCI, V21, P1351; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Nikonov AA, 2002, J CHEM ECOL, V28, P1075, DOI 10.1023/A:1015274104626; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; RODRIGUES V, 1978, P INDIAN ACAD SCI B, V87, P147; Sachse S, 1999, EUR J NEUROSCI, V11, P3970, DOI 10.1046/j.1460-9568.1999.00826.x; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; SANCHEZ MGD, 2005, J COMP PHYSIOL A, V191, P189; Schneider D., 1968, Symposia of the Zoological Society of London, VNo. 23, P279; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Shields VDC, 2001, J COMP PHYSIOL A, V186, P1135, DOI 10.1007/s003590000165; Stensmyr MC, 2003, J EXP BIOL, V206, P715, DOI 10.1242/jeb.00143; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Stortkuhl KF, 2001, P NATL ACAD SCI USA, V98, P9381, DOI 10.1073/pnas.151105698; *TNO, 2004, VOL COMP FOOD QUAL Q; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005	62	787	836	5	136	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2006	125	1					143	160		10.1016/j.cell.2006.01.050	http://dx.doi.org/10.1016/j.cell.2006.01.050			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615896	Bronze			2022-12-24	WOS:000237314200020
J	Kondo, N; Sekijima, T; Kondo, J; Takamatsu, N; Tohya, K; Ohtsu, T				Kondo, N; Sekijima, T; Kondo, J; Takamatsu, N; Tohya, K; Ohtsu, T			Circannual control of hibernation by HP complex in the brain	CELL			English	Article							FATTY-ACID OXIDATION; GROUND-SQUIRRELS; MAMMALIAN HIBERNATION; BINDING GLOBULIN; MYOCARDIUM; CHIPMUNKS; HYPOTHERMIA; PROTEINS; GENE; IDENTIFICATION	Seasonal hibernation in mammals is under a unique adaptation system that protects organisms from various harmful events, such as lowering of body temperature (Tb), during hibernation. However, the precise factors controlling hibernation remain unknown. We have previously demonstrated a decrease in hibernation-specific protein (HP) complex in the blood of chipmunks during hibernation. Here, HP is identified as a candidate hormone for hibernation. In chipmunks kept in constant cold and darkness, HP is regulated by an individual free-running circannual rhythm that correlates with hibernation. The level of HP complex in the brain increases coincident with the onset of hibernation. Such HP regulation proceeds independently of Tb changes in constant warmth, and Tb decreases only when brain HP is increased in the cold. Blocking brain HP activity using an antibody decreases the duration of hibernation. We suggest that HP, a target of endogenously generated circannual rhythm, carries hormonal signals essential for hibernation to the brain.	Mitsubishi Kagaku Inst Life Sci, Machida, Tokyo 1948511, Japan; KAST, Machida, Tokyo 1948511, Japan; Mitsubishi Toky Pharmaceut Inc, Yokohama Res Ctr, Kanagawa 2270033, Japan; Kitasato Univ, Sch Sci, Dept Biosci, Kanagawa 2288555, Japan; Kansai Coll Oriental Med, Dept Anat, Osaka 5900482, Japan	Mitsubishi Kagaku Institute of Life Sciences (MITILS); Kitasato University	Kondo, N (corresponding author), Mitsubishi Kagaku Inst Life Sci, Machida, Tokyo 1948511, Japan.	nkondo@libra.ls.m-kagaku.co.jp						AMORESE DA, 1982, P NATL ACAD SCI-BIOL, V79, P6375, DOI 10.1073/pnas.79.20.6375; Aschoff J., 1981, HDB BEHAVIORAL NEURO, V4, P475; Bayne CJ, 2001, DEV COMP IMMUNOL, V25, P725, DOI 10.1016/S0145-305X(01)00033-7; BRONSON FH, 1989, MAMMALIAM REPROD BIO; Chodobski A, 2001, MICROSC RES TECHNIQ, V52, P65; FLINK IL, 1986, P NATL ACAD SCI USA, V83, P7708, DOI 10.1073/pnas.83.20.7708; Frerichs KU, 1998, J CEREBR BLOOD F MET, V18, P168, DOI 10.1097/00004647-199802000-00007; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Gwinner E, 1996, J EXP BIOL, V199, P39; HAMMOND GL, 1987, P NATL ACAD SCI USA, V84, P5153, DOI 10.1073/pnas.84.15.5153; Harlow HJ, 2001, NATURE, V409, P997, DOI 10.1038/35059165; HOCHACHKA PW, 1986, SCIENCE, V231, P234, DOI 10.1126/science.2417316; Holzer M, 2002, NEW ENGL J MED, V346, P549; KEMPER GB, 1982, COMP BIOCHEM PHYS C, V73, P445, DOI 10.1016/0306-4492(82)90151-4; Kishore U, 1999, IMMUNOPHARMACOLOGY, V42, P15, DOI 10.1016/S0162-3109(99)00011-9; Kojima M, 2001, EUR J BIOCHEM, V268, P5997, DOI 10.1046/j.0014-2956.2001.02572.x; Kondo Jun, 1996, P351; KONDO N, 1992, J BIOL CHEM, V267, P473; KONDO N, 1986, CIRC RES, V59, P221, DOI 10.1161/01.RES.59.2.221; KONDO N, 1988, BRIT J PHARMACOL, V95, P1287, DOI 10.1111/j.1476-5381.1988.tb11766.x; KONDO N, 1987, EXPERIENTIA, V43, P873, DOI 10.1007/BF01951645; KONDO N, 1984, SCIENCE, V225, P641, DOI 10.1126/science.6740332; KONDO N, 1986, EXPERIENTIA, V42, P1220, DOI 10.1007/BF01946394; Kondo Nobuaki, 1992, P89; Kondo Noriaki, 1993, P467; PAKHOTIN PI, 1990, NEUROSCIENCE, V38, P591, DOI 10.1016/0306-4522(90)90053-7; Pengelley E.T., 1974, P95; ROSENTHAL NE, 1984, ARCH GEN PSYCHIAT, V41, P72; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; SHARAPOV VM, 1983, MYCOPATHOLOGIA, V84, P77; SRERE HK, 1992, P NATL ACAD SCI USA, V89, P7119, DOI 10.1073/pnas.89.15.7119; Takamatsu N, 1997, GENE, V204, P127, DOI 10.1016/S0378-1119(97)00532-5; TAKAMATSU N, 1993, MOL CELL BIOL, V13, P1516, DOI 10.1128/MCB.13.3.1516; Wang L.C.H., 1982, P206; Wang L.C.H., 1988, Advances in Comparative and Environmental Physiology, V2, P1; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788	36	88	100	1	36	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 7	2006	125	1					161	172		10.1016/j.cell.2006.03.017	http://dx.doi.org/10.1016/j.cell.2006.03.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615897	Bronze			2022-12-24	WOS:000237314200021
J	Ivanova, N; Dobrin, R; Lu, R; Kotenko, I; Levorse, J; DeCoste, C; Schafer, X; Lun, Y; Lemischka, IR				Ivanova, Natalia; Dobrin, Radu; Lu, Rong; Kotenko, Iulia; Levorse, John; DeCoste, Christina; Schafer, Xenia; Lun, Yi; Lemischka, Ihor R.			Dissecting self-renewal in stem cells with RNA interference	NATURE			English	Article							MOUSE EMBRYOS; DIFFERENTIATION; PLURIPOTENCY; EXPRESSION; NANOG; MAINTENANCE; ACTIVATION; INDUCTION; EPIBLAST; LACKING	We present an integrated approach to identify genetic mechanisms that control self-renewal in mouse embryonic stem cells. We use short hairpin RNA (shRNA) loss-of-function techniques to downregulate a set of gene products whose expression patterns suggest self-renewal regulatory functions. We focus on transcriptional regulators and identify seven genes for which shRNA-mediated depletion negatively affects self-renewal, including four genes with previously unrecognized roles in self-renewal. Perturbations of these gene products are combined with dynamic, global analyses of gene expression. Our studies suggest specific biological roles for these molecules and reveal the complexity of cell fate regulation in embryonic stem cells.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Ivanova, N (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	nivanova@molbio.princeton.edu; ilemischka@molbio.princeton.edu		Dobrin, Radu/0000-0002-3336-0091				Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Corson LB, 2003, DEVELOPMENT, V130, P4527, DOI 10.1242/dev.00669; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Essner JJ, 2000, DEVELOPMENT, V127, P1081; Evans AL, 2005, HUM MOL GENET, V14, P3347, DOI 10.1093/hmg/ddi365; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kang SM, 2005, BLOOD, V105, P1288, DOI 10.1182/blood-2004-04-1453; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kurokawa D, 2004, DEVELOPMENT, V131, P3307, DOI 10.1242/dev.01219; Loebel DAF, 2003, DEV BIOL, V264, P1, DOI 10.1016/S0012-1606(03)00390-7; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luo JM, 1997, NATURE, V388, P778, DOI 10.1038/42022; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mitsunaga K, 2004, MECH DEVELOP, V121, P237, DOI 10.1016/j.mod.2004.01.006; Narducci MG, 2002, P NATL ACAD SCI USA, V99, P11712, DOI 10.1073/pnas.182412399; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Pekarsky Y, 2000, P NATL ACAD SCI USA, V97, P3028, DOI 10.1073/pnas.040557697; Rao M, 2004, DEV BIOL, V275, P269, DOI 10.1016/j.ydbio.2004.08.013; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Tighe AP, 2004, J CELL PHYSIOL, V198, P223, DOI 10.1002/jcp.10424; Ting DT, 2004, METH MOLEC MED, V105, P23; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang C, 2005, DEV DYNAM, V234, P878, DOI 10.1002/dvdy.20565	37	748	799	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2006	442	7102					533	538		10.1038/nature04915	http://dx.doi.org/10.1038/nature04915			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069NQ	16767105				2022-12-24	WOS:000239455900036
J	Yoshida, S; Kono, K; Lowery, DM; Bartolini, S; Yaffe, MB; Ohya, Y; Pellman, D				Yoshida, Satoshi; Kono, Keiko; Lowery, Drew M.; Bartolini, Sara; Yaffe, Michael B.; Ohya, Yoshikazu; Pellman, David			Polo-like kinase Cdc5 controls the local activation of Rho1 to promote cytokinesis	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; FISSION YEAST; CELL-WALL; BUDDING YEAST; PHOSPHORYLATION; PLK1; IDENTIFICATION; ACTOMYOSIN; SUBSTRATE; DIVISION	The links between the cell cycle machinery and the cytoskeletal proteins controlling cytokinesis are poorly understood. The small guanine nucleotide triphosphate (GTP)-binding protein RhoA stimulates type II myosin contractility and formin-dependent assembly of the cytokinetic actin contractile ring. We found that budding yeast Polo-like kinase Cdc5 controls the targeting and activation of Rho1 ( RhoA) at the division site via Rho1 guanine nucleotide exchange factors. This role of Cdc5 (Polo-like kinase) in regulating Rho1 is likely to be relevant to cytokinesis and asymmetric cell division in other organisms.	Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Childrens Hosp Boston, Div Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; MIT, Ctr Canc Res, Cambridge, MA 02139 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Tokyo; Massachusetts Institute of Technology (MIT)	Pellman, D (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	david_pellman@dfci.harvard.edu	Yoshida, Satoshi/C-5016-2011; Ohya, Yoshikazu/AAW-2200-2021	Ohya, Yoshikazu/0000-0003-0837-1239; Kono, Keiko/0000-0003-4057-8790				Abe M, 2003, J CELL BIOL, V162, P85, DOI 10.1083/jcb.200301022; Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; D'Avino PP, 2005, J CELL SCI, V118, P1549, DOI 10.1242/jcs.02335; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Lee KS, 2005, ONCOGENE, V24, P217, DOI 10.1038/sj.onc.1208271; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Lippincott J, 2001, J CELL SCI, V114, P1379; Luo JY, 2004, J CELL BIOL, V165, P843, DOI 10.1083/jcb.200401040; Morrell-Falvey JL, 2005, J CELL SCI, V118, P5563, DOI 10.1242/jcs.02664; Mutoh T, 2005, GENES CELLS, V10, P1189, DOI 10.1111/j.1365-2443.2005.00908.x; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124; Park CJ, 2003, GENETICS, V163, P21; Petersen J, 2005, NATURE, V435, P507, DOI 10.1038/nature03590; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Schmidt M, 2002, J CELL SCI, V115, P293; Song SG, 2001, J CELL BIOL, V152, P451, DOI 10.1083/jcb.152.3.451; Tajadura V, 2004, J CELL SCI, V117, P6163, DOI 10.1242/jcs.01530; Tolliday N, 2002, CURR BIOL, V12, P1864, DOI 10.1016/S0960-9822(02)01238-1; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Vallen EA, 2000, MOL BIOL CELL, V11, P593, DOI 10.1091/mbc.11.2.593; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617	28	123	124	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2006	313	5783					108	111		10.1126/science.1126747	http://dx.doi.org/10.1126/science.1126747			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16763112				2022-12-24	WOS:000238850200043
J	Hebting, Y; Schaeffer, P; Behrens, A; Adam, P; Schmitt, G; Schneckenburger, P; Bernasconi, SM; Albrecht, P				Hebting, Y.; Schaeffer, P.; Behrens, A.; Adam, P.; Schmitt, G.; Schneckenburger, P.; Bernasconi, S. M.; Albrecht, P.			Biomarker evidence for a major preservation pathway of sedimentary organic carbon	SCIENCE			English	Article							GREEN RIVER SHALE; PHOTOSYNTHETIC BACTERIA; NATURAL ENVIRONMENTS; SULFUR BACTERIA; BETA-CAROTENE; LAKE CADAGNO; REDUCTION; MATTER; THIOLS; DERIVATIVES	Hydrogenation processes leading from biomolecules to fossil biomarkers in anoxic sediments are crucial for the preservation of organic matter. However, these processes are still poorly understood. The present identification of several reduced carotenoids in recent sediments attests that these processes operate at the earliest stages of diagenesis without structural or stereochemical specificity, implying a nonbiological reduction pathway. Sulfur species ( e. g., H 2 S) are the hydrogen donors involved in such reduction, as demonstrated with laboratory experiments. These reactions allow the preservation of abundant organic carbon in the rock record.	Univ Strasbourg 1, Ecole Chim Polymeres Mat Strasbourg, UMR 7509, CNRS,Lab Geochim Bioorgan, F-67200 Strasbourg, France; Swiss Fed Inst Technol, Inst Geol, CH-8092 Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Swiss Federal Institutes of Technology Domain; ETH Zurich	Albrecht, P (corresponding author), Univ Strasbourg 1, Ecole Chim Polymeres Mat Strasbourg, UMR 7509, CNRS,Lab Geochim Bioorgan, 25 Rue Becquerel, F-67200 Strasbourg, France.	albrecht@chimie.u-strasbg.fr	Bernasconi, Stefano M/E-5394-2010	Bernasconi, Stefano M/0000-0001-7672-8856				Adam P, 2000, GEOCHIM COSMOCHIM AC, V64, P3485, DOI 10.1016/S0016-7037(00)00443-9; ADAM P, 1993, GEOCHIM COSMOCHIM AC, V57, P3395, DOI 10.1016/0016-7037(93)90547-A; Brocks JJ, 2005, NATURE, V437, P866, DOI 10.1038/nature04068; Burhan RYP, 2002, GEOCHIM COSMOCHIM AC, V66, P4085, DOI 10.1016/S0016-7037(02)00979-1; Cody GD, 2000, SCIENCE, V289, P1337, DOI 10.1126/science.289.5483.1337; Damste JSS, 1997, PURE APPL CHEM, V69, P2067, DOI 10.1351/pac199769102067; Del Don C, 2001, AQUAT SCI, V63, P70, DOI 10.1007/PL00001345; Elsner M, 2004, ENVIRON SCI TECHNOL, V38, P799, DOI 10.1021/es0345569; HARTGERS WA, 1994, ORG GEOCHEM, V22, P703, DOI 10.1016/0146-6380(94)90134-1; HARTGERS WA, 1993, J CHEM SOC CHEM COMM, P1715, DOI 10.1039/c39930001715; Hebting Y, 2003, ORG LETT, V5, P1571, DOI 10.1021/ol034374j; Hedges JI, 2001, NATURE, V409, P801, DOI 10.1038/35057247; HUNT JM, 1996, PETROLEUM GEOCHEMIST, P60; Koopmans MP, 1997, ORG GEOCHEM, V26, P451, DOI 10.1016/S0146-6380(97)00025-9; MAYER R, 1963, ANGEW CHEM, V21, P1011; MEISSNER JWG, 1994, TETRAHEDRON LETT, V35, P2757, DOI 10.1016/S0040-4039(00)77025-0; MURPHY MTJ, 1967, SCIENCE, V157, P1040, DOI 10.1126/science.157.3792.1040; NISHIMURA M, 1978, GEOCHIM COSMOCHIM AC, V42, P349, DOI 10.1016/0016-7037(78)90265-X; Peters K.E., 2005, BIOMARKER GUIDE; Putschew A, 1998, ORG GEOCHEM, V29, P1849, DOI 10.1016/S0146-6380(98)00170-3; QUANDT L, 1977, FEMS MICROBIOL LETT, V1, P125, DOI 10.1016/0378-1097(77)90140-9; Russell MJ, 1997, J GEOL SOC LONDON, V154, P377, DOI 10.1144/gsjgs.154.3.0377; Schaeffer P, 1997, TETRAHEDRON LETT, V38, P8413, DOI 10.1016/S0040-4039(97)10235-0; Schaefle J., 1977, TETRAHEDRON LETT, V18, P3673, DOI [DOI 10.1016/S0040-4039(01)83324-4, 10.1016/S0040-4039(01)83324-4]; Schneckenburger P, 1998, TETRAHEDRON LETT, V39, P447, DOI 10.1016/S0040-4039(97)10572-X; SCHWARZENBACH RP, 1990, ENVIRON SCI TECHNOL, V24, P1566, DOI 10.1021/es00080a017; SINNINGHEDAMSTE JS, 1989, GEOCHIM COSMOCHIM AC, V53, P1343; Tonolla M, 2005, APPL ENVIRON MICROB, V71, P3544, DOI 10.1128/AEM.71.7.3544-3550.2005; WAKEHAM SG, 1989, NATURE, V342, P787, DOI 10.1038/342787a0; WATTS CD, 1977, GEOCHIM COSMOCHIM AC, V41, P493, DOI 10.1016/0016-7037(77)90287-3; Zuallig H., 1985, SCHWEIZ Z HYDROL, V47, P87, DOI 10.1007/BF02551937	31	112	123	2	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1627	1631		10.1126/science.1126372	http://dx.doi.org/10.1126/science.1126372			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16690819				2022-12-24	WOS:000238288600038
J	Sechi, LA; Novello, M; Lapenna, R; Baroselli, S; Nadalini, E; Colussi, GL; Catena, C				Sechi, LA; Novello, M; Lapenna, R; Baroselli, S; Nadalini, E; Colussi, GL; Catena, C			Long-term renal outcomes in patients with primary aldosteronism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIABETIC-NEPHROPATHY; PRIMARY HYPERALDOSTERONISM; ORGAN DAMAGE; HYPERTENSION; PROTEINURIA; EPLERENONE; FAILURE; RENIN; VASOCONSTRICTION; SPIRONOLACTONE	Context Experimental animal studies indicate that exposure to increased aldosterone levels might result in renal damage, but the clinical evidence supporting this role of aldosterone is preliminary. Objective To determine the long-term outcome of renal function in patients with primary aldosteronism after surgical or medical treatment. Design, Setting, and Participants Prospective study conducted at an Italian university medical center among a consecutive sample of 50 patients who were diagnosed as having primary aldosteronism between January 1994 and December 2001 and who were followed up for a mean of 6.4 years after treatment with adrenalectomy or spironolactone. Patients with primary aldosteronism were compared with 100 patients with essential hypertension, matched for severity and duration of hypertension. All patients were treated with antihypertensive drugs to reach a target blood pressure of less than 140/90 mm Hg. Main Outcome Measures Primary outcome measures were rates of change of glomerular filtration rate and albuminuria during follow-up. Detection of new-onset microalbuminuria and restoration of normal albumin excretion during follow-up were considered as secondary outcomes. Results At baseline, glomerular filtration rate and albuminuria were higher in patients with primary aldosteronism than those with essential hypertension. The mean blood pressure during the study was 136/81 mm Hg in the primary aldosteronism group and 137/81 mm Hg in the essential hypertension group. Glomerular filtration rate and albuminuria declined during the initial 6-month period in both groups, with a change that was significantly greater ( P <. 001 for both variables) in patients with primary aldosteronism. Subsequent rate of decline of glomerular filtration was comparable in the 2 groups, whereas albuminuria did not progress in the remainder of the follow-up. Restoration of normal albumin excretion from microalbuminuria was significantly more frequent in primary aldosteronism than in essential hypertension ( P=. 02). Conclusion In the majority of patients in this study, primary aldosteronism was characterized by partially reversible renal dysfunction in which elevated albuminuria is a marker of a dynamic rather than structural renal defect.	Univ Udine, Med Clin, Dept Expt & Clin Pathol & Med, Div Internal Med,Hypertens Unit, I-33100 Udine, Italy	University of Udine	Sechi, LA (corresponding author), Univ Udine, Med Clin, Dept Expt & Clin Pathol & Med, Div Internal Med,Hypertens Unit, Piazzale S Maria della Misericordia 1, I-33100 Udine, Italy.	sechi@uniud.it	Sechi, Leonardo Antonio/Y-3109-2018; Colussi, GianLuca/I-2061-2012	Colussi, GianLuca/0000-0003-1673-540X; Catena, Cristiana/0000-0001-5039-435X; novello, marileda/0000-0003-1573-1845				Arima S, 2004, HYPERTENSION, V43, P352, DOI 10.1161/01.HYP.0000111138.78714.1a; BEEVERS DG, 1976, Q J MED, V45, P401; BERL T, 1978, KIDNEY INT, V14, P228, DOI 10.1038/ki.1978.114; Bianchi S, 2005, AM J KIDNEY DIS, V46, P45, DOI 10.1053/j.ajkd.2005.03.007; Chaturvedi N, 2001, ANN INTERN MED, V134, P370, DOI 10.7326/0003-4819-134-5-200103060-00009; CONN JW, 1964, AM J SURG, V107, P159, DOI 10.1016/0002-9610(64)90252-1; Epstein M, 2003, NEPHROL DIAL TRANSPL, V18, P1984, DOI 10.1093/ndt/gfg339; Epstein M, 2005, AM J KIDNEY DIS, V45, P2, DOI 10.1053/j.ajkd.2004.08.040; Epstein M, 2001, AM J KIDNEY DIS, V37, P677, DOI 10.1016/S0272-6386(01)80115-3; Epstein M, 2002, J AM COLL CARDIOL, V39, p249A, DOI 10.1016/S0735-1097(02)81115-9; Ferrari P, 2004, J HYPERTENS, V22, P377, DOI 10.1097/00004872-200402000-00023; Gordon RD, 2004, J HYPERTENS, V22, P251, DOI 10.1097/00004872-200402000-00006; Greene EL, 1996, J CLIN INVEST, V98, P1063, DOI 10.1172/JCI118867; HENE RJ, 1982, KIDNEY INT, V21, P98, DOI 10.1038/ki.1982.14; Hofmann W, 1989, LAB MED, V13, P470; Hollenberg NK, 2004, KIDNEY INT, V66, P1, DOI 10.1111/j.1523-1755.2004.00701.x; Hostetter TH, 2001, SEMIN NEPHROL, V21, P573, DOI 10.1053/snep.2001.26797; KIMURA G, 1987, HYPERTENSION, V10, P11, DOI 10.1161/01.HYP.10.1.11; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; LARAGH JH, 1973, AM J MED, V55, P261, DOI 10.1016/0002-9343(73)90128-9; Mulatero P, 2004, J CLIN ENDOCR METAB, V89, P1045, DOI 10.1210/jc.2003-031337; Nishimura M, 1999, AM J KIDNEY DIS, V33, P261, DOI 10.1016/S0272-6386(99)70298-2; Oelkers W, 2000, J CLIN ENDOCR METAB, V85, P3266, DOI 10.1210/jc.85.9.3266; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Plouin PF, 2004, NEPHROL DIAL TRANSPL, V19, P774, DOI 10.1093/ndt/gfh112; Ribstein J, 2005, J AM SOC NEPHROL, V16, P1320, DOI 10.1681/ASN.2004100878; Rocha R, 2002, ANN NY ACAD SCI, V970, P89, DOI 10.1111/j.1749-6632.2002.tb04415.x; Rossi GP, 2005, TRENDS ENDOCRIN MET, V16, P104, DOI 10.1016/j.tem.2005.02.010; ROWE JW, 1976, J GERONTOL, V31, P155, DOI 10.1093/geronj/31.2.155; Sato A, 2003, HYPERTENSION, V41, P64, DOI 10.1161/01.HYP.0000044937.95080.E9; Sawka AM, 2001, ANN INTERN MED, V135, P258, DOI 10.7326/0003-4819-135-4-200108210-00010; Schjoedt KJ, 2005, KIDNEY INT, V68, P2829, DOI 10.1111/j.1523-1755.2005.00756.x; Sechi LA, 1999, KIDNEY INT, V56, P1049, DOI 10.1046/j.1523-1755.1999.00621.x; Sechi LA, 2000, HYPERTENSION, V36, P978, DOI 10.1161/01.HYP.36.6.978; Sechi LA, 1997, JAMA-J AM MED ASSOC, V277, P1689, DOI 10.1001/jama.277.21.1689; SEELIG HP, 1969, Z KLIN CHEM KLIN BIO, V7, P581; Uhrenholt TR, 2003, CIRC RES, V93, P1258, DOI 10.1161/01.RES.0000106135.02935.E1	39	273	289	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 14	2006	295	22					2638	2645		10.1001/jama.295.22.2638	http://dx.doi.org/10.1001/jama.295.22.2638			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	052HI	16772627	Green Published, Bronze			2022-12-24	WOS:000238224000026
J	Bradshaw, WE; Holzapfel, CM				Bradshaw, William E.; Holzapfel, Christina M.			Climate change - Evolutionary response to rapid climate change	SCIENCE			English	Editorial Material							DROSOPHILA; SELECTION; SHIFT		Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA	University of Oregon	Bradshaw, WE (corresponding author), Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA.	mosquito@uoregon.edu						Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Bearhop S, 2005, SCIENCE, V310, P502, DOI 10.1126/science.1115661; Berteaux D, 2004, INTEGR COMP BIOL, V44, P140, DOI 10.1093/icb/44.2.140; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; Bradshaw WE, 2004, EVOLUTION, V58, P1748, DOI 10.1111/j.0014-3820.2004.tb00458.x; Bradshaw WE, 2001, P NATL ACAD SCI USA, V98, P14509, DOI 10.1073/pnas.241391498; Danilevskii A.S., 1965, PHOTOPERIODISM SEASO; Houghton J. T., 2001, CLIMATE CHANGE 2001; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Karl TR, 2003, SCIENCE, V302, P1719, DOI 10.1126/science.1090228; Kolbert Elizabeth, 2006, FIELD NOTES CATASTRO; Levitan M, 2003, EVOL ECOL RES, V5, P597; LYNCH M, 1996, CONSERV GENET, pCH15; Nussey DH, 2005, SCIENCE, V310, P304, DOI 10.1126/science.1117004; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Reale D, 2003, EVOLUTION, V57, P2416; Rodriguez-Trelles F, 1998, EVOL ECOL, V12, P829, DOI 10.1023/A:1006546616462; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Umina PA, 2005, SCIENCE, V308, P691, DOI 10.1126/science.1109523; VANVLIET A, 2006, AVOIDING DANGEROUS C, pCH12; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WARREN R, 2006, AVOIDING DANGEROUS C, pCH11	23	530	553	15	360	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1477	1478		10.1126/science.1127000	http://dx.doi.org/10.1126/science.1127000			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	050XT	16763134				2022-12-24	WOS:000238124100030
J	Arora, V; Dunphy, C; Chang, VY; Ahmad, F; Humphrey, HJ; Meltzer, D				Arora, Vineet; Dunphy, Carrie; Chang, Vivian Y.; Ahmad, Fawaz; Humphrey, Holly J.; Meltzer, David			The effects of on-duty napping on intern sleep time and fatigue	ANNALS OF INTERNAL MEDICINE			English	Article							WORK HOURS; BELL COMMISSION; NIGHT-SHIFT; CALL; RESIDENTS; MEDICINE; RISK; PERFORMANCE; ACTIGRAPHY; HOUSESTAFF	Background: Naps during extended work shifts are effective in reducing fatigue in other industries, but the use of a nap as a countermeasure to prevent fatigue in residents is uncertain. Objective: To assess the effects of a call-night nap on resident sleep and fatigue. Design: 1-year, within-participant, paired trial with crossover at midmonth. Setting: Academic teaching hospital. Participants: 38 of 40 internal medicine interns. Measurements: Sleep was measured by using wristwatch actigraphy. By using the experience sampling method on a personal digital assistant, random alerts prompted interns to rate fatigue on the 7-point Stanford Sleepiness Scale (7 is most tired). Hospital paging logs and structured interviews provided information on use of coverage. Intervention: For 2 weeks of every month, interns were assigned to the nap schedule, which provided coverage to on-duty interns from midnight to 7:00 a.m. so that they could finish their work and take a nap. The other 2 weeks of the month constituted a standard schedule. Results: Interns received 41 more minutes of sleep while on call with the nap schedule (185 minutes vs. 144 minutes; P < 0.001). When interns with the nap schedule used coverage, they received 68 more minutes of sleep (210 minutes vs. 142 minutes; P < 0.001). Despite these small increases in sleep, interns reported less overall fatigue while on the nap schedule than while on the standard schedule (1.74 vs. 2.26; P = 0.017). Postcall fatigue with the nap schedule was lower by nearly 1 point (2.23 vs 3.16; P = 0.036), which is almost equivalent to the difference between oncall and postcall fatigue with the standard schedule (2.06 vs. 3.16). However, use of coverage by interns on the nap schedule was impaired by their desire to care for their patients and concerns about discontinuity of care. Limitations: This was a single-institution study that did not have the power to examine outcomes related to intern or patient wellbeing. Conclusions: Coverage to allow a nap during an extended duty-hour shift can increase sleep and decrease fatigue for residents.	Univ Chicago, Chicago, IL 60637 USA; Univ Arkansas Med Sci, Little Rock, AR 72205 USA	University of Chicago; University of Arkansas System; University of Arkansas Medical Sciences	Arora, V (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 2007,AMB W216, Chicago, IL 60637 USA.	varora@medicine.bsd.uchicago.edu	Meltzer, David/C-2926-2009	Meltzer, David/0000-0003-2790-7393; Arora, Vineet/0000-0002-4745-7599	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK062719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075292] Funding Source: NIH RePORTER; NIDDK NIH HHS [5 T35DK062719-16] Funding Source: Medline; NIGMS NIH HHS [1 R01 GM075292-01] Funding Source: Medline; PHS HHS [R01 10597] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*ACCR COUNC GRAD M, RES DUT HOURS COMM P; [Anonymous], AHRQ PUBLICATION, V12-EHC039-EF; Arnedt JT, 2005, JAMA-J AM MED ASSOC, V294, P1025, DOI 10.1001/jama.294.9.1025; Arora V, 2005, QUAL SAF HEALTH CARE, V14, P401, DOI 10.1136/qshc.2005.015107; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; BERKOFF K, 1991, J DEV BEHAV PEDIATR, V12, P6; Boeije H, 2002, QUAL QUANT, V36, P391, DOI 10.1023/A:1020909529486; Cherr Gregory S, 2002, Bull Am Coll Surg, V87, P23; CSIKSZENTMIHALYI M, 1987, J NERV MENT DIS, V175, P526, DOI 10.1097/00005053-198709000-00004; Dimarino AJ, 2005, ALIMENT PHARM THER, V22, P325, DOI 10.1111/j.1365-2036.2005.02573.x; FINS JJ, 1991, B NEW YORK ACAD MED, V67, P359; Fletcher KE, 2004, ANN INTERN MED, V141, P851, DOI 10.7326/0003-4819-141-11-200412070-00009; GRUNEBAUM A, 1987, AM J OBSTET GYNECOL, V157, P79, DOI 10.1016/S0002-9378(87)80350-2; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Holzman IR, 2000, MT SINAI J MED, V67, P136; Institute of Medicine, 2001, CROSSING QUALITY CHA; JAIN RK, 2003, AM MED NEWS     0407; KLEBANOFF MA, 1990, NEW ENGL J MED, V323, P1040, DOI 10.1056/NEJM199010113231506; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; LURIE N, 1989, NEW ENGL J MED, V320, P1673, DOI 10.1056/NEJM198906223202507; Marcus CL, 1996, SLEEP, V19, P763, DOI 10.1093/sleep/19.10.763; MATSUMOTO K, 1994, ERGONOMICS, V37, P899, DOI 10.1080/00140139408963699; Morin CM, 1999, SLEEP, V22, P1134, DOI 10.1093/sleep/22.8.1134; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Purnell MT, 2002, J SLEEP RES, V11, P219, DOI 10.1046/j.1365-2869.2002.00309.x; Rosenbaum JR, 2004, AM J MED, V117, P846, DOI 10.1016/j.amjmed.2004.09.001; Sadeh A, 2002, SLEEP MED REV, V6, P113, DOI 10.1053/smrv.2001.0182; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; SADEH A, 1995, SLEEP, V18, P288, DOI 10.1093/sleep/18.4.288; Sallinen M, 1998, J SLEEP RES, V7, P240, DOI 10.1046/j.1365-2869.1998.00121.x; Steele MT, 1999, ACAD EMERG MED, V6, P1050, DOI 10.1111/j.1553-2712.1999.tb01191.x; Stone AA, 1998, J PERS SOC PSYCHOL, V74, P1670, DOI 10.1037/0022-3514.74.6.1670; TORSVALL L, 1988, SLEEP, V11, P35, DOI 10.1093/sleep/11.1.35; VANCAUTER E, 1997, SLEEP QUALITY ENDOCR; Veasey S, 2002, JAMA-J AM MED ASSOC, V288, P1116, DOI 10.1001/jama.288.9.1116; 2003, SLEEP ALERTNESS FATI	37	105	107	1	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 6	2006	144	11					792	798		10.7326/0003-4819-144-11-200606060-00005	http://dx.doi.org/10.7326/0003-4819-144-11-200606060-00005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	049ZN	16754921				2022-12-24	WOS:000238057000002
J	Sharp, D				Sharp, D			Some like it hottest	LANCET			English	Editorial Material							CAPSAICIN; GROWTH; CELLS		Lancet, London NW1 7BY, England		Sharp, D (corresponding author), Lancet, London NW1 7BY, England.							DAVIDSON A, 1999, OXFORD COMPANION FOO, P171; DEBRUXELLES S, 2006, TIMES LONDON    0401; Mori A, 2006, CANCER RES, V66, P3222, DOI 10.1158/0008-5472.CAN-05-0087; Sanchez AM, 2006, APOPTOSIS, V11, P89, DOI 10.1007/s10495-005-3275-z; 2005, W SCOVILLE PEPPER CH	5	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2006	367	9525					1804	1804		10.1016/S0140-6736(06)68785-0	http://dx.doi.org/10.1016/S0140-6736(06)68785-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051XE	16753472				2022-12-24	WOS:000238194200010
J	Olendorf, R; Rodd, FH; Punzalan, D; Houde, AE; Hurt, C; Reznick, DN; Hughes, KA				Olendorf, Robert; Rodd, F. Helen; Punzalan, David; Houde, Anne E.; Hurt, Carla; Reznick, David N.; Hughes, Kimberly A.			Frequency-dependent survival in natural guppy populations	NATURE			English	Article							RETICULATA-PETERS PISCES; LIFE-HISTORY EVOLUTION; POECILIA-RETICULATA; SEXUAL SELECTION; FEMALE CHOICE; COLOR POLYMORPHISM; MATE PREFERENCE; MALE TRAITS; PREDATION; PATTERNS	The maintenance of genetic variation in traits under natural selection is a long-standing paradox in evolutionary biology(1-3). Of the processes capable of maintaining variation, negative frequency-dependent selection ( where rare types are favoured by selection) is the most powerful, at least in theory(1); however, few experimental studies have confirmed that this process operates in nature. One of the most extreme, unexplained genetic polymorphisms is seen in the colour patterns of male guppies ( Poecilia reticulata)(4,5). Here we manipulated the frequencies of males with different colour patterns in three natural populations to estimate survival rates, and found that rare phenotypes had a highly significant survival advantage compared to common phenotypes. Evidence from humans(6,7) and other species(8,9) implicates frequency-dependent survival in the maintenance of molecular, morphological and health-related polymorphisms. As a controlled manipulation in nature, this study provides unequivocal support for frequency-dependent survival - an evolutionary process capable of maintaining extreme polymorphism.	Univ Illinois, Sch Integrat Biol, Urbana, IL 61801 USA; Univ Illinois, Inst Genome Biol, Urbana, IL 61801 USA; Univ Toronto, Dept Zool, Toronto, ON M5S 3G5, Canada; Lake Forest Coll, Dept Biol, Lake Forest, IL 60045 USA; Naos Marine Lab, Smithsonian Trop Res Inst, Panama City, Panama; Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Toronto; Smithsonian Institution; Smithsonian Tropical Research Institute; University of California System; University of California Riverside	Hughes, KA (corresponding author), Univ Illinois, Sch Integrat Biol, Urbana, IL 61801 USA.	kahughes@life.uiuc.edu	Hurt, Carla/A-3284-2011	Olendorf, Robert/0000-0003-3353-5637; reznick, david/0000-0002-1144-0568; Punzalan, David/0000-0003-2105-4561; Hurt, Carla/0000-0001-5850-033X				Bond AB, 2002, NATURE, V415, P609, DOI 10.1038/415609a; Borghans JAM, 2004, IMMUNOGENETICS, V55, P732, DOI 10.1007/s00251-003-0630-5; Brooks R, 2000, NATURE, V406, P67, DOI 10.1038/35017552; Brooks R, 2001, EVOLUTION, V55, P1002, DOI 10.1554/0014-3820(2001)055[1002:DAISSA]2.0.CO;2; Bryant MJ, 2004, AM NAT, V163, P55, DOI 10.1086/380650; Charlesworth B, 2000, EVOL GENET, P369; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; FARR JA, 1977, EVOLUTION, V31, P162, DOI 10.1111/j.1558-5646.1977.tb00993.x; FARR JA, 1980, BEHAVIOUR, V74, P38, DOI 10.1163/156853980X00311; Godin JGJ, 2003, BEHAV ECOL, V14, P194, DOI 10.1093/beheco/14.2.194; Grether GF, 2000, EVOLUTION, V54, P1712, DOI 10.1111/j.0014-3820.2000.tb00715.x; Houde A.E., 1997, SEX COLOR MATE CHOIC; Hughes KA, 1999, ANIM BEHAV, V58, P907, DOI 10.1006/anbe.1999.1225; Hughes KA, 2005, J EVOLUTION BIOL, V18, P35, DOI 10.1111/j.1420-9101.2004.00806.x; JONES JS, 1977, ANNU REV ECOL SYST, V8, P109, DOI 10.1146/annurev.es.08.110177.000545; KODRICBROWN A, 1989, BEHAV ECOL SOCIOBIOL, V25, P393, DOI 10.1007/BF00300185; Lewontin RC, 1974, GENETIC BASIS EVOLUT; Littell RC, 2002, SAS LINEAR MODELS; Oxford GS, 1998, ANNU REV ENTOMOL, V43, P619, DOI 10.1146/annurev.ento.43.1.619; Punzalan D, 2005, EVOL ECOL, V19, P303, DOI 10.1007/s10682-005-2777-z; REID DG, 1987, BIOL J LINN SOC, V30, P1, DOI 10.1111/j.1095-8312.1987.tb00284.x; Reznick DN, 1996, EVOLUTION, V50, P1651, DOI 10.1111/j.1558-5646.1996.tb03937.x; RODD FH, 1991, OIKOS, V62, P13, DOI 10.2307/3545440; Sinervo B, 2001, EVOLUTION, V55, P2040; Sinervo B, 2000, NATURE, V406, P985, DOI 10.1038/35023149; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; Turelli M, 2004, GENETICS, V166, P1053, DOI 10.1534/genetics.166.2.1053	29	190	196	3	199	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					633	636		10.1038/nature04646	http://dx.doi.org/10.1038/nature04646			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16738659				2022-12-24	WOS:000237920800047
J	Boyle, P; Ariyaratne, MAY; Barrington, R; Bartelink, H; Bartsch, G; Berns, A; de Valeriola, D; Dinshaw, KA; Eggermont, AMM; Gray, N; Kakizoe, T; Karki, BS; Kaslar, M; Kerr, DJ; Khayat, D; Khuhaprema, T; Kim, IH; Martin-Moreno, J; McVie, G; Park, JG; Philip, T; Ringborg, U; Rodger, A; Seffrin, JR; Semiglazov, V; Soo, KC; Sun, YT; Thomas, R; Tursz, T; Veronesi, U; Wiestler, O; Yoo, KY; Zatonski, W; Zhao, P				Boyle, Peter; Ariyaratne, M. A. Yasantha; Barrington, Ruth; Bartelink, Harry; Bartsch, Georg; Berns, Anton; de Valeriola, Dominique; Dinshaw, Ketayun A.; Eggermont, Alexander M. M.; Gray, Nigel; Kakizoe, Tadao; Karki, Balman Singh; Kaslar, Miklos; Kerr, David J.; Khayat, David; Khuhaprema, Thiravud; Kim, In-Hoo; Martin-Moreno, Jose; McVie, Gordon; Park, Jae-Gahb; Philip, Thierry; Ringborg, Ulrik; Rodger, Alan; Seffrin, John R.; Semiglazov, Vlacimir; Soo, Khee Chee; Sun, Yun-tian; Thomas, Robert; Tursz, Thomas; Veronesi, Umberto; Wiestler, Otmar; Yoo, Keun-Young; Zatonski, Witold; Zhao, Ping			Tobacco: deadly in any form or disguise	LANCET			English	Editorial Material							SMOKING		Int Agcy Res Canc, F-69372 Lyon, France; Govt Canc Inst, Canc Control Programme, Maharagamma, Sri Lanka; Hlth Res Board, Dublin, Ireland; Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands; Univ Innsbruck, Urol Clin, A-6020 Innsbruck, Austria; Inst Jules Bordet, B-1000 Brussels, Belgium; Tata Mem Hosp, Bombay, Maharashtra, India; European Org Res Treatment Canc, Brussels, Belgium; Natl Canc Ctr, Tokyo 104, Japan; BP Koirala Mem Canc Hosp, Bharatpur, Chitwan, Nepal; Natl Inst Oncol, Budapest, Hungary; Univ Oxford, Dept Clin Pharmacol, Oxford, England; Natl Canc Inst, Paris, France; Natl Canc Inst, Bangkok, Thailand; Natl Canc Ctr, Seoul, South Korea; Univ Valencia, Fac Med, Valencia, Spain; European Inst Oncol, Milan, Italy; Ctr Leon Berard, F-69373 Lyon, France; Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; Western Infirm & Associated Hosp, Beatson Oncol Ctr, Glasgow G11 6NT, Lanark, Scotland; Amer Canc Soc, Atlanta, GA 30329 USA; NN Petrov Oncol Res Inst, St Petersburg, Russia; Natl Canc Ctr, Singapore, Singapore; Peking Union Med Coll, Beijing, Peoples R China; Peter MacCallum Canc Inst, Melbourne, Vic 3000, Australia; Inst Gustave Roussy, Villejuif, France; German Canc Res Ctr, D-6900 Heidelberg, Germany; Seoul Natl Univ, Coll Med, Seoul, South Korea; Maria Sklodowska Curie Inst Oncol, Warsaw, Poland	World Health Organization; International Agency for Research on Cancer (IARC); Health Research Board - Ireland; Netherlands Cancer Institute; University of Innsbruck; Institut Jules Bordet; Tata Memorial Centre (TMC); Tata Memorial Hospital; European Organisation for Research & Treatment of Cancer; National Cancer Center - Japan; National Institute of Oncology Hungary; University of Oxford; Institut National du Cancer (INCA) France; National Cancer Institute - Thailand; National Cancer Center - Korea (NCC); University of Valencia; IRCCS European Institute of Oncology (IEO); UNICANCER; Centre Leon Berard; Karolinska Institutet; Beatson Oncology Centre; American Cancer Society; N.N. Petrov Research Institute of Oncology; National Cancer Centre Singapore (NCCS); Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peter Maccallum Cancer Center; UNICANCER; Gustave Roussy; Helmholtz Association; German Cancer Research Center (DKFZ); Seoul National University (SNU); Maria Sklodowska-Curie National Research Institute of Oncology	Boyle, P (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	director@iarc.fr	Park, Jae-Gahb/J-5494-2012; Yoo, Keun-Young/J-5548-2012; Boyle, Peter/A-4380-2014; Martin-Moreno, Jose M./S-7733-2016	Boyle, Peter/0000-0001-6251-0610; Martin-Moreno, Jose M./0000-0002-8648-5541				Chen ZM, 1997, JAMA-J AM MED ASSOC, V278, P1500, DOI 10.1001/jama.278.18.1500; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Fernandez E, 2006, TOB CONTROL, V15, P79; Giskes K, 2005, J EPIDEMIOL COMMUN H, V59, P395, DOI 10.1136/jech.2004.025684; *INT AG RES CANC, 2006, REV RISK SMOK CESS; *INT AG RES CANC, 2005, SMOK TOB TOB REL NIT; International Agency for Research on Cancer, 2004, TOB SMOK INV SMOK	7	13	13	1	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 27	2006	367	9524					1710	1712		10.1016/S0140-6736(06)68747-3	http://dx.doi.org/10.1016/S0140-6736(06)68747-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	047BE	16731252				2022-12-24	WOS:000237854000007
J	Bejerano-Sagie, M; Oppenheimer-Shaanan, Y; Berlatzky, I; Rouvinski, A; Meyerovich, M; Ben-Yehuda, S				Bejerano-Sagie, Michal; Oppenheimer-Shaanan, Yaara; Berlatzky, Idit; Rouvinski, Alex; Meyerovich, Mor; Ben-Yehuda, Sigal			A checkpoint protein that scans the chromosome for damage at the start of sporulation in Bacillus subtilis	CELL			English	Article							STRAND BREAK REPAIR; DNA-DAMAGE; TRANSCRIPTION FACTOR; SACCHAROMYCES-CEREVISIAE; CELL-DIVISION; INITIATION; GENE; LOCALIZATION; VISUALIZATION; ACTIVATION	In response to DNA damage, cells activate checkpoint signaling cascades to control cell-cycle progression and elicit DNA repair in order to maintain genomic integrity. The sensing and repair of lesions is critical for Bacillus subtilis cells entering the developmental process of sporulation as damaged DNA may prevent the cells from completing spore morphogenesis. We report the identification of the protein DisA (DNA integrity scanning protein, annotated YacK), which is required to delay the initiation of sporulation in response to chromosomal damage. DisA is a nonspecific DNA binding protein that forms a single focus, which moves rapidly within the bacterial cell, pausing at sites of DNA damage. We propose that the DisA focus scans along the chromosomes searching for lesions. Upon encountering a lesion, DisA delays entry into sporulation until the damage is repaired.	Hebrew Univ Jerusalem, Fac Med, Dept Mol Biol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Ben-Yehuda, S (corresponding author), Hebrew Univ Jerusalem, Fac Med, Dept Mol Biol, POB 12272, IL-91120 Jerusalem, Israel.	sigalbe@md.huji.ac.il						Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; Ben-Yehuda S, 2003, SCIENCE, V299, P532, DOI 10.1126/science.1079914; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Burkholder WF, 2001, CELL, V104, P269, DOI 10.1016/S0092-8674(01)00211-2; Doherty AJ, 1996, NUCLEIC ACIDS RES, V24, P2488, DOI 10.1093/nar/24.13.2488; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Harwood C. R., 1990, MOL BIOL METHODS BAC; IRETON K, 1992, P NATL ACAD SCI USA, V89, P8808, DOI 10.1073/pnas.89.18.8808; IRETON K, 1994, CELL MOL BIOL RES, V40, P193; IRETON K, 1993, GENE DEV, V7, P283, DOI 10.1101/gad.7.2.283; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kidane D, 2004, MOL MICROBIOL, V52, P1627, DOI 10.1111/j.1365-2958.2004.04102.x; Kidane D, 2005, J CELL BIOL, V170, P357, DOI 10.1083/jcb.200412090; Kruger E, 1996, MOL MICROBIOL, V20, P713, DOI 10.1111/j.1365-2958.1996.tb02511.x; LEDEAUX JR, 1995, J BACTERIOL, V177, P166, DOI 10.1128/jb.177.1.166-175.1995; Lemon KP, 2000, J BACTERIOL, V182, P2989, DOI 10.1128/JB.182.10.2989-2991.2000; Levin PA, 1996, GENE DEV, V10, P478, DOI 10.1101/gad.10.4.478; Li L, 2005, J CELL BIOCHEM, V94, P298, DOI 10.1002/jcb.20355; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lisby M, 2005, BIOCHIMIE, V87, P579, DOI 10.1016/j.biochi.2004.10.023; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Molle V, 2003, MOL MICROBIOL, V50, P1683, DOI 10.1046/j.1365-2958.2003.03818.x; Pan Q, 2001, MOL CELL, V8, P873, DOI 10.1016/S1097-2765(01)00362-8; PEREGO M, 2001, BACILLUS SUBTILIS IT, P473; Piggot PJ, 2004, CURR OPIN MICROBIOL, V7, P579, DOI 10.1016/j.mib.2004.10.001; PIGGOT PJ, 2001, BACILLUS SUBTILIS IT, P483; Pogliano J, 2002, J BACTERIOL, V184, P1743, DOI 10.1128/JB.184.4.1743-1749.2002; Rowland SL, 2004, MOL CELL, V13, P689, DOI 10.1016/S1097-2765(04)00084-X; Sambrook JFE, 1989, MOL CLONING LAB MANU; Shafikhani SH, 2004, FEMS MICROBIOL LETT, V231, P99, DOI 10.1016/S0378-1097(03)00936-4; SHARROCK RA, 1984, MOL GEN GENET, V194, P260, DOI 10.1007/BF00383525; Smith BT, 2001, MOL CELL, V8, P1197, DOI 10.1016/S1097-2765(01)00402-6; Sonenshein AL, 2000, CURR OPIN MICROBIOL, V3, P561, DOI 10.1016/S1369-5274(00)00141-7; STERLINI JM, 1969, BIOCHEM J, V113, P29, DOI 10.1042/bj1130029; Straube A, 2004, EUR J NEUROL, V11, P83, DOI 10.1046/j.1468-1331.2003.00754.x; Webb CD, 1997, CELL, V88, P667, DOI 10.1016/S0092-8674(00)81909-1; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; YORK K, 1992, J BACTERIOL, V174, P2648, DOI 10.1128/jb.174.8.2648-2658.1992; YOUNGMAN P, 1984, PLASMID, V12, P1, DOI 10.1016/0147-619X(84)90061-1	41	115	120	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2006	125	4					679	690		10.1016/j.cell.2006.03.039	http://dx.doi.org/10.1016/j.cell.2006.03.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713562	Bronze			2022-12-24	WOS:000237886000014
J	Pavri, R; Zhu, B; Li, GH; Trojer, P; Mandal, S; Shilatifard, A; Reinberg, D				Pavri, Rushad; Zhu, Bing; Li, Guohong; Trojer, Patrick; Mandal, Subhrangsu; Shilatifard, Ali; Reinberg, Danny			Histone H2B monoubiquitination functions cooperatively with FACT to regulate elongation by RNA polymerase II	CELL			English	Article							H3 LYSINE-4 METHYLATION; RETINOIC ACID RECEPTOR; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ELONGATION; IN-VITRO; PAF1 COMPLEX; CHROMATIN-STRUCTURE; X-RECEPTOR; YEAST; MEDIATOR	Over the past years, a large number of histone posttranslational modifications have been described, some of which function to attain a repressed chromatin structure, while others facilitate activation by allowing access of regulators to DNA. Histone H2B monoubiquitination is a mark associated with transcriptional activity. Using a highly reconstituted chromatin-transcription system incorporating the inducible RAR beta 2 promoter, we find that the establishment of H2B monoubiquitination by RNF20/40 and UbcH6 is dependent on the transcription elongation regulator complex PAF, the histone chaperone FACT, and transcription. H2B monoubiquitination facilitates FACT function, thereby stimulating transcript elongation and the generation of longer transcripts. These in vitro analyses and corroborating in vivo experiments demonstrate that elongation by RNA polymerase II through the nucleosomal barrier is minimally dependent upon (1) FACT and (2) the recruitment of PAF and the H2B monoubiquitination machinery.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Howard Hughes Med Inst,Div Nucl Acids Enzymol, Piscataway, NJ 08854 USA; St Louis Univ, Sch Med, Dept Biochem, St Louis, MO 63104 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Saint Louis University	Reinberg, D (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Howard Hughes Med Inst,Div Nucl Acids Enzymol, 683 Hoes Lane, Piscataway, NJ 08854 USA.	reinbedf@umdnj.edu		Reinberg, Danny/0000-0003-4288-2016; Pavri, Rushad/0000-0002-6191-6333; Mandal, Subhrangsu/0000-0001-8495-9881	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037120, R01GM037120] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM37120] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; An WJ, 2002, MOL CELL, V9, P811, DOI 10.1016/S1097-2765(02)00497-5; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bhoite LT, 2001, GENE DEV, V15, P2457, DOI 10.1101/gad.921601; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; Dilworth FJ, 2004, P NATL ACAD SCI USA, V101, P11593, DOI 10.1073/pnas.0404192101; Dilworth FJ, 1999, P NATL ACAD SCI USA, V96, P1995, DOI 10.1073/pnas.96.5.1995; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; FLORES O, 1989, J BIOL CHEM, V264, P8913; FLORES O, 1992, J BIOL CHEM, V267, P2786; Formosa T, 2002, GENETICS, V162, P1557; Glass CK, 2000, GENE DEV, V14, P121; HAWLEY DK, 1985, J BIOL CHEM, V260, P8163; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Lefebvre B, 2002, MOL CELL BIOL, V22, P1446, DOI 10.1128/MCB.22.5.1446-1459.2002; LeRoy G, 1998, SCIENCE, V282, P1900, DOI 10.1126/science.282.5395.1900; Lewis BA, 2003, J CELL SCI, V116, P3667, DOI 10.1242/jcs.00734; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Loyola A, 2003, MOL CELL BIOL, V23, P6759, DOI 10.1128/MCB.23.19.6759-6768.2003; Loyola A, 2001, GENE DEV, V15, P2837; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; MALONE EA, 1991, MOL CELL BIOL, V11, P5710, DOI 10.1128/MCB.11.11.5710; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Nishioka K, 2003, METHODS, V31, P49, DOI 10.1016/S1046-2023(03)00087-2; Noma K, 2002, P NATL ACAD SCI USA, V99, P16438, DOI 10.1073/pnas.182436399; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Rachez C, 2001, CURR OPIN CELL BIOL, V13, P274, DOI 10.1016/S0955-0674(00)00209-X; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Rondon AG, 2004, EMBO REP, V5, P47, DOI 10.1038/sj.embor.7400045; ROWLEY A, 1991, MOL CELL BIOL, V11, P5718, DOI 10.1128/MCB.11.11.5718; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; Shi XM, 1996, MOL CELL BIOL, V16, P669; Shi XM, 1997, MOL CELL BIOL, V17, P1160, DOI 10.1128/MCB.17.3.1160; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; SIMS RJ, 2006, UNPUB REGULATION RNA, V4; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Taatjes DJ, 2004, NAT REV MOL CELL BIO, V5, P403, DOI 10.1038/nrm1369; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025; Zhu B, 2005, GENE DEV, V19, P1668, DOI 10.1101/gad.1292105	66	519	550	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2006	125	4					703	717		10.1016/j.cell.2006.04.029	http://dx.doi.org/10.1016/j.cell.2006.04.029			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713563	Bronze			2022-12-24	WOS:000237886000016
J	Iber, D; Clarkson, J; Yudkin, MD; Campbell, ID				Iber, D; Clarkson, J; Yudkin, MD; Campbell, ID			The mechanism of cell differentiation in Bacillus subtilis	NATURE			English	Article							TRANSCRIPTION FACTOR SIGMA(F); GENE-EXPRESSION; RNA-POLYMERASE; SPORULATION; ACTIVATION; SPOIIAB; REGULATOR; PROTEIN	Sporulation in Bacillus subtilis serves as a model for the development of two different cell types from a single cell(1). Although much information has been accumulated about the mechanisms that initiate the developmental programmes(2), important questions remain that can be answered only by quantitative analysis. Here we develop, with the help of existing and new experimental results, a mathematical model that reproduces published in vitro experiments and explains how the activation of the key transcription factor is regulated. The model identifies the difference in volume between the two cell types as the primary trigger for determining cell fate. It shows that this effect depends on the allosteric behaviour of a key protein kinase and on a low rate of dephosphorylation by the corresponding phosphatase; both predicted effects are confirmed experimentally.	Univ Oxford, Inst Math, Ctr Math Biol, Oxford OX1 3LB, England; Univ Oxford, Dept Biochem, Microbiol Unit, Oxford OX1 3QU, England	University of Oxford; University of Oxford	Iber, D (corresponding author), Univ Oxford, Inst Math, Ctr Math Biol, 24-29 St Giles, Oxford OX1 3LB, England.	iber@maths.ox.ac.uk; michael.yudkin@kellogg.ox.ac.uk	Iber, Dagmar/V-2846-2019	Iber, Dagmar/0000-0001-8051-1035	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Carniol K, 2004, J BIOL CHEM, V279, P14860, DOI 10.1074/jbc.M314274200; Clarkson J, 2004, J MOL BIOL, V342, P1187, DOI 10.1016/j.jmb.2004.07.090; Clarkson J, 2004, J MOL BIOL, V340, P203, DOI 10.1016/j.jmb.2004.04.061; Clarkson J, 2004, BIOCHEMISTRY-US, V43, P3120, DOI 10.1021/bi036014+; DIEDERICH B, 1994, GENE DEV, V8, P2653, DOI 10.1101/gad.8.21.2653; DUNCAN L, 1995, SCIENCE, V270, P641, DOI 10.1126/science.270.5236.641; Dworkin J, 2001, CELL, V107, P339, DOI 10.1016/S0092-8674(01)00528-1; EISENSTADT E, 1973, J BACTERIOL, V113, P1363, DOI 10.1128/JB.113.3.1363-1372.1973; Frandsen N, 1999, GENE DEV, V13, P394, DOI 10.1101/gad.13.4.394; Fujita M, 1998, GENE, V221, P185, DOI 10.1016/S0378-1119(98)00452-1; Garsin DA, 1998, J MOL BIOL, V284, P569, DOI 10.1006/jmbi.1998.2202; Hilbert DW, 2004, MICROBIOL MOL BIOL R, V68, P234, DOI 10.1128/MMBR.68.2.234-262.2004; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; King N, 1999, GENE DEV, V13, P1156, DOI 10.1101/gad.13.9.1156; Lee CS, 2000, J BACTERIOL, V182, P6250, DOI 10.1128/JB.182.21.6250-6253.2000; Lord M, 1999, J BACTERIOL, V181, P2346, DOI 10.1128/JB.181.8.2346-2350.1999; Lucet I, 1999, J BACTERIOL, V181, P3242, DOI 10.1128/JB.181.10.3242-3245.1999; Magnin T, 1997, J BACTERIOL, V179, P3922, DOI 10.1128/jb.179.12.3922-3927.1997; Pan Q, 2001, MOL CELL, V8, P873, DOI 10.1016/S1097-2765(01)00362-8; Schroeter R, 1999, FEMS MICROBIOL LETT, V174, P117, DOI 10.1016/S0378-1097(99)00117-2; Shu JC, 2004, BIOCHEM J, V384, P169, DOI 10.1042/BJ20040923; Yudkin MD, 2005, MOL MICROBIOL, V56, P578, DOI 10.1111/j.1365-2958.2005.04594.x	22	45	47	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					371	374		10.1038/nature04666	http://dx.doi.org/10.1038/nature04666			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710423				2022-12-24	WOS:000237593200053
J	Toff, WD; Jones, CI; Ford, I; Pearse, RJ; Watson, HG; Watt, SJ; Ross, JAS; Gradwell, DP; Batchelor, AJ; Abrams, KR; Meijers, JCM; Goodall, AH; Greaves, M				Toff, WD; Jones, CI; Ford, I; Pearse, RJ; Watson, HG; Watt, SJ; Ross, JAS; Gradwell, DP; Batchelor, AJ; Abrams, KR; Meijers, JCM; Goodall, AH; Greaves, M			Effect of hypobaric hypoxia, simulating conditions during long-haul air travel, on coagulation, fibrinolysis, platelet function, and endothelial activation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FLOW-CYTOMETRIC ANALYSIS; HUMAN-BEINGS; PLASMA; BLOOD	Context The link between long-haul air travel and venous thromboembolism is the subject of continuing debate. It remains unclear whether the reduced cabin pressure and oxygen tension in the airplane cabin create an increased risk compared with seated immobility at ground level. Objective To determine whether hypobaric hypoxia, which may be encountered during air travel, activates hemostasis. Design, Setting, and Participants A single-blind, crossover study, performed in a hypobaric chamber, to assess the effect of an 8- hour seated exposure to hypobaric hypoxia on hemostasis in 73 healthy volunteers, which was conducted in the United Kingdom from September 2003 to November 2005. Participants were screened for factor V Leiden G1691A and prothrombin G20210A mutation and were excluded if they tested positive. Blood was drawn before and after exposure to assess activation of hemostasis. Interventions Individuals were exposed alternately ( >= 1 week apart) to hypobaric hypoxia, similar to the conditions of reduced cabin pressure during commercial air travel ( equivalent to atmospheric pressure at an altitude of 2438 m), and normobaric normoxia ( control condition; equivalent to atmospheric conditions at ground level, circa 70 m above sea level). Main Outcome Measures Comparative changes in markers of coagulation activation, fibrinolysis, platelet activation, and endothelial cell activation. Results Changes were observed in some hemostatic markers during the normobaric exposure, attributed to prolonged sitting and circadian variation. However, there were no significant differences between the changes in the hypobaric and the normobaric exposures. For example, the median difference in change between the hypobaric and normobaric exposure was 0 ng/mL for thrombin-antithrombin complex (95% CI, - 0.30 to 0.30 ng/mL); - 0.20 nmol/L for prothrombin fragment 1 + 2 ( 95% CI, - 0.03 to 0.01 nmol/L); 1.38 ng/mL for D-dimer ( 95% CI, - 3.63 to 9.72 ng/ mL); and - 2.00% for endogenous thrombin potential ( 95% CI, - 4.00% to 1.00%). Conclusion Our findings do not support the hypothesis that hypobaric hypoxia, of the degree that might be encountered during long-haul air travel, is associated with prothrombotic alterations in the hemostatic system in healthy individuals at low risk of venous thromboembolism.	Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; Univ Aberdeen, Dept Med & Therapeut, Aberdeen, Scotland; Univ Aberdeen, Dept Environm & Occupat Med, Aberdeen, Scotland; Royal AF Ctr Aviat Med, Henlow, Beds, England; Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands	University of Leicester; University of Leicester; University of Aberdeen; University of Aberdeen; University of Amsterdam; Academic Medical Center Amsterdam	Toff, WD (corresponding author), Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Clin Sci Wing, Groby Rd, Leicester LE3 9QP, Leics, England.	w.toff@le.ac.uk	Meijers, J.C.M./S-5981-2019; Ford, Ian/ABE-6145-2020; Abrams, Keith/AAA-2557-2020	Meijers, J.C.M./0000-0002-4198-6780; Jones, Chris/0000-0001-7537-1509; Abrams, Keith/0000-0002-7557-1567; Goodall, Alison/0000-0002-7883-9645; Toff, William/0000-0001-5631-4496				*AIRW STAND, 2004, TRANSP CAT AIRPL DES; ANDREOTTI F, 1991, CHRONOBIOL INT, V8, P336, DOI 10.3109/07420529109059170; Bartsch T, 2001, LANCET, V357, P955; Bendz B, 2000, LANCET, V356, P1657, DOI 10.1016/S0140-6736(00)03165-2; Bendz B, 2001, LANCET, V357, P955, DOI 10.1016/S0140-6736(05)71652-4; BOOTH NA, 1988, BRIT J HAEMATOL, V70, P327, DOI 10.1111/j.1365-2141.1988.tb02490.x; Crosby A, 2003, LANCET, V361, P2207, DOI 10.1016/S0140-6736(03)13777-4; Dalen JE, 2003, ARCH INTERN MED, V163, P2674, DOI 10.1001/archinte.163.22.2674; DICK J, 2004, HIGH ALT MED BIOL, V5, P481; GERTLER JP, 1993, J VASC SURG, V18, P939, DOI 10.1016/0741-5214(93)90548-Z; GERTLER JP, 1991, J VASC SURG, V13, P428, DOI 10.1067/mva.1991.25767; Goodall Alison H, 2004, Methods Mol Biol, V272, P225; Harding RM, 1999, AVIATION MED, P43; Hodkinson PD, 2003, J THROMB HAEMOST, V1, P2131, DOI 10.1046/j.1538-7836.2003.00407.x; HOMANS J, 1954, NEW ENGL J MED, V250, P148, DOI 10.1056/NEJM195401282500404; ISHII H, 1990, THROMB HAEMOSTASIS, V63, P157; Iversen PO, 2002, BRIT J HAEMATOL, V119, P1011, DOI 10.1046/j.1365-2141.2002.03953.x; Kapiotis S, 1997, CIRCULATION, V96, P19; LABRECQUE G, 1991, CHRONOBIOL INT, V8, P361, DOI 10.3109/07420529109059172; MACGREGOR I R, 1987, Fibrinolysis, V1, P247, DOI 10.1016/0268-9499(87)90044-0; Michelson AD, 2001, CIRCULATION, V104, P1533, DOI 10.1161/hc3801.095588; Muhm JM, 2004, AVIAT SPACE ENVIR MD, V75, P905; Rosing J, 1997, BRIT J HAEMATOL, V97, P233, DOI 10.1046/j.1365-2141.1997.192707.x; SANDSET PM, 1987, THROMB RES, V47, P389, DOI 10.1016/0049-3848(87)90454-3; Schreijer AJM, 2006, LANCET, V367, P832, DOI 10.1016/S0140-6736(06)68339-6; Senn S, 1993, CROSS OVER TRIALS CL, V2nd; SUDOH M, 2003, AVIAT SPACE ENV MED, V74, P423; SUDOH M, 2002, AVIAT SPACE ENV MED, V73, P278; Undar B, 1999, CHRONOBIOL INT, V16, P335, DOI 10.3109/07420529909116862; Vickers A J, 2001, BMC Med Res Methodol, V1, P6, DOI 10.1186/1471-2288-1-6	30	97	104	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2006	295	19					2251	2261		10.1001/jama.295.19.2251	http://dx.doi.org/10.1001/jama.295.19.2251			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	042UX	16705106	Bronze			2022-12-24	WOS:000237556600023
J	Purandare, N; Burns, A; Daly, KJ; Hardicre, J; Morris, J; Macfarlane, G; McCollum, C				Purandare, Nitin; Burns, Alistair; Daly, Kevin J.; Hardicre, Jayne; Morris, Julie; Macfarlane, Gary; McCollum, Charles			Cerebral emboli as a potential cause of Alzheimer's disease and vascular dementia: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PATENT FORAMEN OVALE; TRANSCRANIAL DOPPLER; MICROEMBOLIC SIGNALS; STROKE PATIENTS; ULTRASOUND; PREVALENCE; ROTTERDAM; STENOSIS; CRITERIA; BYPASS	Objective To compare the occurrence of spontaneous cerebral emboli and venous to arterial circulation shunts in patients with Alzheimer's disease or vascular dementia and controls without dementia. Design Cross sectional case-control study. Setting Secondary care old age psychiatry services, Manchester. Participants 170 patients with dementia (85 with Alzheimer's disease, 85 with vascular dementia) and 150 age and sex matched controls. Patients on anticoagulant treatment, patients with severe dementia, and controls with marked cognitive impairment were excluded. Main outcome measures Frequencies of detection of spontaneous cerebral emboli during one hour monitoring of the middle cerebral arteries with transcranial Doppler and venous to arterial circulation shunts by a transcranial Doppler technique using intravenous microbubbles as an ultrasound contrast. Results Spontaneous cerebral emboli were detected in 32 (40%) of patients with Alzheimer's disease and 31 (37%) of those with vascular dementia compared with just 12 each (15% and 14%) of their controls, giving significant odds ratios adjusted for vascular risk factors of 2.70 (95% confidence interval 1.18 to 6.21) for Alzheimer's disease and 5.36 (1.24 to 23.18) for vascular dementia. These spontaneous cerebral emboli were not caused by carotid disease, which was equally frequent in dementia patients and their controls. A venous to arterial circulation shunt indicative of patent foramen ovale was found in 27 (32%) Alzheimer's disease patients and 25 (29%) vascular dementia patients compared with 19 (22%) and 17 (20%) controls, giving non-significant odds ratios of 1.57 (0.80 to 3.07) and 1.67 (0.81 to 3.41). Conclusion Spontaneous cerebral emboli were significantly associated with both Alzheimer's disease and vascular dementia. They may represent a potentially preventable or treatable cause of dementia.	Univ Manchester, Sch Epidemiol & Hlth Sci, Manchester M13 9PT, Lancs, England; Univ Manchester, Dept Psychiat, Manchester, Lancs, England; Univ Manchester, Acad Surg Unit, Manchester M13 9PL, Lancs, England; S Manchester Univ Hosp NHS Trust, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester; Wythenshawe Hospital NHS Foundation Trust	Macfarlane, G (corresponding author), Univ Manchester, Sch Epidemiol & Hlth Sci, Manchester M13 9PT, Lancs, England.	cnmcc@manchester.ac.uk	Macfarlane, Gary J/I-9521-2014	Macfarlane, Gary J/0000-0003-2322-3314; Burns, Alistair/0000-0002-9837-0645; hardicre, jayne/0000-0002-4047-9779	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anzola Gian Paolo, 2002, Eur J Ultrasound, V16, P11, DOI 10.1016/S0929-8266(02)00043-5; Deklunder G, 1998, STROKE, V29, P1821, DOI 10.1161/01.STR.29.9.1821; DITULLIO M, 1993, STROKE, V24, P1020, DOI 10.1161/01.STR.24.7.1020; Droste DW, 2000, STROKE, V31, P1640, DOI 10.1161/01.STR.31.7.1640; Fearn SJ, 2001, J THORAC CARDIOV SUR, V121, P1150, DOI 10.1067/mtc.2001.114099; FOISTEIN MF, 1975, J PSYCHIATR RES, V12, P189; Folstein MF, 1975, J PSYCHIATR RES, V12, P189, DOI DOI 10.1016/0022-3956(75)90026-6; HAGAN PT, 1984, MAYO CLIN P, V59, P17; Hofman A, 1997, LANCET, V349, P151, DOI 10.1016/S0140-6736(96)09328-2; Hutchinson S, 2002, STROKE, V33, P685, DOI 10.1161/hs0302.104166; Jauss M, 2000, CEREBROVASC DIS, V10, P490, DOI 10.1159/000016119; LECHAT P, 1988, NEW ENGL J MED, V318, P1148, DOI 10.1056/NEJM198805053181802; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meier B, 2005, HEART, V91, P444, DOI 10.1136/hrt.2004.052258; Meier B, 2003, CIRCULATION, V107, P5, DOI 10.1161/01.CIR.0000046073.34261.C1; Nygren T, 1998, CLIN PHYSIOL, V18, P327; Ott A, 1997, STROKE, V28, P316, DOI 10.1161/01.STR.28.2.316; Purandare N, 2005, INT J GERIATR PSYCH, V20, P12, DOI 10.1002/gps.1202; Riding G, 2001, BRIT J SURG, V88, P745; Ringelstein EB, 1998, STROKE, V29, P725; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Russell D, 2002, J NEUROL SCI, V203, P211, DOI 10.1016/S0022-510X(02)00293-9; SASTRY S, 2002, HEART, V88, P32; Sidhu PS, 1997, CLIN RADIOL, V52, P654, DOI 10.1016/S0009-9260(97)80027-X; Skoog I, 1999, ALZ DIS ASSOC DIS, V13, pS106, DOI 10.1097/00002093-199912003-00016; SLIWKA U, 1995, STROKE, V26, P2067, DOI 10.1161/01.STR.26.11.2067; SPENCER MP, 1995, STROKE, V26, P1123, DOI 10.1161/01.STR.26.6.1123; Stewart R, 1999, AUST NZ J PSYCHIAT, V33, P809, DOI 10.1046/j.1440-1614.1999.00657.x; Stork JL, 2002, STROKE, V33, P2014, DOI 10.1161/01.STR.0000021002.17394.7F; Stygall J, 2003, HEALTH PSYCHOL, V22, P579, DOI 10.1037/0278-6133.22.6.579; WEBSTER MWI, 1988, LANCET, V2, P11	31	90	105	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2006	332	7550					1119	1122		10.1136/bmj.38814.696493.AE	http://dx.doi.org/10.1136/bmj.38814.696493.AE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	044OT	16648133	Green Published, Bronze			2022-12-24	WOS:000237682700015
J	Burtsev, M; Turchin, P				Burtsev, M; Turchin, P			Evolution of cooperative strategies from first principles	NATURE			English	Article							KIN-SELECTION; STRONG RECIPROCITY; POPULATIONS; ALTRUISM; GAME	One of the greatest challenges in the modern biological and social sciences is to understand the evolution of cooperative behaviour. General outlines of the answer to this puzzle are currently emerging as a result of developments in the theories of kin selection(1-7), reciprocity(8-10), multilevel selection(11-15) and cultural group selection(16,17). The main conceptual tool used in probing the logical coherence of proposed explanations has been game theory, including both analytical models and agent-based simulations(6,7,9,18-24). The game-theoretic approach yields clear-cut results but assumes, as a rule, a simple structure of payoffs and a small set of possible strategies. Here we propose a more stringent test of the theory by developing a computer model with a considerably extended spectrum of possible strategies. In our model, agents are endowed with a limited set of receptors, a set of elementary actions and a neural net in between. Behavioural strategies are not predetermined; instead, the process of evolution constructs and reconstructs them from elementary actions. Two new strategies of cooperative attack and defence emerge in simulations, as well as the well-known dove, hawk and bourgeois strategies. Our results indicate that cooperative strategies can evolve even under such minimalist assumptions, provided that agents are capable of perceiving heritable external markers of other agents.	RAS, MV Keldysh Appl Math Inst, Dept Nonlinear Dynam, Moscow 125047, Russia; Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA	Russian Academy of Sciences; Keldysh Institute of Applied Mathematics; University of Connecticut	Burtsev, M (corresponding author), RAS, MV Keldysh Appl Math Inst, Dept Nonlinear Dynam, Moscow 125047, Russia.	mbur@narod.ru	Burtsev, Mikhail S/G-6293-2010	Burtsev, Mikhail S/0000-0003-1614-1695				AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R, 2004, EVOLUTION, V58, P1833; Axelrod R., 1997, COMPLEXITY COOPERATI, DOI [10.1515/9781400822300, DOI 10.1515/9781400822300]; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; Bowles S., 2001, SOCIAL DYNAMICS, P155; Boyd R, 1985, CULTURE EVOLUTIONARY; Burtsev MS, 2004, ARTIF LIFE, V10, P397, DOI 10.1162/1064546041766415; Epstein J. M., 1996, GROWING ARTIFICIAL S; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; GRAFEN A, 1987, ANIM BEHAV, V35, P462, DOI 10.1016/S0003-3472(87)80271-3; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; LACY RC, 1983, AM NAT, V121, P489, DOI 10.1086/284078; Maher CR, 2000, AM MIDL NAT, V143, P1, DOI 10.1674/0003-0031(2000)143[0001:AROEDO]2.0.CO;2; Matthiopoulos J, 2002, ECOL MODEL, V147, P291, DOI 10.1016/S0304-3800(01)00420-3; MAYNARDSMITH J, 1974, J THEOR BIOL, V47, P209, DOI DOI 10.1016/0022-5193(74)90110-6; McNamara JM, 2004, NATURE, V428, P745, DOI 10.1038/nature02432; MICHOD RE, 1980, SCIENCE, V210, P667, DOI 10.1126/science.210.4470.667; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; QUELLER DC, 1992, EVOLUTION, V46, P376, DOI [10.2307/2409858, 10.1111/j.1558-5646.1992.tb02045.x]; Richerson P.J., 1998, INDOCTRINABILITY IDE, P71; Riolo RL, 2001, NATURE, V414, P441, DOI 10.1038/35106555; SMITH J. M., 1964, Nature, V201, P1145, DOI 10.1038/2011145a0; Sober Elliott, 1998, OTHERS EVOLUTION PSY; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Turchin P., 2018, HIST DYNAMICS WHY ST, DOI [10.23943/princeton/9780691180779.001.0001, DOI 10.23943/PRINCETON/9780691180779.001.0001]; Wilson David Sloan, 1997, American Naturalist, V150, P122	29	44	50	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2006	440	7087					1041	1044		10.1038/nature04470	http://dx.doi.org/10.1038/nature04470			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16625195				2022-12-24	WOS:000236906000034
J	Yang, FJ; Vought, BW; Satterlee, JS; Walker, AK; Sun, ZYJ; Watts, JL; DeBeaumont, R; Saito, RM; Hyberts, SG; Yang, S; Macol, C; Iyer, L; Tjian, R; van den Heuvel, S; Hart, AC; Wagner, G; Naar, AM				Yang, Fajun; Vought, Bryan W.; Satterlee, John S.; Walker, Amy K.; Sun, Z. -Y. Jim; Watts, Jennifer L.; DeBeaumont, Rosalie; Saito, R. Mako; Hyberts, Sven G.; Yang, Shaosong; Macol, Christine; Iyer, Lakshmanan; Tjian, Robert; van den Heuvel, Sander; Hart, Anne C.; Wagner, Gerhard; Naar, Anders M.			An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis	NATURE			English	Article							TRANSCRIPTION FACTOR-BINDING; CAENORHABDITIS-ELEGANS; KIX DOMAIN; TRANSACTIVATION DOMAIN; SECONDARY STRUCTURE; PROTEIN CBP; C-ELEGANS; COACTIVATOR; ACTIVATION; CREB	The sterol regulatory element binding protein ( SREBP) family of transcription activators are critical regulators of cholesterol and fatty acid homeostasis(1,2). We previously demonstrated that human SREBPs bind the CREB- binding protein ( CBP)/ p300 acetyltransferase KIX domain and recruit activator- recruited co- factor ( ARC)/ Mediator co- activator complexes through unknown mechanisms(3-5). Here we show that SREBPs use the evolutionarily conserved ARC105 ( also called MED15) subunit to activate target genes. Structural analysis of the SREBP- binding domain in ARC105 by NMR revealed a three- helix bundle with marked similarity to the CBP/ p300 KIX domain. In contrast to SREBPs, the CREB and c- Myb activators do not bind the ARC105 KIX domain, although they interact with the CBP KIX domain, revealing a surprising specificity among structurally related activator- binding domains. The Caenorhabditis elegans SREBP homologue SBP- 1 promotes fatty acid homeostasis by regulating the expression of lipogenic enzymes(6,7). We found that, like SBP- 1, the C. elegans ARC105 homologue MDT- 15 is required for fatty acid homeostasis, and show that both SBP- 1 and MDT- 15 control transcription of genes governing desaturation of stearic acid to oleic acid. Notably, dietary addition of oleic acid significantly rescued various defects of nematodes targeted with RNA interference against sbp- 1 and mdt- 15, including impaired intestinal fat storage, infertility, decreased size and slow locomotion, suggesting that regulation of oleic acid levels represents a physiologically critical function of SBP- 1 and MDT- 15. Taken together, our findings demonstrate that ARC105 is a key effector of SREBP-dependent gene regulation and control of lipid homeostasis in metazoans.	Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Washington State University; Harvard University; University of California System; University of California Berkeley	Naar, AM (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Bldg 149,13th St, Charlestown, MA 02129 USA.	naar@helix.mgh.harvard.edu	van den Heuvel, Sander J.L./B-8892-2011; Watts, Jennifer/AAC-7425-2020	van den Heuvel, Sander J.L./0000-0001-9015-7463; Watts, Jennifer/0000-0003-4349-0639; Iyer, Lakshmanan/0000-0001-9167-6396	NCI NIH HHS [R01 CA127990] Funding Source: Medline; NIDDK NIH HHS [R01 DK074114, R01 DK074114-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA127990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074114] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Dai P, 1996, GENE DEV, V10, P528, DOI 10.1101/gad.10.5.528; De Guzman RN, 2006, J MOL BIOL, V355, P1005, DOI 10.1016/j.jmb.2005.09.059; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Goto NK, 2002, J BIOL CHEM, V277, P43168, DOI 10.1074/jbc.M207660200; Jump DB, 2002, CURR OPIN LIPIDOL, V13, P155, DOI 10.1097/00041433-200204000-00007; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kato Y, 2002, NATURE, V418, P641, DOI 10.1038/nature00969; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; McKay RM, 2003, DEV CELL, V4, P131, DOI 10.1016/S1534-5807(02)00411-2; Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Naar AM, 1998, GENE DEV, V12, P3020, DOI 10.1101/gad.12.19.3020; Novatchkova M, 2004, CURR BIOL, V14, pR54, DOI 10.1016/j.cub.2003.12.042; Oliner JD, 1996, GENE DEV, V10, P2903, DOI 10.1101/gad.10.22.2903; Parker D, 1999, MOL CELL BIOL, V19, P5601; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Tabor DE, 1999, J BIOL CHEM, V274, P20603, DOI 10.1074/jbc.274.29.20603; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Watts JL, 2000, BIOCHEM BIOPH RES CO, V272, P263, DOI 10.1006/bbrc.2000.2772; Yang FJ, 2004, P NATL ACAD SCI USA, V101, P2339, DOI 10.1073/pnas.0308676100; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zor T, 2004, J MOL BIOL, V337, P521, DOI 10.1016/j.jmb.2004.01.038	30	277	320	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2006	442	7103					700	704		10.1038/nature04942	http://dx.doi.org/10.1038/nature04942			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UU	16799563				2022-12-24	WOS:000239630200049
J	Macintosh, MCM; Fleming, KM; Bailey, JA; Doyle, P; Modder, J; Acolet, D; Golightly, S; Miller, A				Macintosh, Mary C. M.; Fleming, Kate M.; Bailey, Jaron A.; Doyle, Pat; Modder, Jo; Acolet, Dominique; Golightly, Shona; Miller, Alison			Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study	BRITISH MEDICAL JOURNAL			English	Article							HEART-DISEASE; PREGNANCY; OUTCOMES; MELLITUS; MALFORMATIONS; PREVALENCE; NATIONWIDE; DIAGNOSIS; RISK	Objective To Provide perinatal mortality and congenital anomaly rates for babies born to women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland. Design National Population based pregnancy cohort. Setting 231 maternity units in England, Wales, and Northern Ireland. Participants 2359 pregnancies to women with type 1 or type 2 diabetes who delivered between 1 March 2002 and 28 February 2003. Main outcome measures Stillbirth rates; perinatal and neonatal mortality; prevalence of congenital anomalies. Results Of 2359 women with diabetes, 652 had type 2 diabetes and 1707 had type 1 diabetes. Women with type 2 diabetes were more likely to come front a black, Asian, or other ethnic minority group (type 2, 48.8%; type 1, 9.1%) and from a deprived area (type 2, 46.3% in most deprived fifth; type 1, 22.8%). Perinatal mortality in babies of women with diabetes was 31.8/1000 births. Perinatal mortality was comparable in babies of women with type 1 (31.7/1000 births) and type 2 diabetes (32.3; 1000) and was nearly four times higher than that in the general maternity Population. 141 major congenital anomalies were confirmed in 109 offspring. The Prevalence of major congenital anomaly was 46/1000 births in women with diabetes (48/1000 births for type 1 diabetes; 43/1000 for type 2 diabetes), more than double that expected. This increase was driven by anomalies of the nervous system, notably neural tube defects (4.2-fold), and congenital heart disease (3.4-fold). Anomalies in 71/109 (65%) offspring were diagnosed antenatally. Congenital heart disease was diagnosed antenatally in 23/42 (54.8%) offspring; anomalies other than congenital heart disease were diagnosed antenatally in 48/67 (71.6%) offspring. Conclusion Perinatal mortality and prevalence of congenital anomalies are high in the babies of women with type 1 or type 2 diabetes. The rates do not seem to differ between the two types of diabetes.	Confidential Enquiry Maternal & Child Hlth, London NW1 5SD, England; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Macintosh, MCM (corresponding author), Confidential Enquiry Maternal & Child Hlth, London NW1 5SD, England.	mary.macintosh@hpa.org.uk	Fleming, Kate M/A-6475-2010	Fleming, Kate M/0000-0002-6572-5016				Boulot P, 2003, DIABETES CARE, V26, P2990; Brydon P, 2000, INT J CLIN PRACT, V54, P418; Bull C, 1999, LANCET, V354, P1242, DOI 10.1016/S0140-6736(99)01167-8; Carvalho JS, 2002, HEART, V88, P387, DOI 10.1136/heart.88.4.387; Casson IF, 1997, BRIT MED J, V315, P275, DOI 10.1136/bmj.315.7103.275; Clausen TD, 2005, DIABETES CARE, V28, P323, DOI 10.2337/diacare.28.2.323; COETZEE E J, 1985, Diabetes Research and Clinical Practice, V1, P281, DOI 10.1016/S0168-8227(86)80036-5; *CONF ENQ MAT CHIL, 2005, STILLB NEON POSTN MO; *CONF ENQ MAT CHIL, 2004, MAT SERV 2002 WOM TY; Confidential Enquiry into Maternal and Child Health, 2005, PREGN WOM TYP 1 TYP; Cundy T, 2000, DIABETIC MED, V17, P33, DOI 10.1046/j.1464-5491.2000.00215.x; DAMM P, 1989, AM J OBSTET GYNECOL, V161, P1161; Department of Health, 2001, NAT SERV FRAM DIAB S; Diabet Control Complications Trial Res Grp, 1996, AM J OBSTET GYNECOL, V174, P1343; Dunne F, 2005, SEMIN FETAL NEONAT M, V10, P333, DOI 10.1016/j.siny.2005.04.007; Dunne F, 2003, DIABETIC MED, V20, P734, DOI 10.1046/j.1464-5491.2003.01017.x; Evers IN, 2004, BMJ-BRIT MED J, V328, P915, DOI 10.1136/bmj.38043.583160.EE; Feig DS, 2002, LANCET, V359, P1690, DOI 10.1016/S0140-6736(02)08599-9; FUHRMANN K, 1984, EXP CLIN ENDOCRINOL, V83, P173, DOI 10.1055/s-0029-1210327; HAWTHORNE G, 1994, BRIT MED J, V315, P279; Hotu S, 2004, J PAEDIATR CHILD H, V40, P201, DOI 10.1111/j.1440-1754.2004.00337.x; Jensen DM, 2004, DIABETES CARE, V27, P2819, DOI 10.2337/diacare.27.12.2819; Khoshnood B, 2005, PEDIATRICS, V115, P95, DOI 10.1542/peds.2004-0516; *OFF DEP PRIM MIN, IND MULT DEPR 2004; Penney GC, 2003, BJOG-INT J OBSTET GY, V110, P315, DOI 10.1016/S1470-0328(03)02967-7; Platt MJ, 2002, DIABETIC MED, V19, P216, DOI 10.1046/j.1464-5491.2002.00665.x; Sacks DA, 1997, AM J OBSTET GYNECOL, V177, P1113, DOI 10.1016/S0002-9378(97)70025-5; Scottish Intercollegiate Guidelines Network, 2001, SIGN PUBL; Suhonen L, 2000, DIABETOLOGIA, V43, P79, DOI 10.1007/s001250050010; TOWNER D, 1995, DIABETES CARE, V18, P1446, DOI 10.2337/diacare.18.11.1446; Zhu L, 1997, J Obstet Gynaecol Res, V23, P555; 1990, DIABET MED, V7, P360	32	399	409	1	21	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 22	2006	333	7560					177	180		10.1136/bmj.38856.692986.AE	http://dx.doi.org/10.1136/bmj.38856.692986.AE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	068DJ	16782722	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000239352100021
J	Navarre, WW; Porwollik, S; Wang, YP; McClelland, M; Rosen, H; Libby, SJ; Fang, FC				Navarre, William Wiley; Porwollik, Steffen; Wang, Yipeng; McClelland, Michael; Rosen, Henry; Libby, Stephen J.; Fang, Ferric C.			Selective silencing of foreign DNA with low GC content by the H-NS protein in Salmonella	SCIENCE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; SHIGELLA-FLEXNERI; VIBRIO-CHOLERAE; VIRULENCE; REPRESSOR; ANTIREPRESSION; ORGANIZATION; TEMPERATURE	Horizontal gene transfer plays a major role in microbial evolution. However, newly acquired sequences can decrease fitness unless integrated into preexisting regulatory networks. We found that the histone-like nucleoid structuring protein (H-NS) selectively silences horizontally acquired genes by targeting sequences with GC content lower than the resident genome. Mutations in hns are lethal in Salmonella unless accompanied by compensatory mutations in other regulatory loci. Thus, H-NS provides a previously unrecognized mechanism of bacterial defense against foreign DNA, enabling the acquisition of DNA from exogenous sources while avoiding detrimental consequences from unregulated expression of newly acquired genes. Characteristic GC/AT ratios of bacterial genomes may facilitate discrimination between a cell's own DNA and foreign DNA.	Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Fang, FC (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.	fcfang@u.washington.edu	McClelland, Michael/A-8583-2011	Fang, Ferric/0000-0002-3243-110X; McClelland, Michael/0000-0003-1788-9347; Navarre, William/0000-0002-9293-9220	NIAID NIH HHS [AI049417, AI052237, AI057733, AI034829, AI39557, AI48622] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048622, R21AI039557, R21AI057733, R01AI034829, R01AI049417, R01AI039557, R21AI048622, R01AI052237] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amit R, 2003, BIOPHYS J, V84, P2467, DOI 10.1016/S0006-3495(03)75051-6; Beloin C, 2003, MOL MICROBIOL, V47, P825, DOI 10.1046/j.1365-2958.2003.03347.x; Beltrametti F, 1999, J BACTERIOL, V181, P3409, DOI 10.1128/JB.181.11.3409-3418.1999; Bertin P, 1999, MOL MICROBIOL, V31, P319, DOI 10.1046/j.1365-2958.1999.01176.x; Brunetti R, 2001, BIOCHIMIE, V83, P873, DOI 10.1016/S0300-9084(01)01331-1; Bustamante VH, 2001, MOL MICROBIOL, V39, P664, DOI 10.1046/j.1365-2958.2001.02209.x; Coker C, 2000, J BACTERIOL, V182, P2649, DOI 10.1128/JB.182.9.2649-2653.2000; Dame RT, 2005, J BACTERIOL, V187, P1845, DOI 10.1128/JB.187.5.1845-1848.2005; Dorman CJ, 2004, NAT REV MICROBIOL, V2, P391, DOI 10.1038/nrmicro883; Dorman CJ, 2001, INT J MED MICROBIOL, V291, P89, DOI 10.1078/1438-4221-00105; Ferenci T, 2003, TRENDS MICROBIOL, V11, P457, DOI 10.1016/j.tim.2003.08.003; FORSMAN K, 1992, P NATL ACAD SCI USA, V89, P9880, DOI 10.1073/pnas.89.20.9880; GORANSSON M, 1990, NATURE, V344, P682, DOI 10.1038/344682a0; Haack KR, 2003, INFECT IMMUN, V71, P384, DOI 10.1128/IAI.71.1.384-392.2003; Hardy CD, 2005, MOL MICROBIOL, V57, P1636, DOI 10.1111/j.1365-2958.2005.04799.x; Heroven AK, 2004, MOL MICROBIOL, V53, P871, DOI 10.1111/j.1365-2958.2004.04162.x; HROMOCKYJ AE, 1992, MOL MICROBIOL, V6, P2113, DOI 10.1111/j.1365-2958.1992.tb01385.x; Krishnan HH, 2004, INFECT IMMUN, V72, P3961, DOI 10.1128/IAI.72.7.3961-3967.2004; Lee Shang-Jung, 2004, Appl Bioinformatics, V3, P219, DOI 10.2165/00822942-200403040-00003; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Nasser W, 2002, MOL MICROBIOL, V43, P733, DOI 10.1046/j.1365-2958.2002.02782.x; TUPPER AE, 1994, EMBO J, V13, P258, DOI 10.1002/j.1460-2075.1994.tb06256.x; Westermark M, 2000, J BACTERIOL, V182, P6347, DOI 10.1128/JB.182.22.6347-6357.2000; Williamson HS, 2005, MOL MICROBIOL, V55, P808, DOI 10.1111/j.1365-2958.2004.04421.x; Wyborn NR, 2004, J BACTERIOL, V186, P1620, DOI 10.1128/JB.186.6.1620-1628.2004; Yang J, 2005, MICROBIOL-SGM, V151, P1199, DOI 10.1099/mic.0.27734-0; Yu RR, 2002, MOL MICROBIOL, V43, P119, DOI 10.1046/j.1365-2958.2002.02721.x; Zilberman D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-249; Zimmerman SB, 2006, J STRUCT BIOL, V153, P160, DOI 10.1016/j.jsb.2005.10.011	29	542	558	1	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 14	2006	313	5784					236	238		10.1126/science.1128794	http://dx.doi.org/10.1126/science.1128794			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063GZ	16763111				2022-12-24	WOS:000239008000048
J	Crichton, J; Nyamu-Musembi, C; John-Langba, J; Theobald, S				Crichton, J; Nyamu-Musembi, C; John-Langba, J; Theobald, S			Sexual and reproductive health rights in Africa	LANCET			English	Editorial Material									African Populat & Hlth Res Ctr, Nairobi, Kenya; Univ Sussex, Inst Dev Studies, Brighton, E Sussex, England; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	African Population & Health Research Centre; University of Sussex; Liverpool School of Tropical Medicine; University of Liverpool	Crichton, J (corresponding author), African Populat & Hlth Res Ctr, Shelter Afrigue Bldg, Nairobi, Kenya.	jo.crichton@gmail.com	John-Langba, Johannes/AAC-3252-2019	Theobald, Sally/0000-0002-9053-211X; John-Langba, Johannes/0000-0002-3057-6831				Cornwall A, 2002, REALIZING RIGHTS TRA; *CRLP, 2000, BEIJ 5 ASS REPR RIGH; International Women's Health Coalition, 1995, CAIR CONS RIGHT AG R; Isfahan Merali, 2000, Development in Practice, V10, P609, DOI 10.1080/09614520020008797; Misra G, 2005, SEXUALITY GENDER RIG; Nyamu-Musembi C, 2002, ACTOR ORIENTED PERSP; *REAL RIGHTS, 2005, IMPR SEX REPR HLTH P; SILBERSCHMIDT M, 2005, SEXUAL AFRICA MAGAZI, P2; *UNFRPA, 1998, ENS REPR RIGHTS IMPL; *WHO, 2005, GEND REPR RIGHTS	10	7	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 24	2006	367	9528					2043	2045		10.1016/S0140-6736(06)68903-4	http://dx.doi.org/10.1016/S0140-6736(06)68903-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	058HZ	16798372				2022-12-24	WOS:000238657400009
J	Meinecke, M; Wagner, R; Kovermann, P; Guiard, B; Mick, DU; Hutu, DP; Voos, W; Truscott, KN; Chacinska, A; Pfanner, N; Rehling, P				Meinecke, Michael; Wagner, Richard; Kovermann, Peter; Guiard, Bernard; Mick, David U.; Hutu, Dana P.; Voos, Wolfgang; Truscott, Kaye N.; Chacinska, Agnieszka; Pfanner, Nikolaus; Rehling, Peter			Tim50 maintains the permeability barrier of the mitochondrial inner membrane	SCIENCE			English	Article							TRANSLOCATION CONTACT SITES; TWIN-PORE TRANSLOCASE; PROTEIN IMPORT; PRESEQUENCE TRANSLOCASE; PREPROTEIN TRANSLOCASE; TIM23; COMPONENT; CHANNEL; COMPLEX; MOTOR	Transport of metabolites across the mitochondrial inner membrane is highly selective, thereby maintaining the electrochemical proton gradient that functions as the main driving force for cellular adenosine triphosphate synthesis. Mitochondria import many preproteins via the presequence translocase of the inner membrane. However, the reconstituted Tim23 protein constitutes a pore remaining mainly in its open form, a state that would be deleterious in organello. We found that the intermembrane space domain of Tim50 induced the Tim23 channel to close. Presequences overcame this effect and activated the channel for translocation. Thus, the hydrophilic cis domain of Tim50 maintains the permeability barrier of mitochondria by closing the translocation pore in a presequence-regulated manner.	Univ Osnabruck, FB Biol Chem, D-49034 Osnabruck, Germany; CNRS, Ctr Genet Mol, Lab Propre, F-91190 Gif Sur Yvette, France; Univ Freiburg, Inst Biochem & Molekularbiol, D-79104 Freiburg, Germany; Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia	University Osnabruck; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Freiburg; University of Freiburg; La Trobe University	Wagner, R (corresponding author), Univ Osnabruck, FB Biol Chem, D-49034 Osnabruck, Germany.	wagner@biologie.uni-osnabrueck.de; nikolaus.pfanner@biochemie.uni-freiburg.de	Pfanner, Nikolaus/AAV-7878-2021; Kovermann, Peter/AAF-4411-2020; Truscott, Kaye/D-3362-2012; Mick, David/AAW-3726-2021; Meinecke, Michael/C-4833-2013	Meinecke, Michael/0000-0003-1414-6951; Kovermann, Peter/0000-0001-5296-4918; Mick, David/0000-0003-1427-9412; Truscott, Kaye/0000-0002-5352-9835; Chacinska, Agnieszka/0000-0002-2832-2568				Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174; Bauer MF, 1996, CELL, V87, P33, DOI 10.1016/S0092-8674(00)81320-3; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; GAMBILL BD, 1993, J CELL BIOL, V123, P109, DOI 10.1083/jcb.123.1.109; Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Jensen RE, 2001, NAT STRUCT BIOL, V8, P1008, DOI 10.1038/nsb1201-1008; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Komiya T, 1998, EMBO J, V17, P3886, DOI 10.1093/emboj/17.14.3886; LOEW LM, 1993, BIOPHYS J, V65, P2396, DOI 10.1016/S0006-3495(93)81318-3; Lohret TA, 1997, J CELL BIOL, V137, P377, DOI 10.1083/jcb.137.2.377; Mokranjac D, 2005, J BIOL CHEM, V280, P23437, DOI 10.1074/jbc.C500135200; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Mokranjac D, 2003, EMBO J, V22, P816, DOI 10.1093/emboj/cdg090; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Oka T, 2005, MOL CELL, V18, P145, DOI 10.1016/j.molcel.2005.03.022; Palmieri L, 2000, BBA-BIOENERGETICS, V1459, P363, DOI 10.1016/S0005-2728(00)00173-0; RASSOW J, 1989, J CELL BIOL, V109, P1421, DOI 10.1083/jcb.109.4.1421; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; Voos W, 1996, EMBO J, V15, P2668, DOI 10.1002/j.1460-2075.1996.tb00627.x; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Yamamoto H, 2002, CELL, V111, P519, DOI 10.1016/S0092-8674(02)01053-X	29	147	149	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1523	1526		10.1126/science.1127628	http://dx.doi.org/10.1126/science.1127628			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763150				2022-12-24	WOS:000238124100048
J	Horikawa, K; Ishimatsu, K; Yoshimoto, E; Kondo, S; Takeda, H				Horikawa, Kazuki; Ishimatsu, Kana; Yoshimoto, Eiichi; Kondo, Shigeru; Takeda, Hiroyuki			Noise-resistant and synchronized oscillation of the segmentation clock	NATURE			English	Article							SOMITE SEGMENTATION; GENE-EXPRESSION; ZEBRAFISH SOMITOGENESIS; LUNATIC-FRINGE; VERTEBRATE SEGMENTATION; INDIVIDUAL FIBROBLASTS; MECHANISM; NETWORK; CELLS; HER1	Periodic somite segmentation in vertebrate embryos is controlled by the 'segmentation clock', which consists of numerous cellular oscillators. Although the properties of a single oscillator, driven by a hairy negative-feedback loop, have been investigated, the system-level properties of the segmentation clock remain largely unknown. To explore these characteristics, we have examined the response of a normally oscillating clock in zebrafish to experimental stimuli using in vivo mosaic experiments and mathematical simulation. We demonstrate that the segmentation clock behaves as a coupled oscillator, by showing that Notch-dependent intercellular communication, the activity of which is regulated by the internal hairy oscillator, couples neighbouring cells to facilitate synchronized oscillation. Furthermore, the oscillation phase of individual oscillators fluctuates due to developmental noise such as stochastic gene expression and active cell proliferation. The intercellular coupling was found to have a crucial role in minimizing the effects of this noise to maintain coherent oscillation.	Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Tokyo 1130033, Japan; Nagoya Univ, Div Biol Sci, Grad Sch Sci, Nagoya, Aichi 4648602, Japan	University of Tokyo; Nagoya University	Horikawa, K (corresponding author), Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Hongo 7-3-1, Tokyo 1130033, Japan.	kazu@biol.s.u-tokyo.ac.jp; htakeda@biol.s.u-tokyo.ac.jp	TAKEDA, HIROYUKI/G-4950-2014	Kondo, Shigeru/0000-0003-0192-5526; Horikawa, Kazuki/0000-0002-9285-4171				Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Bessho Y, 2003, GENE DEV, V17, P1451, DOI 10.1101/gad.1092303; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Cooke J, 1998, TRENDS GENET, V14, P85, DOI 10.1016/S0168-9525(98)01396-1; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; COOKE J, 1975, NATURE, V254, P196, DOI 10.1038/254196a0; Dale JK, 2003, NATURE, V421, P275, DOI 10.1038/nature01244; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Hall B. K., 2003, KEYWORDS CONCEPTS EV; Henry CA, 2002, DEVELOPMENT, V129, P3693; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Hirata H, 2004, NAT GENET, V36, P750, DOI 10.1038/ng1372; Holley SA, 2000, GENE DEV, V14, P1678; Holley SA, 2002, DEVELOPMENT, V129, P1175; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Ingolia NT, 2004, PLOS BIOL, V2, P805, DOI 10.1371/journal.pbio.0020123; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Julich D, 2005, DEV BIOL, V286, P391, DOI 10.1016/j.ydbio.2005.06.040; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Oates AC, 2002, DEVELOPMENT, V129, P2929; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; PRESCOTT DM, 1962, EXP CELL RES, V26, P260, DOI 10.1016/0014-4827(62)90176-3; Rida PCG, 2004, DEV BIOL, V265, P2, DOI 10.1016/j.ydbio.2003.07.003; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; Sawada A, 2001, DEVELOPMENT, V128, P4873; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Ueda HR, 2002, J THEOR BIOL, V216, P501, DOI 10.1006/jtbi.2002.3000; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Winfree A.T., 2000, GEOMETRY BIOL TIME; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	44	205	211	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2006	441	7094					719	723		10.1038/nature04861	http://dx.doi.org/10.1038/nature04861			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760970				2022-12-24	WOS:000238095100046
J	Pitman, JL; McGill, JJ; Keegan, KP; Allada, R				Pitman, Jena L.; McGill, Jermaine J.; Keegan, Kevin P.; Allada, Ravi			A dynamic role for the mushroom bodies in promoting sleep in Drosophila	NATURE			English	Article							LOCOMOTOR-ACTIVITY; CIRCADIAN-RHYTHMS; TERM-MEMORY; REST; SHIBIRE; LOCALIZATION; DEPRIVATION; BEHAVIOR; MUTANT; WAKING	The fruitfly, Drosophila melanogaster, exhibits many of the cardinal features of sleep, yet little is known about the neural circuits governing its sleep(1). Here we have performed a screen of GAL4 lines expressing a temperature-sensitive synaptic blocker shibire(ts1) ( ref. 2) in a range of discrete neural circuits, and assayed the amount of sleep at different temperatures. We identified three short-sleep lines at the restrictive temperature with shared expression in the mushroom bodies, a neural locus central to learning and memory(3). Chemical ablation of the mushroom bodies also resulted in reduced sleep. These studies highlight a central role for the mushroom bodies in sleep regulation.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University	Allada, R (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	r-allada@northwestern.edu						ARMSTRONG JD, 1996, FLYTRAP LINES; Belgacem YH, 2002, P NATL ACAD SCI USA, V99, P15154, DOI 10.1073/pnas.232244199; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Cirelli C, 2003, BIOESSAYS, V25, P940, DOI 10.1002/bies.10333; Davis RL, 2004, NEURON, V44, P31, DOI 10.1016/j.neuron.2004.09.008; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Helfrich-Forster C, 2002, J NEUROGENET, V16, P73, DOI 10.1080/01677060290024592; Hendricks JC, 2004, SLEEP, V27, P334, DOI 10.1093/sleep/27.2.334; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2003, SLEEP, V26, P139, DOI 10.1093/sleep/26.2.139; Hendricks JC, 2003, J BIOL RHYTHM, V18, P12, DOI 10.1177/0748730402239673; Hendricks JC, 2001, NAT NEUROSCI, V4, P1108, DOI 10.1038/nn743; Huber R, 2004, SLEEP, V27, P628, DOI 10.1093/sleep/27.4.628; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; KOENIG JH, 1983, J CELL BIOL, V96, P1517, DOI 10.1083/jcb.96.6.1517; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; Martin JR, 1998, LEARN MEMORY, V5, P179; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; RECHTSCHAFFEN A, 1983, SCIENCE, V221, P182, DOI 10.1126/science.6857280; SAPP RJ, 1991, J NEUROCYTOL, V20, P597, DOI 10.1007/BF01215267; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; van Swinderen B, 2004, CURR BIOL, V14, P81, DOI 10.1016/j.cub.2003.12.057; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	30	241	242	1	38	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					753	756		10.1038/nature04739	http://dx.doi.org/10.1038/nature04739			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760979				2022-12-24	WOS:000238095100055
J	Han, JJ; Lee, Y; Yeom, KH; Nam, JW; Heo, I; Rhee, JK; Sohn, SY; Cho, YJ; Zhang, BT; Kim, VN				Han, Jinju; Lee, Yoontae; Yeom, Kyu-Hyeon; Nam, Jin-Wu; Heo, Inha; Rhee, Je-Keun; Sohn, Sun Young; Cho, Yunje; Zhang, Byoung-Tak; Kim, V. Narry			Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex	CELL			English	Article							RNA-INTERFERENCE; NUCLEAR EXPORT; STRUCTURAL BASIS; HUMAN DICER; BIOGENESIS; PRECURSORS; EXPRESSION; CLEAVAGE; TRANSCRIPTS; MATURATION	The Drosha-DGCR8 complex initiates microRNA maturation by precise cleavage of the stem loops that are embedded in primary transcripts (pri-miRNAs). Here we propose a model for this process that is based upon evidence from both computational and biochemical analyses. A typical metazoan pri-miRNA consists of a stem of similar to 33 bp, with a terminal loop and flanking segments. The terminal loop is unessential, whereas the flanking ssRNA segments are critical for processing. The cleavage site is determined mainly by the distance (similar to 11 bp) from the stem-ssRNA junction. Purified DGCR8, but not Drosha, interacts with pri-miRNAs both directly and specifically, and the flanking ssRNA segments are vital for this binding to occur. Thus, DGCR8 may function as the molecular anchor that measures the distance from the dsRNA-ssRNA junction. Our current study thus facilitates the prediction of novel microRNAs and will assist in the rational design of small hairpin RNAs for RNA interference.	Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; Seoul Natl Univ, Res Ctr Funct Cellulom, Seoul, South Korea; Seoul Natl Univ, Sch Comp Sci & Engn, Seoul, South Korea; Pohang Univ Sci & Technol, Natl Creat Res Ctr Sruct Biol, Pohang, Kyungbook, South Korea; Pohang Univ Sci & Technol, Dept Life Sci, Pohang, Kyungbook, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Kim, VN (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea.	narrykim@snu.ac.kr	Nam, Jin-Wu/F-7370-2017; Han, Jinju/D-9091-2017	Rhee, Je-Keun/0000-0003-4811-8895; HAN, Jinju/0000-0003-1844-2301				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basyuk E, 2003, NUCLEIC ACIDS RES, V31, P6593, DOI 10.1093/nar/gkg855; Blaszczyk J, 2001, STRUCTURE, V9, P1225, DOI 10.1016/S0969-2126(01)00685-2; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim VN, 2005, MOL CELLS, V19, P1; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Krol J, 2004, J BIOL CHEM, V279, P42230, DOI 10.1074/jbc.M404931200; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Tomari Y, 2005, CURR BIOL, V15, pR61, DOI 10.1016/j.cub.2004.12.057; Vermeulen A, 2005, RNA, V11, P674, DOI 10.1261/rna.7272305; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zeng Y, 2005, J BIOL CHEM, V280, P27595, DOI 10.1074/jbc.M504714200; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	1098	1225	3	125	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					887	901		10.1016/j.cell.2006.03.043	http://dx.doi.org/10.1016/j.cell.2006.03.043			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751099	Bronze			2022-12-24	WOS:000238116400016
J	Zohn, IE; Li, YQ; Skolnik, EY; Anderson, KV; Han, JH; Niswander, L				Zohn, Irene E.; Li, Yingqiu; Skolnik, Edward Y.; Anderson, Kathryn V.; Han, Jiahuai; Niswander, Lee			p38 and a p38-interacting protein are critical for downregulation of E-cadherin during mouse gastrulation	CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR SNAIL; MAP KINASE; NEURAL-TUBE; PREIMPLANTATION DEVELOPMENT; MESODERM DIFFERENTIATION; STE20-RELATED KINASE; PRIMITIVE STREAK; EXPRESSION; GENE	During vertebrate gastrulation, an epithelial to mesenchymal transition (EMT) is necessary for migration of mesoderm from the primitive streak. We demonstrate that p38 MAP kinase and a p38-interacting protein (p38IP) are critically required for downregulation of E-cadherin during gastrulation. In an ENU-mutagenesis screen we identified the droopy eye (drey) mutation, which affects splicing of p38IP. p38IP(drey) mutant embryos display incompletely penetrant defects in neural tube closure, eye development, and gastrulation. A stronger allele, (p381P(RRK)) exhibits gastrulation defects in which mesoderm migration is defective due to deficiency in E-cadherin protein downregulation in the primitive streak. We show that p38IP binds directly to p38 and is required for p38 activation in vivo. Moreover, both p38 and p38IP are required for E-cadherin downregulation during gastrulation. Finally, p38 regulates E-cadherin protein expression downstream from NCK-interacting kinase (NIK) and independently of the regulation of transcription by Fibroblast Growth Factor (Fgf) signaling and Snail.	Univ Colorado, Sect Dev Biol, Dept Pediat, Howard Hughes Med Inst, Aurora, CO 80045 USA; Hlth Sci Ctr, Aurora, CO 80045 USA; Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10021 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; NYU, Med Ctr, Skirball Inst Biomol Med, Dept Pharmacol, New York, NY 10016 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; Memorial Sloan Kettering Cancer Center; Scripps Research Institute; New York University	Niswander, L (corresponding author), Univ Colorado, Sect Dev Biol, Dept Pediat, Howard Hughes Med Inst, Aurora, CO 80045 USA.	lee.niswander@uchsc.edu	Han, J/G-4671-2010; Niswander, Lee/D-3976-2013	Niswander, Lee/0000-0002-9959-0594; Zohn, Irene/0000-0001-7688-682X; Anderson, Kathryn/0000-0003-1657-2161	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD035455] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD008605, U01HD043478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041637] Funding Source: NIH RePORTER; NIAID NIH HHS [R01-AI041637] Funding Source: Medline; NICHD NIH HHS [U01-HD43478, F32-HD08605, R01-HD035455] Funding Source: Medline; NIGMS NIH HHS [R01-GM37696] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; BARNES JD, 1994, DEV BIOL, V161, P168, DOI 10.1006/dbio.1994.1018; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Buday L, 2002, CELL SIGNAL, V14, P723, DOI 10.1016/S0898-6568(02)00027-X; BURDSAL CA, 1993, DEVELOPMENT, V118, P829; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; Garcia-Garcia MJ, 2005, P NATL ACAD SCI USA, V102, P5913, DOI 10.1073/pnas.0501071102; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Gomes I, 2002, BLOOD, V100, P107, DOI 10.1182/blood.V100.1.107; Holmes G, 2001, DEV DYNAM, V222, P301, DOI 10.1002/dvdy.1182; Kasarskis A, 1998, P NATL ACAD SCI USA, V95, P7485, DOI 10.1073/pnas.95.13.7485; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Kuida K, 2004, J BIOCHEM, V135, P653, DOI 10.1093/jb/mvh078; Liu AM, 1998, MECH DEVELOP, V75, P107, DOI 10.1016/S0925-4773(98)00090-2; Maekawa M, 2005, DEVELOPMENT, V132, P1773, DOI 10.1242/dev.01729; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Mikkola I, 1999, J BIOL CHEM, V274, P15115, DOI 10.1074/jbc.274.21.15115; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Natale DR, 2004, DEV BIOL, V268, P76, DOI 10.1016/j.ydbio.2003.12.011; New LG, 1998, TRENDS CARDIOVAS MED, V8, P220, DOI 10.1016/S1050-1738(98)00012-7; Paricio N, 1999, EMBO J, V18, P4669, DOI 10.1093/emboj/18.17.4669; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Schmidt U, 2005, CANCER LETT, V225, P253, DOI 10.1016/j.canlet.2004.10.037; Schmidt U, 2001, PROSTATE, V47, P91, DOI 10.1002/pros.1051; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; Su YC, 1998, GENE DEV, V12, P2371, DOI 10.1101/gad.12.15.2371; Su YC, 1997, EMBO J, V16, P1279, DOI 10.1093/emboj/16.6.1279; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Timmer JR, 2002, DEVELOPMENT, V129, P2459; Xue YZ, 2001, DEVELOPMENT, V128, P1559; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032; Zohn IE, 2005, BIRTH DEFECTS RES A, V73, P583, DOI 10.1002/bdra.20164	42	193	209	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					957	969		10.1016/j.cell.2006.03.048	http://dx.doi.org/10.1016/j.cell.2006.03.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751104	Bronze			2022-12-24	WOS:000238116400021
J	Halpern, BS; Cottenie, K; Broitman, BR				Halpern, BS; Cottenie, K; Broitman, BR			Strong top-down control in southern California kelp forest ecosystems	SCIENCE			English	Article							BOTTOM-UP; FOOD WEBS; COMMUNITIES; HETEROGENEITY; CLIMATE; FORCES	Global-scale changes in anthropogenic nutrient input into marine ecosystems via terrestrial runoff, coupled with widespread predator removal via fishing, have created greater urgency for understanding the relative role of top-down versus bottom-up control of food web dynamics. Yet recent large-scale studies of community regulation in marine ecosystems have shown dramatically different results that leave this issue largely unresolved. We combined a multiyear, large-scale data set of species abundances for 46 species in kelp forests from the California Channel Islands with satellite-derived primary production and found that top-down control explains 7- to 10-fold more of the variance in abundance of bottom and mid-trophic levels than does bottom-up control. This top-down control was propagated via a variety of species-level direct and indirect responses to predator abundance. Management of top-down influences such as fishing may be more important in coastal marine ecosystems, particularly in kelp forest systems, than is commonly thought.	Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	National Center for Ecological Analysis & Synthesis; University of Guelph; University of California System; University of California Santa Barbara	Halpern, BS (corresponding author), Natl Ctr Ecol Anal & Synth, 735 State St, Santa Barbara, CA 93101 USA.	halpern@nceas.ucsb.edu	Broitman, Bernardo R/D-6007-2013	Broitman, Bernardo R/0000-0001-6582-3188; Cottenie, Karl/0000-0001-9498-8483				BLANCHETTE CA, 2006, MAR BIOL; Broitman BR, 2005, LIMNOL OCEANOGR, V50, P1473, DOI 10.4319/lo.2005.50.5.1473; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Castilla JC, 1999, TRENDS ECOL EVOL, V14, P280, DOI 10.1016/S0169-5347(99)01602-X; Dayton PK, 1999, ECOL MONOGR, V69, P219, DOI 10.1890/0012-9615(1999)069[0219:TASSOK]2.0.CO;2; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Graham MH, 2004, ECOSYSTEMS, V7, P341, DOI 10.1007/s10021-003-0245-6; HALPERN BS, IN PRESS GLOBAL CHAN; HUNTER MD, 1992, ECOLOGY, V73, P724; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Lafferty KD, 2004, ECOL APPL, V14, P1566, DOI 10.1890/03-5088; Legendre L., 1998, NUMERICAL ECOLOGY; Menge BA, 2000, J EXP MAR BIOL ECOL, V250, P257, DOI 10.1016/S0022-0981(00)00200-8; Mitsch W.J., 2001, WETLANDS; Otero MP, 2004, DEEP-SEA RES PT II, V51, P1129, DOI 10.1016/j.dsr2.2004.04.004; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; POWER ME, 1992, ECOLOGY, V73, P733, DOI 10.2307/1940153; Reed DC, 2000, ECOLOGY, V81, P2011; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Vinueza LR, 2006, ECOL MONOGR, V76, P111, DOI 10.1890/04-1957; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2	25	85	90	1	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 26	2006	312	5777					1230	1232		10.1126/science.1128613	http://dx.doi.org/10.1126/science.1128613			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728644				2022-12-24	WOS:000237957400059
J	Workman, CT; Mak, HC; McCuine, S; Tagne, JB; Agarwal, M; Ozier, O; Begley, TJ; Samson, LD; Ideker, T				Workman, CT; Mak, HC; McCuine, S; Tagne, JB; Agarwal, M; Ozier, O; Begley, TJ; Samson, LD; Ideker, T			A systems approach to mapping DNA damage response pathways	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; REGULATORY NETWORKS; TRANSCRIPTION; DATABASE; GENOME; PROGRESSION; INHIBITION; REVEALS; REPAIR; AGENTS	Failure of cells to respond to DNA damage is a primary event associated with mutagenesis and environmental toxicity. To map the transcriptional network controlling the damage response, we measured genomewide binding locations for 30 damage-related transcription factors (TFs) after exposure of yeast to methyl-methanesulfonate (MMS). The resulting 5272 TF-target interactions revealed extensive changes in the pattern of promoter binding and identified damage-specific binding motifs. As systematic functional validation, we identified interactions for which the target changed expression in wild-type cells in response to MMS but was nonresponsive in cells lacking the TF. Validated interactions were assembled into causal pathway models that provide global hypotheses of how signaling, transcription, and phenotype are integrated after damage.	Univ Calif San Diego, La Jolla, CA 92093 USA; Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; SUNY Albany, Rensselaer, NY 12144 USA; MIT, Cambridge, MA 02139 USA	University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); Whitehead Institute; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Massachusetts Institute of Technology (MIT)	Ideker, T (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	trey@bioeng.ucsd.edu	Workman, Christopher T/K-1066-2015	Workman, Christopher T/0000-0002-2210-3743; Tagne, Jean-Bosco/0000-0003-1830-9156; Ideker, Trey/0000-0002-1708-8454	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070743] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES014811-01A1, R01 ES014811] Funding Source: Medline; NIGMS NIH HHS [R01 GM070743, R01 GM070743-01, R01 GM070743-02] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Begley TJ, 2004, MOL CELL, V16, P117, DOI 10.1016/j.molcel.2004.09.005; Begley TJ, 2002, MOL CANCER RES, V1, P103; Birrell GW, 2002, P NATL ACAD SCI USA, V99, P8778, DOI 10.1073/pnas.132275199; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Friedberg EC, 2005, DNA REPAIR MUTAGENES; FRIEDBERG EC, 1991, MOL CELLULAR BIOL YE, V1, P147; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Habeler G, 2002, NUCLEIC ACIDS RES, V30, P80, DOI 10.1093/nar/30.1.80; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Jelinsky SA, 1999, P NATL ACAD SCI USA, V96, P1486, DOI 10.1073/pnas.96.4.1486; Jia YK, 1997, MOL CELL BIOL, V17, P1110, DOI 10.1128/MCB.17.3.1110; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Rouse J, 2002, SCIENCE, V297, P547, DOI 10.1126/science.1074740; Santiago TC, 2003, J BIOL CHEM, V278, P38723, DOI 10.1074/jbc.M303008200; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Workman C T, 2000, Pac Symp Biocomput, P467; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Yeang CH, 2004, J COMPUT BIOL, V11, P243, DOI 10.1089/1066527041410382; Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607	29	197	204	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1054	1059		10.1126/science.1122088	http://dx.doi.org/10.1126/science.1122088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16709784	Green Accepted			2022-12-24	WOS:000237628800046
J	Galindo-Cuspinera, V; Winnig, M; Bufe, B; Meyerhof, W; Breslin, PAS				Galindo-Cuspinera, V; Winnig, M; Bufe, B; Meyerhof, W; Breslin, PAS			A TAS1R receptor-based explanation of sweet 'water-taste'	NATURE			English	Article							BITTER TASTE; INHIBITION; SACCHARIN	Water-tastes' are gustatory after-impressions elicited by water following the removal of a chemical solution from the mouth, akin to colour after-images appearing on 'white' paper after fixation on coloured images. Unlike colour after-images, gustatory aftereffects are poorly understood(1). One theory posits that 'water-tastes' are adaptation phenomena, in which adaptation to one taste solution causes the water presented subsequently to act as a taste stimulus(2,3). An alternative hypothesis is that removal of the stimulus upon rinsing generates a receptor-based, positive, off-response in taste-receptor cells, ultimately inducing a gustatory perception(4). Here we show that a sweet 'water-taste' is elicited when sweet-taste inhibitors are rinsed away. Responses of cultured cells expressing the human sweetener receptor directly parallel the psychophysical responses - water rinses remove the inhibitor from the heteromeric sweetener receptor TAS1R2 - TAS1R3, which activates cells and results in the perception of strong sweetness from pure water. This 'rebound' activity occurs when equilibrium forces on the two-state allosteric sweet receptors result in their coordinated shift to the activated state upon being released from inhibition by rinsing(5-7).	Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; German Inst Human Nutr Potsdam Rehbrucke, D-14558 Nuthetal, Germany	Monell Chemical Senses Center; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Breslin, PAS (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	breslin@monell.org	Bufe, Bernd/N-6685-2018	Bufe, Bernd/0000-0003-1610-0658; Breslin, Paul/0000-0001-5988-8401; Winnig, Marcel/0000-0002-5306-5778				BARTOSHUK LM, 1968, PERCEPT PSYCHOPHYS, V3, P69, DOI 10.3758/BF03212715; Bartoshuk LM, 2000, CHEM SENSES, V25, P447, DOI 10.1093/chemse/25.4.447; Carroll FY, 2001, MOL PHARMACOL, V59, P965, DOI 10.1124/mol.59.5.965; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; COOPERMAN BS, 2004, ENCY BIOL CHEM, P68; Costa T, 2005, TRENDS PHARMACOL SCI, V26, P618, DOI 10.1016/j.tips.2005.10.009; DALZIEL K, 1968, Febs Letters, V1, P346, DOI 10.1016/0014-5793(68)80150-4; DuBois GE, 2004, P NATL ACAD SCI USA, V101, P13972, DOI 10.1073/pnas.0405991101; GENT JF, 1978, PERCEPT PSYCHOPHYS, V23, P171, DOI 10.3758/BF03208298; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; Harvey RD, 2003, BRIT J PHARMACOL, V139, P1074, DOI 10.1038/sj.bjp.0705338; Horne J, 2002, CHEM SENSES, V27, P31, DOI 10.1093/chemse/27.1.31; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Jiang PH, 2005, J BIOL CHEM, V280, P15238, DOI 10.1074/jbc.M414287200; KASAI H, 1991, P NATL ACAD SCI USA, V88, P8855, DOI 10.1073/pnas.88.19.8855; Kashlan OB, 2002, BIOCHEMISTRY-US, V41, P462, DOI 10.1021/bi011653a; Kenakin T, 2004, RECEPTOR CHANNEL, V10, P51, DOI 10.1080/10606820490464316; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; MCBURNEY DH, 1973, PHYSIOL BEHAV, V10, P1101, DOI 10.1016/0031-9384(73)90194-7; MCBURNEY DH, 1972, OLFACTION TASTE, V4, P329; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; SAMAMA P, 1994, MOL PHARMACOL, V45, P390; SCHIFFMAN SS, 1993, NEUROSCI BIOBEHAV R, V17, P313, DOI 10.1016/S0149-7634(05)80015-6; Schiffman SS, 1999, CHEM SENSES, V24, P439, DOI 10.1093/chemse/24.4.439; SCHIFFMAN SS, 1995, BRAIN RES BULL, V36, P505, DOI 10.1016/0361-9230(94)00225-P; Winnig M, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-22; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101	30	96	100	3	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					354	357		10.1038/nature04765	http://dx.doi.org/10.1038/nature04765			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16633339				2022-12-24	WOS:000237593200049
J	Bristow, RE; Berek, JS				Bristow, RE; Berek, JS			Surgery for ovarian cancer: how to improve survival	LANCET			English	Editorial Material							SPECIALIZATION; MANAGEMENT; CARCINOMA; CARE		Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA; Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Dept Gynecol & Obstet, Kelly Gynecol Oncol Serv, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Kelly Gynecol Oncol Serv, Baltimore, MD 21205 USA; Stanford Univ Hosp & Clin, Cooperat Ovarian Canc Grp Immunotherapy, Los Angeles, CA 90095 USA	Stanford University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Stanford University	Berek, JS (corresponding author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA.	jberek@stanford.edu						Carney ME, 2002, GYNECOL ONCOL, V84, P36, DOI 10.1006/gyno.2001.6460; EISENKOP SM, 1992, GYNECOL ONCOL, V47, P203, DOI 10.1016/0090-8258(92)90107-T; Engelen MJA, 2006, CANCER-AM CANCER SOC, V106, P589, DOI 10.1002/cncr.21616; Hillner BE, 2000, J CLIN ONCOL, V18, P2327, DOI 10.1200/JCO.2000.18.11.2327; *IARC, 2006, GLOBOCAN 2002 ANC IN; JUNOR EJ, 1994, BRIT J CANCER, V70, P363, DOI 10.1038/bjc.1994.307; Junor EJ, 1999, BRIT J OBSTET GYNAEC, V106, P1130, DOI 10.1111/j.1471-0528.1999.tb08137.x; KEHOE S, 1994, BRIT J CANCER, V70, P1014, DOI 10.1038/bjc.1994.440; Paulsen T, 2006, INT J GYNECOL CANCER, V16, P11, DOI 10.1111/j.1525-1438.2006.00319.x; SELTZER V, 1995, JAMA-J AM MED ASSOC, V273, P491, DOI 10.1001/jama.1995.03520300065039; Woodman C, 1997, BRIT J OBSTET GYNAEC, V104, P135, DOI 10.1111/j.1471-0528.1997.tb11032.x	11	37	37	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2006	367	9522					1558	1560		10.1016/S0140-6736(06)68671-6	http://dx.doi.org/10.1016/S0140-6736(06)68671-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043JT	16698396				2022-12-24	WOS:000237598000008
J	Stanley, GD				Stanley, GD			Ecology - Photosymbiosis and the evolution of modern coral reefs	SCIENCE			English	Editorial Material									Univ Montana, Paleontol Ctr, Missoula, MT 59812 USA	University of Montana System; University of Montana	Stanley, GD (corresponding author), Univ Montana, Paleontol Ctr, Missoula, MT 59812 USA.	george.stanley@umontana.edu						Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Chen CA, 2005, MAR ECOL PROG SER, V295, P113, DOI 10.3354/meps295113; COPPER P, 1989, CANADIAN SOC PETROLE, V13, P271; Fautin DG, 2004, HYDROBIOLOGIA, V530, P459, DOI 10.1007/s10750-004-2642-z; Flugel E., 2002, PHANEROZOIC REEF PAT, P391; HALLOCK P, 1986, Palaios, V1, P389, DOI 10.2307/3514476; HOEGHGULDBERG O, 2005, J GEOPHYS RES, V110, P1029; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; Leinfelder RR, 2001, T GEOBIOL, V17, P251; Muscatine L, 2005, P NATL ACAD SCI USA, V102, P1525, DOI 10.1073/pnas.0408921102; Palliani RB, 2000, J MICROPALAEONTOL, V19, P133, DOI 10.1144/jm.19.2.133; Perrin Christine, 2002, P587, DOI 10.2110/pec.02.72.0587; Rosen B.R., 1989, Memoir of the Association of Australasian Palaeontologists, V8, P355; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Sotka EE, 2005, TRENDS ECOL EVOL, V20, P59, DOI 10.1016/j.tree.2004.11.015; STANLEY GD, 1995, PALEOBIOLOGY, V21, P179, DOI 10.1017/S0094837300013191; Stanley GD, 2001, SCIENCE, V291, P1913, DOI 10.1126/science.1056632; Talent J.A., 1988, Senckenbergiana Lethaea, V69, P315; Wood R., 1999, REEF EVOLUTION	19	105	108	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					857	858		10.1126/science.1123701	http://dx.doi.org/10.1126/science.1123701			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690848				2022-12-24	WOS:000237452900027
J	Okie, S				Okie, S			Fighting HIV - Lessons from Brazil	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		BEYRER C, 2005, EVALUATION WORLD BAN; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; DOWNIE A, 2005, CHRISTIAN SCI M 0823, P4; *JOINT UN PROGR HI, 2005, AIDS EP UPD SPEC REP; *MIN HLTH BRAZ PRO, 2005, RESP MAG	5	100	104	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2006	354	19					1977	1981		10.1056/NEJMp068069	http://dx.doi.org/10.1056/NEJMp068069			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	040XA	16687709	Bronze			2022-12-24	WOS:000237413100001
J	Vert, G; Chory, J				Vert, G; Chory, J			Downstream nuclear events in brassinosteroid signalling	NATURE			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTOR; BETA-CATENIN; ARABIDOPSIS; KINASE; RECEPTOR; GROWTH; PATHWAY; BZR1; TRANSDUCTION	Brassinosteroids (BRs) are steroid hormones that control many aspects of plant growth and development(1,2). BRs bind to the plasma membrane receptor kinase BRI1, and act through a signalling pathway that involves a glycogen synthase kinase-3-like kinase (BIN2) and a serine/threonine phosphatase (BSU1)(3-5). Previous models proposed that BIN2 negatively regulates BR signalling by controlling the stability and subcellular localization of the related transcription factors BES1 and BZR1 by phosphorylation, in a manner reminiscent of the canonical Wnt signalling pathway of metazoans(6-9). Here we present strong evidence for a different mode of regulation of BR signalling. We show that BES1 is localized constitutively to the nucleus, where its activity is modulated by nuclear-localized BIN2 kinase. BIN2-mediated phosphorylation of BES1 inhibits its DNA-binding activity on BR-responsive target promoters and its transcriptional activity through impaired multimerization. Our observations demonstrate that phosphorylation-dependent inhibition of DNA binding and trans-activation is the key primary mechanism of BES1 regulation.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute	Chory, J (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	chory@salk.edu		Vert, Greg/0000-0002-0844-9991				Choe S, 2002, PLANT PHYSIOL, V130, P1506, DOI 10.1104/pp.010496; Clouse SD, 2002, MOL CELL, V10, P973, DOI 10.1016/S1097-2765(02)00744-X; Clouse SD, 1996, PLANT PHYSIOL, V111, P671, DOI 10.1104/pp.111.3.671; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; He JX, 2005, SCIENCE, V307, P1634, DOI 10.1126/science.1107580; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Li JM, 2002, SCIENCE, V295, P1299; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; MANDAVA NB, 1988, ANNU REV PLANT PHYS, V39, P23, DOI 10.1146/annurev.arplant.39.1.23; Mora-Garcia S, 2004, GENE DEV, V18, P448, DOI 10.1101/gad.1174204; Olefsky JM, 2001, J BIOL CHEM, V276, P36863, DOI 10.1074/jbc.R100047200; Peng P, 2003, J PLANT GROWTH REGUL, V22, P298, DOI 10.1007/s00344-003-0059-y; Perez-Perez JM, 2002, DEV BIOL, V242, P161, DOI 10.1006/dbio.2001.0543; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang ZY, 2002, DEV CELL, V2, P505, DOI 10.1016/S1534-5807(02)00153-3; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Yin YH, 2005, CELL, V120, P249, DOI 10.1016/j.cell.2004.11.044; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3; Zhao J, 2002, PLANT PHYSIOL, V130, P1221, DOI 10.1104/pp.102.010918	27	264	281	4	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2006	441	7089					96	100		10.1038/nature04681	http://dx.doi.org/10.1038/nature04681			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16672972				2022-12-24	WOS:000237248600040
J	Newman, AB; Simonsick, EM; Naydeck, BL; Boudreau, RM; Kritchevsky, SB; Nevitt, MC; Pahor, M; Satterfield, S; Brach, JS; Studenski, SA; Harris, TB				Newman, AB; Simonsick, EM; Naydeck, BL; Boudreau, RM; Kritchevsky, SB; Nevitt, MC; Pahor, M; Satterfield, S; Brach, JS; Studenski, SA; Harris, TB			Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEART-RATE RECOVERY; FUNCTIONING OLDER-ADULTS; PHYSICAL FUNCTION; BODY-COMPOSITION; RESPIRATORY-DISEASE; EXERCISE CAPACITY; 6-MINUTE WALK; HEALTH; PREDICTOR; FAILURE	Context Aerobic fitness, an important predictor of cardiovascular disease and mortality, is difficult to assess by maximal exercise testing in older adults. Extended walking tests have been examined as outcome predictors in medically ill populations but not in community-dwelling older adults. Objective To determine whether an extended walking test predicts poor outcomes in older adults. Design, Setting, and Participants Observational cohort study enrolling 3075 community-dwelling adults aged 70 to 79 years living in Pittsburgh, Pa, or Memphis, Tenn. Of those participating in the Health, Aging, and Body Composition Study, 1584 (52%) were women and 1281 (42%) were black. Participants enrolled from March 1997 to April 1998. Ability to complete the long-distance corridor walk and total performance time was assessed at the baseline examination. Main Outcome Measures Total mortality, incident cardiovascular disease, incident mobility limitation, and mobility disability were ascertained after a mean (SD) of 4.9 (0.9) years. Results Among patients eligible to exercise, 351 died, 308 had episodes of incident cardiovascular disease, 1116 had occurrences of mobility limitation, and 509 had occurrences of mobility disability. Inability to complete walking 400 m tended to be associated with a higher risk of mortality and incident cardiovascular disease and, after accounting for potential confounders, was associated with incident mobility limitation (212.6 vs 79.1 events/1000 person-years; adjusted hazard ratio [HR], 1.86; 95% confidence interval [CI], 1.58-2.18; P <. 001) andmobility disability (85.2 vs 28.8 events/1000 person-years; adjusted HR, 1.95; 95% CI, 1.56- 2.44; P <. 001). Of those who completed 400 m, each additional minute of performance time was associated with an adjusted HR of 1.29 ( 95% CI, 1.12-1.48) for mortality, 1.20 ( 95% CI, 1.01-1.42) for incident cardiovascular disease, 1.52 ( 95% CI, 1.41-1.63) for mobility limitation, and 1.52 ( 95% CI, 1.37-1.70) for disability after adjustment for demographics, health behaviors, clinical and subclinical disease, and cardiovascular disease risk factors. Findings were consistent in both men and women and blacks and whites. Among participants who completed the test and after adjusting for potential confounders, those in the poorest quartile of functional capacity ( walk time > 362 seconds) had a higher risk of death than those in the best quartile ( walk time < 290 seconds; adjusted HR, 3.23; 95% CI, 2.11-4.94; P <. 001). Conclusions Older adults in the community who reported no difficulty walking had a wide range of performance on this extended walking test. Ability to do the test and performance were important prognostic factors for total mortality, cardiovascular disease, mobility limitation, and mobility disability in persons in their eighth decade.	Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Med, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Phys Therapy, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Geriatr Med, Pittsburgh, PA 15213 USA; NIA, Intramural Res Program, Baltimore, MD 21224 USA; Wake Forest Univ, Sch Med, Dept Internal Med, Div Gerontol & Geriatr Med, Winston Salem, NC 27109 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Florida, Coll Med, Dept Aging & Geriatr Res, Gainesville, FL USA; Univ Tennessee, Dept Prevent Med, Memphis, TN 38163 USA; NIA, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Wake Forest University; University of California System; University of California San Francisco; State University System of Florida; University of Florida; University of Tennessee System; University of Tennessee Health Science Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Newman, AB (corresponding author), Univ Pittsburgh, Dept Epidemiol, 130 N Bellefield St,Room 532, Pittsburgh, PA 15213 USA.	newmana@edc.pitt.edu	Simonsick, Eleanor/W-6864-2019; Newman, Anne B./C-6408-2013; Brach, Jennifer/A-6912-2009	Newman, Anne B./0000-0002-0106-1150; Kritchevsky, Stephen/0000-0003-3336-6781; Brach, Jennifer/0000-0002-7793-2004; Boudreau, Robert/0000-0003-0162-5187	NATIONAL INSTITUTE ON AGING [N01AG062101, Z01AG007390, N01AG062103, N01AG062106] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIA NIH HHS [N01-AG-6-2106, N01-AG-6-2103, N01-AG-6-2101] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; BITTNER V, 1993, JAMA-J AM MED ASSOC, V270, P1702, DOI 10.1001/jama.270.14.1702; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Brach JS, 2004, J AM GERIATR SOC, V52, P502, DOI 10.1111/j.1532-5415.2004.52154.x; BUTLAND RJA, 1982, BRIT MED J, V284, P1607, DOI 10.1136/bmj.284.6329.1607; Cole CR, 2000, ANN INTERN MED, V132, P552, DOI 10.7326/0003-4819-132-7-200004040-00007; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Enright PL, 2003, CHEST, V123, P387, DOI 10.1378/chest.123.2.387; FURBERG CD, 1992, AM J CARDIOL, V69, P1329, DOI 10.1016/0002-9149(92)91231-R; Gibbons RJ, 2002, LANCET, V359, P1536, DOI 10.1016/S0140-6736(02)08525-2; Gulati M, 2005, NEW ENGL J MED, V353, P468, DOI 10.1056/NEJMoa044154; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; IMAI K, 1994, J AM COLL CARDIOL, V24, P1529, DOI 10.1016/0735-1097(94)90150-3; Lucas C, 1999, AM HEART J, V138, P618, DOI 10.1016/S0002-8703(99)70174-2; MCGAVIN CR, 1978, BRIT MED J, V2, P241, DOI 10.1136/bmj.2.6132.241; Mora S, 2003, JAMA-J AM MED ASSOC, V290, P1600, DOI 10.1001/jama.290.12.1600; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Newman AB, 2003, J GERONTOL A-BIOL, V58, P715; NEWMAN AB, 1993, CIRCULATION, V88, P837, DOI 10.1161/01.CIR.88.3.837; Peeters P, 1996, J GERONTOL A-BIOL, V51, pM147, DOI 10.1093/gerona/51A.4.M147; Peloquin L, 1998, J AGING PHYS ACTIV, V6, P36, DOI 10.1123/japa.6.1.36; Penninx BWJH, 2003, BIOL PSYCHIAT, V54, P566, DOI 10.1016/S0006-3223(02)01811-5; Pober DM, 2002, CAN J APPL PHYSIOL, V27, P575, DOI 10.1139/h02-033; Sayers SP, 2004, J AM GERIATR SOC, V52, P2099, DOI 10.1111/j.1532-5415.2004.52571.x; SAYERS SP, IN PRESS AGING CLIN; Schwartz PJ, 1998, EUR HEART J, V19, pF72; Simonsick EM, 2000, AGING-CLIN EXP RES, V12, P274, DOI 10.1007/BF03339847; Simonsick EM, 2001, J GERONTOL A-BIOL, V56, pM644, DOI 10.1093/gerona/56.10.M644; Simonsick EM, 2006, J AM GERIATR SOC, V54, P127, DOI 10.1111/j.1532-5415.2005.00530.x; Simonsick EM, 2001, J AM GERIATR SOC, V49, P1544, DOI 10.1046/j.1532-5415.2001.4911247.x; SWERTS PMJ, 1990, PHYS THER, V70, P439, DOI 10.1093/ptj/70.7.439; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; Vivekananthan DP, 2003, J AM COLL CARDIOL, V42, P831, DOI 10.1016/S0735-1097(03)00833-7	33	649	655	1	33	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2006	295	17					2018	2026		10.1001/jama.295.17.2018	http://dx.doi.org/10.1001/jama.295.17.2018			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	038MF	16670410	Bronze			2022-12-24	WOS:000237225100018
J	Riehle, MM; Markianos, K; Niare, O; Xu, JN; Li, J; Toure, AM; Podiougou, B; Oduol, F; Diawara, S; Diallo, M; Coulibaly, B; Ouatara, A; Kruglyak, L; Traore, SF; Vernick, KD				Riehle, MM; Markianos, K; Niare, O; Xu, JN; Li, J; Toure, AM; Podiougou, B; Oduol, F; Diawara, S; Diallo, M; Coulibaly, B; Ouatara, A; Kruglyak, L; Traore, SF; Vernick, KD			Natural malaria infection in Anopheles gambiae is regulated by a single genomic control region	SCIENCE			English	Article							QUANTITATIVE TRAIT LOCI; REFRACTORINESS; RESISTANCE; MOSQUITOS	We surveyed an Anopheles gambiae population in a West African malaria transmission zone for naturally occurring genetic loci that control mosquito infection with the human malaria parasite, Plasmodium falciparum. The strongest Plasmodium resistance loci cluster in a small region of chromosome 2L and each locus explains at least 89% of parasite-free mosquitoes in independent pedigrees. Together, the clustered loci form a genomic Plasmodium-resistance island that explains most of the genetic variation for malaria parasite infection of mosquitoes in nature. Among the candidate genes in this chromosome region, RNA interference knockdown assays confirm a role in Plasmodium resistance for Anopheles Plasmodium-responsive leucine-rich repeat 1 (APL1), encoding a leucine-rich repeat protein that is similar to molecules involved in natural pathogen resistance mechanisms in plants and mammals.	Univ Minnesota, Ctr Microbial & Plant Genom, St Paul, MN 55108 USA; Univ Minnesota, Dept Microbiol, St Paul, MN 55108 USA; Fred Hutchinson Canc Res Ctr, Program Computat Biol, Seattle, WA 98109 USA; Univ Bamako, Dept Epidemiol Affectat Parasitaires, Bamako, Mali; Princeton Univ, Carl Icahn Lab, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Fred Hutchinson Cancer Center; University of Bamako; Princeton University; Princeton University	Vernick, KD (corresponding author), Univ Minnesota, Ctr Microbial & Plant Genom, St Paul, MN 55108 USA.	kvernick@umn.edu		Markianos, Kyriacos/0000-0003-0214-6014				Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Dworkin I, 2005, GENETICS, V169, P2115, DOI 10.1534/genetics.104.035766; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Graham MA, 2002, GENETICS, V162, P1961; Hahn MW, 2004, CURR BIOL, V14, pR264, DOI 10.1016/j.cub.2004.03.018; Kufer TA, 2005, TRENDS MICROBIOL, V13, P381, DOI 10.1016/j.tim.2005.06.004; Macdonald SJ, 2004, GENETICS, V167, P2127, DOI 10.1534/genetics.104.026732; Niare O, 2002, SCIENCE, V298, P213, DOI 10.1126/science.1073420; Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639; Tripet F, 2001, MOL ECOL, V10, P1725, DOI 10.1046/j.0962-1083.2001.01301.x; Zheng LB, 1996, GENETICS, V143, P941; Zheng LB, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-16; Zheng LB, 1997, SCIENCE, V276, P425, DOI 10.1126/science.276.5311.425	16	211	216	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					577	579		10.1126/science.1124153	http://dx.doi.org/10.1126/science.1124153			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16645095				2022-12-24	WOS:000237296700045
J	Cummings, JE; Schweikert, RA; Saliba, WI; Burkhardt, JD; Kilikaslan, F; Saad, E; Natale, A				Cummings, JE; Schweikert, RA; Saliba, WI; Burkhardt, JD; Kilikaslan, F; Saad, E; Natale, A			Brief communication: Atrial-esophageal fistulas after radiofrequency ablation	ANNALS OF INTERNAL MEDICINE			English	Article							CATHETER ABLATION; FIBRILLATION	Background: Ablation of atrial fibrillation is generally considered safe and effective. However, atrial-esophageal fistulas have recently been reported as a rare but fatal complication. Objective: To describe 9 patients with atrial-esophageal fistulas after ablation for atrial fibrillation. Design: Retrospective case series. Setting: Institutions where cardiologists performed atrial fibrillation ablation procedures. Patients: 9 patients with atrial-esophageal fistulas after atrial fibrillation ablation. Measurements: Demographic characteristics, mortality, presenting signs and symptoms, and days to presentation. Results: Patients presented a mean of 12.3 days (range, 10 to 16 days) after their procedures. Nonspecific symptoms included fever, leukocytosis, and neurologic abnormalities. All patients died. Only 4 patients received correct diagnoses before death, although all patients presented to a physician. In 3 patients, surgical repair was attempted. Limitations: Few physicians reported cases, and only approximate numbers of procedures performed by the physicians are known. Thus, the authors could not estimate the incidence of atrial-esophageal fistulas after ablation. Conclusions: Formation of atrial-esophageal fistulas is a rare but potentially devastating complication of atrial fibrillation ablation. This disorder may have an indolent presentation and may mimic other disease states, such as stroke or sepsis.	Cleveland Clin Fdn, Dept Cardiovasc Med, Sect Electrophysiol & Pacing, Cleveland, OH 44195 USA; Hosp Procardiaco, Rio De Janeiro, Brazil	Cleveland Clinic Foundation	Cummings, JE (corresponding author), Cleveland Clin Fdn, Dept Cardiovasc Med, Sect Electrophysiol & Pacing, 9500 Euclid Ave Desk F-15, Cleveland, OH 44195 USA.							Cappato R, 2005, CIRCULATION, V111, P1100, DOI 10.1161/01.CIR.0000157153.30978.67; Cummings JE, 2005, CIRCULATION, V112, P459, DOI 10.1161/CIRCULATIONAHA.104.509612; Doll N, 2003, J THORAC CARDIOV SUR, V125, P836, DOI 10.1067/mtc.2003.165; Gillinov AM, 2001, J THORAC CARDIOV SUR, V122, P1239, DOI 10.1067/mtc.2001.118041; Pappone C, 2004, CIRCULATION, V109, P2724, DOI 10.1161/01.CIR.0000131866.44650.46; Scanavacca MI, 2004, J CARDIOVASC ELECTR, V15, P960, DOI 10.1046/j.1540-8167.2004.04083.x	6	158	165	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2006	144	8					572	574		10.7326/0003-4819-144-8-200604180-00007	http://dx.doi.org/10.7326/0003-4819-144-8-200604180-00007			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	035QZ	16618954				2022-12-24	WOS:000237017900004
J	Stone, JH				Stone, JH			Incidentalomas - Clinical correlation and translational science required	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PREVALENCE		Johns Hopkins Univ, Sch Med, Baltimore, MD 21204 USA	Johns Hopkins University	Stone, JH (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21204 USA.							HEDELAND H, 1968, ACTA MED SCAND, V184, P211; Hellmann David B, 2003, Pharos Alpha Omega Alpha Honor Med Soc, V66, P24; RAVINE D, 1993, AM J KIDNEY DIS, V22, P803, DOI 10.1016/S0272-6386(12)70338-4; WUDKA J, WHAT IS OCKHAMS RAZO	4	44	45	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2006	354	26					2748	2749		10.1056/NEJMp058264	http://dx.doi.org/10.1056/NEJMp058264			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057GQ	16807411				2022-12-24	WOS:000238584700002
J	Rossi, SW; Jenkinson, WE; Anderson, G; Jenkinson, EJ				Rossi, Simona W.; Jenkinson, William E.; Anderson, Graham; Jenkinson, Eric J.			Clonal analysis reveals a common progenitor for thymic cortical and medullary epithelium	NATURE			English	Article							CELLS; DIFFERENTIATION; FATE	The thymus provides an essential environment for the development of T cells from haemopoietic progenitors. This environment is separated into cortical and medullary regions, each containing functionally distinct epithelial populations that are important at successive stages of T-cell development and selection(1,2). However, the developmental origin and lineage relationships between cortical and medullary epithelial cell types remain controversial(3). Here we describe a clonal assay to investigate the developmental potential of single, individually selected, thymic epithelial progenitors ( marked with enhanced yellow fluorescent protein) developing within the normal architecture of the thymus. Using this approach, we show that cortical and medullary epithelial cells share a common origin in bipotent precursors, providing definitive evidence that they have a single rather than dual germ layer origin during embryogenesis. Our findings resolve a long-standing issue in thymus development, and are important in relation to the development of cell-based strategies for thymus disorders and the possibility of restoring function of the atrophied adult thymus.	Univ Birmingham, Sch Med, Inst Biomed Res, Div Immun & Infect,MRC,Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Anderson, G (corresponding author), Univ Birmingham, Sch Med, Inst Biomed Res, Div Immun & Infect,MRC,Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England.	g.anderson@bham.ac.uk		anderson, graham/0000-0002-2917-4085; Jenkinson, William/0000-0003-3422-8372; Rossi, Simona W/0000-0002-8212-0502	MRC [G0401620] Funding Source: UKRI; Medical Research Council [G0401620] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anderson G, 1997, EUR J IMMUNOL, V27, P1838, DOI 10.1002/eji.1830270803; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; CORDIER AC, 1980, AM J ANAT, V157, P227, DOI 10.1002/aja.1001570303; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; FARR A, 1991, J HISTOCHEM CYTOCHEM, V39, P645, DOI 10.1177/39.5.2016514; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Gordon J, 2004, NAT IMMUNOL, V5, P546, DOI 10.1038/ni1064; Gray DHD, 2002, J IMMUNOL METHODS, V260, P15, DOI 10.1016/S0022-1759(01)00493-8; Harman BC, 2005, BLOOD, V106, P886, DOI 10.1182/blood-2004-12-4881; Jenkinson WE, 2005, MECH DEVELOP, V122, P1294, DOI 10.1016/j.mod.2005.08.003; Jenkinson WE, 2003, J EXP MED, V198, P325, DOI 10.1084/jem.20022135; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; Manley NR, 2003, CURR OPIN IMMUNOL, V15, P225, DOI 10.1016/S0952-7915(03)00006-2; Petrie HT, 2003, NAT REV IMMUNOL, V3, P859, DOI 10.1038/nri1223; Pignata C, 2001, BLOOD, V97, P880, DOI 10.1182/blood.V97.4.880; Rodewald HR, 2001, NATURE, V414, P763, DOI 10.1038/414763a; Smalley MJ, 2005, CYTOTHERAPY, V7, P497, DOI 10.1080/14653240500361145; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Wils EJ, 2005, BLOOD REV, V19, P89, DOI 10.1016/j.blre.2004.04.001; Yamamoto N, 2003, CURR BIOL, V13, P333, DOI 10.1016/S0960-9822(03)00081-2	23	239	241	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					988	991		10.1038/nature04813	http://dx.doi.org/10.1038/nature04813			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791197				2022-12-24	WOS:000238422300044
J	Alkalaeva, EZ; Pisarev, AV; Frolova, LY; Kisselev, LL; Pestova, TV				Alkalaeva, Elena Z.; Pisarev, Andrey V.; Frolova, Lyudmila Y.; Kisselev, Lev L.; Pestova, Tatyana V.			In vitro reconstitution of eukaryotic translation reveals cooperativity between release factors eRF1 and eRF3	CELL			English	Article							TERMINATION FACTOR ERF1; INTERNAL RIBOSOMAL ENTRY; TRANSFER-RNA HYDROLYSIS; STOP CODON RECOGNITION; INITIATION-FACTORS; AMINO-ACIDS; GGQ MOTIF; MESSENGER-RNA; FISSION YEAST; ELONGATION	Eukaryotic translation termination is triggered by peptide release factors eRF1 and eRF3. Whereas eRF1 recognizes all three termination codons and induces hydrolysis of peptidyl tRNA, eRF3's function remains obscure. Here, we reconstituted all steps of eukaryotic translation in vitro using purified ribosomal subunits; initiation, elongation, and termination factors; and aminoacyl tRNAs. This allowed us to investigate termination using pretermination complexes assembled on mRNA encoding a tetrapeptide and to propose a model for translation termination that accounts for the cooperative action of eRF1 and eRF3 in ensuring fast release of nascent polypeptide. In this model, binding of eRF1, eRF3, and GTP to pretermination complexes first induces a structural rearrangement that is manifested as a :2 nucleotide forward shift of the toeprint attributed to pretermination complexes that leads to GTP hydrolysis followed by rapid hydrolysis of pepticlyl tRNA. Cooperativity between eRF1 and eRF3 required the eRF3 binding C-terminal domain of eRF1.	Suny Downstate Med Ctr, Dept Microbiol & Immunol, Brooklyn, NY 11203 USA; Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow 119991, Russia; Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119899, Russia	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Lomonosov Moscow State University	Alkalaeva, EZ (corresponding author), Suny Downstate Med Ctr, Dept Microbiol & Immunol, Brooklyn, NY 11203 USA.	kissel@eimb.relarn.ru; tatyana.pestova@downstate.edu	Alkalaeva, Elena/ABC-3888-2021	Alkalaeva, Elena/0000-0003-2078-7261	NIGMS NIH HHS [R01 GM63940] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063940] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Caskey C T, 1974, Methods Enzymol, V30, P293; Chavatte L, 2002, EMBO J, V21, P5302, DOI 10.1093/emboj/cdf484; Ebihara K, 1999, RNA, V5, P739, DOI 10.1017/S135583829998216X; Frolova L, 2002, RNA, V8, P129, DOI 10.1017/S1355838202013262; FROLOVA L, 1994, NATURE, V372, P701, DOI 10.1038/372701a0; FROLOVA L, 1996, RNA, V2, P34; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; Frolova LY, 2000, RNA, V6, P381, DOI 10.1017/S135583820099143X; Frolova LY, 1998, EUR J BIOCHEM, V256, P36, DOI 10.1046/j.1432-1327.1998.2560036.x; Ito K, 2002, P NATL ACAD SCI USA, V99, P8494, DOI 10.1073/pnas.142690099; Ito K, 1998, RNA, V4, P958, DOI 10.1017/S1355838298971874; Jan E, 2003, P NATL ACAD SCI USA, V100, P15410, DOI 10.1073/pnas.2535183100; Kervestin S, 2001, EMBO REP, V2, P680, DOI 10.1093/embo-reports/kve156; Kisselev L, 2003, EMBO J, V22, P175, DOI 10.1093/emboj/cdg017; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; Kobayashi T, 2004, J BIOL CHEM, V279, P45693, DOI 10.1074/jbc.M405163200; Kolosov P, 2005, NUCLEIC ACIDS RES, V33, P6418, DOI 10.1093/nar/gki927; Merkulova TI, 1999, FEBS LETT, V443, P41, DOI 10.1016/S0014-5793(98)01669-X; Mora L, 2003, MOL MICROBIOL, V47, P267, DOI 10.1046/j.1365-2958.2003.03301.x; Nakamura Y, 2003, TRENDS BIOCHEM SCI, V28, P99, DOI 10.1016/S0968-0004(03)00006-9; Nakamura Y, 1996, CELL, V87, P147, DOI 10.1016/S0092-8674(00)81331-8; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Poyry TAA, 2004, GENE DEV, V18, P62, DOI 10.1101/gad.276504; Salas-Marco J, 2004, MOL CELL BIOL, V24, P7769, DOI 10.1128/MCB.24.17.7769-7778.2004; Seit-Nebi A, 2002, EMBO REP, V3, P881, DOI 10.1093/embo-reports/kvf178; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	35	211	221	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2006	125	6					1125	1136		10.1016/j.cell.2006.04.035	http://dx.doi.org/10.1016/j.cell.2006.04.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777602	Bronze			2022-12-24	WOS:000238602700017
J	Valery, PC; Coory, M; Stirling, J; Green, AC				Valery, PC; Coory, M; Stirling, J; Green, AC			Cancer diagnosis, treatment,, and survival in Indigenous and non-indigenous Australians: a matched cohort study	LANCET			English	Article							NORTHERN-TERRITORY; BREAST-CANCER; DISPARITIES; QUEENSLAND; MORTALITY; STAGE	Background Indigenous Australians do not have the high standard of health that Australians in general have, and have worse outcomes for several diseases such as cancer. However, few comparative data exist to prove this disparity. We assessed differences in disease stage at cancer diagnosis, treatment, and survival between these two populations in Queensland. Methods Indigenous people diagnosed with cancer between 1997 and 2002 were identified through the cancer registry and compared with randomly selected non-Indigenous patients who were frequency-matched for age, sex, place of residence, cancer site, and year of diagnosis. We obtained details of treatment from hospital medical records. We restricted analyses to patients treated in the public sector, since less than 5% of Indigenous cases were treated privately. We used multivariate models, mainly Cox regression analyses, to assess differences. Findings We studied 815 Indigenous and 810 non-Indigenous cancer patients. Stage at diagnosis differed significantly (p=0.007): 47% of indigenous versus 53% of non-Indigenous patients had localised cancer, 22% versus 21% had distant metastases, and 12% versus 7% had no information on stage in the medical chart examined. Comorbidities such as diabetes mellitus or chronic renal disease were more common in Indigenous patients. These individuals were less likely to have had treatment for cancer (surgery, chemotherapy, radiotherapy), and waited longer for surgery (hazard ratio=0.84, 95% CI 0.72-0.97) than non-Indigenous patients. After adjustment for stage at diagnosis, treatment, and comorbidities, non-Indigenous patients had better survival than Indigenous ones (hazard ratio=1.3, 95% CI 1.1-1.5). Interpretation Non-Indigenous cancer patients survive longer than Indigenous ones, even after adjustment for stage at diagnosis, cancer treatment, and greater comorbidity in Indigenous cases. We believe that better understanding of cultural differences in attitudes to cancer and its treatment could translate into meaningful public-health and clinical interventions to improve cancer survival in Indigenous Australians.	Royal Brisbane Hosp, Epidemiol & Populat Hlth Div, Queensland Inst Med Res, Brisbane, Qld 4029, Australia; Univ Queensland, Sch Populat Hlth, St Lucia, Qld 4067, Australia	QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Queensland	Valery, PC (corresponding author), Royal Brisbane Hosp, Epidemiol & Populat Hlth Div, Queensland Inst Med Res, PO, Brisbane, Qld 4029, Australia.	Patricia.Valery@qimr.edu.au	VALERY, Patricia/G-6230-2013; Valery, Patricia/AAV-5448-2020; Green, Adele C/P-2736-2014; Green, Adele C/B-5324-2011	VALERY, Patricia/0000-0002-8823-3006; Valery, Patricia/0000-0002-8823-3006; Green, Adele C/0000-0002-2753-4841; 				Adams J, 2004, BRIT MED J, V329, P142, DOI 10.1136/bmj.38114.679387.AE; *AUSTR BUR STAT, 2004, CENS POP HOUS SOC IN; *AUSTR BUR STAT, 2005, HLTH WELF AB TORR ST; *AUSTR BUR STAT, 2003, CAUS DEATH 2002; Baquet C R, 1999, J Assoc Acad Minor Phys, V10, P51; Bramley D, 2005, AM J PUBLIC HEALTH, V95, P844, DOI 10.2105/AJPH.2004.040907; CONDON J, 2004, THESIS C DARWIN U; Condon JR, 2005, MED J AUSTRALIA, V182, P277, DOI 10.5694/j.1326-5377.2005.tb06700.x; Condon JR, 2005, AUST NZ J PUBL HEAL, V29, P123, DOI 10.1111/j.1467-842X.2005.tb00061.x; Condon JR, 2003, CANCER CAUSE CONTROL, V14, P109, DOI 10.1023/A:1023064400004; Coory M, 2000, MED J AUSTRALIA, V173, P301, DOI 10.5694/j.1326-5377.2000.tb125661.x; Department of Health and Aged Care, 2000, MEAS REM ACC REM IND; Eckerman A, 1992, BINANG GOONJ BRIDGIN; Freeman HP, 2004, CA-CANCER J CLIN, V54, P72, DOI 10.3322/canjclin.54.2.72; GLOVER J, 1999, SOCIAL HLTH ATLAS AU; Hall SE, 2004, MED J AUSTRALIA, V181, P191, DOI 10.5694/j.1326-5377.2004.tb06234.x; Hall Sonja E, 2004, Aust Health Rev, V27, P68; HARRIS E, 1999, PERSPECTIVES HLTH IN; HOSMER DW, 1999, MODEL DEV, P158; Jong KE, 2004, MED J AUSTRALIA, V180, P618, DOI 10.5694/j.1326-5377.2004.tb06123.x; O'Brien ED, 2000, INT J EPIDEMIOL, V29, P813, DOI 10.1093/ije/29.5.813; Paradies Y, 2002, AUST NZ J PUBL HEAL, V26, P11, DOI 10.1111/j.1467-842X.2002.tb00264.x; PRIOR D, 2005, THESIS U QUEENSLAND; Robertson H, 1995, Aust Coll Midwives Inc J, V8, P26, DOI 10.1016/S1031-170X(05)80021-2; *SEER, 2001, SUMM STAG MAN 2000 C; Shaw IM, 2003, ANZ J SURG, V73, P758, DOI 10.1046/j.1445-2197.2003.02751.x; South Australian Cancer Registry, 1997, CANC INC MORT CASE S, P13; Threlfall TJ, 2002, CANC INCIDENCE MORTA; *US BUR CENS, 1999, POV 1999 CENS 2000 B; Young M, 2001, ASSESSING QUALITY ID; Zhao YJ, 2004, MED J AUSTRALIA, V180, P498, DOI 10.5694/j.1326-5377.2004.tb06051.x; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	32	149	149	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2006	367	9525					1842	1848		10.1016/S0140-6736(06)68806-5	http://dx.doi.org/10.1016/S0140-6736(06)68806-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051XE	16753487				2022-12-24	WOS:000238194200030
J	Varmus, H				Varmus, Harold			The new era in cancer research	SCIENCE			English	Editorial Material							ADJUVANT CHEMOTHERAPY; LUNG ADENOCARCINOMAS; TRASTUZUMAB; RESISTANCE; ONCOGENES; MUTATION; THERAPY	For many years, discoveries about the genetic determinants of cancer appeared to be having only minor effects on efforts to control the disease in the clinic. Following advances made over the past decade, however, a description of cancer in molecular terms seems increasingly likely to improve the ways in which human cancers are detected, classified, monitored, and treated. Achieving the medical promise of this new era in cancer research will require a deeper understanding of the biology of cancer and imaginative application of new knowledge in the clinic, as well as political, social, and cultural changes.	Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Varmus, H (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	varmus@mskcc.org						Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Berenson Alex, 2006, N Y Times Web, pC2; Bhowmick NA, 2005, CURR OPIN GENET DEV, V15, P97, DOI 10.1016/j.gde.2004.12.003; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; BOS JL, 1989, CANCER RES, V49, P4682; BURCHENAL JH, 1956, PEDIATRICS, V18, P643; COUZIN J, 2006, SCIENCENOW DAIL 0315; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; Felsher DW, 2004, CURR OPIN GENET DEV, V14, P37, DOI 10.1016/j.gde.2003.12.008; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Garber JE, 2005, J CLIN ONCOL, V23, P276, DOI 10.1200/JCO.2005.10.042; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Grimm J, 2005, P NATL ACAD SCI USA, V102, P14404, DOI 10.1073/pnas.0503920102; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jedeszko C, 2004, BIOL CHEM, V385, P1017, DOI 10.1515/BC.2004.132; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2005, J CLIN ONCOL, V23, P2556, DOI 10.1200/JCO.2005.07.799; PEARCE J, 2006, NY TIMES        0316, pA25; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Staudt LM, 2005, ADV IMMUNOL, V87, P163, DOI 10.1016/S0065-2776(05)87005-1; Varmus H, 2005, COLD SH Q B, V70, P1, DOI 10.1101/sqb.2005.70.039; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; WEISS R, 2005, WASH POST, pA3; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930	38	235	254	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1162	1165		10.1126/science.1126758	http://dx.doi.org/10.1126/science.1126758			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728627				2022-12-24	WOS:000237957400038
J	Jager, M; Murienne, J; Clabaut, C; Deutsch, J; Le Guyader, H; Manuel, M				Jager, Muriel; Murienne, Jerome; Clabaut, Celine; Deutsch, Jean; Le Guyader, Herve; Manuel, Michael			Homology of arthropod anterior appendages revealed by Hox gene expression in a sea spider	NATURE			English	Article							APPENDICULAR ORIGIN; NERVOUS-SYSTEM; SEGMENT; HEAD; MORPHOLOGY; CHELICERATE; PHYLOGENY; EVOLUTION; POSITION; ANTENNAE	Arthropod head segments offer a paradigm for understanding the diversification of form during evolution, as a variety of morphologically diverse appendages have arisen from them. There has been long-running controversy, however, concerning which head appendages are homologous among arthropods, and from which ancestral arrangement they have been derived. This controversy has recently been rekindled by the proposition that the probable ancestral arrangement, with appendages on the first head segment, has not been lost in all extant arthropods as previously thought, but has been retained in the pycnogonids, or sea spiders(1). This proposal was based on the neuroanatomical analysis of larvae from the sea spider Anoplodactylus sp., and suggested that the most anterior pair of appendages, the chelifores, are innervated from the first part of the brain, the protocerebrum. Our examination of Hox gene expression in another sea spider, Endeis spinosa, refutes this hypothesis. The anterior boundaries of Hox gene expression domains place the chelifore appendages as clearly belonging to the second head segment, innervated from the second part of the brain, the deutocerebrum. The deutocerebrum must have been secondarily displaced towards the protocerebrum in pycnogonid ancestors. As anterior-most appendages are also deutocerebral in the other two arthropod groups, the Euchelicerata and the Mandibulata, we conclude that the protocerebral appendages have been lost in all extant arthropods.	Univ Paris 06, UMR CNRS UPMC MNHN ENS IRD 7138, F-75005 Paris, France; Univ Paris 06, UMR CNRS UPMC 7622, F-75005 Paris, France	Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Manuel, M (corresponding author), Univ Paris 06, UMR CNRS UPMC MNHN ENS IRD 7138, Case 05,9 Quai St Bernard, F-75005 Paris, France.	Michael.Manuel@snv.jussieu.fr	Murienne, Jerome/J-9015-2019; MURIENNE, Jerome/B-2416-2009	Murienne, Jerome/0000-0003-1474-7829; 				Babu K. S., 1965, Zoologische Jahrbuecher (Anatomie), V82, P1; Brusca R., 2003, INVERTEBRATES; Budd GE, 2005, NATURE, V437, P1099, DOI 10.1038/4371099a; Budd GE, 2002, NATURE, V417, P271, DOI 10.1038/417271a; Bullock T. H., 1965, STRUCTURE FUNCTION N, V2; Damen WGM, 1998, P NATL ACAD SCI USA, V95, P10665, DOI 10.1073/pnas.95.18.10665; Dunlop JA, 2005, J ZOOL SYST EVOL RES, V43, P8, DOI 10.1111/j.1439-0469.2004.00284.x; Eriksson BJ, 2003, J MORPHOL, V255, P1, DOI 10.1002/jmor.10034; Gibert JM, 2000, EVOL DEV, V2, P194, DOI 10.1046/j.1525-142x.2000.00059.x; Giribet G, 2001, NATURE, V413, P157, DOI 10.1038/35093097; HENRY LAURA M., 1953, MICROENTOMOLOGY, V18, P16; Hughes AL, 1999, ADDICT BIOL, V4, P459; Mallatt JM, 2004, MOL PHYLOGENET EVOL, V31, P178, DOI 10.1016/j.ympev.2003.07.013; Maxmen A, 2005, NATURE, V437, P1144, DOI 10.1038/nature03984; Mayer G, 2005, ARTHROPOD STRUCT DEV, V34, P471, DOI 10.1016/j.asd.2005.03.004; Meisenheimer J, 1902, Z WISS ZOOL ABT A, V72, P191; Mittmann B, 2003, DEV GENES EVOL, V213, P9, DOI 10.1007/s00427-002-0285-5; Morgan T.H., 1891, STUD BIOL LAB J HOPK, V5, P1; Popadic A, 1998, DEV GENES EVOL, V208, P142, DOI 10.1007/s004270050165; SANCHEZ S, 1959, DEV PYCNOGONIDES LEU; SANDEMAN DC, 1993, J EXP ZOOL, V265, P112, DOI 10.1002/jez.1402650204; Schmidt-Rhaesa A, 1998, J MORPHOL, V238, P263, DOI 10.1002/(SICI)1097-4687(199812)238:3<263::AID-JMOR1>3.0.CO;2-L; Scholtz G, 2005, CRUSTACEAN ISS, V16, P139, DOI 10.1201/9781420037548.ch6; Scholtz G, 1997, ARTHROPOD RELATIONSH, P317; Simonnet F, 2004, DEV GENES EVOL, V214, P537, DOI 10.1007/s00427-004-0435-z; Telford MJ, 1998, P NATL ACAD SCI USA, V95, P10671, DOI 10.1073/pnas.95.18.10671; Weygoldt P., 1985, P20; WINTER G, 1980, Z ZOOL SYST EVOL, V18, P27; Wiren E, 1918, ZOOL BIDR UPPS, V6, P41	29	74	76	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					506	508		10.1038/nature04591	http://dx.doi.org/10.1038/nature04591			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724066				2022-12-24	WOS:000237778900049
J	Arnold, K; Zuberbuhler, K				Arnold, K; Zuberbuhler, K			Semantic combinations in primate calls	NATURE			English	Article							MONKEYS		Univ St Andrews, Sch Psychol, St Andrews KY16 9JP, Fife, Scotland	University of St Andrews	Arnold, K (corresponding author), Univ St Andrews, Sch Psychol, St Andrews KY16 9JP, Fife, Scotland.	kz3@st-and.ac.uk	Arnold, Kate/B-2021-2014; Zuberbühler, Klaus/A-9053-2011; Arnold, Kate/C-1129-2009	Arnold, Kate/0000-0002-5598-2174; Zuberbühler, Klaus/0000-0001-8378-088X; Arnold, Kate/0000-0002-5598-2174				ARNOLD K, IN PRESS ANIM BEHAV; CLEVELAND J, 1982, Z TIERPSYCHOL, V58, P231; Eckardt W, 2004, BEHAV ECOL, V15, P400, DOI 10.1093/beheco/arh032; Gautier J.-P., 1977, ANIMALS COMMUNICATE, P890; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Marler Peter, 1992, P66; MITANI JC, 1989, BEHAVIOUR, V109, P20, DOI 10.1163/156853989X00141; POHLNER Y, UNPUB BEHAV ECOL SOC; ROBINSON JG, 1984, BEHAVIOUR, V90, P46, DOI 10.1163/156853984X00551; Zuberbuhler K, 2002, ANIM BEHAV, V63, P293, DOI 10.1006/anbe.2001.1914	10	239	250	2	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					303	303		10.1038/441303a	http://dx.doi.org/10.1038/441303a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710411	Bronze			2022-12-24	WOS:000237593200035
J	Cota, D; Proulx, K; Smith, KAB; Kozma, SC; Thomas, G; Woods, SC; Seeley, RJ				Cota, D; Proulx, K; Smith, KAB; Kozma, SC; Thomas, G; Woods, SC; Seeley, RJ			Hypothalamic mTOR signaling regulates food intake	SCIENCE			English	Article							MAMMALIAN TARGET; ARCUATE NUCLEUS; S6 KINASE; PATHWAY; TOR; PROTEIN; TRANSLATION; ACTIVATION; OBESITY; CNS	The mammalian Target of Rapamycin ( mTOR) protein is a serine-threonine kinase that regulates cell-cycle progression and growth by sensing changes in energy status. We demonstrated that mTOR signaling plays a role in the brain mechanisms that respond to nutrient availability, regulating energy balance. In the rat, mTOR signaling is controlled by energy status in specific regions of the hypothalamus and colocalizes with neuropeptide Y and proopiomelanocortin neurons in the arcuate nucleus. Central administration of leucine increases hypothalamic mTOR signaling and decreases food intake and body weight. The hormone leptin increases hypothalamic mTOR activity, and the inhibition of mTOR signaling blunts leptin's anorectic effect. Thus, mTOR is a cellular fuel sensor whose hypothalamic activity is directly tied to the regulation of energy intake.	Univ Cincinnati, Genome Res Inst, Dept Psychiat, Cincinnati, OH 45237 USA; Univ Cincinnati, Genome Res Inst, Dept Genome Sci, Cincinnati, OH 45237 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Seeley, RJ (corresponding author), Univ Cincinnati, Genome Res Inst, Dept Psychiat, 2170 E Galbraith Rd, Cincinnati, OH 45237 USA.	Randy.Seeley@uc.edu	Thomas, George/K-9235-2014	Thomas, George/0000-0003-3518-8149; Cota, Daniela/0000-0002-6909-2156; Seeley, Randy/0000-0002-3721-5625	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK017844, R01DK054080, R01DK054890, R01DK017844] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 17844, DK 54080, DK 54890] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004; Gietzen DW, 2001, J NUTR, V131, p851S, DOI 10.1093/jn/131.3.851S; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Levin BE, 2002, INT REV NEUROBIOL, V51, P219, DOI 10.1016/S0074-7742(02)51007-2; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Meijer AJ, 2004, BIOCHEM BIOPH RES CO, V313, P397, DOI 10.1016/j.bbrc.2003.07.012; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Montagne J, 1999, SCIENCE, V285, P2126, DOI 10.1126/science.285.5436.2126; Niswender KD, 2003, DIABETES, V52, P227, DOI 10.2337/diabetes.52.2.227; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Proud CG, 2002, EUR J BIOCHEM, V269, P5338, DOI 10.1046/j.1432-1033.2002.03292.x; Ritter S, 2001, J COMP NEUROL, V432, P197, DOI 10.1002/cne.1097; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Seeley RJ, 2003, NAT REV NEUROSCI, V4, P901, DOI 10.1038/nrn1245; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102	27	938	986	3	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					927	930		10.1126/science.1124147	http://dx.doi.org/10.1126/science.1124147			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690869				2022-12-24	WOS:000237452900052
J	Coudreuse, DYM; Roel, G; Betist, MC; Destree, O; Korswagen, HC				Coudreuse, DYM; Roel, G; Betist, MC; Destree, O; Korswagen, HC			Wnt gradient formation requires retromer function in Wnt-producing cells	SCIENCE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; XENOPUS EMBRYOS; EXPRESSION; WINGLESS; POLARITY; MIGRATION; HOMOLOG; ENDODERM; RECEPTOR	Wnt proteins function as morphogens that can form long-range concentration gradients to pattern developing tissues. Here, we show that the retromer, a multiprotein complex involved in intracellular protein trafficking, is required for long-range signaling of the Caenorhabditis elegans Wnt ortholog EGL-20. The retromer functions in EGL-20-producing cells to allow the formation of an EGL-20 gradient along the anteroposterior axis. This function is evolutionarily conserved, because Wnt target gene expression is also impaired in the absence of the retromer complex in vertebrates. These results demonstrate that the ability of Wnt to regulate long-range patterning events is dependent on a critical and conserved function of the retromer complex within Wnt-producing cells.	Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Korswagen, HC (corresponding author), Hubrecht Lab, Uppslalaan 8, NL-3584 CT Utrecht, Netherlands.	rkors@niob.knaw.nl	Korswagen, Hendrik/I-8782-2012	Coudreuse, Damien/0000-0003-2534-1621				Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Harris J, 1996, DEVELOPMENT, V122, P3117; HERMAN MA, 1994, DEVELOPMENT, V120, P1035; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Horazdovsky BF, 1997, MOL BIOL CELL, V8, P1529, DOI 10.1091/mbc.8.8.1529; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; NOORDERMEER J, 1989, NUCLEIC ACIDS RES, V17, P11, DOI 10.1093/nar/17.1.11; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; SALSER SJ, 1992, NATURE, V355, P255, DOI 10.1038/355255a0; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Staal FJT, 1999, INT IMMUNOL, V11, P317, DOI 10.1093/intimm/11.3.317; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tanaka K, 2002, J BIOL CHEM, V277, P12816, DOI 10.1074/jbc.M200187200; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Vallin J, 2001, J BIOL CHEM, V276, P30350, DOI 10.1074/jbc.M103167200; Verges M, 2004, NAT CELL BIOL, V6, P763, DOI 10.1038/ncb1153; Whangbo J, 2000, DEVELOPMENT, V127, P4587; Whangbo J, 1999, MOL CELL, V4, P851, DOI 10.1016/S1097-2765(00)80394-9	23	191	209	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					921	924		10.1126/science.1124856	http://dx.doi.org/10.1126/science.1124856			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16645052				2022-12-24	WOS:000237452900050
J	Douglas, T; Young, M				Douglas, T; Young, M			Viruses: Making friends with old foes	SCIENCE			English	Editorial Material							VIRAL NANOPARTICLES; BUILDING-BLOCKS; PROTEIN; PARTICLES; CAGE; SURFACE		Montana State Univ, Ctr Bioinspired Nanomat, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Douglas, T (corresponding author), Montana State Univ, Ctr Bioinspired Nanomat, Bozeman, MT 59717 USA.	tdouglas@chemistry.montana.edu; myoung@montana.edu	Douglas, Trevor/GRS-0012-2022; Douglas, Trevor/F-2748-2011	Douglas, Trevor/0000-0002-7882-2704; 	NIBIB NIH HHS [R01EB000432, R21EB005364] Funding Source: Medline; NIGMS NIH HHS [R01GM61340] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000432, R21EB005364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061340] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen M, 2005, MAGN RESON MED, V54, P807, DOI 10.1002/mrm.20614; BANCROFT JB, 1967, VIROLOGY, V31, P354, DOI 10.1016/0042-6822(67)90180-8; Bothner B, 2005, VIROLOGY, V334, P17, DOI 10.1016/j.virol.2005.01.017; Chatterji A, 2004, BIOCONJUGATE CHEM, V15, P807, DOI 10.1021/bc0402888; Douglas T, 1998, NATURE, V393, P152, DOI 10.1038/30211; Douglas T, 2002, ADV MATER, V14, P415, DOI 10.1002/1521-4095(20020318)14:6<415::AID-ADMA415>3.0.CO;2-W; Flenniken ML, 2005, CHEM COMMUN, P447, DOI 10.1039/b413435d; Gillitzer E, 2002, CHEM COMMUN, P2390, DOI 10.1039/b207853h; Klem MT, 2005, ADV FUNCT MATER, V15, P1489, DOI 10.1002/adfm.200400453; Klem MT, 2003, J AM CHEM SOC, V125, P10806, DOI 10.1021/ja0363718; Knez M, 2003, NANO LETT, V3, P1079, DOI 10.1021/nl0342545; Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368; Mao CB, 2004, SCIENCE, V303, P213, DOI 10.1126/science.1092740; MELDRUM FC, 1991, NATURE, V349, P684, DOI 10.1038/349684a0; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Raja KS, 2003, BIOMACROMOLECULES, V4, P472, DOI 10.1021/bm025740+; Raja KS, 2003, CHEMBIOCHEM, V4, P1348, DOI 10.1002/cbic.200300759; Rice G, 2004, P NATL ACAD SCI USA, V101, P7716, DOI 10.1073/pnas.0401773101; Schlick TL, 2005, J AM CHEM SOC, V127, P3718, DOI 10.1021/ja046239n; Shepherd CM, 2006, NUCLEIC ACIDS RES, V34, pD386, DOI 10.1093/nar/gkj032; SPEIR JA, 1995, STRUCTURE, V3, P63, DOI 10.1016/S0969-2126(01)00135-6; Strable E, 2004, NANO LETT, V4, P1385, DOI 10.1021/nl0493850; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Tang JH, 2006, J STRUCT BIOL, V154, P59, DOI 10.1016/j.jsb.2005.10.013; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; Wang Q, 2002, ANGEW CHEM INT EDIT, V41, P459; Wang Q, 2002, CHEM BIOL, V9, P813, DOI 10.1016/S1074-5521(02)00166-7; Whaley SR, 2000, NATURE, V405, P665, DOI 10.1038/35015043; Zhu YX, 2001, J STRUCT BIOL, V135, P302, DOI 10.1006/jsbi.2001.4415	29	468	484	3	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					873	875		10.1126/science.1123223	http://dx.doi.org/10.1126/science.1123223			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690856				2022-12-24	WOS:000237452900035
J	Madin, JS; Alroy, J; Aberhan, M; Fursich, FT; Kiessling, W; Kosnik, MA; Wagner, PJ				Madin, JS; Alroy, J; Aberhan, M; Fursich, FT; Kiessling, W; Kosnik, MA; Wagner, PJ			Statistical independence of escalatory ecological trends in phanerozoic marine invertebrates	SCIENCE			English	Article							FOSSIL RECORD; BRACHIOPODS; DIVERSITY; SELECTION; EVOLUTION; PATTERNS	Ecological interactions, such as predation and bioturbation, are thought to be fundamental determinants of macroevolutionary trends. A data set containing global occurrences of Phanerozoic fossils of benthic marine invertebrates shows escalatory trends in the relative frequency of ecological groups, such as carnivores and noncarnivorous infaunal or mobile organisms. Associations between these trends are either statistically insignificant or interpretable as preservational effects. Thus, there is no evidence that escalation drives macroecological trends at global and million-year time scales. We also find that taxonomic richness and occurrence data are cross-correlated, which justifies the traditional use of one as a proxy of the other.	Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; Humboldt Univ, Museum Naturkunde, D-10115 Berlin, Germany; Univ Wurzburg, Inst Paleontol, D-97070 Wurzburg, Germany; James Cook Univ N Queensland, Sch Marine Biol & Aquaculture, Townsville, Qld 4811, Australia; Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Wurzburg; James Cook University; Field Museum of Natural History (Chicago)	Madin, JS (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA.	madin@nceas.ucsb.edu	Alroy, John/B-4585-2009; Kosnik, Matthew/G-2312-2010; Kiessling, Wolfgang/E-2259-2015; Wagner, Peter/A-5514-2009; Kosnik, Matthew A./P-9632-2019	Alroy, John/0000-0002-9882-2111; Kosnik, Matthew/0000-0001-5380-7041; Kiessling, Wolfgang/0000-0002-1088-2014; Wagner, Peter/0000-0002-9083-9787; Kosnik, Matthew A./0000-0001-5380-7041; Madin, Joshua/0000-0002-5005-6227				Aberhan M, 2006, PALEOBIOLOGY, V32, P259, DOI 10.1666/05028.1; Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; Bambach RK, 2002, P NATL ACAD SCI USA, V99, P6854, DOI 10.1073/pnas.092150999; BAMBACH RK, 1983, BIOTIC INTERACTIONS, pCH15; Behrensmeyer AK, 2005, PALEOBIOLOGY, V31, P607, DOI 10.1666/0094-8373(2005)031[0607:ATMDST]2.0.CO;2; BUZAS MA, 1982, PALEOBIOLOGY, V8, P143, DOI 10.1017/S0094837300004486; GOULD SJ, 1980, PALEOBIOLOGY, V6, P383, DOI 10.1017/S0094837300003572; Kelley P.H., 2003, PREDATOR PREY INTERA; Kidwell SM, 2005, SCIENCE, V307, P914, DOI 10.1126/science.1106654; Kowalewski M, 2005, SCIENCE, V308, P1774, DOI 10.1126/science.1113408; Kowalewski M, 1998, GEOLOGY, V26, P1091, DOI 10.1130/0091-7613(1998)026<1091:AFRFOH>2.3.CO;2; Lupia R, 1999, PALEOBIOLOGY, V25, P305, DOI 10.1017/S009483730002131X; McKinney FK, 1998, SCIENCE, V281, P807, DOI 10.1126/science.281.5378.807; MORSE JW, 1980, GEOCHIM COSMOCHIM AC, V44, P85, DOI 10.1016/0016-7037(80)90178-7; PAWLIK JR, 1993, CHEM REV, V93, P1911, DOI 10.1021/cr00021a012; Sanders D, 2003, J AFR EARTH SCI, V36, P99, DOI 10.1016/S0899-5362(03)00027-7; Sepkoski J.J., 2002, B AM PALEONTOL, V363, P1; THAYER CW, 1983, BIOTIC INTERACTIONS, pCH11; Vermeij G.J., 1987, EVOLUTION ESCALATION; VERMEIJ GJ, 1994, ANNU REV ECOL SYST, V25, P219, DOI 10.1146/annurev.es.25.110194.001251; VRBA ES, 1986, PALEOBIOLOGY, V12, P217, DOI 10.1017/S0094837300013671	21	68	70	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 12	2006	312	5775					897	900		10.1126/science.1123591	http://dx.doi.org/10.1126/science.1123591			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690862				2022-12-24	WOS:000237452900043
J	Bilous, J; Eggers, R; Gasse, F; Jarrett, S; Lydon, P; Magan, A; Okwo-Bele, JM; Salama, P; Vandelaer, J; Villeneuve, P; Wolfson, L				Bilous, J; Eggers, R; Gasse, F; Jarrett, S; Lydon, P; Magan, A; Okwo-Bele, JM; Salama, P; Vandelaer, J; Villeneuve, P; Wolfson, L			A new global immunisation vision and strategy	LANCET			English	Editorial Material									WHO, Dept Immunizat Vaccines & Biol, CH-1211 Geneva 27, Switzerland; WHO, Family & Community Hlth Immunizat Vaccines & Biol, CH-1211 Geneva, Switzerland; UNICEF, Immunizat & Child Survival Team, New York, NY USA; UNICEF, Supply Div, New York, NY USA; UNICEF, Program Div, New York, NY USA; UNICEF, Hlth Sect, New York, NY USA	World Health Organization; World Health Organization; UNICEF; UNICEF; UNICEF; UNICEF	Okwo-Bele, JM (corresponding author), WHO, Dept Immunizat Vaccines & Biol, CH-1211 Geneva 27, Switzerland.	okwobelej@who.int	Wolfson, Lara/AAC-1400-2019	Wolfson, Lara/0000-0002-6454-3368				[Anonymous], 2005, GIVS GLOB IMM VIS ST; Hadler SC, 2003, VACCINES, P1407; *UN, 2005, DRAFT GLOB IMM STRAT; UNICEF, 2002, WORLD FIT CHILDR MIL; United Nations, 2005, PROGR MILL DEV GOALS; *WHO, 2005, 5815 WHA WHO; *WHO, 2005, GLOB POL ER IN 2004; *WHO, 2004, 2004 GLOB IMM DAT; *WHO, 2002, EST DIS BURD COST EF; *WHO IVB, 2005, WHO VACC PREV DIS MO; World Health Organization, 2005, WORLD HLTH REP 2005; 2004, WKLY EPIDEMIOL REC, V79, P349; 2003, WKLY EPIDEMIOL REC, V78, P366	13	47	48	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2006	367	9521					1464	1466		10.1016/S0140-6736(06)68625-X	http://dx.doi.org/10.1016/S0140-6736(06)68625-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	039RJ	16679143				2022-12-24	WOS:000237324200006
J	Chun, TH; Hotary, KB; Sabeh, F; Saltiel, AR; Allen, ED; Weiss, SJ				Chun, Tae-Hwa; Hotary, Kevin B.; Sabeh, Farideh; Saltiel, Alan R.; Allen, Edward D.; Weiss, Stephen J.			A pericellular collagenase directs the 3-dimensional development of white adipose tissue	CELL			English	Article							ISOLATED RAT ADIPOCYTES; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; INSULIN INCUBATION; GENE-EXPRESSION; MAMMARY-GLAND; CELL-SHAPE; ADIPOGENESIS; MICE; DIFFERENTIATION	White adipose tissue (WAT) serves as the primary energy depot in the body by storing fat. During development, fat cell precursors (i.e., preadipocytes) undergo a hypertrophic response as they mature into lipid-laden adipocytes. However, the mechanisms that regulate adipocyte size and mass remain undefined. Herein, we demonstrate that the membrane-anchored metal loproteinase, MT1-MMP, coordinates adipocyte differentiation in vivo. In the absence of the protease, WAT development is aborted, leaving tissues populated by mini-adipocytes which render null mice lipodystrophic. While MT1-MMP preadipocytes display a cell autonomous defect in vivo, null progenitors retain the ability to differentiate into functional adipocytes during 2-dimensional (2-D) culture. By contrast, within the context of the 3-dimensional (3-D) ECM, normal adipocyte maturation requires a burst in MT1-MMP-mediated proteolysis that modulates pericellular collagen rigidity in a fashion that controls adipogenesis. Hence, MT1-MMP acts as a 3-D-specific adipogenic factor that directs the dynamic adipocyte-ECM interactions critical to WAT development.	Univ Michigan, Dept Internal Med, Div Med & Mol Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Weiss, SJ (corresponding author), Univ Michigan, Dept Internal Med, Div Med & Mol Genet, Ann Arbor, MI 48109 USA.	sjweiss@umich.edu	Saltiel, Alan/L-3632-2019; Chun, Tae-Hwa/H-5959-2019	Chun, Tae-Hwa/0000-0001-9333-2589; Saltiel, Alan/0000-0002-9726-9828	NATIONAL CANCER INSTITUTE [R01CA088308] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA088308] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexander CM, 2001, J CELL BIOL, V152, P693, DOI 10.1083/jcb.152.4.693; BARNARD T, 1969, J ULTRA MOL STRUCT R, V29, P311, DOI 10.1016/S0022-5320(69)90109-9; Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102; Bouloumie A, 2001, DIABETES, V50, P2080, DOI 10.2337/diabetes.50.9.2080; Bradshaw AD, 2003, P NATL ACAD SCI USA, V100, P6045, DOI 10.1073/pnas.1030790100; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chun TH, 2004, J CELL BIOL, V167, P757, DOI 10.1083/jcb.200405001; Croissandeau G, 2002, BIOCHEM J, V364, P739, DOI 10.1042/BJ20011158; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Filippov S, 2005, J EXP MED, V202, P663, DOI 10.1084/jem.20050607; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Gentleman R, 2004, COMPSTAT 2004: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P171; Gonzalez FJ, 2005, CELL METAB, V1, P85, DOI 10.1016/j.cmet.2005.01.004; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hotary KB, 2002, J EXP MED, V195, P295, DOI 10.1084/jem.20010815; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Lazar MA, 2002, GENE DEV, V16, P1, DOI 10.1101/gad.964002; Lehti K, 2005, GENE DEV, V19, P979, DOI 10.1101/gad.1294605; Lijnen HR, 2002, THROMB HAEMOSTASIS, V88, P345; Lilla J, 2002, AM J PATHOL, V160, P1551, DOI 10.1016/S0002-9440(10)61100-5; Mandrup S, 1997, P NATL ACAD SCI USA, V94, P4300, DOI 10.1073/pnas.94.9.4300; Maquoi E, 2003, THROMB HAEMOSTASIS, V89, P696, DOI 10.1055/s-0037-1613586; MARSHALL S, 1980, J CLIN INVEST, V66, P763, DOI 10.1172/JCI109914; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; MORALES LM, 1992, BIOCHEM BIOPH RES CO, V188, P807, DOI 10.1016/0006-291X(92)91128-D; Morroni M, 2004, P NATL ACAD SCI USA, V101, P16801, DOI 10.1073/pnas.0407647101; NAPOLITANO L, 1963, J CELL BIOL, V18, P663, DOI 10.1083/jcb.18.3.663; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Rosen ED, 2000, ANNU REV CELL DEV BI, V16, P145, DOI 10.1146/annurev.cellbio.16.1.145; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Yamauchi T, 2002, NAT GENET, V30, P221, DOI 10.1038/ng829; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	43	295	306	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					577	591		10.1016/j.cell.2006.02.050	http://dx.doi.org/10.1016/j.cell.2006.02.050			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678100	Bronze			2022-12-24	WOS:000237506100022
J	Biddlecom, A; Bankole, A; Patterson, K				Biddlecom, A; Bankole, A; Patterson, K			Vaccine for cervical cancer: reaching adolescents in sub-Saharan Africa	LANCET			English	Editorial Material									Alan Guttmacher Inst, Div Res, New York, NY 10005 USA		Biddlecom, A (corresponding author), Alan Guttmacher Inst, Div Res, 120 Wall St, New York, NY 10005 USA.	abiddlecom@guttmacher.org						[Anonymous], INJ PRACT RAP ASS RE; Bankole A., 2004, RISK PROTECTION YOUT; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; *GLAX, 2006, MARK APPL CERV GSKS; *GUTTM I, IN PRESS SPEC TAB 20; Hewett P. C., 2005, CHANGING TRANSITIONS, P84, DOI [10.17226/11524, DOI 10.17226/11524]; Hughes JP, 2002, EPIDEMIOLOGY, V13, P631, DOI 10.1097/00001648-200211000-00006; Hutin YJF, 2003, BMJ-BRIT MED J, V327, P1075, DOI 10.1136/bmj.327.7423.1075; *MERCK CO, 2006, GARDASIL MERCKS INV; Sankaranarayanan R, 2005, INT J GYNECOL OBSTET, V89, pS4, DOI 10.1016/j.ijgo.2005.01.009; Speizer IS, 2003, J ADOLESCENT HEALTH, V33, P324, DOI 10.1016/S1054-139X(02)00535-9; World Health Organization, 2000, WORLD HLTH REP 2000	12	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 22	2006	367	9519					1299	1300		10.1016/S0140-6736(06)68555-3	http://dx.doi.org/10.1016/S0140-6736(06)68555-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037AG	16631895				2022-12-24	WOS:000237118500007
J	Domek, GJ				Domek, GJ			Social consequences of antiretroviral therapy: preparing for the unexpected futures of HIV-positive children	LANCET			English	Editorial Material							PSYCHOSOCIAL ISSUES; HIV/AIDS; ADOLESCENTS; CARE; AIDS; DISCLOSURE; EFFICACY; ACCESS; HAART; LIFE		Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Domek, GJ (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	gretchen_domek@hms.harvard.edu						Abadia-Barrero CE, 2006, SOC SCI MED, V62, P1219, DOI 10.1016/j.socscimed.2005.07.006; Abadia-Barrero CE, 2006, AIDS PATIENT CARE ST, V20, P36, DOI 10.1089/apc.2006.20.36; Abadia-Barrero César Ernesto, 2002, Interface (Botucatu), V6, P55, DOI 10.1590/S1414-32832002000200005; Atwine B, 2005, SOC SCI MED, V61, P555, DOI 10.1016/j.socscimed.2004.12.018; Battles HB, 2002, J ADOLESCENT HEALTH, V30, P161, DOI 10.1016/S1054-139X(01)00341-X; BRAZARSH J, 2004, COMM INF INSP TEAM J; Brown LK, 2000, J CHILD PSYCHOL PSYC, V41, P81, DOI 10.1111/1469-7610.00550; COHEN J, 1989, PEDIATRICS, V100, P8; DOMEK GJ, 2005, THESIS U OXFORD I; Drew RS, 1998, AIDS CARE, V10, pS9, DOI 10.1080/09540129850124325; Foster G, 1996, AIDS CARE, V8, P389, DOI 10.1080/09540129650125597; Gebo KA, 1999, AIDS, V13, P963, DOI 10.1097/00002030-199905280-00013; Gerson A C, 2001, J Pediatr Health Care, V15, P161, DOI 10.1067/mph.2001.114835; Gortmaker SL, 2001, NEW ENGL J MED, V345, P1522, DOI 10.1056/NEJMoa011157; Ledlie SW, 2001, AIDS PATIENT CARE ST, V15, P231, DOI 10.1089/10872910152050748; Lee CL, 1999, AIDS PATIENT CARE ST, V13, P41, DOI 10.1089/apc.1999.13.41; Loening-Voysey H, 2001, APPROACHES CARING CH; Matida Luiza Harunari, 2004, Braz J Infect Dis, V8, P419, DOI 10.1590/S1413-86702004000600005; Mialky E, 2001, AIDS PATIENT CARE ST, V15, P575, DOI 10.1089/108729101753287667; O'Hare BAM, 2005, AIDS CARE, V17, P443, DOI 10.1080/09540120412331291779; Pillay AL, 1997, SOC SCI MED, V45, P1493, DOI 10.1016/S0277-9536(97)00079-8; Piot P, 2004, SCIENCE, V304, P1909, DOI 10.1126/science.1101137; Puthanakit T, 2005, CLIN INFECT DIS, V41, P100, DOI 10.1086/430714; Ruiz P, 2000, AM J PSYCHIAT, V157, P110, DOI 10.1176/ajp.157.1.110; Selwyn PA, 1998, ANN INTERN MED, V129, P899, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00012; Shetty Avinash K, 2003, Semin Pediatr Infect Dis, V14, P25, DOI 10.1053/spid.2003.127214; Sowell RL, 1998, AIDS PATIENT CARE ST, V12, P33, DOI 10.1089/apc.1998.12.33; Tramarin A, 2004, AIDS CARE, V16, P213, DOI 10.1080/09540120410001641057; *UNAIDS, 2005, AIDS EP UPD DEC 2005; *UNAIDS, 2001, INV OUR FUT PSYCH SU; Wilfert C, 1999, PEDIATRICS, V103, P164	31	32	32	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 22	2006	367	9519					1367	1369		10.1016/S0140-6736(06)68584-X	http://dx.doi.org/10.1016/S0140-6736(06)68584-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	037AG	16631916				2022-12-24	WOS:000237118500032
J	Prud'homme, B; Gompel, N; Rokas, A; Kassner, VA; Williams, TM; Yeh, SD; True, JR; Carroll, SB				Prud'homme, B; Gompel, N; Rokas, A; Kassner, VA; Williams, TM; Yeh, SD; True, JR; Carroll, SB			Repeated morphological evolution through cis-regulatory changes in a pleiotropic gene	NATURE			English	Article							MELANOGASTER SPECIES GROUP; BAYESIAN-INFERENCE; YELLOW GENE; PHYLOGENY; DIVERGENCE; DIPTERA; NUCLEAR	The independent evolution of morphological similarities is widespread(1,2). For simple traits, such as overall body colour, repeated transitions by means of mutations in the same gene may be common(3-5). However, for more complex traits, the possible genetic paths may be more numerous; the molecular mechanisms underlying their independent origins and the extent to which they are constrained to follow certain genetic paths are largely unknown. Here we show that a male wing pigmentation pattern involved in courtship display has been gained and lost multiple times in a Drosophila clade. Each of the cases we have analysed (two gains and two losses) involved regulatory changes at the pleiotropic pigmentation gene yellow. Losses involved the parallel inactivation of the same cis-regulatory element (CRE), with changes at a few nucleotides sufficient to account for the functional divergence of one element between two sibling species. Surprisingly, two independent gains of wing spots resulted from the co-option of distinct ancestral CREs. These results demonstrate how the functional diversification of the modular CREs of pleiotropic genes contributes to evolutionary novelty and the independent evolution of morphological similarities.	Univ Wisconsin, Madison, WI 53706 USA; Howard Hughes Med Inst, Bock Labs, Madison, WI 53706 USA; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Cambridge; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Carroll, SB (corresponding author), Univ Wisconsin, 1525 Linden Dr, Madison, WI 53706 USA.	sbcarrol@wisc.edu	Rokas, Antonis/A-9775-2008	Rokas, Antonis/0000-0002-7248-6551; Yeh, Shu-Dan/0000-0003-0488-1418; True, John/0000-0001-5124-5495; Gompel, Nicolas/0000-0003-3358-7963				Bock I.R., 1972, U TEXAS PUBL, V7213, P1, DOI DOI 10.1590/S0085-56262014000400004; Conway Morris S, 2005, LIFES SOLUTION INEVI; Drapeau MD, 2006, GENETICS, V172, P1009, DOI 10.1534/genetics.105.045666; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Goto SG, 2001, MOL PHYLOGENET EVOL, V18, P404, DOI 10.1006/mpev.2000.0893; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huelsenbeck JP, 2000, SCIENCE, V288, P2349, DOI 10.1126/science.288.5475.2349; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Kopp A, 2002, SYST BIOL, V51, P786, DOI 10.1080/10635150290102410; Lakovaara S., 1982, Genetics and Biology of Drosophila, V3b, P1; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; O'Grady PM, 2002, MOL PHYLOGENET EVOL, V22, P442, DOI 10.1006/mpev.2001.1053; O'Grady PM, 1999, MOL PHYLOGENET EVOL, V12, P124, DOI 10.1006/mpev.1998.0598; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Ronquist F, 2004, TRENDS ECOL EVOL, V19, P475, DOI 10.1016/j.tree.2004.07.002; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Schawaroch V, 2002, BIOL J LINN SOC, V76, P21, DOI 10.1111/j.1095-8312.2002.tb01711.x; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; Sucena E, 2000, P NATL ACAD SCI USA, V97, P4530, DOI 10.1073/pnas.97.9.4530; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Theron E, 2001, CURR BIOL, V11, P550, DOI 10.1016/S0960-9822(01)00158-0; WALTER MF, 1991, DEV BIOL, V147, P32, DOI 10.1016/S0012-1606(05)80005-3; West-Eberhard Mary Jane, 2003, pi; Wittkopp PJ, 2002, CURR BIOL, V12, P1547, DOI 10.1016/S0960-9822(02)01113-2; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849; YEH SD, IN PRESS HEREDITY	29	358	364	4	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2006	440	7087					1050	1053		10.1038/nature04597	http://dx.doi.org/10.1038/nature04597			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16625197				2022-12-24	WOS:000236906000036
J	Kerssemakers, JWJ; Munteanu, EL; Laan, L; Noetzel, TL; Janson, ME; Dogterom, M				Kerssemakers, Jacob W. J.; Munteanu, E. Laura; Laan, Liedewij; Noetzel, Tim L.; Janson, Marcel E.; Dogterom, Marileen			Assembly dynamics of microtubules at molecular resolution	NATURE			English	Article							END-TRACKING PROTEINS; PLUS-END; TRANSITION FREQUENCIES; XENOPUS EGGS; TUBULIN; XMAP215; INSTABILITY; MICROSCOPY; MECHANICS; CLIP-170	Microtubules are highly dynamic protein polymers(1) that form a crucial part of the cytoskeleton in all eukaryotic cells. Although microtubules are known to self- assemble from tubulin dimers, information on the assembly dynamics of microtubules has been limited, both in vitro(2,3) and in vivo(4,5), to measurements of average growth and shrinkage rates over several thousands of tubulin subunits. As a result there is a lack of information on the sequence of molecular events that leads to the growth and shrinkage of microtubule ends. Here we use optical tweezers to observe the assembly dynamics of individual microtubules at molecular resolution. We find that microtubules can increase their overall length almost instantaneously by amounts exceeding the size of individual dimers ( 8 nm). When the microtubule- associated protein XMAP215 ( ref. 6) is added, this effect is markedly enhanced and fast increases in length of about 40 - 60 nm are observed. These observations suggest that small tubulin oligomers are able to add directly to growing microtubules and that XMAP215 speeds up microtubule growth by facilitating the addition of long oligomers. The achievement of molecular resolution on the microtubule assembly process opens the way to direct studies of the molecular mechanism by which the many recently discovered microtubule end-binding proteins regulate microtubule dynamics in living cells(7-9).	FOM, Inst Atom & Mol Phys, AMOLF, Fdn Fundamental Res Matter, NL-1098 SJ Amsterdam, Netherlands; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	AMOLF; Max Planck Society; University of Pennsylvania	Dogterom, M (corresponding author), FOM, Inst Atom & Mol Phys, AMOLF, Fdn Fundamental Res Matter, Kruislaan 407, NL-1098 SJ Amsterdam, Netherlands.	dogterom@amolf.nl		Laan, Liedewij/0000-0002-7138-9004; Kerssemakers, Jacob Willem Jozef/0000-0002-6184-7913				Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Arnal I, 2004, CURR BIOL, V14, P2086, DOI 10.1016/j.cub.2004.11.055; Cassimeris L, 2001, J CELL SCI, V114, P3025; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Diamantopoulos GS, 1999, J CELL BIOL, V144, P99, DOI 10.1083/jcb.144.1.99; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Folker ES, 2005, MOL BIOL CELL, V16, P5373, DOI 10.1091/mbc.E04-12-1106; FYGENSON DK, 1994, PHYS REV E, V50, P1579, DOI 10.1103/PhysRevE.50.1579; Gard DL, 2004, INT REV CYTOL, V239, P179, DOI 10.1016/S0074-7696(04)39004-2; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Janosi IM, 1998, EUR BIOPHYS J BIOPHY, V27, P501, DOI 10.1007/s002490050160; Janson ME, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.248101; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Kerssemakers JWJ, 2003, APPL PHYS LETT, V83, P4441, DOI 10.1063/1.1629796; Kinoshita K, 2002, TRENDS CELL BIOL, V12, P267, DOI 10.1016/S0962-8924(02)02295-X; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; Komarova YA, 2002, J CELL SCI, V115, P3527; Piehl M, 2003, MOL BIOL CELL, V14, P916, DOI 10.1091/mbc.E02-09-0607; Pierce DW, 1998, METHOD ENZYMOL, V298, P154, DOI 10.1016/S0076-6879(98)98016-8; Schek HT, 2005, BIOMED MICRODEVICES, V7, P41, DOI 10.1007/s10544-005-6170-z; Schuyler SC, 2001, CELL, V105, P421, DOI 10.1016/S0092-8674(01)00364-6; Shirasu-Hiza M, 2003, J CELL BIOL, V161, P349, DOI 10.1083/jcb.200211095; Spittle C, 2000, J BIOL CHEM, V275, P20748, DOI 10.1074/jbc.M002597200; VanBuren V, 2005, BIOPHYS J, V89, P2911, DOI 10.1529/biophysj.105.060913; VASQUEZ RJ, 1994, J CELL BIOL, V127, P985, DOI 10.1083/jcb.127.4.985; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wang HW, 2005, CELL CYCLE, V4, P1157, DOI 10.4161/cc.4.9.2042; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606	30	429	435	2	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2006	442	7103					709	712		10.1038/nature04928	http://dx.doi.org/10.1038/nature04928			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UU	16799566				2022-12-24	WOS:000239630200051
J	Langowski, JL; Zhang, XQ; Wu, LL; Mattson, JD; Chen, TY; Smith, K; Basham, B; McClanahan, T; Kastelein, RA; Oft, M				Langowski, John L.; Zhang, Xueqing; Wu, Lingling; Mattson, Jeanine D.; Chen, Taiying; Smith, Kathy; Basham, Beth; McClanahan, Terrill; Kastelein, Robert A.; Oft, Martin			IL-23 promotes tumour incidence and growth	NATURE			English	Article							AUTOIMMUNE INFLAMMATION; ADAPTIVE IMMUNITY; T-CELLS; CANCER; SKIN; DISTINCT; INTERLEUKIN-12; RESISTANCE; CYTOKINE; IL-12	Chronic inflammation has long been associated with increased incidence of malignancy and similarities in the regulatory mechanisms have been suggested for more than a century(1). Infiltration of innate immune cells, elevated activities of matrix metalloproteases and increased angiogenesis and vasculature density are a few examples of the similarities between chronic and tumour-associated inflammation(2). Conversely, the elimination of early malignant lesions by immune surveillance, which relies on the cytotoxic activity of tumour-infiltrating T cells or intra-epithelial lymphocytes, is thought to be rate-limiting for the risk to develop cancer(3). Here we show a molecular connection between the rise in tumour-associated inflammation and a lack of tumour immune surveillance. Expression of the heterodimeric cytokine interleukin (IL)-23, but not of its close relative IL-12, is increased in human tumours. Expression of these cytokines antagonistically regulates local inflammatory responses in the tumour microenvironment and infiltration of intra-epithelial lymphocytes. Whereas IL-12 promotes infiltration of cytotoxic T cells, IL-23 promotes inflammatory responses such as upregulation of the matrix metalloprotease MMP9, and increases angiogenesis but reduces CD8 T-cell infiltration. Genetic deletion or antibody-mediated elimination of IL-23 leads to increased infiltration of cytotoxic T cells into the transformed tissue, rendering a protective effect against chemically induced carcinogenesis. Finally, transplanted tumours are growth-restricted in hosts depleted for IL-23 or in IL-23-receptor-deficient mice. Although many strategies for immune therapy of cancer attempt to stimulate an immune response against solid tumours, infiltration of effector cells into the tumour tissue often appears to be a critical hurdle(4-7). We show that IL-23 is an important molecular link between tumour-promoting pro-inflammatory processes and the failure of the adaptive immune surveillance to infiltrate tumours.	Schering Plough BioPharma, Palo Alto, CA 94304 USA	Merck & Company	Oft, M (corresponding author), Schering Plough BioPharma, 901 Calif Ave, Palo Alto, CA 94304 USA.	martin.oft@spcorp.com	Wu, Ling/GZN-2235-2022					Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Blattman JN, 2004, SCIENCE, V305, P200, DOI 10.1126/science.1100369; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; FUSENIG NE, 1978, B CANCER, V65, P271; Ganss R, 2004, EUR J IMMUNOL, V34, P2635, DOI 10.1002/eji.200425474; Girardi M, 2003, J EXP MED, V198, P747, DOI 10.1084/jem.20021282; GUPTA JW, 1992, CANCER RES, V52, P2530; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Lieberman LA, 2004, J IMMUNOL, V173, P1887, DOI 10.4049/jimmunol.173.3.1887; Lo CH, 2003, J IMMUNOL, V171, P600, DOI 10.4049/jimmunol.171.2.600; Marincola FM, 2003, TRENDS IMMUNOL, V24, P335, DOI 10.1016/S1471-4906(03)00116-9; Mueller MM, 1999, AM J PATHOL, V155, P1557, DOI 10.1016/S0002-9440(10)65472-7; Nagase H, 1999, P NATL ACAD SCI USA, V96, P15032, DOI 10.1073/pnas.96.26.15032; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Tiano HF, 2002, CANCER RES, V62, P3395; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; WYSOCKA M, 1995, EUR J IMMUNOL, V25, P672, DOI 10.1002/eji.1830250307; Yee C, 2002, NAT REV CANCER, V2, P409, DOI 10.1038/nrc820	30	760	840	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2006	442	7101					461	465		10.1038/nature04808	http://dx.doi.org/10.1038/nature04808			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16688182				2022-12-24	WOS:000239278900045
J	Ju, BG; Lunyak, VV; Perissi, V; Garcia-Bassets, I; Rose, DW; Glass, CK; Rosenfeld, MG				Ju, BG; Lunyak, VV; Perissi, V; Garcia-Bassets, I; Rose, DW; Glass, CK; Rosenfeld, MG			A topoisomerase II beta-mediated dsDNA break required for regulated transcription	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; ESTROGEN-RECEPTOR-ALPHA; RNA-POLYMERASE-II; POLY(ADP-RIBOSE) POLYMERASE; KAPPA-B; CHROMATIN-STRUCTURE; NUCLEAR RECEPTORS; ADP-RIBOSYLATION; BINDING PROTEIN; COACTIVATOR	Multiple enzymatic activities are required for transcriptional initiation. The enzyme DNA topoisomerase II associates with gene promoter regions and can generate breaks in double-stranded DNA (dsDNA). Therefore, it is of interest to know whether this enzyme is critical for regulated gene activation. We report that the signal-dependent activation of gene transcription by nuclear receptors and other classes of DNA binding transcription factors, including activating protein 1, requires DNA topoisomerase II beta-dependent, transient, site-specific dsDNA break formation. Subsequent to the break, poly( adenosine diphosphate-ribose) polymerase-1 enzymatic activity is induced, which is required for a nucleosome-specific histone H1-high-mobility group B exchange event and for local changes of chromatin architecture. Our data mechanistically link DNA topoisomerase IIb-dependent dsDNA breaks and the components of the DNA damage and repair machinery in regulated gene transcription.	Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, Div Endocrinol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu	Garcia-Bassets, Ivan/F-5075-2010; Glass, Christopher/AAI-3933-2021; lunyak, victoria/R-3765-2017	Glass, Christopher/0000-0003-4344-3592; Garcia-Bassets, Ivan/0000-0002-6941-9585; lunyak, victoria/0000-0001-9093-2714; Perissi, Valentina/0000-0002-3716-0003				ALTHAUS FR, 1994, MOL CELL BIOCHEM, V138, P53, DOI 10.1007/BF00928443; Barkhem T, 2002, MOL PHARMACOL, V61, P1273, DOI 10.1124/mol.61.6.1273; Binaschi M, 2000, CANCER RES, V60, P3770; Brown DT, 2003, BIOCHEM CELL BIOL, V81, P221, DOI 10.1139/o03-049; Burma S, 2004, DNA REPAIR, V3, P909, DOI 10.1016/j.dnarep.2004.03.021; Butler AJ, 1999, MOL CELL BIOL, V19, P296; Cervellera MN, 2000, J BIOL CHEM, V275, P10692, DOI 10.1074/jbc.275.14.10692; Chibazakura T, 1997, EUR J BIOCHEM, V247, P1166, DOI 10.1111/j.1432-1033.1997.01166.x; Collins I, 2001, MOL CELL BIOL, V21, P8437, DOI 10.1128/MCB.21.24.8437-8451.2001; Das D, 2004, MOL ENDOCRINOL, V18, P2616, DOI 10.1210/me.2004-0125; DVIR A, 1992, P NATL ACAD SCI USA, V89, P11920, DOI 10.1073/pnas.89.24.11920; Glass CK, 2000, GENE DEV, V14, P121; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; JELTSCH JM, 1987, NUCLEIC ACIDS RES, V15, P1401, DOI 10.1093/nar/15.4.1401; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Ko L, 2000, P NATL ACAD SCI USA, V97, P6212, DOI 10.1073/pnas.97.11.6212; Ku MC, 2003, BIOCHEM BIOPH RES CO, V311, P702, DOI 10.1016/j.bbrc.2003.10.053; Le Page C, 1998, BIOCHEM BIOPH RES CO, V243, P451; Lee SK, 2000, MOL ENDOCRINOL, V14, P915, DOI 10.1210/me.14.6.915; Leontiou C, 2006, MOL PHARMACOL, V69, P130, DOI 10.1124/mol.105.015933; Malanga M, 2005, BIOCHEM CELL BIOL, V83, P354, DOI 10.1139/o05-038; Mayeur GL, 2005, J BIOL CHEM, V280, P10827, DOI 10.1074/jbc.M413336200; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; NUNEZ AM, 1989, EMBO J, V8, P823, DOI 10.1002/j.1460-2075.1989.tb03443.x; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Ruh MF, 2004, MOL CELL ENDOCRINOL, V214, P71, DOI 10.1016/j.mce.2003.11.023; Sartorius CA, 2000, J MOL ENDOCRINOL, V24, P165, DOI 10.1677/jme.0.0240165; Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831	34	638	655	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2006	312	5781					1798	1802		10.1126/science.1127196	http://dx.doi.org/10.1126/science.1127196			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16794079				2022-12-24	WOS:000238452800059
J	Losev, E; Reinke, CA; Jellen, J; Strongin, DE; Bevis, BJ; Glick, BS				Losev, Eugene; Reinke, Catherine A.; Jellen, Jennifer; Strongin, Daniel E.; Bevis, Brooke J.; Glick, Benjamin S.			Golgi maturation visualized in living yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; PICHIA-PASTORIS; PROTEIN-TRANSPORT; CISTERNAE; LOCALIZATION; APPARATUS; VESICLES; COMPLEX; LUMEN	The Golgi apparatus is composed of biochemically distinct early (cis, medial) and late ( trans, TGN) cisternae. There is debate about the nature of these cisternae(1-3). The stable compartments model predicts that each cisterna is a long-lived structure that retains a characteristic set of Golgi-resident proteins. In this view, secretory cargo proteins are transported by vesicles from one cisterna to the next. The cisternal maturation model predicts that each cisterna is a transient structure that matures from early to late by acquiring and then losing specific Golgi-resident proteins. In this view, secretory cargo proteins traverse the Golgi by remaining within the maturing cisternae. Various observations have been interpreted as supporting one or the other mechanism(4-9). Here we provide a direct test of the two models using three-dimensional time-lapse fluorescence microscopy of the yeast Saccharomyces cerevisiae. This approach reveals that individual cisternae mature, and do so at a consistent rate. In parallel, we used pulse - chase analysis to measure the transport of two secretory cargo proteins. The rate of cisternal maturation matches the rate of protein transport through the secretory pathway, suggesting that cisternal maturation can account for the kinetics of secretory traffic.	Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Glick, BS (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58th St, Chicago, IL 60637 USA.	bsglick@midway.uchicago.edu						Abe M, 2004, J CELL SCI, V117, P5687, DOI 10.1242/jcs.01491; Behnia R, 2004, NAT CELL BIOL, V6, P405, DOI 10.1038/ncb1120; Bevis BJ, 2002, NAT CELL BIOL, V4, P750, DOI 10.1038/ncb852; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; Brigance WT, 2000, MOL BIOL CELL, V11, P171, DOI 10.1091/mbc.11.1.171; Cosson P, 2002, P NATL ACAD SCI USA, V99, P12831, DOI 10.1073/pnas.192460999; Dean N, 1997, J BIOL CHEM, V272, P31908, DOI 10.1074/jbc.272.50.31908; FRANZUSOFF A, 1991, J CELL BIOL, V112, P27, DOI 10.1083/jcb.112.1.27; Glick BS, 1998, CELL, V95, P883, DOI 10.1016/S0092-8674(00)81713-4; GRAHAM TR, 2000, CURRENT PROTOCOLS CE; Hammond AT, 2000, TRAFFIC, V1, P935, DOI 10.1034/j.1600-0854.2000.011203.x; HORAZDOVSKY BF, 1995, CURR OPIN CELL BIOL, V7, P544, DOI 10.1016/0955-0674(95)80012-3; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Marsh BJ, 2004, P NATL ACAD SCI USA, V101, P5565, DOI 10.1073/pnas.0401242101; Martinez-Menarguez JA, 2001, J CELL BIOL, V155, P1213, DOI 10.1083/jcb.200108029; MATSUURATOKITA K, 2006, NATURE          0514; McNew JA, 1998, FEBS LETT, V435, P89, DOI 10.1016/S0014-5793(98)01044-8; Mironov AA, 2001, J CELL BIOL, V155, P1225, DOI 10.1083/jcb.200108073; Mogelsvang S, 2003, MOL BIOL CELL, V14, P2277, DOI 10.1091/mbc.E02-10-0697; Morin-Ganet MN, 2000, TRAFFIC, V1, P56, DOI 10.1034/j.1600-0854.2000.010109.x; PAYNE WE, 1995, GENE, V163, P19, DOI 10.1016/0378-1119(95)00379-K; Pelham HRB, 2000, CELL, V102, P713, DOI 10.1016/S0092-8674(00)00060-X; PREUSS D, 1992, MOL BIOL CELL, V3, P789, DOI 10.1091/mbc.3.7.789; Rabouille C, 2005, NAT REV MOL CELL BIO, V6, P812, DOI 10.1038/nrm1735; Reinke CA, 2004, P NATL ACAD SCI USA, V101, P18018, DOI 10.1073/pnas.0408256102; Rossanese OW, 2001, J CELL BIOL, V153, P47, DOI 10.1083/jcb.153.1.47; Schekman R., 1997, GOLGI APPARATUS, P219, DOI 10.1007/978-3-0348-8876-9_8; Todorow Z, 2000, P NATL ACAD SCI USA, V97, P13643, DOI 10.1073/pnas.250472397; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; Volchuk A, 2000, CELL, V102, P335, DOI 10.1016/S0092-8674(00)00039-8; Wooding S, 1998, MOL BIOL CELL, V9, P2667, DOI 10.1091/mbc.9.9.2667	31	259	267	4	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					1002	1006		10.1038/nature04717	http://dx.doi.org/10.1038/nature04717			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16699524				2022-12-24	WOS:000238422300047
J	George, A; Tokars, JI; Clutterbuck, EJ; Bamford, KB; Pusey, C; Holmes, AH				George, Abraham; Tokars, Jerome I.; Clutterbuck, Elaine J.; Bamford, Kathleen B.; Pusey, Charles; Holmes, Alison H.			Quality improvement report - Reducing dialysis associated bacteraemia, and recommendations for surveillance in the United Kingdom: prospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEMODIALYSIS; INFECTIONS; MORTALITY	Problem Bacteraemia in dialysis units accounts for major morbidity, mortality and antibiotic usage. Risk is much greater when lines rather than fistulas are used for haemodialysis. Surveillance is critical for infection control, but no standardised surveillance scheme exists in die United Kingdom. Design Prospective study in a London dialysis unit of the implementation and applicability of a dialysis associated bacteraemia surveillance scheme developed in the United States and its effect on bacteraemia, antibiotic usage, and admission. Setting Hammersmith Hospital dialysis unit, London, where 112 outpatients receive dialysis three times weekly. Between June 2002 and December 2004, 3418 patient months of data were collected. Key measures for improvement Successful adoption of the scheme and reductions in bacteraemia rates, antibiotic usage, and admission to hospital. Strategy for improvement Embedding the surveillance scheme in the unit's clinical activity. Effects of change Raised awareness of bacteraemia prevention, prudent antibiotic prescribing, and the need for improved provision of vascular access. The scheme required two hours a month of consultant time. Significant downward trends were seen in bacteraemia rates and antibiotic usage: mean rate ratios from quarter to quarter 0.90 (95% confidence interval 0.85 to 0.94) and 0.91 (0.87 to 0.96), respectively The rate of admission to hospital also showed a significant downward trend, with admissions directly connected to access related infection declining more rapidly: mean rate ratio Of Successive quarters 0.90 (0.84 to 0.96).The overall proportion of patients dialysed through catheters was significantly higher than in US outpatient centres (62.3% v 29.4%, P < 0.01). Study data were successfully, used in a business case to improve access provision. Lessons learnt Dialysis specific surveillance of bacteraemia is critical to infection control in dialysis units and improving quality of care. Such a scheme could be adopted across the United Kingdom.	Imperial Coll London, Dept Infect Dis, London W12 0NN, England; Hammersmith Hosp NHS Trust, Renal Unit, London, England; Ctr Dis Control & Prevent, Atlanta, GA USA	Imperial College London; Imperial College London; Centers for Disease Control & Prevention - USA	Holmes, AH (corresponding author), Imperial Coll London, Dept Infect Dis, London W12 0NN, England.	alison.holmes@imperial.ac.uk						[Anonymous], 2000, KDOQI CLIN PRACT GUI; [Anonymous], 2002, MMWR-MORBID MORTAL W, V51, P565; BLOEMBERGEN WE, 1995, J AM SOC NEPHROL, V6, P184; Briggs JD, 1997, NEPHROL DIAL TRANSPL, V12, P2251, DOI 10.1093/ndt/12.11.2251; CHURCHILL DN, 1992, AM J KIDNEY DIS, V19, P214, DOI 10.1016/S0272-6386(13)80002-9; Dhingra RK, 2001, KIDNEY INT, V60, P1443, DOI 10.1046/j.1523-1755.2001.00947.x; Duckworth G, 2005, BRIT MED J, V331, P976, DOI 10.1136/bmj.331.7523.976; DUCKWORTH G, 2005, BRIT MED J, V351, P976; GREENWOOD RN, 2002, KIDNEY INT, V61, P305; Hugonnet S, 2004, CURR OPIN INFECT DIS, V17, P329, DOI 10.1097/01.qco.0000136931.83167.d2; *NAT AUD OFF, 2004, IMPR PAT RAR RED RIS; *NIH, 2003, USRDS2003 DAT REP AT, P161; *NIT, 2003, USRDS2003 ANN DAT RE, P161; RADY AR, 1997, TRANSPLANT P, V29, P8724; Rayner HC, 2004, NEPHROL DIAL TRANSPL, V19, P108, DOI 10.1093/ndt/gfg483; *REN ASS, 2002, TREATM AD CHILDR REN; RODERICK PJ, 1994, BMJ-BRIT MED J, V300, P1111; SCHWAB SJ, 1988, AM J KIDNEY DIS, V11, P166, DOI 10.1016/S0272-6386(88)80206-3; Taylor G, 2002, INFECT CONT HOSP EP, V23, P716, DOI 10.1086/501999; Tokars JI, 2002, AM J INFECT CONTROL, V30, P288, DOI 10.1067/mic.2002.120904; *UK DEP HLTH, 2004, NAT SERV FRAM REN 1; *UK NAT AUD OFF, 2003, IMPR PAT CAR RED RIS; UNLEY AH, 1989, EPIDEMIOL INFECT, V103, P173; UTTLEY AHC, 1989, EPIDEMIOL INFECT, V103, P173, DOI 10.1017/S0950268800030478	24	35	38	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2006	332	7555					1435	1437		10.1136/bmj.332.7555.1435	http://dx.doi.org/10.1136/bmj.332.7555.1435			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056UO	16777887	Green Published			2022-12-24	WOS:000238550800034
J	Berdichevsky, A; Viswanathan, M; Horvitz, HR; Guarente, L				Berdichevsky, Ala; Viswanathan, Mohan; Horvitz, H. Robert; Guarente, Leonard			C. elegans SIR-2.1 interacts with 14-3-3 proteins to activate DAF-16 and extend life span	CELL			English	Article							FORKHEAD TRANSCRIPTION FACTOR; PROMOTES CELL-SURVIVAL; CAENORHABDITIS-ELEGANS; SIRT1 DEACETYLASE; CALORIE RESTRICTION; SIGNALING PATHWAY; DNA-BINDING; FACTOR FKHR; STRESS; LONGEVITY	The longevity of Caenorhabditis elegans is promoted by extra copies of the sir-2.1 gene in a manner dependent on the forkhead transcription factor DAF-16. We identify two C. elegans 14-3-3 proteins as SIR-2.1 binding partners and show that 14-3-3 genes are required for the life-span extension conferred by extra copies of sir-2.1. 14-3-3 proteins are also required for SIR-2.1-induced transcriptional activation of DAF-16 and stress resistance. Following heat stress, SIR-2.1 can bind DAF-16 in a 14-3-3-dependent manner. Ely contrast, low insulin-like signaling does not promote SIR-2.1/DAF-16 interaction, and sir-2.1 and the 14-3-3 genes are not required for the regulation of life span by the insulin-like signaling pathway. We propose the existence of a stress-dependent pathway in which SIR-2.1 and 14-3-3 act in parallel to the insulin-like pathway to activate DAF16 and extend life span.	MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Berdichevsky, A (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	leng@mit.edu						Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; BRENNER S, 1974, GENETICS, V77, P71; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cahill CM, 2001, J BIOL CHEM, V276, P13402, DOI 10.1074/jbc.M010042200; Chen FL, 2000, SCIENCE, V287, P1485, DOI 10.1126/science.287.5457.1485; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hwang HY, 2002, P NATL ACAD SCI USA, V99, P14224, DOI 10.1073/pnas.172522499; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Lamitina ST, 2005, AM J PHYSIOL-CELL PH, V288, pC467, DOI 10.1152/ajpcell.00451.2004; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; LARSEN PL, 1995, GENETICS, V139, P1567; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; Liu LX, 1999, GENOME RES, V9, P859, DOI 10.1101/gr.9.9.859; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Morton DG, 2002, DEV BIOL, V241, P47, DOI 10.1006/dbio.2001.0489; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Murakami S, 1996, GENETICS, V143, P1207; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Obsil T, 2003, BIOCHEMISTRY-US, V42, P15264, DOI 10.1021/bi0352724; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; Tzivion G, 2001, ONCOGENE, V20, P6331, DOI 10.1038/sj.onc.1204777; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Vanfleteren JR, 1999, NEUROBIOL AGING, V20, P487, DOI 10.1016/S0197-4580(99)00087-1; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Wang WF, 1997, J MOL BIOL, V268, P619, DOI 10.1006/jmbi.1997.1002; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	58	286	317	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2006	125	6					1165	1177		10.1016/j.cell.2006.04.036	http://dx.doi.org/10.1016/j.cell.2006.04.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777605	Bronze			2022-12-24	WOS:000238602700020
J	Chen, JY; Bottjer, DJ; Davidson, EH; Dornbos, SQ; Gao, X; Yang, YH; Li, CW; Li, G; Wang, XQ; Xian, DC; Wu, HJ; Hwu, YK; Tafforeau, P				Chen, Jun-Yuan; Bottjer, David J.; Davidson, Eric H.; Dornbos, Stephen Q.; Gao, Xiang; Yang, Yong-Hua; Li, Chia-Wei; Li, Gang; Wang, Xiu-Qiang; Xian, Ding-Chang; Wu, Hung-Jen; Hwu, Yeu-Kuang; Tafforeau, Paul			Phosphatized polar lobe-forming embryos from the Precambrian of Southwest China	SCIENCE			English	Article							NEOPROTEROZOIC DOUSHANTUO FORMATION; ANIMAL EMBRYOS; FOSSILS	In developing embryos of some extant spiralian animals, polar lobe formation is one of the symmetry-breaking mechanisms for segregation of maternal cytoplasmic substances to certain blastomeres and not others. Polar lobe formation leads to unique early cleavage morphologies that include trilobed, J-shaped, and five-lobed structures. Fossil embryos similar to modern lobe-forming embryos are recognized from the Precambrian Doushantuo Formation phosphates, Weng'an, Guizhou Province, China. These embryos are abundant and form a developmental sequence comparable to different developing stages observed in lobe-forming embryos of extant spiralians. These data imply that lobe formation is an evolutionarily ancient process of embryonic specification.	Nanjing Univ, Inst Evodev Biol, Nanjing Inst Geol & Paleontol, Nanjing 210093, Peoples R China; Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China; Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Wisconsin, Dept Geosci, Milwaukee, WI 53201 USA; Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 300, Taiwan; Inst High Energy Phys, Beijing 100049, Peoples R China; Acad Sinica, Inst Phys, Taipei, Taiwan; European Synchrotron Radiat Facil, F-38043 Grenoble, France; CNRS, UMR 6046, Lab Geobiol Biochronol & Paleontol Humaine, F-86022 Poitiers, France	Chinese Academy of Sciences; Nanjing Institute of Geology & Paleontology, CAS; Nanjing University; Nanjing University; University of Southern California; California Institute of Technology; University of Wisconsin System; University of Wisconsin Milwaukee; National Tsing Hua University; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Academia Sinica - Taiwan; European Synchrotron Radiation Facility (ESRF); Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers	Chen, JY (corresponding author), Nanjing Univ, Inst Evodev Biol, Nanjing Inst Geol & Paleontol, Nanjing 210093, Peoples R China.	chenjy@nju.edu.cn	Hwu, Yeukuang/AAH-9947-2020; Hwu, Yeukuang/ABH-5311-2020	Tafforeau, Paul/0000-0002-5962-1683				Barfod GH, 2002, EARTH PLANET SC LETT, V201, P203, DOI 10.1016/S0012-821X(02)00687-8; Bengtson S, 2004, SCIENCE, V306; BOYER BC, 1988, INT J INVER REP DEV, V13, P157, DOI 10.1080/01688170.1988.10510352; BOYER BC, 1986, INT J INVER REP DEV, V9, P243, DOI 10.1080/01688170.1986.10510199; Browder LW, 1991, DEV BIOL; CHEN J. Y., 2004, DAWN ANIMAL WORLD; Chen JG, 2000, P NATL ACAD SCI USA, V97, P1044, DOI 10.1073/pnas.97.3.1044; Chen JY, 2004, SCIENCE, V306; Chen JY, 2004, SCIENCE, V305, P218, DOI 10.1126/science.1099213; Chen JY, 2002, DEV BIOL, V248, P182, DOI 10.1006/dbio.2002.0714; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; CONN DB, 2000, ALTAS INVERTEBRATE R; CONRAD GW, 1973, J CELL BIOL, V59, P228, DOI 10.1083/jcb.59.1.228; Davidson E. H., 1986, GENE ACTIVITY EARLY; Davidson E. H., 2001, DEV EVOLUTION; Giese A. C., 1977, REPROD MARINE INVERT; GIESE AC, 1979, REPROD MARINE INVERT; GILBERT SF, 1997, EMBRYOLOGY CONSTRUCI; Li CW, 1998, SCIENCE, V279, P879, DOI 10.1126/science.279.5352.879; MacBride E.W., 1914, TXB EMBRYOLOGY; TOMPA AS, 1984, MOLLUSCA REPROD; Xiao SH, 2000, J PALEONTOL, V74, P767, DOI 10.1666/0022-3360(2000)074<0767:PAEFTN>2.0.CO;2; Xiao SH, 2000, P NATL ACAD SCI USA, V97, P13684, DOI 10.1073/pnas.250491697; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Yuan X., 2002, DOUSHANTUO FOSSILS L	25	72	97	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1644	1646		10.1126/science.1125964	http://dx.doi.org/10.1126/science.1125964			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778054				2022-12-24	WOS:000238288600043
J	Zhu, P; Liu, J; Bess, J; Chertova, E; Lifson, JD; Grise, H; Ofek, GA; Taylor, KA; Roux, KH				Zhu, Ping; Liu, Jun; Bess, Julian, Jr.; Chertova, Elena; Lifson, Jeffrey D.; Grise, Henry; Ofek, Gilad A.; Taylor, Kenneth A.; Roux, Kenneth H.			Distribution and three-dimensional structure of AIDS virus envelope spikes	NATURE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; GLYCOPROTEIN TRIMERS; ELECTRON TOMOGRAPHY; ATOMIC-STRUCTURE; TYPE-1 MATRIX; HIV; GP41; NEUTRALIZATION; FUSION; GP120	Envelope glycoprotein (Env) spikes on AIDS retroviruses initiate infection of host cells and are therefore targets for vaccine development. Though crystal structures for partial Env subunits are known, the structure and distribution of native Env spikes on virions is obscure. We applied cryoelectron microscopy tomography to define ultrastructural details of spikes. Virions of wild-type human immunodeficiency virus 1 (HIV-1) and a mutant simian immunodeficiency virus (SIV) had similar to 14 and similar to 73 spikes per particle, respectively, with some clustering of HIV-1 spikes. Three-dimensional averaging showed that the surface glycoprotein (gp120) 'head' of each subunit of the trimeric SIV spike contains a primary mass, with two secondary lobes. The transmembrane glycoprotein 'stalk' of each trimer is composed of three independent legs that project obliquely from the trimer head, tripod-like. Reconciling available atomic structures with the three-dimensional whole spike density map yields insights into the orientation of Env spike structural elements and possible structural bases of their functions.	Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; NCI, AIDS Vaccine Program, SAIC Frederick Inc, Frederick, MD 21702 USA; NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Roux, KH (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	roux@bio.fsu.edu	Ofek, Gilad/A-6965-2010; Bess, Jr., Julian/B-5343-2012; Abrams, William R/A-5782-2008		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055461] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI055461] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Blumenthal R, 1996, J CELL BIOL, V135, P63, DOI 10.1083/jcb.135.1.63; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Caffrey M, 1998, EMBO J, V17, P4572, DOI 10.1093/emboj/17.16.4572; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; CAVACINI LA, 1994, J IMMUNOL, V152, P2538; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chertova E, 2003, CURR MOL MED, V3, P265, DOI 10.2174/1566524033479889; Danieli T, 1996, J CELL BIOL, V133, P559, DOI 10.1083/jcb.133.3.559; Doms RW, 2000, VIROLOGY, V276, P229, DOI 10.1006/viro.2000.0612; Doms RW, 2000, J CELL BIOL, V151, pF9, DOI 10.1083/jcb.151.2.F9; Forster F, 2005, P NATL ACAD SCI USA, V102, P4729, DOI 10.1073/pnas.0409178102; Forster MJ, 2000, J MOL BIOL, V298, P841, DOI 10.1006/jmbi.2000.3715; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; Grundner C, 2002, J VIROL, V76, P3511, DOI 10.1128/JVI.76.7.3511-3521.2002; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Klasse PJ, 2001, CURR TOP MICROBIOL, V260, P87; KODAMA T, 1989, J VIROL, V63, P4709, DOI 10.1128/JVI.63.11.4709-4714.1989; Kuhmann SE, 2000, J VIROL, V74, P7005, DOI 10.1128/JVI.74.15.7005-7015.2000; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LABRANCHE CC, 1995, J VIROL, V69, P5217, DOI 10.1128/JVI.69.9.5217-5227.1995; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Parren PWHI, 2001, ADV IMMUNOL, V77, P195, DOI 10.1016/S0065-2776(01)77018-6; Poignard P, 2001, ANNU REV IMMUNOL, V19, P253, DOI 10.1146/annurev.immunol.19.1.253; Qiao ZS, 2005, J BIOL CHEM, V280, P23138, DOI 10.1074/jbc.M414515200; RAO ZH, 1995, NATURE, V378, P743, DOI 10.1038/378743a0; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Saez-Cirion A, 2003, BIOPHYS J, V85, P3769, DOI 10.1016/S0006-3495(03)74792-4; Salzwedel K, 1999, J VIROL, V73, P2469, DOI 10.1128/JVI.73.3.2469-2480.1999; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; West JT, 2001, J VIROL, V75, P9601, DOI 10.1128/JVI.75.20.9601-9612.2001; Winkler H, 2006, ULTRAMICROSCOPY, V106, P240, DOI 10.1016/j.ultramic.2005.07.007; Winkler H, 1999, ULTRAMICROSCOPY, V77, P141, DOI 10.1016/S0304-3991(99)00035-2; Yang XZ, 2005, J VIROL, V79, P12132, DOI 10.1128/JVI.79.19.12132-12147.2005; Yuste E, 2006, J VIROL, V80, P3030, DOI 10.1128/JVI.80.6.3030-3041.2006; Yuste E, 2005, J VIROL, V79, P12455, DOI 10.1128/JVI.79.19.12455-12463.2005; Yuste E, 2004, J VIROL, V78, P6775, DOI 10.1128/JVI.78.13.6775-6785.2004; Zhu P, 2003, P NATL ACAD SCI USA, V100, P15812, DOI 10.1073/pnas.2634931100; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	48	576	595	2	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					847	852		10.1038/nature04817	http://dx.doi.org/10.1038/nature04817			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16728975	Bronze			2022-12-24	WOS:000238254100036
J	Commerford, P; Mayosi, B				Commerford, Patrick; Mayosi, Bongani			An appropriate research agenda for heart disease in Africa	LANCET			English	Editorial Material							RISK-FACTORS; GLOBAL BURDEN; CARDIOVASCULAR-DISEASES; MYOCARDIAL-INFARCTION; RHEUMATIC-FEVER; SOUTH-AFRICA; INTERHEART		Univ Cape Town, Dept Med, Cardiac Clin, Cape Town, Western Cape, South Africa; Groote Schuur Hosp, Cape Town, Western Cape, South Africa	University of Cape Town; University of Cape Town	Commerford, P (corresponding author), Univ Cape Town, Dept Med, Cardiac Clin, Cape Town, Western Cape, South Africa.	pjcomfrd@uctgsh1.uct.ac.za		Mayosi, Bongani/0000-0001-6641-8950				[Anonymous], 1996, GLOBAL BURDEN DIS CO; Benatar SR, 2004, NEW ENGL J MED, V351, P81, DOI 10.1056/NEJMhpr033471; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Commerford PJ, 2005, SAMJ S AFR MED J, V95, P568; Hakim J. G., 1995, Central African Journal of Medicine, V41, P303; Mayosi B, 2006, SAMJ S AFR MED J, V96, P246; Mayosi BM, 2005, CIRCULATION, V112, P3608, DOI 10.1161/CIRCULATIONAHA.105.543066; Robertson KA, 2006, SAMJ S AFR MED J, V96, P241; SEFTEL HC, 1978, S AFR MED J, V54, P99; Sliwa K, 2005, CIRCULATION, V112, P3577, DOI 10.1161/CIRCULATIONAHA.105.542894; Steyn K, 2005, CIRCULATION, V112, P3554, DOI 10.1161/CIRCULATIONAHA.105.563452; STEYN K, 1991, S AFR MED J, V79, P480; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	15	24	25	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 10	2006	367	9526					1884	1886		10.1016/S0140-6736(06)68822-3	http://dx.doi.org/10.1016/S0140-6736(06)68822-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	051XG	16765744				2022-12-24	WOS:000238194400008
J	Jones, DC; Wein, MN; Oukka, M; Hofstaetter, JG; Glimcher, MJ; Glimcher, LH				Jones, Dallas C.; Wein, Marc N.; Oukka, Mohamed; Hofstaetter, Jochen G.; Glimcher, Melvin J.; Glimcher, Laurie H.			Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3	SCIENCE			English	Article							OSTEOBLAST DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; UBIQUITIN LIGASE; CBFA1; RUNX2; GENE; WNT; OSF2/CBFA1; LRP5	Genetic mutations that disrupt osteoblast function can result in skeletal dysmorphogenesis or, more rarely, in increased postnatal bone formation. Here we show that Schnurri-3 (Shn3), a mammalian homolog of the Drosophila zinc finger adapter protein Shn, is an essential regulator of adult bone formation. Mice lacking Shn3 display adult-onset osteosclerosis with increased bone mass due to augmented osteobtast activity. Shn3 was found to control protein levels of Runx2, the principal transcriptional regulator of osteoblast differentiation, by promoting its degradation through recruitment of the E3 ubiquitin ligase WWP1 to Runx2. By this means, Runx2-mediated extracellular matrix mineralization was antagonized, revealing an essential role for Shn3 as a central regulator of postnatal bone mass.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Brigham & Womens Hosp, Ctr Neurol Dis, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Orthopaed Surg, Lab Study Skeletal Disorders & Rehabil, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Ludwig Boltzmann Inst Osteol, A-1120 Vienna, Austria	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Ludwig Boltzmann Institute	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu		Glimcher, Laurie/0000-0001-9537-3456; Hofstatter, Jochen/0000-0001-7741-7187	NIAID NIH HHS [AI29673] Funding Source: Medline; NIAMS NIH HHS [AR46983] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029673, R37AI029673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046983] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; Johnson ML, 2004, J BONE MINER RES, V19, P1749, DOI 10.1359/JBMR.040816; Kim S, 2003, GENE DEV, V17, P1979, DOI 10.1101/gad.1119303; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Oukka M, 2002, MOL CELL, V9, P121, DOI 10.1016/S1097-2765(01)00434-8; Patterson Cam, 2002, Sci STKE, V2002, ppe4; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Wein MN, 2005, IMMUNOL REV, V208, P66, DOI 10.1111/j.0105-2896.2005.00322.x; WU LC, 1993, NUCLEIC ACIDS RES, V21, P5067, DOI 10.1093/nar/21.22.5067; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; Zamurovic N, 2004, J BIOL CHEM, V279, P37704, DOI 10.1074/jbc.M403813200	25	167	184	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1223	1227		10.1126/science.1126313	http://dx.doi.org/10.1126/science.1126313			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728642				2022-12-24	WOS:000237957400057
J	Weissleder, R				Weissleder, R			Molecular imaging in cancer	SCIENCE			English	Editorial Material							POSITRON-EMISSION-TOMOGRAPHY; ONCOLOGY DRUG DEVELOPMENT; IN-VIVO; LUNG-CANCER; END-POINTS; BREAST; REPORTERS; DISCOVERY; LOOKING; AGENTS		Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Weissleder, R (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA 02129 USA.	weissleder@helix.mgh.harvard.edu	Mullish, Benjamin H/O-9524-2017	Mullish, Benjamin H/0000-0001-6300-3100; /0000-0003-0828-4143				Alencar H, 2005, NEOPLASIA, V7, P977, DOI 10.1593/neo.05376; Anderson TS, 2004, COMPUT SCI ENG, V6, P22, DOI 10.1109/MCSE.2004.77; Avril N, 2005, J CLIN ONCOL, V23, P7445, DOI 10.1200/JCO.2005.06.965; Contag PR, 2002, DRUG DISCOV TODAY, V7, P555, DOI 10.1016/S1359-6446(02)02268-7; Etzioni R, 2003, NAT REV CANCER, V3, P243, DOI 10.1038/nrc1041; Evans JA, 2005, CURR OPIN GASTROEN, V21, P578, DOI 10.1097/01.mog.0000174217.62214.10; Grimm J, 2005, P NATL ACAD SCI USA, V102, P14404, DOI 10.1073/pnas.0503920102; Gross S, 2005, CANCER CELL, V7, P5, DOI 10.1016/j.ccr.2004.12.011; Guller U, 2002, BREAST CANCER RES TR, V71, P171, DOI 10.1023/A:1013828710301; Harisinghani MG, 2003, NEW ENGL J MED, V348, P2491, DOI 10.1056/NEJMoa022749; Heinrich S, 2005, ANN SURG, V242, P235, DOI 10.1097/01.sla.0000172095.97787.84; Herschman HR, 2003, SCIENCE, V302, P605, DOI 10.1126/science.1090585; Jaffer FA, 2005, JAMA-J AM MED ASSOC, V293, P855, DOI 10.1001/jama.293.7.855; Joyce JA, 2003, CANCER CELL, V4, P393, DOI 10.1016/S1535-6108(03)00271-X; Juweid ME, 2006, NEW ENGL J MED, V354, P496, DOI 10.1056/NEJMra050276; Keller M, 2006, BIOL PSYCHIAT, V59, P216, DOI 10.1016/j.biopsych.2005.07.013; Kelloff GJ, 2005, EUR J CANCER, V41, P491, DOI 10.1016/j.ejca.2004.12.006; Kolb HC, 2003, DRUG DISCOV TODAY, V8, P1128, DOI 10.1016/S1359-6446(03)02933-7; Lappin G, 2003, NAT REV DRUG DISCOV, V2, P233, DOI 10.1038/nrd1037; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marten K, 2002, GASTROENTEROLOGY, V122, P406, DOI 10.1053/gast.2002.30990; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Meade TJ, 2003, CURR OPIN NEUROBIOL, V13, P597, DOI 10.1016/j.conb.2003.09.009; Nadler E, 2006, ONCOLOGIST, V11, P90, DOI 10.1634/theoncologist.11-2-90; Ntziachristos V, 2000, P NATL ACAD SCI USA, V97, P2767, DOI 10.1073/pnas.040570597; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; Park JW, 2004, CLIN CANCER RES, V10, P3885, DOI 10.1158/1078-0432.CCR-03-0785; Propper DJ, 2003, J CLIN ONCOL, V21, P203, DOI 10.1200/JCO.2003.02.008; Querol M, 2005, ORG LETT, V7, P1719, DOI 10.1021/ol050208v; Quon A, 2005, J CLIN ONCOL, V23, P1664, DOI 10.1200/JCO.2005.11.024; Rudin M, 2003, NAT REV DRUG DISCOV, V2, P123, DOI 10.1038/nrd1007; Saleem A, 2001, J CLIN ONCOL, V19, P1421, DOI 10.1200/JCO.2001.19.5.1421; Shah K, 2005, MOL THER, V11, P926, DOI 10.1016/j.ymthe.2005.01.017; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Weissleder R, 1999, NAT BIOTECHNOL, V17, P375, DOI 10.1038/7933; Weissleder R, 2005, NAT BIOTECHNOL, V23, P1418, DOI 10.1038/nbt1159; Weissleder R, 2002, NAT REV CANCER, V2, P11, DOI 10.1038/nrc701; Weissleder R, 2003, NAT MED, V9, P123, DOI 10.1038/nm0103-123; Wieder HA, 2004, J CLIN ONCOL, V22, P900, DOI 10.1200/JCO.2004.07.122; Wu KD, 2005, P NATL ACAD SCI USA, V102, P10640, DOI 10.1073/pnas.0504512102	40	902	948	3	253	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 26	2006	312	5777					1168	1171		10.1126/science.1125949	http://dx.doi.org/10.1126/science.1125949			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728630	Green Published			2022-12-24	WOS:000237957400040
J	Knight, ZA; Gonzalez, B; Feldman, ME; Zunder, ER; Goldenberg, DD; Williams, O; Loewith, R; Stokoe, D; Balla, A; Toth, B; Balla, T; Weiss, WA; Williams, RL; Shokat, KM				Knight, Zachary A.; Gonzalez, Beatriz; Feldman, Morri E.; Zunder, Eli R.; Goldenberg, David D.; Williams, Olusegun; Loewith, Robbie; Stokoe, David; Balla, Andras; Toth, Balazs; Balla, Tamas; Weiss, William A.; Williams, Roger L.; Shokat, Kevan M.			A pharmacological map of the PI3-K family defines a role for p110 alpha in insulin signaling	CELL			English	Article							PHOSPHOINOSITIDE 3-KINASE INHIBITORS; DEPENDENT PROTEIN-KINASE; P85 REGULATORY SUBUNIT; CATALYTIC SUBUNIT; EMBRYONIC LETHALITY; TYROSINE KINASE; MICE; ACTIVATION; ATM; INSIGHTS	Phosphoinositide 3-kinases (PI3-Ks) are an important emerging class of drug targets, but the unique roles of PI3-K isoforms remain poorly defined. We describe here an approach to pharmacologically interrogate the PI3-K family. A chemically diverse panel of PI3-K inhibitors was synthesized, and their target selectivity was biochemically enumerated, revealing cryptic homologies across targets and chemotypes. Crystal structures of three inhibitors bound to p110 gamma identify a conformationally mobile region that is uniquely exploited by selective compounds. This chemical array was then used to define the PI3-K isoforms required for insulin signaling. We find that p110 alpha is the primary insulin-responsive PI3-K in cultured cells, whereas p110 beta is dispensable but sets a phenotypic threshold for p110 alpha activity. Compounds targeting p110 alpha block the acute effects of insulin treatment in vivo, whereas a p110 beta inhibitor has no effect. These results illustrate systematic target validation using a matrix of inhibitors that span a protein family.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; NICHHD, Endocrinol & Reprod Res Branch, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; MRC Laboratory Molecular Biology; University of Geneva; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Shokat, KM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	shokat@cmp.ucsf.edu	Gonzalez, Beatriz/M-1219-2014; Toth, Balazs/B-4252-2012; Loewith, Robbie J/S-6289-2016	Gonzalez, Beatriz/0000-0002-0710-0202; Loewith, Robbie J/0000-0002-2482-603X; Williams, Roger/0000-0001-7754-4207; Balla, Tamas/0000-0002-9077-3335; Balla, Andras/0000-0002-6450-2793; Weiss, William/0000-0003-2230-9132; Zunder, Eli/0000-0002-0356-1685; Knight, Zachary/0000-0001-7621-1478	Howard Hughes Medical Institute Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; Medical Research Council [MC_U105184308] Funding Source: Medline; NIAID NIH HHS [R01 AI044009-06, R01 AI044009, AI44009] Funding Source: Medline; MRC [MC_U105184308] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044009] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alaimo PJ, 2005, BIOORGAN MED CHEM, V13, P2825, DOI 10.1016/j.bmc.2005.02.021; Asano T, 2000, J BIOL CHEM, V275, P17671, DOI 10.1074/jbc.M910391199; Barvian N.C., 2004, PCT Int. Appl., Patent No. [04052373, WO 04 052373]; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bi L, 2002, MAMM GENOME, V13, P169, DOI 10.1007/s00335-001-2123-x; Brachmann SM, 2005, MOL CELL BIOL, V25, P1596, DOI 10.1128/MCB.25.5.1596-1607.2005; Bruce I., 2003, [No title captured], Patent No. [WO 03072557, 03072557, WO 03 072557]; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; Domin J, 1997, FEBS LETT, V410, P91, DOI 10.1016/S0014-5793(97)00617-0; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; HALBROOK J, 2002, Patent No. 0220500; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; HAYAKAWA M, 2003, Patent No. 1277754; HAYAKAWA M, 2003, Patent No. 1277738; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Jackson S., 2004, PCT Int. Appl., Patent No. [WO 04 016607, 04016607]; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Knight ZA, 2004, BIOORGAN MED CHEM, V12, P4749, DOI 10.1016/j.bmc.2004.06.022; Lakshmanan Jaganathan, 2003, Methods Mol Med, V83, P97; Lau A, 2005, NAT CELL BIOL, V7, P493, DOI 10.1038/ncb1250; Luo J, 2005, J CELL BIOL, V170, P455, DOI 10.1083/jcb.200503088; MADHUSUDAN T, 1994, PROTEIN SCI, V3, P176; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Peng YL, 2005, CANCER RES, V65, P1670, DOI 10.1158/0008-5472.CAN-04-3451; ROBERTSON AJ, 2001, Patent No. 0153266; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Sadhu C, 2001, [No title captured], Patent No. [WO0181346, 0181346]; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schmid AC, 2004, FEBS LETT, V566, P35, DOI 10.1016/j.febslet.2004.03.102; SERUNIAN LA, 1991, METHOD ENZYMOL, V198, P78; SHIMADA M, 2004, Patent No. 04029058; SMITH GC, 2003, Patent No. 03070726; Ueki K, 2003, J BIOL CHEM, V278, P48453, DOI 10.1074/jbc.M305602200; Ueki K, 2002, P NATL ACAD SCI USA, V99, P419, DOI 10.1073/pnas.012581799; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Viniegra JG, 2005, J BIOL CHEM, V280, P4029, DOI 10.1074/jbc.M410344200; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Ward S, 2003, CHEM BIOL, V10, P207, DOI 10.1016/S1074-5521(03)00048-6; Yart A, 2002, J BIOL CHEM, V277, P21167, DOI 10.1074/jbc.M110411200; Yu JH, 1998, MOL CELL BIOL, V18, P1379, DOI 10.1128/MCB.18.3.1379	50	907	1038	2	62	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2006	125	4					733	747		10.1016/j.cell.2006.03.035	http://dx.doi.org/10.1016/j.cell.2006.03.035			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16647110	Bronze, Green Published, Green Accepted			2022-12-24	WOS:000237886000018
J	Mulcahy, NJ; Call, J				Mulcahy, NJ; Call, J			Apes save tools for future use	SCIENCE			English	Article							MENTAL TIME-TRAVEL; EVOLUTION	Planning for future needs, not just current ones, is one of the most formidable human cognitive achievements. Whether this skill is a uniquely human adaptation is a controversial issue. In a study we conducted, bonobos and orangutans selected, transported, and saved appropriate tools above baseline levels to use them 1 hour later ( experiment 1). Experiment 2 extended these results to a 14-hour delay between collecting and using the tools. Experiment 3 showed that seeing the apparatus during tool selection was not necessary to succeed. These findings suggest that the precursor skills for planning for the future evolved in great apes before 14 million years ago, when all extant great ape species shared a common ancestor.	Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany	Max Planck Society	Call, J (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany.	call@eva.mpg.de		Call Balaguer, Josep/0000-0002-8597-8336				Bailey WJ, 1992, MOL PHYLOGENET EVOL, V1, P97, DOI 10.1016/1055-7903(92)90024-B; BOESCH C, 1984, Primates, V25, P160, DOI 10.1007/BF02382388; Chappell J, 2002, ANIM COGN, V5, P71, DOI 10.1007/s10071-002-0130-2; Clayton NS, 1999, J COMP PSYCHOL, V113, P403, DOI 10.1037/0735-7036.113.4.403; Clayton NS, 2003, NAT REV NEUROSCI, V4, P685, DOI 10.1038/nrn1180; de Heinzelin J, 1999, SCIENCE, V284, P625; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Emery NJ, 2001, NATURE, V414, P443, DOI 10.1038/35106560; GARCIA J, 1955, SCIENCE, V122, P157; Gergely G., 2005, INTERACT STUD, V6, P463, DOI [10.1075/is.6.3.10ger, DOI 10.1075/IS.6.3.10GER]; Kano T., 1992, LAST APE; Kimble G. A, 1961, HILGARD MARQUISCONDI; Kohler W., 1927, MENTALITY APES, V2nd ed.; LIEBERMAN DA, 1979, J EXP PSYCHOL ANIM B, V5, P224, DOI 10.1037/0097-7403.5.3.224; Roberts WA, 2002, PSYCHOL BULL, V128, P473, DOI 10.1037//0033-2909.128.3.473; Schick K. D., 1993, MAKING SILENT STONES; Suddendorf T, 2003, TRENDS COGN SCI, V7, P391, DOI 10.1016/S1364-6613(03)00187-6; Suddendorf T, 1997, GENET SOC GEN PSYCH, V123, P133; TULVING E, 1984, BEHAV BRAIN SCI, V7, P223, DOI 10.1017/S0140525X0004440X; Tulving E., 2004, MISSING LINK COGNITI, P3; van Schaik CP, 2003, J HUM EVOL, V44, P11, DOI 10.1016/S0047-2484(02)00164-1; Vander Wall SB, 1990, FOOD HOARDING ANIMAL	22	329	339	6	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1038	1040		10.1126/science.1125456	http://dx.doi.org/10.1126/science.1125456			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	043UX	16709782				2022-12-24	WOS:000237628800041
J	He, P; Shan, L; Lin, NC; Martin, GB; Kemmerling, B; Nurnberger, T; Sheen, J				He, Ping; Shan, Libo; Lin, Nai-Chun; Martin, Gregory B.; Kemmerling, Birgit; Nuernberger, Thorsten; Sheen, Jen			Specific bacterial suppressors of MAMP signaling upstream of MAPKKK in Arabidopsis innate immunity	CELL			English	Article							PROGRAMMED CELL-DEATH; PTO-MEDIATED RESISTANCE; III EFFECTORS; NONHOST RESISTANCE; DEFENSE RESPONSES; KINASE; PLANT; GENE; DISEASE; PROTEIN	Plants and animals possess innate immune systems to prevent infections and are effectively "nonhosts" for most potential pathogens. The molecular mechanisms underlying nonhost immunity in plants remain obscure. In Arabidopsis, nonhost/nonpathogenic Pseudomonas syringae sustains but pathogenic P. syringae suppresses early MAMP (microbe-associated molecular pattern) marker-gene activation. We performed a cell-based genetic screen of virulence factors and identified AvrPto and AvrPtoB as potent and unique suppressors of early-defense gene transcription and MAP kinase (MAPK) signaling. Unlike effectors of mammalian pathogens, AvrPto and AvrPtoB intercept multiple MAMP-mediated signaling upstream of MAPKKK at the plasma membrane linked to the receptor. In transgenic Arabidopsis, AvrPto blocks early MAMP signaling and enables nonhost P. syringae growth. Deletions of avrPto and avrPtoB from pathogenic P. syringae reduce its virulence. The studies reveal a fundamental role of MAMP signaling in nonhost immunity, and a novel action of type III effectors from pathogenic bacteria.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; Cornell Univ, Dept Plant Pathol, Ithaca, NY 14853 USA; Univ Tubingen, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; Eberhard Karls University of Tubingen	Sheen, J (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	sheen@molbio.mgh.harvard.edu	Martin, Gregory B/F-6262-2011	Martin, Gregory B/0000-0003-0044-6830; Kemmerling, Birgit/0000-0003-1174-0189; LIN, NAI-CHUN/0000-0002-6485-9776; He, Ping/0000-0002-5926-8349	NIGMS NIH HHS [R01 GM70567] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070567] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; de Torres M, 2003, PLANT J, V33, P665, DOI 10.1046/j.1365-313X.2003.01653.x; Eastmond PJ, 2004, PLANT J, V37, P617, DOI 10.1111/j.1365-313X.2003.01989.x; Espinosa A, 2003, MOL MICROBIOL, V49, P377, DOI 10.1046/j.1365-2958.2003.03588.x; Fellbrich G, 2002, PLANT J, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x; Galan JE, 2005, CURR OPIN MICROBIOL, V8, P1, DOI 10.1016/j.mib.2004.12.015; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; He P, 2004, PLANT J, V37, P589, DOI 10.1111/j.1365-313X.2003.01986.x; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Jamir Y, 2004, PLANT J, V37, P554, DOI 10.1046/j.1365-313X.2003.01982.x; Janjusevic R, 2006, SCIENCE, V311, P222, DOI 10.1126/science.1120131; Kang L, 2003, P NATL ACAD SCI USA, V100, P3519, DOI 10.1073/pnas.0637377100; Kim MG, 2005, CELL, V121, P749, DOI 10.1016/j.cell.2005.03.025; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; Lee J, 2001, PLANT CELL, V13, P1079, DOI 10.1105/tpc.13.5.1079; Li XY, 2005, P NATL ACAD SCI USA, V102, P12990, DOI 10.1073/pnas.0502425102; Ligterink W, 1997, SCIENCE, V276, P2054, DOI 10.1126/science.276.5321.2054; Lin NC, 2005, MOL PLANT MICROBE IN, V18, P43, DOI 10.1094/MPMI-18-0043; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; McNellis TW, 1998, PLANT J, V14, P247, DOI 10.1046/j.1365-313X.1998.00106.x; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Mysore KS, 2004, TRENDS PLANT SCI, V9, P97, DOI 10.1016/j.tplants.2003.12.005; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Oh HS, 2005, PLANT J, V44, P348, DOI 10.1111/j.1365-313X.2005.02529.x; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Pedley KF, 2004, J BIOL CHEM, V279, P49229, DOI 10.1074/jbc.M410323200; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; Ramonell K, 2005, PLANT PHYSIOL, V138, P1027, DOI 10.1104/pp.105.060947; Shan LB, 2000, MOL PLANT MICROBE IN, V13, P592, DOI 10.1094/MPMI.2000.13.6.592; Shan LB, 2000, PLANT CELL, V12, P2323, DOI 10.1105/tpc.12.12.2323; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Staskawicz BJ, 2001, SCIENCE, V292, P2285, DOI 10.1126/science.1062013; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Thordal-Christensen H, 2003, CURR OPIN PLANT BIOL, V6, P351, DOI 10.1016/S1369-5266(03)00063-3; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zhang SQ, 2001, TRENDS PLANT SCI, V6, P520, DOI 10.1016/S1360-1385(01)02103-3; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	45	313	342	4	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					563	575		10.1016/j.cell.2006.02.047	http://dx.doi.org/10.1016/j.cell.2006.02.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678099	Bronze, Green Submitted			2022-12-24	WOS:000237506100021
J	Waxman, SW; Morey, AF				Waxman, SW; Morey, AF			Management of urethral strictures	LANCET			English	Editorial Material							FREE TONGUE GRAFT; URETHROPLASTY; VERMILION		Brooke Army Med Ctr, Ft Sam Houston, TX 78234 USA	San Antonio Military Medical Center; United States Department of Defense; United States Army	Morey, AF (corresponding author), Brooke Army Med Ctr, Ft Sam Houston, TX 78234 USA.	allen.morey@amedd.army.mil						Andrich DE, 2001, J UROLOGY, V165, P1131, DOI 10.1016/S0022-5347(05)66447-6; Barbagli G, 1996, BRIT J UROL, V78, P929, DOI 10.1046/j.1464-410X.1996.23121.x; BURGER RA, 1992, J UROLOGY, V147, P662, DOI 10.1016/S0022-5347(17)37340-8; COHEN SR, 1991, PLAST RECONSTR SURG, V88, P613, DOI 10.1097/00006534-199110000-00008; ELKASABY AW, 1993, J UROLOGY, V149, P276, DOI 10.1016/S0022-5347(17)36054-8; Fenton AS, 2005, UROLOGY, V65, P1055, DOI 10.1016/j.urology.2004.12.018; Fenton AS, 2004, J UROLOGY, V171, P64, DOI 10.1016/S0022-5347(18)37506-2; GUERREROSANTOS J, 1985, PLAST RECONSTR SURG, V76, P451, DOI 10.1097/00006534-198509000-00024; Meneghini A, 2001, EUR UROL, V39, P264, DOI 10.1159/000052450; NAKAYAMA Y, 1987, ANN PLAS SURG, V19, P75, DOI 10.1097/00000637-198707000-00013; Simonato A, 2006, J UROLOGY, V175, P589, DOI 10.1016/S0022-5347(05)00166-7; VECCHIONE TR, 1992, PLAST RECONSTR SURG, V89, P1179, DOI 10.1097/00006534-199206000-00042; Wessells H, 2002, UROL CLIN N AM, V29, P381, DOI 10.1016/S0094-0143(02)00029-0	13	57	65	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2006	367	9520					1379	1380		10.1016/S0140-6736(06)68592-9	http://dx.doi.org/10.1016/S0140-6736(06)68592-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650634				2022-12-24	WOS:000237195600008
J	Pepys, MB; Hirschfield, GM; Tennent, GA; Gallimore, JR; Kahan, MC; Bellotti, V; Hawkins, PN; Myers, RM; Smith, MD; Polara, A; Cobb, AJA; Ley, SV; Aquilina, JA; Robinson, CV; Sharif, I; Gray, GA; Sabin, CA; Jenvey, MC; Kolstoe, SE; Thompson, D; Wood, SP				Pepys, MB; Hirschfield, GM; Tennent, GA; Gallimore, JR; Kahan, MC; Bellotti, V; Hawkins, PN; Myers, RM; Smith, MD; Polara, A; Cobb, AJA; Ley, SV; Aquilina, JA; Robinson, CV; Sharif, I; Gray, GA; Sabin, CA; Jenvey, MC; Kolstoe, SE; Thompson, D; Wood, SP			Targeting C-reactive protein for the treatment of cardiovascular disease	NATURE			English	Article							AMYLOID-P-COMPONENT; ACUTE MYOCARDIAL-INFARCTION; HEART-FAILURE; SERUM; SENSITIVITY; COMPLEMENT; ACTIVATION; ARTERIES; BINDING; RAT	Complement-mediated inflammation exacerbates the tissue injury of ischaemic necrosis in heart attacks and strokes, the most common causes of death in developed countries. Large infarct size increases immediate morbidity and mortality and, in survivors of the acute event, larger non-functional scars adversely affect long-term prognosis. There is thus an important unmet medical need for new cardioprotective and neuroprotective treatments. We have previously shown that human C-reactive protein (CRP), the classical acute-phase protein that binds to ligands exposed in damaged tissue and then activates complement(1), increases myocardial and cerebral infarct size in rats subjected to coronary or cerebral artery ligation, respectively(2,3). Rat CRP does not activate rat complement, whereas human CRP activates both rat and human complement(4). Administration of human CRP to rats is thus an excellent model for the actions of endogenous human CRP2,3. Here we report the design, synthesis and efficacy of 1,6-bis(phosphocholine)-hexane as a specific small-molecule inhibitor of CRP. Five molecules of this palindromic compound are bound by two pentameric CRP molecules, crosslinking and occluding the ligand-binding B-face of CRP and blocking its functions. Administration of 1,6-bis(phosphocholine)-hexane to rats undergoing acute myocardial infarction abrogated the increase in infarct size and cardiac dysfunction produced by injection of human CRP. Therapeutic inhibition of CRP is thus a promising new approach to cardioprotection in acute myocardial infarction, and may also provide neuroprotection in stroke. Potential wider applications include other inflammatory, infective and tissue-damaging conditions characterized by increased CRP production, in which binding of CRP to exposed ligands in damaged cells may lead to complement-mediated exacerbation of tissue injury.	UCL, Royal Free & Univ Coll Med Sch, Dept Med, Ctr Amyloidosis & Acute Phase Prot, London NW3 2PF, England; Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; Univ Edinburgh, Ctr Cardiovasc Sci, Endothelial Cell & Mol Cardiol Grp, Edinburgh EH16 4TJ, Midlothian, Scotland; UCL, Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London NW3 2PF, England; Univ Southampton, Sch Biol Sci, Southampton SO16 7PX, Hants, England	University of London; University College London; University of Cambridge; University of Edinburgh; University of London; University College London; University of Southampton	Pepys, MB (corresponding author), UCL, Royal Free & Univ Coll Med Sch, Dept Med, Ctr Amyloidosis & Acute Phase Prot, Rowland Hill St, London NW3 2PF, England.	m.pepys@medsch.ucl.ac.uk	Aquilina, J. Andrew/A-5366-2013; Hawkins, Philip N/C-5573-2008; Ley, Steven V/O-7712-2016; Kolstoe, Simon/O-4996-2019; Wood, Stephen P/B-1438-2009; Cobb, Alexander/Q-5702-2016; Gray, Gillian A/B-4058-2014; Hirschfield, Gideon M/M-2143-2015; Sabin, Caroline/C-2464-2008; Aquilina, John Andrew/AGF-4013-2022; Bellotti, Vittorio/A-6201-2014	Ley, Steven V/0000-0002-7816-0042; Kolstoe, Simon/0000-0003-1472-3966; Cobb, Alexander/0000-0002-3397-9636; Gray, Gillian A/0000-0003-3104-3305; Hirschfield, Gideon M/0000-0002-6736-2255; Sabin, Caroline/0000-0001-5173-2760; Bellotti, Vittorio/0000-0001-8678-662X; robinson, carol/0000-0001-7829-5505	Medical Research Council [G7900510] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G7900510] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bhakdi S, 1999, ARTERIOSCL THROM VAS, V19, P2348, DOI 10.1161/01.ATV.19.10.2348; Clapp BR, 2005, CIRCULATION, V111, P1530, DOI 10.1161/01.CIR.0000159336.31613.31; DEBEER FC, 1982, IMMUNOLOGY, V45, P55; DEBEER FC, 1982, BRIT HEART J, V47, P239; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denvir MA, 2005, J AM SOC ECHOCARDIOG, V18, P155, DOI 10.1016/j.echo.2004.09.001; Eda S, 1998, J CLIN LAB ANAL, V12, P137, DOI 10.1002/(SICI)1098-2825(1998)12:3<137::AID-JCLA2>3.0.CO;2-6; Gill R, 2004, J CEREBR BLOOD F MET, V24, P1214, DOI 10.1097/01.WCB.0000136517.61642.99; Gray GA, 2000, BRIT J PHARMACOL, V130, P1735, DOI 10.1038/sj.bjp.0703503; Griselli M, 1999, J EXP MED, V190, P1733, DOI 10.1084/jem.190.12.1733; HAWKINS PN, 1991, CLIN EXP IMMUNOL, V84, P308; Hirschfield GM, 2005, P NATL ACAD SCI USA, V102, P8309, DOI 10.1073/pnas.0503202102; KUSHNER I, 1978, J CLIN INVEST, V61, P235, DOI 10.1172/JCI108932; Ledue TB, 1998, ANN CLIN BIOCHEM, V35, P745, DOI 10.1177/000456329803500607; Miller AA, 2000, BRIT J PHARMACOL, V131, P29, DOI 10.1038/sj.bjp.0703528; Mora A, 2003, EMBO J, V22, P4666, DOI 10.1093/emboj/cdg469; NELSON SR, 1991, CLIN CHIM ACTA, V200, P191, DOI 10.1016/0009-8981(91)90090-Y; Pepys MB, 2005, ARTERIOSCL THROM VAS, V25, P1091, DOI 10.1161/01.ATV.0000169644.88847.28; Pepys MB, 2002, NATURE, V417, P254, DOI 10.1038/417254a; Pepys MB, 2005, CIRC RES, V97, pE97, DOI 10.1161/01.RES.0000193595.03608.08; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Taylor KE, 2005, ARTERIOSCL THROM VAS, V25, P1225, DOI 10.1161/01.ATV.0000164623.41250.28; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9	23	520	563	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1217	1221		10.1038/nature04672	http://dx.doi.org/10.1038/nature04672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16642000	Green Submitted			2022-12-24	WOS:000237080000051
J	Norden, C; Mendoza, M; Dobbelaere, J; Kotwaliwale, CV; Biggins, S; Barral, Y				Norden, C; Mendoza, M; Dobbelaere, J; Kotwaliwale, CV; Biggins, S; Barral, Y			The NoCut pathway links completion of cytokinesis to spindle midzone funiction to prevent chromosome breakage	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; PROTEIN-KINASE; MITOTIC SPINDLE; CELL-DIVISION; SEGREGATION; CHECKPOINT; ANAPHASE; COMPARTMENTALIZATION; PHOSPHORYLATION	During anaphase, spindle elongation pulls sister chromatids apart until each pair is fully separated. In turn, cytokinesis cleaves the cell between the separated chromosomes. What ensures that cytokinesis proceeds only after that all chromosome arms are pulled out of the cleavage plane was unknown. Here, we show that a signaling pathway, which we call NoCut, delays the completion of cytokinesis in cells with spindle-midzone defects. NoCut depends on the Aurora kinase Ipl1 and the anillin-related proteins Boi1 and Boi2, which localize to the site of cleavage in an Ipl1-dependent manner and act as abscission inhibitors. Inactivation of NoCut leads to premature abscission and chromosome breakage by the cytokinetic machinery and is lethal in cells with spindle-elongation defects. We propose that NoCut monitors clearance of chromatin from the midzone to ensure that cytokinesis completes only after all chromosomes have migrated to the poles.	ETH, Inst Biochem, Dept Biol, CH-8093 Zurich, Switzerland; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Fred Hutchinson Cancer Center	Barral, Y (corresponding author), ETH, Inst Biochem, Dept Biol, CH-8093 Zurich, Switzerland.	yves.barral@bc.biol.ethz.ch	Mendoza, Manuel/AAE-8987-2021; Norden, Caren/I-3918-2014	Mendoza, Manuel/0000-0001-5522-4878; Dobbelaere, Jeroen/0000-0002-6727-532X; Norden, Caren/0000-0001-8835-1451; Biggins, Susan/0000-0002-4499-6319; Barral, Yves/0000-0002-0989-3373				Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Biggins S, 2001, GENE DEV, V15, P3118, DOI 10.1101/gad.934801; Biggins S, 1999, GENE DEV, V13, P532, DOI 10.1101/gad.13.5.532; Bouck DC, 2005, P NATL ACAD SCI USA, V102, P5408, DOI 10.1073/pnas.0405925102; Buvelot S, 2003, J CELL BIOL, V160, P329, DOI 10.1083/jcb.200209018; CIRNINI D, 2002, J CELL SCI, V115, P507; Colman-Lerner A, 2001, CELL, V107, P739, DOI 10.1016/S0092-8674(01)00596-7; Dobbelaere J, 2003, DEV CELL, V4, P345, DOI 10.1016/S1534-5807(03)00061-3; Dobbelaere J, 2004, SCIENCE, V305, P393, DOI 10.1126/science.1099892; Euskirchen GM, 2002, EUKARYOT CELL, V1, P229, DOI 10.1128/EC.1.2.229-240.2002; Fraschini R, 2001, MOL GENET GENOMICS, V266, P115, DOI 10.1007/s004380100533; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; Hallett MA, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-16; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hoepfner D, 2000, MOL BIOL CELL, V11, P1197, DOI 10.1091/mbc.11.4.1197; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; Kim JH, 1999, J CELL BIOL, V145, P1381, DOI 10.1083/jcb.145.7.1381; Korinek WS, 2000, CURR BIOL, V10, P947, DOI 10.1016/S0960-9822(00)00626-6; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Kusch J, 2002, GENE DEV, V16, P1627, DOI 10.1101/gad.222602; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Lim HH, 1996, MOL CELL BIOL, V16, P6385; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; McCollum D, 2004, CURR BIOL, V14, pR953, DOI 10.1016/j.cub.2004.10.040; Melo JA, 2001, GENE DEV, V15, P2809; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Racki WJ, 2000, EMBO J, V19, P4524, DOI 10.1093/emboj/19.17.4524; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Sullivan M, 2001, NAT CELL BIOL, V3, P771, DOI 10.1038/ncb0901-771; Tolliday N, 2001, CURR OPIN MICROBIOL, V4, P690, DOI 10.1016/S1369-5274(01)00270-3; Whistler JL, 1997, J BIOL CHEM, V272, P18790, DOI 10.1074/jbc.272.30.18790; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002; Yanagida M, 1998, TRENDS CELL BIOL, V8, P144, DOI 10.1016/S0962-8924(98)01236-7	46	218	221	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2006	125	1					85	98		10.1016/j.cell.2006.01.045	http://dx.doi.org/10.1016/j.cell.2006.01.045			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615892	Bronze			2022-12-24	WOS:000237314200016
J	Ramu, Y; Xu, YP; Lu, Z				Ramu, Yajamana; Xu, Yanping; Lu, Zhe			Enzymatic activation of voltage-gated potassium channels	NATURE			English	Article							PHOSPHOLIPID SURFACE-CHARGE; LOXOSCELES-RECLUSA; SPHINGOMYELINASES-D; CORYNEBACTERIUM-PSEUDOTUBERCULOSIS; ION CONDUCTION; SPIDER VENOM; K+ CHANNELS; MECHANISM; TARANTULA; CURRENTS	Voltage- gated ion channels in excitable nerve, muscle, and endocrine cells generate electric signals in the form of action potentials(1). However, they are also present in non- excitable eukaryotic cells and prokaryotes, which raises the question of whether voltage- gated channels might be activated by means other than changing the voltage difference between the solutions separated by the plasma membrane. The search for so- called voltage- gated channel activators is motivated in part by the growing importance of such agents in clinical pharmacology. Here we report the apparent activation of voltage- gated K+ ( Kv) channels by a sphingomyelinase.	Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Lu, Z (corresponding author), Univ Penn, Dept Physiol, 3700 Hamilton Walk, Philadelphia, PA 19104 USA.	zhelu@mail.med.upenn.edu						Aggarwal S.K., 1996, THESIS HARVARD U; BARKSDALE L, 1981, J CLIN MICROBIOL, V13, P335, DOI 10.1128/JCM.13.2.335-343.1981; BELL JE, 1984, BIOPHYS J, V45, P279, DOI 10.1016/S0006-3495(84)84154-5; BERNHEIMER AW, 1985, SCIENCE, V228, P590, DOI 10.1126/science.3983643; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; de Andrade SA, 2006, TOXICON, V47, P380, DOI 10.1016/j.toxicon.2005.12.005; de Andrade SA, 2005, BIOCHEM BIOPH RES CO, V327, P117, DOI 10.1016/j.bbrc.2004.11.146; FRANKENHAEUSER B, 1957, J PHYSIOL-LONDON, V137, P218, DOI 10.1113/jphysiol.1957.sp005808; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; KURPIEWSKI G, 1981, BIOCHIM BIOPHYS ACTA, V678, P467, DOI 10.1016/0304-4165(81)90128-8; Lee S, 2005, BIOCHEM J, V391, P317, DOI 10.1042/BJ20050043; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; MOCZYDLOWSKI E, 1985, J MEMBRANE BIOL, V83, P273, DOI 10.1007/BF01868701; Murakami MT, 2005, J BIOL CHEM, V280, P13658, DOI 10.1074/jbc.M412437200; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Ramos-Cerrillo B, 2004, TOXICON, V44, P507, DOI 10.1016/j.toxicon.2004.06.013; REES RS, 1984, J INVEST DERMATOL, V83, P270, DOI 10.1111/1523-1747.ep12340340; Robertson GA, 1996, NEUROPHARMACOLOGY, V35, P841, DOI 10.1016/0028-3908(96)00113-X; SOUCEK A, 1971, BIOCHIM BIOPHYS ACTA, V227, P116, DOI 10.1016/0005-2744(71)90173-2; Stith BJ, 2000, J LIPID RES, V41, P1448; SWARTZ KJ, 1995, NEURON, V15, P941, DOI 10.1016/0896-6273(95)90184-1; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200	30	126	127	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2006	442	7103					696	699		10.1038/nature04880	http://dx.doi.org/10.1038/nature04880			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UU	16799569				2022-12-24	WOS:000239630200048
J	Ferguson, NM; Cummings, DAT; Fraser, C; Cajka, JC; Cooley, PC; Burke, DS				Ferguson, Neil M.; Cummings, Derek A. T.; Fraser, Christophe; Cajka, James C.; Cooley, Philip C.; Burke, Donald S.			Strategies for mitigating an influenza pandemic	NATURE			English	Article							TRANSMISSION DYNAMICS; ANTIVIRAL DRUG; MOUTH EPIDEMIC; HONG-KONG; IMPACT; SARS; INFECTIONS; HOUSEHOLD; SPREAD; FOOT	Development of strategies for mitigating the severity of a new influenza pandemic is now a top global public health priority. Influenza prevention and containment strategies can be considered under the broad categories of antiviral, vaccine and non-pharmaceutical ( case isolation, household quarantine, school or workplace closure, restrictions on travel) measures(1). Mathematical models are powerful tools for exploring this complex landscape of intervention strategies and quantifying the potential costs and benefits of different options(2-5). Here we use a large-scale epidemic simulation(6) to examine intervention options should initial containment(6,7) of a novel influenza outbreak fail, using Great Britain and the United States as examples. We find that border restrictions and/or internal travel restrictions are unlikely to delay spread by more than 2 - 3 weeks unless more than 99% effective. School closure during the peak of a pandemic can reduce peak attack rates by up to 40%, but has little impact on overall attack rates, whereas case isolation or household quarantine could have a significant impact, if feasible. Treatment of clinical cases can reduce transmission, but only if antivirals are given within a day of symptoms starting. Given enough drugs for 50% of the population, household-based prophylaxis coupled with reactive school closure could reduce clinical attack rates by 40 - 50%. More widespread prophylaxis would be even more logistically challenging but might reduce attack rates by over 75%. Vaccine stockpiled in advance of a pandemic could significantly reduce attack rates even if of low efficacy. Estimates of policy effectiveness will change if the characteristics of a future pandemic strain differ substantially from those seen in past pandemics.	Imperial Coll London, Fac Med, Dept Infect Dis Epidemiol, London W2 1PG, England; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; RTI Int Inc, Res Triangle Pk, NC 27709 USA	Imperial College London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Research Triangle Institute	Ferguson, NM (corresponding author), Imperial Coll London, Fac Med, Dept Infect Dis Epidemiol, St Marys Campus,Norfolk Pl, London W2 1PG, England.	neil.ferguson@imperial.ac.uk	Fahimifar, Sepideh/M-5303-2019; Ferguson, Neil/B-8578-2008; Fraser, Christophe/A-8109-2008	Ferguson, Neil/0000-0002-1154-8093; Fraser, Christophe/0000-0003-2399-9657; /0000-0002-5704-8094; Cajka, James/0000-0001-9800-6627				ANDERSON R M, 1991; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bell D, 2006, EMERG INFECT DIS, V12, P81; Bell D, 2006, EMERG INFECT DIS, V12, P88; Bell DM, 2004, EMERG INFECT DIS, V10, P1900, DOI 10.3201/eid1011.040729; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; Coombes R, 2005, BRIT MED J, V330, P495, DOI 10.1136/bmj.330.7490.495; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Ferguson NM, 2004, SCIENCE, V304, P968, DOI 10.1126/science.1096898; Ferguson NM, 2003, J ANTIMICROB CHEMOTH, V51, P977, DOI 10.1093/jac/dkg136; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Ferguson NM, 2003, NATURE, V425, P681, DOI 10.1038/nature02007; Gani R, 2005, EMERG INFECT DIS, V11, P1355; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Lo JYC, 2005, EMERG INFECT DIS, V11, P1738, DOI 10.3201/eid1111.050729; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; *OAKR NAT LAB, 2003, LANDSC GLOB POP DAT; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; World Health Organization (WHO), 2005, WHO GLOB INFL PREP P	23	1410	1456	5	351	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 27	2006	442	7101					448	452		10.1038/nature04795	http://dx.doi.org/10.1038/nature04795			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16642006	Green Published, Bronze			2022-12-24	WOS:000239278900042
J	Shi, XB; Hong, T; Walter, KL; Ewalt, M; Michishita, E; Hung, T; Carney, D; Pena, P; Lan, F; Kaadige, MR; Lacoste, N; Cayrou, C; Davrazou, F; Saha, A; Cairns, BR; Ayer, DE; Kutateladze, TG; Shi, Y; Cote, J; Chua, KF; Gozani, O				Shi, Xiaobing; Hong, Tao; Walter, Kay L.; Ewalt, Mark; Michishita, Eriko; Hung, Tiffany; Carney, Dylan; Pena, Pedro; Lan, Fei; Kaadige, Mohan R.; Lacoste, Nicolas; Cayrou, Christelle; Davrazou, Foteini; Saha, Anjanabha; Cairns, Bradley R.; Ayer, Donald E.; Kutateladze, Tatiana G.; Shi, Yang; Cote, Jacques; Chua, Katrin F.; Gozani, Or			ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression	NATURE			English	Article							ACETYLATION; CHROMATIN; BINDING; ASSOCIATION; FINGER; YEAST	Dynamic regulation of diverse nuclear processes is intimately linked to covalent modifications of chromatin(1,2). Much attention has focused on methylation at lysine 4 of histone H3 (H3K4), owing to its association with euchromatic genomic regions(3,4). H3K4 can be mono-, di- or tri-methylated. Trimethylated H3K4 (H3K4me3) is preferentially detected at active genes, and is proposed to promote gene expression through recognition by transcription-activating effector molecules(5). Here we identify a novel class of methylated H3K4 effector domains-the PHD domains of the ING (for inhibitor of growth) family of tumour suppressor proteins. The ING PHD domains are specific and highly robust binding modules for H3K4me3 and H3K4me2. ING2, a native subunit of a repressive mSin3a-HDAC1 histone deacetylase complex(6), binds with high affinity to the trimethylated species. In response to DNA damage, recognition of H3K4me3 by the ING2 PHD domain stabilizes the mSin3a-HDAC1 complex at the promoters of proliferation genes. This pathway constitutes a new mechanism by which H3K4me3 functions in active gene repression. Furthermore, ING2 modulates cellular responses to genotoxic insults, and these functions are critically dependent on ING2 interaction with H3K4me3. Together, our findings establish a pivotal role for trimethylation of H3K4 in gene repression and, potentially, tumour suppressor mechanisms.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Aurora, CO 80045 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; Univ Laval, Ctr Canc Res, Quebec City, PQ G1R 2J6, Canada; VA Palo Alto Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Palo Alto, CA 94304 USA	Stanford University; Stanford University; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Harvard Medical School; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Laval University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Gozani, O (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	ogozani@stanford.edu	Cote, Jacques/I-8901-2014; Gozani, Or P/I-6157-2013; Ewalt, Mark D/Y-4878-2019	Cote, Jacques/0000-0001-6751-555X; Ewalt, Mark D/0000-0003-4245-752X; Shi, Xiaobing/0000-0001-5242-8189; Ayer, Donald/0000-0002-5595-3269; Gozani, Or/0000-0002-1365-4463; Cayrou, Christelle/0000-0002-6910-8023; Kutateladze, Tatiana/0000-0001-7375-6990	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060415] Funding Source: NIH RePORTER; CIHR [64289-1] Funding Source: Medline; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM060415, R01 GM060415-06] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CIHR(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bannister AJ, 2004, METHOD ENZYMOL, V376, P269; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Eberharter A, 2004, EMBO J, V23, P4029, DOI 10.1038/sj.emboj.7600382; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; PENA PV, 2006, NATURE          0521; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Ragvin A, 2004, J MOL BIOL, V337, P773, DOI 10.1016/j.jmb.2004.01.051; Ricke RM, 2005, BIOL PROCED ONLINE, V7, P60, DOI 10.1251/bpo106; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Stolt PC, 2003, STRUCTURE, V11, P569, DOI 10.1016/S0969-2126(03)00068-6; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; WYSOCKA J, 2006, NATURE          0521; Zimmermann P, 2002, MOL CELL, V9, P1215, DOI 10.1016/S1097-2765(02)00549-X	23	711	751	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2006	442	7098					96	99		10.1038/nature04835	http://dx.doi.org/10.1038/nature04835			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HS	16728974	Green Accepted			2022-12-24	WOS:000238724500044
J	Baer, B; Armitage, SAO; Boomsma, JJ				Baer, Boris; Armitage, Sophie A. O.; Boomsma, Jacobus J.			Sperm storage induces an immunity cost in ants	NATURE			English	Article							ATTA-COLOMBICA; FIRE ANT; HYMENOPTERA; BUMBLEBEE; QUEENS; FITNESS; TRAITS; SIZE	Ant queens are among the most long-lived insects known(1,2). They mate early in adult life and maintain millions of viable sperm in their sperm storage organ until they die many years later(3,4). Because they never re-mate, the reproductive success of queens is ultimately sperm-limited, but it is not known what selective forces determine the upper limit to sperm storage. Here we show that sperm storage carries a significant cost of reduced immunity during colony founding. Newly mated queens of the leaf-cutting ant Atta colombica upregulate their immune response shortly after completing their nest burrow, probably as an adaptive response to a greater exposure to pathogens in the absence of grooming workers. However, the immune response nine days after colony founding is negatively correlated with the amount of sperm in the sperm storage organ, indicating that short-term survival is traded off against long-term reproductive success. The immune response was lower when more males contributed to the stored sperm, indicating that there might be an additional cost of mating or storing genetically different ejaculates.	Inst Biol, Dept Populat Biol, DK-2100 Copenhagen, Denmark		Baer, B (corresponding author), Univ Western Australia, Sch Anim Biol MO92, Zool Bldg, Nedlands, WA 6009, Australia.	bcbaer@bi.ku.dk	Baer, Boris/F-5301-2011; Boomsma, Jacobus J/M-2785-2014; Armitage, Sophie AO/A-6961-2012	Baer, Boris/0000-0002-1136-5967; Boomsma, Jacobus J/0000-0002-3598-1609; Armitage, Sophie AO/0000-0002-5561-9543				Baer B, 2005, APIDOLOGIE, V36, P187, DOI 10.1051/apido:2005013; Baer B, 2003, OIKOS, V101, P563, DOI 10.1034/j.1600-0706.2003.12395.x; Baer B, 2001, EVOLUTION, V55, P1639, DOI 10.1111/j.0014-3820.2001.tb00683.x; Baer B, 2000, INSECT SOC, V47, P183, DOI 10.1007/PL00001699; Baer B, 2005, P ROY SOC B-BIOL SCI, V272, P319, DOI 10.1098/rspb.2004.2958; Baer B, 2004, BEHAV ECOL, V15, P426, DOI 10.1093/beheco/arh025; Birkhead TR, 1998, SPERM COMPETITION SE; Boomsma J.J., 2005, P139, DOI 10.1079/9780851998121.0139; Boomsma JJ, 2005, ANNU REV ENTOMOL, V50, P395, DOI 10.1146/annurev.ento.50.071803.130416; Breque C, 2003, MOL REPROD DEV, V66, P314, DOI 10.1002/mrd.10347; CROZIER RH, 1985, BEHAV ECOL SOCIOBIOL, V18, P105, DOI 10.1007/BF00299039; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Fjerdingstad EJ, 1998, HEREDITY, V80, P118, DOI 10.1038/sj.hdy.6882470; Fjerdingstad EJ, 1998, BEHAV ECOL SOCIOBIOL, V42, P257, DOI 10.1007/s002650050437; Fjerdingstad EJ, 1997, INSECT SOC, V44, P209, DOI 10.1007/s000400050042; Fowler H.G., 1986, P123; Holldobler B., 1990, pi; HOLLDOBLER B, 1985, EXPT BEHAV ECOLOGY S, P237; Keller L, 1997, NATURE, V389, P958, DOI 10.1038/40130; PAMILO P, 1991, INSECT SOC, V38, P111, DOI 10.1007/BF01240961; Rolff J, 2003, SCIENCE, V301, P472, DOI 10.1126/science.1080623; Simmons LW., 2001, MG BEH ECOL; Tian HS, 2004, INSECT BIOCHEM MOLEC, V34, P937, DOI 10.1016/j.ibmb.2004.06.004; TSCHINKEL WR, 1988, ANN ENTOMOL SOC AM, V81, P777, DOI 10.1093/aesa/81.5.777; Weber N. A., 1972, GARDENING ANTS ATTIN; WHEELER DE, 1994, ZOOMORPHOLOGY, V114, P203, DOI 10.1007/BF00416859	26	164	165	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					872	875		10.1038/nature04698	http://dx.doi.org/10.1038/nature04698			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16778889				2022-12-24	WOS:000238254100042
J	Ge, WP; Yang, XJ; Zhang, ZJ; Wang, HK; Shen, WH; Deng, QD; Duan, SM				Ge, Woo-Ping; Yang, Xiu-Juan; Zhang, Zhijun; Wang, Hui-Kun; Shen, Wanhua; Deng, Qiu-Dong; Duan, Shumin			Long-term potentiation of neuron-glia synapses mediated by Ca2+-permeable AMPA receptors	SCIENCE			English	Article							CALCIUM-PERMEABLE AMPA; OLIGODENDROCYTE PRECURSOR CELLS; PROGENITOR CELLS; ASTROCYTES; HIPPOCAMPUS; INTERNEURONS; ACTIVATION; SPERMINE; MATTER; WHITE	Interactions between neurons and glial cells in the brain may serve important functions in the development, maintenance, and plasticity of neural circuits. Fast neuron-glia synaptic transmission has been found between hippocampal neurons and NG2 cells, a distinct population of macroglia-like cells widely distributed in the brain. We report that these neuron-glia synapses undergo activity-dependent modifications analogous to long-term potentiation (LTP) at excitatory synapses, a hallmark of neuronal plasticity. However, unlike the induction of LTP at many neuron-neuron synapses, both induction and expression of LTP at neuron-NG2 synapses involve Ca2+-permeable AMPA receptors on NG2 cells.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Duan, SM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	shumin@ion.ac.cn	Shen, Wanhua/B-5554-2011; Deng, Qiudong/D-2446-2010; Wang, Huikun/V-3677-2017	Shen, Wanhua/0000-0002-5178-9561; Wang, Huikun/0000-0001-8556-3504				Aguirre A, 2004, J NEUROSCI, V24, P10530, DOI 10.1523/JNEUROSCI.3572-04.2004; Araque A, 2001, ANNU REV PHYSIOL, V63, P795, DOI 10.1146/annurev.physiol.63.1.795; Bergles DE, 2000, NATURE, V405, P187, DOI 10.1038/35012083; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chittajallu R, 2004, J PHYSIOL-LONDON, V561, P109, DOI 10.1113/jphysiol.2004.074252; Diamond JS, 1998, NEURON, V21, P425, DOI 10.1016/S0896-6273(00)80551-6; Gallo V, 1996, J NEUROSCI, V16, P2659, DOI 10.1523/jneurosci.16-08-02659.1996; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; KOH DS, 1995, J PHYSIOL-LONDON, V485, P383, DOI 10.1113/jphysiol.1995.sp020737; Koike M, 1997, NEUROSCI RES, V29, P27, DOI 10.1016/S0168-0102(97)00067-9; LEVINE JM, 1987, J NEUROSCI, V7, P2711; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Lin SC, 2004, NAT NEUROSCI, V7, P24, DOI 10.1038/nn1162; Lino M, 2001, SCIENCE, V292, P926, DOI 10.1126/science.1058827; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Stegmuller J, 2003, J BIOL CHEM, V278, P3590, DOI 10.1074/jbc.M210010200; Wan JJ, 1999, SCIENCE, V285, P1725, DOI 10.1126/science.285.5434.1725; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7	29	168	188	3	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1533	1537		10.1126/science.1124669	http://dx.doi.org/10.1126/science.1124669			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763153				2022-12-24	WOS:000238124100051
J	Paredez, AR; Somerville, CR; Ehrhardt, DW				Paredez, Alexander R.; Somerville, Christopher R.; Ehrhardt, David W.			Visualization of cellulose synthase demonstrates functional association with microtubules	SCIENCE			English	Article							CORTICAL MICROTUBULES; PLASMA-MEMBRANE; MICROFIBRIL ALIGNMENT; CELL; DISRUPTION; DEPOSITION; RESISTANCE; COMPLEXES; MECHANISM; EXPANSION	Expression of a functional yellow fluorescent protein fusion to cellulose synthase (CESA) in transgenic Arabidopsis plants allowed the process of cellulose deposition to be visualized in living cells. Spinning disk confocal microscopy revealed that CESA complexes in the plasma membrane moved at constant rates in linear tracks that were aligned and were coincident with cortical microtubules. Within each observed linear track, complex movement was bidirectional. Inhibition of microtubule polymerization changed the fine-scale distribution and pattern of moving CESA complexes in the membrane, indicating a relatively direct mechanism for guidance of cellulose deposition by the cytoskeleton.	Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	Carnegie Institution for Science; Stanford University	Ehrhardt, DW (corresponding author), Carnegie Inst Washington, Dept Plant Biol, 260 Panama St, Stanford, CA 94305 USA.	ehrhardt@stanford.edu	Somerville, Christopher R/A-4048-2009; Paredez, Alexander R/B-9799-2009; Paredez, Alexander/E-7171-2014	Somerville, Christopher R/0000-0003-4647-0094; Paredez, Alexander R/0000-0002-9298-3264; Paredez, Alexander/0000-0002-9298-3264				Alberts B., 2002, OVERVIEW CELL CYCLE, Vfourth; Baskin TI, 2004, PLANT PHYSIOL, V135, P2279, DOI 10.1104/pp.104.040493; Baskin TI, 2001, PROTOPLASMA, V215, P150, DOI 10.1007/BF01280311; Desprez T, 2002, PLANT PHYSIOL, V128, P482, DOI 10.1104/pp.010822; Emons AMC, 2000, TRENDS PLANT SCI, V5, P35, DOI 10.1016/S1360-1385(99)01507-1; Fagard M, 2000, PLANT CELL, V12, P2409, DOI 10.1105/tpc.12.12.2409; Gardiner JC, 2003, PLANT CELL, V15, P1740, DOI 10.1105/tpc.012815; Giddings T.H., 1991, CYTOSKELETAL BASIS P, P85; GREEN PB, 1962, SCIENCE, V138, P1404, DOI 10.1126/science.138.3548.1404; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; HAIGLER CH, 1986, PROTOPLASMA, V134, P111, DOI 10.1007/BF01275709; HEATH IB, 1974, J THEOR BIOL, V48, P445, DOI 10.1016/S0022-5193(74)80011-1; HEPLER PK, 1974, ANNU REV PLANT PHYS, V25, P309, DOI 10.1146/annurev.pp.25.060174.001521; Himmelspach R, 2003, PLANT J, V36, P565, DOI 10.1046/j.1365-313X.2003.01906.x; Kimura S, 1999, PLANT CELL, V11, P2075, DOI 10.1105/tpc.11.11.2075; Lai-Kee-Him J, 2002, J BIOL CHEM, V277, P36931, DOI 10.1074/jbc.M203530200; LEDBETTER MC, 1963, J CELL BIOL, V19, P239, DOI 10.1083/jcb.19.1.239; LLOYD CW, 1984, INT REV CYTOL, V86, P1, DOI 10.1016/S0074-7696(08)60176-X; Nebenfuhr A, 2000, PLANT PHYSIOL, V124, P135, DOI 10.1104/pp.124.1.135; REISS HD, 1984, PLANTA, V160, P428, DOI 10.1007/BF00429759; Robert S, 2005, PLANT CELL, V17, P3378, DOI 10.1105/tpc.105.036228; ROBINSON DG, 1981, EUR J CELL BIOL, V25, P278; Roudier F, 2005, PLANT CELL, V17, P1749, DOI 10.1105/tpc.105.031732; Scheible WR, 2001, P NATL ACAD SCI USA, V98, P10079, DOI 10.1073/pnas.191361598; Shaw SL, 2003, SCIENCE, V300, P1715, DOI 10.1126/science.1083529; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Sugimoto K, 2003, PLANT CELL, V15, P1414, DOI 10.1105/tpc.011593; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Wasteneys GO, 2004, CURR OPIN PLANT BIOL, V7, P651, DOI 10.1016/j.pbi.2004.09.008; YUAN M, 1994, P NATL ACAD SCI USA, V91, P6050, DOI 10.1073/pnas.91.13.6050	30	890	927	9	310	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1491	1495		10.1126/science.1126551	http://dx.doi.org/10.1126/science.1126551			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16627697				2022-12-24	WOS:000238124100038
J	Lehtinen, MK; Yuan, ZQ; Boag, PR; Yang, Y; Villen, J; Becker, EBE; DiBacco, S; de la Iglesia, N; Gygi, S; Blackwell, TK; Bonni, A				Lehtinen, Maria K.; Yuan, Zengqiang; Boag, Peter R.; Yang, Yue; Villen, Judit; Becker, Esther B. E.; DiBacco, Sara; de la Iglesia, Nuria; Gygi, Steven; Blackwell, T. Keith; Bonni, Azad			A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span	CELL			English	Article							CELL-CYCLE; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTORS; PROTEIN-KINASE; HISTONE H2B; APOPTOSIS; PHOSPHORYLATION; DAF-16; DROSOPHILA; GENE	Oxidative stress influences cell survival and homeostasis, but the mechanisms underlying the biological effects of oxidative stress remain to be elucidated. Here, we demonstrate that the protein kinase MST1 mediates oxidative-stress-induced cell death in primary mammalian neurons by directly activating the FOXO transcription factors. MST1 phosphorylates FOXO proteins at a conserved site within the forkhead domain that disrupts their interaction with 14-3-3 proteins, promotes FOXO nuclear translocation, and thereby induces cell death in neurons. We also extend the MST-FOXO signaling link to nematodes. Knockdown of the C. elegans MST1 ortholog CST-1 shortens life span and accelerates tissue aging, while overexpression of cst-1 promotes life span and delays aging. The cst-1-induced life-span extension occurs in a daf-16-dependent manner. The identification of the FOXO transcription factors as major and evolutionarily conserved targets of MST1 suggests that MST kinases play important roles in diverse biological processes including cellular responses to oxidative stress and longevity.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Biomed & Biol Sci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Joslin Diabet Ctr, Sect Dev & Stem Cell Biol, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Joslin Diabetes Center, Inc.	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	azad_bonni@hms.harvard.edu	de la Iglesia, Nuria/E-1420-2015; Yuan, Zengqiang/G-5245-2017	de la Iglesia, Nuria/0000-0002-1083-7715; Becker, Esther B E/0000-0002-5238-4902; Yuan, Zengqiang/0000-0001-5739-2867; Yang, Yue/0000-0002-6201-8818; Villen, Judit/0000-0002-1005-1739; Boag, Peter/0000-0002-0889-0859	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041021] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62891, R01 GM062891] Funding Source: Medline; NINDS NIH HHS [NS41021] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Finkel T, 2000, FEBS LETT, V476, P52, DOI 10.1016/S0014-5793(00)01669-0; FRIEDMAN DB, 1988, GENETICS, V118, P75; Gaudilliere B, 2002, J BIOL CHEM, V277, P46442, DOI 10.1074/jbc.M206653200; Gems D, 1998, GENETICS, V150, P129; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Honda Y, 2002, ANN NY ACAD SCI, V959, P466, DOI 10.1111/j.1749-6632.2002.tb02117.x; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Landis GN, 2005, MECH AGEING DEV, V126, P365, DOI 10.1016/j.mad.2004.08.012; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; O'Neill E, 2004, SCIENCE, V306, P2267, DOI 10.1126/science.1103233; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X	45	636	673	5	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					987	1001		10.1016/j.cell.2006.03.046	http://dx.doi.org/10.1016/j.cell.2006.03.046			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751106	Bronze			2022-12-24	WOS:000238116400023
J	Olsen, A; Vantipalli, MC; Lithgow, GJ				Olsen, Anders; Vantipalli, Maithili C.; Lithgow, Gordon J.			Checkpoint proteins control survival of the postmitotic cells in Caenorhabditis elegans	SCIENCE			English	Article							CYTOPLASMIC POLY(A) POLYMERASE; S-M CHECKPOINT; LIFE-SPAN; C-ELEGANS; MESSENGER-RNA; DNA-DAMAGE; DAF-16; LONGEVITY; SIGNALS; GENE	Checkpoints are evolutionarily conserved signaling mechanisms that arrest cell division and alter cellular stress resistance in response to DNA damage or stalled replication forks. To study the consequences of loss of checkpoint functions in whole animals, checkpoint genes were inactivated in the nematode C. elegans. We show that checkpoint proteins are not only essential for normal development but also determine adult somatic maintenance. Checkpoint proteins play a role in the survival of postmitotic adult cells.	Buck Inst, Novato, CA 94945 USA	Buck Institute for Research on Aging	Lithgow, GJ (corresponding author), Buck Inst, 8001 Redwood Blvd, Novato, CA 94945 USA.	glithgow@buckinstitute.org	Olsen, Anders/T-7301-2018; Olsen, Anders/N-8284-2019	Olsen, Anders/0000-0002-9613-9722; Olsen, Anders/0000-0002-9613-9722	NIA NIH HHS [AG22868, R01 AG022868, AG21069, R01 AG021069, R01 AG021069-04, R01 AG022868-04] Funding Source: Medline; NINDS NIH HHS [NS050789-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS050789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022868, R01AG021069] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ashcroft N, 2002, GENESIS, V33, P1, DOI 10.1002/gene.10083; Ashcroft NR, 1999, DEV BIOL, V206, P15, DOI 10.1006/dbio.1998.9135; Bauer JH, 2005, CURR BIOL, V15, P2063, DOI 10.1016/j.cub.2005.10.051; Brauchle M, 2003, CURR BIOL, V13, P819, DOI 10.1016/S0960-9822(03)00295-1; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Clucas C, 2002, EMBO J, V21, P665, DOI 10.1093/emboj/21.4.665; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Kalogeropoulos N, 2004, CELL CYCLE, V3, P1196; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Saitoh S, 2002, CELL, V109, P563, DOI 10.1016/S0092-8674(02)00753-5; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039; Wang SW, 2000, MOL CELL BIOL, V20, P3234, DOI 10.1128/MCB.20.9.3234-3244.2000; Wodarz D, 2004, ONCOGENE, V23, P7799, DOI 10.1038/sj.onc.1207833; Yokoyama K, 2002, FEBS LETT, V516, P53, DOI 10.1016/S0014-5793(02)02470-5	28	50	62	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 2	2006	312	5778					1381	1385		10.1126/science.1124981	http://dx.doi.org/10.1126/science.1124981			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741121	Green Accepted			2022-12-24	WOS:000237961600056
J	Ashworth, J; Havranek, JJ; Duarte, CM; Sussman, D; Monnat, RJ; Stoddard, BL; Baker, D				Ashworth, Justin; Havranek, James J.; Duarte, Carlos M.; Sussman, Django; Monnat, Raymond J., Jr.; Stoddard, Barry L.; Baker, David			Computational redesign of endonuclease DNA binding and cleavage specificity	NATURE			English	Article							I-CREI; PREDICTION; SITE; RECOMBINATION; RECOGNITION; EVOLUTION	The reprogramming of DNA-binding specificity is an important challenge for computational protein design that tests current understanding of protein - DNA recognition, and has considerable practical relevance for biotechnology and medicine(1-6). Here we describe the computational redesign of the cleavage specificity of the intron-encoded homing endonuclease I-MsoI(7) using a physically realistic atomic-level forcefield(8,9). Using an in silico screen, we identified single base-pair substitutions predicted to disrupt binding by the wild-type enzyme, and then optimized the identities and conformations of clusters of amino acids around each of these unfavourable substitutions using Monte Carlo sampling(10). A redesigned enzyme that was predicted to display altered target site specificity, while maintaining wild-type binding affinity, was experimentally characterized. The redesigned enzyme binds and cleaves the redesigned recognition site similar to 10,000 times more effectively than does the wild-type enzyme, with a level of target discrimination comparable to the original endonuclease. Determination of the structure of the redesigned nuclease-recognition site complex by X-ray crystallography confirms the accuracy of the computationally predicted interface. These results suggest that computational protein design methods can have an important role in the creation of novel highly specific endonucleases for gene therapy and other applications.	Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Ashworth, J (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	ashwortj@u.washington.edu; dabaker@u.washington.edu	Duarte Quesada, Carlos Manuel/ABD-6208-2021; Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Ashworth, Justin/0000-0003-4835-6551	NATIONAL CANCER INSTITUTE [R01CA088942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049857] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA088942-05, R01 CA088942] Funding Source: Medline; NIGMS NIH HHS [R01 GM049857, R01 GM049857-12] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnould S, 2006, J MOL BIOL, V355, P443, DOI 10.1016/j.jmb.2005.10.065; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chevalier B, 2003, J MOL BIOL, V329, P253, DOI 10.1016/S0022-2836(03)00447-9; Doyon JB, 2006, J AM CHEM SOC, V128, P2477, DOI 10.1021/ja057519l; Dunbrack RL, 1997, PROTEIN SCI, V6, P1661, DOI 10.1002/pro.5560060807; Gouble A, 2006, J GENE MED, V8, P616, DOI 10.1002/jgm.879; Havranek JJ, 2004, J MOL BIOL, V344, P59, DOI 10.1016/j.jmb.2004.09.029; Heath PJ, 1997, NAT STRUCT BIOL, V4, P468, DOI 10.1038/nsb0697-468; Kono H, 1999, PROTEINS, V35, P114, DOI 10.1002/(SICI)1097-0134(19990401)35:1<114::AID-PROT11>3.0.CO;2-T; Lucas P, 2001, NUCLEIC ACIDS RES, V29, P960, DOI 10.1093/nar/29.4.960; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Morozov AV, 2005, NUCLEIC ACIDS RES, V33, P5781, DOI 10.1093/nar/gki875; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Pabo CO, 2000, J MOL BIOL, V301, P597, DOI 10.1006/jmbi.2000.3918; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Press WH., 1992, NUMERICAL RECIPES C; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Seligman LM, 2002, NUCLEIC ACIDS RES, V30, P3870, DOI 10.1093/nar/gkf495; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Sussman D, 2004, J MOL BIOL, V342, P31, DOI 10.1016/j.jmb.2004.07.031; Uil TG, 2003, NUCLEIC ACIDS RES, V31, P6064, DOI 10.1093/nar/gkg815; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Voigt CA, 2000, J MOL BIOL, V299, P789, DOI 10.1006/jmbi.2000.3758; Wickelgren I, 2003, SCIENCE, V300, P1646, DOI 10.1126/science.300.5626.1646	26	254	321	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					656	659		10.1038/nature04818	http://dx.doi.org/10.1038/nature04818			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16738662	Green Accepted			2022-12-24	WOS:000237920800052
J	Posfai, G; Plunkett, G; Feher, T; Frisch, D; Keil, GM; Umenhoffer, K; Kolisnychenko, V; Stahl, B; Sharma, SS; de Arruda, M; Burland, V; Harcum, SW; Blattner, FR				Posfai, G; Plunkett, G; Feher, T; Frisch, D; Keil, GM; Umenhoffer, K; Kolisnychenko, V; Stahl, B; Sharma, SS; de Arruda, M; Burland, V; Harcum, SW; Blattner, FR			Emergent properties of reduced-genome Escherichia coli	SCIENCE			English	Article							D-CYCLOSERINE; MUTANTS; CELLS; K-12	With the use of synthetic biology, we reduced the Escherichia coli K-12 genome by making planned, precise deletions. The multiple-deletion series (MDS) strains, with genome reductions up to 15%, were designed by identifying nonessential genes and sequences for elimination, including recombinogenic or mobile DNA and cryptic virulence genes, while preserving good growth profiles and protein production. Genome reduction also led to unanticipated beneficial properties: high electroporation efficiency and accurate propagation of recombinant genes and plasmids that were unstable in other strains. Eradication of stress-induced transposition evidently stabilized the MDS genomes and provided some of the new properties.	Biol Res Ctr, Inst Biochem, H-6726 Szeged, Hungary; Scarab Genom LLC, Madison, WI 53713 USA; Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI 53706 USA; Friedrich Loeffler Inst, Inst Mol Biol, Fed Res Ctr Virus Dis Anim, D-17493 Greifswald, Germany; Clemson Univ, Dept Chem & Biomol Engn, Clemson, SC 29634 USA; Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Friedrich Loeffler Institute; Clemson University; Clemson University	Posfai, G (corresponding author), Biol Res Ctr, Inst Biochem, H-6726 Szeged, Hungary.	posfaigy@nucleus.szbk.u-szeged.hu; fred@genome.wisc.edu	Plunkett, Guy/B-8058-2009; Feher, Tamas/AAH-4479-2019; Harcum, Sarah Waterman/AAG-5431-2021	Plunkett, Guy/0000-0003-1422-469X; Feher, Tamas/0000-0001-9318-3640; Harcum, Sarah Waterman/0000-0001-9417-0489	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035682] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM35682] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; CHATTERJEE SK, COMMUNICATION; Feher T, 2006, MUTAT RES-FUND MOL M, V595, P184, DOI 10.1016/j.mrfmmm.2005.11.004; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Hall BG, 1998, MOL BIOL EVOL, V15, P1; Hashimoto M, 2005, MOL MICROBIOL, V55, P137, DOI 10.1111/j.1365-2958.2004.04386.x; HAYASHI K, 2006, MOL SYST BIOL, V2, pE1, DOI [DOI 10.1038/MSB4100049, 10.1038/MSB4100049]; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; KISS A, COMMUNICATION; Kolisnychenko V, 2002, GENOME RES, V12, P640, DOI 10.1101/gr.217202; MEYERS G, 1991, VIROLOGY, V184, P664, DOI 10.1016/0042-6822(91)90436-F; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; RUSSELL RRB, 1972, J BACTERIOL, V111, P622, DOI 10.1128/JB.111.2.622-624.1972; Santat L, 2005, P NATL ACAD SCI USA, V102, P11053, DOI 10.1073/pnas.0502902102; Sekine Y, 1997, GENE, V191, P183, DOI 10.1016/S0378-1119(97)00057-7; Serres MH, 2004, NUCLEIC ACIDS RES, V32, pD300, DOI 10.1093/nar/gkh087; WARGEL RJ, 1971, J BACTERIOL, V105, P1028, DOI 10.1128/JB.105.3.1028-1035.1971; Yu BJ, 2002, NAT BIOTECHNOL, V20, P1018, DOI 10.1038/nbt740	19	482	537	1	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1044	1046		10.1126/science.1126439	http://dx.doi.org/10.1126/science.1126439			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16645050				2022-12-24	WOS:000237628800043
J	Gilchrist, M; Thorsson, V; Li, B; Rust, AG; Korb, M; Kennedy, K; Hai, T; Bolouri, H; Aderem, A				Gilchrist, M; Thorsson, V; Li, B; Rust, AG; Korb, M; Kennedy, K; Hai, T; Bolouri, H; Aderem, A			Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4	NATURE			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; APOPTOSIS; IDENTIFICATION; EXPRESSION; CELLS; CREB; RNAS; P53	The innate immune system is absolutely required for host defence, but, uncontrolled, it leads to inflammatory disease. This control is mediated, in part, by cytokines that are secreted by macrophages. Immune regulation is extraordinarily complex, and can be best investigated with systems approaches ( that is, using computational tools to predict regulatory networks arising from global, high-throughput data sets). Here we use cluster analysis of a comprehensive set of transcriptomic data derived from Toll-like receptor (TLR)-activated macrophages to identify a prominent group of genes that appear to be regulated by activating transcription factor 3 (ATF3), a member of the CREB/ATF family of transcription factors. Network analysis predicted that ATF3 is part of a transcriptional complex that also contains members of the nuclear factor (NF)-kappa B family of transcription factors. Promoter analysis of the putative ATF3-regulated gene cluster demonstrated an over-representation of closely apposed ATF3 and NF-kappa B binding sites, which was verified by chromatin immunoprecipitation and hybridization to a DNA microarray. This cluster included important cytokines such as interleukin (IL)-6 and IL-12b. ATF3 and Rel ( a component of NF-kappa B) were shown to bind to the regulatory regions of these genes upon macrophage activation. A kinetic model of Il6 and Il12b messenger RNA expression as a function of ATF3 and NF-kappa B promoter binding predicted that ATF3 is a negative regulator of Il6 and Il12b transcription, and this hypothesis was validated using Atf3-null mice. ATF3 seems to inhibit Il6 and Il12b transcription by altering chromatin structure, thereby restricting access to transcription factors. Because ATF3 is itself induced by lipopolysaccharide, it seems to regulate TLR-stimulated inflammatory responses as part of a negative-feedback loop.	Inst Syst Biol, Seattle, WA 98103 USA; Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	Institute for Systems Biology (ISB); University System of Ohio; Ohio State University	Aderem, A (corresponding author), Inst Syst Biol, Seattle, WA 98103 USA.	aaderem@systemsbiology.org	Eckhardt, Erik/G-1567-2010; Hai, Tsonwin/E-3185-2011; Hai, Tsonwin/H-4480-2011	Hai, Tsonwin/0000-0003-4510-0315; Hai, Tsonwin/0000-0003-4510-0315; Rust, Alistair/0000-0001-7287-192X				Aderem A, 2005, CELL, V121, P511, DOI 10.1016/j.cell.2005.04.020; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Furumatsu T, 2005, J BIOL CHEM, V280, P35203, DOI 10.1074/jbc.M502409200; Gilchrist M, 2004, BLOOD, V104, P462, DOI 10.1182/blood-2003-08-2990; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Hua B, 2006, J BIOL CHEM, V281, P1620, DOI 10.1074/jbc.M508471200; Ishiguro T, 1996, CANCER RES, V56, P875; Ishiguro T, 2000, JPN J CANCER RES, V91, P833, DOI 10.1111/j.1349-7006.2000.tb01021.x; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kawauchi J, 2002, J BIOL CHEM, V277, P39025, DOI 10.1074/jbc.M202974200; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Lewis S.E., 2003, GENOME BIOL, V3, P1, DOI [10.1186/gb-2002-3-12-research0082, DOI 10.1186/GB-2002-3-12-RESEARCH0082]; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Royet J, 2005, CURR OPIN IMMUNOL, V17, P11, DOI 10.1016/j.coi.2004.12.002; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Suthram S, 2005, NATURE, V438, P108, DOI 10.1038/nature04135; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Thijs G, 2002, BIOINFORMATICS, V18, P331, DOI 10.1093/bioinformatics/18.2.331; THORSSON VT, 2005, STAT APPL GEN MOL BI, V4, P1; Werner T, 2001, BIOMOL ENG, V17, P87, DOI 10.1016/S1389-0344(00)00071-X; Yan CH, 2005, EMBO J, V24, P2425, DOI 10.1038/sj.emboj.7600712; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403	27	608	633	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2006	441	7090					173	178		10.1038/nature04768	http://dx.doi.org/10.1038/nature04768			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16688168				2022-12-24	WOS:000237418800036
J	Olson, LE; Tollkuhn, J; Scafoglio, C; Krones, A; Zhang, J; Ohgi, KA; Wu, W; Taketo, MM; Kemler, R; Grosschedl, R; Rose, D; Li, X; Rosenfeld, MG				Olson, Lorin E.; Tollkuhn, Jessica; Scafoglio, Claudio; Krones, Anna; Zhang, Jie; Ohgi, Kenneth A.; Wu, Wei; Taketo, Makoto M.; Kemler, Rolf; Grosschedl, Rudolf; Rose, Dave; Li, Xue; Rosenfeld, Michael G.			Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination	CELL			English	Article							WNT SIGNALING PATHWAY; STEM-CELLS; PITUITARY DEVELOPMENT; COREPRESSOR COMPLEX; WNT/BETA-CATENIN; XENOPUS EMBRYOS; AXIS FORMATION; PIT-1 GENE; TRANSCRIPTION; MICE	While the biological roles of canonical Wnt/beta-catenin signaling in development and disease are well documented, understanding the molecular logic underlying the functionally distinct nuclear transcriptional programs mediating the diverse functions of beta-catenin remains a major challenge. Here, we report an unexpected strategy for beta-catenin-dependent regulation of cell-lineage determination based on interactions between beta-catenin and a specific homeodomain factor, Prop1, rather than Lef/Tcfs. beta-catenin acts as a binary switch to simultaneously activate expression of the critical lineage-determining transcription factor, Pit1, and to repress the gene encoding the lineage-inhibiting transcription factor, Hesx1, acting via TLE/Reptin/HDAC1 corepressor complexes. The strategy of functionally distinct actions of a homeodomain factor in response to Wnt signaling is suggested to be prototypic of a widely used mechanism for generating diverse cell types from pluripotent precursor cells in response to common signaling pathways during organogenesis.	Harvard Univ, Sch Med, Dept Pathol, Dept Surg Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA; Univ Calif San Diego, Sch Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; Max Planck Inst Immunbiol, D-79108 Freiburg, Germany; Univ Calif San Diego, Sch Med, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; Univ Naples, Dottorato Ricerca Oncol Med & Chirurg & Immunol, I-80138 Naples, Italy; Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; University of California System; University of California San Diego; Max Planck Society; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Naples Federico II; Kyoto University	Li, X (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Dept Surg Oncol, Boston, MA 02115 USA.	sean.li@childrens.harvard.edu; mrosenfeld@ucsd.edu	Scafoglio, Claudio/I-9489-2012	Tollkuhn, Jessica/0000-0001-5991-7620; Scafoglio, Claudio/0000-0003-1188-8124	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK064744] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 064744] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Bauer A, 2000, EMBO J, V19, P6121, DOI 10.1093/emboj/19.22.6121; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Brault V, 2001, DEVELOPMENT, V128, P1253; Brinkmeier ML, 2003, MOL ENDOCRINOL, V17, P2152, DOI 10.1210/me.2003-0225; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Cha KB, 2004, MECH DEVELOP, V121, P183, DOI 10.1016/j.mod.2003.12.002; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; Dasen JS, 2001, GENE DEV, V15, P3193, DOI 10.1101/gad.932601; Dasen JS, 2001, ANNU REV NEUROSCI, V24, P327, DOI 10.1146/annurev.neuro.24.1.327; DiMattia GE, 1997, DEV BIOL, V182, P180, DOI 10.1006/dbio.1996.8472; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Gage PJ, 1996, MOL ENDOCRINOL, V10, P1570, DOI 10.1210/me.10.12.1570; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hermesz E, 1996, DEVELOPMENT, V122, P41; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kleber M, 2004, CURR OPIN CELL BIOL, V16, P681, DOI 10.1016/j.ceb.2004.08.006; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; LEW D, 1993, GENE DEV, V7, P683, DOI 10.1101/gad.7.4.683; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Martinez-Barbera JP, 2000, DEV BIOL, V223, P422, DOI 10.1006/dbio.2000.9757; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Murtaugh LC, 2005, DEVELOPMENT, V132, P4663, DOI 10.1242/dev.02063; Nasonkin IO, 2004, HUM MOL GENET, V13, P2727, DOI 10.1093/hmg/ddh311; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; RHODES SJ, 1993, GENE DEV, V7, P913, DOI 10.1101/gad.7.6.913; Scully KM, 2002, SCIENCE, V295, P2231, DOI 10.1126/science.1062736; SIMMONS DM, 1990, GENE DEV, V4, P695, DOI 10.1101/gad.4.5.695; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0; Tago K, 2000, GENE DEV, V14, P1741; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Watkins-Chow DE, 1998, TRENDS GENET, V14, P284, DOI 10.1016/S0168-9525(98)01476-0; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	61	210	216	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					593	605		10.1016/j.cell.2006.02.046	http://dx.doi.org/10.1016/j.cell.2006.02.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678101	Bronze			2022-12-24	WOS:000237506100023
J	Kuiken, T; Holmes, EC; McCauley, J; Rimmelzwaan, GF; Williams, CS; Grenfell, BT				Kuiken, T; Holmes, EC; McCauley, J; Rimmelzwaan, GF; Williams, CS; Grenfell, BT			Host species barriers to influenza virus infections	SCIENCE			English	Editorial Material							H5N1 INFECTION; DISEASE; FITNESS; EPIDEMIOLOGY; DETERMINANTS; TRANSMISSION; EVOLUTION; VIRULENCE; DYNAMICS; IMMUNITY		Erasmus MC, Dept Virol, NL-3015 GE Rotterdam, Netherlands; Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; Inst Anim Hlth, Comp Lab, Newbury RG20 7NN, Berks, England; NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Erasmus University Rotterdam; Erasmus MC; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Kuiken, T (corresponding author), Erasmus MC, Dept Virol, NL-3015 GE Rotterdam, Netherlands.	t.kuiken@erasmusmc.nl	Holmes, Edward/GVR-9499-2022; Holmes, Edward/Y-2789-2019	Holmes, Edward/0000-0001-9596-3552; Kuiken, Thijs/0000-0001-5501-9049				ANDERSON R M, 1991; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Baigent SJ, 2003, BIOESSAYS, V25, P657, DOI 10.1002/bies.10303; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Crawford PC, 2005, SCIENCE, V310, P482, DOI 10.1126/science.1117950; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Fenton A, 2005, EMERG INFECT DIS, V11, P1815, DOI 10.3201/eid1112.050306; Ferguson NM, 2003, NATURE, V425, P681, DOI 10.1038/nature02007; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Keawcharoen J, 2004, EMERG INFECT DIS, V10, P2189, DOI 10.3201/eid1012.040759; Kobasa D, 1999, J VIROL, V73, P6743, DOI 10.1128/JVI.73.8.6743-6751.1999; Kuiken T, 2005, SCIENCE, V309, P1680, DOI 10.1126/science.1113310; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; MURPHY BR, 1996, FIELDS VIROLOGY, V1, pCH46; Olofsson S, 2005, LANCET INFECT DIS, V5, P184, DOI 10.1016/S1473-3099(05)01311-3; Rimmelzwaan GF, 2006, AM J PATHOL, V168, P176, DOI 10.2353/ajpath.2006.050466; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Slingenbergh J, 2004, REV SCI TECH OIE, V23, P467, DOI 10.20506/rst.23.2.1492; SMITH H, 1988, REV INFECT DIS, V10, P56; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Viboud C, 2005, J INFECT DIS, V192, P233, DOI 10.1086/431150; Webster RG, 2004, LANCET, V363, P234, DOI 10.1016/S0140-6736(03)15329-9; Woelk CH, 2002, MOL BIOL EVOL, V19, P2333, DOI 10.1093/oxfordjournals.molbev.a004059; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Xia YC, 2005, J R STAT SOC C-APPL, V54, P659, DOI 10.1111/j.1467-9876.2005.05383.x	38	286	306	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2006	312	5772					394	397		10.1126/science.1122818	http://dx.doi.org/10.1126/science.1122818			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034OZ	16627737				2022-12-24	WOS:000236941800038
J	Saleh, M; Mathison, JC; Wolinski, MK; Bensinger, SJ; Fitzgerald, P; Droin, N; Ulevitch, RJ; Green, DR; Nicholson, DW				Saleh, M; Mathison, JC; Wolinski, MK; Bensinger, SJ; Fitzgerald, P; Droin, N; Ulevitch, RJ; Green, DR; Nicholson, DW			Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice	NATURE			English	Article							STRESS-INDUCED APOPTOSIS; CELL-DEATH; ACTIVATION; SURVIVAL; BETA; DEFICIENT; CASPASE-4; ENZYME	Caspases function in both apoptosis and inflammatory cytokine processing and thereby have a role in resistance to sepsis(1). Here we describe a novel role for a caspase in dampening responses to bacterial infection. We show that in mice, gene-targeted deletion of caspase-12 renders animals resistant to peritonitis and septic shock. The resulting survival advantage was conferred by the ability of the caspase-12-deficient mice to clear bacterial infection more efficiently than wild-type littermates. Caspase-12 dampened the production of the pro-inflammatory cytokines interleukin (IL)-1 beta, IL- 18 (interferon (IFN)-gamma inducing factor) and IFN-gamma, but not tumour-necrosis factor-alpha and IL- 6, in response to various bacterial components that stimulate Toll-like receptor and NOD pathways. The IFN-gamma pathway was crucial in mediating survival of septic caspase-12-deficient mice, because administration of neutralizing antibodies to IFN-gamma receptors ablated the survival advantage that otherwise occurred in these animals. Mechanistically, caspase-12 associated with caspase-1 and inhibited its activity. Notably, the protease function of caspase-12 was not necessary for this effect, as the catalytically inactive caspase-12 mutant Cys299Ala also inhibited caspase-1 and IL-1 beta production to the same extent as wild-type caspase-12. In this regard, caspase-12 seems to be the cFLIP counterpart for regulating the inflammatory branch of the caspase cascade. In mice, caspase-12 deficiency confers resistance to sepsis and its presence exerts a dominant-negative suppressive effect on caspase-1, resulting in enhanced vulnerability to bacterial infection and septic mortality.	Merck Res Labs, Rahway, NJ 07065 USA; La Jolla Inst Allergy & Immunol, Dept Cellular Immunol, San Diego, CA 92121 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Merck & Company; La Jolla Institute for Immunology; Scripps Research Institute	Green, DR (corresponding author), Merck Res Labs, Rahway, NJ 07065 USA.	douglas.green@stjude.org; donald_nicholson@merck.com	Green, Douglas R/N-8083-2018; Ulevitch, Richard J/Q-3393-2017; Droin, Nathalie M/Y-5506-2018	Green, Douglas R/0000-0002-7332-1417; Droin, Nathalie M/0000-0002-6099-5324; Saleh, Maya/0000-0003-1538-9146				Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Hotchkiss RS, 2003, P NATL ACAD SCI USA, V100, P6724, DOI 10.1073/pnas.1031788100; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Joshi VD, 2002, INFECT IMMUN, V70, P6896, DOI 10.1128/IAI.70.12.6896-6903.2002; Kalai M, 2003, J CELL BIOL, V162, P457, DOI 10.1083/jcb.200303157; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Obeng EA, 2005, J BIOL CHEM, V280, P29578, DOI 10.1074/jbc.M502685200; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Rasper DM, 1998, CELL DEATH DIFFER, V5, P271, DOI 10.1038/sj.cdd.4400370; Saleh M, 2004, NATURE, V429, P75, DOI 10.1038/nature02451; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Zantl N, 1998, INFECT IMMUN, V66, P2300, DOI 10.1128/IAI.66.5.2300-2309.1998	18	257	275	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2006	440	7087					1064	1068		10.1038/nature04656	http://dx.doi.org/10.1038/nature04656			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16625199				2022-12-24	WOS:000236906000039
J	Chikashige, Y; Tsutsumi, C; Yamane, M; Kamasa, K; Haraguchi, T; Hiraoka, Y				Chikashige, Y; Tsutsumi, C; Yamane, M; Kamasa, K; Haraguchi, T; Hiraoka, Y			Meiotic proteins Bqt1 and Bqt2 tether telomeres to form the bouquet arrangement of chromosomes	CELL			English	Article							SPINDLE POLE BODY; YEAST SCHIZOSACCHAROMYCES-POMBE; OSCILLATORY NUCLEAR-MOVEMENT; FISSION YEAST; DOMAIN PROTEIN; LIVING CELLS; MEIOSIS; PROPHASE; GENE; RECOMBINATION	In many organisms, meiotic chromosomes are bundled at their telomeres to form a "bouquet" arrangement. The bouquet formation plays an important role in homologous chromosome pairing and therefore progression of meiosis. As meiotic telomere clustering occurs in response to mating pheromone signaling in fission yeast, we looked for factors essential for bouquet formation among genes induced under mating pheromone signaling. This genome-wide search identified two proteins, Bqt1 and Bqt2, that connect telomeres to the spindle-pole body (SPB; the centrosome equivalent in fungi). Neither Bqt1 nor Bqt2 alone functions as a connector, but together the two proteins form a bridge between Rap1 (a telomere protein) and Sad1 (an SPB protein). Significantly, when both Bqt1 and Bqt2 are ectopically expressed in mitotic cells, they also form a bridge between Rap1 and Sad1. Thus, a complex including Bqt1 and Bqt2 is essential for connecting telomeres to the SPB.	Natl Inst Informat & Commun Technol, Kansai Adv Res ctr, Cell Biol Grp, Nishi Ku, Kobe, Hyogo 6512492, Japan; Natl Inst Informat & Commun Technol, Kansai Adv Res ctr, CREST Res Project, Nishi Ku, Kobe, Hyogo 6512492, Japan; Osaka Univ, Grad Sch Sci, Dept Biol, Toyonaka, Osaka 5600043, Japan	National Institute of Information & Communications Technology (NICT) - Japan; Japan Science & Technology Agency (JST); National Institute of Information & Communications Technology (NICT) - Japan; Osaka University	Hiraoka, Y (corresponding author), Natl Inst Informat & Commun Technol, Kansai Adv Res ctr, Cell Biol Grp, Nishi Ku, 588-2 Iwaoka, Kobe, Hyogo 6512492, Japan.	yasushi@nict.go.jp	Hiraoka, Yasushi/B-5111-2009	Hiraoka, Yasushi/0000-0001-9407-8228				Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CHIKASHIGE Y, 1994, SCIENCE, V264, P270, DOI 10.1126/science.8146661; Chikashige Y, 2004, GENES CELLS, V9, P671, DOI 10.1111/j.1356-9597.2004.00760.x; Chikashige Y, 1997, EMBO J, V16, P193, DOI 10.1093/emboj/16.1.193; Chikashige Y, 2001, CURR BIOL, V11, P1618, DOI 10.1016/S0960-9822(01)00457-2; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Cooper JP, 1998, NATURE, V392, P828, DOI 10.1038/33947; Cooper JP, 2000, CURR OPIN GENET DEV, V10, P169; Cunliffe L, 2004, MOL GENET GENOMICS, V271, P60, DOI 10.1007/s00438-003-0956-6; Ding DQ, 2004, DEV CELL, V6, P329, DOI 10.1016/S1534-5807(04)00059-0; Ding DQ, 1998, J CELL SCI, V111, P701; Flory MR, 2004, MOL CELL, V16, P619, DOI 10.1016/j.molcel.2004.10.027; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Goto B, 2001, J CELL SCI, V114, P2427; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; HAGAN I, 1995, J CELL BIOL, V129, P1033, DOI 10.1083/jcb.129.4.1033; HAGAN IM, 1988, J CELL SCI, V89, P343; Haraguchi T, 1999, CELL STRUCT FUNCT, V24, P291, DOI 10.1247/csf.24.291; Hassold T, 1996, ENVIRON MOL MUTAGEN, V28, P167; IMAI Y, 1994, GENE DEV, V8, P328, DOI 10.1101/gad.8.3.328; Jin Y, 2002, GENETICS, V160, P861; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Krawchuk MD, 1999, YEAST, V15, P1419, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Malone CJ, 2003, CELL, V115, P825, DOI 10.1016/S0092-8674(03)00985-1; Miki F, 2004, MOL GENET GENOMICS, V270, P449, DOI 10.1007/s00438-003-0938-8; Miki F, 2002, MOL BIOL CELL, V13, P930, DOI 10.1091/mbc.01-11-0543; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nickas ME, 2003, EUKARYOT CELL, V2, P431, DOI 10.1128/EC.2.3.431-445.2003; Nimmo ER, 1998, NATURE, V392, P825, DOI 10.1038/33941; Scherthan H, 2001, NAT REV MOL CELL BIO, V2, P621, DOI 10.1038/35085086; Shimanuki M, 1997, MOL GEN GENET, V254, P238, DOI 10.1007/s004380050412; Starr DA, 2003, J CELL SCI, V116, P211, DOI 10.1242/jcs.00248; Starr DA, 2001, DEVELOPMENT, V128, P5039; SVOBODA A, 1995, CHROMOSOMA, V104, P203, DOI 10.1007/s004120050109; Tanaka K, 2001, EMBO J, V20, P5779, DOI 10.1093/emboj/20.20.5779; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Wood V, 2003, NATURE, V421, P94, DOI 10.1038/nature01203; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yamamoto A, 1999, J CELL BIOL, V145, P1233, DOI 10.1083/jcb.145.6.1233; Yamamoto A, 2001, BIOESSAYS, V23, P526, DOI 10.1002/bies.1072; Yamamoto TG, 2004, J CELL SCI, V117, P3875, DOI 10.1242/jcs.01248; ZHONG Z, 1992, MOL CELL BIOL, V12, P4834, DOI 10.1128/MCB.12.11.4834	46	260	271	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2006	125	1					59	69		10.1016/j.cell.2006.01.048	http://dx.doi.org/10.1016/j.cell.2006.01.048			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615890	Bronze			2022-12-24	WOS:000237314200014
J	Giraudo, CG; Eng, WS; Melia, TJ; Rothman, JE				Giraudo, Claudio G.; Eng, William S.; Melia, Thomas J.; Rothman, James E.			A clamping mechanism involved in SNARE-dependent exocytosis	SCIENCE			English	Article							NEUROTRANSMITTER RELEASE; SYNAPTOTAGMIN-I; MEMBRANE-FUSION; VESICLE EXOCYTOSIS; CA2+ SENSOR; COMPLEX; BINDING; DETERMINANTS; NEUROTOXINS; SPECIFICITY	During neurotransmitter release at the synapse, influx of calcium ions stimulates the release of neurotransmitter. However, the mechanism by which synaptic vesicle fusion is coupled to calcium has been unclear, despite the identification of both the core fusion machinery [soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE)] and the principal calcium sensor (synaptotagmin). Here, we describe what may represent a basic principle of the coupling mechanism: a reversible clamping protein (complexin) that can freeze the SNAREpin, an assembled fusion-competent intermediate en route to fusion. When calcium binds to the calcium sensor synaptotagmin, the clamp would then be released. SNARE proteins, and key regulators like synaptotagmin and complexin, can be ectopically expressed on the cell surface. Celts expressing such "flipped" synaptic SNARES fuse constitutively, but when we coexpressed complexin, fusion was blocked. Adding back calcium triggered fusion from this intermediate in the presence of synaptotagmin.	Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University	Rothman, JE (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.	jr2269@columbia.edu						Archer DA, 2002, J BIOL CHEM, V277, P18249, DOI 10.1074/jbc.C200166200; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; BELTZER JP, 1991, J BIOL CHEM, V266, P973; BHALLA A, 2006, NAT STRUCT MOL BIOL; BRACHER A, 2002, J BIOL CHEM; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Giraudo CG, 2005, J CELL BIOL, V170, P249, DOI 10.1083/jcb.200501093; Heinz DW, 1998, J MOL BIOL, V275, P635, DOI 10.1006/jmbi.1997.1490; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Hu KA, 2002, J BIOL CHEM, V277, P41652, DOI 10.1074/jbc.M205044200; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; ISHIZUKA T, 1995, BIOCHEM BIOPH RES CO, V213, P1107, DOI 10.1006/bbrc.1995.2241; Koh TW, 2003, TRENDS NEUROSCI, V26, P413, DOI 10.1016/S0166-2236(03)00195-4; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Mahal LK, 2002, J CELL BIOL, V158, P273, DOI 10.1083/jcb.200203135; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Ono S, 1998, EUR J NEUROSCI, V10, P2143, DOI 10.1046/j.1460-9568.1998.00225.x; Pabst S, 2002, J BIOL CHEM, V277, P7838, DOI 10.1074/jbc.M109507200; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Pellizzari R, 1996, J BIOL CHEM, V271, P20353, DOI 10.1074/jbc.271.34.20353; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Reim K, 2005, J CELL BIOL, V169, P669, DOI 10.1083/jcb.200502115; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Rhee JS, 2005, P NATL ACAD SCI USA, V102, P18664, DOI 10.1073/pnas.0509153102; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TAKAHASHI S, 1995, FEBS LETT, V368, P455, DOI 10.1016/0014-5793(95)00713-J; Tokumaru H, 2001, CELL, V104, P421, DOI 10.1016/S0092-8674(01)00229-X; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X	36	264	275	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2006	313	5787					676	680		10.1126/science.1129450	http://dx.doi.org/10.1126/science.1129450			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072IQ	16794037				2022-12-24	WOS:000239667500046
J	Khor, WB; Aung, T; Saw, SM; Wong, TY; Tambyah, PA; Tan, AL; Beuerman, R; Lim, L; Chan, WK; Heng, WJ; Lim, J; Loh, RSK; Lee, SB; Tan, DTH				Khor, Wei-Boon; Aung, Tin; Saw, Seang-Mei; Wong, Tien-Yin; Tambyah, Paul A.; Tan, Ai-Ling; Beuerman, Roger; Lim, Li; Chan, Wing-Kwong; Heng, Wee-Jin; Lim, Jimmy; Loh, Raymond S. K.; Lee, Sao-Bing; Tan, Donald T. H.			An outbreak of Fusarium keratitis associated with contact lens wear in Singapore	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FUNGAL KERATITIS; MICROBIAL KERATITIS; ULCERATIVE KERATITIS; SOUTH FLORIDA; RISK-FACTORS; SPECTRUM; ENDOPHTHALMITIS; VORICONAZOLE; ULCERS	Context Fungal keratitis is a potentially blinding condition that is rarely seen with contact lens wear. Objective To describe a nationwide outbreak of fungal keratitis caused by Fusarium species among contact lens wearers in Singapore. Design, Setting, and Patients Nationwide, hospital-based case series. All cases of fungal keratitis among contact lens wearers in all ophthalmology departments in Singapore were reviewed along with the charts of all contact lens wearers with culture-proven fungal keratitis from March 2005 through May 2006. A standardized telephone interview was conducted to obtain additional clinical information. Main Outcome Measure Diagnosis of Fusarium keratitis associated with contact lens wear. Results During the study period, 66 patients ( 68 affected eyes) were diagnosed with Fusarium keratitis associated with contact lens wear; the estimated annual national incidence is 2.35 cases per 10 000 contact lens wearers (95% confidence interval, 0.62-7.22). Patients ranged in age from 13 to 44 years ( mean [SD], 27.1 [8.4] years), of which 32 (48.5%) were men. The vast majority ( 65 patients; 98.5%) wore soft, disposable contact lenses; 62 patients (93.9%) reported using 1 brand of contact lens cleaning solution (ReNu, Bausch & Lomb, Rochester, NY), including 42 patients (63.6%) who recalled using ReNu with MoistureLoc. Most patients (81.8%) reported poor contact lens hygiene practices, including overnight use of daily wear contact lenses (19.7%), and use of contact lenses past the replacement date (43.9%). The final best-corrected visual acuity ranged from 20/20 to 20/80. Five patients ( 5 eyes; 7.4%) required emergency therapeutic or tectonic corneal transplantation. Conclusions A new and evolving epidemic of Fusarium keratitis associated with contact lens wear was found in Singapore. Physicians and eye care practitioners worldwide need to be aware of the likelihood of similar outbreaks emerging among contact lens wearers.	Singapore Eye Res Inst, Singapore 168751, Singapore; Singapore Natl Eye Ctr, Singapore, Singapore; Natl Univ Singapore, Dept Ophthalmol, Yong Loo Lin Sch Med, Singapore 117548, Singapore; Natl Univ Singapore, Dept Community Occupat & Family Med, Yong Loo Lin Sch Med, Singapore 117548, Singapore; Natl Univ Singapore, Dept Med, Yong Loo Lin Sch Med, Singapore 117548, Singapore; Singapore Gen Hosp, Dept Pathol, Singapore 0316, Singapore; Tan Tock Seng Hosp, Dept Ophthalmol, Singapore, Singapore; Changi Gen Hosp, Singapore, Singapore; Natl Univ Singapore Hosp, Dept Ophthalmol, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore; Singapore General Hospital; Tan Tock Seng Hospital; Changi General Hospital; National University of Singapore	Tan, DTH (corresponding author), Singapore Eye Res Inst, 11 3rd Hosp Ave, Singapore 168751, Singapore.	snecdt@pacific.net.sg	Wong, Tien Yin/AAC-9724-2020	Wong, Tien Yin/0000-0002-8448-1264; Khor, Wei Boon/0000-0001-5450-9863				ALFONSO E, 1986, AM J OPHTHALMOL, V101, P429, DOI 10.1016/0002-9394(86)90641-0; ALFONSO E, 2005, ASS RES VIS OPHTH AN; *AM AC OPHTH, RENU MOISTURELOC ID; Bharathi M. Jayahar, 2003, Indian Journal of Ophthalmology, V51, P315; *CDCP, 2006, FUS KER MULT STAT; CHATTERJEE A, 1995, CORNEA, V14, P138; Cheng KH, 1999, LANCET, V354, P181, DOI 10.1016/S0140-6736(98)09385-4; *CTR HLTH PROT, 2006, UPD CAS FUNG CORN IN; DART JKG, 1991, LANCET, V338, P650, DOI 10.1016/0140-6736(91)91231-I; Fong CF, 2004, AM J OPHTHALMOL, V137, P329, DOI 10.1016/j.ajo.2003.09.001; Fridkin SK, 1996, CLIN INFECT DIS, V22, P222, DOI 10.1093/clinids/22.2.222; Hariprasad SM, 2004, ARCH OPHTHALMOL-CHIC, V122, P42, DOI 10.1001/archopht.122.1.42; Hennequin C, 1999, J CLIN MICROBIOL, V37, P3586, DOI 10.1128/JCM.37.11.3586-3589.1999; Lam DSC, 2002, EYE, V16, P608, DOI 10.1038/sj.eye.6700151; Lee Yoon-Chiang Kelvin, 2000, CLAO Journal, V26, P21; LIESEGANG TJ, 1980, AM J OPHTHALMOL, V90, P38, DOI 10.1016/S0002-9394(14)75075-5; Mah-Sadorra JH, 2005, CORNEA, V24, P51, DOI 10.1097/01.ico.0000138839.29823.57; Marangon FB, 2004, AM J OPHTHALMOL, V137, P820, DOI 10.1016/j.ajo.2003.11.078; NELSON PE, 1994, CLIN MICROBIOL REV, V7, P479, DOI 10.1128/CMR.7.4.479-504.1994; PETTIT TH, 1980, ARCH OPHTHALMOL-CHIC, V98, P1025, DOI 10.1001/archopht.1980.01020031015002; ROSA RH, 1994, OPHTHALMOLOGY, V101, P1005; SCHEIN OD, 1994, ARCH OPHTHALMOL-CHIC, V112, P186, DOI 10.1001/archopht.1994.01090140062024; SCHEIN OD, 1989, NEW ENGL J MED, V321, P773, DOI 10.1056/NEJM198909213211201; SCHEIN OD, 1989, CORNEA, V8, P281; Seal D V, 1999, Cont Lens Anterior Eye, V22, P49, DOI 10.1016/S1367-0484(99)80003-4; *SING DEP STAT, 2005, SING RES AG GROUP ET; *SING DEP STAT, POP CENS 2000 CONC D; Sponsel W, 2006, ANTIMICROB AGENTS CH, V50, P262, DOI 10.1128/AAC.50.1.262-268.2006; Srinivasan M, 1997, BRIT J OPHTHALMOL, V81, P965, DOI 10.1136/bjo.81.11.965; STEHRGREEN JK, 1987, JAMA-J AM MED ASSOC, V258, P57, DOI 10.1001/jama.258.1.57; Szklo M, 2004, EPIDEMIOLOGY BASICS; Tabbara KF, 1998, OPHTHALMOLOGY, V105, P522, DOI 10.1016/S0161-6420(98)93037-8; Tan D. T. H., 1995, Annals Academy of Medicine Singapore, V24, P823; Tanure MAG, 2000, CORNEA, V19, P307, DOI 10.1097/00003226-200005000-00010; Thomas PA, 2003, CLIN MICROBIOL REV, V16, P730, DOI 10.1128/CMR.16.4.730-797.2003; *US FDA, 2006, INV SER EYE INF ASS; WILHELMUS K R, 1987, CLAO Journal, V13, P211; WILHELMUS KR, 1988, AM J OPHTHALMOL, V106, P708, DOI 10.1016/0002-9394(88)90705-2; Wong Tien-Yin, 1997, CLAO Journal, V23, P275; Wong TY, 1997, INT OPHTHALMOL, V21, P127, DOI 10.1023/A:1026462631716; Xie LX, 2001, BRIT J OPHTHALMOL, V85, P1070, DOI 10.1136/bjo.85.9.1070	41	178	184	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2006	295	24					2867	2873		10.1001/jama.295.24.2867	http://dx.doi.org/10.1001/jama.295.24.2867			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057DY	16804153	Bronze			2022-12-24	WOS:000238577700024
J	Penalver, E; Grimaldi, DA; Delclos, X				Penalver, Enrique; Grimaldi, David. A.; Delclos, Xavier			Early Cretaceous spider web with its prey	SCIENCE			English	Article									Amer Museum Nat Hist, Dept Entomol, New York, NY 10024 USA; Univ Barcelona, Dept Estratig Paleontol & Geociencies Marines, Fac Geol, E-08028 Barcelona, Spain	American Museum of Natural History (AMNH); University of Barcelona	Grimaldi, DA (corresponding author), Amer Museum Nat Hist, Dept Entomol, New York, NY 10024 USA.	grimaldi@amnh.org	Peñalver, Enrique/AAB-5470-2022; DELCLOS, Xavier/N-1652-2019; DELCLOS, Xavier/D-4363-2014	Peñalver, Enrique/0000-0001-8312-6087; DELCLOS, Xavier/0000-0002-2233-5480; DELCLOS, Xavier/0000-0002-2233-5480				Bond JE, 1998, EVOLUTION, V52, P403, DOI [10.1111/j.1558-5646.1998.tb01641.x, 10.2307/2411077]; Grimaldi David, 2005, pi; NENTWIG W, 1985, OECOLOGIA, V66, P580, DOI 10.1007/BF00379353; Penney D, 2004, T ROY SOC EDIN-EARTH, V94, P275, DOI 10.1017/S0263593300000675; Zschokke S, 2003, NATURE, V424, P636, DOI 10.1038/424636a; ZSCHOKKE S, 2004, EUROPEAN ARACHNOLOGY, P367	6	50	51	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1761	1761		10.1126/science.1126628	http://dx.doi.org/10.1126/science.1126628			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16794072				2022-12-24	WOS:000238452800046
J	Holtmaat, A; Wilbrecht, L; Knott, GW; Welker, E; Svoboda, K				Holtmaat, Anthony; Wilbrecht, Linda; Knott, Graham W.; Welker, Egbert; Svoboda, Karel			Experience-dependent and cell-type-specific spine growth in the neocortex	NATURE			English	Article							RAT BARREL CORTEX; DENDRITIC SPINES; PYRAMIDAL NEURONS; VISUAL-CORTEX; IN-VIVO; CORTICAL PLASTICITY; ADULT CORTEX; SYNAPSES; AMPA; HIPPOCAMPUS	Functional circuits in the adult neocortex adjust to novel sensory experience, but the underlying synaptic mechanisms remain unknown(1). Growth and retraction of dendritic spines with synapse formation and elimination could change brain circuits(2-7). In the apical tufts of layer 5B (L5B) pyramidal neurons in the mouse barrel cortex, a subset of dendritic spines appear and disappear over days, whereas most spines are persistent for months(4-6,8,9). Under baseline conditions, new spines are mostly transient and rarely survive for more than a week. Transient spines tend to be small(4,5,9), whereas persistent spines are usually large(4-6,8,9). Because most excitatory synapses in the cortex occur on spines, and because synapse size(10) and the number of alpha-amino-3- hydroxy-5-methyl-4-isoxazole propionic acid ( AMPA) receptors(11-13) are proportional to spine volume, the excitation of pyramidal neurons is probably driven through synapses on persistent spines. Here we test whether the generation and loss of persistent spines are enhanced by novel sensory experience. We repeatedly imaged dendritic spines for one month after trimming alternate whiskers, a paradigm that induces adaptive functional changes in neocortical circuits(14,15). Whisker trimming stabilized new spines and destabilized previously persistent spines. New-persistent spines always formed synapses. They were preferentially added on L5B neurons with complex apical tufts rather than simple tufts. Our data indicate that novel sensory experience drives the stabilization of new spines on subclasses of cortical neurons. These synaptic changes probably underlie experience-dependent remodelling of specific neocortical circuits.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Univ Lausanne, IBCM, CH-1005 Lausanne, Switzerland	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; GlaxoSmithKline; University of Lausanne	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA.	svoboda@cshl.edu	Wilbrecht, Linda/J-7988-2013	Holtmaat, Anthony/0000-0002-7577-0769; Knott, Graham W/0000-0002-2956-9052				BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CHAGNACAMITAL Y, 1990, J COMP NEUROL, V296, P598, DOI 10.1002/cne.902960407; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; KASPER EM, 1994, J COMP NEUROL, V339, P459, DOI 10.1002/cne.903390402; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; LARKMAN A, 1990, J NEUROSCI, V10, P1407; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Majewska AK, 2006, J NEUROSCI, V26, P3021, DOI 10.1523/JNEUROSCI.4454-05.2006; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Shepherd GMG, 2003, NEURON, V38, P277, DOI 10.1016/S0896-6273(03)00152-1; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tsiola A, 2003, J COMP NEUROL, V461, P415, DOI 10.1002/cne.10628; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	30	461	466	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					979	983		10.1038/nature04783	http://dx.doi.org/10.1038/nature04783			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791195				2022-12-24	WOS:000238422300042
J	Tirosh, A; Mandel, D; Mimouni, FB; Zimlichman, E; Shochat, T; Kochba, I				Tirosh, Amir; Mandel, Dror; Mimouni, Francis B.; Zimlichman, Eyal; Shochat, Tzippora; Kochba, Ilan			Autoimmune diseases in asthma	ANNALS OF INTERNAL MEDICINE			English	Article							HYGIENE HYPOTHESIS; CHILDREN; ALLERGY; TH1; SUPPRESSION; DISORDERS; CHILDHOOD	Background: Previous research has suggested an inverse relationship between T-helper 2-related atopic disorders, such as asthma, and T-helper 1-related autoimmune diseases. One controversial hypothesis postulates that asthma provides a protective effect for the development of autoimmune-related disorders. Objective: To assess the rate of newly diagnosed. autoimmune disorders in a large cohort of young adults. Design: Using cross-sectional data from the Israeli Defense Force database, the authors analyzed the prevalence of auto immune disorders in asthmatic and nonasthmatic military personnel between 1980 and 2003. A follow-up study traced newly diagnosed auto-immune disorders among asthmatic and nonasthmatic individuals from the time of enrollment in military service until discharge (22 and 36 months for women and men, respectively). Setting: General community Patients: 307 367 male and 181 474 female soldiers in compulsory military service who were between 18 and 21 years of age. Measurements: Cases of type 1 diabetes mellitus, vasculitis, immune thrombocytopenic purpura, inflammatory bowel disease, rheumatoid arthritis, and the antiphospholipid syndrome. Results: Of 488 841 participants at enrollment, significantly more women than men had autoimmune disorders. Compared with asthmatic women, nonasthmatic women had a significantly higher prevalence of all autoimmune disorders except for the antiphospholipid syndrome. Type 1 diabetes mellitus, vasculitis, and rheumatoid arthritis were less prevalent in men with asthma than in those without. During the follow-up period, vasculitis and rheumatoid arthritis were more frequently diagnosed in nonasthmatic persons of both sexes. There was a significantly higher incidence of immune thrombocytopenic purpura, inflammatory bowel disease, and the anti phospholipid syndrome in nonasthmatic women and a statistically significantly higher incidence of type 1 diabetes mellitus in nonasthmatic men. Limitations: The study was limited to a population of young military recruits; therefore, its findings are not necessarily applicable to the general population. Because of the noninterventional nature of the study, it describes associations but cannot prove causality. Conclusions: Asthma status may affect the prevalence of. major autoimmune disorders. Preexisting asthma seems to protect against the development of autoimmune disorders to varying degrees in men and women.	Sheba Med Ctr, Dept Internal Med A&C, IL-52662 Tel Hashomer, Israel	Chaim Sheba Medical Center	Tirosh, A (corresponding author), Sheba Med Ctr, Dept Internal Med A&C, IL-52662 Tel Hashomer, Israel.	amirt@bgumail.bgu.ac.il	Mandel, Dror/GRR-6881-2022	Tirosh, Amir/0000-0003-2210-5906				[Anonymous], 2000, Diabetes Care, V23 Suppl 1, pS1; Beagley KW, 2003, FEMS IMMUNOL MED MIC, V38, P13, DOI 10.1016/S0928-8244(03)00202-5; Berger A, 2000, BRIT MED J, V321, P424, DOI 10.1136/bmj.321.7258.424; Caffarelli C, 2004, INT ARCH ALLERGY IMM, V134, P288, DOI 10.1159/000079166; Celedon Juan C, 2004, Treat Respir Med, V3, P291, DOI 10.2165/00151829-200403050-00003; Cutolo M, 2004, LUPUS, V13, P635, DOI 10.1191/0961203304lu1094oa; Cutolo Maurizio, 2002, Autoimmunity Reviews, V1, P284, DOI 10.1016/S1568-9972(02)00064-2; Ente G, 2003, JAMA-J AM MED ASSOC, V289, P842, DOI 10.1001/jama.289.7.842-a; Eskola V, 2003, HORM RES, V59, P195, DOI 10.1159/000069327; *EXP PAN REP 2, 1997, NIH PUBL; Kannisto S, 2000, J CLIN ENDOCR METAB, V85, P652, DOI 10.1210/jc.85.2.652; Kero J, 2001, J ALLERGY CLIN IMMUN, V108, P781, DOI 10.1067/mai.2001.119557; Romagnani S, 2004, IMMUNOLOGY, V112, P352, DOI 10.1111/j.1365-2567.2004.01925.x; Sheikh A, 2003, J ALLERGY CLIN IMMUN, V111, P131, DOI 10.1067/mai.2003.8; Simpson CR, 2002, CLIN EXP ALLERGY, V32, P37, DOI 10.1046/j.0022-0477.2001.01250.x; Singh VK, 1999, IMMUNOL RES, V20, P147, DOI 10.1007/BF02786470; Smit JJ, 2004, CURR OPIN ALLERGY CL, V4, P57, DOI [10.1097/00130832-200402000-00012, 10.1097/01.all.0000113680.18759.17]; Stene LC, 2004, CLIN EXP ALLERGY, V34, P201, DOI 10.1111/j.1365-2222.2004.01864.x; Tanriverdi F, 2003, J ENDOCRINOL, V176, P293, DOI 10.1677/joe.0.1760293; Tulic MK, 2004, LANCET, V363, P1689, DOI 10.1016/S0140-6736(04)16253-3; Weiss ST, 2002, NEW ENGL J MED, V347, P930, DOI 10.1056/NEJMe020092; Wen Jr, 2004, NETWORK THEORY APPLI, V11, P195; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255	23	53	55	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 20	2006	144	12					877	883		10.7326/0003-4819-144-12-200606200-00004	http://dx.doi.org/10.7326/0003-4819-144-12-200606200-00004			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056WJ	16785476				2022-12-24	WOS:000238555500002
J	Matoba, S; Kang, JG; Patino, WD; Wragg, A; Boehm, M; Gavrilova, O; Hurley, PJ; Bunz, F; Hwang, PM				Matoba, Satoaki; Kang, Ju-Gyeong; Patino, Willmar D.; Wragg, Andrew; Boehm, Manfred; Gavrilova, Oksana; Hurley, Paula J.; Bunz, Fred; Hwang, Paul M.			p53 regulates mitochondrial respiration	SCIENCE			English	Article							CANCER-CELLS; LIFE-SPAN; DNA-DAMAGE; MICE; METABOLISM; GENES; IMPAIRMENT; DEFICIENCY; PATHWAYS; CAPACITY	The energy that sustains cancer cells is derived preferentially from glycolysis. This metabolic change, the Warburg effect, was one of the first alterations in cancer cells recognized as conferring a survival advantage. Here, we show that p53, one of the most frequently mutated genes in cancers, modulates the balance between the utilization of respiratory and glycolytic pathways. We identify Synthesis of Cytochrome c Oxidase 2 ( SCO2) as the downstream mediator of this effect in mice and human cancer cell lines. SCO2 is critical for regulating the cytochrome c oxidase ( COX) complex, the major site of oxygen utilization in the eukaryotic cell. Disruption of the SCO2 gene in human cancer cells with wild-type p53 recapitulated the metabolic switch toward glycolysis that is exhibited by p53-deficient cells. That SCO2 couples p53 to mitochondrial respiration provides a possible explanation for the Warburg effect and offers new clues as to how p53 might affect aging and metabolism.	NHLBI, Cardiol Branch, NIH, Bethesda, MD 20892 USA; NIDDKD, Diabet Branch, NIH, Bethesda, MD 20892 USA; Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21231 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Johns Hopkins University; Johns Hopkins Medicine	Hwang, PM (corresponding author), NHLBI, Cardiol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	hwangp@mail.nih.gov		Wragg, Andrew/0000-0002-8934-5712	Intramural NIH HHS Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005101, ZIAHL005066, Z01HL005066, Z01HL005101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK070002, ZICDK070002] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Attardi LD, 2005, MUTAT RES-FUND MOL M, V576, P4, DOI 10.1016/j.mrfmmm.2004.08.022; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Denko NC, 2003, ONCOGENE, V22, P5907, DOI 10.1038/sj.onc.1206703; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Herrmann PC, 2003, PROTEOMICS, V3, P1801, DOI 10.1002/pmic.200300461; Hofseth LJ, 2004, TRENDS PHARMACOL SCI, V25, P177, DOI 10.1016/j.tips.2004.02.009; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Kim JW, 2004, MOL CELL BIOL, V24, P5923, DOI 10.1128/MCB.24.13.5923-5936.2004; Kohli M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh009; Kondoh H, 2005, CANCER RES, V65, P177; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Matsumoto K, 1996, J APPL PHYSIOL, V81, P1843, DOI 10.1152/jappl.1996.81.4.1843; Papadopoulou LC, 1999, NAT GENET, V23, P333; Pecina P, 2004, PHYSIOL RES, V53, pS213; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Poyurovsky MV, 2006, GENE DEV, V20, P125, DOI 10.1101/gad.1397506; SARIBANSOHRABY S, 1983, CANCER RES, V43, P4662; Semenza G L, 2001, Novartis Found Symp, V240, P251; Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378; Stumpferl SW, 2004, EUKARYOT CELL, V3, P200, DOI 10.1128/EC.3.1.200-211.2004; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; WARBURG O, 1956, SCIENCE, V124, P269; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517; Zhou S, 2003, MUTAGENESIS, V18, P287, DOI 10.1093/mutage/18.3.287	32	1244	1300	3	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1650	1653		10.1126/science.1126863	http://dx.doi.org/10.1126/science.1126863			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16728594				2022-12-24	WOS:000238288600045
J	You, HL; Lamanna, MC; Harris, JD; Chiappe, LM; O'Connor, J; Ji, SA; Lu, JC; Yuan, CX; Li, DQ; Zhang, X; Lacovara, KJ; Dodson, P; Ji, Q				You, Hai-lu; Lamanna, Matthew C.; Harris, Jerald D.; Chiappe, Luis M.; O'Connor, Jingmai; Ji, Shu-an; Lu, Jun-chang; Yuan, Chong-xi; Li, Da-qing; Zhang, Xing; Lacovara, Kenneth J.; Dodson, Peter; Ji, Qiang			A nearly modern amphibious bird from the early Cretaceous of Northwestern China	SCIENCE			English	Article								Three-dimensional specimens of the volant fossil bird Gansus yumenensis from the Early Cretaceous Xiagou Formation of northwestern China demonstrate that this taxon possesses advanced anatomical features previously known only in Late Cretaceous and Cenozoic ornithuran birds. Phylogenetic analysis recovers Gansus within the Ornithurae, making it the oldest known member of the clade. The Xiagou Formation preserves the oldest known ornithuromorph-dominated avian assemblage. The anatomy of Gansus, like that of other non-neornithean (nonmodern) ornithuran birds, indicates specialization for an amphibious life-style, supporting the hypothesis that modern birds originated in aquatic or littoral niches.	Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA; Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China; Dixie State Coll, Dept Sci, St George, UT 84770 USA; Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA 90007 USA; Third Geol & Mineral Resources Explorat Acad Gans, Fossil Res & Dev Ctr, Lanzhou 730050, Gansu, Peoples R China; Prov Museum Gansu Prov, Nat Dept, Lanzhou 730050, Peoples R China; Drexel Univ, Dept Biosci & Biotechnol, Geol & Paleontol Program, Philadelphia, PA 19104 USA; Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA	Chinese Academy of Geological Sciences; Utah System of Higher Education; Dixie State University; Drexel University; University of Pennsylvania	Lamanna, MC (corresponding author), Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, 4400 Forbes Ave, Pittsburgh, PA 15213 USA.	lamannam@carnegiemnh.org; jharris@dixie.edu	Dodson, Peter/A-9544-2009	You, Hai-Lu/0000-0003-2203-6461; Chiappe, Luis/0000-0001-9661-0601				Chatterjee Sankar, 2002, P125; Chiappe Luis M., 2002, P281; Chiappe Luis M., 2002, P448; Clarke JA, 2005, NATURE, V433, P305, DOI 10.1038/nature03150; Clarke JA, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)387<0001:TMAPPO>2.0.CO;2; CRACRAFT J, 1982, SYST ZOOL, V31, P35, DOI 10.2307/2413412; de Buffrenil V., 2001, SECONDARY ADAPTATION, P91; Dyke GJ, 2002, NATURWISSENSCHAFTEN, V89, P408, DOI 10.1007/s00114-002-0352-9; Feduccia A, 2003, TRENDS ECOL EVOL, V18, P172, DOI 10.1016/S0169-5347(03)00017-X; Galton Peter M., 2002, P317; Gill F. B., 1995, ORNITHOLOGY; Gradstein F.M., 2004, GEOLOGICAL TIME SCAL; Hope Sylvia, 2002, P339; Hou L., 1997, MESOZOIC BIRDS CHINA; Hou L.H, 2002, MESOZOIC BIRDS W LIA; HOU LH, 1984, SCI SIN B-CHEM B A M, V27, P1296; Kurochkin EN, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)386<0001:ANPBAA>2.0.CO;2; Kurochkin EN, 1999, SM C PALEOB, P275; Lim JD, 2000, NATURWISSENSCHAFTEN, V87, P256, DOI 10.1007/s001140050715; Marsh OC., 1880, REPORT GEOLOGICAL EX, V18, P1; Parris David C., 2002, P113; Robertson DS, 2004, GEOL SOC AM BULL, V116, P760, DOI 10.1130/B25402.1; Sanz Jose L., 2002, P209; SHUFELDT RW, 1909, NY STATE MUS B, V130, P5; [袁崇喜 Yuan Chongxi], 2004, [地质学报, Acta Geologica Sinica], V78, P464; Zhou ZH, 2005, P NATL ACAD SCI USA, V102, P18998, DOI 10.1073/pnas.0507106102; Zhou ZH, 2001, CHINESE SCI BULL, V46, P1258, DOI 10.1007/BF03184320; Zhou ZY, 2002, P SOC PHOTO-OPT INS, V4928, P160, DOI 10.1117/12.483166	28	111	123	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1640	1643		10.1126/science.1126377	http://dx.doi.org/10.1126/science.1126377			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778053				2022-12-24	WOS:000238288600042
J	Dave, SS; Fu, K; Wright, GW; Lam, LT; Kluin, P; Boerma, EJ; Greiner, TC; Weisenburger, DD; Rosenwald, A; Ott, G; Muller-Hermelink, H; Gascoyne, RD; Delabie, J; Rimsza, LM; Braziel, RM; Grogan, TM; Campo, E; Jaffe, ES; Dave, BJ; Sanger, W; Bast, M; Vose, JM; Armitage, JO; Connors, JM; Smeland, EB; Kvaloy, S; Holte, H; Fisher, RI; Miller, TP; Montserrat, E; Wilson, WH; Bahl, M; Zhao, H; Yang, LM; Powell, J; Simon, R; Chan, WC; Staudt, LM				Dave, Sandeep S.; Fu, Kai; Wright, George W.; Lam, Lloyd T.; Kluin, Philip; Boerma, Evert-Jan; Greiner, Timothy C.; Weisenburger, Dennis D.; Rosenwald, Andreas; Ott, German; Mueller-Hermelink, Hans-Konrad; Gascoyne, Randy D.; Delabie, Jan; Rimsza, Lisa M.; Braziel, Rita M.; Grogan, Thomas M.; Campo, Elias; Jaffe, Elaine S.; Dave, Bhavana J.; Sanger, Warren; Bast, Martin; Vose, Julie M.; Armitage, James O.; Connors, Joseph M.; Smeland, Erlend B.; Kvaloy, Stein; Holte, Harald; Fisher, Richard I.; Miller, Thomas P.; Montserrat, Emilio; Wilson, Wyndham H.; Bahl, Manisha; Zhao, Hong; Yang, Liming; Powell, John; Simon, Richard; Chan, Wing C.; Staudt, Louis M.		Lymphoma Leukemia Molecular Profil	Molecular diagnosis of Burkitt's lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							B-CELL LYMPHOMA; NON-HODGKINS-LYMPHOMA; GENE-EXPRESSION; ADULTS; CHEMOTHERAPY; EXPERIENCE; SUBGROUPS; PATTERNS; SURVIVAL; REGIMENS	Background: The distinction between Burkitt's lymphoma and diffuse large-B-cell lymphoma is crucial because these two types of lymphoma require different treatments. We examined whether gene-expression profiling could reliably distinguish Burkitt's lymphoma from diffuse large-B-cell lymphoma. Methods: Tumor-biopsy specimens from 303 patients with aggressive lymphomas were profiled for gene expression and were also classified according to morphology, immunohistochemistry, and detection of the t(8;14) c-myc translocation. Results: A classifier based on gene expression correctly identified all 25 pathologically verified cases of classic Burkitt's lymphoma. Burkitt's lymphoma was readily distinguished from diffuse large-B-cell lymphoma by the high level of expression of c-myc target genes, the expression of a subgroup of germinal-center B-cell genes, and the low level of expression of major-histocompatibility-complex class I genes and nuclear factor-kappa B target genes. Eight specimens with a pathological diagnosis of diffuse large-B-cell lymphoma had the typical gene-expression profile of Burkitt's lymphoma, suggesting they represent cases of Burkitt's lymphoma that are difficult to diagnose by current methods. Among 28 of the patients with a molecular diagnosis of Burkitt's lymphoma, the overall survival was superior among those who had received intensive chemotherapy regimens instead of lower-dose regimens. Conclusions: Gene-expression profiling is an accurate, quantitative method for distinguishing Burkitt's lymphoma from diffuse large-B-cell lymphoma.	NCI, Metab Branch, CCR, NIH, Bethesda, MD 20892 USA; NIH, Ctr Informat Technol, Bethesda, MD 20892 USA; Univ Nebraska, Med Ctr, Omaha, NE USA; Univ Groningen, Med Ctr, Groningen, Netherlands; Univ Wurzburg, Wurzburg, Germany; British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; Norwegian Radium Hosp, Norway Hosp Clin, Oslo, Norway; SW Oncol Grp, Seattle, WA USA; Univ Arizona, Ctr Canc, Tucson, AZ USA; Oregon Hlth Sci Univ, Portland, OR 97201 USA; Univ Barcelona, Barcelona, Spain; Univ Oslo, Oslo, Norway; Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); University of Nebraska System; University of Nebraska Medical Center; University of Groningen; University of Wurzburg; British Columbia Cancer Agency; University of Oslo; Southwest Oncology Group; University of Arizona; Oregon Health & Science University; University of Barcelona; University of Oslo; University of Rochester	Staudt, LM (corresponding author), NCI, Metab Branch, CCR, NIH, Bldg 10,Rm 4N114,9000 Rockville Pike, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov	Gascoyne, Randy D/A-6009-2013; Campo, Elias/AAC-5593-2019; Smeland, Erlend/AAO-3214-2020; Holte, Harald/AAO-5647-2020; Wright, George W/M-1660-2017; Jaffe, Elaine/G-8981-2014; Connors, Joseph/AAF-5284-2019; Staudt, Louis/AAC-5324-2019	Gascoyne, Randy D/0000-0002-2610-5690; Campo, Elias/0000-0001-9850-9793; Connors, Joseph/0000-0002-1361-7531; Delabie, Jan/0000-0001-5023-0689	CENTER FOR INFORMATION TECHNOLOGY [Z01CT000260] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA084967, Z01SC000550, Z01SC004024] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [UO1-CA84967] Funding Source: Medline	CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alizadeh A, 1999, COLD SPRING HARB SYM, V64, P71, DOI 10.1101/sqb.1999.64.71; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bishop PC, 2000, CANCER INVEST, V18, P574, DOI 10.3109/07357900009012197; Butler R D, 1993, Cancer Treat Res, V66, P65; Divine M, 2005, ANN ONCOL, V16, P1928, DOI 10.1093/annonc/mdi403; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Gerbitz A, 1999, ONCOGENE, V18, P1745, DOI 10.1038/sj.onc.1202468; Hecht JL, 2000, J CLIN ONCOL, V18, P3707, DOI 10.1200/JCO.2000.18.21.3707; HILLS M, 1966, J ROY STAT SOC B, V28, P1; Jaffe ES, 2001, TUMOURS HAEMATOPOIET; Kramer MHH, 1998, BLOOD, V92, P3152, DOI 10.1182/blood.V92.9.3152.421a07_3152_3162; Lam LT, 2005, CLIN CANCER RES, V11, P28; Macpherson N, 1999, J CLIN ONCOL, V17, P1558, DOI 10.1200/JCO.1999.17.5.1558; Magrath I, 1996, J CLIN ONCOL, V14, P925, DOI 10.1200/JCO.1996.14.3.925; MANN RB, 1976, NEW ENGL J MED, V295, P685, DOI 10.1056/NEJM197609232951301; Mead GM, 2002, ANN ONCOL, V13, P1961, DOI 10.1093/annonc/mdf353; Mead GM, 2002, ANN ONCOL, V13, P1264, DOI 10.1093/annonc/mdf253; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Morton LM, 2006, BLOOD, V107, P265, DOI 10.1182/blood-2005-06-2508; NERI A, 1988, P NATL ACAD SCI USA, V85, P2748, DOI 10.1073/pnas.85.8.2748; PEES HW, 1992, ANN HEMATOL, V65, P201, DOI 10.1007/BF01703945; Ransohoff DF, 2004, NAT REV CANCER, V4, P309, DOI 10.1038/nrc1322; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Rosenwald A, 2003, CANCER CELL, V3, P185, DOI 10.1016/S1535-6108(03)00028-X; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Smeland S, 2004, ANN ONCOL, V15, P1072, DOI 10.1093/annonc/mdh262; SOUSSAIN C, 1995, BLOOD, V85, P664, DOI 10.1182/blood.V85.3.664.bloodjournal853664; Thomas DA, 1999, J CLIN ONCOL, V17, P2461, DOI 10.1200/JCO.1999.17.8.2461; Voltz R, 1989, Haematol Blood Transfus, V32, P289; Vose JM, 2002, LEUKEMIA LYMPHOMA, V43, P799, DOI 10.1080/10428190290016917; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100	33	577	621	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2006	354	23					2431	2442		10.1056/NEJMoa055759	http://dx.doi.org/10.1056/NEJMoa055759			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	050PQ	16760443	Green Submitted			2022-12-24	WOS:000238100800005
J	Taddei, A; Van Houwe, G; Hediger, F; Kalck, V; Cubizolles, F; Schober, H; Gasser, SM				Taddei, Angela; Van Houwe, Griet; Hediger, Florence; Kalck, Veronique; Cubizolles, Fabien; Schober, Heiko; Gasser, Susan M.			Nuclear pore association confers optimal expression levels for an inducible yeast gene	NATURE			English	Article							LOCALIZATION; TELOMERES; REPRESSION; PROTEINS; DYNAMICS; SIR4	The organization of the nucleus into subcompartments creates microenvironments that are thought to facilitate distinct nuclear functions(1). In budding yeast, regions of silent chromatin, such as those at telomeres and mating-type loci, cluster at the nuclear envelope creating zones that favour gene repression(1,2). Other reports indicate that gene transcription occurs at the nuclear periphery, apparently owing to association of the gene with nuclear pore complexes(3-5). Here we report that transcriptional activation of a subtelomeric gene, HXK1 ( hexokinase isoenzyme 1), by growth on a non-glucose carbon source led to its relocalization to nuclear pores. This relocation required the 30 untranslated region ( UTR), which is essential for efficient messenger RNA processing and export, consistent with an accompanying report(6). However, activation of HXK1 by an alternative pathway based on the transactivator VP16 moved the locus away from the nuclear periphery and abrogated the normal induction of HXK1 by galactose. Notably, when we interfered with HXK1 localization by either antagonizing or promoting association with the pore, transcript levels were reduced or enhanced, respectively. From this we conclude that nuclear position has an active role in determining optimal gene expression levels.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; Inst Curie, CNRS, Sect Rech, UMR 218, F-75231 Paris 05, France; Univ Geneva, NCCR Frontiers Genet, CH-1211 Geneva 4, Switzerland	Friedrich Miescher Institute for Biomedical Research; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); University of Geneva	Gasser, SM (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	susan.gasser@fmi.ch	taddei, angela/AAL-2413-2021	taddei, angela/0000-0002-3217-0739; Gasser, Susan/0000-0003-3610-9123; Cubizolles, Fabien/0000-0002-9822-4074				Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; de la Cera T, 2002, J MOL BIOL, V319, P703, DOI 10.1016/S0022-2836(02)00377-7; Gartenberg MR, 2004, CELL, V119, P955, DOI 10.1016/j.cell.2004.11.008; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349; Hediger F, 2006, EMBO J, V25, P857, DOI 10.1038/sj.emboj.7600976; Hediger F, 2004, METHOD ENZYMOL, V375, P345; Hediger F, 2002, CURR BIOL, V12, P2076, DOI 10.1016/S0960-9822(02)01338-6; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Menon BB, 2005, P NATL ACAD SCI USA, V102, P5749, DOI 10.1073/pnas.0501768102; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Rodriguez A, 2001, BIOCHEM J, V355, P625, DOI 10.1042/bj3550625; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Schmid M, 2006, MOL CELL, V21, P379, DOI 10.1016/j.molcel.2005.12.012; Taddei A, 2004, ANNU REV GENET, V38, P305, DOI 10.1146/annurev.genet.37.110801.142705; Taddei A, 2004, EMBO J, V23, P1301, DOI 10.1038/sj.emboj.7600144; Tham WH, 2001, MOL CELL, V8, P189, DOI 10.1016/S1097-2765(01)00287-8; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	27	299	305	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					774	778		10.1038/nature04845	http://dx.doi.org/10.1038/nature04845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760983				2022-12-24	WOS:000238095100060
J	McKenna, D				McKenna, D			That's our drip counter!	LANCET			English	Editorial Material									Royal Jubilee Matern Serv, Belfast BT12 6BB, Antrim, North Ireland		McKenna, D (corresponding author), Royal Jubilee Matern Serv, Grosvenor Rd, Belfast BT12 6BB, Antrim, North Ireland.	d.mckenna485@btinternet.com							0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 3	2006	367	9525					1873	1873		10.1016/S0140-6736(06)68810-7	http://dx.doi.org/10.1016/S0140-6736(06)68810-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051XE	16753491				2022-12-24	WOS:000238194200034
J	Marlovits, TC; Kubori, T; Lara-Tejero, M; Thomas, D; Unger, VM; Galan, JE				Marlovits, Thomas C.; Kubori, Tomoko; Lara-Tejero, Maria; Thomas, Dennis; Unger, Vinzenz M.; Galan, Jorge E.			Assembly of the inner rod determines needle length in the type III secretion injectisome	NATURE			English	Article							SALMONELLA-TYPHIMURIUM; MOLECULAR CHARACTERIZATION; PROTEINS; CLONING; COMPLEX; GENES	Assembly of multi-component supramolecular machines is fundamental to biology, yet in most cases, assembly pathways and their control are poorly understood. An example is the type III secretion machine, which mediates the transfer of bacterial virulence proteins into host cells(1). A central component of this nanomachine is the needle complex or injectisome, an organelle associated with the bacterial envelope that is composed of a multi-ring base, an inner rod, and a protruding needle(2). Assembly of this organelle proceeds in sequential steps that require the reprogramming of the secretion machine. Here we provide evidence that, in Salmonella typhimurium, completion of the assembly of the inner rod determines the size of the needle substructure. Assembly of the inner rod, which is regulated by the InvJ protein, triggers conformational changes on the cytoplasmic side of the injectisome, reprogramming the secretion apparatus to stop secretion of the needle protein.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA; Brandeis Univ, Dept Biochem, Rosenstiel Basic Med Sci Res Ctr, Howard Hughes Med Inst, Waltham, MA 02454 USA; Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Brandeis University; Howard Hughes Medical Institute; Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA.	jorge.galan@yale.edu	Kubori, Tomoko/AAH-3609-2019; Marlovits, Thomas/A-3568-2019	Kubori, Tomoko/0000-0003-1098-6021; Marlovits, Thomas/0000-0001-8106-4038				Chen LM, 1996, MOL MICROBIOL, V21, P1101, DOI 10.1046/j.1365-2958.1996.471410.x; COLLAZO CM, 1995, MOL MICROBIOL, V15, P25, DOI 10.1111/j.1365-2958.1995.tb02218.x; Collazo CM, 1996, INFECT IMMUN, V64, P3524, DOI 10.1128/IAI.64.9.3524-3531.1996; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; Macnab RM, 2004, BBA-MOL CELL RES, V1694, P207, DOI 10.1016/j.bbamcr.2004.04.005; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610; Sukhan A, 2003, J BACTERIOL, V185, P3480, DOI 10.1128/JB.185.11.3480-3483.2003; Sukhan A, 2001, J BACTERIOL, V183, P1159, DOI 10.1128/JB.183.4.1159-1167.2001; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J	16	163	168	0	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					637	640		10.1038/nature04822	http://dx.doi.org/10.1038/nature04822			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16738660				2022-12-24	WOS:000237920800048
J	Dharmasiri, S; Swarup, R; Mockaitis, K; Dharmasiri, N; Singh, SK; Kowalchyk, M; Marchant, A; Mills, S; Sandberg, G; Bennett, MJ; Estelle, M				Dharmasiri, S.; Swarup, R.; Mockaitis, K.; Dharmasiri, N.; Singh, S. K.; Kowalchyk, M.; Marchant, A.; Mills, S.; Sandberg, G.; Bennett, M. J.; Estelle, M.			AXR4 is required for localization of the auxin influx facilitator AUX1	SCIENCE			English	Article							ROOT GRAVITROPISM; RESISTANT MUTANTS; PERMEASE AUX1; ARABIDOPSIS; TRANSPORT; GROWTH; PROTEINS; MECHANISM; PATHWAYS	The AUX1 and PIN auxin influx and efflux facilitators are key regulators of root growth and development. For root gravitropism to occur, AUX1 and PIN2 must transport auxin via the lateral root cap to elongating epidermal cells. Genetic studies suggest that AXR4 functions in the same pathway as AUX1. Here we show that AXR4 is a previously unidentified accessory protein of the endoplasmic reticulum (ER) that regulates localization of AUX1 but not of PIN proteins. Loss of AXR4 resulted in abnormal accumulation of AUX1 in the ER of epidermal cells, indicating that the axr4 agravitropic phenotype is caused by defective AUX1 trafficking in the root epidermis.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England; SLU, Umea Plant Sci Ctr, Umea, Sweden; Univ Nottingham, Sch Comp Sci & Informat Technol, Nottingham NG7 2UH, England	Indiana University System; Indiana University Bloomington; University of Nottingham; Swedish University of Agricultural Sciences; Umea University; University of Nottingham	Bennett, MJ (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	malcolm.bennett@nottingham.ac.uk; maestell@indiana.edu	Kowalczyk, Mariusz/ABD-2910-2020; Estelle, Mark/ABD-6742-2021; Marchant, Alan/I-4395-2012; Bennett, Malcolm/G-4004-2010	Kowalczyk, Mariusz/0000-0001-7454-4762; Marchant, Alan/0000-0002-8293-2332; Bennett, Malcolm/0000-0003-0475-390X; Singh, Sunil Kumar/0000-0001-6682-1512; Mills, Steven/0000-0002-4933-7777; swarup, Ranjan/0000-0002-6438-9188	Biotechnology and Biological Sciences Research Council [REI20541, BB/C514958/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Crofts AJ, 1998, PLANT CELL, V10, P813, DOI 10.1105/tpc.10.5.813; Dunkley TPJ, 2006, P NATL ACAD SCI USA, V103, P6518, DOI 10.1073/pnas.0506958103; Friml J, 2002, PLANT MOL BIOL, V49, P273, DOI 10.1023/A:1015248926412; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Gonzalez E, 2005, PLANT CELL, V17, P3500, DOI 10.1105/tpc.105.036640; HOBBIE L, 1995, PLANT J, V7, P211, DOI 10.1046/j.1365-313X.1995.7020211.x; Kota J, 2005, J CELL BIOL, V168, P79, DOI 10.1083/jcb.200408106; Kottgen M, 2005, EMBO J, V24, P705, DOI 10.1038/sj.emboj.7600566; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Mullen JL, 1998, PLANT PHYSIOL, V118, P1139, DOI 10.1104/pp.118.4.1139; PICKETT FB, 1990, PLANT PHYSIOL, V94, P1462, DOI 10.1104/pp.94.3.1462; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; SIMMONS C, 1995, PHYSIOL PLANTARUM, V93, P790, DOI 10.1111/j.1399-3054.1995.tb05133.x; Swarup R, 2004, PLANT CELL, V16, P3069, DOI 10.1105/tpc.104.024737; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Swarup R, 2003, DEV CELL, V5, P824, DOI 10.1016/S1534-5807(03)00370-8; TIMPTE C, 1995, PLANT J, V8, P561, DOI 10.1046/j.1365-313X.1995.8040561.x; Yamamoto M, 1999, J PLANT RES, V112, P391, DOI 10.1007/PL00013892	23	138	158	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1218	1220		10.1126/science.1122847	http://dx.doi.org/10.1126/science.1122847			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16690816				2022-12-24	WOS:000237957400055
J	Plevritis, SK; Kurian, AW; Sigal, BM; Daniel, BL; Ikeda, DM; Stockdale, FE; Garber, AM				Plevritis, Sylvia K.; Kurian, Allison W.; Sigal, Bronislava M.; Daniel, Bruce L.; Ikeda, Debra M.; Stockdale, Frank E.; Garber, Alan M.			Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OVARIAN-CANCER; CONSERVING TREATMENT; HIGH-RISK; WOMEN; MAMMOGRAPHY; MASTECTOMY; SURVIVAL; OUTCOMES; SURGERY; PERFORMANCE	Context Women with inherited BRCA1/2 mutations are at high risk for breast cancer, which mammography often misses. Screening with contrast-enhanced breast magnetic resonance imaging (MRI) detects cancer earlier but increases costs and results in more false-positive scans. Objective To evaluate the cost-effectiveness of screening BRCA1/2 mutation carriers with mammography plus breast MRI compared with mammography alone. Design, Setting, and Patients A computer model that simulates the life histories of individual BRCA1/2 mutation carriers, incorporating the effects of mammographic and MRI screening was used. The accuracy of mammography and breast MRI was estimated from published data in high-risk women. Breast cancer survival in the absence of screening was based on the Surveillance, Epidemiology and End Results database of breast cancer patients diagnosed in the prescreening period (1975-1981), adjusted for the current use of adjuvant therapy. Utilization rates and costs of diagnostic and treatment interventions were based on a combination of published literature and Medicare payments for 2005. Main Outcome Measures The survival benefit, incremental costs, and cost-effectiveness of MRI screening strategies, which varied by ages of starting and stopping MRI screening, were computed separately for BRCA1 and BRCA2 mutation carriers. Results Screening strategies that incorporate annual MRI as well as annual mammography have a cost per quality-adjusted life-year ( QALY) gained ranging from less than $45 000 to more than $700 000, depending on the ages selected for MRI screening and the specific BRCA mutation. Relative to screening with mammography alone, the cost per QALY gained by adding MRI from ages 35 to 54 years is $55 420 for BRCA1 mutation carriers, $130 695 for BRCA2 mutation carriers, and $98 454 for BRCA2 mutation carriers who have mammographically dense breasts. Conclusions Breast MRI screening is more cost-effective for BRCA1 than BRCA2 mutation carriers. The cost-effectiveness of adding MRI tomammography varies greatly by age.	Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Ctr Primary Care & Outcomes Res, Div Oncol, Stanford, CA 94305 USA; VA Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Plevritis, SK (corresponding author), Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA.	sylvia.plevritis@stanford.edu	Garber, Alan M/F-1476-2010; Kurian, Allison/A-4560-2019	Ikeda, Debra/0000-0002-8663-8448; Kurian, Allison/0000-0002-6175-9470	NCI NIH HHS [U01 CA088248, R01 CA829040, R01 CA66785] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA088248, R01CA066785] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; *AM MED ASS, 2005, MED RES BAS REL VAL; [Anonymous], SURVEILLANCE EPIDEMI; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Barlow WE, 2001, J NATL CANCER I, V93, P447, DOI 10.1093/jnci/93.6.447; Ben David Y, 2002, J CLIN ONCOL, V20, P463, DOI 10.1200/JCO.20.2.463; Boyd J, 2000, JAMA-J AM MED ASSOC, V283, P2260, DOI 10.1001/jama.283.17.2260; Cass I, 2003, CANCER, V97, P2187, DOI 10.1002/cncr.11310; Chappuis PO, 2000, SEMIN SURG ONCOL, V18, P287, DOI 10.1002/(SICI)1098-2388(200006)18:4<287::AID-SSU3>3.3.CO;2-X; Easton DF, 1997, AM J HUM GENET, V61, P120, DOI 10.1086/513891; EASTON DF, 1995, AM J HUM GENET, V56, P265; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Grann VR, 2002, J CLIN ONCOL, V20, P2520, DOI 10.1200/JCO.2002.10.101; Grann VR, 1999, CANCER J, V5, P283; Gur D, 2005, RADIOLOGY, V235, P396, DOI 10.1148/radiol.2352040422; Henderson IC, 2003, J CLIN ONCOL, V21, P976, DOI 10.1200/JCO.2003.02.063; Hensley ML, 2005, BREAST CANCER RES TR, V91, P153, DOI 10.1007/s10549-004-6497-9; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Kolb TM, 2002, RADIOLOGY, V225, P165, DOI 10.1148/radiol.2251011667; Komenaka IK, 2004, CANCER, V100, P2079, DOI 10.1002/cncr.20221; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; Kuhl CK, 2000, RADIOLOGY, V215, P267, DOI 10.1148/radiology.215.1.r00ap01267; KURIAN AW, 2004, BREAST CANC RES TREA, V88, P5013; Leach MO, 2005, LANCET, V365, P1769, DOI 10.1016/S0140-6736(05)66481-1; Lehman CD, 2005, CANCER, V103, P1898, DOI 10.1002/cncr.20971; Leung PP, 1999, J CLIN ONCOL, V17, P3082, DOI 10.1200/JCO.1999.17.10.3082; Max W, 2003, GYNECOL ONCOL, V88, P96, DOI 10.1016/S0090-8258(02)00101-4; Meijers-Heijboer H, 2001, NEW ENGL J MED, V345, P159, DOI 10.1056/NEJM200107193450301; Metcalfe K, 2004, J CLIN ONCOL, V22, P2328, DOI 10.1200/JCO.2004.04.033; Mock V, 1998, AAOHN J, V46, P425; Naeim A, 2005, CRIT REV ONCOL HEMAT, V53, P81, DOI 10.1016/j.critrevonc.2004.09.001; Narod SA, 2000, LANCET, V356, P1876, DOI 10.1016/S0140-6736(00)03258-X; [National Comprehensive Cancer Network American Cancer Society], 2006, BREAST CANC TREATM G; National Comprehensive Cancer Network, NAT COMPR CANC NETW; Neubauer H, 2003, BRIT J RADIOL, V76, P3, DOI 10.1259/bjr/14883856; Palit TK, 2000, AM J SURG, V179, P441, DOI 10.1016/S0002-9610(00)00383-4; Peshkin BN, 2003, J CLIN ONCOL, V21, P4322, DOI 10.1200/JCO.2003.02.107; Pierce LJ, 2000, J CLIN ONCOL, V18, P3360, DOI 10.1200/JCO.2000.18.19.3360; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Plevritis SK, 2007, STAT MED, V26, P581, DOI 10.1002/sim.2550; Podo F, 2002, J EXP CLIN CANC RES, V21, P115; Rao S, 2004, BREAST CANCER RES TR, V83, P25, DOI 10.1023/B:BREA.0000010689.55559.06; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Rebbeck TR, 2004, J CLIN ONCOL, V22, P1055, DOI 10.1200/JCO.2004.04.188; Robson M, 2005, CANCER, V103, P44, DOI 10.1002/cncr.20728; Rubin SC, 1996, NEW ENGL J MED, V335, P1413, DOI 10.1056/NEJM199611073351901; Salzmann P, 1997, ANN INTERN MED, V127, P955, DOI 10.7326/0003-4819-127-11-199712010-00001; Stolier Alan J, 2004, Breast J, V10, P475, DOI 10.1111/j.1075-122X.2004.21543.x; Stoutjesdijk MJ, 2001, JNCI-J NATL CANCER I, V93, P1095, DOI 10.1093/jnci/93.14.1095; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Swisher Elizabeth, 2003, Curr Treat Options Oncol, V4, P105, DOI 10.1007/s11864-003-0011-1; Tilanus-Linthorst M, 2002, INT J CANCER, V102, P91, DOI 10.1002/ijc.10666; Tilanus-Linthorst MMA, 2000, BREAST CANCER RES TR, V63, P53, DOI 10.1023/A:1006480106487; TRECATE G, 2005, NEW ENGL J MED, V353, P1784; United States Bureau of Labor and Statistics, MED US WEEKL EARN FU; van Roosmalen MS, 2002, J CLIN ONCOL, V20, P2092, DOI 10.1200/jco.2002.08.035; Wainberg S, 2004, CANCER EPIDEM BIOMAR, V13, P1989; Weitzel JN, 2003, ARCH SURG-CHICAGO, V138, P1323, DOI 10.1001/archsurg.138.12.1323; BERKELEY MORTALITY D	59	190	193	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 24	2006	295	20					2374	2384		10.1001/jama.295.20.2374	http://dx.doi.org/10.1001/jama.295.20.2374			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	045HY	16720823	Bronze			2022-12-24	WOS:000237734400023
J	Queralt, E; Lehane, C; Novak, B; Uhlmann, F				Queralt, Ethel; Lehane, Chris; Novak, Bela; Uhlmann, Frank			Downregulation of PP2A(Cdc-95) phosphatase by separase initiates mitotic exit in budding yeast	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; CDC14 PHOSPHATASE; MULTIPLE ROLES; ANAPHASE ONSET; MITOSIS; PHOSPHORYLATION; CLEAVAGE; COMPLEX; LOCALIZATION; CHECKPOINT	After anaphase, the high mitotic cyclin-dependent kinase (Cdk) activity is downregulated to promote exit from mitosis. To this end, in the budding yeast S. cerevisiae, the Cdk counteracting phosphatase Cdc14 is activated. In metaphase, Cdc14 is kept inactive in the nucleolus by its inhibitor Net1. During anaphase, Cdk- and Polo-dependent phosphorylation of Net1 is thought to release active Cdc14. How Netl is phosphorylated specifically in anaphase, when mitotic kinase activity starts to decline, has remained unexplained. Here, we show that PP2A(Cdc55) phosphatase keeps Netl under-phosphorylated in metaphase. The sister chromatid-separating protease separase, activated at anaphase onset, interacts with and down regulates PP2A(Cdc55) , thereby facilitating Cdk dependent Netl phosphorylation. PP2A(CdC55) downregulation also promotes phosphorylation of Bfa1, contributing to activation of the "mitotic exit network" that sustains Cdc14 as Cdk activity declines. These findings allow us to present a new quantitative model for mitotic exit in budding yeast.	Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Chromosome Segregat Lab, London WC2A 3PX, England; Hungarian Acad Sci, Mol Network Dynam Grp, H-1111 Budapest, Hungary; Budapest Univ Technol & Econ, H-1111 Budapest, Hungary	Cancer Research UK; Hungarian Academy of Sciences; Budapest University of Technology & Economics	Uhlmann, F (corresponding author), Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Chromosome Segregat Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	frank.uhlmann@cancer.org.uk	Queralt, Ethel/ABA-8640-2021; Novak, Bela/D-5365-2009; Queralt, Ethel/D-8090-2015	Queralt, Ethel/0000-0003-0045-0039; Novak, Bela/0000-0002-6961-1366; Queralt, Ethel/0000-0003-0045-0039; Uhlmann, Frank/0000-0002-3527-6619				Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402; Bardin AJ, 2000, CELL, V102, P21, DOI 10.1016/S0092-8674(00)00007-6; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Cohen-Fix O, 1999, GENE DEV, V13, P1950, DOI 10.1101/gad.13.15.1950; Cueille N, 2001, J CELL SCI, V114, P2649; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Evans DRH, 1997, GENETICS, V145, P227; Gentry MS, 2002, MOL BIOL CELL, V13, P3477, DOI 10.1091/mbc.02-05-0065; Gorr IH, 2005, MOL CELL, V19, P135, DOI 10.1016/j.molcel.2005.05.022; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; Hu FH, 2001, CELL, V107, P655, DOI 10.1016/S0092-8674(01)00580-3; Jaspersen SL, 2000, CURR BIOL, V10, P615, DOI 10.1016/S0960-9822(00)00491-7; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Lee SE, 2001, CURR BIOL, V11, P784, DOI 10.1016/S0960-9822(01)00228-7; MCGREW JT, 1992, MOL BIOL CELL, V3, P1443, DOI 10.1091/mbc.3.12.1443; McMillan JN, 1999, MOL CELL BIOL, V19, P5981; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Minshull J, 1996, CURR BIOL, V6, P1609, DOI 10.1016/S0960-9822(02)70784-7; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Mortensen EM, 2005, CURR BIOL, V15, P2033, DOI 10.1016/j.cub.2005.10.046; Murakami H, 1999, GENE DEV, V13, P2581, DOI 10.1101/gad.13.19.2581; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Novak B, 1998, PHILOS T ROY SOC B, V353, P2063, DOI 10.1098/rstb.1998.0352; Pandey R, 2005, J CELL SCI, V118, P733, DOI 10.1242/jcs.01663; Papi M, 2005, NAT CELL BIOL, V7, P1029, DOI 10.1038/ncb1303; Park CJ, 2003, GENETICS, V163, P21; Pereira G, 2002, J CELL BIOL, V157, P367, DOI 10.1083/jcb.200112085; Saito RM, 2004, NAT CELL BIOL, V6, P777, DOI 10.1038/ncb1154; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Shou WY, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-3; Shou WY, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-4; Stark MJR, 1996, YEAST, V12, P1647, DOI 10.1002/(SICI)1097-0061(199612)12:16<1647::AID-YEA71>3.0.CO;2-Q; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Stegmeier F, 2004, CURR BIOL, V14, P467, DOI 10.1016/j.cub.2004.03.009; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; Sullivan M, 2001, NAT CELL BIOL, V3, P771, DOI 10.1038/ncb0901-771; Traverso EE, 2001, J BIOL CHEM, V276, P21924, DOI 10.1074/jbc.M011689200; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Wang H, 2001, GENE DEV, V15, P1361, DOI 10.1101/gad.893201; Wang YC, 2006, MOL BIOL CELL, V17, P80, DOI 10.1091/mbc.E04-12-1109; Yang HF, 2000, MOL CELL BIOL, V20, P8143, DOI 10.1128/MCB.20.21.8143-8156.2000; Yellman CM, 2006, MOL BIOL CELL, V17, P658, DOI 10.1091/mbc.E05-04-0336; Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X; Yoshida S, 2002, BIOCHEM BIOPH RES CO, V294, P687, DOI 10.1016/S0006-291X(02)00544-2; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039	52	195	202	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2006	125	4					719	732		10.1016/j.cell.2006.03.038	http://dx.doi.org/10.1016/j.cell.2006.03.038			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713564	Bronze			2022-12-24	WOS:000237886000017
J	Emanuel, EJ; Wertheimer, A				Emanuel, EJ; Wertheimer, A			Public health - Who should get influenza vaccine when not all can?	SCIENCE			English	Editorial Material							AGE		NIH, Dept Clin Bioeth, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Emanuel, EJ (corresponding author), NIH, Dept Clin Bioeth, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA.	eemanuel@nih.gov						[Anonymous], 2005, HHS PAND INFL PLAN; COLLINS SD, 1945, PUBLIC HEALTH REP, V60, P853, DOI 10.2307/4585326; CROPPER ML, 1994, J RISK UNCERTAINTY, V8, P243, DOI 10.1007/BF01064044; DANIELS N, 1988, AM I MY PARENTS KEEP, P66; DWORKIN R, 1978, TAKING RIGHTS SERIOU, P150; Dworkin Ronald, 1993, LIFES DOMINION, P68; Halloran ME, 2006, SCIENCE, V311, P615, DOI 10.1126/science.1122143; Johannesson M, 1997, J HEALTH ECON, V16, P589, DOI 10.1016/S0167-6296(96)00516-4; Murray C. J. L., 1996, GLOBAL BURDEN DIS; MURRAY CJL, 1997, J HLTH EC, V16, P710; Olson DR, 2005, P NATL ACAD SCI USA, V102, P11059, DOI 10.1073/pnas.0408290102; SIMONSEN L, 2004, THREAT PANDEMIC INFL; Williams A, 1997, HEALTH ECON, V6, P117, DOI 10.1002/(SICI)1099-1050(199703)6:2<117::AID-HEC256>3.0.CO;2-B	13	118	122	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 12	2006	312	5775					854	855		10.1126/science.1125347	http://dx.doi.org/10.1126/science.1125347			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	041JQ	16690847	Green Submitted			2022-12-24	WOS:000237452900026
J	Berns, GS; Chappelow, J; Cekic, M; Zink, CF; Pagnoni, G; Martin-Skurski, ME				Berns, GS; Chappelow, J; Cekic, M; Zink, CF; Pagnoni, G; Martin-Skurski, ME			Neurobiological substrates of dread	SCIENCE			English	Article							SOMATOSENSORY CORTEX; HUMAN BRAIN; PAIN; ANTICIPATION; FMRI; LOCALIZATION; EXPERIENCE; MODULATION; MECHANISMS; EMOTION	Given the choice of waiting for an adverse outcome or getting it over with quickly, many people choose the latter. Theoretical models of decision-making have assumed that this occurs because there is a cost to waiting - i.e., dread. Using functional magnetic resonance imaging, we measured the neural responses to waiting for a cutaneous electric shock. Some individuals dreaded the outcome so much that, when given a choice, they preferred to receive more voltage rather than wait. Even when no decision was required, these extreme dreaders were distinguishable from those who dreaded mildly by the rate of increase of neural activity in the posterior elements of the cortical pain matrix. This suggests that dread derives, in part, from the attention devoted to the expected physical response and not simply from fear or anxiety. Although these differences were observed during a passive waiting procedure, they correlated with individual behavior in a subsequent choice paradigm, providing evidence for a neurobiological link between the experienced disutility of dread and subsequent decisions about unpleasant outcomes.	Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA	Emory University	Berns, GS (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, 101 Woodruff Circle,Suite 4000, Atlanta, GA 30322 USA.	gberns@emory.edu	Pagnoni, Giuseppe/F-3398-2015	Pagnoni, Giuseppe/0000-0002-8272-8091	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016434, K08DA000367] Funding Source: NIH RePORTER; NIDA NIH HHS [DA00367, DA016434, R01 DA016434, K08 DA000367] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Bentley DE, 2004, CLIN NEUROPHYSIOL, V115, P1846, DOI 10.1016/j.clinph.2004.03.010; Bentley DE, 2003, PAIN, V102, P265, DOI 10.1016/S0304-3959(02)00405-0; Berridge K.C., 1999, WELL BEING FDN HEDON, P525; Bingel U, 2004, NEUROIMAGE, V23, P224, DOI 10.1016/j.neuroimage.2004.05.021; Camerer C, 2005, J ECON LIT, V43, P9, DOI 10.1257/0022051053737843; Caplin A, 2001, Q J ECON, V116, P55, DOI 10.1162/003355301556347; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Ferretti A, 2004, NEUROIMAGE, V23, P1217, DOI 10.1016/j.neuroimage.2004.08.003; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Kahneman D, 1997, Q J ECON, V112, P375, DOI 10.1162/003355397555235; Koyama T, 2005, P NATL ACAD SCI USA, V102, P12950, DOI 10.1073/pnas.0408576102; LOEWENSTEIN G, 1987, ECON J, V97, P666, DOI 10.2307/2232929; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Morewedge CK, 2005, PSYCHOL SCI, V16, P626, DOI 10.1111/j.1467-9280.2005.01585.x; Petrovic P, 2002, NEUROIMAGE, V16, P1142, DOI 10.1006/nimg.2002.1069; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Ploghaus A, 2003, TRENDS COGN SCI, V7, P197, DOI 10.1016/S1364-6613(03)00061-5; Ploghaus A, 2000, P NATL ACAD SCI USA, V97, P9281, DOI 10.1073/pnas.160266497; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Porro CA, 2002, J NEUROSCI, V22, P3206, DOI 10.1523/JNEUROSCI.22-08-03206.2002; Raij TT, 2005, P NATL ACAD SCI USA, V102, P2147, DOI 10.1073/pnas.0409542102; Rainville P, 1999, PAIN, V82, P159, DOI 10.1016/S0304-3959(99)00048-2; Rescorla RA, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Salomons TV, 2004, J NEUROSCI, V24, P7199, DOI 10.1523/JNEUROSCI.1315-04.2004; Samuelson Paul, 1937, REV ECON STUD, V4, P155, DOI [DOI 10.2307/2967612, 10.2307/2967612]; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1023/A:1022633531479; Tracey I, 2005, CURR OPIN NEUROBIOL, V15, P478, DOI 10.1016/j.conb.2005.06.010; Varian H.R., 2002, INTERMEDIATE MICROEC; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065	31	152	158	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 5	2006	312	5774					754	758		10.1126/science.1123721	http://dx.doi.org/10.1126/science.1123721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	039NF	16675703	Green Accepted			2022-12-24	WOS:000237312100053
J	Doi, M; Hirayama, J; Sassone-Corsi, P				Doi, Masao; Hirayama, Jun; Sassone-Corsi, Paolo			Circadian regulator CLOCK is a histone acetyltransferase	CELL			English	Article							PERIPHERAL CLOCK; GENE-EXPRESSION; PROTEIN SIR2; TRANSCRIPTION; ACETYLATION; CHROMATIN; MOUSE; MECHANISM; ACTIVATION; PHOSPHORYLATION	The molecular machinery that governs circadian rhythmicity comprises proteins whose interplay generates time-specific transcription of clock genes. The role of chromatin remodeling in a physiological setting such as the circadian clock is yet unclear. We show that the protein CLOCK, a central component of the circadian pacemaker, has histone acetyltransferase (HAT) activity. CLOCK shares homology with acetylcoenzyme A binding motifs within the MYST family of HATs. CLOCK displays high sequence similarity to ACTR, a member of SRC family of HATs, with which it shares also enzymatic specificity for histones H3 and H4. BMAL1, the heterodimerization partner of CLOCK, enhances HAT function. The HAT activity of CLOCK is essential to rescue circadian rhythmicity and activation of clock genes in Clock mutant cells. Identification of CLOCK as a novel type of DNA binding HAT reveals that chromatin remodeling is crucial for the core clock mechanism and identifies unforeseen links between histone acetylation and cellular physiology.	Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sassone-Corsi, P (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA.	paolosc@igbmc.u-strasbg.fr	Sassone-Corsi, Paolo/H-6182-2011; Doi, Masao/J-9267-2019	Doi, Masao/0000-0001-6264-9217; Hirayama, Jun/0000-0002-8485-3320				Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Brownell JE, 1999, METH MOL B, V119, P343; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Curtis AM, 2004, J BIOL CHEM, V279, P7091, DOI 10.1074/jbc.M311973200; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Doi M, 2004, CURR BIOL, V14, P975, DOI 10.1016/j.cub.2004.05.043; Doi M, 2001, P NATL ACAD SCI USA, V98, P8089, DOI 10.1073/pnas.141090998; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hirayama J, 2005, CURR OPIN GENET DEV, V15, P548, DOI 10.1016/j.gde.2005.07.003; Hirayama J, 2005, P NATL ACAD SCI USA, V102, P10194, DOI 10.1073/pnas.0502610102; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Loury R, 2004, METHOD ENZYMOL, V377, P197; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Martinez-Balbas MA, 1998, EMBO J, V17, P2886, DOI 10.1093/emboj/17.10.2886; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Mizzen CA, 1999, METHOD ENZYMOL, V304, P675; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Schibler U, 2005, CURR OPIN CELL BIOL, V17, P223, DOI 10.1016/j.ceb.2005.01.007; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; WADE PA, 1997, CURR BIOL, V7, P82; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595; Yan Y, 2000, MOL CELL, V6, P1195, DOI 10.1016/S1097-2765(00)00116-7; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	68	617	642	3	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					497	508		10.1016/j.cell.2006.03.033	http://dx.doi.org/10.1016/j.cell.2006.03.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678094	Bronze			2022-12-24	WOS:000237506100016
J	Haemmerle, G; Lass, A; Zimmermann, R; Gorkiewicz, G; Meyer, C; Rozman, J; Heldmaier, G; Maier, R; Theussl, C; Eder, S; Kratky, D; Wagner, EF; Klingenspor, M; Hoefler, G; Zechner, R				Haemmerle, G; Lass, A; Zimmermann, R; Gorkiewicz, G; Meyer, C; Rozman, J; Heldmaier, G; Maier, R; Theussl, C; Eder, S; Kratky, D; Wagner, EF; Klingenspor, M; Hoefler, G; Zechner, R			Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase	SCIENCE			English	Article							HORMONE-SENSITIVE LIPASE; INSULIN; EXPRESSION; OBESITY; TISSUE; MOBILIZATION; ACCUMULATION; DEFICIENCY; MECHANISMS	Fat tissue is the most important energy depot in vertebrates. The release of free fatty acids (FFAs) from stored fat requires the enzymatic activity of lipases. We showed that genetic inactivation of adipose triglyceride lipase (ATGL) in mice increases adipose mass and leads to triacylglycerol deposition in multiple tissues. ATGL-deficient mice accumulated large amounts of lipid in the heart, causing cardiac dysfunction and premature death. Defective cold adaptation indicated that the enzyme provides FFAs to fuel thermogenesis. The reduced availability of ATGL-derived FFAs leads to increased glucose use, increased glucose tolerance, and increased insulin sensitivity. These results indicate that ATGL is rate limiting in the catabolism of cellular fat depots and plays an important role in energy homeostasis.	Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, Graz, Austria; Univ Marburg, Fac Biol, Dept Anim Physiol, D-35032 Marburg, Germany; Res Inst Mol Pathol, A-1030 Vienna, Austria	University of Graz; Medical University of Graz; Philipps University Marburg; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Zechner, R (corresponding author), Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria.	rudolf.zechner@uni-graz.at	Meyer, Carola/N-5874-2014; Klingenspor, Martin/K-5033-2019; Klingenspor, Martin/D-6930-2011; Lass, Achim/C-3332-2008; Gorkiewicz, Gregor/ABF-1602-2021; Rozman, Jan/A-2540-2010; Hoefler, Gerald/B-7006-2008; Kratky, Dagmar/ABF-5699-2021; Heldmaier, Gerhard/AAI-3286-2020; Hoefler, Gerald/H-1796-2016	Meyer, Carola/0000-0001-7959-1218; Klingenspor, Martin/0000-0002-4502-6664; Lass, Achim/0000-0002-8190-7151; Gorkiewicz, Gregor/0000-0003-1149-4782; Rozman, Jan/0000-0002-8035-8904; Kratky, Dagmar/0000-0003-1357-7573; Zechner, Rudolf/0000-0001-5483-1182; Wagner, Erwin F/0000-0001-7872-0196; Hoefler, Gerald/0000-0002-9056-3063; Zimmermann, Robert/0000-0002-7354-870X; Haemmerle, Guenter/0000-0001-9900-5896	Austrian Science Fund FWF [F 3002, F 3001] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Haemmerle G, 2002, J BIOL CHEM, V277, P12946, DOI 10.1074/jbc.M108640200; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Kralisch S, 2005, MOL CELL ENDOCRINOL, V240, P43, DOI 10.1016/j.mce.2005.06.002; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; Large V, 1998, J LIPID RES, V39, P1688; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; Mulder H, 1999, DIABETES, V48, P228, DOI 10.2337/diabetes.48.1.228; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Raben DM, 2005, TRENDS ENDOCRIN MET, V16, P35, DOI 10.1016/j.tem.2005.01.009; RANDLE PJ, 1963, LANCET, V1, P785; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; SCHOENBORN V, IN PRESS DIABETES; SHULMAN GI, 2000, J CLIN INVEST, V106, P171, DOI DOI 10.1172/JCI10583; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Soni KG, 2004, J BIOL CHEM, V279, P40683, DOI 10.1074/jbc.M400541200; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	27	972	1026	2	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					734	737		10.1126/science.1123965	http://dx.doi.org/10.1126/science.1123965			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675698				2022-12-24	WOS:000237312100047
J	Hetz, C; Bernasconi, P; Fisher, J; Lee, AH; Bassik, MC; Antonsson, B; Brandt, GS; Iwakoshi, NN; Schinzel, A; Glimcher, LH; Korsmeyer, SJ				Hetz, C; Bernasconi, P; Fisher, J; Lee, AH; Bassik, MC; Antonsson, B; Brandt, GS; Iwakoshi, NN; Schinzel, A; Glimcher, LH; Korsmeyer, SJ			Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1 alpha	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; MESSENGER-RNA; ER STRESS; TRANSCRIPTION FACTOR; CELL-DEATH; APOPTOSIS; XBP-1; IRE1; ACTIVATION; BIOGENESIS	Accumulation of misfolded protein in the endoplasmic reticulum (ER) triggers an adaptive stress response-termed the unfolded protein response (UPR)-mediated by the ER transmembrane protein kinase and endoribonuclease inositol-requiring enzyme-1 alpha (IRE1 alpha). We investigated UPR signaling events in mice in the absence of the proapoptotic BCL-2 family members BAX and BAK [double knockout (DKO)]. DKO mice responded abnormally to tunicamycin-induced ER stress in the liver, with extensive tissue damage and decreased expression of the IRE1 substrate X-box-binding protein 1 and its target genes. ER-stressed DKO cells showed deficient IRE1a signaling. BAX and BAK formed a protein complex with the cytosolic domain of IRE1 alpha that was essential for IRE1 alpha activation. Thus, BAX and BAK function at the ER membrane to activate IRE1 alpha signaling and to provide a physical link between members of the core apoptotic pathway and the UPR.	Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Serono Pharmaceut Res Inst, CH-1228 Plan Les Ouates, Switzerland; Brandeis Univ, Rosenstiel Ctr, Dept Biochem, Waltham, MA 02454 USA; Brandeis Univ, Rosenstiel Ctr, Dept Chem, Waltham, MA 02454 USA	Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Brandeis University; Brandeis University	Hetz, C (corresponding author), Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA.	chetz@hsph.harvard.edu; lglimche@hsph.harvard.edu	Hetz, Claudio/I-1900-2013; Hetz, Claudio/ABD-7514-2021; Longo, Kenneth A/A-5631-2010	Hetz, Claudio/0000-0001-7724-1767; Brandt, Gabriel/0000-0002-9148-8042	NCI NIH HHS [P01 CA92625, R37 CA50239, CA100707] Funding Source: Medline; NIAID NIH HHS [P01 AI56296, R01 AI32412] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA092625, P50CA100707, R37CA050239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056296, R01AI032412] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Kimata Y, 2003, MOL BIOL CELL, V14, P2559, DOI 10.1091/mbc.E02-11-0708; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu ZG, 2003, MOL CELL, V12, P795, DOI 10.1016/S1097-2765(03)00399-X; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakajima K, 2004, EMBO J, V23, P3216, DOI 10.1038/sj.emboj.7600333; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Reimold AM, 2000, GENE DEV, V14, P152; Ruiz-Vela A, 2005, EMBO REP, V6, P379, DOI 10.1038/sj.embor.7400375; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Takeuchi O, 2005, P NATL ACAD SCI USA, V102, P11272, DOI 10.1073/pnas.0504783102; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084	32	518	542	6	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					572	576		10.1126/science.1123480	http://dx.doi.org/10.1126/science.1123480			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16645094				2022-12-24	WOS:000237296700044
J	Nemecek, JC; Wuthrich, M; Klein, BS				Nemecek, JC; Wuthrich, M; Klein, BS			Global control of dimorphism and virulence in fungi	SCIENCE			English	Article							BLASTOMYCES-DERMATITIDIS; HISTOPLASMA-CAPSULATUM; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; HISTIDINE KINASE; HYPHAL DEVELOPMENT; PROTEIN-KINASE; YEAST; STRESS; COCCIDIOIDOMYCOSIS	Microbial pathogens that normally inhabit our environment can adapt to thrive inside mammalian hosts. There are six dimorphic fungi that cause disease worldwide, which switch from nonpathogenic molds in soil to pathogenic yeast after spores are inhaled and exposed to elevated temperature. Mechanisms that regulate this switch remain obscure. We show that a hybrid histidine kinase senses host signals and triggers the transition from mold to yeast. The kinase also regulates cell-wall integrity, sporulation, and expression of virulence genes in vivo. This global regulator shapes how dimorphic fungal pathogens adapt to the mammalian host, which has broad implications for treating and preventing systemic fungal disease.	Univ Wisconsin Hosp & Clin, Dept Med Microbiol & Immunol, Madison, WI 53792 USA; Univ Wisconsin Hosp & Clin, Dept Pediat, Madison, WI 53792 USA; Univ Wisconsin Hosp & Clin, Dept Internal Med, Madison, WI 53792 USA; Univ Wisconsin Hosp & Clin, Univ Wisconsin Sch Med, Ctr Comprehens Canc, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Klein, BS (corresponding author), Univ Wisconsin Hosp & Clin, Dept Med Microbiol & Immunol, Madison, WI 53792 USA.	bsklein@wisc.edu						Ajello L., 1971, Histoplasmosis. Proceedings of the Second National Conference., P103; Alex LA, 1998, P NATL ACAD SCI USA, V95, P7069, DOI 10.1073/pnas.95.12.7069; Brandhorst TT, 1999, J EXP MED, V189, P1207, DOI 10.1084/jem.189.8.1207; Chiller TM, 2003, INFECT DIS CLIN N AM, V17, P41, DOI 10.1016/S0891-5520(02)00040-5; Deschenes RJ, 1999, ANTIMICROB AGENTS CH, V43, P1700, DOI 10.1128/AAC.43.7.1700; Galgiani JN, 1999, ANN INTERN MED, V130, P293, DOI 10.7326/0003-4819-130-4-199902160-00015; HOGAN LH, 1994, INFECT IMMUN, V62, P3543, DOI 10.1128/IAI.62.8.3543-3546.1994; Klein B S, 1986, Semin Respir Infect, V1, P29; KLEIN BS, 1990, J CLIN INVEST, V85, P152, DOI 10.1172/JCI114406; Krems B, 1996, CURR GENET, V29, P327, DOI 10.1007/s002940050053; Li S, 1998, EMBO J, V17, P6952, DOI 10.1093/emboj/17.23.6952; MAEDA T, 1993, MOL CELL BIOL, V13, P5408, DOI 10.1128/MCB.13.9.5408; MARESCA B, 1989, MICROBIOL REV, V53, P186, DOI 10.1128/MMBR.53.2.186-209.1989; MEDOFF G, 1986, SCIENCE, V231, P476, DOI 10.1126/science.3001938; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; OTA IM, 1993, SCIENCE, V262, P566, DOI 10.1126/science.8211183; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Rappleye CA, 2004, MOL MICROBIOL, V53, P153, DOI 10.1111/j.1365-2958.2004.04131.x; Rooney PJ, 2001, MOL MICROBIOL, V39, P875, DOI 10.1046/j.1365-2958.2001.02300.x; SALAZAR ME, 1988, INFECT IMMUN, V56, P711, DOI 10.1128/IAI.56.3.711-713.1988; SANTOS JL, 2001, SCI STKE, pRE1, DOI DOI 10.1126/J.STKE.2001.98.RE1; Sebghati TS, 2000, SCIENCE, V290, P1368, DOI 10.1126/science.290.5495.1368; Shieh JC, 1998, MOL BIOL CELL, V9, P311, DOI 10.1091/mbc.9.2.311; Stock J, 1999, CURR BIOL, V9, pR364, DOI 10.1016/S0960-9822(99)80228-0; Sullivan TD, 2002, EUKARYOT CELL, V1, P895, DOI 10.1128/EC.1.6.895-905.2002; VANDERVAART JM, 1995, J BACTERIOL, V177, P3104, DOI 10.1128/jb.177.11.3104-3110.1995; WHEAT LJ, 1990, MEDICINE, V69, P361, DOI 10.1097/00005792-199011000-00004; White S, 1997, CELL MOL LIFE SCI, V53, P744, DOI 10.1007/s000180050094; Winkler A, 2002, EUKARYOT CELL, V1, P163, DOI 10.1128/EC.1.2.163-173.2002; Yamada-Okabe T, 1999, J BACTERIOL, V181, P7243, DOI 10.1128/JB.181.23.7243-7247.1999	30	258	279	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					583	588		10.1126/science.1124105	http://dx.doi.org/10.1126/science.1124105			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16645097				2022-12-24	WOS:000237296700047
J	MacDonald, D; Demarre, G; Bouvier, M; Mazel, D; Gopaul, DN				MacDonald, D; Demarre, G; Bouvier, M; Mazel, D; Gopaul, DN			Structural basis for broad DNA-specificity in integron recombination	NATURE			English	Article							SITE-SPECIFIC RECOMBINATION; CRYSTAL-STRUCTURE; MECHANISM; GENOME; DOMAIN; BINDS; INTI1	Lateral DNA transfer-the movement of genetic traits between bacteria-has a profound impact on genomic evolution and speciation. The efficiency with which bacteria incorporate genetic information reflects their capacity to adapt to changing environmental conditions. Integron integrases are proteins that mediate site-specific DNA recombination between a proximal primary site (attI) and a secondary target site (attC) found within mobile gene cassettes encoding resistance or virulence factors. The lack of sequence conservation among attC sites has led to the hypothesis that a sequence-independent structural recognition determinant must exist within attC. Here we report the crystal structure of an integron integrase bound to an attC substrate. The structure shows that DNA target site recognition and high-order synaptic assembly are not dependent on canonical DNA but on the position of two flipped-out bases that interact in cis and in trans with the integrase. These extrahelical bases, one of which is required for recombination in vivo, originate from folding of the bottom strand of attC owing to its imperfect internal dyad symmetry. The mechanism reported here supports a new paradigm for how sequence-degenerate single-stranded genetic material is recognized and exchanged between bacteria.	Inst Pasteur, Dept Biol Struct & Chim, Lab Biochim & Biophys Macromol, F-75724 Paris 15, France; Inst Pasteur, CNRS,URA 2171, Dept Struct & Dynam Genomes, Unite Postulante Plast Genome Bacterien, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Gopaul, DN (corresponding author), Inst Pasteur, Dept Biol Struct & Chim, Lab Biochim & Biophys Macromol, F-75724 Paris 15, France.	gopauld@pasteur.fr	Mazel, Didier/F-9200-2013	Mazel, Didier/0000-0001-6482-6002; Bouvier, Marie/0000-0002-2111-052X; GOPAUL, Deshmukh/0000-0003-1631-3303				Aihara H, 2003, MOL CELL, V12, P187, DOI 10.1016/S1097-2765(03)00268-5; Arciszewska L, 1997, EMBO J, V16, P3731, DOI 10.1093/emboj/16.12.3731; AZARO MA, 2002, MOBILE DNA, V2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Biskri L, 2005, J BACTERIOL, V187, P1740, DOI 10.1128/JB.187.5.1740-1750.2005; Biswas T, 2005, NATURE, V435, P1059, DOI 10.1038/nature03657; Bouvier M, 2005, EMBO J, V24, P4356, DOI 10.1038/sj.emboj.7600898; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; Chen Y, 2003, ANNU REV BIOPH BIOM, V32, P135, DOI 10.1146/annurev.biophys.32.110601.141732; CRAIG NL, 2002, MOBILE DNA, V2; Francia MV, 1999, J BACTERIOL, V181, P6844, DOI 10.1128/JB.181.21.6844-6849.1999; Gopaul Deshmukh N., 1999, Current Opinion in Structural Biology, V9, P14, DOI 10.1016/S0959-440X(99)80003-7; Gopaul DN, 1998, EMBO J, V17, P4175, DOI 10.1093/emboj/17.14.4175; Gravel A, 1998, NUCLEIC ACIDS RES, V26, P4347, DOI 10.1093/nar/26.19.4347; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; Hansson K, 1997, MOL MICROBIOL, V26, P441, DOI 10.1046/j.1365-2958.1997.5401964.x; Hickman AB, 1997, CELL, V89, P227, DOI 10.1016/S0092-8674(00)80202-0; Johansson C, 2004, NUCLEIC ACIDS RES, V32, P4033, DOI 10.1093/nar/gkh730; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Krogh BO, 2000, MOL CELL, V5, P1035, DOI 10.1016/S1097-2765(00)80268-3; Kwon HJ, 1997, SCIENCE, V276, P126, DOI 10.1126/science.276.5309.126; Llosa M, 2002, MOL MICROBIOL, V45, P1, DOI 10.1046/j.1365-2958.2002.03014.x; Mazel D, 1998, SCIENCE, V280, P605, DOI 10.1126/science.280.5363.605; Messier N, 2001, J BACTERIOL, V183, P6699, DOI 10.1128/JB.183.22.6699-6706.2001; MEYERLEON L, 1990, MOL CELL BIOL, V10, P235, DOI 10.1128/MCB.10.1.235; NUNESDUBY SE, 1995, CURR BIOL, V5, P139, DOI 10.1016/S0960-9822(95)00035-2; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Rafferty JB, 1996, SCIENCE, V274, P415, DOI 10.1126/science.274.5286.415; Ronning DR, 2005, MOL CELL, V20, P143, DOI 10.1016/j.molcel.2005.07.026; Rowe-Magnus DA, 2003, GENOME RES, V13, P428, DOI 10.1101/gr.617103; STARK WM, 1989, TRENDS GENET, V5, P304, DOI 10.1016/0168-9525(89)90113-3; Stokes HW, 1997, MOL MICROBIOL, V26, P731, DOI 10.1046/j.1365-2958.1997.6091980.x; Subramanya HS, 1997, EMBO J, V16, P5178, DOI 10.1093/emboj/16.17.5178; Val ME, 2005, MOL CELL, V19, P559, DOI 10.1016/j.molcel.2005.07.002; VANDUYNE G, 2002, MOBILE DNA, V2; Weeks CM, 2002, Z KRISTALLOGR, V217, P686, DOI 10.1524/zkri.217.12.686.20659	40	117	133	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1157	1162		10.1038/nature04643	http://dx.doi.org/10.1038/nature04643			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641988	Green Submitted			2022-12-24	WOS:000237080000037
J	Muzny, DM; Scherer, SE; Kaul, R; Wang, J; Yu, J; Sudbrak, R; Buhay, CJ; Chen, R; Cree, A; Ding, Y; Dugan-Rocha, S; Gill, R; Gunaratne, P; Harris, RA; Hawes, AC; Hernandez, J; Hodgson, AV; Hume, J; Jackson, A; Khan, ZM; Kovar-Smith, C; Lewis, LR; Lozado, RJ; Metzker, ML; Milosavljevic, A; Miner, GR; Morgan, MB; Nazareth, LV; Scott, G; Sodergren, E; Song, XZ; Steffen, D; Wei, S; Wheeler, DA; Wright, MW; Worley, KC; Yuan, Y; Zhang, ZD; Adams, CQ; Ansari-Lari, MA; Ayele, M; Brown, MJ; Chen, G; Chen, ZJ; Clendenning, J; Clerc-Blankenburg, KP; Chen, RS; Chen, Z; Davis, C; Delgado, O; Dinh, HH; Dong, W; Draper, H; Ernst, S; Fu, G; Gonzalez-Garay, ML; Garcia, DK; Gillett, W; Gu, J; Hao, BL; Haugen, E; Havlak, P; He, X; Hennig, S; Hu, SN; Huang, W; Jackson, LR; Jacob, LS; Kelly, SH; Kube, M; Levy, R; Li, ZW; Liu, B; Liu, J; Liu, W; Lu, J; Maheshwari, M; Nguyen, BV; Okwuonu, GO; Palmeiri, A; Pasternak, S; Perez, LM; Phelps, KA; Plopper, FJH; Qiang, BQ; Raymond, C; Rodriguez, R; Saenphimmachak, C; Santibanez, J; Shen, H; Shen, Y; Subramanian, S; Tabor, PE; Verduzco, D; Waldron, L; Wang, J; Wang, J; Wang, QY; Williams, GA; Wong, GKS; Yao, ZJ; Zhang, JK; Zhang, XQ; Zhao, GP; Zhou, JL; Zhou, Y; Nelson, D; Lehrach, H; Reinhardt, R; Naylor, SL; Yang, HM; Olson, M; Weinstock, G; Gibbs, RA				Muzny, DM; Scherer, SE; Kaul, R; Wang, J; Yu, J; Sudbrak, R; Buhay, CJ; Chen, R; Cree, A; Ding, Y; Dugan-Rocha, S; Gill, R; Gunaratne, P; Harris, RA; Hawes, AC; Hernandez, J; Hodgson, AV; Hume, J; Jackson, A; Khan, ZM; Kovar-Smith, C; Lewis, LR; Lozado, RJ; Metzker, ML; Milosavljevic, A; Miner, GR; Morgan, MB; Nazareth, LV; Scott, G; Sodergren, E; Song, XZ; Steffen, D; Wei, S; Wheeler, DA; Wright, MW; Worley, KC; Yuan, Y; Zhang, ZD; Adams, CQ; Ansari-Lari, MA; Ayele, M; Brown, MJ; Chen, G; Chen, ZJ; Clendenning, J; Clerc-Blankenburg, KP; Chen, RS; Chen, Z; Davis, C; Delgado, O; Dinh, HH; Dong, W; Draper, H; Ernst, S; Fu, G; Gonzalez-Garay, ML; Garcia, DK; Gillett, W; Gu, J; Hao, BL; Haugen, E; Havlak, P; He, X; Hennig, S; Hu, SN; Huang, W; Jackson, LR; Jacob, LS; Kelly, SH; Kube, M; Levy, R; Li, ZW; Liu, B; Liu, J; Liu, W; Lu, J; Maheshwari, M; Nguyen, BV; Okwuonu, GO; Palmeiri, A; Pasternak, S; Perez, LM; Phelps, KA; Plopper, FJH; Qiang, BQ; Raymond, C; Rodriguez, R; Saenphimmachak, C; Santibanez, J; Shen, H; Shen, Y; Subramanian, S; Tabor, PE; Verduzco, D; Waldron, L; Wang, J; Wang, J; Wang, QY; Williams, GA; Wong, GKS; Yao, ZJ; Zhang, JK; Zhang, XQ; Zhao, GP; Zhou, JL; Zhou, Y; Nelson, D; Lehrach, H; Reinhardt, R; Naylor, SL; Yang, HM; Olson, M; Weinstock, G; Gibbs, RA			The DNA sequence, annotation and analysis of human chromosome 3	NATURE			English	Article							HUMAN GENOME; EVOLUTION; CHROMOSOME; REARRANGEMENTS; RECOMBINATION; DUPLICATION; INVERSION; MAP	After the completion of a draft human genome sequence(1), the International Human Genome Sequencing Consortium has proceeded to finish(2) and annotate each of the 24 chromosomes comprising the human genome. Here we describe the sequencing and analysis of human chromosome 3, one of the largest human chromosomes. Chromosome 3 comprises just four contigs, one of which currently represents the longest unbroken stretch of finished DNA sequence known so far. The chromosome is remarkable in having the lowest rate of segmental duplication in the genome. It also includes a chemokine receptor gene cluster as well as numerous loci involved in multiple human cancers such as the gene encoding FHIT, which contains the most common constitutive fragile site in the genome, FRA3B(3). Using genomic sequence from chimpanzee and rhesus macaque, we were able to characterize the breakpoints defining a large pericentric inversion that occurred some time after the split of Homininae from Ponginae, and propose an evolutionary history of the inversion.	Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Univ Washington, Genome Ctr, Dept Med, Div Med Genet, Seattle, WA 98195 USA; Chinese Acad Sci, Beijing Genom Inst, Beijing 101300, Peoples R China; Zhejiang Univ, James D Watson Inst Genome Sci, Hangzhou 310008, Peoples R China; Chinese Natl Human Genome Ctr Shanghai, Shanghai 201203, Peoples R China; Chinese Natl Human Genome Ctr, Beijing 100176, Peoples R China; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; UCL, Dept Biol, Galton Lab, HUGO Gene Nomenclature Comm, London NW1 2HE, England; Univ Texas, Hlth Sci Ctr, San Antonio, TX 78229 USA; RZPD German Resource Ctr Genome Res, D-14059 Berlin, Germany	Baylor College of Medicine; University of Washington; University of Washington Seattle; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Zhejiang University; Max Planck Society; University of Kiel; University of London; University College London; University of Texas System; University of Texas Health San Antonio	Scherer, SE (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, 1 Baylor Plaza, Houston, TX 77030 USA.	sscherer@bcm.tmc.edu; yanghm@genomics.org.cn	Sudbrak, Ralf/HHZ-8821-2022; Liu, Tao/AAO-6310-2021; Wright, Mathew/H-5394-2012; 郑, 征/C-8514-2011; Wheeler, David A/M-9740-2018; Weinstock, George M/C-6314-2013; Wang, Jun/A-7261-2013; Li, Wei/A-8544-2009; Liu, Tao/G-3585-2010; WONG, Gane Ka-Shu/G-5784-2013; Chen, Runsheng/S-9834-2017; Driemeier, David/H-3461-2012; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016; Hu, Songnian/C-6509-2013	Liu, Tao/0000-0002-8818-8313; Wright, Mathew/0000-0002-2650-2426; Wheeler, David A/0000-0002-9056-6299; Weinstock, George M/0000-0002-2997-4592; Liu, Tao/0000-0002-8818-8313; WONG, Gane Ka-Shu/0000-0001-6108-5560; Chen, Runsheng/0000-0001-6049-8347; Driemeier, David/0000-0003-3766-0654; Wang, Jun/0000-0002-8540-8931; Zhao, Guo-Ping/0000-0002-7621-6620; Haugen, Eric/0000-0001-7444-8981; Liu, Tao/0000-0003-0446-9001; Kaul, Rajinder/0000-0002-7895-9284; Wang, Jun/0000-0002-2113-5874; Hu, Songnian/0000-0003-3966-3111; Delgado, Oliver/0000-0003-2547-5857; Worley, Kim/0000-0002-0282-1000; Gonzalez-Garay, Manuel/0000-0003-3412-0353; Reinhardt, Richard/0000-0001-9376-2132	Medical Research Council [G0000107] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; MRC [G0000107] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALLDERDICE PW, 1975, AM J HUM GENET, V27, P699; Bacolla A, 2004, P NATL ACAD SCI USA, V101, P14162, DOI 10.1073/pnas.0405974101; Bourque G, 2005, GENOME RES, V15, P98, DOI 10.1101/gr.3002305; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; CIGUDOSA RC, 1995, CANCER GENET CYTOGEN, V83, P119; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Hughes JF, 2001, NAT GENET, V29, P487, DOI 10.1038/ng775; Jin YS, 2002, INT J CANCER, V98, P475, DOI 10.1002/ijc.10225; Jun Y, 2005, SCI CHINA SER C, V48, P311, DOI 10.1360/062005-173; Kalafus KJ, 2004, GENOME RES, V14, P672, DOI 10.1101/gr.1963804; KALITSIS P, 1993, GENOMICS, V16, P104, DOI 10.1006/geno.1993.1147; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; MARKKANEN A, 1982, HEREDITAS, V96, P317, DOI 10.1111/j.1601-5223.1982.tb00866.x; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Schmutz J, 2004, NATURE, V429, P365, DOI 10.1038/nature02390; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; STINE SB, 1982, AM J MED GENET, V12, P57, DOI 10.1002/ajmg.1320120108; TAGARRO I, 1993, HISTOCHEMISTRY, V99, P453; Ventura M, 2004, GENOME RES, V14, P1696, DOI 10.1101/gr.2608804; Wienberg J, 2004, CURR OPIN GENET DEV, V14, P657, DOI 10.1016/j.gde.2004.10.001; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185; Yue Y, 2005, GENOMICS, V85, P36, DOI 10.1016/j.ygeno.2004.10.007; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003	27	40	661	5	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 27	2006	440	7088					1194	1198		10.1038/nature04728	http://dx.doi.org/10.1038/nature04728			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641997	Bronze			2022-12-24	WOS:000237080000046
J	Yao, SQ; Lum, L; Beachy, P				Yao, SQ; Lum, L; Beachy, P			The ihog cell-surface proteins bind hedgehog and mediate pathway activation	CELL			English	Article							IG SUPERFAMILY MEMBER; SUBCELLULAR-LOCALIZATION; DROSOPHILA ORTHOLOG; DALLY-LIKE; GENE; RECEPTOR; ROLES; CDO; IDENTIFICATION; MUTATIONS	The ihog gene (interference hedgehog), identified by RNA interference in Drosophila cultured cells, encodes a type 1 membrane protein shown here to bind and to mediate response to the active Hedgehog (Hh) protein signal. ihog mutations produce defects characteristic of Hh signaling loss in embryos and imaginal discs, and epistasis analysis places ihog action at or upstream of the negatively acting receptor component, Patched (Ptc). The first of two extracellular fibronectin type III (FNIII) domains of the lhog protein mediates a specific interaction with Hh protein in vitro, but the second FNIII domain is additionally required for in vivo signaling activity and for Ihog-enhanced binding of Hh protein to cells coexpressing Ptc. Other members of the Ihog family, including Drosophila Boi and mammalian CDO and BOC, also interact with Hh ligands via a specific FNIII domain, thus identifying an evolutionarily conserved family of membrane proteins that function in Hh signal response.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Oncol, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Beachy, P (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol, Baltimore, MD 21205 USA.	pbeachy@jhmi.edu						Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; Borycki AG, 1999, DEVELOPMENT, V126, P4053; CAPDEVILA J, 1994, DEVELOPMENT, V120, P987; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Chou TB, 1996, GENETICS, V144, P1673; Cole F, 2004, DEV CELL, V7, P843, DOI 10.1016/j.devcel.2004.10.009; Cole F, 2003, CURR BIOL, V13, P411, DOI 10.1016/S0960-9822(03)00088-5; Connor RM, 2005, J COMP NEUROL, V485, P32, DOI 10.1002/cne.20503; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Desbordes SC, 2003, DEVELOPMENT, V130, P6245, DOI 10.1242/dev.00874; FORBES AJ, 1993, DEVELOPMENT, P115; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Glise B, 2005, DEV CELL, V8, P255, DOI 10.1016/j.devcel.2005.01.003; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Gorfinkiel N, 2005, DEV CELL, V8, P241, DOI 10.1016/j.devcel.2004.12.018; Han C, 2005, DEVELOPMENT, V132, P667, DOI 10.1242/dev.01636; Han C, 2004, DEVELOPMENT, V131, P601, DOI 10.1242/dev.00958; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kang JS, 1998, J CELL BIOL, V143, P403, DOI 10.1083/jcb.143.2.403; Kang JS, 2003, P NATL ACAD SCI USA, V100, P3989, DOI 10.1073/pnas.0736565100; Kang JS, 2002, EMBO J, V21, P114, DOI 10.1093/emboj/21.1.114; Kang JS, 2004, J CELL BIOL, V167, P493, DOI 10.1083/jcb.200405039; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Ma Y, 2002, CELL, V111, P63, DOI 10.1016/S0092-8674(02)00977-7; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Mohler J, 2000, DEVELOPMENT, V127, P55; MUENKE M, 2001, METABOLIC MOL BASES, P6203; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; SAMPEDRO J, 1991, NATURE, V353, P187, DOI 10.1038/353187a0; Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Torroja C, 2004, DEVELOPMENT, V131, P2395, DOI 10.1242/dev.01102; XU T, 1993, DEVELOPMENT, V117, P1223; Zhang C, 2004, P NATL ACAD SCI USA, V101, P17900, DOI 10.1073/pnas.0408093101; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	48	174	188	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					343	357		10.1016/j.cell.2006.02.040	http://dx.doi.org/10.1016/j.cell.2006.02.040			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630821	Bronze			2022-12-24	WOS:000237241500023
J	Deleris, A; Gallego-Bartolome, J; Bao, JS; Kasschau, KD; Carrington, JC; Voinnet, O				Deleris, Angelique; Gallego-Bartolome, Javier; Bao, Jinsong; Kasschau, Kristin D.; Carrington, James C.; Voinnet, Olivier			Hierarchical action and inhibition of plant Dicer-like proteins in antiviral defense	SCIENCE			English	Article							CELL-TO-CELL; RNA INTERFERENCE; SILENCING SIGNAL; INITIATION STEP; DICER-LIKE-4; ARABIDOPSIS; BIOGENESIS; VIRUSES	The mechanisms underlying induction and suppression of RNA silencing in the ongoing plant-virus arms race are poorly understood. We show here that virus-derived small RNAs produced by Arabidopsis Dicer-like 4 (DCL4) program an effector complex conferring antiviral immunity. Inhibition of DCL4 by a viral-encoded suppressor revealed the subordinate antiviral activity of DCL2. Accordingly, inactivating both DCL2 and DCL4 was necessary and sufficient to restore systemic infection of a suppressor-deficient virus. The effects of DCL2 were overcome by increasing viral dosage in inoculated leaves, but this could not surmount additional, non - cell autonomous effects of DCL4 specifically preventing viral unloading from the vasculature. These findings define a molecular framework for studying antiviral silencing and defense in plants.	CNRS, Unite Propre Rech 2357, Inst Biol Mol Plantes, F-67084 Strasbourg, France; Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Oregon State University	Voinnet, O (corresponding author), CNRS, Unite Propre Rech 2357, Inst Biol Mol Plantes, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	olivier.voinnet@ibmp-ulp.u-strasbg.fr	Bao, Jinsong/A-7413-2008; Gallego-Bartolomé, Javier/AAV-7369-2020; Carrington, James C/A-4656-2012	Bao, Jinsong/0000-0002-9606-6615; Carrington, James C/0000-0003-3572-129X; DELERIS, Angelique/0000-0001-7600-9480; Voinnet, Olivier/0000-0001-6982-9544; Gallego-Bartolome, Javier/0000-0003-2225-7168	NIAID NIH HHS [AI43288] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI043288, R37AI043288, R01AI043288] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akbergenov R, 2006, NUCLEIC ACIDS RES, V34, P462, DOI 10.1093/nar/gkj447; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Cohen Y, 2000, VIROLOGY, V273, P258, DOI 10.1006/viro.2000.0441; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Gasciolli V, 2005, CURR BIOL; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Qu F, 2003, J VIROL, V77, P511, DOI 10.1128/JVI.77.1.511-522.2003; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; Scholthof HB, 2005, TRENDS PLANT SCI, V10, P376, DOI 10.1016/j.tplants.2005.07.002; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104	19	647	698	5	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 7	2006	313	5783					68	71		10.1126/science.1128214	http://dx.doi.org/10.1126/science.1128214			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16741077				2022-12-24	WOS:000238850200030
J	Li, HT; Ilin, S; Wang, WK; Duncan, EM; Wysocka, J; Allis, CD; Patel, DJ				Li, Haitao; Ilin, Serge; Wang, Wooikoon; Duncan, Elizabeth M.; Wysocka, Joanna; Allis, C. David; Patel, Dinshaw J.			Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF	NATURE			English	Article							TRANSCRIPTION FACTOR; LYSINE METHYLATION; STRUCTURAL BASIS; H3 TAIL; CHROMODOMAIN; CHROMATIN; BROMODOMAIN; BINDING; DOMAIN; RECOGNIZE	Mono-, di- and trimethylated states of particular histone lysine residues are selectively found in different regions of chromatin, thereby implying specialized biological functions for these marks ranging from heterochromatin formation to X-chromosome inactivation and transcriptional regulation(1-3). A major challenge in chromatin biology has centred on efforts to define the connection between specific methylation states and distinct biological readouts impacting on function(4). For example, histone H3 trimethylated at lysine 4 (H3K4me3) is associated with transcription start sites of active genes(5-7), but the molecular 'effectors' involved in specific recognition of H3K4me3 tails remain poorly understood. Here we demonstrate the molecular basis for specific recognition of H3(1-15)K4me3 (residues 1-15 of histone H3 trimethylated at K4) by a plant homeodomain (PHD) finger of human BPTF (bromodomain and PHD domain transcription factor), the largest subunit of the ATP-dependent chromatin-remodelling complex, NURF (nucleosome remodelling factor). We report on crystallographic and NMR structures of the bromodomain-proximal PHD finger of BPTF in free and H3(1-15)K4me3-bound states. H3(1-15)K4me3 interacts through anti-parallel beta-sheet formation on the surface of the PHD finger, with the long side chains of arginine 2 (R2) and K4me3 fitting snugly in adjacent pre-formed surface pockets, and bracketing an invariant tryptophan. The observed stapling role by non-adjacent R2 and K4me3 provides a molecular explanation for H3K4me3 site specificity. Binding studies establish that the BPTF PHD finger exhibits a modest preference for K4me3- over K4me2-containing H3 peptides, and discriminates against monomethylated and unmodified counterparts. Furthermore, we identified key specificity-determining residues from binding studies of H3(1-15)K4me3 with PHD finger point mutants. Our findings call attention to the PHD finger as a previously uncharacterized chromatin-binding module found in a large number of chromatin-associated proteins.	Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA; Rockefeller Univ, Lab Chromatin Biol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Rockefeller University	Allis, CD (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA.	alliscd@rockefeller.edu; pateld@mskcc.org	Hu, Ruogu/B-2203-2008; Duncan, Elizabeth/AAJ-3351-2020; Li, Haitao/B-2668-2012	Li, Haitao/0000-0001-6741-293X; Duncan, Elizabeth/0000-0003-2003-6417	NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Bottomley MJ, 2005, J BIOL CHEM, V280, P11505, DOI 10.1074/jbc.M413959200; Bottomley MJ, 2004, EMBO REP, V5, P464, DOI 10.1038/sj.embor.7400146; Capili AD, 2001, EMBO J, V20, P165, DOI 10.1093/emboj/20.1.165; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kwan AHY, 2003, STRUCTURE, V11, P803, DOI 10.1016/S0969-2126(03)00122-9; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Pascual J, 2000, J MOL BIOL, V304, P723, DOI 10.1006/jmbi.2000.4308; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; WYSOCKA J, 2006, NATURE          0521; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9	31	574	602	4	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2006	442	7098					91	95		10.1038/nature04802	http://dx.doi.org/10.1038/nature04802			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HS	16728978	Green Accepted			2022-12-24	WOS:000238724500043
J	Klein, BEK; Klein, R; Lee, KE; Grady, LM				Klein, BEK; Klein, R; Lee, KE; Grady, LM			Statin use and incident nuclear cataract	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BEAVER-DAM EYE; AGE-RELATED MACULOPATHY; OPACITIES CASE-CONTROL; LENS OPACITIES; RISK-FACTORS; CORTICAL CATARACT; CIGARETTE-SMOKING; VISUAL-ACUITY; VITAMIN-E; MACULAR DEGENERATION	Context Statins are widely prescribed for their lipid-lowering effects but also have putative antioxidant properties. Oxidative stress is believed to play a role in the development of nuclear cataract, but little is known regarding the relationship of statin use and cataract incidence. Objective To evaluate the relationship of use of statins and incident cataract in adults in a midwestern community in the United States. Design, Setting, and Participants The Beaver Dam Eye Study, an observational, longitudinal, population-based study of age-related eye disease in Beaver Dam, Wis. There were 1299 persons who were seen at the third examination in 1998-2000, had gradable photographs in both eyes, and were deemed to be at risk of developing nuclear cataract within 5 years. Main Outcome Measure Five-year incidence of cataract with respect to statin use. Cataracts were graded from photographs taken through the participant's dilated pupil. Results A total of 210 persons developed incident nuclear cataract in the interval from 1998-2000 to 2003-2005. Five-year incidence of nuclear cataract was 12.2% in statin users compared with 17.2% in nonusers ( odds ratio [ OR], 0.55; 95% confidence interval [CI], 0.36-0.84), controlling for age. When only never smokers without diabetes were assessed, the age-, lipid level -, and sex-adjusted OR was 0.40 ( 95% CI, 0.18-0.90). Five-year incidence of cortical cataract was 9.9% in statin users and 7.5% in nonusers ( OR, 1.28; 95% CI, 0.79-2.08); posterior subcapsular cataract occurred in 3.0% of statin users and 3.4% of nonusers ( OR, 0.82; 95% CI, 0.39-1.71). Conclusion Statin use in a general population appears to be associated with lower risk of nuclear cataract, the most common type of age- related cataract.	Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI 53726 USA	University of Wisconsin System; University of Wisconsin Madison	Klein, BEK (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, 610 N Walnut St,4th Floor WARF, Madison, WI 53726 USA.	kleinb@epi.ophth.wisc.edu			NEI NIH HHS [EY06594] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; ALLAIN CC, 1974, CLIN CHEM, V20, P475; [Anonymous], [No title captured]; Behrens-Baumann W, 1990, Lens Eye Toxic Res, V7, P311; BERMAN ER, 1991, BIOCH EYE; Cumming RG, 1997, NEW ENGL J MED, V337, P8, DOI 10.1056/NEJM199707033370102; GERSON RJ, 1990, EXP EYE RES, V50, P65, DOI 10.1016/0014-4835(90)90012-J; Grosser N, 2004, FREE RADICAL BIO MED, V37, P2064, DOI 10.1016/j.freeradbiomed.2004.09.009; GUPTA PP, 1984, INDIAN J EXP BIOL, V22, P620; Hall NF, 2001, BRIT MED J, V323, P375, DOI 10.1136/bmj.323.7309.375; HARRIS ML, 1995, BRIT J OPHTHALMOL, V79, P996, DOI 10.1136/bjo.79.11.996; HEIBA IM, 1993, AM J MED GENET, V47, P1208, DOI 10.1002/ajmg.1320470816; HEIBA IM, 1995, INVEST OPHTH VIS SCI, V36, P227; HSU I, 1995, ANN PHARMACOTHER, V29, P743, DOI 10.1177/106002809502907-818; Iyengar SK, 2004, P NATL ACAD SCI USA, V101, P14485, DOI 10.1073/pnas.0400778101; JACQUES PF, 1988, ARCH OPHTHALMOL-CHIC, V106, P337, DOI 10.1001/archopht.1988.01060130363022; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1439, DOI 10.1001/archopht.119.10.1439; Klein AP, 2005, AM J EPIDEMIOL, V161, P707, DOI 10.1093/aje/kwi102; Klein B E, 1995, Ophthalmic Epidemiol, V2, P49, DOI 10.3109/09286589509071451; Klein BEK, 2006, AM J OPHTHALMOL, V141, P116, DOI 10.1016/j.ajo.2005.08.021; KLEIN BEK, 1990, OPHTHALMOLOGY, V97, P1428; KLEIN BEK, 1995, AM J OPHTHALMOL, V119, P640, DOI 10.1016/S0002-9394(14)70223-5; KLEIN BEK, 1993, AM J PREV MED, V9, P27, DOI 10.1016/S0749-3797(18)30763-3; KLEIN BEK, 1995, DOC OPHTHALMOL, V88, P295; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; Klein R, 2003, ARCH OPHTHALMOL-CHIC, V121, P1151, DOI 10.1001/archopht.121.8.1151; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Klein R, 2001, OPHTHALMOLOGY, V108, P1757, DOI 10.1016/S0161-6420(01)00769-2; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1310; Klein R, 1996, OPHTHALMOLOGY, V103, P1169, DOI 10.1016/S0161-6420(96)30526-5; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; KLEIN R, 1995, BEAVER DAM EYE STUDY, V2; KLEIN R, 1991, BEAVER DAM EYE STUDY; KORNZWEIG AL, 1977, ANN OPHTHALMOL, V9, P753; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P1113, DOI 10.1001/archopht.1995.01100090039020; LESKE MC, 1991, ARCH OPHTHALMOL-CHIC, V109, P244, DOI 10.1001/archopht.1991.01080020090051; Leske MC, 2002, OPHTHALMOLOGY, V109, P1303, DOI 10.1016/S0161-6420(02)01094-1; Leske MC, 1998, OPHTHALMOLOGY, V105, P831, DOI 10.1016/S0161-6420(98)95021-7; Leung BP, 2003, J IMMUNOL, V170, P1524, DOI 10.4049/jimmunol.170.3.1524; Lyle BJ, 1999, AM J EPIDEMIOL, V149, P801, DOI 10.1093/oxfordjournals.aje.a009895; Lyle BJ, 1999, AM J CLIN NUTR, V69, P272; MARAINI G, 1991, AM J EPIDEMIOL, V133, P541; MARESPERLMAN JA, 1994, OPHTHALMOLOGY, V101, P315; MARESPERLMAN JA, 1995, INVEST OPHTH VIS SCI, V36, P276; McCarty CA, 2001, MED J AUSTRALIA, V175, P340, DOI 10.5694/j.1326-5377.2001.tb143604.x; Pasternak RC, 2002, J AM COLL CARDIOL, V40, P567, DOI 10.1016/S0735-1097(02)02030-2; ROSS WM, 1983, EXP EYE RES, V36, P645, DOI 10.1016/0014-4835(83)90102-1; Rowe N G, 2000, Ophthalmic Epidemiol, V7, P103; SAS Institute Inc, 2004, SAS STAT US GUID VER; Schmidt J, 1990, Lens Eye Toxic Res, V7, P643; Shishehbor MH, 2003, CIRCULATION, V108, P426, DOI 10.1161/01.CIR.0000080895.05158.8B; Shishehbor MH, 2003, JAMA-J AM MED ASSOC, V289, P1675, DOI 10.1001/jama.289.13.1675; Simons M, 2002, ANN NEUROL, V52, P346, DOI 10.1002/ana.10292; Smeeth L, 2003, QJM-INT J MED, V96, P337, DOI 10.1093/qjmed/hcg064; Sperduto RD, 2001, OPHTHALMOLOGY, V108, P1400; Steen B, 1998, INVEST OPHTH VIS SCI, V39, P2194; Stoll LL, 2004, DRUG TODAY, V40, P975, DOI 10.1358/dot.2004.40.12.872573; Stuve O, 2002, NEUROLOGIST, V8, P290, DOI 10.1097/01.nrl.0000031007.85777.18; URBAN RC, 1986, SURV OPHTHALMOL, V31, P102, DOI 10.1016/0039-6257(86)90077-9; VARMA SD, 1982, PHOTOCHEM PHOTOBIOL, V36, P623, DOI 10.1111/j.1751-1097.1982.tb09481.x; VARMA SD, 1991, AM J CLIN NUTR, V53, P335; VITALE S, 1993, EPIDEMIOLOGY, V4, P195, DOI 10.1097/00001648-199305000-00003; WEST S, 1989, ARCH OPHTHALMOL-CHIC, V107, P1166, DOI 10.1001/archopht.1989.01070020232031; YATA K, 1990, OPHTHALMIC RES, V22, P78, DOI 10.1159/000267071	64	62	66	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 21	2006	295	23					2752	2758		10.1001/jama.295.23.2752	http://dx.doi.org/10.1001/jama.295.23.2752			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	054OZ	16788130				2022-12-24	WOS:000238389700030
J	Gregory, SG; Barlow, KF; Mclay, KE; Kaul, R; Swarbreck, D; Dunham, A; Scott, CE; Howe, KL; Woodfine, K; Spencer, CCA; Jones, MC; Gillson, C; Searle, S; Zhou, Y; Kokocinski, F; McDonald, L; Evans, R; Phillips, K; Atkinson, A; Cooper, R; Jones, C; Hall, RE; Andrews, TD; Lloyd, C; Ainscough, R; Almeida, JP; Ambrose, KD; Anderson, F; Andrew, RW; Ashwell, RIS; Aubin, K; Babbage, AK; Bagguley, CL; Bailey, J; Beasley, H; Bethel, G; Bird, CP; Bray-Allen, S; Brown, JY; Brown, AJ; Buckley, D; Burton, J; Bye, J; Carder, C; Chapman, JC; Clark, SY; Clarke, G; Clee, C; Cobley, V; Collier, RE; Corby, N; Coville, GJ; Davies, J; Deadman, R; Dunn, M; Earthrowl, M; Ellington, AG; Errington, H; Frankish, A; Frankland, J; French, L; Garner, P; Garnett, J; Gay, L; Ghori, MRJ; Gibson, R; Gilby, LM; Gillett, W; Glithero, RJ; Grafham, DV; Griffiths, C; Griffiths-Jones, S; Grocock, R; Hammond, S; Harrison, ESI; Hart, E; Haugen, E; Heath, PD; Holmes, S; Holt, K; Howden, PJ; Hunt, AR; Hunt, SE; Hunter, G; Isherwood, J; James, R; Johnson, C; Johnson, D; Joy, A; Kay, M; Kershaw, JK; Kibukawa, M; Kimberley, AM; King, A; Knights, AJ; Lad, H; Laird, G; Lawlor, S; Leongamornlert, DA; Lloyd, DM; Loveland, J; Lovell, J; Lush, MJ; Lyne, R; Martin, S; Mashreghi-Mohammadi, M; Matthews, L; Matthews, NSW; McLaren, S; Milne, S; Mistry, S; Moore, MJF; Nickerson, T; O'Dell, CN; Oliver, K; Palmeiri, A; Palmer, SA; Parker, A; Patel, D; Pearce, AV; Peck, AI; Pelan, S; Phelps, K; Phillimore, BJ; Plumb, R; Rajan, J; Raymond, C; Rouse, G; Saenphimmachak, C; Sehra, HK; Sheridan, E; Shownkeen, R; Sims, S; Skuce, CD; Smith, M; Steward, C; Subramanian, S; Sycamore, N; Tracey, A; Tromans, A; Van Helmond, Z; Wall, M; Wallis, JM; White, S; Whitehead, SL; Wilkinson, JE; Willey, DL; Williams, H; Wilming, L; Wray, PW; Wu, Z; Coulson, A; Vaudin, M; Sulston, JE; Durbin, R; Hubbard, T; Wooster, R; Dunham, I; Carter, NP; McVean, G; Ross, MT; Harrow, J; Olson, MV; Beck, S; Rogers, J; Bentley, DR				Gregory, SG; Barlow, KF; Mclay, KE; Kaul, R; Swarbreck, D; Dunham, A; Scott, CE; Howe, KL; Woodfine, K; Spencer, CCA; Jones, MC; Gillson, C; Searle, S; Zhou, Y; Kokocinski, F; McDonald, L; Evans, R; Phillips, K; Atkinson, A; Cooper, R; Jones, C; Hall, RE; Andrews, TD; Lloyd, C; Ainscough, R; Almeida, JP; Ambrose, KD; Anderson, F; Andrew, RW; Ashwell, RIS; Aubin, K; Babbage, AK; Bagguley, CL; Bailey, J; Beasley, H; Bethel, G; Bird, CP; Bray-Allen, S; Brown, JY; Brown, AJ; Buckley, D; Burton, J; Bye, J; Carder, C; Chapman, JC; Clark, SY; Clarke, G; Clee, C; Cobley, V; Collier, RE; Corby, N; Coville, GJ; Davies, J; Deadman, R; Dunn, M; Earthrowl, M; Ellington, AG; Errington, H; Frankish, A; Frankland, J; French, L; Garner, P; Garnett, J; Gay, L; Ghori, MRJ; Gibson, R; Gilby, LM; Gillett, W; Glithero, RJ; Grafham, DV; Griffiths, C; Griffiths-Jones, S; Grocock, R; Hammond, S; Harrison, ESI; Hart, E; Haugen, E; Heath, PD; Holmes, S; Holt, K; Howden, PJ; Hunt, AR; Hunt, SE; Hunter, G; Isherwood, J; James, R; Johnson, C; Johnson, D; Joy, A; Kay, M; Kershaw, JK; Kibukawa, M; Kimberley, AM; King, A; Knights, AJ; Lad, H; Laird, G; Lawlor, S; Leongamornlert, DA; Lloyd, DM; Loveland, J; Lovell, J; Lush, MJ; Lyne, R; Martin, S; Mashreghi-Mohammadi, M; Matthews, L; Matthews, NSW; McLaren, S; Milne, S; Mistry, S; Moore, MJF; Nickerson, T; O'Dell, CN; Oliver, K; Palmeiri, A; Palmer, SA; Parker, A; Patel, D; Pearce, AV; Peck, AI; Pelan, S; Phelps, K; Phillimore, BJ; Plumb, R; Rajan, J; Raymond, C; Rouse, G; Saenphimmachak, C; Sehra, HK; Sheridan, E; Shownkeen, R; Sims, S; Skuce, CD; Smith, M; Steward, C; Subramanian, S; Sycamore, N; Tracey, A; Tromans, A; Van Helmond, Z; Wall, M; Wallis, JM; White, S; Whitehead, SL; Wilkinson, JE; Willey, DL; Williams, H; Wilming, L; Wray, PW; Wu, Z; Coulson, A; Vaudin, M; Sulston, JE; Durbin, R; Hubbard, T; Wooster, R; Dunham, I; Carter, NP; McVean, G; Ross, MT; Harrow, J; Olson, MV; Beck, S; Rogers, J; Bentley, DR			The DNA sequence and biological annotation of human chromosome 1	NATURE			English	Article							COPY NUMBER POLYMORPHISM; REPLICATION; GENE; GENOME; TRANSCRIPTION; CHROMATIN; MAP; DUPLICATIONS; ORGANIZATION; EVOLUTION	The reference sequence for each human chromosome provides the framework for understanding genome function, variation and evolution. Here we report the finished sequence and biological annotation of human chromosome 1. Chromosome 1 is gene-dense, with 3,141 genes and 991 pseudogenes, and many coding sequences overlap. Rearrangements and mutations of chromosome 1 are prevalent in cancer and many other diseases. Patterns of sequence variation reveal signals of recent selection in specific genes that may contribute to human fitness, and also in regions where no function is evident. Fine-scale recombination occurs in hotspots of varying intensity along the sequence, and is enriched near genes. These and other studies of human biology and disease encoded within chromosome 1 are made possible with the highly accurate annotated sequence, as part of the completed set of chromosome sequences that comprise the reference human genome.	Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; Duke Univ, Ctr Human Genet, Durham, NC 27708 USA; Univ Washington, Sch Med, Dept Med, Div Med Genet, Seattle, WA 98195 USA; Kings Coll London, Dept Med & Mol Genet, London SE1 9RT, England; Univ Oxford, Dept Stat, Oxford OX1 3TG, England; UCL, Dept Biol, Galton Lab, HUGO Gene Nomenclature Comm, London NW1 2HE, England; Solexa Ltd, Saffron Walden CB10 1XL, Essex, England	Wellcome Trust Sanger Institute; Duke University; University of Washington; University of Washington Seattle; University of London; King's College London; University of Oxford; University of London; University College London	Gregory, SG (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	sgregory@chg.duhs.duke.edu	Andrews, Dan/ABG-4815-2020; Johnson, David/A-3907-2011; Frankish, Adam/G-6545-2011; Hubbard, Tim J.P./AAT-4571-2020; Durbin, Richard/AAE-7178-2019; Lyne, Rachel/AAE-2189-2020; Hubbard, Tim J/C-2567-2008; Griffiths-Jones, Sam/H-2998-2014	Johnson, David/0000-0003-0887-3343; Hubbard, Tim J.P./0000-0002-1767-9318; Durbin, Richard/0000-0002-9130-1006; Lyne, Rachel/0000-0001-8050-402X; Hubbard, Tim J/0000-0002-1767-9318; Swarbreck, David/0000-0002-5453-1013; Wass, Elizabeth/0000-0002-8605-9921; Gibson, Richard Charles/0000-0001-5412-1965; Haugen, Eric/0000-0001-7444-8981; Hunt, Adrienne/0000-0002-1227-0310; Kay, Mike/0000-0002-3282-0834; Fosker, Christine/0000-0002-3799-9474; Steward, Charles/0000-0001-8829-5349; Wilming, Laurens/0000-0002-4154-7358; Leongamornlert, Daniel/0000-0002-3486-3168; Harrow, Jennifer/0000-0003-0338-3070; Dunham, Ian/0000-0003-2525-5598; Gregory, Simon/0000-0002-7805-1743; Loveland, Jane/0000-0002-7669-2934; Martin, Sancha/0000-0001-6213-5259; Rajan, Jeena/0000-0002-3613-0013; Davidson, Claire/0000-0002-4910-8202; Griffiths-Jones, Sam/0000-0001-6043-807X; Howe, Kevin/0000-0002-1751-9226; Andrews, Dan/0000-0003-3922-6376; Kokocinski, Felix/0000-0002-8472-9207; Frankish, Adam/0000-0002-4333-628X; Hunt, Sarah/0000-0002-8350-1235	MRC [G0000107] Funding Source: UKRI; Medical Research Council [G0000107] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Adams SH, 2001, BIOCHEM J, V360, P135, DOI 10.1042/bj3600135; Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ashurst JL, 2005, NUCLEIC ACIDS RES, V33, pD459, DOI 10.1093/nar/gki135; Bentley DR, 2001, NATURE, V409, P942, DOI 10.1038/35057165; Buckley PG, 2005, CANCER RES, V65, P2653, DOI 10.1158/0008-5472.CAN-04-3651; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Cimbora DM, 2000, MOL CELL BIOL, V20, P5581, DOI 10.1128/MCB.20.15.5581-5591.2000; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Duan ZJ, 2004, MOL CELL BIOL, V24, P58, DOI 10.1128/MCB.24.1.58-70.2004; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Ferreira J, 1997, J CELL BIOL, V139, P1597, DOI 10.1083/jcb.139.7.1597; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; FRANCKE U, 1994, CYTOGENET CELL GENET, V65, P206, DOI 10.1159/000133633; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gilbert DM, 2002, NAT GENET, V32, P336, DOI 10.1038/ng1102-336; Gilbert DM, 2001, SCIENCE, V294, P96, DOI 10.1126/science.1061724; HASSAN AB, 1994, J CELL SCI, V107, P425; HASSAN AB, 1994, J CELL SCI, V107, P1381; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; HOLMQUIST GP, 1987, AM J HUM GENET, V40, P151; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; Jarbo C, 2006, INT J CANCER, V118, P1159, DOI 10.1002/ijc.21385; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kresse SH, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-39; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Maresco DL, 1998, CYTOGENET CELL GENET, V82, P71, DOI 10.1159/000015067; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Redon R, 2005, J MED GENET, V42, P166, DOI 10.1136/jmg.2004.023861; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schermelleh L, 2001, CHROMOSOME RES, V9, P77, DOI 10.1023/A:1026799818566; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schubeler D, 2002, NAT GENET, V32, P438, DOI 10.1038/ng1005; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; STRANGE RC, 1991, CARCINOGENESIS, V12, P25, DOI 10.1093/carcin/12.1.25; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Vandepoele K, 2005, MOL BIOL EVOL, V22, P2265, DOI 10.1093/molbev/msi222; VANPOPPEL G, 1992, CARCINOGENESIS, V13, P303, DOI 10.1093/carcin/13.2.303; Weise A, 2005, CYTOGENET GENOME RES, V108, P217, DOI 10.1159/000080819; Woodfine K, 2005, CELL CYCLE, V4, P172, DOI 10.4161/cc.4.1.1350; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016	50	156	2081	3	71	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					315	321		10.1038/nature04727	http://dx.doi.org/10.1038/nature04727			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710414	Bronze			2022-12-24	WOS:000237593200040
J	Kennedy, CR; McCann, DC; Campbell, MJ; Law, CM; Mullee, M; Petrou, S; Watkin, P; Worsfold, S; Yuen, HM; Stevenson, J				Kennedy, CR; McCann, DC; Campbell, MJ; Law, CM; Mullee, M; Petrou, S; Watkin, P; Worsfold, S; Yuen, HM; Stevenson, J			Language ability after early detection of permanent childhood hearing impairment	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHILDREN; OUTCOMES	Background: Children with bilateral permanent hearing impairment often have impaired language and speech abilities. However, the effects of universal newborn screening for permanent bilateral childhood hearing impairment and the effects of confirmation of hearing impairment by nine months of age on subsequent verbal abilities are uncertain. Methods: We studied 120 children with bilateral permanent hearing impairment identified from a large birth cohort in southern England, at a mean of 7.9 years of age. Of the 120 children, 61 were born during periods with universal newborn screening and 57 had hearing impairment that was confirmed by nine months of age. The primary outcomes were language as compared with nonverbal ability and speech expressed as z scores (the number of standard deviations by which the score differed from the mean score among 63 age-matched children with normal hearing), adjusted for the severity of the hearing impairment and for maternal education. Results: Confirmation of hearing impairment by nine months of age was associated with higher adjusted mean z scores for language as compared with nonverbal ability (adjusted mean difference for receptive language, 0.82; 95 percent confidence interval, 0.31 to 1.33; and adjusted mean difference for expressive language, 0.70; 95 percent confidence interval, 0.13 to 1.26). Birth during periods with universal newborn screening was also associated with higher adjusted z scores for receptive language as compared with nonverbal ability (adjusted mean difference, 0.60; 95 percent confidence interval, 0.07 to 1.13), although the z scores for expressive language as compared with nonverbal ability were not significantly higher. Speech scores did not differ significantly between those who were exposed to newborn screening or early confirmation and those who were not. Conclusions: Early detection of childhood hearing impairment was associated with higher scores for language but not for speech in midchildhood.	Univ Southampton, Dept Child Hlth, Southampton, Hants, England; Univ Southampton, Dept Publ Hlth Sci & Med Stat, Southampton, Hants, England; Univ Southampton, Dept Psychol, Southampton, Hants, England; Univ Sheffield, Inst Primary Care & Gen Practice, Sheffield, S Yorkshire, England; UCL, Inst Child Hlth, London, England; Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England; Whipps Cross Univ Hosp, Dept Audiol, London, England	University of Southampton; University of Southampton; University of Southampton; University of Sheffield; University of London; University College London; University of Oxford; University of London; Queen Mary University London	Kennedy, CR (corresponding author), Southampton Gen Hosp, Mailpoint 21, Southampton SO16 6YD, Hants, England.	crk1@soton.ac.uk	Campbell, Michael J/I-4253-2014; Law, Catherine/A-1353-2009; Petrou, Stavros/ABD-8323-2021	Campbell, Michael J/0000-0003-3529-2739; Petrou, Stavros/0000-0003-3121-6050; Law, Catherine/0000-0002-1777-9386	MRC [G0501681] Funding Source: UKRI; Medical Research Council [G0501681] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Allen T., 1986, DEAF CHILDREN AM, P161, DOI DOI 10.1177/15257401050270010201; BALDWIN M, 2005, THESIS U MANCHESTER; Bishop D. V. M., 1983, TEST RECEPTION GRAMM; Bishop DVM, 1998, J CHILD PSYCHOL PSYC, V39, P879, DOI 10.1111/1469-7610.00388; BYRNE JM, 1995, CAN PSYCHOL, V36, P115, DOI 10.1037/0708-5591.36.2.115; CALDERON R, 2000, LANGUAGE SPEECH SOCI, P53; Dalzell L, 2000, EAR HEARING, V21, P118, DOI 10.1097/00003446-200004000-00006; DAVIS A, 1992, British Journal of Audiology, V26, P77, DOI 10.3109/03005369209077875; DAVIS A, 1997, HEALTH TECHNOL ASSES, V1, P1, DOI DOI 10.3310/HTA1100; Dunn L. M., 1997, BRIT PICTURE VOCABUL, V3rd; Harrison Melody, 2003, Ear and Hearing, V24, P89, DOI 10.1097/01.AUD.0000051749.40991.1F; Kennedy C, 2005, LANCET, V366, P660, DOI 10.1016/S0140-6736(05)67138-3; Kennedy CR, 1998, LANCET, V352, P1957; Lutman ME, 1999, EUR J PEDIATR, V158, P95, DOI 10.1007/s004310051025; Moeller MP, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.3.e43; *NAT BREAST CANC C, 1994, Q NEWSL NAT BREAST C, V1, P1; *NIH, 1993, EARL ID HEAR IMP INF; *OFF NAT STAT, 2000, STAND OCC CLASS; RAVEN C, 1998, MANUAL RAVENS PROGR; RENFREW C, 1995, RENFREW BUS STORY MA; Schroeder L, 2006, PEDIATRICS, V117, P1101, DOI 10.1542/peds.2005-1335; *STAT CORP, 2003, STAT STAT SOFTW REL; STEVENSON J, IN PRESS J SPEECH LA; Thompson DC, 2001, JAMA-J AM MED ASSOC, V286, P2000, DOI 10.1001/jama.286.16.2000; TUCKER SM, 1992, ARCH DIS CHILD, V67, P911, DOI 10.1136/adc.67.7.911; Wake M, 2005, ARCH DIS CHILD, V90, P238, DOI 10.1136/adc.2003.039354; Wake M, 2004, EAR HEARING, V25, P1, DOI 10.1097/01.AUD.0000111262.12219.2F; Watkin PM, 1999, ARCH DIS CHILD, V81, P380, DOI 10.1136/adc.81.5.380; WATKIN W, 2005, AUDIOL MED, V3, P175; Yoshinaga-Itano C, 2001, Semin Neonatol, V6, P521, DOI 10.1053/siny.2001.0075; Yoshinaga-Itano C, 1998, PEDIATRICS, V102, P1161, DOI 10.1542/peds.102.5.1161	31	321	332	1	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2006	354	20					2131	2141		10.1056/NEJMoa054915	http://dx.doi.org/10.1056/NEJMoa054915			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043BX	16707750	Green Published			2022-12-24	WOS:000237575400007
J	Arita, I; Nakane, M; Fenner, F				Arita, I; Nakane, M; Fenner, F			Public health - Is polio eradication realistic?	SCIENCE			English	Editorial Material									Agcy Cooperat Int Hlth, Kumamoto 8620901, Japan; Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research	Arita, I (corresponding author), Agcy Cooperat Int Hlth, Kumamoto 8620901, Japan.	arita@acih.com						ARITA I, 1998, ERADICATION INFECT D, pCH15; Arita M, 2005, J VIROL, V79, P12650, DOI 10.1128/JVI.79.20.12650-12657.2005; Aylward RB, 2005, SCIENCE, V310, P625, DOI 10.1126/science.1115547; Bloom DE, 2011, ADV EXP MED BIOL, V697, P1, DOI 10.1007/978-1-4419-7185-2_1; FENNER F, 1982, REV INFECT DIS, V4, P916; Fenner F., 1989, SMALLPOX ITS ERADICA, VVolume 43; Heymann DL, 2005, NATURE, V434, P699, DOI 10.1038/434699a; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Nomoto A, 2002, NAT IMMUNOL, V3, P205, DOI 10.1038/ni0302-205; SACHS JD, 2005, END POVERTY EC POSSI, pCH10; *WHO, 2005, WHOVB0505; *WHO UNICEF, 2005, WHOVB0505 UNICEF IVB; World Bank, 2004, WORLD DEV IND 2004; 2005, ECONOMIST       0122, P67	14	66	71	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 12	2006	312	5775					852	854		10.1126/science.1124959	http://dx.doi.org/10.1126/science.1124959			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	041JQ	16690846				2022-12-24	WOS:000237452900025
J	Ferradini, L; Jeannin, A; Pinoges, L; Izopet, J; Odhiambo, D; Mankhambo, L; Karungi, G; Szumilin, E; Balandine, S; Fedida, G; Carrieri, MP; Spire, B; Ford, N; Tassie, JM; Guerin, PI; Brasher, C				Ferradini, L; Jeannin, A; Pinoges, L; Izopet, J; Odhiambo, D; Mankhambo, L; Karungi, G; Szumilin, E; Balandine, S; Fedida, G; Carrieri, MP; Spire, B; Ford, N; Tassie, JM; Guerin, PI; Brasher, C			Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment	LANCET			English	Article; Proceedings Paper	12th Conference on Retroviruses and Opportunistic Infections	FEB 22-25, 2005	Boston, MA				RESOURCE-POOR SETTINGS; DRUG-RESISTANCE; ADHERENCE; SURVIVAL; INTERRUPTION; KHAYELITSHA; COMBINATION; HIV/AIDS; ACCESS; SAFETY	Background The recording of outcomes from large-scale, simplified HAART (highly active antiretroviral therapy) programmes in sub-Saharan Africa is critical. We aimed to assess the effectiveness of such a programme held by Medecins Sans Fronteires (MSF) in the Chiradzulu district, Malawi. Methods We scaled up and simplified HAART in this programme since August, 2002. We analysed survival indicators, CD4 count evolution, virological response, and adherence to treatment. We included adults who all started HAART 6 months or more before the analysis. HIV-1 RNA plasma viral load and self-reported adherence were assessed on a subsample of patients, and antiretroviral resistance mutations were analysed in plasma with viral loads greater than 1000 copies per mL. Analysis was by intention to treat. Findings Of the 1308 patients who were eligible, 827 (64%) were female, the median age was 34.9 years (IQR 29.9-41.0), and 1023 (78%) received d4T/3TC/NVP (stavudine, lamivudine, and nevirapine) as a fixed-dose combination. At baseline, 1266 individuals (97%) were HAART-naive, 357 (27%) were at WHO stage IV, 311 (33%) had a body-mass index of less than 18.5 kg/m(2), and 208 (21%) had a CD4 count lower than 50 cells per mu L. At follow-up (median 8.3 months, IQR 5.5-13.1),967 (74%) were still on HAART, 243 (19%) had died, 91 (7%) were lost to follow-up, and seven (0.5%) discontinued treatment. Low body-mass index, WHO stage IV, male sex, and baseline CD4 count lower than 50 cells per mu L were independent determinants of death in the first 6 months. At 12 months, the probability of individuals still in care was 0.76 (95% CI 0.73-0.78) and the median CD4 gain was 165 (IQR 67-259) cells per mu L. In the cross-sectional survey (n = 398), 334 (84%) had a viral load of less than 400 copies per mL. Of several indicators measuring adherence, self-reported poor adherence (<80%) in the past 4 days was the best predictor of detectable viral load (odds ratio 5.4, 95% CI 1.9-15.6). Interpretation These data show that large numbers of people can rapidly benefit from antiretroviral therapy in rural resource-poor settings and strongly supports the implementation of such large-scale simplified programmes in Africa.	Epictr, Paris, France; Med Sans Frontieres, Paris, France; Purpan Hosp, Toulouse, France; Minist Hlth, Chiradzulu, Malawi; INSERM, U379, F-13258 Marseille, France	Doctors Without Borders; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	Ferradini, L (corresponding author), MSF F Mission Cambodge, 8 Rue St Sabin, F-75011 Paris, France.	msffr.comed@online.com.kh	Spire, Bruno/F-5546-2013; Brasher, Chris/Y-4488-2019; IZOPET, Jacques/L-5756-2014	Spire, Bruno/0000-0002-3546-8020; Brasher, Chris/0000-0003-1037-3604; Carrieri, Patrizia/0000-0002-6794-4837; Guerin, Philippe/0000-0002-6008-2963				Adje C, 2001, J ACQ IMMUN DEF SYND, V26, P501, DOI 10.1097/00126334-200104150-00018; Bangsberg DR, 2003, AIDS, V17, P1925, DOI 10.1097/00002030-200309050-00011; Bartlett JA, 2001, AIDS, V15, P1369, DOI 10.1097/00002030-200107270-00006; Calmy A, 2004, AIDS, V18, P2353; Carrieri MP, 2003, ANTIVIR THER, V8, P585; Carrieri P, 2001, J ACQ IMMUN DEF SYND, V28, P232, DOI 10.1097/00042560-200111010-00005; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Chimzizi R, 2005, INT J TUBERC LUNG D, V9, P582; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Coetzee D, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406003-00006; Dabis F, 2005, INT J EPIDEMIOL, V34, P979, DOI 10.1093/ije/dyi164; Deeks SG, 2003, LANCET, V362, P2002, DOI 10.1016/S0140-6736(03)15022-2; Frater John, 2002, J HIV Ther, V7, P92; *FRENCH ANRS NAT A, AC11 RES GROUP HIV 1; French MA, 2004, AIDS, V18, P1615, DOI 10.1097/01.aids.0000131375.21070.06; Galvao J, 2002, LANCET, V360, P1862, DOI 10.1016/S0140-6736(02)11775-2; Izopet J, 2000, AIDS, V14, P2247, DOI 10.1097/00002030-200010200-00005; Izopet J, 2002, J INFECT DIS, V185, P1506, DOI 10.1086/340215; *JOINT UN PROGR HI, 2004, UNAIDS REP GLOB AIDS; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; Koenig SP, 2004, AIDS, V18, pS21, DOI 10.1097/00002030-200406003-00005; Kumarasamy N, 2003, AIDS, V17, P2267, DOI 10.1097/00002030-200310170-00019; Kuritzkes DR, 2004, AIDS, V18, pS45, DOI 10.1097/00002030-200406003-00009; Lange JMA, 2004, AIDS, V18, pS69, DOI 10.1097/00002030-200406003-00013; Laurent C, 2002, AIDS, V16, P1363, DOI 10.1097/00002030-200207050-00008; Laurent C, 2004, LANCET, V364, P29, DOI 10.1016/S0140-6736(04)16586-0; Marins JRP, 2003, AIDS, V17, P1675, DOI 10.1097/00002030-200307250-00012; *MED SANS FRONT CA, 2005, MSF HIV AIDS TREATM; Mekonnen Y, 2003, ETHIOPIAN MED J, V41, P61; *MIN HLTH POP MAL, 2004, TREATM AIDS 2 YEAR P; Moatti JP, 2004, AIDS, V18, pS55, DOI 10.1097/00002030-200406003-00011; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; *MSF WHO, 2004, ANT THER PRIM HLTH C; Orrell C, 2003, AIDS, V17, P1369, DOI 10.1097/00002030-200306130-00011; Pasquier C, 1999, J VIROL METHODS, V81, P123, DOI 10.1016/S0166-0934(99)00057-9; Tang AM, 2002, JAIDS-J ACQ IMM DEF, V31, P230, DOI 10.1097/00126334-200210010-00014; Teixeira PR, 2004, AIDS, V18, pS5, DOI 10.1097/00002030-200406003-00002; van der Sande MAB, 2004, JAIDS-J ACQ IMM DEF, V37, P1288, DOI 10.1097/01.qai.0000122708.59121.03; Walsh JC, 2002, AIDS, V16, P269, DOI 10.1097/00002030-200201250-00017; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; *WHO, 2005, PROGR GLOB ACC HIV A; *WHO, 2003, PREQ WHO LIST; *WHO, TREATING 3 MILLION 2; *WHO, GUID SURV HIV DRUG R; *WHO MSF UNAIDS, 2003, JOINT REP PROC ARVS; World Health Organization, 2004, SCAL ANT THER RES LT	46	363	368	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 22	2006	367	9519					1335	1342		10.1016/S0140-6736(06)68580-2	http://dx.doi.org/10.1016/S0140-6736(06)68580-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	037AG	16631912				2022-12-24	WOS:000237118500028
J	Ali, MMU; Roe, SM; Vaughan, CK; Meyer, P; Panaretou, B; Piper, PW; Prodromou, C; Pearl, LH				Ali, MMU; Roe, SM; Vaughan, CK; Meyer, P; Panaretou, B; Piper, PW; Prodromou, C; Pearl, LH			Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex	NATURE			English	Article							HSP90 MOLECULAR CHAPERONE; N-TERMINAL DOMAIN; ESCHERICHIA-COLI HSP90; SHOCK-PROTEIN 90; ATPASE ACTIVITY; CLIENT PROTEIN; STEROID-RECEPTOR; BINDING SITE; IN-VIVO; P23	Hsp90 (heat shock protein of 90 kDa) is a ubiquitous molecular chaperone responsible for the assembly and regulation of many eukaryotic signalling systems and is an emerging target for rational chemotherapy of many cancers. Although the structures of isolated domains of Hsp90 have been determined, the arrangement and ATP-dependent dynamics of these in the full Hsp90 dimer have been elusive and contentious. Here we present the crystal structure of full-length yeast Hsp90 in complex with an ATP analogue and the co-chaperone p23/Sba1. The structure reveals the complex architecture of the 'closed' state of the Hsp90 chaperone, the extensive interactions between domains and between protein chains, the detailed conformational changes in the amino-terminal domain that accompany ATP binding, and the structural basis for stabilization of the closed state by p23/Sba1. Contrary to expectations, the closed Hsp90 would not enclose its client proteins but provides a bipartite binding surface whose formation and disruption are coupled to the chaperone ATPase cycle.	Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England; Kings Coll London, Pharmaceut Sci Res Div, London SE1 9NN, England; Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; King's College London; University of Sheffield	Pearl, LH (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	laurence.pearl@icr.ac.uk	Meyer, Philippe/AAC-6038-2019; Prodromou, Chrisostomos/ABA-9133-2021	Meyer, Philippe/0000-0002-6220-0679; Prodromou, Chrisostomos/0000-0003-4320-1147; Piper, Peter William/0000-0003-4019-2329; Roe, Mark/0000-0002-7371-9855; Pearl, Laurence/0000-0002-6910-1809	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; BOHEN SP, 1993, P NATL ACAD SCI USA, V90, P11424, DOI 10.1073/pnas.90.23.11424; Chadli A, 2000, P NATL ACAD SCI USA, V97, P12524, DOI 10.1073/pnas.220430297; Cheung KMJ, 2005, BIOORG MED CHEM LETT, V15, P3338, DOI 10.1016/j.bmcl.2005.05.046; Fang YF, 1998, MOL CELL BIOL, V18, P3727, DOI 10.1128/MCB.18.7.3727; Harris SF, 2004, STRUCTURE, V12, P1087, DOI 10.1016/j.str.2004.03.020; Harst A, 2005, BIOCHEM J, V387, P789, DOI 10.1042/BJ20041283; Huai Q, 2005, STRUCTURE, V13, P579, DOI 10.1016/j.str.2004.12.018; Immormino RM, 2004, J BIOL CHEM, V279, P46162, DOI 10.1074/jbc.M405253200; JOHNSON JL, 1995, MOL ENDOCRINOL, V9, P670, DOI 10.1210/me.9.6.670; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Louvion JF, 1996, P NATL ACAD SCI USA, V93, P13937, DOI 10.1073/pnas.93.24.13937; McLaughlin SH, 2004, J MOL BIOL, V344, P813, DOI 10.1016/j.jmb.2004.09.055; McLaughlin SH, 2002, J MOL BIOL, V315, P787, DOI 10.1006/jmbi.2001.5245; Meyer P, 2004, EMBO J, V23, P511, DOI 10.1038/sj.emboj.7600060; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Oxelmark E, 2003, J BIOL CHEM, V278, P36547, DOI 10.1074/jbc.M305960200; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Pratt WB, 1998, TRENDS ENDOCRIN MET, V9, P244, DOI 10.1016/S1043-2760(98)00059-9; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Prodromou C, 1997, NAT STRUCT BIOL, V4, P477, DOI 10.1038/nsb0697-477; Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064; Richter K, 2002, J BIOL CHEM, V277, P44905, DOI 10.1074/jbc.M208457200; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Sullivan W, 1997, J BIOL CHEM, V272, P8007, DOI 10.1074/jbc.272.12.8007; Weaver AJ, 2000, J BIOL CHEM, V275, P23045, DOI 10.1074/jbc.M003410200; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; Workman P, 2004, CANCER LETT, V206, P149, DOI 10.1016/j.canlet.2003.08.032; Wright L, 2004, CHEM BIOL, V11, P775, DOI 10.1016/j.chembiol.2004.03.033; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930; Zhang W, 2004, J MOL BIOL, V340, P891, DOI 10.1016/j.jmb.2004.05.007	44	689	710	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 20	2006	440	7087					1013	1017		10.1038/nature04716	http://dx.doi.org/10.1038/nature04716			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16625188	Green Accepted			2022-12-24	WOS:000236906000027
J	Lau, NC; Seto, AG; Kim, J; Kuramochi-Miyagawa, S; Nakano, T; Bartel, DP; Kingston, RE				Lau, Nelson C.; Seto, Anita G.; Kim, Jinkuk; Kuramochi-Miyagawa, Satomi; Nakano, Toru; Bartel, David P.; Kingston, Robert E.			Characterization of the piRNA complex from rat testes	SCIENCE			English	Article							SMALL RNAS; DROSOPHILA; PIWI; GENE; DNA; SPERMATOGENESIS; HETEROCHROMATIN; MAINTENANCE; METHYLATION; TETRAHYMENA	Small noncoding RNAs regulate processes essential for cell growth and development, including mRNA degradation, translational repression, and transcriptional gene silencing (TGS). During a search for candidate mammalian factors for TGS, we purified a complex that contains small RNAs and Riwi, the rat homolog to human Piwi. The RNAs, frequently 29 to 30 nucleotides in length, are called Piwi-interacting RNAs (piRNAs), 94% of which map to 100 defined (<= 101 kb) genomic regions. Within these regions, the piRNAs generally distribute across only one genomic strand or distribute on two strands but in a divergent, nonoverlapping manner. Preparations of piRNA complex ( piRC) contain rRecQ1, which is homologous to qde-3 from Neurospora, a gene implicated in silencing pathways. Piwi has been genetically linked to TGS in flies, and slicer activity cofractionates with the purified complex. These results are consistent with a gene-silencing role for piRC in mammals.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Osaka Univ, Microbial Dis Res Inst, Dept Mol Cell Biol, Suita, Osaka 5650871, Japan; MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Osaka University; Massachusetts Institute of Technology (MIT)	Kingston, RE (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, 185 Cambridge St, Boston, MA 02114 USA.	kingston@molbio.mgh.harvard.edu	Kim, Jinkuk/AAJ-1999-2020	Lau, Nelson/0000-0001-9907-1404				Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2004, MOL CELL BIOL, V24, P6742, DOI 10.1128/MCB.24.15.6742-6750.2004; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Catalanotto C, 2002, GENE DEV, V16, P790, DOI 10.1101/gad.222402; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cui S, 2003, J BIOL CHEM, V278, P1424, DOI 10.1074/jbc.M209407200; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P2052, DOI 10.1093/nar/gki323; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lee SR, 2006, GENE DEV, V20, P28, DOI 10.1101/gad.1377006; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Mochizuki K, 2004, GENE DEV, V18, P2068, DOI 10.1101/gad.1219904; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	26	703	778	7	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2006	313	5785					363	367		10.1126/science.1130164	http://dx.doi.org/10.1126/science.1130164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16778019				2022-12-24	WOS:000239154300048
J	Girard, A; Sachidanandam, R; Hannon, GJ; Carmell, MA				Girard, Angelique; Sachidanandam, Ravi; Hannon, Gregory J.; Carmell, Michelle A.			A germline-specific class of small RNAs binds mammalian Piwi proteins	NATURE			English	Article							DOUBLE-STRANDED-RNA; STEM-CELLS; DROSOPHILA; GENE; SPERMATOGENESIS; INTERFERENCE; MECHANISMS; MACHINERY; DIVISION; ENCODES	Small RNAs associate with Argonaute proteins and serve as sequence-specific guides to regulate messenger RNA stability, protein synthesis, chromatin organization and genome structure(1-3). In animals, Argonaute proteins segregate into two subfamilies(4). The Argonaute subfamily acts in RNA interference and in microRNA-mediated gene regulation using 21 - 22-nucleotide RNAs as guides. The Piwi subfamily is involved in germline-specific events such as germline stem cell maintenance and meiosis. However, neither the biochemical function of Piwi proteins nor the nature of their small RNA guides is known. Here we show that MIWI, a murine Piwi protein, binds a previously uncharacterized class of similar to 29-30-nucleotide RNAs that are highly abundant in testes. We have therefore named these Piwi-interacting RNAs (piRNAs). piRNAs show distinctive localization patterns in the genome, being predominantly grouped into 20-90-kilobase clusters, wherein long stretches of small RNAs are derived from only one strand. Similar piRNAs are also found in human and rat, with major clusters occurring in syntenic locations. Although their function must still be resolved, the abundance of piRNAs in germline cells and the male sterility of Miwi mutants suggest a role in gametogenesis.	Watson Sch Biol Sci, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Ecole Natl Super Mines, F-75272 Paris, France	Cold Spring Harbor Laboratory; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech	Hannon, GJ (corresponding author), Watson Sch Biol Sci, Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Hannon, Gregory/AAB-3568-2019; sachidanandam, ravi/Q-6916-2019	sachidanandam, ravi/0000-0001-9844-4459				Ambros Victor, 2004, Methods Mol Biol, V265, P131; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravin AA, 2004, MOL CELL BIOL, V24, P6742, DOI 10.1128/MCB.24.15.6742-6750.2004; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P2052, DOI 10.1093/nar/gki323; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lin HF, 1997, DEVELOPMENT, V124, P2463; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Savitsky M, 2006, GENE DEV, V20, P345, DOI 10.1101/gad.370206; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; VAGIN VV, 2004, RNA BIOL, V1, P51; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102	25	1165	1279	2	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2006	442	7099					199	202		10.1038/nature04917	http://dx.doi.org/10.1038/nature04917			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062XJ	16751776				2022-12-24	WOS:000238979700047
J	Crickmore, MA; Mann, RS				Crickmore, Michael A.; Mann, Richard S.			Hox control of organ size by regulation of morphogen production and mobility	SCIENCE			English	Article							WING IMAGINAL DISC; DPP MORPHOGEN; CELL-PROLIFERATION; GRADIENT FORMATION; DARWINS FINCHES; DROSOPHILA; GENES; PATTERN; HEDGEHOG; RECEPTORS	Selector genes modify developmental pathways to sculpt animal body parts. Although body parts differ in size, the ways in which selector genes create size differences are unknown. We have studied how the Drosophila Hox gene Ultrabithorax (Ubx) limits the size of the haltere, which, by the end of larval development, has similar to fivefold fewer cells than the wing. We find that Ubx controls haltere size by restricting both the transcription and the mobility of the morphogen Decapentaplegic (Dpp). Ubx restricts Dpp's distribution in the haltere by increasing the amounts of the Dpp receptor, thickveins. Because morphogens control tissue growth in many contexts, these findings provide a potentially general mechanism for how selector genes modify organ sizes.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University; Columbia University	Mann, RS (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, HHSC 1104,701 W 168th St, New York, NY 10032 USA.	rsm10@columbia.edu			NIGMS NIH HHS [R01 GM054510, R01 GM054510-13, R01 GM054510-14, R01 GM058575, R01 GM054510-12] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054510, R01GM058575] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BEACHY PA, 1985, NATURE, V313, P545, DOI 10.1038/313545a0; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; BURKE AC, 1995, DEVELOPMENT, V121, P333; Burke R, 1996, DEVELOPMENT, V122, P2261; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x; CARROLL SB, 1995, NATURE, V375, P58, DOI 10.1038/375058a0; CASANOVA J, 1993, NATURE, V362, P152, DOI 10.1038/362152a0; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Cohen S. M., 1993, DEV DROSOPHILA MELAN, P747; Day SJ, 2000, DEVELOPMENT, V127, P2977; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Funakoshi Y, 2001, DEVELOPMENT, V128, P67; Grant PR, 2005, CURR BIOL, V15, pR614, DOI 10.1016/j.cub.2005.08.014; GUILLEN I, 1995, DEVELOPMENT, V121, P3447; Haerry TE, 1998, DEVELOPMENT, V125, P3977; KESSEL M, 1991, CELL, V67, P89, DOI 10.1016/0092-8674(91)90574-I; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lecuit T, 1998, DEVELOPMENT, V125, P4901; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MARTIN PF, 1982, J EXP ZOOL, V222, P97, DOI 10.1002/jez.1402220113; MORATA G, 1976, ROUX ARCH DEV BIOL, V179, P125, DOI 10.1007/BF00848298; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Roch F, 2000, DEVELOPMENT, V127, P97; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; SEKELSKY JJ, 1995, GENETICS, V139, P1347; TABATA T, 1995, DEVELOPMENT, V121, P3359; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262; ZECCA M, 1995, DEVELOPMENT, V121, P2265	39	120	120	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 7	2006	313	5783					63	68		10.1126/science.1128650	http://dx.doi.org/10.1126/science.1128650			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	061DA	16741075	Green Accepted			2022-12-24	WOS:000238850200029
J	Sosnay, PR; Kim, S				Sosnay, PR; Kim, S			Hypothyroid-induced hyporeflexia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Sosnay, PR (corresponding author), Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA.								0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2006	354	26					E27	E27		10.1056/NEJMicm050622	http://dx.doi.org/10.1056/NEJMicm050622			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057GQ	16807409				2022-12-24	WOS:000238584700009
J	Pisitkun, P; Deane, JA; Difilippantonio, MJ; Tarasenko, T; Satterthwaite, AB; Bolland, S				Pisitkun, Prapaporn; Deane, Jonathan A.; Difilippantonio, Michael J.; Tarasenko, Tatyana; Satterthwaite, Anne B.; Bolland, Silvia			Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication	SCIENCE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; TOLL-LIKE RECEPTORS; DEFICIENT MICE; YAA MUTATION; Y-CHROMOSOME; DISEASE; ENGAGEMENT; BTK	Antibodies against nuclear self-antigens are characteristic of systemic autoimmunity, although mechanisms promoting their generation and selection are unclear. Here, we report that B cells containing the Y-linked autoimmune accelerator (Yaa) locus are intrinsically biased toward nucleolar antigens because of increased expression of TLR7, a single-stranded RNA-binding innate immune receptor. The TLR7 gene is duplicated in Yaa mice because of a 4-Megabase expansion of the pseudoautosomal region. These results reveal high divergence in mouse Y chromosomes and represent a good example of gene copy number qualitatively altering a polygenic disease manifestation.	NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; NCI, Sect Canc Genom, Henet Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; Univ Texas SW, Dept Internal Med, Dallas, TX 75390 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; University of Texas Southwestern Medical Center Dallas	Bolland, S (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	sbolland@nih.gov	Difilippantonio, Michael/AAF-2839-2021	Difilippantonio, Michael/0000-0002-4676-7034	Intramural NIH HHS [Z99 CA999999] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000912] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amano H, 2003, J IMMUNOL, V170, P2293, DOI 10.4049/jimmunol.170.5.2293; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Bolland S, 2002, J EXP MED, V195, P1167, DOI 10.1084/jem.20020165; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Dal Zotto L, 1998, HUM MOL GENET, V7, P489, DOI 10.1093/hmg/7.3.489; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; FOSSATI L, 1995, EUR J IMMUNOL, V25, P166, DOI 10.1002/eji.1830250128; IZUI S, 1995, IMMUNOL REV, V144, P137, DOI 10.1111/j.1600-065X.1995.tb00068.x; IZUI S, 1988, EUR J IMMUNOL, V18, P911, DOI 10.1002/eji.1830180612; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Leslie D, 2001, J CLIN INVEST, V108, P1417, DOI 10.1172/JCI200114452; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mary C, 2000, J IMMUNOL, V165, P2987, DOI 10.4049/jimmunol.165.6.2987; Moll T, 2005, J IMMUNOL, V174, P702, DOI 10.4049/jimmunol.174.2.702; Morel L, 2000, P NATL ACAD SCI USA, V97, P6670, DOI 10.1073/pnas.97.12.6670; MURPHY ED, 1979, ARTHRITIS RHEUM, V22, P1188, DOI 10.1002/art.1780221105; Nadeau JH, 2006, NATURE, V439, P798, DOI 10.1038/439798a; Ng YS, 2004, J EXP MED, V200, P927, DOI 10.1084/jem.20040920; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Vollmer J, 2005, J EXP MED, V202, P1575, DOI 10.1084/jem.20051696; WEINER ES, 1991, ARTHRITIS RHEUM, V34, P68, DOI 10.1002/art.1780340111	23	639	667	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1669	1672		10.1126/science.1124978	http://dx.doi.org/10.1126/science.1124978			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16709748				2022-12-24	WOS:000238288600051
J	Bjork, A; Pitnick, S				Bjork, Adam; Pitnick, Scott			Intensity of sexual selection along the anisogamy-isogamy continuum	NATURE			English	Article							SPERM COMPETITION; EVOLUTION; SIZE; EJACULATE; TESTES; COST; LONG	Research into the evolution of giant sperm has uncovered a paradox within the foundations of sexual selection theory. Post-copulatory sexual selection on males ( that is, sperm competition and cryptic female choice) can lead to decreased sperm numbers by favouring the production of larger sperm(1). However, a decline in sperm numbers is predicted to weaken selection on males and increase selection on females(2,3). As isogamy is approached ( that is, as investment per gamete by males approaches that by females), sperm become less abundant, ova become relatively less rare, and competition between males for fertilization success is predicted to weaken. Sexual selection for longer sperm, therefore, is expected to be self limiting. Here we examine this paradox in Drosophila along the anisogamy-isogamy continuum using intraspecific experimental evolution techniques and interspecific comparative techniques. Our results confirm the big-sperm paradox by showing that the sex difference in sexual selection gradients(4) decreases as sperm size increases. However, a resolution to the paradox is provided when this finding is interpreted in concert with the 'opportunity for selection' and the 'opportunity for sexual selection'(5,6). Furthermore, we show that most of the variation in measures of selection intensity is explained by sperm length and relative investment in sperm production.	Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University	Bjork, A (corresponding author), Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA.	acbjork@syr.edu		Bjork, Adam/0000-0001-7544-2987				Andersson Malte, 1994; ARNOLD SJ, 1994, AM NAT, V144, pS126, DOI 10.1086/285656; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BRISKIE JV, 1992, P ROY SOC B-BIOL SCI, V247, P89, DOI 10.1098/rspb.1992.0013; CLUTTONBROCK TH, 1992, Q REV BIOL, V67, P437, DOI 10.1086/417793; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; GAGE MJG, 1994, P ROY SOC B-BIOL SCI, V258, P247, DOI 10.1098/rspb.1994.0169; Joly D., 1991, DROSOPHILA INFORMATI, V70, P104; Jones AG, 2004, AM NAT, V164, P444, DOI 10.1086/423826; Jones AG, 2000, P ROY SOC B-BIOL SCI, V267, P677, DOI 10.1098/rspb.2000.1055; Jones AG, 2002, P ROY SOC B-BIOL SCI, V269, P2533, DOI 10.1098/rspb.2002.2177; Karr TL, 1996, NATURE, V379, P405, DOI 10.1038/379405a0; Kokko H, 2003, TRENDS ECOL EVOL, V18, P103, DOI 10.1016/S0169-5347(03)00009-0; LaMunyon CW, 2002, P ROY SOC B-BIOL SCI, V269, P1125, DOI 10.1098/rspb.2002.1996; Lorch PD, 2002, AM NAT, V159, P645, DOI 10.1086/339992; MARKOW TA, 1992, J INSECT BEHAV, V5, P375, DOI 10.1007/BF01049845; Miller GT, 2002, SCIENCE, V298, P1230, DOI 10.1126/science.1076968; PARKER GA, 1972, J THEOR BIOL, V36, P529, DOI 10.1016/0022-5193(72)90007-0; PARKER GA, 1982, J THEOR BIOL, V96, P281, DOI 10.1016/0022-5193(82)90225-9; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; PITNICK S, 1995, NATURE, V375, P109, DOI 10.1038/375109a0; Pitnick S, 1997, EVOLUTION, V51, P833, DOI [10.2307/2411158, 10.1111/j.1558-5646.1997.tb03665.x]; Pitnick S, 1996, AM NAT, V148, P57, DOI 10.1086/285911; PITNICK S, 1994, AM NAT, V143, P785, DOI 10.1086/285633; PITNICK S, 1995, P NATL ACAD SCI USA, V92, P10614, DOI 10.1073/pnas.92.23.10614; SHUSTER SM, 2003, MG BEH ECOL, pR7; Trivers R. L, 1972, SEXUAL SELECTION DES, P52; WADE MJ, 1979, AM NAT, V114, P742, DOI 10.1086/283520; WADE MJ, 1980, ANIM BEHAV, V28, P446, DOI 10.1016/S0003-3472(80)80052-2	29	84	85	2	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 8	2006	441	7094					742	745		10.1038/nature04683	http://dx.doi.org/10.1038/nature04683			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760976	Green Published			2022-12-24	WOS:000238095100052
J	Shultis, DD; Purdy, MD; Banchs, CN; Wiener, MC				Shultis, David D.; Purdy, Michael D.; Banchs, Christian N.; Wiener, Michael C.			Outer membrane active transport: Structure of the BtuB : TonB complex	SCIENCE			English	Article							C-TERMINAL DOMAIN; ESCHERICHIA-COLI; NUCLEOTIDE-SEQUENCE; CRYSTAL-STRUCTURE; IRON TRANSPORT; RECEPTOR; FHUA; REVEALS; GENE; PROTEINS	In Gram-negative bacteria, the import of essential micronutrients across the outer membrane requires a transporter, an electrochemical gradient of protons across the inner membrane, and an inner membrane protein complex (ExbB, ExbD, TonB) that couples the proton-motive force to the outer membrane transporter. The inner membrane protein TonB binds directly to a conserved region, called the Ton-box, of the transporter. We solved the structure of the cobalamin transporter BtuB in complex with the C-terminal domain of TonB. In contrast to its conformations in the absence of TonB, the Ton-box forms a beta strand that is recruited to the existing b sheet of TonB, which is consistent with a mechanical pulling model of transport.	Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; Univ Virginia, Interdisciplinary Grad Program Biophys, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Wiener, MC (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.	mwiener@virginia.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059999] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK59999] Funding Source: Medline; NIGMS NIH HHS [GM00Z055] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Braun V, 2002, FEBS LETT, V529, P78, DOI 10.1016/S0014-5793(02)03185-X; Braun Volkmar, 2005, V12, P210, DOI 10.1159/000081697; Brockwell DJ, 2003, NAT STRUCT BIOL, V10, P731, DOI 10.1038/nsb968; Cadieux N, 1999, P NATL ACAD SCI USA, V96, P10673, DOI 10.1073/pnas.96.19.10673; Cadieux N, 2000, J BACTERIOL, V182, P5954, DOI 10.1128/JB.182.21.5954-5961.2000; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Chimento DP, 2003, NAT STRUCT BIOL, V10, P394, DOI 10.1038/nsb914; Chimento DP, 2005, PROTEINS, V59, P240, DOI 10.1002/prot.20416; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eisenhauer HA, 2005, J BIOL CHEM, V280, P30574, DOI 10.1074/jbc.M506708200; Endriss F, 2003, J BACTERIOL, V185, P4683, DOI 10.1128/JB.185.16.4683-4692.2003; Ferguson AD, 2004, CELL, V116, P15, DOI 10.1016/S0092-8674(03)01030-4; Ghosh J, 2005, MOL MICROBIOL, V55, P276, DOI 10.1111/j.1365-2958.2004.04384.x; HELLER KJ, 1988, GENE, V64, P147, DOI 10.1016/0378-1119(88)90488-X; Howard SP, 2001, J BACTERIOL, V183, P5885, DOI 10.1128/JB.183.20.5885-5895.2001; KADNER RJ, 1990, MOL MICROBIOL, V4, P2027, DOI 10.1111/j.1365-2958.1990.tb00562.x; Khursigara CM, 2004, J BIOL CHEM, V279, P7405, DOI 10.1074/jbc.M311784200; Klebba PE, 2003, FRONT BIOSCI, V8, pS1422, DOI 10.2741/1233; Kodding J, 2005, J BIOL CHEM, V280, P3022, DOI 10.1074/jbc.M411155200; Lubkowski J, 1999, STRUCTURE, V7, P711, DOI 10.1016/S0969-2126(99)80092-6; LUNDRIGAN MD, 1986, J BIOL CHEM, V261, P797; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Ogierman M, 2003, J BACTERIOL, V185, P1870, DOI 10.1128/JB.185.6.1870-1885.2003; Peacock RS, 2005, J MOL BIOL, V345, P1185, DOI 10.1016/j.jmb.2004.11.026; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; Sauter A, 2003, J BACTERIOL, V185, P5747, DOI 10.1128/JB.185.19.5747-5754.2003; SCHRAMM E, 1987, J BACTERIOL, V169, P3350, DOI 10.1128/jb.169.7.3350-3357.1987; TUCKMAN M, 1992, J BACTERIOL, V174, P320, DOI 10.1128/jb.174.1.320-323.1992; Wiener MC, 2005, CURR OPIN STRUC BIOL, V15, P394, DOI 10.1016/j.sbi.2005.07.001; Zhai YF, 2003, BBA-BIOMEMBRANES, V1614, P201, DOI 10.1016/S0005-2736(03)00176-7	31	225	233	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 2	2006	312	5778					1396	1399		10.1126/science.1127694	http://dx.doi.org/10.1126/science.1127694			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741124				2022-12-24	WOS:000237961600060
J	Imai, KS; Levine, M; Satoh, N; Satou, Y				Imai, Kaoru S.; Levine, Michael; Satoh, Nori; Satou, Yutaka			Regulatory blueprint for a chordate embryo	SCIENCE			English	Article							CIONA-SAVIGNYI EMBRYOS; INTESTINALIS EMBRYOS; ASCIDIAN EMBRYOS; BETA-CATENIN; GENE; NOTOCHORD; DIFFERENTIATION; EXPRESSION; INDUCTION; MUSCLE	Ciona is an emerging model system for elucidating gene networks in development. Comprehensive in situ hybridization assays have identified 76 regulatory genes with localized expression patterns in the early embryo, at the time when naive blastomeres are determined to follow specific cell fates. Systematic gene disruption assays provided more than 3000 combinations of gene expression profiles in mutant backgrounds. Deduced gene circuit diagrams describing the formation of larval tissues were computationally visualized. These diagrams constitute a blueprint for the Ciona embryo and provide a foundation for understanding the evolutionary origins of the chordate body plan.	Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan; Univ Calif Berkeley, Dept Mol & Cellular Biol, Div Genet & Dev, Berkeley, CA 94720 USA	Kyoto University; University of California System; University of California Berkeley	Satou, Y (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan.	yutaka@ascidian.zool.kyoto-u.ac.jp	Satou, Yutaka/AAJ-2194-2021; Satou, Yutaka/K-7131-2012; Satoh, Nori/C-4123-2009	Satou, Yutaka/0000-0001-5193-0708; Satou, Yutaka/0000-0001-5193-0708; Satoh, Nori/0000-0002-4480-3572; Levine, Michael/0000-0001-7629-0081; Imai, Kaoru/0000-0001-9113-6074				Agius E, 2000, DEVELOPMENT, V127, P1173; Bertrand V, 2003, CELL, V115, P615, DOI 10.1016/S0092-8674(03)00928-0; Corbo JC, 1997, DEVELOPMENT, V124, P2335; Corbo JC, 1997, DEVELOPMENT, V124, P589; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Duboc V, 2004, DEV CELL, V6, P397, DOI 10.1016/S1534-5807(04)00056-5; Fujiwara S, 1998, DEVELOPMENT, V125, P2511; Hudson C, 2005, DEVELOPMENT, V132, P1199, DOI 10.1242/dev.01688; Imai K, 2000, DEVELOPMENT, V127, P3009; Imai KS, 2004, DEVELOPMENT, V131, P4047, DOI 10.1242/dev.01270; Imai KS, 2002, DEVELOPMENT, V129, P2723; Imai KS, 2002, DEVELOPMENT, V129, P1729; Imai KS, 2002, DEVELOPMENT, V129, P3441; Katsube KI, 2005, INT J DEV BIOL, V49, P369, DOI 10.1387/ijdb.041950kk; Loose M, 2004, DEV BIOL, V271, P467, DOI 10.1016/j.ydbio.2004.04.014; Nishida H, 2001, NATURE, V409, P724, DOI 10.1038/35055568; Satoh N, 2003, NAT REV GENET, V4, P285, DOI 10.1038/nrg1042; Satou Y, 2002, DEV GENES EVOL, V212, P87, DOI 10.1007/s00427-002-0218-3; Satou Y, 2001, DEVELOPMENT, V128, P3559; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; Takahashi H, 1999, GENE DEV, V13, P1519, DOI 10.1101/gad.13.12.1519; Takatori N, 2002, MECH DEVELOP, V116, P235, DOI 10.1016/S0925-4773(02)00150-8; Tokuoka M, 2005, DEV BIOL, V288, P387, DOI 10.1016/j.ydbio.2005.09.018; Whitman M, 2001, DEV CELL, V1, P605, DOI 10.1016/S1534-5807(01)00076-4; Yagi K, 2005, DEV BIOL, V282, P535, DOI 10.1016/j.ydbio.2005.03.029; Yamada L, 2003, DEVELOPMENT, V130, P6485, DOI 10.1242/dev.00847	27	280	285	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1183	1187		10.1126/science.1123404	http://dx.doi.org/10.1126/science.1123404			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16728634				2022-12-24	WOS:000237957400045
J	Gridi-Papp, M; Rand, AS; Ryan, MJ				Gridi-Papp, M; Rand, AS; Ryan, MJ			Animal communication: Complex call production in the tungara frog	NATURE			English	Article							PHYSALAEMUS-PUSTULOSUS; SEXUAL SELECTION; MORPHOLOGY; SYRINX		Smithsonian Trop Res Inst, Balboa, Panama; Univ Texas, Sect Integrat Biol, Austin, TX 78712 USA; Univ Estadual Paulista, Inst Biociencias, Dept Zool, BR-13506900 Sao Paulo, Brazil	Smithsonian Institution; Smithsonian Tropical Research Institute; University of Texas System; University of Texas Austin; Universidade de Sao Paulo; Universidade Estadual Paulista	Gridi-Papp, M (corresponding author), Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA.	mryan@mail.utexas.edu						Boul KE, 2004, COPEIA, P624, DOI 10.1643/CH-03-153R2; DREWRY GE, 1982, COPEIA, P636, DOI 10.2307/1444664; Fee MS, 1998, NATURE, V395, P67, DOI 10.1038/25725; Fitch WT, 2002, ANIM BEHAV, V63, P407, DOI 10.1006/anbe.2001.1912; Greenwalt C.H., 1968, BIRD SONG ACOUSTICS; Ryan M.J., 1985, TUNGARA FROG; RYAN MJ, 1990, NATURE, V343, P66, DOI 10.1038/343066a0; RYAN MJ, 1980, SCIENCE, V209, P523, DOI 10.1126/science.209.4455.523; RYAN MJ, 1990, BIOL J LINN SOC, V40, P37, DOI 10.1111/j.1095-8312.1990.tb00533.x; SUTHERS RA, 1990, NATURE, V347, P473, DOI 10.1038/347473a0	10	78	80	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2006	441	7089					38	38		10.1038/441038a	http://dx.doi.org/10.1038/441038a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16672962				2022-12-24	WOS:000237248600025
J	Watts, G				Watts, G			You need hands	LANCET			English	Editorial Material							TEACHERS GESTURES				Watts, G (corresponding author), 28 New End Sq, London NW3 1LS, England.	geoff@scileg.freeserve.co.uk						Goldin-Meadow S., 2003, HEARING GESTURE OUR; GOLDINMEADOW S, 2006, ADV SCI SERV SOC M S; NICOLADIS E, 2005, 10 INT ASS STUD CHIL; Perry M., 1995, CONT LEGAL ISSUES, V6, P213; Singer MA, 2005, PSYCHOL SCI, V16, P85, DOI 10.1111/j.0956-7976.2005.00786.x; Valenzeno L, 2003, CONTEMP EDUC PSYCHOL, V28, P187, DOI 10.1016/S0361-476X(02)00007-3; Wagner SM, 2004, J MEM LANG, V50, P395, DOI 10.1016/j.jml.2004.01.002	7	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2006	367	9520					1383	1384		10.1016/S0140-6736(06)68595-4	http://dx.doi.org/10.1016/S0140-6736(06)68595-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650637				2022-12-24	WOS:000237195600011
J	Midorikawa, R; Takei, Y; Hirokawa, N				Midorikawa, R; Takei, Y; Hirokawa, N			KIF4 motor regulates activity-dependent neuronal survival by suppressing PARP-1 enzymatic activity	CELL			English	Article							NF-KAPPA-B; POLY(ADP-RIBOSE) POLYMERASE-1; NERVOUS-SYSTEM; DNA FRAGMENTATION; NUCLEAR CALCIUM; KINESIN; PROTEIN; TRANSCRIPTION; EXPRESSION; DEATH	In brain development, apoptosis is a physiological process that controls the final numbers of neurons. Here, we report that the activity-dependent prevention of apoptosis in juvenile neurons is regulated by kinesin superfamily protein 4 (KIF4), a microtubule-based molecular motor. The C-terminal domain of KIF4 is a module that suppresses the activity of poly (ADPribose) polymerase-1 (PARP-1), a nuclear enzyme known to maintain cell homeostasis by repairing DNA and serving as a transcriptional regulator. When neurons are stimulated by membrane depolarization, calcium signaling mediated by CaMKII induces dissociation of KIF4 from PARP-1, resulting in upregulation of PARP-1 activity, which supports neuron survival. After dissociation from PARP-1, KIF4 enters into the cytoplasm from the nucleus and moves to the distal part of neurites in a microtubule-dependent manner. We suggested that KIF4 controls the activity-dependent survival of postmitotic neurons by regulating PARP-1 activity in brain development.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp	Takei, Yosuke/I-1828-2015	Takei, Yosuke/0000-0002-5026-8027; Midorikawa, Ryosuke/0000-0002-5163-7744				AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Althaus F R, 1987, Mol Biol Biochem Biophys, V37, P1; Bhakar AL, 2002, J NEUROSCI, V22, P8466; Chang WJ, 2001, J BIOL CHEM, V276, P47664, DOI 10.1074/jbc.M104666200; Chiarugi A, 2003, J NEUROCHEM, V85, P306, DOI 10.1046/j.1471-4159.2003.01684.x; Cohen-Armon M, 2004, SCIENCE, V304, P1820, DOI 10.1126/science.1096775; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; DIDIER M, 1994, EUR J NEUROSCI, V6, P1536, DOI 10.1111/j.1460-9568.1994.tb00544.x; FERRARI G, 1989, DEV BIOL, V133, P140, DOI 10.1016/0012-1606(89)90305-9; FRANKLIN JL, 1992, TRENDS NEUROSCI, V15, P501, DOI 10.1016/0166-2236(92)90103-F; GALLO V, 1992, J NEUROCHEM, V58, P406, DOI 10.1111/j.1471-4159.1992.tb09737.x; Garnier P, 2003, J NEUROSCI, V23, P7967; Gilliams-Francis KL, 2003, EXP NEUROL, V184, P359, DOI 10.1016/j.expneurol.2003.07.003; Griesenbeck J, 1999, FEBS LETT, V443, P20, DOI 10.1016/S0014-5793(98)01671-8; Ha HC, 2000, NEUROBIOL DIS, V7, P225, DOI 10.1006/nbdi.2000.0324; Hardingham GE, 1998, CELL CALCIUM, V23, P131, DOI 10.1016/S0143-4160(98)90111-7; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; HORNBURG S, 2000, J CELL BIOL, V150, P293; Ikeuchi T, 1998, Hum Cell, V11, P125; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; KALTSCHMIDT C, 1995, P NATL ACAD SCI USA, V92, P9618, DOI 10.1073/pnas.92.21.9618; Kawahara A, 1998, GENES CELLS, V3, P297, DOI 10.1046/j.1365-2443.1998.00189.x; KOCSIS JD, 1994, J NEUROBIOL, V25, P252, DOI 10.1002/neu.480250306; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Lee YM, 2001, BIOCHEM J, V360, P549, DOI 10.1042/0264-6021:3600549; Lin WW, 1997, J NEUROCHEM, V68, P2577; Macho B, 2002, SCIENCE, V298, P2388, DOI 10.1126/science.1077265; Malviya AN, 1998, CELL, V92, P17, DOI 10.1016/S0092-8674(00)80895-8; Mandir AS, 2000, J NEUROSCI, V20, P8005; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; Nicoletti VG, 2003, NEUROCHEM RES, V28, P187, DOI 10.1023/A:1022316914492; Oh S, 2000, BBA-GENE STRUCT EXPR, V1493, P219, DOI 10.1016/S0167-4781(00)00151-2; Ozaki M, 2004, J NEUROCHEM, V91, P176, DOI 10.1111/j.1471-4159.2004.02719.x; Peretti D, 2000, J CELL BIOL, V149, P141, DOI 10.1083/jcb.149.1.141; Putcha GV, 2002, J CELL BIOL, V157, P441, DOI 10.1083/jcb.200110108; SCHRAUFSTATTER IU, 1988, METHOD ENZYMOL, V163, P328; SCOVASSI AI, 1984, J BIOL CHEM, V259, P973; SEKINE Y, 1994, J CELL BIOL, V127, P187, DOI 10.1083/jcb.127.1.187; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; VERNOS I, 1995, CELL, V81, P117, DOI 10.1016/0092-8674(95)90376-3; WANG SZ, 1995, J CELL BIOL, V128, P761, DOI 10.1083/jcb.128.5.761; Weller M, 1997, J NEURAL TRANSM-SUPP, P115; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	47	91	95	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					371	383		10.1016/j.cell.2006.02.039	http://dx.doi.org/10.1016/j.cell.2006.02.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630823	Bronze			2022-12-24	WOS:000237241500025
J	Kamei, M; Saunders, WB; Bayless, KJ; Dye, L; Davis, GE; Weinstein, BM				Kamei, Makoto; Saunders, W. Brian; Bayless, Kayla J.; Dye, Louis; Davis, George E.; Weinstein, Brant M.			Endothelial tubes assemble from intracellular vacuoles in vivo	NATURE			English	Article							3-DIMENSIONAL EXTRACELLULAR MATRICES; CAPILLARY LUMEN FORMATION; CELL MORPHOGENESIS; FIBRIN MATRICES; ZEBRAFISH; ANGIOGENESIS; MECHANISM; COLLAGEN; INTEGRIN; CAVEOLAE	The formation of epithelial tubes is crucial for the proper development of many different tissues and organs, and occurs by means of a variety of different mechanisms(1). Morphogenesis of seamless, properly patterned endothelial tubes is essential for the development of a functional vertebrate circulatory system, but the mechanism of vascular lumenization in vivo remains unclear. Evidence dating back more than 100 years has hinted at an important function for endothelial vacuoles in lumen formation(2). More than 25 years ago, in some of the first endothelial cell culture experiments in vitro, Folkman and Haudenschild described "longitudinal vacuoles" that "appeared to be extruded and connected from one cell to the next"(3,4), observations confirmed and extended by later studies in vitro showing that intracellular vacuoles arise from integrin-dependent and cdc42/Rac1-dependent pinocytic events downstream of integrin - extracellular-matrix signalling interactions(5-10). Despite compelling data supporting a model for the assembly of endothelial tubes in vitro through the formation and fusion of vacuoles, conclusive evidence in vivo has been lacking, primarily because of difficulties associated with imaging the dynamics of subcellular endothelial vacuoles deep within living animals. Here we use high-resolution time-lapse two-photon imaging of transgenic zebrafish to examine how endothelial tubes assemble in vivo, comparing our results with time-lapse imaging of human endothelial-cell tube formation in three-dimensional collagen matrices in vitro. Our results provide strong support for a model in which the formation and intracellular and intercellular fusion of endothelial vacuoles drives vascular lumen formation.	NICHHD, Mol Genet Lab, NIH, Bethesda, MD 20892 USA; NICHHD, Microscopy & Imaging Core, NIH, Bethesda, MD 20892 USA; Texas A&M Univ Syst, Hlth Sci Ctr, Dept Pathol, College Stn, TX 77843 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Weinstein, BM (corresponding author), NICHHD, Mol Genet Lab, NIH, Bethesda, MD 20892 USA.	bw96w@nih.gov		Kamei, Makoto/0000-0002-1438-0783	Intramural NIH HHS Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001011] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001011] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9; Bayless KJ, 2002, J CELL SCI, V115, P1123; Berry KL, 2003, SCIENCE, V302, P2134, DOI 10.1126/science.1087667; Buechner M, 2002, TRENDS CELL BIOL, V12, P479, DOI 10.1016/S0962-8924(02)02364-4; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Carver LA, 2003, NAT REV CANCER, V3, P571, DOI 10.1038/nrc1146; Childs S, 2002, DEVELOPMENT, V129, P973; Davis GE, 2000, IN VITRO CELL DEV-AN, V36, P513; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Davis GE, 2003, MICROCIRCULATION, V10, P27, DOI 10.1038/sj.mn.7800175; Davis GE, 2002, ANAT RECORD, V268, P252, DOI 10.1002/ar.10159; Downs KM, 2003, MICROCIRCULATION, V10, P5, DOI 10.1038/sj.mn.7800171; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; FOLKMAN J, 1980, T OPHTHAL SOC UK, V100, P346; HANCOCK JF, 1991, EMBO J, V10, P641, DOI 10.1002/j.1460-2075.1991.tb07992.x; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Kamei M, 2004, METHOD CELL BIOL, V76, P51; Kamei M, 2005, ZEBRAFISH, V2, P113, DOI 10.1089/zeb.2005.2.113; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Manning Gerards, 1993, P609; Paul SM, 2003, SCIENCE, V302, P2077, DOI 10.1126/science.1093203; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Schnitzer JE, 2001, ADV DRUG DELIVER REV, V49, P265, DOI 10.1016/S0169-409X(01)00141-7; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Torres-Vazquez J, 2004, DEV CELL, V7, P117, DOI 10.1016/j.devcel.2004.06.008; Weinstein BM, 2002, TRENDS CELL BIOL, V12, P439, DOI 10.1016/S0962-8924(02)02358-9; WESTERFIELD M, 1995, ZEBRAFISH BOOK	30	356	372	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 27	2006	442	7101					453	456		10.1038/nature04923	http://dx.doi.org/10.1038/nature04923			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16799567				2022-12-24	WOS:000239278900043
J	Healton, CG; Vallone, D; McCausland, KL; Xiao, HJ; Green, MP				Healton, CG; Vallone, D; McCausland, KL; Xiao, HJ; Green, MP			Smoking, obesity, and their co-occurrence in the United States: cross sectional analysis	BRITISH MEDICAL JOURNAL			English	Article							RISK-FACTORS; CESSATION; PREVALENCE; OVERWEIGHT; ADULTS	Objectives To describe the prevalence of obesity, smoking, and both health risk factors together among adults in the United States. Design Cross sectional analysis of a national health interview survey. Setting United States. Participants 29 305 adults (aged >= 18) in 2002. Main outcome measures Prevalence of adults who are obese (body mass index >= 30), who smoke, and who are obese and smoke. Prevalence was stratified by age, sex, ethnic group, education, and income. Results 23.5% of adults were obese, 22.7% smoked, and 4.7% smoked and were obese. Conclusions Although die proportion of adults who smoke and are obese is relatively low, this subgroup is concentrated among lower socioeconomic groups.	Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10027 USA; Amer Legacy Fdn, Washington, DC 20036 USA	Columbia University	Healton, CG (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10027 USA.	chealton@americanlegacy.org						Centers for Disease Control and Prevention, 2004, MMWR-MORBID MORTAL W, V53, P427; Copeland AL, 2006, ADDICT BEHAV, V31, P115, DOI 10.1016/j.addbeh.2005.04.020; FLEGAL KM, 1995, NEW ENGL J MED, V333, P1165, DOI 10.1056/NEJM199511023331801; Greenlund KJ, 2004, ARCH INTERN MED, V164, P181, DOI 10.1001/archinte.164.2.181; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Marrero JA, 2005, J HEPATOL, V42, P218, DOI 10.1016/j.jhep.2004.10.005; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106	8	63	64	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 1	2006	333	7557					25	26		10.1136/bmj.38840.608704.80	http://dx.doi.org/10.1136/bmj.38840.608704.80			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062CT	16698804	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000238922900023
J	Mora, C; Andrefouet, S; Costello, MJ; Kranenburg, C; Rollo, A; Veron, J; Gaston, KJ; Myers, RA				Mora, Camilo; Andrefouet, Serge; Costello, Mark J.; Kranenburg, Christine; Rollo, Audrey; Veron, John; Gaston, Kevin J.; Myers, Ransom A.			Coral reefs and the global network of marine protected areas	SCIENCE			English	Editorial Material							POPULATIONS		Univ Auckland, Leigh Marine Lab, Warkworth, New Zealand; Dalhousie Univ, Dept Biol Sci, Halifax, NS B4H 4J1, Canada; Inst Rech Dev, Noumea, New Caledonia; Univ S Florida, Inst Marine Remote Sensing, St Petersburg, FL 33701 USA; Australian Inst Marine Sci, Townsville, Qld 4810, Australia; Univ Sheffield, Biodivers & Macroecol Grp, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Auckland; Dalhousie University; Institut de Recherche pour le Developpement (IRD); State University System of Florida; University of South Florida; Australian Institute of Marine Science; University of Sheffield	Mora, C (corresponding author), Univ Auckland, Leigh Marine Lab, POB 349, Warkworth, New Zealand.	moracamilo@hotmail.com	Costello, Mark/C-9267-2013	Costello, Mark/0000-0003-2362-0328				Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Burke L., 2004, REEFS RISK CARIBBEAN; Burke L., 2002, REEFS RISK SE ASIA; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Kramer DL, 1999, ENVIRON BIOL FISH, V55, P65, DOI 10.1023/A:1007481206399; Mora C, 2002, TRENDS ECOL EVOL, V17, P422, DOI 10.1016/S0169-5347(02)02584-3; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Shanks AL, 2003, ECOL APPL, V13, pS159; Stoms DM, 2005, FRONT ECOL ENVIRON, V3, P429, DOI 10.1890/1540-9295(2005)003[0429:ICRPMT]2.0.CO;2; Wilkinson C, 2004, STATUS CORAL REEF WO	13	327	333	12	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1750	1751		10.1126/science.1125295	http://dx.doi.org/10.1126/science.1125295			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055LS	16794065				2022-12-24	WOS:000238452800039
J	Silva, J; Chambers, I; Pollard, S; Smith, A				Silva, Jose; Chambers, Ian; Pollard, Steven; Smith, Austin			Nanog promotes transfer of pluripotency after cell fusion	NATURE			English	Article							EMBRYONIC STEM-CELLS; X-CHROMOSOME; SOMATIC-CELLS; IN-VITRO; TERATOCARCINOMA; NUCLEI; MAINTENANCE; INITIATION	Through cell fusion, embryonic stem (ES) cells can erase the developmental programming of differentiated cell nuclei and impose pluripotency(1,2). Molecules that mediate this conversion should be identifiable in ES cells. One candidate is the variant homeodomain protein Nanog, which has the capacity to entrain undifferentiated ES cell propagation(3,4). Here we report that in fusions between ES cells and neural stem (NS) cells, increased levels of Nanog stimulate pluripotent gene activation from the somatic cell genome and enable an up to 200-fold increase in the recovery of hybrid colonies, all of which show ES cell characteristics. Nanog also improves hybrid yield when thymocytes or fibroblasts are fused to ES cells; however, fewer colonies are obtained than from ES x NS cell fusions, consistent with a hierarchical susceptibility to reprogramming among somatic cell types. Notably, for NS x ES cell fusions elevated Nanog enables primary hybrids to develop into ES cell colonies with identical frequency to homotypic ES x ES fusion products. This means that in hybrids, increased Nanog is sufficient for the NS cell epigenome to be reset completely to a state of pluripotency. We conclude that Nanog can orchestrate ES cell machinery to instate pluripotency with an efficiency of up to 100% depending on the differentiation status of the somatic cell.	Univ Edinburgh, Inst Stem Cell Res, Ctr Dev Stem Cell Biol, Edinburgh EH9 3JQ, Midlothian, Scotland; Univ Cambridge, Inst Stem Cell Biol, Cambridge CB2 1QT, England	University of Edinburgh; University of Cambridge	Smith, A (corresponding author), Univ Edinburgh, Inst Stem Cell Res, Ctr Dev Stem Cell Biol, Edinburgh EH9 3JQ, Midlothian, Scotland.	austin.smith@ed.ac.uk	Chambers, Ian/H-5416-2011; Silva, Jose/G-1920-2014; Silva, Jose C R/X-5140-2019; Pollard, Steven/B-7966-2010	Chambers, Ian/0000-0003-2605-1597; Silva, Jose/0000-0001-5487-1117; Silva, Jose C R/0000-0001-5487-1117; Smith, Austin/0000-0002-3029-4682; Pollard, Steven/0000-0001-6428-0492	Medical Research Council [G9806702, G0300058] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Medical Research Council [G0300723B] Funding Source: researchfish; MRC [G0300058, G9806702] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bao SQ, 2005, EMBO REP, V6, P748, DOI 10.1038/sj.embor.7400461; BLELLOCH R, 2006, STEM CELLS      0518, DOI DOI 10.1634/STEMCELLS.2006.0050; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Kimura H, 2004, MOL CELL BIOL, V24, P5710, DOI 10.1128/MCB.24.13.5710-5720.2004; Matveeva NM, 1998, MOL REPROD DEV, V50, P128, DOI 10.1002/(SICI)1098-2795(199806)50:2&lt;128::AID-MRD2&gt;3.0.CO;2-M; MILLER RA, 1977, DEV BIOL, V56, P157, DOI 10.1016/0012-1606(77)90159-2; MILLER RA, 1976, CELL, V9, P45, DOI 10.1016/0092-8674(76)90051-9; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; MOUNTFORD P, 1994, P NATL ACAD SCI USA, V91, P4303, DOI 10.1073/pnas.91.10.4303; Mountford P, 1998, REPROD FERT DEVELOP, V10, P527, DOI 10.1071/RD98087; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; POLLARD SM, IN PRESS CEREBRAL CO; Pratt T, 2000, DEV BIOL, V228, P19, DOI 10.1006/dbio.2000.9935; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Smith A, 2005, CELL, V123, P757, DOI 10.1016/j.cell.2005.11.012; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Yates A, 2005, BIOCHEM SOC T, V33, P1518, DOI 10.1042/BST0331518; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	28	272	317	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					997	1001		10.1038/nature04914	http://dx.doi.org/10.1038/nature04914			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791199				2022-12-24	WOS:000238422300046
J	Dally, JM; Emery, NJ; Clayton, NS				Dally, Joanna M.; Emery, Nathan J.; Clayton, Nicola S.			Food-caching western scrub-jays keep track of who was watching when	SCIENCE			English	Article							OBSERVATIONAL SPATIAL MEMORY; MENTAL TIME-TRAVEL; APHELOCOMA-CALIFORNICA; CORVUS-CORAX; STRATEGIES; CONSPECIFICS; COMPETITORS; CACHES; RAVENS	Western scrub-jays (Aphelocoma californica) hide food caches for future consumption, steal others' caches, and engage in tactics to minimize the chance that their own caches will be stolen. We show that scrub-jays remember which individual watched them during particular caching events and alter their recaching behavior accordingly. We found no evidence to suggest that a storer's use of cache protection tactics is cued by the observer's behavior.	Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; Univ Cambridge, Subdept Anim Behav, Cambridge CB3 8AA, England	University of Cambridge; University of Cambridge	Clayton, NS (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.	nsc22@cam.ac.uk	Clayton, Nicola s/A-2891-2010	Clayton, Nicola/0000-0003-1835-423X	Biotechnology and Biological Sciences Research Council [BB/D000335/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bednekoff PA, 1996, ANIM BEHAV, V52, P833, DOI 10.1006/anbe.1996.0228; Bednekoff PA, 1996, BEHAVIOUR, V133, P807, DOI 10.1163/156853996X00251; Bugnyar T, 2005, P ROY SOC B-BIOL SCI, V272, P1641, DOI 10.1098/rspb.2005.3144; Bugnyar T, 2002, ANIM BEHAV, V64, P185, DOI 10.1006/anbe.2002.3056; Byrne R., 1988, MACHIAVELLIAN INTELL; CHENEY D, 1996, ANIM BEHAV, V34, P1722; CLARKSON K, 1986, J ANIM ECOL, V55, P111, DOI 10.2307/4696; CLAYTON N, 2001, PHILOS T R SOC LOND, V0356, P00001; Clayton NS, 1998, NATURE, V395, P272, DOI 10.1038/26216; CONNOR R, 2000, P ROY SOC LOND B BIO, V268, P263; DALLY J, 2001, P ROY SOC LOND B BIO, V271, pS387; Dally JM, 2005, ANIM BEHAV, V70, P1251, DOI 10.1016/j.anbehav.2005.02.009; Dally JM, 2005, BEHAVIOUR, V142, P961, DOI 10.1163/1568539055010084; Emery NJ, 2004, ANIM COGN, V7, P37, DOI 10.1007/s10071-003-0178-7; Emery NJ, 2001, NATURE, V414, P443, DOI 10.1038/35106560; Engh AL, 2005, ANIM BEHAV, V69, P209, DOI 10.1016/j.anbehav.2004.04.013; Hare B, 2001, ANIM BEHAV, V61, P139, DOI 10.1006/anbe.2000.1518; Heinrich B, 1998, ANIM BEHAV, V56, P1083, DOI 10.1006/anbe.1998.0906; Humphrey N. K., 1988, MACHIAVELLIAN INTELL, P13; Povinelli DJ, 2003, TRENDS COGN SCI, V7, P157, DOI 10.1016/S1364-6613(03)00053-6; Silk JB, 1999, ANIM BEHAV, V58, P45, DOI 10.1006/anbe.1999.1129; Suddendorf T, 2005, LEARN MOTIV, V36, P110, DOI 10.1016/j.lmot.2005.02.010; Suddendorf T, 2003, TRENDS COGN SCI, V7, P391, DOI 10.1016/S1364-6613(03)00187-6	23	221	227	3	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1662	1665		10.1126/science.1126539	http://dx.doi.org/10.1126/science.1126539			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16709747				2022-12-24	WOS:000238288600049
J	Mavarez, J; Salazar, CA; Bermingham, E; Salcedo, C; Jiggins, CD; Linares, M				Mavarez, Jesus; Salazar, Camilo A.; Bermingham, Eldredge; Salcedo, Christian; Jiggins, Chris D.; Linares, Mauricio			Speciation by hybridization in Heliconius butterflies	NATURE			English	Article							HYBRID ORIGIN; MELPOMENE; EVOLUTION; MIMICRY; POPULATION; SELECTION; CYDNO	Speciation is generally regarded to result from the splitting of a single lineage. An alternative is hybrid speciation, considered to be extremely rare, in which two distinct lineages contribute genes to a daughter species. Here we show that a hybrid trait in an animal species can directly cause reproductive isolation. The butterfly species Heliconius heurippa is known to have an intermediate morphology and a hybrid genome(1), and we have recreated its intermediate wing colour and pattern through laboratory crosses between H. melpomene, H. cydno and their F-1 hybrids. We then used mate preference experiments to show that the phenotype of H. heurippa reproductively isolates it from both parental species. There is strong assortative mating between all three species, and in H. heurippa the wing pattern and colour elements derived from H. melpomene and H. cydno are both critical for mate recognition by males.	Univ Los Andes, Inst Genet, Bogota, Colombia; Smithsonian Trop Res Inst, Panama City, Panama; Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland	Universidad de los Andes (Colombia); Smithsonian Institution; Smithsonian Tropical Research Institute; University of Edinburgh	Mavarez, J (corresponding author), Univ Los Andes, Inst Genet, Carrera 1E 18a-10,POB 4976, Bogota, Colombia.	mavarezj@sl.edu	Jiggins, Chris D/B-9960-2008; Jiggins, Chris/T-4296-2019; C, Salazar/A-1647-2010; Linares, Mauricio/I-3509-2016	Jiggins, Chris D/0000-0002-7809-062X; Jiggins, Chris/0000-0002-7809-062X; C, Salazar/0000-0001-9217-6588; Linares, Mauricio/0000-0002-1021-0226				BOGGS CL, 1979, SCIENCE, V206, P83, DOI 10.1126/science.206.4414.83; BROWN KS, 1992, HEREDITAS, V117, P109, DOI 10.1111/j.1601-5223.1992.tb00165.x; BROWN KS, 1981, ANNU REV ENTOMOL, V26, P427, DOI 10.1146/annurev.en.26.010181.002235; Buerkle CA, 2000, HEREDITY, V84, P441, DOI 10.1046/j.1365-2540.2000.00680.x; Coyne J. A., 2004, SPECIATION; GILBERT LE, 2003, ECOLOGY EVOLUTION TA, P281; Gross BL, 2005, J HERED, V96, P241, DOI 10.1093/jhered/esi026; Jiggins CD, 2004, J EVOLUTION BIOL, V17, P680, DOI 10.1111/j.1420-9101.2004.00675.x; Jiggins CD, 2001, NATURE, V411, P302, DOI 10.1038/35077075; LINARES M, 1989, THESIS U TEXAS AUSTI; MALLET J, 1995, BIOL J LINN SOC, V55, P159, DOI 10.1006/bijl.1995.0034; MALLET J, 1987, BIOL J LINN SOC, V32, P337, DOI 10.1111/j.1095-8312.1987.tb00435.x; Mallet J, 1999, EVOL ECOL, V13, P777, DOI 10.1023/A:1011060330515; Mallet J, 1998, ENDLESS FORMS, P390; MALLET J, 1989, EVOLUTION, V43, P421, DOI 10.1111/j.1558-5646.1989.tb04237.x; Mavarez J, 2006, MOL ECOL NOTES, V6, P20, DOI 10.1111/j.1471-8286.2005.01115.x; MCCARTHY EM, 1995, HEREDITY, V74, P502, DOI 10.1038/hdy.1995.71; McMillan WO, 1997, P NATL ACAD SCI USA, V94, P8628, DOI 10.1073/pnas.94.16.8628; Naisbit RE, 2003, EVOL DEV, V5, P269, DOI 10.1046/j.1525-142X.2003.03034.x; Naisbit RE, 2002, GENETICS, V161, P1517; Pritchard JK, 2000, GENETICS, V155, P945; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rieseberg LH, 2000, EVOLUTION, V54, P859, DOI 10.1111/j.0014-3820.2000.tb00086.x; Salazar CA, 2005, J EVOLUTION BIOL, V18, P247, DOI 10.1111/j.1420-9101.2004.00839.x; Salzburger W, 2002, MOL ECOL, V11, P619, DOI 10.1046/j.0962-1083.2001.01438.x; Schwarz D, 2005, NATURE, V436, P546, DOI 10.1038/nature03800; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; SMILEY J, 1978, SCIENCE, V201, P745, DOI 10.1126/science.201.4357.745; Smith PF, 2003, MOL ECOL, V12, P2497, DOI 10.1046/j.1365-294X.2003.01905.x	29	333	354	9	201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					868	871		10.1038/nature04738	http://dx.doi.org/10.1038/nature04738			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16778888				2022-12-24	WOS:000238254100041
J	Lin, X; Duan, XY; Liang, YY; Su, Y; Wrighton, KH; Long, JY; Hu, M; Davis, CM; Wang, JR; Brunicardi, FC; Shi, YG; Chen, YG; Meng, AM; Feng, XH				Lin, Xia; Duan, Xueyan; Liang, Yao-Yun; Su, Ying; Wrighton, Katharine H.; Long, Jianyin; Hu, Min; Davis, Candi M.; Wang, Jinrong; Brunicardi, F. Charles; Shi, Yigong; Chen, Ye-Guang; Meng, Anming; Feng, Xin-Hua			PPM1A functions as a Smad phosphatase to terminate TGF beta signaling (Publication with Expression of Concern. See vol. 166, 2016) (Publication with Expression of Concern. See vol. 165, pg. 498, 2016)	CELL			English	Article; Publication with Expression of Concern							GROWTH-FACTOR-BETA; CYCLIN-DEPENDENT KINASES; C-MYC; DIRECT BINDING; INHIBITOR; RECEPTOR; EXPRESSION; TRANSCRIPTION; SPECIFICITY; P15(INK4B)	TGF beta signaling controls diverse normal developmental processes and pathogenesis of diseases including cancer and autoimmune and fibrotic diseases. TGF beta responses are generally mediated through transcriptional functions of Smads. A key step in TGF beta signaling is ligand-induced phosphorylation of receptor-activated Smads (R-Smads) catalyzed by the TGF beta type I receptor kinase. However, the potential of Smad dephosphorylation as a regulatory mechanism of TGF beta signaling and the identity of Smad-specific phosphatases remain elusive. Using a functional genomic approach, we have identified PPM1A/PP2C alpha as a bona fide Smad phosphatase. PPM1A dephosphorylates and promotes nuclear export of TGF beta-activated Smad2/3. Ectopic expression of PPM1A abolishes TGF beta-induced anti proliferative and transcriptional responses, whereas depletion of PPM1A enhances TGF beta signaling in mammalian cells. Smad-antagonizing activity of PPM1A is also observed during Nodal-dependent early embryogenesis in zebrafish. This work demonstrates that PPM1A/PP2C alpha, through dephosphorylation of Smad2/3, plays a critical role in terminating TGF beta signaling.	Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; Princeton Univ, Dept Mol Biol, Lewis Thomas Lab, Princeton, NJ 08544 USA	Baylor College of Medicine; Baylor College of Medicine; Tsinghua University; Tsinghua University; Princeton University	Lin, X (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA.	xialin@bcm.edu; xfeng@bcm.edu	Long, Jianyin/H-8261-2013; Su, Ying/ABA-8545-2021; Su, Ying/M-5825-2013; Meng, Anming/A-4785-2012	Su, Ying/0000-0002-8466-0043; Su, Ying/0000-0002-8466-0043; Shi, Yigong/0000-0003-2030-168X; Wrighton, Katharine/0000-0001-7075-3399; Meng, Anming/0000-0001-7228-3431	NATIONAL CANCER INSTITUTE [R01CA082171, R01CA108454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063773] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA82171, R21CA11293, R01CA108454] Funding Source: Medline; NIAMS NIH HHS [R01 AR053591-05, R01 AR053591] Funding Source: Medline; NIDDK NIH HHS [R01DK073932] Funding Source: Medline; NIGMS NIH HHS [R01GM63773] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akhurst RJ, 2004, NAT GENET, V36, P790, DOI 10.1038/ng0804-790; ALEXANDROW MG, 1995, P NATL ACAD SCI USA, V92, P3239, DOI 10.1073/pnas.92.8.3239; Bennett D, 2002, NAT GENET, V31, P419, DOI 10.1038/ng938; Cao ZH, 2003, BLOOD, V101, P498, DOI 10.1182/blood-2002-05-1549; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen HB, 2006, GENE DEV, V20, P648, DOI 10.1101/gad.1384706; Cheng AY, 1999, GENE DEV, V13, P2946, DOI 10.1101/gad.13.22.2946; Coburn GA, 2001, GENE DEV, V15, P1194, DOI 10.1101/gad.888201; COHEN PTW, 2003, PROTEIN PHOSPHATASES, P1; Cullen Bryan R, 2004, Methods Mol Biol, V257, P85, DOI 10.1385/1-59259-750-5:085; Datta PK, 2000, J BIOL CHEM, V275, P40014, DOI 10.1074/jbc.C000508200; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Gallego M, 2005, CURR OPIN CELL BIOL, V17, P197, DOI 10.1016/j.ceb.2005.01.002; Griswold-Prenner I, 1998, MOL CELL BIOL, V18, P6595, DOI 10.1128/MCB.18.11.6595; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Itoh S, 2003, J BIOL CHEM, V278, P3751, DOI 10.1074/jbc.M208258200; Jackson MD, 2003, BIOCHEMISTRY-US, V42, P8513, DOI 10.1021/bi034074+; Jazag A, 2005, ONCOGENE, V24, P662, DOI 10.1038/sj.onc.1208102; Lin X, 2003, MOL CELL, V11, P1389, DOI 10.1016/S1097-2765(03)00175-8; Lin Xia, 2005, J RNAi Gene Silencing, V1, P38; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schmierer B, 2005, MOL CELL BIOL, V25, P9845, DOI 10.1128/MCB.25.22.9845-9858.2005; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P843; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shi WB, 2004, J CELL BIOL, V164, P291, DOI 10.1083/jcb.200307151; Stroschein SL, 1999, J BIOL CHEM, V274, P9431, DOI 10.1074/jbc.274.14.9431; Strovel ET, 2000, J BIOL CHEM, V275, P2399, DOI 10.1074/jbc.275.4.2399; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; TAMURA S, 2003, PROTEIN PHOSPHATASES, P91; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Waite KA, 2003, NAT REV GENET, V4, P763, DOI 10.1038/nrg1178; Whitman M, 2005, DEVELOPMENT, V132, P4205, DOI 10.1242/dev.02023; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; Wu JY, 2005, J IMMUNOL, V174, P6122, DOI 10.4049/jimmunol.174.10.6122; Xu L, 2002, MOL CELL, V10, P271, DOI 10.1016/S1097-2765(02)00586-5; Yoshizaki T, 2004, J BIOL CHEM, V279, P22715, DOI 10.1074/jbc.M313745200; Zhang LX, 2004, SCIENCE, V306, P114, DOI 10.1126/science.1100569	51	365	393	2	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					915	928		10.1016/j.cell.2006.03.044	http://dx.doi.org/10.1016/j.cell.2006.03.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751101	Green Accepted, Bronze			2022-12-24	WOS:000238116400018
J	Davies, L; Welch, HG				Davies, L; Welch, HG			Increasing incidence of thyroid cancer in the United States, 1973-2002	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARCINOMA; AUTOPSY; ULTRASONOGRAPHY; PREVALENCE; MANAGEMENT; PALPATION; COUNTY; TRENDS	Context Increasing cancer incidence is typically interpreted as an increase in the true occurrence of disease but may also reflect changing pathological criteria or increased diagnostic scrutiny. Changes in the diagnostic approach to thyroid nodules may have resulted in an increase in the apparent incidence of thyroid cancer. Objective To examine trends in thyroid cancer incidence, histology, size distribution, and mortality in the United States. Methods Retrospective cohort evaluation of patients with thyroid cancer, 19732002, using the Surveillance, Epidemiology, and End Results ( SEER) program and data on thyroid cancer mortality from the National Vital Statistics System. Main Outcome Measures Thyroid cancer incidence, histology, size distribution, and mortality. Results The incidence of thyroid cancer increased from 3.6 per 100 000 in 1973 to 8.7 per 100 000 in 2002 - a 2.4-fold increase (95% confidence interval [CI], 2.2-2.6; P <. 001 for trend). There was no significant change in the incidence of the less common histological types: follicular, medullary, and anaplastic ( P >. 20 for trend). Virtually the entire increase is attributable to an increase in incidence of papillary thyroid cancer, which increased from 2.7 to 7.7 per 100 000 - a 2.9-fold increase ( 95% CI, 2.6-3.2; P <. 001 for trend). Between 1988 ( the first year SEER collected data on tumor size) and 2002, 49% ( 95% CI, 47%-51%) of the increase consisted of cancers measuring 1 cm or smaller; 87% ( 95% CI, 85%-89%) consisted of cancers measuring 2 cm or smaller. Mortality from thyroid cancer was stable between 1973 and 2002 ( approximately 0.5 deaths per 100 000). Conclusions The increasing incidence of thyroid cancer in the United States is predominantly due to the increased detection of small papillary cancers. These trends, combined with the known existence of a substantial reservoir of subclinical cancer and stable overall mortality, suggest that increasing incidence reflects increased detection of subclinical disease, not an increase in the true occurrence of thyroid cancer.	White River Junct Dept Vet Affairs Med Ctr, VA Outcomes Grp, White River Jct, VT 05009 USA; Dartmouth Med Sch, Div Otolaryngol, Hanover, NH USA; Dartmouth Med Sch, Dept Community & Family Med, Hanover, NH USA; Dartmouth Med Sch, Ctr Evaluat Clin Sci, Hanover, NH USA	VA Outcomes Group; Dartmouth College; Dartmouth College; Dartmouth College	Davies, L (corresponding author), White River Junct Dept Vet Affairs Med Ctr, VA Outcomes Grp, 215 N Main St,111B, White River Jct, VT 05009 USA.	louise.davies@dartmouth.edu		Welch, H. Gilbert/0000-0002-3448-1207				BONDESON L, 1981, CANCER-AM CANCER SOC, V47, P319, DOI 10.1002/1097-0142(19810115)47:2<319::AID-CNCR2820470218>3.0.CO;2-A; Burke JP, 2005, MAYO CLIN PROC, V80, P753; DAVIES L, IN PRESS OTOLARYNGOL; Etzioni R, 2002, J NATL CANCER I, V94, P981; EZZAT S, 1994, ARCH INTERN MED, V154, P1838; FASSINA AS, 1993, TUMORI J, V79, P314, DOI 10.1177/030089169307900506; HARACH HR, 1985, CANCER-AM CANCER SOC, V56, P531, DOI 10.1002/1097-0142(19850801)56:3<531::AID-CNCR2820560321>3.0.CO;2-3; Haselkorn T, 2000, CANCER CAUSE CONTROL, V11, P163, DOI 10.1023/A:1008932123830; HEITZ P, 1976, CANCER, V37, P2329, DOI 10.1002/1097-0142(197605)37:5<2329::AID-CNCR2820370523>3.0.CO;2-7; Hodgson NC, 2004, ANN SURG ONCOL, V11, P1093, DOI 10.1245/ASO.2004.03.066; Mangano JJ, 1996, EUR J CANCER PREV, V5, P75; MAZZAFERRI EL, 1993, NEW ENGL J MED, V328, P553; Mulla ZD, 2000, ANN EPIDEMIOL, V10, P24, DOI 10.1016/S1047-2797(99)00044-7; ROJESKI MT, 1985, NEW ENGL J MED, V313, P428, DOI 10.1056/NEJM198508153130707; Ron E, 1996, OTOLARYNG HEAD NECK, V115, P403, DOI 10.1016/S0194-5998(96)70073-6; SOBRINHOSIMOES MA, 1979, CANCER-AM CANCER SOC, V43, P1702, DOI 10.1002/1097-0142(197905)43:5<1702::AID-CNCR2820430521>3.0.CO;2-S; Solares CA, 2005, AM J OTOLARYNG, V26, P87, DOI 10.1016/j.amjoto.2004.08.003; VANDERLAAN WP, 1947, NEW ENGL J MED, V237, P221, DOI [10.1056/NEJM194708142370703, 10.1056/NEJM194702132360702]; Wenig B, 1997, ATLAS ENDOCRINE PATH; Wiest PW, 1998, J ULTRAS MED, V17, P487; World Health Organization, 2000, INT CLASS DIS ONC; 2003, AJCC CANC STAGING MA	22	2462	2612	3	133	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2006	295	18					2164	2167		10.1001/jama.295.18.2164	http://dx.doi.org/10.1001/jama.295.18.2164			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040OW	16684987	Bronze			2022-12-24	WOS:000237391300026
J	Sargolini, F; Fyhn, M; Hafting, T; McNaughton, BL; Witter, MP; Moser, MB; Moser, EI				Sargolini, F; Fyhn, M; Hafting, T; McNaughton, BL; Witter, MP; Moser, MB; Moser, EI			Conjunctive representation of position, direction, and velocity in entorhinal cortex	SCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; HIPPOCAMPAL PLACE CELLS; LAYER-V NEURONS; HEAD-DIRECTION; PATH-INTEGRATION; RAT; PRESUBICULUM; ORGANIZATION; PROJECTIONS; SYSTEM	Grid cells in the medial entorhinal cortex (MEC) are part of an environment-independent spatial coordinate system. To determine how information about location, direction, and distance is integrated in the grid-cell network, we recorded from each principal cell layer of MEC in rats that explored two-dimensional environments. Whereas layer II was predominated by grid cells, grid cells colocalized with head-direction cells and conjunctive grid x head-direction cells in the deeper layers. All cell types were modulated by running speed. The conjunction of positional, directional, and translational information in a single MEC cell type may enable grid coordinates to be updated during self-motion-based navigation.	Norwegian Univ Sci & Technol, Ctr Biol Memory, N-7489 Trondheim, Norway; Univ Arizona, Arizona Res Labs, Div Neural Syst Memory & Aging, Tucson, AZ 85724 USA; Vrije Univ Amsterdam, Med Ctr, Dept Anat & Neurosci, Neurosci Res Inst, Amsterdam, Netherlands	Norwegian University of Science & Technology (NTNU); University of Arizona; Vrije Universiteit Amsterdam	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Ctr Biol Memory, N-7489 Trondheim, Norway.	edvard.moser@ntnu.no		Sargolini, Francesca/0000-0002-5038-3746; Hafting, Torkel/0000-0002-0928-3487				ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; CABALLEROBLEDA M, 1994, EXP BRAIN RES, V101, P93; Cacucci F, 2004, J NEUROSCI, V24, P8265, DOI 10.1523/JNEUROSCI.2635-04.2004; CHEN LL, 1994, EXP BRAIN RES, V101, P8, DOI 10.1007/BF00243212; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; FYHN M, 2005, SOC NEUR ABSTR, V31; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hamam BN, 2000, J COMP NEUROL, V418, P457; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Honda Y, 2004, J COMP NEUROL, V473, P463, DOI 10.1002/cne.20093; Iijima T, 1996, SCIENCE, V272, P1176, DOI 10.1126/science.272.5265.1176; Johnson A, 2005, HIPPOCAMPUS, V15, P86, DOI 10.1002/hipo.20033; Kloosterman F, 2003, EUR J NEUROSCI, V18, P3037, DOI 10.1111/j.1460-9568.2003.03046.x; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; McNaughton BL, 1996, J EXP BIOL, V199, P173; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Nitz DA, 2006, NEURON, V49, P747, DOI 10.1016/j.neuron.2006.01.037; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Parron C, 2004, EXP BRAIN RES, V159, P349, DOI 10.1007/s00221-004-1960-8; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; Redish A. D., 1999, COGNITIVE MAP PLACE, DOI DOI 10.1038/nature14445; Redish AD, 1997, HIPPOCAMPUS, V7, P15; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Sharp PE, 1999, HIPPOCAMPUS, V9, P432, DOI 10.1002/(SICI)1098-1063(1999)9:4<432::AID-HIPO9>3.3.CO;2-G; Skaggs W E, 1995, Adv Neural Inf Process Syst, V7, P173; Taube JS, 1998, PROG NEUROBIOL, V55, P225, DOI 10.1016/S0301-0082(98)00004-5; TAUBE JS, 1990, J NEUROSCI, V10, P420; van Haeften T, 2003, HIPPOCAMPUS, V13, P943, DOI 10.1002/hipo.10144; vanHaeften T, 1997, J NEUROSCI, V17, P862; Witter M. P., 2004, RAT NERVOUS SYSTEM, V3rd, P637; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; Wouterlood FG, 2004, BRAIN RES, V1013, P1, DOI 10.1016/j.brainres.2004.03.017; Xing J, 2000, J COGNITIVE NEUROSCI, V12, P601, DOI 10.1162/089892900562363; Zhang K, 1996, J NEUROSCI, V16, P2112	36	846	872	7	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					758	762		10.1126/science.1125572	http://dx.doi.org/10.1126/science.1125572			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675704				2022-12-24	WOS:000237312100054
J	Liu, PY; Swerdloff, RS; Christenson, PD; Handelsman, DJ; Wang, C				Liu, PY; Swerdloff, RS; Christenson, PD; Handelsman, DJ; Wang, C		Hormonal Male Contraception Summit	Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis	LANCET			English	Article							INTRAMUSCULAR TESTOSTERONE UNDECANOATE; EFFECTIVELY SUPPRESSES SPERMATOGENESIS; CYPROTERONE-ACETATE; LEVONORGESTREL IMPLANTS; ORAL DESOGESTREL; NORETHISTERONE ENANTHATE; ETONOGESTREL IMPLANTS; GONADOTROPIN-LEVELS; DEPOT TESTOSTERONE; ETHNIC-DIFFERENCES	Background Hormonal methods for safe, reliable, and reversible contraception based on the suppression of spermatogenesis could soon become available. We have investigated the rate, extent, and predictors of reversibility of hormonal male contraception. Methods We undertook an integrated multivariate time-to-event analysis of data from individual participants in 30 studies published in 1990-2005, in which sperm output was monitored every month until recovery. The primary outcome was the time for the sperm concentration to recover to a threshold of 20 million per mL, an indicator of fertility. We undertook univariate and multivariate analyses, using Kaplan-Meier and Cox's methods. Findings 1549 healthy eugonadal men who were white (n=965), Asian (almost all Chinese men; n=535), or of other origins (n=49) and aged 18-51 years underwent 1283.5 man-years of treatment and 705 man-years of post-treatment recovery. These data represented about 90% of all published data from individuals using androgen or androgen-progestagen regimens. The median times for sperm to recover to thresholds of 20, 10, and 3 million per mL were 3.4 months (95% CI 3.2-3.5), 3.0 months (2.9-3.1), and 2.5 months (2.4-2.7), respectively. Multivariate Cox's analysis showed higher rates of recovery with older age, Asian origin, shorter treatment duration, shorter-acting testosterone preparations, higher sperm concentrations at baseline, faster suppression of spermatogenesis, and lower blood concentrations of luteinising hormone at baseline. The typical probability of recovery to 20 million per mL was 67% (61-72) within 6 months, 90% (85-93) within 12 months, 96% (92-98) within 16 months, and 100% within 24 months. Interpretation Hormonal male contraceptive regimens show full reversibility within a predictable time course. Various covariables affect the rate but not the extent of recovery although their effect sizes are minor. These data are crucial for the further safe and practical development of such regimens.	Concord Hosp, Dept Androl, Sydney, NSW 2139, Australia; Univ Sydney, ANZAC Res Inst, Sydney, NSW 2139, Australia; Harbor UCLA Med Ctr, Torrance, CA 90509 USA; Los Angeles Biomed Res Inst, Torrance, CA USA	Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	Liu, PY (corresponding author), Concord Hosp, Dept Androl, Sydney, NSW 2139, Australia.	pliu@mail.usyd.edu.au	Research Institute, ANZAC/CAE-9030-2022; Handelsman, David/AAR-9580-2021	Handelsman, David/0000-0002-4200-7476	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NCRR NIH HHS [RR M01 00425] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Amory JK, 2006, NAT CLIN PRACT ENDOC, V2, P32, DOI 10.1038/ncpendmet0069; Amory JK, 2001, J ANDROL, V22, P1053; Anawalt BD, 2000, FERTIL STERIL, V74, P707, DOI 10.1016/S0015-0282(00)01490-4; Anawalt BD, 1999, J ANDROL, V20, P407; Anawalt BD, 2005, J ANDROL, V26, P405, DOI 10.2164/jandrol.04135; Anderson RA, 2002, ENDOCR REV, V23, P735, DOI 10.1210/er.2002-0002; Anderson RA, 2002, J CLIN ENDOCR METAB, V87, P3640, DOI 10.1210/jc.87.8.3640; Anderson RA, 2002, HUM REPROD, V17, P2869, DOI 10.1093/humrep/17.11.2869; [Anonymous], 1990, Lancet, V336, P955; Aribarg A, 1996, FERTIL STERIL, V65, P821; ARIBARG A, 1995, INT J ANDROL, V18, P157; Bebb RA, 1996, J CLIN ENDOCR METAB, V81, P757, DOI 10.1210/jc.81.2.757; Berger G S, 1977, Int J Gynaecol Obstet, V15, P125; Bonde JPE, 1998, LANCET, V352, P1172, DOI 10.1016/S0140-6736(97)10514-1; Brady BM, 2004, HUM REPROD, V19, P2658, DOI 10.1093/humrep/deh491; Farrow A, 2002, HUM REPROD, V17, P2754, DOI 10.1093/humrep/17.10.2754; GALLO M, 2005, COCHRANE DB SYST REV, V3; Glasier AF, 2000, HUM REPROD, V15, P646, DOI 10.1093/humrep/15.3.646; Goldzieher JW, 1995, CONTRACEPTION, V52, P327, DOI 10.1016/0010-7824(95)00222-7; Gonzalo ITG, 2002, J CLIN ENDOCR METAB, V87, P3562, DOI 10.1210/jc.87.8.3562; Gu XQ, 2003, J CLIN ENDOCR METAB, V88, P562, DOI 10.1210/jc.2002-020447; Gu YQ, 2004, J CLIN ENDOCR METAB, V89, P2254, DOI 10.1210/jc.2003-031307; Gui YL, 2004, J ANDROL, V25, P720; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; Hair WM, 2001, J CLIN ENDOCR METAB, V86, P5201, DOI 10.1210/jc.86.11.5201; Handelsman DJ, 2003, J CLIN ENDOCR METAB, V88, P559, DOI 10.1210/jc.2002-021997; Handelsman DJ, 1997, HUM REPROD, V12, P2701, DOI 10.1093/humrep/12.12.2701; HANDELSMAN DJ, 2005, ENDOCRINOLOGY, P3247; Hay CJ, 2005, J CLIN ENDOCR METAB, V90, P2042, DOI 10.1210/jc.2004-0895; Heinemann K, 2005, HUM REPROD, V20, P549, DOI 10.1093/humrep/deh574; Hikim APS, 1998, J CLIN ENDOCR METAB, V83, P152; HULL MGR, 1981, LANCET, V1, P1329; Johnson L, 1998, J ANDROL, V19, P348; Kamischke A, 2000, CLIN ENDOCRINOL, V53, P43, DOI 10.1046/j.1365-2265.2000.01024.x; Kamischke A, 2002, J CLIN ENDOCR METAB, V87, P530, DOI 10.1210/jc.87.2.530; Kamischke A, 2001, J CLIN ENDOCR METAB, V86, P303, DOI 10.1210/jc.86.1.303; Kinniburgh D, 2002, HUM REPROD, V17, P1490, DOI 10.1093/humrep/17.6.1490; Li X F, 1992, Adv Contracept, V8, P1, DOI 10.1007/BF01849342; Liu PY, 2004, J CLIN ENDOCR METAB, V89, P4789, DOI 10.1210/jc.2004-0807; Liu PY, 2003, ENDOCR REV, V24, P313, DOI 10.1210/er.2003-0005; Liu PY, 2002, HUM REPROD, V17, P625, DOI 10.1093/humrep/17.3.625; London R S, 1993, J SOGC, V15, P925; LONDON RS, 1993, J SOGC, V15, P932; MACLEOD J, 1951, J UROLOGY, V66, P436, DOI 10.1016/S0022-5347(17)74358-3; Menon DK, 2003, FERTIL STERIL, V79, P1659, DOI 10.1016/S0015-0282(03)00365-0; Meriggiola MC, 1996, J CLIN ENDOCR METAB, V81, P3018, DOI 10.1210/jc.81.8.3018; Meriggiola MC, 1998, HUM REPROD, V13, P1225, DOI 10.1093/humrep/13.5.1225; Meriggiola MC, 2005, J CLIN ENDOCR METAB, V90, P2005, DOI 10.1210/jc.2004-1852; Meriggiola MC, 2003, J CLIN ENDOCR METAB, V88, P5818, DOI 10.1210/jc.2003-030574; Meriggiola MC, 2003, J ANDROL, V24, P466; Meriggiola MC, 2002, J ANDROL, V23, P684; Meriggiola MC, 1997, FERTIL STERIL, V68, P844; MOELOEK N, 1993, FERTIL STERIL, V60, P1062; Muller A, 2004, HUM REPROD, V19, P2838, DOI 10.1093/humrep/deh521; Nieschlag E, 2005, LANCET, V365, P554; Pollanen P, 2001, INT J ANDROL, V24, P369, DOI 10.1046/j.1365-2605.2001.00319.x; Swan SH, 2003, ENVIRON HEALTH PERSP, V111, P414, DOI 10.1289/ehp.5927; Therneau T. M., 2000, STAT BIOL HEALTH; Turner L, 2003, J CLIN ENDOCR METAB, V88, P4659, DOI 10.1210/jc.2003-030107; von Eckardstein S, 2003, J CLIN ENDOCR METAB, V88, P5232, DOI 10.1210/jc.2002-022043; Waites GMH, 2003, FERTIL STERIL, V80, P1, DOI 10.1016/S0015-0282(03)00577-6; Wang C, 1998, J CLIN ENDOCR METAB, V83, P870, DOI 10.1210/jc.83.3.870; Wang C, 2006, J CLIN ENDOCR METAB, V91, P460, DOI 10.1210/jc.2005-1743; Wang C, 2004, AM J OBSTET GYNECOL, V190, pS60, DOI 10.1016/j.ajog.2004.01.057; World Health Organization, 1999, WHO LAB MANUAL EXAMI, V4th; Wu FCW, 1999, J CLIN ENDOCR METAB, V84, P112, DOI 10.1210/jc.84.1.112; Wu FCW, 2003, ENDOCR REV, V24, P183, DOI 10.1210/er.2001-0025; Wu FCW, 1996, FERTIL STERIL, V65, P626, DOI 10.1016/S0015-0282(16)58166-7; 2002, INT J ANDROL, V25, P375	69	148	152	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2006	367	9520					1412	1420		10.1016/S0140-6736(06)68614-5	http://dx.doi.org/10.1016/S0140-6736(06)68614-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650651				2022-12-24	WOS:000237195600029
J	Grottoli, AG; Rodrigues, LJ; Palardy, JE				Grottoli, AG; Rodrigues, LJ; Palardy, JE			Heterotrophic plasticity and resilience in bleached corals	NATURE			English	Article							REEF CORALS; TISSUE BIOMASS; CLIMATE-CHANGE; ZOOPLANKTON; HAWAIIAN; PATTERNS; CARBON; RATES	Mass coral bleaching events caused by elevated seawater temperatures(1,2) have resulted in extensive coral mortality throughout the tropics over the past few decades(3,4). With continued global warming, bleaching events are predicted to increase in frequency and severity, causing up to 60% coral mortality globally within the next few decades(4-6). Although some corals are able to recover and to survive bleaching(7,8), the mechanisms underlying such resilience are poorly understood. Here we show that the coral host has a significant role in recovery and resilience. Bleached and recovering Montipora capitata (branching) corals met more than 100% of their daily metabolic energy requirements by markedly increasing their feeding rates and CHAR (per cent contribution of heterotrophically acquired carbon to daily animal respiration), whereas Porites compressa (branching) and Porites lobata (mounding) corals did not. These findings suggest that coral species with high-CHAR capability during bleaching and recovery, irrespective of morphology, will be more resilient to bleaching events over the long term, could become the dominant coral species on reefs, and may help to safeguard affected reefs from potential local and global extinction.	Ohio State Univ, Dept Geol Sci, Columbus, OH 43210 USA; Villanova Univ, Dept Biol, Villanova, PA 19085 USA; Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	University System of Ohio; Ohio State University; Villanova University; Brown University	Grottoli, AG (corresponding author), Ohio State Univ, Dept Geol Sci, Columbus, OH 43210 USA.	grottoli.1@osu.edu	Grottoli, Andrea/C-9736-2009; Palardy, James/L-9092-2019; Rodrigues, Lisa J/A-2541-2009	Rodrigues, Lisa/0000-0002-0973-0451; Palardy, James/0000-0002-8347-7108				Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Buddemeier R., 2004, CORAL REEFS GLOBAL C, V15, P17789; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Glynn PW, 2001, B MAR SCI, V69, P79; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Heidelberg KB, 2004, CORAL REEFS, V23, P263, DOI 10.1007/s00338-004-0375-0; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Houlbreque F, 2004, MAR ECOL PROG SER, V282, P151, DOI 10.3354/meps282151; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Palardy JE, 2006, J EXP MAR BIOL ECOL, V331, P99, DOI 10.1016/j.jembe.2005.10.001; Palardy JE, 2005, MAR ECOL PROG SER, V300, P79, DOI 10.3354/meps300079; PORTER JW, 1989, P NATL ACAD SCI USA, V86, P9342, DOI 10.1073/pnas.86.23.9342; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; *SAS I, 1999, SAS STAT SOFTW VERS; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stimson J, 2002, CORAL REEFS, V21, P409, DOI 10.1007/s00338-002-0264-3; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Ward S, 2000, P 9 INT COR REEF S, V2, P1123; Wilkinson C, 1999, NATURE RESOUR, V35, P16; Wilkinson C., 2000, STATUS CORAL REEFS W	28	580	591	6	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1186	1189		10.1038/nature04565	http://dx.doi.org/10.1038/nature04565			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641995				2022-12-24	WOS:000237080000044
J	Androutsellis-Theotokis, A; Leker, RR; Soldner, F; Hoeppner, DJ; Ravin, R; Poser, SW; Rueger, MA; Bae, SK; Kittappa, R; McKay, RDG				Androutsellis-Theotokis, Andreas; Leker, Ronen R.; Soldner, Frank; Hoeppner, Daniel J.; Ravin, Rea; Poser, Steve W.; Rueger, Maria A.; Bae, Soo-Kyung; Kittappa, Raja; McKay, Ronald D. G.			Notch signalling regulates stem cell numbers in vitro and in vivo	NATURE			English	Article							HEDGEHOG PATHWAY; NERVOUS-SYSTEM; ADULT BRAIN; DIFFERENTIATION; ACTIVATION; NEUROGENESIS; STAT3; AKT; MEDULLOBLASTOMA; EXPRESSION	The hope of developing new transplantation therapies for degenerative diseases is limited by inefficient stem cell growth and immunological incompatibility with the host(1,2). Here we show that Notch receptor activation induces the expression of the specific target genes hairy and enhancer of split 3 (Hes3) and Sonic hedgehog (Shh) through rapid activation of cytoplasmic signals, including the serine/threonine kinase Akt, the transcription factor STAT3 and mammalian target of rapamycin, and thereby promotes the survival of neural stem cells. In both murine somatic and human embryonic stem cells, these positive signals are opposed by a control mechanism that involves the p38 mitogen-activated protein kinase. Transient administration of Notch ligands to the brain of adult rats increases the numbers of newly generated precursor cells and improves motor skills after ischaemic injury. These data indicate that stem cell expansion in vitro and in vivo, two central goals of regenerative medicine, may be achieved by Notch ligands through a pathway that is fundamental to development and cancer(3-5).	Natl Inst Neurol Disorders & Stroke, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	McKay, RDG (corresponding author), Natl Inst Neurol Disorders & Stroke, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	mckay@codon.nih.gov	Leker, Ronen/ABC-6096-2020	Leker, Ronen/0000-0003-4794-0334; Androutsellis-Theotokis, Andreas/0000-0002-1985-4589	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002981, ZIANS002981, Z01NS002881, ZIANS002881] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; GORIELY A, 1991, DEVELOPMENT, V113, P1395; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Leker RR, 2003, STROKE, V34, P2000, DOI 10.1161/01.STR.0000079817.68944.1E; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Oishi K, 2004, DEV BIOL, V276, P172, DOI 10.1016/j.ydbio.2004.08.039; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Rajan P, 1998, J NEUROSCI, V18, P3620; Romer J, 2005, CANCER RES, V65, P4975, DOI 10.1158/0008-5472.CAN-05-0481; Tokunaga A, 2004, J NEUROCHEM, V90, P142, DOI 10.1111/j.1471-4159.2004.02470.x; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yang J, 2005, CANCER RES, V65, P939; Zhao Y, 2005, EUR J NEUROSCI, V22, P278, DOI 10.1111/j.1460-9568.2005.04200.x	30	779	839	0	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2006	442	7104					823	826		10.1038/nature04940	http://dx.doi.org/10.1038/nature04940			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	074DK	16799564	Green Published			2022-12-24	WOS:000239792700048
J	Keele, BF; Van Heuverswyn, F; Li, YY; Bailes, E; Takehisa, J; Santiago, ML; Bibollet-Ruche, F; Chen, YL; Wain, LV; Liegeois, F; Loul, S; Ngole, EM; Bienvenue, Y; Delaporte, E; Brookfield, JFY; Sharp, PM; Shaw, GM; Peeters, M; Hahn, BH				Keele, Brandon F.; Van Heuverswyn, Fran; Li, Yingying; Bailes, Elizabeth; Takehisa, Jun; Santiago, Mario L.; Bibollet-Ruche, Frederic; Chen, Yalu; Wain, Louise V.; Liegeois, Florian; Loul, Severin; Ngole, Eitel Mpoudi; Bienvenue, Yanga; Delaporte, Eric; Brookfield, John F. Y.; Sharp, Paul M.; Shaw, George M.; Peeters, Martine; Hahn, Beatrice H.			Chimpanzee reservoirs of pandemic and nonpandemic HIV-1	SCIENCE			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; GROUP-N; ORIGIN; CAMEROON; IDENTIFICATION; TROGLODYTES; SEQUENCES; AIDS	Human immunodeficiency virus type 1 (HIV-1), the cause of human acquired immunodeficiency syndrome ( AIDS), is a zoonotic infection of staggering proportions and social impact. Yet uncertainty persists regarding its natural reservoir. The virus most closely related to HIV-1 is a simian immunodeficiency virus ( SIV) thus far identified only in captive members of the chimpanzee subspecies Pan troglodytes troglodytes. Here we report the detection of SIVcpz antibodies and nucleic acids in fecal samples from wild-living P.t. troglodytes apes in southern Cameroon, where prevalence rates in some communities reached 29 to 35%. By sequence analysis of endemic SIVcpz strains, we could trace the origins of pandemic ( group M) and nonpandemic ( group N) HIV-1 to distinct, geographically isolated chimpanzee communities. These findings establish P. t. troglodytes as a natural reservoir of HIV-1.	Univ Alabama, Dept Med, Birmingham, AL 35294 USA; Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; Univ Montpellier 1, Lab Retrovirus, UMR 145, Inst Rech Dev, F-34394 Montpellier, France; Univ Montpellier 1, Dept Int Hlth, F-34394 Montpellier 5, France; Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2UH, England; Projet Prevent Sida Cameroun PRESICA, Yaounde, Cameroon; Howard Hughes Med Inst, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; University of Nottingham; Howard Hughes Medical Institute	Hahn, BH (corresponding author), Univ Alabama, Dept Med, Birmingham, AL 35294 USA.	bhahn@uab.edu	Sharp, Paul/Y-3787-2019; Florian, Liegeois/D-3798-2013; Sharp, Paul M/GPX-1497-2022; Sharp, Paul M/F-5783-2010; Delaporte, Eric/J-5397-2018	Florian, Liegeois/0000-0003-1048-0661; Sharp, Paul M/0000-0001-9771-543X; Sharp, Paul M/0000-0001-9771-543X; Delaporte, Eric/0000-0002-1822-9853; Wain, Louise/0000-0003-4951-1867; Hahn, Beatrice/0000-0002-9400-9887; Santiago, Mario L./0000-0001-7792-2706	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767, R01AI058715, R01AI050529] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI50529, R01 AI058715-05, R01 AI058715, R01 AI58715, P30 AI 27767] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Corbet S, 2000, J VIROL, V74, P529, DOI 10.1128/JVI.74.1.529-534.2000; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Groves Colin P., 1993, P243; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; HUET T, 1990, NATURE, V345, P356, DOI 10.1038/345356a0; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Nerrienet E, 2005, J VIROL, V79, P1312, DOI 10.1128/JVI.79.2.1312-1319.2005; PEETERS M, 1989, AIDS, V3, P625, DOI 10.1097/00002030-198910000-00001; Santiago ML, 2005, J VIROL, V79, P12515, DOI 10.1128/JVI.79.19.12515-12527.2005; Santiago ML, 2003, J VIROL, V77, P7545, DOI 10.1128/JVI.77.13.7545-7562.2003; Santiago ML, 2002, SCIENCE, V295, P465, DOI 10.1126/science.295.5554.465; Sharp PM, 2005, J VIROL, V79, P3891, DOI 10.1128/JVI.79.7.3891-3902.2005; Sharp PM, 2001, PHILOS T R SOC B, V356, P867, DOI 10.1098/rstb.2001.0863; Simon F, 1998, NAT MED, V4, P1032, DOI 10.1038/2017; VandenHaesevelde MM, 1996, VIROLOGY, V221, P346, DOI 10.1006/viro.1996.0384; VANHEUSERSWYN F, 2006, 13 C RETR OPP INF, V132; Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000; Worobey M, 2004, NATURE, V428, P820, DOI 10.1038/428820a; Yamaguchi J, 2006, AIDS RES HUM RETROV, V22, P83, DOI 10.1089/aid.2006.22.83	20	559	601	1	190	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 28	2006	313	5786					523	526		10.1126/science.1126531	http://dx.doi.org/10.1126/science.1126531			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067MZ	16728595	Green Accepted			2022-12-24	WOS:000239308600063
J	Sui, HX; Downing, KH				Sui, Haixin; Downing, Kenneth H.			Molecular architecture of axonemal microtubule doublets revealed by cryo-electron tomography	NATURE			English	Article							DYNEIN-REGULATORY-COMPLEX; INTERMEDIATE-FILAMENT PROTEINS; URCHIN SPERM FLAGELLA; CHLAMYDOMONAS-FLAGELLA; COMPONENTS; TUBULIN; TEKTINS; ARMS; HETEROGENEITY; MUTATIONS	The axoneme, which forms the core of eukaryotic flagella and cilia, is one of the largest macromolecular machines, with a structure that is largely conserved from protists to mammals(1). Microtubule doublets are structural components of axonemes that contain a number of proteins besides tubulin, and are usually found in arrays of nine doublets arranged around two singlet microtubules. Coordinated sliding of adjacent doublets, which involves a host of other proteins in the axoneme, produces periodic beating movements of the axoneme. We have obtained a three-dimensional density map of intact microtubule doublets using cryo-electron tomography and image averaging. Our map, with a resolution of about 3 nm, provides insights into locations of particular proteins within the doublets and the structural features of the doublets that define their mechanical properties. We identify likely candidates for several of these non-tubulin components of the doublets. This work offers insight on how tubulin protofilaments and accessory proteins attach together to form the doublets and provides a structural basis for understanding doublet function in axonemes.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Downing, KH (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA.	khdowning@lbl.gov	Sui, Haixin/L-4265-2017	Sui, Haixin/0000-0002-5560-4325				BOZKURT HH, 1993, CELL MOTIL CYTOSKEL, V24, P109; CHANG XJ, 1987, J CELL BIOL, V104, P1563, DOI 10.1083/jcb.104.6.1563; CHEN R, 1993, J CELL SCI, V106, P909; GARDNER LC, 1994, J CELL BIOL, V127, P1311, DOI 10.1083/jcb.127.5.1311; Hinchcliffe EH, 1998, J CELL SCI, V111, P585; HOOPS HJ, 1983, J CELL BIOL, V97, P902, DOI 10.1083/jcb.97.3.902; HUANG B, 1982, CELL, V28, P115, DOI 10.1016/0092-8674(82)90381-6; Ikeda K, 2003, J BIOL CHEM, V278, P7725, DOI 10.1074/jbc.M210751200; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Kohl L, 2005, INT REV CYTOL, V244, P227, DOI 10.1016/S0074-7696(05)44006-1; LINCK RW, 1985, J CELL BIOL, V100, P126, DOI 10.1083/jcb.100.1.126; LINCK RW, 1982, J CELL SCI, V58, P1; Linck RW, 2003, PROTIST, V154, P299, DOI 10.1078/143446103322454086; LINCK RW, 1987, J CELL BIOL, V104, P1069, DOI 10.1083/jcb.104.4.1069; LINCK RW, 1976, J CELL SCI, V20, P405; Lindemann CB, 2004, BIOL CELL, V96, P681, DOI 10.1016/j.biolcel.2004.08.001; MASTRONARDE DN, 1992, J CELL BIOL, V118, P1145, DOI 10.1083/jcb.118.5.1145; MEZA I, 1972, EXP CELL RES, V74, P535, DOI 10.1016/0014-4827(72)90413-2; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; NORRANDER JM, 1992, P NATL ACAD SCI USA, V89, P8567, DOI 10.1073/pnas.89.18.8567; Patel-King RS, 2002, J BIOL CHEM, V277, P34271, DOI 10.1074/jbc.M204137200; PIPERNO G, 1994, J CELL BIOL, V125, P1109, DOI 10.1083/jcb.125.5.1109; PIPERNO G, 1992, J CELL BIOL, V118, P1455, DOI 10.1083/jcb.118.6.1455; PIRNER MA, 1994, J BIOL CHEM, V269, P31800; STEFFEN W, 1989, CELL MOTIL CYTOSKEL, V14, P359, DOI 10.1002/cm.970140306; Waterman-Storer C, 1998, CURRENT PROTOCOLS CE; WITMAN GB, 1972, J CELL BIOL, V54, P540, DOI 10.1083/jcb.54.3.540; WITMAN GB, 1972, J CELL BIOL, V54, P507, DOI 10.1083/jcb.54.3.507; Woolley DM, 1997, J CELL SCI, V110, P85; [No title captured]	30	119	124	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2006	442	7101					475	478		10.1038/nature04816	http://dx.doi.org/10.1038/nature04816			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067CI	16738547	Green Submitted			2022-12-24	WOS:000239278900048
J	Cooper, AA; Gitler, AD; Cashikar, A; Haynes, CM; Hill, KJ; Bhullar, B; Liu, KN; Xu, KX; Strathearn, KE; Liu, F; Cao, SS; Caldwell, KA; Caldwell, GA; Marsischky, G; Kolodner, RD; LaBaer, J; Rochet, JC; Bonini, NM; Lindquist, S				Cooper, Antony A.; Gitler, Aaron D.; Cashikar, Anil; Haynes, Cole M.; Hill, Kathryn J.; Bhullar, Bhupinder; Liu, Kangning; Xu, Kexiang; Strathearn, Katherine E.; Liu, Fang; Cao, Songsong; Caldwell, Kim A.; Caldwell, Guy A.; Marsischky, Gerald; Kolodner, Richard D.; LaBaer, Joshua; Rochet, Jean-Christophe; Bonini, Nancy M.; Lindquist, Susan			alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models	SCIENCE			English	Article							CARBOXYPEPTIDASE-Y; DISEASE; YEAST; DEGRADATION; PROTEIN; TRANSPORT; REQUIRES; MUTATION; STRESS; NEURODEGENERATION	Alpha-synuclein (alpha Syn) misfolding is associated with several devastating neurodegenerative disorders, including Parkinson's disease (PD). In yeast cells and in neurons alpha Syn accumulation is cytotoxic, but little is known about its normal function or pathobiology. The earliest defect following alpha Syn expression in yeast was a block in endoplasmic reticulum (ER)-to-Golgi vesicular trafficking. In a genomewide screen, the largest class of toxicity modifiers were proteins functioning at this same step, including the Rab guanosine triphosphatase Ypt1p, which associated with cytoplasmic alpha Syn inclusions. Elevated expression of Rab1, the mammalian YPT1 homolog, protected against alpha Syn-induced dopaminergic neuron loss in animal models of PD. Thus, synucleinopathies may result from disruptions in basic cellular functions that interface with the unique biology of particular neurons to make them especially vulnerable.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Univ Missouri, Sch Biol Sci, Kansas City, MO 64110 USA; Harvard Univ, Inst Proteom, Cambridge, MA 02141 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Missouri System; University of Missouri Kansas City; Harvard University; University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Alabama System; University of Alabama Tuscaloosa; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Haynes, CM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	Cashikar, Anil G/F-5968-2011	Rochet, Jean-Christophe/0000-0002-6484-1541; Caldwell, Guy/0000-0002-8283-9090; Caldwell, Kim/0000-0003-1580-6122; Gitler, Aaron/0000-0001-8603-1526; Cooper, Antony/0000-0002-6027-2353	NHGRI NIH HHS [R01-HG002923] Funding Source: Medline; NINDS NIH HHS [P50 NS038372] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS038372] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Cohen M, 2003, NAT CELL BIOL, V5, P661, DOI 10.1038/ncb1003; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Gosavi N, 2002, J BIOL CHEM, V277, P48984, DOI 10.1074/jbc.M208194200; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; KLIONSKY DJ, 1989, EMBO J, V8, P2241, DOI 10.1002/j.1460-2075.1989.tb08348.x; Knop M, 1996, YEAST, V12, P1229, DOI 10.1002/(SICI)1097-0061(19960930)12:12<1229::AID-YEA15>3.0.CO;2-H; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lo BC, 2002, P NATL ACAD SCI USA, V99, P10813; Lotharius J, 2002, J BIOL CHEM, V277, P38884, DOI 10.1074/jbc.M205518200; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McCracken AA, 2003, BIOESSAYS, V25, P868, DOI 10.1002/bies.10320; OSSIG R, 1991, MOL CELL BIOL, V11, P2980, DOI 10.1128/MCB.11.6.2980; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rochet JC, 2004, J MOL NEUROSCI, V23, P23, DOI 10.1385/JMN:23:1-2:023; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spear ED, 2003, MOL BIOL CELL, V14, P2756, DOI 10.1091/mbc.E02-11-0717; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; Vila M, 2004, NAT MED, V10, pS58, DOI 10.1038/nm1068; WILSON BS, 1994, J CELL BIOL, V125, P557, DOI 10.1083/jcb.125.3.557; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	32	1037	1066	1	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2006	313	5785					324	328		10.1126/science.1129462	http://dx.doi.org/10.1126/science.1129462			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16794039	Green Accepted			2022-12-24	WOS:000239154300036
J	Matsuura-Tokita, K; Takeuchi, M; Ichihara, A; Mikuriya, K; Nakano, A				Matsuura-Tokita, Kumi; Takeuchi, Masaki; Ichihara, Akira; Mikuriya, Kenta; Nakano, Akihiko			Live imaging of yeast Golgi cisternal maturation	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; PICHIA-PASTORIS; APPARATUS; MICROSCOPY; TRANSPORT; COMPLEX; SEC7; CONTINUITIES	There is a debate over how protein trafficking is performed through the Golgi apparatus(1-4). In the secretory pathway, secretory proteins that are synthesized in the endoplasmic reticulum enter the early compartment of the Golgi apparatus called cis cisternae, undergo various modifications and processing, and then leave for the plasma membrane from the late ( trans) cisternae. The cargo proteins must traverse the Golgi apparatus in the cis-totrans direction. Two typical models propose either vesicular transport or cisternal progression and maturation for this process. The vesicular transport model predicts that Golgi cisternae are distinct stable compartments connected by vesicular traffic, whereas the cisternal maturation model predicts that cisternae are transient structures that form de novo, mature from cis to trans, and then dissipate. Technical progress in live-cell imaging has long been awaited to address this problem. Here we show, by the use of high-speed three-dimensional confocal microscopy, that yeast Golgi cisternae do change the distribution of resident membrane proteins from the cis nature to the trans over time, as proposed by the maturation model, in a very dynamic way.	RIKEN, Discovery Res Inst, Mol Membrane Biol Lab, Wako, Saitama 3510198, Japan; Yokogawa Elect Corp, Bioctr, Tokyo 1808750, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan	RIKEN; Yokogawa Electric Corporation; University of Tokyo	Nakano, A (corresponding author), RIKEN, Discovery Res Inst, Mol Membrane Biol Lab, Wako, Saitama 3510198, Japan.	nakano@riken.jp	Nakano, Akihiko/G-4942-2014; Nakano, Akihiko/C-6185-2009; Nakano, Akihiko/A-6420-2016	Nakano, Akihiko/0000-0003-3635-548X; Nakano, Akihiko/0000-0003-3635-548X				ACHSTETTER T, 1988, J BIOL CHEM, V263, P11711; Bevis BJ, 2002, NAT CELL BIOL, V4, P750, DOI 10.1038/ncb852; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Glick BS, 1998, CELL, V95, P883, DOI 10.1016/S0092-8674(00)81713-4; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; LOSEV E, 2006, NATURE          0514; Marsh BJ, 2004, P NATL ACAD SCI USA, V101, P5565, DOI 10.1073/pnas.0401242101; McNew JA, 1998, FEBS LETT, V435, P89, DOI 10.1016/S0014-5793(98)01044-8; Nakano A, 2004, CELL MOL LIFE SCI, V61, P186, DOI 10.1007/s00018-003-3356-5; Nakano A, 2002, CELL STRUCT FUNCT, V27, P349, DOI 10.1247/csf.27.349; Pelham H, 2000, TRAFFIC, V1, P191, DOI 10.1034/j.1600-0854.2000.010213.x; Pelham HRB, 2000, CELL, V102, P713, DOI 10.1016/S0092-8674(00)00060-X; Pelham HRB, 2001, J CELL BIOL, V155, P1099, DOI 10.1083/jcb.200110160; PREUSS D, 1992, MOL BIOL CELL, V3, P789, DOI 10.1091/mbc.3.7.789; RAMBOURG A, 1993, ANAT REC, V237, P441, DOI 10.1002/ar.1092370402; RAMBOURG A, 1995, ANAT REC, V243, P283, DOI 10.1002/ar.1092430302; Rambourg A, 2001, J CELL SCI, V114, P2231; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; Sata M, 1998, P NATL ACAD SCI USA, V95, P4204, DOI 10.1073/pnas.95.8.4204; Sato K, 1997, P NATL ACAD SCI USA, V94, P9693, DOI 10.1073/pnas.94.18.9693; Sato K, 2001, J CELL BIOL, V152, P935, DOI 10.1083/jcb.152.5.935; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; Wooding S, 1998, MOL BIOL CELL, V9, P2667, DOI 10.1091/mbc.9.9.2667	24	247	256	4	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					1007	1010		10.1038/nature04737	http://dx.doi.org/10.1038/nature04737			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16699523				2022-12-24	WOS:000238422300048
J	White, PM; Doetzlhofer, A; Lee, YS; Groves, AK; Segil, N				White, Patricia M.; Doetzlhofer, Angelika; Lee, Yun Shain; Groves, Andrew K.; Segil, Neil			Mammalian cochlear supporting cells can divide and trans-differentiate into hair cells	NATURE			English	Article							INNER-EAR; ACOUSTIC TRAUMA; REGENERATION; EXPRESSION; MATH1; GENE; MICE; PROLIFERATION; PROGENITORS; PROTEINS	Sensory hair cells of the mammalian organ of Corti in the inner ear do not regenerate when lost as a consequence of injury, disease, or age-related deafness. This contrasts with other vertebrates such as birds, where the death of hair cells causes surrounding supporting cells to re-enter the cell cycle and give rise to both new hair cells and supporting cells(1,2). It is not clear whether the lack of mammalian hair cell regeneration is due to an intrinsic inability of supporting cells to divide and differentiate or to an absence or blockade of regenerative signals. Here we show that post-mitotic supporting cells(3) purified from the postnatal mouse cochlea retain the ability to divide and trans-differentiate into new hair cells in culture. Furthermore, we show that age-dependent changes in supporting cell proliferative capacity are due in part to changes in the ability to downregulate the cyclin-dependent kinase inhibitor p27(Kip1) ( also known as Cdkn1b). These results indicate that postnatal mammalian supporting cells are potential targets for therapeutic manipulation.	House Ear Res Inst, Gonda Dept Cell & Mol Biol, Los Angeles, CA 90057 USA; Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA	House Research Institute; University of Southern California	Groves, AK (corresponding author), House Ear Res Inst, Gonda Dept Cell & Mol Biol, 2100 W 3rd St, Los Angeles, CA 90057 USA.	agroves@hei.org; nsegil@hei.org		Groves, Andrew/0000-0002-0784-7998	NIDCD NIH HHS [F32 DC005282, R01 DC004189] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC005282, R01DC004189] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; CHARDIN S, 1995, SCIENCE, V267, P707, DOI 10.1126/science.7839151; Chen P, 2002, DEVELOPMENT, V129, P2495; Chen P, 1999, DEVELOPMENT, V126, P1581; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Coppens AG, 2001, DEV BRAIN RES, V126, P191, DOI 10.1016/S0165-3806(00)00153-X; CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100; DECHESNE CJ, 1994, J COMP NEUROL, V346, P517, DOI 10.1002/cne.903460405; Doetzlhofer A, 2004, DEV BIOL, V272, P432, DOI 10.1016/j.ydbio.2004.05.013; DOETZLHOFER A, 2006, BRAIN RES       0406; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Gestwa G, 1999, J COMP NEUROL, V414, P33, DOI 10.1002/(SICI)1096-9861(19991108)414:1<33::AID-CNE3>3.0.CO;2-M; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Helms AW, 2000, DEVELOPMENT, V127, P1185; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Lewis AK, 1998, MECH DEVELOP, V78, P159, DOI 10.1016/S0925-4773(98)00165-8; LIM DJ, 1985, ACTA OTO-LARYNGOL, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meyers JR, 2003, J NEUROSCI, V23, P4054; PUJOL R, 1973, ACTA OTO-LARYNGOL, V76, P1, DOI 10.3109/00016487309121476; Roberson DW, 1996, AUDIT NEUROSCI, V2, P195; Ruben R.J., 1967, ACTA OTO-LARYNGOL, DOI DOI 10.3109/00016486709127790; RYALS BM, 1988, SCIENCE, V240, P1774, DOI 10.1126/science.3381101; Stone JS, 2000, P NATL ACAD SCI USA, V97, P11714, DOI 10.1073/pnas.97.22.11714; Warchol ME, 1996, J NEUROSCI, V16, P5466; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zheng LL, 2000, CELL, V102, P377, DOI 10.1016/S0092-8674(00)00042-8; Zine A, 2001, J NEUROSCI, V21, P4712, DOI 10.1523/JNEUROSCI.21-13-04712.2001	30	309	341	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					984	987		10.1038/nature04849	http://dx.doi.org/10.1038/nature04849			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791196				2022-12-24	WOS:000238422300043
J	Letvin, NL; Mascola, JR; Sun, Y; Gorgone, DA; Buzby, AP; Xu, L; Yang, ZY; Chakrabarti, B; Rao, SS; Schmitz, JE; Montefiori, DC; Barker, BR; Bookstein, FL; Nabel, GJ				Letvin, NL; Mascola, JR; Sun, Y; Gorgone, DA; Buzby, AP; Xu, L; Yang, ZY; Chakrabarti, B; Rao, SS; Schmitz, JE; Montefiori, DC; Barker, BR; Bookstein, FL; Nabel, GJ			Preserved CD4(+) central memory T cells and survival in vaccinated SIV-challenged monkeys	SCIENCE			English	Article							IMMUNODEFICIENCY VIRUS SIVMAC239; RHESUS-MONKEYS; ANTIRETROVIRAL THERAPY; VIRAL REPLICATION; IMMUNE-RESPONSES; INFECTION; LYMPHOCYTES; ENVELOPE; AIDS; GAG	Vaccine-induced cellular immunity controls virus replication in simian immunodeficiency virus (SIV) - infected monkeys only transiently, leading to the question of whether such vaccines for AIDS will be effective. We immunized monkeys with plasmid DNA and replication-defective adenoviral vectors encoding SIV proteins and then challenged them with pathogenic SIV. Although these monkeys demonstrated a reduction in viremia restricted to the early phase of SIV infection, they showed a prolonged survival. This survival was associated with preserved central memory CD4(+) T lymphocytes and could be predicted by the magnitude of the vaccine-induced cellular immune response. These immune correlates of vaccine efficacy should guide the evaluation of AIDS vaccines in humans.	NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; Duke Univ, Med Ctr, Durham, NC 27710 USA; Univ Washington, Dept Stat, Seattle, WA 98195 USA; Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; Univ Vienna, Dept Anthropol, A-1010 Vienna, Austria	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Duke University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Vienna	Letvin, NL (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	nletvin@bidmc.harvard.edu	Mascola, John/AAI-7193-2021; Schmitz, Joern/A-4929-2018; Barker, Brianne/AAW-2583-2020	Schmitz, Joern/0000-0001-8803-0922; Barker, Brianne/0000-0001-6932-479X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI005002, Z01AI005001, Z01AI005011, Z01AI005009] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 AI999999] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Barouch DH, 2000, SCIENCE, V290, P486, DOI 10.1126/science.290.5491.486; Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005; Gilbert PB, 2005, J INFECT DIS, V192, P974, DOI 10.1086/432734; Hulgan T, 2005, J INFECT DIS, V192, P950, DOI 10.1086/432955; Letvin NL, 2004, J VIROL, V78, P7490, DOI 10.1128/JVI.78.14.7490-7497.2004; Letvin NL, 2005, ANNU REV MED, V56, P213, DOI 10.1146/annurev.med.54.101601.152349; Lifson JD, 1997, J VIROL, V71, P9508, DOI 10.1128/JVI.71.12.9508-9514.1997; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Nishimura Y, 2004, P NATL ACAD SCI USA, V101, P12324, DOI 10.1073/pnas.0404620101; Ourmanov I, 2000, J VIROL, V74, P2740, DOI 10.1128/JVI.74.6.2740-2751.2000; Pal R, 2002, J VIROL, V76, P292, DOI 10.1128/JVI.76.1.292-302.2002; Polacino P, 1999, J VIROL, V73, P618, DOI 10.1128/JVI.73.1.618-630.1999; Polacino PS, 1999, J VIROL, V73, P8201, DOI 10.1128/JVI.73.10.8201-8215.1999; Santra S, 2005, J VIROL, V79, P6516, DOI 10.1128/JVI.79.10.6516-6522.2005; Seaman MS, 2005, J VIROL, V79, P2956, DOI 10.1128/JVI.79.5.2956-2963.2005; Seaman MS, 2005, J VIROL, V79, P4580, DOI 10.1128/JVI.79.8.4580-4588.2005; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Sun Y, 2005, J IMMUNOL, V174, P4753, DOI 10.4049/jimmunol.174.8.4753; Veazey RS, 2000, J VIROL, V74, P57, DOI 10.1128/JVI.74.1.57-64.2000; Vogel TU, 2003, J VIROL, V77, P13348, DOI 10.1128/JVI.77.24.13348-13360.2003	22	303	313	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 9	2006	312	5779					1530	1533		10.1126/science.1124226	http://dx.doi.org/10.1126/science.1124226			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763152	Green Accepted			2022-12-24	WOS:000238124100050
J	Grimm, D; Streetz, KL; Jopling, CL; Storm, TA; Pandey, K; Davis, CR; Marion, P; Salazar, F; Kay, MA				Grimm, Dirk; Streetz, Konrad L.; Jopling, Catherine L.; Storm, Theresa A.; Pandey, Kusum; Davis, Corrine R.; Marion, Patricia; Salazar, Felix; Kay, Mark A.			Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways	NATURE			English	Article							NUCLEAR EXPORT; VIRUS; INTERFERENCE; TRANSDUCTION; VECTORS; EXPRESSION; PROTEIN	RNA interference (RNAi) is a universal and evolutionarily conserved phenomenon of post-transcriptional gene silencing by means of sequence-specific mRNA degradation, triggered by small double-stranded RNAs1,2. Because this mechanism can be efficiently induced in vivo by expressing target-complementary short hairpin RNA (shRNA) from non-viral and viral vectors, RNAi is attractive for functional genomics and human therapeutics(3,4). Here we systematically investigate the long-term effects of sustained high-level shRNA expression in livers of adult mice. Robust shRNA expression in all the hepatocytes after intravenous infusion was achieved with an optimized shRNA delivery vector based on duplex-DNA-containing adeno-associated virus type 8 (AAV8). An evaluation of 49 distinct AAV/shRNA vectors, unique in length and sequence and directed against six targets, showed that 36 resulted in dose-dependent liver injury, with 23 ultimately causing death. Morbidity was associated with the downregulation of liver-derived microRNAs (miRNAs), indicating possible competition of the latter with shRNAs for limiting cellular factors required for the processing of various small RNAs. In vitro and in vivo shRNA transfection studies implied that one such factor, shared by the shRNA/miRNA pathways and readily saturated, is the nuclear karyopherin exportin-5. Our findings have fundamental consequences for future RNAi-based strategies in animals and humans, because controlling intracellular shRNA expression levels will be imperative. However, the risk of oversaturating endogenous small RNA pathways can be minimized by optimizing shRNA dose and sequence, as exemplified here by our report of persistent and therapeutic RNAi against human hepatitis B virus in vivo.	Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Comparat Med, Stanford, CA 94305 USA; Hepadnavirus Testing Inc, Mountain View, CA 94043 USA	Stanford University; Stanford University; Stanford University; Stanford University	Kay, MA (corresponding author), Stanford Univ, Sch Med, Dept Pediat, 300 Pasteur Dr, Stanford, CA 94305 USA.	markay@stanford.edu		Jopling, Catherine/0000-0001-6046-1456; Kay, Mark/0000-0002-2799-2615				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Cao Wen, 2005, Journal of Applied Genetics, V46, P217; Dykxhoorn DM, 2005, ANNU REV MED, V56, P401, DOI 10.1146/annurev.med.56.082103.104606; Grimm D., 2003, Current Gene Therapy, V3, P281, DOI 10.2174/1566523034578285; Grimm D, 2002, METHODS, V28, P146, DOI 10.1016/S1046-2023(02)00219-0; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Jackson AL, 2004, TRENDS GENET, V20, P521, DOI 10.1016/j.tig.2004.08.006; Jenkins DD, 2004, TRANSPLANTATION, V78, P530, DOI 10.1097/01.TP.0000130180.42573.B1; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Marion PL, 2003, FRONTIERS IN VIRAL HEPATITIS, P197, DOI 10.1016/B978-044450986-4/50069-2; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; McCarty DM, 2001, GENE THER, V8, P1248, DOI 10.1038/sj.gt.3301514; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Nakai H, 2001, J VIROL, V75, P6969, DOI 10.1128/JVI.75.15.6969-6976.2001; Nakai H, 2005, J VIROL, V79, P214, DOI 10.1128/JVI.79.1.214-224.2005; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Xia HB, 2002, NAT BIOTECHNOL, V20, P1006, DOI 10.1038/nbt739; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Yi R, 2005, RNA, V11, P220, DOI 10.1261/rna.7233305; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803	30	1294	1444	3	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					537	541		10.1038/nature04791	http://dx.doi.org/10.1038/nature04791			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724069				2022-12-24	WOS:000237778900056
J	Ohtsuki, H; Hauert, C; Lieberman, E; Nowak, MA				Ohtsuki, Hisashi; Hauert, Christoph; Lieberman, Erez; Nowak, Martin A.			A simple rule for the evolution of cooperation on graphs and social networks	NATURE			English	Article							FINITE POPULATIONS; ALTRUISM; DYNAMICS; GAME; STABILITY; EMERGENCE	A fundamental aspect of all biological systems is cooperation. Cooperative interactions are required for many levels of biological organization ranging from single cells to groups of animals(1-4). Human society is based to a large extent on mechanisms that promote cooperation(5-7). It is well known that in unstructured populations, natural selection favours defectors over cooperators. There is much current interest, however, in studying evolutionary games in structured populations and on graphs(8-17). These efforts recognize the fact that who-meets-whom is not random, but determined by spatial relationships or social networks(18-24). Here we describe a surprisingly simple rule that is a good approximation for all graphs that we have analysed, including cycles, spatial lattices, random regular graphs, random graphs and scale-free networks(25,26): natural selection favours cooperation, if the benefit of the altruistic act, b, divided by the cost, c, exceeds the average number of neighbours, k, which means b/c > k. In this case, cooperation can evolve as a consequence of 'social viscosity' even in the absence of reputation effects or strategic complexity.	Harvard Univ, Dept Math, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Cambridge, MA 02138 USA; Kyushu Univ, Dept Biol, Fukuoka 8128581, Japan; Harvard Univ, Dept Appl Math, Cambridge, MA 02138 USA	Harvard University; Kyushu University; Harvard University	Nowak, MA (corresponding author), Harvard Univ, Dept Math, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	martin_nowak@harvard.edu	Nowak, Martin A/A-6977-2008; Hauert, Christoph/E-5369-2011; Aiden, Erez Lieberman/A-2908-2010	Hauert, Christoph/0000-0002-1239-281X; 	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078986] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM078986-01, R01 GM078986] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abramson G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.030901; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; HASSELL MP, 1994, NATURE, V370, P290, DOI 10.1038/370290a0; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Ifti M, 2004, J THEOR BIOL, V231, P97, DOI 10.1016/j.jtbi.2004.06.003; Killingback T, 1996, P ROY SOC B-BIOL SCI, V263, P1135, DOI 10.1098/rspb.1996.0166; Le Galliard JF, 2003, EVOLUTION, V57, P1; LEVIN SA, 1974, P NATL ACAD SCI USA, V71, P2744, DOI 10.1073/pnas.71.7.2744; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; Mitteldorf J, 2000, J THEOR BIOL, V204, P481, DOI 10.1006/jtbi.2000.2007; Nakamaru M, 1997, J THEOR BIOL, V184, P65, DOI 10.1006/jtbi.1996.0243; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Skyrms B, 2000, P NATL ACAD SCI USA, V97, P9340, DOI 10.1073/pnas.97.16.9340; Szabo G, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.036107; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; van Baalen M, 1998, J THEOR BIOL, V193, P631, DOI 10.1006/jtbi.1998.0730; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; Wild G, 2004, P ROY SOC B-BIOL SCI, V271, P2345, DOI 10.1098/rspb.2004.2862; Wilson E.O., 1975, P1	30	1334	1373	28	498	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					502	505		10.1038/nature04605	http://dx.doi.org/10.1038/nature04605			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724065	Green Accepted			2022-12-24	WOS:000237778900048
J	Kurland, CG; Collins, LJ; Penny, D				Kurland, CG; Collins, LJ; Penny, D			Genomics and the irreducible nature of eukaryote cells	SCIENCE			English	Review							MITOCHONDRIAL ENDOSYMBIOSIS; PHYLOGENETIC-RELATIONSHIPS; EARLY EVOLUTION; PROTEIN; ORIGIN; ANCESTRY; BACTERIA; SEQUENCE; PROVIDES; REMNANT	Large-scale comparative genomics in harness with proteomics has substantiated fundamental features of eukaryote cellular evolution. The evolutionary trajectory of modern eukaryotes is distinct from that of prokaryotes. Data from many sources give no direct evidence that eukaryotes evolved by genome fusion between archaea and bacteria. Comparative genomics shows that, under certain ecological settings, sequence loss and cellular simplification are common modes of evolution. Subcellular architecture of eukaryote cells is in part a physical-chemical consequence of molecular crowding; subcellular compartmentation with specialized proteomes is required for the efficient functioning of proteins.	Massey Univ, Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand; Lund Univ, Dept Microbial Ecol, Lund, Sweden	Massey University; Lund University	Penny, D (corresponding author), Massey Univ, Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand.	d.penny@massey.ac.nz	Penny, David/E-9410-2011					Akhmanova A, 1998, MOL MICROBIOL, V30, P1017, DOI 10.1046/j.1365-2958.1998.01130.x; Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Beggs JD, 2005, BIOCHEM SOC T, V33, P433, DOI 10.1042/BST0330433; Berg OG, 2000, MOL BIOL EVOL, V17, P951, DOI 10.1093/oxfordjournals.molbev.a026376; Berg OG, 2002, MOL BIOL EVOL, V19, P2265, DOI 10.1093/oxfordjournals.molbev.a004050; Bowler Peter, 1988, NONDARWINIAN REVOLUT, P94; Boxma B, 2005, NATURE, V434, P74, DOI 10.1038/nature03343; Caetano-Anolles G, 2003, GENOME RES, V13, P1563, DOI 10.1101/gr.1161903; Cai JP, 1996, INT J SYST BACTERIOL, V46, P542, DOI 10.1099/00207713-46-2-542; Canback B, 2002, P NATL ACAD SCI USA, V99, P6097, DOI 10.1073/pnas.082112499; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; CAVALIERSMITH T, 1987, NATURE, V326, P332, DOI 10.1038/326332a0; CLARK CG, 1995, P NATL ACAD SCI USA, V92, P6518, DOI 10.1073/pnas.92.14.6518; Collins L, 2006, MOL BIOL EVOL, V23, P901, DOI 10.1093/molbev/msj084; Collins L, 2005, MOL BIOL EVOL, V22, P1053, DOI 10.1093/molbev/msi091; Copley RR, 1999, CURR OPIN STRUC BIOL, V9, P408, DOI 10.1016/S0959-440X(99)80055-4; Dacks JB, 2003, P ROY SOC B-BIOL SCI, V270, pS168, DOI 10.1098/rsbl.2003.0058; DARNELL JE, 1978, SCIENCE, V202, P1257, DOI 10.1126/science.364651; DEDUVE C, 1982, ANN NY ACAD SCI, V386, P1, DOI 10.1111/j.1749-6632.1982.tb21402.x; DOOLITTLE RF, 1995, ANNU REV BIOCHEM, V64, P287, DOI 10.1146/annurev.bi.64.070195.001443; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; EHRENBERG M, 1984, Q REV BIOPHYS, V17, P45, DOI 10.1017/S0033583500005254; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Embley TM, 2006, NATURE, V440, P623, DOI 10.1038/nature04546; Embley TM, 2003, IUBMB LIFE, V55, P387, DOI 10.1080/15216540310001592834; Fedorov A, 2004, J MOL EVOL, V59, P695, DOI 10.1007/s00239-003-0085-1; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; Forterre P, 1999, BIOESSAYS, V21, P871, DOI 10.1002/(SICI)1521-1878(199910)21:10<871::AID-BIES10>3.0.CO;2-Q; Gabaldon T, 2003, SCIENCE, V301, P609, DOI 10.1126/science.1085463; Gabaldon T, 2005, BIOINFORMATICS, V21, P144, DOI 10.1093/bioinformatics/bti1124; Germot A, 1996, P NATL ACAD SCI USA, V93, P14614, DOI 10.1073/pnas.93.25.14614; Gogarten JP, 1996, SCIENCE, V274, P1750; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Hartman H, 2002, P NATL ACAD SCI USA, V99, P1420, DOI 10.1073/pnas.032658599; Jeffares DC, 2006, TRENDS GENET, V22, P16, DOI 10.1016/j.tig.2005.10.006; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Karlberg O, 2000, YEAST, V17, P170, DOI 10.1002/1097-0061(20000930)17:3<170::AID-YEA25>3.0.CO;2-V; Keeling PJ, 2005, CURR OPIN GENET DEV, V15, P601, DOI 10.1016/j.gde.2005.09.003; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Klasson L, 2004, TRENDS MICROBIOL, V12, P37, DOI 10.1016/j.tim.2003.11.006; KNOLL AH, 1992, SCIENCE, V256, P622, DOI 10.1126/science.1585174; Korbel JO, 2002, TRENDS GENET, V18, P158, DOI 10.1016/S0168-9525(01)02597-5; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; Lopez-Garcia P, 1999, TRENDS BIOCHEM SCI, V24, P88, DOI 10.1016/S0968-0004(98)01342-5; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Lynch M, 2002, P NATL ACAD SCI USA, V99, P6118, DOI 10.1073/pnas.092595699; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Padovan ACB, 2005, J MOL EVOL, V60, P726, DOI 10.1007/s00239-004-0164-y; Penny D, 1999, CURR OPIN GENET DEV, V9, P672, DOI 10.1016/S0959-437X(99)00020-9; Pielak GJ, 2005, P NATL ACAD SCI USA, V102, P5901, DOI 10.1073/pnas.0501812102; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Poole A, 1999, BIOESSAYS, V21, P880, DOI 10.1002/(SICI)1521-1878(199910)21:10<880::AID-BIES11>3.0.CO;2-P; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Regoes A, 2005, J BIOL CHEM, V280, P30557, DOI 10.1074/jbc.M500787200; Ribeiro S, 1998, MOL BIOL EVOL, V15, P779, DOI 10.1093/oxfordjournals.molbev.a025983; Rivera MC, 2004, NATURE, V431, P152, DOI 10.1038/nature02848; Roy SW, 2005, P NATL ACAD SCI USA, V102, P5773, DOI 10.1073/pnas.0500383102; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501; STANIER RY, 1962, ARCH MIKROBIOL, V42, P17, DOI 10.1007/BF00425185; Staub E, 2004, BIOESSAYS, V26, P567, DOI 10.1002/bies.20032; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; Williams BAP, 2002, NATURE, V418, P865, DOI 10.1038/nature00949; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yang S, 2005, P NATL ACAD SCI USA, V102, P373, DOI 10.1073/pnas.0408810102	73	152	164	3	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1011	1014		10.1126/science.1121674	http://dx.doi.org/10.1126/science.1121674			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16709776				2022-12-24	WOS:000237628800033
J	Rosi, NL; Giljohann, DA; Thaxton, CS; Lytton-Jean, AKR; Han, MS; Mirkin, CA				Rosi, NL; Giljohann, DA; Thaxton, CS; Lytton-Jean, AKR; Han, MS; Mirkin, CA			Oligonucleotide-modified gold nanoparticles for intracellular gene regulation	SCIENCE			English	Article							ANTISENSE OLIGONUCLEOTIDES; ULTRASENSITIVE DETECTION; MAMMALIAN-CELLS; IN-VIVO; DNA; DELIVERY; TRANSFECTION; THERAPEUTICS; GLUTATHIONE; INHIBITION	We describe the use of gold nanoparticle-oligonucleotide complexes as intracellular gene regulation agents for the control of protein expression in cells. These oligonucleotide-modified nanoparticles have affinity constants for complementary nucleic acids that are higher than their unmodified oligonucleotide counterparts, are less susceptible to degradation by nuclease activity, exhibit greater than 99% cellular uptake, can introduce oligonucleotides at a higher effective concentration than conventional transfection agents, and are nontoxic to the cells under the conditions studied. By chemically tailoring the density of DNA bound to the surface of gold nanoparticles, we demonstrated a tunable gene knockdown.	Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	chadnano@northwestern.edu	Mirkin, Chad A/E-3911-2010; Han, Min Su/S-4827-2016	Han, Min Su/0000-0001-9588-6980; Lytton-Jean, Abigail/0000-0002-1582-0066; Mirkin, Chad/0000-0002-6634-7627				Anderson ME, 1998, CHEM-BIOL INTERACT, V112, P1; Bergen JM, 2005, MRS BULL, V30, P663, DOI 10.1557/mrs2005.194; Bertrand JR, 2002, BIOCHEM BIOPH RES CO, V296, P1000, DOI 10.1016/S0006-291X(02)02013-2; Bharali DJ, 2005, P NATL ACAD SCI USA, V102, P11539, DOI 10.1073/pnas.0504926102; Bielinska AU, 1999, BIOCONJUGATE CHEM, V10, P843, DOI 10.1021/bc990036k; Dulkeith E, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.203002; Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078; Han G, 2005, BIOCONJUGATE CHEM, V16, P1356, DOI 10.1021/bc050173j; He L, 2000, J AM CHEM SOC, V122, P9071, DOI 10.1021/ja001215b; Jason TLH, 2004, TOXICOL APPL PHARM, V201, P66, DOI 10.1016/j.taap.2004.04.017; Jen CP, 2004, LANGMUIR, V20, P1369, DOI 10.1021/la036154k; Jin RC, 2003, J AM CHEM SOC, V125, P1643, DOI 10.1021/ja021096v; Lebedeva I, 2001, ANNU REV PHARMACOL, V41, P403, DOI 10.1146/annurev.pharmtox.41.1.403; Letsinger RL, 2000, BIOCONJUGATE CHEM, V11, P289, DOI 10.1021/bc990152n; Li Z, 2002, NUCLEIC ACIDS RES, V30, P1558, DOI 10.1093/nar/30.7.1558; Lytton-Jean AKR, 2005, J AM CHEM SOC, V127, P12754, DOI 10.1021/ja052255o; Maxwell DJ, 2002, J AM CHEM SOC, V124, P9606, DOI 10.1021/ja025814p; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Nam JM, 2003, SCIENCE, V301, P1884, DOI 10.1126/science.1088755; Patil SD, 2005, AAPS J, V7, pE61, DOI 10.1208/aapsj070109; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; Sandhu KK, 2002, BIOCONJUGATE CHEM, V13, P3, DOI 10.1021/bc015545c; STEPHENSON ML, 1978, P NATL ACAD SCI USA, V75, P285, DOI 10.1073/pnas.75.1.285; Sullivan MMO, 2003, GENE THER, V10, P1882, DOI 10.1038/sj.gt.3302083; Sundaram P, 1996, NUCLEIC ACIDS RES, V24, P1375, DOI 10.1093/nar/24.7.1375; Thomas M, 2003, P NATL ACAD SCI USA, V100, P9138, DOI 10.1073/pnas.1233634100; Tkachenko AG, 2004, BIOCONJUGATE CHEM, V15, P482, DOI 10.1021/bc034189q; Wang ZX, 2004, J MATER CHEM, V14, P578, DOI 10.1039/b314328g; Weissleder R, 2005, NAT BIOTECHNOL, V23, P1418, DOI 10.1038/nbt1159; ZAMECNIK PC, 1978, P NATL ACAD SCI USA, V75, P280, DOI 10.1073/pnas.75.1.280	31	1617	1686	8	715	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1027	1030		10.1126/science.1125559	http://dx.doi.org/10.1126/science.1125559			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16709779				2022-12-24	WOS:000237628800038
J	Siegel, R; Kim, U; Patke, A; Yu, X; Ren, XD; Tarakhovsky, A; Roeder, RG				Siegel, Rachael; Kim, Unkyu; Patke, Alina; Yu, Xin; Ren, Xiaodi; Tarakhovsky, Alexander; Roeder, Robert G.			Nontranscriptional regulation of SYK by the coactivator OCA-B is required at multiple stages of B cell development	CELL			English	Article							ADAPTER PROTEIN SLP-65; TYROSINE KINASE; LYMPHOCYTE DEVELOPMENT; MICE LACKING; TRANSCRIPTION; RECEPTOR; DIFFERENTIATION; SELECTION; IDENTIFICATION; ACTIVATION	OCA-B was originally identified as a nuclear transcriptional coactivator that is essential for antigen-driven immune responses. The later identification of a membrane bound, myristoylated form of OCA-B suggested additional, unique functions in B cell signaling pathways. This study has shown that OCA-B also functions in the pre-B1-to-pre-B2 cell transition and, most surprisingly, that it directly interacts with SYK, a tyrosine kinase critical for pre-BCR and BCR signaling. This unprecedented type of interaction-a transcriptional coactivator with a signaling kinase-occurs in the cytoplasm and directly regulates SYK stability. This study indicates that OCA-B is required for pre-BCR and BCR signaling at multiple stages of B cell development through its nontranscriptional regulation of SYK. Combined with the deregulation of OCA-B target genes, this may help explain the multitude of defects observed in B cell development and immune responses of Oca-b(-/-) mice.	Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA; Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Roeder, RG (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.	roeder@rockefeller.edu			NCI NIH HHS [CA 113872] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA113872] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Casellas R, 2002, CELL, V110, P575, DOI 10.1016/S0092-8674(02)00911-X; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Fleming HE, 2002, SEMIN IMMUNOL, V14, P423, DOI 10.1016/S1044532302000775; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hendriks RW, 2004, TRENDS IMMUNOL, V25, P249, DOI 10.1016/j.it.2004.02.011; Hess J, 2001, MOL CELL BIOL, V21, P1531, DOI 10.1128/MCB.21.5.1531-1539.2001; Jankovic M, 2003, INT IMMUNOL, V15, P1099, DOI 10.1093/intimm/dxg109; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Kim U, 2003, P NATL ACAD SCI USA, V100, P8868, DOI 10.1073/pnas.1033108100; Kim U, 1996, NATURE, V383, P542, DOI 10.1038/383542a0; Kim U, 2000, J IMMUNOL, V165, P6825, DOI 10.4049/jimmunol.165.12.6825; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; LUO Y, 1992, CELL, V71, P231, DOI 10.1016/0092-8674(92)90352-D; Luo Y, 1999, COLD SPRING HARB SYM, V64, P119, DOI 10.1101/sqb.1999.64.119; Ma H, 2001, J IMMUNOL, V166, P1507, DOI 10.4049/jimmunol.166.3.1507; Malone CS, 2002, J IMMUNOL, V168, P3369, DOI 10.4049/jimmunol.168.7.3369; Marshall AJ, 1998, J IMMUNOL, V161, P6038; Middendorp S, 2002, J IMMUNOL, V168, P2695, DOI 10.4049/jimmunol.168.6.2695; Nielsen PJ, 1996, EUR J IMMUNOL, V26, P3214, DOI 10.1002/eji.1830261255; Rao N, 2002, J LEUKOCYTE BIOL, V71, P753; Ray RJ, 1998, J IMMUNOL, V160, P5886; ROLINK A, 1991, BIOCHEM SOC T, V19, P275, DOI 10.1042/bst0190275; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Stevens S, 2000, J IMMUNOL, V164, P5306, DOI 10.4049/jimmunol.164.10.5306; Tang H, 1999, IMMUNITY, V11, P517, DOI 10.1016/S1074-7613(00)80127-2; Teitell MA, 2003, TRENDS IMMUNOL, V24, P546, DOI 10.1016/j.it.2003.08.002; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Turner M, 1997, J EXP MED, V186, P2013, DOI 10.1084/jem.186.12.2013; Wang L, 2003, CANCER RES, V63, P4724; Wang LD, 2003, IMMUNOLOGY, V110, P411, DOI 10.1111/j.1365-2567.2003.01756.x; Yu X, 2001, IMMUNITY, V14, P157, DOI 10.1016/S1074-7613(09)00090-9	34	31	32	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2006	125	4					761	774		10.1016/j.cell.2006.03.036	http://dx.doi.org/10.1016/j.cell.2006.03.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713566	Bronze			2022-12-24	WOS:000237886000020
J	Schildgen, O; Sirma, H; Funk, A; Olotu, C; Wend, UC; Hartmann, H; Helm, M; Rockstroh, JK; Willems, WR; Will, H; Gerlich, WH				Schildgen, O; Sirma, H; Funk, A; Olotu, C; Wend, UC; Hartmann, H; Helm, M; Rockstroh, JK; Willems, WR; Will, H; Gerlich, WH			Brief report: Variant of hepatitis B virus with primary resistance to adefovir	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; LAMIVUDINE; DIPIVOXIL; THERAPY; REPLICATION; MUTATIONS; SUSCEPTIBILITY; HIV	The reverse-transcriptase inhibitor lamivudine ( Zeffix, GlaxoSmithKline) is often treat chronic infection with hepatitis B virus ( HBV) until resistance develops. may then be switched to the reverse-transcriptase inhibitor adefovir Gilead), which has a lower frequency of resistance. Here, we describe cases of primary adefovir resistance that were sensitive to tenofovir ( Viread, All three cases involved a rare HBV variant with a valine at position 233 of transcriptase domain instead of isoleucine ( rtI233V), as in the wild-type This HBV variant also displayed resistance to adefovir and sensitivity to tenofovir vitro.	Univ Bonn, Inst Med Microbiol & Immunol, D-5300 Bonn, Germany; Univ Bonn, Dept Med 1, D-5300 Bonn, Germany; Heinrich Pette Inst, Hamburg, Germany; Inst Med Virol, D-35392 Giessen, Germany; Practice Gastroenterol & Hepatol, Herne, Germany; Practice Abelein Helm, Nurnberg, Germany	University of Bonn; University of Bonn; Heinrich Pette Institute	Gerlich, WH (corresponding author), Inst Med Virol, Frankfurterstr 107, D-35392 Giessen, Germany.	h.gerlich@viro.med.uni-giessen.de	Funk, Anneke/C-5688-2009; Schildgen, Oliver/D-5327-2014	Schildgen, Oliver/0000-0003-4297-9627				Angus P, 2003, GASTROENTEROLOGY, V125, P292, DOI 10.1016/S0016-5085(03)00939-9; Benhamou Y, 2003, NEW ENGL J MED, V348, P177, DOI 10.1056/NEJM200301093480218; Brunelle MN, 2005, HEPATOLOGY, V41, P1391, DOI 10.1002/hep.20723; Dore GJ, 2004, J INFECT DIS, V189, P1185, DOI 10.1086/380398; Erhardt A, 2000, HEPATOLOGY, V31, P716, DOI 10.1002/hep.510310323; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; GANEM D, 2004, NEW ENGL J MED, V351, P351; Grethe S, 2000, J VIROL, V74, P5377, DOI 10.1128/JVI.74.11.5377-5381.2000; GUIDOTTI LG, 1995, J VIROL, V69, P6158, DOI 10.1128/JVI.69.10.6158-6169.1995; Hadziyannis SJ, 2003, NEW ENGL J MED, V348, P800, DOI 10.1056/NEJMoa021812; Hadziyannis SJ, 2005, NEW ENGL J MED, V352, P2673, DOI 10.1056/NEJMoa042957; Huy TTT, 2004, J GEN VIROL, V85, P283, DOI 10.1099/vir.0.19633-0; Jursch CA, 2002, MED MICROBIOL IMMUN, V190, P189, DOI 10.1007/s00430-001-0103-0; Kimbi GC, 2004, J GEN VIROL, V85, P1211, DOI 10.1099/vir.0.19749-0; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Perrillo R, 2004, GASTROENTEROLOGY, V126, P81, DOI 10.1053/j.gastro.2003.10.050; Peters MG, 2004, GASTROENTEROLOGY, V126, P91, DOI 10.1053/j.gastro.2003.10.051; Rang A, 2002, J BIOL CHEM, V277, P7645, DOI 10.1074/jbc.C100729200; Schildgen O, 2004, AIDS, V18, P2325, DOI 10.1097/00002030-200411190-00014; Stuyver LJ, 2001, HEPATOLOGY, V33, P751, DOI 10.1053/jhep.2001.22166; SUMMERS J, 1990, J VIROL, V64, P2819, DOI 10.1128/JVI.64.6.2819-2824.1990; Van Bommel F, 2005, HEPATOLOGY, V42, P239, DOI 10.1002/hep.20765; van Bommel F, 2004, HEPATOLOGY, V40, P1421, DOI 10.1002/hep.20464; Yang HL, 2004, ANTIVIR RES, V61, P27, DOI 10.1016/j.antiviral.2003.07.003; Ying C, 2000, J VIRAL HEPATITIS, V7, P161; Zhang JM, 2005, J MED VIROL, V77, P203, DOI 10.1002/jmv.20453	27	175	196	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 27	2006	354	17					1807	1812		10.1056/NEJMoa051214	http://dx.doi.org/10.1056/NEJMoa051214			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036NF	16641397	Bronze			2022-12-24	WOS:000237077100006
J	Eggan, K; Jurga, S; Gosden, R; Min, IM; Wagers, AJ				Eggan, Kevin; Jurga, Sara; Gosden, Roger; Min, Irene M.; Wagers, Amy J.			Ovulated oocytes in adult mice derive from non-circulating germ cells	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; BONE-MARROW; FOLLICLE NUMBER; CYCLOPHOSPHAMIDE; OVARY; BLOOD	Decades of research in reproductive biology have led to the generally accepted belief that in female mammals, all surviving germ cells enter meiosis at the end of fetal development and as a result, the postnatal ovary harbours a limited supply of oocytes that cannot be replenished or regenerated if lost to injury or disease. However, recent reports have challenged this view, suggesting instead that oocyte production is maintained through continual seeding of the ovary by circulating, bone-marrow-derived germ cells. To test directly the physiological relevance of circulating cells for female fertility, we established transplantation and parabiotic mouse models to assess the capacity of circulating bone marrow cells to generate ovulated oocytes, both in the steady state and after induced damage. Our studies showed no evidence that bone marrow cells, or any other normally circulating cells, contribute to the formation of mature, ovulated oocytes. Instead, cells that travelled to the ovary through the bloodstream exhibited properties characteristic of committed blood leukocytes.	Joslin Diabet Ctr, Sect Dev & Stem Cell Biol, Boston, MA 02215 USA; Harvard Univ, Stowers Med Inst, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02215 USA; Cornell Univ, Weill Med Coll, Ctr Reprod Med & Infertil, New York, NY 10021 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Stowers Institute for Medical Research; Harvard University; Harvard University; Harvard Medical School; Cornell University	Wagers, AJ (corresponding author), Joslin Diabet Ctr, Sect Dev & Stem Cell Biol, Boston, MA 02215 USA.	amy.wagers@joslin.harvard.edu	Min, Irene/AAQ-4186-2021; Eggan, Kevin/P-7119-2018; Jurga, Stefan/E-8862-2017	Min, Irene/0000-0002-1057-4804; Jurga, Stefan/0000-0002-1665-6077				Barlow C, 1998, DEVELOPMENT, V125, P4007; Bhattacharya D, 2006, J EXP MED, V203, P73, DOI 10.1084/jem.20051714; Bunster E, 1933, ANAT REC, V57, P339, DOI 10.1002/ar.1090570404; BURKL W, 1978, CELL TISSUE RES, V186, P351; Byskov AG, 2005, DIFFERENTIATION, V73, P438, DOI 10.1111/j.1432-0436.2005.00045.x; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; FRANCHI LL, 1962, DEV OVARY PROCESS OO; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; Johnson J, 2005, CELL CYCLE, V4, P1471; MATTISON DR, 1981, RES COMMUN CHEM PATH, V31, P155; Meirow D, 2001, HUM REPROD, V16, P632, DOI 10.1093/humrep/16.4.632; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; PETERS H, 1962, NATURE, V195, P915, DOI 10.1038/195915a0; Sherwood RI, 2004, STEM CELLS, V22, P1292, DOI 10.1634/stemcells.2004-0090; SHIROMIZU K, 1984, PEDIATR PHARMACOL, V4, P213; Telfer EE, 2005, CELL, V122, P821, DOI 10.1016/j.cell.2005.09.004; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; ZUCKERMAN S, 1951, RECENT PROG HORM RES, V6, P63	21	187	205	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	2006	441	7097					1109	1114		10.1038/nature04929	http://dx.doi.org/10.1038/nature04929			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057SM	16799565				2022-12-24	WOS:000238615500041
J	Bathgate, AJ				Bathgate, AJ		UK Liver Transplant Units Working	Recommendations for alcohol-related liver disease	LANCET			English	Editorial Material							FOLLOW-UP; TRANSPLANTATION; RELAPSE		Royal Infirm Edinburgh NHS Trust, Scottish Liver Transplant Unit, Edinburgh EH3 9YW, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh	Bathgate, AJ (corresponding author), Royal Infirm Edinburgh NHS Trust, Scottish Liver Transplant Unit, Edinburgh EH3 9YW, Midlothian, Scotland.	andybathgate@luht.scot.nhs.uk						Anand AC, 1997, HEPATOLOGY, V25, P1478, DOI 10.1002/hep.510250628; Cuadrado A, 2005, LIVER TRANSPLANT, V11, P420, DOI 10.1002/lt.20386; DiMartini A, 2001, PSYCHOSOMATICS, V42, P55, DOI 10.1176/appi.psy.42.1.55; Foster PF, 1997, HEPATOLOGY, V25, P1469, DOI 10.1002/hep.510250627; GISH RG, 1993, AM J GASTROENTEROL, V88, P1337; Gish RG, 2001, LIVER TRANSPLANT, V7, P581, DOI 10.1053/jlts.2001.25455; Jauhar S, 2004, LIVER TRANSPLANT, V10, P408, DOI 10.1002/lt.20086; Miguet M, 2004, GASTROEN CLIN BIOL, V28, P845, DOI 10.1016/S0399-8320(04)95146-9; Zibari GB, 1996, CLIN TRANSPLANT, V10, P676	9	53	53	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 24	2006	367	9528					2045	2046		10.1016/S0140-6736(06)68904-6	http://dx.doi.org/10.1016/S0140-6736(06)68904-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058HZ	16798373				2022-12-24	WOS:000238657400010
J	Qi, L; Heredia, JE; Altarejos, JY; Screaton, R; Goebel, N; Niessen, S; MacLeod, IX; Liew, CW; Kulkarni, RN; Bain, J; Newgard, C; Nelson, M; Evans, RM; Yates, J; Montminy, M				Qi, Ling; Heredia, Jose E.; Altarejos, Judith Y.; Screaton, Robert; Goebel, Naomi; Niessen, Sherry; MacLeod, Ian X.; Liew, Chong Wee; Kulkarni, Rohit N.; Bain, James; Newgard, Christopher; Nelson, Michael; Evans, Ronald M.; Yates, John; Montminy, Marc			TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism	SCIENCE			English	Article							NEGATIVE REGULATOR; INSULIN-RESISTANCE; TRIBBLES HOMOLOG; GENE-EXPRESSION; ARABIDOPSIS; PHOTOMORPHOGENESIS; MORPHOGENESIS; DROSOPHILA; PROTEIN; COA	During fasting, increased concentrations of circulating catecholamines promote the mobilization of lipid stores from adipose tissue in part by phosphorylating and inactivating acetyl-coenzyme A carboxylase (ACC), the rate-limiting enzyme in fatty acid synthesis. Here, we describe a parallel pathway, in which the pseudokinase Tribbles 3 (TRB3), whose abundance is increased during fasting, stimulates lipolysis by triggering the degradation of ACC in adipose tissue. TRB3 promoted ACC ubiquitination through an association with the E3 ubiquitin ligase constitutive photomorphogenic protein 1 (COP1). Indeed, adipocytes deficient in TRB3 accumulated larger amounts of ACC protein than did wild-type cells. Because transgenic mice expressing TRB3 in adipose tissue are protected from diet-induced obesity due to enhanced fatty acid oxidation, these results demonstrate how phosphorylation and ubiquitination pathways converge on a key regulator of lipid metabolism to maintain energy homeostasis.	Salk Inst Biol Studies, Peptide Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; Scripps Res Inst, La Jolla, CA 92037 USA; Joslin Diabet Ctr, Boston, MA 02215 USA; Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA	Salk Institute; Salk Institute; Scripps Research Institute; Harvard University; Joslin Diabetes Center, Inc.; Duke University	Montminy, M (corresponding author), Salk Inst Biol Studies, Peptide Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	montminy@salk.edu	Evans, Ronald/AAF-4001-2019; Nelson, Michael Shawn/GXF-4934-2022	Evans, Ronald/0000-0002-9986-5965; Bain, James R./0000-0002-8917-9187; Liew, Chong Wee/0000-0001-9904-0958; Qi, Ling/0000-0001-8229-0184	NIDDK NIH HHS [DK064142] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064142] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abu-Elheiga L, 2003, P NATL ACAD SCI USA, V100, P10207, DOI 10.1073/pnas.1733877100; Bianchi E, 2003, J BIOL CHEM, V278, P19682, DOI 10.1074/jbc.M212681200; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; DENG XW, 1992, CELL, V71, P791, DOI 10.1016/0092-8674(92)90555-Q; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; ENG J, SEQUEST; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Holm M, 2001, EMBO J, V20, P118, DOI 10.1093/emboj/20.1.118; Hu JP, 2002, SCIENCE, V297, P405, DOI 10.1126/science.1073633; Kahn C Ronald, 2003, Trans Am Clin Climatol Assoc, V114, P125; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Nandi A, 2004, PHYSIOL REV, V84, P623, DOI 10.1152/physrev.00032.2003; Oh WK, 2005, P NATL ACAD SCI USA, V102, P1384, DOI 10.1073/pnas.0409451102; Orci L, 2004, P NATL ACAD SCI USA, V101, P2058, DOI 10.1073/pnas.0308258100; PEPPER A, 1994, CELL, V78, P109, DOI 10.1016/0092-8674(94)90577-0; Prudente S, 2005, DIABETES, V54, P2807, DOI 10.2337/diabetes.54.9.2807; Rorth P, 2000, MOL CELL, V6, P23; Ruderman NB, 2003, ENDOCRINOLOGY, V144, P5166, DOI 10.1210/en.2003-0849; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; Tseng YH, 2005, NAT CELL BIOL, V7, P601, DOI 10.1038/ncb1259; VONARNIM AG, 1994, CELL, V79, P1035, DOI 10.1016/0092-8674(94)90034-5; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007	26	241	255	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1763	1766		10.1126/science.1123374	http://dx.doi.org/10.1126/science.1123374			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16794074				2022-12-24	WOS:000238452800048
J	Bshary, R; Grutter, AS				Bshary, Redouan; Grutter, Alexandra S.			Image scoring and cooperation in a cleaner fish mutualism	NATURE			English	Article							EVOLUTION; ALTRUISM; RECIPROCITY; PUNISHMENT; HANDICAP; DIET	Humans are highly social animals and often help unrelated individuals that may never reciprocate the altruist's favour(1-5). This apparent evolutionary puzzle may be explained by the altruist's gain in social image: image-scoring bystanders, also known as eavesdroppers, notice the altruistic act and therefore are more likely to help the altruist in the future(5-7). Such complex indirect reciprocity based on altruistic acts may evolve only after simple indirect reciprocity has been established, which requires two steps. First, image scoring evolves when bystanders gain personal benefits from information gathered, for example, by finding cooperative partners(8-10). Second, altruistic behaviour in the presence of such bystanders may evolve if altruists benefit from access to the bystanders. Here, we provide experimental evidence for both of the requirements in a cleaning mutualism involving the cleaner fish Labroides dimidiatus. These cleaners may cooperate and remove ectoparasites from clients or they may cheat by feeding on client mucus(11,12). As mucus may be preferred over typical client ectoparasites(13), clients must make cleaners feed against their preference to obtain a cooperative service. We found that eavesdropping clients spent more time next to 'cooperative' than 'unknown cooperative level' cleaners, which shows that clients engage in image-scoring behaviour. Furthermore, trained cleaners learned to feed more cooperatively when in an `image-scoring' than in a 'non-image-scoring' situation.	Univ Neuchatel, Dept Zool, CH-2009 Neuchatel, Switzerland; Univ Queensland, Sch Integrat Biol, St Lucia, Qld 4072, Australia	University of Neuchatel; University of Queensland	Bshary, R (corresponding author), Univ Neuchatel, Dept Zool, Rue Emile Argand 11,Case Postale 158, CH-2009 Neuchatel, Switzerland.	redouan.bshary@unine.ch	Grutter, Alexandra S/J-2737-2013	Grutter, Alexandra S/0000-0003-1688-2821; Bshary, Redouan/0000-0001-7198-8472	Natural Environment Research Council [NER/A/S/2002/00898] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Alexander R., 2008, ESSAYS PEDAGOGY; Arnal C, 2000, J FISH BIOL, V57, P1075, DOI 10.1006/jfbi.2000.1371; Bshary R, 2005, BIOL LETTERS, V1, P396, DOI 10.1098/rsbl.2005.0344; Bshary R, 2004, ADV STUD BEHAV, V34, P59, DOI 10.1016/S0065-3454(04)34002-7; Bshary R, 2003, DAHL WS ENV, P167; Bshary R, 2002, P ROY SOC B-BIOL SCI, V269, P2087, DOI 10.1098/rspb.2002.2084; Bshary R., 2005, COMMUNICATION NETWOR, P521; Bshary Redouan, 2001, P146, DOI 10.1017/CBO9780511752421.010; Doutrelant C, 2001, BEHAV ECOL, V12, P283, DOI 10.1093/beheco/12.3.283; Dugatkin L.A., 1997, COOPERATION ANIMALS; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Grutter AS, 2003, P ROY SOC B-BIOL SCI, V270, pS242, DOI 10.1098/rsbl.2003.0077; Grutter AS, 1997, COPEIA, P346, DOI 10.2307/1447754; Johnstone RA, 2004, P ROY SOC B-BIOL SCI, V271, P1917, DOI 10.1098/rspb.2003.2581; Johnstone RA, 2001, P NATL ACAD SCI USA, V98, P9177, DOI 10.1073/pnas.161058798; Leimar O, 2001, P ROY SOC B-BIOL SCI, V268, P745, DOI 10.1098/rspb.2000.1573; Lotem A, 2003, P ROY SOC B-BIOL SCI, V270, P199, DOI 10.1098/rspb.2002.2225; MATOS RJ, 2005, ANIMAL COMMUNICATION, P84; MCGREGOR PK, 1993, PHILOS T ROY SOC B, V340, P237, DOI 10.1098/rstb.1993.0063; McGregor PK, 2005, ANIMAL COMMUNICATION; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Roberts G, 1998, P ROY SOC B-BIOL SCI, V265, P427, DOI 10.1098/rspb.1998.0312; Sherratt TN, 2001, BEHAV ECOL, V12, P313, DOI 10.1093/beheco/12.3.313; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; ZAHAVI A, 1995, J AVIAN BIOL, V26, P1, DOI 10.2307/3677205	28	252	259	0	139	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					975	978		10.1038/nature04755	http://dx.doi.org/10.1038/nature04755			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791194	Green Submitted			2022-12-24	WOS:000238422300041
J	Marinov, I; Gnanadesikan, A; Toggweiler, JR; Sarmiento, JL				Marinov, I; Gnanadesikan, A; Toggweiler, JR; Sarmiento, JL			The Southern Ocean biogeochemical divide	NATURE			English	Article							ATMOSPHERIC CO2; THERMOHALINE CIRCULATION; CARBON-DIOXIDE; HIGH-LATITUDE; MODELS; VENTILATION; THERMOCLINE; WATER; PUMP	Modelling studies have demonstrated that the nutrient and carbon cycles in the Southern Ocean play a central role in setting the air - sea balance of CO2 and global biological production(1-8). Box model studies(1-4) first pointed out that an increase in nutrient utilization in the high latitudes results in a strong decrease in the atmospheric carbon dioxide partial pressure (p(CO2)). This early research led to two important ideas: high latitude regions are more important in determining atmospheric p(CO2) than low latitudes, despite their much smaller area, and nutrient utilization and atmospheric p(CO2) are tightly linked. Subsequent general circulation model simulations show that the Southern Ocean is the most important high latitude region in controlling preindustrial atmospheric CO2 because it serves as a lid to a larger volume of the deep ocean(5,6). Other studies point out the crucial role of the Southern Ocean in the uptake and storage of anthropogenic carbon dioxide(7) and in controlling global biological production(8). Here we probe the system to determine whether certain regions of the Southern Ocean are more critical than others for air - sea CO2 balance and the biological export production, by increasing surface nutrient drawdown in an ocean general circulation model. We demonstrate that atmospheric CO2 and global biological export production are controlled by different regions of the Southern Ocean. The air - sea balance of carbon dioxide is controlled mainly by the biological pump and circulation in the Antarctic deep-water formation region, whereas global export production is controlled mainly by the biological pump and circulation in the Subantarctic intermediate and mode water formation region. The existence of this biogeochemical divide separating the Antarctic from the Subantarctic suggests that it may be possible for climate change or human intervention to modify one of these without greatly altering the other.	Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08540 USA; NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; National Oceanic Atmospheric Admin (NOAA) - USA	Marinov, I (corresponding author), MIT, Program Atmospheres Oceans & Climate, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	imarinov@mit.edu	Toggweiler, J. R./O-5883-2019; Gnanadesikan, Anand/A-2397-2008	Toggweiler, J. R./0000-0001-6345-5756; Gnanadesikan, Anand/0000-0001-5784-1116				Caldeira K, 2000, SCIENCE, V287, P620, DOI 10.1126/science.287.5453.620; Dutkiewicz S, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002342; Gnanadesikan A, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018036; Gnanadesikan A, 2001, DEEP-SEA RES PT II, V49, P363; Gordon A. L., 1971, ANTARCTIC RES SERIES, VI, DOI 10.1029/AR015p0169; Ito T, 2005, J MAR RES, V63, P813, DOI 10.1357/0022240054663231; JOOS F, 1991, NATURE, V349, P772, DOI 10.1038/349772a0; KNOX F, 1984, J GEOPHYS RES-ATMOS, V89, P4629, DOI 10.1029/JD089iD03p04629; Kohfeld KE, 2005, SCIENCE, V308, P74, DOI 10.1126/science.11053 75; MARINOV I, 2005, THESIS PRINCETON U; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Najjar R., 1998, DESIGN OCMIP 2 SIMUL; SARMIENTO JL, 1991, LIMNOL OCEANOGR, V36, P1928, DOI 10.4319/lo.1991.36.8.1928; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; SARMIENTO JL, 1984, NATURE, V308, P620; SCHMITZ WJ, 1995, REV GEOPHYS, V33, P151, DOI 10.1029/95RG00879; SIEGENTHALER U, 1984, NATURE, V308, P624, DOI 10.1038/308624a0; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Sloyan BM, 2001, J PHYS OCEANOGR, V31, P143, DOI 10.1175/1520-0485(2001)031<0143:TSOLOT>2.0.CO;2; Speer K, 2000, J PHYS OCEANOGR, V30, P3212, DOI 10.1175/1520-0485(2000)030<3212:TDDC>2.0.CO;2; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; Sverdrup H.U., 1942, OCEANS THEIR PHYS CH, P1065; TOGGWEILER JR, 1995, DEEP-SEA RES PT I, V42, P477, DOI 10.1016/0967-0637(95)00012-U; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; Toggweiler JR, 1999, PALEOCEANOGRAPHY, V14, P571, DOI 10.1029/1999PA900033; Toggweiler JR, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001841; TOGGWEILER JR, 1991, J GEOPHYS RES-OCEANS, V96, P20467, DOI 10.1029/91JC02063; WYRTKI K, 1961, DEEP-SEA RES, V8, P39, DOI 10.1016/0146-6313(61)90014-4	28	216	223	1	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 22	2006	441	7096					964	967		10.1038/nature04883	http://dx.doi.org/10.1038/nature04883			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791191				2022-12-24	WOS:000238422300038
J	Herbert, KM; La Porta, A; Wong, BJ; Mooney, RA; Neuman, KC; Landick, R; Block, SM				Herbert, Kristina M.; La Porta, Arthur; Wong, Becky J.; Mooney, Rachel A.; Neuman, Keir C.; Landick, Robert; Block, Steven M.			Sequence-resolved detecton of pausing by single RNA polymerase molecules	CELL			English	Article							TRANSCRIPTION ELONGATION; II ELONGATION; DNA HYBRID; IN-VIVO; TERMINATION; PROMOTER; SITE; REGULATOR; COMPLEXES; ARREST	Transcriptional pausing by RNA polymerase (RNAP) plays an important role in the regulation of gene expression. Defined, sequence-specific pause sites have been identified biochemically. Single-molecule studies have also shown that bacterial RNAP pauses frequently during transcriptional elongation, but the relationship of these "ubiquitous" pauses to the underlying DNA sequence has been uncertain. We employed an ultrastable optical-trapping assay to follow the motion of individual molecules of RNAP transcribing templates engineered with repeated sequences carrying imbedded, sequence-specific pause sites of known regulatory function. Both the known and ubiquitous pauses appeared at reproducible locations, identified with base-pair accuracy. Ubiquitous pauses were associated with DNA sequences that show similarities to regulatory pause sequences. Data obtained for the lifetimes and efficiencies of pauses support a model where the transition to pausing branches off of the normal elongation pathway and is mediated by a common elemental state, which corresponds to the ubiquitous pause.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Biophys Program, Stanford, CA 94305 USA; Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; Stanford University; University of Wisconsin System; University of Wisconsin Madison; Stanford University	Herbert, KM (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	sblock@stanford.edu	Neuman, Keir C./F-7400-2011; Herbert, Kristina/A-3105-2010	Neuman, Keir C./0000-0002-0863-5671; Herbert, Kristina/0000-0002-5288-3381	NIGMS NIH HHS [R01 GM057035] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057035] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Adelman K, 2002, P NATL ACAD SCI USA, V99, P13538, DOI 10.1073/pnas.212358999; AIVAZASHVILI V A, 1981, Molekulyarnaya Biologiya (Moscow), V15, P653; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; Bai L, 2004, J MOL BIOL, V344, P335, DOI 10.1016/j.jmb.2004.08.107; Bailey MJA, 1997, MOL MICROBIOL, V26, P845, DOI 10.1046/j.1365-2958.1997.6432014.x; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Chamberlin M., 1976, RNA POLYMERASE, V6, P193; CHAN CL, 1993, J MOL BIOL, V233, P25, DOI 10.1006/jmbi.1993.1482; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; DEMERCOYROL L, 1990, BIOCHEM J, V269, P651, DOI 10.1042/bj2690651; Erie DA, 2002, BBA-GENE STRUCT EXPR, V1577, P224, DOI 10.1016/S0167-4781(02)00454-2; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Foster JE, 2001, CELL, V106, P243, DOI 10.1016/S0092-8674(01)00420-2; Gorodkin J, 1997, COMPUT APPL BIOSCI, V13, P583; GU WG, 1995, J BIOL CHEM, V270, P11238, DOI 10.1074/jbc.270.19.11238; Harrington KJ, 2001, P NATL ACAD SCI USA, V98, P5019, DOI 10.1073/pnas.240431598; Henkin TM, 2002, BIOESSAYS, V24, P700, DOI 10.1002/bies.10125; KASSAVETIS GA, 1981, J BIOL CHEM, V256, P2777; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Kireeva ML, 2000, J MOL BIOL, V299, P325, DOI 10.1006/jmbi.2000.3755; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Kulish D, 2001, MOL CELL BIOL, V21, P4162, DOI 10.1128/MCB.21.13.4162-4168.2001; Landick R, 1996, ESCHERICHIA COLI SAL, P1263; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; NUDLER E, 1995, CELL, V81, P351, DOI 10.1016/0092-8674(95)90388-7; Palangat M, 1998, MOL CELL, V1, P1033, DOI 10.1016/S1097-2765(00)80103-3; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; Pasman Z, 2002, J MOL BIOL, V322, P505, DOI 10.1016/S0022-2836(02)00814-8; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; Richardson J. P., 1996, ESCHERICHIA COLI SAL, P822; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Shundrovsky A, 2004, BIOPHYS J, V87, P3945, DOI 10.1529/biophysj.104.044081; Tang HB, 2000, MOL CELL BIOL, V20, P2569, DOI 10.1128/MCB.20.7.2569-2580.2000; Tolic-Norrelykke SF, 2004, J BIOL CHEM, V279, P3292, DOI 10.1074/jbc.M310290200; Toulokhonov I, 2003, MOL CELL, V12, P1125, DOI 10.1016/S1097-2765(03)00439-8; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; von Hippel PH, 1998, SCIENCE, V281, P660, DOI 10.1126/science.281.5377.660; VONHIPPEL PH, 1991, P NATL ACAD SCI USA, V88, P2307, DOI 10.1073/pnas.88.6.2307; VONHIPPEL PH, 1992, SCIENCE, V255, P809, DOI 10.1126/science.1536005; WANG DG, 1995, CELL, V81, P341, DOI 10.1016/0092-8674(95)90387-9; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Yonaha M, 1999, MOL CELL, V3, P593, DOI 10.1016/S1097-2765(00)80352-4; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	49	221	232	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 16	2006	125	6					1083	1094		10.1016/j.cell.2006.04.032	http://dx.doi.org/10.1016/j.cell.2006.04.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777599	Bronze, Green Accepted			2022-12-24	WOS:000238602700014
J	Komatsu, M; Waguri, S; Chiba, T; Murata, S; Iwata, J; Tanida, I; Ueno, T; Koike, M; Uchiyama, Y; Kominami, E; Tanaka, K				Komatsu, Masaaki; Waguri, Satoshi; Chiba, Tomoki; Murata, Shigeo; Iwata, Jun-ichi; Tanida, Isei; Ueno, Takashi; Koike, Masato; Uchiyama, Yasuo; Kominami, Eiki; Tanaka, Keiji			Loss of autophagy in the central nervous system causes neurodegeneration in mice	NATURE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; CELL-DEATH; DISEASE; CARDIOMYOPATHY; IMPAIRMENT; PATHWAYS; HOMOLOG	Protein quality-control, especially the removal of proteins with aberrant structures, has an important role in maintaining the homeostasis of non-dividing neural cells(1). In addition to the ubiquitin-proteasome system, emerging evidence points to the importance of autophagy-the bulk protein degradation pathway involved in starvation-induced and constitutive protein turnover-in the protein quality-control process(2,3). However, little is known about the precise roles of autophagy in neurons. Here we report that loss of Atg7 (autophagy-related 7), a gene essential for autophagy, leads to neurodegeneration. We found that mice lacking Atg7 specifically in the central nervous system showed behavioural defects, including abnormal limb-clasping reflexes and a reduction in coordinated movement, and died within 28 weeks of birth. Atg7 deficiency caused massive neuronal loss in the cerebral and cerebellar cortices. Notably, polyubiquitinated proteins accumulated in autophagy-deficient neurons as inclusion bodies, which increased in size and number with ageing. There was, however, no obvious alteration in proteasome function. Our results indicate that autophagy is essential for the survival of neural cells, and that impairment of autophagy is implicated in the pathogenesis of neurodegenerative disorders involving ubiquitin-containing inclusion bodies.	Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan; Juntendo Univ, Sch Med, Dept Biochem, Bunkyo Ku, Tokyo 1138421, Japan; Osaka Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Suita, Osaka 5650871, Japan	Tokyo Metropolitan Institute of Medical Science; Juntendo University; Osaka University	Tanaka, K (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan.	tanakak@rinshoken.or.jp	Koike, Masato/F-9584-2010; Tanida, Isei/C-8277-2009; Kominami, Eiki/D-3802-2009; Komatsu, Masaaki/B-8321-2011; Murata, Shigeo/A-1426-2010	Koike, Masato/0000-0002-3174-5684; Komatsu, Masaaki/0000-0001-7672-7722; Murata, Shigeo/0000-0002-3177-3503; Tanida, Isei/0000-0001-8999-3990				Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Betz UAK, 1996, CURR BIOL, V6, P1307, DOI 10.1016/S0960-9822(02)70717-3; Bontekoe CJM, 2002, HUM MOL GENET, V11, P487, DOI 10.1093/hmg/11.5.487; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Fortun J, 2003, J NEUROSCI, V23, P10672; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Juhasz G, 2003, FEBS LETT, V543, P154, DOI 10.1016/S0014-5793(03)00431-9; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Koike M, 2003, MOL CELL NEUROSCI, V22, P146, DOI 10.1016/S1044-7431(03)00035-6; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; WAGURI S, 1995, EUR J CELL BIOL, V67, P308; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082	30	2716	2817	6	317	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					880	884		10.1038/nature04723	http://dx.doi.org/10.1038/nature04723			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16625205				2022-12-24	WOS:000238254100044
J	Davis, CS; McGillicuddy, DJ				Davis, Cabell S.; McGillicuddy, Dennis J., Jr.			Transatlantic abundance of the N-2-fixing colonial cyanobacterium Trichodesmium	SCIENCE			English	Article							NITROGEN-FIXATION; OSCILLATORIA TRICHODESMIUM; WESTERN SARGASSO; N-2 FIXATION; ATLANTIC; SPP.; THIEBAUTII; TAXA	Colonial diazotrophic cyanobacteria of the genus Trichodesmium are thought to play a significant role in the input of new nitrogen to upper layers of the tropical and subtropical oceanic ecosystems that cover nearly half of Earth's surface. Here we describe results of a transatlantic survey in which a noninvasive underwater digital microscope ( the video plankton recorder), was towed across the North Atlantic at 6 meters per second while undulating between the surface and 130 meters. Colony abundance had a basin-scale trend, a clear association with anticyclonic eddies, and was not affected by hurricane-forced mixing. Subsurface abundance was higher than previously reported, which has important implications for the global ocean nitrogen cycle.	Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; Woods Hole Oceanog Inst, Dept Appl Ocean Phys & Engn, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution	Davis, CS (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	cdavis@whoi.edu		McGillicuddy, Dennis/0000-0002-1437-2425				Capone DG, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002331; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Capone DG, 1998, MAR ECOL PROG SER, V172, P281, DOI 10.3354/meps172281; Carpenter E. J., 1983, NITROGEN MARINE ENV, P65; CARPENTER EJ, 1976, SCIENCE, V191, P1278, DOI 10.1126/science.1257749; Carpenter EJ, 2004, DEEP-SEA RES PT I, V51, P173, DOI 10.1016/j.dsr.2003.10.006; CARPENTER EJ, 1991, SCIENCE, V254, P1356, DOI 10.1126/science.254.5036.1356; CARPENTER EJ, 1995, MAR ECOL PROG SER, V118, P267, DOI 10.3354/meps118267; CARPENTER EJ, 1975, LIMNOL OCEANOGR, V20, P389, DOI 10.4319/lo.1975.20.3.0389; CARPENTER EJ, 1977, LIMNOL OCEANOGR, V22, P60, DOI 10.4319/lo.1977.22.1.0060; Chang J, 2000, J EXP MAR BIOL ECOL, V245, P215, DOI 10.1016/S0022-0981(99)00163-X; COLES VJ, 2004, J GEOPHYS RES-OCEANS, V109, P1; Davis CS, 2005, LIMNOL OCEANOGR-METH, V3, P59, DOI 10.4319/lom.2005.3.59; Davis CS, 2004, MAR ECOL PROG SER, V284, P77, DOI 10.3354/meps284077; DAVIS CS, 1992, SCIENCE, V257, P230, DOI 10.1126/science.257.5067.230; Falcon LI, 2004, APPL ENVIRON MICROB, V70, P765, DOI 10.1128/AEM.70.2.765-770.2004; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Hood R. R., 2004, J GEOPHYS RES, V109, P1; Hood RR, 2001, DEEP-SEA RES PT II, V49, P123; JENKINS WJ, 1988, NATURE, V331, P521, DOI 10.1038/331521a0; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; MCCARTHY JJ, 1979, J PHYCOL, V15, P75, DOI 10.1111/j.0022-3646.1979.00075.x; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; Orcutt KM, 2001, DEEP-SEA RES PT II, V48, P1583, DOI 10.1016/S0967-0645(00)00157-0; Post AF, 2002, MAR ECOL PROG SER, V239, P241, DOI 10.3354/meps239241; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; SATHYENDRANATH S, 1991, NATURE, V349, P54, DOI 10.1038/349054a0; Tyrrell T, 2003, J PLANKTON RES, V25, P405, DOI 10.1093/plankt/25.4.405	29	138	147	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 9	2006	312	5779					1517	1520		10.1126/science.1123570	http://dx.doi.org/10.1126/science.1123570			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050XT	16763148				2022-12-24	WOS:000238124100046
J	Stevens, LA; Coresh, J; Greene, T; Levey, AS				Stevens, Lesley A.; Coresh, Josef; Greene, Tom; Levey, Andrew S.			Medical progress - Assessing kidney function - Measured and estimated glomerular filtration rate	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CHRONIC RENAL-INSUFFICIENCY; COCKCROFT-GAULT EQUATIONS; SERUM CYSTATIN-C; CREATININE CLEARANCE; CARDIOVASCULAR-DISEASE; RISK-FACTOR; PREDICTIVE PERFORMANCE; PRACTICE GUIDELINES; ESTIMATING GFR; DIET		Tufts Univ New England Med Ctr, Div Nephrol, Boston, MA 02111 USA; Johns Hopkins Med Inst, Dept Epidemiol, Baltimore, MD 21205 USA; Cleveland Clin Fdn, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA	Tufts Medical Center; Johns Hopkins University; Johns Hopkins Medicine; Cleveland Clinic Foundation	Stevens, LA (corresponding author), Tufts Univ New England Med Ctr, Div Nephrol, 750 Washington St,Box 391, Boston, MA 02111 USA.	lstevens1@tufts-nemc.org			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK067651, R21DK067651, U01DK053869] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akbari A, 2004, ARCH INTERN MED, V164, P1788, DOI 10.1001/archinte.164.16.1788; Anavekar N, 2005, MED J AUSTRALIA, V183, P138, DOI 10.5694/j.1326-5377.2005.tb06958.x; [Anonymous], 2004, AM J KIDNEY DIS, V43, pS1; BERGLUND F, 1975, J UROLOGY, V114, P802, DOI 10.1016/S0022-5347(17)67149-0; Bokenkamp A, 1999, CLIN CHEM, V45, P1866; Bostom AG, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022011.35035.F3; *BRIT COL MIN HLTH, GUID PROT ADV COMM I; BROSIUS FC, IN PRESS CIRCULATION; Cameron JS, 1999, NEPHROL DIAL TRANSPL, V14, P61, DOI 10.1093/ndt/14.suppl_2.61; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cirillo M, 2005, NEPHROL DIAL TRANSPL, V20, P1791, DOI 10.1093/ndt/gfh962; Clase CM, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000013291.78621.26; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; Coresh J, 2004, CURR OPIN NEPHROL HY, V13, P73, DOI 10.1097/00041552-200401000-00011; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; Coresh J, 2002, J AM SOC NEPHROL, V13, P2811, DOI 10.1097/01.ASN.0000037420.89149.C9; Coresh J, 1998, AM J KIDNEY DIS, V32, P32, DOI 10.1053/ajkd.1998.v32.pm9669421; Coresh J, 2006, CURR OPIN NEPHROL HY, V15, P276, DOI 10.1097/01.mnh.0000222695.84464.61; Dharnidharka VR, 2002, AM J KIDNEY DIS, V40, P221, DOI 10.1053/ajkd.2002.34487; Fehrman-Ekholm I, 2004, SCAND J UROL NEPHROL, V38, P73, DOI 10.1080/00365590310015750; Filler G, 2003, PEDIATR NEPHROL, V18, P981, DOI 10.1007/s00467-003-1271-5; Finney H, 1997, CLIN CHEM, V43, P1016; Froissart M, 2005, J AM SOC NEPHROL, V16, P763, DOI 10.1681/ASN.2004070549; Gaspari F, 1998, J AM SOC NEPHROL, V9, P310; Gaspari F, 2004, AM J TRANSPLANT, V4, P1826, DOI 10.1111/j.1600-6143.2004.00579.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gonwa T, 2004, LIVER TRANSPLANT, V10, P301, DOI 10.1002/lt.20017; Grubb A, 2005, CLIN CHEM, V51, P1420, DOI 10.1373/clinchem.2005.051557; Grubb A, 2005, SCAND J CLIN LAB INV, V65, P153, DOI 10.1080/00365510510013596; Grubb A O, 2000, Adv Clin Chem, V35, P63; Hallan S, 2004, AM J KIDNEY DIS, V44, P84, DOI 10.1053/j.ajkd.2004.03.027; Ibrahim H, 2005, J AM SOC NEPHROL, V16, P1051, DOI 10.1681/ASN.2004080692; Jafar TH, 2005, J AM SOC NEPHROL, V16, P1413, DOI 10.1681/ASN.2004121100; Jafar TH, 2003, KIDNEY INT, V64, P1437, DOI 10.1046/j.1523-1755.2003.00212.x; Jones, 2000, AM J KIDNEY DIS, V35, P178; Keevil BG, 1998, CLIN CHEM, V44, P1535; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Kinchen KS, 2002, ANN INTERN MED, V137, P479, DOI 10.7326/0003-4819-137-6-200209170-00007; Knight EL, 2004, KIDNEY INT, V65, P1416, DOI 10.1111/j.1523-1755.2004.00517.x; Lamb EJ, 2003, J AM GERIATR SOC, V51, P1012, DOI 10.1046/j.1365-2389.2003.51330.x; Laterza OF, 2002, CLIN CHEM, V48, P699; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Levey AS, 2003, ANN INTERN MED, V139, P605, DOI 10.7326/0003-4819-139-7-200310070-00029; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; LEVEY AS, 1993, J AM SOC NEPHROL, V4, P1159; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LEVEY AS, 1990, KIDNEY INT, V38, P167, DOI 10.1038/ki.1990.182; Lewis J, 2001, AM J KIDNEY DIS, V38, P744, DOI 10.1053/ajkd.2001.27691; LEWIS J, 2002, AM J KIDNEY DIS, V39, P444; Lin J, 2005, J AM SOC NEPHROL, V16, P2814; Miller WG, 2005, ARCH PATHOL LAB MED, V129, P297; MOHANRAM A, 2005, CHRONIC KIDNEY DIS D, P20; Murthy K, 2005, KIDNEY INT, V68, P1884, DOI 10.1111/j.1523-1755.2005.00608.x; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; *NAT KID FOUND, 2004, AM J KIDNEY DIS, V42, pS1; *NAT KIDN DIS ED P, LAB PROF CREAT STAND; *NAT KIDN FDN, 2000, AM J KIDNEY DIS S, V35, pS56; NILSSONEHLE P, 1996, SCAND J CLIN LA S225, V56, P16; Obrador GT, 1999, J AM SOC NEPHROL, V10, P1793; Obrador GT, 1998, AM J KIDNEY DIS, V31, P398, DOI 10.1053/ajkd.1998.v31.pm9506677; PERRONE RD, 1990, AM J KIDNEY DIS, V16, P224, DOI 10.1016/S0272-6386(12)81022-5; Poge U, 2005, AM J TRANSPLANT, V5, P1306, DOI 10.1111/j.1600-6143.2005.00861.x; Poggio ED, 2005, J AM SOC NEPHROL, V16, P459, DOI 10.1681/ASN.2004060447; Poggio ED, 2005, AM J KIDNEY DIS, V46, P242, DOI 10.1053/j.ajkd.2005.04.023; *REN DAT SYST, 2001, 2001 ANN DAT REP ATL; Renal Data System, 2005, 2005 ANN DAT REP ATL; Rigalleau V, 2005, DIABETES CARE, V28, P838, DOI 10.2337/diacare.28.4.838; Ross JW, 1998, ARCH PATHOL LAB MED, V122, P587; ROUBENOFF R, 1990, ANN INTERN MED, V113, P501, DOI 10.7326/0003-4819-113-7-501; Rule, 2005, AM J KIDNEY DIS, V46, P170; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Rule AD, 2004, AM J KIDNEY DIS, V43, P112, DOI 10.1053/j.ajkd.2003.09.026; Sarnak MJ, 2005, ANN INTERN MED, V142, P497, DOI 10.7326/0003-4819-142-7-200504050-00008; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; SHEMESH O, 1985, KIDNEY INT, V28, P830, DOI 10.1038/ki.1985.205; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; SIEGEL N, 2003, RENAL EXPRESS; Sjostrom P, 2005, SCAND J CLIN LAB INV, V65, P111, DOI 10.1080/00365510510013523; Skluzacek PA, 2003, AM J KIDNEY DIS, V42, P1169, DOI 10.1053/j.ajkd.2003.08.017; SMITH HW, 1951, KIDNEY STRUCTURE FUN, P520; SOKOLL LJ, 1994, CLIN CHEM, V40, P2276; Stevens LA, 2005, NEW ENGL J MED, V352, P2122, DOI 10.1056/NEJMe058035; Stevens LA, 2005, MED CLIN N AM, V89, P457, DOI 10.1016/j.mcna.2004.11.009; STEVENS LA, 2004, FREQUENTLY ASKED QUE; Verhave JC, 2005, AM J KIDNEY DIS, V46, P233, DOI 10.1053/j.ajkd.2005.05.011; Vervoort G, 2002, NEPHROL DIAL TRANSPL, V17, P1909, DOI 10.1093/ndt/17.11.1909; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Wesson LG., 1969, PHYSL HUMAN KIDNEY; Wolf G, 2002, AM J KIDNEY DIS, V39, P1, DOI 10.1053/ajkd.2002.29865; Zuo L, 2005, AM J KIDNEY DIS, V45, P463, DOI 10.1053/j.ajkd.2004.11.012	92	2103	2187	6	130	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2006	354	23					2473	2483		10.1056/NEJMra054415	http://dx.doi.org/10.1056/NEJMra054415			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	050PQ	16760447				2022-12-24	WOS:000238100800009
J	Wilme, L; Goodman, SM; Ganzhorn, JU				Wilme, L; Goodman, SM; Ganzhorn, JU			Biogeographic evolution of Madagascar's microendemic biota	SCIENCE			English	Article							LEMURS	The endemic species richness on Madagascar, relative to landmass area, is unparalleled in the world. Many organisms on the island have restricted geographical ranges. A comprehensive hypothesis explaining the evolution of this microendemism has yet to be developed. Using an analysis of watersheds in the context of Quaternary climatic shifts, we provide a new mechanistic model to explain the process of explosive speciation on the island. River catchments with sources at relatively low elevations were zones of isolation and hence led to the speciation of locally endemic taxa, whereas those at higher elevations were zones of retreat and dispersion and hence contain proportionately lower levels of microendemism. These results provide a framework for biogeographic and phylogeographic studies, as well as a basis for prioritizing conservation actions of the remaining natural forest habitats on the island.	Field Museum Nat Hist, Chicago, IL 60605 USA; Missouri Bot Garden, Antananarivo 101, Madagascar; WWF, Antananarivo 101, Madagascar; Univ Hamburg, Dept Anim Ecol & Conservat, D-20146 Hamburg, Germany	Field Museum of Natural History (Chicago); Missouri Botanical Gardens; World Wildlife Fund; University of Hamburg	Goodman, SM (corresponding author), Field Museum Nat Hist, 1400 S Lake Shore Dr, Chicago, IL 60605 USA.	sgoodman@fieldmuseum.org	Wilmé, Lucienne/A-3818-2016; Wilmé, Lucienne/AAQ-6653-2020; Ganzhorn, Joerg/AAO-6955-2020	Wilmé, Lucienne/0000-0002-8344-1957; Wilmé, Lucienne/0000-0002-8344-1957; Ganzhorn, Joerg/0000-0003-1395-9758				Andreone F, 2005, MOL PHYLOGENET EVOL, V34, P315, DOI 10.1016/j.ympev.2004.10.013; [Anonymous], 2003, NATURAL HIST MADAGAS; Burney DA, 2004, J HUM EVOL, V47, P25, DOI 10.1016/j.jhevol.2004.05.005; Burney David A., 1997, P75; Goodman SM, 2004, J BIOGEOGR, V31, P47, DOI 10.1111/j.1365-2699.2004.00953.x; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hughen KA, 2004, SCIENCE, V304, P1955, DOI 10.1126/science.1092995; Krause David W., 1997, P3; Lynch-Stieglitz J, 2004, SCIENCE, V304, P1919, DOI 10.1126/science.1100374; MARTIN RD, 1972, PHILOS T ROY SOC B, V264, P295, DOI 10.1098/rstb.1972.0013; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Poux C, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234534; Rasoloarison RM, 2000, INT J PRIMATOL, V21, P963, DOI 10.1023/A:1005511129475; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; STOREY M, 1995, SCIENCE, V267, P852, DOI 10.1126/science.267.5199.852; Straka H, 1996, COLLOQ SEMI, P37; Thalmann Urs, 2000, P191; *WORLD CONS UN IUC, 2005, P 5 IUCN WORLD WORLD, P25; Yoder AD, 2005, P NATL ACAD SCI USA, V102, P6587, DOI 10.1073/pnas.0502092102	21	316	328	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1063	1065		10.1126/science.1122806	http://dx.doi.org/10.1126/science.1122806			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16709785				2022-12-24	WOS:000237628800048
J	Berman, E; Nicolaides, M; Maki, RG; Fleisher, M; Chanel, S; Scheu, K; Wilson, BA; Heller, G; Sauter, NP				Berman, E; Nicolaides, M; Maki, RG; Fleisher, M; Chanel, S; Scheu, K; Wilson, BA; Heller, G; Sauter, NP			Altered bone and mineral metabolism in patients receiving imatinib mesylate	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MYELOID-LEUKEMIA; PDGF-BB; RESORPTION; CELLS	BACKGROUND: Imatinib mesylate inhibits several tyrosine kinases, including BCR-ABL, the C-KIT receptor, and the platelet-derived growth factor receptors (alpha) and (beta), all of which are associated with disease. We observed that hypophosphatemia developed in some patients with either chronic myelogenous leukemia or gastrointestinal stromal tumors who were receiving imatinib. METHODS: We identified 16 patients who had low serum phosphate levels and 8 patients who had normal serum phosphate levels, all of whom were receiving imatinib. We performed the following biochemical measurements: whole-blood levels of ionized calcium, plasma levels of intact parathyroid hormone, and serum levels of total calcium, phosphate, 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, magnesium, and markers of bone formation (bone alkaline phosphatase and osteocalcin) and bone resorption (N-telopeptide of collagen cross-links); urinalysis; and phosphate, calcium, and creatinine levels in ``spot'' urine specimens. RESULTS: Patients in the low-phosphate group (median serum phosphate level, 2.0 mg per deciliter [0.6 mmol per liter]; normal level, >2.5 mg per deciliter [0.8 mmol per liter]) had elevated parathyroid hormone levels and low-to-normal serum calcium levels, were younger, and were receiving a higher dose of imatinib than patients in the normal-phosphate group (median level, 3.2 mg per deciliter [1.0 mmol per liter]). Both groups had high levels of phosphate excreted in the urine and markedly decreased serum levels of osteocalcin and N-telopeptide of collagen cross-links. CONCLUSIONS: Hypophosphatemia, with associated changes in bone and mineral metabolism, develops in a proportion of patients taking imatinib for either chronic myelogenous leukemia or gastrointestinal stromal tumors. The drug may inhibit bone remodeling (formation and resorption), even in patients with normal serum phosphate levels.	Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Clin Labs, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Berman, E (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA.	bermane@mskcc.org	Maki, Robert G./AAI-2793-2020; Maki, Robert G/J-9145-2019	Maki, Robert G/0000-0002-9853-2528				BOUILLON R, 1975, J CLIN ENDOCR METAB, V41, P1130, DOI 10.1210/jcem-41-6-1130; Brame LA, 2004, SEMIN NEPHROL, V24, P39, DOI 10.1053/j.semnephrol.2003.08.016; Chaudhary LR, 2001, J CELL BIOCHEM, V81, P304, DOI 10.1002/1097-4644(20010501)81:2<304::AID-JCB1045>3.3.CO;2-L; DAbrera H.J, 1975, NONPARAMETRICS STAT; Dewar AL, 2005, BLOOD, V105, P3127, DOI 10.1182/blood-2004-10-3967; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Efron Bradley., 1994, INTRO BOOTSTRAP; El-Hajj Fuleihan G, 1997, J CLIN ENDOCR METAB, V82, P281, DOI 10.1210/jc.82.1.281; Fiedler J, 2004, J CELL BIOCHEM, V93, P990, DOI 10.1002/jcb.20219; Gertz BJ, 1998, CALCIFIED TISSUE INT, V63, P102, DOI 10.1007/s002239900497; Gottardi M, 2005, NEW ENGL J MED, V353, P2722, DOI 10.1056/NEJMc052500; HALEVY J, 1988, ARCH INTERN MED, V148, P153, DOI 10.1001/archinte.148.1.153; Hannon R, 2000, OSTEOPOROSIS INT, V11, P30, DOI 10.1007/s001980070004; Herbst RS, 2006, J CLIN ONCOL, V24, P190, DOI 10.1200/JCO.2005.04.8678; HICKEY L, 2004, CURR OPIN ENDOCRINOL, V11, P18, DOI DOI 10.1097/00060793-200402000-00006; HOCK JM, 1994, ENDOCRINOLOGY, V134, P1423, DOI 10.1210/en.134.3.1423; Kronenberg HM, 2002, NEW ENGL J MED, V347, P1022, DOI 10.1056/NEJMe020098; Liu F, 2003, J CELL SCI, V116, P1787, DOI 10.1242/jcs.00376; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Mitlak BH, 1996, J BONE MINER RES, V11, P238; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; SHAYMAN JA, 1995, RENAL PATHOPHYSIOLOG, P27; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; WIKTORJEDRZEJCZAK W, 1991, P NATL ACAD SCI USA, V88, P5937; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Zhang ZM, 1998, BIOCHEM BIOPH RES CO, V251, P190, DOI 10.1006/bbrc.1998.9412	27	224	229	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2006	354	19					2006	2013		10.1056/NEJMoa051140	http://dx.doi.org/10.1056/NEJMoa051140			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040XA	16687713				2022-12-24	WOS:000237413100005
J	Holtz, TH; Sternberg, M; Kammerer, S; Laserson, KF; Riekstina, V; Zarovska, E; Skripconoka, V; Wells, CD; Leimane, V				Holtz, TH; Sternberg, M; Kammerer, S; Laserson, KF; Riekstina, V; Zarovska, E; Skripconoka, V; Wells, CD; Leimane, V			Time to sputum culture conversion in multidrug-resistant tuberculosis: Predictors and relationship to treatment outcome	ANNALS OF INTERNAL MEDICINE			English	Article							PULMONARY TUBERCULOSIS; EXPERIENCE; RIFAMPIN; LATVIA	Background: Conversion of sputum mycobacterial cultures from positive growth to negative growth of Mycobacterium tuberculosis in patients with pulmonary tuberculosis (TB) is considered the most important interim indicator of the efficacy of anti-TB pharmacologic treatment for multidrug-resistant disease. Objective: To evaluate and compare time to and predictors of initial sputum culture conversion with predictors of treatment outcome for patients with multidrug-resistant TB. Design: Retrospective cohort study. Setting: Latvia. Patients: All civilian patients with multidrug-resistant TB treated with the DOTS-Plus strategy between 1 January and 31 December 2000. Intervention: Individualized treatment for confirmed sputum culture-positive pulmonary multidrug-resistant TB. Measurements: Time to initial sputum culture conversion and treatment outcome. Results: Among 167 patients who were sputum culture-positive at initiation of second-line therapy, 129 (77%) converted in a median time of 60 days (range, 4 to 462 days) and 38 (23%) did not convert. independent predictors of a longer sputum culture conversion time, using an accelerated failure time regression model, included previous treatment for multidrug-resistant TB, high initial sputum culture colony count, bilateral cavitations on chest radiography, and the number of drugs the initial isolate was resistant to at treatment initiation. Treatment outcomes were statistically significantly worse for patients who did not convert their sputum culture within 2 months. Limitations: Twenty-five percent of patients missed 5 or more monthly sputum collections. Conclusions: Under program conditions in Latvia, most patents with multidrug-resistant TB achieved sputum culture conversion within 12 weeks of starting treatment. Chest radiography and sputum culture drug susceptibility testing can assist physicians in predicting which patients will convert more slowly. Sputum culture conversion is a useful and appropriate interim indicator of treatment outcome in patients with multidrug-resistant TB.	Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30333 USA; State Agcy TB & Lung Dis, Riga, Latvia	Centers for Disease Control & Prevention - USA	Holtz, TH (corresponding author), Ctr Dis Control & Prevent, Div TB Eliminat, 1600 Clifton Rd NE,MS E-10, Atlanta, GA 30333 USA.	tholtz@cdc.gov			PHS HHS [U23 CCU021873] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		*AM SOC SOC, 2003, MMWR MORB MORAL WKLY, V52; Bailey KV, 1995, B WORLD HEALTH ORGAN, V73, P673; Chan ED, 2004, AM J RESP CRIT CARE, V169, P1103, DOI 10.1164/rccm.200308-1159OC; Dominguez-Castellano A, 2003, INT J TUBERC LUNG D, V7, P432; GOBLE M, 1993, NEW ENGL J MED, V328, P527, DOI 10.1056/NEJM199302253280802; Johansen IS, 2003, INT J TUBERC LUNG D, V7, P899; Kim HJ, 2001, INT J TUBERC LUNG D, V5, P1129; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Liu ZY, 1999, ARCH INTERN MED, V159, P1110, DOI 10.1001/archinte.159.10.1110; Maranetra KN, 1999, CHEMOTHERAPY, V45, P12, DOI 10.1159/000048477; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Mukherjee JS, 2004, LANCET, V363, P474, DOI 10.1016/S0140-6736(04)15496-2; Narita M, 2001, CHEST, V120, P343, DOI 10.1378/chest.120.2.343; Organization WH, 1997, WHOTB97229; Park SK, 1998, INT J TUBERC LUNG D, V2, P877; Skenders G, 2005, EMERG INFECT DIS, V11, P1461, DOI 10.3201/eid1109.041236; Suo J, 1996, CHEMOTHERAPY, V42, P20, DOI 10.1159/000239510; Tahaoglu K, 2001, NEW ENGL J MED, V345, P170, DOI 10.1056/NEJM200107193450303; Telzak EE, 1997, CLIN INFECT DIS, V25, P666, DOI 10.1086/513772; *WHO, 2000, WHOCDSTB2000278; *WHO, 2002, WHOCDSTB2002307; *WHO, 2005, WHOHTMTB2004343; *WHO, 2000, WHOCDSTB2000279 GEN; World Health Organization, 2003, TREATM TUB GUID NAT; World Health Organization, 2010, GUIDELINES TREATMENT, V4; Yew WW, 2003, CHEST, V124, P1476, DOI 10.1378/chest.124.4.1476	27	163	170	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 2	2006	144	9					650	659		10.7326/0003-4819-144-9-200605020-00008	http://dx.doi.org/10.7326/0003-4819-144-9-200605020-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	039GJ	16670134				2022-12-24	WOS:000237293700004
J	Sun, L; Peng, Y; Sharrow, AC; Iqbal, J; Zhang, Z; Papachristou, DJ; Zaidi, S; Zhu, LL; Yaroslavskiy, BB; Zhou, H; Zallone, A; Sairam, MR; Kumar, TR; Bo, W; Braun, J; Cardoso-Landa, L; Schaffler, MB; Moonga, BS; Blair, HC; Zaidi, M				Sun, L; Peng, Y; Sharrow, AC; Iqbal, J; Zhang, Z; Papachristou, DJ; Zaidi, S; Zhu, LL; Yaroslavskiy, BB; Zhou, H; Zallone, A; Sairam, MR; Kumar, TR; Bo, W; Braun, J; Cardoso-Landa, L; Schaffler, MB; Moonga, BS; Blair, HC; Zaidi, M			FSH directly regulates bone mass	CELL			English	Article							FOLLICLE-STIMULATING-HORMONE; OSTEOCLAST FORMATION; ESTROGEN DEFICIENCY; CD38/ADP-RIBOSYL CYCLASE; BIOCHEMICAL MARKERS; RECEPTOR FUNCTION; TURNOVER MARKERS; MENSTRUAL-CYCLE; FEMALE MICE; IN-VITRO	Postmenopausal osteoporosis, a global public health problem, has for decades been attributed solely to declining estrogen levels. Although FSH levels rise sharply in parallel, a direct effect of FSH on the skeleton has never been explored. We show that FSH is required for hypogonadal bone loss. Neither FSH beta nor FSH receptor (FSHR) null mice have bone loss despite severe hypogonadism. Bone mass is increased and osteoclastic resorption is decreased in haploin-sufficient FSHD+/- mice with normal ovarian function, suggesting that the skeletal action of FSH is estrogen independent. Osteoclasts and their precursors possess G(i2 alpha)-COupled FSHRs that activate MEK/Erk, NF-kappa B, and Akt to result in enhanced osteoclast formation and function. We suggest that high circulating FSH causes hypogonadal bone loss.	Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA; CUNY Mt Sinai Sch Med, Dept Med, Mt Sinai Bone Program, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Orthopaed, New York, NY 10029 USA; VA Med Ctr, Pittsburgh, PA 15261 USA; Univ Bari, Dept Anat & Histol, I-70124 Bari, Italy; Clin Res Inst Montreal, Montreal, PQ H2W 1R7, Canada; Univ Kansas, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90095 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Universita degli Studi di Bari Aldo Moro; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Kansas; University of California System; University of California Los Angeles	Blair, HC (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA.	hcblair@imap.upitt.edu; mone.zaidi@mssm.edu	Cardoso, Luis/F-1234-2013	Cardoso, Luis/0000-0002-2252-7802; Sharrow, Allison/0000-0002-4611-6020; Braun, Jonathan/0000-0003-1646-2974	NIAMS NIH HHS [R01 AR041210, AR41010, AR47700] Funding Source: Medline; NIA NIH HHS [AG23176, AG12951, AG14907] Funding Source: Medline; NIDDK NIH HHS [DK70526] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047700, R01AR041210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012951, R03AG014907, R01AG023176] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abe E, 2003, CELL, V115, P151, DOI 10.1016/S0092-8674(03)00771-2; Abe E, 2000, J BONE MINER RES, V15, P663, DOI 10.1359/jbmr.2000.15.4.663; Blair HC, 2004, J BONE MINER RES, V19, P1329, DOI 10.1359/JBMR.040403; Britt KL, 2001, J STEROID BIOCHEM, V79, P181, DOI 10.1016/S0960-0760(01)00158-3; Cenci S, 2003, P NATL ACAD SCI USA, V100, P10405, DOI 10.1073/pnas.1533207100; Chiu KM, 1999, J BONE MINER RES, V14, P609, DOI 10.1359/jbmr.1999.14.4.609; CLAYTON RN, 1993, HUM REPROD, V8, P29, DOI 10.1093/humrep/8.suppl_2.29; Conti M, 2002, BIOL REPROD, V67, P1653, DOI 10.1095/biolreprod.102.004952; Couse JF, 2003, MOL ENDOCRINOL, V17, P1039, DOI 10.1210/me.2002-0398; Crepieux P, 2001, ONCOGENE, V20, P4696, DOI 10.1038/sj.onc.1204632; Danilovich N, 2000, ENDOCRINOLOGY, V141, P4295, DOI 10.1210/en.141.11.4295; Devleta B, 2004, J BONE MINER METAB, V22, P360, DOI 10.1007/s00774-004-0495-1; Dierich A, 1998, P NATL ACAD SCI USA, V95, P13612, DOI 10.1073/pnas.95.23.13612; GORAI I, 1995, CALCIFIED TISSUE INT, V57, P100, DOI 10.1007/BF00298428; Kawai Haruko, 2004, Archives of Gynecology and Obstetrics, V269, P192; Khosla S, 1998, J CLIN ENDOCR METAB, V83, P2266, DOI 10.1210/jc.83.7.2266; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Lindberg MK, 2001, J ENDOCRINOL, V171, P229, DOI 10.1677/joe.0.1710229; Lindsay R, 2004, ENDOCRINE, V24, P223, DOI 10.1385/ENDO:24:3:223; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; McCauley LK, 2002, CRIT REV EUKAR GENE, V12, P89, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i2.10; MINEGISH T, 1991, BIOCHEM BIOPH RES CO, V175, P1125, DOI 10.1016/0006-291X(91)91682-3; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; Oz OK, 2000, J BONE MINER RES, V15, P507, DOI 10.1359/jbmr.2000.15.3.507; Oz OK, 2001, J STEROID BIOCHEM, V79, P49, DOI 10.1016/S0960-0760(01)00130-3; PACE AM, 1995, MOL BIOL CELL, V6, P1685, DOI 10.1091/mbc.6.12.1685; PADMANABHAN V, 1989, J CLIN ENDOCR METAB, V69, P968, DOI 10.1210/jcem-69-5-968; Prior JC, 1998, ENDOCR REV, V19, P397, DOI 10.1210/er.19.4.397; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Robker RL, 1998, BIOL REPROD, V59, P476, DOI 10.1095/biolreprod59.3.476; Roggia C, 2001, P NATL ACAD SCI USA, V98, P13960, DOI 10.1073/pnas.251534698; Sairam M. R., 1999, ENCYC REPROD, P552; Sairam MR, 1996, BIOCHEM BIOPH RES CO, V226, P717, DOI 10.1006/bbrc.1996.1419; Saltarelli D, 1999, CELL SIGNAL, V11, P415, DOI 10.1016/S0898-6568(99)00012-1; Shevde NK, 2000, P NATL ACAD SCI USA, V97, P7829, DOI 10.1073/pnas.130200197; Sowers MR, 2003, OSTEOPOROSIS INT, V14, P191, DOI 10.1007/s00198-002-1329-4; Srivastava S, 2001, J BIOL CHEM, V276, P8836, DOI 10.1074/jbc.M010764200; STEPNICK LS, 2004, BONE HLTH OSTEOPOROS, P68; Sun L, 1999, J CELL BIOL, V146, P1161, DOI 10.1083/jcb.146.5.1161; Sun L, 2003, FASEB J, V17, P369, DOI 10.1096/fj.02-0205com; Sun L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0705com; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Windahl SH, 2002, TRENDS ENDOCRIN MET, V13, P195, DOI 10.1016/S1043-2760(02)00594-5; Wu XB, 2003, J CLIN INVEST, V112, P924, DOI 10.1172/JCI200315543; Yeh JK, 1997, BONE, V20, P413, DOI 10.1016/S8756-3282(97)00027-6; Yeh JK, 1996, BONE, V18, P443, DOI 10.1016/8756-3282(96)00045-2; ZAIDI M, 1993, BIOL REV, V68, P197, DOI 10.1111/j.1469-185X.1993.tb00996.x; Zhu LL, 2005, BIOCHEM BIOPH RES CO, V326, P131, DOI 10.1016/j.bbrc.2004.10.212; Zittermann A, 2000, J CLIN ENDOCR METAB, V85, P95, DOI 10.1210/jc.85.1.95	50	489	552	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					247	260		10.1016/j.cell.2006.01.051	http://dx.doi.org/10.1016/j.cell.2006.01.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630814	Bronze			2022-12-24	WOS:000237241500016
J	Clayton, TA; Lindon, JC; Cloarec, O; Antti, H; Charuel, C; Hanton, G; Provost, JP; Le Net, JL; Baker, D; Walley, RJ; Everett, JR; Nicholson, JK				Clayton, TA; Lindon, JC; Cloarec, O; Antti, H; Charuel, C; Hanton, G; Provost, JP; Le Net, JL; Baker, D; Walley, RJ; Everett, JR; Nicholson, JK			Pharmaco-metabonomic phenotyping and personalized drug treatment	NATURE			English	Article							URINARY-EXCRETION; ACETAMINOPHEN; SPECTROSCOPY; VARIABILITY; TAURINE; SYSTEMS	There is a clear case for drug treatments to be selected according to the characteristics of an individual patient, in order to improve efficacy and reduce the number and severity of adverse drug reactions(1,2). However, such personalization of drug treatments requires the ability to predict how different individuals will respond to a particular drug/dose combination. After initial optimism, there is increasing recognition of the limitations of the pharmacogenomic approach, which does not take account of important environmental influences on drug absorption, distribution, metabolism and excretion(3-5). For instance, a major factor underlying inter-individual variation in drug effects is variation in metabolic phenotype, which is influenced not only by genotype but also by environmental factors such as nutritional status, the gut microbiota, age, disease and the co- or pre-administration of other drugs(6,7). Thus, although genetic variation is clearly important, it seems unlikely that personalized drug therapy will be enabled for a wide range of major diseases using genomic knowledge alone. Here we describe an alternative and conceptually new 'pharmaco-metabonomic' approach to personalizing drug treatment, which uses a combination of pre-dose metabolite profiling and chemometrics to model and predict the responses of individual subjects. We provide proof-of-principle for this new approach, which is sensitive to both genetic and environmental influences, with a study of paracetamol (acetaminophen) administered to rats. We show pre-dose prediction of an aspect of the urinary drug metabolite profile and an association between pre-dose urinary composition and the extent of liver damage sustained after paracetamol administration.	Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Biomed Sci, London SW7 2AZ, England; Umea Univ, Dept Chem, S-90187 Umea, Sweden; Pfizer Global Res & Dev, Ctr Rech, F-37401 Amboise, France; Pfizer Inc, Ann Arbor, MI 48105 USA; Pfizer Ltd, Global Res & Dev, Sandwich CT13 9NJ, Kent, England	Imperial College London; Umea University; Pfizer; Pfizer; Pfizer	Nicholson, JK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, Div Biomed Sci, Sir Alexander Fleming Bldg, London SW7 2AZ, England.	j.nicholson@imperial.ac.uk	Nicholson, Jeremy K/B-3395-2012; Everett, Jeremy/B-5613-2012	Nicholson, Jeremy K/0000-0002-8123-8349; Everett, Jeremy/0000-0003-1550-4482; Lindon, John/0000-0002-0916-6360; Walley, Rosalind/0000-0002-4990-2377	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BALES JR, 1984, CLIN CHEM, V30, P1631; Claridge T. D. W., 1999, TETR ORG CH, V19, P285; Cloarec O, 2005, ANAL CHEM, V77, P1282, DOI 10.1021/ac048630x; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; COOMES MW, 1997, TXB BIOCH CLIN CORRE, P473; Grant DM, 2004, BRIT J CLIN PHARMACO, V58, pS788, DOI 10.1111/j.1365-2125.2004.02297.x; GREGUS Z, 1988, J PHARMACOL EXP THER, V244, P91; Ingelman-Sundberg M, 2001, TOXICOL LETT, V120, P259, DOI 10.1016/S0378-4274(01)00278-8; Lenz EM, 2004, J PHARMACEUT BIOMED, V36, P841, DOI 10.1016/j.jpba.2004.08.002; Lindon JC, 2005, PHARMACOGENOMICS, V6, P691, DOI 10.2217/14622416.6.7.691; Lindon JC, 2000, CONCEPT MAGNETIC RES, V12, P289, DOI 10.1002/1099-0534(2000)12:5<289::AID-CMR3>3.0.CO;2-W; Liu L, 1996, TOXICOL APPL PHARM, V139, P128, DOI 10.1006/taap.1996.0151; Nebert Daniel W, 2003, Am J Pharmacogenomics, V3, P361, DOI 10.2165/00129785-200303060-00002; Nicholls AW, 2003, CHEM RES TOXICOL, V16, P1395, DOI 10.1021/tx0340293; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Pagliarulo Vincenzo, 2002, Current Issues in Molecular Biology, V4, P101; Rang H.P., 1995, PHARMACOLOGY; Rawson ES, 2002, ACTA PHYSIOL SCAND, V174, P57, DOI 10.1046/j.1365-201x.2002.00924.x; Shockcor John P., 2002, Current Topics in Medicinal Chemistry, V2, P35, DOI 10.2174/1568026023394498; SMITH JL, 1994, TOXICOL APPL PHARM, V125, P296, DOI 10.1006/taap.1994.1076; Spear BB, 2001, TRENDS MOL MED, V7, P201, DOI 10.1016/S1471-4914(01)01986-4; Tannock G.W., 1995, NORMAL MICROFLORA IN; TIMBRELL JA, 1995, GEN PHARMACOL-VASC S, V26, P453, DOI 10.1016/0306-3623(94)00203-Y; van Aken Jan, 2003, Am J Pharmacogenomics, V3, P149, DOI 10.2165/00129785-200303030-00001; WATERFIELD CJ, 1993, TOXICOLOGY, V77, P1, DOI 10.1016/0300-483X(93)90132-C; Waters E, 2001, AM J PHYSIOL-GASTR L, V280, pG1274, DOI 10.1152/ajpgi.2001.280.6.G1274; Zoratti R, 1998, EUR J EPIDEMIOL, V14, P9, DOI 10.1023/A:1007492202045; Zuppi C, 1997, CLIN CHIM ACTA, V265, P85, DOI 10.1016/S0009-8981(97)00110-1	30	631	687	6	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2006	440	7087					1073	1077		10.1038/nature04648	http://dx.doi.org/10.1038/nature04648			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16625200	Green Accepted			2022-12-24	WOS:000236906000041
J	Ober, EA; Verkade, H; Field, HA; Stainier, DYR				Ober, Elke A.; Verkade, Heather; Field, Holly A.; Stainier, Didier Y. R.			Mesodermal Wnt2b signalling positively regulates liver specification	NATURE			English	Article							WNT/BETA-CATENIN; ENDODERM; MORPHOGENESIS; GROWTH; GENE; ZEBRAFISH; ORGANOGENESIS; EXPRESSION; INITIATION; INDUCTION	Endodermal organs such as the lung, liver and pancreas emerge at precise locations along the primitive gut tube. Although several signalling pathways have been implicated in liver formation(1,2), so far no single gene has been identified that exclusively regulates liver specification. In zebrafish, the onset of liver specification is marked by the localized endodermal expression of hhex and prox1 at 22 hours post fertilization. Here we used a screen for mutations affecting endodermal organ morphogenesis to identify a unique phenotype: prometheus ( prt) mutants exhibit profound, though transient, defects in liver specification. Positional cloning reveals that prt encodes a previously unidentified Wnt2b homologue. prt/ wnt2bb is expressed in restricted bilateral domains in the lateral plate mesoderm directly adjacent to the liver- forming endoderm. Mosaic analyses show the requirement for Prt/ Wnt2bb in the lateral plate mesoderm, in agreement with the inductive properties of Wnt signalling. Taken together, these data reveal an unexpected positive role for Wnt signalling in liver specification, and indicate a possible common theme for the localized formation of endodermal organs along the gut tube.	Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Program Genet & Human Genet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ober, EA (corresponding author), Natl Inst Med Res, Div Dev Biol, Mill Hill, London NW7 1AA, England.	eober@nimr.mrc.ac.uk; didier_stainier@biochem.ucsf.edu	Verkade, Heather/J-2401-2013	Ober, Elke/0000-0002-5195-1012; Stainier, Didier/0000-0002-0382-0026; Verkade, Heather/0000-0002-2817-0509				Bort R, 2004, DEVELOPMENT, V131, P797, DOI 10.1242/dev.00965; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Finley KR, 2003, GENE EXPR PATTERNS, V3, P681, DOI 10.1016/S1567-133X(03)00091-7; FUKUDATAIRA S, 1981, J EMBRYOL EXP MORPH, V63, P111; Holtzinger A, 2005, DEVELOPMENT, V132, P4005, DOI 10.1242/dev.01978; Horne-Badovinac S, 2003, SCIENCE, V302, P662, DOI 10.1126/science.1085397; Hussain SZ, 2004, EXP CELL RES, V292, P157, DOI 10.1016/j.yexcr.2003.08.020; Jasoni C, 1999, DEV DYNAM, V215, P215, DOI 10.1002/(SICI)1097-0177(199907)215:3<215::AID-AJA4>3.0.CO;2-W; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; Kumar M, 2003, DEV BIOL, V259, P109, DOI 10.1016/S0012-1606(03)00183-0; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Landesman Y, 1997, MECH DEVELOP, V63, P199, DOI 10.1016/S0925-4773(97)00041-5; LEDOUARIN NM, 1975, MED BIOL, V53, P427; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lemaigre F, 2004, CURR OPIN GENET DEV, V14, P582, DOI 10.1016/j.gde.2004.08.004; Lewis JL, 2004, DEVELOPMENT, V131, P1299, DOI 10.1242/dev.01007; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; McBride HJ, 2003, DEV BIOL, V256, P18, DOI 10.1016/S0012-1606(02)00118-5; Monga SPS, 2001, HEPATOLOGY, V33, P1098, DOI 10.1053/jhep.2001.23786; Ng JK, 2002, DEVELOPMENT, V129, P5161; Pilcher Karen E., 2002, Gene Expression Patterns, V2, P369, DOI 10.1016/S1567-133X(02)00023-6; Roberts DJ, 1998, DEVELOPMENT, V125, P2791; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Suksaweang S, 2004, DEV BIOL, V266, P109, DOI 10.1016/j.ydbio.2003.10.010; Theodosiou NA, 2003, DEV BIOL, V259, P258, DOI 10.1016/S0012-1606(03)00185-4; Wells JM, 2000, DEVELOPMENT, V127, P1563; Zakin LDJ, 1998, MECH DEVELOP, V73, P107, DOI 10.1016/S0925-4773(98)00040-9; Zhao R, 2005, HEPATOLOGY, V41, P956, DOI 10.1002/hep.20691; Zorn AM, 1999, DEV BIOL, V209, P282, DOI 10.1006/dbio.1999.9257	30	266	273	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2006	442	7103					688	691		10.1038/nature04888	http://dx.doi.org/10.1038/nature04888			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UU	16799568				2022-12-24	WOS:000239630200046
J	Gill, M; Goldacre, MJ; Yeates, DGR				Gill, Mike; Goldacre, Michael J.; Yeates, David G. R.			Changes in safety on England's roads: analysis of hospital statistics	BRITISH MEDICAL JOURNAL			English	Article								Objective To compare trends in the numbers of people with serious traffic injuries according to police statistics and hospital episode statistics (HES). Design Descriptive study based on two independent population based data sources. Setting Police statistics and hospital episode statistics in England. Main outcome measures Rates of injury and death and their change over time reported in each data source, for 1996 to 2004. Results According to police statistics, rates of people killed or seriously injured on the roads fell consistently from 85.9 per 100 000 in 1996 to 59.4 per 100 000 in 2004. Over the same time, however, hospital admission rates for traffic injuries were almost unchanged at 90.0 in 1996 and 91.1 in 2004. Both datasets showed a significant reduction in rates of injury in children aged <= 15, but the reduction in hospital admission rates was substantially less than the reduction shown in the police statistics. The definition of serious injury in police statistics includes every hospital admission; in each year, none the less, the number of admissions exceeded the number of injuries reported in the police system. Conclusions The overall fall seen in police statistics for non-fatal road traffic injuries probably represents a fall in completeness of reporting of these injuries.	Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England; Govt Off SE, SE Publ Hlth Grp, Surrey GU1 4GA, England	University of Oxford	Goldacre, MJ (corresponding author), Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, Oxford OX3 7LF, England.	michael.goldacre@dphpc.ox.ac.uk						*DEP TRANSP, 2004, TOM ROADS SAF EV 1 3; *DEP TRANSP NAT ST, ROAD ACC STAT STATS1; SIMPSON HF, 1996, COMP HOSP POLICE CAS; World Health Organization, EUR HLTH ALL DAT	4	20	20	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUL 8	2006	333	7558					73	75		10.1136/bmj.38883.593831.4F	http://dx.doi.org/10.1136/bmj.38883.593831.4F			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065BA	16798753	Bronze, Green Published, Green Submitted			2022-12-24	WOS:000239133200016
J	Liu, KW; Liu, ZJ; Huang, LQ; Li, LQ; Chen, LJ; Tang, GD				Liu, Ke-Wei; Liu, Zhong-Jian; Huang, LaiQiang; Li, Li-Qiang; Chen, Li-Jun; Tang, Guang-Da			Pollination: Self-fertilization strategy in an orchid	NATURE			English	Article							REPRODUCTIVE ASSURANCE; EVOLUTION; PLANTS; SYSTEMS	Mating in flowering plants normally relies on animals, wind, gravity or secretion to convey pollen grains from the male (anther) to the female (stigma) organ. Here we describe a new type of self-pollination mechanism in the tree-living orchid Holcoglossum amesianum, in which the bisexual flower turns its anther against gravity through 360-degrees in order to insert pollen into its own stigma cavity - without the aid of any pollinating agent or medium. This mode of self-pollination, which occurs under windless, drought conditions when insects are scarce, adds to the variety of mechanisms that have evolved in angiosperms to ensure their reproductive success.	Tsing Hua Univ, Grad Sch Shenzhen, Ctr Biotechnol & Biomed, Shenzhen 518055, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Peoples R China; Natl Orchid Conservat Ctr, Shenzhen 518114, Peoples R China; S China Agr Univ, Coll Forestry, Guangzhou 510642, Peoples R China	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Chinese Academy of Sciences; University of Science & Technology of China, CAS; South China Agricultural University	Huang, LQ (corresponding author), Tsing Hua Univ, Grad Sch Shenzhen, Ctr Biotechnol & Biomed, Shenzhen 518055, Peoples R China.	huanglq@sz.tsinghua.edu.cn		Liu, Zhong-Jian/0000-0003-4390-3878				Barrett SCH, 2002, NAT REV GENET, V3, P274, DOI 10.1038/nrg776; Darwin C., 1890, VARIOUS CONTRIVANCES; DOLE JA, 1992, AM J BOT, V79, P650, DOI 10.2307/2444881; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; Herlihy CR, 2002, NATURE, V416, P320, DOI 10.1038/416320a; Holsinger KE, 2000, P NATL ACAD SCI USA, V97, P7037, DOI 10.1073/pnas.97.13.7037; LORD EM, 1981, BOT REV, V47, P421, DOI 10.1007/BF02860538; PIPER JG, 1984, NATURE, V310, P50, DOI 10.1038/310050a0; SEIDENFADEN G, 1992, OPERA BOT, V114, P441; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Wang YQ, 2004, NATURE, V431, P39, DOI 10.1038/431039b	11	62	76	8	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 22	2006	441	7096					945	946		10.1038/441945a	http://dx.doi.org/10.1038/441945a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791185				2022-12-24	WOS:000238422300029
J	Lu, J; Sherman, D; Devor, M; Saper, CB				Lu, Jun; Sherman, David; Devor, Marshall; Saper, Clifford B.			A putative flip-flop switch for control of REM sleep	NATURE			English	Article							EYE-MOVEMENT SLEEP; PARADOXICAL SLEEP; LOCUS-COERULEUS; WAKING CYCLE; TEGMENTAL NUCLEUS; PONTINE LESIONS; NEURONS; RAT; CAT; GENERATION	Rapid eye movement ( REM) sleep consists of a dreaming state in which there is activation of the cortical and hippocampal electroencephalogram ( EEG), rapid eye movements, and loss of muscle tone. Although REM sleep was discovered more than 50 years ago, the neuronal circuits responsible for switching between REM and non-REM (NREM) sleep remain poorly understood. Here we propose a brainstem flip - flop switch, consisting of mutually inhibitory REM-off and REM-on areas in the mesopontine tegmentum. Each side contains GABA (gamma-aminobutyric acid)- ergic neurons that heavily innervate the other. The REM- on area also contains two populations of glutamatergic neurons. One set projects to the basal forebrain and regulates EEG components of REM sleep, whereas the other projects to the medulla and spinal cord and regulates atonia during REM sleep. The mutually inhibitory interactions of the REM- on and REM- off areas may form a flip - flop switch that sharpens state transitions and makes them vulnerable to sudden, unwanted transitions - for example, in narcolepsy.	Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Hebrew Univ Jerusalem, Dept Cell & Anim Biol, IL-91904 Jerusalem, Israel	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Hebrew University of Jerusalem	Lu, J (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02215 USA.	jlu@bidmc.harvard.edu; csaper@bidmc.harvard.edu						Alvarez FJ, 2005, J COMP NEUROL, V493, P177, DOI 10.1002/cne.20711; ASTONJONES G, 1981, J NEUROSCI, V1, P876; Boissard R, 2003, EUR J NEUROSCI, V18, P1627, DOI 10.1046/j.1460-9568.2003.02861.x; Boissard R, 2002, EUR J NEUROSCI, V16, P1959, DOI 10.1046/j.1460-9568.2002.02257.x; Braak H, 2000, ACTA NEUROPATHOL, V99, P489, DOI 10.1007/s004010051150; CHASE MH, 1989, J NEUROSCI, V9, P743; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chou WB, 2002, ACTA PHARMACOL SIN, V23, P691; Coleman CG, 2004, NEUROSCIENCE, V126, P821, DOI 10.1016/j.neuroscience.2004.04.029; Gerashchenko D, 2001, BRAIN RES, V913, P106, DOI 10.1016/S0006-8993(01)02792-5; HOBSON JA, 1983, J NEUROPHYSIOL, V50, P770, DOI 10.1152/jn.1983.50.4.770; JONES BE, 1977, BRAIN RES, V124, P473, DOI 10.1016/0006-8993(77)90948-9; Kapas L, 1996, BRAIN RES, V712, P53, DOI 10.1016/0006-8993(95)01431-4; KAYAMA Y, 1992, BRAIN RES, V569, P210, DOI 10.1016/0006-8993(92)90632-J; Kimura K, 2000, NEUROLOGY, V55, P894, DOI 10.1212/WNL.55.6.894; Kubin L, 2001, ARCH ITAL BIOL, V139, P147; Lee MG, 2005, J NEUROSCI, V25, P6716, DOI 10.1523/JNEUROSCI.1887-05.2005; Lu J, 2002, J NEUROSCI, V22, P4568, DOI 10.1523/JNEUROSCI.22-11-04568.2002; Manford M, 1998, BRAIN, V121, P1819, DOI 10.1093/brain/121.10.1819; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; McCarley RW, 2004, ARCH ITAL BIOL, V142, P429; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; MOURET J, 1980, BRAIN RES, V186, P273, DOI 10.1016/0006-8993(80)90975-0; ONOE H, 1995, NEUROREPORT, V6, P353, DOI 10.1097/00001756-199501000-00031; Plazzi G, 1996, NEUROLOGY, V46, P1250, DOI 10.1212/WNL.46.5.1250; RYE DB, 1988, J COMP NEUROL, V269, P315, DOI 10.1002/cne.902690302; Sakai K, 2001, ARCH ITAL BIOL, V139, P93; SANFORD LD, 1994, J SLEEP RES, V3, P233; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; SASTRE JP, 1981, BRAIN RES, V229, P147, DOI 10.1016/0006-8993(81)90752-6; SASTRE JP, 1979, PHYSIOL BEHAV, V22, P979; Sastre JP, 1996, NEUROSCIENCE, V74, P415, DOI 10.1016/0306-4522(96)00190-X; SHOUSE MN, 1992, BRAIN RES, V571, P50, DOI 10.1016/0006-8993(92)90508-7; STERIADE M, 1990, J NEUROSCI, V10, P2560; TAAL W, 1994, NEUROREPORT, V5, P2225, DOI 10.1097/00001756-199411000-00005; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Wilson S, 2005, DRUGS, V65, P927, DOI 10.2165/00003495-200565070-00003; Wu MF, 2004, J PHYSIOL-LONDON, V554, P202, DOI 10.1113/jphysiol.2003.052134	39	770	809	4	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					589	594		10.1038/nature04767	http://dx.doi.org/10.1038/nature04767			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16688184				2022-12-24	WOS:000237920800037
J	Foukas, LC; Claret, M; Pearce, W; Okkenhaug, K; Meek, S; Peskett, E; Sancho, S; Smith, AJH; Withers, DJ; Vanhaesebroeck, B				Foukas, LC; Claret, M; Pearce, W; Okkenhaug, K; Meek, S; Peskett, E; Sancho, S; Smith, AJH; Withers, DJ; Vanhaesebroeck, B			Critical role for the p110 alpha phosphoinositide-3-OH kinase in growth and metabolic regulation	NATURE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; HYPOTHALAMIC NEURONS; EMBRYONIC LETHALITY; CATALYTIC SUBUNIT; INDUCED ANOREXIA; MICE LACKING; PI 3-KINASE; CELL-SIZE; INSULIN; P110-BETA	The eight catalytic subunits of the mammalian phosphoinositide-3- OH kinase ( PI( 3) K) family form the backbone of an evolutionarily conserved signalling pathway; however, the roles of most PI( 3) K isoforms in organismal physiology and disease are unknown. To delineate the role of p110 alpha, a ubiquitously expressed PI( 3) K involved in tyrosine kinase and Ras signalling, here we generated mice carrying a knockin mutation (D933A) that abrogates p110 alpha kinase activity. Homozygosity for this kinase-dead p110 alpha led to embryonic lethality. Mice heterozygous for this mutation were viable and fertile, but displayed severely blunted signalling via insulin-receptor substrate (IRS) proteins, key mediators of insulin, insulin-like growth factor-1 and leptin action. Defective responsiveness to these hormones led to reduced somatic growth, hyperinsulinaemia, glucose intolerance, hyperphagia and increased adiposity in mice heterozygous for the D933A mutation. This signalling function of p110 alpha derives from its highly selective recruitment and activation to IRS signalling complexes compared to p110 beta, the other broadly expressed PI( 3) K isoform, which did not contribute to IRS-associated PI( 3) K activity. p110 alpha was the principal IRS-associated PI( 3) K in cancer cell lines. These findings demonstrate a critical role for p110 alpha in growth factor and metabolic signalling and also suggest an explanation for selective mutation or overexpression of p110 alpha in a variety of cancers(1,2).	Ludwig Inst Canc Res, London W1W 7BS, England; UCL, Rayne Inst, Ctr Diabet & Endocrinol, London WC1E 6JJ, England; Univ Edinburgh, Inst Stem Cell Res, Gene Targeting Lab, Edinburgh EH9 3JQ, Midlothian, Scotland; Univ Fribourg, Dept Med, CH-1700 Fribourg, Switzerland; UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England	Ludwig Institute for Cancer Research; University of London; King's College London; University College London; University of Edinburgh; University of Fribourg; University of London; University College London	Vanhaesebroeck, B (corresponding author), Ludwig Inst Canc Res, 91 Riding House St, London W1W 7BS, England.	bartvanh@ludwig.ucl.ac.uk	Withers, Dominic J/D-7671-2014; Okkenhaug, Klaus/D-5149-2012; Okkenhaug, Klaus/H-3154-2019	Withers, Dominic J/0000-0002-8009-7521; Okkenhaug, Klaus/0000-0002-9432-4051; Okkenhaug, Klaus/0000-0002-9432-4051; Pearce, Wayne/0000-0001-5407-4767; Peskett, Emma/0000-0002-0978-5401; Claret, Marc/0000-0001-7766-9296	MRC [G0300058] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C505659/1] Funding Source: Medline; Medical Research Council [G0300058] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Asano T, 2000, J BIOL CHEM, V275, P17671, DOI 10.1074/jbc.M910391199; Beeton CA, 2000, BIOCHEM J, V350, P353, DOI 10.1042/0264-6021:3500353; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Bi L, 2002, MAMM GENOME, V13, P169, DOI 10.1007/s00335-001-2123-x; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Brachmann SM, 2005, MOL CELL BIOL, V25, P1596, DOI 10.1128/MCB.25.5.1596-1607.2005; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Choudhury AI, 2005, J CLIN INVEST, V115, P940; Drees BE, 2004, EXPERT OPIN THER PAT, V14, P703, DOI 10.1517/13543776.14.5.703; Dupont Joelle, 2003, Birth Defects Research, V69, P257, DOI 10.1002/bdrc.10022; Fruman DA, 2000, NAT GENET, V26, P379, DOI 10.1038/81715; Hooshmand-Rad R, 2000, J CELL SCI, V113, P207; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; KLIPPEL A, 1994, MOL CELL BIOL, V14, P2675, DOI 10.1128/MCB.14.4.2675; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; Kubo H, 2005, BIOCHEM J, V392, P607, DOI 10.1042/BJ20050671; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Lawlor MA, 2002, EMBO J, V21, P3728, DOI 10.1093/emboj/cdf387; Niswender KD, 2003, DIABETES, V52, P227, DOI 10.2337/diabetes.52.2.227; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Roche S, 1998, MOL CELL BIOL, V18, P7119, DOI 10.1128/MCB.18.12.7119; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; Wang QH, 1998, BIOCHEM J, V331, P917, DOI 10.1042/bj3310917; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Withers DJ, 2001, BIOCHEM SOC T, V29, P525, DOI 10.1042/BST0290525; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301	30	368	385	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					366	370		10.1038/nature04694	http://dx.doi.org/10.1038/nature04694			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16625210				2022-12-24	WOS:000237593200052
J	Nogue, S; Culla, A				Nogue, S; Culla, A			Burton's line	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Hosp Clin Barcelona, E-08036 Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona	Nogue, S (corresponding author), Hosp Clin Barcelona, E-08036 Barcelona, Spain.								0	11	11	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2006	354	20					E21	E21		10.1056/NEJMicm050064	http://dx.doi.org/10.1056/NEJMicm050064			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043BX	16707743				2022-12-24	WOS:000237575400011
J	Zody, MC; Garber, M; Adams, DJ; Sharpe, T; Harrow, J; Lupski, JR; Nicholson, C; Searle, SM; Wilming, L; Young, SK; Abouelleil, A; Allen, NR; Bi, WM; Bloom, T; Borowsky, ML; Bugalter, BE; Butler, J; Chang, JL; Chen, CK; Cook, A; Corum, B; Cuomo, CA; de Jong, PJ; DeCaprio, D; Dewar, K; FitzGerald, M; Gilbert, J; Gibson, R; Gnerre, S; Goldstein, S; Grafham, DV; Grocock, R; Hafez, N; Hagopian, DS; Hart, E; Norman, CH; Humphray, S; Jaffe, DB; Jones, M; Kamal, M; Khodiyar, VK; LaButti, K; Laird, G; Lehoczky, J; Liu, XH; Lokyitsang, T; Loveland, J; Lui, A; Macdonald, P; Major, JE; Matthews, L; Mauceli, E; McCarroll, SA; Mihalev, AH; Mudge, J; Nguyen, C; Nicol, R; O'Leary, SB; Osoegawa, K; Schwartz, DC; Shaw-Smith, C; Stankiewicz, P; Steward, C; Swarbreck, D; Venkataraman, V; Whittaker, CA; Yang, XP; Zimmer, AR; Bradley, A; Hubbard, T; Birren, BW; Rogers, J; Lander, ES; Nusbaum, C				Zody, MC; Garber, M; Adams, DJ; Sharpe, T; Harrow, J; Lupski, JR; Nicholson, C; Searle, SM; Wilming, L; Young, SK; Abouelleil, A; Allen, NR; Bi, WM; Bloom, T; Borowsky, ML; Bugalter, BE; Butler, J; Chang, JL; Chen, CK; Cook, A; Corum, B; Cuomo, CA; de Jong, PJ; DeCaprio, D; Dewar, K; FitzGerald, M; Gilbert, J; Gibson, R; Gnerre, S; Goldstein, S; Grafham, DV; Grocock, R; Hafez, N; Hagopian, DS; Hart, E; Norman, CH; Humphray, S; Jaffe, DB; Jones, M; Kamal, M; Khodiyar, VK; LaButti, K; Laird, G; Lehoczky, J; Liu, XH; Lokyitsang, T; Loveland, J; Lui, A; Macdonald, P; Major, JE; Matthews, L; Mauceli, E; McCarroll, SA; Mihalev, AH; Mudge, J; Nguyen, C; Nicol, R; O'Leary, SB; Osoegawa, K; Schwartz, DC; Shaw-Smith, C; Stankiewicz, P; Steward, C; Swarbreck, D; Venkataraman, V; Whittaker, CA; Yang, XP; Zimmer, AR; Bradley, A; Hubbard, T; Birren, BW; Rogers, J; Lander, ES; Nusbaum, C			DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage	NATURE			English	Article							HUMAN-GENOME; SEGMENTAL DUPLICATIONS; HOMOLOGOUS RECOMBINATION; EVOLUTION; GENE; ARCHITECTURE; MECHANISM; REGION	Chromosome 17 is unusual among the human chromosomes in many respects. It is the largest human autosome with orthology to only a single mouse chromosome(1), mapping entirely to the distal half of mouse chromosome 11. Chromosome 17 is rich in protein-coding genes, having the second highest gene density in the genome(2,3). It is also enriched in segmental duplications, ranking third in density among the autosomes(4). Here we report a finished sequence for human chromosome 17, as well as a structural comparison with the finished sequence for mouse chromosome 11, the first finished mouse chromosome. Comparison of the orthologous regions reveals striking differences. In contrast to the typical pattern seen in mammalian evolution(5,6), the human sequence has undergone extensive intrachromosomal rearrangement, whereas the mouse sequence has been remarkably stable. Moreover, although the human sequence has a high density of segmental duplication, the mouse sequence has a very low density. Notably, these segmental duplications correspond closely to the sites of structural rearrangement, demonstrating a link between duplication and rearrangement. Examination of the main classes of duplicated segments provides insight into the dynamics underlying expansion of chromosome-specific, low-copy repeats in the human genome.	MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Cambridge, MA 02142 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Childrens Hosp Oakland, Res Inst, BACPAC Resources, Oakland, CA 94609 USA; Univ Wisconsin, Lab Mol & Computat Genom, Madison, WI 53706 USA; UCL, Dept Biol, Galton Lab, HUGO Gene Nomenclature Comm, London NW1 2HE, England	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Wellcome Trust Sanger Institute; Baylor College of Medicine; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of Wisconsin System; University of Wisconsin Madison; University of London; University College London	Zody, MC (corresponding author), MIT, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	mczody@broad.mit.edu; chad@broad.mit.edu	Hubbard, Tim J/C-2567-2008; Stankiewicz, Paweł/AAP-7906-2021; Cuomo, Christina/L-2222-2019; Hubbard, Tim J.P./AAT-4571-2020; McCarroll, Steven A/A-8433-2009	Hubbard, Tim J/0000-0002-1767-9318; Stankiewicz, Paweł/0000-0002-6456-7490; Cuomo, Christina/0000-0002-5778-960X; Hubbard, Tim J.P./0000-0002-1767-9318; Wass, Elizabeth/0000-0002-8605-9921; Whittaker, Charles/0000-0002-2400-0094; Gilbert, James/0000-0001-8079-3159; DeCaprio, Dave/0000-0001-8931-9461; Loveland, Jane/0000-0002-7669-2934; Swarbreck, David/0000-0002-5453-1013; Adams, David/0000-0001-9490-0306; Harrow, Jennifer/0000-0003-0338-3070; Mudge, Jonathan/0000-0003-4789-7495; Nicol, Robert/0000-0003-1932-1392; Khodiyar, Varsha/0000-0002-2743-6918; Steward, Charles/0000-0001-8829-5349; Gibson, Richard Charles/0000-0001-5412-1965; Wilming, Laurens/0000-0002-4154-7358; Bradley, Allan/0000-0002-2349-8839	Medical Research Council [G0000107] Funding Source: Medline; Wellcome Trust [077187] Funding Source: Medline; MRC [G0000107] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Barbouti A, 2004, AM J HUM GENET, V74, P1, DOI 10.1086/380648; Bourque G, 2005, GENOME RES, V15, P98, DOI 10.1101/gr.3002305; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; DeBry RW, 1996, GENOMICS, V33, P337, DOI 10.1006/geno.1996.0209; Deloukas P, 2004, NATURE, V429, P375, DOI 10.1038/nature02462; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Hillier LW, 2005, NATURE, V434, P724, DOI 10.1038/nature03466; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Inoue K, 2001, GENOME RES, V11, P1018, DOI 10.1101/gr.180401; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Lupski JR, 2001, METABOLIC MOL BASES, P5759; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Nusbaum C, 2006, NATURE, V439, P331, DOI 10.1038/nature04406; Nusbaum C, 2005, NATURE, V437, P551, DOI 10.1038/nature03983; Park SS, 2002, GENOME RES, V12, P729, DOI 10.1101/gr.82802; Paulding CA, 2003, P NATL ACAD SCI USA, V100, P2507, DOI 10.1073/pnas.0437015100; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Stankiewicz P, 2004, GENOME RES, V14, P2209, DOI 10.1101/gr.2746604; Stankiewicz P, 2001, GENOME RES, V11, P1205, DOI 10.1101/gr.181101; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861; Zody MC, 2006, NATURE, V440, P671, DOI 10.1038/nature04601	27	108	799	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2006	440	7087					1045	1049		10.1038/nature04689	http://dx.doi.org/10.1038/nature04689			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16625196	Green Accepted, Bronze			2022-12-24	WOS:000236906000035
J	Lopez-Bendito, G; Cautinat, A; Sanchez, JA; Bielle, F; Flames, N; Garratt, AN; Talmage, DA; Role, LW; Charnay, P; Marin, O; Garel, S				Lopez-Bendito, G; Cautinat, A; Sanchez, JA; Bielle, F; Flames, N; Garratt, AN; Talmage, DA; Role, LW; Charnay, P; Marin, O; Garel, S			Tangential neuronal migration controls axon guidance: A role for neuregulin-1 in thalamocortical axon navigation	CELL			English	Article							LATERAL OLFACTORY TRACT; INTERMEDIATE TARGET; BASAL TELENCEPHALON; CONNECTIONS; PROJECTIONS; MICE; FOREBRAIN; CORTEX; MECHANISMS; NETRIN-1	Neuronal migration and axon guidance constitute fundamental processes in brain development that are generally studied independently. Although both share common mechanisms of cell biology and biochemistry, little is known about their coordinated integration in the formation of neural circuits. Here we show that the development of the thalamocortical projection, one of the most prominent tracts in the mammalian brain, depends on the early tangential migration of a population of neurons derived from the ventral telencephalon. This tangential migration contributes to the establishment of a permissive corridor that is essential for thalamocortical axon pathfinding. Our results also demonstrate that in this process two different products of the Neuregulin-1 gene, CRD-NRG1 and lg-NRG1, mediate the guidance of thalamocortical axons. These results show that neuronal tangential migration constitutes a novel mechanism to control the timely arrangement of guidance cues required for axonal tract formation in the mammalian brain.	CSIC, Inst Neurosci Alicante, St Joan DAlacant 03550, Spain; Univ Miguel Hernandez, St Joan DAlacant 03550, Spain; Ecole Normale Super, U368, INSERM, F-75230 Paris 05, France; Max Delbrueck Ctr, D-13125 Berlin, Germany; Columbia Univ, Med Ctr, New York, NY 10032 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; Institut National de la Sante et de la Recherche Medicale (Inserm); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Columbia University	Marin, O (corresponding author), CSIC, Inst Neurosci Alicante, St Joan DAlacant 03550, Spain.	o.marin@umh.es; garel@biologie.ens.fr	Garratt, Alistair/AAG-2715-2021; Marin, Oscar/F-3856-2012; Garratt, Alistair N/D-9893-2013; Garratt, Alistair/HGC-0774-2022; Role, LW/Q-7371-2018; Garel, Sonia/P-4538-2017; Sanchez-Alcaniz, Juan A/U-2285-2018; Flames, Nuria/L-2290-2017; Lopez-Bendito, Guillermina/E-4028-2014; Sanchez-Alcaniz, Juan Antonio/A-8173-2017	Marin, Oscar/0000-0001-6264-7027; Garratt, Alistair N/0000-0001-9631-3041; Role, LW/0000-0001-5851-212X; Garel, Sonia/0000-0003-2984-3645; Flames, Nuria/0000-0003-0961-0609; Bielle, Franck/0000-0001-6564-6388; Lopez-Bendito, Guillermina/0000-0002-8965-6836; Sanchez-Alcaniz, Juan Antonio/0000-0002-4900-5086; Charnay, Patrick/0000-0002-3847-6042; Talmage, David/0000-0003-4627-3007	NINDS NIH HHS [R01 NS029071, R01 NS029071-17, NS29071] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029071] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Auladell C, 2000, ANAT EMBRYOL, V201, P169, DOI 10.1007/PL00008238; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Benson DL, 2000, TRENDS CELL BIOL, V10, P473, DOI 10.1016/S0962-8924(00)01838-9; Braisted JE, 2000, J NEUROSCI, V20, P5792, DOI 10.1523/JNEUROSCI.20-15-05792.2000; Braisted JE, 1999, DEV BIOL, V208, P430, DOI 10.1006/dbio.1999.9216; Bystron I, 2005, J NEUROSCI, V25, P2781, DOI 10.1523/JNEUROSCI.4770-04.2005; Casarosa S, 1999, DEVELOPMENT, V126, P525; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Fukuda T, 1997, J COMP NEUROL, V382, P141; Garel S, 2004, TRENDS NEUROSCI, V27, P533, DOI 10.1016/j.tins.2004.06.014; Garel S, 2003, DEVELOPMENT, V130, P1903, DOI 10.1242/dev.00416; Garel S, 2002, DEVELOPMENT, V129, P5621, DOI 10.1242/dev.00166; Gassmann M, 1997, CURR OPIN NEUROBIOL, V7, P87, DOI 10.1016/S0959-4388(97)80125-0; GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jones L, 2002, DEVELOPMENT, V129, P5041; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Lin JC, 2003, NAT NEUROSCI, V6, P1270, DOI 10.1038/nn1148; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Lopez-Bendito G, 2002, J COMP NEUROL, V451, P153, DOI 10.1002/cne.10345; Marin O, 2002, DEVELOPMENT, V129, P761; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; Metin C, 1996, J NEUROSCI, V16, P3219; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; MITROFANIS J, 1993, J COMP NEUROL, V338, P575, DOI 10.1002/cne.903380407; Molnar Z, 1999, J COMP NEUROL, V413, P1, DOI 10.1002/(SICI)1096-9861(19991011)413:1<1::AID-CNE1>3.0.CO;2-5; Molnar Z, 1998, J NEUROSCI, V18, P5723; Powell EM, 2003, DEV NEUROSCI-BASEL, V25, P197, DOI 10.1159/000072268; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Sato Y, 1998, J NEUROSCI, V18, P7800; Seibt J, 2003, NEURON, V39, P439, DOI 10.1016/S0896-6273(03)00435-5; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Sussel L, 1999, DEVELOPMENT, V126, P3359; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100; Tomioka N, 2000, J NEUROSCI, V20, P5802, DOI 10.1523/JNEUROSCI.20-15-05802.2000; Tuttle R, 1999, DEVELOPMENT, V126, P1903; WISE SP, 1978, J COMP NEUROL, V178, P187, DOI 10.1002/cne.901780202; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9	50	286	289	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2006	125	1					127	142		10.1016/j.cell.2006.01.042	http://dx.doi.org/10.1016/j.cell.2006.01.042			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615895	Bronze, Green Accepted			2022-12-24	WOS:000237314200019
J	Albertini, AAV; Wernimont, AK; Muziol, T; Ravelli, RBG; Clapier, CR; Schoehn, G; Weissenhorn, W; Ruigrok, RWH				Albertini, Aurelie A. V.; Wernimont, Amy K.; Muziol, Tadeusz; Ravelli, Raimond B. G.; Clapier, Cedric R.; Schoehn, Guy; Weissenhorn, Winfried; Ruigrok, Rob W. H.			Crystal structure of the rabies virus nucleoprotein-RNA complex	SCIENCE			English	Article							VESICULAR STOMATITIS-VIRUS; N-PROTEIN; VIRAL-RNA; PHOSPHOPROTEIN; BINDING; IDENTIFICATION; NUCLEOCAPSIDS; DOMAINS; SITE	Negative-strand RNA viruses condense their genome into a helical nucleoprotein-RNA complex, the nucleocapsid, which is packed into virions and serves as a template for the RNA-dependent RNA polymerase complex. The crystal structure of a recombinant rabies virus nucleoprotein-RNA complex, organized in an undecameric ring, has been determined at 3.5 angstrom resolution. Polymerization of the nucleoprotein is achieved by domain exchange between protomers, with flexible hinges allowing nucleocapsid formation. The two core domains of the nucleoprotein clamp around the RNA at their interface and shield it from the environment. RNA sequestering by nucleoproteins is likely a common mechanism used by negative-strand RNA viruses to protect their genomes from the innate immune response directed against viral RNA in human host cells at certain stages of an infectious cycle.	European Mol Biol Lab, F-38042 Grenoble, France; Univ Grenoble 1, Inst Virol Mol & Struct, CNRS, FRE 2854, F-38042 Grenoble, France	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Weissenhorn, W (corresponding author), European Mol Biol Lab, Boite Postale 181, F-38042 Grenoble, France.	weissen@embl-grenoble.fr	Muzioł, Tadeusz M./E-5944-2014; Muziol, Tadeusz Mikolaj/T-8919-2019	Muzioł, Tadeusz M./0000-0002-5220-4430; Muziol, Tadeusz Mikolaj/0000-0002-5220-4430; Ravelli, Raimond/0000-0001-6056-5888; Albertini, Aurelie/0000-0002-2076-1654; Schoehn, Guy/0000-0002-1459-3201				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; ARNHEITER H, 1985, CELL, V41, P259, DOI 10.1016/0092-8674(85)90079-0; BLUMBERG BM, 1983, CELL, V32, P559, DOI 10.1016/0092-8674(83)90475-0; Dietzschold B, 2005, CURR TOP MICROBIOL, V292, P45; DIETZSCHOLD B, 1987, VIRUS RES, V8, P103, DOI 10.1016/0168-1702(87)90023-2; EMERSON SU, 1982, CELL, V31, P635, DOI 10.1016/0092-8674(82)90319-1; EMERSON SU, 1987, P NATL ACAD SCI USA, V84, P5655, DOI 10.1073/pnas.84.16.5655; Espert L, 2003, J BIOL CHEM, V278, P16151, DOI 10.1074/jbc.M209628200; Iseni F, 2000, RNA, V6, P270, DOI 10.1017/S135583820099109X; Iseni F, 1998, J GEN VIROL, V79, P2909, DOI 10.1099/0022-1317-79-12-2909; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Kolakofsky D, 2004, VIROLOGY, V318, P463, DOI 10.1016/j.virol.2003.10.031; KOLAKOFSKY D, 1982, J VIROL, V41, P566, DOI 10.1128/JVI.41.2.566-574.1982; Kouznetzoff A, 1998, J GEN VIROL, V79, P1005, DOI 10.1099/0022-1317-79-5-1005; LAMB R., 2001, FIELDS VIROLOGY, V1, P1305; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Longhi S, 2003, J BIOL CHEM, V278, P18638, DOI 10.1074/jbc.M300518200; LYNCH S, 1978, J VIROL, V28, P584, DOI 10.1128/JVI.28.2.584-589.1978; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Rudolph MG, 2003, STRUCTURE, V11, P1219, DOI 10.1016/j.str.2003.08.011; Schoehn G, 2004, J MOL BIOL, V339, P301, DOI 10.1016/j.jmb.2004.03.073; Schoehn G, 2001, J VIROL, V75, P490, DOI 10.1128/JVI.75.1.490-498.2001; Spehner D, 1997, VIROLOGY, V232, P260, DOI 10.1006/viro.1997.8568; THOMAS D, 1985, J VIROL, V54, P598, DOI 10.1128/JVI.54.2.598-607.1985; Toriumi H, 2005, MICROBIOL IMMUNOL, V49, P757, DOI 10.1111/j.1348-0421.2005.tb03666.x	25	255	269	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2006	313	5785					360	363		10.1126/science.1125280	http://dx.doi.org/10.1126/science.1125280			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16778023				2022-12-24	WOS:000239154300047
J	Pena, PV; Davrazou, F; Shi, XB; Walter, KL; Verkhusha, VV; Gozani, O; Zhao, R; Kutateladze, TG				Pena, Pedro V.; Davrazou, Foteini; Shi, Xiaobing; Walter, Kay L.; Verkhusha, Vladislav V.; Gozani, Or; Zhao, Rui; Kutateladze, Tatiana G.			Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2	NATURE			English	Article							TUMOR-SUPPRESSOR P33(ING1); LYSINE-4 METHYLATION; H3 TAIL; BINDING; CHROMODOMAIN; BROMODOMAIN; PROTEINS; ACETYLATION; FINGER; GROWTH	Covalent modifications of histone tails have a key role in regulating chromatin structure and controlling transcriptional activity. In eukaryotes, histone H3 trimethylated at lysine 4 (H3K4me3) is associated with active chromatin and gene expression(1-4). We recently found that plant homeodomain (PHD) finger of tumour suppressor ING2 (inhibitor of growth 2) binds H3K4me3 and represents a new family of modules that target this epigenetic mark(5). The molecular mechanism of H3K4me3 recognition, however, remains unknown. Here we report a 2.0 angstrom resolution structure of the mouse ING2 PHD finger in complex with a histone H3 peptide trimethylated at lysine 4. The H3K4me3 tail is bound in an extended conformation in a deep and extensive binding site consisting of elements that are conserved among the ING family of proteins. The trimethylammonium group of Lys 4 is recognized by the aromatic side chains of Y215 and W238 residues, whereas the intermolecular hydrogen-bonding and complementary surface interactions, involving Ala 1, Arg 2, Thr 3 and Thr 6 of the peptide, account for the PHD finger's high specificity and affinity. Substitution of the binding site residues disrupts H3K4me3 interaction in vitro and impairs the ability of ING2 to induce apoptosis in vivo. Strong binding of other ING and YNG PHD fingers suggests that the recognition of H3K4me3 histone code is a general feature of the ING/YNG proteins. Elucidation of the mechanisms underlying this novel function of PHD fingers provides a basis for deciphering the role of the ING family of tumour suppressors in chromatin regulation and signalling.	Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Aurora, CO 80045 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Stanford University; Yeshiva University; Albert Einstein College of Medicine	Kutateladze, TG (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Aurora, CO 80045 USA.	Tatiana.Kutateladze@uchsc.edu	Hu, Ruogu/B-2203-2008; Verkhusha, Vladislav/AAU-7784-2020; Gozani, Or P/I-6157-2013	Verkhusha, Vladislav/0000-0002-2083-8121; Gozani, Or/0000-0002-1365-4463; Shi, Xiaobing/0000-0001-5242-8189; Kutateladze, Tatiana/0000-0001-7375-6990	NCI NIH HHS [R01 CA113472] Funding Source: Medline; NIGMS NIH HHS [R01 GM071424] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA113472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071424] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campos EI, 2004, CELL MOL LIFE SCI, V61, P2597, DOI 10.1007/s00018-004-4199-4; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Eberharter A, 2004, EMBO J, V23, P4029, DOI 10.1038/sj.emboj.7600382; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Loewith R, 2000, MOL CELL BIOL, V20, P3807, DOI 10.1128/MCB.20.11.3807-3816.2000; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Nagashima M, 2001, P NATL ACAD SCI USA, V98, P9671, DOI 10.1073/pnas.161151798; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pascual J, 2000, J MOL BIOL, V304, P723, DOI 10.1006/jmbi.2000.4308; Ragvin A, 2004, J MOL BIOL, V337, P773, DOI 10.1016/j.jmb.2004.01.051; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; SHI X, 2006, NATURE; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412	27	533	544	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2006	442	7098					100	103		10.1038/nature04814	http://dx.doi.org/10.1038/nature04814			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HS	16728977	Green Accepted			2022-12-24	WOS:000238724500045
J	Wysocka, J; Swigut, T; Xiao, H; Milne, TA; Kwon, SY; Landry, J; Kauer, M; Tackett, AJ; Chait, BT; Badenhorst, P; Wu, C; Allis, CD				Wysocka, Joanna; Swigut, Tomek; Xiao, Hua; Milne, Thomas A.; Kwon, So Yeon; Landry, Joe; Kauer, Monika; Tackett, Alan J.; Chait, Brian T.; Badenhorst, Paul; Wu, Carl; Allis, C. David			A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling	NATURE			English	Article							TRANSCRIPTION FACTOR; COMPLEX NURF; METHYLATION; H3; BINDING; METHYLTRANSFERASE; ACETYLATION; ASSOCIATION; BROMODOMAIN; DOMAIN	Lysine methylation of histones is recognized as an important component of an epigenetic indexing system demarcating transcriptionally active and inactive chromatin domains. Trimethylation of histone H3 lysine 4 (H3K4me3) marks transcription start sites of virtually all active genes(1-4). Recently, we reported that the WD40-repeat protein WDR5 is important for global levels of H3K4me3 and control of HOX gene expression(5). Here we show that a plant homeodomain (PHD) finger of nucleosome remodelling factor (NURF), an ISWI-containing ATP-dependent chromatin-remodelling complex, mediates a direct preferential association with H3K4me3 tails. Depletion of H3K4me3 causes partial release of the NURF subunit, BPTF (bromodomain and PHD finger transcription factor), from chromatin and defective recruitment of the associated ATPase, SNF2L (also known as ISWI and SMARCA1), to the HOXC8 promoter. Loss of BPTF in Xenopus embryos mimics WDR5 loss-of-function phenotypes, and compromises spatial control of Hox gene expression. These results strongly suggest that WDR5 and NURF function in a common biological pathway in vivo, and that NURF-mediated ATP-dependent chromatin remodelling is directly coupled to H3K4 trimethylation to maintain Hox gene expression patterns during development. We also identify a previously unknown function for the PHD finger as a highly specialized methyl-lysine-binding domain.	Rockefeller Univ, Lab Chromatin Biol, New York, NY 10021 USA; Rockefeller Univ, Lab Mol Vertebrate Embryol, New York, NY 10021 USA; Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA; NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20814 USA; Univ Birmingham, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England	Rockefeller University; Rockefeller University; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Birmingham	Wu, C (corresponding author), Rockefeller Univ, Lab Chromatin Biol, 1230 York Ave, New York, NY 10021 USA.	carlwu@helix.nih.gov	Milne, Tom/E-1872-2016; Kwon, So Yeon/M-5625-2014	Milne, Tom/0000-0002-0413-4271; Kwon, So Yeon/0000-0002-8490-9101; /0000-0002-2542-0250; Swigut, Tomek/0000-0002-7649-6781	Biotechnology and Biological Sciences Research Council [BB/D522470/1] Funding Source: Medline; Intramural NIH HHS Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Badenhorst P, 2002, GENE DEV, V16, P3186, DOI 10.1101/gad.1032202; Badenhorst P, 2005, GENE DEV, V19, P2540, DOI 10.1101/gad.1342605; Barak O, 2003, EMBO J, V22, P6089, DOI 10.1093/emboj/cdg582; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; LI H, 2006, NATURE          0521; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mizuguchi G, 1997, MOL CELL, V1, P141, DOI 10.1016/S1097-2765(00)80015-5; Mizuguchi G, 2001, J BIOL CHEM, V276, P14773, DOI 10.1074/jbc.M100125200; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Ragvin A, 2004, J MOL BIOL, V337, P773, DOI 10.1016/j.jmb.2004.01.051; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; SHI X, 2006, NATURE          0521; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200; Zhou YG, 2005, CURR BIOL, V15, P1434, DOI 10.1016/j.cub.2005.06.057	28	831	864	2	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 6	2006	442	7098					86	90		10.1038/nature04815	http://dx.doi.org/10.1038/nature04815			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	059HS	16728976				2022-12-24	WOS:000238724500042
J	Ingelsson, E; Bjorklund-Bodegard, K; Lind, L; Arnlov, J; Sundstrom, J				Ingelsson, Erik; Bjorklund-Bodegard, Kristina; Lind, Lars; Arnlov, Johan; Sundstrom, Johan			Diurnal blood pressure pattern and risk of congestive heart failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENDOTHELIAL DYSFUNCTION; PROGNOSTIC-SIGNIFICANCE; NOCTURNAL DECLINE; SLEEP-APNEA; HYPERTENSION; RECOMMENDATIONS; VALIDITY; DISEASE	Context High blood pressure is the most important risk factor for congestive heart failure (CHF) at a population level, but the relationship of an altered diurnal blood pressure pattern to risk of subsequent CHF is unknown. Objectives To explore 24-hour ambulatory blood pressure characteristics as predictors of CHF incidence and to investigate whether altered diurnal blood pressure patterns confer any additional risk information beyond that provided by conventional office blood pressure measurements. Design, Setting, and Participants Prospective, community-based, observational cohort in Uppsala, Sweden, including 951 elderly men free of CHF, valvular disease, and left ventricular hypertrophy at baseline between 1990 and 1995, followed up until the end of 2002. Twenty-four-hour ambulatory blood pressure monitoring was performed at baseline, and the blood pressure variables were analyzed as predictors of subsequent CHF. Main Outcome Measure First hospitalization for CHF. Results Seventy men developed heart failure during follow-up, with an incidence rate of 8.6 per 1000 person-years at risk. In multivariable Cox proportional hazards models adjusted for antihypertensive treatment and established risk factors for CHF ( myocardial infarction, diabetes, smoking, body mass index, and serum cholesterol level), a 1-SD (9-mm Hg) increase in nighttime ambulatory diastolic blood pressure ( hazard ratio [HR], 1.26; 95% confidence interval [CI], 1.02-1.55) and the presence of "non-dipping" blood pressure (night-day ambulatory blood pressure ratio >= 1; HR, 2.29; 95% CI, 1.16-4.52) were associated with an increased risk of CHF. After adjusting for office-measured systolic and diastolic blood pressures, nondipping blood pressure remained a significant predictor of CHF ( HR, 2.21; 95% CI, 1.12-4.36 vs normal night-day pattern). Nighttime ambulatory diastolic blood pressure and nondipping blood pressure were also significant predictors of CHF after exclusion of all participants who had an acute myocardial infarction before baseline or during follow-up. Conclusions Nighttime blood pressure appears to convey additional risk information about CHF beyond office-measured blood pressure and other established risk factors for CHF. The clinical value of this association remains to be established in future studies.	Uppsala Univ, Dept Publ Hlth & Caring Sci, SE-75185 Uppsala, Sweden; Uppsala Univ, Dept Med Sci, SE-75185 Uppsala, Sweden; AstraZeneca Res & Dev, Molndal, Sweden	Uppsala University; Uppsala University; AstraZeneca	Ingelsson, E (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala Sci Pk, SE-75185 Uppsala, Sweden.	erik.ingelsson@pubcare.uu.se	Sundstrom, Johan/R-2139-2019; Ärnlöv, Johan/AAF-2746-2019; Sundström, Johan/A-6286-2009	Sundstrom, Johan/0000-0003-2247-8454; Ärnlöv, Johan/0000-0002-6933-4637; Sundström, Johan/0000-0003-2247-8454				Andersen NH, 2005, DIABETIC MED, V22, P1218, DOI 10.1111/j.1464-5491.2005.01589.x; APPEL LJ, 1990, AM J EPIDEMIOL, V132, P343, DOI 10.1093/oxfordjournals.aje.a115664; Bell DSH, 2003, DIABETES CARE, V26, P2433, DOI 10.2337/diacare.26.8.2433; Berry C, 2001, EUR J HEART FAIL, V3, P283, DOI 10.1016/S1388-9842(01)00123-4; Bjorklund K, 2004, J HYPERTENS, V22, P1691; Bradley TD, 2005, NEW ENGL J MED, V353, P2025, DOI 10.1056/NEJMoa051001; Byberg L, 1998, ARTERIOSCL THROM VAS, V18, P258, DOI 10.1161/01.ATV.18.2.258; Chen YT, 1999, AM J MED, V106, P605, DOI 10.1016/S0002-9343(99)00126-6; Chong AY, 2004, CIRCULATION, V110, P1794, DOI 10.1161/01.CIR.0000143073.60937.50; CLELAND JG, 1995, EUR HEART J, V16, P741; Clement DL, 2003, NEW ENGL J MED, V348, P2407, DOI 10.1056/NEJMoa022273; Galderisi M, 1996, AM J CARDIOL, V77, P597, DOI 10.1016/S0002-9149(97)89313-7; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gottdiener JS, 2000, J AM COLL CARDIOL, V35, P1628, DOI 10.1016/S0735-1097(00)00582-9; Goyal D, 2005, EUR J HEART FAIL, V7, P149, DOI 10.1016/j.ejheart.2004.05.010; Hedstrand H, 1975, Ups J Med Sci Suppl, V19, P1; Higashi Y, 2002, J AM COLL CARDIOL, V40, P2039, DOI 10.1016/S0735-1097(02)02535-4; Ingelsson E, 2005, EUR J HEART FAIL, V7, P787, DOI 10.1016/j.ejheart.2004.12.007; Javaheri S, 1998, CIRCULATION, V97, P2154, DOI 10.1161/01.CIR.97.21.2154; Lee KW, 2005, AM J HYPERTENS, V18, P104, DOI 10.1016/j.amjhyper.2004.09.003; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; LINDBLAD U, 1993, SCAND J SOC MED, V21, P3, DOI 10.1177/140349489302100102; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; O'Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/00004872-200305000-00001; Ohkubo T, 1997, AM J HYPERTENS, V10, P1201, DOI 10.1016/S0895-7061(97)00274-4; Ohkubo T, 2002, J HYPERTENS, V20, P2183, DOI 10.1097/00004872-200211000-00017; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Prineas R., 1982, MINNESOTA CODE MANUA; Sherwood A, 2002, AM J HYPERTENS, V15, P111, DOI 10.1016/S0895-7061(01)02251-8; Sica D A, 1999, Blood Press Monit, V4 Suppl 2, pS9; Staessen JA, 1999, JAMA-J AM MED ASSOC, V282, P539, DOI 10.1001/jama.282.6.539; Staessen JA, 1997, HYPERTENSION, V29, P30, DOI 10.1161/01.HYP.29.1.30; Tousoulis D, 2005, INT J CARDIOL, V100, P347, DOI 10.1016/j.ijcard.2004.05.030; VERDECCHIA P, 1990, EUR HEART J, V11, P679, DOI 10.1093/oxfordjournals.eurheartj.a059783; Verdecchia P, 2002, J AM COLL CARDIOL, V39, P878, DOI 10.1016/S0735-1097(01)01827-7; VERDECCHIA P, 1994, HYPERTENSION, V24, P793, DOI 10.1161/01.HYP.24.6.793; von Kanel Roland, 2004, Journal of Hypertension, V22, P2087, DOI 10.1097/00004872-200411000-00009; Ziegler MG, 2003, CURR OPIN NEPHROL HY, V12, P97, DOI 10.1097/00041552-200301000-00016	39	222	239	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 28	2006	295	24					2859	2866		10.1001/jama.295.24.2859	http://dx.doi.org/10.1001/jama.295.24.2859			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057DY	16804152	Bronze			2022-12-24	WOS:000238577700023
J	Lander, GC; Tang, L; Casjens, SR; Gilcrease, EB; Prevelige, P; Poliakov, A; Potter, CS; Carragher, B; Johnson, JE				Lander, Gabriel C.; Tang, Liang; Casjens, Sherwood R.; Gilcrease, Eddie B.; Prevelige, Peter; Poliakov, Anton; Potter, Clinton S.; Carragher, Bridget; Johnson, John E.			The structure of an infectious P22 virion shows the signal for headful DNA packaging	SCIENCE			English	Article							SALMONELLA PHAGE-P22; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; PROTEIN; BACTERIOPHAGE-P22; ENCAPSULATION; MATURATION; MECHANISM	Bacteriophages, herpesviruses, and other large double-stranded DNA (dsDNA) viruses contain molecular machines that pump DNA into preassembled procapsids, generating internal capsid pressures exceeding, by 10-fold, that of bottled champagne. A 17 angstrom resolution asymmetric reconstruction of the infectious P22 virion reveals that tightly spooled DNA about the portal dodecamer forces a conformation that is significantly different from that observed in isolated portals assembled from ectopically expressed protein. We propose that the tight dsDNA spooling activates the switch that signals the headful chromosome packing density to the particle exterior.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA; Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	Scripps Research Institute; Scripps Research Institute; Utah System of Higher Education; University of Utah; University of Alabama System; University of Alabama Birmingham	Johnson, JE (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jackj@scripps.edu	Johnson, Johnson/HDL-9124-2022	Lander, Gabriel C./0000-0003-4921-1135; Carragher, Bridget/0000-0002-0624-5020	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NCRR NIH HHS [RR17573] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Agirrezabala X, 2005, EMBO J, V24, P3820, DOI 10.1038/sj.emboj.7600840; Agirrezabala X, 2005, J MOL BIOL, V347, P895, DOI 10.1016/j.jmb.2005.02.005; Anderson Dwight, 2005, P102; BOTSTEIN D, 1973, J MOL BIOL, V80, P669, DOI 10.1016/0022-2836(73)90204-0; CASJENS S, 1974, Journal of Supramolecular Structure, V2, P202, DOI 10.1002/jss.400020215; CASJENS S, 1992, J MOL BIOL, V224, P1055, DOI 10.1016/0022-2836(92)90469-Z; Casjens S, 1988, BACTERIOPHAGES, P15; Casjens Sherwood, 2005, P80; Fokine A, 2004, P NATL ACAD SCI USA, V101, P6003, DOI 10.1073/pnas.0400444101; HENDRIX RW, 1978, P NATL ACAD SCI USA, V75, P4779, DOI 10.1073/pnas.75.10.4779; HOFFMAN B, 1975, J VIROL, V16, P1547, DOI 10.1128/JVI.16.6.1547-1559.1975; ISRAEL V, 1977, J VIROL, V23, P91, DOI 10.1128/JVI.23.1.91-97.1977; Jiang W, 2003, NAT STRUCT BIOL, V10, P131, DOI 10.1038/nsb891; Jiang W, 2006, NATURE, V439, P612, DOI 10.1038/nature04487; KING J, 1973, J MOL BIOL, V80, P697, DOI 10.1016/0022-2836(73)90205-2; Morais MC, 2005, MOL CELL, V18, P149, DOI 10.1016/j.molcel.2005.03.013; Morais MC, 2001, J STRUCT BIOL, V135, P38, DOI 10.1006/jsbi.2001.4379; Prevelige PEJ, 2005, BACTERIOPHAGES, P457; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Steinbacher S, 1996, P NATL ACAD SCI USA, V93, P10584, DOI 10.1073/pnas.93.20.10584; Steinbacher S, 1997, J MOL BIOL, V267, P865, DOI 10.1006/jmbi.1997.0922; Tang L, 2005, EMBO J, V24, P2087, DOI 10.1038/sj.emboj.7600695; Tao YZ, 1998, CELL, V95, P431, DOI 10.1016/S0092-8674(00)81773-0	23	241	246	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1791	1795		10.1126/science.1127981	http://dx.doi.org/10.1126/science.1127981			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16709746				2022-12-24	WOS:000238452800057
J	Kim, BG; Li, CL; Qiao, WH; Mamura, M; Kasperczak, B; Anver, M; Wolfraim, L; Hong, S; Mushinski, E; Potter, M; Kim, SJ; Fu, XY; Deng, CX; Letterio, JJ				Kim, Byung-Gyu; li, Cuing Li; Qiao, Wenhui; Mamura, Mizuko; Kasperczak, Barbara; Anver, Miriam; Wolfraim, Lawrence; Hong, Suntaek; Mushinski, Elizabeth; Potter, Michael; Kim, Seong-Jin; Fu, Xin-Yuan; Deng, Chuxia; Letterio, John J.			Smad4 signalling in T cells is required for suppression of gastrointestinal cancer	NATURE			English	Article							CONDITIONAL KNOCKOUT MICE; TGF-BETA; JUVENILE POLYPOSIS; COLON-CANCER; TRANSGENIC MICE; TUMOR-GROWTH; GENE; STAT3; IL-6; INACTIVATION	SMAD4 (MAD homologue 4 (Drosophila)), also known as DPC4 ( deleted in pancreatic cancer), is a tumour suppressor gene that encodes a central mediator of transforming growth factor-beta signalling(1-4). Germline mutations in SMAD4 are found in over 50% of patients with familial juvenile polyposis, an autosomal dominant disorder characterized by predisposition to hamartomatous polyps and gastrointestinal cancer(5,6). Dense inflammatory cell infiltrates underlay grossly normal appearing, non-polypoid colonic and gastric mucosa of patients with familial juvenile polyposis(7). This prominent stromal component suggests that loss of SMAD4-dependent signalling in cells within the epithelial microenvironment has an important role in the evolution of intestinal tumorigenesis in this syndrome. Here we show that selective loss of Smad4-dependent signalling in T cells leads to spontaneous epithelial cancers throughout the gastrointestinal tract in mice, whereas epithelial-specific deletion of the Smad4 gene does not. Tumours arising within the colon, rectum, duodenum, stomach and oral cavity are stroma-rich with dense plasma cell infiltrates. Smad4(-/-) T cells produce abundant T(H)2-type cytokines including interleukin (IL)-5, IL-6 and IL-13, known mediators of plasma cell and stromal expansion. The results support the concept that cancer, as an outcome, reflects the loss of the normal communication between the cellular constituents of a given organ(8), and indicate that Smad4-deficient T cells ultimately send the wrong message to their stromal and epithelial neighbours.	NCI, Lab Cell Regulat & Carcinogenesis, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; NIDDKD, Genet Dis & Dev Branch, NIH, Bethesda, MD 20892 USA; NCI, SAIC, Frederick, MD 21702 USA; NIH, Genet Lab, Ctr Canc Res, Bethesda, MD 20892 USA; Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Indiana University System; Indiana University-Purdue University Indianapolis	Letterio, JJ (corresponding author), NCI, Lab Cell Regulat & Carcinogenesis, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	john.letterio@cwru.edu	deng, chuxia/N-6713-2016	Kim, Byung-Gyu/0000-0002-8921-5061; Mamura, Mizuko/0000-0003-4531-0144	NATIONAL CANCER INSTITUTE [Z01BC005596, ZIABC005596, Z01BC005617] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK056012, ZIADK056012, ZIADK056001, Z01DK056001] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Becker C, 2005, CELL CYCLE, V4, P217; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Corvinus FM, 2005, NEOPLASIA, V7, P545, DOI 10.1593/neo.04571; Gorelik L, 2002, NAT REV IMMUNOL, V2, P46, DOI 10.1038/nri704; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howe JR, 2002, AM J HUM GENET, V70, P1357, DOI 10.1086/340258; Jenkins BJ, 2005, NAT MED, V11, P845, DOI 10.1038/nm1282; Kinzler KW, 1998, SCIENCE, V280, P1036, DOI 10.1126/science.280.5366.1036; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Li WM, 2003, DEVELOPMENT, V130, P6143, DOI 10.1242/dev.00820; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Miyaki M, 2003, BIOCHEM BIOPH RES CO, V306, P799, DOI 10.1016/S0006-291X(03)01066-0; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; SUBRAMONY C, 1994, AM J CLIN PATHOL, V102, P91, DOI 10.1093/ajcp/102.1.91; Tsuchida K, 2003, KIDNEY INT, V63, P2000, DOI 10.1046/j.1523-1755.2003.00009.x; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Woodford-Richens K, 2000, CANCER RES, V60, P2477; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; YAN C, 1990, EMBO J, V9, P869, DOI 10.1002/j.1460-2075.1990.tb08184.x; Yang LL, 2005, CANCER RES, V65, P8671, DOI 10.1158/0008-5472.CAN-05-0800; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029	29	240	257	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					1015	1019		10.1038/nature04846	http://dx.doi.org/10.1038/nature04846			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791201				2022-12-24	WOS:000238422300050
J	Okie, S				Okie, S			ADHD in adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DEFICIT HYPERACTIVITY DISORDER											Biederman J, 2006, LANCET, V367, P210; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Cosgrove L, 2006, PSYCHOTHER PSYCHOSOM, V75, P154, DOI 10.1159/000091772; Faraone Stephen V, 2003, World Psychiatry, V2, P104; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; McCann BS, 2004, COMPR PSYCHIAT, V45, P175, DOI 10.1016/j.comppsych.2004.02.006	7	58	59	2	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2006	354	25					2637	2641		10.1056/NEJMp068113	http://dx.doi.org/10.1056/NEJMp068113			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	054ZJ	16790695				2022-12-24	WOS:000238416900001
J	Sturmer, T; Hasselbach, P; Amelang, M				Sturmer, T; Hasselbach, P; Amelang, M			Personality, lifestyle, and risk of cardiovascular disease and cancer: follow-up of population based cohort	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; A BEHAVIOR; MYOCARDIAL-INFARCTION; BREAST-CANCER; 52 COUNTRIES; STRESS; ASSOCIATION; INTERHEART; COMPONENTS; MORTALITY	Objective To study the relation between measures of personality and risk of cardiovascular disease and cancer in a large cohort. Design Follow-up of population based cohort. Setting Heidelberg, Germany. Participants 5114 women and men aged 40-65 in 1992-5. Main outcome measures Psychological traits assessed by several standardised personality questionnaires in 1992-5, related to cause of death (to 2002-3) or reported incidence of cardiovascular diseases and cancer (validated by treating doctors). Relative risks (and 95% confidence intervals) for combined morbidity and mortality according to five important personality traits were estimated using multivariable Cox proportional hazards models. Results During median follow-up of 8.5 years, 257 participants died and 72 participants were diagnosed with a heart attack, 62 with stroke, and 240 with cancer. (morbidity and mortality combined). A high internal locus of control over disease was associated with a decreased risk of myocardial infarction (adjusted relative risk for an increase of 1 SD = 0.75; 95% confidence interval 0.58 to 0.96). An increase of 1 SD in time urgency was associated with a decreased risk of cancer (adjusted relative risk 0.83; 0.73 to 0.95). Other major personality traits-anger control, psychoticism, and symptoms of depression-were not consistently associated with myocardial infarction, stroke, or cancer. Conclusion Internal locus of control over disease and time urgency seem to be associated with reduced risk for common chronic diseases, probably by affecting unmeasured health related behaviour. The other personality traits assessed had no major impact on cardiovascular disease and cancer.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02120 USA; Univ Heidelberg, Dept Psychol, D-6900 Heidelberg, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Ruprecht Karls University Heidelberg	Sturmer, T (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA.	til.sturmer@post.harvard.edu	Stürmer, Til/AAB-5459-2022					Amelang M., 2004, Z GESUNDHEITSPSYCHOL, V12, P102; Black PH, 2002, J PSYCHOSOM RES, V52, P1, DOI 10.1016/S0022-3999(01)00302-6; Borkenau P, 2001, J PERS SOC PSYCHOL, V80, P655, DOI 10.1037/0022-3514.80.4.655; Brayne C, 1998, PERS INDIV DIFFER, V25, P889, DOI 10.1016/S0191-8869(98)00071-3; Butow PN, 2000, J PSYCHOSOM RES, V49, P169, DOI 10.1016/S0022-3999(00)00156-2; Carmelli D, 1996, J PSYCHOSOM RES, V40, P475, DOI 10.1016/0022-3999(95)00637-0; Duijts SFA, 2003, INT J CANCER, V107, P1023, DOI 10.1002/ijc.11504; Garssen B, 2004, CLIN PSYCHOL REV, V24, P315, DOI 10.1016/j.cpr.2004.01.002; Glynn RJ, 2004, J CLIN EPIDEMIOL, V57, P113, DOI 10.1016/j.jclinepi.2003.02.001; HAYNES SG, 1980, AM J EPIDEMIOL, V111, P37, DOI 10.1093/oxfordjournals.aje.a112873; Macleod J, 2002, BMJ-BRIT MED J, V324, P1247, DOI 10.1136/bmj.324.7348.1247; Merz CNB, 2002, BEHAV MED, V27, P141, DOI 10.1080/08964280209596039; RAGLAND DR, 1988, NEW ENGL J MED, V318, P65, DOI 10.1056/NEJM198801143180201; Rosengren A, 2004, LANCET, V364, P953, DOI 10.1016/S0140-6736(04)17019-0; SHEKELLE RB, 1985, AM J EPIDEMIOL, V122, P559, DOI 10.1093/oxfordjournals.aje.a114135; Sutton S.R., 2004, SAGE HDB HLTH PSYCHO; Vaidya JG, 2002, J PERS SOC PSYCHOL, V83, P1469, DOI 10.1037//0022-3514.83.6.1469; Weitkunat R, 2002, J CLIN EPIDEMIOL, V55, P436, DOI 10.1016/S0895-4356(01)00507-8; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	19	75	76	0	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	JUN 10	2006	332	7554					1359	1362		10.1136/bmj.38833.479560.80	http://dx.doi.org/10.1136/bmj.38833.479560.80			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	057HN	16687457	Green Published, Bronze			2022-12-24	WOS:000238587000016
J	Boillee, S; Yamanaka, K; Lobsiger, CS; Copeland, NG; Jenkins, NA; Kassiotis, G; Kollias, G; Cleveland, DW				Boillee, Severine; Yamanaka, Koji; Lobsiger, Christian S.; Copeland, Neal G.; Jenkins, Nancy A.; Kassiotis, George; Kollias, George; Cleveland, Don W.			Onset and progression in inherited ALS determined by motor neurons and microglia	SCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU/ZN SUPEROXIDE-DISMUTASE; SPINAL-CORD TISSUE; FAMILIAL ALS; MOUSE MODEL; TRANSGENIC MODEL; DISEASE ONSET; DEGENERATION; MINOCYCLINE; MICE	Dominant mutations in superoxide dismutase cause amyotrophic lateral sclerosis (ALS), a progressive paralytic disease characterized by loss of motor neurons. With the use of mice carrying a deletable mutant gene, expression within motor neurons was shown to be a primary determinant of disease onset and of an early phase of disease progression. Diminishing the mutant levels in microglia had little effect on the early disease phase but sharply slowed later disease progression. Onset and progression thus represent distinct disease phases defined by mutant action within different cell types to generate non-cell-autonomous killing of motor neurons; these findings validate therapies, including cell replacement, targeted to the non-neuronal cells.	Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; NCI, Mouse Canc Genet Program, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; Biomed Sci Res Ctr Alexander Fleming, Inst Immunol, Vari 16672, Greece	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Alexander Fleming Biomedical Sciences Research Center	Yamanaka, K (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	kyamanaka@ucsd.edu; dcleveland@ucsd.edu	Lobsiger, Christian S/B-2720-2017; Cleveland, Don/AAN-9783-2021; Yamanaka, Koji/ABD-1034-2020; Boillee, Severine/J-4027-2017; Lobsiger, Christian/N-4369-2018; Lobsiger, Christian S./AAA-5311-2019; Kollias, George/A-7079-2012; Yamanaka, Koji/H-5806-2011	Yamanaka, Koji/0000-0003-4655-0035; Lobsiger, Christian S./0000-0002-4313-010X; Kollias, George/0000-0003-1867-3150; Yamanaka, Koji/0000-0003-4655-0035; Cleveland, Don/0000-0002-1934-3682; Kassiotis, George/0000-0002-8457-2633; BOILLEE, Severine/0000-0001-5518-9005	NINDS NIH HHS [R37 NS027036, NS 27036] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036, R01NS027036] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Drachman DB, 2002, ANN NEUROL, V52, P771, DOI 10.1002/ana.10374; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; HICKSTEIN DD, 1992, P NATL ACAD SCI USA, V89, P2105, DOI 10.1073/pnas.89.6.2105; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Liu J, 2005, J NEUROCHEM, V93, P875, DOI 10.1111/j.1471-4159.2005.03054.x; MAZZONE A, 1995, HAEMATOLOGICA, V80, P161; Miller TM, 2005, ANN NEUROL, V57, P773, DOI 10.1002/ana.20453; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S., 2001, BMC DEV BIOL, V1; Van Den Bosch L, 2002, NEUROREPORT, V13, P1067, DOI 10.1097/00001756-200206120-00018; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	28	1191	1243	4	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 2	2006	312	5778					1389	1392		10.1126/science.1123511	http://dx.doi.org/10.1126/science.1123511			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741123				2022-12-24	WOS:000237961600058
J	Frydman, HM; Li, JM; Robson, DN; Wieschaus, E				Frydman, Horacio M.; Li, Jennifer M.; Robson, Drew N.; Wieschaus, Eric			Somatic stem cell niche tropism in Wolbachia	NATURE			English	Article							HORIZONTAL TRANSFER; TRICHOGRAMMA-WASPS; DROSOPHILA OVARIAN; HOST; INFECTIONS; BACTERIA; BEHAVIOR; INSECTS	Wolbachia are intracellular bacteria found in the reproductive tissue of all major groups of arthropods(1,2). They are transmitted vertically from the female hosts to their offspring, in a pattern analogous to mitochondria inheritance. But Wolbachia phylogeny does not parallel that of the host, indicating that horizontal infectious transmission must also occur(3-5). Insect parasitoids are considered the most likely vectors, but the mechanism for horizontal transfer is largely unknown(4,6,7). Here we show that newly introduced Wolbachia cross several tissues and infect the germline of the adult Drosophila melanogaster female. Through investigation of bacterial migration patterns during the course of infection, we found that Wolbachia reach the germline through the somatic stem cell niche in the D. melanogaster germarium. In addition, our data suggest that Wolbachia are highly abundant in the somatic stem cell niche of long-term infected hosts, implying that this location may also contribute to efficient vertical transmission. This is, to our knowledge, the first report of an intracellular parasite displaying tropism for a stem cell niche.	Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08540 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08540 USA	Howard Hughes Medical Institute; Princeton University; Princeton University	Frydman, HM (corresponding author), Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08540 USA.	hfrydman@princeton.edu		Frydman, Horacio/0000-0003-0191-7948; Robson, Drew/0000-0002-0150-1515				Cheng Q, 2000, MED VET ENTOMOL, V14, P44, DOI 10.1046/j.1365-2915.2000.00202.x; Clarkson M, 1999, DNA CELL BIOL, V18, P457, DOI 10.1089/104454999315178; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Ferree PM, 2005, PLOS PATHOG, V1, P111, DOI 10.1371/journal.ppat.0010014; Frydman HM, 2001, DEVELOPMENT, V128, P3209; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Grenier S, 1998, P ROY SOC B-BIOL SCI, V265, P1441, DOI 10.1098/rspb.1998.0455; Hadfield SJ, 1999, NATURE, V402, P482, DOI 10.1038/45002; Heath BD, 1999, CURR BIOL, V9, P313, DOI 10.1016/S0960-9822(99)80139-0; Huigens ME, 2004, P ROY SOC B-BIOL SCI, V271, P509, DOI 10.1098/rspb.2003.2640; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Kang L, 2003, HEREDITY, V90, P71, DOI 10.1038/sj.hdy.6800180; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; LIN H, 1993, DEV BIOL, V159, P140, DOI 10.1006/dbio.1993.1228; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; McGraw EA, 2004, CURR OPIN MICROBIOL, V7, P67, DOI 10.1016/j.mib.2003.12.003; McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; Rigaud T, 2001, J INVERTEBR PATHOL, V77, P251, DOI 10.1006/jipa.2001.5026; Vavre F, 1999, MOL BIOL EVOL, V16, P1711, DOI 10.1093/oxfordjournals.molbev.a026084; Veneti Z, 2004, APPL ENVIRON MICROB, V70, P5366, DOI 10.1128/AEM.70.9.5366-5372.2004; Werren JH, 2001, CURR BIOL, V11, P431, DOI 10.1016/S0960-9822(01)00101-4; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; Zhang Y, 2001, NATURE, V410, P599, DOI 10.1038/35069099	27	155	160	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 25	2006	441	7092					509	512		10.1038/nature04756	http://dx.doi.org/10.1038/nature04756			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	045YP	16724067				2022-12-24	WOS:000237778900050
J	Trotta, CR; Paushkin, SV; Patel, M; Li, H; Peltz, SW				Trotta, CR; Paushkin, SV; Patel, M; Li, H; Peltz, SW			Cleavage of pre-tRNAs by the splicing endonuclease requires a composite active site	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; ARCHAEAL; INTRON; ENZYME; RECOGNITION; SUBSTRATE; EVOLUTION; SUBUNITS; MOTIFS	Splicing is required for the removal of introns from a subset of transfer RNAs in all eukaryotic organisms. The first step of splicing, intron recognition and cleavage, is performed by the tRNA-splicing endonuclease, a tetrameric enzyme composed of the protein subunits Sen54, Sen2, Sen34 and Sen15. It has previously been demonstrated that the active sites for cleavage at the 5' and 3' splice sites of precursor tRNA are contained within Sen2 and Sen34, respectively(1-3). A recent structure of an archaeal endonuclease complexed with a bulge - helix - bulge RNA has led to the unexpected hypothesis that catalysis requires a critical 'cation-pi sandwich' composed of two arginine residues that serve to position the RNA substrate within the active site(4). This motif is derived from a cross-subunit interaction between the two catalytic subunits. Here we test the role of this interaction within the eukaryotic endonuclease and show that catalysis at the 50 splice site requires the conserved cation-pi sandwich derived from the Sen34 subunit in addition to the catalytic triad of Sen2. The catalysis of pre-tRNA by the eukaryotic tRNA-splicing endonuclease therefore requires a previously unrecognized composite active site.	PTC Therapeut, S Plainfield, NJ 07080 USA; Florida State Univ, Inst Mol Biophys, Dept Chem & Biochem, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Trotta, CR (corresponding author), PTC Therapeut, 100 Corp Court, S Plainfield, NJ 07080 USA.	ctrotta@ptcbio.com		Li, Hong/0000-0003-2046-9861	NIGMS NIH HHS [F32 GM018893] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABELSON J, 1992, SCIENCE, V255, P1390, DOI 10.1126/science.1542787; Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; BALDI MI, 1992, SCIENCE, V255, P1404, DOI 10.1126/science.1542788; Belfort M, 1997, CELL, V89, P1003, DOI 10.1016/S0092-8674(00)80287-1; Bujnicki JM, 2000, FEBS LETT, V486, P328, DOI 10.1016/S0014-5793(00)02322-X; DINICOLA NE, 1997, CELL, V89, P859; Fruscoloni P, 2001, EMBO REP, V2, P217, DOI 10.1093/embo-reports/kve040; HO CK, 1990, EMBO J, V9, P1245, DOI 10.1002/j.1460-2075.1990.tb08232.x; KlemanLeyer K, 1997, CELL, V89, P839, DOI 10.1016/S0092-8674(00)80269-X; LEE MC, 1985, J BIOL CHEM, V260, P3108; Li H, 2000, J MOL BIOL, V302, P639, DOI 10.1006/jmbi.2000.3941; Li H, 1998, SCIENCE, V280, P279, DOI 10.1126/science.280.5361.279; LykkeAndersen J, 1997, EMBO J, V16, P6290, DOI 10.1093/emboj/16.20.6290; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; Randau L, 2005, P NATL ACAD SCI USA, V102, P17934, DOI 10.1073/pnas.0509197102; RAUHUT R, 1990, J BIOL CHEM, V265, P18180; REYES VM, 1987, ANAL BIOCHEM, V166, P90, DOI 10.1016/0003-2697(87)90551-3; REYES VM, 1988, CELL, V55, P719, DOI 10.1016/0092-8674(88)90230-9; Tocchini-Valentini GD, 2005, P NATL ACAD SCI USA, V102, P15418, DOI 10.1073/pnas.0506750102; Trotta CR, 1997, CELL, V89, P849, DOI 10.1016/S0092-8674(00)80270-6; Volta V, 2005, BIOCHEM BIOPH RES CO, V337, P89, DOI 10.1016/j.bbrc.2005.09.012; XUE S, IN PRESS SCIENCE	22	45	46	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 18	2006	441	7091					375	377		10.1038/nature04741	http://dx.doi.org/10.1038/nature04741			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710424				2022-12-24	WOS:000237593200054
J	Ridker, PM; Torres, J				Ridker, PM; Torres, J			Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIALS; CORONARY-HEART-DISEASE; PRIMARY PREVENTION; UNCERTAINTY PRINCIPLE; SECONDARY PREVENTION; STATIN THERAPY; DRUG TRIALS; OF-INTEREST; EVENTS; ASSOCIATION	Context In surveys based on data available prior to 2000, clinical trials funded by for-profit organizations appeared more likely to report positive findings than those funded by not-for-profit organizations. Whether this situation has changed over the past 5 years or whether similar effects are present among jointly funded trials is unknown. Objective To determine in contemporary randomized cardiovascular trials the association between funding source and the likelihood of reporting positive findings. Design We reviewed 324 consecutive superiority trials of cardiovascular medicine published between January 1, 2000, and July 30, 2005, in JAMA, The Lancet, and the New England Journal of Medicine. Main Outcome Measure The proportion of trials favoring newer treatments over the standard of care was evaluated by funding source. Results Of the 324 superiority trials, 21 cited no funding source. Of the 104 trials funded solely by not-for-profit organizations, 51 (49%) reported evidence significantly favoring newer treatments over the standard of care, whereas 53 (51%) did not (P=. 80). By contrast, 92 (67.2%) of 137 trials funded solely by for-profit organizations favored newer treatments over standard of care ( P <. 001). Among 62 jointly funded trials, 35 (56.5%), an intermediate proportion, favored newer treatments. For 205 randomized trials evaluating drugs, the proportions favoring newer treatments were 39.5%, not-for-profit; 54.4%, jointly funded; and 65.5%, for-profit trials ( P for trend across groups =. 002). For the 39 randomized trials evaluating cardiovascular devices, the proportions favoring newer treatments were 50.0%, not-for-profit; 69.2%, jointly funded; and 82.4%, for-profit trials ( P for trend across groups=. 07). Regardless of funding source, trials using surrogate end points, such as quantitative angiography, intravascular ultrasound, plasma biomarkers, and functional measures were more likely to report positive findings (67%) than trials using clinical end points (54.1%; P=. 02). Conclusions Recent cardiovascular trials funded by for-profit organizations are more likely to report positive findings than trials funded by not-for-profit organizations, as are trials using surrogate rather than clinical end points. Trials jointly funded by not-for-profit and for-profit organizations appear to report positive findings at a rate approximately midway between rates observed in trials supported solely by one or the other of these entities.	Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA; Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Div Cardiol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ridker, PM (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave E, Boston, MA 02215 USA.	pridker@partners.org						Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bhandari M, 2004, CAN MED ASSOC J, V170, P477; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bodenheimer T, 2000, NEW ENGL J MED, V342, P1539, DOI 10.1056/NEJM200005183422024; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Curfman GD, 2005, NEW ENGL J MED, V353, P2813, DOI 10.1056/NEJMe058314; Curfman GD, 2000, NEW ENGL J MED, V343, P1520; De Angelis C, 2004, ANN INTERN MED, V141, P477, DOI 10.7326/0003-4819-141-6-200409210-00109; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; Djulbegovic B, 1999, BLOOD, V94, p399A; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Fries JF, 2004, ARTHRITIS RES THER, V6, pR250, DOI 10.1186/ar1170; GIFFORD F, 1995, BIOETHICS, V9, P127, DOI 10.1111/j.1467-8519.1995.tb00306.x; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Kjaergard LL, 1999, HEPATOLOGY, V30, P1134, DOI 10.1002/hep.510300510; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Miller PB, 2003, KENNEDY INST ETHIC J, V13, P93, DOI 10.1353/ken.2003.0014; Montaner JSG, 2001, LANCET, V358, P1893, DOI 10.1016/S0140-6736(01)06891-X; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Olson L G, 2002, Monash Bioeth Rev, V21, pS55; PEDERSEN TR, 1994, LANCET, V344, P1383; Rennie D, 1999, JAMA-J AM MED ASSOC, V282, P1766, DOI 10.1001/jama.282.18.1766; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; ROCHON PA, 1994, ARCH INTERN MED, V154, P157, DOI 10.1001/archinte.154.2.157; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Topol EJ, 2001, NEW ENGL J MED, V344, P1888, DOI 10.1056/NEJM200106213442502; Wahlbeck K, 1999, BRIT MED J, V318, P465; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234	41	212	215	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 17	2006	295	19					2270	2274		10.1001/jama.295.19.2270	http://dx.doi.org/10.1001/jama.295.19.2270			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	042UX	16705108	Bronze			2022-12-24	WOS:000237556600025
J	McGuire, BM; Julian, BA; Bynon, JS; Cook, WJ; King, SJ; Curtis, JJ; Accortt, NA; Eckhoff, DE				McGuire, Brendan M.; Julian, Bruce A.; Bynon, J. Steve, Jr.; Cook, William J.; King, Steven J.; Curtis, John J.; Accortt, Neil A.; Eckhoff, Devin E.			Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation	ANNALS OF INTERNAL MEDICINE			English	Article							RENAL-DISEASE	Background: Patients infected with hepatitis C virus (HCV) frequently develop renal failure after liver transplantation. Objective: To describe renal histologic characteristics and concomitant clinical features in HCV-infected patients with end-stage cirrhosis. Design: Case series. Setting: Single-center liver transplant program in the United States. Patients: 30 patients who received liver transplants for HCV-induced cirrhosis. Intervention: Kidney biopsy during liver engraftment. Measurements: Clinical data and laboratory tests of renal function within 6 months before liver transplantation. Results: Twenty-five patients had immune-complex glomerulonephritis: membranoproliferative glomerulonephritis type 1 (n = 12), IgA nelphropathy (n = 7), and mesangial glomerulonephritis (n 6). Of these patients, 10 had normal serum creatinine levels, normal urinalysis results, and normal quantitative proteinuria. For 5 others, the only renal abnormality was an increased serum creatinine level. No patient had cryoglobulins in the blood or kidney. Limitations: This small observational study did not include patients with nonviral cirrhosis and did not document post-transplantation outcomes. Conclusions: immune-complex glomerulonephritis was common in patients with end-stage HCV-induced cirrhosis and was often clinically silent. Its potential to cause renal failure after liver transplantation may be underappreciated.	Univ Alabama Birmingham, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	McGuire, BM (corresponding author), Univ Alabama Birmingham, 1530 3rd Ave S,MCLM 262A, Birmingham, AL 35294 USA.	bmcguire@uab.edu						Arase Y, 1998, INTERNAL MED, V37, P836, DOI 10.2169/internalmedicine.37.836; Belgiojoso G B, 1976, Clin Nephrol, V6, P303; D'Amico G, 1998, KIDNEY INT, V54, P650, DOI 10.1046/j.1523-1755.1998.00028.x; Giclas PC, 1997, MANUAL CLIN LAB IMMU, V5, P181; GONWA TA, 1995, TRANSPLANTATION, V59, P361, DOI 10.1097/00007890-199502150-00010; Gorevic PD, 1997, MANUAL CLIN LAB IMMU, P217; JENNETTE JC, 1988, AM J KIDNEY DIS, V12, P348, DOI 10.1016/S0272-6386(88)80022-2; JINDAL RM, 1995, POSTGRAD MED J, V71, P513, DOI 10.1136/pgmj.71.839.513; JOHNSON RJ, 1993, NEW ENGL J MED, V328, P465, DOI 10.1056/NEJM199302183280703; Kendrick EA, 1997, TRANSPLANTATION, V63, P1287, DOI 10.1097/00007890-199705150-00016; Kim WR, 2002, HEPATOLOGY, V36, pS30, DOI 10.1053/jhep.2002.36791; Meyers CM, 2003, AM J KIDNEY DIS, V42, P631, DOI 10.1016/S0272-6386(03)00828-X; Ojo AO, 2003, NEW ENGL J MED, V349, P931, DOI 10.1056/NEJMoa021744; Pillebout E, 2005, AM J TRANSPLANT, V5, P1120, DOI 10.1111/j.1600-6143.2005.00852.x; WILLIAMS I, 1999, AM J MED S, V107, P2, DOI DOI 10.1016/S0002-9343(99)00373-3	15	125	134	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2006	144	10					735	741		10.7326/0003-4819-144-10-200605160-00007	http://dx.doi.org/10.7326/0003-4819-144-10-200605160-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043XO	16702589				2022-12-24	WOS:000237636400004
J	Thompson, RJ; Zhou, N; MacVicar, BA				Thompson, RJ; Zhou, N; MacVicar, BA			Ischemia opens neuronal gap junction hemichannels	SCIENCE			English	Article							CONNEXIN HEMICHANNELS; ATP RELEASE; BRAIN; DEPOLARIZATION; INHIBITION; MECHANISMS; DEATH; COMMUNICATION; ASTROCYTES; CHANNELS	Neuronal excitotoxicity during stroke is caused by activation of unidentified large-conductance channels, leading to swelling and calcium dysregulation. We show that ischemic-like conditions [O-2/glucose deprivation (OGD)] open hemichannels, or half gap junctions, in neurons. Hemichannel opening was indicated by a large linear current and flux across the membrane of small fluorescent molecules. Single-channel openings of hemichannels ( 530 picosiemens) were observed in OGD. Both the current and dye flux were blocked by inhibitors of hemichannels. Therefore, hemichannel opening contributes to the profound ionic dysregulation during stroke and may be a ubiquitous component of ischemic neuronal death.	Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2B5, Canada; Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada	University of British Columbia; University of British Columbia	MacVicar, BA (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2B5, Canada.	bmacvica@interchange.ubc.ca	Thompson, Roger/L-3930-2016; MacVicar, Brian/P-1553-2015; MacVicar, Brian/AAI-7729-2020; Thompson, Roger/A-3029-2012	Thompson, Roger/0000-0002-7019-7246; MacVicar, Brian/0000-0003-4596-4623; MacVicar, Brian/0000-0003-4596-4623; Zhou, Ning/0000-0003-4693-0679				Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Anderson TR, 2005, J NEUROPHYSIOL, V93, P963, DOI 10.1152/jn.00654.2004; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Bruzzone R, 2005, J NEUROCHEM, V92, P1033, DOI 10.1111/j.1471-4159.2004.02947.x; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fung ML, 1997, BRAIN RES, V762, P97, DOI 10.1016/S0006-8993(97)00371-5; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Kamermans M, 2001, SCIENCE, V292, P1178, DOI 10.1126/science.1060101; Kondo RP, 2000, J MOL CELL CARDIOL, V32, P1859, DOI 10.1006/jmcc.2000.1220; Li HY, 1996, J CELL BIOL, V134, P1019, DOI 10.1083/jcb.134.4.1019; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Saez JC, 2005, BBA-BIOMEMBRANES, V1711, P215, DOI 10.1016/j.bbamem.2005.01.014; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Thompson RJ, 2002, BIOPHYS J, V83, P278, DOI 10.1016/S0006-3495(02)75168-0; TOMASETTO C, 1993, J CELL BIOL, V122, P157, DOI 10.1083/jcb.122.1.157; Zhao HB, 2005, P NATL ACAD SCI USA, V102, P18724, DOI 10.1073/pnas.0506481102	23	424	443	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					924	927		10.1126/science.1126241	http://dx.doi.org/10.1126/science.1126241			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690868				2022-12-24	WOS:000237452900051
J	Popescu, I; Vaughan-Sarrazin, MS; Rosenthal, GE				Popescu, I; Vaughan-Sarrazin, MS; Rosenthal, GE			Certificate of need regulations and use of coronary revascularization after acute myocardial infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GEOGRAPHIC-VARIATION; ADMINISTRATIVE DATA; CLAIMS DATA; ANGIOPLASTY; MEDICARE; OUTCOMES; VOLUME; ANGIOGRAPHY; HOSPITALS; PERSPECTIVE	Context Certificate of need regulations were enacted to control health care costs by limiting unnecessary expansion of services. While many states have repealed certificate of need regulations in recent years, few analyses have examined relationships between certificate of need regulations and outcomes of care. Objective To compare rates of coronary revascularization and mortality after acute myocardial infarction in states with and without certificate of need regulations. Design, Setting, and Participants Retrospective cohort study of 1 139 792 Medicare beneficiaries aged 68 years or older with AMI who were admitted to 4587 US hospitals during 2000-2003. Main Outcome Measures Thirty-day risk-adjusted rates of coronary revascularization with either coronary artery bypass graft surgery or percutaneous coronary intervention and 30-day all-cause mortality. Results The 624 421 patients in states with certificate of need regulations were less likely to be admitted to hospitals with coronary revascularization services ( 321 573 [51.5%] vs 323 695 [62.8%]; P <. 001) or to undergo revascularization at the admitting hospital ( 163 120 [26.1%] vs 163 877 [31.8%]; P <. 001) than patients in states without certificates of need but were more likely to undergo revascularization at a transfer hospital ( 73 379 [11.7%] vs 45 907 [8.9%]; P <. 001). Adjusting for demographic and clinical risk factors, patients in states with highly and moderately stringent certificate of need regulations, respectively, were less likely to undergo revascularization within the first 2 days ( adjusted hazard ratios, 0.68; 95% confidence interval [CI], 0.54-0.87; P =.002 and 0.80; 95% CI, 0.71-0.90; P <. 001) relative to patients in states without certificates of need, although no differences in the likelihood of revascularization were observed during days 3 through 30. Unadjusted 30-day mortality was similar in states with and without certificates of need ( 109 304 [17.5%] vs 90 104 [ 17.5%]; P=.76), as was adjusted mortality ( odds ratio, 1.00; 95% CI, 0.97-1.03; P=.90). Conclusions Patients with acute myocardial infarction were less likely to be admitted to hospitals offering coronary revascularization and to undergo early revascularization in states with certificate of need regulations. However, differences in the availability and use of revascularization therapies were not associated with mortality.	Iowa City VA Med Ctr, CRIISP, Iowa City, IA USA; Univ Iowa, Carver Coll Med, Dept Internal Med, Div Gen Internal Med, Iowa City, IA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa	Popescu, I (corresponding author), Univ Iowa Hosp & Clin, Dept Internal Med, 200 Hawkins Dr,SE615-GH, Iowa City, IA 52240 USA.	ioana-popescu@uiowa.edu		Vaughan Sarrazin, Mary/0000-0001-8717-1061				*AM HLTH PLANN ASS, 2004, IMPR HLTH CAR DOS CO; *AM HLTH PLANN ASS, 2000, NAT DIR HLTH PLANN P; [Anonymous], 2004, IMPROVING HLTH CARE; Ash AS, 2003, HEALTH SERV RES, V38, P1253, DOI 10.1111/1475-6773.00175; BURDA D, 1991, MOD HLTH, V21, P28; BURDA D, 1991, MOD HEALTHCARE, V21, P32; BURDA D, 1991, MOD HEALTHCARE, V21, P36; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Canto JG, 2000, NEW ENGL J MED, V342, P1573, DOI 10.1056/NEJM200005253422106; Canto JG, 2000, NEW ENGL J MED, V342, P1094, DOI 10.1056/NEJM200004133421505; Conover CS, 2003, EVALUATION CERTIFICA, V2; Cram P, 2005, NEW ENGL J MED, V352, P1454, DOI 10.1056/NEJMsa042325; *CTR EV CLIN SCI D, DARTM ATL HEALTHC 19; *CTR MED MED SERV, 2003, MED PRESCR DRUG IMPR; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; *GEN ACC OFF, 2003, PUBL GEN ACC OFF; Guadagnoli E, 2001, MED CARE, V39, P446, DOI 10.1097/00005650-200105000-00005; Hannan EL, 1997, HEALTH SERV RES, V31, P659; HANNAN EL, 1991, MED CARE, V29, P1094, DOI 10.1097/00005650-199111000-00003; Hannan EL, 1997, JAMA-J AM MED ASSOC, V277, P892, DOI 10.1001/jama.277.11.892; Henderson RA, 2003, J AM COLL CARDIOL, V42, P1161, DOI 10.1016/S0735-1097(03)00951-3; Ho V, 2004, AM HEART J, V147, P442, DOI 10.1016/j.ahj.2003.05.002; Krumholz HM, 1998, CIRCULATION, V98, P2010, DOI 10.1161/01.CIR.98.19.2010; Lagerqvist B, 2002, J AM COLL CARDIOL, V40, P1902, DOI 10.1016/S0735-1097(02)02572-X; Lee E. W., 1992, SURVIVAL ANAL STATE, P237, DOI [DOI 10.1007/978-94-015-7983-4_14, 10.1007/978-94-015-7983-4_14]; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; MANARD BB, 1995, GEORGIA CERTIFICATE; O'Connor GT, 1999, JAMA-J AM MED ASSOC, V281, P627, DOI 10.1001/jama.281.7.627; Petersen LA, 2003, NEW ENGL J MED, V348, P2209, DOI 10.1056/NEJMsa021725; Pilote L, 2003, MED CARE, V41, P813, DOI 10.1097/00005650-200307000-00005; Robinson JL, 2001, AM J MED QUAL, V16, P155, DOI 10.1177/106286060101600502; ROMANO M, 2003, MOD HEALTHCARE, V33, P1; Ryan TJ, 1999, J AM COLL CARDIOL, V34, P890, DOI 10.1016/S0735-1097(99)00351-4; SARRAZIN MSV, 2002, JAMA-J AM MED ASSOC, V288, P1859; SHORTELL SM, 1988, NEW ENGL J MED, V318, P1100, DOI 10.1056/NEJM198804283181705; SLOAN FA, 1988, COST QUALITY ACCESS; Southern DA, 2004, MED CARE, V42, P355, DOI 10.1097/01.mlr.0000118861.56848.ee; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Woods KL, 1998, EUR HEART J, V19, P1348, DOI 10.1053/euhj.1998.1027	40	42	42	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 10	2006	295	18					2141	2147		10.1001/jama.295.18.2141	http://dx.doi.org/10.1001/jama.295.18.2141			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	040OW	16684984				2022-12-24	WOS:000237391300023
J	Kato, H; Takeuchi, O; Sato, S; Yoneyama, M; Yamamoto, M; Matsui, K; Uematsu, S; Jung, A; Kawai, T; Ishii, KJ; Yamaguchi, O; Otsu, K; Tsujimura, T; Koh, CS; Sousa, CRE; Matsuura, Y; Fujita, T; Akira, S				Kato, H; Takeuchi, O; Sato, S; Yoneyama, M; Yamamoto, M; Matsui, K; Uematsu, S; Jung, A; Kawai, T; Ishii, KJ; Yamaguchi, O; Otsu, K; Tsujimura, T; Koh, CS; Sousa, CRE; Matsuura, Y; Fujita, T; Akira, S			Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses	NATURE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; IFN-BETA; ANTIVIRAL RESPONSE; SIGNALING PATHWAY; VIRAL REPLICATION; IMMUNE-RESPONSES; ADAPTER PROTEIN; INTERFERON; ACTIVATION	The innate immune system senses viral infection by recognizing a variety of viral components (including double-stranded (ds) RNA) and triggers antiviral responses(1,2). The cytoplasmic helicase proteins RIG-I (retinoic-acid-inducible protein I, also known as Ddx58) and MDA5 (melanoma-differentiation-associated gene 5, also known as Ifih1 or Helicard) have been implicated in viral dsRNA recognition(3-7). In vitro studies suggest that both RIG-I and MDA5 detect RNA viruses and polyinosine-polycytidylic acid (poly(I:C)), a synthetic dsRNA analogue(3). Although a critical role for RIG-I in the recognition of several RNA viruses has been clarified(8), the functional role of MDA5 and the relationship between these dsRNA detectors in vivo are yet to be determined. Here we use mice deficient in MDA5 (MDA5(-/-)) to show that MDA5 and RIG-I recognize different types of dsRNAs: MDA5 recognizes poly(I:C), and RIG-I detects in vitro transcribed dsRNAs. RNA viruses are also differentially recognized by RIG-I and MDA5. We find that RIG-I is essential for the production of interferons in response to RNA viruses including paramyxo-viruses, influenza virus and Japanese encephalitis virus, whereas MDA5 is critical for picornavirus detection. Furthermore, RIG-I-/- and MDA5(-/-) mice are highly susceptible to infection with these respective RNA viruses compared to control mice. Together, our data show that RIG-I and MDA5 distinguish different RNA viruses and are critical for host antiviral responses.	Osaka Univ, Dept Host Def, Suita, Osaka 5650871, Japan; Osaka Univ, Dept Mol Virol, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; Japan Sci & Technol Agcy, ERATO, Suita, Osaka 5650871, Japan; Kyoto Univ, Dept Genet & Mol Biol, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan; Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; Hyogo Med Univ, Dept Pathol, Nishinomiya, Hyogo 6638501, Japan; Shinshu Univ, Sch Allied Med Sci, Dept Med Technol, Matsumoto, Nagano 3908621, Japan; Lincolns Inn Fields Labs, Immunobiol Lab, Canc Res UK London Res Inst, London WC2A 3PX, England	Osaka University; Osaka University; Japan Science & Technology Agency (JST); Kyoto University; Osaka University; Hyogo College of Medicine; University of Hyogo; Shinshu University; Cancer Research UK	Akira, S (corresponding author), Osaka Univ, Dept Host Def, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Reis e Sousa, Caetano/ABD-7322-2021; Reis e Sousa, Caetano/O-1657-2014; Takeuchi, Osamu/D-6007-2011; Akira, Shizuo/C-3134-2009; Takeuchi, Osamu/AAG-9359-2019; Ishii, Ken J/B-1685-2012; Yoneyama, Mitsutoshi/D-8244-2017	Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Takeuchi, Osamu/0000-0002-1260-6232; Ishii, Ken J/0000-0002-6728-3872; Yoneyama, Mitsutoshi/0000-0001-9512-0408; Kawai, Taro/0000-0001-7510-4662; Yamaguchi, Osamu/0000-0002-7461-369X; Sato, Shintaro/0000-0001-5156-3354				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hoshino K, 2002, INT IMMUNOL, V14, P1225, DOI 10.1093/intimm/dxf089; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato A, 2004, J VIROL, V78, P7443, DOI 10.1128/JVI.78.14.7443-7454.2004; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kovacsovics M, 2002, CURR BIOL, V12, P838, DOI 10.1016/S0960-9822(02)00842-4; Melchjorsen J, 2005, J VIROL, V79, P12944, DOI 10.1128/JVI.79.20.12944-12951.2005; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mori Y, 2005, J VIROL, V79, P3448, DOI 10.1128/JVI.79.6.3448-3458.2005; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	28	2733	2897	10	323	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2006	441	7089					101	105		10.1038/nature04734	http://dx.doi.org/10.1038/nature04734			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16625202				2022-12-24	WOS:000237248600041
J	Jeong, KH; Kim, J; Lee, LP				Jeong, KH; Kim, J; Lee, LP			Biologically inspired artificial compound eyes	SCIENCE			English	Article							WAVE-GUIDES; FACET LENS; OPTICS; BEE; SENSITIVITY; RHABDOMERE; ARRAY	This work presents the fabrication of biologically inspired artificial compound eyes. The artificial ommatidium, like that of an insect's compound eyes, consists of a refractive polymer microlens, a light-guiding polymer cone, and a self-aligned waveguide to collect light with a small angular acceptance. The ommatidia are omnidirectionally arranged along a hemispherical polymer dome such that they provide a wide field of view similar to that of a natural compound eye. The spherical configuration of the microlenses is accomplished by reconfigurable microtemplating, that is, polymer replication using the deformed elastomer membrane with microlens patterns. The formation of polymer waveguides self-aligned with microlenses is also realized by a self-writing process in a photosensitive polymer resin. The angular acceptance is directly measured by three-dimensional optical sectioning with a confocal microscope, and the detailed optical characteristics are studied in comparison with a natural compound eye.	Univ Calif Berkeley, Biomol Nanotechnol Ctr, Berkeley Sensor & Actuator Ctr, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Lee, LP (corresponding author), Univ Calif Berkeley, Biomol Nanotechnol Ctr, Berkeley Sensor & Actuator Ctr, Dept Bioengn, 485 Evans Hall 1762, Berkeley, CA 94720 USA.	lplee@socrates.berkeley.edu	Kim, Jaeyoun/B-5291-2012; Lee, Luke/AAN-6695-2021; Jeong, Ki-Hun/C-1667-2011	Jeong, Ki-Hun/0000-0003-4799-7816				BEERSMA DGM, 1982, J OPT SOC AM, V72, P583, DOI 10.1364/JOSA.72.000583; Duparre J, 2005, APPL OPTICS, V44, P2949, DOI 10.1364/AO.44.002949; Feng R, 2003, J MICROMECH MICROENG, V13, P80, DOI 10.1088/0960-1317/13/1/312; Greiner B, 2004, CELL TISSUE RES, V316, P377, DOI 10.1007/s00441-004-0883-9; Hamanaka K, 1996, OPT REV, V3, P264, DOI 10.1007/s10043-996-0264-6; HARDIE R, 1989, J INSECT PHYSIOL, V35, P423, DOI 10.1016/0022-1910(89)90117-0; Kagami M, 2001, APPL PHYS LETT, V79, P1079, DOI 10.1063/1.1389516; Kewitsch AS, 1996, OPT LETT, V21, P24, DOI 10.1364/OL.21.000024; Kim JY, 2005, OPT LETT, V30, P5, DOI 10.1364/OL.30.000005; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; LAUGHLIN SB, 1971, Z VERGL PHYSIOL, V74, P329, DOI 10.1007/BF00297733; Lee LP, 2005, SCIENCE, V310, P1148, DOI 10.1126/science.1115248; OGATA S, 1994, OPT ENG, V33, P3649, DOI 10.1117/12.179889; Ottoson D, 1985, PROGR SENSORY PHYSL, P1; SANDERS JS, 1995, OPT ENG, V34, P222, DOI 10.1117/12.183393; Shoji S, 2002, OPT LETT, V27, P185, DOI 10.1364/OL.27.000185; Snyder A. W., 1979, COMP PHYSL EVOLUTION, P225, DOI DOI 10.1007/978-3-642-66999-6_5; SNYDER AW, 1972, J COMP PHYSIOL, V80, P51, DOI 10.1007/BF00694327; STAVENGA DG, 1991, J OPT SOC AM A, V8, P14, DOI 10.1364/JOSAA.8.000014; Stavenga DG, 2003, J COMP PHYSIOL A, V189, P1, DOI 10.1007/s00359-002-0370-2; Streppel U, 2003, APPL OPTICS, V42, P3570, DOI 10.1364/AO.42.003570; Tanida J, 2001, APPL OPTICS, V40, P1806, DOI 10.1364/AO.40.001806; van Hateren J.H., 1989, P74; Xia YN, 1996, SCIENCE, V273, P347, DOI 10.1126/science.273.5273.347; Yamashita K, 2004, IEEE PHOTONIC TECH L, V16, P801, DOI 10.1109/LPT.2004.823752	25	508	538	17	347	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					557	561		10.1126/science.1123053	http://dx.doi.org/10.1126/science.1123053			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16645090				2022-12-24	WOS:000237296700039
J	Harper, DM; Franco, EL; Wheeler, CM; Moscicki, AB; Romonowski, B; Roteli-Martins, CM; Jenkins, D; Schuind, A; Clemens, SAC; Dubin, G				Harper, DM; Franco, EL; Wheeler, CM; Moscicki, AB; Romonowski, B; Roteli-Martins, CM; Jenkins, D; Schuind, A; Clemens, SAC; Dubin, G		HPV Vaccine Study Grp	Sustained efficacy up to 4-5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial	LANCET			English	Article							HEPATITIS-B-VACCINE; NATURAL-HISTORY; CLINICAL-TRIALS; CERVICAL-CANCER; YOUNG-WOMEN; INFECTION; IMMUNOGENICITY; WORLDWIDE; PROFILE; DESIGN	Background Effective vaccination against HPV 16 and HPV 18 to prevent cervical cancer will require a high level of sustained protection against infection and precancerous lesions. Our aim was to assess the long-term efficacy, immunogenicity, and safety of a bivalent HPV-16/18 L1 virus-like particle AS04 vaccine against incident and persistent infection with HPV 16 and HPV 18 and their associated cytological and histological outcomes. Methods We did a follow-up study of our multicentre, double-blind, randomised, placebo-controlled trial reported in 2004. We included women who originally received all three doses of bivalent HPV-16/18 virus-like particle AS04 vaccine (0.5 mL; n=393) or placebo (n=383). We assessed HPV DNA, using cervical samples, and did yearly cervical cytology assessments. We also studied the long-term immunogenicity and safety of the vaccine. Findings More than 98% seropositivity was maintained for HPV-16/18 antibodies during the extended follow-up phase. We noted significant vaccine efficacy against HPV-16 and HPV-18 endpoints: incident infection, 96.9% (95% CI 81.3-99.9); persistent infection: 6 month definition, 94.3 (63.2-99.9); 12 month definition, 100% (33.6-100). In a combined analysis of the initial efficacy and extended follow-up studies, vaccine efficacy of 100% (42.4-100) against cervical intraepithelial neoplasia (CIN) lesions associated with vaccine types. We noted broad protection against cytohistological outcomes beyond that anticipated for HPV 16/18 and protection against incident infection with HPV 45 and HPV 31. The vaccine has a good long-term safety profile. Interpretation Up to 4.5 years, the HPV-16/18 L1 virus-like particle AS04 vaccine is highly immunogenic and safe, and induces a high degree of protection against HPV-16/18 infection and associated cervical lesions. There is also evidence of cross protection.	Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Obstet & Gynecol, Lebanon, NH 03756 USA; Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Community & Family Med, Lebanon, NH 03756 USA; McGill Univ, Dept Oncol, Montreal, PQ, Canada; McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Dept Obstet & Gynecol, Albuquerque, NM 87131 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Alberta, Edmonton, AB, Canada; Nove Julho Hosp, Sao Paulo, Brazil; GlaxoSmithKline Biol, Rixensart, Belgium; GlaxoSmithKline Biol, King Of Prussia, PA USA; GlaxoSmithKline Biol, Rio De Janeiro, Brazil	Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Norris Cotton Cancer Center; McGill University; McGill University; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of California System; University of California San Francisco; University of Alberta; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Harper, DM (corresponding author), Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Obstet & Gynecol, Rubin 880,1 Med Ctr Dr, Lebanon, NH 03756 USA.	diane.m.harper@dartmouth.edu	Harper, Diane M./I-2180-2014; Moscicki, Anna-Barbara/AAP-3806-2021; Franco, Eduardo/C-6445-2014	Harper, Diane M./0000-0001-7648-883X; Costa Clemens, Sue Ann/0000-0001-9576-0878; Franco, Eduardo/0000-0002-4409-8084				Boland G, 2004, VACCINE, V23, P316, DOI 10.1016/j.vaccine.2004.06.006; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; COGLIANO V, 2005, LANCET ONCOL, V6, P931; Combita AL, 2002, INT J CANCER, V97, P796, DOI 10.1002/ijc.10153; Garcon Nathalie, 2006, P161, DOI 10.1016/B978-012088403-2/50011-3; Goldie SJ, 2003, INT J CANCER, V106, P896, DOI 10.1002/ijc.11334; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Jacques P, 2002, VACCINE, V20, P3644, DOI 10.1016/S0264-410X(02)00397-3; Koutsky LA, 2002, NEW ENGL J MED, V347, P1645, DOI 10.1056/NEJMoa020586; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Marais D, 2000, J MED VIROL, V60, P331, DOI 10.1002/(SICI)1096-9071(200003)60:3&lt;331::AID-JMV12&gt;3.0.CO;2-A; Moscicki AB, 1998, J PEDIATR-US, V132, P277, DOI 10.1016/S0022-3476(98)70445-7; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Pagliusi SR, 2004, VACCINE, V23, P569, DOI 10.1016/j.vaccine.2004.07.046; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Sankaranarayanan R, 2006, BEST PRACT RES CL OB, V20, P207, DOI 10.1016/j.bpobgyn.2005.10.007; STANLEY M, 2005, VACCINE, DOI DOI 10.1016/J.VACCINE2005.09.002; TANG DI, 1993, BIOMETRICS, V49, P23, DOI 10.2307/2532599; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wideroff L, 1999, J INFECT DIS, V180, P1424, DOI 10.1086/315055; Wright TC, 2002, JAMA-J AM MED ASSOC, V287, P2120, DOI 10.1001/jama.287.16.2120	24	1177	1249	5	123	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 15	2006	367	9518					1247	1255		10.1016/S0140-6736(06)68439-0	http://dx.doi.org/10.1016/S0140-6736(06)68439-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	034FC	16631880				2022-12-24	WOS:000236913400029
J	Beasley, R; McNaughton, A; Robinson, G				Beasley, R; McNaughton, A; Robinson, G			New look at the oxyhaemoglobin dissociation curve	LANCET			English	Editorial Material							SUPPLEMENTAL OXYGEN; MYOCARDIAL-INFARCTION; ACUTE EXACERBATIONS; CONTROLLED-TRIAL; HYPEROXIA; VENTILATION; INFANTS; AUDIT; AIR		Med Res Inst New Zealand, Wellington 6001, New Zealand; Univ Southampton, Sch Med, Southampton, Hants, England	Medical Research Institute Of New Zealand; University of Southampton	Beasley, R (corresponding author), Med Res Inst New Zealand, Wellington 6001, New Zealand.	richard.beasley@mrinz.ac.nz	Beasley, Richard/AAH-3908-2019	Beasley, Richard/0000-0003-0337-406X				ALBIN RJ, 1992, CHEST, V102, P1672, DOI 10.1378/chest.102.6.1672; BARON JF, 1990, AM J PHYSIOL, V258, pH1388, DOI 10.1152/ajpheart.1990.258.5.H1388; Davis PG, 2004, LANCET, V364, P1329, DOI 10.1016/S0140-6736(04)17189-4; Denniston AKO, 2002, CLIN MED, V2, P449, DOI 10.7861/clinmedicine.2-5-449; Dodd ME, 2000, BRIT MED J, V321, P864, DOI 10.1136/bmj.321.7265.864; Downs JB, 1999, CRIT CARE MED, V27, P2844, DOI 10.1097/00003246-199912000-00050; Downs John B, 2003, Respir Care, V48, P611; GARNER WL, 1989, SURGERY, V105, P747; Haque WA, 1996, J AM COLL CARDIOL, V27, P353, DOI 10.1016/0735-1097(95)00474-2; KENMURE ACF, 1968, BMJ-BRIT MED J, V4, P360, DOI 10.1136/bmj.4.5627.360; Kor A. C., 2000, Annals Academy of Medicine Singapore, V29, P177; NIIJIMA S, 1988, ARCH DIS CHILD-FETAL, V63, P1126, DOI 10.1136/adc.63.10_Spec_No.1126; Plant PK, 2000, THORAX, V55, P550, DOI 10.1136/thorax.55.7.550; RAWLES JM, 1976, BMJ-BRIT MED J, V1, P1121, DOI 10.1136/bmj.1.6018.1121; Ronning OM, 1999, STROKE, V30, P2033, DOI 10.1161/01.STR.30.10.2033; Thomson AJ, 2002, BMJ-BRIT MED J, V324, P1406, DOI 10.1136/bmj.324.7351.1406; WAGNER PD, 1974, J CLIN INVEST, V54, P54, DOI 10.1172/JCI107750	17	23	23	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 8	2006	367	9517					1124	1126		10.1016/S0140-6736(06)68488-2	http://dx.doi.org/10.1016/S0140-6736(06)68488-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	030ZH	16616545				2022-12-24	WOS:000236673400007
J	Green, TJ; Zhang, X; Wertz, GW; Luo, M				Green, Todd J.; Zhang, Xin; Wertz, Gail W.; Luo, Ming			Structure of the vesicular stomatitis virus nucleoprotein-RNA complex	SCIENCE			English	Article							PROTEIN; POLYMERASE; NS	Vesicular stomatitis virus is a negative-stranded RNA virus. Its nucleoprotein (N) binds the viral genomic RNA and is involved in multiple functions including transcription, replication, and assembly. We have determined a 2.9 angstrom structure of a complex containing 10 molecules of the N protein and 90 bases of RNA. The RNA is tightly sequestered in a cavity at the interface between two lobes of the N protein. This serves to protect the RNA in the absence of polynucleotide synthesis. For the RNA to be accessed, some conformational change in the N protein should be necessary.	Univ Alabama, Sch Med, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Luo, M (corresponding author), Univ Alabama, Sch Med, Dept Microbiol, 1025 18th St S, Birmingham, AL 35294 USA.	mingluo@uab.edu		Green, Todd/0000-0003-1158-4710	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI012464, R56AI050066, R01AI050066] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI012464-29, AI050066, R37 AI012464-28, R37 AI012464-31, R37 AI012464-30, R37 AI012464, R37AI012464] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Chen Z, 2004, STRUCTURE, V12, P227, DOI 10.1016/j.str.2004.01.001; DeLano WL, 2002, PYMOL USERS MANUAL; EMERSON SU, 1972, J VIROL, V10, P297, DOI 10.1128/JVI.10.2.297-309.1972; EMERSON SU, 1975, J VIROL, V15, P1348, DOI 10.1128/JVI.15.6.1348-1356.1975; Green TJ, 2000, J VIROL, V74, P9515, DOI 10.1128/JVI.74.20.9515-9524.2000; Green TJ, 2006, ACTA CRYSTALLOGR D, V62, P498, DOI 10.1107/S0907444906006809; HOWARD M, 1989, J GEN VIROL, V70, P2683, DOI 10.1099/0022-1317-70-10-2683; HOWATSON AF, 1962, VIROLOGY, V16, P466, DOI 10.1016/0042-6822(62)90228-3; HUANG AS, 1966, J MOL BIOL, V22, P381, DOI 10.1016/0022-2836(66)90143-4; Iseni F, 2000, RNA, V6, P270, DOI 10.1017/S135583820099109X; KEENE JD, 1981, P NATL ACAD SCI-BIOL, V78, P6191, DOI 10.1073/pnas.78.10.6191; Martin-Benito J, 2001, EMBO REP, V2, P313, DOI 10.1093/embo-reports/kve063; MCCOMBS RM, 1966, J BACTERIOL, V91, P803, DOI 10.1128/JB.91.2.803-812.1966; NAITO S, 1976, J BIOL CHEM, V251, P4307; NAKAI T, 1968, VIROLOGY, V35, P268, DOI 10.1016/0042-6822(68)90267-5; Schoehn G, 2001, J VIROL, V75, P490, DOI 10.1128/JVI.75.1.490-498.2001; THOMAS D, 1985, J VIROL, V54, P598, DOI 10.1128/JVI.54.2.598-607.1985	18	255	266	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2006	313	5785					357	360		10.1126/science.1126953	http://dx.doi.org/10.1126/science.1126953			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	065IV	16778022				2022-12-24	WOS:000239154300046
J	Klose, RJ; Yamane, K; Bae, YJ; Zhang, DZ; Erdjument-Bromage, H; Tempst, P; Wong, JM; Zhang, Y				Klose, Robert J.; Yamane, Kenichi; Bae, Yangjin; Zhang, Dianzheng; Erdjument-Bromage, Hediye; Tempst, Paul; Wong, Jiemin; Zhang, Yi			The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36	NATURE			English	Article							METHYLATION; BINDING; PROTEIN; DOMAIN; JMJC; CHROMODOMAIN; RECOGNITION; FAMILY; SETDB1; JMJD2A	Post-translational modification of chromatin has profound effects on many biological processes including transcriptional regulation, heterochromatin organization, and X-chromosome inactivation(1,2). Recent studies indicate that methylation on specific histone lysine ( K) residues participates in many of these processes(3). Lysine methylation occurs in three distinct states, having either one (me1), two (me2) or three (me3) methyl groups attached to the amine group of the lysine side chain. These differences in modification state have an important role in defining how methylated chromatin is recognized and interpreted(4-6). Until recently, histone lysine methylation was considered a stable modification(7,8), but the identification of histone demethylase enzymes has demonstrated the reversibility of this epigenetic mark(9-11). So far, all characterized histone demethylases show enzymatic activity towards lysine residues modified in the me1 or me2 state(9-11), leaving open the possibility that me3 constitutes an irreversible modification. Here we demonstrate that JHDM3A ( jumonji C (JmjC)- domain-containing histone demethylase 3A; also known as JMJD2A) is capable of removing the me3 group from modified H3 lysine 9 (H3K9) and H3 lysine 36 (H3K36). Overexpression of JHDM3A abrogates recruitment of HP1 ( heterochromatin protein 1) to heterochromatin, indicating a role for JHDM3A in antagonizing methylated H3K9 nucleated events. siRNA-mediated knockdown of JHDM3A leads to increased levels of H3K9 methylation and upregulation of a JHDM3A target gene, ASCL2, indicating that JHDM3A may function in euchromatin to remove histone methylation marks that are associated with active transcription(12).	Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; Memorial Sloan Kettering Cancer Center	Zhang, Y (corresponding author), Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu	Bae, Yangjin/AAO-1866-2021	Bae, Yangjin/0000-0003-2397-0192; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Zhang, Yi/0000-0002-2789-0811; Wong, Jiemin/0000-0002-5311-842X; Tempst, Paul/0000-0002-6680-3987				Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Clissold PM, 2001, TRENDS BIOCHEM SCI, V26, P7, DOI 10.1016/S0968-0004(00)01700-X; DUERRE JA, 1974, J NEUROCHEM, V23, P541, DOI 10.1111/j.1471-4159.1974.tb06057.x; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Gray SG, 2005, J BIOL CHEM, V280, P28507, DOI 10.1074/jbc.M413687200; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Katoh M, 2004, INT J ONCOL, V24, P1623; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Zhang DZ, 2005, MOL CELL BIOL, V25, P6404, DOI 10.1128/MCB.25.15.6404-6414.2005; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6	28	484	513	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2006	442	7100					312	316		10.1038/nature04853	http://dx.doi.org/10.1038/nature04853			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	064WT	16732292				2022-12-24	WOS:000239122100041
J	Steinbrook, R				Steinbrook, R			For sale: Physician's prescribing data	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						*AM MED ASS, 2004, US PHYS PAT PRESCR D; *AM MED ASS, 2005 ANN REP; *HLTH IMS, 2005 ANN REP; MUSACCHIO RJ, 2006, PHARM EXECUTIVE 0501; SAUL S, 2006, NY TIMES        0504	5	29	30	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 29	2006	354	26					2745	2747		10.1056/NEJMp068125	http://dx.doi.org/10.1056/NEJMp068125			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	057GQ	16807410				2022-12-24	WOS:000238584700001
J	Koh, K; Zheng, XZ; Sehgal, A				Koh, Kyunghee; Zheng, Xiangzhong; Sehgal, Amita			JETLAG resets the Drosophila circadian clock by promoting light-induced degradation of TIMELESS	SCIENCE			English	Article							CRYPTOCHROME; PROTEIN; PHOTORECEPTION; PERIOD; MELANOGASTER; ENTRAINMENT; EXPRESSION; SLIMB	Organisms ranging from bacteria to humans synchronize their internal clocks to daily cycles of light and dark. Photic entrainment of the Drosophila clock is mediated by proteasomal degradation of the clock protein TIMELESS (TIM). We have identified mutations in jetlag-a gene coding for an F-box protein with leucine-rich repeats-that result in reduced light sensitivity of the circadian clock. Mutant flies show rhythmic behavior in constant light, reduced phase shifts in response to light pulses, and reduced light-dependent degradation of TIM. Expression of JET along with the circadian photoreceptor cryptochrome (CRY) in cultured S2R+ cells confers light-dependent degradation onto TIM, thereby reconstituting the acute response of the circadian clock to light in a cell culture system. Our results suggest that JET is essential for resetting the clock by transmitting light signals from CRY to TIM.	Univ Penn, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania	Sehgal, A (corresponding author), Univ Penn, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.	amita@mail.med.upenn.edu		Koh, Kyunghee/0000-0003-0847-8204	Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [R01 NS048471-02, NS048471, R37 NS048471, R01 NS048471, R56 NS048471] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048471, R37NS048471, R56NS048471] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ashmore LJ, 2003, J BIOL RHYTHM, V18, P206, DOI [10.1177/0748730403018003003, 10.1177/0748730403253385]; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Collins B, 2006, CURR BIOL, V16, P441, DOI 10.1016/j.cub.2006.01.034; Dissel S, 2004, NAT NEUROSCI, V7, P834, DOI 10.1038/nn1285; Grima B, 2002, NATURE, V420, P178, DOI 10.1038/nature01122; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Hendricks JC, 2004, SLEEP, V27, P334, DOI 10.1093/sleep/27.2.334; Ivanchenko M, 2001, J BIOL RHYTHM, V16, P205, DOI 10.1177/074873001129001917; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Lin FJ, 2001, MOL CELL BIOL, V21, P7287, DOI 10.1128/MCB.21.21.7287-7294.2001; Mas P, 2003, NATURE, V426, P567, DOI 10.1038/nature02163; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Panda Satchidananda, 2003, Novartis Found Symp, V253, P73; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 1997, EMBO J, V16, P5006, DOI 10.1093/emboj/16.16.5006; Suri VP, 1998, NEURON, V21, P225, DOI 10.1016/S0896-6273(00)80529-2; Tischkau SA, 2003, J BIOL CHEM, V278, P718, DOI 10.1074/jbc.M209241200; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Yang ZH, 1998, NEURON, V21, P215, DOI 10.1016/S0896-6273(00)80528-0	24	223	232	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2006	312	5781					1809	1812		10.1126/science.1124951	http://dx.doi.org/10.1126/science.1124951			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055LS	16794082	Green Accepted			2022-12-24	WOS:000238452800062
J	Tonelli, M; Jose, P; Curhan, G; Sacks, F; Braunwald, E; Pfeffer, M				Tonelli, Marcello; Jose, Powell; Curhan, Gary; Sacks, Frank; Braunwald, Eugene; Pfeffer, Marc		CARE Trial Investigators	Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							URINARY ALBUMIN EXCRETION; CARDIOVASCULAR-DISEASE; RENAL-INSUFFICIENCY; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; RISK-FACTOR; PROGRESSION; MORTALITY; EVENTS; MICROALBUMINURIA	Objectives To determine whether data on proteinuria are useful for refining estimates of risk based on kidney function alone, and whether the results of kidney function tests can be a useful adjunct to data on proteinuria. Design Analysis of data from a randomised trial. Impaired kidney function was defined as low glomerular filtration rate (< 60 ml/min/1.73 m(2)) and proteinuria ( >= 1+ protein) on dipstick urinalysis. Setting Study of cholesterol and recurrent events: a randomised trial of pravastatin 40 mg daily versus placebo. Participants 4098 men and women with previous myocardial infarction. Main outcome measures All cause mortality and cardiovascular events. Results 371 participants died in nearly 60 months of follow-up. Compared with participants without proteinuria or impaired kidney function, patients with both characteristics were at high risk (hazard ratio 2.39, 95% confidence interval 1.72 to 3.30), and those with only proteinuria or only impaired kidney function were at intermediate risk (1.69, 1.32 to 2.16; 1.41, 1.12 to 1.79, respectively) of dying from any cause. The results were similar for cardiovascular outcomes, including new cases of heart failure, stroke, and coronary death or non-fatal myocardial infarction. A graded increase in the risk of all cause mortality was seen for severity of renal impairment and degree of proteinuria by dipstick. Conclusions The presence or absence of proteinuria on dipstick urinalysis may be used to refine estimates of risk based on kidney function alone.	Univ Alberta, Dept Med, Edmonton, AB T6G 2C3, Canada; Yale Univ, Sch Med, New Haven, CT USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	University of Alberta; Yale University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Tonelli, M (corresponding author), Univ Alberta, Dept Med, Edmonton, AB T6G 2C3, Canada.	mtonelli@ualberta.ca	Tonelli, Marcello/B-3028-2009	Tonelli, Marcello/0000-0002-0846-3187				Anavekar NS, 2004, KIDNEY INT, V66, pS50, DOI 10.1111/j.1523-1755.2004.09213.x; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Clausen P, 2001, CIRCULATION, V103, P1869; Culleton BF, 1999, KIDNEY INT, V56, P2214, DOI 10.1046/j.1523-1755.1999.00773.x; Culleton BF, 2000, AM J MED, V109, P1, DOI 10.1016/S0002-9343(00)00444-7; DAMSGAARD EM, 1990, BRIT MED J, V300, P297, DOI 10.1136/bmj.300.6720.297; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Garg AX, 2002, KIDNEY INT, V61, P2165, DOI 10.1046/j.1523-1755.2002.00356.x; Garg AX, 2001, KIDNEY INT, V60, P1867, DOI 10.1046/j.1523-1755.2001.00001.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grimm RH, 1997, KIDNEY INT, pS10; HAKIM RM, 1989, AM J KIDNEY DIS, V14, P396, DOI 10.1016/S0272-6386(89)80173-8; HANNEDOUCHE T, 1993, AM J KIDNEY DIS, V21, P131, DOI 10.1016/0272-6386(93)70104-7; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; Kasiske BI, 2001, ANN INTERN MED, V134, P707, DOI 10.7326/0003-4819-134-8-200104170-00014; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Knight EL, 2004, J AM SOC NEPHROL, V15, P1897, DOI 10.1097/01.asn.0000128966.55133.69; Locatelli F, 1997, MINER ELECTROL METAB, V23, P301; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; McAlister FA, 2004, CIRCULATION, V109, P1004, DOI 10.1161/01.CIR.0000116764.53225.A9; McCullough PA, 2002, AM HEART J, V144, P226, DOI 10.1067/mhj.2002.125513; Nieto FJ, 1996, AM J EPIDEMIOL, V143, P1059; *NKF K DOQI, 2002, AM J KIDNEY DIS S, V39, pS76; Ruilope LM, 2001, J AM SOC NEPHROL, V12, P218, DOI 10.1681/ASN.V122218; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SACKS FM, 1991, AM J CARDIOL, V68, P1436, DOI 10.1016/0002-9149(91)90276-Q; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; SBLIPAK MG, 2002, ANN INTERN MED, V137, P555; Shlipak MG, 2002, ANN INTERN MED, V137, P555, DOI 10.7326/0003-4819-137-7-200210010-00006; Shlipak MG, 2002, KIDNEY INT, V62, P997, DOI 10.1046/j.1523-1755.2002.00522.x; SHULMAN N B, 1989, Hypertension (Dallas), V13, pI80; Stenvinkel P, 2002, KIDNEY INT, V62, P1791, DOI 10.1046/j.1523-1755.2002.00637.x; Stuveling EM, 2004, ATHEROSCLEROSIS, V172, P107, DOI 10.1016/S0021-9150(03)00252-1; Tonelli M, 2001, AM J KIDNEY DIS, V37, P484, DOI 10.1053/ajkd.2001.22070; Wachtell K, 2003, ANN INTERN MED, V139, P901, DOI 10.7326/0003-4819-139-11-200312020-00008	36	150	160	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 17	2006	332	7555					1426	1429		10.1136/bmj.38814.566019.2F	http://dx.doi.org/10.1136/bmj.38814.566019.2F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056UO	16714328	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000238550800032
J	Ikeda, H; Stark, J; Fischer, H; Wagner, M; Drdla, R; Jager, T; Sandkuhler, J				Ikeda, Hiroshi; Stark, Johanna; Fischer, Harald; Wagner, Matthias; Drdla, Ruth; Jager, Tino; Sandkuhler, Jurgen			Synaptic amplifier of inflammatory pain in the spinal dorsal horn	SCIENCE			English	Article							LONG-TERM POTENTIATION; SUBSTANCE-P RECEPTOR; I PROJECTION NEURONS; LAMINA-I; SECONDARY HYPERALGESIA; BRAIN-STEM; HUMANS; CORD; SENSITIZATION; STIMULATION	Inflammation and trauma lead to enhanced pain sensitivity ( hyperalgesia), which is in part due to altered sensory processing in the spinal cord. The synaptic hypothesis of hyperalgesia, which postulates that hyperalgesia is induced by the activity-dependent long-term potentiation (LTP) in the spinal cord, has been challenged, because in previous studies of pain pathways, LTP was experimentally induced by nerve stimulation at high frequencies (similar to 100 hertz). This does not, however, resemble the real low-frequency afferent barrage that occurs during inflammation. We identified a synaptic amplifier at the origin of an ascending pain pathway that is switched-on by low-level activity in nociceptive nerve fibers. This model integrates known signal transduction pathways of hyperalgesia without contradiction.	Med Univ Vienna, Ctr Brain Res, Dept Neurophysiol, Vienna, Austria	Medical University of Vienna	Sandkuhler, J (corresponding author), Med Univ Vienna, Ctr Brain Res, Dept Neurophysiol, Vienna, Austria.	juergen.sandkuehler@meduniwien.ac.at	Sandkühler, Jürgen/B-6648-2012	Sandkühler, Jürgen/0000-0002-5209-485X; Drdla-Schutting, Ruth/0000-0003-0645-986X	Austrian Science Fund FWF [P 18129] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Cavazzini M, 2005, CELL CALCIUM, V38, P355, DOI 10.1016/j.ceca.2005.06.013; CERVERO F, 1993, PAIN, V54, P181, DOI 10.1016/0304-3959(93)90207-6; CRAIG AD, 1995, J COMP NEUROL, V361, P225, DOI 10.1002/cne.903610204; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; HYLDEN JLK, 1989, PAIN, V37, P229, DOI 10.1016/0304-3959(89)90135-8; Ikeda H, 2003, SCIENCE, V299, P1237, DOI 10.1126/science.1080659; Ismailov I, 2004, J NEUROSCI, V24, P9847, DOI 10.1523/JNEUROSCI.0738-04.2004; Khasabov SG, 2002, J NEUROSCI, V22, P9086; Klein T, 2004, J NEUROSCI, V24, P964, DOI 10.1523/JNEUROSCI.1222-03.2004; Koppert W, 2001, ANESTHESIOLOGY, V95, P395, DOI 10.1097/00000542-200108000-00022; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; MALENKA RC, 1992, NEURON, V9, P121, DOI 10.1016/0896-6273(92)90227-5; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; MELLER ST, 1993, PAIN, V52, P127, DOI 10.1016/0304-3959(93)90124-8; Nichols ML, 1999, SCIENCE, V286, P1558, DOI 10.1126/science.286.5444.1558; Perl E. R., 1984, HDB PHYSL 2 1, VIII, P915; Puig S, 1996, PAIN, V64, P345, DOI 10.1016/0304-3959(95)00121-2; Ruscheweyh R, 2004, J PHYSIOL-LONDON, V555, P527, DOI 10.1113/jphysiol.2003.054049; RUSCHEWEYH R, IN PRESS NEUROSCIENC; SIMONE DA, 1991, J NEUROPHYSIOL, V66, P228, DOI 10.1152/jn.1991.66.1.228; Spike RC, 2003, EUR J NEUROSCI, V18, P2433, DOI 10.1046/j.1460-9568.2003.02981.x; Todd AJ, 2000, EUR J NEUROSCI, V12, P689, DOI 10.1046/j.1460-9568.2000.00950.x; Todd AJ, 2002, J NEUROSCI, V22, P4103, DOI 10.1523/JNEUROSCI.22-10-04103.2002; TOREBJORK HE, 1992, J PHYSIOL-LONDON, V448, P765, DOI 10.1113/jphysiol.1992.sp019069; Willis WD, 2001, ANN NY ACAD SCI, V933, P142; Willis WD., 2004, SENSORY MECH SPINAL, V1; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Yaksh TL, 1999, P NATL ACAD SCI USA, V96, P7680, DOI 10.1073/pnas.96.14.7680; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781	29	337	353	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1659	1662		10.1126/science.1127233	http://dx.doi.org/10.1126/science.1127233			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778058				2022-12-24	WOS:000238288600048
J	Williams, MA; Tyznik, AJ; Bevan, MJ				Williams, Matthew A.; Tyznik, Aaron J.; Bevan, Michael J.			Interleukin-2 signals during priming are required for secondary expansion of CD8(+) memory T cells	NATURE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; CD8-T-CELL MEMORY; IMMUNE-RESPONSES; CD4-T-CELL HELP; ACUTE INFECTION; IL-2; MICE; EXPRESSION; EFFECTOR; GENE	Although interleukin-2 (IL-2) was initially characterized as the primary T-cell growth factor following in vitro activation(1), less is known about its role in shaping T-cell responses to acute infections in vivo. The use of IL-2- or IL-2- receptor-deficient mice is problematic owing to their early development of autoimmunity(2-5), attributable to the central role of IL-2 in the generation, maintenance and function of CD4(+) CD25(+) regulatory T cells(6-9). To bypass these inherent difficulties, we have studied the effect of IL-2 on T-cell responses to acute infections by adopting a mixed chimaera strategy in which T cells lacking the high-affinity IL-2 receptor could be studied in an otherwise healthy mouse containing a full complement of regulatory T cells. Here we show that although IL-2 signalling to pathogen-specific CD8(+) T cells affects the number of developing effector and memory cells very little, it is required for the generation of robust secondary responses. This is not due to an altered T-cell-receptor repertoire development or selection, and does not reflect an acute requirement for IL-2 during secondary activation and expansion. Rather, we demonstrate a previously unappreciated role for IL-2 during primary infection in programming the development of CD8(+) memory T cells capable of full secondary expansion. These results have important implications for the development of vaccination or immunotherapeutic strategies aimed at boosting memory T-cell function.	Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	mbevan@u.washington.edu		Williams, Matthew/0000-0002-4721-4482	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019335] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI019335, R01 AI019335-19] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; COUSENS LP, 1995, J IMMUNOL, V155, P5690; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; D'Souza WN, 2003, J IMMUNOL, V171, P5727, DOI 10.4049/jimmunol.171.11.5727; D'Souza WN, 2002, J IMMUNOL, V168, P5566, DOI 10.4049/jimmunol.168.11.5566; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Jameson SC, 2005, SEMIN IMMUNOL, V17, P231, DOI 10.1016/j.smim.2005.02.003; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; KUNDIG TM, 1993, SCIENCE, V262, P1059, DOI 10.1126/science.8235625; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Yu AX, 2003, J IMMUNOL, V170, P236, DOI 10.4049/jimmunol.170.1.236	30	575	586	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					890	893		10.1038/nature04790	http://dx.doi.org/10.1038/nature04790			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16778891	Green Accepted			2022-12-24	WOS:000238254100046
J	Hummel, M; Bentink, S; Berger, H; Klapper, W; Wessendorf, S; Barth, TFE; Bernd, HW; Cogliatti, SB; Dierlamm, J; Feller, AC; Hansmann, ML; Haralambieva, E; Harder, L; Hasenclever, D; Kuhn, M; Lenze, D; Lichter, P; Martin-Subero, JI; Moller, P; Muller-Hermelink, HK; Ott, G; Parwaresch, RM; Pott, C; Rosenwald, A; Rosolowski, M; Schwaenen, C; Sturzenhofecker, B; Szczepanowski, M; Trautmann, H; Wacker, HH; Spang, R; Loeffler, M; Trumper, L; Stein, H; Siebert, R				Hummel, Michael; Bentink, Stefan; Berger, Hilmar; Klapper, Wolfram; Wessendorf, Swen; Barth, Thomas F. E.; Bernd, Heinz-Wolfram; Cogliatti, Sergio B.; Dierlamm, Judith; Feller, Alfred C.; Hansmann, Martin-Leo; Haralambieva, Eugenia; Harder, Lana; Hasenclever, Dirk; Kuehn, Michael; Lenze, Dido; Lichter, Peter; Ignacio Martin-Subero, Jose; Moeller, Peter; Mueller-Hermelink, Hans-Konrad; Ott, German; Parwaresch, Reza M.; Pott, Christiane; Rosenwald, Andreas; Rosolowski, Maciej; Schwaenen, Carsten; Stuerzenhofecker, Benjamin; Szczepanowski, Monika; Trautmann, Heiko; Wacker, Hans-Heinrich; Spang, Rainer; Loeffler, Markus; Truemper, Lorenz; Stein, Harald; Siebert, Reiner		Molecular Mechanisms Malignant Lym	A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C-MYC; CELL; TRANSLOCATIONS; CHEMOTHERAPY; CYTOGENETICS; SUBGROUPS; SURVIVAL; LEUKEMIA; BCL2	Background: The distinction between Burkitt's lymphoma and diffuse large-B-cell lymphoma is unclear. We used transcriptional and genomic profiling to define Burkitt's lymphoma more precisely and to distinguish subgroups in other types of mature aggressive B-cell lymphomas. Methods: We performed gene-expression profiling using Affymetrix U133A GeneChips with RNA from 220 mature aggressive B-cell lymphomas, including a core group of 8 Burkitt's lymphomas that met all World Health Organization (WHO) criteria. A molecular signature for Burkitt's lymphoma was generated, and chromosomal abnormalities were detected with interphase fluorescence in situ hybridization and array-based comparative genomic hybridization. Results: We used the molecular signature for Burkitt's lymphoma to identify 44 cases: 11 had the morphologic features of diffuse large-B-cell lymphomas, 4 were unclassifiable mature aggressive B-cell lymphomas, and 29 had a classic or atypical Burkitt's morphologic appearance. Also, five did not have a detectable IG-myc Burkitt's translocation, whereas the others contained an IG-myc fusion, mostly in simple karyotypes. Of the 176 lymphomas without the molecular signature for Burkitt's lymphoma, 155 were diffuse large-B-cell lymphomas. Of these 155 cases, 21 percent had a chromosomal breakpoint at the myc locus associated with complex chromosomal changes and an unfavorable clinical course. Conclusions: Our molecular definition of Burkitt's lymphoma clarifies and extends the spectrum of the WHO criteria for Burkitt's lymphoma. In mature aggressive B-cell lymphomas without a gene signature for Burkitt's lymphoma, chromosomal breakpoints at the myc locus were associated with an adverse clinical outcome.	Charite Univ Med Berlin, Inst Pathol, D-12200 Berlin, Germany; Max Planck Inst Mol Genet, Dept Computat Mol Biol, Computat Diagnost Grp, Berlin, Germany; Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-7010 Leipzig, Germany; Univ Klinikum Schleswig Holstein, Inst Hematopathol & Lymph Node Registry, Kiel, Germany; Univ Klinikum Schleswig Holstein, Inst Human Genet, Kiel, Germany; Univ Klinikum Schleswig Holstein, Dept Med 2, Kiel, Germany; Univ Ulm Klinikum, Inst Pathol, Ulm, Germany; Univ Klinikum Schleswig Holstein, Inst Pathol, Lubeck, Germany; Univ Hamburg, Klinikum Eppendorf, Dept Hematol & Oncol, Hamburg, Germany; Univ Frankfurt Klinikum, Inst Pathol, D-6000 Frankfurt, Germany; Univ Wurzburg, Inst Pathol, D-8700 Wurzburg, Germany; German Canc Res Ctr, D-6900 Heidelberg, Germany; Interdisciplinary Ctr Bioinformat, Leipzig, Germany; Univ Gottingen, Dept Hematol & Oncol, D-3400 Gottingen, Germany; Kantonsspital St Gallen, Inst Pathol, St Gallen, Switzerland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Leipzig University; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Ulm University; University of Kiel; Schleswig Holstein University Hospital; University of Hamburg; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Wurzburg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Gottingen; Kantonsspital St. Gallen	Stein, H (corresponding author), Charite Univ Med Berlin, Inst Pathol, Campus Benjamin Franklin,Hindenburgdamm 30, D-12200 Berlin, Germany.	Harald.Stein@charite.de	Klapper, Wolfram/S-6314-2016; Klapper, Wolfram/D-2516-2010; Siebert, Reiner/A-8049-2010	Hummel, Michael/0000-0001-6717-605X; Martin-Subero, Jose Ignacio/0000-0001-8809-5195; Spang, Rainer/0000-0002-1326-4297				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Au WY, 2000, HAEMATOLOGICA, V85, P1225; Au WY, 2004, LEUKEMIA LYMPHOMA, V45, P519, DOI 10.1080/10428190310001593120; Bea S, 2005, BLOOD, V106, P3183, DOI 10.1182/blood-2005-04-1399; Boxer LM, 2001, ONCOGENE, V20, P5595, DOI 10.1038/sj.onc.1204595; Chan WC, 1997, BLOOD, V89, P3909; Coiffier B, 2005, J CLIN ONCOL, V23, P6387, DOI 10.1200/JCO.2005.05.015; DIEBOLD J, 2001, PATHOLOGY GENETICS T, V3, P181; Divine M, 2005, ANN ONCOL, V16, P1928, DOI 10.1093/annonc/mdi403; Dunphy CH, 2003, ARCH PATHOL LAB MED, V127, P610; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Gatter KC, 2001, PATHOLOGY GENETICS T, P171; GAUWERKY CE, 1989, P NATL ACAD SCI USA, V86, P8867, DOI 10.1073/pnas.86.22.8867; Hecht JL, 2000, J CLIN ONCOL, V18, P3707, DOI 10.1200/JCO.2000.18.21.3707; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Knezevich S, 2005, LEUKEMIA, V19, P659, DOI 10.1038/sj.leu.2403661; Kramer MHH, 1998, BLOOD, V92, P3152, DOI 10.1182/blood.V92.9.3152.421a07_3152_3162; LEVINE EG, 1989, BLOOD, V74, P1796; Macpherson N, 1999, J CLIN ONCOL, V17, P1558, DOI 10.1200/JCO.1999.17.5.1558; Magrath I, 2001, NEOPLASTIC HEMATOPAT, P953; Martin-Subero JI, 2003, ANTICANCER RES, V23, P1139; Martin-Subero JI, 2002, INT J CANCER, V98, P470, DOI 10.1002/ijc.10169; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; NACHEVA E, 1993, BLOOD, V82, P231, DOI 10.1182/blood.V82.1.231.bloodjournal821231; Pfreundschuh M, 2004, BLOOD, V104, P634, DOI 10.1182/blood-2003-06-2095; PFREUNDSCHUH M, 2004, 46 ANN M AM SOC HEM, P157; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Schwaenen C, 2004, P NATL ACAD SCI USA, V101, P1039, DOI 10.1073/pnas.0304717101; SHIPP MA, 1994, BLOOD, V83, P1165; Ventura RA, 2006, J MOL DIAGN, V8, P141, DOI 10.2353/jmoldx.2006.050083; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100	32	688	714	0	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2006	354	23					2419	2430		10.1056/NEJMoa055351	http://dx.doi.org/10.1056/NEJMoa055351			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	050PQ	16760442				2022-12-24	WOS:000238100800004
J	McCauley, DW; Bronner-Fraser, M				McCauley, DW; Bronner-Fraser, M			Importance of SoxE in neural crest development and the evolution of the pharynx	NATURE			English	Article							EARLY VERTEBRATE EVOLUTION; TRANSCRIPTION FACTOR SOX9; LAMPREY; ORIGIN; HEAD; EXPRESSION; INSIGHTS; GENES; JAW	The neural crest, a defining character of vertebrates(1), is of prime importance to their evolutionary origin(2). To understand neural crest evolution, we explored molecular mechanisms underlying craniofacial development in the basal jawless vertebrate, sea lamprey ( Petromyzon marinus), focusing on the SoxE ( Sox8, Sox9 and Sox10) gene family. In jawed vertebrates, these are important transcriptional regulators of the neural crest(3), and the loss of Sox9 causes abnormal craniofacial development(4,5). Here we report that two lamprey SoxE genes are expressed in migrating neural crest and crest-derived prechondrocytes in posterior branchial arches, whereas a third paralogue is expressed later in the perichondrium and mandibular arch. Morpholino knock-down of SoxE1 reveals that it is essential for posterior branchial arch development, although the mandibular arch is unaffected. The results show that chondrogenic function of SoxE regulators can be traced to the lamprey-gnathostome common ancestor and indicate that lamprey SoxE genes might have undergone independent duplication to have distinct functions in mandibular versus caudal branchial arches. This work sheds light on the homology of vertebrate branchial arches and supports their common origin at the base of vertebrates.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	McCauley, DW (corresponding author), Univ Oklahoma, Dept Zool, Norman, OK 73019 USA.	dwmccauley@ou.edu		Bronner, Marianne/0000-0003-4274-1862				Cerny R, 2004, DEV BIOL, V276, P225, DOI 10.1016/j.ydbio.2004.08.046; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Coates MI, 1998, BIOESSAYS, V20, P371, DOI 10.1002/(SICI)1521-1878(199805)20:5<371::AID-BIES4>3.0.CO;2-R; DAMAS H., 1951, ARCH BIOL, V62, P65; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Graham A, 2001, J ANAT, V199, P133, DOI 10.1017/S0021878201008159; Holland ND, 2001, BIOESSAYS, V23, P142, DOI 10.1002/1521-1878(200102)23:2<142::AID-BIES1021>3.0.CO;2-5; Horigome N, 1999, DEV BIOL, V207, P287, DOI 10.1006/dbio.1998.9175; Janvier P., 1996, EARLY VERTEBRATES; Kimmel CB, 2001, J ANAT, V199, P105, DOI 10.1046/j.1469-7580.2001.19910105.x; Kuratani S, 2004, J EXP ZOOL PART B, V302B, P458, DOI 10.1002/jez.b.21011; Kusakabe R, 2004, J EXP ZOOL PART B, V302B, P121, DOI 10.1002/jez.b.20009; LANGILLE RM, 1988, DEVELOPMENT, V102, P301; MALLATT J, 1984, J ZOOL, V204, P169; McCauley DW, 2003, DEVELOPMENT, V130, P2317, DOI 10.1242/dev.00451; McCauley DW, 2002, GENE, V287, P129, DOI 10.1016/S0378-1119(01)00894-0; Neidert AH, 2001, P NATL ACAD SCI USA, V98, P1665, DOI 10.1073/pnas.98.4.1665; SCHULTZE M, 1956, ENTWICKELUNGSGESCHIC; Spokony RF, 2002, DEVELOPMENT, V129, P421; TAKIO Y, 2004, NATURE          0520; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomsa JM, 1999, DEV BIOL, V207, P26, DOI 10.1006/dbio.1998.9163; Veitch E, 1999, CURR BIOL, V9, P1481, DOI 10.1016/S0960-9822(00)80118-9; Yan YL, 2002, DEVELOPMENT, V129, P5065	24	107	112	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 8	2006	441	7094					750	752		10.1038/nature04691	http://dx.doi.org/10.1038/nature04691			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	050NL	16760978				2022-12-24	WOS:000238095100054
J	Schafer, T; Maco, B; Petfalski, E; Tollervey, D; Bottcher, B; Aebi, U; Hurt, E				Schafer, Thorsten; Maco, Bohumil; Petfalski, Elisabeth; Tollervey, David; Boettcher, Bettina; Aebi, Ueli; Hurt, Ed			Hrr25-dependent phosphorylation state regulates organization of the pre-40S subunit	NATURE			English	Article							PRE-RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; ELECTRON-MICROGRAPHS; NUCLEAR EXPORT; COMPLEX; YEAST; IDENTIFICATION; TRANSCRIPTION; BIOGENESIS; MATURATION	The formation of eukaryotic ribosomes is a multistep process that takes place successively in the nucleolar, nucleoplasmic and cytoplasmic compartments(1-4). Along this pathway, multiple preribosomal particles are generated, which transiently associate with numerous non-ribosomal factors before mature 60S and 40S subunits are formed(5-12). However, most mechanistic details of ribosome biogenesis are still unknown. Here we identify a maturation step of the yeast pre-40S subunit that is regulated by the protein kinase Hrr25 and involves ribosomal protein Rps3. A high salt concentration releases Rps3 from isolated pre-40S particles but not from mature 40S subunits. Electron microscopy indicates that pre-40S particles lack a structural landmark present in mature 40S subunits, the 'beak'. The beak is formed by the protrusion of 18S ribosomal RNA helix 33, which is in close vicinity to Rps3. Two protein kinases Hrr25 and Rio2 are associated with pre-40S particles. Hrr25 phosphorylates Rps3 and the 40S synthesis factor Enp1. Phosphorylated Rsp3 and Enp1 readily dissociate from the pre-ribosome, whereas subsequent dephosphorylation induces formation of the beak structure and salt-resistant integration of Rps3 into the 40S subunit. In vivo depletion of Hrr25 inhibits growth and leads to the accumulation of immature 40S subunits that contain unstably bound Rps3. We conclude that the kinase activity of Hrr25 regulates the maturation of 40S ribosomal subunits.	Univ Heidelberg, Zentrum Biochem, D-69120 Heidelberg, Germany; Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland; Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; European Mol Biol Lab, D-69117 Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Basel; University of Edinburgh; European Molecular Biology Laboratory (EMBL)	Hurt, E (corresponding author), Univ Heidelberg, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	cg5@ix.urz.uni-heidelberg.de	Ed Hurt, Dr./AAE-8874-2019; Bottcher, Bettina/E-9397-2010; Tollervey, David/AAR-6662-2020	Ed Hurt, Dr./0000-0002-4535-8255; Bottcher, Bettina/0000-0002-7962-4849; Tollervey, David/0000-0003-2894-2772; Maco, Bohumil/0000-0001-8444-313X; Schaefer, Thorsten/0000-0003-4867-8374	Natural Environment Research Council [NE/C516928/1] Funding Source: researchfish; Wellcome Trust Funding Source: Medline	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; BELTRAME M, 1992, EMBO J, V11, P1531, DOI 10.1002/j.1460-2075.1992.tb05198.x; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Fatica A, 2002, MOL CELL, V9, P341, DOI 10.1016/S1097-2765(02)00458-6; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; FRANK J, 1982, J MOL BIOL, V161, P107, DOI 10.1016/0022-2836(82)90281-9; FRANK J, 1981, SCIENCE, V214, P1353, DOI 10.1126/science.7313694; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Geerlings TH, 2003, J BIOL CHEM, V278, P22537, DOI 10.1074/jbc.M300759200; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Granneman S, 2005, CURR OPIN CELL BIOL, V17, P281, DOI 10.1016/j.ceb.2005.04.001; Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6; Ho Y, 1997, P NATL ACAD SCI USA, V94, P581, DOI 10.1073/pnas.94.2.581; Leger-Silvestre I, 2004, EMBO J, V23, P2336, DOI 10.1038/sj.emboj.7600252; Loar JW, 2004, GENETICS, V168, P1877, DOI 10.1534/genetics.104.032656; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Milkereit P, 2003, J BIOL CHEM, V278, P4072, DOI 10.1074/jbc.M208898200; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Saveanu C, 2001, EMBO J, V20, P6475, DOI 10.1093/emboj/20.22.6475; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Warner JR, 2001, CELL, V107, P133, DOI 10.1016/S0092-8674(01)00531-1; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006	27	170	173	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					651	655		10.1038/nature04840	http://dx.doi.org/10.1038/nature04840			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16738661				2022-12-24	WOS:000237920800051
J	Vig, M; Peinelt, C; Beck, A; Koomoa, DL; Rabah, D; Koblan-Huberson, M; Kraft, S; Turner, H; Fleig, A; Penner, R; Kinet, JP				Vig, M.; Peinelt, C.; Beck, A.; Koomoa, D. L.; Rabah, D.; Koblan-Huberson, M.; Kraft, S.; Turner, H.; Fleig, A.; Penner, R.; Kinet, J. -P.			CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry	SCIENCE			English	Article							CALCIUM CURRENT; T-LYMPHOCYTES; MAST-CELLS; DEPLETION; CHANNELS; STIM1; ACTIVATION; INFLUX; SENSOR	Store-operited Ca2+ entry is mediated by Ca2+ release-activated Ca2+ (CRAC) channels following Ca2+ release from intracellular stores. We performed a genome-wide RNA interference (RNAi) screen in Drosophila cells to identify proteins that inhibit store-operated Ca2+ influx. A secondary patch-clamp screen identified CRACM1 and CRACM2 (CRAC modulators 1 and 2) as modulators of Drosophila CRAC currents. We characterized the human ortholog of CRACM1, a plasma membrane-resident protein encoded by gene FLJ14466. Although overexpression of CRACM1 did not affect CRAC currents, RNAi-mediated knockdown disrupted its activation. CRACM1 could be the CRAC channel itself, a subunit of it, or a component of the CRAC signaling machinery.	Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96813 USA; Univ Hawaii, Queens Med Ctr, Biomed Res Ctr, Honolulu, HI 96813 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of Hawaii System; The Queen's Medical Center; University of Hawaii System	Vig, M (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.	mvig@bidmc.harvard.edu; rpenner@hawaii.edu; jkinet@bidmc.harvard.edu	Peinelt, Christine/ABH-5292-2020	Peinelt, Christine/0000-0002-3474-6893; Fleig, Andrea/0000-0001-8396-7249; Vig, Monika/0000-0002-4770-8853; Penner, Reinhold/0000-0002-5366-1537	NIAID NIH HHS [R01-AI050200, R01 AI050200] Funding Source: Medline; NIGMS NIH HHS [5-R37-GM053950, R01-GM065360, R37 GM053950, R01 GM065360] Funding Source: Medline; NINDS NIH HHS [R01-NS040927, R01 NS040927] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065360, R37GM053950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040927] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Feske S, 2005, J EXP MED, V202, P651, DOI 10.1084/jem.20050687; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	15	1056	1096	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 26	2006	312	5777					1220	1223		10.1126/science.1127883	http://dx.doi.org/10.1126/science.1127883			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048OW	16645049	Green Accepted			2022-12-24	WOS:000237957400056
J	Bohlenius, H; Huang, T; Charbonnel-Campaa, L; Brunner, AM; Jansson, S; Strauss, SH; Nilsson, O				Bohlenius, H; Huang, T; Charbonnel-Campaa, L; Brunner, AM; Jansson, S; Strauss, SH; Nilsson, O			CO/FT regulatory module controls timing of flowering and seasonal growth cessation in trees	SCIENCE			English	Article							ASPEN POPULUS-TREMULA; BUD SET; BLACK COTTONWOOD; CANDIDATE GENE; SHOOT APEX; ARABIDOPSIS; PHYTOCHROME; FT; INDUCTION; PROTEIN	Forest trees display a perennial growth behavior characterized by a multiple-year delay in flowering and, in temperate regions, an annual cycling between growth and dormancy. We show here that the CO/FT regulatory module, which controls flowering time in response to variations in daylength in annual plants, controls flowering in aspen trees. Unexpectedly, however, it also controls the short-day-induced growth cessation and bud set occurring in the fall. This regulatory mechanism can explain the ecogenetic variation in a highly adaptive trait: the critical daylength for growth cessation displayed by aspen trees sampled across a latitudinal gradient spanning northern Europe.	Swedish Univ Agr Sci, Umea Plant Sci Ctr, Dept Forest Genet & Plant Physiol, S-90183 Umea, Sweden; Virginia Polytech Inst & State Univ, Virginia Tech, Dept Forestry, Blacksburg, VA 24061 USA; Umea Univ, Umea Plant Sci Ctr, Dept Plant Physiol, S-90187 Umea, Sweden; Oregon State Univ, Dept Forest Sci, Corvallis, OR 97331 USA	Swedish University of Agricultural Sciences; Umea University; Virginia Polytechnic Institute & State University; Umea University; Oregon State University	Nilsson, O (corresponding author), Swedish Univ Agr Sci, Umea Plant Sci Ctr, Dept Forest Genet & Plant Physiol, S-90183 Umea, Sweden.	Ove.Nilsson@genfys.slu.se	Jansson, Stefan/A-1119-2009	Jansson, Stefan/0000-0002-7906-6891; Nilsson, Ove/0000-0002-1033-1909				Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Frewen BE, 2000, GENETICS, V154, P837; Horvath DP, 2003, TRENDS PLANT SCI, V8, P534, DOI 10.1016/j.tplants.2003.09.013; Howe GT, 1996, PHYSIOL PLANTARUM, V97, P95, DOI 10.1111/j.1399-3054.1996.tb00484.x; Howe GT, 2003, CAN J BOT, V81, P1247, DOI [10.1139/b03-141, 10.1139/B03-141]; Howe GT, 1998, MOL BIOL EVOL, V15, P160, DOI 10.1093/oxfordjournals.molbev.a025912; Huang T, 2005, SCIENCE, V309, P1694, DOI 10.1126/science.1117768; Ingvarsson PK, 2006, GENETICS, V172, P1845, DOI 10.1534/genetics.105.047522; Ingvarsson PK, 2005, GENETICS, V169, P945, DOI 10.1534/genetics.104.034959; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Olsen JE, 1997, PLANT J, V12, P1339, DOI 10.1046/j.1365-313x.1997.12061339.x; PAULEY S. S., 1954, Journal of the Arnold Arboretum, V35, P167; Pineiro M, 2003, PLANT CELL, V15, P1552, DOI 10.1105/tpc.012153; Rottmann WH, 2000, PLANT J, V22, P235, DOI 10.1046/j.1365-313x.2000.00734.x; Searle I, 2004, EMBO J, V23, P1217, DOI 10.1038/sj.emboj.7600117; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; WEIGEL D, 1995, NATURE, V377, P495, DOI 10.1038/377495a0; WEISER CJ, 1970, SCIENCE, V169, P1299; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996	21	745	837	26	284	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 19	2006	312	5776					1040	1043		10.1126/science.1126038	http://dx.doi.org/10.1126/science.1126038			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043UX	16675663				2022-12-24	WOS:000237628800042
J	Lim, J; Hao, T; Shaw, C; Patel, AJ; Szabo, G; Rual, JF; Fisk, CJ; Li, N; Smolyar, A; Hill, DE; Barabasi, AL; Vidal, M; Zoghbi, HY				Lim, Janghoo; Hao, Tong; Shaw, Chad; Patel, Akash J.; Szabo, Gabor; Rual, Jean-Francois; Fisk, C. Joseph; Li, Ning; Smolyar, Alex; Hill, David E.; Barabasi, Albert-Laszlo; Vidal, Marc; Zoghbi, Huda Y.			A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration	CELL			English	Article							MEDIATES NEURODEGENERATION; CEREBELLAR-ATAXIA; GENE; MOUSE; TOXICITY; MUTATION; MODELS; SCALE; MAP; SPECIFICITY	Many human inherited neurodegenerative disorders are characterized by loss of balance due to cerebellar Purkinje cell (PC) degeneration. Although the disease-causing mutations have been identified for a number of these disorders, the normal functions of the proteins involved remain, in many cases, unknown. To gain insight into the function of proteins involved in PC degeneration, we developed an interaction network for 54 proteins involved in 23 inherited ataxias and expanded the network by incorporating literature-curated and evolutionarily conserved interactions. We identified 770 mostly novel protein-protein interactions using a stringent yeast two-hybrid screen; of 75 pairs tested, 83% of the interactions were verified in mammalian cells. Many ataxia-causing proteins share interacting partners, a subset of which have been found to modify neurodegeneration in animal models. This interactome thus provides a tool for understanding pathogenic mechanisms common for this class of neuroclegenerative disorders and for identifying candidate genes for inherited ataxias.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Howard Hughes Med Inst, Coconut Grove, FL 33133 USA; Harvard Univ, Sch Med, Ctr Canc Syst Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Canc Biol, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Notre Dame, Ctr Complex Network Res, Notre Dame, IN 46556 USA; Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; University of Notre Dame; University of Notre Dame	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	hzoghbi@bcm.tmc.edu	Barabasi, Albert-Laszlo/S-6474-2017; Hill, David E/B-6617-2011	Shaw, Chad/0000-0001-7267-5398; Zoghbi, Huda/0000-0002-0700-3349; Rual, Jean-Francois/0000-0003-4465-8819; Barabasi, Albert/0000-0002-4028-3522	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027699] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24064] Funding Source: Medline; NINDS NIH HHS [NS27699] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Du W, 1996, GENE DEV, V10, P1206, DOI 10.1101/gad.10.10.1206; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; Flajolet M, 2000, GENE, V242, P369, DOI 10.1016/S0378-1119(99)00511-9; Ghosh S, 2004, HUM MOL GENET, V13, P2011, DOI 10.1093/hmg/ddh214; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Hamilton BA, 1996, NATURE, V379, P736, DOI 10.1038/379736a0; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Isaacs AM, 2003, J NEUROSCI, V23, P1631; Ishikawa K, 2005, AM J HUM GENET, V77, P280, DOI 10.1086/432518; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jansen R, 2004, CURR OPIN MICROBIOL, V7, P535, DOI 10.1016/j.mib.2004.08.012; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Kaytor MD, 2005, HUM MOL GENET, V14, P1095, DOI 10.1093/hmg/ddi122; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Legrain P, 2000, FEBS LETT, V480, P32, DOI 10.1016/S0014-5793(00)01774-9; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Matsuda J, 2004, HUM MOL GENET, V13, P2709, DOI 10.1093/hmg/ddh281; Moore RC, 2001, P NATL ACAD SCI USA, V98, P15288, DOI 10.1073/pnas.251550798; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Noveroske JK, 2005, MAMM GENOME, V16, P672, DOI 10.1007/s00335-005-0035-x; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sun XZ, 2001, J NEUROSCI RES, V64, P348, DOI 10.1002/jnr.1085; Taroni F, 2004, NAT REV NEUROSCI, V5, P641, DOI 10.1038/nrn1474; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Vidalain PO, 2004, METHODS, V32, P363, DOI 10.1016/j.ymeth.2003.10.001; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636; Yoshida H, 2002, NEUROBIOL DIS, V10, P88, DOI 10.1006/nbdi.2002.0502; Young A, 2005, BIOINFORMATICS, V21, P275, DOI 10.1093/bioinformatics/bth495; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zoghbi HY, 2002, TRENDS GENET, V18, P463, DOI 10.1016/S0168-9525(02)02729-4	56	596	626	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2006	125	4					801	814		10.1016/j.cell.2006.03.032	http://dx.doi.org/10.1016/j.cell.2006.03.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713569	Bronze			2022-12-24	WOS:000237886000023
J	Sutton, MA; Ito, HT; Cressy, P; Kempf, C; Woo, JC; Schuman, EM				Sutton, Michael A.; Ito, Hiroshi T.; Cressy, Paola; Kempf, Christian; Woo, Jessica C.; Schuman, Erin M.			Miniature neurotransmission stabilizes synaptic function via tonic suppression of local dendritic protein synthesis	CELL			English	Article							GLUTAMATE-RECEPTOR CHANNELS; HIPPOCAMPAL PYRAMIDAL NEURONS; OPTICAL QUANTAL ANALYSIS; HOMEOSTATIC PLASTICITY; NEOCORTICAL NEURONS; CA2+ PERMEABILITY; SPINES; SYNAPSES; EVENTS; TRANSMISSION	Activity deprivation in neurons induces a slow compensatory scaling up of synaptic strength, reflecting a homeostatic mechanism for stabilizing neuronal activity. Prior studies have focused on the loss of action potential (AP) driven neurotransmission in synaptic homeostasis. Here, we show that the miniature synaptic transmission that persists during AP blockade profoundly shapes the time course and mechanism of homeostatic scaling. A brief blockade of NMDA receptor (NMDAR) mediated miniature synaptic events ("minis") rapidly scales up synaptic strength, over an order of magnitude faster than with AP blockade alone. The rapid scaling induced by NMDAR mini blockade is mediated by increased synaptic expression of surface GluR1 and the transient incorporation of Ca2+-permeable AMPA receptors at synapses; both of these changes are implemented locally within dendrites and require dendritic protein synthesis. These results indicate that NMDAR signaling during miniature synaptic transmission serves to stabilize synaptic function through active suppression of dendritic protein synthesis.	CALTECH, Div Biol 11496, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Schuman, EM (corresponding author), CALTECH, Div Biol 11496, Pasadena, CA 91125 USA.	schumane@its.caltech.edu	Sutton, Michael/C-6264-2011; Schuman, Erin M/D-6204-2011	Sutton, Michael/0000-0002-0692-6459				Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; AXELSSON J, 1959, J PHYSIOL-LONDON, V147, P178, DOI 10.1113/jphysiol.1959.sp006233; Benson DL, 1997, NEUROREPORT, V8, P823, DOI 10.1097/00001756-199703030-00004; BLASCHKE M, 1993, P NATL ACAD SCI USA, V90, P6528, DOI 10.1073/pnas.90.14.6528; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Dravid SM, 2003, NEUROSCI LETT, V351, P145, DOI 10.1016/j.neulet.2003.07.017; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Emptage NJ, 2003, NEURON, V38, P797, DOI 10.1016/S0896-6273(03)00325-8; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Gardiol A, 1999, J NEUROSCI, V19, P168, DOI 10.1523/JNEUROSCI.19-01-00168.1999; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Horton AC, 2003, J NEUROSCI, V23, P6188; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Kacharmina JE, 2000, P NATL ACAD SCI USA, V97, P11545, DOI 10.1073/pnas.97.21.11545; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; LERMA J, 1994, EUR J NEUROSCI, V6, P1080, DOI 10.1111/j.1460-9568.1994.tb00605.x; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; MIYASHIRO K, 1994, P NATL ACAD SCI USA, V91, P10800, DOI 10.1073/pnas.91.23.10800; MURPHY TH, 1994, J NEUROSCI, V14, P1320, DOI 10.1523/JNEUROSCI.14-03-01320.1994; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Pierce JP, 2000, NAT NEUROSCI, V3, P311, DOI 10.1038/73868; PRUSS RM, 1991, NEURON, V7, P509, DOI 10.1016/0896-6273(91)90302-G; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Scheenen WJJM, 1996, CHEM BIOL, V3, P765, DOI 10.1016/S1074-5521(96)90253-7; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Smith WB, 2005, NEURON, V45, P765, DOI 10.1016/j.neuron.2005.01.015; Stewart JJ, 2000, J CLIN PHARMACOL, V40, P347, DOI 10.1177/00912700022009044; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Torre ER, 1996, J NEUROSCI, V16, P5967; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Wang S, 1999, CAN J PHYSIOL PHARM, V77, P651, DOI 10.1139/cjpp-77-9-651; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Yin HZ, 1999, J COMP NEUROL, V409, P250; Yuste R, 1999, J NEUROSCI, V19, P1976; Zhang JC, 2005, BRAIN RES, V1050, P110, DOI 10.1016/j.brainres.2005.05.032	42	459	464	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2006	125	4					785	799		10.1016/j.cell.2006.03.040	http://dx.doi.org/10.1016/j.cell.2006.03.040			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16713568	Bronze			2022-12-24	WOS:000237886000022
J	Roberts, DM; Nanda, A; Havenga, MJE; Abbink, P; Lynch, DM; Ewald, BA; Liu, J; Thorner, AR; Swanson, PE; Gorgone, DA; Lifton, MA; Lemckert, AAC; Holterman, L; Chen, B; Dilraj, A; Carville, A; Mansfield, KG; Goudsmit, J; Barouch, DH				Roberts, DM; Nanda, A; Havenga, MJE; Abbink, P; Lynch, DM; Ewald, BA; Liu, J; Thorner, AR; Swanson, PE; Gorgone, DA; Lifton, MA; Lemckert, AAC; Holterman, L; Chen, B; Dilraj, A; Carville, A; Mansfield, KG; Goudsmit, J; Barouch, DH			Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity	NATURE			English	Article							NEUTRALIZING ANTIBODIES; RECOMBINANT ADENOVIRUS; RHESUS-MONKEYS; VACCINE VECTOR; PROTEIN; GENE; IMMUNOGENICITY; VIRUS; RESOLUTION; INFECTION	A common viral immune evasion strategy involves mutating viral surface proteins in order to evade host neutralizing antibodies. Such immune evasion tactics have not previously been intentionally applied to the development of novel viral gene delivery vectors that overcome the critical problem of anti-vector immunity. Recombinant, replication-incompetent adenovirus serotype 5 (rAd5) vector-based vaccines for human immunodeficiency virus type 1 and other pathogens have proved highly immunogenic in preclinical studies(1,2) but will probably be limited by the high prevalence of pre-existing anti-Ad5 immunity in human populations, particularly in the developing world(3-6). Here we show that rAd5 vectors can be engineered to circumvent anti-Ad5 immunity. We constructed novel chimaeric rAd5 vectors in which the seven short hypervariable regions (HVRs) on the surface of the Ad5 hexon protein were replaced with the corresponding HVRs from the rare adenovirus serotype Ad48. These HVR-chimaeric rAd5 vectors were produced at high titres and were stable through serial passages in vitro. HVR-chimaeric rAd5 vectors expressing simian immunodeficiency virus Gag proved comparably immunogenic to parental rAd5 vectors in naive mice and rhesus monkeys. In the presence of high levels of pre-existing anti-Ad5 immunity, the immunogenicity of HVR-chimaeric rAd5 vectors was not detectably suppressed, whereas the immunogenicity of parental rAd5 vectors was abrogated. These data demonstrate that functionally relevant Ad5-specific neutralizing antibodies are focused on epitopes located within the hexon HVRs. Moreover, these studies show that recombinant viral vectors can be engineered to circumvent pre-existing anti-vector immunity by removing key neutralizing epitopes on the surface of viral capsid proteins. Such chimaeric viral vectors may have important practical implications for vaccination and gene therapy.	Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA; Crucell Holland BV, NL-2301 CA Leiden, Netherlands; Harvard Univ, Sch Med, Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA; S African MRC, ZA-4001 Durban, South Africa; New England Reg Primate Res Ctr, Southborough, MA 01772 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Johnson & Johnson; Harvard University; Boston Children's Hospital; Harvard Medical School; South African Medical Research Council	Barouch, DH (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA.	dbarouch@bidmc.harvard.edu	Barouch, Dan/Y-3918-2019					ATHAPPILLY FK, 1994, J MOL BIOL, V242, P430, DOI 10.1006/jmbi.1994.1593; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Casimiro DR, 2003, J VIROL, V77, P6305, DOI 10.1128/JVI.77.11.6305-6313.2003; CrawfordMiksza L, 1996, J VIROL, V70, P1836, DOI 10.1128/JVI.70.3.1836-1844.1996; Gahery-Segard H, 1998, J VIROL, V72, P2388; Gall JGD, 1998, J VIROL, V72, P10260, DOI 10.1128/JVI.72.12.10260-10264.1998; Havenga MJE, 2001, J VIROL, V75, P3335, DOI 10.1128/JVI.75.7.3335-3342.2001; Hong SS, 2003, J VIROL, V77, P10366, DOI 10.1128/JVI.77.19.10366-10375.2003; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kostense S, 2004, AIDS, V18, P1213, DOI 10.1097/00002030-200405210-00019; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Nanda A, 2005, J VIROL, V79, P14161, DOI 10.1128/JVI.79.22.14161-14168.2005; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Rux JJ, 2003, J VIROL, V77, P9553, DOI 10.1128/JVI.77.17.9553-9566.2003; Shiver JW, 2004, ANNU REV MED, V55, P355, DOI 10.1146/annurev.med.55.091902.104344; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Sprangers MC, 2003, J CLIN MICROBIOL, V41, P5046, DOI 10.1128/JCM.41.11.5046-5052.2003; Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876; Sumida SM, 2005, J IMMUNOL, V174, P7179, DOI 10.4049/jimmunol.174.11.7179; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; WOHLFART C, 1988, J VIROL, V62, P2321, DOI 10.1128/JVI.62.7.2321-2328.1988; Youil R, 2002, HUM GENE THER, V13, P311, DOI 10.1089/10430340252769824	22	373	412	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2006	441	7090					239	243		10.1038/nature04721	http://dx.doi.org/10.1038/nature04721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16625206				2022-12-24	WOS:000237418800051
J	Lorenz, RD; Wall, S; Radebaugh, J; Boubin, G; Reffet, E; Janssen, M; Stofan, E; Lopes, R; Kirk, R; Elachi, C; Lunine, J; Mitchell, K; Paganelli, F; Soderblom, L; Wood, C; Wye, L; Zebker, H; Anderson, Y; Ostro, S; Allison, M; Boehmer, R; Callahan, P; Encrenaz, P; Ori, GG; Francescetti, G; Gim, Y; Hamilton, G; Hensley, S; Johnson, W; Kelleher, K; Muhleman, D; Picardi, G; Posa, F; Roth, L; Seu, R; Shaffer, S; Stiles, B; Vetrella, S; Flamini, E; West, R				Lorenz, RD; Wall, S; Radebaugh, J; Boubin, G; Reffet, E; Janssen, M; Stofan, E; Lopes, R; Kirk, R; Elachi, C; Lunine, J; Mitchell, K; Paganelli, F; Soderblom, L; Wood, C; Wye, L; Zebker, H; Anderson, Y; Ostro, S; Allison, M; Boehmer, R; Callahan, P; Encrenaz, P; Ori, GG; Francescetti, G; Gim, Y; Hamilton, G; Hensley, S; Johnson, W; Kelleher, K; Muhleman, D; Picardi, G; Posa, F; Roth, L; Seu, R; Shaffer, S; Stiles, B; Vetrella, S; Flamini, E; West, R			The sand seas of Titan: Cassini RADAR observations of longitudinal dunes	SCIENCE			English	Article							SURFACE; WINDS	The most recent Cassini RADAR images of Titan show widespread regions ( up to 1500 kilometers by 200 kilometers) of near-parallel radar-dark linear features that appear to be seas of longitudinal dunes similar to those seen in the Namib desert on Earth. The Ku-band (2.17-centimeter wavelength) images show similar to 100-meter ridges consistent with duneforms and reveal flow interactions with underlying hills. The distribution and orientation of the dunes support a model of fluctuating surface winds of similar to 0.5 meter per second resulting from the combination of an eastward flow with a variable tidal wind. The existence of dunes also requires geological processes that create sand-sized (100- to 300-micrometer) particulates and a lack of persistent equatorial surface liquids to act as sand traps.	Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Proxemy Res, Bowie, MD 20715 USA; Planetary Sci Inst, Tucson, AZ 85719 USA; Wheeling Jesuit Coll, Wheeling, WV 26003 USA; Stanford Univ, Stanford, CA 94305 USA; NASA, Goddard Inst Space Studies, New York, NY 10025 USA; Observ Paris, F-92195 Meudon, France; Univ G DAnnunzio, Int Res Sch Planetary Sci, I-65127 Pescara, Italy; Fac Ingn, I-80125 Naples, Italy; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Univ Roma La Sapienza, I-00184 Rome, Italy; Politecn Bari, Dipartimento Interateneo Fis, I-70126 Bari, Italy; INFM, I-70126 Bari, Italy; Agenzia Spaziale Italiana, I-00131 Rome, Italy	University of Arizona; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of the Interior; United States Geological Survey; Wheeling University; Stanford University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; G d'Annunzio University of Chieti-Pescara; California Institute of Technology; Sapienza University Rome; Politecnico di Bari; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Agenzia Spaziale Italiana (ASI)	Lorenz, RD (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	rlorenz@lpl.arizona.edu	Lopes, Rosaly M.C./D-1608-2016; Mitchell, Karl Leon/AAG-3821-2020; Mitchell, Karl Leon/AGL-9516-2022; Lorenz, Ralph D/B-8759-2016	Lopes, Rosaly M.C./0000-0002-7928-3167; Mitchell, Karl Leon/0000-0003-1093-8441; Lorenz, Ralph D/0000-0001-8528-4644; ORI, Gian Gabriele/0000-0002-6460-1476; zebker, howard/0000-0001-9931-5237; Lunine, Jonathan/0000-0003-2279-4131				ALLISON M, 1992, P S TIT TOUL FRANC 9, P113; Bagnold R. A., 1941, PHYS WIND BLOWN SAND; Bird MK, 2005, NATURE, V438, P800, DOI 10.1038/nature04060; EDGETT KS, 2000, LUNAR PLANET SCI, V31, P1070; Elachi C, 2005, SCIENCE, V308, P970, DOI 10.1126/science.1109919; ELACHI C, IN PRESS NATURE; FRYBERGER SG, 1979, US GEOLOGICAL SURVEY, V1052, P137; Greeley R., 1985, WIND GEOLOGICAL PROC, DOI 10.1017/CBO9780511573071; Hartung M, 2004, ASTRON ASTROPHYS, V421, pL17, DOI 10.1051/0004-6361:20040171; HUTHNANCE JM, 1982, ESTUAR COAST SHELF S, V14, P79, DOI 10.1016/S0302-3524(82)80068-6; Lancaster N., 1995, GEOMORPHOLOGY DESERT; LEE P, 1995, J GEOPHYS RES-PLANET, V100, P5381, DOI 10.1029/95JE00225; Lorenz R. D., 2002, LIFTING TITANS VEIL; Lorenz RD, 2005, PLANET SPACE SCI, V53, P557, DOI 10.1016/j.pss.2004.06.004; LORENZ RD, 1992, ESA, P119; LORENZ RD, IN PRESS ICARUS; LORENZ RD, 1995, J GEOPHYS RES-PLANET, V88, P26377; Porco CC, 2005, NATURE, V434, P159, DOI 10.1038/nature03436; Rannou P, 2006, SCIENCE, V311, P201, DOI 10.1126/science.1118424; Roe HG, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019871; RUBIN DM, 1990, SEDIMENTOLOGY, V37, P673, DOI 10.1111/j.1365-3091.1990.tb00628.x; Smith PH, 1996, ICARUS, V119, P336, DOI 10.1006/icar.1996.0023; Tokano T, 2002, ICARUS, V158, P499, DOI 10.1006/icar.2002.6883; Tomasko MG, 2005, NATURE, V438, P765, DOI 10.1038/nature04126; West RA, 2005, NATURE, V436, P670, DOI 10.1038/nature03824; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963; [No title captured]	27	271	278	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 5	2006	312	5774					724	727		10.1126/science.1123257	http://dx.doi.org/10.1126/science.1123257			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675695				2022-12-24	WOS:000237312100044
J	Bonetta, L				Bonetta, L			An expression of interest	NATURE			English	Article																			0	5	6	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 27	2006	440	7088					1233	+		10.1038/4401233a	http://dx.doi.org/10.1038/4401233a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16642003	Bronze			2022-12-24	WOS:000237080000054
J	Iimura, T; Pourquie, O				Iimura, Tadahiro; Pourquie, Olivier			Collinear activation of Hoxb genes during gastrulation is linked to mesoderm cell ingression	NATURE			English	Article							MOUSE EMBRYO; EXPRESSION; CHICK; COMPLEXES; PATTERN; MURINE	The vertebral column exhibits segmentation and regionalization along the antero-posterior axis. During embryogenesis, the rhythmic production of the precursors of the vertebrae, the somites, imposes a segmented aspect to the spine, whereas the spine's regional differentiation is controlled by Hox genes(1,2). Here we show that in the paraxial mesoderm, Hoxb genes are first activated in a temporal collinear fashion in precursors located in the epiblast lateral to the primitive streak. Our data suggest that collinear activation of Hoxb genes regulates the flux of cells from the epiblast to the streak and thus directly controls the establishment of the genes' characteristic nested expression domains in the somites. This suggests that establishment of the spatial co-linearity in the embryo is directly controlled by the Hox genes themselves.	Howard Hughes Med Inst, Kansas City, MO 64110 USA; Stowers Inst Med Res, Kansas City, MO 64110 USA	Howard Hughes Medical Institute; Stowers Institute for Medical Research	Pourquie, O (corresponding author), Howard Hughes Med Inst, 1000 E 50th St, Kansas City, MO 64110 USA.	olp@stowers-institute.org	Pourquié, Olivier/CAJ-5443-2022; Iimura, Tadahiro/P-3550-2018	Pourquié, Olivier/0000-0001-5189-1227; Iimura, Tadahiro/0000-0002-1431-0689				Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.3.CO;2-X; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; DUBOULE D, 1994, TRENDS GENET, V10, P358, DOI 10.1016/0168-9525(94)90132-5; Forlani S, 2003, DEVELOPMENT, V130, P3807, DOI 10.1242/dev.00573; GARCIAMARTINEZ V, 1993, J EXP ZOOL, V267, P431, DOI 10.1002/jez.1402670409; GAUNT SJ, 1988, DEVELOPMENT, V104, P169; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Greer JM, 2000, NATURE, V403, P661, DOI 10.1038/35001077; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Kesselman MA, 2004, BOOK LIB IN, V67, P89; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Nicolet G., 1971, Adv Morphogen, V9, P231; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; STERN CD, 2004, GASTRULATION CELLS E, P219; STEWART CL, 1987, EMBO J, V6, P383, DOI 10.1002/j.1460-2075.1987.tb04766.x; TAM PPL, 1992, DEVELOPMENT, V115, P703; Wacker SA, 2004, DEV BIOL, V268, P207, DOI 10.1016/j.ydbio.2003.12.022; Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3	24	162	167	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2006	442	7102					568	571		10.1038/nature04838	http://dx.doi.org/10.1038/nature04838			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	069NQ	16760928				2022-12-24	WOS:000239455900044
J	Brauer, SL; Cadillo-Quiroz, H; Yashiro, E; Yavitt, JB; Zinder, SH				Braeuer, Suzanna L.; Cadillo-Quiroz, Hinsby; Yashiro, Erika; Yavitt, Joseph B.; Zinder, Stephen H.			Isolation of a novel acidiphilic methanogen from an acidic peat bog	NATURE			English	Article							OLIGOTROPHIC FEN; NEW-YORK; BACTERIA; COMMUNITIES; POPULATIONS; PEATLANDS; DIVERSITY	Acidic peatlands are among the largest natural sources of atmospheric methane and harbour a large diversity of methanogenic Archaea(1). Despite the ubiquity of methanogens in these peatlands, indigenous methanogens capable of growth at acidic pH values have resisted culture and isolation(2-4); these recalcitrant methanogens include members of an uncultured family-level clade in the Methanomicrobiales prevalent in many acidic peat bogs in the Northern Hemisphere(1,5,6). However, we recently succeeded in obtaining a mixed enrichment culture of a member of this clade(7). Here we describe its isolation and initial characterization. We demonstrate that the optimum pH for methanogenesis by this organism is lower than that of any previously described methanogen.	Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; Cornell Univ, Dept Nat Resources, Ithaca, NY 14853 USA	Cornell University; Cornell University	Zinder, SH (corresponding author), Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA.	shz1@cornell.edu	Yashiro, Erika/G-6234-2016	Yashiro, Erika/0000-0002-2364-9908; Cadillo-Quiroz, Hinsby/0000-0002-4908-4597				Angert ER, 2005, NAT REV MICROBIOL, V3, P214, DOI 10.1038/nrmicro1096; Basiliko N, 2003, GEOMICROBIOL J, V20, P563, DOI 10.1080/713851165; Brauer SL, 2004, GEOMICROBIOL J, V21, P433, DOI 10.1080/01490450490505400; BRAUER SL, IN PRESS FEMS MICROB; Brook EJ, 2005, SCIENCE, V310, P1285, DOI 10.1126/science.1121535; CADILLOQUIROZ H, IN PRESS ENV MICROBI; Cicerone RJ, 1988, GLOBAL BIOGEOCHEM CY, V2, P299, DOI 10.1029/GB002i004p00299; Dedysh SN, 1998, SCIENCE, V282, P281, DOI 10.1126/science.282.5387.281; Franzmann PD, 1997, INT J SYST BACTERIOL, V47, P1068, DOI 10.1099/00207713-47-4-1068; Galand PE, 2003, ENVIRON MICROBIOL, V5, P1133, DOI 10.1046/j.1462-2920.2003.00520.x; Galand PE, 2002, FEMS MICROBIOL ECOL, V42, P441, DOI 10.1111/j.1574-6941.2002.tb01033.x; GOODWIN S, 1987, APPL ENVIRON MICROB, V53, P57, DOI 10.1128/AEM.53.1.57-64.1987; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Hales BA, 1996, APPL ENVIRON MICROB, V62, P668, DOI 10.1128/AEM.62.2.668-675.1996; Horn MA, 2003, APPL ENVIRON MICROB, V69, P74, DOI 10.1128/AEM.69.1.74-83.2003; Juottonen H, 2005, ENVIRON MICROBIOL, V7, P1547, DOI 10.1111/j.1462-2920.2005.00838.x; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Kotsyurbenko OR, 2004, ENVIRON MICROBIOL, V6, P1159, DOI 10.1111/j.1462-2920.2004.00634.x; MAESTROJUAN GM, 1991, INT J SYST BACTERIOL, V41, P267, DOI 10.1099/00207713-41-2-267; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; PATEL GB, 1990, INT J SYST BACTERIOL, V40, P12, DOI 10.1099/00207713-40-1-12; RASKIN L, 1994, APPL ENVIRON MICROB, V60, P1232, DOI 10.1128/AEM.60.4.1232-1240.1994; Sizova MV, 2003, FEMS MICROBIOL ECOL, V45, P301, DOI 10.1016/S0168-6496(03)00165-X; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; WILLIAMS RT, 1985, APPL ENVIRON MICROB, V50, P1542, DOI 10.1128/AEM.50.6.1542-1544.1985	25	121	134	5	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2006	442	7099					192	194		10.1038/nature04810	http://dx.doi.org/10.1038/nature04810			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062XJ	16699521	Green Submitted			2022-12-24	WOS:000238979700045
J	Belsky, J; Melhuish, E; Barnes, J; Leyland, AH; Romaniuk, H				Belsky, Jay; Melhuish, Edward; Barnes, Jacqueline; Leyland, Alastair H.; Romaniuk, Helena		Natl Evaluation Sure Start Res	Effects of Sure Start local programmes on children and families: early findings from a quasi-experimental, cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To evaluate die effects of Sure Start local programmes (SSLPs) on children and their families. To assess whether variations in the effectiveness of SSLPs are due to differences in implementation. Design Quasi-experimental cross sectional study using interviews with mothers and cognitive assessment of children aged 36 months who speak English. Setting Socially deprived communities in England: 150 communities with ongoing SSLPs and 50 comparison communities. Participants Mothers of 12 575 children aged 9 months and 3927 children aged 36 months in SSLP areas; mothers of 1509 children aged 9 months and 110 1 children aged 36 months in comparison communities. Outcome measures Mothers' reports of community services and local area, family functioning and parenting skills, child health and development, and verbal ability at 36 months. Results Differences between SSLP areas and comparison areas were limited, small, and varied by degree of social deprivation. SSLPs had beneficial effects on non-teenage mothers (better parenting, better social functioning in children) and adverse effects on children of teenage mothers (poorer social functioning) and children of single parents or parents who did not work (lower verbal ability). SSLPs led by health services were slightly more effective than other SSLPs. Conclusion SSLPs seem to benefit relatively less socially deprived parents (who have greater personal resources) and their children but seem to have an adverse effect on the most disadvantaged children. Programmes led by health services seem to be more effective than programmes led by other agencies.	Univ London, Birkbeck, Inst Study Children Families & Social Issues, London WC1B 3RA, England; Univ Glasgow, MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland	University of London; Birkbeck University London; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	Belsky, J (corresponding author), Univ London, Birkbeck, Inst Study Children Families & Social Issues, London WC1B 3RA, England.	j.belsky@bbk.ac.uk	Leyland, Alastair/C-6069-2011	Leyland, Alastair/0000-0003-3741-7099; Romaniuk, Helena/0000-0002-5801-2077; Belsky, Jay/0000-0003-2191-2503	Medical Research Council [MC_U130059823] Funding Source: Medline; Chief Scientist Office [SPHSU2] Funding Source: Medline; MRC [MC_U130059823] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bachman J. G., 1978, ADOLESCENCE ADULTHOO; BARNES J, 2003, CHARACTERISTICS SURE; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Krull JL, 1999, EVALUATION REV, V23, P418, DOI 10.1177/0193841X9902300404; Love JM., 2002, MAKING DIFFERENCE LI, VI; McGuire JB, 1997, J COMMUNITY PSYCHOL, V25, P551; MEADOWS P, 2006, INTERIM REPORT COST; *NAT EV SUR START, 2005, 13 NAT EV SUR START; RAMEY CT, 2000, APPL DEV SCI, V0004; Rutter M., 1970, ED HLTH BEHAV; Schafer J., 1999, ANAL INCOMPLETE MULT; WEBSTERSTRATTON C, 1993, SCHOOL PSYCHOL REV, V22, P437	12	115	115	0	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2006	332	7556					1476	+		10.1136/bmj.38853.451748.2F	http://dx.doi.org/10.1136/bmj.38853.451748.2F			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	060RV	16782721	Green Accepted, Green Published, Green Submitted, Bronze			2022-12-24	WOS:000238820200015
J	August, P; Suthanthiran, M				August, P; Suthanthiran, M			Transforming growth factor beta signaling, vascular remodeling, and hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BLOOD-PRESSURE		Cornell Univ, Weill Med Coll, New York, NY 10021 USA; New York Hosp Queens, Theresa & Eugene Lang Ctr Res & Educ, Flushing, NY USA	Cornell University; NewYork-Presbyterian Hospital	August, P (corresponding author), Cornell Univ, Weill Med Coll, New York, NY 10021 USA.		Suthanthiran, Manikkam/AAL-9104-2020					Border WA, 1998, HYPERTENSION, V31, P181, DOI 10.1161/01.HYP.31.1.181; Cambien F, 1996, HYPERTENSION, V28, P881, DOI 10.1161/01.HYP.28.5.881; Lavoie P, 2005, J HYPERTENS, V23, P1895, DOI 10.1097/01.hjh.0000182521.44440.c5; Suthanthiran M, 2000, P NATL ACAD SCI USA, V97, P3479, DOI 10.1073/pnas.050420897; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035	5	53	54	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2006	354	25					2721	2723		10.1056/NEJMcibr062143	http://dx.doi.org/10.1056/NEJMcibr062143			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	054ZJ	16790709				2022-12-24	WOS:000238416900016
J	Villar, J; Valladares, E; Wojdyla, D; Zavaleta, N; Carroli, G; Velazco, A; Shah, A; Campodonico, L; Bataglia, V; Faundes, A; Langer, A; Narvaez, A; Donner, A; Romero, M; Reynoso, S; de Padua, KS; Giordano, D; Kublickas, M; Acosta, A				Villar, Jose; Valladares, Eliette; Wojdyla, Daniel; Zavaleta, Nelly; Carroli, Guillermo; Velazco, Alejandro; Shah, Archana; Campodonico, Liana; Bataglia, Vicente; Faundes, Anibal; Langer, Ana; Narvaez, Alberto; Donner, Allan; Romero, Mariana; Reynoso, Sofia; Simonia de Padua, Karla; Giordano, Daniel; Kublickas, Marius; Acosta, Arnaldo		WHO 2005 global survey maternal pe	Caesarean delivery rates and pregnancy outcomes: the 2005 WHO global survey on maternal and perinatal health in Latin America	LANCET			English	Article							SECTION; RISK; OBSTETRICIANS	Background Caesarean delivery rates continue to increase worldwide. Our aim was to assess the association between Caesarean delivery and pregnancy outcome at the institutional level, adjusting for the pregnant population and institutional characteristics. Methods For the 2005 WHO global survey on maternal and perinatal health, we assessed a multistage stratified sample, comprising 24 geographic regions in eight countries in Latin America. We obtained individual data for all women admitted for delivery over 3 months to 120 institutions randomly selected from of 410 identified institutions. We also obtained institutional-level data. Findings We obtained data for 97095 of 106 546 deliveries (91% coverage). The median rate of Caesarean delivery was 33% (quartile range 24-43), with the highest rates of Caesarean delivery noted in private hospitals (51%, 43-57). Institution-specific rates of Caesarean delivery were affected by primiparity previous Caesarean delivery, and institutional complexity. Rate of Caesarean delivery was positively associated with postpartum antibiotic treatment and severe maternal morbidity and mortality; even after adjustment for risk factors. Increase in the rate of Caesarean delivery was associated with an increase in fetal mortality rates and higher numbers of babies admitted to intensive care for 7 days or longer even after adjustment for preterm, delivery. Rates of preterm delivery and neonatal mortality both rose at rates of Caesarean delivery of between 10% and 20%. Interpretation High rates of Caesarean delivery do not necessarily indicate better perinatal care and can be associated with harm.	WHO, UNDP UNFPA, World Bank Special Programme Res Dev & Res Traini, Dept Reprod Hlth & Res, CH-1211 Geneva 27, Switzerland; Univ Nacl Autonoma Nicaragua, Leon, Nicaragua; Ctr Rosarino Estud Perinatales, Rosario, Argentina; Inst Invest Nutr, Lima, Peru; Hosp Docente Ginecobstet Amer Arias, Havana, Cuba; Hosp Nacl Itaugua, Dept Obstet & Gynecol, Asuncion, Paraguay; Ctr Pesquisas Saude Reprod Campinas, Campinas, SP, Brazil; EngenderHlth, New York, NY USA; Fdn Salud Ambientey & Desarrollo, Quito, Ecuador; Univ Western Ontario, Dept Epidemiol & Biostat, Schulich Sch Med & Dent, London, ON, Canada; Consejo Nacl Invest Cient & Tecn, Ctr Estud Estado & Sociedad, RA-1033 Buenos Aires, DF, Argentina; Latin Amer Off, Populat Council, Mexico City, DF, Mexico; Karolinska Inst, Stockholm, Sweden; Univ Nacl Asuncion, Dept Obstet & Gynaecol, Asuncion, Paraguay	The World Bank; United Nations Population Fund; World Health Organization; Western University (University of Western Ontario); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Karolinska Institutet; Universidad Nacional de Asuncion	Villar, J (corresponding author), WHO, UNDP UNFPA, World Bank Special Programme Res Dev & Res Traini, Dept Reprod Hlth & Res, CH-1211 Geneva 27, Switzerland.	villarj@who.int		Romero, Mariana/0000-0003-4272-3138; Zavaleta, Nelly/0000-0002-6929-5834				AlMufti R, 1996, LANCET, V347, P544, DOI 10.1016/S0140-6736(96)91176-9; Althabe F, 2004, LANCET, V363, P1934, DOI 10.1016/S0140-6736(04)16406-4; [Anonymous], 1985, LANCET, V2, P436; [Anonymous], 1997, LANCET, V349, P815; Arias E, 2003, PEDIATRICS, V112, P1215, DOI 10.1542/peds.112.6.1215; Belizan JM, 1999, BMJ-BRIT MED J, V319, P1397, DOI 10.1136/bmj.319.7222.1397; Bonilla E, 1990, Jordemodern, V103, P24; CLEVELAND SW, 1993, VISUALIZING DATA; Cotzias CS, 2001, EUR J OBSTET GYN R B, V97, P15, DOI 10.1016/S0301-2115(00)00360-2; Draper N.R., 1998, WILEY SERIES PROBABI, V326; Kalish RB, 2004, OBSTET GYNECOL, V103, P1137, DOI 10.1097/01.AOG.0000128118.37737.df; Lavender T, 2005, BMJ-BRIT MED J, V331, P490, DOI 10.1136/bmj.38560.572639.3A; Li T, 2003, OBSTET GYNECOL, V101, P1204, DOI 10.1016/S0029-7844(03)00175-3; Linton A, 2004, BIRTH-ISS PERINAT C, V31, P3, DOI 10.1111/j.0730-7659.2004.0268.x; Magann EF, 2005, SOUTH MED J, V98, P681, DOI 10.1097/01.SMJ.0000163309.53317.B8; MARIESKIND H, 1979, EVALUATION CESAREAN; Merchant KM, 2001, BRIT J OBSTET GYNAEC, V108, P689, DOI 10.1111/j.1471-0528.2001.00181.x; Minkoff H, 2004, OBSTET GYNECOL, V103, P387, DOI 10.1097/01.AOG.0000107288.44622.2a; MORGENSTERN H, 1998, MODERN EPIDEMIOLOGY, P459; Murray SF, 2000, BRIT MED J, V321, P1501, DOI 10.1136/bmj.321.7275.1501; National Collaborating Centre for Women's and Children's Health, 2004, CAES SECT CLIN GUID; Ryan Kristi, 2005, Conn Med, V69, P139; Sachs BP, 1999, NEW ENGL J MED, V340, P54, DOI 10.1056/NEJM199901073400112; Salihu HM, 2006, OBSTET GYNECOL, V107, P383, DOI 10.1097/01.AOG.0000195103.46999.32; Turcotte Leo, 2005, Int J Health Care Finance Econ, V5, P255, DOI 10.1007/s10754-005-1789-0; US Department of Health and Human-Services Public Health Service National Institutes of Health., 1981, NIH PUBL, V82-2067; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089; *WHO, 2004, WHO GLOB SURV MAT PE; Wilkinson C, 1998, BRIT J OBSTET GYNAEC, V105, P45, DOI 10.1111/j.1471-0528.1998.tb09349.x; Wu JM, 2005, OBSTET GYNECOL, V105, P301, DOI 10.1097/01.AOG.0000151110.05801.c0	30	597	643	0	56	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 3	2006	367	9525					1819	1829		10.1016/S0140-6736(06)68704-7	http://dx.doi.org/10.1016/S0140-6736(06)68704-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	051XE	16753484				2022-12-24	WOS:000238194200027
J	Noma, KI; Cam, HP; Maraia, RJ; Grewal, SIS				Noma, Ken-ichi; Cam, Hugh P.; Maraia, Richard J.; Grewal, Shiv I. S.			A role for TFIIIC transcription factor complex in genome organization	CELL			English	Article							RNA-POLYMERASE-III; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; HETEROCHROMATIN DOMAIN; EPIGENETIC CONTROL; CHROMATIN DOMAINS; GENE-EXPRESSION; BOUNDARIES; MACHINERY	Eukaryotic genome complexity necessitates boundary and insulator elements to partition genomic content into distinct domains. We show that inverted repeat (IR) boundary elements flanking the fission yeast mating-type heterochromatin domain contain B-box sequences, which prevent heterochromatin from spreading into neighboring euchromatic regions by recruiting transcription factor TFIIIC complex without RNA polymerase III (Pol III). Genome-wide analysis reveals TFIIIC with Pol III at all tRNA genes, many of which cluster at pericentromeric heterochromatin domain boundaries. However, a single tRNA(phe), gene with modest TFIIIC enrichment is insufficient to serve as boundary and requires RNAi-associated element to restrain heterochromatin spreading. Remarkably, we found TFIIIC localization without Pol III at many sites located between divergent promoters. These sites appear to act as chromosome-organizing clamps by tethering distant loci to the nuclear periphery, at which TFIIIC: is concentrated into several distinct bodies. Our analyses uncover a general genome organization mechanism involving conserved TFIIIC complex.	NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA; NICHHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Grewal, SIS (corresponding author), NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov	Maraia, Richard/ABC-1442-2020	Maraia, Richard/0000-0002-5209-0066; Grewal, Shiv/0000-0002-4552-9261	Intramural NIH HHS Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000412] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000412] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01BC010523, ZIABC010523] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ayoub N, 2003, MOL CELL BIOL, V23, P4356, DOI 10.1128/MCB.23.12.4356-4370.2003; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Bi X, 2004, MOL CELL BIOL, V24, P2118, DOI 10.1128/MCB.24.5.2118-2131.2004; Blanton J, 2003, GENE DEV, V17, P664, DOI 10.1101/gad.1052003; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Cavalli G, 2002, CURR OPIN CELL BIOL, V14, P269, DOI 10.1016/S0955-0674(02)00324-1; Deininger PL, 1989, MOBILE DNA, P619; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hamada M, 2001, MOL CELL BIOL, V21, P6870, DOI 10.1128/MCB.21.20.6870-6881.2001; Hsieh YJ, 1999, MOL CELL BIOL, V19, P7697; Huang Y, 2001, NUCLEIC ACIDS RES, V29, P2675, DOI 10.1093/nar/29.13.2675; Huang Y, 2000, J BIOL CHEM, V275, P31480, DOI 10.1074/jbc.M004635200; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Kuhn AN, 2003, CURR GENET, V42, P241, DOI 10.1007/s00294-002-0355-2; Labrador M, 2002, CELL, V111, P151, DOI 10.1016/S0092-8674(02)01004-8; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Moqtaderi Z, 2004, MOL CELL BIOL, V24, P4118, DOI 10.1128/MCB.24.10.4118-4127.2004; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Oki M, 2005, MOL CELL, V19, P707, DOI 10.1016/j.molcel.2005.07.022; Partridge JF, 2000, GENE DEV, V14, P783; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; Roberts DN, 2003, P NATL ACAD SCI USA, V100, P14695, DOI 10.1073/pnas.2435566100; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Sadaie M, 2003, GENE DEV, V17, P2271, DOI 10.1101/gad.1112103; Scott KC, 2006, CURR BIOL, V16, P119, DOI 10.1016/j.cub.2005.11.065; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Sun FL, 1999, CELL, V99, P459, DOI 10.1016/S0092-8674(00)81534-2; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Thon G, 2002, GENETICS, V161, P611; WEINMANN R, 1974, P NATL ACAD SCI USA, V71, P1790, DOI 10.1073/pnas.71.5.1790; West AG, 2004, MOL CELL, V16, P453, DOI 10.1016/j.molcel.2004.10.005; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2	48	225	235	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					859	872		10.1016/j.cell.2006.04.028	http://dx.doi.org/10.1016/j.cell.2006.04.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751097	Bronze			2022-12-24	WOS:000238116400014
J	Pawelek, PD; Croteau, N; Ng-Thow-Hing, C; Khursigara, CM; Moiseeva, N; Allaire, M; Coulton, JW				Pawelek, Peter D.; Croteau, Nathalie; Ng-Thow-Hing, Christopher; Khursigara, Cezar M.; Moiseeva, Natalia; Allaire, Marc; Coulton, James W.			Structure of TonB in complex with FhuA, E-coli outer membrane receptor	SCIENCE			English	Article							C-TERMINAL DOMAIN; CRYSTAL-STRUCTURE; BOUND-STATES; TRANSPORT; PROTEIN; REVEALS; REGION; BTUB	The cytoplasmic membrane protein TonB spans the periplasm of the Gram-negative bacterial cell envelope, contacts cognate outer membrane receptors, and facilitates siderophore transport. The outer membrane receptor FhuA from Escherichia coli mediates TonB-dependent import of ferrichrome. We report the 3.3 angstrom resolution crystal structure of the TonB carboxyl-terminal domain in complex with FhuA. TonB contacts stabilize FhuA's amino-terminal residues, including those of the consensus Ton box sequence that form an interprotein beta sheet with TonB through strand exchange. The highly conserved TonB residue arginine-166 is oriented to form multiple contacts with the FhuA cork, the globular domain enclosed by the beta barrel.	McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; Brookhaven Natl Lab, Natl Synchrotron Light Source, Upton, NY 11973 USA	McGill University; State University of New York (SUNY) System; United States Department of Energy (DOE); Brookhaven National Laboratory	Coulton, JW (corresponding author), McGill Univ, Dept Microbiol & Immunol, 3775 Univ St, Montreal, PQ H3A 2B4, Canada.	james.coulton@mcgill.ca	Pawelek, Peter/E-7950-2014	Pawelek, Peter/0000-0002-8361-6593				Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Cadieux N, 2000, J BACTERIOL, V182, P5954, DOI 10.1128/JB.182.21.5954-5961.2000; Chang CS, 2001, J BIOL CHEM, V276, P27535, DOI 10.1074/jbc.M102778200; Chimento DP, 2003, NAT STRUCT BIOL, V10, P394, DOI 10.1038/nsb914; Chimento DP, 2005, PROTEINS, V59, P240, DOI 10.1002/prot.20416; Faraldo-Gomez JD, 2003, BIOPHYS J, V85, P1406, DOI 10.1016/S0006-3495(03)74573-1; Ferguson AD, 2004, CELL, V116, P15, DOI 10.1016/S0092-8674(03)01030-4; Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Khursigara CM, 2005, PROTEIN SCI, V14, P1266, DOI 10.1110/ps.051342505; Khursigara CM, 2005, BIOCHEMISTRY-US, V44, P3441, DOI 10.1021/bi047882p; Kodding J, 2005, J BIOL CHEM, V280, P3022, DOI 10.1074/jbc.M411155200; Larsen RA, 1996, J BACTERIOL, V178, P1363, DOI 10.1128/jb.178.5.1363-1373.1996; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; Peacock RS, 2005, J MOL BIOL, V345, P1185, DOI 10.1016/j.jmb.2004.11.026; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811	17	202	207	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 2	2006	312	5778					1399	1402		10.1126/science.1128057	http://dx.doi.org/10.1126/science.1128057			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048QM	16741125				2022-12-24	WOS:000237961600061
J	Jacque, JM; Stevenson, M				Jacque, Jean-Marc; Stevenson, Mario			The inner-nuclear-envelope protein emerin regulates HIV-1 infectivity	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TO-AUTOINTEGRATION FACTOR; PREINTEGRATION COMPLEXES; PRIMARY MACROPHAGES; CDNA INTEGRATION; TYPE-1; DNA; BAF; REPLICATION; CHROMATIN	Primate lentiviruses such as human immunodeficiency type 1 (HIV-1) have the capacity to infect non-dividing cells such as tissue macrophages(1). In the process, viral complementary DNA traverses the nuclear envelope to integrate within chromatin(2). Given the intimate association between chromatin and the nuclear envelope(3), we examined whether HIV-1 appropriates nuclear envelope components during infection. Here we show that emerin, an integral inner-nuclear-envelope protein, is necessary for HIV-1 infection. Infection of primary macrophages lacking emerin was abortive in that viral cDNA localized to the nucleus but integration into chromatin was inefficient, and conversion of viral cDNA to non-functional episomal cDNA increased. HIV-1 cDNA associated with emerin in vivo, and the interaction of viral cDNA with chromatin was dependent on emerin. Barrier-to-autointegration factor (BAF), the LEM ( LAP, emerin, MAN) binding partner of emerin, was required for the association of viral cDNA with emerin and for the ability of emerin to support virus infection. Therefore emerin, which bridges the interface between the inner nuclear envelope and chromatin, may be necessary for chromatin engagement by viral cDNA before integration.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Stevenson, M (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St,Suite 319, Worcester, MA 01605 USA.	mario.stevenson@umassmed.edu	Jacque, Jean-Marc/B-6875-2008					Beitzel B, 2003, NUCLEIC ACIDS RES, V31, P5025, DOI 10.1093/nar/gkg684; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Farnet CM, 1997, CELL, V88, P483, DOI 10.1016/S0092-8674(00)81888-7; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896; Lau A, 2004, EMBO J, V23, P3421, DOI 10.1038/sj.emboj.7600348; Lee KK, 2001, J CELL SCI, V114, P4567; Lee MS, 1998, P NATL ACAD SCI USA, V95, P1528, DOI 10.1073/pnas.95.4.1528; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Li L, 2000, J VIROL, V74, P10965, DOI 10.1128/JVI.74.23.10965-10974.2000; Lin CW, 2003, J VIROL, V77, P5030, DOI 10.1128/JVI.77.8.5030-5036.2003; Lu R, 2004, J VIROL, V78, P12735, DOI 10.1128/JVI.78.23.12735-12746.2004; Mansharamani M, 2003, J VIROL, V77, P13084, DOI 10.1128/JVI.77.24.13084-13092.2003; Miccoli L, 2003, NUCLEIC ACIDS RES, V31, P4162, DOI 10.1093/nar/gkg459; Segura-Totten M, 2002, J CELL BIOL, V158, P475, DOI 10.1083/jcb.200202019; Segura-Totten M, 2004, TRENDS CELL BIOL, V14, P261, DOI 10.1016/j.tcb.2004.03.004; Song EW, 2003, J VIROL, V77, P7174, DOI 10.1128/JVI.77.13.7174-7181.2003; Stevenson M, 2003, NAT MED, V9, P853, DOI 10.1038/nm0703-853; STEVENSON M, 1990, J VIROL, V64, P2421, DOI 10.1128/JVI.64.5.2421-2425.1990; Suzuki Y, 2004, EMBO J, V23, P4670, DOI 10.1038/sj.emboj.7600452; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; WISKERCHEN M, 1995, J VIROL, V69, P376, DOI 10.1128/JVI.69.1.376-386.1995; Zastrow MS, 2004, J CELL SCI, V117, P979, DOI 10.1242/jcs.01102; Zielske SP, 2005, J VIROL, V79, P11541, DOI 10.1128/JVI.79.17.11541-11546.2005	27	80	98	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 1	2006	441	7093					641	645		10.1038/nature04682	http://dx.doi.org/10.1038/nature04682			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048AU	16680152				2022-12-24	WOS:000237920800049
J	Alfonso, I; Yaylali, I				Alfonso, I; Yaylali, I			Sympathetic-nerve damage in brachial-plexus palsy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Miami Childrens Hosp, Miami, FL 33155 USA		Alfonso, I (corresponding author), Miami Childrens Hosp, Miami, FL 33155 USA.								0	0	0	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 18	2006	354	20					2165	2165		10.1056/NEJMicm050048	http://dx.doi.org/10.1056/NEJMicm050048			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	043BX	16707753				2022-12-24	WOS:000237575400010
J	Capone, DG; Popa, R; Flood, B; Nealson, KH				Capone, DG; Popa, R; Flood, B; Nealson, KH			Follow the nitrogen	SCIENCE			English	Editorial Material							ENCELADUS		Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; Portland State Univ, Dept Biol, Portland, OR 97207 USA	University of Southern California; University of Southern California; Portland State University	Capone, DG (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	knealson@usc.edu						Brandes JA, 1998, NATURE, V395, P365, DOI 10.1038/26450; CHICARELLI MI, 1993, GEOCHIM COSMOCHIM AC, V57, P1307, DOI 10.1016/0016-7037(93)90067-7; Galloway J. N., 2004, TREATISE GEOCHEMISTR, V8, P557; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Kargel JS, 2006, SCIENCE, V311, P1389, DOI 10.1126/science.1124495; KASTING JF, 1993, ICARUS, V101, P108, DOI 10.1006/icar.1993.1010; Mancinelli RL., 2003, INT J ASTROBIOL, V2, P217, DOI DOI 10.1017/S1473550403001599; McElroy M. B., 1977, Journal of Geophysical Research, V82, P4379, DOI 10.1029/JS082i028p04379; PLUMB RC, 1989, NATURE, V338, P633, DOI 10.1038/338633a0; Porco CC, 2006, SCIENCE, V311, P1393, DOI 10.1126/science.1123013; Smil V., 2001, ENRICHING THE EARTH; VANDEGRAAF AA, 1995, APPL ENVIRON MICROB, V61, P1246, DOI 10.1128/AEM.61.4.1246-1251.1995; Waite JH, 2006, SCIENCE, V311, P1419, DOI 10.1126/science.1121290; Yung Y. L., 1999, PHOTOCHEMISTRY PLANE; YUNG YL, 1979, SCIENCE, V203, P1002, DOI 10.1126/science.203.4384.1002	15	45	47	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					708	709		10.1126/science.1111863	http://dx.doi.org/10.1126/science.1111863			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675690				2022-12-24	WOS:000237312100037
J	Chen, BE; Kondo, M; Garnier, A; Watson, FL; Puettmann-Holgado, R; Lamar, DR; Schmucker, D				Chen, Brian E.; Kondo, Masahiro; Garnier, Amelie; Watson, Fiona L.; Puettmann-Holgado, Roland; Lamar, David R.; Schmucker, Dietmar			The molecular diversity of Dscam is functionally required for neuronal wiring specificity in Drosophila	CELL			English	Article							AXON GUIDANCE; NEURAL DEVELOPMENT; SENSORY NEURONS; ALPHA-NEUREXINS; NERVOUS-SYSTEM; BINDING; RECEPTORS; FAMILY; SUPERFAMILY; PROJECTIONS	Alternative splicing of Dscam generates an enormous molecular diversity with maximally 38,016 different receptors. Whether this large diversity is required in vivo is currently unclear. We examined the role of Dscam in neuron-target recognition of single mechanosensory neurons, which connect with different target cells through multiple axonal branches' Analysis of Dscam null neurons demonstrated an essential role of Dscam for growth and directed extension of axon branches. Expression of randomly chosen single isoforms could not rescue connectivity but did restore basic axonal extension and rudimentary branching. Moreover, two Dscam alleles were generated that each reduced the maximally possible Dscam diversity to 22,176 isoforms. Reduction of Dscam diversity resulted in specific connectivity defects of mechanosensory neurons. Furthermore, the observed allele-specific phenotypes suggest functional differences among isoforms. Our findings provide evidence that a very large number of structurally unique receptor isoforms is required to ensure fidelity and precision of neuronal connectivity.	Harvard Univ, Sch Med, Dept Neurobiol, Dana Farber Canc Inst,Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Schmucker, D (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Dana Farber Canc Inst,Dept Canc Biol, Boston, MA 02115 USA.	dietmar_schmucker@dfci.harvard.edu			NCI NIH HHS [T32CA09361] Funding Source: Medline; NINDS NIH HHS [R01-NS46747] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046747] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Boulanger LM, 2004, NAT REV NEUROSCI, V5, P521, DOI 10.1038/nrn1428; Canal I, 1998, J NEUROSCI, V18, P999; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; GHYSEN A, 1980, DEV BIOL, V78, P521, DOI 10.1016/0012-1606(80)90351-6; GHYSEN A, 1978, NATURE, V274, P869, DOI 10.1038/274869a0; Grillenzoni N, 1998, DEVELOPMENT, V125, P3563; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Kreahling JM, 2005, MOL CELL BIOL, V25, P10251, DOI 10.1128/MCB.25.23.10251-10260.2005; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Missler M, 1998, J BIOL CHEM, V273, P34716, DOI 10.1074/jbc.273.52.34716; Nern A, 2005, P NATL ACAD SCI USA, V102, P12944, DOI 10.1073/pnas.0502888102; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Takeichi M, 1997, DEV NEUROSCI-BASEL, V19, P86, DOI 10.1159/000111189; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Uemura T, 1998, CELL, V93, P1095, DOI 10.1016/S0092-8674(00)81452-X; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; Williams DW, 2002, DEVELOPMENT, V129, P617; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zlatic M, 2003, NEURON, V37, P41, DOI 10.1016/S0896-6273(02)01131-5	39	144	149	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 5	2006	125	3					607	620		10.1016/j.cell.2006.03.034	http://dx.doi.org/10.1016/j.cell.2006.03.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	042CY	16678102	Bronze			2022-12-24	WOS:000237506100024
J	Bejerano, G; Lowe, CB; Ahituv, N; King, B; Siepel, A; Salama, SR; Rubin, EM; Kent, WJ; Haussler, D				Bejerano, G; Lowe, CB; Ahituv, N; King, B; Siepel, A; Salama, SR; Rubin, EM; Kent, WJ; Haussler, D			A distal enhancer and an ultraconserved exon are derived from a novel retroposon	NATURE			English	Article							ELEMENTS; MOTOR; VERTEBRATE; GENE; RNAS	Hundreds of highly conserved distal cis-regulatory elements have been characterized so far in vertebrate genomes(1). Many thousands more are predicted on the basis of comparative genomics(2,3). However, in stark contrast to the genes that they regulate, in invertebrates virtually none of these regions can be traced by using sequence similarity, leaving their evolutionary origins obscure. Here we show that a class of conserved, primarily non-coding regions in tetrapods originated from a previously unknown short interspersed repetitive element (SINE) retroposon family that was active in the Sarcopterygii (lobe-finned fishes and terrestrial vertebrates) in the Silurian period at least 410 million years ago (ref. 4), and seems to be recently active in the 'living fossil' Indonesian coelacanth, Latimeria menadoensis. Using a mouse enhancer assay we show that one copy, 0.5 million bases from the neuro-developmental gene ISL1, is an enhancer that recapitulates multiple aspects of Isl1 expression patterns. Several other copies represent new, possibly regulatory, alternatively spliced exons in the middle of pre-existing Sarcopterygian genes. One of these, a more than 200-base-pair ultraconserved region(5), 100% identical in mammals, and 80% identical to the coelacanth SINE, contains a 31-amino-acid-residue alternatively spliced exon of the messenger RNA processing gene PCBP2 (ref. 6). These add to a growing list of examples(7) in which relics of transposable elements have acquired a function that serves their host, a process termed 'exaptation'(8), and provide an origin for at least some of the many highly conserved vertebrate-specific genomic sequences.	Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; United States Department of Energy (DOE); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Bejerano, G (corresponding author), Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA.	jill@soe.ucsc.edu	Salama, Sofie/K-6412-2019	Salama, Sofie/0000-0001-6999-7193; Ahituv, Nadav/0000-0002-7434-8144; Siepel, Adam/0000-0002-3557-7219				Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bejerano G, 2004, BIOINFORMATICS, V20, P40, DOI 10.1093/bioinformatics/bth946; BRITTEN RJ, 1971, Q REV BIOL, V46, P111, DOI 10.1086/406830; Brosius J, 2003, GENETICA, V118, P99, DOI 10.1023/A:1024141306559; Caton A, 2000, DEVELOPMENT, V127, P1751; Chkheidze AN, 2003, MOL CELL BIOL, V23, P8405, DOI 10.1128/MCB.23.23.8405-8415.2003; Danke J, 2004, J EXP ZOOL PART A, V301A, P228, DOI 10.1002/jez.a.20024; Deininger PL, 2002, GENOME RES, V12, P1455, DOI 10.1101/gr.282402; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Graur D., 2000, FUNDAMENTALS MOL EVO; Gunduz E, 2005, INT J ONCOL, V26, P201; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kim JH, 2000, J MOL BIOL, V298, P395, DOI 10.1006/jmbi.2000.3687; KOTHARY R, 1988, NATURE, V335, P435, DOI 10.1038/335435a0; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Li YH, 2005, BIOCHEM BIOPH RES CO, V333, P868, DOI 10.1016/j.bbrc.2005.05.170; Makalowski W, 2003, SCIENCE, V300, P1246, DOI 10.1126/science.1085690; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; McEwen GK, 2006, GENOME RES, V16, P451, DOI 10.1101/gr.4143406; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Poulin F, 2005, GENOMICS, V85, P774, DOI 10.1016/j.ygeno.2005.03.003; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Uemura O, 2005, DEV BIOL, V278, P587, DOI 10.1016/j.ydbio.2004.11.031; Waggoner SA, 2003, MOL CELL BIOL, V23, P7055, DOI 10.1128/MCB.23.19.7055-7067.2003; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weiner AM, 2002, CURR OPIN CELL BIOL, V14, P343, DOI 10.1016/S0955-0674(02)00338-1; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007	30	379	388	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2006	441	7089					87	90		10.1038/nature04696	http://dx.doi.org/10.1038/nature04696			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16625209				2022-12-24	WOS:000237248600038
J	Qvarnstrom, A; Brommer, JE; Gustafsson, L				Qvarnstrom, A; Brommer, JE; Gustafsson, L			Testing the genetics underlying the co-evolution of mate choice and ornament in the wild	NATURE			English	Article							SECONDARY SEXUAL CHARACTER; COLLARED FLYCATCHER; MATING PREFERENCES; FEMALE PREFERENCE; MALE COMPETITION; BADGE SIZE; SELECTION; EVOLUTION; FITNESS; HERITABILITY	One of the most debated questions in evolutionary biology is whether female choice of males with exaggerated sexual displays can evolve as a correlated response to selection acting on genes coding for male attractiveness or high overall viability. To date, empirical studies have provided support for parts of this scenario(1), but evidence for all key genetic components in a natural population is lacking. Here we use animal-model quantitative genetic analysis(2,3) on data from over 8,500 collared flycatchers (Ficedula albicollis) followed for 24 years to quantify all of the key genetic requirements of both fisherian(4,5) and 'good-genes' models(6,7) on sexual selection in the wild. We found significant additive genetic variances of all the main components: male ornament (forehead patch size), female mate choice for this ornament, male fitness and female fitness. However, when the necessary genetic correlations between these components were taken into account, the estimated strength of indirect sexual selection on female mate choice was negligible. Our results show that the combined effect of environmental influences on several components reduces the potential for indirect sexual selection in the wild. This study provides insight into the field of sexual selection by showing that genes coding for mate choice for an ornament probably evolve by their own pathways instead of 'hitchhiking' with genes coding for the ornament.	Uppsala Univ, Dept Ecol & Evolut, SE-75236 Uppsala, Sweden; Univ Helsinki, Bird Ecol Unit, Dept Biol & Environm Sci, FI-00014 Helsinki, Finland	Uppsala University; University of Helsinki	Qvarnstrom, A (corresponding author), Uppsala Univ, Dept Ecol & Evolut, Norbyvagen 18D, SE-75236 Uppsala, Sweden.		Gustafsson, Lars/A-7634-2012; Gustafsson, Lars/O-8056-2019; Brommer, Jon E/C-3613-2008	Gustafsson, Lars/0000-0001-6566-2863; Gustafsson, Lars/0000-0001-6566-2863; Brommer, Jon E/0000-0002-2435-2612; Qvarnstrom, Anna/0000-0002-1178-4053				ANDERSSOPN M, 1994, SEXUAL SELECTION; BAKKER TCM, 1993, NATURE, V363, P255, DOI 10.1038/363255a0; Bakker TCM, 1999, BEHAVIOUR, V136, P1237, DOI 10.1163/156853999501748; Brooks R, 1999, AM NAT, V154, P37, DOI 10.1086/303219; BURT A, 1995, EVOLUTION, V49, P1, DOI 10.1111/j.1558-5646.1995.tb05954.x; Charmantier A, 2005, MOL ECOL, V14, P2839, DOI 10.1111/j.1365-294X.2005.02619.x; DALE S, 1992, BEHAV ECOL SOCIOBIOL, V30, P165, DOI 10.1007/BF00166699; Fisher R. A., 1930, GENETICAL THEORY NAT, DOI 10.5962/bhl.title.27468; Garant D, 2004, EVOLUTION, V58, P634, DOI 10.1111/j.0014-3820.2004.tb01685.x; Hine E, 2002, P ROY SOC B-BIOL SCI, V269, P2215, DOI 10.1098/rspb.2002.2149; HOGLUND J, 1995, TEKS; HOUDE AE, 1994, P ROY SOC B-BIOL SCI, V256, P125, DOI 10.1098/rspb.1994.0059; Hunt J, 2005, AM NAT, V166, P79, DOI 10.1086/430672; IWASA Y, 1991, EVOLUTION, V45, P1431, DOI 10.1111/j.1558-5646.1991.tb02646.x; Iyengar VK, 2002, NATURE, V419, P830, DOI 10.1038/nature01027; Kirkpatrick M, 1997, P NATL ACAD SCI USA, V94, P1282, DOI 10.1073/pnas.94.4.1282; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; Kruuk LEB, 2000, P NATL ACAD SCI USA, V97, P698, DOI 10.1073/pnas.97.2.698; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Lesna I, 1999, NATURE, V401, P581, DOI 10.1038/44125; LYNCH M, 1996, GENETICS ANAL QUANTI; Part T, 1997, ANIM BEHAV, V54, P893, DOI 10.1006/anbe.1997.0514; POMIANKOWSKI A, 1995, P ROY SOC B-BIOL SCI, V260, P21, DOI 10.1098/rspb.1995.0054; Qvarnstrom A, 1999, EVOLUTION, V53, P1564, DOI 10.1111/j.1558-5646.1999.tb05419.x; Qvarnstrom A, 1997, P ROY SOC B-BIOL SCI, V264, P1225, DOI 10.1098/rspb.1997.0169; Qvarnstrom A, 2000, NATURE, V405, P344, DOI 10.1038/35012605; SERVICE PM, 1985, EVOLUTION, V39, P943, DOI [10.2307/2408694, 10.1111/j.1558-5646.1985.tb00436.x]; Sheldon BC, 1997, P ROY SOC B-BIOL SCI, V264, P297, DOI 10.1098/rspb.1997.0042; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	30	172	173	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 4	2006	441	7089					84	86		10.1038/nature04564	http://dx.doi.org/10.1038/nature04564			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038TB	16672970				2022-12-24	WOS:000237248600037
J	Woods, NB; Bottero, V; Schmidt, M; von Kalle, C; Verma, IM				Woods, NB; Bottero, V; Schmidt, M; von Kalle, C; Verma, IM			Therapeutic gene causing lymphoma	NATURE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; COMMON GAMMA-CHAIN; CYTOKINE RECEPTOR; BONE-MARROW; MICE; LYMPHOCYTES; CELLS; MODEL		Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; Natl Ctr Tumor Dis Heidelberg, D-69120 Heidelberg, Germany; German Canc Res Ctr, Dept Translat Oncol, Otto Meyerhof Zentrum, D-69120 Heidelberg, Germany; Univ Hosp, Dept Internal Med 1, D-79106 Freiburg, Germany; Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany	Salk Institute; Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; University of Freiburg	Woods, NB (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	verma@salk.edu	Woods, Niels-Bjarne/B-7390-2019	Woods, Niels-Bjarne/0000-0001-6052-922X				An DS, 2001, J VIROL, V75, P3547, DOI 10.1128/JVI.75.8.3547-3555.2001; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Kersseboom R, 2003, J EXP MED, V198, P91, DOI 10.1084/jem.20030615; LARSON RC, 1995, ONCOGENE, V11, P853; Lo M, 1999, BLOOD, V94, P3027, DOI 10.1182/blood.V94.9.3027.421k11_3027_3036; Mendoza GJA, 2001, MOL THER, V3, P565, DOI 10.1006/mthe.2001.0292; Otsu M, 2000, HUM GENE THER, V11, P2051, DOI 10.1089/10430340050143462; Otsu M, 2000, MOL THER, V1, P145, DOI 10.1006/mthe.1999.0020; Otsu M, 2001, BLOOD, V97, P1618, DOI 10.1182/blood.V97.6.1618; Soudais C, 2000, BLOOD, V95, P3071, DOI 10.1182/blood.V95.10.3071.010k06_3071_3077; Whitwam T, 1998, BLOOD, V92, P1565, DOI 10.1182/blood.V92.5.1565.417k12_1565_1575	12	219	230	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2006	440	7088					1123	1123		10.1038/4401123a	http://dx.doi.org/10.1038/4401123a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	036OG	16641981	Bronze			2022-12-24	WOS:000237080000027
J	Trojer, P; Reinberg, D				Trojer, P; Reinberg, D			Histone lysine demethylases and their impact on epigenetics	CELL			English	Editorial Material							METHYLATION; BINDING; PROTEINS; REQUIRES; ZESTE; MARKS		Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Nucle Acids Enzymol, Dept Biochem,Howard Hughes Med Inst, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center	Reinberg, D (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Nucle Acids Enzymol, Dept Biochem,Howard Hughes Med Inst, Piscataway, NJ 08854 USA.	reinbedf@umdnj.edu		Reinberg, Danny/0000-0003-4288-2016				Bannister AJ, 2005, NATURE, V436, P1103, DOI 10.1038/nature04048; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Heard E, 2005, CURR OPIN GENET DEV, V15, P482, DOI 10.1016/j.gde.2005.08.009; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Karachentsev D, 2005, GENE DEV, V19, P431, DOI 10.1101/gad.1263005; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Kubicek S, 2004, CELL, V119, P903, DOI 10.1016/j.cell.2004.12.006; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Mulholland NM, 2003, GENE DEV, V17, P2741, DOI 10.1101/gad.1143303; Poux S, 2001, GENE DEV, V15, P2509, DOI 10.1101/gad.208901; RASTELLI L, 1993, EMBO J, V12, P1513, DOI 10.1002/j.1460-2075.1993.tb05795.x; Reinberg D, 2004, COLD SPRING HARB SYM, V69, P171, DOI 10.1101/sqb.2004.69.171; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Waddington C.H., 1957, STRATEGY GENES; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027	22	163	171	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 21	2006	125	2					213	217		10.1016/j.cell.2006.04.003	http://dx.doi.org/10.1016/j.cell.2006.04.003			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	038RT	16630806	Bronze			2022-12-24	WOS:000237241500008
J	Smith-Bindman, R; Miglioretti, DL; Lurie, N; Abraham, L; Barbash, RB; Strzelczyk, J; Dignan, M; Barlow, WE; Beasley, CM; Kerlikowske, K				Smith-Bindman, R; Miglioretti, DL; Lurie, N; Abraham, L; Barbash, RB; Strzelczyk, J; Dignan, M; Barlow, WE; Beasley, CM; Kerlikowske, K			Does utilization of screening mammography explain racial and ethnic differences in breast cancer?	ANNALS OF INTERNAL MEDICINE			English	Article							WHITE WOMEN; BLACK-WOMEN; SOCIOECONOMIC-FACTORS; CARCINOMA SURVIVAL; AMERICAN WOMEN; UNITED-STATES; RACE; DIAGNOSIS; STAGE; DISPARITIES	Background: Reasons for persistent differences in breast cancer mortality rates among various racial and ethnic groups have been difficult to ascertain. Objective: To determine reasons for disparities in breast cancer outcomes across racial and ethnic groups. Design: Prospective cohort. Setting: The authors pooled data from 7 mammography registries that participate in the National Cancer Institute-funded'Breast Cancer Surveillance Consortium. Cancer diagnoses were ascertained through linkage with pathology databases; Surveillance, Epidemiology, and End Results programs; and state tumor registries. Participants: 1010515 women 40 years of age and older who had at least 1 mammogram between 1996 and 2002; 17558 of these women had diagnosed breast cancer. Measurements: Patterns of mammography and the probability of inadequate mammography screening were examined. The authors evaluated whether overall and advanced cancer rates were similar across racial and ethnic groups and whether these rates were affected by the use of mammography. Results: African-American, Hispanic, Asian, and Native American women were more likely than white women to have received inadequate mammographic screening (relative risk, 1.2 [95% Cl, 1.2 to 1.2], 1.3 [Cl, 1.2 to 1.3], 1.4 [Cl, 1.3 to 1.4], and 1.2 [Cl, 1.1 to 1.2) respectively). African-American women were more likely than white, Asian, and Native American women to have large, advanced-stage, high-grade, and lymph node-positive tumors of the breast. The observed differences in advanced cancer rates between African American and white women were attenuated or eliminated after the cohort was stratified by screening history. Among women who were previously screened at intervals of 4 to 41 months, African -American women were no more likely to have large, advanced-stage tumors or lymph node involvement than white women with the same screening history. African-American women had higher rates of high-grade tumors than white women regardless of screening history. The lower rates of advanced cancer among Asian and Native American women persisted when the cohort was stratified by mammography history. Limitations: Results are based on a cohort of women who had received mammographic evaluations. Conclusions: African-American women are less likely to receive adequate mammographic screening than white women, which may explain the higher prevalence of advanced breast tumors among African-American women. Tumor characteristics may also contribute to differences in cancer outcomes because African-American women have higher-grade tumors than white women regardless of screening. These results suggest that adherence to recommended mammography screening intervals may reduce breast cancer mortality rates.	Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94115 USA; San Francisco VA Med Ctr, San Francisco, CA USA; Grp Hlth Cooperat Puget Sound, Seattle, WA 98121 USA; RAND Corp, Arlington, VA USA; NCI, Bethesda, MD 20892 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Univ Kentucky, Prevent Res Ctr, Lexington, KY USA; Canc Res & Biostat, Seattle, WA USA; Univ N Carolina, Pembroke, NC USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Group Health Cooperative; RAND Corporation; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Kentucky; Cancer Research & Biostatistics; University of North Carolina	Smith-Bindman, R (corresponding author), Univ Calif San Francisco, Dept Radiol, 1600 Divisadero St, San Francisco, CA 94115 USA.	Rebecca.Smith-Bindman@Radiology.UCSF.edu		Beasley, Cherry/0000-0002-2848-994X	NCI NIH HHS [U01CA86076, U01CA70040, U01CA70013, U01CA69976, U01CA63740, U01CA63736, U01CA63731, K07 CA86032, U01CA86082] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K07CA086032, U01CA063731, U01CA086082, U01CA063736, U01CA070040, U01CA070013, U01CA063740, U01CA086076, U01CA069976] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON LM, 1995, AM J PUBLIC HEALTH, V85, P840, DOI 10.2105/AJPH.85.6.840; [Anonymous], 1997, AJCC CANC STAGING MA; Bach PB, 2002, JAMA-J AM MED ASSOC, V287, P2106, DOI 10.1001/jama.287.16.2106; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Blackman D K, 1999, MMWR CDC Surveill Summ, V48, P1; Breen N, 2001, J NATL CANCER I, V93, P1704, DOI 10.1093/jnci/93.22.1704; Breen N, 1996, BREAST CANCER RES TR, V40, P105, DOI 10.1007/BF01806006; Burns RB, 1996, ANN INTERN MED, V125, P173, DOI 10.7326/0003-4819-125-3-199608010-00002; Champion VL, 1998, AM J PREV MED, V14, P111, DOI 10.1016/S0749-3797(97)00021-4; Chang SW, 1996, CANCER, V78, P1395, DOI 10.1002/(SICI)1097-0142(19961001)78:7<1395::AID-CNCR5>3.0.CO;2-K; CHEN VW, 1994, CANCER EPIDEM BIOMAR, V3, P127; Chu KC, 2003, CANCER, V97, P2853, DOI 10.1002/cncr.11411; Chu KC, 1996, JNCI-J NATL CANCER I, V88, P1571, DOI 10.1093/jnci/88.21.1571; DEGNAN D, 1992, AM J PUBLIC HEALTH, V82, P1386, DOI 10.2105/AJPH.82.10.1386; ELEY JW, 1994, JAMA-J AM MED ASSOC, V272, P947, DOI 10.1001/jama.272.12.947; ELLEDGE RM, 1994, J NATL CANCER I, V86, P705, DOI 10.1093/jnci/86.9.705; Ernster VL, 2002, J NATL CANCER I, V94, P1546; FACIONE NC, 1993, SOC SCI MED, V36, P1521, DOI 10.1016/0277-9536(93)90340-A; FOX SA, 1991, MED CARE, V29, P1065, DOI 10.1097/00005650-199111000-00001; Gill KS, 2004, CANCER, V100, P139, DOI 10.1002/cncr.11878; GORDON NH, 1992, AM J EPIDEMIOL, V135, P609, DOI 10.1093/oxfordjournals.aje.a116340; GORDON NP, 1993, J NATL CANCER I, V85, P566, DOI 10.1093/jnci/85.7.566; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Haggstrom DA, 2005, CANCER, V104, P2347, DOI 10.1002/cncr.21443; Hankey, 1973, SEER CANC STAT REV; Joensuu H, 2004, JAMA-J AM MED ASSOC, V292, P1064, DOI 10.1001/jama.292.9.1064; JONES BA, 1995, CANCER, V75, P2103, DOI 10.1002/1097-0142(19950415)75:8<2103::AID-CNCR2820750813>3.0.CO;2-2; Joslyn SA, 2000, CANCER-AM CANCER SOC, V88, P114, DOI 10.1002/(SICI)1097-0142(20000101)88:1<114::AID-CNCR16>3.0.CO;2-J; Kerlikowske K, 2005, ARCH INTERN MED, V165, P1862, DOI 10.1001/archinte.165.16.1862; LANE PW, 1982, BIOMETRICS, V38, P613, DOI 10.2307/2530043; Li CI, 2003, ARCH INTERN MED, V163, P49, DOI 10.1001/archinte.163.1.49; May DS, 1998, ANN EPIDEMIOL, V8, P439, DOI 10.1016/S1047-2797(98)00010-6; McCarthy EP, 1998, ANN INTERN MED, V128, P729, DOI 10.7326/0003-4819-128-9-199805010-00005; NATARAJAN N, 1985, CANCER-AM CANCER SOC, V56, P1704, DOI 10.1002/1097-0142(19851001)56:7<1704::AID-CNCR2820560740>3.0.CO;2-L; Pearlman DN, 1996, AM J PREV MED, V12, P327, DOI 10.1016/S0749-3797(18)30287-3; Peek ME, 2004, J GEN INTERN MED, V19, P184, DOI 10.1111/j.1525-1497.2004.30254.x; Rosenberg J, 2005, BREAST CANCER RES TR, V89, P47, DOI 10.1007/s10549-004-1470-1; Selvin E, 2003, AM J PUBLIC HEALTH, V93, P618, DOI 10.2105/AJPH.93.4.618; Shen Y, 2005, JNCI-J NATL CANCER I, V97, P1195, DOI 10.1093/jnci/dji239; Sickles EA, 2005, RADIOLOGY, V235, P775, DOI 10.1148/radiol.2353040738; Singh GK, 2002, JNCI-J NATL CANCER I, V94, P916, DOI 10.1093/jnci/94.12.916; STEIN JA, 1991, J HEALTH SOC BEHAV, V32, P101, DOI 10.2307/2137146; Torck BJ, 1996, BREAST CANCER RES TR, V40, P11, DOI 10.1007/BF01805999; Tu SP, 2003, CANCER, V97, P1293, DOI 10.1002/cncr.11169; Ward E, 2004, CA-CANCER J CLIN, V54, P78, DOI 10.3322/canjclin.54.2.78; WELLS BL, 1992, AM J PUBLIC HEALTH, V82, P1383, DOI 10.2105/AJPH.82.10.1383; Yood MU, 1999, J NATL CANCER I, V91, P1487, DOI 10.1093/jnci/91.17.1487; Zapka JG, 1996, AM J PUBLIC HEALTH, V86, P1016, DOI 10.2105/AJPH.86.7.1016; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	49	256	260	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2006	144	8					541	553		10.7326/0003-4819-144-8-200604180-00004	http://dx.doi.org/10.7326/0003-4819-144-8-200604180-00004			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	035QZ	16618951				2022-12-24	WOS:000237017900001
J	Mosoiu, D; Ryan, KM; Joranson, DE; Garthwaite, JP				Mosoiu, Daniela; Ryan, Karen M.; Joranson, David E.; Garthwaite, Jody P.			Reform of drug control policy for palliative care in Romania	LANCET			English	Article							CANCER PAIN; CURRENT PERSPECTIVES; AIDS; UNDERTREATMENT; MORPHINE; OPIOIDS	Unrelieved pain from cancer and HIV/AIDS is a substantial worldwide public-health problem. Inadequate pain relief is partly due to excessively strict national drug-control policies that constrain medical use of essential medicines such as morphine. Romania's drug-control policies are more than 35 years old and impose an antiquated regulatory system that is based on inpatient post-surgical management of acute pain that restricts prescription authority and makes access to opioid treatment difficult for outpatients with severe chronic pain due to cancer or HIV/AIDS. A Ministry of Health palliative-care commission used WHO guidelines to assess and recommend changes to Romania's national drug control law and regulations. The Romanian parliament has adopted a new law that will simplify prescribing requirements and allow modern pain management. Achievement of adequate pain relief is a vital part of worldwide health and will be dependent on reform of antidrug regulations in many countries.	Univ Wisconsin, Ctr Comprehens Canc, Pain & Policy Studies Grp, Madison, WI 53711 USA; Hospice Casa Sperantei, Brasov 500074, Romania	University of Wisconsin System; University of Wisconsin Madison	Ryan, KM (corresponding author), Univ Wisconsin, Ctr Comprehens Canc, Pain & Policy Studies Grp, Madison, WI 53711 USA.	kmryan2@wisc.edu	Mosoiu, Daniela/AAB-9021-2020; Mosoiu, Daniela/AAR-4779-2021					[Anonymous], 1961, SINGL CONV NARC DRUG; [Anonymous], 2000, ACH BAL NAT OP CONTR; Blengini C, 2003, EUR J CANCER CARE, V12, P28, DOI 10.1046/j.1365-2354.2003.00325.x; BRASSEUR L, 1993, J PAIN SYMPTOM MANAG, V8, P412, DOI 10.1016/0885-3924(93)90066-5; Breitbart W, 2002, ONCOLOGY-NY, V16, P818; Breitbart W, 2002, ONCOLOGY-NY, V16, P964; Breitbart W, 1996, PAIN, V65, P243, DOI 10.1016/0304-3959(95)00217-0; Clark D, 2002, TRANSITIONS END LIFE; *COMM SPEC PAIN TH, 2003, REC MIN HLTH BUCH; *COUNC EUR COMM MI, REC 24 COMM MIN MEMB; Dale A, 2005, PALLIATIVE MED, V19, P177, DOI 10.1191/0269216305pm1012ed; De Conno F, 2005, PALLIATIVE MED, V19, P179, DOI 10.1191/0269216305pm1002oa; Dobrossy L, 2002, LANCET ONCOL, V3, P374, DOI 10.1016/S1470-2045(02)00778-7; Ferlay J, 2004, GLOBOCAN 2002 CANC I; Hanks GW, 2001, BRIT J CANCER, V84, P587, DOI 10.1054/bjoc.2001.1680; *I MED COMM CAR EN, 1997, APPR DEATH IMPR CAR; *INT NARC CONTR BO, 2003, EUR REG GLOB CONS MO; *INT NARC CONTR BO, 1989, REP INT NARC CONTR B; International Narcotics Control Board, 2002, REP INT NARC CONTR B; International Narcotics Control Board, 1996, REP INT NARC CONTR B; International Narcotics Control Board, 2005, REP INT NARC CONTR B; *JOINT UN PROGR HI, 2005, AIDS EP UPD; Krizanova K, 2002, J PAIN SYMPTOM MANAG, V24, P231, DOI 10.1016/S0885-3924(02)00439-6; Larue F, 1997, BRIT MED J, V314, P23, DOI 10.1136/bmj.314.7073.23; LARUE F, 1997, REV PRAT MED GEN, V11, P11; Luczak J, 2002, J PAIN SYMPTOM MANAG, V24, P215, DOI 10.1016/S0885-3924(02)00464-5; Mosoiu D, 2002, J PAIN SYMPTOM MANAG, V24, P225, DOI 10.1016/S0885-3924(02)00446-3; Muszbek K, 2002, J PAIN SYMPTOM MANAG, V24, P188, DOI 10.1016/S0885-3924(02)00457-8; Sepulveda C, 2002, J PAIN SYMPTOM MANAG, V24, P91, DOI 10.1016/S0885-3924(02)00440-2; Seskevicius A, 2002, J PAIN SYMPTOM MANAG, V24, P205, DOI 10.1016/S0885-3924(02)00438-4; SOHN W, 1998, MORPHINVERSCHREIBUNG; STEWART BW, 2003, WHO WORLD CANC REPOR; *UN AIDS PROGR, 2004, EP FACT SHEETS HIV A; *WHO, HIGHL HLTH ROM; *WHO, HIV AIDS PALL CAR; *WHO, ESS MED WHO MOD LIST; *WHO, 1990, WHO TECHN REP SER, V804; WHO, ESS MED; *WHO, 1996, ESS MED; *WHO REG OFF EUR, 2002, ASS AV OP AN PALL CA; World Health Assembly, 2005, CANC PREV CONTR; World Health Organization, 1996, CANC PAIN REL GUID O; ZENZ M, 1993, J PAIN SYMPTOM MANAG, V8, P416, DOI 10.1016/0885-3924(93)90067-6	43	24	24	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 24	2006	367	9528					2110	2117		10.1016/S0140-6736(06)68482-1	http://dx.doi.org/10.1016/S0140-6736(06)68482-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	058HZ	16798394				2022-12-24	WOS:000238657400036
J	Henrich, J; McElreath, R; Barr, A; Ensminger, J; Barrett, C; Bolyanatz, A; Cardenas, JC; Gurven, M; Gwako, E; Henrich, N; Lesorogol, C; Marlowe, FW; Tracer, D; Ziker, J				Henrich, Joseph; McElreath, Richard; Barr, Abigail; Ensminger, Jean; Barrett, Clark; Bolyanatz, Alexander; Camilo Cardenas, Juan; Gurven, Michael; Gwako, Edwins; Henrich, Natalie; Lesorogol, Carolyn; Marlowe, Frank W.; Tracer, David; Ziker, John			Costly punishment across human societies	SCIENCE			English	Article							ALTRUISTIC PUNISHMENT; ULTIMATUM GAME; NEURAL BASIS; COOPERATION; FAIRNESS; NORMS; PERSPECTIVE; ENFORCEMENT; RECIPROCITY; EVOLUTION	Recent behavioral experiments aimed at understanding the evolutionary foundations of human cooperation have suggested that a willingness to engage in costly punishment, even in one-shot situations, may be part of human psychology and a key element in understanding our sociality. However, because most experiments have been confined to students in industrialized societies, generalizations of these insights to the species have necessarily been tentative. Here, experimental results from 15 diverse populations show that (i) all populations demonstrate some willingness to administer costly punishment as unequal behavior increases, (ii) the magnitude of this punishment varies substantially across populations, and (iii) costly punishment positively covaries with altruistic behavior across populations. These findings are consistent with models of the gene-culture coevolution of human altruism and further sharpen what any theory of human cooperation needs to explain.	Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; Univ Calif Davis, Dept Anthropol, Grad Grp Ecol, Anim Behav Grad Grp,Populat Biol Grad Grp, Davis, CA 95616 USA; Univ Oxford, Dept Econ, GPRG, Oxford OX1 3UQ, England; CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA; Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90095 USA; Coll DuPage, Dept Anthropol, Glen Ellyn, IL 60137 USA; Univ Los Andes, CEDE, Fac Econ, Bogota, Colombia; Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA; Guilford Coll, Dept Sociol & Anthropol, Greensboro, NC 27410 USA; Washington Univ, George Warren Brown Sch Social Work, St Louis, MO 63130 USA; Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; Univ Colorado, Dept Anthropol, Denver, CO 80217 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO 80217 USA; Boise State Univ, Dept Anthropol, Boise, ID 83725 USA	Emory University; University of California System; University of California Davis; University of Oxford; California Institute of Technology; University of California System; University of California Los Angeles; Universidad de los Andes (Colombia); University of California System; University of California Santa Barbara; Washington University (WUSTL); Harvard University; University of Colorado System; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Idaho; Boise State University	Henrich, J (corresponding author), Emory Univ, Dept Anthropol, 1557 Dickey Dr, Atlanta, GA 30322 USA.	jhenric@emory.edu	cardenas, juan-camilo/B-4658-2009; Barrett, H Clark/AAE-2086-2019; Marlowe, Frank/G-9752-2012; Ziker, John/H-4395-2019	cardenas, juan-camilo/0000-0003-0005-7595; Barrett, H Clark/0000-0002-4157-6511; Ziker, John/0000-0001-9059-5594; Gurven, Michael/0000-0002-5661-527X; McElreath, Richard/0000-0002-0387-5377	Economic and Social Research Council [M571255001] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Andreoni J, 2003, AM ECON REV, V93, P672, DOI 10.1257/000282803322157034; Bahry DL, 2006, J ECON BEHAV ORGAN, V60, P37, DOI 10.1016/j.jebo.2004.07.005; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Boyd R, 2002, J THEOR BIOL, V215, P287, DOI 10.1006/jtbi.2001.2515; Camerer C., 2004, FDN HUMAN SOCIALITY, P55, DOI DOI 10.1093/0199262055.003.0003; Camerer C., 2004, FDN HUMAN SOCIALITY, P194, DOI DOI 10.1093/0199262055.003.0007; CARTER JR, 1991, J ECON PERSPECT, V5, P171, DOI 10.1257/jep.5.2.171; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; Gachter S, 2005, BEHAV BRAIN SCI, V28, P822, DOI 10.1017/S0140525X05290143; Gardner A, 2004, AM NAT, V164, P753, DOI 10.1086/425623; Gintis H, 2003, J THEOR BIOL, V220, P407, DOI 10.1006/jtbi.2003.3104; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; Harbaugh WT, 2000, ECON INQ, V38, P95, DOI 10.1093/ei/38.1.95; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2004, J ECON BEHAV ORGAN, V53, P3, DOI 10.1016/S0167-2681(03)00094-5; Henrich J, 2001, J THEOR BIOL, V208, P79, DOI 10.1006/jtbi.2000.2202; Huck S, 1999, J ECON PSYCHOL, V20, P183, DOI 10.1016/S0167-4870(99)00004-5; Marlowe F. W., 2004, FDN HUMAN SOCIALITY, P168, DOI DOI 10.1093/0199262055.003.0006; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Price ME, 2002, EVOL HUM BEHAV, V23, P203, DOI 10.1016/S1090-5138(01)00093-9; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; SUTTER M, 2005, TRUST RECIPROCITY DI; Tracer D., 2004, FDN HUMAN SOCIALITY, P232, DOI DOI 10.1093/0199262055.003.0008; Tracer DP, 2003, CURR ANTHROPOL, V44, P432, DOI 10.1086/374904	34	906	918	10	303	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2006	312	5781					1767	1770		10.1126/science.1127333	http://dx.doi.org/10.1126/science.1127333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	055LS	16794075				2022-12-24	WOS:000238452800049
J	Bleul, CC; Corbeaux, T; Reuter, A; Fisch, P; Monting, JS; Boehm, T				Bleul, Conrad C.; Corbeaux, Tatiana; Reuter, Alexander; Fisch, Paul; Moenting, Juergen Schulte; Boehm, Thomas			Formation of a functional thymus initiated by a postnatal epithelial progenitor cell	NATURE			English	Article							MOUSE; GENE; DIFFERENTIATION; MICROENVIRONMENT; EXPRESSION; PHENOTYPE; PROTEIN; STRAIN	The thymus is essential for the generation of self-tolerant effector and regulatory T cells. Intrathymic T-cell development requires an intact stromal microenvironment, of which thymic epithelial cells (TECs) constitute a major part(1-3). For instance, cell-autonomous genetic defects of forkhead box N1 (Foxn1)(4) and autoimmune regulator (Aire)(5) in thymic epithelial cells cause primary immunodeficiency and autoimmunity, respectively. During development, the thymic epithelial rudiment gives rise to two major compartments, the cortex and medulla. Cortical TECs positively select T cells(6), whereas medullary TECs are involved in negative selection of potentially autoreactive T cells(7). It has long been unclear whether these two morphologically and functionally distinct types of epithelial cells arise from a common bi-potent progenitor cell(8) and whether such progenitors are still present in the postnatal period. Here, using in vivo cell lineage analysis in mice, we demonstrate the presence of a common progenitor of cortical and medullary TECs after birth. To probe the function of postnatal progenitors, a conditional mutant allele of Foxn1 was reverted to wild-type function in single epithelial cells in vivo. This led to the formation of small thymic lobules containing both cortical and medullary areas that supported normal thymopoiesis. Thus, single epithelial progenitor cells can give rise to a complete and functional thymic microenvironment, suggesting that cell-based therapies could be developed for thymus disorders.	Max Planck Inst Immunobiol, Dept Dev Immunol, D-79108 Freiburg, Germany; Univ Freiburg, Dept Pathol, D-79110 Freiburg, Germany; Univ Freiburg, Inst Med Biometry & Informat, D-79104 Freiburg, Germany	Max Planck Society; University of Freiburg; University of Freiburg	Boehm, T (corresponding author), Max Planck Inst Immunobiol, Dept Dev Immunol, Stuebeweg 51, D-79108 Freiburg, Germany.	boehm@immunbio.mpg.de						Adriani M, 2004, ANN HUM GENET, V68, P265, DOI 10.1046/j.1529-8817.2004.00091.x; Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Blackburn CC, 2002, TRENDS IMMUNOL, V23, P391, DOI 10.1016/S1471-4906(02)02265-2; Boehm T, 2003, IMMUNOL REV, V195, P15, DOI 10.1034/j.1600-065X.2003.00070.x; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Cunningham-Rundles C, 2005, NAT REV IMMUNOL, V5, P880, DOI 10.1038/nri1713; Frank J, 1999, NATURE, V398, P473, DOI 10.1038/18997; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Gray DHD, 2005, CURR OPIN IMMUNOL, V17, P137, DOI 10.1016/j.coi.2005.02.001; Hogquist K A, 1996, Semin Immunol, V8, P63, DOI 10.1006/smim.1996.0009; Huth M, 1997, IMMUNOGENETICS, V45, P282, DOI 10.1007/s002510050206; Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436; Li M, 2000, NATURE, V407, P633, DOI 10.1038/35036595; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; NEHLS M, 1994, CURR BIOL, V4, P983, DOI 10.1016/S0960-9822(00)00222-0; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; NEHLS M, 1994, BIOTECHNIQUES, V17, P770; Pignata C, 2001, BLOOD, V97, P880, DOI 10.1182/blood.V97.4.880; RIELE HT, 1990, NATURE, V348, P649, DOI 10.1038/348649a0; Rodewald HR, 2001, NATURE, V414, P763, DOI 10.1038/414763a; Schorpp M, 1997, IMMUNOGENETICS, V46, P509, DOI 10.1007/s002510050312; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563	29	283	286	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 22	2006	441	7096					992	996		10.1038/nature04850	http://dx.doi.org/10.1038/nature04850			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AT	16791198				2022-12-24	WOS:000238422300045
J	Gollob, MH; Jones, DL; Krahn, AD; Danis, L; Gong, XQ; Shao, Q; Liu, XQ; Veinot, JP; Tang, ASL; Stewart, AFR; Tesson, F; Klein, GJ; Yee, R; Skanes, AC; Guiraudon, GM; Ebihara, L; Bai, D				Gollob, Michael H.; Jones, Douglas L.; Krahn, Andrew D.; Danis, Lynne; Gong, Xiang-Qun; Shao, Qing; Liu, Xiaoqin; Veinot, John P.; Tang, Anthony S. L.; Stewart, Alexandre F. R.; Tesson, Frederique; Klein, George J.; Yee, Raymond; Skanes, Allan C.; Guiraudon, Gerard M.; Ebihara, Lisa; Bai, Donglin			Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MARIE-TOOTH NEUROPATHY; GAP JUNCTION CHANNELS; PROLINE RESIDUE; RISK-FACTOR; IDENTIFICATION; CONDUCTION; DISEASE; VULNERABILITY; EXPRESSION; CATARACT	Background: Atrial fibrillation is the most common type of cardiac arrhythmia and a leading cause of cardiovascular morbidity, particularly stroke. The cardiac gap-junction protein connexin 40 is expressed selectively in atrial myocytes and mediates the coordinated electrical activation of the atria. We hypothesized that idiopathic atrial fibrillation has a genetic basis and that tissue-specific mutations in GJA5, the gene encoding connexin 40, may predispose the atria to fibrillation. Methods: We sequenced GJA5 from genomic DNA isolated from resected cardiac tissue and peripheral lymphocytes from 15 patients with idiopathic atrial fibrillation. Identified GJA5 mutations were transfected into a gap-junction-deficient cell line to assess their functional effects on protein transport and intercellular electrical coupling. Results: Four novel heterozygous missense mutations were identified in 4 of the 15 patients. In three patients, the mutations were found in the cardiac-tissue specimens but not in the lymphocytes, indicating a somatic source of the genetic defects. In the fourth patient, the sequence variant was detected in both cardiac tissue and lymphocytes, suggesting a germ-line origin. Analysis of the expression of mutant proteins revealed impaired intracellular transport or reduced intercellular electrical coupling. Conclusions: Mutations in GJA5 may predispose patients to idiopathic atrial fibrillation by impairing gap-junction assembly or electrical coupling. Our data suggest that common diseases traditionally considered to be idiopathic may have a genetic basis, with mutations confined to the diseased tissue.	Univ Ottawa, Inst Heart, Arrhythmia Res Lab, Dept Med, Ottawa, ON K1Y 4W7, Canada; Univ Western Ontario, Dept Med, London, ON, Canada; Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada; Univ Western Ontario, Dept Surg, London, ON N6A 3K7, Canada; Rosalind Franklin Univ Med & Sci, Dept Physiol & Biophys, N Chicago, IL USA	University of Ottawa; University of Ottawa Heart Institute; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Rosalind Franklin University Medical & Science	Gollob, MH (corresponding author), Univ Ottawa, Inst Heart, Arrhythmia Res Lab, Dept Med, Rm H350,40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.	mgollob@ottawaheart.ca	Bai, Donglin/ABB-9924-2021; Guiraudon, Gerard M/B-7811-2015; Bai, Donglin/A-5799-2008; Tesson, Frederique/A-3218-2013; Skanes, Allan/G-3347-2011; Jones, Douglas Lloyd/M-7806-2015; Stewart, Alexandre F.R./A-5677-2011; Yee, Raymond/H-1323-2011; Tang, Anthony S/E-6203-2014; Klein, George/G-3313-2011	Bai, Donglin/0000-0003-1112-6947; Guiraudon, Gerard M/0000-0002-7418-2500; Bai, Donglin/0000-0003-1112-6947; Jones, Douglas Lloyd/0000-0002-5577-0091; Stewart, Alexandre/0000-0003-2673-9164; Gollob, Michael/0000-0003-0242-5208				Barnes TM, 1997, J NEUROCHEM, V69, P2251; Bayazit YA, 2003, INT J PEDIATR OTORHI, V67, P1331, DOI 10.1016/j.ijporl.2003.08.003; Beck JA, 2004, HUM MOL GENET, V13, P1219, DOI 10.1093/hmg/ddh134; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Bort S, 1997, HUM GENET, V99, P746, DOI 10.1007/s004390050442; Brugada R, 1997, NEW ENGL J MED, V336, P905, DOI 10.1056/NEJM199703273361302; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; COX JL, 1991, J THORAC CARDIOV SUR, V101, P406, DOI 10.1016/s0022-5223(19)36723-6; Dilaveris PE, 1998, AM HEART J, V135, P733, DOI 10.1016/S0002-8703(98)70030-4; Ellinor PT, 2003, CIRCULATION, V107, P2880, DOI 10.1161/01.CIR.0000077910.80718.49; Erickson RP, 2003, MUTAT RES-REV MUTAT, V543, P125, DOI 10.1016/S1383-5742(03)00010-3; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Firouzi M, 2004, CIRC RES, V95, P29, DOI 10.1161/01.RES.0000141134.64811.0a; Fritz S, 2002, J CLIN ENDOCR METAB, V87, P1362, DOI 10.1210/jc.87.3.1362; Gutstein DE, 2001, CIRCULATION, V104, P1194, DOI 10.1161/hc3601.093990; Hagendorff A, 1999, CIRCULATION, V99, P1508, DOI 10.1161/01.CIR.99.11.1508; Janssen EAM, 1997, HUM GENET, V99, P501, DOI 10.1007/s004390050396; Kanno S, 2001, CARDIOVASC PATHOL, V10, P169, DOI 10.1016/S1054-8807(01)00078-3; KONINGS KTS, 1994, CIRCULATION, V89, P1665, DOI 10.1161/01.CIR.89.4.1665; Krutovskikh V, 2000, MUTAT RES-REV MUTAT, V462, P197, DOI 10.1016/S1383-5742(00)00037-5; Kuntzer T, 2003, J NEUROL SCI, V207, P77, DOI 10.1016/S0022-510X(02)00394-5; Lerman BB, 1998, J CLIN INVEST, V101, P2862, DOI 10.1172/JCI1582; Nelis E, 1997, HUM MUTAT, V9, P47, DOI 10.1002/(SICI)1098-1004(1997)9:1<47::AID-HUMU8>3.3.CO;2-N; Pal JD, 1999, AM J PHYSIOL-CELL PH, V276, pC1443, DOI 10.1152/ajpcell.1999.276.6.C1443; Phelan P, 2001, BIOESSAYS, V23, P388, DOI 10.1002/bies.1057; Puck JM, 2004, NEW ENGL J MED, V351, P1388, DOI 10.1056/NEJMp048116; Ri Y, 1999, BIOPHYS J, V76, P2887, DOI 10.1016/S0006-3495(99)77444-8; Shiels A, 1998, AM J HUM GENET, V62, P526, DOI 10.1086/301762; SPACH MS, 1994, J CARDIOVASC ELECTR, V5, P182, DOI 10.1111/j.1540-8167.1994.tb01157.x; SUCHYNA TM, 1993, NATURE, V365, P847, DOI 10.1038/365847a0; Valiunas V, 2001, AM J PHYSIOL-HEART C, V281, pH1675, DOI 10.1152/ajpheart.2001.281.4.H1675; Waldo, 1996, ATRIAL FLUTTER, P248; Wattigney WA, 2003, CIRCULATION, V108, P711, DOI 10.1161/01.CIR.0000083722.42033.0A; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980	35	381	408	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 22	2006	354	25					2677	2688		10.1056/NEJMoa052800	http://dx.doi.org/10.1056/NEJMoa052800			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	054ZJ	16790700				2022-12-24	WOS:000238416900006
J	Kumar, KR; Li, LN; Yan, M; Bhaskarabhatla, M; Mobley, AB; Nguyen, C; Mooney, JM; Schatzle, JD; Wakeland, EK; Mohan, C				Kumar, Kirthi Raman; Li, Liunan; Yan, Mei; Bhaskarabhatla, Madhavi; Mobley, Angela B.; Nguyen, Charles; Mooney, Jill M.; Schatzle, John D.; Wakeland, Edward K.; Mohan, Chandra			Regulation of B cell tolerance by the lupus susceptibility gene Ly108	SCIENCE			English	Article							REACTIVE LYMPHOCYTES-B; SLE PATHOGENESIS; SELF-ANTIGEN; ERYTHEMATOSUS; DISSECTION; ELIMINATION; EXPRESSION; CLUSTER; MICE	The susceptibility locus for the autoimmune disease lupus on murine chromosome 1, Sle1(z)/Sle1b(z), and the orthologous human locus are associated with production of autoantibody to chromatin. We report that the presence of Sle1(z)/Sle1b(z) impairs B cell anergy, receptor revision, and deletion. Members of the SLAM costimulatory molecule family constitute prime candidates for Sle1b(z), among which the Ly108.1 isoform of the Ly108 gene was most highly expressed in immature B cells from lupus-prone B6. Sle1(z) mice. The normal Ly108.2 allele, but not the lupus-associated Ly108.1 allele, was found to sensitize immature B cells to deletion and RAG reexpression. As a potential regulator of tolerance checkpoints, Ly108 may censor self-reactive B cells, hence safeguarding against autoimmunity.	Univ Texas, SW Med Ctr, Dept Internal Med Rheumatol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Immunol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Mohan, C (corresponding author), Univ Texas, SW Med Ctr, Dept Internal Med Rheumatol, Dallas, TX 75390 USA.	chandra.mohan@utsouthwestern.edu	Mohan, Chandra/GPX-8233-2022; yan, mei/AAA-1379-2022		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044894] Funding Source: NIH RePORTER; NIAID NIH HHS [AI54902] Funding Source: Medline; NIAMS NIH HHS [NIH RO1 AR44894] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Benschop RJ, 1999, J EXP MED, V190, P749, DOI 10.1084/jem.190.6.749; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; HOLMAN HR, 1957, SCIENCE, V126, P162, DOI 10.1126/science.126.3265.162; Kono D H, 2000, Int Rev Immunol, V19, P367, DOI 10.3109/08830180009055504; Melamed D, 1997, P NATL ACAD SCI USA, V94, P9267, DOI 10.1073/pnas.94.17.9267; Mohan C, 1999, J CLIN INVEST, V103, P1685, DOI 10.1172/JCI5827; Mohan C, 1998, J CLIN INVEST, V101, P1362; MOREL L, 1994, IMMUNITY, V1, P219, DOI 10.1016/1074-7613(94)90100-7; Morel L, 2001, P NATL ACAD SCI USA, V98, P1787, DOI 10.1073/pnas.031336098; Raman K, 2003, CURR OPIN IMMUNOL, V15, P651, DOI 10.1016/j.coi.2003.09.007; RATHMELL JC, 1994, J IMMUNOL, V153, P2831; Rubio CF, 1996, J IMMUNOL, V157, P65; Sobel ES, 1999, J IMMUNOL, V162, P2415; Tsao BP, 1997, J CLIN INVEST, V99, P725, DOI 10.1172/JCI119217; Tze LE, 2003, J IMMUNOL, V171, P678, DOI 10.4049/jimmunol.171.2.678; Veillette A, 2003, CURR OPIN IMMUNOL, V15, P277, DOI 10.1016/S0952-7915(03)00041-4; Wakeland EK, 2001, IMMUNITY, V15, P397, DOI 10.1016/S1074-7613(01)00201-1; Wandstrat AE, 2004, IMMUNITY, V21, P769, DOI 10.1016/j.immuni.2004.10.009; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251	22	191	199	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 16	2006	312	5780					1665	1669		10.1126/science.1125893	http://dx.doi.org/10.1126/science.1125893			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053EO	16778059				2022-12-24	WOS:000238288600050
J	Zhang, XW; Gureasko, J; Shen, K; Cole, PA; Kuriyan, J				Zhang, Xuewu; Gureasko, Jodi; Shen, Kui; Cole, Philip A.; Kuriyan, John			An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor	CELL			English	Article							PROTEIN-TYROSINE KINASE; CRYSTAL-STRUCTURE; EGF RECEPTOR; LUNG CANCERS; GENE-MUTATIONS; GEFITINIB; INHIBITOR; COMPLEX; PHOSPHORYLATION; DIMERIZATION	The mechanism by which the epidermal growth factor receptor (EGFR) is activated upon dimerization has eluded definition. We find that the EGFR kinase domain can be activated by increasing its local concentration or by mutating a leucine (L834R) in the activation loop, the phosphorylation of which is not required for activation. This suggests that the kinase domain is intrinsically autoinhibited, and an intermolecular interaction promotes its activation. Using further mutational analysis and crystallography we demonstrate that the autoinhibited conformation of the EGFR kinase domain resembles that of Src and cyclin-dependent kinases (CDKs). EGFR activation results from the formation of an asymmetric dimer in which the C-terminal lobe of one kinase domain plays a role analogous to that of cyclin in activated CDK/cyclin complexes. The CDK/cyclin-like complex formed by two kinase domains thus explains the activation of EGFR.-family receptors by homo- or heterodimerization.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Johns Hopkins University	Zhang, XW (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu			NCI NIH HHS [R01 CA74305, R01 CA96504] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA074305, R01CA096504] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARKER SC, 1995, BIOCHEMISTRY-US, V34, P14843, DOI 10.1021/bi00045a027; Bishayee A, 1999, MOL BIOL CELL, V10, P525, DOI 10.1091/mbc.10.3.525; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Burke CL, 1998, MOL CELL BIOL, V18, P5371, DOI 10.1128/MCB.18.9.5371; CHANG CM, 1995, J VIROL, V69, P1172, DOI 10.1128/JVI.69.2.1172-1180.1995; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Deb TB, 2001, J BIOL CHEM, V276, P15554, DOI 10.1074/jbc.M100928200; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Dorn IT, 1998, J AM CHEM SOC, V120, P2753, DOI 10.1021/ja9735620; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; GOTOH N, 1992, BIOCHEM BIOPH RES CO, V186, P768, DOI 10.1016/0006-291X(92)90812-Y; Groenen LC, 1997, BIOCHEMISTRY-US, V36, P3826, DOI 10.1021/bi9614141; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jiang JR, 2005, CANCER RES, V65, P8968, DOI 10.1158/0008-5472.CAN-05-1829; KASHLES O, 1991, MOL CELL BIOL, V11, P1454, DOI 10.1128/MCB.11.3.1454; Landau M, 2004, STRUCTURE, V12, P2265, DOI 10.1016/j.str.2004.10.006; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McLaughlin S, 2005, J GEN PHYSIOL, V126, P41, DOI 10.1085/jgp.200509274; MOHAMMADI M, 1993, BIOCHEMISTRY-US, V32, P8742, DOI 10.1021/bi00085a004; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Parang K, 2001, NAT STRUCT BIOL, V8, P37; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; SCHREIBER AB, 1983, J BIOL CHEM, V258, P846; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Shrout AL, 2003, BIOCHEMISTRY-US, V42, P13379, DOI 10.1021/bi0352769; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; USHIRO H, 1980, J BIOL CHEM, V255, P8363; WEDEGAERTNER PB, 1989, J BIOL CHEM, V264, P11346; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034	41	1112	1151	7	134	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUN 16	2006	125	6					1137	1149		10.1016/j.cell.2006.05.013	http://dx.doi.org/10.1016/j.cell.2006.05.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	057NO	16777603	Bronze			2022-12-24	WOS:000238602700018
J	Noubissi, FK; Elcheva, I; Bhatia, N; Shakoori, A; Ougolkov, A; Liu, JH; Minamoto, T; Ross, J; Fuchs, SY; Spiegelman, VS				Noubissi, Felicite K.; Elcheva, Irina; Bhatia, Neehar; Shakoori, Abbas; Ougolkov, Andrei; Liu, Jianghuai; Minamoto, Toshinari; Ross, Jeff; Fuchs, Serge Y.; Spiegelman, Vladimir S.			CRD-BP mediates stabilization of beta TrCP1 and c-myc mRNA in response to beta-catenin signalling	NATURE			English	Article							UBIQUITIN LIGASE RECEPTOR; NF-KAPPA-B; BINDING-PROTEIN; CODING REGION; IN-VITRO; EXPRESSION; CANCER; TARGET; TRCP; DETERMINANT	Although constitutive activation of beta-catenin/Tcf signalling is implicated in the development of human cancers(1), the mechanisms by which the beta-catenin/Tcf pathway promotes tumorigenesis are incompletely understood. Messenger RNA turnover has a major function in regulating gene expression and is responsive to developmental and environmental signals. mRNA decay rates are dictated by cis-acting elements within the mRNA and by trans-acting factors, such as RNA-binding proteins ( reviewed in refs 2, 3). Here we show that beta-catenin stabilizes the mRNA encoding the F-box protein beta TrCP1, and identify the RNA-binding protein CRD-BP ( coding region determinant-binding protein) as a previously unknown target of beta-catenin/Tcf transcription factor. CRD-BP binds to the coding region of bTrCP1 mRNA. Overexpression of CRD-BP stabilizes bTrCP1 mRNA and elevates beta TrCP1 levels ( both in cells and in vivo), resulting in the activation of the Skp1-Cullin1-F-box protein (SCF) beta TrCP E3 ubiquitin ligase and in accelerated turnover of its substrates including I kappa B and beta-catenin. CRD-BP is essential for the induction of both beta TrCP1 and c-Myc by beta-catenin signalling in colorectal cancer cells. High levels of CRD-BP that are found in primary human colorectal tumours exhibiting active beta-catenin/Tcf signalling implicates CRD-BP induction in the upregulation of beta TrCP1, in the activation of dimeric transcription factor NF-kappa B and in the suppression of apoptosis in these cancers.	Univ Wisconsin, Sch Med & Publ Hlth, Dept Dermatol, Madison, WI 53706 USA; Kanazawa Univ, Div Translat & Clin Oncol, Canc Res Inst, Kanazawa, Ishikawa 9200934, Japan; Univ Penn, Dept Anim Biol, Philadelphia, PA 19104 USA; Univ Wisconsin, Sch Med & Publ Hlth, McArdle Lab Canc Res, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Kanazawa University; University of Pennsylvania; University of Wisconsin System; University of Wisconsin Madison	Spiegelman, VS (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Dermatol, Madison, WI 53706 USA.	spiegelman@dermatology.wisc.edu	Ugolkov, Andrey/T-3012-2019	Liu, Jianghuai/0000-0002-2382-9140; shakoori, abbas/0000-0002-4363-1967; Spiegelman, Vladimir S/0000-0003-4847-155X				Atlas R, 2004, J NEUROCHEM, V89, P613, DOI 10.1111/j.1471-4159.2004.02371.x; BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; Doyle GAR, 1998, NUCLEIC ACIDS RES, V26, P5036, DOI 10.1093/nar/26.22.5036; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ioannidis P, 2004, CANCER LETT, V209, P245, DOI 10.1016/j.canlet.2003.12.015; Ioannidis P, 2003, ANTICANCER RES, V23, P2179; Ioannidis P, 2003, INT J CANCER, V104, P54, DOI 10.1002/ijc.10794; Ioannidis P, 2001, INT J CANCER, V94, P480, DOI 10.1002/ijc.1512; Kudo Y, 2004, MOL CELL BIOL, V24, P8184, DOI 10.1128/MCB.24.18.8184-8194.2004; Leeds P, 1997, ONCOGENE, V14, P1279, DOI 10.1038/sj.onc.1201093; Lin A, 2003, SEMIN CANCER BIOL, V13, P107, DOI 10.1016/S1044-579X(02)00128-1; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Nielsen FC, 2001, SCAND J CLIN LAB INV, V61, P93; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Ougolkov A, 2004, JNCI-J NATL CANCER I, V96, P1161, DOI 10.1093/jnci/djh219; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; PROKIPCAK RD, 1994, J BIOL CHEM, V269, P9261; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Ross J, 2001, ONCOGENE, V20, P6544, DOI 10.1038/sj.onc.1204838; Ross J, 1999, METH MOL B, V118, P459; Runge S, 2000, J BIOL CHEM, V275, P29562, DOI 10.1074/jbc.M001156200; Spiegelman VS, 2000, MOL CELL, V5, P877, DOI 10.1016/S1097-2765(00)80327-5; Tessier CR, 2004, CANCER RES, V64, P209, DOI 10.1158/0008-5472.CAN-03-2927; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025	28	171	175	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					898	901		10.1038/nature04839	http://dx.doi.org/10.1038/nature04839			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16778892				2022-12-24	WOS:000238254100048
J	Nussbaumer, AD; Fisher, CR; Bright, M				Nussbaumer, AD; Fisher, CR; Bright, M			Horizontal endosymbiont transmission in hydrothermal vent tubeworms	NATURE			English	Article							BACTERIAL ENDOSYMBIONTS; APOPTOSIS; POGONOPHORA; ANNELIDA; WORMS; GUT	Transmission of obligate bacterial symbionts between generations is vital for the survival of the host. Although the larvae of certain hydrothermal vent tubeworms (Vestimentifera, Siboglinidae) are symbiont-free and possess a transient digestive system, these structures are lost during development, resulting in adult animals that are nutritionally dependent on their bacterial symbionts. Thus, each generation of tubeworms must be newly colonized with its specific symbiont(1,2). Here we present a model for tubeworm symbiont acquisition and the development of the symbiont-housing organ, the trophosome. Our data indicate that the bacterial symbionts colonize the developing tube of the settled larvae and enter the host through the skin, a process that continues through the early juvenile stages during which the trophosome is established from mesodermal tissue. In later juvenile stages we observed massive apoptosis of host epidermis, muscles and undifferentiated mesodermal tissue, which was coincident with the cessation of the colonization process. Characterizing the symbiont transmission process in this finely tuned mutualistic symbiosis provides another model of symbiont acquisition and additional insights into underlying mechanisms common to both pathogenic infections and beneficial host - symbiont interactions.	Univ Vienna, Dept Marine Biol, A-1090 Vienna, Austria; Penn State Univ, Dept Biol, Mueller Lab 208, University Pk, PA 16802 USA	University of Vienna; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bright, M (corresponding author), Univ Vienna, Dept Marine Biol, Althanstr 14, A-1090 Vienna, Austria.	monika.bright@univie.ac.at	Bright, Monika/I-5542-2012; Nussbaumer, Andrea D/C-6080-2013; Fisher, Charles/H-7912-2012; Bright, Monika/AAA-7015-2021	Bright, Monika/0000-0001-7066-1363				Benson DA, 1999, NUCLEIC ACIDS RES, V27, P12, DOI 10.1093/nar/27.1.12; Bright M, 2003, INVERTEBR BIOL, V122, P347; CALLSENCENCIC P, 1995, SARSIA, V80, P73, DOI 10.1080/00364827.1995.10413582; Cary S. C., 1993, Molecular Marine Biology and Biotechnology, V2, P51; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Cordes EE, 2005, PLOS BIOL, V3, P497, DOI 10.1371/journal.pbio.0030077; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Di Meo CA, 2000, APPL ENVIRON MICROB, V66, P651, DOI 10.1128/AEM.66.2.651-658.2000; DUBILIER N, 1995, APPL ENVIRON MICROB, V61, P2346, DOI 10.1128/AEM.61.6.2346-2350.1995; Feldman RA, 1997, MOL MAR BIOL BIOTECH, V6, P268; Foster JS, 1998, DEV GENES EVOL, V208, P295, DOI 10.1007/s004270050185; Heimler W., 1988, Microfauna Marina, V4, P353; JONES ML, 1988, P BIOL SOC WASH, V101, P423; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Marsh AG, 2001, NATURE, V411, P77, DOI 10.1038/35075063; McFall-Ngai MJ, 2000, CURR OPIN MICROBIOL, V3, P603, DOI 10.1016/S1369-5274(00)00147-8; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; Mullineaux LS, 2000, OECOLOGIA, V123, P275, DOI 10.1007/s004420051014; Rouse GW, 2004, SCIENCE, V305, P668, DOI 10.1126/science.1098650; Shank TM, 1998, DEEP-SEA RES PT II, V45, P465, DOI 10.1016/S0967-0645(97)00089-1; Southward EC, 2005, HYDROBIOLOGIA, V535, P227, DOI 10.1007/s10750-004-4401-6; SOUTHWARD EC, 1988, J MAR BIOL ASSOC UK, V68, P465, DOI 10.1017/S0025315400043344; TRENCH RK, 1993, ENDOCYTOBIOSIS CELL, V9, P135; Twomey C, 2005, J CELL MOL MED, V9, P345, DOI 10.1111/j.1582-4934.2005.tb00360.x; VANRHIJN P, 1995, MICROBIOL REV, V59, P124, DOI 10.1128/MMBR.59.1.124-142.1995; VAUX DL, 1993, P NATL ACAD SCI USA, V90, P786, DOI 10.1073/pnas.90.3.786; Young CM, 1996, NATURE, V381, P514, DOI 10.1038/381514a0; Zychlinsky A, 1997, J CLIN INVEST, V100, P493, DOI 10.1172/JCI119557	30	176	188	0	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 18	2006	441	7091					345	348		10.1038/nature04793	http://dx.doi.org/10.1038/nature04793			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	043IB	16710420				2022-12-24	WOS:000237593200047
J	Bouman, HA; Ulloa, O; Scanlan, DJ; Zwirglmaier, K; Li, WKW; Platt, T; Stuart, V; Barlow, R; Leth, O; Clementson, L; Lutz, V; Fukasawa, M; Watanabe, S; Sathyendranath, S				Bouman, HA; Ulloa, O; Scanlan, DJ; Zwirglmaier, K; Li, WKW; Platt, T; Stuart, V; Barlow, R; Leth, O; Clementson, L; Lutz, V; Fukasawa, M; Watanabe, S; Sathyendranath, S			Oceanographic basis of the global surface distribution of Prochlorococcus ecotypes	SCIENCE			English	Article							NORTH-ATLANTIC OCEAN; COMMUNITY STRUCTURE; CYANOBACTERIUM PROCHLOROCOCCUS; PHYTOPLANKTON; POPULATIONS; GENOME; FLUORESCENCE; SEQUENCE; GULF; SEA	By using data collected during a continuous circumnavigation of the Southern Hemisphere, we observed clear patterns in the population-genetic structure of Prochlorococcus, the most abundant photosynthetic organism on Earth, between and within the three Southern Subtropical Gyres. The same mechanisms that were previously invoked to account for the vertical distribution of ecotypes at local scales accounted for the global ( horizontal) patterns we observed. Basin-scale and seasonal variations in the structure and strength of vertical stratification provide a basis for understanding large-scale horizontal distribution in genetic and physiological traits of Prochlorococcus, and perhaps of marine microbial communities in general.	Univ Concepcion, Dept Oceanog, Lab Proc Oceanog & Clima, Concepcion, Chile; Univ Concepcion, Ctr Invest Oceanog Pacifico SurOriental, Dept Geofis, Concepcion, Chile; Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; Fisheries & Oceans Canada, Bedford Inst Oceanog, Dartmouth, NS B2Y 4A2, Canada; Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4J1, Canada; Marine & Coastal Management, ZA-8012 Cape Town, South Africa; CSIRO, Marine Res, Hobart, Tas 7001, Australia; Inst Nacl Invest & Desarrollo Pesquero, RA-7600 Mar Del Plata, Argentina; Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan	Universidad de Concepcion; Universidad de Concepcion; University of Warwick; Bedford Institute of Oceanography; Fisheries & Oceans Canada; Dalhousie University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Fisheries Research & Development Institute (INIDEP); Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Bouman, HA (corresponding author), Univ Concepcion, Dept Oceanog, Lab Proc Oceanog & Clima, Concepcion, Chile.	heather@profc.udec.cl	Zwirglmaier, Katrin/H-9799-2014; Ulloa, Osvaldo/E-1821-2011; Scanlan, David J/G-4080-2016; Clementson, Lesley A/M-6905-2013	Zwirglmaier, Katrin/0000-0001-8598-9572; Ulloa, Osvaldo/0000-0002-9501-5576; Scanlan, David J/0000-0003-3093-4245; Clementson, Lesley/0000-0003-4415-993X	Natural Environment Research Council [NE/C000536/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Babin M, 1996, DEEP-SEA RES PT I, V43, P1241, DOI 10.1016/0967-0637(96)00058-1; Bailey S, 2005, FEBS LETT, V579, P275, DOI 10.1016/j.febslet.2004.11.091; Bouman HA, 2003, MAR ECOL PROG SER, V258, P19, DOI 10.3354/meps258019; Dufresne A, 2003, P NATL ACAD SCI USA, V100, P10020, DOI 10.1073/pnas.1733211100; Dusenberry JA, 1999, LIMNOL OCEANOGR, V44, P431, DOI 10.4319/lo.1999.44.2.0431; Ferris MJ, 1998, NATURE, V396, P226, DOI 10.1038/24297; Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; Fuller NJ, 2005, LIMNOL OCEANOGR, V50, P363, DOI 10.4319/lo.2005.50.1.0363; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Li WKW, 2002, NATURE, V419, P154, DOI 10.1038/nature00994; LI WKW, IN PRESS MARINE MACR; Longhurst A., 2010, ECOLOGICAL GEOGRAPHY; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; Moore LR, 2005, AQUAT MICROB ECOL, V39, P257, DOI 10.3354/ame039257; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Moore LR, 1999, LIMNOL OCEANOGR, V44, P628, DOI 10.4319/lo.1999.44.3.0628; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; PALENIK B, 1994, APPL ENVIRON MICROB, V60, P3212, DOI 10.1128/AEM.60.9.3212-3219.1994; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Partensky F., 1999, B I OCEANOGRAPHIQUE, V19, P457; Pommier T, 2005, AQUAT MICROB ECOL, V41, P79, DOI 10.3354/ame041079; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Rodriguez J, 2001, NATURE, V410, P360, DOI 10.1038/35066560; Selje N, 2004, NATURE, V427, P445, DOI 10.1038/nature02272; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Ting CS, 2002, TRENDS MICROBIOL, V10, P134, DOI 10.1016/S0966-842X(02)02319-3; UCHIDA H, 2005, WHP P6 13 14 REVISIT; Urbach E, 1998, LIMNOL OCEANOGR, V43, P1615, DOI 10.4319/lo.1998.43.7.1615; Veldhuis MJW, 2004, DEEP-SEA RES PT I, V51, P507, DOI 10.1016/j.dsr.2003.12.002; West NJ, 1999, APPL ENVIRON MICROB, V65, P2585; Zinser ER, 2006, APPL ENVIRON MICROB, V72, P723, DOI 10.1128/AEM.72.1.723-732.2006	32	161	165	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2006	312	5775					918	921		10.1126/science.1122692	http://dx.doi.org/10.1126/science.1122692			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	041JQ	16690867				2022-12-24	WOS:000237452900049
J	Field, J; Cronin, A; Bridge, C				Field, J; Cronin, A; Bridge, C			Future fitness and helping in social queues	NATURE			English	Article							EUSOCIAL HOVER WASPS; KIN SELECTION; REPRODUCTIVE SKEW; ANIMAL SOCIETIES; GENETIC-MARKERS; GROUP-SIZE; RELATEDNESS; VERTEBRATES; EVOLUTION; HELPERS	Helpers in primitively eusocial and cooperatively breeding animal societies forfeit their own reproduction to rear the offspring of a queen or breeding pair, but may eventually attain breeding status themselves. Kin selection(1) provides a widely accepted theoretical framework for understanding these societies, but differences in genetic relatedness do not explain a universal societal feature: the huge variation between individuals in helping effort(2-10). An alternative explanation for this variation lies in a fundamental trade-off faced by helpers: by working harder, they increase the indirect component of their fitness, but simultaneously decrease their own future survival and fecundity(2,4,8). Here, we show that individuals work less hard when they stand to lose more future fitness through working. We experimentally manipulated two components of future fitness in social queues of hover wasps (Stenogastrinae): a helper's chance of inheriting an egg-laying position, and the workforce available to rear her offspring should she inherit. After each manipulation, helpers increased or decreased their effort as appropriate to the change in expected future fitness that they experienced. Although helping provides significant indirect fitness benefits for hover wasps(11), our study shows that variation in the costs associated with helping is the major determinant of helping effort.	UCL, Dept Biol, London NW1 2HE, England	University of London; University College London	Field, J (corresponding author), UCL, Dept Biol, Wolfson House,4 Stephenson Way, London NW1 2HE, England.	jeremy.field@ucl.ac.uk						BRIDGE CAL, 2005, THESIS U COL LONDON; Cant MA, 2005, BEHAV ECOL, V16, P708, DOI 10.1093/beheco/ari051; Cant MA, 2001, P ROY SOC B-BIOL SCI, V268, P1959, DOI 10.1098/rspb.2001.1754; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Clutton-Brock TH, 2000, P ROY SOC B-BIOL SCI, V267, P301, DOI 10.1098/rspb.2000.1000; Crawley M.J, 2002, STAT COMPUTING INTRO; Field J, 1999, ANIM BEHAV, V57, P633, DOI 10.1006/anbe.1999.0995; Field J, 1999, BEHAV ECOL SOCIOBIOL, V45, P378, DOI 10.1007/s002650050574; Field J, 2000, NATURE, V404, P869, DOI 10.1038/35009097; Goodnight KF, 1999, MOL ECOL, V8, P1231, DOI 10.1046/j.1365-294x.1999.00664.x; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; Griffin AS, 2002, TRENDS ECOL EVOL, V17, P15, DOI 10.1016/S0169-5347(01)02355-2; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Heinsohn R, 1999, TRENDS ECOL EVOL, V14, P53, DOI 10.1016/S0169-5347(98)01545-6; HEINSOHN R, 1994, P ROY SOC B-BIOL SCI, V256, P293, DOI 10.1098/rspb.1994.0083; Houston AI, 2005, TRENDS ECOL EVOL, V20, P33, DOI 10.1016/j.tree.2004.10.008; Keller L, 1997, TRENDS ECOL EVOL, V12, P99, DOI 10.1016/S0169-5347(96)10065-3; Kokko H, 1999, P ROY SOC B-BIOL SCI, V266, P571, DOI 10.1098/rspb.1999.0674; Kokko H, 2001, P ROY SOC B-BIOL SCI, V268, P187, DOI 10.1098/rspb.2000.1349; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Queller DC, 2000, NATURE, V405, P784, DOI 10.1038/35015552; Shreeves G, 2003, P ROY SOC B-BIOL SCI, V270, P1617, DOI 10.1098/rspb.2003.2409; Shreeves G, 2002, AM NAT, V159, P81, DOI 10.1086/324125; Stiver KA, 2005, P ROY SOC B-BIOL SCI, V272, P1593, DOI 10.1098/rspb.2005.3123; Sumner S, 2002, P ROY SOC B-BIOL SCI, V269, P179, DOI 10.1098/rspb.2001.1884; Sundstrom L, 1996, SCIENCE, V274, P993, DOI 10.1126/science.274.5289.993; *U TECHN, 2005, R PROJ STAT COMP; West-Eberhard M.J., 1981, P3	28	89	94	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 11	2006	441	7090					214	217		10.1038/nature04560	http://dx.doi.org/10.1038/nature04560			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16688175				2022-12-24	WOS:000237418800045
J	Ho, PM; Rumsfeld, JS				Ho, PM; Rumsfeld, JS			Cardiac risk management in severe mental illness	LANCET			English	Editorial Material							DISEASE; SCHIZOPHRENIA		Univ Colorado, Hlth Sci Ctr, Denver Vet Affairs Med Ctr, Cardiol Sect, Denver, CO 80220 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Ho, PM (corresponding author), Univ Colorado, Hlth Sci Ctr, Denver Vet Affairs Med Ctr, Cardiol Sect, 4200 E 9th Ave, Denver, CO 80220 USA.	Michael.ho@uchsc.edu						Baptista T, 2002, PHARMACOPSYCHIATRY, V35, P205, DOI 10.1055/s-2002-36391; De Luca V, 2004, NEUROPSYCHOPHARMACOL, V29, P1522, DOI 10.1038/sj.npp.1300466; Goff DC, 2005, J CLIN PSYCHIAT, V66, P183, DOI 10.4088/JCP.v66n0205; Hennekens CH, 2005, AM HEART J, V150, P1115, DOI 10.1016/j.ahj.2005.02.007; Marder SR, 2003, J CLIN PSYCHIAT, V64, P3; Osborn DPJ, 2006, BRIT J PSYCHIAT, V188, P271, DOI 10.1192/bjp.bp.104.008060; Rumsfeld JS, 2004, EUR HEART J, V25, P1565, DOI 10.1016/j.ehj.2004.08.004; Whellan DJ, 2005, AM HEART J, V149, P722, DOI 10.1016/j.ahj.2004.09.023	8	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2006	367	9521					1469	1471		10.1016/S0140-6736(06)68628-5	http://dx.doi.org/10.1016/S0140-6736(06)68628-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	039RJ	16679146				2022-12-24	WOS:000237324200009
J	Veneault-Fourrey, C; Barooah, M; Egan, M; Wakley, G; Talbot, NJ				Veneault-Fourrey, C; Barooah, M; Egan, M; Wakley, G; Talbot, NJ			Autophagic fungal cell death is necessary for infection by the rice blast fungus	SCIENCE			English	Article							MAGNAPORTHE-GRISEA; ASPERGILLUS-NIDULANS; TURGOR; MONODANSYLCADAVERINE; PENETRATION; BIOLOGY; PROTEIN; KINASE; GENE	Rice blast is caused by the fungus Magnaporthe grisea, which elaborates specialized infection cells called appressoria to penetrate the tough outer cuticle of the rice plant Oryza sativa. We found that the formation of an appressorium required, sequentially, the completion of mitosis, nuclear migration, and death of the conidium (fungal spore) from which the infection originated. Genetic intervention during mitosis prevented both appressorium development and conidium death. Impairment of autophagy, by the targeted mutation of the MgATG8 gene, arrested conidial cell death but rendered the fungus nonpathogenic. Thus, the initiation of rice blast requires autophagic cell death of the conidium.	Univ Exeter, Sch Biosci, Washington Singer Labs, Exeter EX4 4QG, Devon, England	University of Exeter	Talbot, NJ (corresponding author), Univ Exeter, Sch Biosci, Washington Singer Labs, Perry Rd, Exeter EX4 4QG, Devon, England.	N.J.Talbot@exeter.ac.uk	Talbot, Nicholas J/I-9584-2014; Talbot, Nicholas J/I-5618-2019	Talbot, Nicholas J/0000-0001-6434-7757; Talbot, Nicholas J/0000-0001-6434-7757; Barooah, Madhumita/0000-0002-3768-5336				BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; BOURETT TM, 1990, CAN J BOT, V68, P329, DOI 10.1139/b90-044; Contento AL, 2005, PLANT J, V42, P598, DOI 10.1111/j.1365-313X.2005.02396.x; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; Folco HD, 2003, EUKARYOT CELL, V2, P341, DOI 10.1128/EC.2.2.341-350.2003; HAMER JE, 1988, SCIENCE, V239, P288, DOI 10.1126/science.239.4837.288; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; MORRIS NR, 1976, EXP CELL RES, V98, P204, DOI 10.1016/0014-4827(76)90480-8; OSMANI SA, 1988, CELL, V52, P241, DOI 10.1016/0092-8674(88)90513-2; PU RT, 1995, J BIOL CHEM, V270, P18110, DOI 10.1074/jbc.270.30.18110; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; VALENT B, 1991, ANNU REV PHYTOPATHOL, V29, P443, DOI 10.1146/annurev.py.29.090191.002303; Wang ZY, 2005, BIOCHEM SOC T, V33, P384, DOI 10.1042/BST0330384; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696	17	356	388	9	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2006	312	5773					580	583		10.1126/science.1124550	http://dx.doi.org/10.1126/science.1124550			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HN	16645096				2022-12-24	WOS:000237296700046
J	Partridge, T				Partridge, T			Disciplining the stem cell into myogenesis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MYOFIBERS		Genethon, Evry, France		Partridge, T (corresponding author), Genethon, Evry, France.							Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Skuk D, 2004, MOL THER, V9, P475, DOI 10.1016/j.ymthe.2003.11.023	5	3	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 27	2006	354	17					1844	1845		10.1056/NEJMcibr053168	http://dx.doi.org/10.1056/NEJMcibr053168			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036NF	16641403				2022-12-24	WOS:000237077100014
J	Mermin, J; Ekwaru, JP; Liechty, CA; Were, W; Downing, R; Ransom, R; Weidle, P; Lule, J; Coutinho, A; Solberg, P				Mermin, J; Ekwaru, JP; Liechty, CA; Were, W; Downing, R; Ransom, R; Weidle, P; Lule, J; Coutinho, A; Solberg, P			Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study	LANCET			English	Article							CD4 CELL COUNT; PLASMODIUM-FALCIPARUM; RANDOMIZED-TRIAL; HIV-INFECTION; RURAL UGANDA; TRANSMISSION; EPISODES; AFRICA; REGION; KENYA	Background HIV-1 and malaria are common infections in Africa, and cause substantial morbidity and mortality. HIV infection has been associated with an increased incidence of malaria, and more severe disease. Our aim was to assess the effect of antiretroviral treatment (ART) on the frequency of clinical malaria in people with HIV, and to measure the additive effects of co-trimoxazole (trimethoprim and sulfamethoxazole) prophylaxis, ART, and insecticide-treated bednets. Methods In 2001, we enrolled 466 HIV-infected individuals aged 18 years or older in Uganda in a prospective cohort study that provided co-trimoxazole prophylaxis to 399 participants after 5 months of no intervention. In 2003, we enrolled 138 survivors from the initial study, and 897 new participants from the same community, to take antiretroviral therapy (ART) in addition to co-trimoxazole prophylaxis. The ART was in most cases a combination of stavudine, lamivudine, and nevirapine or efavirenz. In 2004, we also gave participants insecticide-treated bednets. Households were visited weekly by study staff to record fever, illness, or death in the preceding 7 days. In cases of reported fever in the previous 2 days, we took blood to test for malaria parasites. We compared the frequency of clinical malaria, adjusting for CD4-cell count, age, sex, and season. Findings 1035 individuals were given co-trimoxazole and ART (median age 38 years, 74% female, and median CD4-cell count 124 cells/mu L); 985 of these, plus four new participants, received co-trimoxazole, ART, and bednets. There were 166 cases of clinical malaria in the study. Compared with a baseline malaria incidence of 50.8 episodes per 100 person-years, co-trimoxazole prophylaxis was associated with 9.0 episodes per 100 person-years (adjusted incidence rate ratio [IRR] 0.24, 95% CI 0.15-0.38); ART and co-trimoxazole with 3.5 episodes per 100 person-years (0.08, 0.04-0.17); and co-trimoxazole, ART, and bednets with 2.1 episodes per 100 person-years (0.05, 0.03-0.08). Malaria incidence was significantly lower during ART and co-trimoxazole than during co-trimoxazole alone (IRR 0.36 [95% CI 0.18-0.74], p=0.0056). Interpretation A combination of co-trimoxazole, antiretroviral therapy, and insecticide-treated bednets substantially reduced the frequency of malaria in adults with HIV.	CDC Uganda, Uganda Virus Res Inst, Global AIDS Program,Ctr Dis Control & Prevent CD, Natl Ctr HIV STD & TB Prevent, Entebbe, Uganda; CDC, Div HIV AIDS Prevent, Atlanta, GA 30333 USA; AIDS Support Org, Kampala, Uganda	Uganda Virus Research Institute; Centers for Disease Control & Prevention - USA	Mermin, J (corresponding author), CDC Uganda, Uganda Virus Res Inst, Global AIDS Program,Ctr Dis Control & Prevent CD, Natl Ctr HIV STD & TB Prevent, POB 49, Entebbe, Uganda.	jhm7@cdc.gov	Mermin, Jonathan/J-9847-2012					Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Dorsey G, 2002, LANCET, V360, P2031, DOI 10.1016/S0140-6736(02)12021-6; Francesconi P, 2001, AIDS, V15, P2445, DOI 10.1097/00002030-200112070-00013; French N, 2001, AIDS, V15, P899, DOI 10.1097/00002030-200105040-00010; Grimwade K, 2004, AIDS, V18, P547, DOI 10.1097/00002030-200402200-00023; Grimwade K, 2003, PEDIATR INFECT DIS J, V22, P1057, DOI 10.1097/01.inf.0000101188.95433.60; Hawley WA, 2003, AM J TROP MED HYG, V68, P168, DOI 10.4269/ajtmh.2003.68.168; Hoffman IF, 1999, AIDS, V13, P487, DOI 10.1097/00002030-199903110-00007; Kilian AHD, 1998, T ROY SOC TROP MED H, V92, P197, DOI 10.1016/S0035-9203(98)90748-9; Korenromp EL, 2005, EMERG INFECT DIS, V11, P1410, DOI 10.3201/eid1109.050337; Kublin JG, 2005, LANCET, V365, P233, DOI 10.1016/S0140-6736(05)17743-5; Ladner J, 2003, AIDS, V17, P275, DOI 10.1097/00002030-200301240-00025; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; *MARA, UG MAL DISTR GRAD MA; Mermin J, 2006, JAIDS-J ACQ IMM DEF, V41, P129, DOI 10.1097/01.qai.0000179427.11789.a7; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Parikh S, 2005, ANTIMICROB AGENTS CH, V49, P2983, DOI 10.1128/AAC.49.7.2983-2985.2005; Patnaik P, 2005, J INFECT DIS, V192, P984, DOI 10.1086/432730; Skinner-Adams TS, 2004, J INFECT DIS, V190, P1998, DOI 10.1086/425584; *UG MIN HLTH, 2001, HLTH MAN INF SYST DA; *UG MIN HLTH, 2006, UG HIV AIDS IND SURV; van Eijk AM, 2003, AIDS, V17, P595, DOI 10.1097/00002030-200303070-00015; Viard JP, 2004, AIDS, V18, P45, DOI 10.1097/00002030-200401020-00005; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; Whitworth JAG, 2005, LANCET, V365, P196; *WHO UNAIDS, PROV WHO UNAIDS SECR; World Health Organization, 2002, US ANT THER SIMPL AP	28	145	149	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 15	2006	367	9518					1256	1261		10.1016/S0140-6736(06)68541-3	http://dx.doi.org/10.1016/S0140-6736(06)68541-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	034FC	16631881				2022-12-24	WOS:000236913400030
J	Rennard, SI; Vestbo, J				Rennard, SI; Vestbo, J			COPD: the dangerous underestimate of 15%	LANCET			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; VENTILATORY FUNCTION; MORTALITY; OXYGEN; RISK		Univ Nebraska, Med Ctr, Omaha, NE 68198 USA; Univ Manchester, Manchester, Lancs, England; Hvidovre Univ Hosp, DK-2650 Hvidovre, Denmark	University of Nebraska System; University of Nebraska Medical Center; University of Manchester; University of Copenhagen	Rennard, SI (corresponding author), Univ Nebraska, Med Ctr, 600 S 42nd St, Omaha, NE 68198 USA.	srennard@unmc.edu	Vestbo, Jorgen/Y-2912-2019	Vestbo, Jorgen/0000-0001-6355-6362				*AM THOR SOC EUR R, 2005, STAND DIAGN MAN PAT; Anto JM, 2001, EUR RESPIR J, V17, P982, DOI 10.1183/09031936.01.17509820; ASHLEY F, 1975, ANN INTERN MED, V82, P739, DOI 10.7326/0003-4819-82-6-739; BURROWS B, 1977, AM REV RESPIR DIS, V115, P195; Emtner M, 2003, AM J RESP CRIT CARE, V168, P1034, DOI 10.1164/rccm.200212-1525OC; Fletcher CM, 1976, NATURAL HIST CHRONIC; *GLOB IN CHRON OBS, 2003, GLOB STRAT DIAGN MAN; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; HUMERFELT S, 1993, EUR RESPIR J, V6, P1095; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; LANGE P, 1991, EUR RESPIR J, V4, P1080; LARSSON C, 1978, ACTA MED SCAND, V204, P345, DOI 10.1111/j.0954-6820.1978.tb08452.x; Mannino DM, 2003, THORAX, V58, P388, DOI 10.1136/thorax.58.5.388; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Postma Dirkje S, 2004, Chest, V126, p96S, DOI 10.1378/chest.126.2_suppl_1.96S; Silverman EK, 2001, NOVART FDN SYMP, V234, P45; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Somfay A, 2001, EUR RESPIR J, V18, P77, DOI 10.1183/09031936.01.00082201	18	147	155	1	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 15	2006	367	9518					1216	1219		10.1016/S0140-6736(06)68516-4	http://dx.doi.org/10.1016/S0140-6736(06)68516-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	034FC	16631861				2022-12-24	WOS:000236913400005
J	Hara, T; Nakamura, K; Matsui, M; Yamamoto, A; Nakahara, Y; Suzuki-Migishima, R; Yokoyama, M; Mishima, K; Saito, I; Okano, H; Mizushima, N				Hara, Taichi; Nakamura, Kenji; Matsui, Makoto; Yamamoto, Akitsugu; Nakahara, Yohko; Suzuki-Migishima, Rika; Yokoyama, Minesuke; Mishima, Kenji; Saito, Ichiro; Okano, Hideyuki; Mizushima, Noboru			Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice	NATURE			English	Article							CEREBELLAR PURKINJE-CELLS; TRANSGENIC MICE; NEURONAL DEATH; MUTANT MOUSE; POLYGLUTAMINE; AGGRESOMES; HUNTINGTIN; PROTEIN; GENE; DEGRADATION	Autophagy is an intracellular bulk degradation process through which a portion of the cytoplasm is delivered to lysosomes to be degraded(1-4). Although the primary role of autophagy in many organisms is in adaptation to starvation, autophagy is also thought to be important for normal turnover of cytoplasmic contents, particularly in quiescent cells such as neurons. Autophagy may have a protective role against the development of a number of neurodegenerative diseases(5-8). Here we report that loss of autophagy causes neurodegeneration even in the absence of any disease-associated mutant proteins. Mice deficient for Atg5 (autophagy-related 5) specifically in neural cells develop progressive deficits in motor function that are accompanied by the accumulation of cytoplasmic inclusion bodies in neurons. In Atg5(-/-) cells, diffuse, abnormal intracellular proteins accumulate, and then form aggregates and inclusions. These results suggest that the continuous clearance of diffuse cytosolic proteins through basal autophagy is important for preventing the accumulation of abnormal proteins, which can disrupt neural function and ultimately lead to neurodegeneration.	Tokyo Metropolitan Inst Med Sci, Dept Bioregulat & Metab, Tokyo 1138613, Japan; Mitsubishi Kagaku Inst Life Sci, Mouse Genome Technol Lab, Tokyo, Japan; Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4448585, Japan; Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan; Nagahama Inst Biosci & Technol, Dept Biosci, Nagahama 5260829, Japan; Niigata Univ, Brain Res Inst, Niigata 9518510, Japan; Tsurumi Univ, Sch Dent Med, Dept Pathol, Yokohama, Kanagawa 2308501, Japan; Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi 3320012, Japan; Japan Sci & Technol Agcy, SORST, Kawaguchi 3320012, Japan	Tokyo Metropolitan Institute of Medical Science; Mitsubishi Kagaku Institute of Life Sciences (MITILS); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Niigata University; Tsurumi University; Keio University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Mizushima, N (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Bioregulat & Metab, Tokyo 1138613, Japan.	nmizu@rinshoken.or.jp	Mizushima, Noboru/C-3635-2009; Okano, Hideyuki/I-7584-2019	Mizushima, Noboru/0000-0002-6258-6444; 				Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Betz UAK, 1996, CURR BIOL, V6, P1307, DOI 10.1016/S0960-9822(02)70717-3; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Fortun J, 2003, J NEUROSCI, V23, P10672; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; KIKUCHI T, 1990, ACTA NEUROPATHOL, V80, P145, DOI 10.1007/BF00308917; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kuemmerle S, 1999, ANN NEUROL, V46, P842; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lossi L, 2002, NEUROSCIENCE, V112, P509, DOI 10.1016/S0306-4522(02)00112-4; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; SOTELO C, 1990, J NEUROCYTOL, V19, P737, DOI 10.1007/BF01188042; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; YAMAMOTO A, 1991, CELL STRUCT FUNCT, V16, P419, DOI 10.1247/csf.16.419	30	2963	3071	19	407	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					885	889		10.1038/nature04724	http://dx.doi.org/10.1038/nature04724			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16625204				2022-12-24	WOS:000238254100045
J	Newman, JRS; Ghaemmaghami, S; Ihmels, J; Breslow, DK; Noble, M; DeRisi, JL; Weissman, JS				Newman, John R. S.; Ghaemmaghami, Sina; Ihmels, Jan; Breslow, David K.; Noble, Matthew; DeRisi, Joseph L.; Weissman, Jonathan S.			Single-cell proteomic analysis of S-cerevisiae reveals the architecture of biological noise	NATURE			English	Article							STOCHASTIC GENE-EXPRESSION; MESSENGER-RNA; FLUORESCENT PROTEIN; EUKARYOTIC GENOME; GLOBAL ANALYSIS; YEAST PROTEOME; SYSTEM; LOCALIZATION; DYNAMICS; SWITCH	A major goal of biology is to provide a quantitative description of cellular behaviour. This task, however, has been hampered by the difficulty in measuring protein abundances and their variation. Here we present a strategy that pairs high-throughput flow cytometry and a library of GFP-tagged yeast strains to monitor rapidly and precisely protein levels at single-cell resolution. Bulk protein abundance measurements of >2,500 proteins in rich and minimal media provide a detailed view of the cellular response to these conditions, and capture many changes not observed by DNA microarray analyses. Our single-cell data argue that noise in protein expression is dominated by the stochastic production/destruction of messenger RNAs. Beyond this global trend, there are dramatic protein-specific differences in noise that are strongly correlated with a protein's mode of transcription and its function. For example, proteins that respond to environmental changes are noisy whereas those involved in protein synthesis are quiet. Thus, these studies reveal a remarkable structure to biological noise and suggest that protein noise levels have been selected to reflect the costs and potential benefits of this variation.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94107 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94107 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94107 USA; Calif Inst Quantitat Biomed Res, San Francisco, CA 94107 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Newman, JRS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 1700 4th St, San Francisco, CA 94107 USA.	weissman@cmp.ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X; Ghaemmaghami, Sina/0000-0002-8696-2950; Breslow, David/0000-0003-0245-3348				Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Edwards BS, 1999, CYTOMETRY, V37, P156, DOI 10.1002/(SICI)1097-0320(19991001)37:2<156::AID-CYTO9>3.0.CO;2-T; EITZMAN PD, 1989, CYTOMETRY, V10, P475, DOI 10.1002/cyto.990100417; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fagarasanu M, 2005, J CELL BIOL, V169, P765, DOI 10.1083/jcb.200503083; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2005, NAT GENET, V37, P925, DOI 10.1038/ng0905-925; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; Schrodinger E., 1944, WHAT IS LIFE PHYS AS; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; WARNER JR, 1989, MICROBIOL REV, V53, P256, DOI 10.1128/MMBR.53.2.256-271.1989; Washburn MP, 2003, P NATL ACAD SCI USA, V100, P3107, DOI 10.1073/pnas.0634629100; Wei J, 2005, J PROTEOME RES, V4, P801, DOI 10.1021/pr0497632; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Yu LN, 1999, MOL CELL BIOL, V19, P5279; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348	45	1118	1131	3	225	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 15	2006	441	7095					840	846		10.1038/nature04785	http://dx.doi.org/10.1038/nature04785			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	052SL	16699522				2022-12-24	WOS:000238254100035
J	Buhler, M; Verdel, A; Moazed, D				Buhler, Marc; Verdel, Andre; Moazed, Danesh			Tethering RITS to a nascent transcript initiates RNAi- and heterochromatin-dependent gene silencing	CELL			English	Article							DOUBLE-STRANDED-RNA; H3 LYSINE-9 METHYLATION; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; HISTONE H3; CHROMOSOME SEGREGATION; EPIGENETIC CONTROL; POLYMERASE-II; INTERFERENCE; MECHANISMS	In the fission yeast Schizosaccharomyces pombe, the RNA-Induced Transcriptional Silencing (RITS) complex has been proposed to target the chromosome via siRNA-dependent base-pairing interactions to initiate heterochromatin formation. Here we show that tethering of the RITS subunit, Tas3, to the RNA transcript of the normally active ura4(+) gene silences ura4(+) expression. This silencing depends on a functional RNAi pathway, requires the heterochromatin proteins, Swi6/HP1, CIr4/Suv39h, and Sir2, and is accompanied by the generation of ura4(+) siRNAs, histone H3-lysine 9 methylation, and Swi6 binding. Furthermore, the ability of the newly generated ura4(+) siRNAs; to silence a second ura4(+) allele in trans is strongly inhibited by the conserved siRNA nuclease, Eri1. Surprisingly, silencing of tethered ura4(+), or ura4(+) inserted within centromeric heterochromatin, or some of the endogenous centromeric repeat promoters, is not associated with changes in RNA polymerase II occupancy. These findings support a model in which targeting of nascent transcripts by RITS mediates chromatin modifications and suggest that cotranscriptional processing events play a primary role in the silencing mechanism.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Moazed, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	danesh@hms.harvard.edu	Verdel, André/M-5201-2013; Buehler, Marc/S-5866-2019; Bühler, Marc/B-1134-2010	Buehler, Marc/0000-0001-6661-9795; Bühler, Marc/0000-0001-6661-9795; VERDEL, Andre/0000-0001-6048-3794				ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Baron-Benhamou Julie, 2004, Methods Mol Biol, V257, P135, DOI 10.1385/1-59259-750-5:135; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bjerling P, 2002, MOL CELL BIOL, V22, P2170, DOI 10.1128/MCB.22.7.2170-2181.2002; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Caudy AA, 2003, NATURE, V425, P411, DOI 10.1038/nature01956; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GATERMANN KB, 1989, MOL CELL BIOL, V9, P1526, DOI 10.1128/MCB.9.4.1526; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Grewal SIS, 1998, GENETICS, V150, P563; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Grewal SIS, 2000, J CELL PHYSIOL, V184, P311, DOI 10.1002/1097-4652(200009)184:3<311::AID-JCP4>3.0.CO;2-D; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Hong Eun-Jin Erica, 2005, RNA Biol, V2, P106, DOI 10.4161/rna.2.3.2131; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; KATO H, 2005, SCIENCE; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Keogh MC, 2003, MOL CELL BIOL, V23, P7005, DOI 10.1128/MCB.23.19.7005-7018.2003; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; Li F, 2005, CURR BIOL, V15, P1448, DOI 10.1016/j.cub.2005.07.021; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; MORRIS KV, 2004, SCIENCE; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Partridge JF, 2000, GENE DEV, V14, P783; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Pirrotta V, 2005, MOL CELL, V18, P395, DOI 10.1016/j.molcel.2005.04.013; Plasterk RHA, 2000, CURR OPIN GENET DEV, V10, P562, DOI 10.1016/S0959-437X(00)00128-3; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Shankaranarayana GD, 2003, CURR BIOL, V13, P1240, DOI 10.1016/S0960-9822(03)00489-5; Sigova A, 2004, GENE DEV, V18, P2359, DOI 10.1101/gad.1218004; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zamore PD, 2002, SCIENCE, V296, P1265, DOI 10.1126/science.1072457	60	299	317	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 2	2006	125	5					873	886		10.1016/j.cell.2006.04.025	http://dx.doi.org/10.1016/j.cell.2006.04.025			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	050VG	16751098	Bronze			2022-12-24	WOS:000238116400015
J	Hsu, J; Price, M; Huang, J; Brand, R; Fung, V; Hui, R; Fireman, B; Newhouse, JP; Selby, JV				Hsu, John; Price, Mary; Huang, Jie; Brand, Richard; Fung, Vicki; Hui, Rita; Fireman, Bruce; Newhouse, Joseph P.; Selby, Joseph V.			Unintended consequences of caps on medicare drug benefits	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRESCRIPTION DRUGS; HEALTH-INSURANCE; CHRONICALLY ILL; COST; BENEFICIARIES; COVERAGE; ADMISSION; OUTCOMES; RISK	Background: Little information exists about the consequences of limits on prescription-drug benefits for Medicare beneficiaries. Methods: We compared the clinical and economic outcomes in 2003 among 157,275 Medicare+Choice beneficiaries whose annual drug benefits were capped at $1,000 and 41,904 beneficiaries whose drug benefits were unlimited because of employer supplements. Results: After adjusting for individual characteristics, we found that subjects whose benefits were capped had pharmacy costs for drugs applicable to the cap that were lower by 31 percent than subjects whose benefits were not capped (95 percent confidence interval, 29 to 33 percent) but had total medical costs that were only 1 percent lower (95 percent confidence interval, -4 to 6 percent). Subjects whose benefits were capped had higher relative rates of visits to the emergency department (relative rate, 1.09 [95 percent confidence interval, 1.04 to 1.14]), nonelective hospitalizations (relative rate, 1.13 [1.05 to 1.21]), and death (relative rate, 1.22 [1.07 to 1.38]; difference, 0.68 per 100 person-years [0.30 to 1.07]). Among subjects who used drugs for hypertension, hyperlipidemia, or diabetes in 2002, those whose benefits were capped were more likely to be nonadherent to long-term drug therapy in 2003; the respective odds ratios were 1.30 (95 percent confidence interval, 1.23 to 1.38), 1.27 (1.19 to 1.34), and 1.33 (1.18 to 1.48) for subjects using drugs for hypertension, hyperlipidemia, and diabetes. In each subgroup, the physiological outcomes were worse for subjects whose drug benefits were capped than for those whose benefits were not capped; the odds ratios were 1.05 (95 percent confidence interval, 1.00 to 1.09), 1.13 (1.03 to 1.25), and 1.23 (1.03 to 1.46), respectively, for subjects with a systolic blood pressure of 140 mm Hg or more, a serum low-density-lipoprotein cholesterol level of 130 mg per deciliter or more, and a glycated hemoglobin level of 8 percent or more. Conclusions: A cap on drug benefits was associated with lower drug consumption and unfavorable clinical outcomes. In patients with chronic disease, the cap was associated with poorer adherence to drug therapy and poorer control of blood pressure, lipid levels, and glucose levels. The savings in drug costs from the cap were offset by increases in the costs of hospitalization and emergency department care.	Kaiser Permanente, Div Res, Oakland, CA 94612 USA; Kaiser Permanente, Pharm Outcomes Res Grp, Oakland, CA 94612 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Kaiser Permanente; Kaiser Permanente; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Hsu, J (corresponding author), Kaiser Permanente, Div Res, 2000 Broadway,3rd Fl, Oakland, CA 94612 USA.	jth@dor.kaiser.org	Newhouse, Joseph/AGJ-5632-2022; Newhouse, Joseph/AAD-9763-2019		AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P01HS010803, R01HS013902] Funding Source: NIH RePORTER; AHRQ HHS [P01-HS-10803, R01-HS-013902] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		ACHMAN L, 2004, COMMONWEALTH FUND PU, V795; Baker DW, 2001, NEW ENGL J MED, V345, P1106, DOI 10.1056/NEJMsa002887; Cox ER, 2001, MED CARE, V39, P296, DOI 10.1097/00005650-200103000-00009; Federman AD, 2001, JAMA-J AM MED ASSOC, V286, P1732, DOI 10.1001/jama.286.14.1732; Freemantle N, 1996, BRIT MED J, V312, P1469, DOI 10.1136/bmj.312.7044.1469; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; Joyce GF, 2002, JAMA-J AM MED ASSOC, V288, P2409; Joyce GF, 2002, JAMA-J AM MED ASSOC, V288, P1733, DOI 10.1001/jama.288.14.1733; *KAIS FAM FDN HEW, 2004, CURR TRENDS FUT OUTL; Krieger N, 1999, AM J EPIDEMIOL, V150, P892; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; LURIE N, 1984, NEW ENGL J MED, V311, P480, DOI 10.1056/NEJM198408163110735; Mayes R, 2004, HEALTH AFFAIR, V23, P282, DOI 10.1377/hlthaff.23.2.282; MCARDLE FB, 2004, HLTH AFF MILLWOOD S; Mojtabai R, 2003, HEALTH AFFAIR, V22, P220, DOI 10.1377/hlthaff.22.4.220; Morgan S, 2004, HEALTH AFFAIR, V23, P269, DOI 10.1377/hlthaff.23.3.269; Newhouse JP, 2004, HEALTH AFFAIR, V23, P89, DOI 10.1377/hlthaff.23.1.89; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; PHELPS CE, 1992, HLTH EC; Piette JD, 2004, AM J PUBLIC HEALTH, V94, P1782, DOI 10.2105/AJPH.94.10.1782; Rector TS, 2004, HEALTH AFFAIR, V23, P213, DOI 10.1377/hlthaff.23.4.213; Reed M, 2005, MED CARE, V43, P810, DOI 10.1097/01.mlr.0000170416.68260.78; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; RUBIN RJ, 1995, NEW ENGL J MED, V333, P733; SOUMERAI SB, 1991, NEW ENGL J MED, V325, P1072, DOI 10.1056/NEJM199110103251505; Soumerai SB, 1999, NEW ENGL J MED, V340, P722, DOI 10.1056/NEJM199903043400909; Soumerai SB, 1999, NEW ENGL J MED, V340, P976; SOUMERAI SB, 1987, NEW ENGL J MED, V317, P550, DOI 10.1056/NEJM198708273170906; STEINER JF, 1988, MED CARE, V26, P814, DOI 10.1097/00005650-198808000-00007; Steinman MA, 2001, J GEN INTERN MED, V16, P793, DOI 10.1046/j.1525-1497.2001.10412.x; STUART B, 2005, HLTH AFF MILLWOOD S; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Tseng CW, 2004, JAMA-J AM MED ASSOC, V292, P952, DOI 10.1001/jama.292.8.952; Tseng CW, 2003, JAMA-J AM MED ASSOC, V290, P222, DOI 10.1001/jama.290.2.222; Valenstein M, 2002, MED CARE, V40, P630, DOI 10.1097/00005650-200208000-00002; Zhao Y, 2001, Health Serv Res, V36, P180; ZWEIFEL P, 2000, HDB HLTH EC, P409	37	287	287	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 1	2006	354	22					2349	2359		10.1056/NEJMsa054436	http://dx.doi.org/10.1056/NEJMsa054436			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	047ZZ	16738271				2022-12-24	WOS:000237918500007
J	Chen, ZZ; Zang, JY; Whetstine, J; Hong, X; Davrazou, F; Kutateladze, TG; Simpson, M; Mao, QL; Pan, CH; Dai, SD; Hagman, J; Hansen, K; Shi, Y; Zhang, GY				Chen, Zhongzhou; Zang, Jianye; Whetstine, Johnathan; Hong, Xia; Davrazou, Foteini; Kutateladze, Tatiana G.; Simpson, Michael; Mao, Qilong; Pan, Cheol-Ho; Dai, Shaodong; Hagman, James; Hansen, Kirk; Shi, Yang; Zhang, Gongyi			Structural insights into histone demethylation by JMJD2 family members	CELL			English	Article							PROTEIN; METHYLATION; JUMONJI; IDENTIFICATION; HYDROXYLASES; CHROMATIN; RECEPTOR; OXIDASE; BINDING; MODELS	Posttranslational modifications of histones regulate chromatin structure and gene expression. Histone demethylases, members of a newly emerging transcription-factor family, remove methyl groups from the lysine residues of the histone tails and thereby regulate the transcriptional activity of target genes. JmjC-domaincontaining proteins have been predicted to be demethylases. For example, the JmjC-containing protein JMJD2A has been characterized as a H3-K9me3- and H3-K36me3-specific demethylase. Here, structures of the catalytic-core domain of JMJD2A with and without alpha-ketoglutarate in the presence of Fe2+ have been determined by X-ray crystallography. The structure of the core domain, consisting of the JmjN domain, the JmjC domain, the C-terminal domain, and a zinc-finger motif, revealed the unique elements that form a potential substrate binding pocket. Sited-directed mutagenesis in conjunction with demethylase activity assays allowed us to propose a molecular model for substrate selection by the JMJD2 histone demethylase family.	Natl Jewish Med & Res Ctr, Dept Immunol, Denver, CO 80206 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80045 USA; Univ Colorado, Hlth Sci Ctr, Sch Med, Program Biomol Struct, Denver, CO 80045 USA; Univ Colorado, Ctr Canc, Aurora, CO 80045 USA	National Jewish Health; Harvard University; Harvard Medical School; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus	Zhang, GY (corresponding author), Natl Jewish Med & Res Ctr, Dept Immunol, Denver, CO 80206 USA.	zhangg@njc.org	Hagman, James/R-7013-2019; Zang, Jianye/E-5228-2013; chen, zhong/E-3900-2015	Hagman, James/0000-0002-5436-8455; chen, zhong/0000-0003-1319-9664; Kutateladze, Tatiana/0000-0001-7375-6990	NIAID NIH HHS [AI22295] Funding Source: Medline; NIGMS NIH HHS [GM071004, GM058012] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI022295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071004] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; ALLIS CD, 1980, CELL, V20, P55; ARAVIND L, 2001, GENOME BIOL, V2; Balciunas D, 2000, TRENDS BIOCHEM SCI, V25, P274, DOI 10.1016/S0968-0004(00)01593-0; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; Cikala M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-26; Clissold PM, 2001, TRENDS BIOCHEM SCI, V26, P7, DOI 10.1016/S0968-0004(00)01700-X; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Dunwell JM, 2000, MICROBIOL MOL BIOL R, V64, P153, DOI 10.1128/MMBR.64.1.153-179.2000; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Gane PJ, 1998, J MOL EVOL, V46, P488, DOI 10.1007/PL00006329; Gray SG, 2005, J BIOL CHEM, V280, P28507, DOI 10.1074/jbc.M413687200; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; HUANG Y, 2006, SCIENCE; Johnson K, 2004, NAT IMMUNOL, V5, P853, DOI 10.1038/ni1099; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jung J, 2005, DEV DYNAM, V232, P21, DOI 10.1002/dvdy.20204; Katoh M, 2004, INT J ONCOL, V24, P1623; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Lancaster DE, 2004, BIOCHEM SOC T, V32, P943, DOI 10.1042/BST0320943; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tomchick DR, 1998, STRUCTURE, V6, P337, DOI 10.1016/S0969-2126(98)00036-7; Trewick SC, 2005, EMBO REP, V6, P315, DOI 10.1038/sj.embor.7400379; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wysocka J, 2005, CELL, V122, P654, DOI 10.1016/j.cell.2005.08.022; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yang ZQ, 2000, CANCER RES, V60, P4735; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	39	292	309	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 19	2006	125	4					691	702		10.1016/j.cell.2006.04.024	http://dx.doi.org/10.1016/j.cell.2006.04.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	047NM	16677698	Bronze			2022-12-24	WOS:000237886000015
J	Satoh-Nagasawa, N; Nagasawa, N; Malcomber, S; Sakai, H; Jackson, D				Satoh-Nagasawa, N; Nagasawa, N; Malcomber, S; Sakai, H; Jackson, D			A trehalose metabolic enzyme controls inflorescence architecture in maize	NATURE			English	Article							ARABIDOPSIS-THALIANA; TREHALOSE-6-PHOSPHATE; GENES; GROWTH; SHOOT; IDENTIFICATION; BIOSYNTHESIS; ACCUMULATION; PHOSPHATASES; 6-PHOSPHATE	Inflorescence branching is a major yield trait in crop plants controlled by the developmental fate of axillary shoot meristems(1). Variations in branching patterns lead to diversity in flower-bearing architectures ( inflorescences) and affect crop yield by influencing seed number or harvesting ability(2,3). Several growth regulators such as auxins, cytokinins and carotenoid derivatives regulate branching architectures(4). Inflorescence branching in maize is regulated by three RAMOSA genes(5). Here we show that one of these genes, RAMOSA3 (RA3), encodes a trehalose-6-phosphate phosphatase expressed in discrete domains subtending axillary inflorescence meristems. Genetic and molecular data indicate that RA3 functions through the predicted transcriptional regulator RAMOSA1 (RA1)(5). We propose that RA3 regulates inflorescence branching by modification of a sugar signal that moves into axillary meristems. Alternatively, the fact that RA3 acts upstream of RA1 supports a hypothesis that RA3 itself may have a transcriptional regulatory function.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; DuPont Crop Genet Expt Stn E353, Wilmington, DE 19880 USA; Univ Missouri, Dept Biol, St Louis, MO 63121 USA	Cold Spring Harbor Laboratory; DuPont; University of Missouri System; University of Missouri Saint Louis	Jackson, D (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	jacksond@cshl.edu		Malcomber, Simon/0000-0001-6440-6606				Bommert P, 2005, PLANT CELL PHYSIOL, V46, P69, DOI 10.1093/pcp/pci504; CABIB E, 1958, J BIOL CHEM, V231, P259; DEVIRGILIO C, 1993, EUR J BIOCHEM, V212, P315; DOEBLEY J, 1992, TRENDS GENET, V8, P302, DOI 10.1016/0168-9525(92)90261-2; Eastmond PJ, 2003, J EXP BOT, V54, P533, DOI 10.1093/jxb/erg039; Emrich SJ, 2004, BIOINFORMATICS, V20, P140, DOI 10.1093/bioinformatics/bth017; Goddijn OJM, 1999, TRENDS PLANT SCI, V4, P315, DOI 10.1016/S1360-1385(99)01446-6; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; *I GEN RES, TIGR MAIZ DAT ONL; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Klutts S, 2003, J BIOL CHEM, V278, P2093, DOI 10.1074/jbc.M209937200; Kolbe A, 2005, P NATL ACAD SCI USA, V102, P11118, DOI 10.1073/pnas.0503410102; Leyman B, 2001, TRENDS PLANT SCI, V6, P510, DOI 10.1016/S1360-1385(01)02125-2; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Pellny TK, 2004, PLANT BIOTECHNOL J, V2, P71, DOI 10.1111/j.1467-7652.2004.00053.x; PERRY HS, MAIZE GENETICS GENOM; Schluepmann H, 2004, PLANT PHYSIOL, V135, P879, DOI 10.1104/pp.104.039503; Schluepmann H, 2003, P NATL ACAD SCI USA, V100, P6849, DOI 10.1073/pnas.1132018100; Schmitz G, 2005, CURR OPIN PLANT BIOL, V8, P506, DOI 10.1016/j.pbi.2005.07.010; STROM AR, 1993, MOL MICROBIOL, V8, P205, DOI 10.1111/j.1365-2958.1993.tb01564.x; Taguchi-Shiobara F, 2001, GENE DEV, V15, P2755, DOI 10.1101/gad.208501; Thaller MC, 1998, PROTEIN SCI, V7, P1647, DOI 10.1002/pro.5560070722; THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0; van Dijken AJH, 2004, PLANT PHYSIOL, V135, P969, DOI 10.1104/pp.104.039743; Vogel G, 1998, PLANT J, V13, P673, DOI 10.1046/j.1365-313X.1998.00064.x; Vollbrecht E, 2005, NATURE, V436, P1119, DOI 10.1038/nature03892; Ward SP, 2004, CURR OPIN PLANT BIOL, V7, P73, DOI 10.1016/j.pbi.2003.10.002	27	289	316	7	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 11	2006	441	7090					227	230		10.1038/nature04725	http://dx.doi.org/10.1038/nature04725			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040YP	16688177				2022-12-24	WOS:000237418800048
J	Shu, DG; Morris, SC; Han, J; Li, Y; Zhang, XL; Hua, H; Zhang, ZF; Liu, JN; Guo, JF; Yao, Y; Yasui, K				Shu, DG; Morris, SC; Han, J; Li, Y; Zhang, XL; Hua, H; Zhang, ZF; Liu, JN; Guo, JF; Yao, Y; Yasui, K			Lower Cambrian vendobionts from China and early diploblast evolution	SCIENCE			English	Article							EDIACARAN; FOSSILS; PHYLOGENY; ORIGIN	Ediacaran assemblages immediately predate the Cambrian explosion of metazoans and should have played a crucial role in this radiation. Their wider relationships, however, have remained refractory and difficult to integrate with early metazoan phylogeny. Here, we describe a frondlike fossil, Stromatoveris ( S. psygmoglena sp. nov.), from the Lower Cambrian Chengjiang Lagerstatte ( Yunnan, China) that is strikingly similar to Ediacaran vendobionts. The exquisite preservation reveals closely spaced branches, probably ciliated, that appear to represent precursors of the diagnostic comb rows of ctenophores. Therefore, this finding has important implications for the early evolution of this phylum and related diploblasts, some of which independently evolved a frondose habit.	NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China; NW Univ Xian, Key Lab Continental Dynam, Xian 710069, Peoples R China; China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Changan Univ, Coll Earth Sci & Land Resources, Xian 710054, Peoples R China; Hiroshima Univ, Grad Sch Sci, Marine Biol Lab, Hiroshima 7220073, Japan	Northwest University Xi'an; Northwest University Xi'an; China University of Geosciences; University of Cambridge; Chang'an University; Hiroshima University	Shu, DG (corresponding author), NW Univ Xian, Early Life Inst, Xian 710069, Peoples R China.	elidgshu@nwu.edu.cn; sc113@esc.cam.ac.uk		zhang, zhifei/0000-0003-0325-5116				BUSS LW, 1994, PALEOBIOLOGY, V20, P1, DOI 10.1017/S0094837300011088; Clapham ME, 2003, PALEOBIOLOGY, V29, P527, DOI 10.1666/0094-8373(2003)029<0527:POTOKA>2.0.CO;2; Collins AG, 2006, SYST BIOL, V55, P97, DOI 10.1080/10635150500433615; CONWAY MS, 1993, PALAEONTOLOGY, V36, P593; Dzik J, 2002, J MORPHOL, V252, P315, DOI 10.1002/jmor.1108; Ender A, 2003, MOL BIOL EVOL, V20, P130, DOI 10.1093/molbev/msg018; Fedonkin M.A., 1990, VENDIAN SYSTEM, P71, DOI DOI 10.1007/978-3-642-73972-9_3; Fedonkin MA, 1997, NATURE, V388, P868, DOI 10.1038/42242; Ford T. D., 1958, Proceedings of the Yorkshire Geological Society, V31, P211; Gehling JG, 1996, J PALEONTOL, V70, P185, DOI 10.1017/S0022336000023283; Glaessner M.F., 1984, DAWN ANIMAL LIFE BIO; Grazhdankin D, 2004, PALEOBIOLOGY, V30, P203, DOI 10.1666/0094-8373(2004)030<0203:PODITE>2.0.CO;2; Hadrys T, 2005, MOL BIOL EVOL, V22, P1569, DOI 10.1093/molbev/msi150; Hagadorn JW, 2000, J PALEONTOL, V74, P731, DOI 10.1666/0022-3360(2000)074<0731:ECETFF>2.0.CO;2; Ivantsov AY, 2002, PALAEONTOLOGY, V45, P1219, DOI 10.1111/1475-4983.00283; JENKINS R J F, 1978, Records of the South Australian Museum (Adelaide), V17, P347; Jensen S, 1998, NATURE, V393, P567, DOI 10.1038/31215; Medina M, 2001, P NATL ACAD SCI USA, V98, P9707, DOI 10.1073/pnas.171316998; Narbonne GM, 2005, ANNU REV EARTH PL SC, V33, P421, DOI 10.1146/annurev.earth.33.092203.122519; Narbonne GM, 2004, SCIENCE, V305, P1141, DOI 10.1126/science.1099727; Peterson KJ, 2003, INTEGR COMP BIOL, V43, P127, DOI 10.1093/icb/43.1.127; Peterson KJ, 2005, PALEOBIOLOGY, V31, P36, DOI 10.1666/0094-8373(2005)031[0036:TAMOEA]2.0.CO;2; Podar M, 2001, MOL PHYLOGENET EVOL, V21, P218, DOI 10.1006/mpev.2001.1036; RETALLACK GJ, 1994, PALEOBIOLOGY, V20, P523, DOI 10.1017/S0094837300012975; Runnegar Bruce, 1995, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V195, P303; SEILACHER A, 1992, J GEOL SOC LONDON, V149, P607, DOI 10.1144/gsjgs.149.4.0607; Seilacher Adolf, 2003, Paleontological Research, V7, P43, DOI 10.2517/prpsj.7.43; WAGGONER BM, 1995, PALEOBIOLOGY, V21, P393, DOI 10.1017/S0094837300013373; Zhang Wen-Tang, 2001, Acta Palaeontologica Sinica, V40, P201; Zhang XL, 2003, PALAEONTOLOGY, V46, P447, DOI 10.1111/1475-4983.00307; ZHURAVLEV AY, 1993, NEUES JB GEOL PAL, V180, P299	31	56	70	3	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2006	312	5774					731	734		10.1126/science.1124565	http://dx.doi.org/10.1126/science.1124565			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039NF	16675697				2022-12-24	WOS:000237312100046
J	Newman, TB; Liljestrand, P; Jeremy, RJ; Ferriero, DM; Wu, YW; Hudes, ES; Escobar, GJ				Newman, TB; Liljestrand, P; Jeremy, RJ; Ferriero, DM; Wu, YW; Hudes, ES; Escobar, GJ		Jaunde Infant Feeding Study	Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	56th Annual Meeting of the American-Academy-of-Pediatrics	OCT 08-10, 2004	San Francisco, CA	Amer Acad Pediat			NEONATAL HYPERBILIRUBINEMIA; CEREBRAL-PALSY; FOLLOW-UP; ERYTHROBLASTOSIS FETALIS; TERM; HEALTH; INTELLIGENCE; PERFORMANCE; CHILDREN; INFANTS	BACKGROUND: The neurodevelopmental risks associated with high total serum bilirubin levels in newborns are not well defined. METHODS: We identified 140 infants with neonatal total serum bilirubin levels of at least 25 mg per deciliter (428 micromol per liter) and 419 randomly selected controls from a cohort of 106,627 term and near-term infants born from 1995 through 1998 in Kaiser Permanente hospitals in northern California. Data on outcomes were obtained from electronic records, interviews, responses to questionnaires, and neurodevelopmental evaluations that had been performed in a blinded fashion. RESULTS: Peak bilirubin levels were between 25 and 29.9 mg per deciliter (511 micromol per liter) in 130 of the newborns with hyperbilirubinemia and 30 mg per deciliter (513 micromol per liter) or more in 10 newborns; treatment involved phototherapy in 136 cases and exchange transfusion in 5. Follow-up data to the age of at least two years were available for 132 of 140 children with a history of hyperbilirubinemia (94 percent) and 372 of 419 controls (89 percent) and included formal evaluation at a mean (+/-SD) age of 5.1+/-0.12 years for 82 children (59 percent) and 168 children (40 percent), respectively. There were no cases of kernicterus. Neither crude nor adjusted scores on cognitive tests differed significantly between the two groups; on most tests, 95 percent confidence intervals excluded a 3-point (0.2 SD) decrease in adjusted scores in the hyperbilirubinemia group. There was no significant difference between groups in the proportion of children with abnormal neurologic findings on physical examination or with documented diagnoses of neurologic abnormalities. Fourteen of the children with hyperbilirubinemia (17 percent) had ``questionable'' or abnormal findings on neurologic examination, as compared with 48 controls (29 percent; P=0.05; adjusted odds ratio, 0.47; 95 percent confidence interval, 0.23 to 0.98; P=0.04). The frequencies of parental concern and reported behavioral problems also were not significantly different between the two groups. Within the hyperbilirubinemia group, those with positive direct antiglobulin tests had lower scores on cognitive testing but not more neurologic or behavioral problems. CONCLUSIONS: When treated with phototherapy or exchange transfusion, total serum bilirubin levels in the range included in this study were not associated with adverse neurodevelopmental outcomes in infants born at or near term.	Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA 94143 USA; Kaiser Permanente Med Care Program, Div Res, Oakland, CA 94611 USA; Kaiser Permanente Med Ctr, Dept Pediat, Walnut Creek, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kaiser Permanente; Kaiser Permanente	Newman, TB (corresponding author), Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.				NCRR NIH HHS [M01 RR01271] Funding Source: Medline; NINDS NIH HHS [R01 NS39683] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039683] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Achenbach T. M., 1991, CHILD BEHAV CHECKLIS; *AM AC PED SUBC HY, 2004, PEDIATRICS, V0114, P01138; Ashwal S, 2004, NEUROLOGY, V62, P851, DOI 10.1212/01.WNL.0000117981.35364.1B; Atkinson LR, 2003, PEDIATRICS, V111, pE555, DOI 10.1542/peds.111.5.e555; BEERY KE, 1997, BEERYBUKTENICA DEV T; Civic D, 2000, Matern Child Health J, V4, P215, DOI 10.1023/A:1026667720478; Colver AF, 2000, ARCH DIS CHILD-FETAL, V83, pF7, DOI 10.1136/fn.83.1.F7; DAY R, 1954, PEDIATRICS, V13, P333; Escobar GJ, 2002, ARCH PEDIAT ADOL MED, V156, P155, DOI 10.1001/archpedi.156.2.155; Glascoe FP, 1998, COLLABORATING PARENT; Grimmer I, 1999, ACTA PAEDIATR, V88, P661, DOI 10.1080/08035259950169341; Gwynne K, 2004, J PAEDIATR CHILD H, V40, P369, DOI 10.1111/j.1440-1754.2004.00404.x; HOLMES GE, 1968, AM J DIS CHILD, V116, P37, DOI 10.1001/archpedi.1968.02100020039005; HYMAN CB, 1969, AM J DIS CHILD, V117, P395, DOI 10.1001/archpedi.1969.02100030397002; Ip S, 2004, PEDIATRICS, V114, pE130, DOI 10.1542/peds.114.1.e130; JOHNSTON WH, 1967, PEDIATRICS, V39, P88; MADAN A, 2004, AVERYS DIS NEWBORN, P1247; Maisels MJ, 2004, PEDIATRICS, V114, P297; NEWMAN TB, 1993, PEDIATRICS, V92, P651; NEWMAN TB, 1990, CLIN PERINATOL, V17, P331, DOI 10.1016/S0095-5108(18)30571-2; Newman TB, 2003, PEDIATRICS, V111, P1303, DOI 10.1542/peds.111.6.1303; Newman TB, 2002, PEDIATRICS, V110, P1032, DOI 10.1542/peds.110.5.1032; Newman TB, 2000, ARCH PEDIAT ADOL MED, V154, P1140, DOI 10.1001/archpedi.154.11.1140; Newman TB, 1999, PEDIATRICS, V104, P1198; NILSEN ST, 1984, ACTA PAEDIATR SCAND, V73, P176, DOI 10.1111/j.1651-2227.1984.tb09924.x; Ozmert E, 1996, ACTA PAEDIATR, V85, P1440, DOI 10.1111/j.1651-2227.1996.tb13949.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; SCHEIDT PC, 1991, PEDIATRICS, V87, P797; SEIDMAN DS, 1991, PEDIATRICS, V88, P828; Soorani-Lunsing I, 2001, PEDIATR RES, V50, P701, DOI 10.1203/00006450-200112000-00012; Watchko JF, 2005, PEDIATRICS, V115, P1747, DOI 10.1542/peds.2004-1748; Wechsler D., 2014, WECHSLER PRESCHOOL P; Winter S, 2002, PEDIATRICS, V110, P1220, DOI 10.1542/peds.110.6.1220; Wu YW, 2005, J PEDIATR NEUROL, V3, P141; Wu YW, 2003, JAMA-J AM MED ASSOC, V290, P2677, DOI 10.1001/jama.290.20.2677; Yilmaz Y, 2001, Indian Pediatr, V38, P165	36	126	140	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2006	354	18					1889	1900		10.1056/NEJMoa054244	http://dx.doi.org/10.1056/NEJMoa054244			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	038RE	16672700				2022-12-24	WOS:000237239900005
J	Mounier-Jack, S; Coker, RJ				Mounier-Jack, S; Coker, RJ			How prepared is Europe for pandemic influenza? Analysis of national plans	LANCET			English	Article								Background The threat of a human pandemic of influenza has prompted urgent development of national preparedness plans. We assessed these plans, to judge Europe's preparedness for pandemic influenza. Methods Published national pandemic influenza preparedness plans from the European Union countries, the two acceding countries (Bulgaria and Romania), Norway, and Switzerland, were evaluated against criteria taken from a WHO checklist. Plans were eligible for inclusion if formally published between Jan 1, 2002, and Nov 30, 2005. Findings 21 national plans were eligible for inclusion for analysis. Although preparation for surveillance, planning and coordination, and communication were good, maintenance of essential services, putting plans into action, and public-health interventions were probably inadequate. Few countries have addressed in their plans the need for collaboration with adjacent countries, despite this being an acknowledged imperative. Similarly, plans for the timely distribution of available medical supplies are notably absent. Interpretation Governmental commitment in most European countries is strong, and levels of preparedness are broadly good. However, gaps in preparedness planning remain, and substantial variations exist between countries, with important implications for the region and nation states. improved cooperation between countries may be needed to share experience, and to ensure coherence of approaches.	Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Coker, RJ (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England.	richard.coker@lshtm.ac.uk						CIOTTI M, 2005, EUROSURVEILL WKLY, V10, P136; *EU AG, 2005, EU PAND PREP BE COMP; Mounier-Jack S, 2006, EUR J PUBLIC HEALTH, V16, P119, DOI 10.1093/eurpub/ckl034; MOUNIERJACK S, PREPARED IS EUROPE P; Paget W J, 2001, Euro Surveill, V6, P136; Pitman RJ, 2005, BRIT MED J, V331, P1242, DOI 10.1136/bmj.38573.696100.3A; University of Toronto Joint Center for Bioethics, 2005, STAND GUARD THEE ETH; WHO, 2004, WHOCDSCSRRMD20048; *WHO, 2005, WHOCDSCSRGIP20058; WHO, 2005, WHOCDSCSRGIP20054; *WHO EC, 2005, 2 JOINT WHO EC WORKS; World Health Organization, 2005, WHO GLOB INFL PREP P; 2005, LANCET INFECT DIS, V5, P191	13	129	132	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2006	367	9520					1405	1411		10.1016/S0140-6736(06)68511-5	http://dx.doi.org/10.1016/S0140-6736(06)68511-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	038CI	16650650				2022-12-24	WOS:000237195600028
J	Zink, TM				Zink, TM			Dog pals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												Zink0003@umn.edu							0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2006	295	16					1877	1878		10.1001/jama.295.16.1877	http://dx.doi.org/10.1001/jama.295.16.1877			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	036GI	16639037				2022-12-24	WOS:000237059200001
J	Partridge, J				Partridge, J			Patient's journey - From burns unit to boardroom	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Changing Faces, London WC1E 6JN, England		Partridge, J (corresponding author), Changing Faces, London WC1E 6JN, England.	jamesp@changingfaces.org.uk							0	13	15	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2006	332	7547					956	959		10.1136/bmj.332.7547.956	http://dx.doi.org/10.1136/bmj.332.7547.956			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	037JV	16627513	Green Published			2022-12-24	WOS:000237143900020
J	Schneidman, E; Berry, MJ; Segev, R; Bialek, W				Schneidman, E; Berry, MJ; Segev, R; Bialek, W			Weak pairwise correlations imply strongly correlated network states in a neural population	NATURE			English	Article							MOVEMENT DIRECTION; CORTICAL-NEURONS; EXPRESSION DATA; GANGLION-CELLS; SPIKE TRAINS; INFORMATION; PATTERNS; RETINA; VARIABILITY; ADAPTATION	Biological networks have so many possible states that exhaustive sampling is impossible. Successful analysis thus depends on simplifying hypotheses, but experiments on many systems hint that complicated, higher-order interactions among large groups of elements have an important role. Here we show, in the vertebrate retina, that weak correlations between pairs of neurons coexist with strongly collective behaviour in the responses of ten or more neurons. We find that this collective behaviour is described quantitatively by models that capture the observed pairwise correlations but assume no higher-order interactions. These maximum entropy models are equivalent to Ising models, and predict that larger networks are completely dominated by correlation effects. This suggests that the neural code has associative or error-correcting properties, and we provide preliminary evidence for such behaviour. As a first test for the generality of these ideas, we show that similar results are obtained from networks of cultured cortical neurons.	Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Schneidman, E (corresponding author), Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA.	elads@princeton.edu		Segev, Ronen/0000-0002-8109-1076; schneidman, elad/0000-0001-8653-9848	NATIONAL EYE INSTITUTE [R01EY014196] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY014196] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Amit DJ, 1989, MODELING BRAIN FUNCT, DOI 10.1017/CBO9780511623257; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BARLOW H, 1990, VISION RES, V30, P1561, DOI 10.1016/0042-6989(90)90144-A; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; BRILLOUIN L, 1962, SCI INFORMATION THEO; Cover T.M., 2006, ELEMENTS INFORM THEO, DOI [10.1002/047174882X, DOI 10.1002/047174882X]; Dan Y, 1998, NAT NEUROSCI, V1, P501, DOI 10.1038/2217; DARROCH JN, 1980, ANN STAT, V43, P1470; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eytan D, 2003, J NEUROSCI, V23, P9349; Frechette ES, 2005, J NEUROPHYSIOL, V94, P119, DOI 10.1152/jn.01175.2004; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Grun S, 2002, NEURAL COMPUT, V14, P43, DOI 10.1162/089976602753284455; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hatsopoulos NG, 1998, P NATL ACAD SCI USA, V95, P15706, DOI 10.1073/pnas.95.26.15706; Holter NS, 2001, P NATL ACAD SCI USA, V98, P1693, DOI 10.1073/pnas.98.4.1693; HOPFIELD JJ, 1986, SCIENCE, V233, P625, DOI 10.1126/science.3755256; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; Landau LD., 1980, STAT PHYS, V3rd; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Martignon L, 2000, NEURAL COMPUT, V12, P2621, DOI 10.1162/089976600300014872; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Mezard M., 1987, SPIN GLASS THEORY IN; *NIPS, 2003, NIPS 2003 WORKSH EST; Perkel D.H., 1968, NEUROSCI RES PROGRAM, V6, P221; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Puchalla JL, 2005, NEURON, V46, P493, DOI 10.1016/j.neuron.2005.03.026; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Rieke F., 1997, SPIKES EXPLORING NEU; Schneidman E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.238701; Schnitzer MJ, 2003, NEURON, V37, P499, DOI 10.1016/S0896-6273(03)00004-7; Segev R, 2004, NAT NEUROSCI, V7, P1155, DOI 10.1038/nn1323; Shamir M, 2004, NEURAL COMPUT, V16, P1105, DOI 10.1162/089976604773717559; Smirnakis SM, 1997, NATURE, V386, P69, DOI 10.1038/386069a0; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	43	1056	1065	1	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2006	440	7087					1007	1012		10.1038/nature04701	http://dx.doi.org/10.1038/nature04701			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	034DL	16625187	Green Submitted, Green Accepted			2022-12-24	WOS:000236906000026
J	Atala, A; Bauer, SB; Soker, S; Yoo, JJ; Retik, AB				Atala, A; Bauer, SB; Soker, S; Yoo, JJ; Retik, AB			Tissue-engineered autologous bladders for patients needing cystoplasty	LANCET			English	Article							LONG-TERM COMPLICATIONS; SMOOTH-MUSCLE-CELLS; URINARY-BLADDER; IN-VITRO; UROTHELIAL CELLS; ACELLULAR MATRIX; ALLOPLASTIC REPLACEMENT; PRESERVED BLADDER; RECONSTRUCTION; BIOMATERIALS	Background Patients with end-stage bladder disease can be treated with cystoplasty using gastrointestinal segments. The presence of such segments in the urinary tract has been associated with many complications. We explored an alternative approach using autologous engineered bladder tissues for reconstruction. Methods Seven patients with myelomeningocele, aged 4-19 years, with high-pressure or poorly compliant bladders, were identified as candidates for cystoplasty. A bladder biopsy was obtained from each patient. Urothelial and muscle cells were grown in culture, and seeded on a biodegradable bladder-shaped scaffold made of Collagen, or a composite of Collagen and polyglycolic acid. About 7 weeks after the biopsy, the autologous engineered bladder constructs were used for reconstruction and implanted either with or without an omental wrap. Serial urodynamics, cystograms, ultrasounds, bladder biopsies, and serum analyses were done. Results Follow-up range was 22-61 months (mean 46 months). Post-operatively, the mean bladder leak point pressure decrease at capacity, and the volume and compliance increase was greatest in the composite engineered bladders with an omental wrap (56%, 1.58-fold, and 2.79-fold, respectively). Bowel function returned promptly after surgery. No metabolic consequences were noted, urinary calculi did not form, mucus production was normal, and renal function was preserved. The engineered bladder biopsies showed an adequate structural architecture and phenotype. Conclusions Engineered bladder tissues, created with autologous cells seeded on collagen-polyglycolic acid scaffolds, and wrapped in omentum after implantation, can be used in patients who need cystoplasty.	Wake Forest Univ, Bowman Gray Sch Med, Dept Urol, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA; Childrens Hosp, Dept Urol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Atala, A (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Urol, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.	aatala@wfubmc.edu	Yoo, James J./L-4850-2017	Atala, Anthony/0000-0001-8186-2160				ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5; ATALA A, 1993, J UROLOGY, V150, P608, DOI 10.1016/S0022-5347(17)35561-1; Atala Anthony, 1997, P149; Bona A. V, 1966, MINERVA UROL, V18, P43; Brown AL, 2005, BIOMATERIALS, V26, P529, DOI 10.1016/j.biomaterials.2004.02.055; Cassell OCS, 2002, BRIT J PLAST SURG, V55, P603, DOI 10.1054/bjps.2002.3950; CHENG E, 1994, J UROLOGY, V152, P2252, DOI 10.1016/S0022-5347(17)31652-X; CILENTO BG, 1994, J UROLOGY, V152, P665, DOI 10.1016/S0022-5347(17)32676-9; Danielsson C, 2006, BIOMATERIALS, V27, P1054, DOI 10.1016/j.biomaterials.2005.07.027; De Coppi P, 2005, TISSUE ENG, V11, P1034, DOI 10.1089/ten.2005.11.1034; Fraser M, 2004, BJU INT, V93, P609, DOI 10.1111/j.1464-410X.2003.04675.x; FUJITA K, 1978, INVEST UROL, V15, P355; Gilbert SM, 2005, J UROLOGY, V173, P1080, DOI 10.1097/01.ju.0000155248.57049.4e; GLASSBERG KI, 1985, UROL CLIN N AM, V12, P175; GLEESON MJ, 1992, J UROLOGY, V148, P1377, DOI 10.1016/S0022-5347(17)36916-1; Kanematsu A, 2003, J UROLOGY, V170, P1633, DOI 10.1097/01.ju.0000084021.51099.8a; KELAMI A, 1970, EUR SURG RES, V2, P195, DOI 10.1159/000127514; Kiddoo DA, 2004, UROL CLIN N AM, V31, P417, DOI 10.1016/j.ucl.2004.04.023; KUDISH HG, 1957, J UROLOGY, V78, P232, DOI 10.1016/S0022-5347(17)66428-0; Lai JY, 2002, J UROLOGY, V168, P1853, DOI 10.1016/S0022-5347(05)64429-1; MCDOUGAL WS, 1992, J UROLOGY, V147, P1199, DOI 10.1016/S0022-5347(17)37517-1; Mingin GC, 1999, J UROLOGY, V162, P1122, DOI 10.1016/S0022-5347(01)68092-3; MONSOUR MJ, 1987, UROL RES, V15, P235; Nakanishi Y, 2003, J PEDIATR SURG, V38, P1781, DOI 10.1016/j.jpedsurg.2003.08.034; NEUHOF H, 1917, SURG GYNECOL OBSTET, V25, P383; Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0; Nuininga JE, 2004, BIOMATERIALS, V25, P1657, DOI 10.1016/S0142-9612(03)00519-2; Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149, DOI 10.1038/6146; Pariente JL, 2002, J UROLOGY, V167, P1867, DOI 10.1016/S0022-5347(05)65251-2; Pariente JL, 2001, J BIOMED MATER RES, V55, P33, DOI 10.1002/1097-4636(200104)55:1<33::AID-JBM50>3.0.CO;2-7; Pattison MA, 2005, BIOMATERIALS, V26, P2491, DOI 10.1016/j.biomaterials.2004.07.011; Probst M, 1997, BRIT J UROL, V79, P505, DOI 10.1046/j.1464-410X.1997.00103.x; Rohrmann D, 1996, J UROLOGY, V156, P2094, DOI 10.1016/S0022-5347(01)65442-9; Schoeller T, 2001, J UROLOGY, V165, P980, DOI 10.1016/S0022-5347(05)66588-3; Schultheiss D, 2005, J UROLOGY, V173, P276, DOI 10.1097/01.ju.0000145882.80339.18; Sievert KD, 2006, WORLD J UROL, V24, P101, DOI 10.1007/s00345-006-0052-8; Snodgrass WT, 2004, UROL CLIN N AM, V31, P427, DOI 10.1016/j.ucl.2004.04.001; Soergel TM, 2004, J UROLOGY, V172, P1649, DOI 10.1097/01.ju.0000140194.87974.56; Southgate J, 2003, P I MECH ENG H, V217, P311, DOI 10.1243/095441103322060776; TSUJI I, 1967, J UROLOGY, V98, P91, DOI 10.1016/S0022-5347(17)62828-3; TSUJI I, 1961, J UROLOGY, V85, P42, DOI 10.1016/S0022-5347(17)65279-0; Vaught JD, 1996, J UROLOGY, V155, P374, DOI 10.1016/S0022-5347(01)66663-1; Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4	43	1290	1401	2	219	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 15	2006	367	9518					1241	1246		10.1016/S0140-6736(06)68438-9	http://dx.doi.org/10.1016/S0140-6736(06)68438-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	034FC	16631879				2022-12-24	WOS:000236913400028
J	Kostelansky, MS; Sun, J; Lee, SH; Kim, J; Ghirlando, R; Hierro, A; Emr, SD; Hurley, JH				Kostelansky, MS; Sun, J; Lee, SH; Kim, J; Ghirlando, R; Hierro, A; Emr, SD; Hurley, JH			Structural and functional organization of the ESCRT-I trafficking complex	CELL			English	Article							EPIDERMAL-GROWTH-FACTOR; SORTING COMPLEX; POLYCISTRONIC EXPRESSION; PROTEIN-TRANSPORT; CRYSTAL-STRUCTURE; HIV-1 P6; UBIQUITIN; TSG101; BINDING; DOMAIN	The endosomal sorting complex required for transport (ESCRT) complexes are central to receptor downregulation, lysosome biogenesis, and budding of HIV. The yeast ESCRT-I complex contains the Vps23, Vps28, and Vps37 proteins, and its assembly is directed by the C-terminal steadiness box of Vps23, the N-terminal half of Vps28, and the C-terminal half of Vps37. The crystal structures of a Vps23:Vps28 core sub-complex and the Vps23:Vps28:Vps37 core were solved at 2.1 and 2.8 angstrom resolution. Each subunit contains a structurally similar pair of helices that form the core. The N-terminal domain of Vps28 has a hydrophobic binding site on its surface that is conformationally dynamic. The C-terminal domain of Vps28 binds the ESCRT-II complex. The structure shows how ESCRT-I is assembled by a compact core from which the Vps23 UEV domain, the Vps28 C domain, and other domains project to bind their partners.	NIDDKD, Mol Biol Lab, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Univ Calif San Diego, Dept Chem & Biochem, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	hurley@helix.nih.gov	Ghirlando, Rodolfo/A-8880-2009; Hierro, Aitor/F-9998-2011; Lee, Sangho/P-4204-2018	Hierro, Aitor/0000-0002-7721-1581; Lee, Sangho/0000-0003-3886-4579	NIDDK NIH HHS [Z01 DK036118-12] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036123, Z01DK036123, R01DK036118, Z01DK033007, R37DK036118, Z01DK036118, ZIADK033007] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Amit I, 2004, GENE DEV, V18, P1737, DOI 10.1101/gad.294904; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Bache KG, 2004, MOL BIOL CELL, V15, P4337, DOI 10.1091/mbc.E04-03-0250; Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bilodeau PS, 2003, J CELL BIOL, V163, P237, DOI 10.1083/jcb.200305007; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Bruger AT, 1998, ACTA CRYSTALLOGR D, V54, P905; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Conibear E, 2002, MOL CELL, V10, P215, DOI 10.1016/S1097-2765(02)00601-9; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; Eastman SW, 2005, J BIOL CHEM, V280, P628, DOI 10.1074/jbc.M410384200; Feng GH, 2000, CANCER RES, V60, P1736; Freeman D, 2003, OIL GAS J, V101, P56; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Goila-Gaur R, 2003, J VIROL, V77, P6507, DOI 10.1128/JVI.77.11.6507-6519.2003; Gonzalez A, 1999, ACTA CRYSTALLOGR D, V55, P1449, DOI 10.1107/S0907444999006745; GORDEN P, 1978, P NATL ACAD SCI USA, V75, P5025, DOI 10.1073/pnas.75.10.5025; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; HAIGLER HT, 1979, J CELL BIOL, V81, P382, DOI 10.1083/jcb.81.2.382; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hierro A, 2005, METHOD ENZYMOL, V403, P322, DOI 10.1016/S0076-6879(05)03027-2; Hierro A, 2004, NATURE, V431, P221, DOI 10.1038/nature02914; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; HURLEY JH, 2006, IN PRESS ANN REV BIO; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pommier Y, 2005, TRENDS PHARMACOL SCI, V26, P138, DOI 10.1016/j.tips.2005.01.008; Pornillos O, 2002, NAT STRUCT BIOL, V9, P812, DOI 10.1038/nsb856; Pornillos O, 2003, J CELL BIOL, V162, P425, DOI 10.1083/jcb.200302138; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Scarlata S, 2003, BBA-BIOMEMBRANES, V1614, P62, DOI 10.1016/S0005-2736(03)00163-9; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; Slagsvold T, 2005, J BIOL CHEM, V280, P19600, DOI 10.1074/jbc.M501510200; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Stuchell MD, 2004, J BIOL CHEM, V279, P36059, DOI 10.1074/jbc.M405226200; Sundquist WI, 2004, MOL CELL, V13, P783, DOI 10.1016/S1097-2765(04)00129-7; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Teo H, 2004, J BIOL CHEM, V279, P28689, DOI 10.1074/jbc.M400023200; Teo H, 2004, DEV CELL, V7, P559, DOI 10.1016/j.devcel.2004.09.003; Terwilliger TC, 2004, ACTA CRYSTALLOGR D, V60, P2144, DOI 10.1107/S0907444904019535; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1	60	73	79	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 7	2006	125	1					113	126		10.1016/j.cell.2006.01.049	http://dx.doi.org/10.1016/j.cell.2006.01.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	039NY	16615894	Green Accepted, Bronze			2022-12-24	WOS:000237314200018
